PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Di Bernardo, MC; Crowther-Swanepoel, D; Broderick, P; Webb, E; Sellick, G; Wild, R; Sullivan, K; Vijayakrishnan, J; Wang, YF; Pittman, AM; Sunter, NJ; Hall, AG; Dyer, MJS; Matutes, E; Dearden, C; Mainou-Fowler, T; Jackson, GH; Summerfield, G; Harris, RJ; Pettitt, AR; Hillmen, P; Allsup, DJ; Bailey, JR; Pratt, G; Pepper, C; Fegan, C; Allan, JM; Catovsky, D; Houlston, RS				Di Bernardo, Maria Chiara; Crowther-Swanepoel, Dalemari; Broderick, Peter; Webb, Emily; Sellick, Gabrielle; Wild, Ruth; Sullivan, Kate; Vijayakrishnan, Jayaram; Wang, Yufei; Pittman, Alan M.; Sunter, Nicola J.; Hall, Andrew G.; Dyer, Martin J. S.; Matutes, Estella; Dearden, Claire; Mainou-Fowler, Tryfonia; Jackson, Graham H.; Summerfield, Geoffrey; Harris, Robert J.; Pettitt, Andrew R.; Hillmen, Peter; Allsup, David J.; Bailey, James R.; Pratt, Guy; Pepper, Chris; Fegan, Chris; Allan, James M.; Catovsky, Daniel; Houlston, Richard S.			A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia	NATURE GENETICS			English	Article							CELL DEVELOPMENT; NUCLEAR-BODY; EXPRESSION; FAMILIES; RISK	We conducted a genome-wide association study of 299,983 tagging SNPs for chronic lymphocytic leukemia (CLL) and performed validation in two additional series totaling 1,529 cases and 3,115 controls. We identified six previously unreported CLL risk loci at 2q13 (rs17483466; P = 2.36 x 10(-10)), 2q37.1 (rs13397985, SP140; P = 5.40 x 10(-10)), 6p25.3 (rs872071, IRF4; P = 1.91 x 10(-20)), 11q24.1 (rs735665; P = 3.78 x 10(-12)), 15q23 (rs7176508; P = 4.54 x 10(-12)) and 19q13.32 (rs11083846, PRKD2; P = 3.96 x 10(-9)). These data provide the first evidence for the existence of common, low-penetrance susceptibility to a hematological malignancy and new insights into disease causation in CLL.	[Di Bernardo, Maria Chiara; Crowther-Swanepoel, Dalemari; Broderick, Peter; Webb, Emily; Sellick, Gabrielle; Wild, Ruth; Sullivan, Kate; Vijayakrishnan, Jayaram; Wang, Yufei; Pittman, Alan M.; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; [Sunter, Nicola J.; Hall, Andrew G.; Allan, James M.] Newcastle Univ, No Inst Canc Res, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Dyer, Martin J. S.] Univ Leicester, MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England; [Matutes, Estella; Dearden, Claire; Catovsky, Daniel] Inst Canc Res, Sect Haematooncol, Sutton SM2 5NG, Surrey, England; [Mainou-Fowler, Tryfonia] Newcastle Univ, Sch Med, Newcastle Upon Tyne, Tyne & Wear, England; [Jackson, Graham H.] Royal Victoria Infirm, Dept Haematol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Summerfield, Geoffrey] Queen Elizabeth Hosp, Dept Haematol, Newcastle Upon Tyne NE9 6SX, Tyne & Wear, England; [Harris, Robert J.; Pettitt, Andrew R.] Univ Liverpool, Sch Canc Studies, Div Haematol, Liverpool L69 3BX, Merseyside, England; [Hillmen, Peter] Gen Infirm, Dept Haematol, Leeds LS1 3EX, W Yorkshire, England; [Allsup, David J.] Hull Royal Infirm, Dept Haematol, Kingston Upon Hull HU3 2JZ, N Humberside, England; [Bailey, James R.] Hull York Med Sch, Kingston Upon Hull HU16 5JQ, N Humberside, England; [Bailey, James R.] Univ Hull, Kingston Upon Hull HU16 5JQ, N Humberside, England; [Pratt, Guy] Birmingham Heartlands Hosp, Dept Haematol, Birmingham B9, W Midlands, England; [Pepper, Chris] Cardiff Univ, Sch Med, Dept Haematol, Cardiff, S Glam, Wales; [Fegan, Chris] Cardiff & Vale NHS Trust, Cardiff CF14 4XW, S Glam, Wales	University of London; Institute of Cancer Research - UK; Newcastle University - UK; University of Leicester; University of London; Institute of Cancer Research - UK; Newcastle University - UK; Newcastle University - UK; University of Liverpool; Leeds General Infirmary; University of Hull; University of Hull; University of York - UK; University of Hull; Heart of England NHS Foundation Trust; Cardiff University; Cardiff University	Houlston, RS (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England.	richard.houlston@icr.ac.uk	Pittman, Alan M/D-6231-2012; Allsup, David/H-2195-2017; Hall, Andy/AAD-8622-2020; Jackson, Graham/GMW-7638-2022; Hall, Andrew G/B-3485-2009; Pepper, Chris/B-4357-2009; Pittman, Alan/AAP-2534-2020; Allan, James/B-4448-2009; Dyer, Martin/F-2691-2014	Pittman, Alan M/0000-0002-8112-2987; Allsup, David/0000-0001-6159-6109; Jackson, Graham/0000-0003-0756-969X; Pittman, Alan/0000-0002-8112-2987; Broderick, Peter/0000-0002-8348-5829; Houlston, Richard/0000-0002-5268-0242; Allan, James/0000-0002-7580-5087; Vijayakrishnan, Jayaram/0000-0002-8284-2249; Dyer, Martin/0000-0002-5033-2236; Pepper, Chris/0000-0003-3603-8839; Webb, Emily/0000-0002-4019-7456	Leukaemia Research Fund (LRF) [LRF05001 and 06002]; CLL Global Research Foundation, Cancer Research UK; Bobby Moore Fund [C1298/A8362]; European Union [CPRB LSHC-CT-2004-503465]; MRC [G0000934, MC_U132670597] Funding Source: UKRI; Medical Research Council [G0000934, MC_U132670597] Funding Source: researchfish	Leukaemia Research Fund (LRF); CLL Global Research Foundation, Cancer Research UK(Cancer Research UK); Bobby Moore Fund; European Union(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Leukaemia Research Fund (LRF) provided principal funding for the study (LRF05001 and 06002). Additional funding was provided by CLL Global Research Foundation, Cancer Research UK (C1298/A8362 supported by the Bobby Moore Fund), the Arbib fund and the European Union (CPRB LSHC-CT-2004-503465). D. C.-S. was in receipt of a PhD studentship from the Institute of Cancer Research. We are grateful to M. Yuille for input into our early work on familial CLL. This study made use of genotyping data on the 1958 Birth Cohort. Genotyping data on controls was generated and generously supplied to us by P. Deloukas of the Wellcome Trust Sanger Institute. A full list of the investigators who contributed to the generation of the data are available from http:// www. wtccc. org. uk. We are grateful to all investigators who contributed to the study of acute leukemia, from which phase 3 controls were drawn, to members of the ICLLLC (Supplementary Note online) and to investigators who contributed to NSCCG and GELCAPS, from which phase 1 and 2 controls were drawn. Finally, we are grateful to all the study subjects for their participation.	Allan JM, 2001, P NATL ACAD SCI USA, V98, P11592, DOI 10.1073/pnas.191211198; Bloch DB, 1996, J BIOL CHEM, V271, P29198, DOI 10.1074/jbc.271.46.29198; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Catovsky D, 2007, LANCET, V370, P230, DOI 10.1016/S0140-6736(07)61125-8; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Damle RN, 1999, BLOOD, V94, P1840, DOI 10.1182/blood.V94.6.1840; Dent AL, 1996, BLOOD, V88, P1423, DOI 10.1182/blood.V88.4.1423.bloodjournal8841423; Goldin LR, 2004, BLOOD, V104, P1850, DOI 10.1182/blood-2004-01-0341; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Klein U, 2008, NAT REV IMMUNOL, V8, P22, DOI 10.1038/nri2217; Kovalevska L. M., 2006, Experimental Oncology, V28, P225; Ling PD, 2005, EMBO J, V24, P3565, DOI 10.1038/sj.emboj.7600820; Madani N, 2002, J VIROL, V76, P11133, DOI 10.1128/JVI.76.21.11133-11138.2002; Oliver PM, 2004, J EXP MED, V200, P1179, DOI 10.1084/jem.20041129; Petitti D, 1994, METAANALYSIS DECISIO; Pfeifer D, 2007, BLOOD, V109, P1202, DOI 10.1182/blood-2006-07-034256; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Sayala HA, 2006, BLOOD, V108, p14A, DOI 10.1182/blood.V108.11.34.34; Sellick GS, 2007, BLOOD, V110, P3326, DOI 10.1182/blood-2007-05-091561; Sellick GS, 2006, SEMIN ONCOL, V33, P195, DOI 10.1053/j.seminoncol.2006.01.013; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; van Krieken JHJM, 2007, LEUKEMIA, V21, P201, DOI 10.1038/sj.leu.2404467; Weiss N S, 1979, Natl Cancer Inst Monogr, P139	28	274	281	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2008	40	10					1204	1210		10.1038/ng.219	http://dx.doi.org/10.1038/ng.219			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18758461				2022-12-27	WOS:000259651000020
J	Muller, T; Hess, MW; Schiefermeier, N; Pfaller, K; Ebner, HL; Heinz-Erian, P; Ponstingl, H; Partsch, J; Rollinghoff, B; Kohler, H; Berger, T; Lenhartz, H; Schlenck, B; Houwen, RJ; Taylor, CJ; Zoller, H; Lechner, S; Goulet, O; Utermann, G; Ruemmele, FM; Huber, LA; Janecke, AR				Mueller, Thomas; Hess, Michael W.; Schiefermeier, Natalia; Pfaller, Kristian; Ebner, Hannes L.; Heinz-Erian, Peter; Ponstingl, Hannes; Partsch, Joachim; Roellinghoff, Barbara; Koehler, Henrik; Berger, Thomas; Lenhartz, Henning; Schlenck, Barbara; Houwen, Roderick J.; Taylor, Christopher J.; Zoller, Heinz; Lechner, Silvia; Goulet, Olivier; Utermann, Gerd; Ruemmele, Frank M.; Huber, Lukas A.; Janecke, Andreas R.			MYO5B mutations cause microvillus inclusion disease and disrupt epithelial cell polarity	NATURE GENETICS			English	Article							MEMBRANE-PROTEIN; APICAL MEMBRANE; PLASMA-MEMBRANE; MYOSIN-VB; ATROPHY; RAB8	Following homozygosity mapping in a single kindred, we identified nonsense and missense mutations in MYO5B, encoding type Vb myosin motor protein, in individuals with microvillus inclusion disease (MVID). MVID is characterized by lack of microvilli on the surface of enterocytes and occurrence of intracellular vacuolar structures containing microvilli. In addition, mislocalization of transferrin receptor in MVID enterocytes suggests that MYO5B deficiency causes defective trafficking of apical and basolateral proteins in MVID.	[Lechner, Silvia; Utermann, Gerd; Janecke, Andreas R.] Innsbruck Med Univ, Div Clin Genet, A-6020 Innsbruck, Austria; [Mueller, Thomas; Heinz-Erian, Peter] Innsbruck Med Univ, Dept Pediat 2, A-6020 Innsbruck, Austria; [Hess, Michael W.; Pfaller, Kristian; Ebner, Hannes L.] Innsbruck Med Univ, Div Histol & Embryol, A-6020 Innsbruck, Austria; [Schiefermeier, Natalia; Huber, Lukas A.] Innsbruck Med Univ, Div Cell Biol, Bioctr, A-6020 Innsbruck, Austria; [Ponstingl, Hannes] Sanger Inst, Wellcome Trust, Sequencing Informat Div, Cambridge CB10 1SA, England; [Partsch, Joachim; Roellinghoff, Barbara] Childrens Hosp Esslingen, D-73730 Esslingen, Germany; [Koehler, Henrik] Univ Erlangen Nurnberg, Dept Pediat, D-91054 Erlangen, Germany; [Berger, Thomas] Univ Witten Herdecke, Dept Pediat, D-45711 Datteln, Germany; [Lenhartz, Henning] Childrens Hosp Wilhelmstift, D-22194 Hamburg, Germany; [Schlenck, Barbara] Innsbruck Med Univ, Div Pediat Urol, A-6020 Innsbruck, Austria; [Houwen, Roderick J.] Wilhelmina Childrens Hosp, NL-3508 AB Utrecht, Netherlands; [Taylor, Christopher J.] Univ Sheffield, Dept Child Hlth, Sheffield S10 2TH, S Yorkshire, England; [Zoller, Heinz] Innsbruck Med Univ, Clin Div Gastroenterol & Hepatol, A-6020 Innsbruck, Austria; [Lechner, Silvia] Univ Hlth Sci Med Informat & Technol, Inst Appl Syst Res & Dev, A-6060 Hall In Tirol, Austria; [Goulet, Olivier; Ruemmele, Frank M.] Univ Paris 05, AP HP, Inst Natl Sante Rech Med,INSERM U 793, Fac Necker,Dept Pediat,Serv Gastroenterol Pediat, F-75743 Paris, France	Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Medical University of Innsbruck; Wellcome Trust Sanger Institute; University of Erlangen Nuremberg; Witten Herdecke University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Medical University of Innsbruck; Wilhelmina Kinderziekenhuis; University of Sheffield; Medical University of Innsbruck; Assistance Publique Hopitaux Paris (APHP); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Janecke, AR (corresponding author), Innsbruck Med Univ, Div Clin Genet, A-6020 Innsbruck, Austria.	Andreas.Janecke@i-med.ac.at	Janecke, Andreas/AAA-5227-2019; Zoller, Heinz/AAD-7225-2019; Berger, Thomas/AAY-8488-2020; Hess, Michael/AAE-1985-2019; Schiefermeier-Mach, Natalia/AAW-6428-2021; Huber, Lukas Alfons/AAM-3499-2021	Hess, Michael/0000-0002-5154-3553; Schiefermeier-Mach, Natalia/0000-0001-6638-5298; Huber, Lukas Alfons/0000-0003-1116-2120; Janecke, Andreas/0000-0001-7155-0315	Austrian Science Funds (FWF) [P18470, SFB021, P19486-B12]; Jubilaumsfonds [P-11050]; TILAK-Universitartskliniken	Austrian Science Funds (FWF)(Austrian Science Fund (FWF)); Jubilaumsfonds; TILAK-Universitartskliniken	We thank S. Steiner, V. Wild, K. Gutleben, A. Florl, T. Erdel and D. Hilber for technical assistance. The work was supported by the Austrian Science Funds (FWF), grants P18470 to A. R.J., SFB021 to L. A. H., P19486-B12 to M. W. H., Jubilaumsfonds grant P-11050 and support from TILAK-Universitartskliniken to M. W. H., a Dr.-Legerlotz-Stiftung grant to A. R. J. and a grant by Raiffeisen Landesbank-Tirol AG to T. M.	Ameen NA, 2000, TRAFFIC, V1, P76, DOI 10.1034/j.1600-0854.2000.010111.x; CARRUTHERS L, 1985, J PEDIATR GASTR NUTR, V4, P902, DOI 10.1097/00005176-198512000-00009; GILBERT T, 1991, J CELL SCI, V100, P451; HUBER LA, 1993, J CELL BIOL, V123, P35, DOI 10.1083/jcb.123.1.35; Menasche G, 2003, J CLIN INVEST, V112, P450, DOI 10.1172/JCI200318264; MERCER JA, 1991, NATURE, V349, P709, DOI 10.1038/349709a0; Reinshagen K, 2002, GUT, V51, P514, DOI 10.1136/gut.51.4.514; Rodriguez OC, 2002, J CELL SCI, V115, P991; Roland JT, 2007, MOL BIOL CELL, V18, P2828, DOI 10.1091/mbc.E07-02-0169; Ruemmele FM, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-22; Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929; Sharma N, 2005, BIOCHEM J, V390, P437, DOI 10.1042/BJ20050256; Tako E, 2008, BRIT J NUTR, V99, P472, DOI 10.1017/S0007114507825128; Wakabayashi Y, 2005, P NATL ACAD SCI USA, V102, P15087, DOI 10.1073/pnas.0503702102; Wang EX, 2001, J CELL SCI, V114, P3309	15	240	250	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2008	40	10					1163	1165		10.1038/ng.225	http://dx.doi.org/10.1038/ng.225			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18724368				2022-12-27	WOS:000259651000014
J	Xu, B; Roos, JL; Levy, S; Van Rensburg, EJ; Gogos, JA; Karayiorgou, M				Xu, Bin; Roos, J. Louw; Levy, Shawn; Van Rensburg, E. J.; Gogos, Joseph A.; Karayiorgou, Maria			Strong association of de novo copy number mutations with sporadic schizophrenia	NATURE GENETICS			English	Article							CARDIO-FACIAL SYNDROME; BIPOLAR DISORDER; GENES; CITRON; SUSCEPTIBILITY; REARRANGEMENTS; METAANALYSIS; BIOGENESIS; PATHWAYS; DELETION	Schizophrenia is an etiologically heterogeneous psychiatric disease, which exists in familial and nonfamilial (sporadic) forms(1). Here, we examine the possibility that rare de novo copy number (CN) mutations with relatively high penetrance contribute to the genetic component of schizophrenia. We carried out a whole-genome scan and implemented a number of steps for finding and confirming CN mutations. Confirmed de novo mutations were significantly associated with schizophrenia (P = 0.00078) and were collectively similar to 8 times more frequent in sporadic (but not familial) cases with schizophrenia than in unaffected controls. In comparison, rare inherited CN mutations were only modestly enriched in sporadic cases. Our results suggest that rare de novo germline mutations contribute to schizophrenia vulnerability in sporadic cases and that rare genetic lesions at many different loci can account, at least in part, for the genetic heterogeneity of this disease.	[Xu, Bin; Gogos, Joseph A.] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Xu, Bin; Karayiorgou, Maria] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Roos, J. Louw] Weskoppies Hosp, ZA-0001 Pretoria, South Africa; [Levy, Shawn] Vanderbilt Univ, Nashville, TN 37232 USA; [Van Rensburg, E. J.] Univ Pretoria, Dept Genet, ZA-0001 Pretoria, South Africa; [Gogos, Joseph A.] Columbia Univ, Dept Neurosci, New York, NY 10032 USA	Columbia University; Columbia University; Vanderbilt University; University of Pretoria; Columbia University	Gogos, JA (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, 630 W 168th St, New York, NY 10032 USA.	jag90@columbia.edu; mk2758@columbia.edu	van Rensburg, Elizabeth J./B-9104-2011	van Rensburg, Elizabeth/0000-0003-2077-230X; Levy, Shawn/0000-0002-1369-5740; Roos, Johannes/0000-0002-0572-1072	NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061399, R01MH077235] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA68485] Funding Source: Medline; NEI NIH HHS [P30 EY08126] Funding Source: Medline; NIMH NIH HHS [MH077235, MH061399] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abecasis GR, 2004, AM J HUM GENET, V74, P403, DOI 10.1086/381713; Bennett RL, 1997, AM J HUM GENET, V61, P1450, DOI 10.1086/301634; Chen XN, 2006, HUM MOL GENET, V15, P3329, DOI 10.1093/hmg/ddl409; Di Cunto F, 2000, NEURON, V28, P115, DOI 10.1016/S0896-6273(00)00090-8; Furuyashiki T, 1999, J NEUROSCI, V19, P109, DOI 10.1523/JNEUROSCI.19-01-00109.1999; Gottesman I.I., 1991, SCHIZOPHRENIA GENESI; GOTTESMAN II, 1967, P NATL ACAD SCI USA, V58, P199, DOI 10.1073/pnas.58.1.199; Karayiorgou M, 2006, EUR J HUM GENET, V14, P512, DOI 10.1038/sj.ejhg.5201587; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006; Kuiperij HB, 2003, BBA-MOL CELL RES, V1593, P141, DOI 10.1016/S0167-4889(02)00365-8; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu H, 2002, P NATL ACAD SCI USA, V99, P16859, DOI 10.1073/pnas.232186099; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; Lyons-Warren A, 2005, MOL PSYCHIATR, V10, P807, DOI 10.1038/sj.mp.4001703; MacIntyre D, 2003, MOL PSYCHIATR, V8, P275, DOI 10.1038/sj.mp.4001232; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Murchison EP, 2004, CURR OPIN CELL BIOL, V16, P223, DOI 10.1016/j.ceb.2004.04.003; Murphy KC, 1999, ARCH GEN PSYCHIAT, V56, P940, DOI 10.1001/archpsyc.56.10.940; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Stark KL, 2008, NAT GENET, V40, P751, DOI 10.1038/ng.138; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wiehahn GJ, 2004, AM J MED GENET B, V129B, P20, DOI 10.1002/ajmg.b.20168; Yue Y, 1999, J NEUROSCI, V19, P2090	30	617	642	1	36	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					880	885		10.1038/ng.162	http://dx.doi.org/10.1038/ng.162			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18511947				2022-12-27	WOS:000257166500023
J	Xue, WY; Xing, YZ; Weng, XY; Zhao, Y; Tang, WJ; Wang, L; Zhou, HJ; Yu, SB; Xu, CG; Li, XH; Zhang, QF				Xue, Weiya; Xing, Yongzhong; Weng, Xiaoyu; Zhao, Yu; Tang, Weijiang; Wang, Lei; Zhou, Hongju; Yu, Sibin; Xu, Caiguo; Li, Xianghua; Zhang, Qifa			Natural variation in Ghd7 is an important regulator of heading date and yield potential in rice	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; TIME GENE CONSTANS; RESPONSE REGULATOR; FLOWERING-TIME; PHOTOPERIOD SENSITIVITY; FLORAL INDUCTION; ALPHA-SUBUNIT; PLANT HEIGHT; ORYZA-SATIVA; GRAIN WIDTH	Yield potential, plant height and heading date are three classes of traits that determine the productivity of many crop plants. Here we show that the quantitative trait locus (QTL) Ghd7, isolated from an elite rice hybrid and encoding a CCT domain protein, has major effects on an array of traits in rice, including number of grains per panicle, plant height and heading date. Enhanced expression of Ghd7 under long-day conditions delays heading and increases plant height and panicle size. Natural mutants with reduced function enable rice to be cultivated in temperate and cooler regions. Thus, Ghd7 has played crucial roles for increasing productivity and adaptability of rice globally.	[Xue, Weiya; Xing, Yongzhong; Weng, Xiaoyu; Zhao, Yu; Tang, Weijiang; Wang, Lei; Zhou, Hongju; Yu, Sibin; Xu, Caiguo; Li, Xianghua; Zhang, Qifa] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Natl Ctr Plant Gene Res Wuhan, Wuhan 430070, Peoples R China	Huazhong Agricultural University	Zhang, QF (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Natl Ctr Plant Gene Res Wuhan, Wuhan 430070, Peoples R China.	qifazh@mail.hzau.edu.cn	Weng, Xiaoyu/J-4899-2019; xue, weiya/L-5834-2015	weng, xiaoyu/0000-0002-3831-7551; , sibin/0000-0003-0458-7526; Xing, Yongzhong/0000-0003-1376-1514				Abe M, 2005, SCIENCE, V309, P1052, DOI 10.1126/science.1115983; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Ashikari M, 1999, P NATL ACAD SCI USA, V96, P10284, DOI 10.1073/pnas.96.18.10284; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; DEBLOCK M, 1993, ANAL BIOCHEM, V215, P86, DOI 10.1006/abio.1993.1558; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; Dubcovsky J, 2006, PLANT MOL BIOL, V60, P469, DOI 10.1007/s11103-005-4814-2; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Griffiths S, 2003, PLANT PHYSIOL, V131, P1855, DOI 10.1104/pp.102.016188; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Hua JP, 2003, P NATL ACAD SCI USA, V100, P2574, DOI 10.1073/pnas.0437907100; Hua JP, 2002, GENETICS, V162, P1885; Itoh H, 2004, PLANT MOL BIOL, V54, P533, DOI 10.1023/B:PLAN.0000038261.21060.47; Kaczorowski KA, 2003, PLANT CELL, V15, P2654, DOI 10.1105/tpc.015065; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; Li JX, 2000, THEOR APPL GENET, V101, P248, DOI 10.1007/s001220051476; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Murakami M, 2007, PLANT CELL PHYSIOL, V48, P110, DOI 10.1093/pcp/pcl043; Oka H. I., 1988, Origin of cultivated rice.; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Peng KM, 1998, ACTA BOT SIN, V40, P1108; PUTTERILL J, 1995, CELL, V80, P847, DOI 10.1016/0092-8674(95)90288-0; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Salome PA, 2006, PLANT CELL, V18, P55, DOI 10.1105/tpc.105.037994; Simpson GG, 2002, SCIENCE, V296, P285, DOI 10.1126/science.296.5566.285; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Spielmeyer W, 2002, P NATL ACAD SCI USA, V99, P9043, DOI 10.1073/pnas.132266399; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; Tamaki S, 2007, SCIENCE, V316, P1033, DOI 10.1126/science.1141753; Trevaskis B, 2006, PLANT PHYSIOL, V140, P1397, DOI 10.1104/pp.105.073486; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; Wenkel S, 2006, PLANT CELL, V18, P2971, DOI 10.1105/tpc.106.043299; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Xing YZ, 2002, THEOR APPL GENET, V105, P248, DOI 10.1007/s00122-002-0952-y; Xing YZ, 2001, ACTA BOT SIN, V43, P721; Yan LL, 2004, SCIENCE, V303, P1640, DOI 10.1126/science.1094305; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yu SB, 2002, THEOR APPL GENET, V104, P619, DOI 10.1007/s00122-001-0772-5; Yu SB, 1997, P NATL ACAD SCI USA, V94, P9226, DOI 10.1073/pnas.94.17.9226	44	1023	1267	23	418	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2008	40	6					761	767		10.1038/ng.143	http://dx.doi.org/10.1038/ng.143			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18454147				2022-12-27	WOS:000256212000018
J	Qiu, W; Hu, M; Sridhar, A; Opeskin, K; Fox, S; Shipitsin, M; Trivett, M; Thompson, ER; Ramakrishna, M; Gorringe, KL; Polyak, K; Haviv, I; Campbell, IG				Qiu, Wen; Hu, Min; Sridhar, Anita; Opeskin, Ken; Fox, Stephen; Shipitsin, Michail; Trivett, Melanie; Thompson, Ella R.; Ramakrishna, Manasa; Gorringe, Kylie L.; Polyak, Kornelia; Haviv, Izhak; Campbell, Ian G.			No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas	NATURE GENETICS			English	Article							STROMAL CELLS; TUMOR STROMA; MUTATIONS; HETEROZYGOSITY; INSTABILITY; PCR	There is increasing evidence showing that the stromal cells surrounding cancer epithelial cells, rather than being passive bystanders, might have a role in modifying tumor outgrowth. The molecular basis of this aspect of carcinoma etiology is controversial. Some studies have reported a high frequency of genetic aberrations in carcinoma-associated fibroblasts (CAFs), whereas other studies have reported very low or zero mutation rates. Resolution of this contentious area is of critical importance in terms of understanding both the basic biology of cancer as well as the potential clinical implications of CAF somatic alterations. We undertook genome-wide copy number and loss of heterozygosity (LOH) analysis of CAFs derived from breast and ovarian carcinomas using a 500K SNP array platform. Our data show conclusively that LOH and copy number alterations are extremely rare in CAFs and cannot be the basis of the carcinoma-promoting phenotypes of breast and ovarian CAFs.	[Qiu, Wen; Sridhar, Anita; Thompson, Ella R.; Ramakrishna, Manasa; Gorringe, Kylie L.; Campbell, Ian G.] Peter MacCallum Canc Ctr, VBCRC Canc Genet Lab, Melbourne, Vic 3002, Australia; [Qiu, Wen; Haviv, Izhak] Univ Melbourne, Dept Biochem, Melbourne, Vic 3010, Australia; [Hu, Min; Shipitsin, Michail; Polyak, Kornelia] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Hu, Min; Shipitsin, Michail; Polyak, Kornelia] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Opeskin, Ken] St Vincents Hosp, Dept Pathol, Fitzroy, Vic 3065, Australia; [Opeskin, Ken; Thompson, Ella R.; Ramakrishna, Manasa; Campbell, Ian G.] Univ Melbourne, Dept Pathol, Melbourne, Vic 3010, Australia; [Fox, Stephen; Trivett, Melanie] Peter MacCallum Canc Ctr, Dept Pathol, Melbourne, Vic 3002, Australia; [Haviv, Izhak] Peter MacCallum Canc Ctr, Canc Cell Biol Lab, Melbourne, Vic 3002, Australia	Peter Maccallum Cancer Center; University of Melbourne; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; St Vincent's Hospital Melbourne; University of Melbourne; Peter Maccallum Cancer Center; Peter Maccallum Cancer Center	Campbell, IG (corresponding author), Peter MacCallum Canc Ctr, VBCRC Canc Genet Lab, Melbourne, Vic 3002, Australia.	ian.campbell@petermac.org	Gorringe, Kylie L/H-3264-2019; campbell, Ian G/F-6006-2011; Haviv, Izhak/E-3782-2015; Fox, Stephen/G-9719-2016	Gorringe, Kylie L/0000-0001-5681-2022; Haviv, Izhak/0000-0002-0837-5005; Fox, Stephen/0000-0002-7648-8896; Campbell, Ian/0000-0002-7773-4155; Thompson, Ella/0000-0001-5206-5111	NATIONAL CANCER INSTITUTE [R01CA116235, P50CA089393, R01CA094074] Funding Source: NIH RePORTER; NCI NIH HHS [CA116235, R01 CA116235-01A1, R01 CA094074, R01 CA094074-05, P50 CA089393, R01 CA116235-03, R01 CA116235-02, R01 CA116235, P50 CA089393-080014] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Fiegl H, 2006, CANCER RES, V66, P29, DOI 10.1158/0008-5472.CAN-05-2508; Fukino K, 2004, CANCER RES, V64, P7231, DOI 10.1158/0008-5472.CAN-04-2866; Fukino K, 2007, JAMA-J AM MED ASSOC, V297, P2103, DOI 10.1001/jama.297.19.2103; Gorringe KL, 2007, CLIN CANCER RES, V13, P4731, DOI 10.1158/1078-0432.CCR-07-0502; Grum-Schwensen B, 2005, CANCER RES, V65, P3772, DOI 10.1158/0008-5472.CAN-04-4510; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Huang Jing, 2004, Human Genomics, V1, P287; Jiang XX, 1996, CANCER RES, V56, P3534; Kern SE, 2006, CANCER BIOL THER, V5, P349, DOI 10.4161/cbt.5.4.2551; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Kurose K, 2002, NAT GENET, V32, P355, DOI 10.1038/ng1013; Lebret SC, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1656; Littlepage LE, 2005, CANCER CELL, V7, P499, DOI 10.1016/j.ccr.2005.05.019; Macintosh CA, 1998, CANCER RES, V58, P23; Maffini MV, 2004, J CELL SCI, V117, P1495, DOI 10.1242/jcs.01000; Matsumoto N, 2003, CANCER RES, V63, P6158; Moinfar F, 2000, CANCER RES, V60, P2562; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Orimo A, 2006, CELL CYCLE, V5, P1597, DOI 10.4161/cc.5.15.3112; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Sieben NLG, 2000, HUM PATHOL, V31, P1414, DOI 10.1053/hupa.2000.20381; Tuhkanen H, 2004, INT J CANCER, V109, P247, DOI 10.1002/ijc.11733; Tuhkanen H, 2006, INT J CANCER, V119, P1345, DOI 10.1002/ijc.21785; Weber F, 2006, AM J HUM GENET, V78, P961, DOI 10.1086/504090; Winter JM, 2006, CANCER BIOL THER, V5, P360, DOI 10.4161/cbt.5.4.2552; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809	30	224	228	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					650	655		10.1038/ng.117	http://dx.doi.org/10.1038/ng.117			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18408720	Green Accepted			2022-12-27	WOS:000255366700035
J	Thomas, G; Jacobs, KB; Yeager, M; Kraft, P; Wacholder, S; Orr, N; Yu, K; Chatterjee, N; Welch, R; Hutchinson, A; Crenshaw, A; Cancel-Tassin, G; Staats, BJ; Wang, Z; Gonzalez-Bosquet, J; Fang, J; Deng, X; Berndt, SI; Calle, EE; Feigelson, HS; Thun, MJ; Rodriguez, C; Albanes, D; Virtamo, J; Weinstein, S; Schumacher, FR; Giovannucci, E; Willett, WC; Cussenot, O; Valeri, A; Andriole, GL; Crawford, ED; Tucker, M; Gerhard, DS; Fraumeni, JF; Hoover, R; Hayes, RB; Hunter, DJ; Chanock, SJ				Thomas, Gilles; Jacobs, Kevin B.; Yeager, Meredith; Kraft, Peter; Wacholder, Sholom; Orr, Nick; Yu, Kai; Chatterjee, Nilanjan; Welch, Robert; Hutchinson, Amy; Crenshaw, Andrew; Cancel-Tassin, Geraldine; Staats, Brian J.; Wang, Zhaoming; Gonzalez-Bosquet, Jesus; Fang, Jun; Deng, Xiang; Berndt, Sonja I.; Calle, Eugenia E.; Feigelson, Heather Spencer; Thun, Michael J.; Rodriguez, Carmen; Albanes, Demetrius; Virtamo, Jarmo; Weinstein, Stephanie; Schumacher, Fredrick R.; Giovannucci, Edward; Willett, Walter C.; Cussenot, Olivier; Valeri, Antoine; Andriole, Gerald L.; Crawford, E. David; Tucker, Margaret; Gerhard, Daniela S.; Fraumeni, Joseph F., Jr.; Hoover, Robert; Hayes, Richard B.; Hunter, David J.; Chanock, Stephen J.			Multiple loci identified in a genome-wide association study of prostate cancer	NATURE GENETICS			English	Article							94 AMINO-ACIDS; SECRETORY PROTEIN; BINDING-PROTEIN; GENE; SUSCEPTIBILITY; VARIANTS; RISK	We followed our initial genome-wide association study (GWAS) of 527,869 SNPs on 1,172 individuals with prostate cancer and 1,157 controls of European origin-nested in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial prospective study-by testing 26,958 SNPs in four independent studies (total of 3,941 cases and 3,964 controls). In the combined joint analysis, we confirmed three previously reported loci (two independent SNPs at 8q24 and one in HNF1B (formerly known as TCF2 on 17q); P < 10(-10)). In addition, loci on chromosomes 7, 10 (two loci) and 11 were highly significant (between P < 7.31 x 10(-13) and P < 2.14 x 10(-6)). Loci on chromosome 10 include MSMB, which encodes beta-microseminoprotein, a primary constituent of semen and a proposed prostate cancer biomarker, and CTBP2, a gene with antiapoptotic activity; the locus on chromosome 7 is at JAZF1, a transcriptional repressor that is fused by chromosome translocation to SUZ12 in endometrial cancer. Of the nine loci that showed highly suggestive associations (P < 2.5 x 10(-5)), four best fit a recessive model and included candidate susceptibility genes: CPNE3, IL16 and CDH13. Our findings point to multiple loci with moderate effects associated with susceptibility to prostate cancer that, taken together, in the future may predict high risk in select individuals.	[Thomas, Gilles; Yeager, Meredith; Wacholder, Sholom; Orr, Nick; Yu, Kai; Chatterjee, Nilanjan; Welch, Robert; Hutchinson, Amy; Crenshaw, Andrew; Staats, Brian J.; Wang, Zhaoming; Gonzalez-Bosquet, Jesus; Fang, Jun; Deng, Xiang; Berndt, Sonja I.; Albanes, Demetrius; Weinstein, Stephanie; Tucker, Margaret; Fraumeni, Joseph F., Jr.; Hoover, Robert; Hayes, Richard B.; Hunter, David J.; Chanock, Stephen J.] NCI, NIH, Dept Hlth & Human Serv, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Jacobs, Kevin B.] Bioinformed Consulting Serv, Gaithersburg, MD 20877 USA; [Yeager, Meredith; Welch, Robert; Hutchinson, Amy; Crenshaw, Andrew; Staats, Brian J.; Wang, Zhaoming; Deng, Xiang] NCI Frederick, SAIC Frederick Inc, Adv Technol Program, Core Genotyping Facil, Frederick, MD 21702 USA; [Kraft, Peter; Schumacher, Fredrick R.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Calle, Eugenia E.; Feigelson, Heather Spencer; Thun, Michael J.; Rodriguez, Carmen] Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA; [Virtamo, Jarmo] Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, FIN-0030 Helsinki, Finland; [Thomas, Gilles; Giovannucci, Edward; Willett, Walter C.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Andriole, Gerald L.] Washington Univ, Sch Med, Div Urol Surg, St Louis, MO 63108 USA; [Crawford, E. David] Univ Colorado, Hlth Sci Ctr, Dept Surg, Denver, CO 80014 USA; [Gerhard, Daniela S.] NCI, NIH, Dept Hlth & Human Serv, Ctr Canc Res,Off Canc Genom, Bethesda, MD 20892 USA; [Chanock, Stephen J.] NCI, NIH, Dept Hlth & Human Serv, Ctr Canc Res,Pediat Oncol Branch, Bethesda, MD 20892 USA; [Cancel-Tassin, Geraldine; Cussenot, Olivier; Valeri, Antoine] CeRePP Hop Tenon, AP HP, F-75970 Paris, France	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Harvard University; Harvard T.H. Chan School of Public Health; American Cancer Society; Finland National Institute for Health & Welfare; Harvard University; Harvard T.H. Chan School of Public Health; Washington University (WUSTL); University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Chanock, SJ (corresponding author), NCI, NIH, Dept Hlth & Human Serv, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	chanocks@mail.nih.gov	Berndt, Sonja I/J-8423-2016; Yeager, Meredith/AAA-5322-2020; Schumacher, Fredrick/R-6043-2019; Albanes, Demetrius/B-9749-2015; Weinstein, Stephanie J/P-1627-2017; Tucker, Margaret A/B-4297-2015; Wang, Zhaoming/R-5527-2018	Schumacher, Fredrick/0000-0002-3073-7463; Weinstein, Stephanie J/0000-0002-3834-1535; Wang, Zhaoming/0000-0001-7556-3869; Hayes, Richard/0000-0002-0918-661X; cussenot, olivier/0000-0002-9912-0533; Cancel-Tassin, Geraldine/0000-0002-9583-6382; Staats, Brian/0000-0002-3818-3792; Gonzalez Bosquet, Jesus/0000-0002-2079-4528	DIVISION OF CANCER PREVENTION AND CONTROL [N01CN045165] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA098233, Z01CP010178, T32CA009001, U01CA098710] Funding Source: NIH RePORTER; Direct For Biological Sciences [0820821] Funding Source: National Science Foundation; Div Of Molecular and Cellular Bioscience [0821096, 1021718] Funding Source: National Science Foundation; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [T32 CA 09001, U01 CA098710, CA55075, N01-CN-45165, U01CA098233, N01-CO-12400] Funding Source: Medline; CCR NIH HHS [N01-RC-37004, N01-RC-45035] Funding Source: Medline	DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); CCR NIH HHS		Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; *ATBC CANC PREV ST, 1994, ANN EPIDEMIOL, V4, P1; Beke L, 2007, ONCOGENE, V26, P4590, DOI 10.1038/sj.onc.1210248; Buckland PR, 2005, HUM MUTAT, V26, P214, DOI 10.1002/humu.20207; Calle EE, 2002, CANCER-AM CANCER SOC, V94, P2490, DOI 10.1002/cncr.101970; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chen YC, 2005, CANCER RES, V65, P11771, DOI 10.1158/0008-5472.CAN-05-2078; Crawford ED, 2003, UROLOGY, V62, P3, DOI 10.1016/j.urology.2003.10.013; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Gimm O, 2001, J CLIN ENDOCR METAB, V86, P1801, DOI 10.1210/jc.86.4.1801; Gohagan JK, 2000, CONTROL CLIN TRIALS, V21, p251S, DOI 10.1016/S0197-2456(00)00097-0; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Janssen JWG, 2000, BLOOD, V95, P2691; Koontz JI, 2001, P NATL ACAD SCI USA, V98, P6348, DOI 10.1073/pnas.101132598; Nam RK, 2006, J UROLOGY, V175, P1291, DOI 10.1016/S0022-5347(05)00695-6; Paliwal S, 2007, CANCER RES, V67, P9322, DOI 10.1158/0008-5472.CAN-07-1743; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Reeves JR, 2006, CLIN CANCER RES, V12, P6018, DOI 10.1158/1078-0432.CCR-06-0625; Schaid DJ, 2004, HUM MOL GENET, V13, pR103, DOI 10.1093/hmg/ddh072; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Valeri A, 2003, ANN HUM GENET, V67, P125, DOI 10.1046/j.1469-1809.2003.00022.x; Wang XD, 2007, DIFFERENTIATION, V75, P219, DOI 10.1111/j.1432-0436.2006.00135.x; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	30	736	775	0	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2008	40	3					310	315		10.1038/ng.91	http://dx.doi.org/10.1038/ng.91			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18264096	Green Published			2022-12-27	WOS:000253548400021
J	Franklin, KA; Whitelam, GC				Franklin, Keara A.; Whitelam, Garry C.			Light-quality regulation of freezing tolerance in Arabidopsis thaliana	NATURE GENETICS			English	Article							LOW-TEMPERATURE INDUCTION; CIRCADIAN CLOCK; GENE-EXPRESSION; FLOWERING TIME; ABSCISIC-ACID; TRANSCRIPTIONAL ACTIVATORS; PHYTOCHROME-A; RESPONSES; CBF2; MUTANTS	To acquire freezing tolerance, higher plants require a period of low temperature ( usually < 4 degrees C) termed cold acclimation. Upon transfer of plants to low temperature, increased expression of the (C) under bar RT/ DRE (b) under bar inding (f) under bar actor (CBF) family of transcriptional activators leads to the upregulation of genes containing a C-repeat/drought-responsive (CRT/DRE) promoter element and metabolic changes that enhance tolerance to subzero temperatures(1). Here, we show that a low red to farred ratio (R/FR) light signal increases CBF gene expression in Arabidopsis thaliana in a manner dependent on the circadian clock. This light quality-dependent increase in CBF expression is sufficient to confer freezing tolerance at temperatures higher than those required for cold acclimation. Furthermore, the use of light-quality signals to stimulate CBF expression has revealed ambient temperature-dependent coupling of CBF transcription factors to downstream COLD REGULATED ( COR) genes, providing evidence for a second temperature-regulated step in this pathway.	Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England	University of Leicester	Franklin, KA (corresponding author), Univ Leicester, Dept Biol, Leicester LE1 7RH, Leics, England.	kaf5@le.ac.uk						Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Amasino R, 2004, NAT GENET, V36, P111, DOI 10.1038/ng0204-111; Ausin I, 2004, NAT GENET, V36, P162, DOI 10.1038/ng1295; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; CARABELLI M, 1993, PLANT J, V4, P469, DOI 10.1046/j.1365-313X.1993.04030469.x; Edwards KD, 2006, PLANT CELL, V18, P639, DOI 10.1105/tpc.105.038315; Fowler SG, 2005, PLANT PHYSIOL, V137, P961, DOI 10.1104/pp.104.058354; Franklin KA, 2005, ANN BOT-LONDON, V96, P169, DOI 10.1093/aob/mci165; Franklin KA, 2003, PLANT PHYSIOL, V131, P1340, DOI 10.1104/pp.102.015487; Gilmour SJ, 2004, PLANT MOL BIOL, V54, P767, DOI 10.1023/B:PLAN.0000040902.06881.d4; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Halliday KJ, 2003, PLANT PHYSIOL, V131, P1913, DOI 10.1104/pp.102.018135; Halliday KJ, 2003, PLANT J, V33, P875, DOI 10.1046/j.1365-313X.2003.01674.x; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; JOHNSON E, 1994, PLANT PHYSIOL, V105, P141, DOI 10.1104/pp.105.1.141; Kim HJ, 2004, NAT GENET, V36, P167, DOI 10.1038/ng1298; Kim HJ, 2002, PLANT J, V29, P693, DOI 10.1046/j.1365-313X.2002.01249.x; Knight H, 1999, PLANT CELL, V11, P875, DOI 10.1105/tpc.11.5.875; Knight H, 2004, PLANT PHYSIOL, V135, P1710, DOI 10.1104/pp.104.043562; Linkosalo T, 2006, TREE PHYSIOL, V26, P1249, DOI 10.1093/treephys/26.10.1249; Salter MG, 2003, NATURE, V426, P680, DOI 10.1038/nature02174; Sharrock RA, 2004, P NATL ACAD SCI USA, V101, P11500, DOI 10.1073/pnas.0404286101; Soderman E, 1996, PLANT J, V10, P375, DOI 10.1046/j.1365-313X.1996.10020375.x; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Vogel JT, 2005, PLANT J, V41, P195, DOI 10.1111/j.1365-313X.2004.02288.x; WHITELAM GC, 1993, PLANT CELL, V5, P757, DOI 10.1105/tpc.5.7.757; Zarka DG, 2003, PLANT PHYSIOL, V133, P910, DOI 10.1104/pp.103.027169	28	200	221	2	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2007	39	11					1410	1413		10.1038/ng.2007.3	http://dx.doi.org/10.1038/ng.2007.3			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17965713				2022-12-27	WOS:000250575900027
J	Dixon, AL; Liang, L; Moffatt, MF; Chen, W; Heath, S; Wong, KCC; Taylor, J; Burnett, E; Gut, I; Farrall, M; Lathrop, GM; Abecasis, GR; Cookson, WOC				Dixon, Anna L.; Liang, Liming; Moffatt, Miriam F.; Chen, Wei; Heath, Simon; Wong, Kenny C. C.; Taylor, Jenny; Burnett, Edward; Gut, Ivo; Farrall, Martin; Lathrop, G. Mark; Abecasis, Goncalo R.; Cookson, William O. C.			A genome-wide association study of global gene expression	NATURE GENETICS			English	Article							NORMALIZATION; VARIANTS; RISK	We have created a global map of the effects of polymorphism on gene expression in 400 children from families recruited through a proband with asthma. We genotyped 408,273 SNPs and identified expression quantitative trait loci from measurements of 54,675 transcripts representing 20,599 genes in Epstein-Barr virus-transformed lymphoblastoid cell lines. We found that 15,084 transcripts (28%) representing 6,660 genes had narrow-sense heritabilities (H-2) > 0.3. We executed genome-wide association scans for these traits and found peak lod scores between 3.68 and 59.1. The most highly heritable traits were markedly enriched in Gene Ontology descriptors for response to unfolded protein (chaperonins and heat shock proteins), regulation of progression through the cell cycle, RNA processing, DNA repair, immune responses and apoptosis. SNPs that regulate expression of these genes are candidates in the study of degenerative diseases, malignancy, infection and inflammation. We have created a downloadable database to facilitate use of our findings in the mapping of complex disease loci.	Imperial Coll London, Natl Heart & Lung Inst, London SW3 6LY, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Ctr Stat Genet, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; Ctr Natl Genotypage, Inst Genom, Commissariat Lenergie Atom, F-91057 Evry, France; European Collect Cell Cultures, Salisbury SP4 0JG, Wilts, England	Imperial College London; University of Oxford; Wellcome Centre for Human Genetics; CEA; UDICE-French Research Universities; Universite Paris Saclay	Cookson, WOC (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London SW3 6LY, England.	w.cookson@imperial.ac.uk	Chen, Wei/AAX-5994-2020; Taylor, Jennifer M/A-1686-2010; Cookson, William/HHC-1790-2022; Gut, Ivo/ABF-3188-2020; Heath, Simon C/J-4138-2012; Abecasis, Goncalo R/B-7840-2010	Chen, Wei/0000-0001-7196-8703; Taylor, Jennifer M/0000-0003-4231-0181; Gut, Ivo/0000-0001-7219-632X; Heath, Simon C/0000-0002-9550-0897; Abecasis, Goncalo/0000-0003-1509-1825	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BEATY JS, 1995, MOL CELL BIOL, V15, P4771; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; *BRIT THOR SOC, 2003, THORAX S1, V58, pI1; Cardon LR, 1999, AM J HUM GENET, V65, pA245; CHEN WM, IN PRESS AM J HUM GE; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545	26	769	804	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2007	39	10					1202	1207		10.1038/ng2109	http://dx.doi.org/10.1038/ng2109			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17873877				2022-12-27	WOS:000249737400015
J	Tarpey, PS; Raymond, FL; Nguyen, LS; Rodriguez, J; Hackett, A; Vandeleur, L; Smith, R; Shoubridge, C; Edkins, S; Stevens, C; O'Meara, S; Tofts, C; Barthorpe, S; Buck, G; Cole, J; Halliday, K; Hills, K; Jones, D; Mironenko, T; Perry, J; Varian, J; West, S; Widaa, S; Teague, J; Dicks, E; Butler, A; Menzies, A; Richardson, D; Jenkinson, A; Shepherd, R; Raine, K; Moon, J; Luo, Y; Parnau, J; Bhat, SS; Gardner, A; Corbett, M; Brooks, D; Thomas, P; Parkinson-Lawrence, E; Porteous, ME; Warner, JP; Sanderson, T; Pearson, P; Simensen, RJ; Skinner, C; Hoganson, G; Superneau, D; Wooster, R; Bobrow, M; Turner, G; Stevenson, RE; Schwartz, CE; Futreal, PA; Srivastava, AK; Stratton, MR; Gecz, J				Tarpey, Patrick S.; Raymond, F. Lucy; Nguyen, Lam S.; Rodriguez, Jayson; Hackett, Anna; Vandeleur, Lucianne; Smith, Raffaella; Shoubridge, Cheryl; Edkins, Sarah; Stevens, Claire; O'Meara, Sarah; Tofts, Calli; Barthorpe, Syd; Buck, Gemma; Cole, Jennifer; Halliday, Kelly; Hills, Katy; Jones, David; Mironenko, Tatiana; Perry, Janet; Varian, Jennifer; West, Sofie; Widaa, Sara; Teague, John; Dicks, Ed; Butler, Adam; Menzies, Andrew; Richardson, David; Jenkinson, Andrew; Shepherd, Rebecca; Raine, Keiran; Moon, Jenny; Luo, Yin; Parnau, Josep; Bhat, Shambhu S.; Gardner, Alison; Corbett, Mark; Brooks, Doug; Thomas, Paul; Parkinson-Lawrence, Emma; Porteous, Mary E.; Warner, John P.; Sanderson, Tracy; Pearson, Pauline; Simensen, Richard J.; Skinner, Cindy; Hoganson, George; Superneau, Duane; Wooster, Richard; Bobrow, Martin; Turner, Gillian; Stevenson, Roger E.; Schwartz, Charles E.; Futreal, P. Andrew; Srivastava, Anand K.; Stratton, Michael R.; Gecz, Jozef			Mutations in UPF3B, a member of the nonsense-mediated mRNA decay complex, cause syndromic and nonsyndromic mental retardation	NATURE GENETICS			English	Article							EXON-JUNCTION COMPLEX; MARFANOID HABITUS; FG SYNDROME; SURVEILLANCE; TRANSLATION; ELEGANS; HUPF3B; GENE; FORM	Nonsense- mediated mRNA decay ( NMD) is of universal biological significance(1-3). It has emerged as an important global RNA, DNA and translation regulatory pathway(4). By systematically sequencing 737 genes ( annotated in the Vertebrate Genome Annotation database) on the human X chromosome in 250 families with X- linked mental retardation, we identified mutations in the UPF3 regulator of nonsense transcripts homolog B ( yeast) ( UPF3B) leading to protein truncations in three families: two with the Lujan- Fryns phenotype5,6 and one with the FG phenotype7. We also identified a missense mutation in another family with nonsyndromic mental retardation. Three mutations lead to the introduction of a premature termination codon and subsequent NMD of mutant UPF3B mRNA. Protein blot analysis using lymphoblastoid cell lines from affected individuals showed an absence of the UPF3B protein in two families. The UPF3B protein is an important component of the NMD surveillance machinery(8,9). Our results directly implicate abnormalities of NMD in human disease and suggest at least partial redundancy of NMD pathways.	Womens & Childrens Hosp, Dept Med Genet, Adelaide, SA 5006, Australia; Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England; Cambridge Inst Med Res, Cambridge CB2 2XY, England; Greenwood Genet Ctr, JC Self Res Inst Human Genet, Greenwood, SC 29646 USA; GOLD Serv, Waratah, NSW 2298, Australia; Univ S Australia, Sansom Inst, Adelaide, SA 5001, Australia; Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5001, Australia; SE Scotland Genet Serv, Edinburgh EH4 2XU, Midlothian, Scotland; Rockford Mem Hosp, Rockford, IL 61103 USA; Genet Serv Louisiana, Baton Rouge, LA 70884 USA; Inst Canc Res, Sutton SM2 5NG, Surrey, England; Univ Adelaide, Dept Paediat, Adelaide, SA 5001, Australia	Womens & Childrens Hospital Australia; University of Cambridge; Wellcome Trust Sanger Institute; University of Cambridge; Greenwood Genetic Center; University of South Australia; University of Adelaide; University of London; Institute of Cancer Research - UK; University of Adelaide	Gecz, J (corresponding author), Womens & Childrens Hosp, Dept Med Genet, Adelaide, SA 5006, Australia.	jozef.gecz@adelaide.edu.au	Parkinson-Lawrence, Emma/F-4085-2013; Thomas, Paul Q/K-4497-2012; Brooks, Doug A/K-6714-2012; Gecz, Jozef/X-3469-2019; Shoubridge, Cheryl/A-1571-2016; Corbett, Mark/A-8063-2010	Gecz, Jozef/0000-0002-7884-6861; Shoubridge, Cheryl/0000-0002-0157-3084; Corbett, Mark/0000-0001-9298-3072; Richardson, David/0000-0003-0247-9118; Jenkinson, Andrew/0000-0002-0703-6984; Raine, Keiran/0000-0002-5634-1539; Nguyen, Lam Son/0000-0002-0114-1222; warner, jonathan peter/0000-0001-5301-675X; Brooks, Doug/0000-0001-9098-3626; Parkinson-Lawrence, Emma/0000-0002-3845-4847; Buck, Gemma/0000-0001-5289-1050	NICHD NIH HHS [HD26202, R01 HD026202] Funding Source: Medline; Wellcome Trust [077012] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026202] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bateman JF, 2003, HUM MOL GENET, V12, P217, DOI 10.1093/hmg/ddg054; Battaglia A, 2006, AM J MED GENET A, V140A, P2075, DOI 10.1002/ajmg.a.31302; Chan WK, 2007, EMBO J, V26, P1820, DOI 10.1038/sj.emboj.7601628; Conti E, 2005, CURR OPIN CELL BIOL, V17, P316, DOI 10.1016/j.ceb.2005.04.005; DeHert M, 1996, AM J MED GENET, V67, P212; FRYNS JP, 1987, AM J MED GENET, V28, P267, DOI 10.1002/ajmg.1320280202; Gecz J, 2000, GENOME RES, V10, P157, DOI 10.1101/gr.10.2.157; Gehring NH, 2005, MOL CELL, V20, P65, DOI 10.1016/j.molcel.2005.08.012; Gehring NH, 2003, MOL CELL, V11, P939, DOI 10.1016/S1097-2765(03)00142-4; Graham JM, 1998, AM J MED GENET, V80, P145; Kadlec J, 2004, NAT STRUCT MOL BIOL, V11, P330, DOI 10.1038/nsmb741; Kim VN, 2001, SCIENCE, V293, P1832, DOI 10.1126/science.1062829; Kunz JB, 2006, RNA, V12, P1015, DOI 10.1261/rna.12506; LeBlanc JJ, 2004, J VIROL, V78, P5139, DOI 10.1128/JVI.78.10.5139-5146.2004; LUJAN JE, 1984, AM J MED GENET, V17, P311, DOI 10.1002/ajmg.1320170124; Lykke-Andersen J, 2000, CELL, V103, P1121, DOI 10.1016/S0092-8674(00)00214-2; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Medghalchi SM, 2001, HUM MOL GENET, V10, P99, DOI 10.1093/hmg/10.2.99; Mitrovich QM, 2005, CURR BIOL, V15, P963, DOI 10.1016/j.cub.2005.04.055; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; OPITZ JM, 1974, Z KINDERHEILKD, V117, P1, DOI 10.1007/BF00439020; Raymond FL, 2007, AM J HUM GENET, V80, P982, DOI 10.1086/513609; Raymond FL, 2006, HUM MOL GENET, V15, pR110, DOI 10.1093/hmg/ddl189; Risheg H, 2007, NAT GENET, V39, P451, DOI 10.1038/ng1992; Schwartz CE, 2007, J MED GENET, V44, P472, DOI 10.1136/jmg.2006.048637; Serin G, 2001, MOL CELL BIOL, V21, P209, DOI 10.1128/MCB.21.1.209-223.2001; Tarpey PS, 2006, AM J HUM GENET, V79, P1119, DOI 10.1086/510137; Van Buggenhout G, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-26; Weischenfeldt J, 2005, CURR BIOL, V15, pR559, DOI 10.1016/j.cub.2005.07.002	29	180	184	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2007	39	9					1127	1133		10.1038/ng2100	http://dx.doi.org/10.1038/ng2100			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17704778	Green Accepted			2022-12-27	WOS:000249122400023
J	Buch, S; Schafmayer, C; Volzke, H; Becker, C; Franke, A; von Eller-Eberstein, H; Kluck, C; Bassmann, I; Brosch, M; Lammert, F; Miquel, JF; Nervi, F; Wittig, M; Rosskopf, D; Timm, B; Holl, C; Seeger, M; ElSharawy, A; Lu, T; Egberts, J; Fandrich, F; Folsch, UR; Krawczak, M; Schreiber, S; Nurnberg, P; Tepel, J; Hampe, J				Buch, Stephan; Schafmayer, Clemens; Volzke, Henry; Becker, Christian; Franke, Andre; von Eller-Eberstein, Huberta; Kluck, Christian; Bassmann, Ingelore; Brosch, Mario; Lammert, Frank; Miquel, Juan Francisco; Nervi, Flavio; Wittig, Michael; Rosskopf, Dieter; Timm, Birgit; Holl, Christine; Seeger, Marcus; ElSharawy, Abdou; Lu, Tim; Egberts, Jan; Fandrich, Fred; Folsch, Ulrich R.; Krawczak, Michael; Schreiber, Stefan; Nurnberg, Peter; Tepel, Jurgen; Hampe, Jochen			A genome-wide association scan identifies the hepatic cholesterol transporter ABCG8 as a susceptibility factor for human gallstone disease	NATURE GENETICS			English	Article							GALLBLADDER-DISEASE; MICE; POLYMORPHISMS; ABCG5/ABCG8; SITOSTEROLEMIA; DETERMINANTS; ACCUMULATION; POPULATION; PREVALENCE; STEROLS	With an overall prevalence of 10-20%, gallstone disease (cholelithiasis) represents one of the most frequent and economically relevant health problems of industrialized countries1,2. We performed an association scan of 4500,000 SNPs in 280 individuals with gallstones and 360 controls. A follow-up study of the 235 most significant SNPs in 1,105 affected individuals and 873 controls replicated the disease association of SNP A-1791411 in ABCG8 (allelic P value P-CCA = 4.1 x 10(-9)), which was subsequently attributed to coding variant rs11887534 (D19H). Additional replication was achieved in 728 German (P = 2.8 x 10(-7)) and 167 Chilean subjects (P = 0.02). The overall odds ratio for D19H carriership was 2.2 (95% confidence interval: 1.8-2.6, P = 1.4 x 10(-14)) in the full German sample. Association was stronger in subjects with cholesterol gallstones (odds ratio = 3.3), suggesting that His19 might be associated with a more efficient transport of cholesterol into the bile.	Univ Hosp Schleswig Holstein, Dept Med 1, D-24105 Kiel, Germany; Univ Hosp Schleswig Holstein, Inst Clin Mol Biol, D-24105 Kiel, Germany; Univ Hosp Schleswig Holstein, POPGEN Biobank, D-24105 Kiel, Germany; Univ Hosp Schleswig Holstein, Dept Gen & Thorac Surg, D-24105 Kiel, Germany; Univ Hosp Greifswald, Inst Community Med, D-17487 Greifswald, Germany; Univ Cologne, Cologne Ctr Genom, D-50674 Cologne, Germany; RZPD German Resource Ctr Genome Res, D-14059 Berlin, Germany; Univ Hosp Bonn, Dept Internal Med 1, D-53105 Bonn, Germany; Pontificia Univ Catolica Chile, Fac Med, Santiago, Chile; Univ Greifswald, Inst Pharmacol, D-17487 Greifswald, Germany; Univ Hosp Schleswig Holstein, Inst Med Stat & Informat, D-24105 Kiel, Germany; Univ Cologne, CMMC, D-50931 Cologne, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Cologne; University of Bonn; Pontificia Universidad Catolica de Chile; Ernst Moritz Arndt Universitat Greifswald; University of Kiel; Schleswig Holstein University Hospital; University of Cologne	Hampe, J (corresponding author), Univ Hosp Schleswig Holstein, Dept Med 1, D-24105 Kiel, Germany.	jhampe@1med.uni-kiel.de	Faendrich, Fred/B-1705-2010; Egberts, Jan-Hendrik/E-3211-2015; Franke, Andre/B-2151-2010; Hampe, Jochen/A-2555-2010; Buch, Stephan/AAV-5028-2021; Elsharawy, Abdou/C-9848-2010; Krawczak, Michael/A-8964-2010	Franke, Andre/0000-0003-1530-5811; Hampe, Jochen/0000-0002-2421-6127; Krawczak, Michael/0000-0003-2603-1502; Brosch, Mario/0000-0001-8983-6557				Acalovschi M, 2006, EUR J INTERN MED, V17, P490, DOI 10.1016/j.ejim.2006.04.012; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; Berge KE, 2002, J LIPID RES, V43, P486; DUBDRIDGE F, 2003, EPIDEMIOLOGY, V25, P115; Duggirala R, 1999, GENET EPIDEMIOL, V16, P191, DOI 10.1002/(SICI)1098-2272(1999)16:2<191::AID-GEPI6>3.0.CO;2-6; Franke A, 2006, HUM MUTAT, V27, P583, DOI 10.1002/humu.20306; Gylling H, 2004, J LIPID RES, V45, P1660, DOI 10.1194/jlr.M300522-JLR200; Hazard SE, 2007, PFLUG ARCH EUR J PHY, V453, P745, DOI 10.1007/s00424-005-0040-7; Hubacek J A, 2001, Hum Mutat, V18, P359, DOI 10.1002/humu.1206; Iida A, 2002, J HUM GENET, V47, P285, DOI 10.1007/s100380200041; Katsika D, 2005, HEPATOLOGY, V41, P1138, DOI 10.1002/hep.20654; KHANUJA B, 1995, P NATL ACAD SCI USA, V92, P7729, DOI 10.1073/pnas.92.17.7729; KORNER G, 1937, Z MENSCHLICHE VERERB, V20, P528; Lammert F, 2005, NAT CLIN PRACT GASTR, V2, P423, DOI 10.1038/ncpgasthep0257; Lammert F, 2002, HEPATOLOGY, V36, P1145, DOI 10.1053/jhep.2002.36821; Nakeeb A, 2002, ANN SURG, V235, P842, DOI 10.1097/00000658-200206000-00012; NURNBERG D, 1989, DEUT MED WOCHENSCHR, V114, P1059, DOI 10.1055/s-2008-1066716; Paigen B, 2000, PHYSIOL GENOMICS, V4, P59, DOI 10.1152/physiolgenomics.2000.4.1.59; Puppala S, 2006, AM J HUM GENET, V78, P377, DOI 10.1086/500274; SALEN G, 1992, J LIPID RES, V33, P945; SARIN SK, 1995, HEPATOLOGY, V22, P138; SCHAFMAYER C, IN PRESS LIVER INT; Schafmayer C, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-36; Schafmayer C, 2006, HEPATOLOGY, V44, P650, DOI 10.1002/hep.21289; Steffens M, 2006, HUM HERED, V62, P20, DOI 10.1159/000095850; Volzke H, 2005, DIGESTION, V71, P97, DOI 10.1159/000084525; Wittenburg H, 2005, MAMM GENOME, V16, P495, DOI 10.1007/s00335-005-0006-2; Wittenburg H, 2003, GASTROENTEROLOGY, V125, P868, DOI 10.1016/S0016-5085(03)01053-9; Wittenburg H, 2002, J CLIN INVEST, V110, P605, DOI 10.1172/JCI200216548	30	243	255	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					995	999		10.1038/ng2101	http://dx.doi.org/10.1038/ng2101			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17632509				2022-12-27	WOS:000248446900017
J	Carter, NP				Carter, Nigel P.			Methods and strategies for analyzing copy number variation using DNA microarrays	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; CDNA MICROARRAYS; ARRAY CGH; STRUCTURAL VARIATION; BREAST-CANCER; RESOLUTION; SEQUENCE; OLIGONUCLEOTIDES; IDENTIFICATION	The association of DNA copy-number variation (CNV) with specific gene function and human disease has been long known, but the wide scope and prevalence of this form of variation has only recently been fully appreciated. The latest studies using microarray technology have demonstrated that as much as 12% of the human genome and thousands of genes are variable in copy number, and this diversity is likely to be responsible for a significant proportion of normal phenotypic variation. Current challenges involve developing methods not only for detecting and cataloging CNVs in human populations at increasingly higher resolution but also for determining the association of CNVs with biological function, recent human evolution, and common and complex human disease.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Wellcome Trust Sanger Institute	Carter, NP (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	npc@sanger.ac.uk			Wellcome Trust [077008] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bentley DR, 2001, NATURE, V409, P942, DOI 10.1038/35057165; Carvalho B, 2004, J CLIN PATHOL, V57, P644, DOI 10.1136/jcp.2003.013029; Cheung VG, 2001, NATURE, V409, P953, DOI 10.1038/35057192; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Dhami P, 2005, AM J HUM GENET, V76, P750, DOI 10.1086/429588; EDWARDS A, 1991, AM J HUM GENET, V49, P746; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gribble SM, 2007, J MED GENET, V44, P51, DOI 10.1136/jmg.2006.044909; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ishkanian AS, 2004, NAT GENET, V36, P299, DOI 10.1038/ng1307; JACOBS PA, 1959, LANCET, V1, P710; Kallioniemi Anne, 1996, Methods (Orlando), V9, P113, DOI 10.1006/meth.1996.0015; KALLIONIEMI OP, 1993, SEMIN CANCER BIOL, V4, P41; Kauraniemi P, 2001, CANCER RES, V61, P8235; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; KUNZE J, 1980, NEUROPEDIATRICS, V11, P203, DOI 10.1055/s-2008-1071392; Kwok PY, 1996, GENOMICS, V31, P123, DOI 10.1006/geno.1996.0019; Lejeune J, 1965, Ann Genet, V8, P11; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lucito R, 2003, GENOME RES, V13, P2291, DOI 10.1101/gr.1349003; Mantripragada KK, 2003, J MOL MED-JMM, V81, P443, DOI 10.1007/s00109-003-0458-3; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Mir KU, 2000, ANNU REV GENOM HUM G, V1, P329, DOI 10.1146/annurev.genom.1.1.329; Monni O, 2001, P NATL ACAD SCI USA, V98, P5711, DOI 10.1073/pnas.091582298; MORTON CC, 1981, ACTA GENET MED GEMEL, V30, P39, DOI 10.1017/S0001566000006607; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Perry GH, 2006, P NATL ACAD SCI USA, V103, P8006, DOI 10.1073/pnas.0602318103; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pollack JR, 1999, NAT GENET, V23, P41, DOI 10.1038/12640; Porkka K, 2002, LAB INVEST, V82, P629, DOI 10.1038/labinvest.3780457; Price TS, 2005, NUCLEIC ACIDS RES, V33, P3455, DOI 10.1093/nar/gki643; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; SEDANO H O, 1971, Birth Defects Original Article Series, V7, P89; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; Squire JA, 2003, GENE CHROMOSOME CANC, V38, P215, DOI 10.1002/gcc.10273; Taillon-Miller P, 1998, GENOME RES, V8, P748, DOI 10.1101/gr.8.7.748; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; VERMA RS, 1977, HUM GENET, V38, P231, DOI 10.1007/BF00527408; Vermeesch JR, 2005, J HISTOCHEM CYTOCHEM, V53, P413, DOI 10.1369/jhc.4A6436.2005; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Ylstra B, 2006, NUCLEIC ACIDS RES, V34, P445, DOI 10.1093/nar/gkj456	52	336	384	0	40	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39			7			S16	S21		10.1038/ng2028	http://dx.doi.org/10.1038/ng2028			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	274AO	17597776	Green Accepted			2022-12-27	WOS:000253974400004
J	Hunter, DJ; Kraft, P; Jacobs, KB; Cox, DG; Yeager, M; Hankinson, SE; Wacholder, S; Wang, ZM; Welch, R; Hutchinson, A; Wang, JW; Yu, K; Chatterjee, N; Orr, N; Willett, WC; Colditz, GA; Ziegler, RG; Berg, CD; Buys, SS; McCarty, CA; Feigelson, HS; Calle, EE; Thun, MJ; Hayes, RB; Tucker, M; Gerhard, DS; Fraumeni, JF; Hoover, RN; Thomas, G; Chanock, SJ				Hunter, David J.; Kraft, Peter; Jacobs, Kevin B.; Cox, David G.; Yeager, Meredith; Hankinson, Susan E.; Wacholder, Sholom; Wang, Zhaoming; Welch, Robert; Hutchinson, Amy; Wang, Junwen; Yu, Kai; Chatterjee, Nilanjan; Orr, Nick; Willett, Walter C.; Colditz, Graham A.; Ziegler, Regina G.; Berg, Christine D.; Buys, Saundra S.; McCarty, Catherine A.; Feigelson, Heather Spencer; Calle, Eugenia E.; Thun, Michael J.; Hayes, Richard B.; Tucker, Margaret; Gerhard, Daniela S.; Fraumeni, Joseph F., Jr.; Hoover, Robert N.; Thomas, Gilles; Chanock, Stephen J.			A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer	NATURE GENETICS			English	Article							LOCI; PREMENOPAUSAL; BRCA1	We conducted a genome- wide association study ( GWAS) of breast cancer by genotyping 528,173 SNPs in 1,145 postmenopausal women of European ancestry with invasive breast cancer and 1,142 controls. We identified four SNPs in intron 2 of FGFR2 ( which encodes a receptor tyrosine kinase and is amplified or overexpressed in some breast cancers) that were highly associated with breast cancer and confirmed this association in 1,776 affected individuals and 2,072 controls from three additional studies. Across the four studies, the association with all four SNPs was highly statistically significant ( P-trend for the most strongly associated SNP ( rs1219648) = 1.1 x 10(-10); population attributable risk = 16%). Four SNPs at other loci most strongly associated with breast cancer in the initial GWAS were not associated in the replication studies. Our summary results from the GWAS are available online in a form that should speed the identification of additional risk loci.	Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; MIT, Broad Inst, Cambridge, MA 02142 USA; NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Bethesda, MD 20892 USA; Bioinformed Consulting Serv, Gaithersburg, MD 20877 USA; SAIC Frederick, NCI FCRDC, Frederick, MD 21702 USA; NCI, Pediat Oncol Branch, Canc Res Ctr, NIH,DHHS, Bethesda, MD USA; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Washington Univ, Sch Med, St Louis, MO 63130 USA; NCI, Div Canc Prevent, NIH, DHHS, Bethesda, MD 20892 USA; Univ Utah, Dept Internal Med, Salt Lake City, UT 84112 USA; Marshfield Clin Fdn Med Res & Educ, Ctr Human Genet, Marshfield, WI 54449 USA; Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA; NCI, Off Canc Genom, NIH, DHHS, Bethesda, MD 20892 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard T.H. Chan School of Public Health; Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Utah System of Higher Education; University of Utah; Marshfield Clinic; American Cancer Society; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG)	Hunter, DJ (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Lab, 75 Francis St, Boston, MA 02115 USA.	dhunter@hsph.harvard.edu	Yeager, Meredith/AAA-5322-2020; Cox, David/ABA-7454-2020; Wang, Junwen/D-3700-2011; Colditz, Graham/A-3963-2009; Tucker, Margaret A/B-4297-2015; Wang, Zhaoming/R-5527-2018; Cox, David G/A-2023-2009; Wang, Junwen/C-4432-2009	Wang, Junwen/0000-0002-4432-4707; Colditz, Graham/0000-0002-7307-0291; Wang, Zhaoming/0000-0001-7556-3869; Cox, David G/0000-0002-2152-9259; McCarty, Catherine/0000-0003-1089-0142; Jacobs, Kevin/0000-0002-4657-6473; Cox, David/0000-0003-2047-4687; Hayes, Richard/0000-0002-0918-661X; Edsall, Lee Elizabeth/0000-0002-0326-2829	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [U01 CA098233, U01 CA098710, R01 CA067262, U01 CA049449, R01 CA049449, R01 CA050385, 5U01CA098233, CA87969, U01 CA067262, R01 CA065725, P01 CA087969, CA67262, CA50385, CA49449, CA65725] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA049449, U01CA098710, Z01SC010083, U01CA067262, U01CA098233, R01CA050385, R01CA067262, U01CA049449, P01CA087969, R01CA065725] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; CHANOCK SJ, IN PRESS NATURE; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Eliassen AH, 2007, CANCER EPIDEM BIOMAR, V16, P161, DOI 10.1158/1055-9965.EPI-06-0693; Falush D, 2003, GENETICS, V164, P1567; Grose R, 2005, CYTOKINE GROWTH F R, V16, P179, DOI 10.1016/j.cytogfr.2005.01.003; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Hayes RB, 2000, CONTROL CLIN TRIALS, V21, p349S, DOI 10.1016/S0197-2456(00)00101-X; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; Kraft P, 2005, GENET EPIDEMIOL, V28, P261, DOI 10.1002/gepi.20061; Minichiello MJ, 2006, AM J HUM GENET, V79, P910, DOI 10.1086/508901; Moffa AB, 2007, J CELL PHYSIOL, V210, P720, DOI 10.1002/jcp.20880; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Risch HA, 2006, JNCI-J NATL CANCER I, V98, P1694, DOI 10.1093/jnci/djj465; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stevens VL, 2006, CANCER EPIDEM BIOMAR, V15, P1226, DOI 10.1158/1055-9965.EPI-05-0930; Tworoger SS, 2007, J CLIN ONCOL, V25, P1482, DOI 10.1200/JCO.2006.07.6356; Wang HS, 2006, GENET EPIDEMIOL, V30, P356, DOI 10.1002/gepi.20150; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	23	1172	1225	2	102	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39	7					870	874		10.1038/ng2075	http://dx.doi.org/10.1038/ng2075			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17529973	Green Accepted			2022-12-27	WOS:000247619800017
J	Rahman, N; Seal, S; Thompson, D; Kelly, P; Renwick, A; Elliott, A; Reid, S; Spanova, K; Barfoot, R; Chagtai, T; Jayatilake, H; McGuffog, L; Hanks, S; Evans, DG; Eccles, D; Easton, DF; Stratton, MR				Rahman, Nazneen; Seal, Sheila; Thompson, Deborah; Kelly, Patrick; Renwick, Anthony; Elliott, Anna; Reid, Sarah; Spanova, Katarina; Barfoot, Rita; Chagtai, Tasnim; Jayatilake, Hiran; McGuffog, Lesley; Hanks, Sandra; Evans, D. Gareth; Eccles, Diana; Easton, Douglas F.; Stratton, Michael R.		Breast Canc Susceptibility Collabo	PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene	NATURE GENETICS			English	Article							FANCONI-ANEMIA; HELICASE BRIP1; BRCA2; MUTATIONS	PALB2 interacts with BRCA2, and biallelic mutations in PALB2 ( also known as FANCN), similar to biallelic BRCA2 mutations, cause Fanconi anemia. We identified monoallelic truncating PALB2 mutations in 10/ 923 individuals with familial breast cancer compared with 0/1,084 controls ( P= 0.0004) and show that such mutations confer a 2.3- fold higher risk of breast cancer ( 95% confidence interval (c.i.) 1.4 - 3.9, P =0.0025). The results show that PALB2 is a breast cancer susceptibility gene and further demonstrate the close relationship of the Fanconi anemia - DNA repair pathway and breast cancer predisposition.	Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Univ Cambridge, Canc Res UK Genet Epidemiol Unit, Strangeways Res Lab, Cambridge, England; St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England; Princess Anne Hosp, Wessex Clin Genet Serv, Southampton SO16 6YA, Hants, England; Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, Cambs, England	University of London; Institute of Cancer Research - UK; Cancer Research UK; University of Cambridge; University of Manchester; Wellcome Trust Sanger Institute	Rahman, N (corresponding author), Inst Canc Res, Sect Canc Genet, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England.	nazneen.rahman@icr.ac.uk	Rahman, Nazneen/B-8890-2012; Evans, D Gareth/AAB-4308-2022; Eccles, Diana/K-6327-2019; Rahman, Nazneen/D-2802-2013	Evans, D Gareth/0000-0002-8482-5784; Eccles, Diana/0000-0002-9935-3169; Rahman, Nazneen/0000-0003-4376-0440	Wellcome Trust [077012, 068545/Z/02] Funding Source: Medline; Breast Cancer Now [2005NOV53, 2003:592] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission); Breast Cancer Now		Antoniou AC, 2006, ONCOGENE, V25, P5898, DOI 10.1038/sj.onc.1209879; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Reid S, 2005, J MED GENET, V42, P147, DOI 10.1136/jmg.2004.022673; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Seal S, 2003, CANCER RES, V63, P8596; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022	15	699	709	1	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					165	167		10.1038/ng1959	http://dx.doi.org/10.1038/ng1959			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17200668	Green Accepted			2022-12-27	WOS:000244063900013
J	de Bakker, PIW; Burtt, NP; Graham, RR; Guiducci, C; Yelensky, R; Drake, JA; Bersaglieri, T; Penney, KL; Butler, J; Young, S; Onofrio, RC; Lyon, HN; O Stram, D; Haiman, CA; Freedman, ML; Zhu, XF; Cooper, R; Groop, L; Kolonel, LN; Henderson, BE; Daly, MJ; Hirschhorn, JN; Altshuler, D				de Bakker, Paul I. W.; Burtt, Noel P.; Graham, Robert R.; Guiducci, Candace; Yelensky, Roman; Drake, Jared A.; Bersaglieri, Todd; Penney, Kathryn L.; Butler, Johannah; Young, Stanton; Onofrio, Robert C.; Lyon, Helen N.; O Stram, Daniel; Haiman, Christopher A.; Freedman, Matthew L.; Zhu, Xiaofeng; Cooper, Richard; Groop, Leif; Kolonel, Laurence N.; Henderson, Brian E.; Daly, Mark J.; Hirschhorn, Joel N.; Altshuler, David			Transferability of tag SNPs in genetic association studies in multiple populations	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM PATTERNS; SINGLE-NUCLEOTIDE POLYMORPHISMS; HUMAN GENOME; MULTIETHNIC COHORT; HAPMAP; EFFICIENCY; PERFORMANCE; PORTABILITY; DIVERSITY; SELECTION	A general question for linkage disequilibrium-based association studies is how power to detect an association is compromised when tag SNPs are chosen from data in one population sample and then deployed in another sample. Specifically, it is important to know how well tags picked from the HapMap DNA samples capture the variation in other samples. To address this, we collected dense data uniformly across the four HapMap population samples and eleven other population samples. We picked tag SNPs using genotype data we collected in the HapMap samples and then evaluated the effective coverage of these tags in comparison to the entire set of common variants observed in the other samples. We simulated case-control association studies in the non-HapMap samples under a disease model of modest risk, and we observed little loss in power. These results demonstrate that the HapMap DNA samples can be used to select tags for genome-wide association studies in many samples around the world.	Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; MIT, Cambridge Ctr 7, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; Childrens Hosp, Div Endocrinol, Program Genom, Boston, MA 02115 USA; Childrens Hosp, Div Genet, Program Genom, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; Dana Farber Canc Inst, Boston, MA 02115 USA; Loyola Univ, Dept Prevent Med & Epidemiol, Maywood, IL 60153 USA; Lund Univ, Univ Hosp, Dept Clin Sci, S-20502 Malmo, Sweden; Univ Helsinki, Dept Med, Helsinki, Finland; Univ Hawaii, Canc Res Ctr, Honolulu, HI 96813 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of Southern California; Harvard University; Dana-Farber Cancer Institute; Loyola University Chicago; Lund University; Skane University Hospital; University of Helsinki; Cancer Research Center of Hawaii; University of Hawaii System; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Altshuler, D (corresponding author), Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA.	altshuler@molbio.mgh.harvard.edu	Altshuler, David M/A-4476-2009; Daly, Mark J/B-2453-2017; de Bakker, Paul IW/B-8730-2009; Zhu, Xiaofeng/O-6874-2019	Altshuler, David M/0000-0002-7250-4107; Daly, Mark J/0000-0002-0949-8752; de Bakker, Paul IW/0000-0001-7735-7858; Zhu, Xiaofeng/0000-0003-0037-411X	NATIONAL CANCER INSTITUTE [R37CA054281, U01CA063464, R01CA063464, U01CA098758, R01CA054281] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK067288] Funding Source: NIH RePORTER; NCI NIH HHS [CA098758, CA54281, CA63464] Funding Source: Medline; NHLBI NIH HHS [HL074166] Funding Source: Medline; NIDDK NIH HHS [DK067288] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahmadi KR, 2005, NAT GENET, V37, P84, DOI 10.1038/ng1488; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Beaty TH, 2005, GENETICS, V171, P259, DOI 10.1534/genetics.105.043075; Cann HM, 2002, SCIENCE, V296, P261; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Evans DM, 2005, AM J HUM GENET, V76, P681, DOI 10.1086/429274; Gonzalez-Neira A, 2006, GENOME RES, V16, P323, DOI 10.1101/gr.4138406; Howie BN, 2006, HUM GENET, V120, P58, DOI 10.1007/s00439-006-0182-5; Huang W, 2006, P NATL ACAD SCI USA, V103, P1418, DOI 10.1073/pnas.0510360103; Ke XY, 2004, HUM MOL GENET, V13, P2557, DOI 10.1093/hmg/ddh294; Kolonel LN, 2004, NAT REV CANCER, V4, P519, DOI 10.1038/nrc1389; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Montpetit A, 2006, PLOS GENET, V2, P282, DOI 10.1371/journal.pgen.0020027; Mueller JC, 2005, AM J HUM GENET, V76, P387, DOI 10.1086/427925; Nejentsev S, 2004, HUM MOL GENET, V13, P1633, DOI 10.1093/hmg/ddh169; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Ramirez-Soriano A, 2005, GENES IMMUN, V6, P646, DOI 10.1038/sj.gene.6364251; Ribas G, 2006, HUM GENET, V118, P669, DOI 10.1007/s00439-005-0094-9; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sawyer SL, 2005, EUR J HUM GENET, V13, P677, DOI 10.1038/sj.ejhg.5201368; Shifman S, 2003, HUM MOL GENET, V12, P771, DOI 10.1093/hmg/ddg088; SMITH EM, 2006, GENOMICS; Stankovich J, 2006, HUM GENET, V119, P220, DOI 10.1007/s00439-005-0120-y; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Weale ME, 2003, AM J HUM GENET, V73, P551, DOI 10.1086/378098; Wheeler DL, 2006, NUCLEIC ACIDS RES, V34, pD173, DOI 10.1093/nar/gkj158; Zeggini E, 2005, NAT GENET, V37, P1320, DOI 10.1038/ng1670	30	179	180	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2006	38	11					1298	1303		10.1038/ng1899	http://dx.doi.org/10.1038/ng1899			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17057720				2022-12-27	WOS:000241592700018
J	Romeo, S; Kozlitina, J; Xing, C; Pertsemlidis, A; Cox, D; Pennacchio, LA; Boerwinkle, E; Cohen, JC; Hobbs, HH				Romeo, Stefano; Kozlitina, Julia; Xing, Chao; Pertsemlidis, Alexander; Cox, David; Pennacchio, Len A.; Boerwinkle, Eric; Cohen, Jonathan C.; Hobbs, Helen H.			Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease	NATURE GENETICS			English	Article							LIPID ACYL HYDROLASE; HEPATIC STEATOSIS; UNITED-STATES; ETHNIC-DIFFERENCES; AFRICAN-AMERICANS; FAMILY-MEMBERS; POPULATION; PREVALENCE; PATATIN; EXPRESSION	Nonalcoholic fatty liver disease (NAFLD) is a burgeoning health problem of unknown etiology that varies in prevalence among ancestry groups. To identify genetic variants contributing to differences in hepatic fat content, we carried out a genome-wide association scan of nonsynonymous sequence variations (n = 9,229) in a population comprising Hispanic, African American and European American individuals. An allele in PNPLA3 (rs738409[G], encoding I148M) was strongly associated with increased hepatic fat levels (P = 5.9 x 10(-10)) and with hepatic inflammation (P = 3.7 x 10(-4)). The allele was most common in Hispanics, the group most susceptible to NAFLD; hepatic fat content was more than twofold higher in PNPLA3 rs738409[G] homozygotes than in noncarriers. Resequencing revealed another allele of PNPLA3 (rs6006460[T], encoding S453I) that was associated with lower hepatic fat content in African Americans, the group at lowest risk of NAFLD. Thus, variation in PNPLA3 contributes to ancestry-related and inter-individual differences in hepatic fat content and susceptibility to NAFLD.	[Romeo, Stefano; Xing, Chao; Pertsemlidis, Alexander; Cohen, Jonathan C.; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Donald W Reynolds Cardiovasc Clin Res Ctr, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; [Kozlitina, Julia; Xing, Chao] Univ Texas SW Med Ctr Dallas, Dept Clin Sci, Dallas, TX 75390 USA; [Kozlitina, Julia] So Methodist Univ, Dept Stat Sci, Dallas, TX 75275 USA; [Cox, David] Perlegen Sci, Mountain View, CA 94043 USA; [Pennacchio, Len A.] Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; [Pennacchio, Len A.] US Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr, Inst Mol Med, Houston, TX 77030 USA; [Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Southern Methodist University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hobbs, HH (corresponding author), Univ Texas SW Med Ctr Dallas, Donald W Reynolds Cardiovasc Clin Res Ctr, Eugene McDermott Ctr Human Growth & Dev, 6000 Harry Hines Blvd Dallas, Dallas, TX 75390 USA.	jonathan.cohen@utsouthwestern.edu; helen.hobbs@utsouthwestern.edu	Romeo, Stefano/L-6861-2015; Pertsemlidis, Alexander/Q-7899-2017; Adiels, Martin/C-9278-2011	Romeo, Stefano/0000-0001-9168-4898; Pertsemlidis, Alexander/0000-0003-1624-9372; Xing, Chao/0000-0002-1838-0502; Kozlitina, Julia/0000-0001-7720-2290; Pennacchio, Len/0000-0002-8748-3732	Donald W. Reynolds Foundation; US National Institutes of Health [RL1HL-092550, 1PL1DK081182, HL-20948]; US National Heart, Lung, and Blood Institute (NHLBI) Program for Genomic Applications [HL-066681]; US Department of Energy [DE-AC02-05CH11231]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RL1HL092550, P01HL020948, U01HL066681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [PL1DK081182] Funding Source: NIH RePORTER	Donald W. Reynolds Foundation; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Heart, Lung, and Blood Institute (NHLBI) Program for Genomic Applications(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US Department of Energy(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T. Hyatt, J. Martin, W. Schackwitz, A. Ustaszewska, C. Wright and the team at Perlegen Sciences for technical assistance. We thank K. Lawson for the statistical analysis of the data from the ARIC study. We thank J. Horton and D. Hinds for helpful discussions. We are grateful to the staff and participants of the Dallas Heart Study and the Atherosclerosis Risk in Communities Study for their contributions. This work was supported by grants from the Donald W. Reynolds Foundation, the US National Institutes of Health (RL1HL-092550, 1PL1DK081182 and HL-20948), the US National Heart, Lung, and Blood Institute (NHLBI) Program for Genomic Applications (HL-066681) and the US Department of Energy (Contract DE-AC02-05CH11231).	Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014; Baulande S, 2001, J BIOL CHEM, V276, P33336, DOI 10.1074/jbc.M105193200; BROWN SA, 1993, ARTERIOSCLER THROMB, V13, P1139, DOI 10.1161/01.ATV.13.8.1139; Browning JD, 2004, AM J GASTROENTEROL, V99, P292, DOI 10.1111/j.1572-0241.2004.04059.x; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Caldwell SH, 2002, AM J GASTROENTEROL, V97, P1496, DOI 10.1016/S0002-9270(02)04151-5; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; Falush D, 2003, GENETICS, V164, P1567; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Lake AC, 2005, J LIPID RES, V46, P2477, DOI 10.1194/jlr.M500290-JLR200; LONGO R, 1995, JMRI-J MAGN RESON IM, V5, P281, DOI 10.1002/jmri.1880050311; McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004; Minehira K, 2008, J LIPID RES, V49, P2038, DOI 10.1194/jlr.M800248-JLR200; Monetti M, 2007, CELL METAB, V6, P69, DOI 10.1016/j.cmet.2007.05.005; National Heart Lung and Blood Institute, 1987, ATH RISK COMM ARIC S; Rietz S, 2004, PLANTA, V219, P743, DOI 10.1007/s00425-004-1275-9; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; STRICKLAND JA, 1995, PLANT PHYSIOL, V109, P667, DOI 10.1104/pp.109.2.667; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Wang MY, 2008, P NATL ACAD SCI USA, V105, P6139, DOI 10.1073/pnas.0801981105; Wilson PA, 2006, J LIPID RES, V47, P1940, DOI 10.1194/jlr.M600185-JLR200; YUAN X, AM J HUM GE IN PRESS; Zhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510	29	2060	2112	5	93	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1461	1465		10.1038/ng.257	http://dx.doi.org/10.1038/ng.257			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	18820647	Green Accepted			2022-12-27	WOS:000261215900023
J	Chadt, A; Leicht, K; Deshmukh, A; Jiang, LQ; Scherneck, S; Bernhardt, U; Dreja, T; Vogel, H; Schmolz, K; Kluge, R; Zierath, JR; Hultschig, C; Hoeben, RC; Schurmann, A; Joost, HG; Al-Hasani, H				Chadt, Alexandra; Leicht, Katja; Deshmukh, Atul; Jiang, Lake Q.; Scherneck, Stephan; Bernhardt, Ulrike; Dreja, Tanja; Vogel, Heike; Schmolz, Katja; Kluge, Reinhart; Zierath, Juleen R.; Hultschig, Claus; Hoeben, Rob C.; Schuermann, Annette; Joost, Hans-Georg; Al-Hasani, Hadi			Tbc1d1 mutation in lean mouse strain confers leanness and protects from diet-induced obesity	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; SUSCEPTIBILITY LOCUS; CELL DESTRUCTION; MICE; HYPERCHOLESTEROLEMIA; CARBOHYDRATE; CONTRIBUTES; DOMAIN; GENES; RISK	We previously identified Nob1 as a quantitative trait locus for high-fat diet-induced obesity and diabetes in genome-wide scans of outcross populations of obese and lean mouse strains. Additional crossbreeding experiments indicated that Nob1 represents an obesity suppressor from the lean Swiss Jim Lambert (SJL) strain. Here we identify a SJL-specific mutation in the Tbc1d1 gene that results in a truncated protein lacking the TBC Rab-GTPase-activating protein domain. TBC1D1, which has been recently linked to human obesity, is related to the insulin signaling protein AS160 and is predominantly expressed in skeletal muscle. Knockdown of TBC1D1 in skeletal muscle cells increased fatty acid uptake and oxidation, whereas overexpression of TBC1D1 had the opposite effect. Recombinant congenic mice lacking TBC1D1 showed reduced body weight, decreased respiratory quotient, increased fatty acid oxidation and reduced glucose uptake in isolated skeletal muscle. Our data strongly suggest that mutation of Tbc1d1 suppresses high-fat diet-induced obesity by increasing lipid use in skeletal muscle.	[Chadt, Alexandra; Leicht, Katja; Scherneck, Stephan; Bernhardt, Ulrike; Dreja, Tanja; Vogel, Heike; Schmolz, Katja; Kluge, Reinhart; Schuermann, Annette; Joost, Hans-Georg; Al-Hasani, Hadi] German Inst Nutr, Dept Pharmacol, Potsdam Rehbruecke, D-14558 Nuthetal, Germany; [Deshmukh, Atul; Jiang, Lake Q.; Zierath, Juleen R.] Karolinska Inst, Dept Mol Med & Surg, SE-17177 Stockholm, Sweden; [Hultschig, Claus] Max Planck Inst Mol Genet, Dept Vertebrate Genom, D-14195 Berlin, Germany; [Hoeben, Rob C.] Leiden Univ, Med Ctr, Dept Mol Cell Biol, NL-2300 RC Leiden, Netherlands	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Karolinska Institutet; Max Planck Society; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Al-Hasani, H (corresponding author), German Inst Nutr, Dept Pharmacol, Potsdam Rehbruecke, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany.	al-hasani@dife.de	Deshmukh, Atul S/R-1967-2019; Hoeben, Rob C./A-5771-2008; Deshmukh, Atul s/K-9572-2015; Joost, Hans-Georg/J-4462-2013	Deshmukh, Atul S/0000-0002-2278-1843; Hoeben, Rob C./0000-0001-9443-8377; Deshmukh, Atul s/0000-0002-2278-1843; Joost, Hans-Georg/0000-0002-5860-606X; Scherneck, Stephan/0000-0002-2811-5040; Zierath, Juleen/0000-0001-6891-7497; Schurmann, Annette/0000-0002-4113-4377	German Bundesministerium fur Bildung und Forschung [NGFN2, 01GS0487, 01GR0472, 0313325]; Deutsche Forschungsgemeinschaft [FOR441, Jo-117/11-2, GRK-1208]; Swedish Research Council; European Union [EUGENE2, LSHM-CT-2004-512013, SysProt, LSHG-CT-2006-37457]	German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Swedish Research Council(Swedish Research CouncilEuropean Commission); European Union(European Commission)	We thank C. Borchert, P. Grossmann, A. Karasinsky, B. Rischke and T. Przewieslik for expert technical assistance; R. Herwig for the array analysis; and F. Russchendorf for the linkage analysis. This work was supported in part by the German Bundesministerium fur Bildung und Forschung (NGFN2, 01GS0487 and 01GR0472; PhysioSim, 0313325), the Deutsche Forschungsgemeinschaft (FOR441, Jo-117/11-2 and GRK-1208), the Swedish Research Council and the European Union (EUGENE2, LSHM-CT-2004-512013; SysProt, LSHG-CT-2006-37457).	Barnes BR, 2004, J BIOL CHEM, V279, P38441, DOI 10.1074/jbc.M405533200; Bastie CC, 2004, DIABETES, V53, P2209, DOI 10.2337/diabetes.53.9.2209; Bernards A, 2003, BBA-REV CANCER, V1603, P47, DOI 10.1016/S0304-419X(02)00082-3; Carlotti F, 2004, MOL THER, V9, P209, DOI 10.1016/j.ymthe.2003.11.021; CROFFORD OB, 1965, METABOLIS, V14, P271, DOI 10.1016/0026-0495(65)90068-5; Giesen K, 2003, BIOCHEM BIOPH RES CO, V304, P812, DOI 10.1016/S0006-291X(03)00664-8; Herwig R, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.23.e117; Jurgens HS, 2007, DIABETOLOGIA, V50, P1481, DOI 10.1007/s00125-007-0662-8; Jurgens HS, 2006, PHYSIOL GENOMICS, V25, P234, DOI 10.1152/physiolgenomics.00252.2005; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kluge R, 2000, DIABETOLOGIA, V43, P1565, DOI 10.1007/s001250051570; Kotani K, 2004, J CLIN INVEST, V114, P1666, DOI 10.1172/JCI200421341; Leiter EH, 1998, DIABETES, V47, P1287, DOI 10.2337/diabetes.47.8.1287; Meyre D, 2008, HUM MOL GENET, V17, P1798, DOI 10.1093/hmg/ddn070; Ortlepp JR, 2000, EUR J CLIN INVEST, V30, P195; Pan XJ, 2006, NATURE, V442, P303, DOI 10.1038/nature04847; Plum L, 2000, DIABETES, V49, P1590, DOI 10.2337/diabetes.49.9.1590; Plum L, 2002, DIABETOLOGIA, V45, P823, DOI 10.1007/s00125-002-0796-7; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Rehwinkel J, 2006, TRENDS BIOCHEM SCI, V31, P639, DOI 10.1016/j.tibs.2006.09.005; Reifsnyder PC, 2000, GENOME RES, V10, P1568, DOI 10.1101/gr.147000; Sakkou M, 2007, CELL METAB, V5, P450, DOI 10.1016/j.cmet.2007.05.007; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Stone S, 2006, HUM MOL GENET, V15, P2709, DOI 10.1093/hmg/ddl204; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; Wong GW, 2004, P NATL ACAD SCI USA, V101, P10302, DOI 10.1073/pnas.0403760101; Wuschke S, 2007, INT J OBESITY, V31, P829, DOI 10.1038/sj.ijo.0803473; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	28	153	156	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1354	1359		10.1038/ng.244	http://dx.doi.org/10.1038/ng.244			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18931681				2022-12-27	WOS:000260501500030
J	Dieterich, C; Clifton, SW; Schuster, LN; Chinwalla, A; Delehaunty, K; Dinkelacker, I; Fulton, L; Fulton, R; Godfrey, J; Minx, P; Mitreva, M; Roeseler, W; Tian, H; Witte, H; Yang, SP; Wilson, RK; Sommer, RJ				Dieterich, Christoph; Clifton, Sandra W.; Schuster, Lisa N.; Chinwalla, Asif; Delehaunty, Kimberly; Dinkelacker, Iris; Fulton, Lucinda; Fulton, Robert; Godfrey, Jennifer; Minx, Pat; Mitreva, Makedonka; Roeseler, Waltraud; Tian, Huiyu; Witte, Hanh; Yang, Shiaw-Pyng; Wilson, Richard K.; Sommer, Ralf J.			The Pristionchus pacificus genome provides a unique perspective on nematode lifestyle and parasitism	NATURE GENETICS			English	Article							SEQUENCE; GENE; EVOLUTION; CELLULASES; ORTHOLOGS; FAMILIES; BEETLE	Here we present a draft genome sequence of the nematode Pristionchus pacificus, a species that is associated with beetles and is used as a model system in evolutionary biology. With 169 Mb and 23,500 predicted protein-coding genes, the P. pacificus genome is larger than those of Caenorhabditis elegans and the human parasite Brugia malayi. Compared to C. elegans, the P. pacificus genome has more genes encoding cytochrome P450 enzymes, glucosyltransferases, sulfotransferases and ABC transporters, many of which were experimentally validated. The P. pacificus genome contains genes encoding cellulase and diapausin, and cellulase activity is found in P. pacificus secretions, indicating that cellulases can be found in nematodes beyond plant parasites. The relatively higher number of detoxification and degradation enzymes in P. pacificus is consistent with its necromenic lifestyle and might represent a preadaptation for parasitism. Thus, comparative genomics analysis of three ecologically distinct nematodes offers a unique opportunity to investigate the association between genome structure and lifestyle.	[Clifton, Sandra W.; Chinwalla, Asif; Delehaunty, Kimberly; Fulton, Lucinda; Fulton, Robert; Godfrey, Jennifer; Minx, Pat; Mitreva, Makedonka; Yang, Shiaw-Pyng; Wilson, Richard K.] Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63108 USA; [Dieterich, Christoph; Schuster, Lisa N.; Dinkelacker, Iris; Roeseler, Waltraud; Tian, Huiyu; Witte, Hanh; Sommer, Ralf J.] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany	Washington University (WUSTL); Max Planck Society	Wilson, RK (corresponding author), Washington Univ, Sch Med, Genome Sequencing Ctr, Campus Box 8501,Forest Pk Blvd, St Louis, MO 63108 USA.	rwilson@wustl.edu; ralf.sommer@tuebingen.mpg.de	Dieterich, Christoph/ABF-8459-2021; Wilson, Richard K./AAF-4139-2019	Wilson, Richard K./0000-0002-1992-1358; Mitreva, Makedonka/0000-0001-9572-3436; Chinwalla, Asif/0000-0001-7831-3996	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079] Funding Source: NIH RePORTER; NHGRI NIH HHS [U54 HG003079] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Alexeyenko A, 2006, BIOINFORMATICS, V22, pE9, DOI 10.1093/bioinformatics/btl213; Allen JE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s9; Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502; Blaxter M, 2007, CELL HOST MICROBE, V2, P211, DOI 10.1016/j.chom.2007.09.008; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Herrmann M, 2007, ZOOL SCI, V24, P883, DOI 10.2108/zsj.24.883; Hong RL, 2006, BIOESSAYS, V28, P651, DOI 10.1002/bies.20404; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; Huang XQ, 2006, NUCLEIC ACIDS RES, V34, P201, DOI 10.1093/nar/gkj419; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Keen NT, 1998, P NATL ACAD SCI USA, V95, P4789, DOI 10.1073/pnas.95.9.4789; Kikuchi T, 2004, FEBS LETT, V572, P201, DOI 10.1016/j.febslet.2004.07.039; Kiontke Karin, 2005, P1; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Mayer WE, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-104; Oesch F, 1999, TOXICOLOGY, P83; Poulin R., 2007, EVOL ECOL, V2; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Schlager B, 2006, CURR BIOL, V16, P1386, DOI 10.1016/j.cub.2006.06.058; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Smant G, 1998, P NATL ACAD SCI USA, V95, P4906, DOI 10.1073/pnas.95.9.4906; Sommer RJ, 1996, FUND APPL NEMATOL, V19, P511; Srinivasan J, 2002, GENETICS, V162, P129; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Stein LD, 2003, PLOS BIOL, V1, P166, DOI 10.1371/journal.pbio.0000045; Tanaka H, 2003, PEPTIDES, V24, P1327, DOI 10.1016/j.peptides.2003.07.021; Tian H, 2008, CURR BIOL, V18, P142, DOI 10.1016/j.cub.2007.12.048; Weischer B., 2000, INTRO NEMATODES; Yi BQ, 2007, DEVELOPMENT, V134, P3111, DOI 10.1242/dev.008375; Zheng M, 2005, NAT GENET, V37, P300, DOI 10.1038/ng1512	37	262	267	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2008	40	10					1193	1198		10.1038/ng.227	http://dx.doi.org/10.1038/ng.227			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18806794	Green Accepted			2022-12-27	WOS:000259651000018
J	Ferreira, MAR; O'Donovan, MC; Meng, YA; Jones, IR; Ruderfer, DM; Jones, L; Fan, J; Kirov, G; Perlis, RH; Green, EK; Smoller, JW; Grozeva, D; Stone, J; Nikolov, I; Chambert, K; Hamshere, ML; Nimgaonkar, VL; Moskvina, V; Thase, ME; Caesar, S; Sachs, GS; Franklin, J; Gordon-Smith, K; Ardlie, KG; Gabriel, SB; Fraser, C; Blumenstiel, B; Defelice, M; Breen, G; Gill, M; Morris, DW; Elkin, A; Muir, WJ; McGhee, KA; Williamson, R; MacIntyre, DJ; MacLean, AW; Clair, DS; Robinson, M; Van Beck, M; Pereira, ACP; Kandaswamy, R; McQuillin, A; Collier, DA; Bass, NJ; Young, AH; Lawrence, J; Ferrier, IN; Anjorin, A; Farmer, A; Curtis, D; Scolnick, EM; McGuffin, P; Daly, MJ; Corvin, AP; Holmans, PA; Blackwood, DH; Gurling, HM; Owen, MJ; Purcell, SM; Sklar, P; Craddock, N				Ferreira, Manuel A. R.; O'Donovan, Michael C.; Meng, Yan A.; Jones, Ian R.; Ruderfer, Douglas M.; Jones, Lisa; Fan, Jinbo; Kirov, George; Perlis, Roy H.; Green, Elaine K.; Smoller, Jordan W.; Grozeva, Detelina; Stone, Jennifer; Nikolov, Ivan; Chambert, Kimberly; Hamshere, Marian L.; Nimgaonkar, Vishwajit L.; Moskvina, Valentina; Thase, Michael E.; Caesar, Sian; Sachs, Gary S.; Franklin, Jennifer; Gordon-Smith, Katherine; Ardlie, Kristin G.; Gabriel, Stacey B.; Fraser, Christine; Blumenstiel, Brendan; Defelice, Matthew; Breen, Gerome; Gill, Michael; Morris, Derek W.; Elkin, Amanda; Muir, Walter J.; McGhee, Kevin A.; Williamson, Richard; MacIntyre, Donald J.; MacLean, Alan W.; Clair, David St; Robinson, Michelle; Van Beck, Margaret; Pereira, Ana C. P.; Kandaswamy, Radhika; McQuillin, Andrew; Collier, David A.; Bass, Nicholas J.; Young, Allan H.; Lawrence, Jacob; Ferrier, I. Nicol; Anjorin, Adebayo; Farmer, Anne; Curtis, David; Scolnick, Edward M.; McGuffin, Peter; Daly, Mark J.; Corvin, Aiden P.; Holmans, Peter A.; Blackwood, Douglas H.; Gurling, Hugh M.; Owen, Michael J.; Purcell, Shaun M.; Sklar, Pamela; Craddock, Nick		Wellcome Trust Case Control Consor	Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder	NATURE GENETICS			English	Article							LOCI; DISEASES; RANVIER; GENES	To identify susceptibility loci for bipolar disorder, we tested 1.8 million variants in 4,387 cases and 6,209 controls and identified a region of strong association (rs10994336, P = 9.1 x 10(-9)) in ANK3 (ankyrin G). We also found further support for the previously reported CACNA1C (alpha 1C subunit of the L-type voltage-gated calcium channel; combined P = 7.0 x 10(-8), rs1006737). Our results suggest that ion channelopathies may be involved in the pathogenesis of bipolar disorder.	[Ferreira, Manuel A. R.; Meng, Yan A.; Ruderfer, Douglas M.; Fan, Jinbo; Perlis, Roy H.; Stone, Jennifer; Sachs, Gary S.; Purcell, Shaun M.; Sklar, Pamela] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Ferreira, Manuel A. R.; Meng, Yan A.; Smoller, Jordan W.; Stone, Jennifer; Sachs, Gary S.; Purcell, Shaun M.; Sklar, Pamela] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA; [Ferreira, Manuel A. R.; Meng, Yan A.; Ruderfer, Douglas M.; Fan, Jinbo; Perlis, Roy H.; Stone, Jennifer; Purcell, Shaun M.; Sklar, Pamela] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Ctr Human Genet Res, Boston, MA 02114 USA; [Ferreira, Manuel A. R.; Meng, Yan A.; Ruderfer, Douglas M.; Fan, Jinbo; Perlis, Roy H.; Smoller, Jordan W.; Stone, Jennifer; Chambert, Kimberly; Ardlie, Kristin G.; Gabriel, Stacey B.; Blumenstiel, Brendan; Defelice, Matthew; Scolnick, Edward M.; Daly, Mark J.; Purcell, Shaun M.; Sklar, Pamela] Harvard Univ, Stanley Ctr Psychiat Res, Broad Inst, Cambridge, MA 02142 USA; [Ferreira, Manuel A. R.; Meng, Yan A.; Ruderfer, Douglas M.; Fan, Jinbo; Perlis, Roy H.; Smoller, Jordan W.; Stone, Jennifer; Chambert, Kimberly; Ardlie, Kristin G.; Gabriel, Stacey B.; Blumenstiel, Brendan; Defelice, Matthew; Scolnick, Edward M.; Daly, Mark J.; Purcell, Shaun M.; Sklar, Pamela] MIT, Cambridge, MA 02142 USA; [Ferreira, Manuel A. R.] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [O'Donovan, Michael C.; Jones, Ian R.; Kirov, George; Green, Elaine K.; Grozeva, Detelina; Nikolov, Ivan; Hamshere, Marian L.; Moskvina, Valentina; Fraser, Christine; Holmans, Peter A.; Owen, Michael J.; Craddock, Nick] Cardiff Univ, Sch Med, Dept Psychol Med, Cardiff CF14 4XN, England; [Jones, Lisa; Caesar, Sian; Gordon-Smith, Katherine] Univ Birmingham, Div Neurosci, Dept Psychiat, Birmingham B15 2QZ, England; [Nikolov, Ivan; Hamshere, Marian L.; Moskvina, Valentina; Holmans, Peter A.] Cardiff Univ, Sch Med, Biostat & Bioinformat Unit, Cardiff CF14 4XN, England; [Nimgaonkar, Vishwajit L.] Univ Pittsburgh, Western Psychiat Inst & Clin, Pittsburgh, PA 15213 USA; [Thase, Michael E.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Thase, Michael E.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA 15213 USA; [Breen, Gerome; Clair, David St] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; [Breen, Gerome; Elkin, Amanda; Williamson, Richard; Collier, David A.; McGuffin, Peter] Kings Coll London, Inst Psychiat, SGDP, London SE5 8AF, England; [Gill, Michael; Morris, Derek W.; Corvin, Aiden P.] St James Hosp, Trinity Coll, Trinity Ctr hlth Sci, Dublin 8, Ireland; [Muir, Walter J.; McGhee, Kevin A.; MacIntyre, Donald J.; MacLean, Alan W.; Van Beck, Margaret; Blackwood, Douglas H.] Univ Edinburgh, Royal Edinburgh Hosp, Div Psychiat, Edinburgh EH10 5HF, Midlothian, Scotland; [Robinson, Michelle; Pereira, Ana C. P.; Kandaswamy, Radhika; McQuillin, Andrew; Bass, Nicholas J.; Lawrence, Jacob; Anjorin, Adebayo; Curtis, David; Gurling, Hugh M.] UCL, Windeyer Inst Med Sci, Dept Mental Hlth Sci, Mol Psychiat Lab, London W1T 4JF, England; [Young, Allan H.; Ferrier, I. Nicol] Royal Victoria Infirm, Sch Neurol Neurolbiol & Psychiat, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Young, Allan H.] UBC, Inst Mental Hlth, Vancouver, BC V6T 2A1, Canada; [Scolnick, Edward M.; Sklar, Pamela] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Daly, Mark J.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Daly, Mark J.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Daly, Mark J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); QIMR Berghofer Medical Research Institute; Cardiff University; University of Birmingham; Cardiff University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Western Psychiatric Institute & Clinic of UPMC; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Aberdeen; University of London; King's College London; Trinity College Dublin; Royal Infirmary of Edinburgh; University of Edinburgh; University of London; University College London; Newcastle University - UK; University of British Columbia; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Sklar, P (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA.	sklar@chgr.mgh.harvard.edu; craddockn@Cardiff.ac.uk	Holmans, Peter/F-4518-2015; Curtis, David/HGB-3921-2022; Daly, Mark J/B-2453-2017; Breen, Gerome D/A-5540-2010; Jones, Ian R/B-4925-2009; blackwood, douglas/AIB-8874-2022; Morris, Derek/AAW-8343-2021; Ferreira, Manuel A R/D-3609-2013; Breen, Gerome/Y-2706-2019; McQuillin, Andrew/C-1623-2008; McGuffin, Peter/A-1565-2012; O'Donovan, Michael C/P-7005-2018; Gurling, Hugh M/A-5029-2010; Collier, David A/D-1649-2011; Ruderfer, Douglas M/M-5795-2016; anand, amit/A-7222-2009	Holmans, Peter/0000-0003-0870-9412; Curtis, David/0000-0002-4089-9183; Daly, Mark J/0000-0002-0949-8752; Breen, Gerome D/0000-0003-2053-1792; Jones, Ian R/0000-0001-5821-5889; Morris, Derek/0000-0002-3413-570X; Ferreira, Manuel A R/0000-0001-9059-1825; Breen, Gerome/0000-0003-2053-1792; McQuillin, Andrew/0000-0003-1567-2240; McGuffin, Peter/0000-0002-9888-2907; O'Donovan, Michael C/0000-0001-7073-2379; Collier, David A/0000-0003-4087-1559; Ruderfer, Douglas M/0000-0002-2365-386X; Escott-Price, Valentina/0000-0003-1784-5483; Corvin, Aiden/0000-0001-6717-4089; Gill, Michael/0000-0003-0206-5337; Kirov, George/0000-0002-3427-3950; MacIntyre, Donald J/0000-0001-6963-1335; Grozeva, Detelina/0000-0003-3239-8415; Gordon-Smith, Katherine/0000-0003-4083-1143; Walters, James/0000-0002-6980-4053; Jones, Lisa/0000-0002-5122-8334	US National Institute of Mental Health [MH062137, MH067288, MH063445, MH63420, N01MH80001]; Johnson & Johnson Pharmaceutical Research & Development, Sylvan C. Herman Foundation, Stanley Medical Research Institute, Dauten Family, Merck Genome Research Institute; National Health Medical Research Council; National Center for Research Resources [U54 RR020278]; MDF - The Bipolar Organization; Neuroscience Research Charitable Trust; central London NHS Blood Transfusion Service; Priory Hospitals; UK MRC [G9623693N, G0500791]; Health Research Board and Science Foundation Ireland; Trinity College Biobank; Wellcome Trust, London; Chief Scientist Office of the Scottish Executive; MRC, London; MRC [G9309834, G0500791, G0701003] Funding Source: UKRI; Medical Research Council [G9309834, G0701003, G0500791] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067288, R01MH063445, R01MH063420, R01MH062137, N01MH080001] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Johnson & Johnson Pharmaceutical Research & Development, Sylvan C. Herman Foundation, Stanley Medical Research Institute, Dauten Family, Merck Genome Research Institute(Johnson & JohnsonJohnson & Johnson USA); National Health Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); MDF - The Bipolar Organization; Neuroscience Research Charitable Trust; central London NHS Blood Transfusion Service; Priory Hospitals; UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Health Research Board and Science Foundation Ireland(Science Foundation Ireland); Trinity College Biobank; Wellcome Trust, London(Wellcome Trust); Chief Scientist Office of the Scottish Executive; MRC, London(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Study supported by US National Institute of Mental Health (MH062137, MH067288, P. S.; MH063445, J. W. S.; MH63420, V. L. N.; N01MH80001, G. S. S., M. E. T. and M. S. Bauer), NARSAD (R. H. P., S. P., J. F., P. S.); Johnson & Johnson Pharmaceutical Research & Development, Sylvan C. Herman Foundation, Stanley Medical Research Institute, Dauten Family, Merck Genome Research Institute (E. M. S.); and National Health Medical Research Council (MRC), Australia (M. A. R. F.). Broad Institute Center for Genotyping and Analysis supported by U54 RR020278, National Center for Research Resources. UCL sample collection supported by MDF - The Bipolar Organization, Neuroscience Research Charitable Trust, central London NHS Blood Transfusion Service, Priory Hospitals and UK MRC (G9623693N, G0500791). Dublin sample collection supported by the Health Research Board and Science Foundation Ireland; controls supplied by J. McPartlin, Trinity College Biobank. Edinburgh cohort collection supported by the Wellcome Trust, London, Chief Scientist Office of the Scottish Executive and MRC, London. WTCCC genotype analyses were funded by the Wellcome Trust and undertaken within the context of the WTCCC. WTCCC members are listed in Supplementary Note.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Evans DM, 2006, PLOS GENET, V2, P1424, DOI 10.1371/journal.pgen.0020157; Gargus JJ, 2006, BIOL PSYCHIAT, V60, P177, DOI 10.1016/j.biopsych.2005.12.008; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; KORDELI E, 1995, J BIOL CHEM, V270, P2352, DOI 10.1074/jbc.270.5.2352; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; McQuillin A, 2007, PHARMACOGENET GENOM, V17, P605, DOI 10.1097/FPC.0b013e328011b5b2; Poliak S, 2003, NAT REV NEUROSCI, V4, P968, DOI 10.1038/nrn1253; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Sklar P, 2008, MOL PSYCHIATR, V13, P558, DOI 10.1038/sj.mp.4002151	15	890	907	0	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2008	40	9					1056	1058		10.1038/ng.209	http://dx.doi.org/10.1038/ng.209			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	18711365	Green Accepted			2022-12-27	WOS:000258761200015
J	Yamaji, M; Seki, Y; Kurimoto, K; Yabuta, Y; Yuasa, M; Shigeta, M; Yamanaka, K; Ohinata, Y; Saitou, M				Yamaji, Masashi; Seki, Yoshiyuki; Kurimoto, Kazuki; Yabuta, Yukihiro; Yuasa, Mihoko; Shigeta, Mayo; Yamanaka, Kaori; Ohinata, Yasuhide; Saitou, Mitinori			Critical function of Prdm14 for the establishment of the germ cell lineage in mice	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; OLIGONUCLEOTIDE MICROARRAY ANALYSIS; CDNA AMPLIFICATION; BREAST CANCERS; MOUSE EMBRYO; SPECIFICATION; EXPRESSION; DYNAMICS; BLIMP1; SOX2	Specification of germ cell fate is fundamental in development and heredity. Recent evidence indicates that in mice, specification of primordial germ cells (PGCs), the common source of both oocytes and spermatozoa, occurs through the integration of three key events: repression of the somatic program(1), reacquisition of potential pluripotency(2,3) and ensuing genome-wide epigenetic reprogramming(4,5). Here we provide genetic evidence that Prdm14, a PR domain-containing transcriptional regulator with exclusive expression in the germ cell lineage and pluripotent cell lines, is critical in two of these events, the reacquisition of potential pluripotency and successful epigenetic reprogramming. In Prdm14 mutants, the failure of these two events manifests even in the presence of Prdm1 (also known as Blimp1), a key transcriptional regulator for PGC specification(6,7). Our combined evidence demonstrates that Prdm14 defines a previously unknown genetic pathway, initiating independently from Prdm1, for ensuring the launching of the mammalian germ cell lineage.	[Yamaji, Masashi; Seki, Yoshiyuki; Kurimoto, Kazuki; Yabuta, Yukihiro; Yuasa, Mihoko; Shigeta, Mayo; Yamanaka, Kaori; Ohinata, Yasuhide; Saitou, Mitinori] RIKEN, Kobe Inst, Ctr Dev Biol, Lab Mammalian Germ Cell Biol,Chuo Ku, Kobe, Hyogo 6500047, Japan; [Saitou, Mitinori] Kyoto Univ, Grad Sch Biostudies, Lab Mol Cell Biol & Dev, Sakyo Ku, Kyoto 6068501, Japan	RIKEN; Kyoto University	Saitou, M (corresponding author), RIKEN, Kobe Inst, Ctr Dev Biol, Lab Mammalian Germ Cell Biol,Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	saitou@cdb.riken.jp	Yamaji, Masashi/ABA-5267-2020	Yamaji, Masashi/0000-0002-8215-2184				Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; BERNSTEIN A, 1990, CIBA F SYMP, V148, P158; Bernstein A, 1990, CIBA F SYMP, V148, P166; Cox WG, 1999, J HISTOCHEM CYTOCHEM, V47, P1443, DOI 10.1177/002215549904701110; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Hayashi K, 2002, MECH DEVELOP, V118, P99, DOI 10.1016/S0925-4773(02)00237-X; Hu M, 2005, NAT GENET, V37, P899, DOI 10.1038/ng1596; Kimura T, 2003, DEVELOPMENT, V130, P1691, DOI 10.1242/dev.00392; Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050; Kurimoto K, 2007, NAT PROTOC, V2, P739, DOI 10.1038/nprot.2007.79; Lawson KA, 1999, GENE DEV, V13, P424, DOI 10.1101/gad.13.4.424; Maruyama M, 2005, J BIOL CHEM, V280, P24371, DOI 10.1074/jbc.M501423200; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nishikawa N, 2007, CANCER RES, V67, P9649, DOI 10.1158/0008-5472.CAN-06-4111; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Saitou M, 1997, EUR J CELL BIOL, V73, P222; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Saitou M, 2005, CELL CYCLE, V4, P1736, DOI 10.4161/cc.4.12.2209; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Vincent SD, 2005, DEVELOPMENT, V132, P1315, DOI 10.1242/dev.01711; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595	31	396	420	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					1016	1022		10.1038/ng.186	http://dx.doi.org/10.1038/ng.186			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18622394				2022-12-27	WOS:000258026900020
J	[Anonymous]				[Anonymous]			All in the mind	NATURE GENETICS			English	Editorial Material																		Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174	4	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					805	805		10.1038/ng0708-805	http://dx.doi.org/10.1038/ng0708-805			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18583963	Bronze			2022-12-27	WOS:000257166500001
J	Kanno, T; Bucher, E; Daxinger, L; Huettel, B; Bohmdorfer, G; Gregor, W; Kreil, DP; Matzke, M; Matzke, AJM				Kanno, Tatsuo; Bucher, Etienne; Daxinger, Lucia; Huettel, Bruno; Boehmdorfer, Gudrun; Gregor, Wolfgang; Kreil, David P.; Matzke, Marjori; Matzke, Antonius J. M.			A structural-maintenance-of-chromosomes hinge domain-containing protein is required for RNA-directed DNA methylation	NATURE GENETICS			English	Article							SEQUENCES; GENOME; IV; TRANSCRIPTION; DIMERIZATION; PATHWAY; GENE; DRD1	RNA-directed DNA methylation (RdDM) is a process in which dicer-generated small RNAs guide de novo cytosine methylation at the homologous DNA region(1,2). To identify components of the RdDM machinery important for Arabidopsis thaliana development, we targeted an enhancer active in meristems for methylation, which resulted in silencing of a downstream GFP reporter gene. This silencing system also features secondary siRNAs, which trigger methylation that spreads beyond the targeted enhancer region. A screen for mutants defective in meristem silencing and enhancer methylation retrieved six dms complementation groups, which included the known factors DRD1 (ref. 3; a SNF2-like chromatin-remodeling protein) and Pol IVb subunits(4,5). Additionally, we identified a previously unknown gene DMS3 (At3g49250), encoding a protein similar to the hinge-domain region of structural maintenance of chromosomes (SMC) proteins. This finding implicates a putative chromosome architectural protein that can potentially link nucleic acids(6) in facilitating an RNAi-mediated epigenetic modification involving secondary siRNAs and spreading of DNA methylation.	[Kanno, Tatsuo; Bucher, Etienne; Daxinger, Lucia; Huettel, Bruno; Boehmdorfer, Gudrun; Matzke, Marjori; Matzke, Antonius J. M.] Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, A-1030 Vienna, Austria; [Gregor, Wolfgang] Univ Vet Med, Res Grp Mol Pharmacol & Toxicol, Dept Sci, A-1210 Vienna, Austria; [Kreil, David P.] Boku Univ, Dept Bioinformat, A-1190 Vienna, Austria	Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); University of Veterinary Medicine Vienna; University of Natural Resources & Life Sciences, Vienna	Matzke, M (corresponding author), Austrian Acad Sci, Gregor Mendel Inst Mol Plant Biol, Dr Bohrgasse 3, A-1030 Vienna, Austria.	marjori.matzke@gmi.oeaw.ac.at	Bucher, Etienne/E-7681-2013; Daxinger, Lucia/A-6840-2013; Kreil, D/O-1783-2013; Matzke, Marjori/H-8689-2015; Matzke, Antonius/H-8698-2015	Bucher, Etienne/0000-0002-3114-3763; Kreil, D/0000-0001-7538-2056; Daxinger, Lucia/0000-0001-6557-6201; KANNO, Tatsuo/0000-0001-5958-4686				Aufsatz W, 2002, P NATL ACAD SCI USA, V99, P16499, DOI 10.1073/pnas.162371499; Baulcombe DC, 2007, SCIENCE, V315, P199, DOI 10.1126/science.1138030; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Chiu A, 2004, J BIOL CHEM, V279, P26233, DOI 10.1074/jbc.M402439200; Cobbe N, 2006, GENETICS, V172, P991, DOI 10.1534/genetics.105.050567; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Frishman D, 1996, PROTEIN ENG, V9, P133, DOI 10.1093/protein/9.2.133; Gregor W, 2004, PLANT PHYSIOL, V134, P1191, DOI 10.1104/pp.103.031112; Hagstrom KA, 2003, NAT REV GENET, V4, P520, DOI 10.1038/nrg1110; Hazen SP, 2005, PLANT PHYSIOL, V138, P990, DOI 10.1104/pp.105.061408; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Hirano M, 2002, EMBO J, V21, P5733, DOI 10.1093/emboj/cdf575; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Huettel B, 2007, BBA-GENE STRUCT EXPR, V1769, P358, DOI 10.1016/j.bbaexp.2007.03.001; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Kanno T, 2004, CURR BIOL, V14, P801, DOI 10.1016/j.cub.2004.04.037; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; KONIECZNY A, 1993, PLANT J, V4, P403, DOI 10.1046/j.1365-313X.1993.04020403.x; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; Mette MF, 2002, EMBO J, V21, P461, DOI 10.1093/emboj/21.3.461; Obayashi T, 2007, NUCLEIC ACIDS RES, V35, pD863, DOI 10.1093/nar/gkl783; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Vaistij FE, 2002, PLANT CELL, V14, P857, DOI 10.1105/tpc.010480; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2	29	154	164	1	35	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					670	675		10.1038/ng.119	http://dx.doi.org/10.1038/ng.119			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18425128				2022-12-27	WOS:000255366700038
J	Hunt, KA; Zhernakova, A; Turner, G; Heap, GAR; Franke, L; Bruinenberg, M; Romanos, J; Dinesen, LC; Ryan, AW; Panesar, D; Gwilliam, R; Takeuchi, F; McLaren, WM; Holmes, GKT; Howdle, PD; Walters, JRF; Sanders, DS; Playford, RJ; Trynka, G; Mulder, CJJ; Mearin, ML; Verbeek, WHM; Trimble, V; Stevens, FM; O'Morain, C; Kennedy, NP; Kelleher, D; Pennington, DJ; Strachan, DP; McArdle, WL; Mein, CA; Wapenaar, MC; Deloukas, P; McGinnis, R; McManus, R; Wijmenga, C; van Heel, DA				Hunt, Karen A.; Zhernakova, Alexandra; Turner, Graham; Heap, Graham A. R.; Franke, Lude; Bruinenberg, Marcel; Romanos, Jihane; Dinesen, Lotte C.; Ryan, Anthony W.; Panesar, Davinder; Gwilliam, Rhian; Takeuchi, Fumihiko; McLaren, William M.; Holmes, Geoffrey K. T.; Howdle, Peter D.; Walters, Julian R. F.; Sanders, David S.; Playford, Raymond J.; Trynka, Gosia; Mulder, Chris J. J.; Mearin, M. Luisa; Verbeek, Wieke H. M.; Trimble, Valerie; Stevens, Fiona M.; O'Morain, Colm; Kennedy, Nicholas P.; Kelleher, Dermot; Pennington, Daniel J.; Strachan, David P.; McArdle, Wendy L.; Mein, Charles A.; Wapenaar, Martin C.; Deloukas, Panos; McGinnis, Ralph; McManus, Ross; Wijmenga, Cisca; van Heel, David A.			Newly identified genetic risk variants for celiac disease related to the immune response	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RHEUMATOID-ARTHRITIS; B-LYMPHOCYTES; REPLICATION; PROTEIN; POPULATION; ACTIVATION; EXPRESSION; REGION; MOUSE	Our genome-wide association study of celiac disease previously identified risk variants in the IL2-IL21 region. To identify additional risk variants, we genotyped 1,020 of the most strongly associated non-HLA markers in an additional 1,643 cases and 3,406 controls. Through joint analysis including the genome-wide association study data (767 cases, 1,422 controls), we identified seven previously unknown risk regions (P < 5 x 10(-7)). Six regions harbor genes controlling immune responses, including CCR3, IL12A, IL18RAP, RGS1, SH2B3 (nsSNP rs3184504) and TAGAP. Whole-blood IL18RAP mRNA expression correlated with IL18RAP genotype. Type 1 diabetes and celiac disease share HLA-DQ, IL2-IL21, CCR3 and SH2B3 risk regions. Thus, this extensive genome-wide association follow-up study has identified additional celiac disease risk variants in relevant biological pathways.	[Hunt, Karen A.; Heap, Graham A. R.; Panesar, Davinder; Playford, Raymond J.; Pennington, Daniel J.; van Heel, David A.] Inst Cell & Mol Sci, Barts E1 2AT, England; [Zhernakova, Alexandra; Franke, Lude; Wijmenga, Cisca] Univ Utrecht, Med Ctr, Dept Biomed Genet, Complex Genet Sect, NL-3584 CG Utrecht, Netherlands; [Hunt, Karen A.; Heap, Graham A. R.; Panesar, Davinder; Playford, Raymond J.; Pennington, Daniel J.; van Heel, David A.] London Sch Med & Dent, London E1 2AT, England; [Turner, Graham; Ryan, Anthony W.; Trimble, Valerie; O'Morain, Colm; Kennedy, Nicholas P.; Kelleher, Dermot; McManus, Ross] Trinity Coll Dublin, Inst Mol Med, Dept Clin Med, Dublin, Ireland; [Bruinenberg, Marcel; Romanos, Jihane; Trynka, Gosia; Wapenaar, Martin C.; Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Bruinenberg, Marcel; Romanos, Jihane; Trynka, Gosia; Wapenaar, Martin C.; Wijmenga, Cisca] Univ Groningen, NL-9700 RB Groningen, Netherlands; [Dinesen, Lotte C.] Univ Oxford, Gastroenterol Unit, Oxford OX3 7BN, England; [Gwilliam, Rhian; Takeuchi, Fumihiko; McLaren, William M.; Deloukas, Panos; McGinnis, Ralph] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Holmes, Geoffrey K. T.] Derbyshire Royal Infirm, Dept Gastroenterol, Derby DE1 2QY, England; [Howdle, Peter D.] St James Univ Hosp, Acad Med Unit, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Walters, Julian R. F.] Hammersmith Hosp, Univ London Imperial Coll Sci Technol & Med, Gastroenterol Sect, London W12 0HS, England; [Sanders, David S.] Royal Hallamshire Hosp, Dept Gastroenterol, Sheffield S10 2JF, S Yorkshire, England; [Sanders, David S.] Royal Hallamshire Hosp, Liver Unit, Sheffield S10 2JF, S Yorkshire, England; [Mulder, Chris J. J.; Verbeek, Wieke H. M.] VU Med Ctr, Dept Gastroenterol, NL-1007 MB Amsterdam, Netherlands; [Mearin, M. Luisa] VU Med Ctr, Dept Pediat Gastroenterol, NL-1007 MB Amsterdam, Netherlands; [Mearin, M. Luisa] Leiden Univ, Med Ctr, Dept Paediat Gastroenterol, NL-2300 RC Leiden, Netherlands; [Stevens, Fiona M.] Natl Univ Ireland, Dept Med, Galway, Ireland; [Strachan, David P.] Univ London St Georges Hosp, Div Commun Hlth Sci, London SW17 0RE, England; [McArdle, Wendy L.] Univ Bristol, ALSPAC, Bristol BS8 1TQ, Avon, England; [Mein, Charles A.] London Sch Med & Dent, London EC1M 6BQ, England; [Mein, Charles A.] Genome Ctr, Barts EC1M 6BQ, England	University of London; Queen Mary University London; Utrecht University; University of London; Queen Mary University London; Trinity College Dublin; University of Groningen; University of Groningen; University of Oxford; Wellcome Trust Sanger Institute; Saint James's University Hospital; University of Leeds; Imperial College London; University of Sheffield; University of Sheffield; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Ollscoil na Gaillimhe-University of Galway; St Georges University London; University of Bristol; University of London; Queen Mary University London	van Heel, DA (corresponding author), Inst Cell & Mol Sci, 4 Newark St, Barts E1 2AT, England.	d.vanheel@qmul.ac.uk	Franke, Lude/P-7036-2016; McManus, Ross/AAE-9236-2020; Wijmenga, Cisca/D-2173-2009; Heap, Graham/A-9344-2011; Deloukas, Panos/B-2922-2013; Walters, Julian/D-5189-2009; Romanos, Jihane/F-7372-2012; Ryan, Anthony W/A-1336-2010; Wijmenga, Cisca/AAE-7719-2019; Zhernakova, Alexandra/ABA-9372-2020; Kennedy, Nicholas/A-8055-2008	Franke, Lude/0000-0002-5159-8802; Deloukas, Panos/0000-0001-9251-070X; Walters, Julian/0000-0001-9720-5835; Wijmenga, Cisca/0000-0002-5635-1614; Trynka, Gosia/0000-0002-6955-9529; van Heel, David/0000-0002-0637-2265; McManus, Ross/0000-0002-0529-9617; Heap, Graham/0000-0003-4131-6792; McGinnis, Ralph/0000-0003-4540-9857; Pennington, Daniel/0000-0001-7889-9923; Playford, Raymond/0000-0003-1235-8504; McLaren, William/0000-0001-6218-1116; Ryan, Anthony/0000-0001-5005-3344; Mein, Charles/0000-0003-0811-9658; Zhernakova, Alexandra/0000-0002-4574-0841	Medical Research Council [G0000934] Funding Source: Medline; Wellcome Trust [084743, GR068094MA, 068094, 068545/Z/02] Funding Source: Medline; MRC [G0000934] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abraham C, 2006, INFLAMM BOWEL DIS, V12, P641, DOI 10.1097/01.MIB.0000225332.83861.5f; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Clarke GM, 2007, AM J HUM GENET, V81, P995, DOI 10.1086/521952; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Han SB, 2005, IMMUNITY, V22, P343, DOI 10.1016/j.immuni.2005.01.017; Howard TD, 2002, AM J HUM GENET, V70, P230, DOI 10.1086/338242; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Li YJ, 2000, J IMMUNOL, V164, P5199, DOI 10.4049/jimmunol.164.10.5199; Mao M, 2004, GENOMICS, V83, P989, DOI 10.1016/j.ygeno.2003.12.019; Pennington DJ, 2003, NAT IMMUNOL, V4, P991, DOI 10.1038/ni979; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; ROSENTHAL R, 1991, META ANAL PROCEDURE; Salvati VM, 2002, GUT, V50, P186, DOI 10.1136/gut.50.2.186; Shi GX, 2004, J IMMUNOL, V172, P5175, DOI 10.4049/jimmunol.172.9.5175; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; van Heel DA, 2006, GUT, V55, P1037, DOI 10.1136/gut.2005.075119; van Heel DA, 2007, NAT GENET, V39, P827, DOI 10.1038/ng2058; Velazquez L, 2002, J EXP MED, V195, P1599, DOI 10.1084/jem.20011883; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zhernakova A, 2007, AM J HUM GENET, V81, P1284, DOI 10.1086/522037	29	479	496	2	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2008	40	4					395	402		10.1038/ng.102	http://dx.doi.org/10.1038/ng.102			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18311140	Green Submitted, Green Accepted			2022-12-27	WOS:000254388100009
J	Lu, J; Shen, Y; Wu, Q; Kumar, S; He, B; Shi, S; Carthew, RW; Wang, SM; Wu, CI				Lu, Jian; Shen, Yang; Wu, Qingfa; Kumar, Supriya; He, Bin; Shi, Suhua; Carthew, Richard W.; Wang, San Ming; Wu, Chung-I			The birth and death of microRNA genes in Drosophila	NATURE GENETICS			English	Article							ARABIDOPSIS-THALIANA; EXPRESSION; EVOLUTION; SEQUENCES; MELANOGASTER; BIOGENESIS; ELEGANS; CLONING; GENOME; RNAS	MicroRNAs (miRNAs) are small, endogenously expressed RNAs that regulate mRNAs post-transcriptionally. The class of miRNA genes, like other gene classes, should experience birth, death and persistence of its members. We carried out deep sequencing of miRNAs from three species of Drosophila, and obtained 107,000 sequences that map to no fewer than 300 loci that were not previously known. We observe a large class of miRNA genes that are evolutionarily young, with a rate of birth of 12 new genes per million years (Myr). Most of these new miRNAs originated from non-miRNA sequences. Among the new genes, we estimate that 96% disappeared quickly in the course of evolution; only 4% of new miRNA genes were retained by natural selection. Furthermore, only 60% of these retained genes became integrated into the transcriptome in the long run (60 Myr). This small fraction (2.5%) of surviving miRNAs may later on become moderately or highly expressed. Our results suggest that there is a high birth rate of new miRNA genes, accompanied by a comparably high death rate. The estimated net gain of long-lived miRNA genes, which is not strongly affected by either the depth or the breadth (number of tissues) of sequencing, is 0.3 genes per Myr in Drosophila.	[Lu, Jian; Kumar, Supriya; He, Bin; Wu, Chung-I] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Shen, Yang; Shi, Suhua; Wu, Chung-I] Sun Yat Sen Zhongshan Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Peoples R China; [Carthew, Richard W.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Wu, Qingfa; Wang, San Ming] Northwestern Univ, Feinberg Sch Med, Evanston Northwestern Healthcare Res Inst, Dept Med,Div Med Genet,Ctr Funct Genom, Evanston, IL 60208 USA	University of Chicago; Sun Yat Sen University; Northwestern University; Northwestern University; Feinberg School of Medicine	Wang, SM (corresponding author), Northwestern Univ, Feinberg Sch Med, Evanston Northwestern Healthcare Res Inst, Dept Med,Div Med Genet,Ctr Funct Genom, Evanston, IL 60208 USA.	swang1@northwestern.edu; ciwu@uchicago.edu	, san ming wang/ABG-4910-2020; He, Bin/AAB-6779-2020	He, Bin/0000-0002-3072-6238; Kumar, Supriya/0000-0001-8373-105X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077581] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM077581] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2006, NAT GENET, V38, P1375, DOI 10.1038/ng1914; Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; *DROS COMP GEN SEQ, 2007, NATURE, V450, P230; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hochsmann M, 2004, IEEE ACM T COMPUT BI, V1, P53, DOI 10.1109/TCBB.2004.11; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Manak JR, 2006, NAT GENET, V38, P1151, DOI 10.1038/ng1875; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Stark A, 2007, GENOME RES, V17, P1865, DOI 10.1101/gr.6593807; Steffen P, 2006, BIOINFORMATICS, V22, P500, DOI 10.1093/bioinformatics/btk010; Stolc V, 2004, SCIENCE, V306, P655, DOI 10.1126/science.1101312; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	26	200	220	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2008	40	3					351	355		10.1038/ng.73	http://dx.doi.org/10.1038/ng.73			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18278047				2022-12-27	WOS:000253548400028
J	Unger, S; Bohm, D; Kaiser, FJ; Kaulfuss, S; Borozdin, W; Buiting, K; Burfeind, P; Bohm, J; Barrionuevo, F; Craig, A; Borowski, K; Keppler-Noreuil, K; Schmitt-Mechelke, T; Steiner, B; Bartholdi, D; Lemke, J; Mortier, G; Sandford, R; Zabel, B; Superti-Furga, A; Kohlhase, J				Unger, Sheila; Boehm, Detlef; Kaiser, Frank J.; Kaulfuss, Silke; Borozdin, Wiktor; Buiting, Karin; Burfeind, Peter; Boehm, Johann; Barrionuevo, Francisco; Craig, Alexander; Borowski, Kristi; Keppler-Noreuil, Kim; Schmitt-Mechelke, Thomas; Steiner, Bernhard; Bartholdi, Deborah; Lemke, Johannes; Mortier, Geert; Sandford, Richard; Zabel, Bernhard; Superti-Furga, Andrea; Kohlhase, Juergen			Mutations in the cyclin family member FAM58A cause an X-linked dominant disorder characterized by syndactyly, telecanthus and anogenital and renal malformations	NATURE GENETICS			English	Article							GENE; PATTERN; SALL4; MYC	We identified four girls with a consistent constellation of facial dysmorphism and malformations previously reported in a single mother-daughter pair. Toe syndactyly, telecanthus and anogenital and renal malformations were present in all affected individuals; thus, we propose the name 'STAR syndrome' for this disorder. Using array CGH, qPCR and sequence analysis, we found causative mutations in FAM58A on Xq28 in all affected individuals, suggesting an X-linked dominant inheritance pattern for this recognizable syndrome.	[Boehm, Detlef; Borozdin, Wiktor; Kohlhase, Juergen] Ctr Human Genet Freiburg, D-79100 Freiburg, Germany; [Unger, Sheila; Boehm, Johann; Barrionuevo, Francisco; Craig, Alexander; Zabel, Bernhard] Univ Freiburg, Inst Human Genet, D-79106 Freiburg, Germany; [Unger, Sheila; Zabel, Bernhard; Superti-Furga, Andrea] Univ Freiburg, Ctr Pediat & Adolescent Med, D-79106 Freiburg, Germany; [Kaiser, Frank J.] Univ Klinikum Schleswig Holstein, Inst Human Genet, D-23538 Lubeck, Germany; [Kaulfuss, Silke; Burfeind, Peter] Univ Gottingen, Inst Human Genet, D-37073 Gottingen, Germany; [Buiting, Karin] Univ Klinikum Essen, Inst Human Genet, D-45122 Essen, Germany; [Borowski, Kristi; Keppler-Noreuil, Kim] Univ Iowa Hosp & Clin, Div Med Genet, Iowa City, IA 52242 USA; [Schmitt-Mechelke, Thomas] Abt Neuropadiat, CH-6000 Luzern, Switzerland; [Steiner, Bernhard; Bartholdi, Deborah; Lemke, Johannes] Univ Zurich, Inst Med Genet, CH-8603 Schwerzenbach, Switzerland; [Mortier, Geert] Univ Ghent, Ctr Med Genet, B-9000 Ghent, Belgium; [Sandford, Richard] Univ Cambridge, Addenbrookes Hosp, Inst Med Res, Dept Med Genet, Cambridge CB2 0XY, England	University of Freiburg; University of Freiburg; University of Kiel; Schleswig Holstein University Hospital; University of Gottingen; University of Duisburg Essen; University of Iowa; University of Zurich; Ghent University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Kohlhase, J (corresponding author), Ctr Human Genet Freiburg, D-79100 Freiburg, Germany.	jkohlhase@humangenetik-freiburg.de	Barrionuevo, Francisco/AAA-7639-2019; unger, sheila/E-9177-2015; Böhm, Johann/O-1652-2016; Mortier, Geert/D-2542-2012; superti-furga, andrea/E-9162-2015	Barrionuevo, Francisco/0000-0003-2651-1530; Böhm, Johann/0000-0001-8019-9504; Mortier, Geert/0000-0001-9871-4578; superti-furga, andrea/0000-0002-3543-7531; Kaulfuss, Silke/0000-0003-2577-9711; Unger, Sheila/0000-0002-9539-8941; Bohm, Johann/0000-0001-7370-3469	Wellcome Trust [051279] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Archer HL, 2006, J MED GENET, V43, P451, DOI 10.1136/jmg.2005.033464; Bohm J, 2007, BIOCHEM BIOPH RES CO, V356, P773, DOI 10.1016/j.bbrc.2007.03.050; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Green AJ, 1996, J MED GENET, V33, P594, DOI 10.1136/jmg.33.7.594; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Kohlhase J, 2002, HUM MOL GENET, V11, P2979, DOI 10.1093/hmg/11.23.2979; Kohlhase J, 1998, NAT GENET, V18, P81, DOI 10.1038/ng0198-81; Ma CY, 1998, P NATL ACAD SCI USA, V95, P9938, DOI 10.1073/pnas.95.17.9938; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Spitz R, 2006, GENE CHROMOSOME CANC, V45, P1130, DOI 10.1002/gcc.20376; van Bokhoven H, 2005, NAT GENET, V37, P465, DOI 10.1038/ng1546; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549	13	40	43	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2008	40	3					287	289		10.1038/ng.86	http://dx.doi.org/10.1038/ng.86			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18297069				2022-12-27	WOS:000253548400018
J	Hollox, EJ; Huffmeier, U; Zeeuwen, PLJM; Palla, R; Lascorz, J; Rodijk-Olthuis, D; van de Kerkhof, PCM; Traupe, H; de Jongh, G; den Heijer, M; Reis, A; Armour, JAL; Schalkwijk, J				Hollox, Edward J.; Huffmeier, Ulrike; Zeeuwen, Patrick L. J. M.; Palla, Raquel; Lascorz, Jesus; Rodijk-Olthuis, Diana; van de Kerkhof, Peter C. M.; Traupe, Heiko; de Jongh, Gys; den Heijer, Martin; Reis, Andre; Armour, John A. L.; Schalkwijk, Joost			Psoriasis is associated with increased beta-defensin genomic copy number	NATURE GENETICS			English	Article							GENE-CLUSTER; SUSCEPTIBILITY; KERATINOCYTES; DUPLICATIONS; POLYMORPHISM; EXPRESSION; SKIN	Psoriasis is a common inflammatory skin disease with a strong genetic component. We analyzed the genomic copy number polymorphism of the beta-defensin region on human chromosome 8 in 179 Dutch individuals with psoriasis and 272 controls and in 319 German individuals with psoriasis and 305 controls. Comparisons in both cohorts showed a significant association between higher genomic copy number for beta-defensin genes and risk of psoriasis.	[Hollox, Edward J.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Huffmeier, Ulrike; Lascorz, Jesus; Reis, Andre] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany; [Zeeuwen, Patrick L. J. M.; Rodijk-Olthuis, Diana; van de Kerkhof, Peter C. M.; de Jongh, Gys; Schalkwijk, Joost] Univ Nijmegen, Med Ctr, Dept Dermatol, Nijmegen Ctr Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Palla, Raquel] Univ Nottingham, Inst Genet, Nottingham NG7 2UH, England; [Traupe, Heiko] Univ Nottingham, Dept Dermatol, Nottingham NG7 2UH, England; [den Heijer, Martin] Radboud Univ Nijmegen Med Ctr, Dept Endocrinol, NL-6500 HB Nijmegen, Netherlands; [den Heijer, Martin] Radboud Univ Nijmegen Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands	University of Leicester; University of Erlangen Nuremberg; Radboud University Nijmegen; University of Nottingham; University of Nottingham; Radboud University Nijmegen; Radboud University Nijmegen	Armour, JAL (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	john.armour@nottingham.ac.uk	Schalkwijk, Joost/R-7509-2019; Zeeuwen, Patrick/N-1779-2013; Reis, André/D-2309-2009; van de Kerkhof, P.C.M./H-8059-2014; Huffmeier, Ulrike/D-2806-2013; den Heijer, Martin/J-8036-2015	Schalkwijk, Joost/0000-0002-1308-1319; Zeeuwen, Patrick/0000-0002-6878-2438; Reis, André/0000-0002-6301-6363; Huffmeier, Ulrike/0000-0001-6448-4671; Hollox, Edward/0000-0002-0115-2298; Armour, John/0000-0002-8558-8506; den Heijer, Martin/0000-0003-3620-5617	Wellcome Trust [071024] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aldred PMR, 2005, HUM MOL GENET, V14, P2045, DOI 10.1093/hmg/ddi209; Armour JAL, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1089; Bowcock AM, 2005, NAT REV IMMUNOL, V5, P699, DOI 10.1038/nri1689; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Harder J, 1997, NATURE, V387, P861, DOI 10.1038/43088; Hollox EJ, 2005, J NEGAT RESULTS BIOM, V4, DOI 10.1186/1477-5751-4-9; Hollox EJ, 2003, AM J HUM GENET, V73, P591, DOI 10.1086/378157; Joly S, 2005, MOL IMMUNOL, V42, P1073, DOI 10.1016/j.molimm.2004.11.001; Niyonsaba F, 2005, J IMMUNOL, V175, P1776, DOI 10.4049/jimmunol.175.3.1776; Niyonsaba F, 2004, IMMUNOLOGY, V111, P273, DOI 10.1111/j.0019-2805.2004.01816.x; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257	15	504	523	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2008	40	1					23	25		10.1038/ng.2007.48	http://dx.doi.org/10.1038/ng.2007.48			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18059266	Green Accepted			2022-12-27	WOS:000252118600012
J	Zhou, WL; Lin, LZ; Majumdar, A; Li, X; Zhang, XX; Liu, W; Etheridge, L; Shi, YQ; Martin, J; Van de Ven, W; Kaartinen, V; Wynshaw-Boris, A; McMahon, AP; Rosenfeld, MG; Evans, SM				Zhou, Wenlai; Lin, Lizhu; Majumdar, Arindam; Li, Xue; Zhang, Xiaoxue; Liu, Wei; Etheridge, Leah; Shi, Yunqing; Martin, James; Van de Ven, Wim; Kaartinen, Vesa; Wynshaw-Boris, Anthony; McMahon, Andrew P.; Rosenfeld, Michael G.; Evans, Sylvia M.			Modulation of morphogenesis by noncanonical Wnt signaling requires ATF/CREB family-mediated transcriptional activation of TGF beta 2	NATURE GENETICS			English	Article							BETA-CATENIN; TRANSFORMING GROWTH-FACTOR-BETA-2; OUTFLOW TRACT; EXPRESSION; HEART; GENE; MOUSE; MICE; ATF-2; PITX2	Transcriptional readout downstream of canonical Wnt signaling is known to be mediated by beta-catenin activation of well-described targets, but potential transcriptional readout in response to noncanonical Wnt signaling remains poorly understood. Here, we define a transcriptional pathway important in noncanonical Wnt signaling. We have found that Wnt11 is a direct target of a canonical beta-catenin pathway in developing heart and that Wnt11 mutants show cardiac outflow tract defects. We provide genetic and biochemical evidence that Wnt11 signaling affects extracellular matrix composition, cytoskeletal rearrangements and polarized cell movement required for morphogenesis of the cardiac outflow tract. Notably, transforming growth factor beta 2 (TGF beta 2), a key effector of organ morphogenesis, is regulated by Wnt11- mediated noncanonical signaling in developing heart and somites via one or more activating transcription factor (ATF)/cyclic AMP response element binding protein ( CREB) family members. Thus, we propose that transcriptional readout mediated at least in part by a Wnt11 -> ATF/CREB -> TGF beta 2 pathway is critical in regulating morphogenesis in response to noncanonical Wnt signaling.	Univ Calif San Diego, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; Univ Calif San Diego, Skaggs Sch Pharm, Dept Pharmacol, La Jolla, CA 92093 USA; Univ Calif San Diego, Skaggs Sch Pharm, Dept Med, La Jolla, CA 92093 USA; Karolinska Inst, Dept Med Biochem & Biophys, Div Matrix Biol, S-17177 Stockholm, Sweden; Texas A&M Syst Hlth Sci Ctr, Alkek Inst Biosci & Technol, Houston, TX 77030 USA; Univ Calif San Diego, Ctr Comprehens Canc, Dept Pediat, La Jolla, CA 92093 USA; Katholieke Univ Leuven, Dept Human Genet, Lab Mol Oncol, B-3000 Louvain, Belgium; Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Karolinska Institutet; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of California System; University of California San Diego; KU Leuven; University of Southern California; Harvard University	Evans, SM (corresponding author), Univ Calif San Diego, Dept Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA.	mrosenfeld@ucsd.edu; syevans@ucsd.edu	Evans, Sylvia/G-1980-2015; McMahon, Andrew P/ABE-7520-2020; Kaartinen, Vesa/AAU-5396-2021	Kaartinen, Vesa/0000-0002-9432-510X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445, R01HL074066, R01HL070867, R01HL066276, DP1HL117649] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK064744, R01DK054364, R37DK054364, R01DK018477] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073159] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006428] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL066276, HL66276, R01 HL065445, HL74066, DP1 HL117649, HL65445, HL70867, R01 HL070867, R01 HL074066] Funding Source: Medline; NIDDK NIH HHS [DK054364, R01 DK054364, DK18477, DK 064744, R37 DK054364, R01 DK018477, K01 DK064744] Funding Source: Medline; NIH HHS [DP1 OD006428] Funding Source: Medline; NINDS NIH HHS [R01 NS073159] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alward WLM, 2000, AM J OPHTHALMOL, V130, P107, DOI 10.1016/S0002-9394(00)00525-0; Bartram U, 2001, CIRCULATION, V103, P2745; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bleckmann SC, 2002, MOL CELL BIOL, V22, P1919, DOI 10.1128/MCB.22.6.1919-1925.2002; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Campione M, 1999, DEVELOPMENT, V126, P1225; Campione M, 2001, DEV BIOL, V231, P252, DOI 10.1006/dbio.2000.0133; Chien KR, 2000, SEMIN ONCOL, V27, P9, DOI 10.1053/sonc.2000.19892; CHRISTIANSEN JH, 1995, MECH DEVELOP, V51, P341, DOI 10.1016/0925-4773(95)00383-5; Costell M, 2002, CIRC RES, V91, P158, DOI 10.1161/01.RES.0000026056.81424.DA; Delot EC, 2003, DEVELOPMENT, V130, P209, DOI 10.1242/dev.00181; Ganga M, 2003, J BIOL CHEM, V278, P22437, DOI 10.1074/jbc.M210163200; Garriock RJ, 2005, DEV BIOL, V279, P179, DOI 10.1016/j.ydbio.2004.12.013; Gruber PJ, 2004, CIRC RES, V94, P273, DOI 10.1161/01.RES.0000116144.43797.3B; Henderson DJ, 2001, CIRC RES, V89, P6, DOI 10.1161/hh1301.092497; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; Iozzo RV, 1997, J BIOL CHEM, V272, P5219, DOI 10.1074/jbc.272.8.5219; JAKOWLEW SB, 1994, DIFFERENTIATION, V55, P105, DOI 10.1046/j.1432-0436.1994.5520105.x; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Kawasaki H, 2000, NATURE, V405, P195, DOI 10.1038/35012097; Kelly RG, 2000, MICROSC RES TECHNIQ, V50, P510, DOI 10.1002/1097-0029(20000915)50:6<510::AID-JEMT8>3.0.CO;2-1; KIM SJ, 1992, NATURE, V358, P331, DOI 10.1038/358331a0; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kispert A, 1998, DEVELOPMENT, V125, P4225; Kispert A, 1996, DEVELOPMENT, V122, P3627; Li H, 2001, ARCH BIOCHEM BIOPHYS, V394, P1, DOI 10.1006/abbi.2001.2518; Lin CR, 1999, NATURE, V401, P279, DOI 10.1038/45803; Lin LZ, 2007, P NATL ACAD SCI USA, V104, P9313, DOI 10.1073/pnas.0700923104; Liu CY, 2002, DEVELOPMENT, V129, P5081; LYONS KM, 1995, MECH DEVELOP, V50, P71, DOI 10.1016/0925-4773(94)00326-I; Maekawa T, 1999, J BIOL CHEM, V274, P17813, DOI 10.1074/jbc.274.25.17813; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Marcelle C, 1997, DEVELOPMENT, V124, P3955; Maye P, 2004, J BIOL CHEM, V279, P24659, DOI 10.1074/jbc.M311724200; Monzen K, 2001, J CELL BIOL, V153, P687, DOI 10.1083/jcb.153.4.687; Moon RT, 2005, SCI STKE; Murdoch JN, 2003, HUM MOL GENET, V12, P87, DOI 10.1093/hmg/ddg014; Phillips HM, 2005, CIRC RES, V96, P292, DOI 10.1161/01.RES.0000154912.08695.88; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Reimold AM, 1996, NATURE, V379, P262, DOI 10.1038/379262a0; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Schmidt M, 2000, DEVELOPMENT, V127, P4105; Srivastava D, 2000, NATURE, V407, P221, DOI 10.1038/35025190; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; TANDA N, 1995, BIOCHEM BIOPH RES CO, V211, P123, DOI 10.1006/bbrc.1995.1786; Torban E, 2004, TRENDS GENET, V20, P570, DOI 10.1016/j.tig.2004.09.003; van den Hoff MJB, 2004, BIOESSAYS, V26, P248, DOI 10.1002/bies.20006; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Viegas-Pequignot E., 1992, PRACTICAL APPROACHES, P137; Yang L, 2006, DEVELOPMENT, V133, P1575, DOI 10.1242/dev.02322	50	134	139	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2007	39	10					1225	1234		10.1038/ng2112	http://dx.doi.org/10.1038/ng2112			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17767158	Green Accepted			2022-12-27	WOS:000249737400018
J	Lundmark, F; Duvefelt, K; Iacobaeus, E; Kockum, I; Wallstrom, E; Khademi, M; Oturai, A; Ryder, LP; Saarela, J; Harbo, HF; Celius, EG; Salter, H; Olsson, T; Hillert, J				Lundmark, Frida; Duvefelt, Kristina; Iacobaeus, Ellen; Kockum, Ingrid; Wallstroem, Erik; Khademi, Mohsen; Oturai, Annette; Ryder, Lars P.; Saarela, Janna; Harbo, Hanne F.; Celius, Elisabeth G.; Salter, Hugh; Olsson, Tomas; Hillert, Jan			Variation in interleukin 7 receptor a chain (IL7R) influences risk of multiple sclerosis	NATURE GENETICS			English	Article							TYROSINE-PHOSPHATASE; GENE; SUSCEPTIBILITY; DISEASE; POLYMORPHISMS; ASSOCIATIONS; EXPRESSION; LOCUS	Multiple sclerosis is a chronic, often disabling, disease of the central nervous system affecting more than 1 in 1,000 people in most western countries. The inflammatory lesions typical of multiple sclerosis show autoimmune features and depend partly on genetic factors. Of these genetic factors, only the HLA gene complex has been repeatedly confirmed to be associated with multiple sclerosis, despite considerable efforts. Polymorphisms in a number of non- HLA genes have been reported to be associated with multiple sclerosis, but so far confirmation has been difficult. Here, we report compelling evidence that polymorphisms in IL7R, which encodes the interleukin 7 receptor a chain ( IL7R alpha), indeed contribute to the non- HLA genetic risk in multiple sclerosis, demonstrating a role for this pathway in the pathophysiology of this disease. In addition, we report altered expression of the genes encoding IL7R alpha and its ligand, IL7, in the cerebrospinal fluid compartment of individuals with multiple sclerosis.	Karolinska Univ Hosp, Dept Clin Neurosci, Div Neurol, SE-14186 Stockholm, Sweden; Karolinska Univ Hosp, Clin Res Ctr, Mutat Anal Facil, SE-14186 Huddinge, Sweden; Karolinska Univ Hosp Solna, Karolinska Inst, Dept Clin Neurosci, Neuroimmunol Unit, SE-17176 Stockholm, Sweden; Copenhagen Univ Hosp, Rigshosp, Danish Multiple Sclerosis Res Ctr, DK-2100 Copenhagen, Denmark; Copenhagen Univ Hosp, Rigshosp, Dept Clin Immunol, DK-2100 Copenhagen, Denmark; Natl Publ Hlth Inst, Dept Mol Med, FI-00290 Helsinki, Finland; Univ Oslo, Inst Immunol, N-0027 Oslo, Norway; Ulleval Hosp, Dept Neurol, N-0407 Oslo, Norway; AstraZeneca R&D, Dept Dis Biol, Pharmacogenom Sect, SE-15185 Sodertalje, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; Finland National Institute for Health & Welfare; University of Oslo; University of Oslo; AstraZeneca	Hillert, J (corresponding author), Karolinska Univ Hosp, Dept Clin Neurosci, Div Neurol, SE-14186 Stockholm, Sweden.	jan.hillert@ki.se	ryder, lars p/Q-2060-2015; Celius, Elisabeth Gulowsen/S-1387-2019; Saarela, Janna S/E-5369-2014; Kockum, Ingrid/O-8781-2018	ryder, lars p/0000-0002-4744-3496; Celius, Elisabeth Gulowsen/0000-0002-9127-6488; Kockum, Ingrid/0000-0002-0867-4726; Saarela, Janna/0000-0002-0853-6219; Khademi, Mohsen/0000-0003-0801-1444; Olsson, Tomas/0000-0002-2938-1877				Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Booth DR, 2005, J MOL MED, V83, P822, DOI 10.1007/s00109-005-0684-y; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Burwick RM, 2006, NEUROLOGY, V66, P1373, DOI 10.1212/01.wnl.0000210531.19498.3f; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gregory SG, 2007, NAT GENET, V39, P1083, DOI 10.1038/ng2103; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kurz T, 2006, J ALLERGY CLIN IMMUN, V118, P396, DOI 10.1016/j.jaci.2006.04.036; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; OGUA Y, 2001, NATURE, V411, P603; Roxburgh RH, 2006, J NEUROIMMUNOL, V171, P193, DOI 10.1016/j.jneuroim.2005.10.006; Sawcer S, 2005, AM J HUM GENET, V77, P454; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; SVEJGAARD A, 1994, TISSUE ANTIGENS, V43, P18, DOI 10.1111/j.1399-0039.1994.tb02291.x; Teutsch SM, 2003, EUR J HUM GENET, V11, P509, DOI 10.1038/sj.ejhg.5200994; Ye SK, 1999, IMMUNITY, V11, P213, DOI 10.1016/S1074-7613(00)80096-5; Zhang Z, 2005, GENES IMMUN, V6, P145, DOI 10.1038/sj.gene.6364171	23	363	374	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1108	1113		10.1038/ng2106	http://dx.doi.org/10.1038/ng2106			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17660816				2022-12-27	WOS:000249122400020
J	Attanasio, M; Uhlenhaut, NH; Sousa, VH; O'Toole, JF; Otto, E; Anlag, K; Klugmann, C; Treier, AC; Helou, J; Sayer, JA; Seelow, D; Nurnberg, G; Becker, C; Chudley, AE; Nurnberg, P; Hildebrandt, F; Treier, M				Attanasio, Massimo; Uhlenhaut, N. Henriette; Sousa, Vitor H.; O'Toole, John F.; Otto, Edgar; Anlag, Katrin; Klugmann, Claudia; Treier, Anna-Corina; Helou, Juliana; Sayer, John A.; Seelow, Dominik; Nurnberg, Gudrun; Becker, Christian; Chudley, Albert E.; Nurnberg, Peter; Hildebrandt, Friedhelm; Treier, Mathias			Loss of GLIS2 causes nephronophthisis in humans and mice by increased apoptosis and fibrosis	NATURE GENETICS			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; POLYCYSTIC KIDNEY-DISEASE; TISSUE GROWTH-FACTOR; RENAL FIBROSIS; TRANSCRIPTION FACTOR; CYSTIC-DISEASE; PRIMARY CILIA; TGF-BETA; PROGRESSION; PROTEIN	Nephronophthisis (NPHP), an autosomal recessive kidney disease, is the most frequent genetic cause of end-stage renal failure in the first three decades of life. Positional cloning of the six known NPHP genes1-4 has linked its pathogenesis to primary cilia function3,5. Here we identify mutation of GLIS2 as causing an NPHP-like phenotype in humans and mice, using positional cloning and mouse transgenics, respectively. Kidneys of Glis2 mutant mice show severe renal atrophy and fibrosis starting at 8 weeks of age. Differential gene expression studies on Glis2 mutant kidneys demonstrate that genes promoting epithelial-to-mesenchymal transition and fibrosis are upregulated in the absence of Glis2. Thus, we identify Glis2 as a transcription factor mutated in NPHP and demonstrate its essential role for the maintenance of renal tissue architecture through prevention of apoptosis and fibrosis.	Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; Univ Cologne, Cologne Ctr Genom, D-50674 Cologne, Germany; RZPD Deutsches Ressourcenzentrum Genomforsch GmbH, D-14059 Berlin, Germany; Univ Manitoba, Dept Pediat & Child Hlth, Winnipeg, MB R3E3P4, Canada; Univ Manitoba, Dept Biochem, Winnipeg, MB R3E3P4, Canada; Univ Manitoba, Dept Med Genet, Winnipeg, MB R3E3P4, Canada; Univ Cologne, Inst Genet, D-50674 Cologne, Germany	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; European Molecular Biology Laboratory (EMBL); University of Cologne; University of Manitoba; University of Manitoba; University of Manitoba; University of Cologne	Treier, M (corresponding author), Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA.	treier@embl.de	Sousa, Vitor/E-3679-2016; Uhlenhaut, Henriette/AFR-1141-2022; Treier, Mathias/AAD-6388-2021; Seelow, Dominik/HGB-3124-2022; Sayer, John A./AAN-2729-2020; Uhlenhaut, Nina Henriette/C-6288-2014; Uhlenhaut, Henriette/AAP-5400-2020	Sousa, Vitor/0000-0001-8768-2742; Seelow, Dominik/0000-0002-9746-4412; Sayer, John A./0000-0003-1881-3782; Otto, Edgar/0000-0002-2387-9973; Attanasio, Massimo/0000-0002-1278-3650; Uhlenhaut, Henriette/0000-0002-4220-4779	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069274, R01DK068306, K08DK071108, R01DK064614] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK064614, DK068306, DK069274, DK071108] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Anders HJ, 2003, KIDNEY INT, V63, P401, DOI 10.1046/j.1523-1755.2003.00750.x; Bonner JC, 2004, CYTOKINE GROWTH F R, V15, P255, DOI 10.1016/j.cytogfr.2004.03.006; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Harris RC, 2006, ANNU REV MED, V57, P365, DOI 10.1146/annurev.med.57.121304.131342; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Hildebrandt F, 2005, NAT REV GENET, V6, P928, DOI 10.1038/nrg1727; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Hu MC, 2006, DEVELOPMENT, V133, P569, DOI 10.1242/dev.02220; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Igarashi P, 2002, J AM SOC NEPHROL, V13, P2384, DOI 10.1097/01.ASN.0000028643.17901.42; Lin FM, 2005, J CLIN INVEST, V115, P1756, DOI 10.1172/JCI23015; Louro ID, 2002, CANCER RES, V62, P5867; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Mollet G, 2005, HUM MOL GENET, V14, P645, DOI 10.1093/hmg/ddi061; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Okada H, 2000, KIDNEY INT, V58, P587, DOI 10.1046/j.1523-1755.2000.00205.x; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Qi W, 2005, AM J PHYSIOL-RENAL, V288, pF800, DOI 10.1152/ajprenal.00179.2004; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Strutz F, 2006, NEPHROL DIAL TRANSPL, V21, P3368, DOI 10.1093/ndt/gfl199; Watnick T, 2003, NAT GENET, V34, P355, DOI 10.1038/ng0803-355; Yu J, 2002, DEVELOPMENT, V129, P5301; Zhang F, 2002, J BIOL CHEM, V277, P10139, DOI 10.1074/jbc.M108062200; Zhang F, 2001, GENE, V280, P49, DOI 10.1016/S0378-1119(01)00764-8; Zhang M, 2005, NEPHRON EXP NEPHROL, V99, P68, DOI 10.1159/000083414; ZOLLINGER HU, 1980, HELV PAEDIATR ACTA, V35, P509	30	165	168	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					1018	1024		10.1038/ng2072	http://dx.doi.org/10.1038/ng2072			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17618285				2022-12-27	WOS:000248446900021
J	Grzeschik, KH; Bornholdt, D; Oeffner, F; Konig, A; Boente, MD; Enders, H; Fritz, B; Hertl, M; Grasshoff, U; Hofling, K; Oji, V; Paradisi, M; Schuchardt, C; Szalai, Z; Tadini, G; Traupe, H; Happle, R				Grzeschik, Karl-Heinz; Bornholdt, Dorothea; Oeffner, Frank; Koenig, Arne; del Carmen Boente, Maria; Enders, Herbert; Fritz, Barbara; Hertl, Michael; Grasshoff, Ute; Hoefling, Katja; Oji, Vinzenz; Paradisi, Mauro; Schuchardt, Christian; Szalai, Zsuzsanna; Tadini, Gianluca; Traupe, Heiko; Happle, Rudolf			Deficiency of PORCN, a regulator of Wnt signaling, is associated with focal dermal hypoplasia	NATURE GENETICS			English	Article							GENE; MUTATIONS	Focal dermal hypoplasia ( FDH) is an X- linked dominant multisystem birth defect affecting tissues of ectodermal and mesodermal origin. Using a stepwise approach of ( i) genetic mapping of FDH, ( ii) high- resolution comparative genome hybridization to seek deletions in candidate chromosome areas and ( iii) point mutation analysis in candidate genes, we identified PORCN, encoding a putative O- acyltransferase and potentially crucial for cellular export of Wnt signaling proteins, as the gene mutated in FDH. The findings implicate FDH as a developmental disorder caused by a deficiency in PORCN.	Univ Marburg, Dept Human Genet, D-35033 Marburg, Germany; Univ Marburg, Dept Dermatol, D-35033 Marburg, Germany; Hosp Nino Jesus, Dept Dermatol, RA-4000 San Miguel De Tucuman, Argentina; Univ Tubingen, Dept Human Genet, D-72076 Tubingen, Germany; Univ Bonn, Inst Med Microbiol Immunol & Parasitol, D-53105 Bonn, Germany; Univ Munster, Dept Dermatol, D-48149 Munster, Germany; Ist Dermopat Immacolata, Div Pediat Dermatol, I-00167 Rome, Italy; Klin Pieper, D-79837 St Blasien Menzenschwand, Germany; Heim Pal Childrens Hosp, Dept Pediat Dermatol, H-1089 Budapest, Hungary; Univ Milan, Ist Sci Dermatol, Ctr Hereditary Skin Dis, I-20122 Milan, Italy	Philipps University Marburg; Philipps University Marburg; Eberhard Karls University of Tubingen; University of Bonn; University of Munster; IRCCS Istituto Dermopatico dell'Immacolata (IDI); University of Milan	Grzeschik, KH (corresponding author), Univ Marburg, Dept Human Genet, Bahnhofstr 7, D-35033 Marburg, Germany.	grzeschi@staff.uni-marburg.de		Oji, Vinzenz/0000-0003-1380-4828				Behninger C, 2000, GENET COUNSEL, V11, P157; Caricasole A, 2002, GENE, V288, P147, DOI 10.1016/S0378-1119(02)00467-5; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Derry JMJ, 1999, NAT GENET, V22, P286, DOI 10.1038/10350; Freude K, 2004, AM J HUM GENET, V75, P305, DOI 10.1086/422507; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; GORLIN RJ, 2001, OXFORD MONOGRAPHS ME, V42, P571; Hancock S, 2002, AM J MED GENET, V110, P370, DOI 10.1002/ajmg.10456; HAPPLE R, 1977, BRIT J DERMATOL, V96, P133, DOI 10.1111/j.1365-2133.1977.tb12534.x; He X, 2006, DEVELOPMENT, V133, P2597, DOI 10.1242/dev.02452; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Puck JM, 1998, NEW ENGL J MED, V338, P325, DOI 10.1056/NEJM199801293380511; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Tanaka K, 2000, EUR J BIOCHEM, V267, P4300, DOI 10.1046/j.1432-1033.2000.01478.x; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611	15	185	199	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39	7					833	835		10.1038/ng2052	http://dx.doi.org/10.1038/ng2052			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17546031				2022-12-27	WOS:000247619800011
J	Cox, A; Dunning, AM; Garcia-Closas, M; Balasubramanian, S; Reed, MWR; Pooley, KA; Scollen, S; Baynes, C; Ponder, BAJ; Chanock, S; Lissowska, J; Brinton, L; Peplonska, B; Southey, MC; Hopper, JL; McCredie, MRE; Giles, GG; Fletcher, O; Johnson, N; Silva, ID; Gibson, L; Bojesen, SE; Nordestgaard, BG; Axelsson, CK; Torres, D; Hamann, U; Justenhoven, C; Brauch, H; Chang-Claude, J; Kropp, S; Risch, A; Wang-Gohrke, S; Schurmann, P; Bogdanova, N; Dork, T; Fagerholm, R; Aaltonen, K; Blomqvist, C; Nevanlinna, H; Seal, S; Renwick, A; Stratton, MR; Rahman, N; Sangrajrang, S; Hughes, D; Odefrey, F; Brennan, P; Spurdle, AB; Chenevix-Trench, G; Beesley, J; Mannermaa, A; Hartikainen, J; Kataja, V; Kosma, VM; Couch, FJ; Olson, JE; Goode, EL; Broeks, A; Schmidt, MK; Hogervorst, FBL; Van't Veer, LJ; Kang, D; Yoo, KY; Noh, DY; Ahn, SH; Wedren, S; Hall, P; Low, YL; Liu, JJ; Milne, RL; Ribas, G; Gonzalez-Neira, A; Benitez, J; Sigurdson, AJ; Stredrick, DL; Alexander, BH; Struewing, JP; Pharoah, PDP; Easton, DF				Cox, Angela; Dunning, Alison M.; Garcia-Closas, Montserrat; Balasubramanian, Sabapathy; Reed, Malcolm W. R.; Pooley, Karen A.; Scollen, Serena; Baynes, Caroline; Ponder, Bruce A. J.; Chanock, Stephen; Lissowska, Jolanta; Brinton, Louise; Peplonska, Beata; Southey, Melissa C.; Hopper, John L.; McCredie, Margaret R. E.; Giles, Graham G.; Fletcher, Olivia; Johnson, Nichola; dos Santos Silva, Isabel; Gibson, Lorna; Bojesen, Stig E.; Nordestgaard, Borge G.; Axelsson, Christen K.; Torres, Diana; Hamann, Ute; Justenhoven, Christina; Brauch, Hiltrud; Chang-Claude, Jenny; Kropp, Silke; Risch, Angela; Wang-Gohrke, Shan; Schuermann, Peter; Bogdanova, Natalia; Doerk, Thilo; Fagerholm, Rainer; Aaltonen, Kirsimari; Blomqvist, Carl; Nevanlinna, Heli; Seal, Sheila; Renwick, Anthony; Stratton, Michael R.; Rahman, Nazneen; Sangrajrang, Suleeporn; Hughes, David; Odefrey, Fabrice; Brennan, Paul; Spurdle, Amanda B.; Chenevix-Trench, Georgia; Beesley, Jonathan; Mannermaa, Arto; Hartikainen, Jaana; Kataja, Vesa; Kosma, Veli-Matti; Couch, Fergus J.; Olson, Janet E.; Goode, Ellen L.; Broeks, Annegien; Schmidt, Marjanka K.; Hogervorst, Frans B. L.; Van't Veer, Laura J.; Kang, Daehee; Yoo, Keun-Young; Noh, Dong-Young; Ahn, Sei-Hyun; Wedren, Sara; Hall, Per; Low, Yen-Ling; Liu, Jianjun; Milne, Roger L.; Ribas, Gloria; Gonzalez-Neira, Anna; Benitez, Javier; Sigurdson, Alice J.; Stredrick, Denise L.; Alexander, Bruce H.; Struewing, Jeffery P.; Pharoah, Paul D. P.; Easton, Douglas F.		Kathleen Cunningham Fdn Consortium; Breast Canc Assoc Consortium	A common coding variant in CASP8 is associated with breast cancer risk	NATURE GENETICS			English	Article							TRANSFORMING-GROWTH-FACTOR-BETA-1 GENE; ATAXIA-TELANGIECTASIA; REDUCED RISK; TGF-BETA; SUSCEPTIBILITY; POLYMORPHISMS; WOMEN; IGFBP3; REGION; LOCUS	The Breast Cancer Association Consortium (BCAC) has been established to conduct combined case-control analyses with augmented statistical power to try to confirm putative genetic associations with breast cancer. We genotyped nine SNPs for which there was some prior evidence of an association with breast cancer: CASP8 D302H (rs1045485), IGFBP3-202 C -> A (rs2854744), SOD2 V16A (rs1799725), TGFB1 L10P (rs1982073), ATM S49C (rs1800054), ADH1B 3' UTR A -> G (rs1042026), CDKN1A S31R (rs1801270), ICAM5 V301I (rs1056538) and NUMA1 A794G (rs3750913). We included data from 9-15 studies, comprising 11,391-18,290 cases and 14,753-22,670 controls. We found evidence of an association with breast cancer for CASP8 D302H (with odds ratios (OR) of 0.89 (95% confidence interval (c.i.): 0.85-0.94) and 0.74 (95% c.i.: 0.62-0.87) for heterozygotes and rare homozygotes, respectively, compared with common homozygotes; P(trend) = 1.1 x 10(-7)) and weaker evidence for TGFB1 L10P (OR = 1.07 (95% c.i.: 1.02-1.13) and 1.16 (95% c.i.: 1.08-1.25), respectively; P(trend) = 2.8 x 10(-5)). These results demonstrate that common breast cancer susceptibility alleles with small effects on risk can be identified, given sufficiently powerful studies.	Univ Sheffield, Sch Med, Sheffield S10 2RX, S Yorkshire, England; Univ Cambridge, Dept Oncol, Cambridge CB2 1TN, England; Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB2 1TN, England; NCI, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA; NCI, Core Genotyping Facil, Ctr Adv Technol, Bethesda, MD 20892 USA; Ctr Canc, PL-02781 Warsaw, Poland; M Sklodowska Curie Inst Oncol, PL-02781 Warsaw, Poland; Nofer Inst Occupat Med, PL-90950 Lodz, Poland; Univ Melbourne, Melbourne, Vic 3010, Australia; Univ Otago, Dunedin, New Zealand; Canc Council Victoria, Canc Epidemiol Ctr, Melbourne, Vic 3053, Australia; Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; Univ Copenhagen, Herlev Hosp, Dept Clin Biochem, DK-2730 Herlev, Denmark; Univ Copenhagen, Herlev Hosp, Dept Breast Surg, DK-2730 Herlev, Denmark; Deutsch Krebsforschungszentrum, D-69120 Heidelberg, Germany; Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; Univ Tubingen, D-72074 Tubingen, Germany; German Canc Res Ctr, D-69120 Heidelberg, Germany; Univ Ulm, D-89069 Ulm, Germany; Hannover Med Sch, Dept Gynecol & Obstet, D-30625 Hannover, Germany; Hannover Med Sch, Dept Radiat Oncol, D-30625 Hannover, Germany; Univ Helsinki, Cent Hosp, Dept Obstet & Gynecol, FIN-00290 Helsinki, Finland; Univ Helsinki, Cent Hosp, Dept Oncol, FIN-00290 Helsinki, Finland; Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Natl Canc Inst, Bangkok 10400, Thailand; Int Agcy Res Canc, F-69372 Lyon, France; Queensland Inst Med Res, Brisbane, Qld 4029, Australia; Univ Kuopio, Inst Clin Med Pathol & Forens Med, FI-70211 Kuopio, Finland; Kuopio Univ Hosp, Dept Oncol, FI-70211 Kuopio, Finland; Kuopio Univ Hosp, Dept Pathol, FI-70211 Kuopio, Finland; Mayo Clin Coll Med, Rochester, MN 55905 USA; Netherlands Canc Inst, Dept Expt Therapy, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Dept Epidemiol & Mol Pathol, NL-1066 CX Amsterdam, Netherlands; Seoul Natl Univ, Coll Med, Seoul 151742, South Korea; Univ Ulsan, Coll Med, Dept Surg, Ulsan 680749, South Korea; Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; Genome Inst Singapore, Singapore 138672, Singapore; CNIO, Spanish Natl Canc Res Ctr, E-28049 Madrid, Spain; NCI, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; Univ Minnesota, Div Environm Hlth Sci, Minneapolis, MN 55455 USA	University of Sheffield; University of Cambridge; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Maria Sklodowska-Curie National Research Institute of Oncology; Nofer Institute of Occupational Medicine; University of Melbourne; University of Otago; Cancer Council Victoria; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; London School of Hygiene & Tropical Medicine; University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University; Hannover Medical School; Hannover Medical School; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of London; Institute of Cancer Research - UK; National Cancer Institute - Thailand; World Health Organization; International Agency for Research on Cancer (IARC); QIMR Berghofer Medical Research Institute; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Mayo Clinic; Netherlands Cancer Institute; Netherlands Cancer Institute; Seoul National University (SNU); University of Ulsan; Karolinska Institutet; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Centro Nacional de Investigaciones Oncologicas (CNIO); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Minnesota System; University of Minnesota Twin Cities	Cox, A (corresponding author), Univ Sheffield, Sch Med, Sheffield S10 2RX, S Yorkshire, England.	a.cox@shef.ac.uk	Garcia-Closas, Montserrat/F-3871-2015; balasubramanian, saba prakash/H-2830-2019; Spurdle, Amanda B/A-4978-2011; Brinton, Louise A/G-7486-2015; Noh, Dong-Young/G-5531-2011; Peplonska, Beata/F-6004-2010; Rahman, Nazneen/B-8890-2012; Dörk, Thilo/J-8620-2012; Risch, Angela/H-2669-2013; Chenevix-Trench, Georgia/AAV-2014-2020; Peplonska, Beata/AAO-1265-2020; Struewing, Jeffery P/I-7502-2013; Hartikainen, Jaana M/E-6256-2015; Lissowska, Jolanta/AAH-3252-2020; Nordestgaard, Borge Gronne/ABF-1310-2020; Kang, Dae Hee/E-8631-2012; Bogdanova, Natalia V./Y-2205-2019; Yoo, Keun-Young/J-5548-2012; Schmidt, Marjanka K/G-9058-2011; Gonzalez-Neira, Anna/C-5791-2015; Pharoah, Paul/V-6658-2019; Garcia-Closas, Montserrat/AAZ-6930-2021; Ribas-Despuig, Gloria/M-6190-2017; Reed, Malcolm Walter/AAG-9219-2020; Liu, Jianjun/AAK-4989-2020; Ribas, Gloria/K-3379-2013; Rahman, Nazneen/D-2802-2013	Garcia-Closas, Montserrat/0000-0003-1033-2650; balasubramanian, saba prakash/0000-0001-5953-2843; Spurdle, Amanda B/0000-0003-1337-7897; Brinton, Louise A/0000-0003-3853-8562; Dörk, Thilo/0000-0002-9458-0282; Risch, Angela/0000-0002-8026-5505; Chenevix-Trench, Georgia/0000-0002-1878-2587; Peplonska, Beata/0000-0003-3915-2872; Struewing, Jeffery P/0000-0002-4848-3334; Hartikainen, Jaana M/0000-0001-8267-1905; Lissowska, Jolanta/0000-0003-2695-5799; Schmidt, Marjanka K/0000-0002-2228-429X; Gonzalez-Neira, Anna/0000-0002-5421-2020; Pharoah, Paul/0000-0001-8494-732X; Garcia-Closas, Montserrat/0000-0003-1033-2650; Reed, Malcolm Walter/0000-0001-7442-2132; Liu, Jianjun/0000-0002-3255-3019; Brauch, Hiltrud/0000-0001-7531-2736; Giles, Graham/0000-0003-4946-9099; Ribas, Gloria/0000-0001-6883-4130; Blomqvist, Carl/0000-0003-3041-1938; Beesley, Jonathan/0000-0003-1942-325X; Cox, Angela/0000-0002-5138-1099; Southey, Melissa/0000-0002-6313-9005; Kang, Daehee/0000-0003-4031-5878; Nevanlinna, Heli/0000-0002-0916-2976; dos Santos Silva, Isabel/0000-0002-6596-8798; Kataja, Vesa/0000-0003-4846-4843; Dunning, Alison Margaret/0000-0001-6651-7166; Bowcock, Anne/0000-0001-8691-9090; Hughes, David John/0000-0003-1668-8770; Rahman, Nazneen/0000-0003-4376-0440; Scollen, Serena/0000-0002-9311-1337; Fletcher, Olivia/0000-0001-9387-7116; Torres-Lopez, Diana Maria/0000-0002-9879-9775	NATIONAL CANCER INSTITUTE [Z01SC010083, Z01CP010126, P01CA082267, R01CA095003] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [CA82267, CA-95-003] Funding Source: Medline; Wellcome Trust [068545/Z/02] Funding Source: Medline; Breast Cancer Now [BREAST CANCER NOW RESEARCH CENTRE, 2004NOV49] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission); Breast Cancer Now		Al-Zahrani A, 2006, HUM MOL GENET, V15, P1, DOI 10.1093/hmg/ddi398; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Buchholz TA, 2004, CANCER, V100, P1345, DOI 10.1002/cncr.20133; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dunning AM, 2003, CANCER RES, V63, P2610; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Feigelson HS, 2006, CANCER EPIDEM BIOMAR, V15, P1236, DOI 10.1158/1055-9965.EPI-06-0163; Ferlay J, 2004, GLOBOCAN 2002 CANC I; Frank B, 2005, J NATL CANCER I, V97, P1012, DOI 10.1093/jnci/dji178; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Kaklamani VG, 2005, CANCER RES, V65, P3454, DOI 10.1158/0008-5472.CAN-04-2961; Kammerer S, 2005, P NATL ACAD SCI USA, V102, P2004, DOI 10.1073/pnas.0409806102; Kammerer S, 2004, CANCER RES, V64, P8906, DOI 10.1158/0008-5472.CAN-04-1788; Krippl P, 2003, CANCER LETT, V201, P181, DOI 10.1016/S0304-3835(03)00468-3; Le Marchand L, 2004, CANCER EPIDEM BIOMAR, V13, P412; MacPherson G, 2004, JNCI-J NATL CANCER I, V96, P1866, DOI 10.1093/jnci/dji001; Pharoah P, 2006, JNCI-J NATL CANCER I, V98, P1382, DOI 10.1093/jnci/djj374; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; PIEGORSCH WW, 1994, STAT MED, V13, P153, DOI 10.1002/sim.4780130206; Ren ZF, 2004, CANCER EPIDEM BIOMAR, V13, P1290; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Rohrbacher M, 2005, CANCER EPIDEM BIOMAR, V14, P289; Schernhammer ES, 2003, INT J CANCER, V107, P60, DOI 10.1002/ijc.11358; Shin AS, 2005, CANCER EPIDEM BIOMAR, V14, P1567, DOI 10.1158/1055-9965.EPI-05-0078; Stredrick DL, 2006, HUM MUTAT, V27, P538, DOI 10.1002/humu.20323; Yokota M, 2000, CIRCULATION, V101, P2783, DOI 10.1161/01.CIR.101.24.2783; Ziv E, 2001, JAMA-J AM MED ASSOC, V285, P2859, DOI 10.1001/jama.285.22.2859	30	429	445	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2007	39	3					352	358		10.1038/ng1981	http://dx.doi.org/10.1038/ng1981			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17293864				2022-12-27	WOS:000244480000017
J	Man, O; Pilpel, Y				Man, Orna; Pilpel, Yitzhak			Differential translation efficiency of orthologous genes is involved in phenotypic divergence of yeast species	NATURE GENETICS			English	Article							EVOLUTION; EXPRESSION	A major challenge in comparative genomics is to understand how phenotypic differences between species are encoded in their genomes. Phenotypic divergence may result from differential transcription of orthologous genes, yet less is known about the involvement of differential translation regulation in species phenotypic divergence. In order to assess translation effects on divergence, we analyzed similar to 2,800 orthologous genes in nine yeast genomes. For each gene in each species, we predicted translation efficiency, using a measure of the adaptation of its codons to the organism's tRNA pool. Mining this data set, we found hundreds of genes and gene modules with correlated patterns of translational efficiency across the species. One signal encompassed entire modules that are either needed for oxidative respiration or fermentation and are efficiently translated in aerobic or anaerobic species, respectively. In addition, the efficiency of translation of the mRNA splicing machinery strongly correlates with the number of introns in the various genomes. Altogether, we found extensive selection on synonymous codon usage that modulates translation according to gene function and organism phenotype. We conclude that, like factors such as transcription regulation, translation efficiency affects and is affected by the process of species divergence.	Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Pilpel, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	pilpel@weizmann.ac.il						Alexeyenko A, 2006, BIOINFORMATICS, V22, pE9, DOI 10.1093/bioinformatics/btl213; Arnaud MB, 2007, NUCLEIC ACIDS RES, V35, pD452, DOI 10.1093/nar/gkl899; Barth G, 1997, FEMS MICROBIOL REV, V19, P219, DOI 10.1016/S0168-6445(97)00002-8; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berbee ML, 2001, MYCOTA, V7, P229; Braun BR, 2005, PLOS GENET, V1, P36, DOI 10.1371/journal.pgen.0010001; dos Reis M, 2004, NUCLEIC ACIDS RES, V32, P5036, DOI 10.1093/nar/gkh834; Fraser HB, 2004, P NATL ACAD SCI USA, V101, P9033, DOI 10.1073/pnas.0402591101; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; Issel-Tarver L, 2002, METHOD ENZYMOL, V350, P329, DOI 10.1016/S0076-6879(02)50972-1; KANZ C, 2003, NUCLEIC ACIDS RES, V33, pD29; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Lithwick G, 2005, NUCLEIC ACIDS RES, V33, P1051, DOI 10.1093/nar/gki261; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Nantel A, 2006, FUNGAL GENET BIOL, V43, P311, DOI 10.1016/j.fgb.2006.01.002; Percudani R, 1997, J MOL BIOL, V268, P322, DOI 10.1006/jmbi.1997.0942; Powers DA, 1998, J EXP ZOOL, V282, P71; PREUSS M, 2005, IN SILICO BIOL, V5, P179; Prillinger H, 2002, CHEM IMMUNOL, V81, P207; Rice J., 1995, MATH STAT DATA ANAL; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Tanay A, 2005, P NATL ACAD SCI USA, V102, P7203, DOI 10.1073/pnas.0502521102; Wolfe KH, 2006, PHILOS T ROY SOC B, V361, P403, DOI 10.1098/rstb.2005.1799; WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9	29	99	102	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2007	39	3					415	421		10.1038/ng1967	http://dx.doi.org/10.1038/ng1967			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17277776				2022-12-27	WOS:000244480000027
J	Le Marechal, C; Masson, E; Chen, JM; Morel, F; Ruszniewski, P; Levy, P; Ferec, C				Le Marechal, Cedric; Masson, Emmanuelle; Chen, Jian-Min; Morel, Frederic; Ruszniewski, Philippe; Levy, Philippe; Ferec, Claude			Hereditary pancreatitis caused by triplication of the trypsinogen locus	NATURE GENETICS			English	Article							GENE; DISEASE; MUTATIONS	Hereditary pancreatitis has been reported to be caused by 'gain-of-function' missense mutations in the cationic trypsinogen gene (PRSS1). Here we report the triplication of a similar to 605-kb segment containing the PRSS1 gene on chromosome 7 in five families with hereditary pancreatitis. This triplication, which seems to result in a gain of trypsin through a gene dosage effect, represents a previously unknown molecular mechanism causing hereditary pancreatitis.	INSERM, U613, F-29220 Brest, France; Univ Bretagne Occidentale, Fac Med Brest & Sci Sante, F-29238 Brest, France; CHU Brest, Hop Morvan, Lab Genet Mol & Histocompatibil, F-29220 Brest, France; Etablissement Francais Sang Bretagne, F-29220 Brest, France; CHRU Brest, Hop Morvan, Serv Cytogenet Cytol & Biol Reprod, F-29238 Brest, France; Hop Beaujon, AP HP, Pole Maladies Appareil Digest, F-92118 Clichy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; CHU Brest; Universite de Bretagne Occidentale; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite	Chen, JM (corresponding author), INSERM, U613, F-29220 Brest, France.	Jian-Min.Chen@univ-brest.fr	Ferec, Claude/ABG-9699-2020	Ferec, Claude/0000-0002-2325-0710; MASSON, Emmanuelle/0000-0001-9777-523X; Chen, Jian-Min/0000-0002-2424-3969				Audrezet M, 2004, HUM MUTAT, V23, P343, DOI 10.1002/humu.20009; Chen JM, 2003, MOL GENET METAB, V79, P67, DOI 10.1016/S1096-7192(03)00050-7; CHIARA H, 1896, Z HEILKUNDE, V17, P70; COMFORT MW, 1952, GASTROENTEROLOGY, V21, P54; ELLIS D, 1994, NAT GENET, V6, P333, DOI 10.1038/ng0494-333; LeBodic L, 1996, HUM MOL GENET, V5, P549, DOI 10.1093/hmg/5.4.549; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Rowen L, 1996, SCIENCE, V272, P1755, DOI 10.1126/science.272.5269.1755; Sahin-Toth M, 2006, ENDOCRIN METAB CLIN, V35, P303, DOI 10.1016/j.ecl.2006.02.002; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Witt H, 2006, NAT GENET, V38, P668, DOI 10.1038/ng1797; Yau SC, 1996, J MED GENET, V33, P550, DOI 10.1136/jmg.33.7.550	15	151	154	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2006	38	12					1372	1374		10.1038/ng1904	http://dx.doi.org/10.1038/ng1904			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110TR	17072318				2022-12-27	WOS:000242404200012
J	Ingraham, CR; Kinoshita, A; Kondo, S; Yang, BL; Sajan, S; Trout, KJ; Malik, MI; Dunnwald, M; Goudy, SL; Lovett, M; Murray, JC; Schutte, BC				Ingraham, Christopher R.; Kinoshita, Akira; Kondo, Shinji; Yang, Baoli; Sajan, Samin; Trout, Kurt J.; Malik, Margaret I.; Dunnwald, Martine; Goudy, Stephen L.; Lovett, Michael; Murray, Jeffrey C.; Schutte, Brian C.			Abnormal skin, limb and craniofacial morphogenesis in mice deficient for interferon regulatory factor 6 (Irf6)	NATURE GENETICS			English	Article							DER-WOUDE-SYNDROME; INTERFERON-REGULATORY FACTOR-6; NONSYNDROMIC CLEFT-LIP; GENE INDUCTION; TRANSCRIPTION FACTORS; PALATE; VAN; IDENTIFICATION; POPULATION; MUTATIONS	Transcription factor paralogs may share a common role in staged or overlapping expression in specific tissues, as in the Hox family. In other cases, family members have distinct roles in a range of embryologic, differentiation or response pathways (as in the Tbx and Pax families). For the interferon regulatory factor (IRF) family of transcription factors, mice deficient in Irf1, Irf2, Irf3, Irf4, Irf5, Irf7, Irf8 or Irf9 have defects in the immune response but show no embryologic abnormalities(1-7). Mice deficient for Irf6 have not been reported, but in humans, mutations in IRF6 cause two mendelian orofacial clefting syndromes(8-10), and genetic variation in IRF6 confers risk for isolated cleft lip and palate(11-15). Here we report that mice deficient for Irf6 have abnormal skin, limb and craniofacial development. Histological and gene expression analyses indicate that the primary defect is in keratinocyte differentiation and proliferation. This study describes a new role for an IRF family member in epidermal development.	Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; Nagasaki Univ, Div Funct Genom, Ctr Frontier Life Sci, Nagasaki 852, Japan; Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; Univ Iowa, Dept Dermatol, Iowa City, IA 52242 USA; Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; Vanderbilt Univ, Dept Otolaryngol, Nashville, TN 37232 USA	University of Iowa; Nagasaki University; University of Iowa; University of Iowa; Washington University (WUSTL); Vanderbilt University	Schutte, BC (corresponding author), Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.	brian-schutte@uiowa.edu			NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013513, P50DE016215, R01DE008559] Funding Source: NIH RePORTER; NIDCR NIH HHS [DE13513, R37 DE008559, P50 DE016215, R01 DE008559, R01 DE013513, DE08559, P50 DE016215-01, R01 DE008559-10, DE16215] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Bailey CM, 2005, J BIOL CHEM, V280, P34210, DOI 10.1074/jbc.M503523200; Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; Blanton SH, 2005, AM J MED GENET A, V137A, P259, DOI 10.1002/ajmg.a.30887; Dornan D, 2004, MOL CELL BIOL, V24, P10083, DOI 10.1128/MCB.24.22.10083-10098.2004; FISHER C, 1987, J CELL BIOL, V105, P1807, DOI 10.1083/jcb.105.4.1807; Ghassibe M, 2005, EUR J HUM GENET, V13, P1239, DOI 10.1038/sj.ejhg.5201486; Herron BJ, 2005, NAT GENET, V37, P1210, DOI 10.1038/ng1652; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Kayano S, 2003, J HUM GENET, V48, P622, DOI 10.1007/s10038-003-0089-0; Kimura T, 1996, GENES CELLS, V1, P115, DOI 10.1046/j.1365-2443.1996.08008.x; Knight AS, 2006, DEV DYNAM, V235, P1441, DOI 10.1002/dvdy.20598; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Li QT, 2005, P NATL ACAD SCI USA, V102, P15977, DOI 10.1073/pnas.0508310102; MacPartlin M, 2005, J BIOL CHEM, V280, P30604, DOI 10.1074/jbc.M503352200; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; Mittrucker HW, 1997, SCIENCE, V275, P540, DOI 10.1126/science.275.5299.540; Qin BY, 2005, STRUCTURE, V13, P1269, DOI 10.1016/j.str.2005.06.011; Richardson RJ, 2006, NAT GENET, V38, P1329, DOI 10.1038/ng1894; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Scapoli L, 2005, AM J HUM GENET, V76, P180, DOI 10.1086/427344; Sil AK, 2004, NATURE, V428, P660, DOI 10.1038/nature02421; Srichomthong C, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.032235; Sugihara TM, 2001, J BIOL CHEM, V276, P33036, DOI 10.1074/jbc.M103000200; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Wang XF, 2003, HUM GENET, V113, P382, DOI 10.1007/s00439-003-0989-2; Yang HM, 2003, J BIOL CHEM, V278, P15495, DOI 10.1074/jbc.M212940200; Zambrowicz BP, 1998, NATURE, V392, P608, DOI 10.1038/33423; Zucchero TM, 2004, NEW ENGL J MED, V351, P769, DOI 10.1056/NEJMoa032909	30	245	251	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2006	38	11					1335	1340		10.1038/ng1903	http://dx.doi.org/10.1038/ng1903			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17041601	Green Accepted			2022-12-27	WOS:000241592700024
J	McKay, JD; Hung, RJ; Gaborieau, V; Boffetta, P; Chabrier, A; Byrnes, G; Zaridze, D; Mukeria, A; Szeszenia-Dabrowska, N; Lissowska, J; Rudnai, P; Fabianova, E; Mates, D; Bencko, V; Foretova, L; Janout, V; McLaughlin, J; Shepherd, F; Montpetit, A; Narod, S; Krokan, HE; Skorpen, F; Elvestad, MB; Vatten, L; Njolstad, I; Axelsson, T; Chen, C; Goodman, G; Barnett, M; Loomis, MM; Lubinski, J; Matyjasik, J; Lener, M; Oszutowska, D; Field, J; Liloglou, T; Xinarianos, G; Cassidy, A; Zelenika, D; Boland, A; Delepine, M; Foglio, M; Lechner, D; Matsuda, F; Blanche, H; Gut, I; Heath, S; Lathrop, M; Brennan, P				McKay, James D.; Hung, Rayjean J.; Gaborieau, Valerie; Boffetta, Paolo; Chabrier, Amelie; Byrnes, Graham; Zaridze, David; Mukeria, Anush; Szeszenia-Dabrowska, Neonilia; Lissowska, Jolanta; Rudnai, Peter; Fabianova, Eleonora; Mates, Dana; Bencko, Vladimir; Foretova, Lenka; Janout, Vladimir; McLaughlin, John; Shepherd, Frances; Montpetit, Alexandre; Narod, Steven; Krokan, Hans E.; Skorpen, Frank; Elvestad, Maiken Bratt; Vatten, Lars; Njolstad, Inger; Axelsson, Tomas; Chen, Chu; Goodman, Gary; Barnett, Matt; Loomis, Melissa M.; Lubinski, Jan; Matyjasik, Joanna; Lener, Marcin; Oszutowska, Dorota; Field, John; Liloglou, Triantafillos; Xinarianos, George; Cassidy, Adrian; Zelenika, Diana; Boland, Anne; Delepine, Marc; Foglio, Mario; Lechner, Doris; Matsuda, Fumihiko; Blanche, Helene; Gut, Ivo; Heath, Simon; Lathrop, Mark; Brennan, Paul		EPIC Study	Lung cancer susceptibility locus at 5p15.33	NATURE GENETICS			English	Article							HUMAN TELOMERASE; GENES; RNA	We carried out a genome-wide association study of lung cancer (3,259 cases and 4,159 controls), followed by replication in 2,899 cases and 5,573 controls. Two uncorrelated disease markers at 5p15.33, rs402710 and rs2736100 were detected by the genome-wide data (P - 2 x 10(-7) and P = 4 x 10(-6)) and replicated by the independent study series (P = 7 x 10(-5) and P = 0.016). The susceptibility region contains two genes, TERT and CLPTM1L, suggesting that one or both may have a role in lung cancer etiology.	[McKay, James D.; Hung, Rayjean J.; Gaborieau, Valerie; Boffetta, Paolo; Chabrier, Amelie; Byrnes, Graham; Brennan, Paul] Int Agcy Res Canc, F-69008 Lyon, France; [Hung, Rayjean J.; McLaughlin, John] Samuel Lunenfeld Res Inst, Toronto, ON M5T 3L9, Canada; [Zaridze, David; Mukeria, Anush] Russian Acad Med Sci, Canc Res Ctr, Inst Carcinogenesis, Moscow 115478, Russia; [Szeszenia-Dabrowska, Neonilia] Inst Occupat Med, Dept Epidemiol, PL-90950 Lodz, Poland; [Lissowska, Jolanta] M Sklodowska Curie Mem Canc Ctr, PL-02781 Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, PL-02781 Warsaw, Poland; [Rudnai, Peter] Natl Inst Environm Hlth, H-1097 Budapest, Hungary; [Fabianova, Eleonora] Specialized Inst Hyg & Epidemiol, Banska Bystrica 97556, Slovakia; [Mates, Dana] Inst Publ Hlth, Bucharest 050463, Romania; [Bencko, Vladimir] Charles Univ Prague, Fac Med 1, Inst Hyg & Epidemiol, Prague 12800 2, Czech Republic; [Foretova, Lenka] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno 65653, Czech Republic; [Janout, Vladimir] Palacky Univ, Olomouc 77515, Czech Republic; [McLaughlin, John] Canc Care Ontario, Toronto, ON M5G 2L7, Canada; [Shepherd, Frances] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Montpetit, Alexandre] McGill Univ, Montreal, PQ H3A 1A4, Canada; [Montpetit, Alexandre] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Narod, Steven] Womens Coll Res Inst, Toronto, ON M5G 1N8, Canada; [Krokan, Hans E.; Skorpen, Frank; Elvestad, Maiken Bratt; Vatten, Lars] Norwegian Univ Sci & Technol, N-7489 Trondheim, Norway; [Njolstad, Inger] Univ Tromso, Inst Community Med, N-9037 Tromso, Norway; [Axelsson, Tomas] Uppsala Univ, Acad Hosp, Dept Med Sci, SNP Technol Platform, Uppsala 75185, Sweden; [Chen, Chu; Goodman, Gary; Barnett, Matt; Loomis, Melissa M.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Lubinski, Jan; Matyjasik, Joanna; Lener, Marcin; Oszutowska, Dorota] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, PL-70115 Szczecin, Poland; [Field, John; Liloglou, Triantafillos; Xinarianos, George; Cassidy, Adrian] Univ Liverpool, Canc Res Ctr, Roy Castle Lung Canc Res Programme, Liverpool L3 9TA, Merseyside, England; [Zelenika, Diana; Boland, Anne; Delepine, Marc; Foglio, Mario; Lechner, Doris; Matsuda, Fumihiko; Gut, Ivo; Heath, Simon; Lathrop, Mark] CEA, Inst Genom, Ctr Natl Genotypage, F-91000 Evry, France; [Blanche, Helene; Lathrop, Mark] Fdn Jean Dausset CEPH, F-75010 Paris, France	World Health Organization; International Agency for Research on Cancer (IARC); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Russian Academy of Medical Sciences; Nofer Institute of Occupational Medicine; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Charles University Prague; Masaryk Memorial Cancer Institute; Palacky University Olomouc; Cancer Care Ontario; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; McGill University; University of Toronto; University Toronto Affiliates; Womens College Hospital; Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; Uppsala University; Fred Hutchinson Cancer Center; Pomeranian Medical University; University of Liverpool; CEA; UDICE-French Research Universities; Universite Paris Saclay; Foundation Jean Dausset-CEPH	Brennan, P (corresponding author), Int Agcy Res Canc, F-69008 Lyon, France.	brennan@iarc.fr	Narod, Steven A/AAA-6112-2022; Szeszenia-Dabrowska, Neonila/F-7190-2010; Bencko, Vladimir/H-8598-2017; Hung, Rayjean J/A-7439-2013; Gut, Ivo/ABF-3188-2020; Linseisen, Jakob/B-5353-2014; Trubicka, Joanna/R-1215-2018; Krogh, Vittorio/K-2628-2016; Janout, Vladimir/M-5133-2014; McLaughlin, John R/E-4577-2013; Oszutowska-Mazurek, Dorota/D-2000-2017; Njolstad, Inger/X-3784-2019; Zaridze, David/K-5605-2013; Boffetta, Paolo/AAI-7767-2021; Xinarianos, George/B-7534-2012; Heath, Simon C/J-4138-2012; Matsuda, Fumihiko/B-9893-2009; Vatten, Lars/AAF-9380-2022; Vatten, Lars/AFK-2073-2022; Field, John K./AAD-5674-2020; Lissowska, Jolanta/AAH-3252-2020; Panico, Salvatore/K-6506-2016; Clavel-Chapelon, Francoise/G-6733-2014; Foglio, mary A./B-9149-2012	Bencko, Vladimir/0000-0003-1935-2228; Gut, Ivo/0000-0001-7219-632X; Linseisen, Jakob/0000-0002-9386-382X; Trubicka, Joanna/0000-0002-9848-3674; Krogh, Vittorio/0000-0003-0122-8624; Oszutowska-Mazurek, Dorota/0000-0001-6403-4160; Boffetta, Paolo/0000-0002-3811-2791; Heath, Simon C/0000-0002-9550-0897; Field, John K./0000-0003-3951-6365; Lissowska, Jolanta/0000-0003-2695-5799; Panico, Salvatore/0000-0002-5498-8312; Foglio, mary A./0000-0001-7715-4452; Skorpen, Frank/0000-0001-7093-8000; PALLI, Domenico/0000-0002-5558-2437; Byrnes, Graham/0000-0003-3893-7539; mates, dana/0000-0002-6219-9807; Riboli, Elio/0000-0001-6795-6080; tumino, rosario/0000-0003-2666-414X; Larranaga, Nerea/0000-0002-9993-9880; Overvad, Kim/0000-0001-6429-7921; Tjonneland, Anne/0000-0003-4385-2097; Navarro, Carmen/0000-0001-8896-7483; Xinarianos, George/0000-0001-9185-5554; Foretova, Lenka/0000-0003-0494-2620; Hung, Rayjean/0000-0002-4486-7496	Institut National du Cancer, France; European Community [LSHG-CT-2005-512113, MTKD-CT-2004-510114]; Norwegian Cancer Association; Research Council of Norway; Ontario Institute of Cancer Research; US National Cancer Institute [R01 CA092039]; NATIONAL CANCER INSTITUTE [R01CA092039] Funding Source: NIH RePORTER	Institut National du Cancer, France(Institut National du Cancer (INCA) France); European Community(European Commission); Norwegian Cancer Association; Research Council of Norway(Research Council of Norway); Ontario Institute of Cancer Research; US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	P. Brennan and M. Lathrop designed the study. J.D.M., R.J.H., V.G., M.B.E., A. B. and H. Blanche coordinated the preparation and inclusion of all biological samples. J.D.M., S.H. and V.G. undertook the statistical analysis. Bioinformatics analysis was undertaken by F.M., M.F. and S.H. D. Z., D.L. and I.G. coordinated the genotyping of the central Europe samples. A.M. and R.J.H. coordinated the genotyping of the Toronto samples. J.D.M., D.Z., M.D., A.C., T.A. and H.E.K. coordinated the genotyping of the other studies. All other coauthors coordinated the initial recruitment and management of the studies. M. Lathrop obtained financial support for genotyping of the central Europe study; P. Brennan, R.J.H. and H.E.K. obtained financial support for genotyping of the other studies. P. Brennan and J.D.M. drafted the manuscript with substantial contributions from R.J.H. and M. Lathrop. All authors contributed to the final paper. The authors thank all of the participants who took part in this research and the funders and support and technical staff who made this study possible. Support for the central Europe, HUNT2/Tromso and CARET genome-wide studies and follow- up genotyping was provided by Institut National du Cancer, France. Support for the HUNT2/Tromso genome-wide study was also provided by the European Community (Integrated Project DNA repair, grant no. LSHG-CT-2005-512113), the Norwegian Cancer Association and the Functional Genomics Programme of Research Council of Norway. Funding for the Toronto genome-wide study was provided by the Ontario Institute of Cancer Research. Funding for the Szczecin/Poland replication study was provided by European Community program "Marie- Curie Host Fellowships for the Transfer of Knowledge,'' grant no. MTKD-CT-2004-510114. Additional funding for study coordination, genotyping of replication studies and statistical analysis was provided by the US National Cancer Institute (R01 CA092039).	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Garcia CK, 2007, NUCLEIC ACIDS RES, V35, P7406, DOI 10.1093/nar/gkm644; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Janknecht R, 2004, FEBS LETT, V564, P9, DOI 10.1016/S0014-5793(04)00356-4; Lantuejoul S, 2007, INT J CANCER, V120, P1835, DOI 10.1002/ijc.22473; Mavrogiannou E, 2007, CLIN CHEM, V53, P53, DOI 10.1373/clinchem.2006.073015; Savage SA, 2005, HUM MUTAT, V26, P343, DOI 10.1002/humu.20226; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Weinrich SL, 1997, NAT GENET, V17, P498, DOI 10.1038/ng1297-498; Wu TC, 2003, LUNG CANCER-J IASLC, V41, P163, DOI 10.1016/S0169-5002(03)00195-8; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250	15	449	469	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1404	1406		10.1038/ng.254	http://dx.doi.org/10.1038/ng.254			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	18978790	Green Accepted			2022-12-27	WOS:000261215900014
J	Scott, RH; Douglas, J; Baskcomb, L; Huxter, N; Barker, K; Hanks, S; Craft, A; Gerrard, M; Kohler, JA; Levitt, GA; Picton, S; Pizer, B; Ronghe, MD; Williams, D; Cook, JA; Pujol, P; Maher, ER; Birch, JM; Stiller, CA; Pritchard-Jones, K; Rahman, N				Scott, Richard H.; Douglas, Jenny; Baskcomb, Linda; Huxter, Nikki; Barker, Karen; Hanks, Sandra; Craft, Alan; Gerrard, Mary; Kohler, Janice A.; Levitt, Gill A.; Picton, Sue; Pizer, Barry; Ronghe, Milind D.; Williams, Denise; Cook, Jackie A.; Pujol, Pascal; Maher, Eamonn R.; Birch, Jillian M.; Stiller, Charles A.; Pritchard-Jones, Kathy; Rahman, Nazneen		FACT Collaboration	Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor	NATURE GENETICS			English	Article							BECKWITH-WIEDEMANN-SYNDROME; CHROMOSOME 11P15; H19; MICRODELETION; INDIVIDUALS; METHYLATION; DEFECTS; CANCER; REGION; IGF2	Constitutional abnormalities at the imprinted 11p15 growth regulatory region cause syndromes characterized by disordered growth, some of which include a risk of Wilms tumor(1-3). We explored their possible contribution to nonsyndromic Wilms tumor and identified constitutional 11p15 abnormalities in genomic lymphocyte DNA from 13 of 437 individuals (3%) with sporadic Wilms tumor without features of growth disorders, including 12% of bilateral cases (P = 0.001) and in one familial Wilms tumor pedigree. No abnormality was detected in 220 controls (P = 0.006). Abnormalities identified included H19 DMR epimutations, uniparental disomy 11p15 and H19 DMR imprinting center mutations (one microinsertion and one microdeletion), thus identifying microinsertion as a new class of imprinting center mutation. Our data identify constitutional 11p15 defects as one of the most common known causes of Wilms tumor, provide mechanistic insights into imprinting disruption and reveal clinically important epigenotype-phenotype associations. The impact on clinical management dictates that constitutional 11p15 analysis should be considered in all individuals with Wilms tumor.	[Scott, Richard H.; Douglas, Jenny; Baskcomb, Linda; Huxter, Nikki; Barker, Karen; Hanks, Sandra; Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; [Scott, Richard H.; Douglas, Jenny; Baskcomb, Linda; Huxter, Nikki; Barker, Karen; Hanks, Sandra; Pritchard-Jones, Kathy; Rahman, Nazneen] Royal Marsden Hosp, Sutton SM2 5NG, Surrey, England; [Craft, Alan] Royal Victoria Infirm, Dept Paediat, Newcastle Upon Tyne NE7 7DN, Tyne & Wear, England; [Gerrard, Mary] Sheffield Childrens Hosp, Dept Paediat Oncol, Sheffield S10 2TH, S Yorkshire, England; [Kohler, Janice A.] Southampton Gen Hosp, Dept Paediat Oncol, Southampton SO16 6YD, Hants, England; [Levitt, Gill A.] Great Ormond St Hosp Sick Children, Dept Haematol Oncol, London WC1N 3JH, England; [Picton, Sue] St James Univ Hosp, Reg Paediat Oncol Unit, Leeds LS9 7TF, W Yorkshire, England; [Pizer, Barry] Alder Hey Childrens Hosp, Dept Paediat Oncol, Liverpool L12 2AP, Merseyside, England; [Ronghe, Milind D.] Royal Hosp Sick Children, Schiehall Unit, Glasgow G3 8SJ, Lanark, Scotland; [Williams, Denise] Addenbrookes NHS Trust, Dept Paediat Oncol, Cambridge CB2 0QR, England; [Cook, Jackie A.] Sheffield Childrens Hosp, Dept Clin Genet, Sheffield S10 2TH, S Yorkshire, England; [Pujol, Pascal] Ctr Hosp Univ, Serv Genet Med, F-34000 Montpellier, France; [Maher, Eamonn R.] Univ Birmingham, Inst Biomed Res, Dept Med & Mol Genet, Birmingham B15 2TT, W Midlands, England; [Birch, Jillian M.] Royal Manchester Childrens Hosp, Canc Res UK Paediat & Familial Canc Res Grp, Manchester M27 4HA, Lancs, England; [Stiller, Charles A.] Univ Oxford, Dept Paediat, Childhood Canc Res Grp, Oxford OX2 6HJ, England; [Pritchard-Jones, Kathy] Inst Canc Res, Sect Paediat Oncol, Sutton SM2 5NG, Surrey, England	University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Newcastle University - UK; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; University of Southampton; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Saint James's University Hospital; Alder Hey Children's NHS Foundation Trust; Alder Hey Children's Hospital; University of Glasgow; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Sheffield Children's NHS Foundation Trust; Sheffield Children's Hospital; Universite de Montpellier; CHU de Montpellier; University of Birmingham; Cancer Research UK; Royal Manchester Children's Hospital; University of Oxford; University of London; Institute of Cancer Research - UK	Rahman, N (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England.	nazneen.rahman@icr.ac.uk	Rahman, Nazneen/B-8890-2012; Pharoah, Paul/V-6658-2019; Graf, Norbert/H-1328-2011; Pritchard-Jones, Kathy/F-4286-2014; MAHER, EAMONN R/A-9507-2008; Rahman, Nazneen/D-2802-2013	Pharoah, Paul/0000-0001-8494-732X; Graf, Norbert/0000-0002-2248-323X; Pritchard-Jones, Kathy/0000-0002-2384-9475; MAHER, EAMONN R/0000-0002-6226-6918; albright, lisa/0000-0003-2602-3668; Arbour, Laura/0000-0002-9589-0880; Rahman, Nazneen/0000-0003-4376-0440; Stiller, Charles/0000-0002-3006-7869	Michael and Betty Kadoorie Cancer Genetics Research Programme; Medical Research Council (UK); Cancer Research UK; Institute of Cancer Research (UK); Medical Research Council [G0400188] Funding Source: researchfish; MRC [G0400188] Funding Source: UKRI	Michael and Betty Kadoorie Cancer Genetics Research Programme; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Institute of Cancer Research (UK)(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the affected individuals and families involved in the research. We thank the many physicians and nurses who referred families and provided samples and clinical information. The following members of the FACT Collaboration provided familial Wilms tumor pedigrees analyzed in this study: L. Arbour, C. Bonaiti-Pellie, L. Cannon-Albright, A. Chompret, T. Cole, C. Dhooge, W. Dupuis, A. Foot, W. Foulkes, H. Galvin, A. Gnekow, N. Graf, D. King, J. Kingston, I. Lewis, A. O'Meara, F. Millot, H. Price, B. Royer-Pokora, V. Schumacher, C. Schwartz, R. Shannon, E. Sheridan, J. Skeen, P. Tonin and A. Weirich. We thank B. Messahel, R. Al-Saadi, M. Cohen, N. Coleman and M. Malone for providing Wilms tumor specimens. We thank M. Stratton and C. Turnbull for their comments on the manuscript. The research was carried out as part of the Investigation of Familial Wilms Tumour Genes and the Factors Associated with Childhood Tumours (FACT) study, which are UK Children's Cancer and Leukaemia Group (CCLG) studies. The Childhood Cancer Research Group receives funding from the Department of Health and the Scottish Ministers. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health and the Scottish Ministers. R.H.S. is supported by the Michael and Betty Kadoorie Cancer Genetics Research Programme. This work was supported by grants from Medical Research Council (UK), Cancer Research UK and the Institute of Cancer Research (UK).	Bastepe M, 2005, NAT GENET, V37, P25, DOI 10.1038/ng1487; BECKWITH J B, 1990, Pediatric Pathology, V10, P1; Bliek J, 2004, J PEDIATR-US, V145, P796, DOI 10.1016/j.jpeds.2004.08.007; BUITING K, 1995, NAT GENET, V9, P395, DOI 10.1038/ng0495-395; Cooper WN, 2005, EUR J HUM GENET, V13, P1025, DOI 10.1038/sj.ejhg.5201463; DeBaun MR, 2002, AM J HUM GENET, V70, P604, DOI 10.1086/338934; Engel JR, 2000, J MED GENET, V37, P921, DOI 10.1136/jmg.37.12.921; Ferner RE, 2007, J MED GENET, V44, P81, DOI 10.1136/jmg.2006.045906; Gaston V, 2001, EUR J HUM GENET, V9, P409, DOI 10.1038/sj.ejhg.5200649; Gicquel C, 2005, NAT GENET, V37, P1003, DOI 10.1038/ng1629; Kagami M, 2008, NAT GENET, V40, P237, DOI 10.1038/ng.2007.56; Little SE, 2004, J CLIN ONCOL, V22, P4140, DOI 10.1200/JCO.2004.02.136; MOULTON T, 1994, NAT GENET, V7, P440, DOI 10.1038/ng0794-440; Niemitz EL, 2004, AM J HUM GENET, V75, P844, DOI 10.1086/425343; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; Okamoto K, 1997, P NATL ACAD SCI USA, V94, P5367, DOI 10.1073/pnas.94.10.5367; Porteus MH, 2000, J CLIN ONCOL, V18, P2026, DOI 10.1200/JCO.2000.18.10.2026; Prawitt D, 2005, NAT GENET, V37, P785, DOI 10.1038/ng0805-785; Prawitt D, 2005, P NATL ACAD SCI USA, V102, P4085, DOI 10.1073/pnas.0500037102; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; REIK W, 1995, HUM MOL GENET, V4, P2379, DOI 10.1093/hmg/4.12.2379; Scott RH, 2008, J MED GENET, V45, P106, DOI 10.1136/jmg.2007.053207; Scott RH, 2006, ARCH DIS CHILD, V91, P995, DOI 10.1136/adc.2006.101295; Scott RH, 2006, J MED GENET, V43, P705, DOI 10.1136/jmg.2006.041723; Sparago A, 2004, NAT GENET, V36, P958, DOI 10.1038/ng1410; Sparago A, 2007, HUM MOL GENET, V16, P254, DOI 10.1093/hmg/ddl448; STEENMAN MJC, 1994, NAT GENET, V7, P433, DOI 10.1038/ng0794-433; Tatton-Brown K, 2005, AM J HUM GENET, V77, P193, DOI 10.1086/432082; Weksberg R, 2005, AM J MED GENET C, V137C, P12, DOI 10.1002/ajmg.c.30058; Weksberg R, 2001, HUM MOL GENET, V10, P2989, DOI 10.1093/hmg/10.26.2989	30	105	108	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1329	1334		10.1038/ng.243	http://dx.doi.org/10.1038/ng.243			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18836444				2022-12-27	WOS:000260501500026
J	Hazra, A; Kraft, P; Selhub, J; Giovannucci, EL; Thomas, G; Hoover, RN; Chanock, SJ; Hunter, DJ				Hazra, Aditi; Kraft, Peter; Selhub, Jacob; Giovannucci, Edward L.; Thomas, Gilles; Hoover, Robert N.; Chanock, Stephen J.; Hunter, David J.			Common variants of FUT2 are associated with plasma vitamin B-12 levels	NATURE GENETICS			English	Article							HELICOBACTER-PYLORI INFECTION; SECRETOR PHENOTYPE; HUMAN-POPULATIONS; GENE FUT2; MALABSORPTION; HOMOCYSTEINE; CANCER; RISK	We identified a strong association (P = 5.36 x 10(-17)) between rs492602 in FUT2 and plasma vitamin B-12 levels in a genome-wide scan (n = 1,658) and an independent replication sample (n = 1,059) from the Nurses' Health Study. Women homozygous for the rs492602[G] allele had higher B12 levels. This allele is in strong linkage disequilibrium with the FUT2 nonsecretor variant encoding W143X, suggesting a plausible mechanism for altered B12 absorption and plasma levels.	[Hazra, Aditi; Kraft, Peter; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; [Hazra, Aditi; Giovannucci, Edward L.; Hunter, David J.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Hazra, Aditi; Giovannucci, Edward L.; Hunter, David J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Selhub, Jacob] Tufts Univ, Jean Mayer US Dept Agr, Human Nutr Res Ctr Aging, Vitamin Metab & Aging Lab, Boston, MA 02111 USA; [Giovannucci, Edward L.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Thomas, Gilles; Hoover, Robert N.; Chanock, Stephen J.; Hunter, David J.] NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Bethesda, MD 20892 USA; [Hunter, David J.] MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Hunter, David J.] Harvard Univ, Cambridge, MA 02142 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Tufts University; United States Department of Agriculture (USDA); Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Hunter, DJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, 677 Huntington Ave, Boston, MA 02115 USA.	dhunter@hsph.harvard.edu			National Institutes of Health Research [U54 CA100971, P01 CA87969, P01 CA55075, U01 CA098233, R01 CA 065725, CA070817]; NIH [T-32 CA 09001-30]; NATIONAL CANCER INSTITUTE [U01CA098233, U54CA100971, P01CA087969, T32CA009001, P01CA055075, R01CA065725, R01CA070817] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank H. Ranu, C. Chen and the staff at the Core Genotyping Facility at the National Cancer Institute for their expertise. This research is supported by the National Institutes of Health Research Grants U54 CA100971, P01 CA87969, P01 CA55075, U01 CA098233, R01 CA 065725 and CA070817. A. H. is supported in part by training grant NIH T-32 CA 09001-30.	Annibale B, 2002, DIGEST LIVER DIS, V34, pS72, DOI 10.1016/S1590-8658(02)80170-0; Azevedo M, 2008, J PATHOL, V215, P308, DOI 10.1002/path.2363; CARMEL R, 1987, J LAB CLIN MED, V109, P454; Dahlin AM, 2008, INT J CANCER, V122, P2057, DOI 10.1002/ijc.23299; Dholakia KR, 2005, WORLD J GASTROENTERO, V11, P7078, DOI 10.3748/wjg.v11.i45.7078; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kang JH, 2006, EPIDEMIOLOGY, V17, P650, DOI 10.1097/01.ede.0000239727.59575.da; KELLY RJ, 1995, J BIOL CHEM, V270, P4640, DOI 10.1074/jbc.270.9.4640; Koda Y, 2001, GENETICS, V158, P747; Lindesmith LC, 2008, PLOS MED, V5, P269, DOI 10.1371/journal.pmed.0050031; Siva A, 2007, QJM-INT J MED, V100, P495, DOI 10.1093/qjmed/hcm054; Tamura A, 2002, AM J GASTROENTEROL, V97, P861, DOI 10.1111/j.1572-0241.2002.05601.x; Tanner SM, 2004, HUM MUTAT, V23, P327, DOI 10.1002/humu.20014; Van Oijen MGH, 2004, J NUTR SCI VITAMINOL, V50, P305, DOI 10.3177/jnsv.50.305; Watanabe F, 2007, EXP BIOL MED, V232, P1266, DOI 10.3181/0703-MR-67	15	108	117	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2008	40	10					1160	1162		10.1038/ng.210	http://dx.doi.org/10.1038/ng.210			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18776911	Green Accepted			2022-12-27	WOS:000259651000013
J	Sulem, P; Gudbjartsson, DF; Stacey, SN; Helgason, A; Rafnar, T; Jakobsdottir, M; Steinberg, S; Gudjonsson, SA; Palsson, A; Thorleifsson, G; Palsson, S; Sigurgeirsson, B; Thorisdottir, K; Ragnarsson, R; Benediktsdottir, KR; Aben, KK; Vermeulen, SH; Goldstein, AM; Tucker, MA; Kiemeney, LA; Olafsson, JH; Gulcher, J; Kong, A; Thorsteinsdottir, U; Stefansson, K				Sulem, Patrick; Gudbjartsson, Daniel F.; Stacey, Simon N.; Helgason, Agnar; Rafnar, Thorunn; Jakobsdottir, Margret; Steinberg, Stacy; Gudjonsson, Sigurjon A.; Palsson, Arnar; Thorleifsson, Gudmar; Palsson, Snaebjoern; Sigurgeirsson, Bardur; Thorisdottir, Kristin; Ragnarsson, Rafn; Benediktsdottir, Kristrun R.; Aben, Katja K.; Vermeulen, Sita H.; Goldstein, Alisa M.; Tucker, Margaret A.; Kiemeney, Lambertus A.; Olafsson, Jon H.; Gulcher, Jeffrey; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari			Two newly identified genetic determinants of pigmentation in Europeans	NATURE GENETICS			English	Article							TYRP1 GENE; POLYMORPHISM; AGOUTI; SKIN; POPULATION; SEQUENCE; ALBINISM; MELANOMA; HUMANS	We present results from a genome-wide association study for variants associated with human pigmentation characteristics among 5,130 Icelanders, with follow-up analyses in 2,116 Icelanders and 1,214 Dutch individuals. Two coding variants in TPCN2 are associated with hair color, and a variant at the ASIP locus shows strong association with skin sensitivity to sun, freckling and red hair, phenotypic characteristics similar to those affected by well-known mutations in MC1R.	[Sulem, Patrick; Gudbjartsson, Daniel F.; Stacey, Simon N.; Helgason, Agnar; Rafnar, Thorunn; Jakobsdottir, Margret; Steinberg, Stacy; Gudjonsson, Sigurjon A.; Palsson, Arnar; Thorleifsson, Gudmar; Palsson, Snaebjoern; Gulcher, Jeffrey; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE genet, IS-101 Reykjavik, Iceland; [Sigurgeirsson, Bardur; Thorisdottir, Kristin; Benediktsdottir, Kristrun R.; Olafsson, Jon H.] Landspitali Univ Hosp, Dept Dermatol, IS-101 Reykjavik, Iceland; [Sigurgeirsson, Bardur; Benediktsdottir, Kristrun R.; Olafsson, Jon H.] Landspitali Univ Hosp, Dept Pathol, IS-101 Reykjavik, Iceland; [Thorisdottir, Kristin; Ragnarsson, Rafn] Landspitali Univ Hosp, Dept Plast Surg, IS-101 Reykjavik, Iceland; [Aben, Katja K.; Kiemeney, Lambertus A.] Ctr Comprehens Canc, NL-6501 BG Nijmegen, Netherlands; [Aben, Katja K.; Vermeulen, Sita H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; [Goldstein, Alisa M.; Tucker, Margaret A.] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Services, Bethesda, MD 20892 USA; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Dept Urol, NL-6500 HB Nijmegen, Netherlands	Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; Radboud University Nijmegen; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Radboud University Nijmegen	Gudbjartsson, DF (corresponding author), deCODE genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	daniel.gudbjartsson@decode.is; kstefans@decode.is	Palsson, Snaebjorn/J-9113-2012; Sigurgeirsson, Bardur/AAP-7755-2020; Aben, Katja KH/G-9686-2016; Vermeulen, Sita H./L-4716-2015; Sigurgeirsson, Bárður/B-6130-2011; Palsson, Arnar/M-2742-2015; Tucker, Margaret A/B-4297-2015; Kiemeney, Lambertus A./D-3357-2009; Helgason, Agnar/K-1522-2015; Stefansson, Kari/AAE-7187-2019	Aben, Katja KH/0000-0002-0214-2147; Vermeulen, Sita H./0000-0003-4913-8601; Palsson, Arnar/0000-0002-6525-8112; Kiemeney, Lambertus A./0000-0002-2368-1326; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Helgason, Agnar/0000-0002-8545-3767; Gudbjartsson, Daniel/0000-0002-5222-9857; Sigurgeirsson, Bardur/0000-0002-9733-9742; Kong, Augustine/0000-0001-8193-5438; Palsson, Snaebjorn/0000-0002-4297-3500	Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01CP005803] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000732] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Box NF, 1998, MAMM GENOME, V9, P50, DOI 10.1007/s003359900678; Frudakis T, 2003, GENETICS, V165, P2071; FUKAI K, 1995, NAT GENET, V9, P92, DOI 10.1038/ng0195-92; Kanetsky PA, 2002, AM J HUM GENET, V70, P770, DOI 10.1086/339076; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Landi MT, 2005, J NATL CANCER I, V97, P998, DOI 10.1093/jnci/dji176; Manga P, 1997, AM J HUM GENET, V61, P1095, DOI 10.1086/301603; Meziani R, 2005, J DERMATOL SCI, V40, P133, DOI 10.1016/j.jdermsci.2005.08.001; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Rees JL, 2004, AM J HUM GENET, V75, P739, DOI 10.1086/425285; Schmutz SM, 2007, J HERED, V98, P351, DOI 10.1093/jhered/esm036; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Voisey J, 2002, PIGM CELL RES, V15, P10, DOI 10.1034/j.1600-0749.2002.00039.x	14	262	269	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					835	837		10.1038/ng.160	http://dx.doi.org/10.1038/ng.160			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18488028				2022-12-27	WOS:000257166500016
J	Zhu, J; Zhang, B; Smith, EN; Drees, B; Brem, RB; Kruglyak, L; Bumgarner, RE; Schadt, EE				Zhu, Jun; Zhang, Bin; Smith, Erin N.; Drees, Becky; Brem, Rachel B.; Kruglyak, Leonid; Bumgarner, Roger E.; Schadt, Eric E.			Integrating large-scale functional genomic data to dissect the complexity of yeast regulatory networks	NATURE GENETICS			English	Article							SEGREGATING MOUSE-POPULATION; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; PROTEIN; PHOSPHATE; PATHWAYS; DISEASE; OBESITY; TRAITS	A key goal of biology is to construct networks that predict complex system behavior. We combine multiple types of molecular data, including genotypic, expression, transcription factor binding site (TFBS), and protein-protein interaction (PPI) data previously generated from a number of yeast experiments, in order to reconstruct causal gene networks. Networks based on different types of data are compared using metrics devised to assess the predictive power of a network. We show that a network reconstructed by integrating genotypic, TFBS and PPI data is the most predictive. This network is used to predict causal regulators responsible for hot spots of gene expression activity in a segregating yeast population. We also show that the network can elucidate the mechanisms by which causal regulators give rise to larger-scale changes in gene expression activity. We then prospectively validate predictions, providing direct experimental evidence that predictive networks can be constructed by integrating multiple, appropriate data types.	[Zhu, Jun; Zhang, Bin; Schadt, Eric E.] LLC, Rosetta Inpharmat, Seattle, WA 98109 USA; [Smith, Erin N.; Kruglyak, Leonid] Princeton Univ, Lewis Sigler Inst Integrat Genom, Carl Icahn Lab, Princeton, NJ 08544 USA; [Smith, Erin N.; Kruglyak, Leonid] Princeton Univ, Dept Ecol & Evolutionary Biol, Carl Icahn Lab, Princeton, NJ 08544 USA; [Smith, Erin N.] Univ Washington, Dept Mol & Cellular Biol, Seattle, WA 98195 USA; [Bumgarner, Roger E.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Brem, Rachel B.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Merck & Company; Princeton University; Princeton University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California Berkeley	Schadt, EE (corresponding author), LLC, Rosetta Inpharmat, Seattle, WA 98109 USA.	eric_schadt@merck.com	Bumgarner, Roger E/K-3531-2015; Smith, Erin/E-5933-2011; Bumgarner, Roger/AAA-6846-2020	Bumgarner, Roger E/0000-0002-8168-6985; 	NIGMS NIH HHS [P50 GM071508, P50GM071508] Funding Source: Medline; NIMH NIH HHS [R37 MH059520, R37 MH059520-11] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059520] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Chen XJ, 2004, GENETICS, V167, P607, DOI 10.1534/genetics.103.023655; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Deeds EJ, 2006, P NATL ACAD SCI USA, V103, P311, DOI 10.1073/pnas.0509715102; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Ge H, 2001, NAT GENET, V29, P482, DOI 10.1038/ng776; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; Giots F, 2003, MOL MICROBIOL, V47, P1163, DOI 10.1046/j.1365-2958.2003.03365.x; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Kulp DC, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-125; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee SI, 2006, P NATL ACAD SCI USA, V103, P14062, DOI 10.1073/pnas.0601852103; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lum PY, 2006, J NEUROCHEM, V97, P50, DOI 10.1111/j.1471-4159.2006.03661.x; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Mehrabian M, 2005, NAT GENET, V37, P1224, DOI 10.1038/ng1619; Nielsen J, 2005, TRENDS BIOTECHNOL, V23, P544, DOI 10.1016/j.tibtech.2005.08.005; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; Ong Irene M, 2002, Bioinformatics, V18 Suppl 1, pS241; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Rajagopalan D, 2005, BIOINFORMATICS, V21, P788, DOI 10.1093/bioinformatics/bti069; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Ronald J, 2005, PLOS GENET, V1, P213, DOI 10.1371/journal.pgen.0010025; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Sinha H, 2006, PLOS GENET, V2, P140, DOI 10.1371/journal.pgen.0020013; Tan K, 2007, P NATL ACAD SCI USA, V104, P1283, DOI 10.1073/pnas.0606914104; Workman CT, 2006, SCIENCE, V312, P1054, DOI 10.1126/science.1122088; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhu J, 2004, CYTOGENET GENOME RES, V105, P363, DOI 10.1159/000078209; Zhu J, 2007, PLOS COMPUT BIOL, V3, P692, DOI 10.1371/journal.pcbi.0030069	36	383	387	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2008	40	7					854	861		10.1038/ng.167	http://dx.doi.org/10.1038/ng.167			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18552845	Green Accepted			2022-12-27	WOS:000257166500020
J	Tenesa, A; Farrington, SM; Prendergast, JGD; Porteous, ME; Walker, M; Haq, N; Barnetson, RA; Theodoratou, E; Cetnarskyj, R; Cartwright, N; Semple, C; Clark, AJ; Reid, FJL; Smith, LA; Kavoussanakis, K; Koessler, T; Pharoah, PDP; Buch, S; Schafmayer, C; Tepel, J; Schreiber, S; Volzke, H; Schmidt, CO; Hampe, J; Chang-Claude, J; Hoffmeister, M; Brenner, H; Wilkening, S; Canzian, F; Capella, G; Moreno, V; Deary, IJ; Starr, JM; Tomlinson, IPM; Kemp, Z; Howarth, K; Carvajal-Carmona, L; Webb, E; Broderick, P; Vijayakrishnan, J; Houlston, RS; Rennert, G; Ballinger, D; Rozek, L; Gruber, SB; Matsuda, K; Kidokoro, T; Nakamura, Y; Zanke, BW; Greenwood, CMT; Rangrej, J; Kustra, R; Montpetit, A; Hudson, TJ; Gallinger, S; Campbell, H; Dunlop, MG				Tenesa, Albert; Farrington, Susan M.; Prendergast, James G. D.; Porteous, Mary E.; Walker, Marion; Haq, Naila; Barnetson, Rebecca A.; Theodoratou, Evropi; Cetnarskyj, Roseanne; Cartwright, Nicola; Semple, Colin; Clark, Andrew J.; Reid, Fiona J. L.; Smith, Lorna A.; Kavoussanakis, Kostas; Koessler, Thibaud; Pharoah, Paul D. P.; Buch, Stephan; Schafmayer, Clemens; Tepel, Juergen; Schreiber, Stefan; Voelzke, Henry; Schmidt, Carsten O.; Hampe, Jochen; Chang-Claude, Jenny; Hoffmeister, Michael; Brenner, Hermann; Wilkening, Stefan; Canzian, Federico; Capella, Gabriel; Moreno, Victor; Deary, Ian J.; Starr, John M.; Tomlinson, Ian P. M.; Kemp, Zoe; Howarth, Kimberley; Carvajal-Carmona, Luis; Webb, Emily; Broderick, Peter; Vijayakrishnan, Jayaram; Houlston, Richard S.; Rennert, Gad; Ballinger, Dennis; Rozek, Laura; Gruber, Stephen B.; Matsuda, Koichi; Kidokoro, Tomohide; Nakamura, Yusuke; Zanke, Brent W.; Greenwood, Celia M. T.; Rangrej, Jagadish; Kustra, Rafal; Montpetit, Alexandre; Hudson, Thomas J.; Gallinger, Steven; Campbell, Harry; Dunlop, Malcolm G.			Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21	NATURE GENETICS			English	Article							GENETIC RISK; SNPS	In a genome-wide association study to identify loci associated with colorectal cancer (CRC) risk, we genotyped 555,510 SNPs in 1,012 early- onset Scottish CRC cases and 1,012 controls (phase 1). In phase 2, we genotyped the 15,008 highest-ranked SNPs in 2,057 Scottish cases and 2,111 controls. We then genotyped the five highest-ranked SNPs from the joint phase 1 and 2 analysis in 14,500 cases and 13,294 controls from seven populations, and identified a previously unreported association, rs3802842 on 11q23 (OR 1.1; P=5.8 x 10(-10)),showing population differences in risk. We also replicated and fine-mapped associations at 8q24 (rs7014346; OR 1.19; P=8.6x10(-26)) and 18q21 (rs4939827; OR 1.2; P=7.8 x 10(-28)). Risk was greater for rectal than for colon cancer for rs3802842 (P < 0.008) and rs4939827 (P < 0.009). Carrying all six possible risk alleles yielded OR 2.6 (95% CI 1.75-3.89) for CRC. These findings extend our understanding of the role of common genetic variation in CRC etiology.	[Tenesa, Albert; Farrington, Susan M.; Prendergast, James G. D.; Walker, Marion; Haq, Naila; Barnetson, Rebecca A.; Theodoratou, Evropi; Cartwright, Nicola; Semple, Colin; Clark, Andrew J.; Campbell, Harry; Dunlop, Malcolm G.] Univ Edinburgh, Colon Canc Genet Grp, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Tenesa, Albert; Farrington, Susan M.; Prendergast, James G. D.; Walker, Marion; Haq, Naila; Barnetson, Rebecca A.; Theodoratou, Evropi; Cartwright, Nicola; Semple, Colin; Clark, Andrew J.; Campbell, Harry; Dunlop, Malcolm G.] MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Porteous, Mary E.; Cetnarskyj, Roseanne] Western Gen Hosp, Dept Clin Genet, Edinburgh EH4 2XU, Midlothian, Scotland; [Theodoratou, Evropi] Univ Edinburgh, Edinburgh EH8 9AG, Midlothian, Scotland; [Reid, Fiona J. L.; Smith, Lorna A.; Kavoussanakis, Kostas] Univ Edinburgh, Edinburgh Parallel Comp Ctr, Edinburgh EH9 3JZ, Midlothian, Scotland; [Koessler, Thibaud; Pharoah, Paul D. P.] Univ Cambridge, Canc Res UK Labs, Dept Oncol, Cambridge CB1 8RN, England; [Buch, Stephan; Tepel, Juergen; Hampe, Jochen] Univ Hosp Schleswig Holstein, Dept Gen Internal Med, D-24105 Kiel, Germany; [Buch, Stephan; Schafmayer, Clemens; Schreiber, Stefan] Univ Hosp Schleswig Holstein, POPGEN Biobank, D-24105 Kiel, Germany; [Schafmayer, Clemens; Tepel, Juergen] Univ Hosp Schleswig Holstein, Dept Gen & Thorac Surg, D-24105 Kiel, Germany; [Schreiber, Stefan] Univ Hosp Schleswig Holstein, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Voelzke, Henry; Schmidt, Carsten O.] Univ Hosp Greifswald, Inst Community Med, D-17487 Greifswald, Germany; [Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol, D-69120 Heidelberg, Germany; [Hoffmeister, Michael; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, D-69120 Heidelberg, Germany; [Wilkening, Stefan; Canzian, Federico] German Canc Res Ctr, Genom Epidemiol Grp, D-69120 Heidelberg, Germany; [Capella, Gabriel] IDIBELL Catalan Inst Oncol, Translat Res Lab, Barcelona 08907, Spain; [Moreno, Victor] IDIBELL Catalan Inst Oncol, Bioinformat Unit, Barcelona 08907, Spain; [Moreno, Victor] Univ Barcelona, Barcelona 08907, Spain; [Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh EH8 9JZ, Midlothian, Scotland; [Starr, John M.] Univ Edinburgh, Royal Victoria Hosp, Edinburgh EH4 2DN, Midlothian, Scotland; [Tomlinson, Ian P. M.; Kemp, Zoe; Howarth, Kimberley; Carvajal-Carmona, Luis; Rangrej, Jagadish] Canc Res UK London Res Inst, Mol & Populat Genet Lab, London WC2A 3PX, England; [Webb, Emily; Broderick, Peter; Vijayakrishnan, Jayaram; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; [Rennert, Gad] Technion x2013 Israel Inst Technol, CHS Natl Canc Control Ctr, Haifa, Israel; [Ballinger, Dennis] Technion x2013 Israel Inst Technol, Dept Community Med & Epidemiol, Carmel Med Ctr, Haifa, Israel; [Ballinger, Dennis] Technion x2013 Israel Inst Technol, B Rappaport Fac Med, Haifa, Israel; [Ballinger, Dennis] Perlegen Sci, Mountain View, CA 94043 USA; [Rozek, Laura; Gruber, Stephen B.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Rozek, Laura; Gruber, Stephen B.] Univ Michigan, Sch Med, Dept Epidemiol & Human Genet, Ann Arbor, MI 48109 USA; [Matsuda, Koichi; Kidokoro, Tomohide; Nakamura, Yusuke] Univ Tokyo, Mol Med Lab, Ctr Human Genome, Inst Med Sci, Tokyo 1088639, Japan; [Zanke, Brent W.; Greenwood, Celia M. T.; Kustra, Rafal; Hudson, Thomas J.; Gallinger, Steven] Canc Care Ontario, Toronto, ON M5G 1L7, Canada; [Hudson, Thomas J.] Ontario Inst Canc Res, Toronto, ON M5G 1L7, Canada; [Zanke, Brent W.] Univ Ottawa, Fac Med, Div Hematol, Ottawa, ON K1H 8L6, Canada; [Greenwood, Celia M. T.; Rangrej, Jagadish] Hosp Sick Children, Toronto, ON M5G 1L7, Canada; [Greenwood, Celia M. T.] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON M57 3M7, Canada; [Montpetit, Alexandre] McGill Univ, Montreal, PQ H3G 1A4, Canada; [Montpetit, Alexandre] Genome Quebec Innovat Ctr, Montreal, PQ H3G 1A4, Canada; [Gallinger, Steven] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Gallinger, Steven] Univ Toronto, Toronto, ON M5G 1X5, Canada	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; Cancer Research UK; University of Cambridge; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; University of Edinburgh; University of Edinburgh; Cancer Research UK; University of London; Institute of Cancer Research - UK; Clalit Health Services; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Tokyo; Cancer Care Ontario; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Ottawa; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; McGill University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Dunlop, MG (corresponding author), Univ Edinburgh, Colon Canc Genet Grp, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland.	Malcolm.Dunlop@hgu.mrc.ac.uk	Hoffmeister, Michael/AAB-2321-2022; Semple, Colin A M/A-5613-2009; Capella, Gabriel/I-1879-2015; Hampe, Jochen/A-2555-2010; Farrington, Susan M/Q-2710-2019; Theodoratou, Evropi/C-3430-2014; Hoffmeister, Michael/T-7187-2019; Dunlop, Malcolm G/F-1973-2011; Brenner, Hermann/B-4627-2017; Deary, Ian J/C-6297-2009; Brenner, Hermann/ABE-6383-2020; Pharoah, Paul/V-6658-2019; Schmidt, Carsten Oliver/AAH-2778-2019; Campbell, Harry/E-2959-2010; Farrington, Susan M/C-7319-2013; Buch, Stephan/AAV-5028-2021; Moreno, Victor/A-1697-2010; Canzian, Federico/I-2804-2014; Gallinger, Steven/E-4575-2013; Hoffmeister, Michael/B-5745-2012; Carvajal-Carmona, Luis G/B-3882-2010; Kössler, Thibaud/AAZ-9734-2020; Matsuda, Koichi/D-4597-2011	Hoffmeister, Michael/0000-0002-8307-3197; Semple, Colin A M/0000-0003-1765-4118; Capella, Gabriel/0000-0002-4669-7320; Hampe, Jochen/0000-0002-2421-6127; Farrington, Susan M/0000-0001-5955-7389; Theodoratou, Evropi/0000-0001-5887-9132; Hoffmeister, Michael/0000-0002-8307-3197; Dunlop, Malcolm G/0000-0002-3033-5851; Brenner, Hermann/0000-0002-6129-1572; Deary, Ian J/0000-0002-1733-263X; Brenner, Hermann/0000-0002-6129-1572; Pharoah, Paul/0000-0001-8494-732X; Schmidt, Carsten Oliver/0000-0001-5266-9396; Campbell, Harry/0000-0002-6169-6262; Moreno, Victor/0000-0002-2818-5487; Hoffmeister, Michael/0000-0002-8307-3197; Carvajal-Carmona, Luis G/0000-0001-7129-2918; Houlston, Richard/0000-0002-5268-0242; Tenesa, Albert/0000-0003-4884-4475; Matsuda, Koichi/0000-0001-7292-2686; Vijayakrishnan, Jayaram/0000-0002-8284-2249; Greenwood, Celia/0000-0002-2427-5696; Prendergast, James/0000-0001-8916-018X; Kossler, Thibaud/0000-0001-9196-9076; Canzian, Federico/0000-0002-4261-4583; Webb, Emily/0000-0002-4019-7456; Broderick, Peter/0000-0002-8348-5829; Kavoussanakis, Kostas/0000-0001-9167-7145	NATIONAL CANCER INSTITUTE [R01CA081488, U24CA074783, U01CA074783, K22CA095011, P30CA046592] Funding Source: NIH RePORTER; MRC [MC_U127527198] Funding Source: UKRI; Cancer Research UK [C48/A6361, A8896, C348/A3758] Funding Source: Medline; Medical Research Council [MC_U127527198, G0000657-53203] Funding Source: Medline; NCI NIH HHS [U01 CA074783-06, U24 CA074783, P30 CA46592, U01 CA074783-05, R01 CA81488, U01 CA076783, P30 CA046592, U01 CA074783, CA-95-011, U01 CA074783-07, R01 CA081488] Funding Source: Medline; Chief Scientist Office [CZB/4/449] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chief Scientist Office		Barnetson RA, 2006, NEW ENGL J MED, V354, P2751, DOI 10.1056/NEJMoa053493; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; CHURCHILL GA, 1994, GENETICS, V138, P963; Farrington SM, 2005, AM J HUM GENET, V77, P112, DOI 10.1086/431213; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sokal R.R., 2012, BIOMETRY; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tenesa A, 2006, BRIT J CANCER, V95, P239, DOI 10.1038/sj.bjc.6603239; Tenesa A, 2006, EUR J HUM GENET, V14, P357, DOI 10.1038/sj.ejhg.5201554; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	16	479	492	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2008	40	5					631	637		10.1038/ng.133	http://dx.doi.org/10.1038/ng.133			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18372901	Green Accepted			2022-12-27	WOS:000255366700032
J	Zheng, P; Allen, WB; Roesler, K; Williams, ME; Zhang, S; Li, J; Glassman, K; Ranch, J; Nubel, D; Solawetz, W; Bhattramakki, D; Llaca, V; Deschamps, S; Zhong, GY; Tarczynski, MC; Shen, B				Zheng, Peizhong; Allen, William B.; Roesler, Keith; Williams, Mark E.; Zhang, Shirong; Li, Jiming; Glassman, Kimberly; Ranch, Jerry; Nubel, Douglas; Solawetz, William; Bhattramakki, Dinakar; Llaca, Victor; Deschamps, Stephane; Zhong, Gan-Yuan; Tarczynski, Mitchell C.; Shen, Bo			A phenylalanine in DGAT is a key determinant of oil content and composition in maize	NATURE GENETICS			English	Article							DIACYLGLYCEROL ACYLTRANSFERASE; EXPRESSION; SELECTION; PLANT	Plant oil is an important renewable resource for biodiesel production and for dietary consumption by humans and livestock. Through genetic mapping of the oil trait in plants, studies have reported multiple quantitative trait loci (QTLs) with small effects, but the molecular basis of oil QTLs remains largely unknown(1-5). Here we show that a high-oil QTL (qHO6) affecting maize seed oil and oleic-acid contents encodes an acyl-CoA: diacylglycerol acyltransferase (DGAT1-2), which catalyzes the final step of oil synthesis. We further show that a phenylalanine insertion in DGAT1-2 at position 469 (F469) is responsible for the increased oil and oleic-acid contents. The DGAT1-2 allele with F469 is ancestral, whereas the allele without F469 is a more recent mutant selected by domestication or breeding. Ectopic expression of the high-oil DGAT1-2 allele increases oil and oleic-acid contents by up to 41% and 107%, respectively. This work provides insights into the molecular basis of natural variation of oil and oleic-acid contents in plants and highlights DGAT as a promising target for increasing oil and oleic-acid contents in other crops.	[Zheng, Peizhong; Allen, William B.; Roesler, Keith; Zhang, Shirong; Li, Jiming; Glassman, Kimberly; Ranch, Jerry; Nubel, Douglas; Solawetz, William; Bhattramakki, Dinakar; Zhong, Gan-Yuan; Tarczynski, Mitchell C.; Shen, Bo] Pioneer HiBred Int Inc, Dupont Co, Johnston, IA 50131 USA; [Williams, Mark E.; Llaca, Victor; Deschamps, Stephane] Dupont Corp Genet Res, Expt Stn, Wilmington, DE 19880 USA	DuPont; DuPont	Shen, B (corresponding author), Pioneer HiBred Int Inc, Dupont Co, 7300 NW 62nd Ave,POB 1004, Johnston, IA 50131 USA.	Bo.Shen@pioneer.com	Deschamps, Stephane/R-3806-2019	Li, Jiming/0000-0003-4344-1896				ALREFAI R, 1995, GENOME, V38, P894, DOI 10.1139/g95-118; AN GH, 1989, PLANT CELL, V1, P115, DOI 10.1105/tpc.1.1.115; Belo A, 2008, MOL GENET GENOMICS, V279, P1, DOI 10.1007/s00438-007-0289-y; BERKE TG, 1995, CROP SCI, V35, P1542, DOI 10.2135/cropsci1995.0011183X003500060004x; CHRISTENSEN AH, 1992, PLANT MOL BIOL, V18, P675, DOI 10.1007/BF00020010; Clark D, 2006, CROP SCI, V46, P807, DOI 10.2135/cropsci2005.06-0153; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; HARA A, 1978, ANAL BIOCHEM, V90, P420, DOI 10.1016/0003-2697(78)90046-5; Ishida Y, 1996, NAT BIOTECHNOL, V14, P745, DOI 10.1038/nbt0696-745; Jako C, 2001, PLANT PHYSIOL, V126, P861, DOI 10.1104/pp.126.2.861; Kinney AJ, 2002, BIOCHEM SOC T, V30, P1099, DOI 10.1042/BST0301099; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lambert R. J., 2004, Plant Breeding Reviews, V24, P153; Laurie CC, 2004, GENETICS, V168, P2141, DOI 10.1534/genetics.104.029686; Lung SC, 2006, LIPIDS, V41, P1073, DOI 10.1007/s11745-006-5057-y; Mangolin CA, 2004, EUPHYTICA, V137, P251, DOI 10.1023/B:EUPH.0000041588.95689.47; Milcamps A, 2005, J BIOL CHEM, V280, P5370, DOI 10.1074/jbc.M410276200; Moose SP, 2004, TRENDS PLANT SCI, V9, P358, DOI 10.1016/j.tplants.2004.05.005; OHLROGGE J, 1995, PLANT CELL, V7, P957, DOI 10.1105/tpc.7.7.957; PONELEIT CG, 1965, SCIENCE, V147, P1585, DOI 10.1126/science.147.3665.1585; Shen B, 2006, PLANT MOL BIOL, V60, P377, DOI 10.1007/s11103-005-4110-1; Song XF, 2004, MAYDICA, V49, P41; Voelker T, 2001, ANNU REV PLANT PHYS, V52, P335, DOI 10.1146/annurev.arplant.52.1.335; White P. J., 2003, Corn: chemistry and technology, P355; Zhao Zuo-yu, 2006, Methods Mol Biol, V318, P315	25	285	352	3	71	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2008	40	3					367	372		10.1038/ng.85	http://dx.doi.org/10.1038/ng.85			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18278045				2022-12-27	WOS:000253548400031
J	Peterfy, M; Ben-Zeev, O; Mao, HZ; Weissglas-Volkov, D; Aouizerat, BE; Pullinger, CR; Frost, PH; Kane, JP; Malloy, MJ; Reue, K; Pajukanta, P; Doolittle, MH				Peterfy, Miklos; Ben-Zeev, Osnat; Mao, Hui Z.; Weissglas-Volkov, Daphna; Aouizerat, Bradley E.; Pullinger, Clive R.; Frost, Philip H.; Kane, John P.; Malloy, Mary J.; Reue, Karen; Pajukanta, Paeivi; Doolittle, Mark H.			Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia	NATURE GENETICS			English	Article							LIPOPROTEIN-LIPASE; HEPATIC LIPASE; ENDOPLASMIC-RETICULUM; MATURATION; CLD/CLD; MICE; CLD; TRANSPORT; MOUSE	Hypertriglyceridemia is a hallmark of many disorders, including metabolic syndrome, diabetes, atherosclerosis and obesity(1-3). A well-known cause is the deficiency of lipoprotein lipase ( LPL), a key enzyme in plasma triglyceride hydrolysis(4-6). Mice carrying the combined lipase deficiency ( cld) mutation show severe hypertriglyceridemia owing to a decrease in the activity of LPL and a related enzyme, hepatic lipase ( HL)(7-9), caused by impaired maturation of nascent LPL and hepatic lipase polypeptides in the endoplasmic reticulum ( ER)(10). Here we identify the gene containing the cld mutation as Tmem112 and rename it Lmf1 ( Lipase maturation factor 1). Lmf1 encodes a transmembrane protein with an evolutionarily conserved domain of unknown function that localizes to the ER. A human subject homozygous for a deleterious mutation in LMF1 also shows combined lipase deficiency with concomitant hypertriglyceridemia and associated disorders. Thus, through its profound effect on lipase activity, LMF1 emerges as an important candidate gene in hypertriglyceridemia(4,11,12).	Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; VA Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif San Francisco, Sch Nursing, Dept Physiol Nursing, San Francisco, CA 94143 USA; Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Cardiovasc Res Inst, San Francisco, CA 94143 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Peterfy, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA.	mpeterfy@ucla.edu; markdool@ucla.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481, R01HL082762] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER; NCRR NIH HHS [KL2-RR024130] Funding Source: Medline; NHGRI NIH HHS [T32 HG002536, T32 HG02536] Funding Source: Medline; NHLBI NIH HHS [HL28481, HL082762] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Austin MA, 1998, AM J CARDIOL, V81, p7B, DOI 10.1016/S0002-9149(98)00031-9; Ben-Zeev O, 2004, J BIOL CHEM, V279, P6171, DOI 10.1074/jbc.M310051200; Ben-Zeev O, 2002, J BIOL CHEM, V277, P10727, DOI 10.1074/jbc.M108128200; BLANCHETTEMACKIE EJ, 1986, LAB INVEST, V55, P347; BOBERG J, 1964, CLIN CHIM ACTA, V10, P420, DOI 10.1016/0009-8981(64)90171-8; Boedeker JC, 2001, J LIPID RES, V42, P1858; Boonyaratanakornkit J, 2004, MAMM GENOME, V15, P914, DOI 10.1007/s00335-004-2409-x; Briquet-Laugier V, 1999, J LIPID RES, V40, P2044; DAVIS RC, 1990, J BIOL CHEM, V265, P17960; ELBEIN SC, 1994, J CLIN ENDOCR METAB, V79, P1450, DOI 10.1210/jc.79.5.1450; Ginsberg HN, 2003, J CARDIOVASC RISK, V10, P121, DOI 10.1097/00043798-200304000-00007; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HELIO T, 1994, HUM GENET, V94, P271; Henderson HE, 1999, J LIPID RES, V40, P735; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; Okamoto Y, 1995, J Atheroscler Thromb, V2, P66; PATERNITI JR, 1983, SCIENCE, V221, P167, DOI 10.1126/science.6857276; Pejic RN, 2006, J AM BOARD FAM MED, V19, P310, DOI 10.3122/jabfm.19.3.310; Peterfy M, 2005, J BIOL CHEM, V280, P32883, DOI 10.1074/jbc.M503885200; Peterfy M, 2006, MAMM GENOME, V17, P1013, DOI 10.1007/s00335-006-0045-3; Ranganathan S, 2002, J ENDOCRINOL, V172, P155, DOI 10.1677/joe.0.1720155; Reue K, 1996, J LIPID RES, V37, P1387; Scow RO, 1998, CHEM PHYS LIPIDS, V93, P149, DOI 10.1016/S0009-3084(98)00039-5; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L	26	154	161	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2007	39	12					1483	1487		10.1038/ng.2007.24	http://dx.doi.org/10.1038/ng.2007.24			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	17994020				2022-12-27	WOS:000251267400016
J	Richards, A; van den Maagdenberg, AMJM; Jen, JC; Kavanagh, D; Bertram, P; Spitzer, D; Liszewski, MK; Barilla-LaBarca, ML; Terwindt, GM; Kasai, Y; McLellan, M; Grand, MG; Vanmolkot, KRJ; de Vries, B; Wan, J; Kane, MJ; Mamsa, H; Schafer, R; Stam, AH; Haan, J; Paulus, TVMDJ; Storimans, CW; van Schooneveld, MJ; Oosterhuis, JA; Gschwendter, A; Dichgans, M; Kotschet, KE; Hodgkinson, S; Hardy, TA; Delatycki, MB; Hajj-Ali, RA; Kothari, PH; Nelson, SF; Frants, RR; Baloh, RW; Ferrari, MD; Atkinson, JP				Richards, Anna; van den Maagdenberg, Arn M. J. M.; Jen, Joanna C.; Kavanagh, David; Bertram, Paula; Spitzer, Dirk; Liszewski, M. Kathryn; Barilla-LaBarca, Maria-Louise; Terwindt, Gisela M.; Kasai, Yumi; McLellan, Mike; Grand, Mark Gilbert; Vanmolkot, Kaate R. J.; de Vries, Boukje; Wan, Jijun; Kane, Michael J.; Mamsa, Hafsa; Schaefer, Ruth; Stam, Anine H.; Haan, Joost; Paulus, T. V. M. de Jong; Storimans, Caroline W.; van Schooneveld, Mary J.; Oosterhuis, Jendo A.; Gschwendter, Andreas; Dichgans, Martin; Kotschet, Katya E.; Hodgkinson, Suzanne; Hardy, Todd A.; Delatycki, Martin B.; Hajj-Ali, Rula A.; Kothari, Parul H.; Nelson, Stanley F.; Frants, Rune R.; Baloh, Robert W.; Ferrari, Michel D.; Atkinson, John P.			C-terminal truncations in human 3 '-5 ' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy	NATURE GENETICS			English	Article							CEREBRORETINAL VASCULOPATHY; HEREDITARY ENDOTHELIOPATHY; VASCULAR RETINOPATHY; NEPHROPATHY	Autosomal dominant retinal vasculopathy with cerebral leukodystrophy is a microvascular endotheliopathy with middle- age onset. In nine families, we identified heterozygous C- terminal frameshift mutations in TREX1, which encodes a 3'-5' exonuclease. These truncated proteins retain exonuclease activity but lose normal perinuclear localization. These data have implications for the maintenance of vascular integrity in the degenerative cerebral microangiopathies leading to stroke and dementias.	Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA; Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands; Leiden Univ, Med Ctr, Dept Neurol, NL-2300 RC Leiden, Netherlands; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; N Shore Long Isl Jewish Hlth Syst, Dept Med, Div Rheumatol, Manhasset, NY 11030 USA; Washington Univ, Sch Med, Genome Sequencing Ctr, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Ophthalmol, St Louis, MO 63110 USA; Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Dept Ophthalmogenet, NL-1000 GC Amsterdam, Netherlands; Acad Med Ctr, Dept Ophthalmol, NL-1100 DD Amsterdam, Netherlands; Erasmus MC, Dept Epidemiol & Biostat, NL-3000 CA Rotterdam, Netherlands; Meander Med Ctr, NL-3800 BM Amersfoort, Netherlands; Univ Med Ctr, Dept Ophthalmol, NL-3508 GA Utrecht, Netherlands; Leiden Univ, Med Ctr, Dept Ophthalmol, NL-2300 RC Leiden, Netherlands; Univ Munich, Klinikum Grosshadern, Dept Neurol, D-81377 Munich, Germany; Monash Med Ctr, Dept Neurol, Clayton, Vic 3168, Australia; Liverpool Hosp, Dept Neurol, Liverpool, NSW 2170, Australia; Concord Repatriat Gen Hosp, Dept Neurol, Concord, NSW 2139, Australia; Bruce Lefroy Ctr Genet Hlth Res, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Parkville, Vic 3052, Australia; Cleveland Clin Fdn, Dept Rheumat & Immunol Dis, Cleveland, OH 44195 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA	Washington University (WUSTL); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of California System; University of California Los Angeles; Northwell Health; Washington University (WUSTL); Washington University (WUSTL); Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of Amsterdam; Academic Medical Center Amsterdam; Erasmus University Rotterdam; Erasmus MC; Meander Medisch Centrum; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Munich; Monash University; Liverpool Hospital; Concord Repatriation General Hospital; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Cleveland Clinic Foundation; University of California System; University of California Los Angeles	Atkinson, JP (corresponding author), Washington Univ, Sch Med, Dept Med, Div Rheumatol, St Louis, MO 63110 USA.	jatkinso@im.wustl.edu	Barillla-LaBarca, Maria Louise/AAR-9207-2021; van den Maagdenberg, Arn M.J.M./AAE-9052-2019; Dichgans, Martin/HCH-3247-2022; Richards, Anna/E-8337-2013; Nelson, Stanley F/D-4771-2009; Ferrari, Michel D./ABE-3758-2021; Delatycki, Martin B/A-5409-2013; Kavanagh, David/E-8498-2011	Dichgans, Martin/0000-0002-0654-387X; Nelson, Stanley F/0000-0002-2082-3114; Ferrari, Michel D./0000-0001-9691-9449; Kavanagh, David/0000-0003-4718-0072; MCLELLAN, MICHAEL/0000-0002-2703-8784; Atkinson, John/0000-0002-2514-3441; Hardy, Todd/0000-0003-4145-3172; Schafer, Ruth Christine/0000-0002-4324-1854; Hodgkinson, Suzanne/0000-0002-9029-6663	NATIONAL EYE INSTITUTE [R01EY015311] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P01DC002952] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY15311] Funding Source: Medline; NIDCD NIH HHS [P50 DC02952] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Cohn AC, 2005, CLIN EXP OPHTHALMOL, V33, P181, DOI 10.1111/j.1442-9071.2005.00976.x; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Goutieres F, 2005, BRAIN DEV-JPN, V27, P201, DOI 10.1016/j.braindev.2003.12.011; GRAND MG, 1988, OPHTHALMOLOGY, V95, P649, DOI 10.1016/s0161-6420(88)33131-3; Hoss M, 1999, EMBO J, V18, P3868, DOI 10.1093/emboj/18.13.3868; Jen J, 1997, NEUROLOGY, V49, P1322, DOI 10.1212/WNL.49.5.1322; Martinvalet D, 2005, IMMUNITY, V22, P355, DOI 10.1016/j.immuni.2005.02.004; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; Ophoff RA, 2001, AM J HUM GENET, V69, P447, DOI 10.1086/321975; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Storimans C W, 1991, Eur J Ophthalmol, V1, P73; Terwindt GM, 1998, BRAIN, V121, P303, DOI 10.1093/brain/121.2.303; Weil S, 1999, NEUROLOGY, V53, P629, DOI 10.1212/WNL.53.3.629	15	279	296	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1068	1070		10.1038/ng2082	http://dx.doi.org/10.1038/ng2082			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17660820				2022-12-27	WOS:000249122400014
J	Wang, XL; Sutton, VR; Peraza-Llanes, JO; Yu, ZY; Rosetta, R; Kou, YC; Eble, TN; Patel, A; Thaller, C; Fang, P; Van den Veyver, IB				Wang, Xiaoling; Sutton, V. Reid; Peraza-Llanes, J. Omar; Yu, Zhiyin; Rosetta, Rebecca; Kou, Ying-Chuck; Eble, Tanya N.; Patel, Ankita; Thaller, Christina; Fang, Ping; Van den Veyver, Ignatia B.			Mutations in X-linked PORCN, a putative regulator of Wnt signaling, cause focal dermal hypoplasia	NATURE GENETICS			English	Article							DOMINANT CHONDRODYSPLASIA PUNCTATA; PORCUPINE; GENE; INACTIVATION; DISORDERS; FAMILY	Focal dermal hypoplasia is an X- linked dominant disorder characterized by patchy hypoplastic skin and digital, ocular and dental malformations. We used array comparative genomic hybridization to identify a 219- kb deletion in Xp11.23 in two affected females. We sequenced genes in this region and found heterozygous and mosaic mutations in PORCN in other affected females and males, respectively. PORCN encodes the human homolog of Drosophila melanogaster porcupine, an endoplasmic reticulum protein involved in secretion of Wnt proteins.	Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; IMSS, Dept Pediat, Merida 97109, Mexico; Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Van den Veyver, IB (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.	iveyver@bcm.edu	Patel, Ankita/D-3247-2013; Van den Veyver, Ignatia B/AAF-4510-2021	Van den Veyver, Ignatia B/0000-0002-0651-5924	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD051805] Funding Source: NIH RePORTER; NICHD NIH HHS [HD024064, HD051805] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Caricasole A, 2002, GENE, V288, P147, DOI 10.1016/S0378-1119(02)00467-5; Derry JMJ, 1999, NAT GENET, V22, P286, DOI 10.1038/10350; Froyen G, 2007, HUM GENET, V121, P539, DOI 10.1007/s00439-007-0343-1; GOLTZ RW, 1992, ARCH DERMATOL, V128, P1108; GORSKI JL, 1991, AM J MED GENET, V40, P332, DOI 10.1002/ajmg.1320400317; HALL EH, 1983, J AM ACAD DERMATOL, V9, P443, DOI 10.1016/S0190-9622(83)70157-X; Kato M, 2004, HUM MUTAT, V23, P147, DOI 10.1002/humu.10310; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Shirahama S, 2003, HUM GENET, V112, P78, DOI 10.1007/s00439-002-0844-x; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tanaka K, 2002, J BIOL CHEM, V277, P12816, DOI 10.1074/jbc.M200187200; Tanaka K, 2000, EUR J BIOCHEM, V267, P4300, DOI 10.1046/j.1432-1033.2000.01478.x; TSUJI T, 1982, J CUTAN PATHOL, V9, P271, DOI 10.1111/j.1600-0560.1982.tb01063.x; Van den Veyver IB, 2002, CYTOGENET GENOME RES, V99, P289, DOI 10.1159/000071606; Zhai L, 2004, J BIOL CHEM, V279, P33220, DOI 10.1074/jbc.M403407200	15	180	224	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39	7					836	838		10.1038/ng2057	http://dx.doi.org/10.1038/ng2057			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17546030				2022-12-27	WOS:000247619800012
J	Chuck, G; Cigan, AM; Saeteurn, K; Hake, S				Chuck, George; Cigan, A. Mark; Saeteurn, Koy; Hake, Sarah			The heterochronic maize mutant Corngrass1 results from overexpression of a tandem microRNA	NATURE GENETICS			English	Article							PHASE-CHANGE; GLOSSY15; MUTATIONS; SHOOT; MORPHOGENESIS; EXPRESSION; IDENTITY; PROTEIN; GENE	Retention of juvenile traits in the adult reproductive phase characterizes a process known as neoteny, and speculation exists over whether it has contributed to the evolution of new species. The dominant Corngrass1 (Cg1) mutant of maize is a neotenic mutation that results in phenotypes that may be present in the grass-like ancestors of maize. We cloned Cg1 and found that it encodes two tandem miR156 genes that are overexpressed in the meristem and lateral organs. Furthermore, a target of Cg1 is teosinte glume architecture1 (tga1) 1, a gene known to have had a role in the domestication of maize from teosinte. Cg1 mutant plants overexpressing miR156 have lower levels of mir172, a microRNA that targets genes controlling juvenile development(2). By altering the relative levels of both microRNAs, it is possible to either prolong or shorten juvenile development in maize, thus providing a mechanism for how species-level heterochronic changes can occur in nature.	Plant Gene Express Ctr, Albany, CA 94710 USA; Pioneer HiBred Int Inc, Johnston, IA 50131 USA	DuPont	Chuck, G (corresponding author), Plant Gene Express Ctr, 800 Buchanan St, Albany, CA 94710 USA.	gchuck@nature.berkeley.edu						Allsopp A., 1965, DIFFERENTIATION DEV, P1236; Bortiri E, 2006, PLANT CELL, V18, P574, DOI 10.1105/tpc.105.039032; CHENG PC, 1983, AM J BOT, V70, P450, DOI 10.2307/2443252; Chuck G, 2002, SCIENCE, V298, P1238, DOI 10.1126/science.1076920; Cigan AM, 2001, SEX PLANT REPROD, V14, P135, DOI 10.1007/s004970100099; DOEBLEY J, 1991, GENETICS, V129, P285; EVANS MMS, 1994, DEVELOPMENT, V120, P1971; GALINAT WC, 1954, AM J BOT, V41, P803, DOI 10.2307/2438545; GALINAT WC, 1954, AM NAT, V88, P101, DOI 10.1086/281815; Goldschmidt R.B., 1940, MAT BASIS EVOLUTION, P436; GOLIBER TE, 1990, AM J BOT, V77, P399, DOI 10.2307/2444726; JACKSON D, 1994, DEVELOPMENT, V120, P405; Jackson DP, 1991, MOL PLANT PATHOL, P163; KELLOGG EA, 2000, P 2 INT C COMP BIOL, V2; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Moose SP, 1996, GENE DEV, V10, P3018, DOI 10.1101/gad.10.23.3018; MOOSE SP, 1994, PLANT CELL, V6, P1343, DOI 10.1105/tpc.6.10.1343; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; POETHIG RS, 1988, GENETICS, V119, P959; POETHIG RS, 1990, SCIENCE, V250, P923, DOI 10.1126/science.250.4983.923; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; SINGLETON WR, 1951, AM NAT, V85, P81, DOI 10.1086/281656; Steeves T.A., 1989, PATTERNS PLANT DEV, DOI 10.1017/CBO9780511626227; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; TAKHTAJAN A, 1976, NEOTENY ORIGIN FLOW, P207; Unger E, 2002, TRANSGENIC RES, V11, P455, DOI 10.1023/A:1020350208095; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; WESSLER SR, 1985, P NATL ACAD SCI USA, V82, P4177, DOI 10.1073/pnas.82.12.4177; WHALEY W. GORDON, 1950, BULL TORREY BOT CLUB, V77, P274, DOI 10.2307/2481899	30	446	490	3	95	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2007	39	4					544	549		10.1038/ng2001	http://dx.doi.org/10.1038/ng2001			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17369828				2022-12-27	WOS:000245271200027
J	Parma, P; Radi, O; Vidal, V; Chaboissier, MC; Dellambra, E; Valentini, S; Guerra, L; Schedl, A; Camerino, G				Parma, Pietro; Radi, Orietta; Vidal, Valerie; Chaboissier, Marie Christine; Dellambra, Elena; Valentini, Stella; Guerra, Liliana; Schedl, Andreas; Camerino, Giovanna			R-spondin1 is essential in sex determination, skin differentiation and malignancy	NATURE GENETICS			English	Article							SQUAMOUS-CELL CARCINOMA; PALMOPLANTAR KERATODERMA; HURIEZ-SYNDROME; R-SPONDIN; SOX9; MICE; ASSOCIATION; ACTIVATION; PROTEINS; REVERSAL	R-spondins are a recently characterized small family of growth factors. Here we show that human R-spondin1 (RSPO1) is the gene disrupted in a recessive syndrome characterized by XX sex reversal, palmoplantar hyperkeratosis and predisposition to squamous cell carcinoma of the skin. Our data show, for the first time, that disruption of a single gene can lead to complete female-to-male sex reversal in the absence of the testis-determining gene, SRY.	Univ Pavia, Dipartimento Patol Umana & Ereditaria, Sez Biol Gen & Genet Med, I-27100 Pavia, Italy; Fac Sci, Ctr Biochim, INSERM, U636, F-06108 Nice, France; IRCCS, Ist Dermopat Immacolata, Lab Ingn Tessuti & Fisiopatol Cutanea, I-00167 Rome, Italy	University of Pavia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; IRCCS Istituto Dermopatico dell'Immacolata (IDI)	Camerino, G (corresponding author), Univ Pavia, Dipartimento Patol Umana & Ereditaria, Sez Biol Gen & Genet Med, Via Forianini 14, I-27100 Pavia, Italy.	camerino@unipv.it	Schedl, Andreas/F-8823-2015; vidal, valerie/S-2597-2019; CHABOISSIER, Marie-Christine/AAZ-5905-2021; CHABOISSIER, Marie-Christine/F-6166-2019; Schedl, Andreas/GOP-3427-2022; Vidal, Valerie/M-1477-2018; Dellambra, Elena/A-4005-2014; Guerra, Liliana/G-8849-2016	Schedl, Andreas/0000-0001-9380-7396; CHABOISSIER, Marie-Christine/0000-0003-0934-8217; CHABOISSIER, Marie-Christine/0000-0003-0934-8217; Dellambra, Elena/0000-0002-4329-3312; Parma, Pietro/0000-0003-1544-6673; Guerra, Liliana/0000-0001-6274-6607	Telethon [GGP06252] Funding Source: Medline	Telethon(Fondazione Telethon)		Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Bernerd F, 2001, P NATL ACAD SCI USA, V98, P7817, DOI 10.1073/pnas.141221998; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; Brennan J, 2004, NAT REV GENET, V5, P509, DOI 10.1038/nrg1381; Christiano AM, 1997, TRENDS GENET, V13, P227, DOI 10.1016/S0168-9525(97)01104-9; Guerra L, 2003, ARCH DERMATOL, V139, P1303, DOI 10.1001/archderm.139.10.1303; HOGAN B, 1996, MANIPULATING MOUSE E; Kamata T, 2004, BBA-GENE STRUCT EXPR, V1676, P51, DOI 10.1016/j.bbaexp.2003.10.009; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Kim Y, 2006, PLOS BIOL, V4, P1000, DOI 10.1371/journal.pbio.0040187; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Micali G, 2005, J AM ACAD DERMATOL, V53, pS234, DOI 10.1016/j.jaad.2005.02.033; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Qin YJ, 2004, HUM MOL GENET, V13, P1213, DOI 10.1093/hmg/ddh141; Radi O, 2005, AM J MED GENET A, V138A, P241, DOI 10.1002/ajmg.a.30935; Riggio E, 2005, PLAST RECONSTR SURG, V116, P689, DOI 10.1097/01.prs.0000175966.01538.73; Ross AJ, 2005, TRENDS ENDOCRIN MET, V16, P19, DOI 10.1016/j.tem.2004.11.004; TERWILLIGER JD, 1994, HDB HUMAN GENETIC LI; Vernole P, 2000, CLIN GENET, V57, P61, DOI 10.1034/j.1399-0004.2000.570109.x; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; Viegas-Pequignot E., 1992, PRACTICAL APPROACHES, P137; Wilhelm D, 2006, NAT REV GENET, V7, P620, DOI 10.1038/nrg1903; Yao HHC, 2005, MOL CELL ENDOCRINOL, V230, P87, DOI 10.1016/j.mce.2004.11.003; [No title captured]	26	442	470	1	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2006	38	11					1304	1309		10.1038/ng1907	http://dx.doi.org/10.1038/ng1907			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17041600				2022-12-27	WOS:000241592700019
J	Bilguvar, K; Yasuno, K; Niemela, M; Ruigrok, YM; Fraunberg, MVZ; van Duijn, CM; van den Berg, LH; Mane, S; Mason, CE; Choi, M; Gaal, E; Bayri, Y; Kolb, L; Arlier, Z; Ravuri, S; Ronkainen, A; Tajima, A; Laakso, A; Hata, A; Kasuya, H; Koivisto, T; Rinne, J; Ohman, J; Breteler, MMB; Wijmenga, C; State, MW; Rinkel, GJE; Hernesniemi, J; Jaaskelainen, JE; Palotie, A; Inoue, I; Lifton, RP; Gunel, M				Bilguvar, Kaya; Yasuno, Katsuhito; Niemela, Mika; Ruigrok, Ynte M.; Fraunberg, Mikael von und zu; van Duijn, Cornelia M.; van den Berg, Leonard H.; Mane, Shrikant; Mason, Christopher E.; Choi, Murim; Gaal, Emilia; Bayri, Yasar; Kolb, Luis; Arlier, Zulfikar; Ravuri, Sudhakar; Ronkainen, Antti; Tajima, Atsushi; Laakso, Aki; Hata, Akira; Kasuya, Hidetoshi; Koivisto, Timo; Rinne, Jaakko; Ohman, Juha; Breteler, Monique M. B.; Wijmenga, Cisca; State, Matthew W.; Rinkel, Gabriel J. E.; Hernesniemi, Juha; Jaaskelainen, Juha E.; Palotie, Aarno; Inoue, Ituro; Lifton, Richard P.; Guenel, Murat			Susceptibility loci for intracranial aneurysm in European and Japanese populations	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; HEMATOPOIETIC STEM-CELLS; REDUNDANT ROLES; LARGE-SCALE; ANGIOGENESIS; REPLICATION; VARIANTS; LINKAGE; SOX17; CONTRIBUTE	Stroke is the world's third leading cause of death. One cause of stroke, intracranial aneurysm, affects similar to 2% of the population and accounts for 500,000 hemorrhagic strokes annually in mid-life (median age 50), most often resulting in death or severe neurological impairment(1). The pathogenesis of intracranial aneurysm is unknown, and because catastrophic hemorrhage is commonly the first sign of disease, early identification is essential. We carried out a multistage genome-wide association study (GWAS) of Finnish, Dutch and Japanese cohorts including over 2,100 intracranial aneurysm cases and 8,000 controls. Genome-wide genotyping of the European cohorts and replication studies in the Japanese cohort identified common SNPs on chromosomes 2q, 8q and 9p that show significant association with intracranial aneurysm with odds ratios 1.24-1.36. The loci on 2q and 8q are new, whereas the 9p locus was previously found to be associated with arterial diseases, including intracranial aneurysm(2-5). Associated SNPs on 8q likely act via SOX17, which is required for formation and maintenance of endothelial cells(6-8), suggesting a role in development and repair of the vasculature; CDKN2A at 9p may have a similar role(9). These findings have implications for the pathophysiology, diagnosis and therapy of intracranial aneurysm.	[Bilguvar, Kaya; Mason, Christopher E.; Choi, Murim; Gaal, Emilia; Bayri, Yasar; Kolb, Luis; Arlier, Zulfikar; State, Matthew W.; Lifton, Richard P.; Guenel, Murat] Yale Univ, Sch Med, Yale Ctr Human Genet & Genom, Yale Program Neurogenet,Dept Genet, New Haven, CT 06510 USA; [Bilguvar, Kaya; Gaal, Emilia; Bayri, Yasar; Kolb, Luis; Arlier, Zulfikar; Guenel, Murat] Yale Univ, Sch Med, Yale Ctr Human Genet & Genom, Dept Neurosurg, New Haven, CT 06510 USA; [Bilguvar, Kaya; Gaal, Emilia; Bayri, Yasar; Kolb, Luis; Arlier, Zulfikar; Guenel, Murat] Yale Univ, Sch Med, Yale Ctr Human Genet & Genom, Dept Neurobiol, New Haven, CT 06510 USA; [Yasuno, Katsuhito; Tajima, Atsushi] Tokai Univ, Sch Med, Div Mol Life Sci, Kanagawa 2591193, Japan; [Niemela, Mika; Gaal, Emilia; Laakso, Aki; Hernesniemi, Juha] Univ Helsinki, Cent Hosp, Dept Neurosurg, FI-00029 Helsinki, Hus, Finland; [Ruigrok, Ynte M.; van den Berg, Leonard H.; Rinkel, Gabriel J. E.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, NL-3584 CX Utrecht, Netherlands; [Fraunberg, Mikael von und zu; Ronkainen, Antti; Koivisto, Timo; Rinne, Jaakko; Jaaskelainen, Juha E.] Kuopio Univ Hosp, Dept Neurosurg, FI-70211 Kuopio, Finland; [van Duijn, Cornelia M.; Breteler, Monique M. B.] Erasmus MC, Dept Epidemiol & Biostat, Genet Epidemiol Unit, NL-3000 CA Rotterdam, Netherlands; [van Duijn, Cornelia M.; Breteler, Monique M. B.] Erasmus MC, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; [Mane, Shrikant; Ravuri, Sudhakar] Yale Univ, Keck Fdn Biotechnol Resource Lab, New Haven, CT 06510 USA; [Mason, Christopher E.; State, Matthew W.] Yale Univ, Sch Med, Ctr Child Study, New Haven, CT 06510 USA; [Hata, Akira] Chiba Univ, Sch Med, Dept Publ Hlth, Chiba 2608670, Japan; [Kasuya, Hidetoshi] Tokyo Womens Univ, Med Ctr E, Dept Neurosurg, Tokyo 1168567, Japan; [Ohman, Juha] Tampere Univ Hosp, Dept Neurosurg, Tampere 33521, Finland; [Wijmenga, Cisca] Univ Med Ctr Utrecht, Dept Biomed Genet, Complex Genet Sect, NL-3508 AB Utrecht, Netherlands; [Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9700 RR Groningen, Netherlands; [Wijmenga, Cisca] Univ Groningen, NL-9700 RR Groningen, Netherlands; [Palotie, Aarno] Univ Helsinki, Res Program Mol Med, Helsinki, Finland; [Palotie, Aarno] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Lifton, Richard P.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Tokai University; Hyvinkaan Sairaala; University of Helsinki; Helsinki University Central Hospital; Utrecht University; Utrecht University Medical Center; Kuopio University Hospital; University of Eastern Finland; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Yale University; Yale University; Chiba University; Tokyo Women's Medical University; Tampere University; Tampere University Hospital; Utrecht University; Utrecht University Medical Center; University of Groningen; University of Groningen; University of Helsinki; Wellcome Trust Sanger Institute; Howard Hughes Medical Institute; Yale University; Yale University	Lifton, RP (corresponding author), Yale Univ, Sch Med, Yale Ctr Human Genet & Genom, Yale Program Neurogenet,Dept Genet, 333 Cedar St, New Haven, CT 06510 USA.	richard.lifton@yale.edu; murat.gunel@yale.edu	Niemelä, Mika R/F-2539-2015; Wijmenga, Cisca/AAE-7719-2019; Wijmenga, Cisca/D-2173-2009; Breteler, Monique M.B./J-5058-2014; Mason, Christopher/HCH-3977-2022; State, Matthew/W-2256-2019; Choi, Murim/AAP-9120-2021; Tajima, Atsushi/C-1053-2008; Yasuno, Katsuhito/E-1960-2012; Bayri, Yasar/B-1287-2017	Niemelä, Mika R/0000-0003-1526-0684; Wijmenga, Cisca/0000-0002-5635-1614; Breteler, Monique M.B./0000-0002-0626-9305; Tajima, Atsushi/0000-0001-6808-5491; Yasuno, Katsuhito/0000-0002-3606-532X; State, Matthew/0000-0003-1624-8302; Van Duijn, Cornelia/0000-0002-2374-9204; Laakso, Aki/0000-0002-5312-4926; Bayri, Yasar/0000-0003-1707-6055; Ohman, Juha/0000-0002-6592-1367; von und zu Fraunberg, Mikael/0000-0002-8457-4639	Yale Center for Human Genetics and Genomics; Yale Program on Neurogenetics; US National Institutes of Health [R01NS057756, U24 NS051869]; Howard Hughes Medical Institute; Netherlands Heart Foundation [2005T014]; Core Research for Evolutional Science and Technology; Japan Science and Technology Corporation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057756, U24NS051869] Funding Source: NIH RePORTER	Yale Center for Human Genetics and Genomics; Yale Program on Neurogenetics; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Netherlands Heart Foundation(Netherlands Heart Foundation); Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Corporation(Japan Science & Technology Agency (JST)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We are grateful to the participants who made this study possible. We thank A. Chamberlain, O. Tornwall, M. Alalahti, K. Helin, S. Malin and J. Budzinack for their technical help. This study was supported by the Yale Center for Human Genetics and Genomics and the Yale Program on Neurogenetics, the US National Institutes of Health grants R01NS057756 (M.G.) and U24 NS051869 (S.M.) and the Howard Hughes Medical Institute (R.P.L.). C.E.M. and M.W.S. are supported by a gift from the Lawrence Family and Y.M.R. by the Dr E. Dekker program of The Netherlands Heart Foundation (2005T014). K.Y. and I.I. were supported by the Core Research for Evolutional Science and Technology, Japan Science and Technology Corporation.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bederson JB, 2000, STROKE, V31, P2742, DOI 10.1161/01.STR.31.11.2742; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Foroud T, 2008, STROKE, V39, P1434, DOI 10.1161/STROKEAHA.107.502930; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Nahed BV, 2005, AM J HUM GENET, V76, P172, DOI 10.1086/426953; Ozturk AK, 2006, STROKE, V37, P1021, DOI 10.1161/01.STR.0000206153.92675.b9; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Purhonen S, 2008, P NATL ACAD SCI USA, V105, P6620, DOI 10.1073/pnas.0710516105; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Ruigrok YM, 2008, STROKE, V39, P1096, DOI 10.1161/STROKEAHA.107.495168; Sakamoto Y, 2007, BIOCHEM BIOPH RES CO, V360, P539, DOI 10.1016/j.bbrc.2007.06.093; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; SCHIEVINK WI, 1995, J NEUROSURG, V83, P426, DOI 10.3171/jns.1995.83.3.0426; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shibuya M, 2006, J BIOCHEM MOL BIOL, V39, P469; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Ziegler BL, 1999, SCIENCE, V285, P1553, DOI 10.1126/science.285.5433.1553	30	211	220	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2008	40	12					1472	1477		10.1038/ng.240	http://dx.doi.org/10.1038/ng.240			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	18997786	Green Accepted			2022-12-27	WOS:000261215900025
J	Cizkova, A; Stranecky, V; Mayr, JA; Tesarova, M; Havlickova, V; Paul, J; Ivanek, R; Kuss, AW; Hansikova, H; Kaplanova, V; Vrbacky, M; Hartmannova, H; Noskova, L; Honzik, T; Drahota, Z; Magner, M; Hejzlarova, K; Sperl, W; Zeman, J; Houstek, J; Kmoch, S				Cizkova, Alena; Stranecky, Viktor; Mayr, Johannes A.; Tesarova, Marketa; Havlickova, Vendula; Paul, Jan; Ivanek, Robert; Kuss, Andreas W.; Hansikova, Hana; Kaplanova, Vilma; Vrbacky, Marek; Hartmannova, Hana; Noskova, Lenka; Honzik, Tomas; Drahota, Zdenek; Magner, Martin; Hejzlarova, Katerina; Sperl, Wolfgang; Zeman, Jiri; Houstek, Josef; Kmoch, Stanislav			TMEM70 mutations cause isolated ATP synthase deficiency and neonatal mitochondrial encephalocardiomyopathy	NATURE GENETICS			English	Article							ASSEMBLY FACTORS; DEFECTS; COMPLEX	We carried out whole-genome homozygosity mapping, gene expression analysis and DNA sequencing in individuals with isolated mitochondrial ATP synthase deficiency and identified disease-causing mutations in TMEM70. Complementation of the cell lines of these individuals with wild-type TMEM70 restored biogenesis and metabolic function of the enzyme complex. Our results show that TMEM70 is involved in mitochondrial ATP synthase biogenesis in higher eukaryotes.	[Cizkova, Alena; Havlickova, Vendula; Paul, Jan; Kaplanova, Vilma; Vrbacky, Marek; Drahota, Zdenek; Hejzlarova, Katerina; Houstek, Josef] Acad Sci Czech Republ, Inst Physiol, Dept Bioenerget, CR-14220 Prague, Czech Republic; [Cizkova, Alena; Stranecky, Viktor; Ivanek, Robert; Hartmannova, Hana; Noskova, Lenka; Kmoch, Stanislav] Charles Univ Prague, Fac Med 1, Inst Inherited Metab Disorders, Prague 12808, Czech Republic; [Mayr, Johannes A.; Sperl, Wolfgang] Paracelsus Med Univ, Dept Pediat, A-5020 Salzburg, Austria; [Tesarova, Marketa; Hansikova, Hana; Honzik, Tomas; Magner, Martin; Zeman, Jiri] Charles Univ Prague, Fac Med 1, Dept Pediat, Prague 12808, Czech Republic; [Kuss, Andreas W.] Max Planck Inst Mol Genet, D-14195 Berlin, Germany	Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague; Paracelsus Private Medical University; Charles University Prague; Max Planck Society	Houstek, J (corresponding author), Acad Sci Czech Republ, Inst Physiol, Dept Bioenerget, CR-14220 Prague, Czech Republic.	houstek@biomed.cas.cz; skmoch@lf1.cuni.cz	Stranecky, Viktor/I-8524-2017; Ivanek, Robert/A-8852-2008; Magner, Martin/J-3553-2017; Karbanova, Vendula/I-6851-2013; /F-8296-2014; Honzik, Tomas/N-7509-2017; Vrbacky, Marek/A-1044-2010; Kmoch, Stanislav/C-1575-2010; Kaplanova, Vilma/C-7960-2012; Houstek, Josef/C-5019-2012; Noskova, Lenka/F-6564-2017; Hansikova, Hana/E-9350-2017; Tauchmannova, Katerina/G-1023-2014; Hartmannova, Hana/H-4735-2017; Cizkova Vrbacka, Alena/F-4100-2011; Tesarova, Marketa/I-1531-2016; Zeman, Jiri/K-2691-2017	Stranecky, Viktor/0000-0002-2599-6479; Magner, Martin/0000-0002-5883-9509; /0000-0003-2117-6809; Honzik, Tomas/0000-0003-4300-2519; Vrbacky, Marek/0000-0001-7218-8370; Kmoch, Stanislav/0000-0002-6239-707X; Houstek, Josef/0000-0002-8413-4772; Noskova, Lenka/0000-0001-7011-4327; Hansikova, Hana/0000-0002-2734-225X; Tauchmannova, Katerina/0000-0002-3745-8790; Hartmannova, Hana/0000-0001-7787-832X; Cizkova Vrbacka, Alena/0000-0003-4640-1646; Tesarova, Marketa/0000-0002-5141-2289; Kuss, Andreas/0000-0002-9401-4627; Zeman, Jiri/0000-0002-2678-7919; Mayr, Johannes/0000-0001-6970-336X; Ivanek, Robert/0000-0002-8403-056X	Ministry of Education of Czech Republic [1M6837805002, AV0Z 50110509, MSM0021620806, 14/2006]; GACR [305/08/H037]; OeNB [12568]; Pad. Forschungsverein and PMU Salzburg [06/04/022]	Ministry of Education of Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); GACR(Grant Agency of the Czech Republic); OeNB; Pad. Forschungsverein and PMU Salzburg	This study was supported by grants from Ministry of Education of Czech Republic (1M6837805002, AV0Z 50110509, MSM0021620806, Kontakt 14/2006), GACR (305/08/H037), OeNB 12568, Pad. Forschungsverein and PMU Salzburg (06/04/022). We thank R. Gallyova, S.. Rosipal, V. Smolka, A. Hlavata, P. Freisinger, M. Huemer and O. Bodamer, who provided samples from affected individuals for this study, and D. Seelow for bioinformatic support.	Ackerman SH, 2005, PROG NUCLEIC ACID RE, V80, P95, DOI 10.1016/S0079-6603(05)80003-0; Calvo S, 2006, NAT GENET, V38, P576, DOI 10.1038/ng1776; Cizkova A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-38; Collinson IR, 1996, BIOCHEMISTRY-US, V35, P12640, DOI 10.1021/bi960969t; De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047; Houstek J, 1999, HUM MOL GENET, V8, P1967; Houstek J, 2006, BBA-BIOENERGETICS, V1757, P1400, DOI 10.1016/j.bbabio.2006.04.006; Jonckheere AI, 2008, J MED GENET, V45, P129, DOI 10.1136/jmg.2007.052084; Mayr JA, 2004, PEDIATR RES, V55, P988, DOI 10.1203/01.pdr.0000127016.67809.6b; Pickova A, 2005, PROTEINS, V59, P393, DOI 10.1002/prot.20452; Schon EA, 2001, SEMIN CELL DEV BIOL, V12, P441, DOI 10.1006/scdb.2001.0281; Sperl W, 2006, NEUROMUSCULAR DISORD, V16, P821, DOI 10.1016/j.nmd.2006.08.008; Wang ZG, 2001, J BIOL CHEM, V276, P30773, DOI 10.1074/jbc.M104133200; Zeng XM, 2007, MOL BIOL CELL, V18, P617, DOI 10.1091/mbc.E06-09-0801	14	148	155	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2008	40	11					1288	1290		10.1038/ng.246	http://dx.doi.org/10.1038/ng.246			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18953340				2022-12-27	WOS:000260501500019
J	Frokjaer-Jensen, C; Davis, MW; Hopkins, CE; Newman, BJ; Thummel, JM; Olesen, SP; Grunnet, M; Jorgensen, EM				Frokjaer-Jensen, Christian; Davis, M. Wayne; Hopkins, Christopher E.; Newman, Blake J.; Thummel, Jason M.; Olesen, Soren-Peter; Grunnet, Morten; Jorgensen, Erik M.			Single-copy insertion of transgenes in Caenorhabditis elegans	NATURE GENETICS			English	Article							INDUCED GAP REPAIR; GENE CONVERSION; C-ELEGANS; DNA TRANSFORMATION; EXPRESSION; PROTEIN; GENOME; DROSOPHILA; TRANSPOSON; SEQUENCES	At present, transgenes in Caenorhabditis elegans are generated by injecting DNA into the germline. The DNA assembles into a semistable extrachromosomal array composed of many copies of injected DNA. These transgenes are typically overexpressed in somatic cells and silenced in the germline. We have developed a method that inserts a single copy of a transgene into a defined site. Mobilization of a Mos1 transposon generates a double-strand break in noncoding DNA. The break is repaired by copying DNA from an extrachromosomal template into the chromosomal site. Homozygous single-copy insertions can be obtained in less than 2 weeks by injecting approximately 20 worms. We have successfully inserted transgenes as long as 9 kb and verified that single copies are inserted at the targeted site. Single-copy transgenes are expressed at endogenous levels and can be expressed in the female and male germlines.	[Frokjaer-Jensen, Christian; Davis, M. Wayne; Hopkins, Christopher E.; Newman, Blake J.; Thummel, Jason M.; Jorgensen, Erik M.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Frokjaer-Jensen, Christian; Davis, M. Wayne; Hopkins, Christopher E.; Newman, Blake J.; Thummel, Jason M.; Jorgensen, Erik M.] Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; [Frokjaer-Jensen, Christian; Olesen, Soren-Peter; Grunnet, Morten] Univ Copenhagen, Danish Natl Res Fdn Ctr Cardiac Arrhythmia, DK-2200 Copenhagen N, Denmark; [Grunnet, Morten] NeuroSearch AS, DK-2750 Ballerup, Denmark	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Danmarks Grundforskningsfond; University of Copenhagen	Jorgensen, EM (corresponding author), Univ Utah, Dept Biol, 257 S 1400 E, Salt Lake City, UT 84112 USA.	jorgensen@biology.utah.edu	Olesen, Søren P/H-4206-2011; Olesen, Søren-Peter/B-9621-2012; Frøkjær-Jensen, Christian/ABB-4637-2020	Olesen, Søren P/0000-0002-4381-5192; Davis, Mikel/0000-0003-1867-1593; Hopkins, Chris/0000-0002-6981-6329; Frokjaer-Jensen, Christian/0000-0002-3178-0906	Fonden af 17.12.1981; Lundbeck Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034307] Funding Source: NIH RePORTER	Fonden af 17.12.1981; Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Segalat and the NemaGENETAG consortium for generating and supplying Mos1 insertion alleles; L. Salkoff for twk-18 cDNA clones; G. Seydoux for promoter plasmids; J. Rand for UNC-18 antibodies; C. Thacker at the Utah worm core facility for generating biolistic transformants; G. Stanfield for help in confirming sperm expression; J.-L. Bessereau and V. Robert for sharing unpublished data; and M. Ailion, G. Hollopeter and the rest of the Jorgensen laboratory for scientific input. E. M. J. is an Investigator of the Howard Hughes Medical Institute. S.-P.O. is an Investigator of the Danish National Research Foundation. C.F.-J. was funded by fellowships from Fonden af 17.12.1981 and the Lundbeck Foundation.	Barrett PL, 2004, NAT GENET, V36, P1231, DOI 10.1038/ng1459; Berezikov E, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh033; Bessereau JL, 2001, NATURE, V413, P70, DOI 10.1038/35092567; Chen JM, 2007, NAT REV GENET, V8, P762, DOI 10.1038/nrg2193; Dupuy D, 2004, GENOME RES, V14, P2169, DOI 10.1101/gr.2497604; Duverger Y, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1046; GLOOR GB, 1991, SCIENCE, V253, P1110, DOI 10.1126/science.1653452; Hammarlund M, 2007, PLOS BIOL, V5, P1695, DOI 10.1371/journal.pbio.0050198; Hsieh J, 1999, GENE DEV, V13, P2958, DOI 10.1101/gad.13.22.2958; Hsieh J, 2000, ANNU REV GENET, V34, P187, DOI 10.1146/annurev.genet.34.1.187; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kelly WG, 1997, GENETICS, V146, P227; Kim JK, 2005, SCIENCE, V308, P1164, DOI 10.1126/science.1109267; MADURO M, 1995, GENETICS, V141, P977; Mello C, 1995, METHOD CELL BIOL, V48, P451; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; NASSIF N, 1994, MOL CELL BIOL, V14, P1613, DOI 10.1128/MCB.14.3.1613; PLASTERK RHA, 1992, EMBO J, V11, P287, DOI 10.1002/j.1460-2075.1992.tb05051.x; Praitis V, 2001, GENETICS, V157, P1217; Reboul J, 2003, NAT GENET, V34, P35, DOI 10.1038/ng1140; Robert V, 2007, EMBO J, V26, P170, DOI 10.1038/sj.emboj.7601463; Robert VJ, 2008, GENETICS, V180, P673, DOI 10.1534/genetics.108.089698; Sha K, 2005, GENETICS, V170, P1633, DOI 10.1534/genetics.104.040303; STINCHCOMB DT, 1985, MOL CELL BIOL, V5, P3484, DOI 10.1128/MCB.5.12.3484; Thellmann M, 2003, DEVELOPMENT, V130, P4057, DOI 10.1242/dev.00597; Vastenhouw NL, 2006, NATURE, V442, P882, DOI 10.1038/442882a	26	684	700	1	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2008	40	11					1375	1383		10.1038/ng.248	http://dx.doi.org/10.1038/ng.248			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18953339	Green Accepted			2022-12-27	WOS:000260501500034
J	Barnes, C; Plagnol, V; Fitzgerald, T; Redon, R; Marchini, J; Clayton, D; Hurles, ME				Barnes, Chris; Plagnol, Vincent; Fitzgerald, Tomas; Redon, Richard; Marchini, Jonathan; Clayton, David; Hurles, Matthew E.			A robust statistical method for case-control association testing with copy number variation	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; STRUCTURAL VARIATION; ALPHA-THALASSEMIA; DISEASE; SUSCEPTIBILITY; DUPLICATIONS; POLYMORPHISM; PREDISPOSES; SCALE	Copy number variation (CNV) is pervasive in the human genome and can play a causal role in genetic diseases. The functional impact of CNV cannot be fully captured through linkage disequilibrium with SNPs. These observations motivate the development of statistical methods for performing direct CNV association studies. We show through simulation that current tests for CNV association are prone to false-positive associations in the presence of differential errors between cases and controls, especially if quantitative CNV measurements are noisy. We present a statistical framework for performing case-control CNV association studies that applies likelihood ratio testing of quantitative CNV measurements in cases and controls. We show that our methods are robust to differential errors and noisy data and can achieve maximal theoretical power. We illustrate the power of these methods for testing for association with binary and quantitative traits, and have made this software available as the R package CNVtools.	[Barnes, Chris; Fitzgerald, Tomas; Redon, Richard; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Plagnol, Vincent; Clayton, David] Univ Cambridge, Cambridge Inst Med Res,Dept Med Genet, Wellcome Trust Diabet & Inflammat Lab, Juvenile Diabet Res Fdn, Cambridge CB2 0XY, England; [Marchini, Jonathan] Univ Oxford, Dept Stat, Oxford OX1 3TG, England	Wellcome Trust Sanger Institute; University of Cambridge; University of Oxford	Hurles, ME (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	meh@sanger.ac.uk	Plagnol, Vincent/A-5667-2011; Marchini, Jonathan/ABE-9024-2020; Redon, Richard/F-3303-2014	Marchini, Jonathan/0000-0003-0610-8322; Redon, Richard/0000-0001-7751-2280; Plagnol, Vincent/0000-0002-5597-9215; Barnes, Chris/0000-0002-9459-1395; Fitzgerald, Tomas/0000-0002-2370-8496	Wellcome Trust; WT; National Institute of General Medical Sciences; Juvenile Diabetes Research Foundation (JDRF) fellowship; JDRF/WT fellowship	Wellcome Trust(Wellcome TrustEuropean Commission); WT; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Juvenile Diabetes Research Foundation (JDRF) fellowship(Juvenile Diabetes Research Foundation); JDRF/WT fellowship(Juvenile Diabetes Research Foundation)	C.B., T.F., R.R. and M. E. H. are funded by the Wellcome Trust (WT), J.M. is funded by the WT and the National Institute of General Medical Sciences, V. P. is supported by a Juvenile Diabetes Research Foundation (JDRF) fellowship, and D. C. is supported by a JDRF/WT fellowship. The authors would like to thank the Wellcome Trust Case Control Consortium, D. Conrad, A. Moses, N. Carter, M. Dermitzakis, B. Stranger, J. Armour and E. Hollox for data access and helpful discussions.	Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Armour JAL, 2002, HUM MUTAT, V20, P325, DOI 10.1002/humu.10133; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chong SS, 2000, BLOOD, V95, P360; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; FLINT J, 1986, NATURE, V321, P744, DOI 10.1038/321744a0; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Lupski J.R., 2006, GENOMIC DISORDERS TH; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; McCullagh P, 1989, GEN LINEAR MODELS; MENG XL, 1993, BIOMETRIKA, V80, P267, DOI 10.2307/2337198; Newman TL, 2006, HUM MOL GENET, V15, P1159, DOI 10.1093/hmg/ddl031; Plagnol V, 2007, PLOS GENET, V3, P759, DOI 10.1371/journal.pgen.0030074; PRENTICE RL, 1979, BIOMETRIKA, V66, P403, DOI 10.1093/biomet/66.3.403; R Development Core Team, 2007, R LANG ENV STAT COMP; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257	23	127	137	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2008	40	10					1245	1252		10.1038/ng.206	http://dx.doi.org/10.1038/ng.206			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18776912	Green Accepted			2022-12-27	WOS:000259651000027
J	She, XW; Cheng, Z; Zollner, S; Church, DM; Eichler, EE				She, Xinwei; Cheng, Ze; Zoellner, Sebastian; Church, Deanna M.; Eichler, Evan E.			Mouse segmental duplication and copy number variation	NATURE GENETICS			English	Article							HUMAN GENOME; STRUCTURAL VARIATION; ARRAY CGH; EVOLUTION; CHROMOSOME; EXPANSION; SELECTION; HOTSPOTS; STRAINS; SYNTENY	Detailed analyses of the clone-based genome assembly reveal that the recent duplication content of mouse (4.94%) is now comparable to that of human (5.5%), in contrast to previous estimates from the whole-genome shotgun sequence assembly. However, the architecture of mouse and human genomes differs markedly: most mouse duplications are organized into discrete clusters of tandem duplications that show depletion of genes and transcripts and enrichment of long interspersed nuclear element (LINE) and long terminal repeat (LTR) retroposons. We assessed copy number variation of the C57BL/6J duplicated regions within 15 mouse strains previously used for genetic association studies, sequencing and the Mouse Phenome Project. We determined that over 60% of these base pairs are polymorphic among the strains (on average, there was 20 Mb of copy-number-variable DNA between different mouse strains). Our data suggest that different mouse strains show comparable, if not greater, copy number polymorphism when compared to human; however, such variation is more locally restricted. We show large and complex patterns of interstrain copy number variation restricted to large gene families associated with spermatogenesis, pregnancy, viviparity, pheromone signaling and immune response.	[She, Xinwei; Cheng, Ze; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Zoellner, Sebastian] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Zoellner, Sebastian] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA; [Church, Deanna M.] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20894 USA; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Howard Hughes Medical Institute	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, 1705 NE Pacific St, Seattle, WA 98195 USA.	eee@gs.washington.edu			Howard Hughes Medical Institute Funding Source: Medline; NHGRI NIH HHS [R01 HG002385-07, R01 HG002385, HG002385] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002385] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIHLM200888] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Armengol L, 2005, GENOMICS, V86, P692, DOI 10.1016/j.ygeno.2005.08.008; Armengol L, 2003, HUM MOL GENET, V12, P2201, DOI 10.1093/hmg/ddg223; Bailey JA, 2004, GENOME RES, V14, P789, DOI 10.1101/gr.2238404; Bailey JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r23; Bailey JA, 2003, AM J HUM GENET, V73, P823, DOI 10.1086/378594; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; BAILEY JA, 2003, P 68 COLD SPRING HAR; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-8-r47; Egan CM, 2007, NAT GENET, V39, P1384, DOI 10.1038/ng.2007.19; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Jurka J, 2004, P NATL ACAD SCI USA, V101, P1268, DOI 10.1073/pnas.0308084100; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/ng0501-42; Li JZ, 2004, NAT GENET, V36, P952, DOI 10.1038/ng1417; Medstrand P, 2002, GENOME RES, V12, P1483, DOI 10.1101/gr.388902; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Perry GH, 2006, P NATL ACAD SCI USA, V103, P8006, DOI 10.1073/pnas.0602318103; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sainz J, 2006, EUR J HUM GENET, V14, P216, DOI 10.1038/sj.ejhg.5201534; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; She XW, 2006, GENOME RES, V16, P576, DOI 10.1101/gr.4949406; Snijders AM, 2005, GENOME RES, V15, P302, DOI 10.1101/gr.2902505; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Watkins-Chow DE, 2008, GENOME RES, V18, P60, DOI 10.1101/gr.6927808	30	172	176	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					909	914		10.1038/ng.172	http://dx.doi.org/10.1038/ng.172			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18500340	Green Accepted			2022-12-27	WOS:000257166500028
J	Fisher, SA; Tremelling, M; Anderson, CA; Gwilliam, R; Bumpstead, S; Prescott, NJ; Nimmo, ER; Massey, D; Berzuini, C; Johnson, C; Barrett, JC; Cummings, FR; Drummond, H; Lees, CW; Onnie, CM; Hanson, CE; Blaszczyk, K; Inouye, M; Ewels, P; Ravindrarajah, R; Keniry, A; Hunt, S; Carter, M; Watkins, N; Ouwehand, W; Lewis, CM; Cardon, L; Lobo, A; Forbes, A; Sanderson, J; Jewell, DP; Mansfield, JC; Deloukas, P; Mathew, CG; Parkes, M; Satsangi, J				Fisher, Sheila A.; Tremelling, Mark; Anderson, Carl A.; Gwilliam, Rhian; Bumpstead, Suzannah; Prescott, Natalie J.; Nimmo, Elaine R.; Massey, Dunecan; Berzuini, Carlo; Johnson, Christopher; Barrett, Jeffrey C.; Cummings, Fraser R.; Drummond, Hazel; Lees, Charlie W.; Onnie, Clive M.; Hanson, Catherine E.; Blaszczyk, Katarzyna; Inouye, Mike; Ewels, Philip; Ravindrarajah, Radhi; Keniry, Andrew; Hunt, Sarah; Carter, Martyn; Watkins, Nick; Ouwehand, Willem; Lewis, Cathryn M.; Cardon, Lon; Lobo, Alan; Forbes, Alastair; Sanderson, Jeremy; Jewell, Derek P.; Mansfield, John C.; Deloukas, Panos; Mathew, Christopher G.; Parkes, Miles; Satsangi, Jack		Wellcome Trust Case Control Consor	Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY; IL23R; IDENTIFICATION; PHENOTYPE; VARIANTS	We report results of a nonsynonymous SNP scan for ulcerative colitis and identify a previously unknown susceptibility locus at ECM1. We also show that several risk loci are common to ulcerative colitis and Crohn's disease (IL23R, IL12B, HLA, NKX2-3 and MST1), whereas autophagy genes ATG16L1 and IRGM, along with NOD2 (also known as CARD15), are specific for Crohn's disease. These data provide the first detailed illustration of the genetic relationship between these common inflammatory bowel diseases.	[Nimmo, Elaine R.; Lees, Charlie W.; Satsangi, Jack] Univ Edinburgh, Western Gen Hosp, Gastrointestinal Unit, Div Med Sci,Sch Mol & Clin Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Fisher, Sheila A.; Prescott, Natalie J.; Onnie, Clive M.; Blaszczyk, Katarzyna; Lewis, Cathryn M.; Mathew, Christopher G.] Guys Hosp, Dept Med & Mol Genet, Univ London Kings Coll, Sch Med, London SE1 9RT, England; [Tremelling, Mark; Massey, Dunecan; Berzuini, Carlo; Johnson, Christopher; Parkes, Miles] Univ Cambridge, Addenbrookes Hosp, Inflammatory Bowel Dis Res Grp, Cambridge CB2 2QQ, England; [Anderson, Carl A.; Barrett, Jeffrey C.; Cardon, Lon] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Gwilliam, Rhian; Bumpstead, Suzannah; Inouye, Mike; Ewels, Philip; Ravindrarajah, Radhi; Keniry, Andrew; Hunt, Sarah; Deloukas, Panos] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Cummings, Fraser R.; Jewell, Derek P.] Univ Oxford, Radcliffe Infirm, Gastroenterol Unit, Oxford OX2 6HE, England; [Hanson, Catherine E.; Mansfield, John C.] Newcastle Univ, Royal Victoria Infirm, Dept Gastroenterol & Hepatol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Carter, Martyn] Univ Sheffield, Sch Med, Royal Hallamshire Hosp, Div Mol & Genet Med, Sheffield S10 2JF, S Yorkshire, England; [Watkins, Nick; Ouwehand, Willem] Univ Cambridge, Dept Haematol, Natl Blood Serv Ctr, Cambridge CB2 2PT, England; [Forbes, Alastair] UCL Hosp Trust, Inst Digest Dis, London NW1 2BU, England; [Sanderson, Jeremy] Guys & St Thomas NHS Fdn Trust, Dept Gastroenterol, London SE1 7EH, England	University of Edinburgh; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics; Wellcome Trust Sanger Institute; Radcliffe Infirmary; University of Oxford; Newcastle University - UK; University of Sheffield; University of Cambridge; University College London Hospitals NHS Foundation Trust; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust	Satsangi, J (corresponding author), Univ Edinburgh, Western Gen Hosp, Gastrointestinal Unit, Div Med Sci,Sch Mol & Clin Med, Edinburgh EH4 2XU, Midlothian, Scotland.	j.satsangi@ed.ac.uk	Mathew, Christopher G/G-3434-2015; Prescott, Natalie J/F-6490-2011; Lewis, Cathryn/M-8766-2019; eyre, stephen/K-3776-2017; Yuldasheva, Dr. Nadira Yusupovna/GXM-9013-2022; Dominiczak, Anna F/P-9390-2017; Lewis, Cathryn M/A-5225-2010; Ewels, Philip/J-7771-2013; HILL, Adrian V>S>/C-1306-2008; Deloukas, Panos/B-2922-2013; Berzuini, Carlo/AAA-7023-2019; Breen, Gerome/Y-2706-2019; Anderson, Carl A/B-8327-2013	Mathew, Christopher G/0000-0003-4178-1838; Prescott, Natalie J/0000-0002-5901-7371; Lewis, Cathryn/0000-0002-8249-8476; eyre, stephen/0000-0002-1251-6974; Yuldasheva, Dr. Nadira Yusupovna/0000-0001-6213-6358; Dominiczak, Anna F/0000-0003-4913-3608; Lewis, Cathryn M/0000-0002-8249-8476; Ewels, Philip/0000-0003-4101-2502; Deloukas, Panos/0000-0001-9251-070X; Berzuini, Carlo/0000-0001-6056-0489; Breen, Gerome/0000-0003-2053-1792; Anderson, Carl A/0000-0003-1719-7009; Hunt, Sarah/0000-0002-8350-1235; Massey, Dunecan/0000-0002-7144-4579; Zeggini, Eleftheria/0000-0003-4238-659X; Hattersley, Andrew/0000-0001-5620-473X; Lees, Charlie/0000-0002-0732-8215; Forbes, Alastair/0000-0001-7416-9843; Cummings, Fraser/0000-0002-9659-3247; Munroe, Patricia/0000-0002-4176-2947; Barrett, Jeffrey/0000-0002-1152-370X; Inouye, Michael/0000-0001-9413-6520; Parkes, Miles/0000-0002-6467-0631; Lindgren, Cecilia/0000-0002-4903-9374; Weedon, Michael/0000-0002-6174-6135; Dunger, Professor David/0000-0002-2566-9304; Lango Allen, Hana/0000-0002-7803-8688	Medical Research Council [G0000934, G0802320, G0800759, MC_QA137934, G0800383, G0600329, G0400874, MC_U105260799] Funding Source: Medline; Wellcome Trust [089120, 090532, 077011, 076113] Funding Source: Medline; Chief Scientist Office [CZB/4/540] Funding Source: Medline; MRC [G0800383, G0600329, MC_qA137934, G0000934, MC_U105260799, G0400874] Funding Source: UKRI; Medical Research Council [MC_qA137934] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chan I, 2007, EXP DERMATOL, V16, P881, DOI 10.1111/j.1600-0625.2007.00608.x; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; Matsuda A, 2003, ONCOGENE, V22, P3307, DOI 10.1038/sj.onc.1206406; Mochida A, 2007, TISSUE ANTIGENS, V70, P128, DOI 10.1111/j.1399-0039.2007.00866.x; Morrison AC, 2004, J IMMUNOL, V172, P1825, DOI 10.4049/jimmunol.172.3.1825; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Satsangi J, 1996, LANCET, V347, P1212, DOI 10.1016/S0140-6736(96)90734-5; Silverberg MS, 2003, INFLAMM BOWEL DIS, V9, P1, DOI 10.1097/00054725-200301000-00001; Stokkers PCF, 1999, GUT, V45, P395, DOI 10.1136/gut.45.3.395; Thomas DC, 2004, JNCI-J NATL CANCER I, V96, P421, DOI 10.1093/jnci/djh094; Tremelling M, 2007, GASTROENTEROLOGY, V132, P1657, DOI 10.1053/j.gastro.2007.02.051	15	333	338	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2008	40	6					710	712		10.1038/ng.145	http://dx.doi.org/10.1038/ng.145			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18438406	Green Accepted			2022-12-27	WOS:000256212000010
J	DeLuna, A; Vetsigian, K; Shoresh, N; Hegreness, M; Colon-Gonzalez, M; Chao, S; Kishony, R				DeLuna, Alexander; Vetsigian, Kalin; Shoresh, Noam; Hegreness, Matthew; Colon-Gonzalez, Maritrini; Chao, Sharon; Kishony, Roy			Exposing the fitness contribution of duplicated genes	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; GENOME DUPLICATION; YEAST; ROBUSTNESS; NETWORK; BACKUP; NEOFUNCTIONALIZATION; REDUNDANCY; MUTATIONS; EVOLUTION	Duplicate genes from the whole-genome duplication (WGD) in yeast are often dispensable-removing one copy has little or no phenotypic consequence(1,2). It is unknown, however, whether such dispensability reflects insignificance of the ancestral function or compensation from paralogs(3-7). Here, using precise competition-based measurements of the fitness cost of single and double deletions, we estimate the exposed fitness contribution of WGD duplicate genes in metabolism and bound the importance of their ancestral pre-duplication function. We find that the functional overlap between paralogs sufficiently explains the apparent dispensability of individual WGD genes. Furthermore, the lower bound on the fitness value of the ancestral function, which is estimated by the degree of synergistic epistasis, is at least as large as the average fitness cost of deleting single non-WGD genes. These results suggest that most metabolic functions encoded by WGD genes are important today and were also important at the time of duplication.	[DeLuna, Alexander; Vetsigian, Kalin; Shoresh, Noam; Hegreness, Matthew; Colon-Gonzalez, Maritrini; Chao, Sharon; Kishony, Roy] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Kishony, Roy] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Kishony, R (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, 200 Longwood Ave, Boston, MA 02115 USA.	roy_kishony@hms.harvard.edu	DeLuna, Alexander/H-9986-2016	DeLuna, Alexander/0000-0002-9236-2804; Colon-Gonzalez, Maritrini/0000-0001-6821-1726				Conant GC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100170; DeLuna A, 2001, J BIOL CHEM, V276, P43775, DOI 10.1074/jbc.M107986200; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Guan YF, 2007, GENETICS, V175, P933, DOI 10.1534/genetics.106.064329; Harrison R, 2007, P NATL ACAD SCI USA, V104, P2307, DOI 10.1073/pnas.0607153104; He XL, 2006, MOL BIOL EVOL, V23, P144, DOI 10.1093/molbev/msj015; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hegreness M, 2006, SCIENCE, V311, P1615, DOI 10.1126/science.1122469; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ihmels J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100127; Kafri R, 2005, NAT GENET, V37, P295, DOI 10.1038/ng1523; Kafri R, 2006, P NATL ACAD SCI USA, V103, P11653, DOI 10.1073/pnas.0604883103; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Kuepfer L, 2005, GENOME RES, V15, P1421, DOI 10.1101/gr.3992505; Lynch M, 2000, GENETICS, V154, P459; Makino T, 2006, GENE, V385, P57, DOI 10.1016/j.gene.2006.06.028; Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636; Presser A, 2008, P NATL ACAD SCI USA, V105, P950, DOI 10.1073/pnas.0707293105; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Seoighe C, 1999, CURR OPIN MICROBIOL, V2, P548, DOI 10.1016/S1369-5274(99)00015-6; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Thatcher JW, 1998, P NATL ACAD SCI USA, V95, P253, DOI 10.1073/pnas.95.1.253; Tirosh I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r50; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Vitkup D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r39; Wagner A, 2000, NAT GENET, V24, P355, DOI 10.1038/74174; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711	30	118	122	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					676	681		10.1038/ng.123	http://dx.doi.org/10.1038/ng.123			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18408719				2022-12-27	WOS:000255366700039
J	Kabashi, E; Valdmanis, PN; Dion, P; Spiegelman, D; McConkey, BJ; Velde, CV; Bouchard, JP; Lacomblez, L; Pochigaeva, K; Salachas, F; Pradat, PF; Camu, W; Meininger, V; Dupre, N; Rouleau, GA				Kabashi, Edor; Valdmanis, Paul N.; Dion, Patrick; Spiegelman, Dan; McConkey, Brendan J.; Velde, Christine Vande; Bouchard, Jean-Pierre; Lacomblez, Lucette; Pochigaeva, Ksenia; Salachas, Francois; Pradat, Pierre-Francois; Camu, William; Meininger, Vincent; Dupre, Nicolas; Rouleau, Guy A.			TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis	NATURE GENETICS			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; TDP-43; PROTEIN; DISEASE; BODIES	Recently, TDP-43 was identified as a key component of ubiquitinated aggregates in amyotrophic lateral sclerosis (ALS), an adult-onset neurological disorder that leads to the degeneration of motor neurons. Here we report eight missense mutations in nine individuals-six from individuals with sporadic ALS ( SALS) and three from those with familial ALS ( FALS)-and a concurring increase of a smaller TDP-43 product. These findings further corroborate that TDP-43 is involved in ALS pathogenesis.	[Kabashi, Edor; Valdmanis, Paul N.; Dion, Patrick; Spiegelman, Dan; Velde, Christine Vande; Dupre, Nicolas; Rouleau, Guy A.] Ctr Hosp Univ Montreal, Ctr Excellence Neurom, Montreal, PQ H2L 4M1, Canada; [Kabashi, Edor; Valdmanis, Paul N.; Dion, Patrick; Spiegelman, Dan; Velde, Christine Vande; Dupre, Nicolas; Rouleau, Guy A.] Univ Montreal, Dept Med, Montreal, PQ H2L 4M1, Canada; [McConkey, Brendan J.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Bouchard, Jean-Pierre; Dupre, Nicolas] Univ Laval, Fac Med, Ctr Hosp Affilie Univ Quebec, Hop Enfants Jesus, Quebec City, PQ G1J 1Z4, Canada; [Lacomblez, Lucette; Pochigaeva, Ksenia; Salachas, Francois; Pradat, Pierre-Francois; Meininger, Vincent] Hop La Pitie Salpetriere, Div Paul Castaigne, Federat Malad Syst Nerveux, F-75651 Paris, France; [Camu, William] Inst Biol, Unite Neurol Comportementale & Degenerat, F-34967 Montpellier, France	Universite de Montreal; Universite de Montreal; University of Waterloo; Laval University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Rouleau, GA (corresponding author), Ctr Hosp Univ Montreal, Ctr Excellence Neurom, Montreal, PQ H2L 4M1, Canada.	guy.rouleau@umontreal.ca	Dupre, Nicolas/Y-1828-2019; Kabashi, Edor/C-5408-2014; Velde, Christine Vande/AAB-8828-2020; camu, william/AAB-4727-2020; Vande Velde, Christine/F-2721-2016; Pochigaeva, Ksenia/Y-8280-2018	Kabashi, Edor/0000-0003-4118-251X; Vande Velde, Christine/0000-0001-5926-1529; Valdmanis, Paul/0000-0001-8840-6969; spiegelman, dan/0000-0003-4971-8868; Pochigaeva, Ksenia/0000-0002-9803-6807				Amador-Ortiz C, 2007, ANN NEUROL, V61, P435, DOI 10.1002/ana.21154; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Buratti E, 2005, J BIOL CHEM, V280, P37572, DOI 10.1074/jbc.M505557200; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Forman MS, 2007, CURR OPIN NEUROBIOL, V17, P548, DOI 10.1016/j.conb.2007.08.005; Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516; GIJSELINCK I, IN PRESS NEUROBIOL A; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Strong MJ, 2007, MOL CELL NEUROSCI, V35, P320, DOI 10.1016/j.mcn.2007.03.007; Wang HY, 2004, GENOMICS, V83, P130, DOI 10.1016/S0888-7543(03)00214-3; Wang IF, 2002, P NATL ACAD SCI USA, V99, P13583, DOI 10.1073/pnas.212483099	15	1166	1202	3	82	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					572	574		10.1038/ng.132	http://dx.doi.org/10.1038/ng.132			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18372902				2022-12-27	WOS:000255366700024
J	Kozlov, SV; Bogenpohl, JW; Howell, MP; Wevrick, R; Panda, S; Hogenesch, JB; Muglia, LJ; Van Gelder, RN; Herzog, ED; Stewart, CL				Kozlov, Serguei V.; Bogenpohl, James W.; Howell, Maureen P.; Wevrick, Rachel; Panda, Satchin; Hogenesch, John B.; Muglia, Louis J.; Van Gelder, Russell N.; Herzog, Erik D.; Stewart, Colin L.			The imprinted gene Magel2 regulates normal circadian output	NATURE GENETICS			English	Article							PRADER-WILLI-SYNDROME; MOUSE; DISRUPTION; NECDIN; SNRPN; MICE; EXPRESSION; OBESITY; GROWTH; ROLES	Mammalian circadian rhythms of activity are generated within the suprachiasmatic nucleus ( SCN). Transcripts from the imprinted, paternally expressed Magel2 gene, which maps to the chromosomal region associated with Prader-Willi Syndrome (PWS), are highly enriched in the SCN. The Magel2 message is circadianly expressed and peaks during the subjective day. Mice deficient in Magel2 expression entrain to light cycles and express normal running-wheel rhythms, but with markedly reduced amplitude of activity and increased daytime activity. These changes are associated with reductions in food intake and male fertility. Orexin levels and orexin-positive neurons in the lateral hypothalamus are substantially reduced, suggesting that some of the consequences of Magel2 loss are mediated through changes in orexin signaling. The robust rhythmicity of Magel2 expression in the SCN and the altered behavioral rhythmicity of null mice reveal Magel2 to be a clock-controlled circadian output gene whose disruption results in some of the phenotypes characteristic of PWS.	Washington Univ, Dept Biol, St Louis, MO 63130 USA; Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Univ Alberta, Dept Med Genet, Edmonton, AB T6G 2H7, Canada; Salk Inst Biol Studies, Regulat Biol Lab, La Jolla, CA 92037 USA; Genom Inst Novartis Res Fdn, San Diego, CA 92121 USA; Washington Univ, Sch Med, Dept Mol Biol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Pharmacol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; NCI, Canc & Dev Biol Lab, Frederick, MD 21702 USA	Washington University (WUSTL); Washington University (WUSTL); University of Alberta; Salk Institute; Novartis; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Stewart, CL (corresponding author), Inst Med Biol, 03-03 Proteos,61 Biopolis Dr, Singapore 113867, Singapore.	stewartc@ncifcrf.gov	Van Gelder, Russell/ABB-4225-2021; Panda, Satchidananda/J-6891-2012	Van Gelder, Russell/0000-0001-5368-3659; Herzog, Erik/0000-0001-7209-5174; Wevrick, Rachel/0000-0002-3343-5794; Bogenpohl, James/0000-0001-7214-3404	Intramural NIH HHS Funding Source: Medline; NEI NIH HHS [EY14988] Funding Source: Medline; NIMH NIH HHS [MH63104] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC010349] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY014988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063104] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Boccaccio I, 1999, HUM MOL GENET, V8, P2497, DOI 10.1093/hmg/8.13.2497; Bressler J, 2001, NAT GENET, V28, P232, DOI 10.1038/90067; Card JP, 2000, J BIOL RHYTHM, V15, P453, DOI 10.1177/074873000129001567; Davies W, 2005, NEUROSCI BIOBEHAV R, V29, P421, DOI 10.1016/j.neubiorev.2004.11.007; Gerard M, 1999, NAT GENET, V23, P199, DOI 10.1038/13828; Goldstone AP, 2006, PROG BRAIN RES, V153, P57, DOI 10.1016/S0079-6123(06)53033-1; Goldstone AP, 2004, TRENDS ENDOCRIN MET, V15, P12, DOI 10.1016/j.tem.2003.11.003; Hara J, 2005, NEUROSCI LETT, V380, P239, DOI 10.1016/j.neulet.2005.01.046; Herzog ED, 2004, J BIOL RHYTHM, V19, P35, DOI 10.1177/0748730403260776; Ibata Y, 1999, FRONT NEUROENDOCRIN, V20, P241, DOI 10.1006/frne.1999.0180; Keverne EB, 1996, DEV BRAIN RES, V92, P91, DOI 10.1016/0165-3806(95)00209-X; KONTGEN F, 1993, INT IMMUNOL, V5, P957, DOI 10.1093/intimm/5.8.957; Lee S, 2000, HUM MOL GENET, V9, P1813, DOI 10.1093/hmg/9.12.1813; Lee S, 2003, GENE EXPR PATTERNS, V3, P599, DOI 10.1016/S1567-133X(03)00113-3; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Muscatelli F, 2000, HUM MOL GENET, V9, P3101, DOI 10.1093/hmg/9.20.3101; Pagliardini S, 2005, AM J PATHOL, V167, P175, DOI 10.1016/S0002-9440(10)62964-1; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; PAXINOS G, 1990, TRENDS NEUROSCI, V13, P169, DOI 10.1016/0166-2236(90)90041-8; Ren J, 2003, J NEUROSCI, V23, P1569; Runte M, 2001, HUM MOL GENET, V10, P2687, DOI 10.1093/hmg/10.23.2687; Sakurai T, 2005, SLEEP MED REV, V9, P231, DOI 10.1016/j.smrv.2004.07.007; Silver R, 2005, METHOD ENZYMOL, V393, P451, DOI 10.1016/S0076-6879(05)93022-X; SIMMONS DM, 1989, J HISTOTECHNOL, V12, P169; Tsai TF, 1999, HUM MOL GENET, V8, P1357, DOI 10.1093/hmg/8.8.1357; Willie JT, 2003, NEURON, V38, P715, DOI 10.1016/S0896-6273(03)00330-1; Yang T, 1998, NAT GENET, V19, P25, DOI 10.1038/ng0598-25; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	29	135	142	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2007	39	10					1266	1272		10.1038/ng2114	http://dx.doi.org/10.1038/ng2114			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17893678				2022-12-27	WOS:000249737400024
J	Ballif, BC; Hornor, SA; Jenkins, E; Madan-Khetarpal, S; Surti, U; Jackson, KE; Asamoah, A; Brock, PL; Gowans, GC; Conway, RL; Graham, JM; Medne, L; Zackai, EH; Shaikh, TH; Geoghegan, J; Selzer, RR; Eis, PS; Bejjani, BA; Shaffer, LG				Ballif, Blake C.; Hornor, Sara A.; Jenkins, Elizabeth; Madan-Khetarpal, Suneeta; Surti, Urvashi; Jackson, Kelly E.; Asamoah, Alexander; Brock, Pamela L.; Gowans, Gordon C.; Conway, Robert L.; Graham, John M., Jr.; Medne, Livija; Zackai, Elaine H.; Shaikh, Tamim H.; Geoghegan, Joel; Selzer, Rebecca R.; Eis, Peggy S.; Bejjani, Bassem A.; Shaffer, Lisa G.			Discovery of a previously unrecognized microdeletion syndrome of 16p11.2-p12.2	NATURE GENETICS			English	Article							HUMAN GENOME; COPY NUMBER; ARCHITECTURE; DUPLICATION; REARRANGEMENTS; POLYMORPHISM; DISORDERS; CGH	We have identified a recurrent de novo pericentromeric deletion in 16p11.2 - p12.2 in four individuals with developmental disabilities by microarray- based comparative genomic hybridization analysis. The identification of common clinical features in these four individuals along with the characterization of complex segmental duplications flanking the deletion regions suggests that nonallelic homologous recombination mediated these rearrangements and that deletions in 16p11.2 - p12.2 constitute a previously undescribed syndrome.	Signature Genom Labs, Spokane, WA 99202 USA; Washington State Univ, Hlth Res & Educ Ctr, Spokane, WA 99210 USA; Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA; Magee Womens Hosp, Pittsburgh, PA 15213 USA; Weisskopf Child Evaluat Ctr, Louisville, KY 40202 USA; Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; NimbleGen Syst, Madison, WI 53711 USA; Sacred Heart Med Ctr, Spokane, WA 99204 USA	Washington State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Cedars Sinai Medical Center; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Roche Holding; Roche NimbleGen	Shaffer, LG (corresponding author), Signature Genom Labs, Spokane, WA 99202 USA.	lshaffer@wsu.edu	Graham, John M./J-1429-2019	Eis, Peggy/0000-0002-3075-8707	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657, R21HD047280] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008243] Funding Source: NIH RePORTER; NICHD NIH HHS [HD22657-11, HD047280-02] Funding Source: Medline; NIGMS NIH HHS [GM08243] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ballif BC, 2007, GENET MED, V9, P150, DOI 10.1097/GIM.0b013e3180312087; Bejjani BA, 2005, AM J MED GENET A, V134A, P259, DOI 10.1002/ajmg.a.30621; Finelli P, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.016311; Hernando C, 2002, J Med Genet, V39, pE24, DOI 10.1136/jmg.39.5.e24; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Martin J, 2004, NATURE, V432, P988, DOI 10.1038/nature03187; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Stankiewicz P, 2003, AM J HUM GENET, V72, P1101, DOI 10.1086/374385; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1	14	159	166	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2007	39	9					1071	1073		10.1038/ng2107	http://dx.doi.org/10.1038/ng2107			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17704777				2022-12-27	WOS:000249122400015
J	Zanke, BW; Greenwood, CMT; Rangrej, J; Kustra, R; Tenesa, A; Farrington, SM; Prendergast, J; Olschwang, S; Chiang, T; Crowdy, E; Ferretti, V; Laflamme, P; Sundararajan, S; Roumy, S; Olivier, JF; Robidoux, F; Sladek, R; Montpetit, A; Campbell, P; Bezieau, S; O'Shea, AM; Zogopoulos, G; Cotterchio, M; Newcomb, P; McLaughlin, J; Younghusband, B; Green, R; Green, J; Porteous, MEM; Campbell, H; Blanche, H; Sahbatou, M; Tubacher, E; Bonaiti-Pellie, C; Buecher, B; Riboli, E; Kury, S; Chanock, SJ; Potter, J; Thomas, G; Gallinger, S; Hudson, TJ; Dunlop, MG				Zanke, Brent W.; Greenwood, Celia M. T.; Rangrej, Jagadish; Kustra, Rafal; Tenesa, Albert; Farrington, Susan M.; Prendergast, James; Olschwang, Sylviane; Chiang, Theodore; Crowdy, Edgar; Ferretti, Vincent; Laflamme, Philippe; Sundararajan, Saravanan; Roumy, Stephanie; Olivier, Jean-Francois; Robidoux, Frederick; Sladek, Robert; Montpetit, Alexandre; Campbell, Peter; Bezieau, Stephane; O'Shea, Anne Marie; Zogopoulos, George; Cotterchio, Michelle; Newcomb, Polly; McLaughlin, John; Younghusband, Ban; Green, Roger; Green, Jane; Porteous, Mary E. M.; Campbell, Harry; Blanche, Helene; Sahbatou, Mourad; Tubacher, Emmanuel; Bonaiti-Pellie, Catherine; Buecher, Bruno; Riboli, Elio; Kury, Sebastien; Chanock, Stephen J.; Potter, John; Thomas, Gilles; Gallinger, Steven; Hudson, Thomas J.; Dunlop, Malcolm G.			Genome-wide association scan identifies a colorectal cancer susceptibility locus on chromosome 8q24	NATURE GENETICS			English	Article							PROSTATE-CANCER	Using a multistage genetic association approach comprising 7,480 affected individuals and 7,779 controls, we identified markers in chromosomal region 8q24 associated with colorectal cancer. In stage 1, we genotyped 99,632 SNPs in 1,257 affected individuals and 1,336 controls from Ontario. In stages 2-4, we performed serial replication studies using 4,024 affected individuals and 4,042 controls from Seattle, Newfoundland and Scotland. We identified one locus on chromosome 8q24 and another on 9p24 having combined odds ratios (OR) for stages 1-4 of 1.18 (trend; P = 1.41 x 10(-8)) and 1.14 (trend; P = 1.32 x 10(-5)), respectively. Additional analyses in 2,199 affected individuals and 2,401 controls from France and Europe supported the association at the 8q24 locus (OR = 1.16, trend; 95% confidence interval (c.i.): 1.07-1.26; P = 5.05 = 10-4). A summary across all seven studies at the 8q24 locus was highly significant (OR = 1.17, c.i.: 1.12-1.23; P = 3.16 x 10(-11)). This locus has also been implicated in prostate cancer(1-3).	Ontario Inst Canc Res, Toronto, ON M5G 2L7, Canada; Canc Care Ontario, Toronto, ON M5G 1L7, Canada; Univ Ottawa, Fac Med, Div Hematol, Ottawa, ON K1H 8L6, Canada; Hosp Sick Children, Toronto, ON M5G 1L7, Canada; Univ Toronto, Dept Publ Hlth Sci, Toronto, ON M5T 3M7, Canada; Univ Edinburgh, Canc Res Ctr, Colon Canc Genet Grp, Edinburgh EH4 2XU, Midlothian, Scotland; Western Gen Hosp, Human Genet Unit, UK Med Res Council, Edinburgh EH4 2XU, Midlothian, Scotland; Inst J Paoli I Calmettes, INSERM, U599, F-13009 Marseille, France; McGill Univ, Montreal, PQ H3G 1A4, Canada; Genome Quebec Innovat Ctr, Montreal, PQ H3G 1A4, Canada; Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; Univ Toronto, Toronto, ON M5G 1X5, Canada; Ctr Hosp Univ Hotel Dieu, IMAD, F-44093 Nantes 01, France; Ctr Hosp Univ Hotel Dieu, EA3823, F-44093 Nantes 01, France; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Mem Univ Newfoundland, St John, NF A1C 5S7, Canada; Univ Edinburgh, Dept Clin Genet, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Edinburgh, Edinburgh EH8 9AG, Midlothian, Scotland; Ctr Etud Polymorphisme Humain, F-75010 Paris, France; Hop Paul Brousse, INSERM, U535, F-94800 Villejuif, France; Imperial Coll, Fac Med, London W2 1PG, England; NCI, Canc Res Ctr, NIH, DHHS, Gaithersburg, MD 20877 USA; NCI, Div Canc Genet & Epidemiol, NIH, DHHS, Gaithersburg, MD 20877 USA; NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA	Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; Cancer Care Ontario; University of Ottawa; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Edinburgh; University of Edinburgh; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Institut Paoli-Calmette (IPC); McGill University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Fred Hutchinson Cancer Center; Memorial University Newfoundland; University of Edinburgh; University of Edinburgh; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Imperial College London; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hudson, TJ (corresponding author), Ontario Inst Canc Res, 101 Coll St, Toronto, ON M5G 2L7, Canada.	tom.hudson@oicr.on.ca	Campbell, Harry/E-2959-2010; Farrington, Susan M/Q-2710-2019; Gallinger, Steven/E-4575-2013; McLaughlin, John R/E-4577-2013; Bézieau, stéphane/G-5621-2015; Dunlop, Malcolm G/F-1973-2011; Farrington, Susan M/C-7319-2013; KÜRY, Sébastien/G-5971-2015; Olschwang, Sylviane/G-2716-2013; Sladek, Robert/R-2391-2019	Campbell, Harry/0000-0002-6169-6262; Farrington, Susan M/0000-0001-5955-7389; Bézieau, stéphane/0000-0003-0095-1319; Dunlop, Malcolm G/0000-0002-3033-5851; KÜRY, Sébastien/0000-0001-5497-0465; Olschwang, Sylviane/0000-0001-7078-3029; Sladek, Robert/0000-0002-2730-1204; Riboli, Elio/0000-0001-6795-6080; Tenesa, Albert/0000-0003-4884-4475; Cotterchio, Michelle/0000-0003-2862-7895; Potter, John/0000-0001-5439-1500; Prendergast, James/0000-0001-8916-018X	NATIONAL CANCER INSTITUTE [U01CA074794, U01CA074783, K22CA095011, Z01SC010083] Funding Source: NIH RePORTER; Medical Research Council [MC_U127527198] Funding Source: Medline; NCI NIH HHS [U01 CA076783, U01 CA074783, RFA CA-95-011, U01 CA074794] Funding Source: Medline; Chief Scientist Office [CZB/4/449] Funding Source: Medline; MRC [MC_U127527198] Funding Source: UKRI	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cotterchio M, 2000, Chronic Dis Can, V21, P81; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Fan JB, 2006, METHOD ENZYMOL, V410, P57, DOI 10.1016/S0076-6879(06)10003-8; Greenwood CMT, 2007, GENET EPIDEMIOL, V31, P396, DOI 10.1002/gepi.20220; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Nicolae DL, 2006, PLOS GENET, V2, P665, DOI 10.1371/journal.pgen.0020067; Sasieni PD, 1997, BIOMETRICS, V53, P1253, DOI 10.2307/2533494; Wang YK, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni177; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	13	579	602	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2007	39	8					989	994		10.1038/ng2089	http://dx.doi.org/10.1038/ng2089			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17618283				2022-12-27	WOS:000248446900016
J	Cooper, GM; Nickerson, DA; Eichler, EE				Cooper, Gregory M.; Nickerson, Deborah A.; Eichler, Evan E.			Mutational and selective effects on copy-number variants in the human genome	NATURE GENETICS			English	Article							INSERTION-DELETION POLYMORPHISMS; SEGMENTAL DUPLICATIONS; STRUCTURAL VARIATION; ULTRACONSERVED ELEMENTS; LINKAGE DISEQUILIBRIUM; CHROMOSOME EVOLUTION; MAMMALIAN EVOLUTION; COMMON INVERSION; GENE DESERTS; CLUSTER	Comprehensive descriptions of large insertion/deletion or segmental duplication polymorphisms (SDs) in the human genome have recently been generated. These annotations, known collectively as structural or copy-number variants (CNVs), include thousands of discrete genomic regions and span hundreds of millions of nucleotides. Here we review the genomic distribution of CNVs, which is strongly correlated with gene, repeat and segmental duplication content. We explore the evolutionary mechanisms giving rise to this nonrandom distribution, considering the available data on both human polymorphisms and the fixed changes that differentiate humans from other species. It is likely that mutational biases, selective effects and interactions between these forces all contribute substantially to the spectrum of human copy-number variation. Although defining these variants with nucleotide-level precision remains a largely unmet but critical challenge, our understanding of their potential medical impact and evolutionary importance is rapidly emerging.	[Cooper, Gregory M.; Nickerson, Deborah A.; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Cooper, GM (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	coopergm@u.washington.edu	Cooper, Gregory/D-6914-2011	Cooper, Gregory/0000-0001-5509-9923	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066682] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035] Funding Source: NIH RePORTER; NHGRI NIH HHS [T32 HG00035] Funding Source: Medline; NHLBI NIH HHS [HL066682] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Armengol L, 2003, HUM MOL GENET, V12, P2201, DOI 10.1093/hmg/ddg223; Bailey JA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r23; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2002, AM J HUM GENET, V70, P83, DOI 10.1086/338458; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bhangale TR, 2005, HUM MOL GENET, V14, P59, DOI 10.1093/hmg/ddi006; Bhangale TR, 2006, NAT GENET, V38, P1457, DOI 10.1038/ng1925; Bourque G, 2004, GENOME RES, V14, P507, DOI 10.1101/gr.1975204; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Ciccarelli FD, 2005, GENOME RES, V15, P343, DOI 10.1101/gr.3266405; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Cooper GM, 2004, GENOME RES, V14, P539, DOI 10.1101/gr.2034704; Courseaux A, 2001, SCIENCE, V291, P1293, DOI 10.1126/science.1057284; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Deeb SS, 2006, CURR OPIN GENET DEV, V16, P301, DOI 10.1016/j.gde.2006.04.002; Derti A, 2006, NAT GENET, V38, P1216, DOI 10.1038/ng1888; Eichler EE, 1996, HUM MOL GENET, V5, P899, DOI 10.1093/hmg/5.7.899; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Feuk L, 2005, PLOS GENET, V1, P489, DOI 10.1371/journal.pgen.0010056; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Force A, 1999, GENETICS, V151, P1531; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Goidts V, 2005, GENOME RES, V15, P1232, DOI 10.1101/gr.3732505; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Le Marechal C, 2006, NAT GENET, V38, P1372, DOI 10.1038/ng1904; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Murphy William J., 2003, Human Genomics, V1, P30; Murphy WJ, 2005, SCIENCE, V309, P613, DOI 10.1126/science.1111387; Newman TL, 2005, GENOME RES, V15, P1344, DOI 10.1101/gr.4338005; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Nobrega MA, 2004, NATURE, V431, P988, DOI 10.1038/nature03022; Noonan JP, 2004, GENOME RES, V14, P354, DOI 10.1101/gr.2133704; Noonan JP, 2003, AM J HUM GENET, V72, P621, DOI 10.1086/368060; OHNO S, 1968, HEREDITAS-GENETISK A, V59, P169; Paulding CA, 2003, P NATL ACAD SCI USA, V100, P2507, DOI 10.1073/pnas.0437015100; Peng Q, 2006, PLOS COMPUT BIOL, V2, P100, DOI 10.1371/journal.pcbi.0020014; Pevzner P, 2003, P NATL ACAD SCI USA, V100, P7672, DOI 10.1073/pnas.1330369100; Popesco MC, 2006, SCIENCE, V313, P1304, DOI 10.1126/science.1127980; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; She XW, 2006, GENOME RES, V16, P576, DOI 10.1101/gr.4949406; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Small KS, 2007, P NATL ACAD SCI USA, V104, P5698, DOI 10.1073/pnas.0700890104; Spitz F, 2003, CELL, V113, P405, DOI 10.1016/S0092-8674(03)00310-6; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Trask BJ, 1998, HUM MOL GENET, V7, P13, DOI 10.1093/hmg/7.1.13; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yu FH, 2005, PHARMACOL REV, V57, P387, DOI 10.1124/pr.57.4.13; Zhang LQ, 2005, MOL BIOL EVOL, V22, P135, DOI 10.1093/molbev/msh262	75	189	199	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2007	39			7			S22	S29		10.1038/ng2054	http://dx.doi.org/10.1038/ng2054			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	274AO	17597777				2022-12-27	WOS:000253974400005
J	Beales, PL; Bland, E; Tobin, JL; Bacchelli, C; Tuysuz, B; Hill, J; Rix, S; Pearson, CG; Kai, M; Hartley, J; Johnson, C; Irving, M; Elcioglu, N; Winey, M; Tada, M; Scambler, PJ				Beales, Philip L.; Bland, Elizabeth; Tobin, Jonathan L.; Bacchelli, Chiara; Tuysuz, Beyhan; Hill, Josephine; Rix, Suzanne; Pearson, Chad G.; Kai, Masatake; Hartley, Jane; Johnson, Colin; Irving, Melita; Elcioglu, Nursel; Winey, Mark; Tada, Masazumi; Scambler, Peter J.			IFT80, which encodes a conserved intraflagellar transport protein, is mutated in Jeune asphyxiating thoracic dystrophy	NATURE GENETICS			English	Article							REPRESSOR FUNCTIONS; C-ELEGANS; GENES; CILIA; ACTIVATOR; GLI	Jeune asphyxiating thoracic dystrophy, an autosomal recessive chondrodysplasia, often leads to death in infancy because of a severely constricted thoracic cage and respiratory insufficiency; retinal degeneration, cystic renal disease and polydactyly may be complicating features. We show that IFT80 mutations underlie a subset of Jeune asphyxiating thoracic dystrophy cases, establishing the first association of a defective intraflagellar transport (IFT) protein with human disease. Knockdown of ift80 in zebrafish resulted in cystic kidneys, and knockdown in Tetrahymena thermophila produced shortened or absent cilia.	UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Univ Istanbul, Dept Pediat & Genet, Cerrahpasa Med Sch, TR-34452 Istanbul, Turkey; Univ Colorado, Boulder, CO 80309 USA; UCL, Dept Anat & Dev Biol, London WC1E 6BT, England; Univ Birmingham, Sch Med, Dept Paediat & Child Hlth, Sect Med & Mol Genet, Birmingham B15 2TG, W Midlands, England; St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds LS9 7TF, W Yorkshire, England; Marmara Univ Hosp, Dept Pediat Genet, Istanbul, Turkey	University of London; University College London; Istanbul University; Istanbul University - Cerrahpasa; University of Colorado System; University of Colorado Boulder; University of London; University College London; University of Birmingham; Saint James's University Hospital; University of Leeds; Marmara University	Scambler, PJ (corresponding author), UCL, Inst Child Hlth, Mol Med Unit, 30 Guilford St, London WC1N 1EH, England.	p.scambler@ich.ucl.ac.uk	Tüysüz, Beyhan/AAN-4858-2020; Beales, Philip L/C-7367-2009; Tada, Masazumi/A-1431-2009; Scambler, Peter/AAZ-6026-2020; Zebrafish, UCL/A-3125-2009; Scambler, Peter J/C-4998-2008	Scambler, Peter/0000-0002-1487-4628; Scambler, Peter J/0000-0002-1487-4628; Johnson, Colin/0000-0002-2979-8234; Tuysuz, Beyhan/0000-0002-9620-5021	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074746] Funding Source: NIH RePORTER; MRC [G0601347] Funding Source: UKRI; Medical Research Council [G0601347, G0801843] Funding Source: Medline; NIGMS NIH HHS [GM074746] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome Trust)		Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; Collins K, 2005, CURR BIOL, V15, pR317, DOI 10.1016/j.cub.2005.04.039; Efimenko E, 2005, DEVELOPMENT, V132, P1923, DOI 10.1242/dev.01775; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Kunitomo H, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r17; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Sun ZX, 2004, DEVELOPMENT, V131, P4085, DOI 10.1242/dev.01240; Wada N, 2005, DEVELOPMENT, V132, P3977, DOI 10.1242/dev.01943	14	225	235	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2007	39	6					727	729		10.1038/ng2038	http://dx.doi.org/10.1038/ng2038			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17468754				2022-12-27	WOS:000246859100015
J	Chen, TP; Hevi, S; Gay, F; Tsujimoto, N; He, T; Zhang, BL; Ueda, Y; Li, E				Chen, Taiping; Hevi, Sarah; Gay, Frederique; Tsujimoto, Naomi; He, Timothy; Zhang, Bailin; Ueda, Yoshihide; Li, En			Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; METHYLATION PATTERNS; MAMMALIAN-CELLS; CPG METHYLATION; DNA; P53; PHOSPHORYLATION; EXPRESSION; COOPERATE; DAMAGE	Studies have shown that DNA (cytosine-5-)-methyltransferase 1 (DNMT1) is the principal enzyme responsible for maintaining CpG methylation and is required for embryonic development and survival of somatic cells in mice(1-3). The role of DNMT1 in human cancer cells, however, remains highly controversial(4-7). Using homologous recombination, here we have generated a DNMT1 conditional allele in the human colorectal carcinoma cell line HCT116 in which several exons encoding the catalytic domain are flanked by loxP sites. Cre recombinase-mediated disruption of this allele results in hemimethylation of similar to 20% of CpG-CpG dyads in the genome, coupled with activation of the G2/M checkpoint, leading to arrest in the G2 phase of the cell cycle. Although cells gradually escape from this arrest, they show severe mitotic defects and undergo cell death either during mitosis or after arresting in a tetraploid G1 state. Our results thus show that DNMT1 is required for faithfully maintaining DNA methylation patterns in human cancer cells and is essential for their proliferation and survival.	Novartis Inst Biomed Res, Epigenet Program, Cambridge, MA 02139 USA; Novartis Inst Biomed Res, Cent Technol, Cambridge, MA 02139 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, Charlestown, MA 02129 USA	Novartis; Novartis; Harvard University; Massachusetts General Hospital	Li, E (corresponding author), Novartis Inst Biomed Res, Epigenet Program, 250 Massachusette Ave, Cambridge, MA 02139 USA.	en.li@novartis.com	Ueda, Yoshihide/S-7620-2016	Ueda, Yoshihide/0000-0003-3196-3494				Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200; CRAIN PF, 1990, METHOD ENZYMOL, V193, P782, DOI 10.1016/0076-6879(90)93450-Y; Egger G, 2006, P NATL ACAD SCI USA, V103, P14080, DOI 10.1073/pnas.0604602103; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Fenech M, 2002, DRUG DISCOV TODAY, V7, P1128, DOI 10.1016/S1359-6446(02)02502-3; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Laird CD, 2004, P NATL ACAD SCI USA, V101, P204, DOI 10.1073/pnas.2536758100; Lanni JS, 1998, MOL CELL BIOL, V18, P1055, DOI 10.1128/MCB.18.2.1055; Lei H, 1996, DEVELOPMENT, V122, P3195; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Minn AJ, 1996, GENE DEV, V10, P2621, DOI 10.1101/gad.10.20.2621; Rhee I, 2000, NATURE, V404, P1003, DOI 10.1038/35010000; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; Siliciano JD, 1997, GENE DEV, V11, P3471, DOI 10.1101/gad.11.24.3471; Ting AH, 2004, NAT GENET, V36, P582, DOI 10.1038/ng1365; Ueda Y, 2006, DEVELOPMENT, V133, P1183, DOI 10.1242/dev.02293	23	249	260	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2007	39	3					391	396		10.1038/ng1982	http://dx.doi.org/10.1038/ng1982			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17322882				2022-12-27	WOS:000244480000023
J	Tartaglia, M; Pennacchio, LA; Zhao, C; Yadav, KK; Fodale, V; Sarkozy, A; Pandit, B; Oishi, K; Martinelli, S; Schackwitz, W; Ustaszewska, A; Martin, J; Bristow, J; Carta, C; Lepri, F; Neri, C; Vasta, I; Gibson, K; Curry, CJ; Siguero, JPL; Digilio, MC; Zampino, G; Dallapiccola, B; Bar-Sagi, D; Gelb, BD				Tartaglia, Marco; Pennacchio, Len A.; Zhao, Chen; Yadav, Kamlesh K.; Fodale, Valentina; Sarkozy, Anna; Pandit, Bhaswati; Oishi, Kimihiko; Martinelli, Simone; Schackwitz, Wendy; Ustaszewska, Anna; Martin, Joel; Bristow, James; Carta, Claudio; Lepri, Francesca; Neri, Cinzia; Vasta, Isabella; Gibson, Kate; Curry, Cynthia J.; Lopez Siguero, Juan Pedro; Digilio, Maria Cristina; Zampino, Giuseppe; Dallapiccola, Bruno; Bar-Sagi, Dafna; Gelb, Bruce D.			Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome	NATURE GENETICS			English	Article							FACIO-CUTANEOUS SYNDROME; RAS ACTIVATOR SON; PTPN11 MUTATIONS; GERMLINE MUTATIONS; PHENOTYPE; SEVENLESS; GENE; KRAS; MUTANTS; PATHWAY	Noonan syndrome is a developmental disorder characterized by short stature, facial dysmorphia, congenital heart defects and skeletal anomalies(1). Increased RAS-mitogen-activated protein kinase (MAPK) signaling due to PTPN11 and KRAS mutations causes 50% of cases of Noonan syndrome(2-6). Here, we report that 22 of 129 individuals with Noonan syndrome without PTPN11 or KRAS mutation have missense mutations in SOS1, which encodes a RAS-specific guanine nucleotide exchange factor. SOS1 mutations cluster at codons encoding residues implicated in the maintenance of SOS1 in its autoinhibited form. In addition, ectopic expression of two Noonan syndrome-associated mutants induces enhanced RAS and ERK activation. The phenotype associated with SOS1 defects lies within the Noonan syndrome spectrum but is distinctive, with a high prevalence of ectodermal abnormalities but generally normal development and linear growth. Our findings implicate gain-of-function mutations in a RAS guanine nucleotide exchange factor in disease for the first time and define a new mechanism by which upregulation of the RAS pathway can profoundly change human development.	Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, I-00161 Rome, Italy; Lawrence Berkeley Lab, Div Genom, Berkeley, CA 94720 USA; US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; Ist Ricovero & Cura Carattere Sci, San Giovanni Rotondo & CSS Mendel Inst, I-00198 Rome, Italy; Univ Roma La Sapienza, Dept Expt Med & Pathol, I-00198 Rome, Italy; Mt Sinai Sch Med, Ctr Mol Cardiol, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA; Univ Cattolica Sacro Cuore, Ist Clin Pediat, I-00168 Rome, Italy; Royal Childrens Hosp, Herston, Qld 4029, Australia; Genet Med Cent Florida, Fresno, CA 93710 USA; Hosp Materno Infantil, Malaga 29011, Spain; Osped Bambino Gesu, I-00165 Rome, Italy	Istituto Superiore di Sanita (ISS); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; New York University; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Sapienza University Rome; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Royal Children's Hospital Brisbane; IRCCS Bambino Gesu	Tartaglia, M (corresponding author), Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, Viale Regina Elena 299, I-00161 Rome, Italy.	mtartaglia@iss.it; bruce.gelb@mssm.edu	Schackwitz, Wendy/GXH-9536-2022; Zampino, Giuseppe/AAC-2152-2019; Digilio, Maria Cristina/AAI-2434-2019; Carta, Claudio/A-7305-2013; Lepri, Francesca Romana/AAA-6115-2020; Martinelli, Simone/J-9432-2018; zhao, chen/C-7358-2011; Tartaglia, Marco/K-2955-2018; Dallapiccola, Bruno/K-8692-2016	Carta, Claudio/0000-0003-3545-198X; Martinelli, Simone/0000-0002-5843-419X; Tartaglia, Marco/0000-0001-7736-9672; Bar-Sagi, Dafna/0000-0003-2597-8948; Dallapiccola, Bruno/0000-0002-5031-1013; Martin, Joel/0000-0001-9511-6441; Oishi, Kimihiko/0000-0001-9446-8912; Schackwitz, Wendy/0000-0002-3013-9180; Lepri, Francesca Romana/0000-0001-5331-0473; Pennacchio, Len/0000-0002-8748-3732	NCI NIH HHS [CA28146, CA55360] Funding Source: Medline; NHLBI NIH HHS [HL074728, HL71207] Funding Source: Medline; NICHD NIH HHS [HD01294] Funding Source: Medline; Telethon [GGP04172] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD001294] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA028146, R56CA055360, R01CA055360, R37CA055360] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071207, P50HL074728] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Telethon(Fondazione Telethon); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; BOWTELL D, 1992, P NATL ACAD SCI USA, V89, P6511, DOI 10.1073/pnas.89.14.6511; Carta C, 2006, AM J HUM GENET, V79, P129, DOI 10.1086/504394; Collins JS, 2002, AM J HUM GENET, V71, P1251, DOI 10.1086/344344; Corbalan-Garcia S, 1998, MOL CELL BIOL, V18, P880, DOI 10.1128/MCB.18.2.880; Digilio MC, 2002, AM J HUM GENET, V71, P389, DOI 10.1086/341528; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Hart TC, 2002, AM J HUM GENET, V70, P943, DOI 10.1086/339689; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Legius E, 2002, J MED GENET, V39, P571, DOI 10.1136/jmg.39.8.571; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; NIMNUAL A, 2002, SCI STKE, pPE36, DOI DOI 10.1126/STKE.2002.145; Nimnual AS, 1998, SCIENCE, V279, P560, DOI 10.1126/science.279.5350.560; NOONAN JA, 1968, AM J DIS CHILD, V116, P373, DOI 10.1001/archpedi.1968.02100020377005; Qian XL, 2000, EMBO J, V19, P642, DOI 10.1093/emboj/19.4.642; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; SHARLAND M, 1992, ARCH DIS CHILD, V67, P178, DOI 10.1136/adc.67.2.178; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; Sondermann H, 2005, P NATL ACAD SCI USA, V102, P16632, DOI 10.1073/pnas.0508315102; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Wang DZM, 1997, GENE DEV, V11, P309, DOI 10.1101/gad.11.3.309; YANG SS, 1995, J BIOL CHEM, V270, P18212, DOI 10.1074/jbc.270.31.18212	28	415	439	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2007	39	1					75	79		10.1038/ng1939	http://dx.doi.org/10.1038/ng1939			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	17143282	Green Submitted			2022-12-27	WOS:000243136500020
J	Stransky, N; Vallot, C; Reyal, F; Bernard-Pierrot, I; de Medina, SGD; Segraves, R; de Rycke, Y; Elvin, P; Cassidy, A; Spraggon, C; Graham, A; Southgate, J; Asselain, B; Allory, Y; Abbou, CC; Albertson, DG; Thiery, JP; Chopin, DK; Pinkel, D; Radvanyi, F				Stransky, Nicolas; Vallot, Celine; Reyal, Fabien; Bernard-Pierrot, Isabelle; de Medina, Sixtina Gil Diez; Segraves, Rick; de Rycke, Yann; Elvin, Paul; Cassidy, Andrew; Spraggon, Carolyn; Graham, Alexander; Southgate, Jennifer; Asselain, Bernard; Allory, Yves; Abbou, Claude C.; Albertson, Donna G.; Thiery, Jean Paul; Chopin, Dominique K.; Pinkel, Daniel; Radvanyi, Francois			Regional copy number-independent deregulation of transcription in cancer	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; GENE-EXPRESSION; CHROMOSOMAL REGIONS; DNA; METHYLATION; INDUCTION; CHROMATIN; PATTERNS; REVEALS; DOMAINS	Genetic and epigenetic alterations have been identified that lead to transcriptional deregulation in cancers. Genetic mechanisms may affect single genes or regions containing several neighboring genes, as has been shown for DNA copy number changes. It was recently reported that epigenetic suppression of gene expression can also extend to a whole region; this is known as long-range epigenetic silencing. Various techniques are available for identifying regional genetic alterations, but no large-scale analysis has yet been carried out to obtain an overview of regional epigenetic alterations. We carried out an exhaustive search for regions susceptible to such mechanisms using a combination of transcriptome correlation map analysis and array CGH data for a series of bladder carcinomas. We validated one candidate region experimentally, demonstrating histone methylation leading to the loss of expression of neighboring genes without DNA methylation.	Inst Curie, CNRS, UMR 144, F-75248 Paris 05, France; Hop Henri Mondor, INSERM, EMI 0337, F-94010 Creteil, France; Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; Inst Curie, Dept Biostat, F-75248 Paris 05, France; AstraZeneca, Canc & Infect Res Area, Macclesfield SK10 4TG, Cheshire, England; Univ York, Dept Biol, Jack Birch Unit Mol Carcinogenesis, York YO10 5DD, N Yorkshire, England; Hop Henri Mondor, Dept Pathol, F-94010 Creteil, France; Hop Henri Mondor, Dept Urol, F-94010 Creteil, France; Univ Calif San Francisco, Inst Canc Res, San Francisco, CA 94143 USA; Inst Curie, Dept Translat Res, F-75248 Paris, France; Inst Mol & Cell Biol, Singapore 138673, Singapore	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; AstraZeneca; University of York - UK; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; University of California System; University of California San Francisco; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Radvanyi, F (corresponding author), Inst Curie, CNRS, UMR 144, F-75248 Paris 05, France.	Francois.Radvanyi@curie.fr	Southgate, Jennifer/AAJ-9089-2021; Thiery, Jean Paul/M-9387-2019; Thiery, Jean Paul/H-1550-2011	Southgate, Jennifer/0000-0002-0135-480X; Thiery, Jean Paul/0000-0003-0478-5020; Radvanyi, Francois/0000-0002-5696-6424				Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Cohen BA, 2000, NAT GENET, V26, P183, DOI 10.1038/79896; COOMBS LM, 1990, ANAL BIOCHEM, V188, P338, DOI 10.1016/0003-2697(90)90617-I; Crawley JJ, 2002, GENOME BIOL, V3; Daigo Y, 1999, CANCER RES, V59, P1966; deMedina SGD, 1997, ONCOGENE, V14, P323, DOI 10.1038/sj.onc.1200830; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; Fujii T, 2002, CANCER RES, V62, P3340; Furge KA, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-67; Gialitakis M, 2006, NUCLEIC ACIDS RES, V34, P765, DOI 10.1093/nar/gkj462; Heidenblad M, 2005, ONCOGENE, V24, P1794, DOI 10.1038/sj.onc.1208383; Huebert DJ, 2005, CURR OPIN GENET DEV, V15, P476, DOI 10.1016/j.gde.2005.08.001; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Hyman E, 2002, CANCER RES, V62, P6240; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; Kano M, 2003, PHYSIOL GENOMICS, V13, P31, DOI 10.1152/physiolgenomics.00116.2002; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Masayesva BG, 2004, P NATL ACAD SCI USA, V101, P8715, DOI 10.1073/pnas.0400027101; Midorikawa Y, 2004, CANCER RES, V64, P7263, DOI 10.1158/0008-5472.CAN-04-1275; Nakamura Y, 2003, EMBO J, V22, P2981, DOI 10.1093/emboj/cdg302; Neuvial P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-264; Nguyen CT, 2002, CANCER RES, V62, P6456; O'Neill LP, 2003, METHODS, V31, P76, DOI 10.1016/S1046-2023(03)00090-2; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; R Development Core Team, 2006, R LANG ENV STAT COMP; Reyal F, 2005, CANCER RES, V65, P1376, DOI 10.1158/0008-5472.CAN-04-2706; Snijders AM, 2003, ONCOGENE, V22, P4281, DOI 10.1038/sj.onc.1206621; SolinasToldo S, 1997, GENE CHROMOSOME CANC, V20, P399, DOI 10.1002/(SICI)1098-2264(199712)20:4<399::AID-GCC12>3.0.CO;2-I; SOUTHGATE J, 1994, LAB INVEST, V71, P583; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; Turner BM, 2002, CELL, V111, P285, DOI 10.1016/S0092-8674(02)01080-2; van Driel R, 2003, J CELL SCI, V116, P4067, DOI 10.1242/jcs.00779; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yang XMJ, 2005, CANCER RES, V65, P5628, DOI 10.1158/0008-5472.CAN-05-0533; Yi YJ, 2005, GENOMICS, V85, P401, DOI 10.1016/j.ygeno.2004.11.011; Zardo G, 2002, NAT GENET, V32, P453, DOI 10.1038/ng1007; Zhou Y, 2003, CANCER RES, V63, P5781	45	167	170	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2006	38	12					1386	1396		10.1038/ng1923	http://dx.doi.org/10.1038/ng1923			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110TR	17099711				2022-12-27	WOS:000242404200015
J	Wang, YF; Broderick, P; Webb, E; Wu, XF; Vijayakrishnan, J; Matakidou, A; Qureshi, M; Dong, Q; Gu, XJ; Chen, WV; Spitz, MR; Eisen, T; Amos, CI; Houlston, RS				Wang, Yufei; Broderick, Peter; Webb, Emily; Wu, Xifeng; Vijayakrishnan, Jayaram; Matakidou, Athena; Qureshi, Mobshra; Dong, Qiong; Gu, Xiangjun; Chen, Wei Vivien; Spitz, Margaret R.; Eisen, Timothy; Amos, Christopher I.; Houlston, Richard S.			Common 5p15.33 and 6p21.33 variants influence lung cancer risk	NATURE GENETICS			English	Article							MICROSATELLITE INSTABILITY; SUSCEPTIBILITY LOCUS	We conducted a genome-wide association (GWA) study of lung cancer comparing 511,919 SNP genotypes in 1,952 cases and 1,438 controls. The most significant association was attained at 15q25.1 (rs8042374; P = 7.75 x 10(-12)), confirming recent observations. Pooling data with two other GWA studies (5,095 cases, 5,200 controls) and with replication in an additional 2,484 cases and 3,036 controls, we identified two newly associated risk loci mapping to 6p21.33 (rs3117582, BAT3-MSH5; P-combined 4.97 x 10(-10)) and 5p15.33 (rs401681, CLPTM1L; P-combined 7.90 x 10(-9)).	[Wang, Yufei; Broderick, Peter; Webb, Emily; Vijayakrishnan, Jayaram; Matakidou, Athena; Qureshi, Mobshra; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; [Wu, Xifeng; Dong, Qiong; Gu, Xiangjun; Chen, Wei Vivien; Spitz, Margaret R.; Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Eisen, Timothy] Univ Cambridge, Dept Oncol, Cambridge CB2 2RE, England	University of London; Institute of Cancer Research - UK; University of Texas System; UTMD Anderson Cancer Center; University of Cambridge	Houlston, RS (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England.	richard.houlston@icr.ac.uk	Wang, Weili/D-1546-2011	Houlston, Richard/0000-0002-5268-0242; Vijayakrishnan, Jayaram/0000-0002-8284-2249; Broderick, Peter/0000-0002-8348-5829; Webb, Emily/0000-0002-4019-7456	Cancer Research UK [A1298/A8780]; HEAL; Sanofi-Aventis; US NIH [P50CA70907, R01CA121197, R01CA133996]; Medical Research Council [G0000934] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA133996, P50CA070907, R01CA121197] Funding Source: NIH RePORTER; MRC [G0000934] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); HEAL; Sanofi-Aventis(Sanofi-Aventis); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Cancer Research UK (A1298/A8780) provided principal funding for this study. Additional funding was provided by HEAL and Sanofi-Aventis and US NIH Grants P50CA70907, R01CA121197 and R01CA133996. We would like to thank all individuals who participated in this study. We are grateful to colleagues at UK Clinical Genetics Centres and the UK National Cancer Research Network.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Hirose T, 2002, MOL CARCINOGEN, V33, P172, DOI 10.1002/mc.10035; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Kang JU, 2008, CANCER GENET CYTOGEN, V182, P1, DOI 10.1016/j.cancergencyto.2007.12.004; Li XJ, 2004, INT J CANCER, V112, P451, DOI 10.1002/ijc.20436; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Wang YC, 2006, ANN NY ACAD SCI, V1075, P179, DOI 10.1196/annals.1368.024; Xu LH, 2001, INT J CANCER, V91, P200, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1031>3.0.CO;2-0; Yamamoto K, 2001, BIOCHEM BIOPH RES CO, V280, P1148, DOI 10.1006/bbrc.2001.4250	11	450	459	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1407	1409		10.1038/ng.273	http://dx.doi.org/10.1038/ng.273			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	18978787	Green Accepted			2022-12-27	WOS:000261215900015
J	Jaks, V; Barker, N; Kasper, M; Van Es, JH; Snippert, HJ; Clevers, H; Toftgard, R				Jaks, Viljar; Barker, Nick; Kasper, Maria; Van Es, Johan H.; Snippert, Hugo J.; Clevers, Hans; Toftgard, Rune			Lgr5 marks cycling, yet long-lived, hair follicle stem cells	NATURE GENETICS			English	Article							LABEL-RETAINING CELLS; SONIC-HEDGEHOG; POPULATION; KERATINOCYTES; BULGE; IDENTIFICATION; PROLIFERATION; DISTINCT; RENEWAL; NICHE	In mouse hair follicles, a group of quiescent cells in the bulge is believed to have stem cell activity. Lgr5, a marker of intestinal stem cells, is expressed in actively cycling cells in the bulge and secondary germ of telogen hair follicles and in the lower outer root sheath of anagen hair follicles. Here we show that Lgr5(+) cells comprise an actively proliferating and multipotent stem cell population able to give rise to new hair follicles and maintain all cell lineages of the hair follicle over long periods of time. Lgr5(+) progeny repopulate other stem cell compartments in the hair follicle, supporting the existence of a stem or progenitor cell hierarchy. By marking Lgr5(+) cells during trafficking through the lower outer root sheath, we show that these cells retain stem cell properties and contribute to hair follicle growth during the next anagen. Expression analysis suggests involvement of autocrine Hedgehog signaling in maintaining the Lgr5(+) stem cell population.	[Jaks, Viljar; Kasper, Maria; Toftgard, Rune] Novum, Karolinska Inst, Dept Biosci & Nutr, SE-14157 Huddinge, Sweden; [Jaks, Viljar] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Jaks, Viljar] Estonian Bioctr, EE-51010 Tartu, Estonia; [Barker, Nick; Van Es, Johan H.; Snippert, Hugo J.; Clevers, Hans] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands	Karolinska Institutet; University of Tartu; Estonian Biocentre; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Clevers, H (corresponding author), Novum, Karolinska Inst, Dept Biosci & Nutr, SE-14157 Huddinge, Sweden.	h.clevers@niob.knaw.nl; rune.toftgard@ki.se	Barker, Nick/AAS-2774-2020; van+Es, Johan/ABD-5411-2021; Barker, Nick/AAE-9833-2021; Jaks, Viljar/H-2467-2012; Kasper, Maria/Q-6318-2016; Barker, Nick/A-5535-2011	Barker, Nick/0000-0003-3566-4475; Jaks, Viljar/0000-0002-2221-6262; Kasper, Maria/0000-0002-6117-2717	Swedish Cancer Society; Swedish Research Council; National Institutes of Health [AR47898, U01CA105491]; Genmab BV; Koninklijke Nederlandse Akademie van Wetenschappen; Koningin Wilhelmina Fonds; Louis Jeantet Foundation; International Agency for Research on Cancer Research Training Fellowship; Marie-Curie Intra-European Fellowship; Wenner-Gren Foundation; NATIONAL CANCER INSTITUTE [U01CA105491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR047898] Funding Source: NIH RePORTER	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genmab BV(Genmab); Koninklijke Nederlandse Akademie van Wetenschappen; Koningin Wilhelmina Fonds; Louis Jeantet Foundation; International Agency for Research on Cancer Research Training Fellowship; Marie-Curie Intra-European Fellowship(European Commission); Wenner-Gren Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank D. Roop and W. Buitrago for help with setting up the keratinocyte transplantation assay; A.-L. Dackland for help with cell sorting; A. Bergstrom and I. Sur for contributions during work with animals and preparation of samples; and M. van den Born, M. Cozijnsen and H. Begthel for help with histological procedures. This work was supported by the Swedish Cancer Society (to R. T.), the Swedish Research Council (to R. T.), the National Institutes of Health (AR47898 and U01CA105491 to R. T.), Genmab BV (to H. C.), Koninklijke Nederlandse Akademie van Wetenschappen (to H. C.), Koningin Wilhelmina Fonds (to H. C.), the Louis Jeantet Foundation (to H. C.), an International Agency for Research on Cancer Research Training Fellowship (to V. J.), a Marie-Curie Intra-European Fellowship (to V. J.) and a fellowship from the Wenner-Gren Foundation (M. K.).	Albert MR, 2001, J INVEST DERMATOL, V117, P943, DOI 10.1046/j.0022-202x.2001.01517.x; Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; CHASE HB, 1951, PHYSIOL ZOOL, V24, P1; Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Depreter MGL, 2008, P NATL ACAD SCI USA, V105, P961, DOI 10.1073/pnas.0711170105; DRY FW, 1925, J GENET, V16, P278; FIERING SN, 1991, CYTOMETRY, V12, P291, DOI 10.1002/cyto.990120402; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Hsu SY, 1998, MOL ENDOCRINOL, V12, P1830, DOI 10.1210/me.12.12.1830; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; Jensen UB, 2008, J CELL SCI, V121, P609, DOI 10.1242/jcs.025502; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Kopan R, 2002, DEV BIOL, V242, P44, DOI 10.1006/dbio.2001.0516; Lee J, 1997, DEVELOPMENT, V124, P2537; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nijhof JGW, 2006, DEVELOPMENT, V133, P3027, DOI 10.1242/dev.02443; Nilsson M, 2000, P NATL ACAD SCI USA, V97, P3438, DOI 10.1073/pnas.050467397; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; St-Jacques B, 1998, CURR BIOL, V8, P1058, DOI 10.1016/S0960-9822(98)70443-9; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Trempus CS, 2007, J INVEST DERMATOL, V127, P2904, DOI 10.1038/sj.jid.5700917; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Triel C, 2004, EXP CELL RES, V295, P79, DOI 10.1016/j.yexcr.2003.11.032; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72; Wu WY, 2004, METH MOL B, V289, P79; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	35	704	739	2	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2008	40	11					1291	1299		10.1038/ng.239	http://dx.doi.org/10.1038/ng.239			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18849992				2022-12-27	WOS:000260501500020
J	Hashibe, M; Mckay, JD; Curado, MP; Oliveira, JC; Koifman, S; Koifman, R; Zaridze, D; Shangina, O; Wunsch, V; Eluf, J; Levi, JE; Matos, E; Lagiou, P; Lagiou, A; Benhamou, S; Bouchardy, C; Szeszenia-Dabrowska, N; Menezes, A; Dall'Agnol, MM; Merletti, F; Richiardi, L; Fernandez, L; Lence, J; Talamini, R; Barzan, L; Mates, D; Mates, IN; Kjaerheim, K; Macfarlane, GJ; Macfarlane, TV; Simonato, L; Canova, C; Holcatova, I; Agudo, A; Castellsague, X; Lowry, R; Janout, V; Kollarova, H; Conway, DI; McKinney, PA; Znaor, A; Fabianova, E; Bencko, V; Lissowska, J; Chabrier, A; Hung, RJ; Gaborieau, V; Boffetta, P; Brennan, P				Hashibe, Mia; Mckay, James D.; Curado, Maria Paula; Oliveira, Jose Carlos; Koifman, Sergio; Koifman, Rosalina; Zaridze, David; Shangina, Oxana; Wuensch-Filho, Victor; Eluf-Neto, Jose; Levi, Jose Eduardo; Matos, Elena; Lagiou, Pagona; Lagiou, Areti; Benhamou, Simone; Bouchardy, Christine; Szeszenia-Dabrowska, Neonilia; Menezes, Ana; Dall'Agnol, Marinel Mor; Merletti, Franco; Richiardi, Lorenzo; Fernandez, Leticia; Lence, Juan; Talamini, Renato; Barzan, Luigi; Mates, Dana; Mates, Ioan Nicolae; Kjaerheim, Kristina; Macfarlane, Gary J.; Macfarlane, Tatiana V.; Simonato, Lorenzo; Canova, Cristina; Holcatova, Ivana; Agudo, Antonio; Castellsague, Xavier; Lowry, Ray; Janout, Vladimir; Kollarova, Helena; Conway, David I.; McKinney, Patricia A.; Znaor, Ariana; Fabianova, Eleonora; Bencko, Vladimir; Lissowska, Jolanta; Chabrier, Amelie; Hung, Rayjean J.; Gaborieau, Valerie; Boffetta, Paolo; Brennan, Paul			Multiple ADH genes are associated with upper aerodigestive cancers	NATURE GENETICS			English	Article							ALCOHOL-DEHYDROGENASE	Alcohol is an important risk factor for upper aerodigestive cancers and is principally metabolized by alcohol dehydrogenase (ADH) enzymes. We have investigated six ADH genetic variants in over 3,800 aerodigestive cancer cases and 5,200 controls from three individual studies. Gene variants rs1229984 (ADH1B) and rs1573496 (ADH7) were significantly protective against aerodigestive cancer in each individual study and overall (P = 10(-10) and 10(-9), respectively). These effects became more apparent with increasing alcohol consumption (P for trend = 0.0002 and 0.065, respectively). Both gene effects were independent of each other, implying that multiple ADH genes may be involved in upper aerodigestive cancer etiology.	[Hashibe, Mia; Mckay, James D.; Curado, Maria Paula; Chabrier, Amelie; Hung, Rayjean J.; Gaborieau, Valerie; Boffetta, Paolo; Brennan, Paul] Int Agcy Res Canc, F-69372 Lyon, France; [Curado, Maria Paula; Oliveira, Jose Carlos] Hosp Araujo Jorge, Goiania, Go, Brazil; [Curado, Maria Paula; Oliveira, Jose Carlos] Populat Canc Register Goiania, Goiania, Go, Brazil; [Koifman, Sergio; Koifman, Rosalina] Escola Nacl Suade Publ, Rio De Janeiro, Brazil; [Zaridze, David; Shangina, Oxana] Russian Acad Med Sci, Canc Res Ctr, Moscow, Russia; [Wuensch-Filho, Victor; Eluf-Neto, Jose; Levi, Jose Eduardo] Univ Sao Paulo, Sao Paulo, Brazil; [Matos, Elena] Univ Buenos Aires, Inst Oncol Angel H Roffo, RA-1053 Buenos Aires, DF, Argentina; [Lagiou, Areti; Benhamou, Simone] Univ Athens, Sch Med, GR-11527 Athens, Greece; [Benhamou, Simone] Inst Natl Sante & Rech Med, U794, Evry, France; [Bouchardy, Christine] Geneva Canc Registry, Geneva, Switzerland; [Szeszenia-Dabrowska, Neonilia] Inst Occupat Med, Lodz, Poland; [Menezes, Ana; Dall'Agnol, Marinel Mor] Univ Fed Pelotas, Pelotas, Brazil; [Merletti, Franco; Richiardi, Lorenzo] CeRMS, Canc Epidemiol Unit, Turin, Italy; [Merletti, Franco; Richiardi, Lorenzo] Univ Turin, Turin, Italy; [Fernandez, Leticia; Lence, Juan] Inst Oncol & Radiobiol, Havana, Cuba; [Talamini, Renato] Aviano Canc Ctr, I-33081 Aviano, Italy; [Barzan, Luigi] Gen Hosp, Pordenone, Italy; [Mates, Dana] Inst Publ Hlth, Bucharest, Romania; [Mates, Ioan Nicolae] Univ Med & Pharm Carol Davila, Bucharest, Romania; [Kjaerheim, Kristina] Canc Registry Norway, Oslo, Norway; [Macfarlane, Gary J.; Macfarlane, Tatiana V.] Univ Aberdeen, Sch Med, Aberdeen AB9 2ZD, Scotland; [Simonato, Lorenzo; Canova, Cristina] Univ Padua, Padua, Italy; [Holcatova, Ivana; Bencko, Vladimir] Inst Hyg & Epidemiol, CR-10042 Prague, Czech Republic; [Agudo, Antonio; Castellsague, Xavier] Inst Catala Oncol, Barcelona, Spain; [Lowry, Ray] Univ Newcastle, Sch Dent, Newcastle Upon Tyne, Tyne & Wear, England; [Janout, Vladimir; Kollarova, Helena] Palacky Univ, CR-77147 Olomouc, Czech Republic; [Conway, David I.] Univ Glasgow, Sch Dent, Glasgow, Lanark, Scotland; [McKinney, Patricia A.] Univ Leeds, Ctr Biostat & Epidemiol, Leeds, W Yorkshire, England; [McKinney, Patricia A.] NHS Natl Serv Scotland, Informat Serv Div, Edinburgh, Midlothian, Scotland; [Znaor, Ariana] Croatian Natl Canc Registry, Zagreb, Croatia; [Fabianova, Eleonora] Specialized State Hlth Inst, Banska Bystrica, Slovakia; [Lissowska, Jolanta] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland; [Lissowska, Jolanta] Inst Oncol, Warsaw, Poland; [Hung, Rayjean J.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA	World Health Organization; International Agency for Research on Cancer (IARC); Russian Academy of Medical Sciences; Universidade de Sao Paulo; University of Buenos Aires; Athens Medical School; National & Kapodistrian University of Athens; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Geneva; Nofer Institute of Occupational Medicine; Universidade Federal de Pelotas; University of Turin; Carol Davila University of Medicine & Pharmacy; University of Oslo; University of Aberdeen; University of Padua; Catalan Institute of Oncology; Newcastle University - UK; Palacky University Olomouc; University of Glasgow; University of Leeds; NHS National Services Scotland; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; University of California System; University of California Berkeley	Brennan, P (corresponding author), Int Agcy Res Canc, 150 Cours Albert Thomas, F-69372 Lyon, France.	Brennan@iarc.fr	Boffetta, Paolo/AAI-7767-2021; Filho, Victor Wunsch/C-4475-2012; Holcatova, Ivana/C-8327-2017; Szeszenia-Dabrowska, Neonila/F-7190-2010; Menezes, Ana MB/G-7266-2012; Benhamou, Simone/K-6554-2015; Agudo, Antonio/J-1805-2016; Bencko, Vladimir/H-8598-2017; Lissowska, Jolanta/AAH-3252-2020; Pique, Xavier Castellsagué/N-5795-2014; Benhamou, Simone/ABD-2590-2020; Mates, Ioan Nicolae/E-9255-2017; Eluf-Neto, Jose/B-2522-2009; Zaridze, David/K-5605-2013; Macfarlane, Gary J/I-9521-2014; Curado, Maria Paula/M-6200-2013; Hung, Rayjean J/A-7439-2013; Janout, Vladimir/M-5133-2014; Znaor, A/H-6718-2019; richiardi, lorenzo/J-3480-2018	Boffetta, Paolo/0000-0002-3811-2791; Holcatova, Ivana/0000-0002-1366-0337; Menezes, Ana MB/0000-0002-2996-9427; Agudo, Antonio/0000-0001-9900-5677; Bencko, Vladimir/0000-0003-1935-2228; Lissowska, Jolanta/0000-0003-2695-5799; Pique, Xavier Castellsagué/0000-0002-0802-3595; Eluf-Neto, Jose/0000-0001-7504-2115; Macfarlane, Gary J/0000-0003-2322-3314; Curado, Maria Paula/0000-0001-8172-2483; Kollarova, Helena/0000-0001-6951-6716; Macfarlane, Tatiana/0000-0002-9392-0812; Hung, Rayjean/0000-0002-4486-7496; Kjaerheim, Kristina/0000-0003-0691-3735; richiardi, lorenzo/0000-0003-0316-9402; mates, dana/0000-0002-6219-9807; SIMONATO, LORENZO/0000-0002-9914-1000; Conway, David/0000-0001-7762-4063; BENHAMOU, Simone/0000-0001-5853-8047; CANOVA, CRISTINA/0000-0001-7027-7935; Ioan Nicoale, Mates/0000-0001-7210-0615	NATIONAL CANCER INSTITUTE [R01CA092039] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA 092039-01A2] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Birley AJ, 2008, HUM MOL GENET, V17, P179, DOI 10.1093/hmg/ddm295; Brennan P, 2004, AM J EPIDEMIOL, V159, P1, DOI 10.1093/aje/kwh003; CARR LG, 1989, ALCOHOL CLIN EXP RES, V13, P594, DOI 10.1111/j.1530-0277.1989.tb00383.x; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hashibe M, 2006, CANCER EPIDEM BIOMAR, V15, P696, DOI 10.1158/1055-9965.EPI-05-0710; HOOG JO, 1986, EUR J BIOCHEM, V159, P215, DOI 10.1111/j.1432-1033.1986.tb09855.x; Smigielski EM, 2000, NUCLEIC ACIDS RES, V28, P352, DOI 10.1093/nar/28.1.352; SMITH M, 1986, ADV HUM GENET, V15, P249	8	137	140	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2008	40	6					707	709		10.1038/ng.151	http://dx.doi.org/10.1038/ng.151			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18500343	Green Published			2022-12-27	WOS:000256212000009
J	Norman, PJ; Abi-Rached, L; Gendzekhadze, K; Korbel, D; Gleimer, M; Rowley, D; Bruno, D; Carrington, CVF; Chandanayingyong, D; Chang, YH; Crespi, C; Saruhan-Direskeneli, G; Fraser, PA; Hameed, K; Kamkamidze, G; Koram, KA; Layrisse, Z; Matamoros, N; Mila, J; Park, MH; Pitchappan, RM; Ramdath, DD; Shiau, MY; Stephens, HAF; Struik, S; Verity, DH; Vaughan, RW; Tyan, D; Davis, RW; Riley, EM; Ronaghi, M; Parham, P				Norman, Paul J.; Abi-Rached, Laurent; Gendzekhadze, Ketevan; Korbel, Daniel; Gleimer, Michael; Rowley, Don; Bruno, Dan; Carrington, Christine V. F.; Chandanayingyong, Dasdayanee; Chang, Yih-Hsin; Crespi, Catalina; Saruhan-Direskeneli, Gueher; Fraser, Patricia A.; Hameed, Kamran; Kamkamidze, Giorgi; Koram, Kwadwo A.; Layrisse, Zulay; Matamoros, Nuria; Mila, Joan; Park, Myoung Hee; Pitchappan, Ramasamy M.; Ramdath, D. Dan; Shiau, Ming-Yuh; Stephens, Henry A. F.; Struik, Siske; Verity, David H.; Vaughan, Robert W.; Tyan, Dolly; Davis, Ronald W.; Riley, Eleanor M.; Ronaghi, Mostafa; Parham, Peter			Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans	NATURE GENETICS			English	Article							IMMUNOGLOBULIN-LIKE RECEPTOR; CRYSTAL-STRUCTURE; HLA-B; CUTTING EDGE; GENES; KIR3DS1; HISTORY; COMPLEX; MODEL; POLYMORPHISMS	Interactions of killer cell immunoglobulin- like receptors ( KIRs) with major histocompatibility complex ( MHC) class I ligands diversify natural killer cell responses to infection. By analyzing sequence variation in diverse human populations, we show that the KIR3DL1/ S1 locus encodes two lineages of polymorphic inhibitory KIR3DL1 allotypes that recognize Bw4 epitopes of HLA- A and HLA- B and one lineage of conserved activating KIR3DS1 allotypes, also implicated in Bw4 recognition. Balancing selection has maintained these three lineages for over 3 million years. Variation was selected at D1 and D2 domain residues that contact HLA class I and at two sites on D0, the domain that enhances the binding of KIR3D to HLA class I. HLA- B variants that gained Bw4 through interallelic microconversion are also products of selection. A worldwide comparison uncovers unusual KIR3DL1/ S1 evolution in modern sub- Saharan Africans. Balancing selection is weak and confined to D0, KIR3DS1 is rare and KIR3DL1 allotypes with similar binding sites predominate. Natural killer cells express the dominant KIR3DL1 at a high frequency and with high surface density, providing strong responses to cells perturbed in Bw4 expression.	Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England; Stanford Univ, Sch Med, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; Univ W Indies, Fac Med Sci, Dept Preclin Sci, St Augustine, Trinidad Tobago; Mahidol Univ, Fac Med, Dept Transfus Med, Bangkok 10700, Thailand; Mahidol Univ, Siriraj Hosp, Bangkok 10700, Thailand; Chung Shan Med Univ, Sch Med Lab & Biotechnol, Taichung 402, Taiwan; Hosp Univ Son Dureta, Serv Immunol, Palma de Mallorca 07014, Spain; Istanbul Univ, Dept Physiol, Fac Med, Istanbul, Turkey; CBR, Biomed Res Inst, Boston, MA 02115 USA; Aga Khan Univ Hosp, Dept Med, Karachi, Pakistan; REA Ctr, Dept Clin Immunol, GE-0160 Tbilisi, Georgia; Univ Ghana, Noguchi Mem Inst Med Res, Legon, Ghana; IVIC, Ctr Expt Med Miguel Layrisse, Caracas 21827, Venezuela; Seoul Natl Univ, Coll Med, Dept Lab Med, Seoul 110744, South Korea; Madurai Kamaraj Univ, Sch Biol Sci, Ctr Adv Studies Funct Genom, Madurai 625021, Tamil Nadu, India; Hungkuang Univ, Inst Technol, Taichung 433, Taiwan; Royal Free & Unic Coll Med Sch, Ctr Nephrol & Anthony Nolan Trust, London NW3 2QG, England; Moorfields Eye Hosp, London EC1V 2PD, England; Guys & St Thomas Fdn Trust, Clin Transplantat Lab, London SE1 9RT, England; Kings Coll London, London SE1 9RT, England; Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University; University of London; London School of Hygiene & Tropical Medicine; Stanford University; University West Indies Mona Jamaica; University West Indies Saint Augustine; Mahidol University; Mahidol University; Chung Shan Medical University; Hospital Universitari Son Espases; Hospital Universitari Son Dureta; Istanbul University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Aga Khan University; University of Ghana; Venezuelan Institute Science Research; Seoul National University (SNU); Madurai Kamaraj University; Fooyin University; Hungkuang University; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; King's College London; Stanford University	Norman, PJ (corresponding author), Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.	paul.norman@stanford.edu; peropa@stanford.edu	Abi-Rached, Laurent/H-7236-2012; Riley, Eleanor/AAL-1382-2020; Riley, Eleanor M/C-8960-2013; Crespí, Catalina/A-5543-2013; Park, Myoung Hee/J-5483-2012	Riley, Eleanor/0000-0003-3447-3570; Riley, Eleanor M/0000-0003-3447-3570; Crespí, Catalina/0000-0003-0781-9708; Korbel, Daniel/0000-0002-4682-9928; Carrington, Christine/0000-0001-6533-9302; Verity, David/0000-0001-6982-6896; Norman, Paul/0000-0001-8370-7703	NIAID NIH HHS [AI64520, AI24258, AI17892] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI024258, R01AI017892, R55AI024258, P01AI064520, R37AI017892] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abi-Rached L, 2005, J EXP MED, V201, P1319, DOI 10.1084/jem.20042558; Adams EJ, 2001, IMMUNOL REV, V183, P41, DOI 10.1034/j.1600-065x.2001.1830104.x; Akey JM, 2004, PLOS BIOL, V2, P1591, DOI 10.1371/journal.pbio.0020286; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Bubb KL, 2006, GENETICS, V173, P2165, DOI 10.1534/genetics.106.055715; CANN RL, 1987, NATURE, V325, P31, DOI 10.1038/325031a0; Carr WH, 2005, J IMMUNOL, V175, P5222, DOI 10.4049/jimmunol.175.8.5222; Carr WH, 2007, J IMMUNOL, V178, P647, DOI 10.4049/jimmunol.178.2.647; CELLA M, 1994, J EXP MED, V180, P1235, DOI 10.1084/jem.180.4.1235; Chivian D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl480; Fakhrai-Rad H, 2002, HUM MUTAT, V19, P479, DOI 10.1002/humu.10078; Fan QR, 2001, NAT IMMUNOL, V2, P452, DOI 10.1038/87766; Gardiner CM, 2001, J IMMUNOL, V166, P2992, DOI 10.4049/jimmunol.166.5.2992; GUMPERZ JE, 1995, J EXP MED, V181, P1133, DOI 10.1084/jem.181.3.1133; HELD W, 1995, NATURE, V376, P355, DOI 10.1038/376355a0; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kelley J, 2005, PLOS GENET, V1, P129, DOI 10.1371/journal.pgen.0010027; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Khakoo SI, 2002, J EXP MED, V196, P911, DOI 10.1084/jem.20020304; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Luque I, 1996, EUR J IMMUNOL, V26, P1974, DOI 10.1002/eji.1830260845; Maenaka K, 1999, STRUCTURE, V7, P391, DOI 10.1016/S0969-2126(99)80052-5; Marsh SGE, 2003, IMMUNOGENETICS, V55, P220, DOI 10.1007/s00251-003-0571-z; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Moretta L, 2006, SEMIN IMMUNOL, V18, P151, DOI 10.1016/j.smim.2006.03.002; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Peng B, 2005, BIOINFORMATICS, V21, P3686, DOI 10.1093/bioinformatics/bti584; Rajagopalan S, 2005, J EXP MED, V201, P1025, DOI 10.1084/jem.20050499; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; TAJIMA F, 1989, GENETICS, V123, P585; Thananchai H, 2007, J IMMUNOL, V178, P33, DOI 10.4049/jimmunol.178.1.33; Tian D, 2003, NATURE, V423, P74, DOI 10.1038/nature01588; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Treanor B, 2006, J CELL BIOL, V174, P153, DOI 10.1083/jcb.200601108; Trundley A, 2007, EUR J IMMUNOL, V37, P780, DOI 10.1002/eji.200636773; Valiante NM, 1997, IMMUNITY, V7, P739, DOI 10.1016/S1074-7613(00)80393-3; WAN AM, 1986, J IMMUNOL, V137, P3671; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884	49	182	186	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1092	1099		10.1038/ng2111	http://dx.doi.org/10.1038/ng2111			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17694054				2022-12-27	WOS:000249122400018
J	Arts, HH; Doherty, D; van Beersum, SEC; Parisi, MA; Letteboer, SJF; Gorden, NT; Peters, TA; Marker, T; Voesenek, K; Kartono, A; Ozyurek, H; Farin, FM; Kroes, HY; Wolfrum, U; Brunner, HG; Cremers, FPM; Glass, IA; Knoers, NVAM; Roepman, R				Arts, Heleen H.; Doherty, Dan; van Beersum, Sylvia E. C.; Parisi, Melissa A.; Letteboer, Stef J. F.; Gorden, Nicholas T.; Peters, Theo A.; Maerker, Tina; Voesenek, Krysta; Kartono, Aileen; Ozyurek, Hamit; Farin, Federico M.; Kroes, Hester Y.; Wolfrum, Uwe; Brunner, Han G.; Cremers, Frans P. M.; Glass, Ian A.; Knoers, Nine V. A. M.; Roepman, Ronald			Mutations in the gene encoding the basal body protein RPGRIP1L, a nephrocystin-4 interactor, cause Joubert syndrome	NATURE GENETICS			English	Article							LEBER CONGENITAL AMAUROSIS; PIGMENTOSA GTPASE REGULATOR; JUVENILE NEPHRONOPHTHISIS; CENTROSOMAL PROTEIN; CHOROID-PLEXUS; SENIOR-LOKEN; CILIA; PHOTORECEPTORS; DELETION; CEP290	Protein- protein interaction analyses have uncovered a ciliary and basal body protein network that, when disrupted, can result in nephronophthisis ( NPHP), Leber congenital amaurosis, Senior- Loken syndrome ( SLSN) or Joubert syndrome ( JBTS)(1-6). However, details of the molecular mechanisms underlying these disorders remain poorly understood. RPGRIP1- like protein ( RPGRIP1L) is a homolog of RPGRIP1 ( RPGR-interacting protein 1), a ciliary protein defective in Leber congenital amaurosis(7,8). We show that RPGRIP1L interacts with nephrocystin- 4 and that mutations in the gene encoding nephrocystin- 4 ( NPHP4) that are known to cause SLSN disrupt this interaction. RPGRIP1L is ubiquitously expressed, and its protein product localizes to basal bodies. Therefore, we analyzed RPGRIP1L as a candidate gene for JBTS and identified loss- of- function mutations in three families with typical JBTS, including the characteristic mid- hindbrain malformation. This work identifies RPGRIP1L as a gene responsible for JBTS and establishes a central role for cilia and basal bodies in the pathophysiology of this disorder.	Radboud Univ Nijmegen, Ctr Mol Life Sci, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, NL-6500 HB Nijmegen, Netherlands; Univ Mainz, Inst Zool, D-55099 Mainz, Germany; Ondokuz Mayis Univ, Dept Pediat, TR-55139 Kurupelit, Turkey; Univ Washington, Sch Publ Hlth, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; Univ Utrecht, Med Ctr, Div Biomed Genet, NL-3508 AB Utrecht, Netherlands	Radboud University Nijmegen; University of Washington; University of Washington Seattle; Radboud University Nijmegen; Johannes Gutenberg University of Mainz; Ondokuz Mayis University; University of Washington; University of Washington Seattle; Utrecht University	Roepman, R (corresponding author), Radboud Univ Nijmegen, Ctr Mol Life Sci, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands.	r.roepman@antrg.umcn.nl	Peters, T.A./L-4571-2015; Brunner, Han/C-9928-2013; Roepman, Ronald/B-1339-2014; van Beersum, Sylvia E.C./P-8653-2015; Cremers, Frans/A-5625-2014; arts, heleen/ACL-6040-2022; Letteboer, Stef JF/P-8272-2015	Peters, T.A./0000-0001-8443-5500; Roepman, Ronald/0000-0002-5178-8163; van Beersum, Sylvia E.C./0000-0002-4552-2908; Cremers, Frans/0000-0002-4954-5592; Arts, Heleen/0000-0002-9860-3744	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002274] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD046712] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K23NS045832] Funding Source: NIH RePORTER; NCRR NIH HHS [K12-RR023265] Funding Source: Medline; NICHD NIH HHS [P30 HD02274, K24-HD46712] Funding Source: Medline; NIEHS NIH HHS [P30ES07033] Funding Source: Medline; NINDS NIH HHS [K23-NS45832] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Banizs B, 2005, DEVELOPMENT, V132, P5329, DOI 10.1242/dev.02153; Brandstatter JH, 1996, J NEUROSCI, V16, P4749; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; DOOLIN PF, 1966, J CELL BIOL, V29, P333, DOI 10.1083/jcb.29.2.333; Dryja TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Fliegauf M, 2006, J AM SOC NEPHROL, V17, P2424, DOI 10.1681/ASN.2005121351; Kantardzhieva A, 2005, INVEST OPHTH VIS SCI, V46, P2192, DOI 10.1167/iovs.04-1417; Maria BL, 1999, J CHILD NEUROL, V14, P368, DOI 10.1177/088307389901400605; Mogensen MM, 2000, J CELL SCI, V113, P3013; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Otto E, 2002, AM J HUM GENET, V71, P1161, DOI 10.1086/344395; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Parisi MA, 2007, EUR J HUM GENET, V15, P511, DOI 10.1038/sj.ejhg.5201648; Pellegrino JE, 1997, AM J MED GENET, V72, P59, DOI 10.1002/(SICI)1096-8628(19971003)72:1<59::AID-AJMG12>3.0.CO;2-T; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rattner A, 2004, J BIOL CHEM, V279, P42202, DOI 10.1074/jbc.M407928200; Roepman R, 2000, HUM MOL GENET, V9, P2095, DOI 10.1093/hmg/9.14.2095; Roepman R, 2000, METHOD ENZYMOL, V316, P688; Roepman R, 2005, P NATL ACAD SCI USA, V102, P18520, DOI 10.1073/pnas.0505774102; Satran D, 1999, AM J MED GENET, V86, P459; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; van Wijk E, 2006, HUM MOL GENET, V15, P751, DOI 10.1093/hmg/ddi490; WOLFRUM U, 1995, CELL MOTIL CYTOSKEL, V32, P55, DOI 10.1002/cm.970320107	30	242	250	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2007	39	7					882	888		10.1038/ng2069	http://dx.doi.org/10.1038/ng2069			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17558407				2022-12-27	WOS:000247619800019
J	Dickins, RA; McJunkin, K; Hernando, E; Premsrirut, PK; Krizhanovsky, V; Burgess, DJ; Kim, SY; Cordon-Cardo, C; Zender, L; Hannon, GJ; Lowe, SW				Dickins, Ross A.; McJunkin, Katherine; Hernando, Eva; Premsrirut, Prem K.; Krizhanovsky, Valery; Burgess, Darren J.; Kim, Sang Yong; Cordon-Cardo, Carlos; Zender, Lars; Hannon, Gregory J.; Lowe, Scott W.			Tissue-specific and reversible RNA interference in transgenic mice	NATURE GENETICS			English	Article							GENE-EXPRESSION; MAMMALIAN-CELLS; IN-VIVO; P53 RESTORATION; MOUSE; PHENOTYPES; APOPTOSIS; MYC; LYMPHOMAGENESIS; TUMORIGENESIS	Genetically engineered mice provide powerful tools for understanding mammalian gene function. These models traditionally rely on gene overexpression from transgenes or targeted, irreversible gene mutation. By adapting the tetracycline ( tet)- responsive system previously used for gene overexpression, we have developed a simple transgenic system to reversibly control endogenous gene expression using RNA interference ( RNAi) in mice. Transgenic mice harboring a tet- responsive RNA polymerase II promoter driving a microRNA- based short hairpin RNA targeting the tumor suppressor Trp53 reversibly express short hairpin RNA when crossed with existing mouse strains expressing general or tissue- specific 'tet- on' or 'tet- off' transactivators. Reversible Trp53 knockdown can be achieved in several tissues, and restoring Trp53 expression in lymphomas whose development is promoted by Trp53 knockdown leads to tumor regression. By leaving the target gene unaltered, this approach permits tissue- specific, reversible regulation of endogenous gene expression in vivo, with potential broad application in basic biology and drug target validation.	Cold Spring Harbor Lab, Howard Hughes Med Inst, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Mem Sloan Kettering Canc Ctr, Div Mol Pathol, New York, NY 10021 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Memorial Sloan Kettering Cancer Center	Lowe, SW (corresponding author), Cold Spring Harbor Lab, Howard Hughes Med Inst, POB 100, Cold Spring Harbor, NY 11724 USA.	lowe@cshl.edu	Hannon, Gregory/AAB-3568-2019; Dickins, Ross A/K-2852-2012; Krizhanovsky, Valery/D-1336-2010	Dickins, Ross A/0000-0003-4112-5304; Krizhanovsky, Valery/0000-0002-3977-5482; Kim, Sang Yong/0000-0001-7326-7505; McJunkin, Katherine/0000-0001-9730-442X; Burgess, Darren/0000-0002-8434-7540; Hernando, Eva/0000-0003-1023-0312	NCI NIH HHS [P01 CA013106, P30 CA008748, P01 CA087497] Funding Source: Medline; NIGMS NIH HHS [T32 GM008444] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA087497, P01CA013106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008444] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Benson JD, 2006, NATURE, V441, P451, DOI 10.1038/nature04873; Capecchi MR, 2005, NAT REV GENET, V6, P507, DOI 10.1038/nrg1619; Ceccarelli AV, 2002, COMPARATIVE MED, V52, P171; Coumoul X, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni100; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Felsher DW, 2004, CURR OPIN GENET DEV, V14, P37, DOI 10.1016/j.gde.2003.12.008; Fritsch L, 2004, EMBO REP, V5, P178, DOI 10.1038/sj.embor.7400064; FURTH PA, 1994, P NATL ACAD SCI USA, V91, P9302, DOI 10.1073/pnas.91.20.9302; Glaser S, 2005, NAT GENET, V37, P1187, DOI 10.1038/ng1668; GORDON JW, 1980, P NATL ACAD SCI-BIOL, V77, P7380, DOI 10.1073/pnas.77.12.7380; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; HSU B, 1995, ONCOGENE, V11, P175; Kim M, 2006, CELL, V125, P1269, DOI 10.1016/j.cell.2006.06.008; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; Kubicka S, 1999, J BIOL CHEM, V274, P32137, DOI 10.1074/jbc.274.45.32137; Kuhnel F, 2000, J BIOL CHEM, V275, P6421, DOI 10.1074/jbc.275.9.6421; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lewandoski M, 2001, NAT REV GENET, V2, P743, DOI 10.1038/35093537; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; MIDGLEY CA, 1995, J CELL SCI, V108, P1843; Rao MK, 2006, GENE DEV, V20, P147, DOI 10.1101/gad1367806; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Schmitt CA, 1999, GENE DEV, V13, P2670, DOI 10.1101/gad.13.20.2670; Shin MK, 1999, NATURE, V402, P496, DOI 10.1038/990040; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wiznerowicz M, 2006, NAT METHODS, V3, P682, DOI 10.1038/NMETH914; Xia XG, 2006, PLOS GENET, V2, P73, DOI 10.1371/journal.pgen.0020010; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yu J, 2006, GENESIS, V44, P252, DOI 10.1002/dvg.20213	39	135	147	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2007	39	7					914	921		10.1038/ng2045	http://dx.doi.org/10.1038/ng2045			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17572676	Green Accepted			2022-12-27	WOS:000247619800024
J	Dierick, HA; Greenspan, RJ				Dierick, Herman A.; Greenspan, Ralph J.			Serotonin and neuropeptide F have opposite modulatory effects on fly aggression	NATURE GENETICS			English	Article							TARGETED GENE-EXPRESSION; DROSOPHILA-MELANOGASTER; BEHAVIOR; DOPAMINE; NEURONS; RECEPTOR; SYSTEMS; BRAIN	Both serotonin (5-HT) and neuropeptide Y have been shown to affect a variety of mammalian behaviors(1-3), including aggression(4,5). Here we show in Drosophila melanogaster that both 5-HT and neuropeptide F, the invertebrate homolog of neuropeptide Y, modulate aggression. We show that drug-induced increases of 5-HT in the fly brain increase aggression. Elevating 5-HT genetically in the serotonergic circuits recapitulates these pharmacological effects, whereas genetic silencing of these circuits makes the flies behaviorally unresponsive to the drug-induced increase of 5-HT but leaves them capable of aggression. Genetic silencing of the neuropeptide F (npf) circuit also increases fly aggression, demonstrating an opposite modulation to 5-HT. Moreover, this neuropeptide F effect seems to be independent of 5-HT. The implication of these two modulatory systems in fly and mouse aggression suggest a marked degree of conservation and a deep molecular root for this behavior.	Inst Neurosci, San Diego, CA 92121 USA		Dierick, HA (corresponding author), Inst Neurosci, 10640 John J Hopkins Dr, San Diego, CA 92121 USA.	dierick@nsi.edu						Baier A, 2002, J EXP BIOL, V205, P1233; BRAND AH, 1993, DEVELOPMENT, V118, P401; Carvajal C., 2006, CNS & Neurological Disorders-Drug Targets, V5, P181, DOI 10.2174/187152706776359592; Coleman CM, 2005, ARCH INSECT BIOCHEM, V59, P12, DOI 10.1002/arch.20050; Cransac H, 1996, J NEURAL TRANSM, V103, P391, DOI 10.1007/BF01276416; Dierick HA, 2006, NAT GENET, V38, P1023, DOI 10.1038/ng1864; FERVEUR JF, 1995, SCIENCE, V267, P902, DOI 10.1126/science.7846534; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; HOFFMANN AA, 1990, J INSECT BEHAV, V3, P1, DOI 10.1007/BF01049191; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; Karl T, 2004, P NATL ACAD SCI USA, V101, P12742, DOI 10.1073/pnas.0404085101; Kravitz EA, 2003, CURR OPIN NEUROBIOL, V13, P736, DOI 10.1016/j.conb.2003.10.003; Lee GH, 2006, P NATL ACAD SCI USA, V103, P12580, DOI 10.1073/pnas.0601171103; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Lindsey JW, 1998, J TOXICOL ENV HEAL A, V54, P421; Lucki I, 1998, BIOL PSYCHIAT, V44, P151, DOI 10.1016/S0006-3223(98)00139-5; LUNDELL MJ, 1994, DEV BIOL, V165, P385, DOI 10.1006/dbio.1994.1261; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; Pedrazzini T, 2003, CELL MOL LIFE SCI, V60, P350, DOI 10.1007/s000180300029; Popova NK, 2006, BIOESSAYS, V28, P495, DOI 10.1002/bies.20412; SLEMMON JR, 1982, J BIOL CHEM, V257, P3847; Stevenson PA, 2000, J NEUROBIOL, V43, P107; Suster ML, 2003, J NEUROBIOL, V55, P233, DOI 10.1002/neu.10202; Vrontou E, 2006, NAT NEUROSCI, V9, P1469, DOI 10.1038/nn1809; Wen TQ, 2005, P NATL ACAD SCI USA, V102, P2141, DOI 10.1073/pnas.0406814102; Wu Q, 2005, NAT NEUROSCI, V8, P1350, DOI 10.1038/nn1540; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032	29	218	222	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2007	39	5					678	682		10.1038/ng2029	http://dx.doi.org/10.1038/ng2029			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17450142				2022-12-27	WOS:000245971300026
J	Yamanouchi, J; Rainbow, D; Serra, P; Howlett, S; Hunter, K; Garner, VES; Gonzalez-Munoz, A; Clark, J; Veijola, R; Cubbon, R; Chen, SL; Rosa, R; Cumiskey, AM; Serreze, DV; Gregory, S; Rogers, J; Lyons, PA; Healy, B; Smink, LJ; Todd, JA; Peterson, LB; Wicker, LS; Santamaria, P				Yamanouchi, Jun; Rainbow, Dan; Serra, Pau; Howlett, Sarah; Hunter, Kara; Garner, Valerie E. S.; Gonzalez-Munoz, Andrea; Clark, Jan; Veijola, Riitta; Cubbon, Rose; Chen, Show-Ling; Rosa, Raymond; Cumiskey, Anne Marie; Serreze, David V.; Gregory, Simon; Rogers, Jane; Lyons, Paul A.; Healy, Barry; Smink, Luc J.; Todd, John A.; Peterson, Laurence B.; Wicker, Linda S.; Santamaria, Pere			Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity	NATURE GENETICS			English	Article							NONOBESE DIABETIC MICE; ALPHA-CHAIN; NOD MICE; IL-2; REGION; LOCUS; ACTIVATION; EXPRESSION; DISEASE; COMPLEX	Autoimmune diseases are thought to result from imbalances in normal immune physiology and regulation. Here, we show that autoimmune disease susceptibility and resistance alleles on mouse chromosome 3 (Idd3) correlate with differential expression of the key immunoregulatory cytokine interleukin-2 (IL-2). In order to test directly that an approximately twofold reduction in IL-2 underpins the Idd3-linked destabilization of immune homeostasis, we show that engineered haplodeficiency of Il2 gene expression not only reduces T cell IL-2 production by twofold but also mimics the autoimmune dysregulatory effects of the naturally occurring susceptibility alleles of Il2. Reduced IL-2 production achieved by either genetic mechanism correlates with reduced function of CD4(+) CD25(+) regulatory T cells, which are critical for maintaining immune homeostasis.	Univ Calgary, Fac Med, JMDRC, Inst Inflammat Infect & Immun, Calgary, AB T2N 4N1, Canada; Univ Calgary, Fac Med, Dept Microbiol & Infect Dis, Inst Inflammat Infect & Immun, Calgary, AB T2N 4N1, Canada; Univ Cambridge, Cambridge Inst Med Genet, Dept Med Genet, Juvenile Diabet Res Fdn,Wellcome Trust Diabet & I, Cambridge CB2 2XY, England; Merck Res Labs, Rahway, NJ 07065 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England	University of Calgary; University of Calgary; University of Cambridge; Merck & Company; Jackson Laboratory; Wellcome Trust Sanger Institute	Wicker, LS (corresponding author), Univ Calgary, Fac Med, JMDRC, Inst Inflammat Infect & Immun, Calgary, AB T2N 4N1, Canada.	linda.wicker@cimr.cam.ac.uk; psantama@ucalgary.ca	Santamaria, Pere/ABF-6823-2021; Todd, John A/A-3542-2010; Wicker, Linda S/F-7384-2010	Todd, John A/0000-0003-2740-8148; Gregory, Simon/0000-0002-7805-1743	Wellcome Trust [061859] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adachi S, 2005, NUCLEIC ACIDS RES, V33, P3200, DOI 10.1093/nar/gki637; Almeida ARM, 2002, J IMMUNOL, V169, P4850, DOI 10.4049/jimmunol.169.9.4850; Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Amrani A, 2002, IMMUNITY, V16, P719, DOI 10.1016/S1074-7613(02)00315-1; Anderson B, 1999, P NATL ACAD SCI USA, V96, P9311, DOI 10.1073/pnas.96.16.9311; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Bayer AL, 2005, J EXP MED, V201, P769, DOI 10.1084/jem.20041179; Brusko TM, 2005, DIABETES, V54, P1407, DOI 10.2337/diabetes.54.5.1407; Cervino ACL, 2006, MAMM GENOME, V17, P565, DOI 10.1007/s00335-005-0170-4; de la Rosa M, 2004, EUR J IMMUNOL, V34, P2480, DOI 10.1002/eji.200425274; DiLorenzo TP, 1998, P NATL ACAD SCI USA, V95, P12538, DOI 10.1073/pnas.95.21.12538; Encinas JA, 1999, NAT GENET, V21, P158, DOI 10.1038/5941; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Hurez V, 2003, J EXP MED, V198, P123, DOI 10.1084/jem.20022230; Kim HP, 2005, J BIOL CHEM, V280, P25291, DOI 10.1074/jbc.M501459200; King C, 2004, CELL, V117, P265, DOI 10.1016/S0092-8674(04)00335-6; Kukreja A, 2002, J CLIN INVEST, V109, P131, DOI 10.1172/JCI13605; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; LORD CJ, 1995, MAMM GENOME, V6, P563, DOI 10.1007/BF00352359; Lyons PA, 2000, GENOME RES, V10, P446, DOI 10.1101/gr.10.4.446; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; MCALEER MA, 1995, DIABETES, V44, P1186, DOI 10.2337/diabetes.44.10.1186; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Podolin PL, 2000, CYTOKINE, V12, P477, DOI 10.1006/cyto.1999.0609; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Samy ET, 2005, J EXP MED, V202, P771, DOI 10.1084/jem.20041033; Saparov A, 1999, IMMUNITY, V11, P271, DOI 10.1016/S1074-7613(00)80102-8; SCHORLE H, 1991, NATURE, V352, P621, DOI 10.1038/352621a0; Serra P, 2003, IMMUNITY, V19, P877, DOI 10.1016/S1074-7613(03)00327-3; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Sharfe N, 1997, P NATL ACAD SCI USA, V94, P3168, DOI 10.1073/pnas.94.7.3168; Smink LJ, 2005, NUCLEIC ACIDS RES, V33, pD544; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Teuscher C, 1996, J EXP MED, V183, P631, DOI 10.1084/jem.183.2.631; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Trudeau JD, 2003, J CLIN INVEST, V111, P217, DOI 10.1172/JCI200316409; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; Verdaguer J, 1996, J IMMUNOL, V157, P4726; Wang L, 2005, BIOCHEM BIOPH RES CO, V331, P589, DOI 10.1016/j.bbrc.2005.03.216; WICKER LS, 1994, J EXP MED, V180, P1705, DOI 10.1084/jem.180.5.1705; WILLERFORD DM, 1995, IMMUNITY, V3, P521, DOI 10.1016/1074-7613(95)90180-9; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Wolf M, 2001, EUR J IMMUNOL, V31, P1637, DOI 10.1002/1521-4141(200106)31:6<1637::AID-IMMU1637>3.0.CO;2-T; Yui MA, 2001, J IMMUNOL, V166, P1730, DOI 10.4049/jimmunol.166.3.1730; Zhang YQ, 2002, J IMMUNOL, V168, P1466, DOI 10.4049/jimmunol.168.3.1466	50	301	311	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2007	39	3					329	337		10.1038/ng1958	http://dx.doi.org/10.1038/ng1958			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17277778	Green Accepted			2022-12-27	WOS:000244480000014
J	Choudhury, AR; Ju, ZY; Djojosubroto, MW; Schienke, A; Lechel, A; Schaetzlein, S; Jiang, H; Stepczynska, A; Wang, CF; Buer, J; Lee, HW; von Zglinicki, T; Ganser, A; Schirmacher, P; Nakauchi, H; Rudolph, KL				Choudhury, Aaheli Roy; Ju, Zhenyu; Djojosubroto, Meta W.; Schienke, Andrea; Lechel, Andre; Schaetzlein, Sonja; Jiang, Hong; Stepczynska, Anna; Wang, Chunfang; Buer, Jan; Lee, Han-Woong; von Zglinicki, Thomas; Ganser, Arnold; Schirmacher, Peter; Nakauchi, Hiromitsu; Rudolph, K. Lenhard			Cdkn1a deletion improves stem cell function and lifespan of mice with dysfunctional telomeres without accelerating cancer formation	NATURE GENETICS			English	Article							HUMAN FIBROBLASTS; MOUSE TELOMERASE; DNA-DAMAGE; SENESCENCE; LENGTH; P21(CIP1/WAF1); REGENERATION; CAPACITY; AGE; P53	Telomere shortening limits the proliferative lifespan of human cells by activation of DNA damage pathways, including upregulation of the cell cycle inhibitor p21 (encoded by Cdkn1a, also known as Cip1 and Waf1)) (refs. 1-5). Telomere shortening in response to mutation of the gene encoding telomerase is associated with impaired organ maintenance and shortened lifespan in humans(6) and in mice(7-9). The in vivo function of p21 in the context of telomere dysfunction is unknown. Here we show that deletion of p21 prolongs the lifespan of telomerase-deficient mice with dysfunctional telomeres. p21 deletion improved hematolymphopoiesis and the maintenance of intestinal epithelia without rescuing telomere function. Moreover, deletion of p21 rescued proliferation of intestinal progenitor cells and improved the repopulation capacity and self-renewal of hematopoietic stem cells from mice with dysfunctional telomeres. In these mice, apoptotic responses remained intact, and p21 deletion did not accelerate chromosomal instability or cancer formation. This study provides experimental evidence that telomere dysfunction induces p21-dependent checkpoints in vivo that can limit longevity at the organismal level.	Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; Helmholtz Ctr Infect Res, Dept Mucosal Immun, D-38124 Braunschweig, Germany; Univ Newcastle Upon Tyne, Inst Hlth & Aging, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Hannover Med Sch, Inst Med Microbiol, D-30625 Hannover, Germany; Yonsei Univ, Coll Sci, Seoul 120749, South Korea; Dept Hematol & Oncol, D-30625 Hannover, Germany; Univ Hosp, Inst Pathol, D-69120 Heidelberg, Germany; Univ Tokyo, Inst Med Sci, Lab Stem Cell Therapy, Tokyo 1088693, Japan	Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Newcastle University - UK; Hannover Medical School; Yonsei University; Ruprecht Karls University Heidelberg; University of Tokyo	Rudolph, KL (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	Rudolph.Lenhard@MH-Hannover.de	Lechel, André/AAQ-2041-2021	Lechel, André/0000-0003-0221-6959; Roy Choudhury, Aaheli/0000-0001-6907-0734; Rudolph, Karl Lenhard/0000-0002-4839-2862; von Zglinicki, Thomas/0000-0002-5939-0248; Buer, Jan/0000-0002-7602-1698				ALLSOPP RC, 1992, P NATL ACAD SCI USA, V89, P10114, DOI 10.1073/pnas.89.21.10114; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Brown JP, 1997, SCIENCE, V277, P831, DOI 10.1126/science.277.5327.831; Carnero A, 2004, ONCOGENE, V23, P6006, DOI 10.1038/sj.onc.1207839; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Greenberg RA, 1999, CELL, V97, P515, DOI 10.1016/S0092-8674(00)80761-8; Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Lechel A, 2005, EMBO REP, V6, P275, DOI 10.1038/sj.embor.7400352; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Lieber MR, 2004, NAT REV MOL CELL BIO, V5, P69, DOI 10.1038/nrm1281; LIPSCHITZ DA, 1984, BLOOD, V63, P502; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Min HY, 2005, IMMUNOL REV, V205, P7, DOI 10.1111/j.0105-2896.2005.00263.x; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818; Randall TD, 1998, STEM CELLS, V16, P38, DOI 10.1002/stem.160038; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Satyanarayana A, 2003, EMBO J, V22, P4003, DOI 10.1093/emboj/cdg367; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Wagers AJ, 2005, CELL, V122, P659, DOI 10.1016/j.cell.2005.08.021; WRIGHT WE, 1992, EXP GERONTOL, V27, P383, DOI 10.1016/0531-5565(92)90069-C	30	332	349	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2007	39	1					99	105		10.1038/ng1937	http://dx.doi.org/10.1038/ng1937			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	17143283				2022-12-27	WOS:000243136500024
J	Carroll, JS; Meyer, CA; Song, J; Li, W; Geistlinger, TR; Eeckhoute, J; Brodsky, AS; Keeton, EK; Fertuck, KC; Hall, GF; Wang, QB; Bekiranov, S; Sementchenko, V; Fox, EA; Silver, PA; Gingeras, TR; Liu, XS; Brown, M				Carroll, Jason S.; Meyer, Clifford A.; Song, Jun; Li, Wei; Geistlinger, Timothy R.; Eeckhoute, Jerome; Brodsky, Alexander S.; Keeton, Erika Krasnickas; Fertuck, Kirsten C.; Hall, Giles F.; Wang, Qianben; Bekiranov, Stefan; Sementchenko, Victor; Fox, Edward A.; Silver, Pamela A.; Gingeras, Thomas R.; Liu, X. Shirley; Brown, Myles			Genome-wide analysis of estrogen receptor binding sites	NATURE GENETICS			English	Article							BREAST-CANCER CELLS; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; ACTIVATION; REVEALS; PROGRESSION; RECRUITMENT; PROMOTERS; CHROMATIN; NETWORKS	The estrogen receptor is the master transcriptional regulator of breast cancer phenotype and the archetype of a molecular therapeutic target. We mapped all estrogen receptor and RNA polymerase II binding sites on a genome-wide scale, identifying the authentic cis binding sites and target genes, in breast cancer cells. Combining this unique resource with gene expression data demonstrates distinct temporal mechanisms of estrogen-mediated gene regulation, particularly in the case of estrogen-suppressed genes. Furthermore, this resource has allowed the identification of cis-regulatory sites in previously unexplored regions of the genome and the cooperating transcription factors underlying estrogen signaling in breast cancer.	Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Biostat & Computat Biol, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Brown Univ, Labs Mol Med, Ctr Genom & Proteom, Providence, RI 02903 USA; Harvard Univ, Sch Med, Dept Canc Biol, Dana Farber Canc Inst, Boston, MA 02115 USA; Affymetrix, Santa Clara, CA 95051 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Brown University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Affymetrix; Harvard University; Harvard Medical School	Liu, XS (corresponding author), Harvard Univ, Sch Med, Dept Med Oncol, Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	xsliu@jimmy.harvard.edu; myles_brown@dfci.harvard.edu	Brown, Myles/B-6906-2008; Li, Wei/A-8544-2009; Wang, Qianben/E-4267-2011; Pillay, Nischalan/F-9536-2012; Brown, Myles/AAX-5332-2021; Song, Jun S/E-2526-2016; Eeckhoute, Jerome/AAN-8219-2021	Brown, Myles/0000-0002-8213-1658; Song, Jun S/0000-0002-0422-2175; Eeckhoute, Jerome/0000-0002-7222-9264; Li, Wei/0000-0001-9931-5990; Liu, Xiaole/0000-0003-4736-7339; Carroll, Jason/0000-0003-3643-0080; Gingeras, Thomas/0000-0001-9106-3573	NCI NIH HHS [CA089393] Funding Source: Medline; NHGRI NIH HHS [R01 HG004069-01, R01 HG004069] Funding Source: Medline; NIDDK NIH HHS [DK074967] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA089393] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK074967, R01DK074967] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boruk M, 1998, MOL ENDOCRINOL, V12, P1749, DOI 10.1210/me.12.11.1749; Brodsky AS, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r64; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Chen ZP, 2004, ASIA PAC J OPER RES, V21, P393, DOI 10.1142/S0217595904000308; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Cicatiello L, 2004, MOL CELL BIOL, V24, P7260, DOI 10.1128/MCB.24.16.7260-7274.2004; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Cirillo LA, 1998, EMBO J, V17, P244, DOI 10.1093/emboj/17.1.244; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; DARROCH JN, 1980, ANN STAT, V8, P522, DOI 10.1214/aos/1176345006; DUBIK D, 1992, ONCOGENE, V7, P1587; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Ghosh MG, 2000, CANCER RES, V60, P6367; Hoch RV, 1999, INT J CANCER, V84, P122; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; JOHNSON WE, 2006, IN PRESS P NATL ACAD; Kalaitzidis D, 2005, TRENDS ENDOCRIN MET, V16, P46, DOI 10.1016/j.tem.2005.01.004; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Laganiere J, 2005, P NATL ACAD SCI USA, V102, P11651, DOI 10.1073/pnas.0505575102; Lazennec G, 1995, GENE, V166, P243, DOI 10.1016/0378-1119(95)00601-X; Lee CH, 1998, MOL CELL BIOL, V18, P6745, DOI 10.1128/MCB.18.11.6745; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; LYDON JP, 1995, GENE DEV, V9, P2266, DOI 10.1101/gad.9.18.2266; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Nishidate T, 2004, INT J ONCOL, V25, P797; O'Lone R, 2004, MOL ENDOCRINOL, V18, P1859, DOI 10.1210/me.2003-0044; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prefontaine GG, 1999, J BIOL CHEM, V274, P26713, DOI 10.1074/jbc.274.38.26713; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; SONG JG, UNPUB; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Teyssier C, 2003, MOL ENDOCRINOL, V17, P287, DOI 10.1210/me.2002-0324; UMAYAHARA Y, 1994, J BIOL CHEM, V269, P16433; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Steensel B, 2005, NAT GENET, V37, pS18, DOI 10.1038/ng1559; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Webb P, 1999, MOL ENDOCRINOL, V13, P1672, DOI 10.1210/me.13.10.1672	49	1036	1066	0	69	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2006	38	11					1289	1297		10.1038/ng1901	http://dx.doi.org/10.1038/ng1901			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17013392				2022-12-27	WOS:000241592700017
J	Pielberg, GR; Golovko, A; Sundstrom, E; Curik, I; Lennartsson, J; Seltenhammer, MH; Druml, T; Binns, M; Fitzsimmons, C; Lindgren, G; Sandberg, K; Baumung, R; Vetterlein, M; Stromberg, S; Grabherr, M; Wade, C; Lindblad-Toh, K; Ponten, F; Heldin, CH; Solkner, J; Andersson, L				Pielberg, Gerli Rosengren; Golovko, Anna; Sundstrom, Elisabeth; Curik, Ino; Lennartsson, Johan; Seltenhammer, Monika H.; Druml, Thomas; Binns, Matthew; Fitzsimmons, Carolyn; Lindgren, Gabriella; Sandberg, Kaj; Baumung, Roswitha; Vetterlein, Monika; Stromberg, Sara; Grabherr, Manfred; Wade, Claire; Lindblad-Toh, Kerstin; Ponten, Fredrik; Heldin, Carl-Henrik; Soelkner, Johann; Andersson, Leif			A cis-acting regulatory mutation causes premature hair graying and susceptibility to melanoma in the horse	NATURE GENETICS			English	Article							STIMULATING-HORMONE-RECEPTOR; STEM-CELL MAINTENANCE; COAT COLOR GENE; EQUUS-CABALLUS; MC1R; MECHANISMS; LINKAGE; GENOME	In horses, graying with age is an autosomal dominant trait associated with a high incidence of melanoma and vitiligo-like depigmentation. Here we show that the Gray phenotype is caused by a 4.6-kb duplication in intron 6 of STX17 (syntaxin-17) that constitutes a cis-acting regulatory mutation. Both STX17 and the neighboring NR4A3 gene are overexpressed in melanomas from Gray horses. Gray horses carrying a loss-of-function mutation in ASIP ( agouti signaling protein) had a higher incidence of melanoma, implying that increased melanocortin-1 receptor signaling promotes melanoma development in Gray horses. The Gray horse provides a notable example of how humans have cherry-picked mutations with favorable phenotypic effects in domestic animals.	[Pielberg, Gerli Rosengren; Golovko, Anna; Fitzsimmons, Carolyn; Lindblad-Toh, Kerstin; Andersson, Leif] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75124 Uppsala, Sweden; [Sundstrom, Elisabeth; Lindgren, Gabriella; Sandberg, Kaj; Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, SE-75124 Uppsala, Sweden; [Curik, Ino] Univ Zagreb, Dept Anim Sci, Fac Agr, HR-10000 Zagreb, Croatia; [Lennartsson, Johan; Heldin, Carl-Henrik] Uppsala Univ, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden; [Seltenhammer, Monika H.] Univ Vet Med, Dept Clin Surg & Ophthalmol, A-1200 Vienna, Austria; [Druml, Thomas; Baumung, Roswitha; Soelkner, Johann] Univ Nat Resources & Appl Life Sci, Dept Sustainable Agr Syst, A-1180 Vienna, Austria; [Binns, Matthew] Univ London Royal Vet Coll, London NW1 0TU, England; [Vetterlein, Monika] Med Univ Vienna, Dept Cell Biol & Ultrastruct Res, Ctr Anat & Cell Biol, A-1080 Vienna, Austria; [Stromberg, Sara; Ponten, Fredrik] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden; [Grabherr, Manfred; Wade, Claire; Lindblad-Toh, Kerstin] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Wade, Claire] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA	Uppsala University; Swedish University of Agricultural Sciences; University of Zagreb; Ludwig Institute for Cancer Research; Uppsala University; University of Veterinary Medicine Vienna; University of Natural Resources & Life Sciences, Vienna; University of London; University of London Royal Veterinary College; Medical University of Vienna; Uppsala University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital	Andersson, L (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Box 597, SE-75124 Uppsala, Sweden.	leif.andersson@imbim.uu.se		Solkner, Johann/0000-0002-1517-5829; Lindgren, Gabriella/0000-0001-6046-9669; Wade, Claire/0000-0003-3413-4771; Grabherr, Manfred/0000-0001-8792-6508				Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; COMFORT A, 1958, NATURE, V182, P1531, DOI 10.1038/1821531a0; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DESSER H, 1980, ZBL VET MED A, V27, P45; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Fleury C, 2000, PIGM CELL RES, V13, P47, DOI 10.1034/j.1600-0749.2000.130109.x; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Henner J, 2002, MAMM GENOME, V13, P535, DOI 10.1007/s00335-002-2174-7; Locke MM, 2002, ANIM GENET, V33, P329, DOI 10.1046/j.1365-2052.2002.00885.x; LU DS, 1994, NATURE, V371, P799, DOI 10.1038/371799a0; Marklund L, 1996, MAMM GENOME, V7, P895, DOI 10.1007/s003359900264; Maxwell Megan A, 2006, Nucl Recept Signal, V4, pe002; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Nomiyama T, 2006, J BIOL CHEM, V281, P33467, DOI 10.1074/jbc.M603436200; Pielberg G, 2005, ANIM GENET, V36, P390, DOI 10.1111/j.1365-2052.2005.01334.x; Rieder S, 2001, MAMM GENOME, V12, P450, DOI 10.1007/s003350020017; Seltenhammer MH, 2004, PIGM CELL RES, V17, P674, DOI 10.1111/j.1600-0749.2004.00192.x; Smith AG, 2008, J BIOL CHEM, V283, P12564, DOI 10.1074/jbc.M800480200; SPONENBERG DP, 2003, EQUINE COAT COLOR GE, P215; Steegmaier M, 1998, J BIOL CHEM, V273, P34171, DOI 10.1074/jbc.273.51.34171; Steingrimsson E, 2005, CELL, V121, P9, DOI 10.1016/j.cell.2005.03.021; SUTTON RH, 1997, MELANOMA GRAYING HOR, P1; Swinburne JE, 2002, ANIM GENET, V33, P338, DOI 10.1046/j.1365-2052.2002.00895.x; Van Neste D, 2004, MICRON, V35, P193, DOI 10.1016/j.micron.2003.11.006; VANDORSSEN J, 1903, GENESE MELANOME HAUT; Zhang Q, 2005, J HISTOCHEM CYTOCHEM, V53, P1371, DOI 10.1369/jhc.4A6508.2005	28	209	226	0	42	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					1004	1009		10.1038/ng.185	http://dx.doi.org/10.1038/ng.185			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18641652	Green Published			2022-12-27	WOS:000258026900018
J	Amos, CI; Wu, XF; Broderick, P; Gorlov, IP; Gu, J; Eisen, T; Dong, Q; Zhang, Q; Gu, XJ; Vijayakrishnan, J; Sullivan, K; Matakidou, A; Wang, YF; Mills, G; Doheny, K; Tsai, YY; Chen, WV; Shete, S; Spitz, MR; Houlston, RS				Amos, Christopher I.; Wu, Xifeng; Broderick, Peter; Gorlov, Ivan P.; Gu, Jian; Eisen, Timothy; Dong, Qiong; Zhang, Qing; Gu, Xiangjun; Vijayakrishnan, Jayaram; Sullivan, Kate; Matakidou, Athena; Wang, Yufei; Mills, Gordon; Doheny, Kimberly; Tsai, Ya-Yu; Chen, Wei Vivien; Shete, Sanjay; Spitz, Margaret R.; Houlston, Richard S.			Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1	NATURE GENETICS			English	Article							POPULATION; EXPRESSION; CELLS; RISK; RETINOBLASTOMA; RELATIVES; MAPS	To identify risk variants for lung cancer, we conducted a multistage genome-wide association study. In the discovery phase, we analyzed 315,450 tagging SNPs in 1,154 current and former (ever) smoking cases of European ancestry and 1,137 frequency-matched, ever-smoking controls from Houston, Texas. For replication, we evaluated the ten SNPs most significantly associated with lung cancer in an additional 711 cases and 632 controls from Texas and 2,013 cases and 3,062 controls from the UK. Two SNPs, rs1051730 and rs8034191, mapping to a region of strong linkage disequilibrium within 15q25.1 containing PSMA4 and the nicotinic acetylcholine receptor subunit genes CHRNA3 and CHRNA5, were significantly associated with risk in both replication sets. Combined analysis yielded odds ratios of 1.32 (P < 1 x 10(-17)) for both SNPs. Haplotype analysis was consistent with there being a single risk variant in this region. We conclude that variation in a region of 15q25.1 containing nicotinic acetylcholine receptors genes contributes to lung cancer risk.	[Amos, Christopher I.; Wu, Xifeng; Gorlov, Ivan P.; Gu, Jian; Dong, Qiong; Zhang, Qing; Gu, Xiangjun; Chen, Wei Vivien; Shete, Sanjay; Spitz, Margaret R.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Broderick, Peter; Vijayakrishnan, Jayaram; Matakidou, Athena; Wang, Yufei; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; [Eisen, Timothy] Univ Cambridge, Dept Oncol, Cambridge CB2 2RE, England; [Mills, Gordon] Univ Texas Houston, MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Doheny, Kimberly; Tsai, Ya-Yu] Johns Hopkins Univ, Sch Med, Inst Med Genet, Ctr Inherited Dis Res, Baltimore, MD 21224 USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of London; Institute of Cancer Research - UK; University of Cambridge; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Johns Hopkins University	Amos, CI (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Epidemiol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	camos@mdanderson.org	Gu, Jian/Q-4780-2018; Peng, Bo/A-6920-2009	Gu, Jian/0000-0003-3499-0973; Peng, Bo/0000-0001-8225-2284; Houlston, Richard/0000-0002-5268-0242; Vijayakrishnan, Jayaram/0000-0002-8284-2249; Broderick, Peter/0000-0002-8348-5829	Cancer Research UK Funding Source: Medline; NCI NIH HHS [R01CA133996, R01 CA127219-02, R01CA55769, P50 CA070907, P30 CA016672, R01 CA133996, R01 CA121197-02, P50 CA70907, R01 CA121197, R01 CA127219, R01CA121197, R01 CA055769] Funding Source: Medline; NHGRI NIH HHS [N01HG65403] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA070907, R01CA133996, R01CA127219, R01CA055769, P30CA016672, R01CA121197] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Amos CI, 1999, RECENT RESULTS CANC, V151, P3; Bailey-Wilson JE, 2004, AM J HUM GENET, V75, P460, DOI 10.1086/423857; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Devlin B, 2001, THEOR POPUL BIOL, V60, P155, DOI 10.1006/tpbi.2001.1542; Ho YS, 2005, TOXICOL APPL PHARM, V205, P133, DOI 10.1016/j.taap.2004.09.019; Hwang SJ, 2003, HUM GENET, V113, P238, DOI 10.1007/s00439-003-0968-7; Jonsson S, 2004, JAMA-J AM MED ASSOC, V292, P2977, DOI 10.1001/jama.292.24.2977; Kleinerman RA, 2000, JNCI-J NATL CANCER I, V92, P2037, DOI 10.1093/jnci/92.24.2037; Lam DCL, 2007, CANCER RES, V67, P4638, DOI 10.1158/0008-5472.CAN-06-4628; Minna JD, 2003, J CLIN INVEST, V111, P31, DOI 10.1172/JCI200317492; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; SACCONE SF, 1976, HUM MOL GENET, V16, P36; SANDERS BM, 1989, BRIT J CANCER, V60, P358, DOI 10.1038/bjc.1989.285; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; TAKEMIYA M, 1987, CLIN GENET, V31, P35; TOKUHATA GEORGE K., 1963, JOUR NATL CANCER INST, V30, P289; Trombino S, 2004, CANCER RES, V64, P135, DOI 10.1158/0008-5472.CAN-03-1672; Webb EL, 2006, HUM MOL GENET, V15, P3263, DOI 10.1093/hmg/ddl401; Yamanaka A, 1997, JPN J CLIN ONCOL, V27, P415, DOI 10.1093/jjco/27.6.415; Zhang QZ, 2007, CLIN CANCER RES, V13, P4686, DOI 10.1158/1078-0432.CCR-06-2898	23	961	1007	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2008	40	5					616	622		10.1038/ng.109	http://dx.doi.org/10.1038/ng.109			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18385676	Green Accepted			2022-12-27	WOS:000255366700030
J	Saenz, HL; Engel, P; Stoeckli, MC; Lanz, C; Raddatz, G; Vayssier-Taussat, M; Birtles, R; Schuster, SC; Dehio, C				Saenz, Henri L.; Engel, Philipp; Stoeckli, Michele C.; Lanz, Christa; Raddatz, Gunter; Vayssier-Taussat, Muriel; Birtles, Richard; Schuster, Stephan C.; Dehio, Christoph			Genomic analysis of Bartonella identifies type IV secretion systems as host adaptability factors	NATURE GENETICS			English	Article							PATHOGEN BARTONELLA; NEGATIVE SELECTION; SEQUENCE ALIGNMENT; GENUS BARTONELLA; BACILLIFORMIS; ERYTHROCYTES; TRANSPOSASE; STRATEGY; HENSELAE; HISTORY	The bacterial genus Bartonella comprises 21 pathogens causing characteristic intraerythrocytic infections. Bartonella bacilliformis is a severe pathogen representing an ancestral lineage, whereas the other species are benign pathogens that evolved by radial speciation. Here, we have used comparative and functional genomics to infer pathogenicity genes specific to the radiating lineage, and we suggest that these genes may have facilitated adaptation to the host environment. We determined the complete genome sequence of Bartonella tribocorum by shotgun sequencing and functionally identified 97 pathogenicity genes by signature-tagged mutagenesis. Eighty-one pathogenicity genes belong to the core genome ( 1,097 genes) of the radiating lineage inferred from genome comparison of B. tribocorum, Bartonella henselae and Bartonella quintana. Sixty-six pathogenicity genes are present in B. bacilliformis, and one has been lost by deletion. The 14 pathogenicity genes specific for the radiating lineage encode two laterally acquired type IV secretion systems, suggesting that these systems have a role in host adaptability.	Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland; Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; Ecol Natl Vet Alfort, INRA, Unite Biol Mol Immunol Parasitaire Fongique, F-94700 Maisons Alfort, France; Univ Liverpool, Fac Vet Sci, Dept Vet Pathol, Liverpool L69 7LB, Merseyside, England; Penn State Univ, Ctr Infect Dis Dynam, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA	University of Basel; Max Planck Society; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; University of Liverpool; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Schuster, SC (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland.	scs@bx.psu.edu; christoph.dehio@unibas.ch	Dehio, Christoph/AAD-5572-2019; Engel, Philipp/N-1788-2015; Dehio, Christoph/R-8277-2016	Dehio, Christoph/0000-0001-7288-1052; Engel, Philipp/0000-0002-4678-6200; Dehio, Christoph/0000-0001-7288-1052; Saenz, Henri/0000-0001-7536-7817; Birtles, Richard/0000-0002-4216-5044				Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008; Birtles RJ, 1996, INT J SYST BACTERIOL, V46, P891, DOI 10.1099/00207713-46-4-891; Birtles RJ, 2002, J CLIN MICROBIOL, V40, P3606, DOI 10.1128/JCM.40.10.3606-3612.2002; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753; Dehio C, 2004, ANNU REV MICROBIOL, V58, P365, DOI 10.1146/annurev.micro.58.030603.123700; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Halling SM, 2005, J BACTERIOL, V187, P2715, DOI 10.1128/JB.187.8.2715-2726.2005; Heller R, 1998, INT J SYST BACTERIOL, V48, P1333, DOI 10.1099/00207713-48-4-1333; HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105; Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330; Houpikian P, 2001, FEMS MICROBIOL LETT, V200, P1, DOI 10.1111/j.1574-6968.2001.tb10684.x; Ihler GM, 1996, FEMS MICROBIOL LETT, V144, P1, DOI [10.1016/0378-1097(96)00307-2, 10.1111/j.1574-6968.1996.tb08501.x]; Jacomo V, 2002, CLIN DIAGN LAB IMMUN, V9, P8, DOI 10.1128/CDLI.9.1.8-18.2002; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lampe DJ, 1999, P NATL ACAD SCI USA, V96, P11428, DOI 10.1073/pnas.96.20.11428; Lampe DJ, 1996, EMBO J, V15, P5470, DOI 10.1002/j.1460-2075.1996.tb00930.x; Lindroos HL, 2005, J BACTERIOL, V187, P6155, DOI 10.1128/JB.187.17.6155-6165.2005; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Marston EL, 1999, INT J SYST BACTERIOL, V49, P1015, DOI 10.1099/00207713-49-3-1015; McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; Preston A, 2004, NAT REV MICROBIOL, V2, P379, DOI 10.1038/nrmicro886; Saenz HL, 2005, CURR OPIN MICROBIOL, V8, P612, DOI 10.1016/j.mib.2005.08.013; Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115; Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102; Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x; Schulein R, 2001, J EXP MED, V193, P1077, DOI 10.1084/jem.193.9.1077; Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x; Seubert A, 2002, INT J MED MICROBIOL, V291, P555; Sweger D, 2000, CLIN DIAGN LAB IMMUN, V7, P251, DOI 10.1128/CDLI.7.2.251-257.2000; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wren BW, 2003, NAT REV MICROBIOL, V1, P55, DOI 10.1038/nrmicro730	44	109	373	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2007	39	12					1469	1476		10.1038/ng.2007.38	http://dx.doi.org/10.1038/ng.2007.38			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	18037886				2022-12-27	WOS:000251267400014
J	Kertesz, M; Iovino, N; Unnerstall, U; Gaul, U; Segal, E				Kertesz, Michael; Iovino, Nicola; Unnerstall, Ulrich; Gaul, Ulrike; Segal, Eran			The role of site accessibility in microRNA target recognition	NATURE GENETICS			English	Article							ANIMAL MICRORNAS; RNA RECOGNITION; GENE-EXPRESSION; PREDICTION; CARDIOGENESIS; COMPLEX	MicroRNAs are key regulators of gene expression(1-4), but the precise mechanisms underlying their interaction with their mRNA targets are still poorly understood. Here, we systematically investigate the role of target-site accessibility, as determined by base-pairing interactions within the mRNA, in microRNA target recognition. We experimentally show that mutations diminishing target accessibility substantially reduce microRNA-mediated translational repression, with effects comparable to those of mutations that disrupt sequence complementarity. We devise a parameter-free model for microRNA-target interaction that computes the difference between the free energy gained from the formation of the microRNA-target duplex and the energetic cost of unpairing the target to make it accessible to the microRNA. This model explains the variability in our experiments, predicts validated targets more accurately than existing algorithms, and shows that genomes accommodate site accessibility by preferentially positioning targets in highly accessible regions. Our study thus demonstrates that target accessibility is a critical factor in microRNA function.	Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; Rockefeller Univ, Lab Dev Neurogenet, New York, NY 10021 USA	Weizmann Institute of Science; Rockefeller University	Gaul, U (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	gaul@mail.rockefeller.edu; eran@weizmann.ac.il	Segal, Eran/AAF-4855-2019	Segal, Eran/0000-0002-6859-1164; Iovino, Nicola/0000-0002-3335-7618				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Enright AJ, 2004, GENOME BIOL, V5; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Lai EC, 2005, GENE DEV, V19, P1067, DOI 10.1101/gad.1291905; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226; Muckstein U, 2006, BIOINFORMATICS, V22, P1177, DOI 10.1093/bioinformatics/btl024; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rehwinkel J, 2006, MOL CELL BIOL, V26, P2965, DOI 10.1128/MCB.26.8.2965-2975.2006; Robins H, 2005, P NATL ACAD SCI USA, V102, P4006, DOI 10.1073/pnas.0500775102; Sethupathy P, 2006, RNA, V12, P192, DOI 10.1261/rna.2239606; Sontheimer EJ, 2005, NAT REV MOL CELL BIO, V6, P127, DOI 10.1038/nrm1568; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Vella MC, 2004, CHEM BIOL, V11, P1619, DOI 10.1016/j.chembiol.2004.09.010; Wiese KC, 2006, BIOINFORMATICS, V22, P934, DOI 10.1093/bioinformatics/btl043; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	30	1797	1856	1	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2007	39	10					1278	1284		10.1038/ng2135	http://dx.doi.org/10.1038/ng2135			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17893677				2022-12-27	WOS:000249737400026
J	Stranger, BE; Nica, AC; Forrest, MS; Dimas, A; Bird, CP; Beazley, C; Ingle, CE; Dunning, M; Flicek, P; Koller, D; Montgomery, S; Tavare, S; Deloukas, P; Dermitzakis, ET				Stranger, Barbara E.; Nica, Alexandra C.; Forrest, Matthew S.; Dimas, Antigone; Bird, Christine P.; Beazley, Claude; Ingle, Catherine E.; Dunning, Mark; Flicek, Paul; Koller, Daphne; Montgomery, Stephen; Tavare, Simon; Deloukas, Panos; Dermitzakis, Emmanouil T.			Population genomics of human gene expression	NATURE GENETICS			English	Article							CONSERVED NONCODING SEQUENCES; COPY NUMBER VARIATION; REGULATORY VARIATION; WIDE ASSOCIATION; POLYMORPHISMS; LOCI; SUSCEPTIBILITY; MECHANISMS; MUTATION; ELEMENTS	Genetic variation influences gene expression, and this variation in gene expression can be efficiently mapped to specific genomic regions and variants. Here we have used gene expression profiling of Epstein-Barr virus-transformed lymphoblastoid cell lines of all 270 individuals genotyped in the HapMap Consortium to elucidate the detailed features of genetic variation underlying gene expression variation. We find that gene expression is heritable and that differentiation between populations is in agreement with earlier small-scale studies. A detailed association analysis of over 2.2 million common SNPs per population ( 5% frequency in HapMap) with gene expression identified at least 1,348 genes with association signals in cis and at least 180 in trans. Replication in at least one independent population was achieved for 37% of cis signals and 15% of trans signals, respectively. Our results strongly support an abundance of cis-regulatory variation in the human genome. Detection of trans effects is limited but suggests that regulatory variation may be the key primary effect contributing to phenotypic variation in humans. We also explore several methodologies that improve the current state of analysis of gene expression variation.	Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Cambridge, Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Dept Oncol, Cambridge CB2 0RE, England; Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA	Wellcome Trust Sanger Institute; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; Stanford University	Dermitzakis, ET (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	panos@sanger.ac.uk; md4@sanger.ac.uk		Dunning, Mark/0000-0002-8853-9435; Montgomery, Stephen/0000-0002-5200-3903; Forrest, Matthew/0000-0002-2141-0303; Stranger, Barbara/0000-0001-9021-7331; Flicek, Paul/0000-0002-3897-7955; Deloukas, Panos/0000-0001-9251-070X; Fosker, Christine/0000-0002-3799-9474	Wellcome Trust [077011, 077046] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abbasi AA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000366; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bansal A, 2002, P NATL ACAD SCI USA, V99, P16871, DOI 10.1073/pnas.262671399; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Camon Evelyn, 2004, In Silico Biology, V4, P5; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; CHURCHILL GA, 1994, GENETICS, V138, P963; Dermitzakis ET, 2003, SCIENCE, V302, P1033, DOI 10.1126/science.1087047; Doerge RW, 1996, GENETICS, V142, P285; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; DUNNING M, 2006, R NEWS, V6, P17; Dunning M, 2006, REVSTAT-STAT J, V4, P1; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Ferrari SL, 2004, AM J HUM GENET, V74, P866, DOI 10.1086/420771; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; Hoogendoorn B, 2004, HUM MUTAT, V24, P35, DOI 10.1002/humu.20061; *INT HAPMAP CONS, IN PRESS NATURE; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Knight JC, 2005, J MOL MED, V83, P97, DOI 10.1007/s00109-004-0603-7; KOREAN M, 2006, BRIT J CANCER, V94, P1539; Kuhn K, 2004, GENOME RES, V14, P2347, DOI 10.1101/gr.2739104; Lee SI, 2006, P NATL ACAD SCI USA, V103, P14062, DOI 10.1073/pnas.0601852103; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Mahley RW, 1999, CURR OPIN LIPIDOL, V10, P207, DOI 10.1097/00041433-199906000-00003; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Storey JD, 2005, PLOS BIOL, V3, P1380, DOI 10.1371/journal.pbio.0030267; Stranger Barbara E., 2006, Human Genomics, V2, P383; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger Barbara E., 2005, Human Genomics, V2, P126; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Woolfe A, 2005, PLOS BIOL, V3, P116, DOI 10.1371/journal.pbio.0030007; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	43	874	893	1	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2007	39	10					1217	1224		10.1038/ng2142	http://dx.doi.org/10.1038/ng2142			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17873874	Green Accepted			2022-12-27	WOS:000249737400017
J	Scherer, SW; Lee, C; Birney, E; Altshuler, DM; Eichler, EE; Carter, NP; Hurles, ME; Feuk, L				Scherer, Stephen W.; Lee, Charles; Birney, Ewan; Altshuler, David M.; Eichler, Evan E.; Carter, Nigel P.; Hurles, Matthew E.; Feuk, Lars			Challenges and standards in integrating surveys of structural variation	NATURE GENETICS			English	Article							COPY-NUMBER VARIATION; COMPARATIVE GENOMIC HYBRIDIZATION; HUMAN GENETIC-VARIATION; SEGMENTAL DUPLICATIONS; HOMOLOGOUS RECOMBINATION; OLIGONUCLEOTIDE ARRAYS; LINKAGE DISEQUILIBRIUM; EXPRESSION PROFILES; NORMAL INDIVIDUALS; WIDE DETECTION	There has been an explosion of data describing newly recognized structural variants in the human genome. In the flurry of reporting, there has been no standard approach to collecting the data, assessing its quality or describing identified features. This risks becoming a rampant problem, in particular with respect to surveys of copy number variation and their application to disease studies. Here, we consider the challenges in characterizing and documenting genomic structural variants. From this, we derive recommendations for standards to be adopted, with the aim of ensuring the accurate presentation of this form of genetic variation to facilitate ongoing research.	[Scherer, Stephen W.; Feuk, Lars] Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1L7, Canada; [Scherer, Stephen W.; Feuk, Lars] Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1L7, Canada; [Scherer, Stephen W.] Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1L7, Canada; [Lee, Charles] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lee, Charles] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Birney, Ewan] European Bioinformat Inst, Cambridge CB10 1SA, England; [Carter, Nigel P.; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Altshuler, David M.] Harvard Univ, Board Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Altshuler, David M.] Harvard Univ, MIT, Cambridge, MA 02142 USA; [Eichler, Evan E.] Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; European Molecular Biology Laboratory (EMBL); Wellcome Trust Sanger Institute; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Scherer, SW (corresponding author), Hosp Sick Children, Ctr Appl Genom, 14th Floor,Toronoto Med Discovery Tower,MaRS Disc, Toronto, ON M5G 1L7, Canada.	steve@genet.sickkids.on.ca	Altshuler, David M/A-4476-2009; Scherer, Stephen W./B-3785-2013	Altshuler, David M/0000-0002-7250-4107; Scherer, Stephen W./0000-0002-8326-1999; Birney, Ewan/0000-0001-8314-8497	Wellcome Trust [077014, 077008] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett ST, 2005, PHARMACOGENOMICS, V6, P373, DOI 10.1517/14622416.6.4.373; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Budarf ML, 1997, HUM MOL GENET, V6, P1657, DOI 10.1093/hmg/6.10.1657; Burgoon LD, 2006, NAT BIOTECHNOL, V24, P1369, DOI 10.1038/nbt1106-1369; Carson Andrew R., 2006, Human Genomics, V2, P403; Carter NP, 2007, NAT GENET, V39, pS16, DOI 10.1038/ng2028; CHANCE PF, 1994, HUM MOL GENET, V3, P223, DOI 10.1093/hmg/3.2.223; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Conrad DF, 2007, NAT GENET, V39, pS30, DOI 10.1038/ng2042; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Eichler EE, 2006, NAT GENET, V38, P9, DOI 10.1038/ng0106-9; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Feuk L, 2006, HUM MOL GENET, V15, pR57, DOI 10.1093/hmg/ddl057; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Heim S, 1996, PEDIATR HEMAT ONCOL, V13, pR3, DOI 10.3109/08880019609030800; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ikeo K, 2003, CR BIOL, V326, P1079, DOI 10.1016/j.crvi.2003.09.034; *ISCN, 1985, BIRTH DEFECTS ORIG A, V21, P1; Istrail S, 2004, P NATL ACAD SCI USA, V101, P1916, DOI 10.1073/pnas.0307971100; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lee C, 2007, NAT GENET, V39, pS48, DOI 10.1038/ng2092; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Locke DP, 2004, J MED GENET, V41, P175, DOI 10.1136/jmg.2003.013813; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Mullikin JC, 2000, NATURE, V407, P516, DOI 10.1038/35035089; Nannya Y, 2005, CANCER RES, V65, P6071, DOI 10.1158/0008-5472.CAN-05-0465; Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; RISIN S, 1992, CANCER GENET CYTOGEN, V60, P164, DOI 10.1016/0165-4608(92)90010-6; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Small K, 1997, NAT GENET, V16, P96, DOI 10.1038/ng0597-96; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Urban AE, 2006, P NATL ACAD SCI USA, V103, P4534, DOI 10.1073/pnas.0511340103; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916	73	265	279	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39			7			S7	S15		10.1038/ng2093	http://dx.doi.org/10.1038/ng2093			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	274AO	17597783	Green Accepted			2022-12-27	WOS:000253974400003
J	Bowman, AB; Lam, YC; Jafar-Nejad, P; Chen, HK; Richman, R; Samaco, RC; Fryer, JD; Kahle, JJ; Orr, HT; Zoghbi, HY				Bowman, Aaron B.; Lam, Yung C.; Jafar-Nejad, Paymaan; Chen, Hung-Kai; Richman, Ronald; Samaco, Rodney C.; Fryer, John D.; Kahle, Juliette J.; Orr, Harry T.; Zoghbi, Huda Y.			Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes	NATURE GENETICS			English	Article							NEURODEGENERATION IN-VIVO; MUTANT HUNTINGTIN; MEDIATES NEURODEGENERATION; TRANSCRIPTIONAL REPRESSION; NEURONAL DYSFUNCTION; INCLUSION FORMATION; CELLULAR TOXICITY; AXH DOMAIN; DISEASE; PROTEIN	Spinocerebellar ataxia type 1 (SCA1) is a dominantly inherited neurodegenerative disease caused by expansion of a glutamine tract in ataxin-1 (ATXN1). SCA1 pathogenesis studies support a model in which the expanded glutamine tract causes toxicity by modulating the normal activities of ATXN1. To explore native interactions that modify the toxicity of ATXN1, we generated a targeted duplication of the mouse ataxin-1-like (Atxn1I, also known as Boat) locus, a highly conserved paralog of SCA1, and tested the role of this protein in SCA1 pathology. Using a knock-in mouse model of SCA1 that recapitulates the selective neurodegeneration seen in affected individuals, we found that elevated Atxn1I levels suppress neuropathology by displacing mutant Atxn1 from its native complex with Capicua (CIC). Our results provide genetic evidence that the selective neuropathology of SCA1 arises from modulation of a core functional activity of ATXN1, and they underscore the importance of studying the paralogs of genes mutated in neurodegenerative diseases to gain insight into mechanisms of pathogenesis.	Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; Univ Minnesota, Dept Biochem, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; Univ Minnesota, Inst Human Genet, Minneapolis, MN 55455 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Baylor College of Medicine	Zoghbi, HY (corresponding author), Vanderbilt Univ, Vanderbilt Kennedy Ctr Res & Human Dev, Dept Neurol, Nashville, TN 37232 USA.	hzoghbi@bcm.tmc.edu		Chen, Hung-Kai/0000-0002-2169-4924; Bowman, Aaron/0000-0001-8728-3346; Samaco, Rodney/0000-0001-5636-5314; Orr, Harry/0000-0001-6118-741X; Zoghbi, Huda/0000-0002-0700-3349	NICHD NIH HHS [HD024064] Funding Source: Medline; NINDS NIH HHS [NS45667, NS27699, NS22920] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045667, R01NS027699, R37NS022920, R01NS022920] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arrasate M, 2004, NATURE, V431, P805, DOI 10.1038/nature02998; Auerbach W, 2001, HUM MOL GENET, V10, P2515, DOI 10.1093/hmg/10.22.2515; Bodner RA, 2006, P NATL ACAD SCI USA, V103, P4246, DOI 10.1073/pnas.0511256103; Bowman AB, 2005, HUM MOL GENET, V14, P679, DOI 10.1093/hmg/ddi064; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Chen HK, 2003, CELL, V113, P457, DOI 10.1016/S0092-8674(03)00349-0; Copps K, 1998, EMBO J, V17, P5409, DOI 10.1093/emboj/17.18.5409; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; da Costa CA, 2003, J BIOL CHEM, V278, P37330, DOI 10.1074/jbc.M306083200; Dragatsis I, 2000, NAT GENET, V26, P300, DOI 10.1038/81593; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Graham RK, 2006, CELL, V125, P1179, DOI 10.1016/j.cell.2006.04.026; Ho LW, 2001, J MED GENET, V38, P450, DOI 10.1136/jmg.38.7.450; Klement IA, 1998, CELL, V95, P41, DOI 10.1016/S0092-8674(00)81781-X; Lam YC, 2006, CELL, V127, P1335, DOI 10.1016/j.cell.2006.11.038; Leavitt BR, 2001, AM J HUM GENET, V68, P313, DOI 10.1086/318207; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Matilla A, 1998, J NEUROSCI, V18, P5508, DOI 10.1523/JNEUROSCI.18-14-05508.1998; Mizutani A, 2005, EMBO J, V24, P3339, DOI 10.1038/sj.emboj.7600785; Slow EJ, 2005, P NATL ACAD SCI USA, V102, P11402, DOI 10.1073/pnas.0503634102; Taylor JP, 2003, HUM MOL GENET, V12, P749, DOI 10.1093/hmg/ddg074; Tsai CC, 2004, P NATL ACAD SCI USA, V101, P4047, DOI 10.1073/pnas.0400615101; Tsuda H, 2005, CELL, V122, P633, DOI 10.1016/j.cell.2005.06.012; Van Raamsdonk JM, 2005, HUM MOL GENET, V14, P1379, DOI 10.1093/hmg/ddi147; Watase K, 2002, NEURON, V34, P905, DOI 10.1016/S0896-6273(02)00733-X; Yoo SY, 2003, NEURON, V37, P383, DOI 10.1016/S0896-6273(02)01190-X; Zhai WG, 2005, CELL, V123, P1241, DOI 10.1016/j.cell.2005.10.030; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219	29	62	67	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2007	39	3					373	379		10.1038/ng1977	http://dx.doi.org/10.1038/ng1977			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17322884				2022-12-27	WOS:000244480000020
J	Xia, B; Dorsman, JC; Ameziane, N; de Vries, Y; Rooimans, MA; Sheng, Q; Pals, G; Errami, A; Gluckman, E; Llera, J; Wang, W; Livingston, DM; Joenje, H; de Winter, JP				Xia, Bing; Dorsman, Josephine C.; Ameziane, Najim; de Vries, Yne; Rooimans, Martin A.; Sheng, Qing; Pals, Gerard; Errami, Abdellatif; Gluckman, Eliane; Llera, Julian; Wang, Weidong; Livingston, David M.; Joenje, Hans; de Winter, Johan P.			Fanconi anemia is associated with a defect in the BRCA2 partner PALB2	NATURE GENETICS			English	Article								The Fanconi anemia and BRCA networks are considered interconnected, as BRCA2 gene defects have been discovered in individuals with Fanconi anemia subtype D1. Here we show that a defect in the BRCA2- interacting protein PALB2 is associated with Fanconi anemia in an individual with a new subtype. PALB2- deficient cells showed hypersensitivity to cross- linking agents and lacked chromatin- bound BRCA2; these defects were corrected upon ectopic expression of PALB2 or by spontaneous reversion.	Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, NL-1081 BT Amsterdam, Netherlands; Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; MRC Holland BV, NL-1057 SN Amsterdam, Netherlands; Hop St Louis, Bone Marrow Transplant Unit, F-75475 Paris 10, France; Hosp Italiano Buenos Aires, Dept Pediat, Buenos Aires, DF, Argentina; NIA, Genet Lab, US Natl Inst Hlth, Baltimore, MD 21224 USA	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Hospital Italiano de Buenos Aires; University of Buenos Aires; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	de Winter, JP (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Van Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	David_Livingston@dfci.harvard.edu; j.dewinter@vumc.nl	Pals, Gerard/A-5198-2011; Wang, Weidong/AAV-2446-2021; eliane, Gluckman/AAA-5024-2021	Pals, Gerard/0000-0003-4091-7115; Wang, Weidong/0000-0002-0658-7928	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE ON AGING [Z01AG000688, ZIAAG000688] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alter BP, 2007, J MED GENET, V44, P1, DOI 10.1136/jmg.2006.043257; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bermejo JL, 2004, ANN ONCOL, V15, P1834, DOI [10.1093/annone/mdh474, 10.1093/annonc/mdh474]; Chang Mary Wu, 2003, Lymphat Res Biol, V1, P259; Friedenson Bernard, 2005, MedGenMed, V7, P60; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levitus M, 2006, CELL ONCOL, V28, P3; Mueller BU, 1999, SEMIN PERINATOL, V23, P332, DOI 10.1016/S0146-0005(99)80041-X; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Waisfisz Q, 1999, NAT GENET, V22, P379, DOI 10.1038/11956; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022	13	352	358	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					159	161		10.1038/ng1942	http://dx.doi.org/10.1038/ng1942			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17200672				2022-12-27	WOS:000244063900011
J	Mu, JB; Awadalla, P; Duan, JH; McGee, KM; Keebler, J; Seydel, K; McVean, GAT; Su, XZ				Mu, Jianbing; Awadalla, Philip; Duan, Junhui; McGee, Kate M.; Keebler, Jon; Seydel, Karl; McVean, Gilean A. T.; Su, Xin-zhuan			Genome-wide variation and identification of vaccine targets in the Plasmodium falciparum genome	NATURE GENETICS			English	Article							DIVERSIFYING SELECTION; GENETIC DIVERSITY; MALARIA; RECOMBINATION; POLYMORPHISMS; ERYTHROCYTES; RESISTANCE; PROTEINS; LOCUS; ASSAY	One goal in sequencing the Plasmodium falciparum genome, the agent of the most lethal form of malaria, is to discover vaccine and drug targets(1). However, identifying those targets in a genome in which similar to 60% of genes have unknown functions is an enormous challenge. Because the majority of known malaria antigens and drug-resistant genes are highly polymorphic and under various selective pressures(2-6), genome-wide analysis for signatures of selection may lead to discovery of new vaccine and drug candidates. Here we surveyed 3,539 P. falciparum genes (similar to 65% of the predicted genes) for polymorphisms and identified various highly polymorphic loci and genes, some of which encode new antigens that we confirmed using human immune sera. Our collections of genome-wide SNPs (similar to 65% nonsynonymous) and polymorphic microsatellites and indels provide a high-resolution map (one marker per similar to 4 kb) for mapping parasite traits and studying parasite populations. In addition, we report new antigens, providing urgently needed vaccine candidates for disease control.	NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA; N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; Univ Oxford, Dept Stat, Oxford OX1 3TG, England	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of North Carolina; North Carolina State University; University of Oxford	Awadalla, P (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	pawadalla@ncsu.edu; xsu@niaid.nih.gov	Awadalla, Philip/AAC-4896-2021	Su, Xinzhuan/0000-0003-3246-3248	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000892, Z01AI000892] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Baum J, 2003, GENETICS, V163, P1327; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Conway DJ, 2000, NAT MED, V6, P689, DOI 10.1038/76272; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Hardenbol P, 2005, GENOME RES, V15, P269, DOI 10.1101/gr.3185605; Hey J, 1999, CURR BIOL, V9, pR565, DOI 10.1016/S0960-9822(99)80356-X; HUDSON RR, 1988, GENETICS, V120, P831; Kennedy GC, 2003, NAT BIOTECHNOL, V21, P1233, DOI 10.1038/nbt869; Kissinger JC, 2002, NATURE, V419, P490, DOI 10.1038/419490a; Lindblad-Toh K, 2000, NAT GENET, V24, P381, DOI 10.1038/74215; Mu JB, 2005, PLOS BIOL, V3, P1734, DOI 10.1371/journal.pbio.0030335; Mu JB, 2002, NATURE, V418, P323, DOI 10.1038/nature00836; Myers SR, 2003, GENETICS, V163, P375; Nordborg M, 1996, P ROY SOC B-BIOL SCI, V263, P1033, DOI 10.1098/rspb.1996.0152; Polley SD, 2001, GENETICS, V158, P1505; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Sato S, 2005, CURR TOP MICROBIOL, V295, P251; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Su XZ, 1997, CELL, V91, P593, DOI 10.1016/S0092-8674(00)80447-X; Trimnell AR, 2006, MOL BIOCHEM PARASIT, V148, P169, DOI 10.1016/j.molbiopara.2006.03.012; VAIDYA AB, 1995, MOL BIOCHEM PARASIT, V69, P65, DOI 10.1016/0166-6851(94)00199-W; Volkman SK, 2002, SCIENCE, V298, P216, DOI 10.1126/science.1075642; Wang P, 1997, MOL MICROBIOL, V23, P979, DOI 10.1046/j.1365-2958.1997.2821646.x; WELLEMS TE, 1991, P NATL ACAD SCI USA, V88, P3382, DOI 10.1073/pnas.88.8.3382; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813	29	164	165	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2007	39	1					126	130		10.1038/ng1924	http://dx.doi.org/10.1038/ng1924			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	17159981	Bronze			2022-12-27	WOS:000243136500028
J	Saburi, S; Hester, I; Fischer, E; Pontoglio, M; Eremina, V; Gessler, M; Quaggin, SE; Harrison, R; Mount, R; McNeill, H				Saburi, Sakura; Hester, Ian; Fischer, Evelyne; Pontoglio, Marco; Eremina, Vera; Gessler, Manfred; Quaggin, Sue E.; Harrison, Robert; Mount, Richard; McNeill, Helen			Loss of Fat4 disrupts PCP signaling and oriented cell division and leads to cystic kidney disease	NATURE GENETICS			English	Article							PLANAR POLARITY; DROSOPHILA EYE; MICE LACKING; HAIR-CELLS; CILIA; ORIENTATION; EXPRESSION; CADHERINS; DEFECTS; GENES	Tissue organization in Drosophila is regulated by the core planar cell polarity (PCP) proteins Frizzled, Dishevelled, Prickle, Van Gogh and Flamingo. Core PCP proteins are conserved in mammals and function in mammalian tissue organization. Recent studies have identified another group of Drosophila PCP proteins, consisting of the protocadherins Fat and Dachsous (Ds) and the transmembrane protein Four-jointed (Fj). In Drosophila, Fat represses fj transcription, and Ds represses Fat activity in PCP. Here we show that Fat4 is an essential gene that has a key role in vertebrate PCP. Loss of Fat4 disrupts oriented cell divisions and tubule elongation during kidney development, leading to cystic kidney disease. Fat4 genetically interacts with the PCP genes Vangl2 and Fjx1 in cyst formation. In addition, Fat4 represses Fjx1 expression, indicating that Fat signaling is conserved. Together, these data suggest that Fat4 regulates vertebrate PCP and that loss of PCP signaling may underlie some cystic diseases in humans.	[Saburi, Sakura; Hester, Ian; Eremina, Vera; Quaggin, Sue E.; McNeill, Helen] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Fischer, Evelyne; Pontoglio, Marco] Ctr Natl Rech Sci URA 2578, Dept Dev Biol, Gene Express Dev & Dis Lab, Inst Pasteur, Paris, France; [Gessler, Manfred] Univ Wurzburg, Theodor Boveri Inst, D-97074 Wurzburg, Germany; [Quaggin, Sue E.] St Michaels Hosp, Toronto, ON M5G 1X5, Canada; [Harrison, Robert; Mount, Richard] Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [McNeill, Helen] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Wurzburg; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	McNeill, H (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	mcneill@mshri.on.ca	fischer, evelyne/GLT-9457-2022; McNeill, Helen/E-4579-2013	McNeill, Helen/0000-0003-1126-5154; Gessler, Manfred/0000-0002-7915-6045; fischer, evelyne/0000-0001-5054-1444	Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; Casal J, 2002, CURR BIOL, V12, P1189, DOI 10.1016/S0960-9822(02)00974-0; Casal J, 2006, DEVELOPMENT, V133, P4561, DOI 10.1242/dev.02641; Ciani L, 2003, MOL CELL BIOL, V23, P3575, DOI 10.1128/MCB.23.10.3575-3582.2003; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Fanto M, 2003, DEVELOPMENT, V130, P763, DOI 10.1242/dev.00304; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; Hildebrandt F, 2005, NAT REV GENET, V6, P928, DOI 10.1038/nrg1727; Jones C, 2007, BIOESSAYS, V29, P120, DOI 10.1002/bies.20526; Kume T, 2000, DEVELOPMENT, V127, P1387; Ma D, 2003, NATURE, V421, P543, DOI 10.1038/nature01366; Matakatsu H, 2004, DEVELOPMENT, V131, P3785, DOI 10.1242/dev.01254; Matakatsu H, 2006, DEVELOPMENT, V133, P2315, DOI 10.1242/dev.02401; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Patel V, 2008, HUM MOL GENET, V17, P1578, DOI 10.1093/hmg/ddn045; Probst B, 2007, DEV BIOL, V312, P461, DOI 10.1016/j.ydbio.2007.09.054; Rawls AS, 2002, CURR BIOL, V12, P1021, DOI 10.1016/S0960-9822(02)00893-X; Rock R, 2005, DEV DYNAM, V234, P747, DOI 10.1002/dvdy.20515; Saburi S, 2005, CURR OPIN CELL BIOL, V17, P482, DOI 10.1016/j.ceb.2005.08.011; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Simon MA, 2004, DEVELOPMENT, V131, P6175, DOI 10.1242/dev.01550; Simons M, 2006, KIDNEY INT, V70, P854, DOI 10.1038/sj.ki.5001534; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Yang CH, 2002, CELL, V108, P675, DOI 10.1016/S0092-8674(02)00658-X; Yoder BK, 2007, J AM SOC NEPHROL, V18, P1381, DOI 10.1681/ASN.2006111215; Zeidler MP, 1999, CURR BIOL, V9, P1363, DOI 10.1016/S0960-9822(00)80081-0	30	384	394	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					1010	1015		10.1038/ng.179	http://dx.doi.org/10.1038/ng.179			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18604206				2022-12-27	WOS:000258026900019
J	Nousiainen, HO; Kestila, M; Pakkasjarvi, N; Honkala, H; Kuure, S; Tallila, J; Vuopala, K; Ignatius, J; Herva, R; Peltonen, L				Nousiainen, Heidi O.; Kestila, Marjo; Pakkasjarvi, Niklas; Honkala, Heli; Kuure, Satu; Tallila, Jonna; Vuopala, Katri; Ignatius, Jaakko; Herva, Riitta; Peltonen, Leena			Mutations in mRNA export mediator GLE1 result in a fetal motoneuron disease	NATURE GENETICS			English	Article							BOX PROTEIN DBP5; PATHWAY	The most severe forms of motoneuron disease manifest in utero are characterized by marked atrophy of spinal cord motoneurons and fetal immobility. Here, we report that the defective gene underlying lethal motoneuron syndrome LCCS1 is the mRNA export mediator GLE1. Our finding of mutated GLE1 exposes a common pathway connecting the genes implicated in LCCS1, LCCS2 and LCCS3 and elucidates mRNA processing as a critical molecular mechanism in motoneuron development and maturation.	[Nousiainen, Heidi O.; Kestila, Marjo; Pakkasjarvi, Niklas; Honkala, Heli; Tallila, Jonna; Peltonen, Leena] Natl Publ Hlth Inst, Dept Mol Med, Helsinki 00290, Finland; [Kuure, Satu] Univ Helsinki, Inst Biomed, FIN-00014 Helsinki, Finland; [Vuopala, Katri] Lapland Cent Hosp, Dept Pathol, Rovaniemi 96100, Finland; [Ignatius, Jaakko] Oulu Univ Hosp, Dept Clin Genet, Oulu 90014, Finland; [Ignatius, Jaakko] Univ Oulu, Oulu 90014, Finland; [Herva, Riitta] Oulu Univ Hosp, Dept Pathol, Oulu 90029, Finland; [Peltonen, Leena] Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; [Peltonen, Leena] Broad Inst, Cambridge, MA 02142 USA; [Peltonen, Leena] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England	Finland National Institute for Health & Welfare; University of Helsinki; University of Oulu; University of Oulu; University of Oulu; University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Wellcome Trust Sanger Institute	Kestila, M (corresponding author), Natl Publ Hlth Inst, Dept Mol Med, Helsinki 00290, Finland.	marjo.kestila@ktl.fi	, shkuure/AAE-2751-2019	, shkuure/0000-0002-9076-0622	NIEHS NIH HHS [P01 ES11253-03, P01 ES011253] Funding Source: Medline; Wellcome Trust [089061] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011253] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Dubowitz V, 1999, Eur J Paediatr Neurol, V3, P49; HERVA R, 1988, AM J MED GENET, V29, P67, DOI 10.1002/ajmg.1320290109; Kendirgi F, 2003, J CELL BIOL, V160, P1029, DOI 10.1083/jcb.200211081; Kendirgi F, 2005, MOL BIOL CELL, V16, P4304, DOI 10.1091/mbc.E04-11-0998; Makela-Bengs P, 1998, AM J HUM GENET, V63, P506, DOI 10.1086/301968; Narkis G, 2007, AM J HUM GENET, V81, P530, DOI 10.1086/520771; Narkis G, 2007, AM J HUM GENET, V81, P589, DOI 10.1086/520770; Pakkasjarvi N, 2005, J NEUROBIOL, V65, P269, DOI 10.1002/neu.20185; Rayala HJ, 2004, MOL CELL PROTEOMICS, V3, P145, DOI 10.1074/mcp.M300106-MCP200; VUOPALA K, 1995, HUM PATHOL, V26, P12, DOI 10.1016/0046-8177(95)90109-4; Wang WL, 2007, DEV NEUROBIOL, V67, P1166, DOI 10.1002/dneu.20511; Watkins JL, 1998, P NATL ACAD SCI USA, V95, P6779, DOI 10.1073/pnas.95.12.6779; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424	15	133	142	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2008	40	2					155	157		10.1038/ng.2007.65	http://dx.doi.org/10.1038/ng.2007.65			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18204449	Green Accepted			2022-12-27	WOS:000252732900012
J	Sanna, S; Jackson, AU; Nagaraja, R; Willer, CJ; Chen, WM; Bonnycastle, LL; Shen, HQ; Timpson, N; Lettre, G; Usala, G; Chines, PS; Stringham, HM; Scott, LJ; Dei, M; Lai, S; Albai, G; Crisponi, L; Naitza, S; Doheny, KF; Pugh, EW; Ben-Shlomo, Y; Ebrahim, S; Lawlor, DA; Bergman, RN; Watanabe, RM; Uda, M; Tuomilehto, J; Coresh, J; Hirschhorn, JN; Shuldiner, AR; Schlessinger, D; Collins, FS; Smith, GD; Boerwinkle, E; Cao, A; Boehnke, M; Abecasis, GR; Mohlke, KL				Sanna, Serena; Jackson, Anne U.; Nagaraja, Ramaiah; Willer, Cristen J.; Chen, Wei-Min; Bonnycastle, Lori L.; Shen, Haiqing; Timpson, Nicholas; Lettre, Guillaume; Usala, Gianluca; Chines, Peter S.; Stringham, Heather M.; Scott, Laura J.; Dei, Mariano; Lai, Sandra; Albai, Giuseppe; Crisponi, Laura; Naitza, Silvia; Doheny, Kimberly F.; Pugh, Elizabeth W.; Ben-Shlomo, Yoav; Ebrahim, Shah; Lawlor, Debbie A.; Bergman, Richard N.; Watanabe, Richard M.; Uda, Manuela; Tuomilehto, Jaakko; Coresh, Josef; Hirschhorn, Joel N.; Shuldiner, Alan R.; Schlessinger, David; Collins, Francis S.; Smith, George Davey; Boerwinkle, Eric; Cao, Antonio; Boehnke, Michael; Abecasis, Goncalo R.; Mohlke, Karen L.			Common variants in the GDF5-UQCC region are associated with variation in human height	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY; EXPRESSION; ADULT; OSTEOARTHRITIS; HERITABILITY; GENE; GDF5	Identifying genetic variants that influence human height will advance our understanding of skeletal growth and development. Several rare genetic variants have been convincingly and reproducibly associated with height in mendelian syndromes, and common variants in the transcription factor gene HMGA2 are associated with variation in height in the general population(1). Here we report genome-wide association analyses, using genotyped and imputed markers, of 6,669 individuals from Finland and Sardinia, and follow-up analyses in an additional 28,801 individuals. We show that common variants in the osteoarthritis-associated locus(2) GDF5-UQCC contribute to variation in height with an estimated additive effect of 0.44 cm (overall P < 10(-15)). Our results indicate that there may be a link between the genetic basis of height and osteoarthritis, potentially mediated through alterations in bone growth and development.	[Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Sanna, Serena; Jackson, Anne U.; Willer, Cristen J.; Chen, Wei-Min; Stringham, Heather M.; Scott, Laura J.; Boehnke, Michael; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Sanna, Serena; Usala, Gianluca; Dei, Mariano; Lai, Sandra; Albai, Giuseppe; Crisponi, Laura; Naitza, Silvia; Uda, Manuela; Cao, Antonio] Citta Univ Monserrato, CNR, INN, I-09042 Cagliari, Italy; [Nagaraja, Ramaiah; Schlessinger, David] NIA, Gerontol Res Ctr, Baltimore, MD 21224 USA; [Chen, Wei-Min] Univ Virginia, Sch Med, Dept Publ Hlth Sci, Div Biostat & Epidemiol, Charlottesville, VA 22908 USA; [Bonnycastle, Lori L.; Chines, Peter S.; Collins, Francis S.] NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; [Shen, Haiqing; Shuldiner, Alan R.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Timpson, Nicholas; Ben-Shlomo, Yoav; Lawlor, Debbie A.; Smith, George Davey] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; [Timpson, Nicholas; Lawlor, Debbie A.; Smith, George Davey] Univ Bristol, MRC, Ctr Causal Anal Translat Epidemiol, Bristol BS8 2PR, Avon, England; [Lettre, Guillaume; Hirschhorn, Joel N.] Harvard & MIT, Broad Inst, Program Med & Populat Genet, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Doheny, Kimberly F.; Pugh, Elizabeth W.] Johns Hopkins Univ, Sch Med, Inst Med Genet, CIDR, Baltimore, MD 21224 USA; [Ebrahim, Shah] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Bergman, Richard N.; Watanabe, Richard M.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Watanabe, Richard M.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; [Tuomilehto, Jaakko] Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, Diabet Unit, SF-00300 Helsinki, Finland; [Tuomilehto, Jaakko] Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland; [Coresh, Josef] Johns Hopkins Med Inst, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; [Shuldiner, Alan R.] Vet Adm Med Ctr, Geriatr Res & Educ Ctr, Baltimore, MD 21201 USA; [Boerwinkle, Eric] Univ Texas Houston, Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77225 USA; [Boerwinkle, Eric] Univ Texas Houston, Hlth Sci Ctr, Inst Mol Med, Houston, TX 77225 USA	University of North Carolina; University of North Carolina Chapel Hill; University of Michigan System; University of Michigan; Consiglio Nazionale delle Ricerche (CNR); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Virginia; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University System of Maryland; University of Maryland Baltimore; University of Bristol; University of Bristol; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Johns Hopkins University; University of London; London School of Hygiene & Tropical Medicine; University of Southern California; University of Southern California; Finland National Institute for Health & Welfare; University of Helsinki; Johns Hopkins University; Johns Hopkins Medicine; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Mohlke, KL (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA.	goncalo@umich.edu; mohlke@med.unc.edu	Timpson, Nicholas John/O-7548-2015; Ben-Shlomo, Yoav/ABD-2004-2021; NAITZA, SILVIA/AAB-8775-2022; Chen, Wei-Min/A-8469-2009; Uda, Manuela/AAC-2645-2019; Abecasis, Goncalo R/B-7840-2010; Lai, Sandra/AAY-4176-2020; Dei, Mariano/AAY-3870-2020; sanna, serena/H-3009-2019; Fox, Laura J/C-6249-2016; Davey Smith, George/A-7407-2013; Naitza, Silvia/D-5620-2017; Crisponi, Laura/AAC-2642-2019; Attrill, Lauren/V-1688-2018	Timpson, Nicholas John/0000-0002-7141-9189; Ben-Shlomo, Yoav/0000-0001-6648-3007; NAITZA, SILVIA/0000-0002-0108-757X; Uda, Manuela/0000-0002-4890-6456; sanna, serena/0000-0002-3768-1749; Davey Smith, George/0000-0002-1407-8314; Crisponi, Laura/0000-0001-9128-8537; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Abecasis, Goncalo/0000-0003-1509-1825; Shuldiner, Alan/0000-0001-9921-4305; Lawlor, Debbie A/0000-0002-6793-2262; s, hema/0000-0002-3440-9475; Willer, Cristen/0000-0001-5645-4966; Dei, Mariano/0000-0002-7404-508X	Intramural NIH HHS [Z01 HG000024] Funding Source: Medline; Medical Research Council [G0000934, G0600705] Funding Source: Medline; NCRR NIH HHS [M01 RR 16500, M01 RR016500] Funding Source: Medline; NHGRI NIH HHS [R01 HG002651, HG002651, R01 HG002651-05S2, N01HG65403] Funding Source: Medline; NHLBI NIH HHS [N01-HC-55018, N01-HC-55021, N01HC55022, HL72515, N01HC55021, N01-HC-55016, U01 HL084729-03, HL084729, N01-HC-55015, N01-HC-55019, N01-HC-55020, N01HC55016, U01 HL072515, N01HC55020, U01 HL084729, N01HC55018, N01-HC-55022, N01HC55015, N01HC55019] Funding Source: Medline; NIAMS NIH HHS [R01 AR046838, AR046838] Funding Source: Medline; NIA NIH HHS [R01 AG018728, AG18728] Funding Source: Medline; NIDDK NIH HHS [DK062370, P30 DK072488, R01 DK062370, R56 DK062370, R01 DK029867, DK072193, R01 DK072193, U01 DK062370, R01 DK072193-04, DK54361] Funding Source: Medline; Wellcome Trust [068545/Z/02] Funding Source: Medline; Direct For Biological Sciences [0820619] Funding Source: National Science Foundation; Division Of Environmental Biology [1020271] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [0820940] Funding Source: National Science Foundation; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055020, N01HC055016, N01HC055015, N01HC055022, N01HC055021, N01HC055018, N01HC055019] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR016500] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R42HL055018, R41HL055019, U01HL084729, R41HL055018, U01HL072515] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG000024, R01HG002651, N01HG065403, ZIAHG000024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046838] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK029867, R56DK062370, R01DK062370, U01DK062370, R01DK072193, P30DK072488] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000675, R01AG018728] Funding Source: NIH RePORTER; MRC [G0600705, G0000934] Funding Source: UKRI	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome Trust); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Burdick JT, 2006, NAT GENET, V38, P1002, DOI 10.1038/ng1863; CHANG SC, 1994, J BIOL CHEM, V269, P28227; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Chujo T, 2006, SPINE, V31, P2909, DOI 10.1097/01.brs.0000248428.22823.86; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; ELWOOD PC, 1984, J EPIDEMIOL COMMUN H, V38, P259, DOI 10.1136/jech.38.3.259; FEHILY AM, 1990, EUR J CLIN NUTR, V44, P107; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frere C, 2006, BLOOD, V108, P1562, DOI 10.1182/blood-2006-01-008094; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Hsueh WC, 2000, DIABETES CARE, V23, P595, DOI 10.2337/diacare.23.5.595; Imabayashi H, 2003, EXP CELL RES, V288, P35, DOI 10.1016/S0014-4827(03)00130-7; Lawlor DA, 2003, J EPIDEMIOL COMMUN H, V57, P134, DOI 10.1136/jech.57.2.134; McKenzie CA, 2001, HUM MOL GENET, V10, P1077, DOI 10.1093/hmg/10.10.1077; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Southam L, 2007, HUM MOL GENET, V16, P2226, DOI 10.1093/hmg/ddm174; Streeten EA, 2004, J BONE MINER RES, V19, P308, DOI 10.1359/JBMR.0301223; Valdes AM, 2007, ARTHRITIS RHEUM-US, V56, P137, DOI 10.1002/art.22301; Vetter K, 2001, MECH DEVELOP, V100, P123, DOI 10.1016/S0925-4773(00)00511-6; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	29	293	306	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					198	203		10.1038/ng.74	http://dx.doi.org/10.1038/ng.74			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18193045	Green Submitted, Green Accepted			2022-12-27	WOS:000252732900018
J	Xu, N; Donohoe, ME; Silva, SS; Lee, JT				Xu, Na; Donohoe, Mary E.; Silva, Susana S.; Lee, Jeannie T.			Evidence that homologous X-chromosome pairing requires transcription and Ctcf protein	NATURE GENETICS			English	Article							XIST GENE; CHROMATIN CONFORMATION; INACTIVATION CHOICE; TSIX TRANSCRIPTION; METHYLATION; RNA; COLOCALIZATION; IDENTIFICATION; NUCLEUS; BINDING	X-chromosome inactivation (XCI) ensures the equality of X-chromosome dosages in male and female mammals by silencing one X in the female(1). To achieve the mutually exclusive designation of active X (Xa) and inactive X ( Xi), the process necessitates that two Xs communicate in trans through homologous pairing(2,3). Pairing depends on a 15-kb region within the genes Tsix and Xite(2). Here, we dissect molecular requirements and find that pairing can be recapitulated by 1- to 2-kb subfragments of Tsix or Xite with little sequence similarity. However, a common denominator among them is the presence of the protein Ctcf, a chromatin insulator(4-7) that we find to be essential for pairing. By contrast, the Ctcf-interacting partner, Yy1 (ref. 8), is not required. Pairing also depends on transcription. Transcriptional inhibition prevents new pair formation but does not perturb existing pairs. The kinetics suggest a pairing half-life of < 1 h. We propose that pairing requires Ctcf binding and co-transcriptional activity of Tsix and Xite.	Harvard Univ, Sch Med,Dept Genet, Massachusetts Gen Hosp, Dept Mol Biol,Howard Hughes Med Inst, Boston, MA 02114 USA; Programme Biomed, P-2780156 Oeiras, Portugal	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute	Lee, JT (corresponding author), Harvard Univ, Sch Med,Dept Genet, Massachusetts Gen Hosp, Dept Mol Biol,Howard Hughes Med Inst, Boston, MA 02114 USA.	lee@molbio.mgh.harvard.edu			NIGMS NIH HHS [R01-GM58839] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058839] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; BROCKDORFF N, 1992, CELL, V71, P515, DOI 10.1016/0092-8674(92)90519-I; BROWN CJ, 1992, CELL, V71, P527, DOI 10.1016/0092-8674(92)90520-M; Chao W, 2002, SCIENCE, V295, P345, DOI 10.1126/science.1065982; Cohen DE, 2007, DEV CELL, V12, P57, DOI 10.1016/j.devcel.2006.11.014; Donohoe ME, 2007, MOL CELL, V25, P43, DOI 10.1016/j.molcel.2006.11.017; Hark AT, 2000, NATURE, V405, P486, DOI 10.1038/35013106; Kanduri C, 2000, CURR BIOL, V10, P853, DOI 10.1016/S0960-9822(00)00597-2; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lee JT, 2005, SCIENCE, V309, P768, DOI 10.1126/science.1113673; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Lee JT, 2002, NAT GENET, V32, P195, DOI 10.1038/ng939; Lee JT, 1999, NAT GENET, V21, P400, DOI 10.1038/7734; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Navarro P, 2005, GENE DEV, V19, P1474, DOI 10.1101/gad.341105; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Ogawa Y, 2003, MOL CELL, V11, P731, DOI 10.1016/S1097-2765(03)00063-7; Sado T, 2005, DEV CELL, V9, P159, DOI 10.1016/j.devcel.2005.05.015; Sado T, 2001, DEVELOPMENT, V128, P1275; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Stavropoulos N, 2005, MOL CELL BIOL, V25, P2757, DOI 10.1128/MCB.25.7.2757-2769.2005; Sun BK, 2006, MOL CELL, V21, P617, DOI 10.1016/j.molcel.2006.01.028; Syken J, 1999, P NATL ACAD SCI USA, V96, P8499, DOI 10.1073/pnas.96.15.8499; Vigneau S, 2006, P NATL ACAD SCI USA, V103, P7390, DOI 10.1073/pnas.0602381103; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984	30	160	165	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2007	39	11					1390	1396		10.1038/ng.2007.5	http://dx.doi.org/10.1038/ng.2007.5			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17952071				2022-12-27	WOS:000250575900024
J	Weedon, MN; Lettre, G; Freathy, RM; Lindgren, CM; Voight, BF; Perry, JRB; Elliott, KS; Hackett, R; Guiducci, C; Shields, B; Zeggini, E; Lango, H; Lyssenko, V; Timpson, NJ; Burtt, NP; Rayner, NW; Saxena, R; Ardlie, K; Tobias, JH; Ness, AR; Ring, SM; Palmer, CNA; Morris, AD; Peltonen, L; Salomaa, V; Smith, GD; Groop, LC; Hattersley, AT; McCarthy, MI; Hirschhorn, JN; Frayling, TM				Weedon, Michael N.; Lettre, Guillaume; Freathy, Rachel M.; Lindgren, Cecilia M.; Voight, Benjamin F.; Perry, John R. B.; Elliott, Katherine S.; Hackett, Rachel; Guiducci, Candace; Shields, Beverley; Zeggini, Eleftheria; Lango, Hana; Lyssenko, Valeriya; Timpson, Nicholas J.; Burtt, Noel P.; Rayner, Nigel W.; Saxena, Richa; Ardlie, Kristin; Tobias, Jonathan H.; Ness, Andrew R.; Ring, Susan M.; Palmer, Colin N. A.; Morris, Andrew D.; Peltonen, Leena; Salomaa, Veikko; Smith, George Davey; Groop, Leif C.; Hattersley, Andrew T.; McCarthy, Mark I.; Hirschhorn, Joel N.; Frayling, Timothy M.		Diabet Genetics Initiative; Wellcome Trust Case Control Con	A common variant of HMGA2 is associated with adult and childhood height in the general population	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; BODY HEIGHT; C GENE; RISK; HERITABILITY; DISEASE; STRATIFICATION; SUSCEPTIBILITY; METHODOLOGY; PHENOTYPE	Human height is a classic, highly heritable quantitative trait. To begin to identify genetic variants influencing height, we examined genome-wide association data from 4,921 individuals. Common variants in the HMGA2 oncogene, exemplified by rs1042725, were associated with height (P= 4x10(-8)). HMGA2 is also a strong biological candidate for height, as rare, severe mutations in this gene alter body size in mice and humans, so we tested rs1042725 in additional samples. We confirmed the association in 19,064 adults from four further studies (P= 3x10(-11), overall P= 4x10(-16), including the genome-wide association data). We also observed the association in children (P=1x 10(-6), N= 6,827) and a tall/short case-control study (P= 4x10(-6), N=3,207). We estimate that rs1042725 explains similar to 0.3% of population variation in height (similar to 0.4 cm increased adult height per C allele). There are few examples of common genetic variants reproducibly associated with human quantitative traits; these results represent, to our knowledge, the first consistently replicated association with adult and childhood height.	Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX1 2LU, Devon, England; Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England; Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; Childrens Hosp, Div Genet & Endocrinol, Program Genom, Boston, MA 02115 USA; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, Churchill Hosp, Oxford Ctr Diab Endocrinol & Metab, Oxford OX3 7LJ, England; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Lund Univ, Malmo Univ Hosp, Dept Clin Sci Diab & Endocrinol, S-20502 Malmo, Sweden; Univ Helsinki, Helsinki Univ Cent Hosp,Dep Med, Folkhalsan Genet Inst,Folkhalsan Res Ctr, Res Program Mol Med, Helsinki, Finland; Univ Bristol, MRC Ctr Causal Analyses Translat Epidemiol, Bristol BS8 2PR, Avon, England; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Univ Bristol, Clin Sci S Bristol, Bristol BS2 8AE, Avon, England; Univ Bristol, Bristol Dent Sch, Dept Oral & Dent Sci, Bristol BS1 2LY, Avon, England; Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; Univ Dundee, Ninewells Hosp, Sch Med,Populat Pharmacogenet Grp, Biomed Res Ctr, Dundee DD1 9SY, Scotland; Univ Dundee, Ninewells Hosp, Sch Med, Div Med & Therapeut,Diab Res Grp, Dundee DD1 9SY, Scotland; Natl Publ Hlth Inst, Dept Mol Med, FI-00290 Helsinki, Finland; Univ Helsinki, Dept Med Genet, FI-00014 Helsinki, Finland; Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, FI-00300 Helsinki, Finland; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	University of Exeter; University of Exeter; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Harvard University; Massachusetts General Hospital; Lund University; Skane University Hospital; Folkhalsan Research Center; University of Helsinki; Helsinki University Central Hospital; University of Bristol; Harvard University; Massachusetts General Hospital; University of Bristol; University of Bristol; University of Bristol; University of Dundee; University of Dundee; Finland National Institute for Health & Welfare; University of Helsinki; Finland National Institute for Health & Welfare; Harvard University; Harvard Medical School	Frayling, TM (corresponding author), Peninsula Med Sch, Inst Biomed & Clin Sci, Magdalen Rd, Exeter EX1 2LU, Devon, England.	Tim.Frayling@pms.ac.uk	Tobias, Jon/E-2832-2014; Attrill, Lauren/V-1688-2018; Allen, Hana Lango/G-9026-2012; Fox, Laura J/C-6249-2016; Ness, Andy R/M-7612-2013; Timpson, Nicholas John/O-7548-2015; Study, GoDARTS/K-9448-2016; Saxena, Richa/AAG-7279-2020; Berryman, Katie/J-4236-2014; Voight, Benjamin/F-1775-2011; Morris, Andrew D/C-2837-2009; Palmer, Colin NA/C-7053-2008; Davey Smith, George/A-7407-2013; McCarthy, Mark/M-3763-2015	Tobias, Jon/0000-0002-7475-3932; Allen, Hana Lango/0000-0002-7803-8688; Ness, Andy R/0000-0003-3548-9523; Timpson, Nicholas John/0000-0002-7141-9189; Palmer, Colin NA/0000-0002-6415-6560; Davey Smith, George/0000-0002-1407-8314; Frayling, Timothy/0000-0001-8362-2603; Voight, Benjamin/0000-0002-6205-9994; McCarthy, Mark/0000-0002-4393-0510; Saxena, Richa/0000-0003-2233-1065; Zeggini, Eleftheria/0000-0003-4238-659X; Lindgren, Cecilia/0000-0002-4903-9374; Hattersley, Andrew/0000-0001-5620-473X; Freathy, Rachel/0000-0003-4152-2238; Weedon, Michael/0000-0002-6174-6135; s, hema/0000-0002-3440-9475; Venkatasubramanian, Siddharth/0000-0002-5860-0768	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004171] Funding Source: NIH RePORTER; MRC [G0500070, G0600705] Funding Source: UKRI; Medical Research Council [G9815508(74882), G0600705, G9815508, G0500070] Funding Source: Medline; NHGRI NIH HHS [U01 HG004171] Funding Source: Medline; Wellcome Trust [GR072960, 079557, 090532, 076113, 072960, 076467] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Wellcome Trust(Wellcome Trust)		Battista S, 1999, CANCER RES, V59, P4793; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Gunnell D, 2001, EPIDEMIOL REV, V23, P313, DOI 10.1093/oxfordjournals.epirev.a000809; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hock R, 2007, TRENDS CELL BIOL, V17, P72, DOI 10.1016/j.tcb.2006.12.001; Knight B, 2006, PAEDIATR PERINAT EP, V20, P172, DOI 10.1111/j.1365-3016.2006.00701.x; Leary SD, 2006, OBESITY, V14, P2284, DOI 10.1038/oby.2006.268; Ligon AH, 2005, AM J HUM GENET, V76, P340, DOI 10.1086/427565; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Macgregor S, 2006, HUM GENET, V120, P571, DOI 10.1007/s00439-006-0240-z; Mills GW, 2004, DIABETOLOGIA, V47, P732, DOI 10.1007/s00125-004-1338-2; Palmert MR, 2003, MOL GENET METAB, V80, P1, DOI 10.1016/S1096-7192(03)00107-0; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Preece MA, 1996, HORM RES, V45, P56, DOI 10.1159/000184849; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rogers IS, 2006, AM J CLIN NUTR, V84, P739, DOI 10.1093/ajcn/84.4.739; Ruyter-Spira CP, 1998, J HERED, V89, P295, DOI 10.1093/jhered/89.4.295; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Silventoinen K, 2000, AM J PUBLIC HEALTH, V90, P627, DOI 10.2105/AJPH.90.4.627; Smith GD, 2000, J EPIDEMIOL COMMUN H, V54, P97, DOI 10.1136/jech.54.2.97; Vartiainen E, 2000, INT J EPIDEMIOL, V29, P49, DOI 10.1093/ije/29.1.49; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	30	321	341	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2007	39	10					1245	1250		10.1038/ng2121	http://dx.doi.org/10.1038/ng2121			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17767157	Green Accepted			2022-12-27	WOS:000249737400020
J	Chintapalli, VR; Wang, J; Dow, JAT				Chintapalli, Venkateswara R.; Wang, Jing; Dow, Julian A. T.			Using FlyAtlas to identify better Drosophila melanogaster models of human disease	NATURE GENETICS			English	Article							REVERSE GENETICS; PHENOTYPE; CRYPTOCHROME; EXPRESSION; CLOCK; TRANSCRIPTION; PROTEINS; GENOMICS; CHANNELS; SEQUENCE	FlyAtlas, a new online resource, provides the most comprehensive view yet of expression in multiple tissues of Drosophila melanogaster. Meta-analysis of the data shows that a significant fraction of the genome is expressed with great tissue specificity in the adult, demonstrating the need for the functional genomic community to embrace a wide range of functional phenotypes. Well-known developmental genes are often reused in surprising tissues in the adult, suggesting new functions. The homologs of many human genetic disease loci show selective expression in the Drosophila tissues analogous to the affected human tissues, providing a useful filter for potential candidate genes. Additionally, the contributions of each tissue to the whole-fly array signal can be calculated, demonstrating the limitations of whole-organism approaches to functional genomics and allowing modeling of a simple tissue fractionation procedure that should improve detection of weak or tissuespecific signals.	Univ Glasgow, Div Mol Genet, Glasgow G11 6NU, Lanark, Scotland	University of Glasgow	Chintapalli, VR (corresponding author), Univ Glasgow, Div Mol Genet, Glasgow G11 6NU, Lanark, Scotland.	j.a.t.dow@bio.gla.ac.uk	Dow, Julian/M-2371-2019	Dow, Julian/0000-0002-9595-5146	Biotechnology and Biological Sciences Research Council [G17767] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Adams MD, 2002, NAT REV GENET, V3, P189, DOI 10.1038/nrg752; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Aldaz S, 2003, DEVELOPMENT, V130, P4473, DOI 10.1242/dev.00643; Allan AK, 2005, PHYSIOL GENOMICS, V22, P128, DOI 10.1152/physiolgenomics.00233.2004; Andrews J, 2000, GENOME RES, V10, P2030, DOI 10.1101/gr.10.12.2030; Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; Bargmann CI, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews1005; Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown SDM, 1996, TRENDS GENET, V12, P433, DOI 10.1016/0168-9525(96)30094-2; Bullard Daniel C., 2001, Trends in Molecular Medicine, V7, P537, DOI 10.1016/S1471-4914(01)02198-0; BYERS D, 1981, NATURE, V289, P79, DOI 10.1038/289079a0; Carthew RW, 2005, CURR OPIN GENET DEV, V15, P358, DOI 10.1016/j.gde.2005.06.002; Chien S, 2002, NUCLEIC ACIDS RES, V30, P149, DOI 10.1093/nar/30.1.149; Davies SA, 1996, J BIOL CHEM, V271, P30677, DOI 10.1074/jbc.271.48.30677; DENT CE, 1954, LANCET, V1, P182, DOI 10.1016/S0140-6736(54)91257-X; Dominguez M, 2004, NAT GENET, V36, P31, DOI 10.1038/ng1281; Dow JAT, 2003, PHYSIOL REV, V83, P687, DOI 10.1152/physrev.00035.2002; DOW JAT, 2003, FUNCT GENOMIC PROTEO, V2, P121; Dow JAT, 2006, J INSECT PHYSIOL, V52, P365, DOI 10.1016/j.jinsphys.2005.10.007; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Evans JM, 2005, J EXP BIOL, V208, P3771, DOI 10.1242/jeb.01829; Giebultowicz JM, 2000, CURR BIOL, V10, P107, DOI 10.1016/S0960-9822(00)00299-2; GLASSMAN E, 1959, GENETICS, V44, P153; Graham LA, 2002, GENE, V292, P43, DOI 10.1016/S0378-1119(02)00672-8; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Ivanchenko M, 2001, J BIOL RHYTHM, V16, P205, DOI 10.1177/074873001129001917; JIMENEZ F, 1995, EMBO J, V14, P3487, DOI 10.1002/j.1460-2075.1995.tb07355.x; KAISER K, 1990, BIOESSAYS, V12, P297, DOI 10.1002/bies.950120609; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; KROGH AUGUST, 1929, AMER JOUR PHYSIOL, V90, P243; Manak JR, 2006, NAT GENET, V38, P1151, DOI 10.1038/ng1875; McGettigan J, 2005, INSECT BIOCHEM MOLEC, V35, P741, DOI 10.1016/j.ibmb.2005.02.017; ORKIN SH, 1986, CELL, V47, P845, DOI 10.1016/0092-8674(86)90799-3; Robinson DN, 1997, J CELL BIOL, V138, P799, DOI 10.1083/jcb.138.4.799; Ruddle F H, 1982, Adv Neurol, V35, P239; SALKOFF L, 1981, NATURE, V293, P228, DOI 10.1038/293228a0; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang J, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r69; YANG J, 2007, GENOMICS, DOI DOI 10.1152/PHYSIOLGENOMICS.00018.2007; Yang ZY, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni149	44	1163	1190	5	123	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2007	39	6					715	720		10.1038/ng2049	http://dx.doi.org/10.1038/ng2049			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17534367				2022-12-27	WOS:000246859100012
J	Martin, G; Elena, SF; Lenormand, T				Martin, Guillaume; Elena, Santiago F.; Lenormand, Thomas			Distributions of epistasis in microbes fit predictions from a fitness landscape model	NATURE GENETICS			English	Article							DELETERIOUS MUTATIONS; ESCHERICHIA-COLI; RNA VIRUSES; EVOLUTION; RECOMBINATION; ADAPTATION; STRAINS	How do the fitness effects of several mutations combine? Despite its simplicity, this question is central to the understanding of multilocus evolution. Epistasis (the interaction between alleles at different loci), especially epistasis for fitness traits such as reproduction and survival, influences evolutionary predictions(1,2) "almost whenever multilocus genetics matters''(3). Yet very few models(4,5) have sought to predict epistasis, and none has been empirically tested. Here we show that the distribution of epistasis can be predicted from the distribution of single mutation effects, based on a simple fitness landscape model(6). We show that this prediction closely matches the empirical measures of epistasis that have been obtained for Escherichia coli(7) and the RNA virus vesicular stomatitis virus(8). Our results suggest that a simple fitness landscape model may be sufficient to quantitatively capture the complex nature of gene interactions. This model may offer a simple and widely applicable alternative to complex metabolic network models, in particular for making evolutionary predictions.	CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, F-34293 Montpellier, France; Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; UPV, CSIC, Inst Biol Mol & Celular Plantas, Valencia 46022, Spain	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; University of Lausanne; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Biologia Molecular y Celular de Plantas (IBMCP)	Martin, G (corresponding author), CNRS, Ctr Ecol Fonct & Evolut, UMR 5175, 1919 Route Mende, F-34293 Montpellier, France.	guillaume.martin@unil.ch	Elena, Santiago F./A-4191-2011; Martin, Guillaume/P-8964-2016; Lenormand, Thomas/A-5328-2012	Elena, Santiago F./0000-0001-8249-5593; Martin, Guillaume/0000-0002-5203-5091; Lenormand, Thomas/0000-0001-8930-5393				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Bonhoeffer S, 2004, SCIENCE, V306, P1547, DOI 10.1126/science.1101786; Burch CL, 2003, J EVOLUTION BIOL, V16, P1223, DOI 10.1046/j.1420-9101.2003.00632.x; BURGER R, 2000, MATH THEORY SELECTIO, P158; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; Elena SF, 1998, GENETICA, V102-3, P349, DOI 10.1023/A:1017031008316; Fisher RA, 1930, GENETICAL THEORY NAT; Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432; Kidwell MG, 1997, P NATL ACAD SCI USA, V94, P7704, DOI 10.1073/pnas.94.15.7704; Kouyos RD, 2006, GENETICS, V173, P589, DOI 10.1534/genetics.105.053108; LANDE R, 1980, GENETICS, V94, P203; LENSKI RE, 1994, P NATL ACAD SCI USA, V91, P6808, DOI 10.1073/pnas.91.15.6808; Malmberg RL, 2005, GENET RES, V86, P89, DOI 10.1017/S0016672305007780; Martin G, 2006, EVOLUTION, V60, P2413, DOI 10.1554/06-162.1; Martin G, 2006, EVOLUTION, V60, P893; Mathai A., 1992, QUADRATIC FORMS RAND; Michalakis Y, 2004, SCIENCE, V306, P1492, DOI 10.1126/science.1106677; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; Orr HA, 2001, EVOL DEV, V3, P121, DOI 10.1046/j.1525-142x.2001.003003121.x; Otto SP, 1997, THEOR POPUL BIOL, V51, P134, DOI 10.1006/tpbi.1997.1301; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Phillips PC., 2000, EPISTASIS EVOLUTIONA, P20; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P8396, DOI 10.1073/pnas.0400146101; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; SZATHMARY E, 1993, GENETICS, V133, P127; Waxman D, 2005, AM NAT, V166, P447, DOI 10.1086/444404; Whitlock MC, 2000, EVOLUTION, V54, P1654, DOI 10.1111/j.0014-3820.2000.tb00709.x; Wloch DM, 2001, J EVOLUTION BIOL, V14, P310, DOI 10.1046/j.1420-9101.2001.00267.x	30	134	135	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2007	39	4					555	560		10.1038/ng1998	http://dx.doi.org/10.1038/ng1998			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17369829	Green Published			2022-12-27	WOS:000245271200029
J	Cao, LQ; Shitara, H; Horii, T; Nagao, Y; Imai, H; Abe, K; Hara, T; Hayashi, JI; Yonekawa, H				Cao, Liqin; Shitara, Hiroshi; Horii, Takuro; Nagao, Yasumitsu; Imai, Hiroshi; Abe, Kuniya; Hara, Takahiko; Hayashi, Jun-Ichi; Yonekawa, Hiromichi			The mitochondrial bottleneck occurs without reduction of mtDNA content in female mouse germ cells	NATURE GENETICS			English	Article							PREIMPLANTATION DEVELOPMENT; RAPID SEGREGATION; HUMAN OOCYTES; DNA; EMBRYOGENESIS; ELIMINATION; OOGENESIS; EVOLUTION; MUTATION; DISEASE	Observations of rapid shifts in mitochondrial DNA (mtDNA) variants between generations prompted the creation of the bottleneck theory. A prevalent hypothesis is that a massive reduction in mtDNA content during early oogenesis leads to the bottleneck(1,2). To test this, we estimated the mtDNA copy number in single germline cells and in single somatic cells of early embryos in mice. Primordial germ cells (PGCs) show consistent, moderate mtDNA copy numbers across developmental stages, whereas primary oocytes demonstrate substantial mtDNA expansion during early oocyte maturation. Some somatic cells possess a very low mtDNA copy number. We also demonstrated that PGCs have more than 100 mitochondria per cell. We conclude that the mitochondrial bottleneck is not due to a drastic decline in mtDNA copy number in early oogenesis but rather to a small effective number of segregation units for mtDNA in mouse germ cells. These results provide new information for mtDNA segregation models and for understanding the recurrence risks for mtDNA diseases.	Tokyo Metropolitan Inst Med Sci, Dept Lab Anim Sci, Tokyo 1138613, Japan; Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; Kyoto Univ, Grad Sch Agr, Reprod Biol Lab, Kyoto 6068502, Japan; RIKEN, Tsukuba Inst, BRC, Technol & Dev Team Mammalian Cellular Disorders, Tsukuba, Ibaraki 3050074, Japan; Tokyo Metropolitan Inst Med Sci, Stem Cell Project Grp, Tokyo 1138613, Japan	Tokyo Metropolitan Institute of Medical Science; University of Tsukuba; Kyoto University; RIKEN; Tokyo Metropolitan Institute of Medical Science	Yonekawa, H (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Lab Anim Sci, Tokyo 1138613, Japan.	yonekawa@rinshoken.or.jp						ASHLEY MV, 1989, NUCLEIC ACIDS RES, V17, P7325, DOI 10.1093/nar/17.18.7325; Battersby BJ, 2003, NAT GENET, V33, P183, DOI 10.1038/ng1073; BIRKY CW, 1994, J HERED, V85, P355, DOI 10.1093/oxfordjournals.jhered.a111480; Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; BROWN WM, 1979, P NATL ACAD SCI USA, V76, P1967, DOI 10.1073/pnas.76.4.1967; DHERDE K, 1995, REPROD NUTR DEV, V35, P305, DOI 10.1051/rnd:19950306; HAUSWIRTH WW, 1982, P NATL ACAD SCI-BIOL, V79, P4686, DOI 10.1073/pnas.79.15.4686; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Jansen RPS, 1998, MOL CELL ENDOCRINOL, V145, P81, DOI 10.1016/S0303-7207(98)00173-7; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; KANEDA H, 1995, P NATL ACAD SCI USA, V92, P4542, DOI 10.1073/pnas.92.10.4542; Kono T, 1996, NAT GENET, V13, P91, DOI 10.1038/ng0596-91; Krakauer DC, 1999, NATURE, V400, P125, DOI 10.1038/22026; LAIPIS PJ, 1988, P NATL ACAD SCI USA, V85, P8107, DOI 10.1073/pnas.85.21.8107; LARSSON NG, 1992, AM J HUM GENET, V51, P1201; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; Marchington DR, 1998, AM J HUM GENET, V63, P769, DOI 10.1086/302009; Meirelles FV, 1998, GENETICS, V148, P877; Nagy A., 2003, MANIPULATING MOUSE E; NASS MMK, 1969, J MOL BIOL, V42, P521, DOI 10.1016/0022-2836(69)90240-X; NOGAWA T, 1988, J MORPHOL, V195, P225, DOI 10.1002/jmor.1051950208; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2; Shitara H, 2000, GENETICS, V156, P1277; Smith LC, 2005, REPROD FERT DEVELOP, V17, P15, DOI 10.1071/RD04084; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; Steuerwald N, 2000, ZYGOTE, V8, P209, DOI 10.1017/S0967199400001003; Wallace DC, 2005, GENE, V354, P169, DOI 10.1016/j.gene.2005.05.001; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675	30	233	243	1	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2007	39	3					386	390		10.1038/ng1970	http://dx.doi.org/10.1038/ng1970			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17293866				2022-12-27	WOS:000244480000022
J	Wang, YM; Medvid, R; Melton, C; Jaenisch, R; Blelloch, R				Wang, Yangming; Medvid, Rostislav; Melton, Collin; Jaenisch, Rudolf; Blelloch, Robert			DGCR8 is essential for microRNA biogenesis and silencing of embryonic stem cell self-renewal	NATURE GENETICS			English	Article							NUCLEAR EXPORT; DICER; COMPLEX	The molecular controls that govern the differentiation of embryonic stem (ES) cells remain poorly understood. DGCR8 is an RNA-binding protein that assists the RNase III enzyme Drosha in the processing of microRNAs (miRNAs), a subclass of small RNAs. Here we study the role of miRNAs in ES cell differentiation by generating a Dgcr8 knockout model. Analysis of mouse knockout ES cells shows that DGCR8 is essential for biogenesis of miRNAs. On the induction of differentiation, DGCR8-deficient ES cells do not fully downregulate pluripotency markers and retain the ability to produce ES cell colonies; however, they do express some markers of differentiation. This phenotype differs from that reported for Dicer1 knockout cells, suggesting that Dicer has miRNA-independent roles in ES cell function. Our findings indicate that miRNAs function in the silencing of ES cell self-renewal that normally occurs with the induction of differentiation.	Univ Calif San Francisco, Dept Urol, Dev & Stem Cell Biol Program, San Francisco, CA 94143 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	University of California System; University of California San Francisco; Massachusetts Institute of Technology (MIT); Whitehead Institute	Blelloch, R (corresponding author), Univ Calif San Francisco, Dept Urol, Dev & Stem Cell Biol Program, San Francisco, CA 94143 USA.	blellochr@stemcell.ucsf.edu	Wang, Yangming/J-8939-2015	Wang, Yangming/0000-0001-6974-6060	NINDS NIH HHS [K08 NS048118, K08 NS048118-01A1, K08 NS048118-02, K08 NS48118] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS048118] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Blelloch RH, 2004, P NATL ACAD SCI USA, V101, P13985, DOI 10.1073/pnas.0405015101; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Han J, 2001, DRUG DELIV, V8, P125; Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; HEBERT JM, 1991, DEVELOPMENT, V112, P407; Houbaviy HB, 2005, RNA, V11, P1245, DOI 10.1261/rna.2890305; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Pelton TA, 2002, J CELL SCI, V115, P329; Rathjen J, 1999, J CELL SCI, V112, P601; Tomari Y, 2005, CURR BIOL, V15, pR61, DOI 10.1016/j.cub.2004.12.057; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; Wu HJ, 2000, J BIOL CHEM, V275, P36957, DOI 10.1074/jbc.M005494200; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803	28	750	806	1	56	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2007	39	3					380	385		10.1038/ng1969	http://dx.doi.org/10.1038/ng1969			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17259983	Green Accepted			2022-12-27	WOS:000244480000021
J	Baltus, AE; Menke, DB; Hu, YC; Goodheart, ML; Carpenter, AE; de Rooij, DG; Page, DC				Baltus, Andrew E.; Menke, Douglas B.; Hu, Yueh-Chiang; Goodheart, Mary L.; Carpenter, Anne E.; de Rooij, Dirk G.; Page, David C.			In germ cells of mouse embryonic ovaries, the decision to enter meiosis precedes premeiotic DNA replication	NATURE GENETICS			English	Article							CHROMOSOME SYNAPSIS; PROTEIN; OOGENESIS; TESTIS; GENE	The transition from mitosis to meiosis is a defining juncture in the life cycle of sexually reproducing organisms. In yeast, the decision to enter meiosis is made before the single round of DNA replication that precedes the two meiotic divisions(1). We present genetic evidence of an analogous decision point in the germ line of a multicellular organism. The mouse Stra8 gene is expressed in germ cells of embryonic ovaries, where meiosis is initiated, but not in those of embryonic testes, where meiosis does not begin until after birth(2). Here we report that in female embryos lacking Stra8 gene function, the early, mitotic development of germ cells is normal, but these cells then fail to undergo premeiotic DNA replication, meiotic chromosome condensation, cohesion, synapsis and recombination. Combined with previous findings, these genetic data suggest that active differentiation of ovarian germ cells commences at a regulatory point upstream of premeiotic DNA replication.	MIT, Howard Hughes Med Inst, Cambridge, MA 02142 USA; MIT, Whitehead Inst, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA; Univ Utrecht, Fac Biol, Dept Endocrinol, NL-3584 CH Utrecht, Netherlands; Univ Utrecht, Med Ctr, Dept Cell Biol, NL-3584 CH Utrecht, Netherlands	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Utrecht University; Utrecht University	Page, DC (corresponding author), MIT, Howard Hughes Med Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	page_admin@wi.mit.edu	Hu, Yueh-Chiang/AAX-2370-2020; Carpenter, Anne/C-4982-2008; Holt, Janet E/B-2415-2013; de Rooij, D.G./AAW-1195-2021	Carpenter, Anne/0000-0003-1555-8261; de Rooij, Dirk/0000-0003-3932-4419; Hu, Yueh-Chiang/0000-0002-7992-0525; Menke, Douglas/0000-0002-7109-1451				Adams IR, 2002, DEVELOPMENT, V129, P1155; Albrecht KH, 2001, DEV BIOL, V240, P92, DOI 10.1006/dbio.2001.0438; Bannister LA, 2004, GENESIS, V40, P184, DOI 10.1002/gene.20085; Baudat F, 2000, MOL CELL, V6, P989, DOI 10.1016/S1097-2765(00)00098-8; BORUM K, 1961, EXP CELL RES, V24, P495, DOI 10.1016/0014-4827(61)90449-9; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Brennan J, 2004, NAT REV GENET, V5, P509, DOI 10.1038/nrg1381; Bullejos M, 2004, MOL REPROD DEV, V68, P422, DOI 10.1002/mrd.20105; CRONE M, 1965, EXP CELL RES, V39, P678, DOI 10.1016/0014-4827(65)90071-6; DEVICTOR M, 1979, J GENET HUM, V27, P21; Eijpe M, 2003, J CELL BIOL, V160, P657, DOI 10.1083/jcb.200212080; Fujiwara S, 2003, ZOOL SCI, V20, P809, DOI 10.2108/zsj.20.809; HARTUNG M, 1977, CYTOGENET CELL GENET, V18, P309, DOI 10.1159/000130777; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Lee J, 2003, J CELL SCI, V116, P2781, DOI 10.1242/jcs.00495; Marston AL, 2004, NAT REV MOL CELL BIO, V5, P983, DOI 10.1038/nrm1526; McLaren A, 1997, DEV BIOL, V187, P107, DOI 10.1006/dbio.1997.8584; Menke DB, 2003, DEV BIOL, V262, P303, DOI 10.1016/S0012-1606(03)00391-9; MOENS PB, 1995, CHROMOSOMA, V104, P175, DOI 10.1007/BF00352182; OuladAbdelghani M, 1996, J CELL BIOL, V135, P469, DOI 10.1083/jcb.135.2.469; Pittman DL, 1998, MOL CELL, V1, P697, DOI 10.1016/S1097-2765(00)80069-6; Prieto I, 2004, CHROMOSOME RES, V12, P197, DOI 10.1023/B:CHRO.0000021945.83198.0e; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Romanienko PJ, 2000, MOL CELL, V6, P975, DOI 10.1016/S1097-2765(00)00097-6; SPEED RM, 1982, CHROMOSOMA, V85, P427, DOI 10.1007/BF00330366; Toyooka Y, 2000, MECH DEVELOP, V93, P139, DOI 10.1016/S0925-4773(00)00283-5; Xu HL, 2005, DEV CELL, V8, P949, DOI 10.1016/j.devcel.2005.03.018; Yao HHC, 2003, DEVELOPMENT, V130, P5895, DOI 10.1242/dev.00836; YOSHIDA N, 1998, REC RES DEV FERMEN 1, V1, P1; Yuan L, 2000, MOL CELL, V5, P73, DOI 10.1016/S1097-2765(00)80404-9	30	366	389	1	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2006	38	12					1430	1434		10.1038/ng1919	http://dx.doi.org/10.1038/ng1919			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110TR	17115059				2022-12-27	WOS:000242404200021
J	Khaja, R; Zhang, JJ; MacDonald, JR; He, YS; Joseph-George, AM; Wei, J; Rafiq, MA; Qian, C; Shago, M; Pantano, L; Aburatani, H; Jones, K; Redon, R; Hurles, M; Armengol, L; Estivill, X; Mural, RJ; Lee, C; Scherer, SW; Feuk, L				Khaja, Razi; Zhang, Junjun; MacDonald, Jeffrey R.; He, Yongshu; Joseph-George, Ann M.; Wei, John; Rafiq, Muhammad A.; Qian, Cheng; Shago, Mary; Pantano, Lorena; Aburatani, Hiroyuki; Jones, Keith; Redon, Richard; Hurles, Matthew; Armengol, Lluis; Estivill, Xavier; Mural, Richard J.; Lee, Charles; Scherer, Stephen W.; Feuk, Lars			Genome assembly comparison identifies structural variants in the human genome	NATURE GENETICS			English	Article							DNA-SEQUENCE; POLYMORPHISMS; DATABASE	Numerous types of DNA variation exist, ranging from SNPs to larger structural alterations such as copy number variants (CNVs) and inversions. Alignment of DNA sequence from different sources has been used to identify SNPs(1,2) and intermediate-sized variants (ISVs)(3). However, only a small proportion of total heterogeneity is characterized, and little is known of the characteristics of most smaller-sized (< 50 kb) variants. Here we show that genome assembly comparison is a robust approach for identification of all classes of genetic variation. Through comparison of two human assemblies (Celera's R27c compilation and the Build 35 reference sequence), we identified megabases of sequence (in the form of 13,534 putative non-SNP events) that were absent, inverted or polymorphic in one assembly. Database comparison and laboratory experimentation further demonstrated overlap or validation for 240 variable regions and confirmed < 1.5 million SNPs. Some differences were simple insertions and deletions, but in regions containing CNVs, segmental duplication and repetitive DNA, they were more complex. Our results uncover substantial undescribed variation in humans, highlighting the need for comprehensive annotation strategies to fully interpret genome scanning and personalized sequencing projects.	Hosp Sick Children, Program Genet & Genom Biol, Toronto, ON M5G 1L7, Canada; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5G 1L7, Canada; MaRS Ctr, Ctr Appl Genom, Toronto, ON M5G 1L7, Canada; S Inst Informat Technol, Dept Biosci, Commiss Sci & Technol Sustainable Dev, Islamabad 44000, Pakistan; Charles Darwin SN, Ctr Genom Regulat, Genes & Dis Program, Barcelona 08003, Catalonia, Spain; Univ Tokyo, Adv Sci & Technol Res Ctr, Genome Sci Lab, Tokyo 1538904, Japan; Affymetrix Inc, Santa Clara, CA 95051 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Pompeu Fabra Univ, Barcelona, Spain; Natl Genotyping Ctr, Barcelona, Spain; Windber Res Inst, Windber, PA 15963 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; COMSATS University Islamabad (CUI); Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Tokyo; Affymetrix; Wellcome Trust Sanger Institute; Pompeu Fabra University; Windber Research Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Scherer, SW (corresponding author), Hosp Sick Children, Program Genet & Genom Biol, 555 Univ Ave, Toronto, ON M5G 1L7, Canada.	steve@genet.sickkids.on.ca	Scherer, Stephen W./B-3785-2013; MacDonald, Jeffrey Robert/GLU-2255-2022; Estivill, Xavier/A-3125-2013; Estivill, Xavier/E-2957-2012; Redon, Richard/F-3303-2014	Scherer, Stephen W./0000-0002-8326-1999; Estivill, Xavier/0000-0002-0723-2256; Redon, Richard/0000-0001-7751-2280; MacDonald, Jeffrey/0000-0001-5058-2393	Wellcome Trust [077014] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adams MD, 2003, P NATL ACAD SCI USA, V100, P3025, DOI 10.1073/pnas.0637478100; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bennett ST, 2005, PHARMACOGENOMICS, V6, P373, DOI 10.1517/14622416.6.4.373; Cheung J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r25; Feuk L, 2005, PLOS GENET, V1, P489, DOI 10.1371/journal.pgen.0010056; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Hillier LW, 2003, NATURE, V424, P157, DOI 10.1038/nature01782; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Istrail S, 2004, P NATL ACAD SCI USA, V101, P1916, DOI 10.1073/pnas.0307971100; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; MOBARRY C, 2003, P 3 ANN RECOMB SAT M; Myers EW, 2002, P NATL ACAD SCI USA, V99, P4145, DOI 10.1073/pnas.092136699; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; REDON R, IN PRESS NATURE; Scherer SW, 2003, SCIENCE, V300, P767, DOI 10.1126/science.1083423; Schmutz J, 2004, NATURE, V431, P268, DOI 10.1038/nature02919; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Shendure J, 2004, NAT REV GENET, V5, P335, DOI 10.1038/nrg1325; Tsui C, 2003, NUCLEIC ACIDS RES, V31, P4910, DOI 10.1093/nar/gkg664; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang JX, 2006, HUM MUTAT, V27, P323, DOI 10.1002/humu.20307; Waterston RH, 2003, P NATL ACAD SCI USA, V100, P3022, DOI 10.1073/pnas.0634129100; Waterston RH, 2002, P NATL ACAD SCI USA, V99, P3712, DOI 10.1073/pnas.042692499; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	30	129	135	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2006	38	12					1413	1418		10.1038/ng1921	http://dx.doi.org/10.1038/ng1921			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110TR	17115057	Green Accepted			2022-12-27	WOS:000242404200018
J	Blaydon, DC; Ishii, Y; O'Toole, EA; Unsworth, HC; Teh, MT; Ruschendorf, F; Sinclair, C; Hopsu-Havu, VK; Tidman, N; Moss, C; Watson, R; de Berker, D; Wajid, M; Christiano, AM; Kelsell, DP				Blaydon, Diana C.; Ishii, Yoshiyuki; O'Toole, Edel A.; Unsworth, Harriet C.; Teh, Muy-Teck; Rueschendorf, Franz; Sinclair, Claire; Hopsu-Havu, Vaino K.; Tidman, Nicholas; Moss, Celia; Watson, Rosemarie; de Berker, David; Wajid, Muhammad; Christiano, Angela M.; Kelsell, David P.			The gene encoding R-spondin 4 (RSPO4), a secreted protein implicated in Wnt signaling, is mutated in inherited anonychia	NATURE GENETICS			English	Article							NAIL-PATELLA SYNDROME; R-SPONDIN; FAMILY; LMX1B; LIMB	Anonychia and hyponychia congenita (OMIM 206800) are rare autosomal recessive conditions in which the only presenting phenotype is the absence or severe hypoplasia of all fingernails and toenails. After determining linkage to chromosome 20p13, we identified homozygous or compound heterozygous mutations in the gene encoding R-spondin 4 (RSPO4), a secreted protein implicated in Wnt signaling, in eight affected families. Rspo4 expression was specifically localized to developing mouse nail mesenchyme at embryonic day 15.5, suggesting a crucial role in nail morphogenesis.	Univ London Queen Mary Coll, Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, Ctr Cutaneous Res, London E1 4AT, England; Columbia Univ Coll Phys & Surg, Dept Dermatol & Genet, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Dept Dev, New York, NY 10032 USA; Max Delbruck Ctr Mol Med, Dept Funct Genet & Genom, D-13092 Berlin, Germany; Univ Turku, Cent Hosp, Dept Dermatol, FIN-20520 Turku, Finland; Canc Res UK, London WC2A 3PX, England; Birmingham Childrens Hosp, Birmingham B4 6NH, W Midlands, England; Our Ladys Hosp Sick Children, Dept Paediat Dermatol, Dublin 12, Ireland; Bristol Royal Infirm & Gen Hosp, Bristol Dermatol Ctr, Bristol BS2 8HW, Avon, England	University of London; Queen Mary University London; Columbia University; Columbia University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Turku; Cancer Research UK; University of Birmingham; Our Ladys Children Hospital Crumlin; Bristol Royal Infirmary	Kelsell, DP (corresponding author), Univ London Queen Mary Coll, Queen Marys Sch Med & Dent, Inst Cell & Mol Sci, Ctr Cutaneous Res, Whitechapel, London E1 4AT, England.	d.p.kelsell@qmul.ac.uk	Wajid, Muhammad/F-5087-2015; Teh, Muy-Teck/B-9284-2016; Kelsell, David P/F-8767-2011	Teh, Muy-Teck/0000-0002-7725-8355; Kelsell, David/0000-0002-9910-7144; O'Toole, Edel/0000-0002-4084-4836; Blaydon, Diana/0000-0002-9998-2563	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044924] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01AR44924] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Chen H, 1998, NAT GENET, V19, P51, DOI 10.1038/ng0598-51; Chuong CM, 1996, J INVEST DERMATOL, V107, P639, DOI 10.1111/1523-1747.ep12584254; DAWBER R, 2001, DIS NAILS THEIR MANA; Dreyer SD, 1998, NAT GENET, V19, P47, DOI 10.1038/ng0598-47; Garshasbi M, 2006, HUM GENET, V118, P708, DOI 10.1007/s00439-005-0104-y; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HOPSUHAVU VK, 1973, ARCH DERMATOL, V107, P752; Jumlongras D, 2001, AM J HUM GENET, V69, P67, DOI 10.1086/321271; Kamata T, 2004, BBA-GENE STRUCT EXPR, V1676, P51, DOI 10.1016/j.bbaexp.2003.10.009; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Loomis CA, 1996, NATURE, V382, P360, DOI 10.1038/382360a0; Nam JS, 2006, J BIOL CHEM, V281, P13247, DOI 10.1074/jbc.M508324200; Viegas-Pequignot E., 1992, PRACTICAL APPROACHES, P137	14	128	165	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2006	38	11					1245	1247		10.1038/ng1883	http://dx.doi.org/10.1038/ng1883			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17041604				2022-12-27	WOS:000241592700011
J	de Bakker, PIW; McVean, G; Sabeti, PC; Miretti, MM; Green, T; Marchini, J; Ke, XY; Monsuur, AJ; Whittaker, P; Delgado, M; Morrison, J; Richardson, A; Walsh, EC; Gao, XJ; Galver, L; Hart, J; Hafler, DA; Pericak-Vance, M; Todd, JA; Daly, MJ; Trowsdale, J; Wijmenga, C; Vyse, TJ; Beck, S; Murray, SS; Carrington, M; Gregory, S; Deloukas, P; Rioux, JD				de Bakker, Paul I. W.; McVean, Gil; Sabeti, Pardis C.; Miretti, Marcos M.; Green, Todd; Marchini, Jonathan; Ke, Xiayi; Monsuur, Alienke J.; Whittaker, Pamela; Delgado, Marcos; Morrison, Jonathan; Richardson, Angela; Walsh, Emily C.; Gao, Xiaojiang; Galver, Luana; Hart, John; Hafler, David A.; Pericak-Vance, Margaret; Todd, John A.; Daly, Mark J.; Trowsdale, John; Wijmenga, Cisca; Vyse, Tim J.; Beck, Stephan; Murray, Sarah Shaw; Carrington, Mary; Gregory, Simon; Deloukas, Panos; Rioux, John D.			A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC	NATURE GENETICS			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; NONCODING SEQUENCE POLYMORPHISMS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; HUMAN GENOME; LINKAGE-DISEQUILIBRIUM; CELIAC-DISEASE; REGION; RISK	The proteins encoded by the classical HLA class I and class II genes in the major histocompatibility complex (MHC) are highly polymorphic and are essential in self versus non-self immune recognition. HLA variation is a crucial determinant of transplant rejection and susceptibility to a large number of infectious and autoimmune diseases(1). Yet identification of causal variants is problematic owing to linkage disequilibrium that extends across multiple HLA and non-HLA genes in the MHC2,3. We therefore set out to characterize the linkage disequilibrium patterns between the highly polymorphic HLA genes and background variation by typing the classical HLA genes and > 7,500 common SNPs and deletion-insertion polymorphisms across four population samples. The analysis provides informative tag SNPs that capture much of the common variation in the MHC region and that could be used in disease association studies, and it provides new insight into the evolutionary dynamics and ancestral origins of the HLA loci and their haplotypes.	Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; MIT, Cambridge Ctr 7, Cambridge, MA 02142 USA; Massachusetts Gen Hosp, Ctr Human Genet, Boston, MA 02114 USA; Univ Oxford, Dept Stat, Oxford OX1 2JD, England; Wellcome Trust Sanger Inst, Hinxton, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England; Univ Utrecht, Med Ctr, Dept Med Genet, Complex Genet Sect, NL-3508 TC Utrecht, Netherlands; SAIC Frederick Inc, Lab Genom Divers, Frederick, MD USA; NCI, Frederick, MD 21701 USA; Illumina Inc, San Diego, CA USA; Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27706 USA; Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Cambridge, Inst Med Res, Wellcome Trust Diabet & Inflammat Lab, Juventil Diabet Res Fdn, Cambridge CB2 1TN, England; Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge, England; Imperial Coll Sch Med, London, England; Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; University of Oxford; Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics; Utrecht University; Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Illumina; Duke University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Imperial College London; Universite de Montreal; Universite de Montreal	Rioux, JD (corresponding author), Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA.	rioux@broad.mit.edu	Daly, Mark J/B-2453-2017; Ke, Xiayi/C-7674-2009; Sabeti, Pardis/GQH-8610-2022; Richardson, Angela/AAN-8731-2020; Marchini, Jonathan/ABE-9024-2020; Todd, John A/A-3542-2010; Wijmenga, Cisca/D-2173-2009; de Bakker, Paul IW/B-8730-2009; Miretti, Marcos M./AAY-5895-2020; Deloukas, Panos/B-2922-2013; Wijmenga, Cisca/AAE-7719-2019; Rioux, John D/A-9599-2015	Daly, Mark J/0000-0002-0949-8752; Richardson, Angela/0000-0003-2656-7438; Marchini, Jonathan/0000-0003-0610-8322; Todd, John A/0000-0003-2740-8148; de Bakker, Paul IW/0000-0001-7735-7858; Miretti, Marcos M./0000-0001-8179-1606; Deloukas, Panos/0000-0001-9251-070X; Wijmenga, Cisca/0000-0002-5635-1614; Rioux, John D/0000-0001-7560-8326; Gregory, Simon/0000-0002-7805-1743	Intramural NIH HHS Funding Source: Medline; Medical Research Council [G9800943] Funding Source: Medline; NCI NIH HHS [N01CO12400, N01-CO-12400] Funding Source: Medline; NIAID NIH HHS [U19 AI050864] Funding Source: Medline; Wellcome Trust [077011] Funding Source: Medline; MRC [G9800943] Funding Source: UKRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI050864] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allcock RJN, 2002, TISSUE ANTIGENS, V59, P520, DOI 10.1034/j.1399-0039.2002.590609.x; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Chadha S, 2006, EUR J HUM GENET, V14, P69, DOI 10.1038/sj.ejhg.5201527; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; DUPONT B, 1977, TRANSPLANT P, V9, P1271; Froeschke G, 2005, MOL BIOL EVOL, V22, P1254, DOI 10.1093/molbev/msi112; FRY B, 2005, COMPUTATIONAL INFORM; Gonzalez-Neira A, 2006, GENOME RES, V16, P323, DOI 10.1101/gr.4138406; Graham RR, 2002, AM J HUM GENET, V71, P543, DOI 10.1086/342290; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; KLEIN J, 1987, HUM IMMUNOL, V19, P155, DOI 10.1016/0198-8859(87)90066-8; LIMM TM, 1993, HUM IMMUNOL, V38, P57, DOI 10.1016/0198-8859(93)90520-B; Malkki M, 2005, TISSUE ANTIGENS, V66, P114, DOI 10.1111/j.1399-0039.2005.00453.x; Marsh SGE, 2005, TISSUE ANTIGENS, V66, P338, DOI 10.1111/j.1399-0039.2005.00479.x; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; Monsuur AJ, 2005, NAT GENET, V37, P1341, DOI 10.1038/ng1680; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nei M., 1987, MOL EVOLUTIONARY GEN; Raymond CK, 2005, GENOME RES, V15, P1250, DOI 10.1101/gr.3554305; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; SIMONS MJ, 1993, HUM IMMUNOL, V38, P69, DOI 10.1016/0198-8859(93)90521-2; Stenzel A, 2004, HUM GENET, V114, P377, DOI 10.1007/s00439-003-1075-5; Stewart CA, 2004, GENOME RES, V14, P1176, DOI 10.1101/gr.2188104; Traherne JA, 2006, PLOS GENET, V2, P81, DOI 10.1371/journal.pgen.0020009; Vader W, 2003, P NATL ACAD SCI USA, V100, P12390, DOI 10.1073/pnas.2135229100; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Walsh EC, 2003, AM J HUM GENET, V73, P580, DOI 10.1086/378101	29	574	602	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2006	38	10					1166	1172		10.1038/ng1885	http://dx.doi.org/10.1038/ng1885			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	16998491	Green Accepted			2022-12-27	WOS:000241251100016
J	Hillmer, AM; Brockschmidt, FF; Hanneken, S; Eigelshoven, S; Steffens, M; Flaquer, A; Herms, S; Becker, T; Kortum, AK; Nyholt, DR; Zhao, ZZ; Montgomery, GW; Martin, NG; Muhleisen, TW; Alblas, MA; Moebus, S; Jockel, KH; Brocker-Preuss, M; Erbel, R; Reinartz, R; Betz, RC; Cichon, S; Propping, P; Baur, MP; Wienker, TF; Kruse, R; Nothen, MM				Hillmer, Axel M.; Brockschmidt, Felix F.; Hanneken, Sandra; Eigelshoven, Sibylle; Steffens, Michael; Flaquer, Antonia; Herms, Stefan; Becker, Tim; Kortuem, Anne-Katrin; Nyholt, Dale R.; Zhao, Zhen Zhen; Montgomery, Grant W.; Martin, Nicholas G.; Muehleisen, Thomas W.; Alblas, Margrieta A.; Moebus, Susanne; Joeckel, Karl-Heinz; Broecker-Preuss, Martina; Erbel, Raimund; Reinartz, Roman; Betz, Regina C.; Cichon, Sven; Propping, Peter; Baur, Max P.; Wienker, Thomas F.; Kruse, Roland; Noethen, Markus M.			Susceptibility variants for male-pattern baldness on chromosome 20p11	NATURE GENETICS			English	Article							ANDROGEN RECEPTOR GENE; ALOPECIA; POLYMORPHISM	We carried out a genome-wide association study in 296 individuals with male-pattern baldness (androgenetic alopecia) and 347 controls. We then investigated the 30 best SNPs in an independent replication sample and found highly significant association for five SNPs on chromosome 20p11 (rs2180439 combined P = 2.7 x 10(-15)). No interaction was detected with the X-chromosomal androgen receptor locus, suggesting that the 20p11 locus has a role in a yet-to-be-identified androgen-independent pathway.	[Hillmer, Axel M.; Brockschmidt, Felix F.; Herms, Stefan; Muehleisen, Thomas W.; Alblas, Margrieta A.; Reinartz, Roman; Cichon, Sven; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; [Hanneken, Sandra; Eigelshoven, Sibylle; Kortuem, Anne-Katrin; Kruse, Roland] Univ Dusseldorf, Dept Dermatol, D-40225 Dusseldorf, Germany; [Steffens, Michael; Flaquer, Antonia; Becker, Tim; Baur, Max P.; Wienker, Thomas F.] Univ Bonn, Inst Med Biometry Informat & Epidemiol, D-53105 Bonn, Germany; [Nyholt, Dale R.; Zhao, Zhen Zhen; Montgomery, Grant W.; Martin, Nicholas G.] Queensland Inst Med Res, Herston, Qld 4006, Australia; [Moebus, Susanne; Joeckel, Karl-Heinz] Univ Duisburg Essen, Inst Med Bioinformat Biometry & Epidemiol, D-45122 Essen, Germany; [Broecker-Preuss, Martina] Univ Duisburg Essen, Univ Hosp Essen, Cent Lab Unit Res & Educ, Clin Endocrinol, D-45122 Essen, Germany; [Erbel, Raimund] Univ Duisburg Essen, W German Heart Ctr Essen, Clin Cardiol, D-45122 Essen, Germany; [Betz, Regina C.; Cichon, Sven; Propping, Peter; Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany	University of Bonn; Heinrich Heine University Dusseldorf; University of Bonn; QIMR Berghofer Medical Research Institute; University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen; University of Bonn	Hillmer, AM (corresponding author), Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany.	axel.hillmer@uni-bonn.de	Nöthen, Markus/B-2027-2009; Hillmer, Axel M/B-7485-2015; Nyholt, Dale Robert/J-3174-2017; Montgomery, Grant W/B-7148-2008; Hillmer, Axel M/N-2927-2014; Cichon, Sven/B-9618-2014; Herms, Stefan/J-1949-2014; Betz, Regina C/E-8591-2011; Cichon, Sven/H-8803-2013	Nöthen, Markus/0000-0002-8770-2464; Hillmer, Axel M/0000-0002-3381-7266; Nyholt, Dale Robert/0000-0001-7159-3040; Montgomery, Grant W/0000-0002-4140-8139; Hillmer, Axel M/0000-0002-3381-7266; Cichon, Sven/0000-0002-9475-086X; Herms, Stefan/0000-0002-2786-8200; Betz, Regina C/0000-0001-5024-3623; Cichon, Sven/0000-0002-9475-086X; Reinartz, Roman/0000-0002-6417-9156; Martin, Nicholas/0000-0003-4069-8020; Steffens, Michael/0000-0002-6445-8593; Moebus, Susanne/0000-0002-0072-5410	Deutsche Forschungsgemeinschaft; Alfried Krupp von Bohlen; Halbach-Stiftung; Heinz Nixdorf Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alfried Krupp von Bohlen; Halbach-Stiftung; Heinz Nixdorf Foundation	We thank all probands for participating in the study and providing blood samples. This study was supported by the Deutsche Forschungsgemeinschaft (FOR 423 and Emmy Noether) and the Alfried Krupp von Bohlen und Halbach-Stiftung. The Heinz Nixdorf Recall cohort was established with the support of the Heinz Nixdorf Foundation (G. Schmidt, Chairman).	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Ellis JA, 2001, J INVEST DERMATOL, V116, P452, DOI 10.1046/j.1523-1747.2001.01261.x; Ellis JA, 2007, HUM GENET, V121, P451, DOI 10.1007/s00439-006-0317-8; HAMILTON JB, 1951, ANN NY ACAD SCI, V53, P708, DOI 10.1111/j.1749-6632.1951.tb31971.x; Hillmer AM, 2005, AM J HUM GENET, V77, P140, DOI 10.1086/431425; Hillmer AM, 2008, AM J HUM GENET, V82, P737, DOI 10.1016/j.ajhg.2007.11.014; Kleinjan DA, 2006, DEV BIOL, V299, P563, DOI 10.1016/j.ydbio.2006.08.060; Lotufo PA, 2000, ARCH INTERN MED, V160, P165, DOI 10.1001/archinte.160.2.165; Matilainen V, 2000, LANCET, V356, P1165, DOI 10.1016/S0140-6736(00)02763-X; NORWOOD OT, 1975, SOUTHERN MED J, V68, P1359, DOI 10.1097/00007611-197511000-00009; Nyholt DR, 2003, J INVEST DERMATOL, V121, P1561, DOI 10.1111/j.1523-1747.2003.12615.x; Paik JH, 2001, BRIT J DERMATOL, V145, P95, DOI 10.1046/j.1365-2133.2001.04289.x; RISCH N, 1996, SCIENCE, V273, P1517	15	88	92	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1279	1281		10.1038/ng.228	http://dx.doi.org/10.1038/ng.228			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18849994				2022-12-27	WOS:000260501500016
J	Kao, WHL; Klag, MJ; Meoni, LA; Reich, D; Berthier-Schaad, Y; Li, M; Coresh, J; Patterson, N; Tandon, A; Powe, NR; Fink, NE; Sadler, JH; Weir, MR; Abboud, HE; Adler, SG; Divers, J; Iyengar, SK; Freedman, BI; Kimmel, PL; Knowler, WC; Kohn, OF; Kramp, K; Leehey, DJ; Nicholas, SB; Pahl, MV; Schelling, JR; Sedor, JR; Thornley-Brown, D; Winkler, CA; Smith, MW; Parekh, RS				Kao, W. H. Linda; Klag, Michael J.; Meoni, Lucy A.; Reich, David; Berthier-Schaad, Yvette; Li, Man; Coresh, Josef; Patterson, Nick; Tandon, Arti; Powe, Neil R.; Fink, Nancy E.; Sadler, John H.; Weir, Matthew R.; Abboud, Hanna E.; Adler, Sharon G.; Divers, Jasmin; Iyengar, Sudha K.; Freedman, Barry I.; Kimmel, Paul L.; Knowler, William C.; Kohn, Orly F.; Kramp, Kristopher; Leehey, David J.; Nicholas, Susanne B.; Pahl, Madeleine V.; Schelling, Jeffrey R.; Sedor, John R.; Thornley-Brown, Denyse; Winkler, Cheryl A.; Smith, Michael W.; Parekh, Rulan S.		FIND Res Grp	MYH9 is associated with nondiabetic end-stage renal disease in African Americans	NATURE GENETICS			English	Article							MYOSIN HEAVY-CHAIN; ADMIXTURE LINKAGE DISEQUILIBRIUM; MAY-HEGGLIN; ADMIXED POPULATIONS; KIDNEY-DISEASE; GENE; GENOME; RISK; NEPHROPATHY; PROGRESSION	As end-stage renal disease (ESRD) has a four times higher incidence in African Americans compared to European Americans, we hypothesized that susceptibility alleles for ESRD have a higher frequency in the West African than the European gene pool. We carried out a genome-wide admixture scan in 1,372 ESRD cases and 806 controls and found a highly significant association between excess African ancestry and nondiabetic ESRD (lod score = 5.70) but not diabetic ESRD (lod = 0.47) on chromosome 22q12. Each copy of the European ancestral allele conferred a relative risk of 0.50 (95% CI = 0.39-0.63) compared to African ancestry. Multiple common SNPs (allele frequencies ranging from 0.2 to 0.6) in the gene encoding nonmuscle myosin heavy chain type II isoform A (MYH9) were associated with two to four times greater risk of nondiabetic ESRD and accounted for a large proportion of the excess risk of ESRD observed in African compared to European Americans.	[Kao, W. H. Linda; Klag, Michael J.; Berthier-Schaad, Yvette; Li, Man; Coresh, Josef; Powe, Neil R.; Fink, Nancy E.; Parekh, Rulan S.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD 21287 USA; [Kao, W. H. Linda; Klag, Michael J.; Meoni, Lucy A.; Powe, Neil R.; Fink, Nancy E.; Parekh, Rulan S.] Johns Hopkins Univ, Dept Med, Baltimore, MD 21287 USA; [Kao, W. H. Linda; Klag, Michael J.; Meoni, Lucy A.; Coresh, Josef; Powe, Neil R.; Fink, Nancy E.; Parekh, Rulan S.] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21287 USA; [Meoni, Lucy A.; Coresh, Josef] Johns Hopkins Univ, Dept Biostat, Sch Med, Baltimore, MD 21287 USA; [Meoni, Lucy A.; Coresh, Josef] Johns Hopkins Univ, Dept Biostat, Bloomberg Sch Publ Hlth, Baltimore, MD 21287 USA; [Reich, David; Tandon, Arti] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Reich, David; Patterson, Nick; Tandon, Arti] Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; [Reich, David; Patterson, Nick; Tandon, Arti] MIT, Cambridge, MA 02142 USA; [Sadler, John H.; Weir, Matthew R.] Univ Maryland, Dept Med, Baltimore, MD 21201 USA; [Abboud, Hanna E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Adler, Sharon G.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Dept Med, Los Angeles, CA 90502 USA; [Divers, Jasmin; Freedman, Barry I.] Wake Forest Univ, Bowman Gray Sch Med, Dept Med, Winston Salem, NC 27157 USA; [Iyengar, Sudha K.; Kramp, Kristopher] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44109 USA; [Kimmel, Paul L.] NIDDK, NIH, Bethesda, MD 20892 USA; [Knowler, William C.] NIDDK, Diabet Epidemiol & Clin Res Sect, NIH, Phoenix, AZ 85014 USA; [Kohn, Orly F.] Loyola Univ, Dept Med, Chicago, IL 60153 USA; [Leehey, David J.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Nicholas, Susanne B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90024 USA; [Pahl, Madeleine V.] Univ Calif Irvine, Dept Med, Irvine, CA 92868 USA; [Schelling, Jeffrey R.; Sedor, John R.] Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44109 USA; [Sedor, John R.] Case Western Reserve Univ, Sch Med, Dept Biophysiol & Biophys, Cleveland, OH 44109 USA; [Thornley-Brown, Denyse] Univ Alabama, Dept Med, Birmingham, AL 35294 USA; [Winkler, Cheryl A.; Smith, Michael W.] NCI, Lab Genom Divers, SAIC Frederick Inc, Frederick, MD 21702 USA; [Parekh, Rulan S.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University System of Maryland; University of Maryland Baltimore; University of Texas System; University of Texas Health San Antonio; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Case Western Reserve University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Loyola University Chicago; University of Chicago; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Irvine; Case Western Reserve University; Case Western Reserve University; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Johns Hopkins University	Kao, WHL (corresponding author), Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD 21287 USA.	wkao@jhsph.edu	Weir, Matthew R/ABC-3654-2021; Nelson, Robert G/B-1470-2012; Parekh, Rulan/AAQ-4411-2020; Li, Man/AAX-3400-2020; Smith, Michael/B-5341-2012; /S-1190-2019	Weir, Matthew R/0000-0001-8820-5702; Li, Man/0000-0002-3839-0281; /0000-0001-7488-250X; Kramp, Kristopher/0000-0003-2121-9274; Parekh, Rulan/0000-0001-6313-5752; Jun, Gyungah/0000-0002-3230-8697	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS008365] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC010022, ZIABC010297] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001346, M01RR000827, M01RR007122, M01RR000425, M01RR000080] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK069094, U01DK070657, ZIADK069000, R01DK059997, K01DK067207, R01DK072348, R01DK067528, U01DK057304, T32DK007024, U01DK057292] Funding Source: NIH RePORTER; AHRQ HHS [R01 HS008365, HS08365] Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [N01-CO-12400, N01CO12400] Funding Source: Medline; NCRR NIH HHS [M01 RR007122, M01-RR-000080, M01 RR000827, M01-RR-00827-29, M01 RR001346, M01-RR-01346, M01-RR-00425, M01-RR-07122, M01 RR000080, M01 RR000425] Funding Source: Medline; NHLBI NIH HHS [R01 HL062985, HL62985] Funding Source: Medline; NIDDK NIH HHS [U01 DK070657-02, U01DK070657, U01 DK070657, DK07024, U01DK57304, R01 DK059997, U01 DK070657-03, U01 DK070657-01, U01 DK057292, U01 DK057304, K01 DK067207, R01 DK067528-05, R01 DK072348-04, R01 DK067528, R01 DK072348, K01DK067207, U01DK57292, R01 DK059997-04] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHAKRABORTY R, 1988, P NATL ACAD SCI USA, V85, P9119, DOI 10.1073/pnas.85.23.9119; D'Apolito M, 2002, GENE, V286, P215, DOI 10.1016/S0378-1119(02)00455-9; Fox CS, 2004, J AM SOC NEPHROL, V15, P2457, DOI 10.1097/01.ASN.0000135972.13396.6F; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; FREEDMAN BI, 1993, AM J KIDNEY DIS, V21, P387, DOI 10.1016/S0272-6386(12)80266-6; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hunt SC, 2004, AM J HYPERTENS, V17, P511, DOI 10.1016/j.amjhyper.2004.02.019; Iyengar SK, 2003, J AM SOC NEPHROL, V14, pS195, DOI 10.1097/01.ASN.0000070078.66465.55; Kelley MJ, 2000, NAT GENET, V26, P106, DOI 10.1038/79069; Klag MJ, 1997, JAMA-J AM MED ASSOC, V277, P1293, DOI 10.1001/jama.277.16.1293; Knowler WC, 2005, J DIABETES COMPLICAT, V19, P1, DOI 10.1016/j.jdiacomp.2003.12.007; Kong X, 2004, AM J HUM GENET, V75, P1143, DOI 10.1086/426405; Kopp JB, 2008, NAT GENET, V40, P1175, DOI 10.1038/ng.226; Kunishima S, 1999, HUM GENET, V105, P379, DOI 10.1007/s004390051119; Kunishima S, 2008, EUR J HAEMATOL, V80, P540, DOI 10.1111/j.1600-0609.2008.01046.x; Lei HH, 1998, J AM SOC NEPHROL, V9, P1270; Marini M, 2006, INT J MOL MED, V17, P729; McKeigue PM, 1998, AM J HUM GENET, V63, P241, DOI 10.1086/301908; McKeigue PM, 2000, ANN HUM GENET, V64, P171, DOI 10.1017/S0003480000008022; Nalls MA, 2008, AM J HUM GENET, V82, P81, DOI 10.1016/j.ajhg.2007.09.003; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; PERNEGER TV, 1995, ARCH INTERN MED, V155, P1201, DOI 10.1001/archinte.155.11.1201; Powe NR, 1996, SEMIN DIALYSIS, V9, P9, DOI 10.1111/j.1525-139X.1996.tb00890.x; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Remuzzi G, 2006, J CLIN INVEST, V116, P288, DOI 10.1172/JCI27699; Saito H, 2008, AM J HEMATOL, V83, P304, DOI 10.1002/ajh.21102; Seri M, 2002, HUM GENET, V110, P182, DOI 10.1007/s00439-001-0659-1; Smith MW, 2005, NAT REV GENET, V6, P623, DOI 10.1038/nrg1657; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; STEPHENS JC, 1994, AM J HUM GENET, V55, P809; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tarver-Carr ME, 2002, J AM SOC NEPHROL, V13, P2363, DOI 10.1097/01.ASN.0000026493.18542.6A; USRDS, 2011, ANN DAT REP ATL END; Wright JT, 2002, JAMA-J AM MED ASSOC, V288, P2421, DOI 10.1001/jama.288.19.2421	35	498	525	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2008	40	10					1185	1192		10.1038/ng.232	http://dx.doi.org/10.1038/ng.232			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18794854	Green Accepted			2022-12-27	WOS:000259651000017
J	Raychaudhuri, S; Remmers, EF; Lee, AT; Hackett, R; Guiducci, C; Burtt, NP; Gianniny, L; Korman, BD; Padyukov, L; Kurreeman, FAS; Chang, M; Catanese, JJ; Ding, B; Wong, S; Mil, AHMV; Neale, BM; Coblyn, J; Cui, J; Tak, PP; Wolbink, GJ; Crusius, JBA; van der Horst-Bruinsma, IE; Criswell, LA; Amos, CI; Seldin, MF; Kastner, DL; Ardlie, KG; Alfredsson, L; Costenbader, KH; Altshuler, D; Huizinga, TWJ; Shadick, NA; Weinblatt, ME; de Vries, N; Worthington, J; Seielstad, M; Toes, REM; Karlson, EW; Begovich, AB; Klareskog, L; Gregersen, PK; Daly, MJ; Plenge, RM				Raychaudhuri, Soumya; Remmers, Elaine F.; Lee, Annette T.; Hackett, Rachel; Guiducci, Candace; Burtt, Noel P.; Gianniny, Lauren; Korman, Benjamin D.; Padyukov, Leonid; Kurreeman, Fina A. S.; Chang, Monica; Catanese, Joseph J.; Ding, Bo; Wong, Sandra; Mil, Annette H. M. van der Helm-van; Neale, Benjamin M.; Coblyn, Jonathan; Cui, Jing; Tak, Paul P.; Wolbink, Gert Jan; Crusius, J. Bart A.; van der Horst-Bruinsma, Irene E.; Criswell, Lindsey A.; Amos, Christopher I.; Seldin, Michael F.; Kastner, Daniel L.; Ardlie, Kristin G.; Alfredsson, Lars; Costenbader, Karen H.; Altshuler, David; Huizinga, Tom W. J.; Shadick, Nancy A.; Weinblatt, Michael E.; de Vries, Niek; Worthington, Jane; Seielstad, Mark; Toes, Rene E. M.; Karlson, Elizabeth W.; Begovich, Ann B.; Klareskog, Lars; Gregersen, Peter K.; Daly, Mark J.; Plenge, Robert M.			Common variants at CD40 and other loci confer risk of rheumatoid arthritis	NATURE GENETICS			English	Article							NF-KAPPA-B; SINGLE-NUCLEOTIDE POLYMORPHISM; GENOME-WIDE ASSOCIATION; GRAVES-DISEASE; SUSCEPTIBILITY; GENE; COOPERATION; EXPRESSION; INTERACTS; ANTIBODY	To identify rheumatoid arthritis risk loci in European populations, we conducted a meta-analysis of two published genome-wide association (GWA) studies totaling 3,393 cases and 12,462 controls(1,2). We genotyped 31 top-ranked SNPs not previously associated with rheumatoid arthritis in an independent replication of 3,929 autoantibody-positive rheumatoid arthritis cases and 5,807 matched controls from eight separate collections. We identified a common variant at the CD40 gene locus (rs4810485, P = 0.0032 replication, P = 8.2 x 10(-9) overall, OR = 0.87). Along with other associations near TRAF1 (refs. 2,3) and TNFAIP3 (refs. 4,5), this implies a central role for the CD40 signaling pathway in rheumatoid arthritis pathogenesis. We also identified association at the CCL21 gene locus (rs2812378, P = 0.00097 replication, P = 2.8 x 10(-7) overall), a gene involved in lymphocyte trafficking. Finally, we identified evidence of association at four additional gene loci: MMEL1-TNFRSF14 (rs3890745, P = 0.0035 replication, P = 1.1 x 10(-7) overall), CDK6 (rs42041, P = 0.010 replication, P = 4.0 x 10(-6) overall), PRKCQ (rs4750316, P = 0.0078 replication, P = 4.4 x 10(-6) overall), and KIF5A-PIP4K2C (rs1678542, P = 0.0026 replication, P = 8.8 x 10(-8) overall).	[Raychaudhuri, Soumya; Hackett, Rachel; Guiducci, Candace; Burtt, Noel P.; Gianniny, Lauren; Wong, Sandra; Neale, Benjamin M.; Ardlie, Kristin G.; Altshuler, David; Daly, Mark J.; Plenge, Robert M.] Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Raychaudhuri, Soumya; Hackett, Rachel; Guiducci, Candace; Burtt, Noel P.; Gianniny, Lauren; Wong, Sandra; Neale, Benjamin M.; Ardlie, Kristin G.; Altshuler, David; Daly, Mark J.; Plenge, Robert M.] MIT, Cambridge, MA 02142 USA; [Raychaudhuri, Soumya; Coblyn, Jonathan; Cui, Jing; Costenbader, Karen H.; Shadick, Nancy A.; Weinblatt, Michael E.; Karlson, Elizabeth W.; Plenge, Robert M.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Raychaudhuri, Soumya; Neale, Benjamin M.; Altshuler, David; Daly, Mark J.; Plenge, Robert M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Remmers, Elaine F.; Korman, Benjamin D.; Kastner, Daniel L.] NIAMSD, Genet & Genom Branch, NIH, Bethesda, MD 20892 USA; [Lee, Annette T.; Gregersen, Peter K.] N Shore Long Isl Jewish Hlth Syst, Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Padyukov, Leonid; Klareskog, Lars] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Med, Rheumatol Unit, S-17176 Stockholm, Sweden; [Kurreeman, Fina A. S.; Mil, Annette H. M. van der Helm-van; Huizinga, Tom W. J.; Toes, Rene E. M.] Leiden Univ, Med Ctr, Dept Rheumatol, NL-2333 ZA Leiden, Netherlands; [Chang, Monica; Catanese, Joseph J.; Begovich, Ann B.] Celera, Alameda, CA 94502 USA; [Ding, Bo; Alfredsson, Lars] Karolinska Inst, Inst Environm Med, S-17177 Stockholm, Sweden; [Neale, Benjamin M.] Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London SE5 8AF, England; [Tak, Paul P.] Univ Amsterdam, Acad Med Ctr, NL-326 Amsterdam, Netherlands; [Wolbink, Gert Jan] Jan van Breemen Inst, NL-1056 AB Amsterdam, Netherlands; [Wolbink, Gert Jan] Univ Amsterdam, Acad Med Ctr, Sanquin Res Landsteiner Lab, NL-1006 AD Amsterdam, Netherlands; [van der Horst-Bruinsma, Irene E.] Vrije Univ Amsterdam, Med Ctr, Dept Rheumatol, NL-1007 MB Amsterdam, Netherlands; [Crusius, J. Bart A.] Vrije Univ Amsterdam, Med Ctr, Immunogenet Lab, Dept Pathol, NL-1007 MB Amsterdam, Netherlands; [Criswell, Lindsey A.] Univ Calif San Francisco, Dept Med, Rosalind Russell Med Res Ctr Arthrit, San Francisco, CA 94143 USA; [Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Seldin, Michael F.] Univ Calif Davis, Rowe Program Genet, Davis, CA 95616 USA; [Ardlie, Kristin G.] SeraCare Life Sci, Cambridge, MA 02139 USA; [Worthington, Jane] Univ Manchester, Arthrit Res Campaign Epidemiol Unit, Manchester M13 9PT, Lancs, England; [Seielstad, Mark] Genome Inst Singapore, Singapore 138672, Singapore	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Massachusetts General Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Northwell Health; Karolinska Institutet; Karolinska University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Karolinska Institutet; University of London; King's College London; University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of California System; University of California San Francisco; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California Davis; University of Manchester; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS)	Plenge, RM (corresponding author), Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA.	rplenge@partners.org	Worthington, Jane/M-9770-2014; Daly, Mark J/B-2453-2017; de Vries, Niek/J-9348-2013; Crusius, Jakob Bart/AAE-9051-2019; van der Horst-Bruinsma, Irene/AAC-7744-2022; Altshuler, David M/A-4476-2009; Seielstad, Mark/T-7841-2019; Padyukov, Leonid/A-4890-2009; Alfredsson, Lars/AAC-9007-2019	Worthington, Jane/0000-0003-0544-042X; Daly, Mark J/0000-0002-0949-8752; de Vries, Niek/0000-0002-6257-8604; Crusius, Jakob Bart/0000-0001-9046-0155; van der Horst-Bruinsma, Irene/0000-0002-8086-9915; Altshuler, David M/0000-0002-7250-4107; Padyukov, Leonid/0000-0003-2950-5670; Alfredsson, Lars/0000-0003-1688-6697; Wolbink, Gerrit Jan/0000-0003-1924-7460; Remmers, Elaine F/0000-0002-9522-1249; Klareskog, Lars/0000-0001-9601-6186; Hearn, Sandra/0000-0002-9748-697X; Seielstad, Mark/0000-0001-5783-1401; Toes, Rene/0000-0002-9618-6414; Raychaudhuri, Soumya/0000-0002-1901-8265; van der Helm - van Mil, Annette/0000-0001-8572-1437; Korman, Benjamin/0000-0002-4873-2628	T32 NIH training grant [AR007530-23]; NIH [KAR055688A, AI55314-3, RO1-AR44422, NO1-AR-2-2263, R01 AR49880, CA87969, P60 AR047782, K24 AR0524-01, BIRCWH K12 HD051959]; Fox Trot Fund; William Randolph Hearst Fund of Harvard University; Burroughs Wellcome Fund; UO1 NIH [UO1 HG004171]; Millennium Pharmaceuticals and Biogen-Idec; National Center for Research Resources [U54 RR020278]; National Institutes of Health; Swedish Medical Research Council; Swedish Council for Working Life and Social Research; King Gustaf V's 80-year Foundation; Swedish Rheumatic Foundation; Stockholm County Council; Arbetsmarknadens Forrsarkringsaktiebolag; lCounty of Sormland Research and Development Center; Agency for Science Technology and Research (Singapore); Doris Duke Charitable Foundation; US National Institute of Mental Health; National Institute of Allergy and Infectious Diseases; National Institute of Child Health and Human Development; American College of Rheumatology Arthritis Investigator Award; Katherine Swan Ginsburg Memorial Award; Kirkland Scholar Awardee [K24 AR02175, R01 AI065841, 5 M01 RR-00079]; European Community's FP6 funding; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD051959] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000079, U54RR020278] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI055314, R01AI065841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055688, N01AR022263, R01AR049880, K24AR002175, T32AR007530, R01AR044422, Z01AR041180, P60AR047782, ZIAAR041139] Funding Source: NIH RePORTER	T32 NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fox Trot Fund; William Randolph Hearst Fund of Harvard University; Burroughs Wellcome Fund(Burroughs Wellcome Fund); UO1 NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Millennium Pharmaceuticals and Biogen-Idec; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); King Gustaf V's 80-year Foundation; Swedish Rheumatic Foundation; Stockholm County Council(Stockholm County Council); Arbetsmarknadens Forrsarkringsaktiebolag; lCounty of Sormland Research and Development Center; Agency for Science Technology and Research (Singapore)(Agency for Science Technology & Research (A*STAR)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); American College of Rheumatology Arthritis Investigator Award; Katherine Swan Ginsburg Memorial Award; Kirkland Scholar Awardee; European Community's FP6 funding(European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the WTCCC for making access to genotype data available online, and for providing autoantibody status of the WTCCC rheumatoid arthritis cases. We thank S. Myers and J. Marchini for help with IMPUTE. S. R. is supported by a T32 NIH training grant (AR007530-23), a K08 grant from the NIH (KAR055688A), and through the BWH Rheumatology Fellowship program, directed by S. Helfgott. R. M. P. is supported by a K08 grant from the NIH (AI55314-3), a private donation from the Fox Trot Fund, the William Randolph Hearst Fund of Harvard University, and holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. M. J. D. is supported by a UO1 NIH grant (UO1 HG004171). The BRASS Registry is supported by a grant from Millennium Pharmaceuticals and Biogen-Idec. The Broad Institute Center for Genotyping and Analysis is supported by grant U54 RR020278 from the National Center for Research Resources. The NARAC is supported by NIH grants RO1-AR44422 and NO1-AR-2-2263 (P. K. G.). This work was also supported in part by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health. The EIRA study is supported by grants from the Swedish Medical Research Council, the Swedish Council for Working Life and Social Research, King Gustaf V's 80-year Foundation, the Swedish Rheumatic Foundation, the Stockholm County Council, the insurance company Arbetsmarknadens Forrsarkringsaktiebolag, and the County of Sormland Research and Development Center. Genotyping of the EIRA cohort was supported by the Agency for Science Technology and Research (Singapore). Genotyping of the GCI and LUMC samples was funded by Celera. D. A. is a Burroughs Wellcome Fund Clinical Scholar in Translational Research, and a Distinguished Clinical Scholar of the Doris Duke Charitable Foundation. B. D. K. was supported by the NIH Clinical Research Training Program, a public-private partnership between the Foundation for the National Institutes of Health and Pfizer Inc. E. W. K. is supported by NIH grants R01 AR49880, CA87969, P60 AR047782, K24 AR0524-01 and BIRCWH K12 HD051959 (supported by US National Institute of Mental Health, National Institute of Allergy and Infectious Diseases, National Institute of Child Health and Human Development and the Office of the Director). K. H. C. is the recipient of an Arthritis Foundation/American College of Rheumatology Arthritis Investigator Award and a Katherine Swan Ginsburg Memorial Award. L. A. C. is a Kirkland Scholar Awardee and her work on this project was supported by K24 AR02175, R01 AI065841 and 5 M01 RR-00079. P. P. T. and N. d. V. were supported by European Community's FP6 funding (Autocure). We acknowledge the help of C. Ellen van der Schoot for healthy control samples for GENRA and the help of B. A. C. Dijkmans, D. van Schaardenburg, A. S. Pena, P.L. Klarenbeek, Z. Zhang, M. T. Nurmohammed, W. F. Lems, R. R. J. van de Stadt, W. H. Bos, J. Ursum, M. G. M. Bartelds, D. M. Gerlag, M. G. H. van der Sande, C. A. Wijbrandts and M. M. J. Herenius in gathering GENRA subject samples and data. We thank Y. Li, S. Schrodi, and J. Sninsky (Celera); and B. Voight and C. Cotsapas (Broad Institute) for comments on the manuscript.	Balasa B, 1997, J IMMUNOL, V159, P4620; Barton A, 2008, NAT GENET, V40, P1156, DOI 10.1038/ng.218; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Carpenter CL, 2004, BIOCHEM SOC T, V32, P326, DOI 10.1042/BST0320326; DURIE FH, 1993, SCIENCE, V261, P1328, DOI 10.1126/science.7689748; Gruber T, 2008, MOL IMMUNOL, V45, P117, DOI 10.1016/j.molimm.2007.05.003; HARNETT MM, 2004, SCI STKE, pPE25; Heward JM, 2004, CLIN ENDOCRINOL, V61, P269, DOI 10.1111/j.1365-2265.2004.02099.x; Houston FA, 2004, THYROID, V14, P506, DOI 10.1089/1050725041517039; ISHIDA T, 1995, J IMMUNOL, V155, P5527; Jacobson EM, 2007, GENES IMMUN, V8, P205, DOI 10.1038/sj.gene.6364375; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kurreeman FAS, 2007, PLOS MED, V4, P1515, DOI 10.1371/journal.pmed.0040278; Lougaris V, 2005, IMMUNOL REV, V203, P48, DOI 10.1111/j.0105-2896.2005.00229.x; MacGregor AJ, 2000, ARTHRITIS RHEUM, V43, P30, DOI 10.1002/1529-0131(200001)43:1<30::AID-ANR5>3.0.CO;2-B; Manzo A, 2005, EUR J IMMUNOL, V35, P1347, DOI 10.1002/eji.200425830; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marsters SA, 1997, J BIOL CHEM, V272, P14029, DOI 10.1074/jbc.272.22.14029; Plenge RM, 2005, AM J HUM GENET, V77, P1044, DOI 10.1086/498651; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; STASTNY P, 1978, NEW ENGL J MED, V298, P869, DOI 10.1056/NEJM197804202981602; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Veiga-Fernandes H, 2004, NAT IMMUNOL, V5, P31, DOI 10.1038/ni1015; Xie P, 2006, J IMMUNOL, V176, P5388, DOI 10.4049/jimmunol.176.9.5388; Zhernakova A, 2007, AM J HUM GENET, V81, P1284, DOI 10.1086/522037	30	413	426	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2008	40	10					1216	1223		10.1038/ng.233	http://dx.doi.org/10.1038/ng.233			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18794853	Green Accepted			2022-12-27	WOS:000259651000022
J	Mackay, DJG; Callaway, JLA; Marks, SM; White, HE; Acerini, CL; Boonen, SE; Dayanikli, P; Firth, HV; Goodship, JA; Haemers, AP; Hahnemann, JMD; Kordonouri, O; Masoud, AF; Oestergaard, E; Storr, J; Ellard, S; Hattersley, AT; Robinson, DO; Temple, IK				Mackay, Deborah J. G.; Callaway, Jonathan L. A.; Marks, Sophie M.; White, Helen E.; Acerini, Carlo L.; Boonen, Susanne E.; Dayanikli, Pinar; Firth, Helen V.; Goodship, Judith A.; Haemers, Andreas P.; Hahnemann, Johanne M. D.; Kordonouri, Olga; Masoud, Ahmed F.; Oestergaard, Elsebet; Storr, John; Ellard, Sian; Hattersley, Andrew T.; Robinson, David O.; Temple, I. Karen			Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57	NATURE GENETICS			English	Article							STEM-CELLS; MELLITUS; IDENTIFICATION; REGION; ZFP-57	We have previously described individuals presenting with transient neonatal diabetes and showing a variable pattern of DNA hypomethylation at imprinted loci throughout the genome. We now report mutations in ZFP57, which encodes a zinc-finger transcription factor expressed in early development, in seven pedigrees with a shared pattern of mosaic hypomethylation and a conserved range of clinical features. This is the first description of a heritable global imprinting disorder that is compatible with life.	[Mackay, Deborah J. G.; Callaway, Jonathan L. A.; Robinson, David O.; Temple, I. Karen] Univ Southampton, Div Human Genet, Southampton SO16 6YD, England; [Mackay, Deborah J. G.; Callaway, Jonathan L. A.; Marks, Sophie M.; Robinson, David O.] Salisbury Dist Hosp, Wessex Reg Genet Lab, Salisbury SP2 8BJ, England; [White, Helen E.] Natl Genet Reference Lab Wessex, Salisbury SP2 8BJ, England; [Acerini, Carlo L.] Univ Cambridge, Dept Paediat, Cambridge CB2 0QQ, England; [Boonen, Susanne E.] Kennedy Ctr, Genet Counselling Clin, DK-2600 Glostrup, Denmark; [Dayanikli, Pinar] Amer Hosp, TR-80200 Istanbul, Turkey; [Firth, Helen V.] Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 0QQ, England; [Goodship, Judith A.] Univ Newcastle, Inst Human Genet, Newcastle upon Tyne NE1 3BZ, Tyne & Wear, England; [Hahnemann, Johanne M. D.] Kennedy Ctr, Med Genet Lab, DK-2600 Glostrup, Denmark; [Kordonouri, Olga] Kinderkrankenhaus Bult, D-30173 Hannover, Germany; [Masoud, Ahmed F.] Northwick Pk Hosp & Clin Res Ctr, Childrens Serv, Harrow HA1 3UJ, Middx, England; [Oestergaard, Elsebet] Natl Univ Hosp Rigshospitalet, Dept Clin Genet, DK-2100 Copenhagen, Denmark; [Storr, John] Cumberland Infirm, Dept Paediat, Carlisle CA2 7HY, Cumbria, England; [Ellard, Sian; Hattersley, Andrew T.] Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England; [Temple, I. Karen] Southampton Univ Hosp, Acad Unit Genet Med, Wessex Clin Genet Serv, Southampton SO16 5YA, England	University of Southampton; Salisbury District Hospital; University of Cambridge; Amerikan Hospital; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Newcastle University - UK; Imperial College London; Rigshospitalet; University of Copenhagen; University of Exeter; University of Southampton	Mackay, DJG (corresponding author), Univ Southampton, Div Human Genet, Southampton SO16 6YD, England.	djgm@soton.ac.uk	temple, isabel K/K-2391-2015; Mackay, Deborah JG/B-2879-2015	Mackay, Deborah JG/0000-0003-3088-4401; Hattersley, Andrew/0000-0001-5620-473X; Acerini, Carlo/0000-0003-2121-5871; Boonen, Susanne Eriksen/0000-0002-7824-2080; Temple, Isabel Karen/0000-0002-6045-1781; Ellard, Sian/0000-0002-7620-5526				Akagi T, 2005, BIOCHEM BIOPH RES CO, V331, P23, DOI 10.1016/j.bbrc.2005.03.118; Allegrucci C, 2005, REPRODUCTION, V129, P137, DOI 10.1530/rep.1.00360; Alonso MBD, 2004, J BIOL CHEM, V279, P25653, DOI 10.1074/jbc.M400415200; Bastepe M, 2005, NAT GENET, V37, P25, DOI 10.1038/ng1487; Boonen SE, 2008, EUR J HUM GENET, V16, P453, DOI 10.1038/sj.ejhg.5201993; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Mackay DJG, 2006, HUM GENET, V120, P262, DOI 10.1007/s00439-006-0205-2; Mackay DJG, 2005, HUM GENET, V116, P255, DOI 10.1007/s00439-004-1236-1; OKAZAKI S, 1994, J BIOL CHEM, V269, P6900; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rossignol S, 2006, J MED GENET, V43, P902, DOI 10.1136/jmg.2006.042135; Temple IK, 2002, J MED GENET, V39, P872, DOI 10.1136/jmg.39.12.872; Valerio G, 2001, J PEDIATR ENDOCR MET, V14, P897; Wood AJ, 2007, NUCLEIC ACIDS RES, V35, P7031, DOI 10.1093/nar/gkm742	15	373	385	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2008	40	8					949	951		10.1038/ng.187	http://dx.doi.org/10.1038/ng.187			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18622393				2022-12-27	WOS:000258026900009
J	Kerkel, K; Spadola, A; Yuan, E; Kosek, J; Jiang, L; Hod, E; Li, K; Murty, VV; Schupf, N; Vilain, E; Morris, M; Haghighi, F; Tycko, B				Kerkel, Kristi; Spadola, Alexandra; Yuan, Eric; Kosek, Jolanta; Jiang, Le; Hod, Eldad; Li, Kerry; Murty, Vundavalli V.; Schupf, Nicole; Vilain, Eric; Morris, Mitzi; Haghighi, Fatemeh; Tycko, Benjamin			Genomic surveys by methylation-sensitive SNP analysis identify sequence-dependent allele-specific DNA methylation	NATURE GENETICS			English	Article							SINGLE NUCLEOTIDE POLYMORPHISM; PRADER-WILLI-SYNDROME; MONOALLELIC EXPRESSION; PROMOTER ACTIVITY; GENE; CYP2A6; IDENTIFICATION; EPIMUTATION	Allele-specific DNA methylation (ASM) is a hallmark of imprinted genes, but ASM in the larger nonimprinted fraction of the genome is less well characterized. Using methylation-sensitive SNP analysis (MSNP), we surveyed the human genome at 50K and 250K resolution, identifying ASM as recurrent genotype call conversions from heterozygosity to homozygosity when genomic DNAs were predigested with the methylation-sensitive restriction enzyme HpaII. Using independent assays, we confirmed ASM at 16 SNP-tagged loci distributed across various chromosomes. At 12 of these loci (75%), the ASM tracked strongly with the sequence of adjacent SNPs. Further analysis showed allele-specific mRNA expression at two loci from this methylation-based screen -the vanin and CYP2A6-CYP2A7 gene clusters -both implicated in traits of medical importance. This recurrent phenomenon of sequence-dependent ASM has practical implications for mapping and interpreting associations of noncoding SNPs and haplotypes with human phenotypes.	[Kerkel, Kristi; Yuan, Eric; Kosek, Jolanta; Jiang, Le; Li, Kerry; Murty, Vundavalli V.; Tycko, Benjamin] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA; [Spadola, Alexandra] Columbia Univ, Med Ctr, Dept Obstet & Gynecol, New York, NY 10032 USA; [Hod, Eldad; Murty, Vundavalli V.; Tycko, Benjamin] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; [Schupf, Nicole] Columbia Univ, Med Ctr, Gertrude H Sergievsky Ctr, New York, NY 10032 USA; [Schupf, Nicole] Columbia Univ, Med Ctr, Dept Epidemiol, New York, NY 10032 USA; [Vilain, Eric] Univ Calif Los Angeles, Dept Urol, Los Angeles, CA 90095 USA; [Vilain, Eric] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Morris, Mitzi; Haghighi, Fatemeh] Columbia Univ, Med Ctr, Dept Psychiat, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Columbia University	Tycko, B (corresponding author), Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA.	bt12@columbia.edu			NCI NIH HHS [R21 CA125461, R21 CA128556] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA128556, R21CA125461] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Boccaccio I, 1999, HUM MOL GENET, V8, P2497, DOI 10.1093/hmg/8.13.2497; Chan TL, 2006, NAT GENET, V38, P1178, DOI 10.1038/ng1866; CHANDLER LA, 1987, CELL, V50, P711, DOI 10.1016/0092-8674(87)90329-1; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Gimelbrant A, 2007, SCIENCE, V318, P1136, DOI 10.1126/science.1148910; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Lee S, 2000, HUM MOL GENET, V9, P1813, DOI 10.1093/hmg/9.12.1813; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Murrell A, 2004, HUM MOL GENET, V13, P247, DOI 10.1093/hmg/ddh013; Ohlsson R, 1998, TRENDS GENET, V14, P435, DOI 10.1016/S0168-9525(98)01583-2; Pitarque M, 2004, HUM MUTAT, V23, P258, DOI 10.1002/humu.20002; Pitarque M, 2001, BIOCHEM BIOPH RES CO, V284, P455, DOI 10.1006/bbrc.2001.4990; Saitoh S, 1997, AM J MED GENET, V68, P195, DOI 10.1002/(SICI)1096-8628(19970120)68:2<195::AID-AJMG15>3.3.CO;2-T; SILVA AJ, 1988, CELL, V54, P145, DOI 10.1016/0092-8674(88)90546-6; Suter CM, 2007, NAT GENET, V39, P573, DOI 10.1038/ng0507-573a; SUTER CM, 2007, NAT GENET, V39, P576; Tyndale RF, 2003, ANN MED, V35, P94, DOI 10.1080/07853890310010014; von Richter O, 2004, PHARMACOGENETICS, V14, P369, DOI 10.1097/00008571-200406000-00006; Wang JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001293; Yamada Y, 2004, GENOME RES, V14, P247, DOI 10.1101/gr.1351604; Yuan E, 2006, CANCER RES, V66, P3443, DOI 10.1158/0008-5472.CAN-05-3739; Zogel C, 2006, EUR J HUM GENET, V14, P752, DOI 10.1038/sj.ejhg.5201602	22	334	342	2	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					904	908		10.1038/ng.174	http://dx.doi.org/10.1038/ng.174			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18568024	Green Published			2022-12-27	WOS:000257166500027
J	Aitman, TJ; Critser, JK; Cuppen, E; Dominiczak, A; Fernandez-Suarez, XM; Flint, J; Gauguier, D; Geurts, AM; Gould, M; Harris, PC; Holmdahl, R; Hubner, N; Izsvak, Z; Jacob, HJ; Kuramoto, T; Kwitek, AE; Marrone, A; Mashimo, T; Moreno, C; Mullins, J; Mullins, L; Olsson, T; Pravenec, M; Riley, L; Saar, K; Serikawa, T; Shull, JD; Szpirer, C; Twigger, SN; Voigt, B; Worley, K				Aitman, Timothy J.; Critser, John K.; Cuppen, Edwin; Dominiczak, Anna; Fernandez-Suarez, Xose M.; Flint, Jonathan; Gauguier, Dominique; Geurts, Aron M.; Gould, Michael; Harris, Peter C.; Holmdahl, Rikard; Hubner, Norbert; Izsvak, Zsuzsanna; Jacob, Howard J.; Kuramoto, Takashi; Kwitek, Anne E.; Marrone, Anna; Mashimo, Tomoji; Moreno, Carol; Mullins, John; Mullins, Linda; Olsson, Tomas; Pravenec, Michal; Riley, Lela; Saar, Kathrin; Serikawa, Tadao; Shull, James D.; Szpirer, Claude; Twigger, Simon N.; Voigt, Birger; Worley, Kim			Progress and prospects in rat genetics: a community view	NATURE GENETICS			English	Article							POLYCYSTIC KIDNEY-DISEASE; RECOMBINANT INBRED STRAINS; QUANTITATIVE TRAIT LOCI; TRANSGENIC RATS; LABORATORY RAT; FATTY-ACID; GENOME; IDENTIFICATION; GENERATION; MOUSE	The rat is an important system for modeling human disease. Four years ago, the rich 150-year history of rat research was transformed by the sequencing of the rat genome, ushering in an era of exceptional opportunity for identifying genes and pathways underlying disease phenotypes. Genome-wide association studies in human populations have recently provided a direct approach for finding robust genetic associations in common diseases, but identifying the precise genes and their mechanisms of action remains problematic. In the context of significant progress in rat genomic resources over the past decade, we outline achievements in rat gene discovery to date, show how these findings have been translated to human disease, and document an increasing pace of discovery of new disease genes, pathways and mechanisms. Finally, we present a set of principles that justify continuing and strengthening genetic studies in the rat model, and further development of genomic infrastructure for rat research.	[Aitman, Timothy J.; Marrone, Anna] MRC, Ctr Clin Sci, London W12 0NN, England; [Aitman, Timothy J.; Marrone, Anna] Univ London Imperial Coll Sci Technol & Med, London W12 0NN, England; [Critser, John K.; Riley, Lela] Univ Missouri, Columbia, MO 65211 USA; [Cuppen, Edwin] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Dominiczak, Anna] Univ Glasgow, Glasgow G12 8TA, Lanark, Scotland; [Fernandez-Suarez, Xose M.] European Bioinformat Inst, Cambridge CB10 1SD, England; [Flint, Jonathan; Gauguier, Dominique] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Geurts, Aron M.; Jacob, Howard J.; Moreno, Carol; Twigger, Simon N.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Gould, Michael] Univ Wisconsin, Madison, WI 53706 USA; [Harris, Peter C.] Mayo Clin, Rochester, MN 55905 USA; [Holmdahl, Rikard] Karolinska Inst, S-17177 Stockholm, Sweden; [Hubner, Norbert; Izsvak, Zsuzsanna; Saar, Kathrin] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Kuramoto, Takashi; Mashimo, Tomoji; Serikawa, Tadao; Voigt, Birger] Kyoto Univ, Sakyo Ku, Kyoto 6068501, Japan; [Kwitek, Anne E.] Univ Iowa, Iowa City, IA 52242 USA; [Mullins, John; Mullins, Linda] Univ Edinburgh, Edinburgh EH16 4TJ, Midlothian, Scotland; [Olsson, Tomas] Karolinska Hosp, Karolinska Inst, S-17176 Stockholm, Sweden; [Pravenec, Michal] Acad Sci Czech Republ, Inst Physiol, CR-14220 Prague 4, Czech Republic; [Pravenec, Michal] Ctr Appl Genom, Prague 14220 4, Czech Republic; [Pravenec, Michal] Charles Univ Prague, Inst Biol & Med Genet, Prague 12800 2, Czech Republic; [Shull, James D.] Univ Nebraska, Med Ctr, Ctr Mol Genet & Genom, Omaha, NE 68198 USA; [Szpirer, Claude] Univ Libre Bruxelles, BE-6041 Gosselies, Charleroi, Belgium; [Worley, Kim] Baylor Coll Med, Houston, TX 77030 USA	Imperial College London; University of Missouri System; University of Missouri Columbia; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); University of Glasgow; European Molecular Biology Laboratory (EMBL); University of Oxford; Wellcome Centre for Human Genetics; Medical College of Wisconsin; University of Wisconsin System; University of Wisconsin Madison; Mayo Clinic; Karolinska Institutet; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Kyoto University; University of Iowa; University of Edinburgh; Karolinska Institutet; Karolinska University Hospital; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague; University of Nebraska System; University of Nebraska Medical Center; Universite Libre de Bruxelles; Baylor College of Medicine	Aitman, TJ (corresponding author), MRC, Ctr Clin Sci, Du Cane Rd, London W12 0NN, England.	t.aitman@csc.mrc.ac.uk; jacob@mcw.edu	Cuppen, Edwin/F-5696-2011; Dominiczak, Anna F/D-2262-2009; Pravenec, Michal/B-1666-2012; Holmdahl, Rikard/AAI-7682-2020; Llamas, Bastien/Y-2781-2018; Fernandez, Xose/ABA-7117-2020; Gauguier, Dominique/G-2190-2016; Cuppen, Edwin/H-2389-2016; Dominiczak, Anna F/P-9390-2017	Cuppen, Edwin/0000-0002-0400-9542; Pravenec, Michal/0000-0001-9197-5871; Llamas, Bastien/0000-0002-5550-9176; Fernandez, Xose/0000-0001-7139-6215; Gauguier, Dominique/0000-0001-6156-9530; Cuppen, Edwin/0000-0002-0400-9542; Dominiczak, Anna F/0000-0003-4913-3608; Mullins, Linda/0000-0002-6743-8707; Izsvak, Zsuzsanna/0000-0002-2053-2384; Flint, Jonathan/0000-0002-9427-4429; Aitman, Timothy/0000-0002-7875-4502; Saar, Kathrin/0000-0002-4483-1557; Olsson, Tomas/0000-0002-2938-1877; Kwitek, Anne/0000-0003-1024-4116; Twigger, Simon/0000-0001-5659-3632; Worley, Kim/0000-0002-0282-1000	Medical Research Council [MC_U120061454] Funding Source: Medline; NCI NIH HHS [R01 CA077876] Funding Source: Medline; NIDDK NIH HHS [R01 DK059597] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA077876] Funding Source: NIH RePORTER; MRC [MC_U120061454] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Aitman TJ, 1997, NAT GENET, V16, P197, DOI 10.1038/ng0697-197; Amos-Landgraf JM, 2007, P NATL ACAD SCI USA, V104, P4036, DOI 10.1073/pnas.0611690104; Behmoaras J, 2008, NAT GENET, V40, P553, DOI 10.1038/ng.137; Belknap JK, 1998, BEHAV GENET, V28, P29, DOI 10.1023/A:1021404714631; Broser P, 2008, CEREB CORTEX, V18, P1588, DOI 10.1093/cercor/bhm189; Buehr M, 2003, BIOL REPROD, V68, P222, DOI 10.1095/biolreprod.102.006197; Cowley AW, 2004, J PHYSIOL-LONDON, V554, P46, DOI 10.1113/jphysiol.2003.052613; Dann CT, 2007, TRANSGENIC RES, V16, P571, DOI 10.1007/s11248-007-9121-z; Demers SP, 2007, CLONING STEM CELLS, V9, P512, DOI 10.1089/clo.2007.0029; Dewey C, 2004, GENOME RES, V14, P661, DOI 10.1101/gr.1939804; Dozortsev D, 1998, ZYGOTE, V6, P143, DOI 10.1017/S0967199498000069; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Flood DG, 2009, NEUROBIOL AGING, V30, P1078, DOI 10.1016/j.neurobiolaging.2007.10.006; Gattone VH, 2003, NAT MED, V9, P1323, DOI 10.1038/nm935; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Guryev V, 2008, NAT GENET, V40, P538, DOI 10.1038/ng.141; Hamra FK, 2005, P NATL ACAD SCI USA, V102, P17430, DOI 10.1073/pnas.0508780102; Hamta A, 2006, CYTOGENET GENOME RES, V115, P158, DOI 10.1159/000095237; HANSEN C, 1984, ALCOHOL CLIN EXP RES, V8, P477, DOI 10.1111/j.1530-0277.1984.tb05706.x; HEDRICH HJ, 1990, RECOMBINANT INBRED S, P487; Hirabayashi M, 2005, MOL REPROD DEV, V70, P422, DOI 10.1002/mrd.20223; Hirabayashi M, 2002, TRANSGENIC RES, V11, P221, DOI 10.1023/A:1015210604906; Hornum L, 2002, DIABETES, V51, P1972, DOI 10.2337/diabetes.51.6.1972; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Jacob HJ, 1999, GENOME RES, V9, P1013, DOI 10.1101/gr.9.11.1013; JACOB HJ, 1995, NAT GENET, V9, P63, DOI 10.1038/ng0195-63; Kashiwazaki N, 2007, REPROD FERT DEVELOP, V19, P124, DOI 10.1071/RDv19n1Ab12; Kato M, 2004, MOL REPROD DEV, V69, P153, DOI 10.1002/mrd.20161; Kemlink D, 2003, FOLIA BIOL-PRAGUE, V49, P165; Kitada K, 2007, NAT METHODS, V4, P131, DOI 10.1038/nmeth1002; Kwitek AE, 2004, GENOME RES, V14, P750, DOI 10.1101/gr.1968704; Lindsey J. R., 1979, The laboratory rat. Volume I. Biology and diseases., P1; Lu BS, 2007, MAMM GENOME, V18, P338, DOI 10.1007/s00335-007-9025-5; MacMurray AJ, 2002, GENOME RES, V12, P1029, DOI 10.1101/gr.412702; Mashimo T, 2005, J APPL PHYSIOL, V98, P371, DOI 10.1152/japplphysiol.01006.2004; Mashimo T, 2008, NAT GENET, V40, P514, DOI 10.1038/ng0508-514; Masyuk TV, 2007, GASTROENTEROLOGY, V132, P1104, DOI 10.1053/j.gastro.2006.12.039; Masyuk TV, 2003, GASTROENTEROLOGY, V125, P1303, DOI 10.1016/j.gastro.2003.09.001; MONTI J, 2009, NAT GENET, V40, P560; Mott R, 2000, P NATL ACAD SCI USA, V97, P12649, DOI 10.1073/pnas.230304397; Nagao S, 2006, J AM SOC NEPHROL, V17, P2220, DOI 10.1681/ASN.2006030251; Olofsson P, 2003, NAT GENET, V33, P25, DOI 10.1038/ng1058; Petretto E, 2008, NAT GENET, V40, P546, DOI 10.1038/ng.134; Popova E, 2006, BIOL REPROD, V75, P524, DOI 10.1095/biolreprod.106.053330; Pravenec M, 2004, PHYSIOL RES, V53, pS15; PRAVENEC M, 1989, J HYPERTENS, V7, P217; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Roh SH, 2003, ZYGOTE, V11, P317, DOI 10.1017/S0967199403002375; Saar K, 2008, NAT GENET, V40, P560, DOI 10.1038/ng.124; SAMAD AH, 1995, NATURE, V378, P516, DOI 10.1038/378516a0; Samuelson DJ, 2007, P NATL ACAD SCI USA, V104, P6299, DOI 10.1073/pnas.0701687104; SERIKAWA T, 1992, GENETICS, V131, P701; Shinohara T, 2006, P NATL ACAD SCI USA, V103, P13624, DOI 10.1073/pnas.0604205103; Smith CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r7; Smits BMG, 2006, PHARMACOGENET GENOM, V16, P159; Swanberg M, 2005, NAT GENET, V37, P486, DOI 10.1038/ng1544; Tesson L, 2005, TRANSGENIC RES, V14, P531, DOI 10.1007/s11248-005-5077-z; Twigger SN, 2008, NAT GENET, V40, P523, DOI 10.1038/ng0508-523; Twigger SN, 2007, NUCLEIC ACIDS RES, V35, pD658, DOI 10.1093/nar/gkl988; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; van den Brandt J, 2004, GENESIS, V39, P94, DOI 10.1002/gene.20037; Vassilieva S, 2000, EXP CELL RES, V258, P361, DOI 10.1006/excr.2000.4940; Voigt B, 2008, PHYSIOL GENOMICS, V32, P335, DOI 10.1152/physiolgenomics.00158.2007; Wang XF, 2005, J AM SOC NEPHROL, V16, P846, DOI 10.1681/ASN.2004121090; Wang XF, 2008, J AM SOC NEPHROL, V19, P102, DOI 10.1681/ASN.2007060688; Ward CJ, 2002, NAT GENET, V30, P259, DOI 10.1038/ng833; Watanabe TK, 1999, NAT GENET, V22, P27, DOI 10.1038/8737; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103; Wilder SP, 2004, GENOME RES, V14, P758, DOI 10.1101/gr.2001604; Yokoi N, 2002, NAT GENET, V31, P391, DOI 10.1038/ng927; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Zan YH, 2003, NAT BIOTECHNOL, V21, P645, DOI 10.1038/nbt830; Zhou Q, 2003, SCIENCE, V302, P1179, DOI 10.1126/science.1088313; Zilka N, 2006, FEBS LETT, V580, P3582, DOI 10.1016/j.febslet.2006.05.029; Zimdahl H, 2004, SCIENCE, V303, P807, DOI 10.1126/science.1092427	79	235	247	1	29	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					516	522		10.1038/ng.147	http://dx.doi.org/10.1038/ng.147			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18443588				2022-12-27	WOS:000255366700016
J	Acar, M; Mettetal, JT; van Oudenaarden, A				Acar, Murat; Mettetal, Jerome T.; van Oudenaarden, Alexander			Stochastic switching as a survival strategy in fluctuating environments	NATURE GENETICS			English	Article							GENE-EXPRESSION; ESCHERICHIA-COLI; TOGGLE SWITCH; NOISE; HETEROGENEITY; CONSEQUENCES; PHENOTYPES; DIVERSITY; BACTERIA; NETWORKS	A classic problem in population and evolutionary biology is to understand how a population optimizes its fitness in fluctuating environments(1-4). A population might enhance its fitness by allowing individual cells to stochastically transition among multiple phenotypes, thus ensuring that some cells are always prepared for an unforeseen environmental fluctuation. Here we experimentally explore how switching affects population growth by using the galactose utilization network of Saccharomyces cerevisiae. We engineered a strain that randomly transitions between two phenotypes as a result of stochastic gene expression(5-9). Each phenotype was designed to confer a growth advantage over the other phenotype in a certain environment. When we compared the growth of two populations with different switching rates, we found that fast-switching populations outgrow slow switchers when the environment fluctuates rapidly, whereas slow-switching phenotypes outgrow fast switchers when the environment changes rarely. These results suggest that cells may tune inter-phenotype switching rates to the frequency of environmental changes.	[Acar, Murat; Mettetal, Jerome T.; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019; Acar, Murat/AIB-8244-2022		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077183] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM077183] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Avery SV, 2006, NAT REV MICROBIOL, V4, P577, DOI 10.1038/nrmicro1460; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bishop AL, 2007, MOL MICROBIOL, V63, P507, DOI 10.1111/j.1365-2958.2006.05504.x; Blake WJ, 2006, MOL CELL, V24, P853, DOI 10.1016/j.molcel.2006.11.003; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; BRYSON V, 1952, SCIENCE, V115, P45; Casadesus J, 2006, MICROBIOL MOL BIOL R, V70, P830, DOI 10.1128/MMBR.00016-06; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Hasty J, 2000, P NATL ACAD SCI USA, V97, P2075, DOI 10.1073/pnas.040411297; Hawkins KM, 2006, J BIOL CHEM, V281, P13485, DOI 10.1074/jbc.M512317200; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kaufmann BB, 2007, CURR OPIN GENET DEV, V17, P107, DOI 10.1016/j.gde.2007.02.007; Kepler TB, 2001, BIOPHYS J, V81, P3116, DOI 10.1016/S0006-3495(01)75949-8; Kussell E, 2005, GENETICS, V169, P1807, DOI 10.1534/genetics.104.035352; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Lachmann M, 1996, J THEOR BIOL, V181, P1, DOI 10.1006/jtbi.1996.0109; LEVINS RICHARD, 1968; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Samoilov MS., 2006, NAT REV GENET, V2006, pr, DOI [DOI 10.1126/STKE.3662006RE17, 10.1126/stke.3662006re17]; SCHAFFER WM, 1974, AM NAT, V108, P783, DOI 10.1086/282954; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Wolf DM, 2005, J THEOR BIOL, V234, P227, DOI 10.1016/j.jtbi.2004.11.020	30	629	637	2	106	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2008	40	4					471	475		10.1038/ng.110	http://dx.doi.org/10.1038/ng.110			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18362885				2022-12-27	WOS:000254388100020
J	Vermulst, M; Wanagat, J; Kujoth, GC; Bielas, JH; Rabinovitch, PS; Prolla, TA; Loeb, LA				Vermulst, Marc; Wanagat, Jonathan; Kujoth, Gregory C.; Bielas, Jason H.; Rabinovitch, Peter S.; Prolla, Tomas A.; Loeb, Lawrence A.			DNA deletions and clonal mutations drive premature aging in mitochondrial mutator mice	NATURE GENETICS			English	Article							SUBSTANTIA-NIGRA NEURONS; LIFE-SPAN; DIRECT REPEATS; RECOMBINATION	Mitochondrial DNA (mtDNA) mutations are thought to have a causal role in many age-related pathologies. Here we identify mtDNA deletions as a driving force behind the premature aging phenotype of mitochondrial mutator mice, and provide evidence for a homology-directed DNA repair mechanism in mitochondria that is directly linked to the formation of mtDNA deletions. In addition, our results demonstrate that the rate at which mtDNA mutations reach phenotypic expression differs markedly among tissues, which may be an important factor in determining the tolerance of a tissue to random mitochondrial mutagenesis.	[Vermulst, Marc; Bielas, Jason H.; Rabinovitch, Peter S.; Loeb, Lawrence A.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Wanagat, Jonathan] Univ Washington, Dept Gerontol & Geriat Med, Seattle, WA 98195 USA; [Kujoth, Gregory C.; Prolla, Tomas A.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Kujoth, Gregory C.; Prolla, Tomas A.] Univ Wisconsin, Dept Med Genet, Madison, WI 53706 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Loeb, LA (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	laloeb@u.washington.edu	Wanagat, Jonathan/B-2856-2009	Wanagat, Jonathan/0000-0002-8460-8616; Kujoth, Gregory/0000-0002-6636-2800	NATIONAL CANCER INSTITUTE [R01CA102029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES011045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021905, P01AG001751] Funding Source: NIH RePORTER; NCI NIH HHS [CA102029] Funding Source: Medline; NIA NIH HHS [AG01751, AG021905] Funding Source: Medline; NIEHS NIH HHS [ES11045] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103; Khaidakov M, 2006, MECH AGEING DEV, V127, P808, DOI 10.1016/j.mad.2006.07.008; Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Kraytsberg Y, 2004, SCIENCE, V304, P981, DOI 10.1126/science.1096342; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Kujoth GC, 2007, PLOS GENET, V3, P161, DOI 10.1371/journal.pgen.0030024; LINNANE AW, 1989, LANCET, V1, P642, DOI 10.1016/S0140-6736(89)92145-4; MITA S, 1990, NUCLEIC ACIDS RES, V18, P561, DOI 10.1093/nar/18.3.561; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082; TANHAUSER SM, 1995, J BIOL CHEM, V270, P24769, DOI 10.1074/jbc.270.42.24769; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Vermulst M, 2007, NAT GENET, V39, P540, DOI 10.1038/ng1988	15	292	298	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2008	40	4					392	394		10.1038/ng.95	http://dx.doi.org/10.1038/ng.95			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18311139				2022-12-27	WOS:000254388100008
J	Choi, JK; Kim, YJ				Choi, Jung Kyoon; Kim, Young-Joon			Epigenetic regulation and the variability of gene expression	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL REGULATION; MASS-SPECTROMETRY; EUKARYOTIC GENOME; YEAST; IDENTIFICATION; REPRESSION; MACHINERY; LANDSCAPE; COMPLEXES	We characterized the genetic variability of gene expression in terms of trans and cis variability for each yeast transcript. Genes that are highly regulated by nucleosomes showed a high degree of trans variability. From the expression profiles of mutants for various chromatin modifiers, we found that transvariable genes are distinctly regulated at the chromatin level. The effect of chromatin regulators was highly significant, even when compared with that of transcription factors. The DNA-binding activities of transcription factors had a low influence on trans variability. In the case of the basal transcription factor TBP and TBP- associated factor TAF1, expression variability was coupled with the histone acetyltransferase activities of TAF1 and other factors, rather than with the binding of TBP to DNA. Additionally, we found that the correlation of TATA-box presence and expression variability could be explained in terms of chromatin regulation. The lack of activating histone modifications may subject TATA- containing promoters to chromatin regulation processes. Our results propose that epigenetic regulation has a central role in the variation and evolution of gene expression.	[Choi, Jung Kyoon; Kim, Young-Joon] Yonsei Univ, Genome Regulat Ctr, Seoul 120749, South Korea; [Kim, Young-Joon] Yonsei Univ, Dept Biochem, Seoul 120749, South Korea	Yonsei University; Yonsei University	Kim, YJ (corresponding author), Yonsei Univ, Genome Regulat Ctr, 134 Sinchon Dong, Seoul 120749, South Korea.	yjkim@yonsei.ac.kr	Choi, Jung Kyoon/C-2070-2011					Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Chitikila C, 2002, MOL CELL, V10, P871, DOI 10.1016/S1097-2765(02)00683-4; Choi JK, 2007, GENETICS, V175, P1607, DOI 10.1534/genetics.106.069047; Durant M, 2006, MOL CELL BIOL, V26, P2791, DOI 10.1128/MCB.26.7.2791-2802.2006; Fazzio TG, 2001, MOL CELL BIOL, V21, P6450, DOI 10.1128/MCB.21.19.6450-6460.2001; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Guarente L, 1999, NAT GENET, V23, P281, DOI 10.1038/15458; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Jackson-Fisher AJ, 1999, MOL CELL, V3, P717, DOI 10.1016/S1097-2765(01)80004-6; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Lee SI, 2006, P NATL ACAD SCI USA, V103, P14062, DOI 10.1073/pnas.0601852103; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Prendergast JGD, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-72; Ronald J, 2005, PLOS GENET, V1, P213, DOI 10.1371/journal.pgen.0010025; Rudra D, 2005, EMBO J, V24, P533, DOI 10.1038/sj.emboj.7600553; Sabet N, 2003, P NATL ACAD SCI USA, V100, P4084, DOI 10.1073/pnas.0637524100; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; Steinfeld I, 2007, NAT GENET, V39, P303, DOI 10.1038/ng1965; STEPHENS MA, 1970, J ROY STAT SOC B, V32, P115; Tirosh I, 2006, NAT GENET, V38, P830, DOI 10.1038/ng1819; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Wyrick JJ, 1999, NATURE, V402, P418, DOI 10.1038/46567; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	31	83	84	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					141	147		10.1038/ng.2007.58	http://dx.doi.org/10.1038/ng.2007.58			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18227874				2022-12-27	WOS:000252732900009
J	Harley, JB; Alarcon-Riquelme, ME; Criswell, LA; Jacob, CO; Kimberly, RP; Moser, KL; Tsao, BP; Vyse, TJ; Langefeld, CD				Harley, John B.; Alarcon-Riquelme, Marta E.; Criswell, Lindsey A.; Jacob, Chaim O.; Kimberly, Robert P.; Moser, Kathy L.; Tsao, Betty P.; Vyse, Timothy J.; Langefeld, Carl D.		Int Consortium Systemic Lupus Ery	Genome-wide association scan in women with systemic lupus erythematosus identifies susceptibility variants in ITGAM, PXK, KIAA1542 and other loci	NATURE GENETICS			English	Article							RHEUMATOID-ARTHRITIS; HUMAN SLE; DISEASE; LINKAGE; POLYMORPHISM; RISK; METAANALYSIS; EXPRESSION	Systemic lupus erythematosus (SLE) is a common systemic autoimmune disease with complex etiology but strong clustering in families (lambda(S) = similar to 30). We performed a genomewide association scan using 317,501 SNPs in 720 women of European ancestry with SLE and in 2,337 controls, and we genotyped consistently associated SNPs in two additional independent sample sets totaling 1,846 affected women and 1,825 controls. Aside from the expected strong association between SLE and the HLA region on chromosome 6p21 and the previously confirmed non-HLA locus IRF5 on chromosome 7q32, we found evidence of association with replication (1.1 x 10(-7) < P-overall < 1.6 x 10(-23); odds ratio 0.82-1.62) in four regions: 16p11.2 (ITGAM), 11p15.5 (KIAA1542), 3p14.3 (PXK) and 1q25.1 (rs10798269). We also found evidence for association (P < 1 x 10(-5)) at FCGR2A, PTPN22 and STAT4, regions previously associated with SLE and other autoimmune diseases, as well as at >= 9 other loci (P < 2 x 10(-7)). Our results show that numerous genes, some with known immune-related functions, predispose to SLE.	[Harley, John B.; Moser, Kathy L.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA; [Harley, John B.] US Dept Vet Affairs Med Ctr, Oklahoma City, OK 73104 USA; [Harley, John B.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK 73104 USA; [Alarcon-Riquelme, Marta E.] Uppsala Univ, SE-75105 Uppsala, Sweden; [Criswell, Lindsey A.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Jacob, Chaim O.] Univ So Calif, Los Angeles, CA 90033 USA; [Kimberly, Robert P.] Univ Alabama, Birmingham, AL 35294 USA; [Moser, Kathy L.] Univ Minnesota, Minneapolis, MN 55455 USA; [Tsao, Betty P.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Vyse, Timothy J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London W12 0NN, England; [Langefeld, Carl D.] Wake Forest Univ Hlth Sci, Winston Salem, NC 27157 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; Uppsala University; University of California System; University of California San Francisco; University of Southern California; University of Alabama System; University of Alabama Birmingham; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California Los Angeles; Imperial College London; Wake Forest University; Wake Forest University School of Medicine	Harley, JB (corresponding author), Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.		Alarcón-Riquelme, Marta E./ABF-8163-2020; Fernando, Michelle/F-5554-2012; Gillespie, Emily/N-1265-2013; Frank, Summer G/E-6861-2016; Rioux, John D/A-9599-2015	Alarcón-Riquelme, Marta E./0000-0002-7632-4154; Gillespie, Emily/0000-0001-5261-3931; Frank, Summer G/0000-0003-0779-4926; Rioux, John D/0000-0001-7560-8326; Gaffney, Patrick/0000-0002-1580-869X; Kelly, Jennifer/0000-0002-3203-2467; Tsao, Betty/0000-0001-7938-5975; Guthridge, Joel/0000-0002-9308-237X; Kimberly, Robert/0000-0002-5330-3086	NCRR NIH HHS [P20 RR020143, RR020143, U54 RR020278, RR020278] Funding Source: Medline; NIAID NIH HHS [AI24717, R01 AI024717, R37 AI024717] Funding Source: Medline; NIAMS NIH HHS [AR33062, AR22804, P30 AR053483, AR43814, AR43815, AR02175, K24 AR002175, R01 AR033062, AR43247, R01 AR052300, P01 AR049084, AR052300, AR49084, N01AR62277, P60 AR053308, AR24260, R01 AR043814-10A2, R01 AR043814] Funding Source: Medline; Wellcome Trust [051276] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278, P20RR020143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI024717, R01AI024717] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR033062, R01AR043815, R01AR052300, K24AR002175, N01AR62277, R01AR043814, R55AR043814, P01AR049084, P60AR053308, P30AR053483] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alarcon-Segovia D, 2005, ARTHRITIS RHEUM-US, V52, P1138, DOI 10.1002/art.20999; Danchenko N, 2006, LUPUS, V15, P308, DOI 10.1191/0961203306lu2305xx; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; Duits AJ, 1995, ARTHRITIS RHEUM, V38, P1832, DOI 10.1002/art.1780381217; Edberg JC, 2002, ARTHRITIS RHEUM, V46, P2132, DOI 10.1002/art.10438; Forabosco P, 2006, GENES IMMUN, V7, P609, DOI 10.1038/sj.gene.6364338; Graham RR, 2007, EUR J HUM GENET, V15, P823, DOI 10.1038/sj.ejhg.5201827; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; James JA, 1997, J CLIN INVEST, V100, P3019, DOI 10.1172/JCI119856; Kyogoku C, 2004, AM J HUM GENET, V75, P504, DOI 10.1086/423790; Lee YH, 2005, HUM GENET, V118, P434, DOI 10.1007/s00439-005-0073-1; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; MORGAN BP, 1991, IMMUNOL TODAY, V12, P301, DOI 10.1016/0167-5699(91)90003-C; Moser KL, 1998, P NATL ACAD SCI USA, V95, P14869, DOI 10.1073/pnas.95.25.14869; NARAYANASWAMY CR, 1991, APPL STAT-J ROY ST C, V40, P309; NATH SK, 2008, NAT GENET       0120; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; RISCH N, 1990, AM J HUM GENET, V46, P229; Sigurdsson S, 2005, AM J HUM GENET, V76, P528, DOI 10.1086/428480; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P66, DOI 10.1001/jama.294.1.66; Tsao BP, 1997, J CLIN INVEST, V99, P725, DOI 10.1172/JCI119217; Zou XQ, 2005, INT J MOL MED, V16, P701	29	1003	1031	0	65	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					204	210		10.1038/ng.81	http://dx.doi.org/10.1038/ng.81			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18204446	Green Accepted			2022-12-27	WOS:000252732900019
J	Tanouye, MA				Tanouye, Mark A.			Seymour Benzer 1921-2007	NATURE GENETICS			English	Biographical-Item									[Tanouye, Mark A.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Tanouye, Mark A.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Tanouye, MA (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	tanouye@berkeley.edu			NINDS NIH HHS [R01 NS031231-13, R01 NS031231] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS031231] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BENZER S, PUBLICATION LIST	1	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2008	40	2					121	121		10.1038/ng0208-121	http://dx.doi.org/10.1038/ng0208-121			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18227864	Bronze, Green Accepted			2022-12-27	WOS:000252732900002
J	Al Aqeel, AI				Al Aqeel, Aida I.			Islamic ethical framework for research into and prevention of genetic diseases	NATURE GENETICS			English	Editorial Material							MULTICENTRIC OSTEOLYSIS; THALASSEMIA; ARTHRITIS; IRAN	Medical genetics involves the application of genetic knowledge and technology to specific clinical and epidemiologic concerns. Using genetics to benefit society requires that empirically verified knowledge be used within an ethical framework that combines appeal to written precedent with sensitivity to the options of individuals and families dealing with choices and necessities within the laws, norms and traditions of their society. Islamic bioethics is derived from a combination of principles, duties and rights, and to a certain extent a call to virtue, ihsan. It emphasizes prevention, and it teaches that the patient must be treated with respect and compassion and that the physical, mental and spiritual dimensions of the illness experience must be taken into account. Strategic planning for the prevention and care of genetic disorders, and for genomic research, within the context of Islamic religion and culture is promising and may provide lessons to the developed world. Islamic bioethics provides fundamental principles for genetic counseling, particularly in regard to consanguinity, which was part of the Arabian culture long before Islam but which was discouraged by the second Islamic khalifa. These fundamental principles are important for implementing many preventive and genomic research programs and for maintaining flexibility to respond to new biomedical technologies.	Riyadh Mil Hosp, Dept Pediat, Riyadh, Saudi Arabia; King Faisal Specialist Hosp & Res Ctr, Dept Genet, Riyadh 11211, Saudi Arabia	Prince Sultan Military Medical City; King Faisal Specialist Hospital & Research Center	Al Aqeel, AI (corresponding author), Riyadh Mil Hosp, Dept Pediat, Riyadh, Saudi Arabia.	aalaqeel@rmh.ed.sa						Abolghasemi H, 2007, J PEDIAT HEMATOL ONC, V29, P233, DOI 10.1097/MPH.0b013e3180437e02; AJLOUNI KMS, CLONING SCI RELIG; Al Aqeel A, 2000, AM J MED GENET, V93, P11, DOI 10.1002/1096-8628(20000703)93:1<11::AID-AJMG3>3.0.CO;2-3; Al-Aqeel AI, 2005, SAUDI MED J, V26, P1862; Al-Gazali L, 2006, BMJ-BRIT MED J, V333, P831, DOI 10.1136/bmj.38982.704931.AE; ALAQEEL AI, 2006, J INHERIT METAB DIS, V29, P63; Albar MA, 2002, SAUDI MED J, V23, P627; AlHamdan NA, 2007, GENET MED, V9, P372, DOI 10.1097/GIM.0b013e318065a9e8; ALOTHIAMINA MS, FUNDAMENTALS ISLAMIC; ALSAYYAD IA, LEGAL DIRECTIVES MED; [Anonymous], 2006, NAT GENET, V38, P851; BILL J, 1994, MAHJUBA, V13, P5; Blatt R J R, 2000, Community Genet, V3, P204, DOI 10.1159/000051140; Christianson A, 2004, BMJ-BRIT MED J, V329, P1115, DOI 10.1136/bmj.329.7475.1115; Cotton RGH, 2007, NAT GENET, V39, P433, DOI 10.1038/ng2024; Daar AS, 2001, CAN MED ASSOC J, V164, P60; Donnai D, 2002, CLIN GENET, V61, P1, DOI 10.1034/j.1399-0004.2002.610101.x; Elton P, 2005, BRIT MED J, V330, P478, DOI 10.1136/bmj.330.7489.478-b; GATRAD AR, 1999, E MED HLTH J, V5, P1129; Giles J, 2006, NATURE, V444, P28, DOI 10.1038/444028a; Kamali MohammadHashim., 1991, PRINCIPLES ISLAMIC J, P283; MA A, 1999, E MED HLTH J, V5, P129; Martignetti JA, 2001, NAT GENET, V28, P261, DOI 10.1038/90100; Modell B, 2002, NAT REV GENET, V3, P225, DOI 10.1038/nrg754; Samavat A, 2004, BMJ-BRIT MED J, V329, P1134, DOI 10.1136/bmj.329.7475.1134; Teebi AS, 2006, LANCET, V367, P970, DOI 10.1016/S0140-6736(06)68406-7; ZAKI HA, 1987, AL MUSTASFA MIN ILM, V1	27	42	42	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2007	39	11					1293	1298		10.1038/ng.2007.14	http://dx.doi.org/10.1038/ng.2007.14			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17952074				2022-12-27	WOS:000250575900003
J	Tomlinson, I; Webb, E; Carvajal-Carmona, L; Broderick, P; Kemp, Z; Spain, S; Penegar, S; Chandler, I; Gorman, M; Wood, W; Barclay, E; Lubbe, S; Martin, L; Sellick, G; Jaeger, E; Hubner, R; Wild, R; Rowan, A; Fielding, S; Howarth, K; Silver, A; Atkin, W; Muir, K; Logan, R; Kerr, D; Johnstone, E; Sieber, O; Gray, R; Thomas, H; Peto, J; Cazier, B; Houlston, R				Tomlinson, Ian; Webb, Emily; Carvajal-Carmona, Luis; Broderick, Peter; Kemp, Zoe; Spain, Sarah; Penegar, Steven; Chandler, Ian; Gorman, Maggie; Wood, Wendy; Barclay, Ella; Lubbe, Steven; Martin, Lynn; Sellick, Gabrielle; Jaeger, Emma; Hubner, Richard; Wild, Ruth; Rowan, Andrew; Fielding, Sarah; Howarth, Kimberley; Silver, Andrew; Atkin, Wendy; Muir, Kenneth; Logan, Richard; Kerr, David; Johnstone, Elaine; Sieber, Oliver; Gray, Richard; Thomas, Huw; Peto, Julian; Cazier, Baptiste; Houlston, Richard		CORGI Consortium	A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21	NATURE GENETICS			English	Article							PROSTATE-CANCER; RISK; METAANALYSIS; TUMORS	Much of the variation in inherited risk of colorectal cancer (CRC) is probably due to combinations of common low risk variants. We conducted a genome- wide association study of 550,000 tag SNPs in 930 familial colorectal tumor cases and 960 controls. The most strongly associated SNP (P = 1.72 x 10(-7), allelic test) was rs6983267 at 8q24.21. To validate this finding, we genotyped rs6983267 in three additional CRC case-control series (4,361 affected individuals and 3,752 controls; 1,901 affected individuals and 1,079 controls; 1,072 affected individuals and 415 controls) and replicated the association, providing P = 1.27 x 10(-14) (allelic test) overall, with odds ratios (ORs) of 1.27 (95% confidence interval (c.i.): 1.16-1.39) and 1.47 (95% c.i.: 1.34-1.62) for heterozygotes and rare homozygotes, respectively. Analyses based on 1,477 individuals with colorectal adenoma and 2,136 controls suggest that susceptibility to CRC is mediated through development of adenomas (OR = 1.21, 95% c.i.: 1.10-1.34; P = 6.89 x 10(-5)). These data show that common, low-penetrance susceptibility alleles predispose to colorectal neoplasia.	Canc Res UK, Mol & Populat Genet Lab, London WC2A 3PX, England; Univ London, Queen Mary Coll, Barts & London Med Sch, Inst Canc, London WC1E 7HU, England; Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; St Marks Hosp, Canc Res UK, Colorectal Canc Unit, Harrow HA1 3UJ, Middx, England; Univ Nottingham, Sch Med, Div Epidemiol & Publ Hlth, Queens Med Ctr, Nottingham NG7 2UH, England; Univ Oxford, Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HA, England; Univ Oxford, Canc & Immunogenet Lab, Weatherall Inst Mol Med, Oxford OX3 9DS, England; Univ Birmingham, Birmingham Clin Trials Unit, Birmingham B15 2RR, W Midlands, England; St Marks Hosp, Canc Res UK, Family Canc Clin, Harrow HA1 3UJ, Middx, England; Univ London London Sch Hyg & Trop Med, Non Communicable Dis Epidemiol Unit, London WC1E 7HT, England; Inst Canc Res, Epidemiol Sect, Sutton SM2 5NG, Surrey, England	Cancer Research UK; University of London; Queen Mary University London; University of London; Institute of Cancer Research - UK; Cancer Research UK; Imperial College London; University of Nottingham; Radcliffe Infirmary; University of Oxford; University of Oxford; University of Birmingham; Cancer Research UK; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of London; Institute of Cancer Research - UK	Tomlinson, I (corresponding author), Canc Res UK, Mol & Populat Genet Lab, London WC2A 3PX, England.	ian.tomlinson@cancer.org.uk	Cazier, Jean-Baptiste/GLR-2949-2022; Hubner, Richard/N-8051-2015; Sieber, Oliver/ABA-9211-2021; Lubbe, Steven/L-8261-2013; Cazier, Jean-Baptiste/F-2369-2010; Evans, D Gareth/AAB-4308-2022; Carvajal-Carmona, Luis G/B-3882-2010; Sieber, Oliver/M-9473-2015; Spain, Sarah/G-1968-2010	Cazier, Jean-Baptiste/0000-0001-7581-9051; Hubner, Richard/0000-0002-7081-8823; Sieber, Oliver/0000-0001-9480-0786; Lubbe, Steven/0000-0002-7103-6671; Cazier, Jean-Baptiste/0000-0001-7581-9051; Evans, D Gareth/0000-0002-8482-5784; Carvajal-Carmona, Luis G/0000-0001-7129-2918; Sieber, Oliver/0000-0001-9480-0786; Atkin, Wendy/0000-0001-9073-9658; Penegar, Steven/0000-0002-3768-0236; Broderick, Peter/0000-0002-8348-5829; Gray, Richard/0000-0003-4440-574X; Houlston, Richard/0000-0002-5268-0242; Spain, Sarah/0000-0002-7591-8364; Webb, Emily/0000-0002-4019-7456	MRC [G9615910, G0301100] Funding Source: UKRI; Medical Research Council [G9615910, G0301100] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aaltonen L, 2007, CLIN CANCER RES, V13, P356, DOI 10.1158/1078-0432.CCR-06-1256; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Atkin WS, 2002, LANCET, V359, P1291, DOI 10.1016/s0140-6736(02)08268-5; Boland CR, 1998, CANCER RES, V58, P5248; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Johns LE, 2001, AM J GASTROENTEROL, V96, P2992, DOI 10.1111/j.1572-0241.2001.04677.x; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; LOGAN RFA, 2006, GUT, V55, pA90; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; PETITTI D, 1994, MEAT ANAL DECISION A; World Health Organization, 1977, INT CLASS DIS; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zhou XP, 1998, GENE CHROMOSOME CANC, V21, P101, DOI 10.1002/(SICI)1098-2264(199802)21:2<101::AID-GCC4>3.0.CO;2-4	16	661	719	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					984	988		10.1038/ng2085	http://dx.doi.org/10.1038/ng2085			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17618284				2022-12-27	WOS:000248446900015
J	Amit, I; Citri, A; Shay, T; Lu, YL; Katz, M; Zhang, F; Tarcic, G; Siwak, D; Lahad, J; Jacob-Hirsch, J; Amariglio, N; Vaisman, N; Segal, E; Rechavi, G; Alon, U; Mills, GB; Domany, E; Yarden, Y				Amit, Ido; Citri, Ami; Shay, Tal; Lu, Yiling; Katz, Menachem; Zhang, Fan; Tarcic, Gabi; Siwak, Doris; Lahad, John; Jacob-Hirsch, Jasmine; Amariglio, Ninette; Vaisman, Nora; Segal, Eran; Rechavi, Gideon; Alon, Uri; Mills, Gordon B.; Domany, Eytan; Yarden, Yosef			A module of negative feedback regulators defines growth factor signaling	NATURE GENETICS			English	Article							KRUPPEL-LIKE FACTOR-2; NF-KAPPA-B; TRANSCRIPTION FACTORS; GENE-EXPRESSION; MESSENGER-RNAS; C-FOS; SPECIFICITY; ACTIVATION; PROTEINS; CANCER	Signaling pathways invoke interplays between forward signaling and feedback to drive robust cellular response. In this study, we address the dynamics of growth factor signaling through profiling of protein phosphorylation and gene expression, demonstrating the presence of a kinetically defined cluster of delayed early genes that function to attenuate the early events of growth factor signaling. Using epidermal growth factor receptor signaling as the major model system and concentrating on regulation of transcription and mRNA stability, we demonstrate that a number of genes within the delayed early gene cluster function as feedback regulators of immediate early genes. Consistent with their role in negative regulation of cell signaling, genes within this cluster are downregulated in diverse tumor types, in correlation with clinical outcome. More generally, our study proposes a mechanistic description of the cellular response to growth factors by defining architectural motifs that underlie the function of signaling networks.	Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; Baylor Coll Med, MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; Tel Aviv Univ, Chaim Sheba Med Ctr, Dept Pediat Hematooncol & Funct Genom, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; Sigma Aldrich Israel Ltd, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Comp Sci, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; Chaim Sheba Medical Center; Tel Aviv University; Tel Aviv University; Sackler Faculty of Medicine; Merck KGaA; MilliporeSigma; Weizmann Institute of Science; Weizmann Institute of Science	Yarden, Y (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	yosef.yarden@weizmann.ac.il	Shay, Tal/J-4028-2016; Segal, Eran/AAF-4855-2019; Citri, Ami/R-8973-2019; YARDEN, YOSEF/K-1467-2012; DOMANY, EYTAN/K-1560-2012	Shay, Tal/0000-0003-0755-1350; Citri, Ami/0000-0002-9914-0278; Segal, Eran/0000-0002-6859-1164	NCI NIH HHS [CA099031, CA102537, CA72981, CA64602, CA65930] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA072981, R01CA102537, P01CA064602, R37CA072981, P01CA065930, P01CA099031, R56CA102537] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alon U., 2006, INTRO SYSTEMS BIOL D; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; Barton K, 1996, NATURE, V379, P81, DOI 10.1038/379081a0; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Carballo E, 1998, SCIENCE, V281, P1001, DOI 10.1126/science.281.5379.1001; Casci T, 1999, CANCER METAST REV, V18, P181, DOI 10.1023/A:1006313122373; Chen CY, 2001, CELL, V107, P451, DOI 10.1016/S0092-8674(01)00578-5; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Claret FX, 1996, NATURE, V383, P453, DOI 10.1038/383453a0; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Farooq A, 2004, CELL SIGNAL, V16, P769, DOI 10.1016/j.cellsig.2003.12.008; Freeman M, 2000, NATURE, V408, P313, DOI 10.1038/35042500; Fu SL, 1999, P NATL ACAD SCI USA, V96, P5716, DOI 10.1073/pnas.96.10.5716; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hoffmann E, 2005, J BIOL CHEM, V280, P9706, DOI 10.1074/jbc.M407071200; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jones SM, 2001, NAT CELL BIOL, V3, P165, DOI 10.1038/35055073; Kalir S, 2001, SCIENCE, V292, P2080, DOI 10.1126/science.1058758; KASZUBSKA W, 1993, MOL CELL BIOL, V13, P7180, DOI 10.1128/MCB.13.11.7180; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Klein OD, 2006, DEV CELL, V11, P181, DOI 10.1016/j.devcel.2006.05.014; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Lu JY, 2006, GENE DEV, V20, P3174, DOI 10.1101/gad.1467606; Mangan S, 2006, J MOL BIOL, V356, P1073, DOI 10.1016/j.jmb.2005.12.003; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MEIJLINK F, 1985, P NATL ACAD SCI USA, V82, P4987, DOI 10.1073/pnas.82.15.4987; Motohashi H, 2000, CELL, V103, P865, DOI 10.1016/S0092-8674(00)00190-2; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Qu ZC, 1998, J CELL BIOL, V142, P1075, DOI 10.1083/jcb.142.4.1075; SASSONECORSI P, 1988, NATURE, V334, P314, DOI 10.1038/334314a0; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Sevetson BR, 2000, J BIOL CHEM, V275, P9749, DOI 10.1074/jbc.275.13.9749; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sheehan KM, 2005, MOL CELL PROTEOMICS, V4, P346, DOI 10.1074/mcp.T500003-MCP200; Stephenson AJ, 2005, CANCER-AM CANCER SOC, V104, P290, DOI 10.1002/cncr.21157; SUN H, 1993, CELL, V75, P487, DOI 10.1016/0092-8674(93)90383-2; Szabowski A, 2000, CELL, V103, P745, DOI 10.1016/S0092-8674(00)00178-1; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Wang F, 2005, ONCOGENE, V24, P3875, DOI 10.1038/sj.onc.1208546; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; WISDOM R, 1993, MOL CELL BIOL, V13, P2635, DOI 10.1128/MCB.13.5.2635; Yates PR, 1999, EMBO J, V18, P968, DOI 10.1093/emboj/18.4.968; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16	50	359	368	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2007	39	4					503	512		10.1038/ng1987	http://dx.doi.org/10.1038/ng1987			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17322878				2022-12-27	WOS:000245271200020
J	Scheper, GC; van der Klok, T; van Andel, RJ; van Berkel, CGM; Sissler, M; Smet, J; Muravina, TI; Serkov, SV; Uziel, G; Bugiani, M; Schiffmann, R; Krageloh-Mann, I; Smeitink, JAM; Florentz, C; Van Coster, R; Pronk, JC; van der Knaap, MS				Scheper, Gert C.; van der Klok, Thom; van Andel, Rob J.; van Berkel, Carola G. M.; Sissler, Marie; Smet, Joel; Muravina, Tatjana I.; Serkov, Sergey V.; Uziel, Graziella; Bugiani, Marianna; Schiffmann, Raphael; Kraegeloh-Mann, Ingeborg; Smeitink, Jan A. M.; Florentz, Catherine; Van Coster, Rudy; Pronk, Jan C.; van der Knaap, Marjo S.			Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation	NATURE GENETICS			English	Article							VANISHING WHITE-MATTER; DISEASE; FIBROBLASTS; TRANSLATION; MUTATIONS; DEFECTS; GENE	Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation (LBSL) has recently been defined based on a highly characteristic constellation of abnormalities observed by magnetic resonance imaging and spectroscopy(1). LBSL is an autosomal recessive disease, most often manifesting in early childhood. Affected individuals develop slowly progressive cerebellar ataxia, spasticity and dorsal column dysfunction, sometimes with a mild cognitive deficit or decline. We performed linkage mapping with microsatellite markers in LBSL families and found a candidate region on chromosome 1, which we narrowed by means of shared haplotypes. Sequencing of genes in this candidate region uncovered mutations in DARS2, which encodes mitochondrial aspartyl-tRNA synthetase, in affected individuals from all 30 families. Enzyme activities of mutant proteins were decreased. We were surprised to find that activities of mitochondrial complexes from fibroblasts and lymphoblasts derived from affected individuals were normal, as determined by different assays.	Vrije Univ Amsterdam, Dept Pediat & Child Neurol, NL-1081 HV Amsterdam, Netherlands; Univ Strasbourg 1, CNRS, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France; Univ Hosp, Dept Pediat, Div Neurol & Metab, B-9000 Ghent, Belgium; Ist Nazl Neurol, Child Neurol Dept, I-20133 Milan, Italy; Russian Acad Med Sci, Burdenko Neurosurg Inst, Dept Neuroimaging, Moscow, Russia; NINDS, Dev & Metab Neurol BRanch, NIH, Bethesda, MD 20892 USA; Univ Tubingen, Childrens Hosp, Dept Pediat Neurol, D-72076 Tubingen, Germany; Radboud Univ Nijmegen, Nijmegen Ctr Mitochondrial Disorders, Ctr Med, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; Vrije Univ Amsterdam, Ctr Med, Dept Human Genet, NL-1081 BT Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Ghent University; Ghent University Hospital; Burnazyan Federal Medical Biophysical Center; Russian Academy of Medical Sciences; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Radboud University Nijmegen; Vrije Universiteit Amsterdam	Scheper, GC (corresponding author), Vrije Univ Amsterdam, Dept Pediat & Child Neurol, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	gc.scheper@vumc.nl	Smeitink, Jan A.M./D-6064-2011; Scheper, Gert C/D-7001-2014; Smeitink, Jan/C-1351-2013; Smet, Joel/B-7428-2013	SISSLER, Marie/0000-0001-8594-5238; Smet, Joel/0000-0002-9551-6282	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [Z01NS002984] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Antonellis A, 2003, AM J HUM GENET, V72, P1293, DOI 10.1086/375039; Antonellis A, 2006, J NEUROSCI, V26, P10397, DOI 10.1523/JNEUROSCI.1671-06.2006; Bonnefond L, 2005, BIOCHEMISTRY-US, V44, P4805, DOI 10.1021/bi047527z; Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878; De Paepe B, 2006, PEDIATR RES, V59, P2, DOI 10.1203/01.pdr.0000191294.34122.ab; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Eiler S, 1999, EMBO J, V18, P6532, DOI 10.1093/emboj/18.22.6532; Forshew T, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.023663; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Jacobs EH, 2002, FASEB J, V16, P1961, DOI 10.1096/fj.02-0272fje; Jacobs HT, 2005, TRENDS GENET, V21, P312, DOI 10.1016/j.tig.2005.04.003; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Leegwater PAJ, 1999, AM J HUM GENET, V65, P728, DOI 10.1086/302548; Linnankivi T, 2004, NEUROLOGY, V63, P688, DOI 10.1212/01.WNL.0000134658.35601.41; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Petzold GC, 2006, J NEUROL NEUROSUR PS, V77, P889, DOI 10.1136/jnnp.2005.078568; Schapira AHV, 2006, LANCET, V368, P70, DOI 10.1016/S0140-6736(06)68970-8; SCHOLTE HR, 1992, J INHERIT METAB DIS, V15, P347, DOI 10.1007/BF02435973; Seneca S, 2005, AM J MED GENET A, V137A, P170, DOI 10.1002/ajmg.a.30854; Serkov SV, 2004, NEUROPEDIATRICS, V35, P1, DOI 10.1055/s-2003-43548; Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277; Smeitink JAM, 2006, AM J HUM GENET, V79, P869, DOI 10.1086/508434; SMET J, 2005, CELL BIOL LAB HDB, P259; t Hart LM, 2005, DIABETES, V54, P1892, DOI 10.2337/diabetes.54.6.1892; Van Coster R, 2001, PEDIATR RES, V50, P658, DOI 10.1203/00006450-200111000-00020; van der Knaap MS, 2003, ANN NEUROL, V53, P252, DOI 10.1002/ana.10456; Van der Knaap MS., 2005, MAGNETIC RESONANCE M; van Kollenburg B, 2006, J NEUROPATH EXP NEUR, V65, P707, DOI 10.1097/01.jnen.0000228201.27539.50	30	334	354	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2007	39	4					534	539		10.1038/ng2013	http://dx.doi.org/10.1038/ng2013			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17384640				2022-12-27	WOS:000245271200025
J	Steinfeld, I; Shamir, R; Kupiec, M				Steinfeld, Israel; Shamir, Ron; Kupiec, Martin			A genome-wide analysis in Saccharomyces cerevisiae demonstrates the influence of chromatin modifiers on transcription	NATURE GENETICS			English	Article							GENE-EXPRESSION; HISTONE DEACETYLASE; BINDING PROTEIN; IN-VIVO; YEAST; COMPLEX; SAGA; RECRUITMENT; REGULATOR; NETWORKS	Chromatin structure is important in transcription regulation. Many factors influencing chromatin structure have been identified, but the transcriptional programs in which they participate are still poorly understood. Chromatin modifiers participate in transcriptional control together with DNA-bound transcription factors. High-throughput experimental methods allow the genome-wide identification of binding sites for transcription factors as well as quantification of gene expression under various environmental and genetic conditions. We have developed a new methodology that uses the vast amount of available data to dissect the contribution of chromatin structure to transcription. We measure and characterize the dependence of transcription factor function on specific chromatin modifiers. We apply our methodology to S. cerevisiae, using a compendium of 170 gene expression profiles of strains defective for chromatin modifiers, taken from 26 different studies. Our method succeeds in identifying known intricate genetic interactions between chromatin modifiers and transcription factors and uncovers many previously unknown genetic interactions, giving the first genome-wide picture of the contribution of chromatin structure to transcription in a eukaryote.	Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; Tel Aviv Univ, Sch Comp Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Kupiec, M (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	martin@post.tau.ac.il	Shamir, Ron/E-6514-2011	Shamir, Ron/0000-0003-1889-9870				Bahler J, 2005, ANNU REV GENET, V39, P69, DOI 10.1146/annurev.genet.39.110304.095808; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Belotserkovskaya R, 2000, MOL CELL BIOL, V20, P634, DOI 10.1128/MCB.20.2.634-647.2000; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Bernstein NA, 1999, MOTOR CONTROL, V3, P4; Bhaumik SR, 2002, MOL CELL BIOL, V22, P7365, DOI 10.1128/MCB.22.21.7365-7371.2002; Chitikila C, 2002, MOL CELL, V10, P871, DOI 10.1016/S1097-2765(02)00683-4; Clapier CR, 2001, MOL CELL BIOL, V21, P875, DOI 10.1128/MCB.21.3.875-883.2001; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Fazzio TG, 2005, MOL CELL BIOL, V25, P9165, DOI 10.1128/MCB.25.21.9165-9174.2005; Fazzio TG, 2001, MOL CELL BIOL, V21, P6450, DOI 10.1128/MCB.21.19.6450-6460.2001; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Goldmark JP, 2000, CELL, V103, P423, DOI 10.1016/S0092-8674(00)00134-3; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hartemink Alexander J, 2002, Pac Symp Biocomput, P437; Hinnebusch AG, 2005, ANNU REV MICROBIOL, V59, P407, DOI 10.1146/annurev.micro.59.031805.133833; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Kadosh D, 1997, CELL, V89, P365, DOI 10.1016/S0092-8674(00)80217-2; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; Kuo MH, 2000, MOL CELL, V6, P1309, DOI 10.1016/S1097-2765(00)00129-5; Kurdistani SK, 2003, NAT REV MOL CELL BIO, V4, P276, DOI 10.1038/nrm1075; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Mendizabal I, 1998, FEBS LETT, V425, P323, DOI 10.1016/S0014-5793(98)00249-X; Natarajan K, 1999, MOL CELL, V4, P657, DOI 10.1016/S1097-2765(00)80217-8; Natarajan K, 2001, MOL CELL BIOL, V21, P4347, DOI 10.1128/MCB.21.13.4347-4368.2001; Pugh BF, 2000, GENE, V255, P1, DOI 10.1016/S0378-1119(00)00288-2; Raitt DC, 2000, MOL BIOL CELL, V11, P2335, DOI 10.1091/mbc.11.7.2335; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; RubinBejerano I, 1996, MOL CELL BIOL, V16, P2518; Sabet N, 2004, MOL CELL BIOL, V24, P8823, DOI 10.1128/MCB.24.20.8823-8833.2004; Santos-Rosa H, 2004, J BIOL CHEM, V279, P47506, DOI 10.1074/jbc.M407949200; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shamir R, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-232; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; STEPHENS MA, 1970, J ROY STAT SOC B, V32, P115; Sterner DE, 2002, P NATL ACAD SCI USA, V99, P11622, DOI 10.1073/pnas.182021199; Swanson MJ, 2003, MOL CELL BIOL, V23, P2800, DOI 10.1128/MCB.23.8.2800-2820.2003; Tanay A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100005; Tsukiyama T, 2002, NAT REV MOL CELL BIO, V3, P422, DOI 10.1038/nrm828; Workman CT, 2006, SCIENCE, V312, P1054, DOI 10.1126/science.1122088; Wu JS, 2001, MOL CELL, V7, P117, DOI 10.1016/S1097-2765(01)00160-5; Zhang L, 1999, CELL MOL LIFE SCI, V56, P415, DOI 10.1007/s000180050442	46	59	62	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2007	39	3					303	309		10.1038/ng1965	http://dx.doi.org/10.1038/ng1965			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17325681				2022-12-27	WOS:000244480000011
J	Lu, CW; Yabuuchi, A; Chen, LY; Viswanathan, S; Kim, K; Daley, GQ				Lu, Chi-Wei; Yabuuchi, Akiko; Chen, Lingyi; Viswanathan, Srinivas; Kim, Kitai; Daley, George Q.			Ras-MAPK signaling promotes trophectoderm formation from embryonic stem cells and mouse embryos	NATURE GENETICS			English	Article							PREIMPLANTATION DEVELOPMENT; DIFFERENTIATION; LINEAGE; KINASE; SPECIFICATION; REQUIREMENT; BLASTOCYSTS; BLASTOMERES; EXPRESSION; ENDODERM	In blastocyst chimeras, embryonic stem (ES) cells contribute to embryonic tissues but not extraembryonic trophectoderm. Conditional activation of HRas1(Q61L) in ES cells in vitro induces the trophectoderm marker Cdx2 and enables derivation of trophoblast stem (TS) cell lines that, when injected into blastocysts, chimerize placental tissues. Erk2, the downstream effector of Ras-mitogen-activated protein kinase (MAPK) signaling, is asymmetrically expressed in the apical membranes of the 8-cell-stage embryo just before morula compaction. Inhibition of MAPK signaling in cultured mouse embryos compromises Cdx2 expression, delays blastocyst development and reduces trophectoderm outgrowth from embryo explants. These data show that ectopic Ras activation can divert ES cells toward extraembryonic trophoblastic fates and implicate Ras-MAPK signaling in promoting trophectoderm formation from mouse embryos.	[Lu, Chi-Wei; Yabuuchi, Akiko; Chen, Lingyi; Viswanathan, Srinivas; Kim, Kitai; Daley, George Q.] Childrens Hosp, Div Pediat Hematol & Oncol, Boston, MA 02115 USA; [Lu, Chi-Wei; Yabuuchi, Akiko; Chen, Lingyi; Viswanathan, Srinivas; Kim, Kitai; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Lu, Chi-Wei; Yabuuchi, Akiko; Chen, Lingyi; Kim, Kitai] Harvard Univ, Stem Cell Inst, Boston, MA 02115 USA; [Viswanathan, Srinivas] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Daley, GQ (corresponding author), Childrens Hosp, Div Pediat Hematol & Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	Chen, Lingyi/G-6309-2013; Viswanathan, Srinivas/ABA-6316-2021	Viswanathan, Srinivas/0000-0003-1856-3023	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070055, R01DK059279] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000256] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [R01 DK059279-06, R01 DK070055, R01 DK070055-01, R01 DK059279] Funding Source: Medline; NIH HHS [DP1 OD000256-01, DP1 OD000256] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Auman HJ, 2002, DEVELOPMENT, V129, P2733; Burdon T, 1999, CELLS TISSUES ORGANS, V165, P131, DOI 10.1159/000016693; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; de Vries WN, 2004, DEVELOPMENT, V131, P4435, DOI 10.1242/dev.01316; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; JOHNSON MH, 1981, J CELL BIOL, V91, P303, DOI 10.1083/jcb.91.1.303; KATSUKI M, 1989, MOL BIOL MED, V6, P567; Klucher KM, 1998, BLOOD, V91, P3927, DOI 10.1182/blood.V91.10.3927.3927_3927_3934; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Kyba M, 2002, CELL, V109, P29, DOI 10.1016/S0092-8674(02)00680-3; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; Maekawa M, 2005, DEVELOPMENT, V132, P1773, DOI 10.1242/dev.01729; Maekawa M, 2007, DEVELOPMENT, V134, P2751, DOI 10.1242/dev.003756; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; NAGY A, 1990, DEVELOPMENT, V110, P815; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Piotrowska-Nitsche K, 2005, DEVELOPMENT, V132, P479, DOI 10.1242/dev.01602; Plusa B, 2005, J CELL SCI, V118, P505, DOI 10.1242/jcs.01666; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Saba-El-Leil MK, 2003, EMBO REP, V4, P964, DOI 10.1038/sj.embor.embor939; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; SUTHERLAND AE, 1990, DEV BIOL, V137, P13, DOI 10.1016/0012-1606(90)90003-2; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252	30	117	117	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2008	40	7					921	926		10.1038/ng.173	http://dx.doi.org/10.1038/ng.173			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18536715	Green Accepted			2022-12-27	WOS:000257166500030
J	Sakamoto, H; Yoshimura, K; Saeki, N; Katai, H; Shimoda, T; Matsuno, Y; Saito, D; Sugimura, H; Tanioka, F; Kato, S; Matsukura, N; Matsuda, N; Nakamura, T; Hyodo, I; Nishina, T; Yasui, W; Hirose, H; Hayashi, M; Toshiro, E; Ohnami, S; Sekine, A; Sato, Y; Totsuka, H; Ando, M; Takemura, R; Takahashi, Y; Ohdaira, M; Aoki, K; Honmyo, I; Chiku, S; Aoyagi, K; Sasaki, H; Ohnami, S; Yanagihara, K; Yoon, KA; Kook, MC; Lee, YS; Park, SR; Kim, CG; Choi, IJ; Yoshida, T; Nakamura, Y; Hirohashi, S				Sakamoto, Hiromi; Yoshimura, Kimio; Saeki, Norihisa; Katai, Hitoshi; Shimoda, Tadakazu; Matsuno, Yoshihiro; Saito, Daizo; Sugimura, Haruhiko; Tanioka, Fumihiko; Kato, Shunji; Matsukura, Norio; Matsuda, Noriko; Nakamura, Tsuneya; Hyodo, Ichinosuke; Nishina, Tomohiro; Yasui, Wataru; Hirose, Hiroshi; Hayashi, Matsuhiko; Toshiro, Emi; Ohnami, Sumiko; Sekine, Akihiro; Sato, Yasunori; Totsuka, Hirohiko; Ando, Masataka; Takemura, Ryo; Takahashi, Yoriko; Ohdaira, Minoru; Aoki, Kenichi; Honmyo, Izumi; Chiku, Suenori; Aoyagi, Kazuhiko; Sasaki, Hiroki; Ohnami, Shumpei; Yanagihara, Kazuyoshi; Yoon, Kyong-Ah; Kook, Myeong-Cherl; Lee, Yeon-Su; Park, Sook Ryun; Kim, Chan Gyoo; Choi, Il Ju; Yoshida, Teruhiko; Nakamura, Yusuke; Hirohashi, Setsuo		Study Grp Millennium Genome Projec	Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer	NATURE GENETICS			English	Article							STEM-CELL ANTIGEN; MILLENNIUM GENOME; TUMOR-GROWTH; EXPRESSION; RISK; POLYMORPHISM; METASTASIS; CARCINOMA; INFERENCE; PROJECT	Gastric cancer is classified into intestinal and diffuse types, the latter including a highly malignant form, linitis plastica. A two-stage genome-wide association study (stage 1: 85,576 SNPs on 188 cases and 752 references; stage 2: 2,753 SNPs on 749 cases and 750 controls) in Japan identified a significant association between an intronic SNP (rs2976392) in PSCA (prostate stem cell antigen) and diffuse-type gastric cancer (allele-specific odds ratio (OR) 1.62, 95% CI = 1.38-1.89, P = 1.11 x 10(-9)). The association was far less significant in intestinal-type gastric cancer. We found that PSCA is expressed in differentiating gastric epithelial cells, has a cell-proliferation inhibition activity in vitro and is frequently silenced in gastric cancer. Substitution of the C allele with the risk allele T at a SNP in the first exon (rs2294008, which has r(2) = 0.995, D' = 0.999 with rs2976392) reduces transcriptional activity of an upstream fragment of the gene. The same risk allele was also significantly associated with diffuse-type gastric cancer in 457 cases and 390 controls in Korea (allele-specific OR 1.90, 95% CI = 1.56-2.33, P = 8.01 x 10(-11)). The polymorphism of the PSCA gene, which is possibly involved in regulating gastric epithelial-cell proliferation, influences susceptibility to diffuse-type gastric cancer.	[Sakamoto, Hiromi; Yoshimura, Kimio; Saeki, Norihisa; Ohnami, Sumiko; Sato, Yasunori; Aoyagi, Kazuhiko; Sasaki, Hiroki; Yoshida, Teruhiko] Natl Canc Ctr, Inst Res, Div Genet, Chuo Ku, Tokyo 1040045, Japan; [Yoshimura, Kimio] Keio Univ, Sch Med, Dept Hlth Policy & Management, Shinjuku Ku, Tokyo 1608582, Japan; [Katai, Hitoshi; Saito, Daizo; Toshiro, Emi] Natl Canc Ctr, Dept Surg Oncol, Chuo Ku, Tokyo 1040045, Japan; [Shimoda, Tadakazu; Matsuno, Yoshihiro] Natl Canc Ctr, Pathol Clin Lab Div, Chuo Ku, Tokyo 1040045, Japan; [Sugimura, Haruhiko] Hamamatsu Univ Sch Med, Dept Pathol 1, Hamamatsu, Shizuoka 4313192, Japan; [Tanioka, Fumihiko] Iwata City Hosp, Iwata, Shizuoka 4388550, Japan; [Kato, Shunji; Matsukura, Norio; Matsuda, Noriko] Nippon Med Coll Hosp, Dept Surg, Bunkyo Ku, Tokyo 1138602, Japan; [Nakamura, Tsuneya] Aichi Canc Ctr Hosp, Dept Endoscopy, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Hyodo, Ichinosuke; Nishina, Tomohiro] Shikoku Canc Ctr, Dept Internal Med, Matsuyama, Ehime 7910280, Japan; [Yasui, Wataru] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol Pathol, Minami Ku, Hiroshima 7348551, Japan; [Hirose, Hiroshi; Hayashi, Matsuhiko] Keio Univ, Sch Med, Dept Internal Med, Shinjuku Ku, Tokyo 1608582, Japan; [Sekine, Akihiro; Nakamura, Yusuke] RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Totsuka, Hirohiko] Hitachi Govt & Publ Corp Syst Engn Ltd, Bioinformat Grp, Ctr Res & Dev, Solut Div 4,Koto Ku, Tokyo 1358633, Japan; [Ando, Masataka] NEC Corp Ltd, BioIT Business Promot Ctr, Solut Dev Labs, Minato Ku, Tokyo 1088001, Japan; [Takemura, Ryo] StaGen Co Ltd, Stat Genet Anal Div, Taito Ku, Tokyo 1110051, Japan; [Takahashi, Yoriko; Ohdaira, Minoru; Aoki, Kenichi; Honmyo, Izumi] Mitsui Knowledge Ind Co Ltd, Chiyoda Ku, Tokyo 1010054, Japan; [Chiku, Suenori] Mizuho Informat & Res Inst Inc, Sci Solut Div, Chiyoda Ku, Tokyo 1018443, Japan; [Ohnami, Shumpei] Natl Canc Ctr, Res Inst, Cent RI Lab, Chuo Ku, Tokyo 1040045, Japan; [Yanagihara, Kazuyoshi] Natl Canc Ctr, Res Inst, Cent Anim Lab, Chuo Ku, Tokyo 1040045, Japan; [Yoon, Kyong-Ah; Kook, Myeong-Cherl; Lee, Yeon-Su; Park, Sook Ryun; Kim, Chan Gyoo; Choi, Il Ju] Natl Canc Ctr, Res Inst & Hosp, Goyang Si 411764, Gyeonggi Do, South Korea; [Nakamura, Yusuke] Univ Tokyo, Ctr Human Genome, Inst Med Sci, Minato Ku, Tokyo 1088639, Japan	National Cancer Center - Japan; Keio University; National Cancer Center - Japan; National Cancer Center - Japan; Hamamatsu University School of Medicine; Nippon Medical School; Aichi Cancer Center; Hiroshima University; Keio University; RIKEN; NEC Corporation; Mizuho Research & Technologies, Ltd.; National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Korea (NCC); University of Tokyo	Yoshida, T (corresponding author), Natl Canc Ctr, Inst Res, Div Genet, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	tyoshida@ncc.go.jp	Hirose, Hiroshi/F-8556-2014; Hayashi, Matsuhiko/J-4748-2013	Kim, Chan Gyoo/0000-0002-1651-2559				Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Bahrenberg G, 2000, BIOCHEM BIOPH RES CO, V275, P783, DOI 10.1006/bbrc.2000.3393; CORREA P, 1994, CANCER RES, V54, pS1941; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Dalen AGD, 2003, INT J CANCER, V103, P768, DOI 10.1002/ijc.10903; Epstein MP, 2003, AM J HUM GENET, V73, P1316, DOI 10.1086/380204; Falush D, 2003, GENETICS, V164, P1567; Fenoglio-Preiser C, 2000, WHO CLASSIFICATION T, P39; Fukaya M, 2006, GASTROENTEROLOGY, V131, P14, DOI 10.1053/j.gastro.2006.05.008; Gonzalez CA, 2002, INT J CANCER, V100, P249, DOI 10.1002/ijc.10466; Gu Z, 2000, ONCOGENE, V19, P1288, DOI 10.1038/sj.onc.1203426; Gu ZN, 2005, CANCER RES, V65, P9495, DOI 10.1158/0008-5472.CAN-05-2086; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Henson DE, 2004, ARCH PATHOL LAB MED, V128, P765; Hirakawa M, 2002, NUCLEIC ACIDS RES, V30, P158, DOI 10.1093/nar/30.1.158; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; Hohenberger P, 2003, LANCET, V362, P305, DOI 10.1016/S0140-6736(03)13975-X; Humar B, 2002, ONCOGENE, V21, P8192, DOI 10.1038/sj.onc.1205921; Japanese Gastric Cancer Association, 1998, Gastric Cancer, V1, P10; Japanese Gastric Cancer Association Registration Committee, 2006, Gastric Cancer, V9, P51; Kamangar F, 2006, CANCER EPIDEM BIOMAR, V15, P1920, DOI 10.1158/1055-9965.EPI-06-0267; KARAM S, 1995, MICROSC RES TECHNIQ, V31, P193, DOI 10.1002/jemt.1070310304; Karam SM, 2003, STEM CELLS, V21, P322, DOI 10.1634/stemcells.21-3-322; Kato N, 2008, HUM MOL GENET, V17, P617, DOI 10.1093/hmg/ddm335; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Machado JC, 1999, LAB INVEST, V79, P459; Nei M., 1987, MOL EVOLUTIONARY GEN; Noguchi M, 1997, PATHOL INT, V47, P685, DOI 10.1111/j.1440-1827.1997.tb04442.x; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Pharoah PDP, 2002, INT J CANCER, V101, P196, DOI 10.1002/ijc.10590; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; ROSAI J, 2004, ROSAI ACKERMANS SURG, P648; Saeki N, 2007, ONCOGENE, V26, P6488, DOI 10.1038/sj.onc.1210475; Saffran DC, 2001, P NATL ACAD SCI USA, V98, P2658, DOI 10.1073/pnas.051624698; Saito A, 2001, PATHOL INT, V51, P165, DOI 10.1046/j.1440-1827.2001.01179.x; Sasazuki S, 2006, CANCER EPIDEM BIOMAR, V15, P1341, DOI 10.1158/1055-9965.EPI-05-0901; Sato Y, 2004, J HUM GENET, V49, P669, DOI 10.1007/s10038-004-0205-9; Schier S, 2005, ONCOLOGY-BASEL, V69, P9, DOI 10.1159/000086625; Sharom FJ, 2004, SUB CELL BIOCHEM, V37, P285; Shinmura K, 1999, CARCINOGENESIS, V20, P1127, DOI 10.1093/carcin/20.6.1127; Smith MG, 2006, WORLD J GASTROENTERO, V12, P2979, DOI 10.3748/wjg.v12.i19.2979; Tran CP, 2002, MOL CANCER RES, V1, P113; Ushijima T, 2004, CANCER CELL, V5, P121, DOI 10.1016/S1535-6108(04)00033-9; Wang GY, 2008, AM J EPIDEMIOL, V167, P7, DOI 10.1093/aje/kwm264; Yokota T, 1999, CAN J SURG, V42, P371; Yoshida T, 2003, P JPN ACAD B-PHYS, V79, P34, DOI 10.2183/pjab.79B.34; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210	49	308	324	1	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2008	40	6					730	740		10.1038/ng.152	http://dx.doi.org/10.1038/ng.152			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18488030				2022-12-27	WOS:000256212000015
J	Tomlinson, IPM; Webb, E; Carvajal-Carmona, L; Broderick, P; Howarth, K; Pittman, AM; Spain, S; Lubbe, S; Walther, A; Sullivan, K; Jaeger, E; Fielding, S; Rowan, A; Vijayakrishnan, J; Domingo, E; Chandler, I; Kemp, Z; Qureshi, M; Farrington, SM; Tenesa, A; Prendergast, JGD; Barnetson, RA; Penegar, S; Barclay, E; Wood, W; Martin, L; Gorman, M; Thomas, H; Peto, J; Bishop, DT; Gray, R; Maher, ER; Lucassen, A; Kerr, D; Evans, DGR; Schafmayer, C; Buch, S; Volzke, H; Hampe, J; Schreiber, S; John, U; Koessler, T; Pharoah, P; van Wezel, T; Morreau, H; Wijnen, JT; Hopper, JL; Southey, MC; Giles, GG; Severi, G; Castellvi-Bel, S; Ruiz-Ponte, C; Carracedo, A; Castells, A; Forsti, A; Hemminki, K; Vodicka, P; Naccarati, A; Lipton, L; Ho, JWC; Cheng, KK; Sham, PC; Luk, J; Agundez, JAG; Ladero, JM; de la Hoya, M; Caldes, T; Niittymaeki, I; Tuupanen, S; Karhu, A; Aaltonen, L; Cazier, JB; Campbell, H; Dunlop, MG; Houlston, RS				Tomlinson, Ian P. M.; Webb, Emily; Carvajal-Carmona, Luis; Broderick, Peter; Howarth, Kimberley; Pittman, Alan M.; Spain, Sarah; Lubbe, Steven; Walther, Axel; Sullivan, Kate; Jaeger, Emma; Fielding, Sarah; Rowan, Andrew; Vijayakrishnan, Jayaram; Domingo, Enric; Chandler, Ian; Kemp, Zoe; Qureshi, Mobshra; Farrington, Susan M.; Tenesa, Albert; Prendergast, James G. D.; Barnetson, Rebecca A.; Penegar, Steven; Barclay, Ella; Wood, Wendy; Martin, Lynn; Gorman, Maggie; Thomas, Huw; Peto, Julian; Bishop, D. Timothy; Gray, Richard; Maher, Eamonn R.; Lucassen, Anneke; Kerr, David; Evans, D. Gareth R.; Schafmayer, Clemens; Buch, Stephan; Voelzke, Henry; Hampe, Jochen; Schreiber, Stefan; John, Ulrich; Koessler, Thibaud; Pharoah, Paul; van Wezel, Tom; Morreau, Hans; Wijnen, Juul T.; Hopper, John L.; Southey, Melissa C.; Giles, Graham G.; Severi, Gianluca; Castellvi-Bel, Sergi; Ruiz-Ponte, Clara; Carracedo, Angel; Castells, Antoni; Foersti, Asta; Hemminki, Kari; Vodicka, Pavel; Naccarati, Alessio; Lipton, Lara; Ho, Judy W. C.; Cheng, K. K.; Sham, Pak C.; Luk, J.; Agundez, Jose A. G.; Ladero, Jose M.; de la Hoya, Miguel; Caldes, Trinidad; Niittymaeki, Iina; Tuupanen, Sari; Karhu, Auli; Aaltonen, Lauri; Cazier, Jean-Baptiste; Campbell, Harry; Dunlop, Malcolm G.; Houlston, Richard S.		CORGI Consortium; EPICOLON Consortium	A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3	NATURE GENETICS			English	Article							PROSTATE-CANCER; BREAST-CANCER; RISK; METAANALYSIS; VARIANT; EIF3S3; TUMORS; GENES; SCAN	To identify colorectal cancer (CRC) susceptibility alleles, we conducted a genome-wide association study. In phase 1, we genotyped 550,163 tagSNPs in 940 familial colorectal tumor cases (627 CRC, 313 high-risk adenoma) and 965 controls. In phase 2, we genotyped 42,708 selected SNPs in 2,873 CRC cases and 2,871 controls. In phase 3, we evaluated 11 SNPs showing association at P < 10(-4) in a joint analysis of phases 1 and 2 in 4,287 CRC cases and 3,743 controls. Two SNPs were taken forward to phase 4 genotyping ( 10,731 CRC cases and 10,961 controls from eight centers). In addition to the previously reported 8q24, 15q13 and 18q21 CRC risk loci, we identified two previously unreported associations: rs10795668, located at 10p14 (P=2.5 x 10(-13) overall; P=6.9 x 10(-12) replication), and rs16892766, at 8q23.3 (P=3.3 x 10(-18) overall; P=9.6 x 10(-17) replication), which tags a plausible causative gene, EIF3H. These data provide further evidence for the 'common-disease common-variant' model of CRC predisposition.	[Tomlinson, Ian P. M.; Carvajal-Carmona, Luis; Howarth, Kimberley; Spain, Sarah; Walther, Axel; Jaeger, Emma; Rowan, Andrew; Domingo, Enric; Kemp, Zoe; Barclay, Ella; Martin, Lynn; Gorman, Maggie] London Res Inst, Mol & Populat Genet Lab, London WC2A 3PX, England; [Webb, Emily; Broderick, Peter; Pittman, Alan M.; Lubbe, Steven; Sullivan, Kate; Fielding, Sarah; Vijayakrishnan, Jayaram; Chandler, Ian; Qureshi, Mobshra; Penegar, Steven; Wood, Wendy; Houlston, Richard S.] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Univ Edinburgh, Colon Canc Genet Grp, Inst Genet & Mol Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Farrington, Susan M.; Tenesa, Albert; Prendergast, James G. D.; Barnetson, Rebecca A.; Dunlop, Malcolm G.] Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Farrington, Susan M.; Tenesa, Albert; Prendergast, James G. D.; Barnetson, Rebecca A.; Martin, Lynn; Evans, D. Gareth R.; Dunlop, Malcolm G.] St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England; [Martin, Lynn; Maher, Eamonn R.] Univ Birmingham, Sch Med, Dept Med & Mol Genet, Birmingham B15 2TG, W Midlands, England; [Martin, Lynn; Maher, Eamonn R.] Birmingham Womens Hosp, W Midlands Reg Genet Serv, Birmingham B15 2TG, W Midlands, England; [Thomas, Huw] St Marks Hosp, Family Canc Clin, Harrow HA1 3UJ, Middx, England; [Peto, Julian] Univ London London Sch Hyg & Trop Med, Noncommunicable Dis Epidemiol Unit, London WC1E 7HT, England; [Peto, Julian] Inst Canc Res, Canc Res UK Epidemiol & Genet Unit, Sutton SM2 5NG, Surrey, England; [Bishop, D. Timothy] Univ Leeds, Epidemiol & Biostat Sect, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Gray, Richard] Univ Birmingham, Birmingham Clin Trials Unit, Birmingham B15 2TA, W Midlands, England; [Lucassen, Anneke] Univ Southampton, Southampton SO16 5YA, Hants, England; [Lucassen, Anneke] Princess Anne Hosp, Wessex Clib Genet Serv, Southampton SO16 5YA, Hants, England; [Kerr, David] Univ Oxford, Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HA, England; [Schafmayer, Clemens] Univ Hosp Schleswig Holstein, Dept Gen & Thorac Surg, D-24105 Kiel, Germany; [Schafmayer, Clemens; Schreiber, Stefan] Univ Hosp Schleswig Holstein, POPGEN Biobank, D-24105 Kiel, Germany; [Voelzke, Henry; John, Ulrich] Ernst Moritz Arndt Univ Greifswald, Univ Hosp, SHIP Biobank, D-17487 Greifswald, Germany; [Voelzke, Henry; John, Ulrich] Ernst Moritz Arndt Univ Greifswald, Univ Hosp, Dept Community Med, D-17487 Greifswald, Germany; [Buch, Stephan; Hampe, Jochen] Univ Hosp Schleswig Holstein, Dept Gen Internal Med, D-24105 Kiel, Germany; [Buch, Stephan; Schreiber, Stefan] Univ Hosp Schleswig Holstein, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Wijnen, Juul T.] Leiden Univ, Med Ctr, Ctr Human & Clin Genet, NL-2333 ZA Leiden, Netherlands; [Hopper, John L.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic 3053, Australia; [Southey, Melissa C.] Univ Melbourne, Genet Epidemiol Lab, Dept Pathol, Parkville, Vic 3052, Australia; [Giles, Graham G.; Severi, Gianluca] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic 3053, Australia; [Castellvi-Bel, Sergi; Castells, Antoni] IDIBAPS, Dept Gastroenterol, Inst Malalties Digest & Metab, Hosp Clin,CIBER EHD, Barcelona, Catalonia, Spain; [Ruiz-Ponte, Clara; Carracedo, Angel] CeGen USC, CIBERER, Genom Med Grp, FPGMX,Spanish Natl Genotyping Ctr,Hosp Clin, Santiago De Compostela, Galicia, Spain; [Foersti, Asta; Hemminki, Kari] DKFZ, Div Mol Genet Epidemiol, German Canc Res Ctr, D-69120 Heidelberg, Germany; [Foersti, Asta; Hemminki, Kari] Karolinska Inst, Ctr Family & Community Med, S-14183 Huddinge, Sweden; [Vodicka, Pavel; Naccarati, Alessio] Acad Sci Czech Republic, Inst Expt Med, Prague 14200, Czech Republic; [Lipton, Lara] Western Hosp, Dept Med Oncol & Clin Haematol, Footscray, Vic 3011, Australia; [Ho, Judy W. C.; Cheng, K. K.; Sham, Pak C.; Luk, J.] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Agundez, Jose A. G.] Univ Extremadura, Dept Pharmacol, Sch Med, Badajoz, Spain; [Ladero, Jose M.] San Carlos Univ Hosp, Serv Gastroenterol, Madrid, Spain; [de la Hoya, Miguel; Caldes, Trinidad] Hosp San Carlos, Mol Oncol Lab, Madrid 28040, Spain; [Niittymaeki, Iina; Tuupanen, Sari; Karhu, Auli; Aaltonen, Lauri] Univ Helsinki, Dept Med Genet, Genome Scale Biol Res Program, Helsinki, Finland; [Cazier, Jean-Baptiste] London Res Inst, London WC2A 3PX, England; [Campbell, Harry] Univ Edinburgh, Edinburgh EH8 9AG, Midlothian, Scotland; [Koessler, Thibaud; Pharoah, Paul] Univ Cambridge, Can Res United Kingdom Dept Oncol, Strangeways Res Lab, Cambridge CB1 8RN, England; [van Wezel, Tom; Morreau, Hans] Leiden Univ, Med Ctr, Dept Pathol, NL-2333 ZA Leiden, Netherlands	University of London; Institute of Cancer Research - UK; University of Edinburgh; University of Edinburgh; University of Manchester; University of Birmingham; Birmingham Women's Hospital; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of London; Institute of Cancer Research - UK; University of Leeds; University of Birmingham; University of Southampton; Radcliffe Infirmary; University of Oxford; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Melbourne; University of Melbourne; Cancer Council Victoria; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Complexo Hospitalario Universitario de Santiago de Compostela; Helmholtz Association; German Cancer Research Center (DKFZ); Karolinska Institutet; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Western Hospital; University of Hong Kong; Universidad de Extremadura; Hospital Clinico San Carlos; Hospital Clinico San Carlos; University of Helsinki; University of Edinburgh; University of Cambridge; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Tomlinson, IPM (corresponding author), London Res Inst, Mol & Populat Genet Lab, London WC2A 3PX, England.	ian.tomlinson@cancer.org.uk; richard.houlston@icr.ac.uk	Agúndez, José A. G./A-5503-2008; Pittman, Alan/AAP-2534-2020; Cazier, Jean-Baptiste/F-2369-2010; Severi, Gianluca/H-3774-2018; van Wezel, Tom/A-9599-2008; Sham, Pak Chung/C-4388-2009; Castells, Antoni/ABC-1002-2021; MAHER, EAMONN R/A-9507-2008; de la Hoya, MIguel/Z-2911-2019; Evans, D Gareth/AAB-4308-2022; Hampe, Jochen/A-2555-2010; Pittman, Alan M/D-6231-2012; Vodicka, Pavel/H-3370-2014; van Wezel, Tom/Z-3092-2019; Farrington, Susan M/C-7319-2013; Carracedo, Angel/D-4257-2012; Ruiz-Ponte, Clara/I-3849-2015; Severi, Gianluca/Q-1824-2019; Campbell, Harry/E-2959-2010; Lubbe, Steven/L-8261-2013; Cheng, King Yip/C-4551-2009; Luk, John/A-4085-2008; Domingo, Enric/A-9099-2018; Pharoah, Paul/V-6658-2019; van Wezel, Tom/AAL-5626-2021; Dunlop, Malcolm G/F-1973-2011; Farrington, Susan M/Q-2710-2019; Kössler, Thibaud/AAZ-9734-2020; Carvajal-Carmona, Luis G/B-3882-2010; Buch, Stephan/AAV-5028-2021; Cazier, Jean-Baptiste/GLR-2949-2022; Aaltonen, Lauri/A-5375-2010; Lucassen, Anneke/D-7764-2017; Spain, Sarah/G-1968-2010	Agúndez, José A. G./0000-0001-6895-9160; Pittman, Alan/0000-0002-8112-2987; Cazier, Jean-Baptiste/0000-0001-7581-9051; Severi, Gianluca/0000-0001-7157-419X; van Wezel, Tom/0000-0001-5773-7730; Castells, Antoni/0000-0001-8431-2033; MAHER, EAMONN R/0000-0002-6226-6918; Evans, D Gareth/0000-0002-8482-5784; Hampe, Jochen/0000-0002-2421-6127; Pittman, Alan M/0000-0002-8112-2987; van Wezel, Tom/0000-0001-5773-7730; Carracedo, Angel/0000-0003-1085-8986; Ruiz-Ponte, Clara/0000-0002-2200-0162; Severi, Gianluca/0000-0001-7157-419X; Campbell, Harry/0000-0002-6169-6262; Lubbe, Steven/0000-0002-7103-6671; Luk, John/0000-0002-6323-7940; Domingo, Enric/0000-0003-4390-8767; Pharoah, Paul/0000-0001-8494-732X; Dunlop, Malcolm G/0000-0002-3033-5851; Farrington, Susan M/0000-0001-5955-7389; Carvajal-Carmona, Luis G/0000-0001-7129-2918; Cazier, Jean-Baptiste/0000-0001-7581-9051; Aaltonen, Lauri/0000-0001-6839-4286; Castellvi-Bel, Sergi/0000-0003-1217-5097; Webb, Emily/0000-0002-4019-7456; Kossler, Thibaud/0000-0001-9196-9076; Penegar, Steven/0000-0002-3768-0236; Karhu, Auli/0000-0002-7927-0796; de la Hoya, Miguel/0000-0002-8113-1410; Prendergast, James/0000-0001-8916-018X; Giles, Graham/0000-0003-4946-9099; Lucassen, Anneke/0000-0003-3324-4338; Bishop, Tim/0000-0002-8752-8785; John, Ulrich/0000-0003-0587-5298; Naccarati, Alessio/0000-0001-5774-0905; Vodicka, Pavel/0000-0003-2376-1243; Spain, Sarah/0000-0002-7591-8364; Wood, Wendy/0000-0001-9062-4455; Broderick, Peter/0000-0002-8348-5829; Vijayakrishnan, Jayaram/0000-0002-8284-2249; Tenesa, Albert/0000-0003-4884-4475; Houlston, Richard/0000-0002-5268-0242; Southey, Melissa/0000-0002-6313-9005; Gray, Richard/0000-0003-4440-574X	MRC [G0301096, MC_U127527198] Funding Source: UKRI; Cancer Research UK [A8896, C348/A3758, C48/A6361] Funding Source: Medline; Medical Research Council [G0301096, G0000657-53203, MC_U127527198] Funding Source: Medline; Chief Scientist Office [CZB/4/449] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office		Aaltonen L, 2007, CLIN CANCER RES, V13, P356, DOI 10.1158/1078-0432.CCR-06-1256; Antoniou AC, 2003, GENET EPIDEMIOL, V25, P190, DOI 10.1002/gepi.10261; Boland CR, 1998, CANCER RES, V58, P5248; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Houlston RS, 2003, HUM GENET, V112, P434, DOI 10.1007/s00439-002-0902-4; Jaeger EEM, 2003, AM J HUM GENET, V72, P1261, DOI 10.1086/375144; Jaeger E, 2008, NAT GENET, V40, P26, DOI 10.1038/ng.2007.41; Johns LE, 2001, AM J GASTROENTEROL, V96, P2992, DOI 10.1111/j.1572-0241.2001.04677.x; Okamoto H, 2003, HEPATOLOGY, V38, P1242, DOI 10.1053/jhep.2003.50457; PETITTI D, 1994, META ANAL DECISION A; Savinainen KJ, 2004, BRIT J CANCER, V90, P1041, DOI 10.1038/sj.bjc.6601648; Shima H, 2005, PATHOBIOLOGY, V72, P220, DOI 10.1159/000086792; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; World Heath Organization, 1977, INT CLASS DIS 1975 R; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zhou XP, 1998, GENE CHROMOSOME CANC, V21, P101, DOI 10.1002/(SICI)1098-2264(199802)21:2<101::AID-GCC4>3.0.CO;2-4	22	463	473	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2008	40	5					623	630		10.1038/ng.111	http://dx.doi.org/10.1038/ng.111			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18372905				2022-12-27	WOS:000255366700031
J	Barreiro, LB; Laval, G; Quach, H; Patin, E; Quintana-Murci, L				Barreiro, Luis B.; Laval, Guillaume; Quach, Helene; Patin, Etienne; Quintana-Murci, Lluis			Natural selection has driven population differentiation in modern humans	NATURE GENETICS			English	Article							HUMAN GENOME; POSITIVE SELECTION; HAPLOTYPE MAP; SIGNATURES; REGIONS; POLYMORPHISM; PATTERNS; SNPS	The considerable range of observed phenotypic variation in human populations may reflect, in part, distinctive processes of natural selection and adaptation to variable environmental conditions. Although recent genome-wide studies have identified candidate regions under selection(1-5), it is not yet clear how natural selection has shaped population differentiation. Here, we have analyzed the degree of population differentiation at 2.8 million Phase II HapMap single-nucleotide polymorphisms(6). We find that negative selection has globally reduced population differentiation at amino acid-altering mutations, particularly in disease-related genes. Conversely, positive selection has ensured the regional adaptation of human populations by increasing population differentiation in gene regions, primarily at nonsynonymous and 5'-UTR variants. Our analyses identify a fraction of loci that have contributed, and probably still contribute, to the morphological and disease-related phenotypic diversity of current human populations.	[Barreiro, Luis B.; Laval, Guillaume; Quach, Helene; Patin, Etienne; Quintana-Murci, Lluis] Inst Pasteur, CNRS URA3012, Human Evolutionary Genet Unit, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Quintana-Murci, L (corresponding author), Inst Pasteur, CNRS URA3012, Human Evolutionary Genet Unit, 25 Rue Dr Roux, F-75015 Paris, France.	quintana@pasteur.fr	Quintana-Murci, Lluis/AAB-7468-2022; Barreiro, Luis/I-7772-2015; Patin, Etienne/G-6768-2012	Barreiro, Luis/0000-0001-9456-367X; Quach, Helene/0000-0002-3493-0973; Quintana-Murci, Lluis/0000-0003-2429-6320; Patin, Etienne/0000-0002-9911-4459				Akey JM, 2002, GENOME RES, V12, P1805, DOI 10.1101/gr.631202; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Cockburn IA, 2004, P NATL ACAD SCI USA, V101, P272, DOI 10.1073/pnas.0305306101; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; EXCOFFIER L, 1992, GENETICS, V131, P491; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hamblin MT, 2000, AM J HUM GENET, V66, P1669, DOI 10.1086/302879; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Kelley JL, 2006, GENOME RES, V16, P980, DOI 10.1101/gr.5157306; McVean G, 2006, CURR OPIN GENET DEV, V16, P624, DOI 10.1016/j.gde.2006.09.004; Meyre D, 2005, NAT GENET, V37, P863, DOI 10.1038/ng1604; Monreal AW, 1999, NAT GENET, V22, P366, DOI 10.1038/11937; Mou C, 2006, P NATL ACAD SCI USA, V103, P9075, DOI 10.1073/pnas.0600825103; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Weir BS, 2005, GENOME RES, V15, P1468, DOI 10.1101/gr.4398405; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Williamson S, 2002, MOL BIOL EVOL, V19, P1376, DOI 10.1093/oxfordjournals.molbev.a004199; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102	30	406	416	1	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2008	40	3					340	345		10.1038/ng.78	http://dx.doi.org/10.1038/ng.78			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18246066				2022-12-27	WOS:000253548400026
J	Chang, TC; Yu, DN; Lee, YS; Wentzel, EA; Arking, DE; West, KM; Dang, CV; Thomas-Tikhonenko, A; Mendell, JT				Chang, Tsung-Cheng; Yu, Duonan; Lee, Yun-Sil; Wentzel, Erik A.; Arking, Dan E.; West, Kristin M.; Dang, Chi V.; Thomas-Tikhonenko, Andrei; Mendell, Joshua T.			Widespread microRNA repression by Myc contributes to tumorigenesis	NATURE GENETICS			English	Article							HUMAN LUNG CANCERS; C-MYC; TRANSCRIPTIONAL REPRESSION; GENES; EXPRESSION; ACTIVATION; TARGET; TRANSACTIVATION; IDENTIFICATION; TRANSFORMATION	The c-Myc oncogenic transcription factor (Myc) is pathologically activated in many human malignancies. Myc is known to directly upregulate a pro-tumorigenic group of microRNAs (miRNAs) known as the miR-17 - 92 cluster. Through the analysis of human and mouse models of B cell lymphoma, we show here that Myc regulates a much broader set of miRNAs than previously anticipated. Unexpectedly, the predominant consequence of activation of Myc is widespread repression of miRNA expression. Chromatin immunoprecipitation reveals that much of this repression is likely to be a direct result of Myc binding to miRNA promoters. We further show that enforced expression of repressed miRNAs diminishes the tumorigenic potential of lymphoma cells. These results demonstrate that extensive reprogramming of the miRNA transcriptome by Myc contributes to tumorigenesis.	[Chang, Tsung-Cheng; Lee, Yun-Sil; Wentzel, Erik A.; Arking, Dan E.; West, Kristin M.; Mendell, Joshua T.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Mendell, Joshua T.] Johns Hopkins Univ, Dept Mol Biol & Genet, Sch Med, Baltimore, MD 21205 USA; [Mendell, Joshua T.] Johns Hopkins Univ, Dept Pediat, Sch Med, Baltimore, MD 21205 USA; [Yu, Duonan] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Dang, Chi V.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Can Ctr, Baltimore, MD 21205 USA; [Arking, Dan E.; Dang, Chi V.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University of Pennsylvania; Johns Hopkins University; Johns Hopkins University	Mendell, JT (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	andreit@mail.vet.upenn.edu; jmendell@jhmi.edu	Thomas-Tikhonenko, Andrei/E-5329-2011; Chang, Tsung-Cheng/C-2761-2008; Dang, Chi/Y-3375-2019	Thomas-Tikhonenko, Andrei/0000-0002-2739-2206; Chang, Tsung-Cheng/0000-0003-4706-0468; Dang, Chi/0000-0002-4031-2522	NCI NIH HHS [R01 CA120185, R01 CA122334, R01 CA122334-02, R01 CA102709-02, R01 CA102709-03, R01 CA102709, R01 CA102709-01, R01 CA122334-01A1, R01 CA102709-04] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA120185, R01CA102709, R01CA122334] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adhikary S, 2005, NAT REV MOL CELL BIO, V6, P635, DOI 10.1038/nrm1703; ALT F, 1981, CELL, V27, P381, DOI 10.1016/0092-8674(81)90421-9; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Cimmino A, 2005, P NATL ACAD SCI USA, V102, P13944, DOI 10.1073/pnas.0506654102; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Feng XH, 2002, MOL CELL, V9, P133, DOI 10.1016/S1097-2765(01)00430-0; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Izumi H, 2001, J CELL SCI, V114, P1533; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kleine-Kohlbrecher D, 2006, CURR TOP MICROBIOL, V302, P51; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Leaman D, 2005, CELL, V121, P1097, DOI 10.1016/j.cell.2005.04.016; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu LS, 1998, J IMMUNOL, V161, P1284; Mao DYL, 2003, CURR BIOL, V13, P882, DOI 10.1016/S0960-9822(03)00297-5; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; O'Donnell KA, 2006, MOL CELL BIOL, V26, P2373, DOI 10.1128/MCB.26.6.2373-2386.2006; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Ota A, 2004, CANCER RES, V64, P3087, DOI 10.1158/0008-5472.CAN-03-3773; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Seoane J, 2002, NATURE, V419, P729, DOI 10.1038/nature01119; Soutschek J, 2004, NATURE, V432, P173, DOI 10.1038/nature03121; Staller P, 2001, NAT CELL BIOL, V3, P392, DOI 10.1038/35070076; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu D, 2003, BLOOD, V101, P1950, DOI 10.1182/blood-2002-06-1797; Yu DN, 2005, ANN NY ACAD SCI, V1059, P145, DOI 10.1196/annals.1339.047; Yu DN, 2005, CANCER RES, V65, P5454, DOI 10.1158/0008-5472.CAN-04-4197; Yu DN, 2002, ONCOGENE, V21, P1922, DOI 10.1038/sj.onc.1205244; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103	51	1031	1083	2	90	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2008	40	1					43	50		10.1038/ng.2007.30	http://dx.doi.org/10.1038/ng.2007.30			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18066065	Green Accepted			2022-12-27	WOS:000252118600017
J	Jones, C; Roper, VC; Foucher, I; Qian, D; Banizs, B; Petit, C; Yoder, BK; Chen, P				Jones, Chonnettia; Roper, Venus C.; Foucher, Isabelle; Qian, Dong; Banizs, Boglarka; Petit, Christine; Yoder, Bradley K.; Chen, Ping			Ciliary proteins link basal body polarization to planar cell polarity regulation	NATURE GENETICS			English	Article							INTRAFLAGELLAR TRANSPORT; CONVERGENT EXTENSION; HAIR-CELLS; DISEASE GENE; LOCALIZATION; REGENERATION; CILIOGENESIS; ORIENTATION; STEREOCILIA; DEFECTS	Planar cell polarity (PCP) refers to coordinated polarization of cells within the plane of a cell sheet. A conserved signaling pathway is required for the establishment of PCP in epithelial tissues and for polarized cellular rearrangements known as convergent extension. During PCP signaling, core PCP proteins are sorted asymmetrically along the polarization axis; this sorting is thought to direct coordinated downstream morphogenetic changes across the entire tissue. Here, we show that a gene encoding a ciliary protein (a 'ciliary gene'), Ift88, also known as Polaris, is required for establishing epithelial PCP and for convergent extension of the cochlear duct of Mus musculus. We also show that the proper positioning of ciliary basal bodies and the formation of polarized cellular structures are disrupted in mice with mutant ciliary proteins('ciliary mutants'), whereas core PCP proteins are partitioned normally along the polarization axis. Thus, our data uncover a distinct requirement for ciliary genes in basal body positioning and morphological polarization during PCP regulation.	[Jones, Chonnettia; Qian, Dong; Chen, Ping] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; [Roper, Venus C.; Banizs, Boglarka; Yoder, Bradley K.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Petit, Christine] Inst Pasteur, Unite Genet Deficits Sensoriels,Coll France, INSERM, UMRS 587, F-75724 Paris, France	Emory University; University of Alabama System; University of Alabama Birmingham; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; PSL Research University Paris; College de France; Universite de Bordeaux	Chen, P (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, 615 Michael St, Atlanta, GA 30322 USA.	ping.chen@emory.edu		Petit, Christine/0000-0002-9069-002X; Jones, Chonnettia/0000-0003-3430-8110	NIDCD NIH HHS [R01 DC007423, F32DC008731, DC007423, R01 DC005213] Funding Source: Medline; NIDDK NIH HHS [P30 DK074038, DK065655] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065655, P30DK074038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005213, F32DC008731, R01DC007423] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Absalon S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000437; Badea TC, 2003, J NEUROSCI, V23, P2314; Beech PL, 1996, J CELL SCI, V109, P889; Beisson J, 1999, BIOL CELL, V91, P367, DOI 10.1016/S0248-4900(99)80097-5; BOISVIEUXULRICH E, 1985, BIOL CELL, V55, P147, DOI 10.1111/j.1768-322X.1985.tb00417.x; Cano DA, 2004, DEVELOPMENT, V131, P3457, DOI 10.1242/dev.01189; COTANCHE DA, 1991, HEARING RES, V52, P379, DOI 10.1016/0378-5955(91)90027-7; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Deans MR, 2007, J NEUROSCI, V27, P3139, DOI 10.1523/JNEUROSCI.5151-06.2007; Denman-Johnson K, 1999, J NEUROCYTOL, V28, P821, DOI 10.1023/A:1007061819934; Hagiwara H, 2000, HISTOCHEM J, V32, P669, DOI 10.1023/A:1004163315822; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Hebert JM, 2000, DEV BIOL, V222, P296, DOI 10.1006/dbio.2000.9732; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Jones C, 2007, BIOESSAYS, V29, P120, DOI 10.1002/bies.20526; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kikuchi K, 1965, Acta Otolaryngol, V60, P207, DOI 10.3109/00016486509127003; KIKUCHI T, 1988, ACTA OTO-LARYNGOL, V106, P200, DOI 10.3109/00016488809106426; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Mitchell B, 2007, NATURE, V447, P97, DOI 10.1038/nature05771; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Montcouquiol M, 2006, ANNU REV NEUROSCI, V29, P363, DOI 10.1146/annurev.neuro.29.051605.112933; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Murcia NS, 2000, DEVELOPMENT, V127, P2347; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Pauley S, 2006, DEV DYNAM, V235, P2470, DOI 10.1002/dvdy.20839; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Robert A, 2007, J CELL SCI, V120, P628, DOI 10.1242/jcs.03366; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; SANDOZ D, 1988, BIOL CELL, V63, P183, DOI 10.1016/0248-4900(88)90057-3; Schneider L, 2005, CURR BIOL, V15, P1861, DOI 10.1016/j.cub.2005.09.012; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; SOBKOWICZ HM, 1995, J NEUROCYTOL, V24, P633, DOI 10.1007/BF01179815; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; TILNEY LG, 1992, ANNU REV CELL BIOL, V8, P257, DOI 10.1146/annurev.cb.08.110192.001353; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Ybot-Gonzalez P, 2007, DEVELOPMENT, V134, P789, DOI 10.1242/dev.000380; Yoder BK, 2002, AM J PHYSIOL-RENAL, V282, pF541, DOI 10.1152/ajprenal.00273.2001	49	249	252	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2008	40	1					69	77		10.1038/ng.2007.54	http://dx.doi.org/10.1038/ng.2007.54			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18066062				2022-12-27	WOS:000252118600020
J	Croker, B; Crozat, K; Berger, M; Xia, Y; Sovath, S; Schaffer, L; Eleftherianos, I; Imler, JL; Beutler, B				Croker, Ben; Crozat, Karine; Berger, Michael; Xia, Yu; Sovath, Sosathya; Schaffer, Lana; Eleftherianos, Ioannis; Imler, Jean-Luc; Beutler, Bruce			ATP-sensitive potassium channels mediate survival during infection in mammals and insects	NATURE GENETICS			English	Article							TUMOR-NECROSIS-FACTOR; DOUBLE-STRANDED-RNA; NEGATIVE REGULATOR; TNF-ALPHA; RIG-I; CYTOMEGALOVIRUS-INFECTION; MOUSE-CYTOMEGALOVIRUS; ENDOTOXIN TOLERANCE; ANTIVIRAL RESPONSE; VIRAL-INFECTION	Specific homeostatic mechanisms confer stability in innate immune responses, preventing injury or death from infection. Here we identify, from a screen of N-ethyl-N-nitrosourea-mutagenized mice, a mutation causing both profound susceptibility to infection by mouse cytomegalovirus and similar to 20,000-fold sensitization to lipopolysaccharide ( LPS), poly( I. C) and immunostimulatory ( CpG) DNA. The LPS hypersensitivity phenotype is not suppressed by mutations in Myd88, Trif, Tnf, Tnfrsf1a, Ifnb, Ifng or Stat1, genes contributing to LPS responses, and results from an abnormality extrinsic to hematopoietic cells. The phenotype is due to a null allele of Kcnj8, encoding Kir6.1, a protein that combines with SUR2 to form an ATP-sensitive potassium channel ( KATP) expressed in coronary artery smooth muscle and endothelial cells. In Drosophila melanogaster, suppression of dSUR by RNA interference similarly causes hypersensitivity to infection by flock house virus. Thus, KATP evolved to serve a homeostatic function during infection, and in mammals it prevents coronary artery vasoconstriction induced by cytokines dependent on TLR and/ or MDA5 immunoreceptors.	Scripps Res Inst, Dept Genet, IMM 31, La Jolla, CA 92037 USA; Scripps Res Inst, DNA Array Core Facil, La Jolla, CA 92037 USA; CNRS, Inst Biol Mol Cellulaire, UPR 9022, F-67084 Strasbourg, France	Scripps Research Institute; Scripps Research Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Beutler, B (corresponding author), Scripps Res Inst, Dept Genet, IMM 31, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bruce@scripps.edu	Imler, Jean-Luc/GXH-4323-2022; Crozat, Karine/L-7297-2019	Crozat, Karine/0000-0003-4761-3675; Croker, Ben/0000-0002-0885-3599	NIAID NIH HHS [AI070167] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akasaka T, 2006, P NATL ACAD SCI USA, V103, P11999, DOI 10.1073/pnas.0603098103; Alekseev AE, 1998, J GEN PHYSIOL, V111, P381, DOI 10.1085/jgp.111.2.381; BERG DJ, 1995, J CLIN INVEST, V96, P2339, DOI 10.1172/JCI118290; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brown MG, 2001, SCIENCE, V292, P934, DOI 10.1126/science.1060042; Cherry S, 2006, NAT IMMUNOL, V7, P911, DOI 10.1038/ni1388; Chutkow WA, 2002, J CLIN INVEST, V110, P203, DOI 10.1172/JCI200215672; Croker BA, 2004, IMMUNITY, V20, P153, DOI 10.1016/S1074-7613(04)00022-6; Crozat K, 2007, J EXP MED, V204, P853, DOI 10.1084/jem.20062447; Crozat K, 2006, MAMM GENOME, V17, P398, DOI 10.1007/s00335-005-0164-2; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Georgel P, 2007, VIROLOGY, V362, P304, DOI 10.1016/j.virol.2006.12.032; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; HART PH, 1989, P NATL ACAD SCI USA, V86, P3803, DOI 10.1073/pnas.86.10.3803; HAUSMANN EHS, 1994, INFECT IMMUN, V62, P3625, DOI 10.1128/IAI.62.9.3625-3632.1994; Hoebe K, 2003, J ENDOTOXIN RES, V9, P250, DOI 10.1179/096805103225001459; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Inohara N, 2005, ANNU REV BIOCHEM, V74, P355, DOI 10.1146/annurev.biochem.74.082803.133347; Kane GC, 2006, FASEB J, V20, P2271, DOI 10.1096/fj.06-6349com; Kano A, 2003, J EXP MED, V198, P1517, DOI 10.1084/jem.20030077; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; KEPPLER DOR, 1982, BIOCHEM J, V206, P139, DOI 10.1042/bj2060139; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/ng0501-42; LEHMANN V, 1987, J EXP MED, V165, P657, DOI 10.1084/jem.165.3.657; LEIST M, 1994, J IMMUNOL, V153, P1778; Miki T, 2002, NAT MED, V8, P466, DOI 10.1038/nm0502-466; Muchamuel T, 1997, J IMMUNOL, V158, P2898; Nakagawa R, 2002, IMMUNITY, V17, P677, DOI 10.1016/S1074-7613(02)00449-1; Pao LI, 2005, J IMMUNOL, V175, P3235, DOI 10.4049/jimmunol.175.5.3235; Presti RM, 1998, J EXP MED, V188, P577, DOI 10.1084/jem.188.3.577; Rutschmann S, 2006, J IMMUNOL, V176, P7525, DOI 10.4049/jimmunol.176.12.7525; Salazar-Mather TP, 2002, J CLIN INVEST, V110, P321, DOI 10.1172/JCI200215376; Sly LM, 2004, IMMUNITY, V21, P227, DOI 10.1016/j.immuni.2004.07.010; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Takahashi K, 2006, J IMMUNOL, V176, P4520, DOI 10.4049/jimmunol.176.8.4520; van Dommelen SLH, 2006, IMMUNITY, V25, P835, DOI 10.1016/j.immuni.2006.09.010; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x	49	51	53	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2007	39	12					1453	1460		10.1038/ng.2007.25	http://dx.doi.org/10.1038/ng.2007.25			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	18026101				2022-12-27	WOS:000251267400012
J	Pujana, MA; Han, JDJ; Starita, LM; Stevens, KN; Tewari, M; Ahn, JS; Rennert, G; Moreno, V; Kirchhoff, T; Gold, B; Assmann, V; ElShamy, WM; Rual, JF; Levine, D; Rozek, LS; Gelman, RS; Gunsalus, KC; Greenberg, RA; Sobhian, B; Bertin, N; Venkatesan, K; Ayivi-Guedehoussou, N; Sole, X; Hernandez, P; Lazaro, C; Nathanson, KL; Weber, BL; Cusick, ME; Hill, DE; Offit, K; Livingston, DM; Gruber, SB; Parvin, JD; Vidal, M				Pujana, Miguel Angel; Han, Jing-Dong J.; Starita, Lea M.; Stevens, Kristen N.; Tewari, Muneesh; Ahn, Jin Sook; Rennert, Gad; Moreno, Victor; Kirchhoff, Tomas; Gold, Bert; Assmann, Volker; ElShamy, Wael M.; Rual, Jean-Francois; Levine, Douglas; Rozek, Laura S.; Gelman, Rebecca S.; Gunsalus, Kristin C.; Greenberg, Roger A.; Sobhian, Bijan; Bertin, Nicolas; Venkatesan, Kavitha; Ayivi-Guedehoussou, Nono; Sole, Xavier; Hernandez, Pilar; Lazaro, Conxi; Nathanson, Katherine L.; Weber, Barbara L.; Cusick, Michael E.; Hill, David E.; Offit, Kenneth; Livingston, David M.; Gruber, Stephen B.; Parvin, Jeffrey D.; Vidal, Marc			Network modeling links breast cancer susceptibility and centrosome dysfunction	NATURE GENETICS			English	Article							CAENORHABDITIS-ELEGANS; C-ELEGANS; GENETIC INSTABILITY; ZYG-9 FORM; PROTEIN; BRCA1; AMPLIFICATION; MUTATIONS; COMPLEX; TAC-1	Many cancer-associated genes remain to be identified to clarify the underlying molecular mechanisms of cancer susceptibility and progression. Better understanding is also required of how mutations in cancer genes affect their products in the context of complex cellular networks. Here we have used a network modeling strategy to identify genes potentially associated with higher risk of breast cancer. Starting with four known genes encoding tumor suppressors of breast cancer, we combined gene expression profiling with functional genomic and proteomic ( or `omic') data from various species to generate a network containing 118 genes linked by 866 potential functional associations. This network shows higher connectivity than expected by chance, suggesting that its components function in biologically related pathways. One of the components of the network is HMMR, encoding a centrosome subunit, for which we demonstrate previously unknown functional associations with the breast cancer associated gene BRCA1. Two case-control studies of incident breast cancer indicate that the HMMR locus is associated with higher risk of breast cancer in humans. Our network modeling strategy should be useful for the discovery of additional cancer-associated genes.	Harvard Univ, Sch Med, CCSB, Dept Genet, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; Carmel Hosp, Dept Community Med & Epidemiol, CHS Natl Canc Control Ctr, IL-34362 Haifa, Israel; Technion, Bruce Rappaport Fac Med, IL-34362 Haifa, Israel; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; IDIBELL, Catalan Inst Oncol, Dept Epidemiol, Barcelona 08907, Spain; IDIBELL, Catalan Inst Oncol, Canc Registry, Barcelona 08907, Spain; IDIBELL, Catalan Inst Oncol, Translat Res Lab, Barcelona 08907, Spain; Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, New York, NY 10021 USA; Natl Canc Inst, Human Genet Sect, Lab Genome Divers, Frederick, MD 21702 USA; Univ Hamburg, Hosp Eppendorf, Inst Tumor Biol, Ctr Med Expt, D-20246 Hamburg, Germany; Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; NYU, Dept Biol, Ctr Comparat Funct Genom, New York, NY 10003 USA; IDIBELL, Catalan Inst Oncol, Translat Res Lab, Barcelona 08907, Spain; Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Michigan System; University of Michigan; Clalit Health Services; Carmel Medical Center; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; University of Michigan System; University of Michigan; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Memorial Sloan Kettering Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Hamburg; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; New York University; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; University of Pennsylvania; Pennsylvania Medicine; University of Michigan System; University of Michigan	Pujana, MA (corresponding author), Harvard Univ, Sch Med, CCSB, Dept Genet, 44 Binney St, Boston, MA 02115 USA.		Solé, Xavier/AAF-3015-2019; GARCIA, CONXI LAZARO/Q-2410-2016; Purrington, Kristen/AAN-6494-2021; ElShamy, Wael/AAF-2867-2019; Moreno, Victor/A-1697-2010; Parvin, Jeffrey D/C-8955-2009; Hill, David E/B-6617-2011; Bertin, Nicolas/O-9602-2019; Pujana, Miquel Angel/N-3127-2014; ElShamy, Wael M./L-1090-2018; Bertin, Nicolas/C-3025-2008	Solé, Xavier/0000-0002-2197-3325; GARCIA, CONXI LAZARO/0000-0002-7198-5906; Purrington, Kristen/0000-0002-5710-1692; Moreno, Victor/0000-0002-2818-5487; Pujana, Miquel Angel/0000-0003-3222-4044; Bertin, Nicolas/0000-0002-9835-9606; jhangiry, parvin/0000-0003-1415-7212; Levine, Douglas/0000-0003-1038-8232; Kirchhoff, Tomas/0000-0002-9055-2364; Sobhian, Bijan/0000-0001-7255-6006; Rual, Jean-Francois/0000-0003-4465-8819; Rennert, Gad/0000-0002-8512-068X; Nathanson, Katherine/0000-0002-6740-0901	NCI NIH HHS [P30 CA046592, CA90281] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA046592, R01CA090281] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [0644282] Funding Source: National Science Foundation	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bellanger JM, 2003, CURR BIOL, V13, P1488, DOI 10.1016/S0960-9822(03)00582-7; Bieche I, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-37; Boulton SJ, 2004, CURR BIOL, V14, P33, DOI 10.1016/j.cub.2003.11.029; CLAUS EB, 1990, ANN HUM GENET, V54, P169, DOI 10.1111/j.1469-1809.1990.tb00373.x; Cunliffe HE, 2003, CANCER RES, V63, P7158; Entwistle J, 1996, J CELL BIOCHEM, V61, P569, DOI 10.1002/(SICI)1097-4644(19960616)61:4<569::AID-JCB10>3.0.CO;2-B; Formstecher E, 2005, GENOME RES, V15, P376, DOI 10.1101/gr.2659105; Freed E, 1999, GENE DEV, V13, P2242, DOI 10.1101/gad.13.17.2242; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; HASHIMOTO H, 1976, B KOCHI FRUIT TREE E, V1, P1; Hsu LC, 1998, P NATL ACAD SCI USA, V95, P12983, DOI 10.1073/pnas.95.22.12983; Joukov V, 2006, CELL, V127, P539, DOI 10.1016/j.cell.2006.08.053; Khalil IG, 2005, CURR OPIN ONCOL, V17, P44, DOI 10.1097/01.cco.0000150951.38222.16; Kim SK, 2001, SCIENCE, V293, P2087, DOI 10.1126/science.1061603; Kitano H, 2004, NAT REV CANCER, V4, P227, DOI 10.1038/nrc1300; Le Bot N, 2003, CURR BIOL, V13, P1499, DOI 10.1016/S0960-9822(03)00577-3; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Marmorstein LY, 2001, CELL, V104, P247, DOI 10.1016/S0092-8674(01)00209-4; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Maxwell CA, 2005, CANCER RES, V65, P850; Maxwell CA, 2003, MOL BIOL CELL, V14, P2262, DOI 10.1091/mbc.E02-07-0377; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; Ouchi M, 2004, J BIOL CHEM, V279, P19643, DOI 10.1074/jbc.M311780200; Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070; Pihan GA, 2003, CANCER RES, V63, P1398; Raff JW, 2002, TRENDS CELL BIOL, V12, P222, DOI 10.1016/S0962-8924(02)02268-7; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sole X, 2006, BIOINFORMATICS, V22, P1928, DOI 10.1093/bioinformatics/btl268; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Srayko M, 2003, CURR BIOL, V13, P1506, DOI 10.1016/S0960-9822(03)00597-9; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tutt A, 1999, CURR BIOL, V9, P1107, DOI 10.1016/S0960-9822(99)80479-5; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vidal M, 2001, CELL, V104, P333, DOI 10.1016/S0092-8674(01)00221-5; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Wang X, 2006, ONCOGENE, V25, P7148, DOI 10.1038/sj.onc.1209707; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9	50	465	486	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2007	39	11					1338	1349		10.1038/ng.2007.2	http://dx.doi.org/10.1038/ng.2007.2			12	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17922014				2022-12-27	WOS:000250575900018
J	Keinan, A; Mullikin, JC; Patterson, N; Reich, D				Keinan, Alon; Mullikin, James C.; Patterson, Nick; Reich, David			Measurement of the human allele frequency spectrum demonstrates greater genetic drift in East Asians than in Europeans	NATURE GENETICS			English	Article							HUMAN GENOME; HUMAN-POPULATIONS; LINKAGE DISEQUILIBRIUM; SEQUENCE; POLYMORPHISMS; SELECTION; PATTERNS; ISRAEL	Large data sets on human genetic variation have been collected recently, but their usefulness for learning about history and natural selection has been limited by biases in the ways polymorphisms were chosen. We report large subsets of SNPs from the International HapMap Project(1,2) that allow us to overcome these biases and to provide accurate measurement of a quantity of crucial importance for understanding genetic variation: the allele frequency spectrum. Our analysis shows that East Asian and northern European ancestors shared the same population bottleneck expanding out of Africa but that both also experienced more recent genetic drift, which was greater in East Asians.	Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Broad Inst Harvard & MIT, Cambridge, MA 02139 USA; NIH, Natl Human Genome Res Inst, Genome Technol Branch, Bethesda, MD 20892 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Keinan, A (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	akeinan@genetics.med.harvard.edu		Keinan, Alon/0000-0002-9760-1122	Intramural NIH HHS Funding Source: Medline; NHGRI NIH HHS [U01 HG004168] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [Z01HG200330, U01HG004168] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Adams AM, 2004, GENETICS, V168, P1699, DOI 10.1534/genetics.104.030171; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Becquet C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030066; BOWCOCK AM, 1991, P NATL ACAD SCI USA, V88, P839, DOI 10.1073/pnas.88.3.839; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Garrigan D, 2005, GENETICS, V170, P1849, DOI 10.1534/genetics.105.041095; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Lagarias JC, 1998, SIAM J OPTIMIZ, V9, P112, DOI 10.1137/S1052623496303470; Lahiri S. N., 2003, RESAMPLING METHODS D, P115; Lahr Marta Mirazon, 1994, Evolutionary Anthropology, V3, P48, DOI 10.1002/evan.1360030206; Marth GT, 2004, GENETICS, V166, P351, DOI 10.1534/genetics.166.1.351; Mellars P, 2006, SCIENCE, V313, P796, DOI 10.1126/science.1128402; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Nielsen R, 2004, GENETICS, V168, P2373, DOI 10.1534/genetics.104.031039; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Plagnol V, 2006, PLOS GENET, V2, P972, DOI 10.1371/journal.pgen.0020105; Pluzhnikov A, 2002, GENETICS, V161, P1209; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Stephens M, 2006, NAT GENET, V38, P375, DOI 10.1038/ng1746; STRINGER CB, 1989, NATURE, V338, P756, DOI 10.1038/338756a0; Vanhaeren M, 2006, SCIENCE, V312, P1785, DOI 10.1126/science.1128139; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Williamson SH, 2005, P NATL ACAD SCI USA, V102, P7882, DOI 10.1073/pnas.0502300102	29	210	211	2	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2007	39	10					1251	1255		10.1038/ng2116	http://dx.doi.org/10.1038/ng2116			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17828266	Green Accepted			2022-12-27	WOS:000249737400021
J	Chong, SY; Vickaryous, N; Ashe, A; Zamudio, N; Youngson, N; Hemley, S; Stopka, T; Skoultchi, A; Matthews, J; Scott, HS; de Kretser, D; O'Bryan, M; Blewitt, M; Whitelaw, E				Chong, Suyinn; Vickaryous, Nicola; Ashe, Alyson; Zamudio, Natasha; Youngson, Neil; Hemley, Sarah; Stopka, Tomas; Skoultchi, Arthur; Matthews, Jacqui; Scott, Hamish S.; de Kretser, David; O'Bryan, Moira; Blewitt, Marnie; Whitelaw, Emma			Modifiers of epigenetic reprogramming show paternal effects in the mouse	NATURE GENETICS			English	Article							POSITION EFFECT VARIEGATION; SMALL RNAS; EMBRYONIC-DEVELOPMENT; METHYLATION IMPRINTS; AGOUTI LOCUS; GERM-CELLS; INHERITANCE; GENE; MICE; EXPRESSION	There is increasing evidence that epigenetic information can be inherited across generations in mammals, despite extensive reprogramming both in the gametes and in the early developing embryo. One corollary to this is that disrupting the establishment of epigenetic state in the gametes of a parent, as a result of heterozygosity for mutations in genes involved in reprogramming, could affect the phenotype of offspring that do not inherit the mutant allele. Here we show that such effects do occur following paternal inheritance in the mouse. We detected changes to transcription and chromosome ploidy in adult animals. Paternal effects of this type have not been reported previously in mammals and suggest that the untransmitted genotype of male parents can influence the phenotype of their offspring.	Queensland Inst Med Res, Epigenet Lab, Brisbane, Qld 4006, Australia; Monash Inst Med Res, Clayton, Vic 3168, Australia; Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; Walter & Eliza Hall Inst Med Res, Div Mol Med, Genet & Bioinformat Div, Melbourne, Vic 3050, Australia	QIMR Berghofer Medical Research Institute; Monash University; University of Sydney; Yeshiva University; Albert Einstein College of Medicine; Walter & Eliza Hall Institute	Whitelaw, E (corresponding author), Queensland Inst Med Res, Epigenet Lab, 300 Herston Rd, Brisbane, Qld 4006, Australia.	emma.whitelaw@qimr.edu.au	Chong, Suyinn/B-6715-2012; Scott, Hamish/B-2122-2009; Stopka, Tomáš/D-5864-2017; O'Bryan, Moira K/F-8256-2012; Blewitt, Marnie/B-1796-2012; Youngson, Neil/AAB-7389-2019	Chong, Suyinn/0000-0001-8062-7281; Scott, Hamish/0000-0002-5813-631X; Stopka, Tomáš/0000-0001-7236-6894; O'Bryan, Moira K/0000-0001-7298-4940; Matthews, Jacqueline/0000-0001-8518-3472; Blewitt, Marnie/0000-0002-2984-1474; hemley, sarah/0000-0003-3064-861X; Youngson, Neil/0000-0003-0690-4580; Zamudio, Natasha/0000-0002-2532-5931	NATIONAL CANCER INSTITUTE [R01CA079057] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA079057] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Arnaud P, 2003, HUM MOL GENET, V12, P1005, DOI 10.1093/hmg/ddg110; Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Blewitt ME, 2005, P NATL ACAD SCI USA, V102, P7629, DOI 10.1073/pnas.0409375102; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Cattanach B. M., 1974, Birth defects. Proceedings of the Fourth International Conference, Vienna, Austria, 2-8 September, 1973., P129; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Chong SY, 2004, CURR OPIN GENET DEV, V14, P692, DOI 10.1016/j.gde.2004.09.001; Christians E, 2000, NATURE, V407, P693, DOI 10.1038/35037669; Dean J, 2002, J REPROD IMMUNOL, V53, P171, DOI 10.1016/S0165-0378(01)00100-0; Dodge JE, 2005, J BIOL CHEM, V280, P17986, DOI 10.1074/jbc.M413246200; DUHL DMJ, 1994, NAT GENET, V8, P59, DOI 10.1038/ng0994-59; Fiering S, 2000, BIOESSAYS, V22, P381, DOI 10.1002/(SICI)1521-1878(200004)22:4<381::AID-BIES8>3.0.CO;2-E; Fitch KR, 1998, CURR TOP DEV BIOL, V38, P1; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Gaudet F, 2004, MOL CELL BIOL, V24, P1640, DOI 10.1128/MCB.24.4.1640-1648.2004; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Grivna ST, 2006, GENE DEV, V20, P1709, DOI 10.1101/gad.1434406; GRUENBAUM Y, 1982, NATURE, V295, P620, DOI 10.1038/295620a0; Gurtu VE, 2002, GENETICS, V160, P271; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; La Salle S, 2004, DEV BIOL, V268, P403, DOI 10.1016/j.ydbio.2003.12.031; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lazzaro MA, 2001, J NEUROCHEM, V77, P1145, DOI 10.1046/j.1471-4159.2001.00324.x; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Li JY, 2004, GENOMICS, V84, P952, DOI 10.1016/j.ygeno.2004.08.012; LOCKE J, 1988, GENETICS, V120, P181; McClive PJ, 2001, MOL REPROD DEV, V60, P225, DOI 10.1002/mrd.1081; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Payer B, 2003, CURR BIOL, V13, P2110, DOI 10.1016/j.cub.2003.11.026; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Rakyan V, 2003, CURR BIOL, V13, pR6, DOI 10.1016/S0960-9822(02)01377-5; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rakyan VK, 2002, TRENDS GENET, V18, P348, DOI 10.1016/S0168-9525(02)02709-9; Rassoulzadegan M, 2006, NATURE, V441, P469, DOI 10.1038/nature04674; REUTER G, 1992, BIOESSAYS, V14, P605, DOI 10.1002/bies.950140907; Sassone-Corsi P, 2002, SCIENCE, V296, P2176, DOI 10.1126/science.1070963; SPOFFORD JB, 1976, GENETICS BIOL DROS C, V1, P955; Stopka T, 2003, P NATL ACAD SCI USA, V100, P14097, DOI 10.1073/pnas.2336105100; SZABAD J, 1995, GENETICS, V139, P1585; TAKAGI N, 1990, DEVELOPMENT, V109, P189; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Torres-Padilla ME, 2006, J CELL BIOL, V174, P329, DOI 10.1083/jcb.200603146; Tsukiyama T, 2002, NAT REV MOL CELL BIO, V3, P422, DOI 10.1038/nrm828; van der Heijden GW, 2006, DEV BIOL, V298, P458, DOI 10.1016/j.ydbio.2006.06.051; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102; WOLFF GL, 1978, GENETICS, V88, P529; Wu XM, 2003, NAT GENET, V33, P187, DOI 10.1038/ng1079	50	137	139	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2007	39	5					614	622		10.1038/ng2031	http://dx.doi.org/10.1038/ng2031			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17450140	Green Accepted			2022-12-27	WOS:000245971300016
J	Gout, AM; Ravine, D				Gout, Alexander M.; Ravine, David		ADPKD Gene Variant Consortium	Analysis of published PKD1 gene sequence variants	NATURE GENETICS			English	Letter							MUTATION NOMENCLATURE; QUALITY		Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; Univ Western Australia, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; Mayo Clin, Coll Med, Rochester, NY USA; Leiden Univ, Ctr Med, Leiden, Netherlands; Fox Chase Canc Ctr, Philadelphia, PA USA; Kyoto Univ, Dept Hlth & Environm Sci, Kyoto, Japan; Mahidol Univ, Siriraj Hosp, Fac Med, Bangkok, Thailand; Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus; Addenbrookes Hosp, Cambridge Inst Med Res, Dept Med Genet, Cambridge, England; Fundacio Puigvert, Nephrol Dept, Barcelona, Spain; Univ Verona, Sch Med, Dept Mother & Child Genet, Verona, Italy; St George Hosp, Med Sch, Med Genet, London, England; INSERM, Marseille, France; Yale Univ, Sch Med, Sect Nephrol, New Haven, CT USA; Free Univ Amsterdam, Med Ctr, Dept Internal Med, Amsterdam, Netherlands; CHU, Lab Genet Mol, Brest, France; Univ Toronto, Dept Med, Div Nephrol, Toronto, ON, Canada; Univ Western Australia, Ctr Med Res, Western Australina Inst Med Res, Perth, WA, Australia; Univ Munster, Inst Human Genet, Munster, Germany; Edith Cowan Univ, Ctr Human Genet, Joondalup, Australia; Seoul Natl Univ, Eulju Med Coll, Dept Internal Med, Seoul, South Korea; Dept Clin Genet, Rotterdam, Netherlands; Charles Univ Prague, Dept Nephrol, Prague, Czech Republic; Charles Univ Prague, Dept Biol & Med Genet, Prague, Czech Republic; Hosp Ramo, Dept Endocrinol, Madrid, Spain; Hosp Ramo, Dept Mol Genet, Madrid, Spain; Univ Ferrara, Dipartimento Biochim & Biol Mol, Ferrara, Italy	Walter & Eliza Hall Institute; University of Melbourne; University of Western Australia; University of Western Australia; Mayo Clinic; Leiden University; Leiden University - Excl LUMC; Fox Chase Cancer Center; Kyoto University; Mahidol University; University of Cyprus; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Fundacio Puigvert; University of Verona; St Georges University London; Institut National de la Sante et de la Recherche Medicale (Inserm); Yale University; Vrije Universiteit Amsterdam; CHU Brest; Universite de Bretagne Occidentale; University of Toronto; University of Western Australia; University of Munster; Edith Cowan University; Seoul National University (SNU); Charles University Prague; Charles University Prague; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomembrane e Bioenergetica (IBBE-CNR); University of Ferrara	Gout, AM (corresponding author), Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3050, Australia.	david.ravine@uwa.edu.au	Aguiari, Gianluca/AAA-4514-2019; Stekrova, Jitka/D-2865-2017; Deltas, Constantinos/A-4936-2013; Ravine, David/A-6797-2008; Breuning, Martijn H/E-3429-2010; Burtey, Stéphane/S-2433-2019; Deltas, Constantinos/J-9345-2013; Torra, Roser/A-9983-2008	Stekrova, Jitka/0000-0002-9154-549X; Deltas, Constantinos/0000-0001-5549-9169; Burtey, Stéphane/0000-0003-1813-7884; Deltas, Constantinos/0000-0001-5549-9169; Torra, Roser/0000-0001-8714-2332; Wouters, Carine/0000-0002-6426-8845				Cotton RGH, 1998, HUM MUTAT, V12, P1, DOI 10.1002/(SICI)1098-1004(1998)12:1<1::AID-HUMU1>3.0.CO;2-M; den Dunnen JT, 2003, HUM MUTAT, V22, P181, DOI 10.1002/humu.10262; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Dequeker E, 2000, NAT GENET, V25, P259, DOI 10.1038/77008; GOUT AM, IN PRESS HUM MUTAT; Horaitis O, 2004, HUM MUTAT, V23, P447, DOI 10.1002/humu.20038; Maddalena A, 2005, GENET MED, V7, P571, DOI 10.1097/01.GIM.0000182738.95726.ca; Patton SJ, 2006, CLIN CHEM, V52, P728, DOI 10.1373/clinchem.2005.061887; Pilotti M, 2004, J GEN PSYCHOL, V131, P242, DOI 10.3200/GENP.131.3.242-267; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Zeeberg BR, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-80	11	17	17	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2007	39	4					427	428		10.1038/ng0407-427	http://dx.doi.org/10.1038/ng0407-427			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17392796				2022-12-27	WOS:000245271200004
J	Vermulst, M; Bielas, JH; Kujoth, GC; Ladiges, WC; Rabinovitch, PS; Prolla, TA; Loeb, LA				Vermulst, Marc; Bielas, Jason H.; Kujoth, Gregory C.; Ladiges, Warren C.; Rabinovitch, Peter S.; Prolla, Tomas A.; Loeb, Lawrence A.			Mitochondrial point mutations do not limit the natural lifespan of mice	NATURE GENETICS			English	Article							SUBSTANTIA-NIGRA NEURONS; DNA MUTATIONS; OXIDATIVE DAMAGE; DELETIONS; REPAIR; POLYMERASE; DISEASE; AGE	Whether mitochondrial mutations cause mammalian aging, or are merely correlated with it, is an area of intense debate(1). Here, we use a new, highly sensitive assay(2) to redefine the relationship between mitochondrial mutations and age. We measured the in vivo rate of change of the mitochondrial genome at a single-base pair level in mice, and we demonstrate that the mutation frequency in mouse mitochondria is more than ten times lower than previously reported. Although we observed an 11-fold increase in mitochondrial point mutations with age, we report that a mitochondrial mutator mouse(3) was able to sustain a 500-fold higher mutation burden than normal mice, without any obvious features of rapidly accelerated aging. Thus, our results strongly indicate that mitochondrial mutations do not limit the lifespan of wild-type mice.	Univ Washington, Dept Pathol, Seattle, WA 98195 USA; Univ Wisconsin, Dept Genet & Med Genet, Madison, WI 53706 USA; Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Wisconsin System; University of Wisconsin Madison; University of Washington; University of Washington Seattle	Loeb, LA (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	laloeb@u.washington.edu		Kujoth, Gregory/0000-0002-6636-2800	NCI NIH HHS [CA102029] Funding Source: Medline; NIA NIH HHS [AG001751, AG021905] Funding Source: Medline; NIEHS NIH HHS [ES11045] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA102029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES011045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021905, P01AG001751] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; Bielas JH, 2005, NAT METHODS, V2, P285, DOI 10.1038/NMETH751; Copeland William C, 2002, Methods Mol Biol, V197, pv; Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801; FREDERICO LA, 1990, BIOCHEMISTRY-US, V29, P2532, DOI 10.1021/bi00462a015; Hamilton ML, 2001, P NATL ACAD SCI USA, V98, P10469, DOI 10.1073/pnas.171202698; Khrapko K, 1997, P NATL ACAD SCI USA, V94, P13798, DOI 10.1073/pnas.94.25.13798; Khrapko K, 2006, AGING CELL, V5, P279, DOI 10.1111/j.1474-9726.2006.00209.x; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Kreutzer DA, 1998, P NATL ACAD SCI USA, V95, P3578, DOI 10.1073/pnas.95.7.3578; Kujoth GC, 2005, SCIENCE, V309, P481, DOI 10.1126/science.1112125; Larsen NB, 2005, MITOCHONDRION, V5, P89, DOI 10.1016/j.mito.2005.02.002; Mandavilli BS, 2002, MUTAT RES-FUND MOL M, V509, P127, DOI 10.1016/S0027-5107(02)00220-8; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; PINZ KG, 1995, J BIOL CHEM, V270, P9202, DOI 10.1074/jbc.270.16.9202; Saraste M, 1999, SCIENCE, V283, P1488, DOI 10.1126/science.283.5407.1488; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; TANAKA M, 1994, GENOMICS, V22, P327, DOI 10.1006/geno.1994.1391; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Trifunovic A, 2006, BBA-BIOENERGETICS, V1757, P611, DOI 10.1016/j.bbabio.2006.03.003; Tyynismaa H, 2005, P NATL ACAD SCI USA, V102, P17687, DOI 10.1073/pnas.0505551102; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang D, 1998, MUTAT RES-FUND MOL M, V400, P99, DOI 10.1016/S0027-5107(98)00066-9; Zhang DK, 2000, GENOMICS, V69, P151, DOI 10.1006/geno.2000.6333	28	288	298	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2007	39	4					540	543		10.1038/ng1988	http://dx.doi.org/10.1038/ng1988			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17334366				2022-12-27	WOS:000245271200026
J	Ohm, JE; McGarvey, KM; Yu, X; Cheng, LZ; Schuebel, KE; Cope, L; Mohammad, HP; Chen, W; Daniel, VC; Yu, W; Berman, DM; Jenuwein, T; Pruitt, K; Sharkis, SJ; Watkins, DN; Herman, JG; Baylin, SB				Ohm, Joyce E.; McGarvey, Kelly M.; Yu, Xiaobing; Cheng, Linzhao; Schuebel, Kornel E.; Cope, Leslie; Mohammad, Helai P.; Chen, Wei; Daniel, Vincent C.; Yu, Wayne; Berman, David M.; Jenuwein, Thomas; Pruitt, Kevin; Sharkis, Saul J.; Watkins, D. Neil; Herman, James G.; Baylin, Stephen B.			A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing	NATURE GENETICS			English	Article							HISTONE H3 LYSINE-9; CANCER-CELLS; DEVELOPMENTAL REGULATORS; METHYLATION; POLYCOMB; EXPRESSION; PATHWAY; MARKS; FATE	Adult cancers may derive from stem or early progenitor cells(1,2). Epigenetic modulation of gene expression is essential for normal function of these early cells but is highly abnormal in cancers, which often show aberrant promoter CpG island hypermethylation and transcriptional silencing of tumor suppressor genes and pro-differentiation factors(3-5). We find that for such genes, both normal and malignant embryonic cells generally lack the hypermethylation of DNA found in adult cancers. In embryonic stem cells, these genes are held in a 'transcription- ready' state mediated by a 'bivalent' promoter chromatin pattern consisting of the repressive mark, histone H3 methylated at Lys27 ( H3K27) by Polycomb group proteins, plus the active mark, methylated H3K4. However, embryonic carcinoma cells add two key repressive marks, dimethylated H3K9 and trimethylated H3K9, both associated with DNA hypermethylation in adult cancers(6-8). We hypothesize that cell chromatin patterns and transient silencing of these important regulatory genes in stem or progenitor cells may leave these genes vulnerable to aberrant DNA hypermethylation and heritable gene silencing during tumor initiation and progression.	Johns Hopkins Univ, Inst Med, Div Canc Biol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; Johns Hopkins Univ, Inst Med, Program Cellular & Mol Med, Baltimore, MD 21231 USA; Johns Hopkins Univ, Inst Med, Inst Cell Engn, Baltimore, MD 21231 USA; Johns Hopkins Univ, Inst Med, Biometry & Clin Trials Div, Baltimore, MD 21231 USA; Johns Hopkins Univ, Inst Med, Program Human Genet & Mol Biol, Baltimore, MD 21231 USA; Johns Hopkins Univ, Inst Med, Dept Pathol, Baltimore, MD 21231 USA; Vienna Bioctr, Res Inst Mol Pathol, A-1030 Vienna, Austria	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Baylin, SB (corresponding author), Johns Hopkins Univ, Inst Med, Div Canc Biol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA.	sbaylin@jhmi.edu	berman, david/HIR-4177-2022; Watkins, David N/I-6113-2013; Ohm, Joyce E/B-1497-2012	berman, david/0000-0001-5985-3698	NATIONAL CANCER INSTITUTE [R01CA116160, R01CA043318] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073781] Funding Source: NIH RePORTER; NCI NIH HHS [CA116160, CA043318, R01 CA116160, R01 CA043318, R01 CA043318-23, R01 CA116160-04] Funding Source: Medline; NHLBI NIH HHS [HL073781] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ANDREWS DF, 1989, MOL CELL BIOL, V9, P2748, DOI 10.1128/MCB.9.6.2748; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Fahrner JA, 2002, CANCER RES, V62, P7213; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jackson JP, 2004, CHROMOSOMA, V112, P308, DOI 10.1007/s00412-004-0275-7; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; JONES A, 1967, ECON BOT, V21, P163, DOI 10.1007/BF02897864; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kondo Y, 2003, MOL CELL BIOL, V23, P206, DOI 10.1128/MCB.23.1.206-215.2003; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Liang GG, 2002, MOL CELL BIOL, V22, P480, DOI 10.1128/MCB.22.2.480-491.2002; McGarvey KM, 2006, CANCER RES, V66, P3541, DOI 10.1158/0008-5472.CAN-05-2481; Nguyen CT, 2002, CANCER RES, V62, P6456; PRUITT K, 2006, PLOS GENET, V2, P344, DOI ARTN e40; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Tamaru H, 2003, NAT GENET, V34, P75, DOI 10.1038/ng1143; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431	29	816	847	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2007	39	2					237	242		10.1038/ng1972	http://dx.doi.org/10.1038/ng1972			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17211412	Green Accepted			2022-12-27	WOS:000244063900023
J	Simonis, M; Klous, P; Splinter, E; Moshkin, Y; Willemsen, R; de Wit, E; van Steensel, B; de Laat, W				Simonis, Marieke; Klous, Petra; Splinter, Erik; Moshkin, Yuri; Willemsen, Rob; de Wit, Elzo; van Steensel, Bas; de Laat, Wouter			Nuclear organization of active and inactive chromatin domains uncovered by chromosome conformation capture-on-chip (4C)	NATURE GENETICS			English	Article							SPATIAL PROXIMITY; GENES; TRANSCRIPTION; LOCI	The spatial organization of DNA in the cell nucleus is an emerging key contributor to genomic function(1-12). We developed 4C technology (chromosome conformation capture (3C)-on-chip), which allows for an unbiased genome-wide search for DNA loci that contact a given locus in the nuclear space. We demonstrate here that active and inactive genes are engaged in many long-range intrachromosomal interactions and can also form interchromosomal contacts. The active beta-globin locus in fetal liver preferentially contacts transcribed, but not necessarily tissue-specific, loci elsewhere on chromosome 7, whereas the inactive locus in fetal brain contacts different transcriptionally silent loci. A housekeeping gene in a gene-dense region on chromosome 8 forms long-range contacts predominantly with other active gene clusters, both in cis and in trans, and many of these intra- and interchromosomal interactions are conserved between the tissues analyzed. Our data demonstrate that chromosomes fold into areas of active chromatin and areas of inactive chromatin and establish 4C technology as a powerful tool to study nuclear architecture.	Erasmus MC, Dept Cell Biol & Genet, NL-3000 CA Rotterdam, Netherlands; Erasmus MC, Dept Biochem, NL-3000 CA Rotterdam, Netherlands; Erasmus MC, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Netherlands Cancer Institute	de Laat, W (corresponding author), Erasmus MC, Dept Cell Biol & Genet, NL-3000 CA Rotterdam, Netherlands.	w.delaat@erasmusmc.nl	Moshkin, Yuri M./M-3093-2016; Moshkin, Yuri/ABA-3435-2021	Moshkin, Yuri M./0000-0003-2964-8823; Moshkin, Yuri/0000-0003-2964-8823; de Laat, Wouter/0000-0002-6393-595X; de Wit, Elzo/0000-0003-2883-1415				Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Brown JM, 2006, J CELL BIOL, V172, P177, DOI 10.1083/jcb.200507073; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Chakalova L, 2005, NAT REV GENET, V6, P669, DOI 10.1038/nrg1673; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Lemaitre JM, 2005, CELL, V123, P787, DOI 10.1016/j.cell.2005.08.045; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Misteli T, 2005, BIOESSAYS, V27, P477, DOI 10.1002/bies.20226; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; RIPPE K, 1995, TRENDS BIOCHEM SCI, V20, P500, DOI 10.1016/S0968-0004(00)89117-3; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Sokal R.R., 2012, BIOMETRY; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Splinter E, 2004, METHOD ENZYMOL, V375, P493; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; Volpi EV, 2000, J CELL SCI, V113, P1565; Wurtele H, 2006, CHROMOSOME RES, V14, P477, DOI 10.1007/s10577-006-1075-0; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	22	919	993	4	103	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2006	38	11					1348	1354		10.1038/ng1896	http://dx.doi.org/10.1038/ng1896			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17033623				2022-12-27	WOS:000241592700026
J	Steidl, U; Rosenbauer, F; Verhaak, RGW; Gu, XS; Ebralidze, A; Otu, HH; Klippel, S; Steidl, C; Bruns, I; Costa, DB; Wagner, K; Aivado, M; Kobbe, G; Valk, PJM; Passegue, E; Libermann, TA; Delwel, R; Tenen, DG				Steidl, Ulrich; Rosenbauer, Frank; Verhaak, Roel G. W.; Gu, Xuesong; Ebralidze, Alexander; Otu, Hasan H.; Klippel, Steffen; Steidl, Christian; Bruns, Ingmar; Costa, Daniel B.; Wagner, Katharina; Aivado, Manuel; Kobbe, Guido; Valk, Peter J. M.; Passegue, Emmanuelle; Libermann, Towia A.; Delwel, Ruud; Tenen, Daniel G.			Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells	NATURE GENETICS			English	Article							CD34(+) HEMATOPOIETIC STEM; GENE-EXPRESSION; SELF-RENEWAL; PROGENITOR CELLS; CANCER; DIFFERENTIATION; PROLIFERATION; INTEGRATION; DISRUPTION; MUTATIONS	Knockdown of the transcription factor PU.1 (encoded by Sfpi1) leads to acute myeloid leukemia (AML) in mice. We examined the transcriptome of preleukemic hematopoietic stem cells (HSCs) in which PU.1 was knocked down (referred to as `PU.1-knockdown HSCs') to identify transcriptional changes preceding malignant transformation. Transcription factors c-Jun and JunB were among the top-downregulated targets. Restoration of c-Jun expression in preleukemic cells rescued the PU.1 knockdown initiated myelomonocytic differentiation block. Lentiviral restoration of JunB at the leukemic stage led to loss of leukemic self-renewal capacity and prevented leukemia in NOD-SCID mice into which leukemic PU.1-knockdown cells were transplanted. Examination of human individuals with AML confirmed the correlation between PU.1 and JunB downregulation. These results delineate a transcriptional pattern that precedes leukemic transformation in PU.1- knockdown HSCs and demonstrate that decreased levels of c-Jun and JunB contribute to the development of PU.1 knockdown-induced AML by blocking differentiation and increasing self-renewal. Therefore, examination of disturbed gene expression in HSCs can identify genes whose dysregulation is essential for leukemic stem cell function and that are targets for therapeutic interventions.	Harvard Univ, Sch Med, Harvard Inst Med, Boston, MA 02115 USA; Harvard Univ, Harvard Stem Cell Inst, Boston, MA 02115 USA; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Erasmus Univ, Med Ctr, Dept Hematol, NL-3015 GE Rotterdam, Netherlands; Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; Yeditepe Univ, Dept Genet & Bioengn, TR-34755 Istanbul, Turkey; Univ Gottingen, Dept Hematol & Oncol, D-37075 Gottingen, Germany; Univ Dusseldorf, Dept Hematol Oncol & Clin Immunol, D-40225 Dusseldorf, Germany; Univ Calif San Francisco, Dev & Stem Cell Biol Program, San Francisco, CA 94314 USA	Harvard University; Harvard Medical School; Harvard University; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Erasmus University Rotterdam; Erasmus MC; Harvard University; Beth Israel Deaconess Medical Center; Yeditepe University; University of Gottingen; Heinrich Heine University Dusseldorf; University of California System; University of California San Francisco	Tenen, DG (corresponding author), Harvard Univ, Sch Med, Harvard Inst Med, Boston, MA 02115 USA.	dtenen@bidmc.harvard.edu	Valk, Peter/AAX-2823-2020; Verhaak, Roel/ABE-7058-2020; Kobbe, Guido/ABG-9472-2021	Bruns, Ingmar/0000-0001-6316-8378; Libermann, Towia/0000-0002-4006-8179; Rosenbauer, Frank/0000-0001-7977-9421; Passegue, Emmanuelle/0000-0002-3516-297X; Otu, Hasan/0000-0002-9253-8152; Tenen, Daniel/0000-0002-6423-3888; Costa, Daniel/0000-0002-0689-395X	NCI NIH HHS [CA41456] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA041456] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Behre G, 1999, J BIOL CHEM, V274, P4939, DOI 10.1074/jbc.274.8.4939; Bellon T, 1997, BLOOD, V90, P1828, DOI 10.1182/blood.V90.5.1828; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Bjerregaard MD, 2003, BLOOD, V101, P4322, DOI 10.1182/blood-2002-03-0835; BORRAS FE, 1995, J BIOL CHEM, V270, P24385, DOI 10.1074/jbc.270.41.24385; Bullinger L, 2004, NEW ENGL J MED, V350, P1605, DOI 10.1056/NEJMoa031046; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; DOLBEARE F, 1983, P NATL ACAD SCI-BIOL, V80, P5573, DOI 10.1073/pnas.80.18.5573; Donninger H, 2004, ONCOGENE, V23, P8065, DOI 10.1038/sj.onc.1207959; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Gilliland DG, 2002, CANCER CELL, V1, P417, DOI 10.1016/S1535-6108(02)00081-8; Higuchi M, 2002, CANCER CELL, V1, P63, DOI 10.1016/S1535-6108(02)00016-8; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kobayashi S, 2002, J BIOL CHEM, V277, P33968, DOI 10.1074/jbc.M203350200; Landgrebe J, 2002, GENOME BIOL, V3; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li YL, 2001, BLOOD, V98, P2958, DOI 10.1182/blood.V98.10.2958; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Mueller BU, 2002, BLOOD, V100, P998, DOI 10.1182/blood.V100.3.998; Okuno Y, 2005, MOL CELL BIOL, V25, P2832, DOI 10.1128/MCB.25.7.2832-2845.2005; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; Phinney DG, 1996, ONCOGENE, V13, P1875; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rosenbauer F, 2005, BLOOD, V106, P1519, DOI 10.1182/blood-2005-02-0717; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Steidl U, 2002, BLOOD, V99, P2037, DOI 10.1182/blood.V99.6.2037; Steidl U, 2004, BLOOD, V104, P81, DOI 10.1182/blood-2004-01-0373; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Tenen DG, 1997, BLOOD, V90, P489, DOI 10.1182/blood.V90.2.489.489_489_519; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Vangala RK, 2003, BLOOD, V101, P270, DOI 10.1182/blood-2002-04-1288; Verhaak RGW, 2005, BLOOD, V106, P3747, DOI 10.1182/blood-2005-05-2168; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wang Q, 2005, J CELL PHYSIOL, V204, P962, DOI 10.1002/jcp.20355	50	143	146	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2006	38	11					1269	1277		10.1038/ng1898	http://dx.doi.org/10.1038/ng1898			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17041602				2022-12-27	WOS:000241592700015
J	Abd El-Aziz, MM; Barragan, I; O'Driscoll, CA; Goodstadt, L; Prigmore, E; Borrego, S; Mena, M; Pieras, JI; El-Ashry, MF; Abu Safieh, L; Shah, A; Cheetham, ME; Carter, NP; Chakarova, C; Ponting, CP; Bhattacharya, SS; Antinolo, G				Abd El-Aziz, Mai M.; Barragan, Isabel; O'Driscoll, Ciara A.; Goodstadt, Leo; Prigmore, Elena; Borrego, Salud; Mena, Marcela; Pieras, Juan I.; El-Ashry, Mohamed F.; Abu Safieh, Leen; Shah, Amna; Cheetham, Michael E.; Carter, Nigel P.; Chakarova, Christina; Ponting, Chris P.; Bhattacharya, Shomi S.; Antinolo, Guillermo			EYS, encoding an ortholog of Drosophila spacemaker, is mutated in autosomal recessive retinitis pigmentosa	NATURE GENETICS			English	Article							LOCUS; REFINEMENT; PHYLOGENY; EYES; 6Q	Using a positional cloning approach supported by comparative genomics, we have identified a previously unreported gene, EYS, at the RP25 locus on chromosome 6q12 commonly mutated in autosomal recessive retinitis pigmentosa. Spanning over 2 Mb, this is the largest eye-specific gene identified so far. EYS is independently disrupted in four other mammalian lineages, including that of rodents, but is well conserved from Drosophila to man and is likely to have a role in the modeling of retinal architecture.	[Abd El-Aziz, Mai M.; O'Driscoll, Ciara A.; El-Ashry, Mohamed F.; Abu Safieh, Leen; Shah, Amna; Chakarova, Christina; Bhattacharya, Shomi S.] Inst Ophthalmol, Dept Mol Genet, London EC1V 9EL, England; [Barragan, Isabel; Borrego, Salud; Mena, Marcela; Pieras, Juan I.; Antinolo, Guillermo] Hosp Univ Virgen Rocio, Unidad Gest Clin Genet Reprod & Med Fetal, Seville 41013, Spain; [Barragan, Isabel; Borrego, Salud; Mena, Marcela; Pieras, Juan I.; Antinolo, Guillermo] CIBERER, Seville, Spain; [Goodstadt, Leo; Ponting, Chris P.] Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genom Unit, Oxford OX1 3QX, England; [Prigmore, Elena; Carter, Nigel P.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Cheetham, Michael E.] Inst Ophthalmol, Div Mol & Cellular Neurosci, London EC1V 9EL, England; [Bhattacharya, Shomi S.] Univ Paris 06, INSERM U592, Inst Vis, UMR 592, Paris, France	University of London; University College London; Virgen del Rocio University Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Oxford; Wellcome Trust Sanger Institute; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Bhattacharya, SS (corresponding author), Inst Ophthalmol, Dept Mol Genet, London EC1V 9EL, England.	smbcssb@ucl.ac.uk; guillermo.antinolo.sspa@juntadeandalucia.es	Borrego, Salud/M-6314-2015; Bhattacharya, Shom/N-2926-2016; Chakarova, Christina/C-9479-2013; IBIS, GENETICA/P-3384-2015; Barragan, Isabel/AAJ-6532-2020; IBIS, REPRODUCCION/P-3399-2015; Shah, Amna/C-4471-2013; Ponting, Chris/AAV-2621-2021; Cheetham, Michael/B-4672-2011	Bhattacharya, Shom/0000-0002-1601-6344; Barragan, Isabel/0000-0002-8586-6502; Ponting, Chris/0000-0003-0202-7816; Mena, Marcela Daniela/0000-0002-8734-9031; Antinolo Gil, Guillermo/0000-0002-2113-074X; Cheetham, Michael/0000-0001-6429-654X	Fondo de Investigacion Sanitaria, Spain [PI050857]; Consejeria de Salud [PI-0334/2007]; Junta de Andalucia, Spain; British Retinitis Pigmentosa Society [GR556]; Foresight, Dubai; Foundation Fighting Blindness (USA); National Institute of Health Research Biomedical Research Centre for Ophthalmology; Special Trustees of Moorfields Eye Hospital London; UK Medical Research Council; EU-Neurotrain [MEST-CT-2005020235]; EU-GENORET [LSHG-CT-2005-512036]; Wellcome Trust; MRC [MC_U137761446] Funding Source: UKRI; Medical Research Council [MC_U137761446] Funding Source: researchfish	Fondo de Investigacion Sanitaria, Spain(Instituto de Salud Carlos III); Consejeria de Salud; Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission); British Retinitis Pigmentosa Society; Foresight, Dubai; Foundation Fighting Blindness (USA); National Institute of Health Research Biomedical Research Centre for Ophthalmology(National Institute for Health Research (NIHR)); Special Trustees of Moorfields Eye Hospital London; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU-Neurotrain; EU-GENORET; Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank the families who participated in the study. This study was funded by Fondo de Investigacion Sanitaria (PI050857), Spain; Consejeria de Salud (PI-0334/2007), Junta de Andalucia, Spain; British Retinitis Pigmentosa Society (grant ref. GR556); Foresight, Dubai; Foundation Fighting Blindness (USA); National Institute of Health Research Biomedical Research Centre for Ophthalmology, The Special Trustees of Moorfields Eye Hospital London; the UK Medical Research Council and EU-Neurotrain (grant ref. MEST-CT-2005020235); EU-GENORET (grant ref. LSHG-CT-2005-512036). The El Centro de Investigacion Biomedica en Red de Enfermedades Raras is an initiative of the Instituto de Salud Carlos III. N.P.C. and E. P. were supported by the Wellcome Trust. We would like also to thank R. Molday (University of British Columbia, Vancouver) for the gift of 1D4 antibody and G. Jeffery for his advice with immunohistochemistry.	Barragan I, 2008, ANN HUM GENET, V72, P454, DOI 10.1111/j.1469-1809.2008.00448.x; Barragan I, 2005, OPHTHALMIC RES, V37, P89, DOI 10.1159/000084250; den Hollander AI, 2007, NAT GENET, V39, P889, DOI 10.1038/ng2066; El-Aziz MMA, 2008, ANN HUM GENET, V72, P463, DOI 10.1111/j.1469-1809.2008.00455.x; El-Aziz MMA, 2007, ANN HUM GENET, V71, P281, DOI 10.1111/j.1469-1809.2006.00333.x; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; Huang H, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r47; Huchon D, 2002, MOL BIOL EVOL, V19, P1053, DOI 10.1093/oxfordjournals.molbev.a004164; Husain N, 2006, DEV CELL, V11, P483, DOI 10.1016/j.devcel.2006.08.012; Khaliq S, 1999, AM J HUM GENET, V65, P571, DOI 10.1086/302493; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Ruiz A, 1998, AM J HUM GENET, V62, P1452, DOI 10.1086/301866; Zelhof AC, 2006, NATURE, V443, P696, DOI 10.1038/nature05128	13	140	143	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2008	40	11					1285	1287		10.1038/ng.241	http://dx.doi.org/10.1038/ng.241			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18836446	Green Accepted			2022-12-27	WOS:000260501500018
J	Kugathasan, S; Baldassano, RN; Bradfield, JP; Sleiman, PMA; Imielinski, M; Guthery, SL; Cucchiara, S; Kim, CE; Frackelton, EC; Annaiah, K; Glessner, JT; Santa, E; Willson, T; Eckert, AW; Bonkowski, E; Shaner, JL; Smith, RM; Otieno, FG; Peterson, N; Abrams, DJ; Chiavacci, RM; Grundmeier, R; Mamula, P; Tomer, G; Piccoli, DA; Monos, DS; Annese, V; Denson, LA; Grant, SFA; Hakonarson, H				Kugathasan, Subra; Baldassano, Robert N.; Bradfield, Jonathan P.; Sleiman, Patrick M. A.; Imielinski, Marcin; Guthery, Stephen L.; Cucchiara, Salvatore; Kim, Cecilia E.; Frackelton, Edward C.; Annaiah, Kiran; Glessner, Joseph T.; Santa, Erin; Willson, Tara; Eckert, Andrew W.; Bonkowski, Erin; Shaner, Julie L.; Smith, Ryan M.; Otieno, F. George; Peterson, Nicholas; Abrams, Debra J.; Chiavacci, Rosetta M.; Grundmeier, Robert; Mamula, Petar; Tomer, Gitit; Piccoli, David A.; Monos, Dimitri S.; Annese, Vito; Denson, Lee A.; Grant, Struan F. A.; Hakonarson, Hakon			Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; DECOY RECEPTOR-3; T-CELLS; SUSCEPTIBILITY; GENE; EXPRESSION; VARIANTS; DIFFERENTIATION; POLYMORPHISM	Inflammatory bowel disease (IBD) is a common inflammatory disorder with complex etiology that involves both genetic and environmental triggers, including but not limited to defects in bacterial clearance, defective mucosal barrier and persistent dysregulation of the immune response to commensal intestinal bacteria. IBD is characterized by two distinct phenotypes: Crohn's disease (CD) and ulcerative colitis (UC). Previously reported GWA studies have identified genetic variation accounting for a small portion of the overall genetic susceptibility to CD and an even smaller contribution to UC pathogenesis. We hypothesized that stratification of IBD by age of onset might identify additional genes associated with IBD. To that end, we carried out a GWA analysis in a cohort of 1,011 individuals with pediatric-onset IBD and 4,250 matched controls. We identified and replicated significantly associated, previously unreported loci on chromosomes 20q13 (rs2315008[T] and rs4809330[A]; P = 6.30 x 10(-8) and 6.95 x 10(-8), respectively; odds ratio (OR) 0.74 for both) and 21q22 (rs2836878[A]; P = 6.01 x 10(-8); OR = 0.73), located close to the TNFRSF6B and PSMG1 genes, respectively.	[Bradfield, Jonathan P.; Sleiman, Patrick M. A.; Imielinski, Marcin; Kim, Cecilia E.; Frackelton, Edward C.; Annaiah, Kiran; Glessner, Joseph T.; Santa, Erin; Eckert, Andrew W.; Shaner, Julie L.; Smith, Ryan M.; Otieno, F. George; Chiavacci, Rosetta M.; Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Abramson Res Ctr, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Kugathasan, Subra; Peterson, Nicholas] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Kugathasan, Subra; Peterson, Nicholas] Childrens Res Inst, Dept Pediat, Milwaukee, WI 53226 USA; [Kugathasan, Subra] Childrens Hlth Care Atlanta, Atlanta, GA 30322 USA; [Kugathasan, Subra] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Baldassano, Robert N.; Abrams, Debra J.; Mamula, Petar; Piccoli, David A.] Childrens Hosp Philadelphia, Abramson Res Ctr, Dept Pediat, Philadelphia, PA 19104 USA; [Baldassano, Robert N.] Childrens Hosp Philadelphia, Abramson Res Ctr, Div Gastroenterol, Philadelphia, PA 19104 USA; [Guthery, Stephen L.] Primary Childrens Med Ctr, Salt Lake City, UT 84132 USA; [Guthery, Stephen L.] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT 84132 USA; [Cucchiara, Salvatore] Univ Roma La Sapienza, Pediat Gastroenterol & Liver Unit, I-00185 Rome, Italy; [Willson, Tara; Bonkowski, Erin; Tomer, Gitit; Denson, Lee A.] Childrens Hosp, Med Ctr, Div Gastroenterol, Cincinnati, OH 45229 USA; [Grundmeier, Robert; Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Grundmeier, Robert] Childrens Hosp Philadelphia, Ctr Biomed Informat, Philadelphia, PA 19104 USA; [Monos, Dimitri S.] Childrens Hosp Philadelphia, Div Immunol, Philadelphia, PA 19104 USA; [Monos, Dimitri S.] Childrens Hosp Philadelphia, Div Pathol, Philadelphia, PA 19104 USA; [Annese, Vito] Casa Sollievo Sofferenza Hosp, IRCCS, Unit Endoscopy, I-71013 San Giovanni Rotondo, Italy; [Annese, Vito] Casa Sollievo Sofferenza Hosp, IRCCS, Gastroenterol Unit, I-71013 San Giovanni Rotondo, Italy; [Grant, Struan F. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Medical College of Wisconsin; Children's Healthcare of Atlanta (CHOA); Emory University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Utah System of Higher Education; University of Utah; Sapienza University Rome; Cincinnati Children's Hospital Medical Center; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; IRCCS Casa Sollievo Della Sofferenza; IRCCS Casa Sollievo Della Sofferenza; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Hakonarson, H (corresponding author), Childrens Hosp Philadelphia, Abramson Res Ctr, Ctr Appl Genom, Philadelphia, PA 19104 USA.	hakonarson@chop.edu	Annese, Vito/AGW-4200-2022; Cucchiara, Salvatore/K-1628-2016	Annese, Vito/0000-0002-0082-892X; Grant, Struan/0000-0003-2025-5302; Glessner, Joseph/0000-0001-5131-2811; Cucchiara, Salvatore/0000-0002-2939-9698	US National Institutes of Health [K23RR016111]; Crohn's & Colitis Foundation of America (CCFA); Koss foundation; NIH General Clinical Research Center; NIH [R01 DK058259, 1P30DK078392-01]; CCFA; Primary Children's Medical Center Foundation; National Center for Research Resources (S. L. G.) [K23DK069513, M01-RR00064, C06-RR11234]; Edmunds Fund; Heineman Foundation; IBD Family Research Council; Cotswold Foundation; CTSA [UL1-RR024134-03]; Institute Development Award, Children's Hospital of Philadelphia; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024134, C06RR011234, M01RR000064, K23RR016111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068164, K23DK069513, R01DK058259, P30DK078392] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's & Colitis Foundation of America (CCFA); Koss foundation; NIH General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CCFA; Primary Children's Medical Center Foundation; National Center for Research Resources (S. L. G.)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Edmunds Fund; Heineman Foundation; IBD Family Research Council; Cotswold Foundation; CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Institute Development Award, Children's Hospital of Philadelphia; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank all participating subjects and families. We thank M. Garris, K. Thomas, A. Albano, E. Dabaghyan, K. Fain, W. Glaberson, K. Harden, A. Hill, C. Johnson-Honesty, L. McCleery, K. Lake, R. Bezold, A. Ryan, A. Thomas, A. Latiano and R. Skraban for their expert assistance with DNA processing, genotyping, RNA preparation, DCR3 ELISA, data collection or study management. We thank A. Rutherford and J. Nebel for study coordination. We also thank S. Kristinsson, L. Arni Hermannsson and A. Krisbjo r rnsson of Raforninn ehf for their extensive software design and informatics contribution. This research was financially supported by US National Institutes of Health grant (K23RR016111), Crohn's & Colitis Foundation of America (CCFA), The Koss foundation, the NIH General Clinical Research Center of the Medical College of Wisconsin (S. K.), NIH grant R01 DK058259, the CCFA (L. D.), the Primary Children's Medical Center Foundation, K23DK069513, M01-RR00064, C06-RR11234 from the National Center for Research Resources (S. L. G.), the Edmunds Fund, the Heineman Foundation, the IBD Family Research Council (R. B.), a Research Development Award from the Cotswold Foundation (H. H. and S. F. A. G.) and a CTSA award, UL1-RR024134-03 (H. H.). Colon microarray experiments were performed and analyzed in the Microarray and Bioinformatics Cores of the NIH-supported Cincinnati Children's Hospital Research Foundation Digestive Health Center (1P30DK078392-01). H. Xu of the Bioinformatics Core assisted with analysis of the microarray experiments. All genotyping and other aspects of the study were funded by an Institute Development Award (H. H., S. F. A. G.) from the Children's Hospital of Philadelphia. We thank the members of the International HapMap and Wellcome Trust Case Control Consortiums for publicly providing valuable data, which were crucial for part of our analyses.	Baldassano RN, 2007, CLIN GASTROENTEROL H, V5, P972, DOI 10.1016/j.cgh.2007.04.024; Baldassano RN, 2007, GUT, V56, P1171, DOI 10.1136/gut.2007.122747; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chang YC, 2004, J LEUKOCYTE BIOL, V75, P486, DOI 10.1189/jlb.0903448; Chang YC, 2008, BLOOD, V111, P5054, DOI 10.1182/blood-2007-12-130609; D'Haens G, 1999, GASTROENTEROLOGY, V116, P1029, DOI 10.1016/S0016-5085(99)70005-3; D'Haens GR, 1998, GASTROENTEROLOGY, V114, P262, DOI 10.1016/S0016-5085(98)70476-7; Dideberg V, 2007, HUM MOL GENET, V16, P3008, DOI 10.1093/hmg/ddm259; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Falush D, 2003, GENETICS, V164, P1567; Fayad R, 2006, EUR J IMMUNOL, V36, P2215, DOI 10.1002/eji.200535477; Hakonarson H, 2007, NATURE, V448, P591, DOI 10.1038/nature06010; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hsu TL, 2002, J IMMUNOL, V168, P4846, DOI 10.4049/jimmunol.168.10.4846; Ina K, 1999, J IMMUNOL, V163, P1081; Kim S, 2005, CLIN IMMUNOL, V115, P286, DOI 10.1016/j.clim.2005.02.014; Levine A, 2007, INFLAMM BOWEL DIS, V13, P1509, DOI 10.1002/ibd.20244; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Mathew CG, 2004, HUM MOL GENET, V13, pR161, DOI 10.1093/hmg/ddh079; Meinzer U, 2005, INFLAMM BOWEL DIS, V11, P639, DOI 10.1097/01.MIB.0000165114.10687.bf; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Satsangi J, 1996, LANCET, V347, P1212, DOI 10.1016/S0140-6736(96)90734-5; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; van Heel DA, 2002, HUM MOL GENET, V11, P1281, DOI 10.1093/hmg/11.11.1281; Wortinger MA, 2003, IMMUNOLOGY, V110, P225, DOI 10.1046/j.1365-2567.2003.01724.x	28	239	247	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2008	40	10					1211	1215		10.1038/ng.203	http://dx.doi.org/10.1038/ng.203			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18758464	Green Accepted			2022-12-27	WOS:000259651000021
J	Le Goff, C; Morice-Picard, F; Dagoneau, N; Wang, LW; Perrot, C; Crow, YJ; Bauer, F; Flori, E; Prost-Squarcioni, C; Krakow, D; Ge, GX; Greenspan, DS; Bonnet, D; Le Merrer, M; Munnich, A; Apte, SS; Cormier-Daire, V				Le Goff, Carine; Morice-Picard, Fanny; Dagoneau, Nathalie; Wang, Lauren W.; Perrot, Claire; Crow, Yanick J.; Bauer, Florence; Flori, Elisabeth; Prost-Squarcioni, Catherine; Krakow, Deborah; Ge, Gaoxiang; Greenspan, Daniel S.; Bonnet, Damien; Le Merrer, Martine; Munnich, Arnold; Apte, Suneel S.; Cormier-Daire, Valerie			ADAMTSL2 mutations in geleophysic dysplasia demonstrate a role for ADAMTS-like proteins in TGF-beta bioavailability regulation	NATURE GENETICS			English	Article							GLYCOPROTEIN; ACTIVATION	Geleophysic dysplasia is an autosomal recessive disorder characterized by short stature, brachydactyly, thick skin and cardiac valvular anomalies often responsible for an early death. Studying six geleophysic dysplasia families, we first mapped the underlying gene to chromosome 9q34.2 and identified five distinct nonsense and missense mutations in ADAMTSL2 (a disintegrin and metalloproteinase with thrombospondin repeats-like 2), which encodes a secreted glycoprotein of unknown function. Functional studies in HEK293 cells showed that ADAMTSL2 mutations lead to reduced secretion of the mutated proteins, possibly owing to the misfolding of ADAMTSL2. A yeast two-hybrid screen showed that ADAMTSL2 interacts with latent TGF-beta-binding protein 1. In addition, we observed a significant increase in total and active TGF-beta in the culture medium as well as nuclear localization of phosphorylated SMAD2 in fibroblasts from individuals with geleophysic dysplasia. These data suggest that ADAMTSL2 mutations may lead to a dysregulation of TGF-beta signaling and may be the underlying mechanism of geleophysic dysplasia.	[Le Goff, Carine; Morice-Picard, Fanny; Dagoneau, Nathalie; Perrot, Claire; Le Merrer, Martine; Munnich, Arnold; Cormier-Daire, Valerie] Univ Paris 05, Dept Genet, Unite INSERM U781, Hop Necker Enfants Malad,AP HP, F-75015 Paris, France; [Wang, Lauren W.; Apte, Suneel S.] Cleveland Clin Fdn, Lerner Res Inst, Dept Biomed Engn, Cleveland, OH 44195 USA; [Crow, Yanick J.] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS2 9JT, W Yorkshire, England; [Bauer, Florence] Clin Paofai, Papeete, Tahiti, France; [Flori, Elisabeth] Hop Hautepierre, Dept Genet, F-67000 Strasbourg, France; [Prost-Squarcioni, Catherine] Hop Avicennes, Fac Med, CNRS, UPRES 3410, F-93000 Bobigny, France; [Krakow, Deborah] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Ge, Gaoxiang; Greenspan, Daniel S.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Bonnet, Damien] Hop Necker Enfants Malad, Serv Cardiol Pediat, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Cleveland Clinic Foundation; Saint James's University Hospital; University of Leeds; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); Cedars Sinai Medical Center; University of Wisconsin System; University of Wisconsin Madison; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Cormier-Daire, V (corresponding author), Univ Paris 05, Dept Genet, Unite INSERM U781, Hop Necker Enfants Malad,AP HP, F-75015 Paris, France.	valerie.cormier-daire@inserm.fr	Le Goff, Carine/N-9940-2017; MORICE-PICARD, Fanny/M-5125-2014; Crow, Yanick J/N-6120-2014; Krakow, Deborah/B-5778-2009; LE GOFF, Carine/AAG-2390-2020; cormier-daire, valerie/H-6520-2017	Crow, Yanick J/0000-0001-7211-7564; Krakow, Deborah/0000-0001-9906-4968; LE GOFF, Carine/0000-0002-7788-708X; Apte, Suneel/0000-0001-8441-1226; cormier-daire, valerie/0000-0002-2839-9856; Greenspan, Daniel/0000-0001-8096-7446	French National Research Agency (ANR) [R06215KS]; Medical Research Foundation; US National Institutes of Health; NIH [GM71679, HD22657]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071679] Funding Source: NIH RePORTER	French National Research Agency (ANR)(French National Research Agency (ANR)); Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Kazusa DNA Research Institute for providing the KIAA0605 cDNA. We thank J. Martinovic for her help. We also thank T. Arai and M. Papouin. The work presented here was supported by French National Research Agency (ANR) award R06215KS (to V.C.-D.), the Medical Research Foundation (FRM, to C.L.G.), US National Institutes of Health (NIH) award AR53890 (to S.S.A.), NIH award GM71679 (to D.S.G.) and NIH award HD22657 (to D.K.).	Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Apte SS, 2004, INT J BIOCHEM CELL B, V36, P981, DOI 10.1016/j.biocel.2004.01.014; Collod-Beroud G, 2002, EUR J HUM GENET, V10, P673, DOI 10.1038/sj.ejhg.5200876; Ge GX, 2006, J CELL BIOL, V175, P111, DOI 10.1083/jcb.200606058; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Hall NG, 2003, MATRIX BIOL, V22, P501, DOI 10.1016/S0945-053X(03)00075-1; Hirohata S, 2002, J BIOL CHEM, V277, P12182, DOI 10.1074/jbc.M109665200; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Jones KB, 2005, SPINE, V30, P291, DOI 10.1097/01.brs.0000152166.88174.1c; Kinoshita A, 2000, NAT GENET, V26, P19, DOI 10.1038/79128; Koo BH, 2007, MATRIX BIOL, V26, P431, DOI 10.1016/j.matbio.2007.03.003; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Pontz BF, 1996, AM J MED GENET, V63, P50, DOI 10.1002/(SICI)1096-8628(19960503)63:1<50::AID-AJMG11>3.0.CO;2-T; SHOHAT M, 1990, J PEDIATR-US, V117, P227, DOI 10.1016/S0022-3476(05)80534-7; Sinha S, 1998, MATRIX BIOL, V17, P529, DOI 10.1016/S0945-053X(98)90106-8; SPRANGER JW, 1971, LANCET, V2, P97; ten Dijke P, 2007, NAT REV MOL CELL BIO, V8, P857, DOI 10.1038/nrm2262; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200	20	159	162	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2008	40	9					1119	1123		10.1038/ng.199	http://dx.doi.org/10.1038/ng.199			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	18677313	Green Accepted			2022-12-27	WOS:000258761200027
J	van Es, MA; van Vught, PW; Blauw, HM; Franke, L; Saris, CG; Van Den Bosch, L; de Jong, SW; de Jong, V; Baas, F; van't Slot, R; Lemmens, R; Schelhaas, HJ; Birve, A; Sleegers, K; Van Broeckhoven, C; Schymick, JC; Traynor, BJ; Wokke, JH; Wijmenga, C; Robberecht, W; Andersen, PM; Veldink, JH; Ophoff, RA; van den Berg, LH				van Es, Michael A.; van Vught, Paul Wj; Blauw, Hylke M.; Franke, Lude; Saris, Christiaan G. J.; Van Den Bosch, Ludo; de Jong, Sonja W.; de Jong, Vianney; Baas, Frank; van't Slot, Ruben; Lemmens, Robin; Schelhaas, Helenius J.; Birve, Anna; Sleegers, Kristel; Van Broeckhoven, Christine; Schymick, Jennifer C.; Traynor, Bryan J.; Wokke, John H. J.; Wijmenga, Cisca; Robberecht, Wim; Andersen, Peter M.; Veldink, Jan H.; Ophoff, Roel A.; van den Berg, Leonard H.			Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis	NATURE GENETICS			English	Article							SPORADIC ALS; MUTATIONS	We identified a SNP in the DPP6 gene that is consistently strongly associated with susceptibility to amyotrophic lateral sclerosis (ALS) in different populations of European ancestry, with an overall P value of 5.04x10(-8) in 1,767 cases and 1,916 healthy controls and with an odds ratio of 1.30 (95% confidence interval (CI) of 1.18 - 1.43). Our finding is the first report of a genome-wide significant association with sporadic ALS and may be a target for future functional studies.	[van Es, Michael A.; van Vught, Paul Wj; Blauw, Hylke M.; Saris, Christiaan G. J.; de Jong, Sonja W.; Wokke, John H. J.; Veldink, Jan H.; van den Berg, Leonard H.] Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands; [Franke, Lude; van't Slot, Ruben; Wijmenga, Cisca] Univ Med Utrecht, Dept Biomed Genet, Complex Genet Sect, NL-3584 CX Utrecht, Netherlands; [Van Den Bosch, Ludo; Robberecht, Wim] Univ Hosp Gasthuisberg, Dept Neurol, B-3000 Louvain, Belgium; [de Jong, Vianney] Univ Amsterdam, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [Baas, Frank] Univ Amsterdam, Dept Neurogenet, NL-1105 AZ Amsterdam, Netherlands; [Schelhaas, Helenius J.] Univ Nijmegen, Med Ctr, Dept Neurol, NL-6525 GA Nijmegen, Netherlands; [Birve, Anna] Umea Univ Hosp, Inst Clin Neurosci, SE-90185 Umea, Sweden; [Baas, Frank; Sleegers, Kristel] VIB, Dept Mol Genet, Neurodegenerat Brain Dis Grp, B-2610 Antwerp, Belgium; [Sleegers, Kristel; Van Broeckhoven, Christine] Univ Antwerp VIB, B-2610 Antwerp, Belgium; [Schymick, Jennifer C.] NIA, Neurogenet Lab, Natl Inst Hlth, Bethesda, MD 20892 USA; [Traynor, Bryan J.] NIMH, Sect Dev Genet Epidemiol, Bethesda, MD 20892 USA; [Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Ophoff, Roel A.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 CX Utrecht, Netherlands; [Wijmenga, Cisca] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, NL-3584 CX Utrecht, Netherlands; [Ophoff, Roel A.] Univ Calif Los Angeles, Inst Neuropsychiat, Los Angeles, CA 90095 USA	Utrecht University; Utrecht University Medical Center; Utrecht University; KU Leuven; University Hospital Leuven; University of Amsterdam; University of Amsterdam; Radboud University Nijmegen; Umea University; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); University of Antwerp; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of Groningen; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; University of California System; University of California Los Angeles	van den Berg, LH (corresponding author), Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands.	Ophoff@ucla.edu; L.H.vandenBerg@umcutrecht.nl	Van Broeckhoven, Christine/M-7853-2019; van+Es, Michael/AAC-5772-2021; Traynor, Bryan J/G-5690-2010; Van Broeckhoven, Christine/G-8362-2017; Wijmenga, Cisca/D-2173-2009; Saris, C.G.J./L-4623-2015; Schelhaas, Helenius Jurgen/E-2815-2010; Van Den Bosch, Ludo/B-7258-2012; Franke, Lude/P-7036-2016; Wijmenga, Cisca/AAE-7719-2019; Resource Center, NINDS Human Genetics/AGF-2474-2022; Baas, Frank/F-9574-2010; Sander-Effron, Samuel/AAX-2231-2020	Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665; Franke, Lude/0000-0002-5159-8802; Wijmenga, Cisca/0000-0002-5635-1614; Baas, Frank/0000-0003-3912-5428; Van Den Bosch, Ludo/0000-0003-0104-4067; Veldink, Jan/0000-0001-5572-9657; van Es, Michael/0000-0002-7709-5883; Lemmens, Robin/0000-0002-4948-5956	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000933, ZIAAG000933] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM68875] Funding Source: Medline; NIMH NIH HHS [MH078075] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; Graham AJ, 1997, J NEUROL NEUROSUR PS, V62, P562, DOI 10.1136/jnnp.62.6.562; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Pasinelli P, 2006, NAT REV NEUROSCI, V7, P710, DOI 10.1038/nrn1971; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Saeed M, 2006, NEUROLOGY, V67, P771, DOI 10.1212/01.wnl.0000227187.52002.88; Schymick JC, 2007, LANCET NEUROL, V6, P322, DOI 10.1016/S1474-4422(07)70037-6; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sutedja NA, 2007, ARCH NEUROL-CHICAGO, V64, P63, DOI 10.1001/archneur.64.1.63; Tachibana T, 2002, NEUROSCI LETT, V327, P133, DOI 10.1016/S0304-3940(02)00375-0; Veldink JH, 2005, NEUROLOGY, V65, P820, DOI 10.1212/01.wnl.0000174472.03292.dd; WADA K, 1993, MAMM GENOME, V4, P234, DOI 10.1007/BF00417570; Zaitlen N, 2007, AM J HUM GENET, V80, P683, DOI 10.1086/513109	14	176	180	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2008	40	1					29	31		10.1038/ng.2007.52	http://dx.doi.org/10.1038/ng.2007.52			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18084291				2022-12-27	WOS:000252118600014
J	Mi, W; Pawlik, M; Sastre, M; Jung, SS; Radvinsky, DS; Klein, AM; Sommer, J; Schmidt, SD; Nixon, RA; Mathews, PM; Levy, E				Mi, Weiqian; Pawlik, Monika; Sastre, Magdalena; Jung, Sonia S.; Radvinsky, David S.; Klein, Andrew M.; Sommer, John; Schmidt, Stephen D.; Nixon, Ralph A.; Mathews, Paul M.; Levy, Efrat			Cystatin C inhibits amyloid-beta deposition in Alzheimer's disease mouse models	NATURE GENETICS			English	Article						`	CEREBRAL-HEMORRHAGE; ANGIOPATHY; PROTEIN; VARIANT; STROKE	Using transgenic mice expressing human cystatin C ( encoded by CST3), we show that cystatin C binds soluble amyloid-beta peptide and inhibits cerebral amyloid deposition in amyloid-beta precursor protein ( APP) transgenic mice. Cystatin C expression twice that of the endogenous mouse cystatin C was sufficient to substantially diminish amyloid-beta deposition. Thus, cystatin C has a protective role in Alzheimer's disease pathogenesis, and modulation of cystatin C concentrations may have therapeutic implications for the disease.	Nathan S Kline Inst, Orangeburg, NY 10962 USA; NYU, Sch Med, New York, NY 10016 USA; Centocor Res & Dev Inc, Radnor, PA 19087 USA	Nathan Kline Institute for Psychiatric Research; New York University; Johnson & Johnson; Johnson & Johnson USA	Levy, E (corresponding author), Nathan S Kline Inst, Orangeburg, NY 10962 USA.	elevy@nki.rfmh.org	Schmidt, Stephen/AAC-6967-2019; Schmidt, Stephen/B-5398-2012	Mathews, Paul/0000-0003-1742-7687	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG017617] Funding Source: NIH RePORTER; NIA NIH HHS [AG017617] Funding Source: Medline; NINDS NIH HHS [NS42029] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Benussi L, 2003, NEUROBIOL DIS, V13, P15, DOI 10.1016/S0969-9961(03)00012-3; Ghidoni R, 2007, NEUROBIOL AGING, V28, P371, DOI 10.1016/j.neurobiolaging.2006.01.007; GUDMUNDSSON G, 1972, BRAIN, V95, P387, DOI 10.1093/brain/95.2.387; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; ITOH Y, 1993, J NEUROL SCI, V116, P135, DOI 10.1016/0022-510X(93)90317-R; Levy E, 2006, BRAIN PATHOL, V16, P60, DOI 10.1111/j.1750-3639.2006.tb00562.x; LEVY E, 1989, J EXP MED, V169, P1771, DOI 10.1084/jem.169.5.1771; Levy E, 2001, J NEUROPATH EXP NEUR, V60, P94, DOI 10.1093/jnen/60.1.94; Madero M, 2006, CURR OPIN NEPHROL HY, V15, P610, DOI 10.1097/01.mnh.0000247505.71915.05; MARUYAMA K, 1990, STROKE, V21, P397, DOI 10.1161/01.STR.21.3.397; Paraoan L, 2004, TRAFFIC, V5, P884, DOI 10.1111/j.1600-0854.2004.00230.x; Pawlik M, 2004, J MOL NEUROSCI, V22, P13, DOI 10.1385/JMN:22:1-2:13; Sastre M, 2004, NEUROBIOL AGING, V25, P1033, DOI 10.1016/j.neurobiolaging.2003.11.006; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; VINTERS HV, 1990, AM J PATHOL, V137, P233	15	142	148	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2007	39	12					1440	1442		10.1038/ng.2007.29	http://dx.doi.org/10.1038/ng.2007.29			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	18026100				2022-12-27	WOS:000251267400010
J	Myers, AJ; Gibbs, JR; AWebster, J; Rohrer, K; Zhao, A; Marlowe, L; Kaleem, M; Leung, D; Bryden, L; Nath, P; Zismann, VL; Joshipura, K; Huentelman, MJ; Hu-Lince, D; Coon, KD; Craig, DW; Pearson, JV; Holmans, P; Heward, CB; Reiman, EM; Stephan, D; Hardy, J				Myers, Amanda J.; Gibbs, J. Raphael; AWebster, Jennifer; Rohrer, Kristen; Zhao, Alice; Marlowe, Lauren; Kaleem, Mona; Leung, Doris; Bryden, Leslie; Nath, Priti; Zismann, Victoria L.; Joshipura, Keta; Huentelman, Matthew J.; Hu-Lince, Diane; Coon, Keith D.; Craig, David W.; Pearson, John V.; Holmans, Peter; Heward, Christopher B.; Reiman, Eric M.; Stephan, Dietrich; Hardy, John			A survey of genetic human cortical gene expression	NATURE GENETICS			English	Article							WHOLE-GENOME ASSOCIATION; MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; ALZHEIMERS-DISEASE; ALLELIC EXPRESSION; BRAIN; HAPLOTYPE; INFERENCE; MICE; APOE	It is widely assumed that genetic differences in gene expression underpin much of the difference among individuals and many of the quantitative traits of interest to geneticists. Despite this, there has been little work on genetic variability in human gene expression and almost none in the human brain, because tools for assessing this genetic variability have not been available. Now, with whole-genome SNP genotyping arrays and whole-transcriptome expression arrays, such experiments have become feasible. We have carried out whole-genome genotyping and expression analysis on a series of 193 neuropathologically normal human brain samples using the Affymetrix GeneChip Human Mapping 500K Array Set and Illumina HumanRefseq-8 Expression BeadChip platforms. Here we present data showing that 58% of the transcriptome is cortically expressed in at least 5% of our samples and that of these cortically expressed transcripts, 21% have expression profiles that correlate with their genotype. These genetic-expression effects should be useful in determining the underlying biology of associations with common diseases of the human brain and in guiding the analysis of the genomic regions involved in the control of normal gene expression.	NIH, NIA, Neurogenet Lab, Bethesda, MD 20892 USA; Univ Miami, Miller Sch Med, Dept Psychiat & Biobehav Sci, Div Neurosci, Miami, FL 33136 USA; Reta Lila Weston Inst, Neurol Inst, Dept Mol Neurosci & Neurodegenerat Dis, London WC1N 3BG, England; Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA; Arizona Alzheimers Consortium, Phoenix, AZ 85006 USA; St Josephs Hosp, Med Ctr, Div Thorac Oncol Res, Phoenix, AZ 85013 USA; Cardiff Univ, Dept Psychol Med, Bioinformat Unit, Cardiff CF14 4XN, Wales; Kronos Sci Lab, Phoenix, AZ 85016 USA; Banner Alzheimers Inst, Phoenix, AZ 85006 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Miami; University of London; University College London; Translational Genomics Research Institute; St. Joseph's Hospital and Medical Center; Cardiff University; Banner Research; Banner Health; Banner Alzheimer's Institute	Myers, AJ (corresponding author), NIH, NIA, Neurogenet Lab, Bldg 10,Main Campus,Porter Neurosci Bldg, Bethesda, MD 20892 USA.	amyers@med.miami.edu	Pearson, John V/F-2249-2011; Leung, Doris G/R-5447-2016; Myers, Amanda J/B-1796-2010; Pearson, John/AAT-4211-2020; Holmans, Peter/F-4518-2015; Gibbs, J. Raphael/A-3984-2010; Craig, David Wesley/K-6961-2019; Hardy, John/C-2451-2009	Pearson, John V/0000-0003-0904-4598; Leung, Doris G/0000-0002-2558-7798; Myers, Amanda J/0000-0002-3100-9396; Holmans, Peter/0000-0003-0870-9412; Gibbs, J. Raphael/0000-0002-6985-0658; Craig, David Wesley/0000-0003-2040-1955; Hardy, John/0000-0002-3122-0423	Medical Research Council [G0701075, G9810900] Funding Source: Medline; NHLBI NIH HHS [UO1HL084744] Funding Source: Medline; NIA NIH HHS [P30-AG13846, P50AG05681, P50-AG08671, P30 AG19610, AG10161, AG05144, U01 AG016976, AG05128, P50 AG16570, P50 AG05136, AG05146] Funding Source: Medline; NIMH NIH HHS [MH60451] Funding Source: Medline; NINDS NIH HHS [U24NS051872, NS39764] Funding Source: Medline; MRC [G9810900, G0701075] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH060451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U24NS051872, P50NS039764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010161, U01AG016976, P50AG005136, P50AG005681, P50AG016570, P30AG019610, P30AG013846, P50AG008671, P50AG005144, P50AG005146] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bray NJ, 2004, HUM MOL GENET, V13, P2885, DOI 10.1093/hmg/ddh299; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; Falush D, 2003, GENETICS, V164, P1567; GILBERT JM, 1981, J NEUROCHEM, V36, P976, DOI 10.1111/j.1471-4159.1981.tb01689.x; Hovatta I, 2005, NATURE, V438, P662, DOI 10.1038/nature04250; Hovatta I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r25; Lambert JC, 1997, HUM MOL GENET, V6, P2151, DOI 10.1093/hmg/6.12.2151; McClurg P, 2007, GENETICS, V176, P675, DOI 10.1534/genetics.106.066241; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Myers AJ, 2007, NEUROBIOL DIS, V25, P561, DOI 10.1016/j.nbd.2006.10.018; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tseng GC, 2001, NUCLEIC ACIDS RES, V29, P2549, DOI 10.1093/nar/29.12.2549; Tukey JW, 1977, EXPLORATORY DATA ANA; WORKMAN C, 2002, GENOME BIOL, V0003	20	388	395	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2007	39	12					1494	1499		10.1038/ng.2007.16	http://dx.doi.org/10.1038/ng.2007.16			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	17982457				2022-12-27	WOS:000251267400018
J	Peacock, CS; Seeger, K; Harris, D; Murphy, L; Ruiz, JC; Quail, MA; Peters, N; Adlem, E; Tivey, A; Aslett, M; Kerhornou, A; Ivens, A; Fraser, A; Rajandream, MA; Carver, T; Norbertczak, H; Chillingworth, T; Hance, Z; Jagels, K; Moule, S; Ormond, D; Rutter, S; Squares, R; Whitehead, S; Rabbinowitsch, E; Arrowsmith, C; White, B; Thurston, S; Bringaud, F; Baldauf, SL; Faulconbridge, A; Jeffares, D; Depledge, DP; Oyola, SO; Hilley, JD; Brito, LO; Tosi, LRO; Barrell, B; Cruz, AK; Mottram, JC; Smith, DF; Berriman, M				Peacock, Christopher S.; Seeger, Kathy; Harris, David; Murphy, Lee; Ruiz, Jeronimo C.; Quail, Michael A.; Peters, Nick; Adlem, Ellen; Tivey, Adrian; Aslett, Martin; Kerhornou, Arnaud; Ivens, Alasdair; Fraser, Audrey; Rajandream, Marie-Adele; Carver, Tim; Norbertczak, Halina; Chillingworth, Tracey; Hance, Zahra; Jagels, Kay; Moule, Sharon; Ormond, Doug; Rutter, Simon; Squares, Rob; Whitehead, Sally; Rabbinowitsch, Ester; Arrowsmith, Claire; White, Brian; Thurston, Scott; Bringaud, Frederic; Baldauf, Sandra L.; Faulconbridge, Adam; Jeffares, Daniel; Depledge, Daniel P.; Oyola, Samuel O.; Hilley, James D.; Brito, Loislene O.; Tosi, Luiz R. O.; Barrell, Barclay; Cruz, Angela K.; Mottram, Jeremy C.; Smith, Deborah F.; Berriman, Matthew			Comparative genomic analysis of three Leishmania species that cause diverse human disease	NATURE GENETICS			English	Article							DOUBLE-STRANDED-RNA; TRYPANOSOMA-BRUCEI; GOLGI-COMPLEX; GENE FAMILY; PROTEIN; PARASITE; CRUZI; RETROTRANSPOSONS; TRYPANOTHIONE; BIOSYNTHESIS	Leishmania parasites cause a broad spectrum of clinical disease. Here we report the sequencing of the genomes of two species of Leishmania: Leishmania infantum and Leishmania braziliensis. The comparison of these sequences with the published genome of Leishmania major reveals marked conservation of synteny and identifies only similar to 200 genes with a differential distribution between the three species. L. braziliensis, contrary to Leishmania species examined so far, possesses components of a putative RNA- mediated interference pathway, telomere- associated transposable elements and spliced leader - associated SLACS retrotransposons. We show that pseudogene formation and gene loss are the principal forces shaping the different genomes. Genes that are differentially distributed between the species encode proteins implicated in host- pathogen interactions and parasite survival in the macrophage.	Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, BR-14049900 Ribeirao Preto, Brazil; Univ Bordeaux 2, CNRS, Lab Genome Fonct Trypanosomatides, UMR 5162, F-33076 Bordeaux, France; Univ York, Dept Biol, Immunol & Infect Unit, York YO10 5YW, N Yorkshire, England; Univ Glasgow, Ctr Biomed Res, Wellcome Ctr Mol Parasitol, Glasgow G12 8TN, Lanark, Scotland; Univ Glasgow, Ctr Biomed Res, Div Infect & Immun, Glasgow G12 8TN, Lanark, Scotland	Wellcome Trust Sanger Institute; Universidade de Sao Paulo; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; University of York - UK; University of Glasgow; University of Glasgow	Peacock, CS (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Hinxton CB10 1SA, Cambs, England.	csp@sanger.ac.uk; mb4@sanger.ac.uk	Tosi, Luiz R.O./A-4610-2013; Cruz, Angela Kaysel/N-8445-2014; Berriman, Matthew/A-7618-2011; Quail, michael/ABE-6131-2020; Peacock, Christopher/A-4052-2012; Jeffares, Daniel/N-2632-2018	Tosi, Luiz R.O./0000-0001-9932-5486; Cruz, Angela Kaysel/0000-0002-4260-4713; Berriman, Matthew/0000-0002-9581-0377; Jeffares, Daniel/0000-0001-7320-0706; Murphy, Lee/0000-0001-6467-7449; Oyola, Samuel O./0000-0002-6425-7345; Schofield, Ellen/0000-0003-0648-1418; /0000-0002-1361-9721; Mottram, Jeremy/0000-0001-5574-3766; Baldauf, Sandra/0000-0003-4485-6671; Ivens, Al/0000-0002-0112-3876; Kerhornou, Arnaud/0000-0002-2890-295X; Faulconbridge, Adam/0000-0002-4733-3270	MRC [G0000508] Funding Source: UKRI; Medical Research Council [G0000508] Funding Source: Medline; Wellcome Trust [076355, 085775] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		AKSOY S, 1990, NUCLEIC ACIDS RES, V18, P785, DOI 10.1093/nar/18.4.785; BACHRACH U, 1980, FEBS LETT, V121, P287, DOI 10.1016/0014-5793(80)80364-4; BANKAITIS VA, 1989, J CELL BIOL, V108, P1271, DOI 10.1083/jcb.108.4.1271; BEACH DH, 1979, J PARASITOL, V65, P203, DOI 10.2307/3280147; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; Bringaud F, 2006, MOL BIOCHEM PARASIT, V145, P158, DOI 10.1016/j.molbiopara.2005.09.017; Britto C, 1998, GENE, V222, P107, DOI 10.1016/S0378-1119(98)00472-7; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; CASSAGO A, 2006, MOL BIOCH PARASITOL; CLAVERIE JM, 1990, METHOD ENZYMOL, V183, P237; CRUZ A, 1991, P NATL ACAD SCI USA, V88, P7170, DOI 10.1073/pnas.88.16.7170; Denise H, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-42; Depledge DP, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-122; Durand-Dubief M, 2003, MOL BIOCHEM PARASIT, V129, P11, DOI 10.1016/S0166-6851(03)00071-9; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Hall BS, 2006, J BIOL CHEM, V281, P27600, DOI 10.1074/jbc.M602183200; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jones SM, 1998, J BIOL CHEM, V273, P10349, DOI 10.1074/jbc.273.17.10349; Kedzierski L, 2004, J IMMUNOL, V172, P4902, DOI 10.4049/jimmunol.172.8.4902; Kerr SF, 2006, MEM I OSWALDO CRUZ, V101, P25, DOI 10.1590/S0074-02762006000100006; Knuepfer E, 2001, BIOCHEM J, V356, P335, DOI 10.1042/0264-6021:3560335; Kooij TWA, 2005, PLOS PATHOG, V1, P349, DOI 10.1371/journal.ppat.0010044; Laurentino EC, 2004, MOL BIOCHEM PARASIT, V137, P81, DOI 10.1016/j.molbiopara.2004.05.001; Lipoldova M, 2006, NAT REV GENET, V7, P294, DOI 10.1038/nrg1832; MARSDEN PD, 1986, T ROY SOC TROP MED H, V80, P859, DOI 10.1016/0035-9203(86)90243-9; McKean PG, 2001, CELL MICROBIOL, V3, P511, DOI 10.1046/j.1462-5822.2001.00135.x; Momen H, 2000, MEM I OSWALDO CRUZ, V95, P583, DOI 10.1590/S0074-02762000000400023; Myler PJ, 1999, P NATL ACAD SCI USA, V96, P2902, DOI 10.1073/pnas.96.6.2902; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Oza SL, 2002, J BIOL CHEM, V277, P35853, DOI 10.1074/jbc.M204403200; Oza SL, 2005, MOL BIOCHEM PARASIT, V139, P107, DOI 10.1016/j.molbiopara.2004.10.004; Price AL, 2005, BIOINFORMATICS, V21, pI351, DOI 10.1093/bioinformatics/bti1018; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3; Rochette A, 2005, MOL BIOCHEM PARASIT, V140, P205, DOI 10.1016/j.molbiopara.2005.01.006; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Shi HF, 2004, J BIOL CHEM, V279, P49889, DOI 10.1074/jbc.M409280200; Shi HF, 2006, RNA, V12, P2063, DOI 10.1261/rna.246906; Shi H, 2006, RNA, V12, P943, DOI 10.1261/rna.20806; STADEN R, 1982, NUCLEIC ACIDS RES, V10, P141, DOI 10.1093/nar/10.1.141; STUART KD, 1992, P NATL ACAD SCI USA, V89, P8596, DOI 10.1073/pnas.89.18.8596; Victoir K, 2002, TRENDS PARASITOL, V18, P81, DOI 10.1016/S1471-4922(01)02199-7; VILLANUEVA MS, 1991, MOL CELL BIOL, V11, P6139, DOI 10.1128/MCB.11.12.6139; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yan SF, 2002, MOL BIOCHEM PARASIT, V119, P217, DOI 10.1016/S0166-6851(01)00418-2; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yao CQ, 2003, MOL BIOCHEM PARASIT, V132, P1, DOI 10.1016/S0166-6851(03)00211-1; Zhang WW, 2003, J BIOL CHEM, V278, P35508, DOI 10.1074/jbc.M305030200	50	547	628	1	45	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39	7					839	847		10.1038/ng2053	http://dx.doi.org/10.1038/ng2053			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17572675	Green Accepted			2022-12-27	WOS:000247619800013
J	Dina, C; Meyre, D; Gallina, S; Durand, E; Korner, A; Jacobson, P; Carlsson, LMS; Kiess, W; Vatin, V; Lecoeur, C; Delplanque, J; Vaillant, E; Pattou, F; Ruiz, J; Weill, J; Levy-Marchal, C; Horber, F; Potoczna, N; Hercberg, S; Le Stunff, C; Bougneres, P; Kovacs, P; Marre, M; Balkau, B; Cauchi, S; Chevre, JC; Froguel, P				Dina, Christian; Meyre, David; Gallina, Sophie; Durand, Emmanuelle; Koerner, Antje; Jacobson, Peter; Carlsson, Lena M. S.; Kiess, Wieland; Vatin, Vincent; Lecoeur, Cecile; Delplanque, Jerome; Vaillant, Emmanuel; Pattou, Francois; Ruiz, Juan; Weill, Jacques; Levy-Marchal, Claire; Horber, Fritz; Potoczna, Natascha; Hercberg, Serge; Le Stunff, Catherine; Bougneres, Pierre; Kovacs, Peter; Marre, Michel; Balkau, Beverley; Cauchi, Stephane; Chevre, Jean-Claude; Froguel, Philippe			Variation in FTO contributes to childhood obesity and severe adult obesity	NATURE GENETICS			English	Article							INSULIN-RESISTANCE; MOUSE	We identified a set of SNPs in the first intron of the FTO (fat mass and obesity associated) gene on chromosome 16q12.2 that is consistently strongly associated with early-onset and severe obesity in both adults and children of European ancestry with an experiment-wise P value of 1.67 x 10(-26) in 2,900 affected individuals and 5,100 controls. The at- risk haplotype yields a proportion of attributable risk of 22% for common obesity. We conclude that FTO contributes to human obesity and hence may be a target for subsequent functional analyses.	Inst Pasteur, CNRS 8090, Inst Biol, F-59019 Lille, France; Univ Leipzig, Univ Hosp Children & Adolescents, D-7010 Leipzig, Germany; Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, S-40020 Gothenburg, Sweden; Univ Lille 2, INSERM, U859, F-59045 Lille, France; CHU Vaudois, Lausanne, Switzerland; Jeanne Flandre Hosp, Paediat Endocrine Unit, Lille, France; Hop Robert Debre, INSERM, U690, F-75019 Paris, France; Klin Lindberg, Winterthur, Switzerland; INRA, U1125, Bobigny, France; INSERM, U557, Bobigny, France; CNAM, EA3200, Paris, France; Univ Paris 13, Paris, France; CRNH, Paris, France; Univ Paris 05, St Vincent Paul Hosp, Dept Pediat Endocrinol, F-75005 Paris, France; Univ Paris 05, St Vincent Paul Hosp, INSERM U561, F-75005 Paris, France; Univ Leipzig, Dept Internal Med 2, D-7010 Leipzig, Germany; Univ Leipzig, Interdisciplinary Ctr Clin Res, D-7010 Leipzig, Germany; Hop Bichat Claude Bernard, AP HP, Dept Diabetol, F-75877 Paris 18, France; INSERM, U780, IFR69, Villejuif, France; Univ Paris Sud, Villejuif, France; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London SW7 2AY, England	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Leipzig University; University of Gothenburg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); heSam Universite; Conservatoire National Arts & Metiers (CNAM); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Leipzig University; Leipzig University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Imperial College London	Dina, C (corresponding author), Inst Pasteur, CNRS 8090, Inst Biol, F-59019 Lille, France.	dina@good.ibl.fr	Dina, Christian R/D-3535-2015; Serge, Hercberg/F-3038-2017; Carlsson, Lena/F-7570-2018; LE STUNFF, CATHERINE/Y-3270-2018; Chèvre, Jean-Claude/C-3943-2015; horber, Fritz/AAL-5419-2020; Körner, Antje/B-3988-2015; Meyre, David/D-7315-2011; FROGUEL, Philippe/O-6799-2017; Pattou, Francois/O-6151-2017; HERCBERG, Serge/B-4429-2008	Dina, Christian R/0000-0002-7722-7348; Serge, Hercberg/0000-0002-3168-1350; Carlsson, Lena/0000-0003-4145-6242; LE STUNFF, CATHERINE/0000-0001-8419-0451; Chèvre, Jean-Claude/0000-0002-5329-5231; Körner, Antje/0000-0001-6001-0356; Meyre, David/0000-0003-4850-7444; FROGUEL, Philippe/0000-0003-2972-0784; Pattou, Francois/0000-0001-8388-3766; HERCBERG, Serge/0000-0002-3168-1350; Gallina, Sophie/0000-0002-6194-3649; Jacobson, Peter/0000-0002-1769-1827; Kovacs, Peter/0000-0002-0290-5423; Marre, Michel/0000-0002-3071-1837	Medical Research Council [G0000477, G0600331] Funding Source: Medline; MRC [G0000477, G0600331] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Dina C, 2007, SCIENCE, V315, DOI [10.1126/science.1129402, 10.1126/science.1130571, 10.1126/science.1130012]; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Jacobson P, 2007, AM J EPIDEMIOL, V165, P101, DOI 10.1093/aje/kwj342; King DC, 2005, GENOME RES, V15, P1051, DOI 10.1101/gr.3642605; KORNER A, 2007, J CLIN ENDOCRINOL ME; Le Fur S, 2002, DIABETES, V51, pS304, DOI 10.2337/diabetes.51.2007.S304; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Ott J, 2004, NEUROLOGY, V63, P955, DOI 10.1212/WNL.63.6.955; Peters T, 1999, MAMM GENOME, V10, P983, DOI 10.1007/s003359901121; Stratakis CA, 2000, J CLIN ENDOCR METAB, V85, P3396, DOI 10.1210/jc.85.9.3396; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Vu-Hong TA, 2006, J CLIN ENDOCR METAB, V91, P2437, DOI 10.1210/jc.2005-2245	12	1350	1418	1	128	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2007	39	6					724	726		10.1038/ng2048	http://dx.doi.org/10.1038/ng2048			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17496892				2022-12-27	WOS:000246859100014
J	Martin, MP; Qi, Y; Gao, XJ; Yamada, E; Martin, JN; Pereyra, F; Colombo, S; Brown, EE; Shupert, WL; Phair, J; Goedert, JJ; Buchbinder, S; Kirk, GD; Telenti, A; Connors, M; O'Brien, SJ; Walker, BD; Parham, P; Deeks, SG; McVicar, DW; Carrington, M				Martin, Maureen P.; Qi, Ying; Gao, Xiaojiang; Yamada, Eriko; Martin, Jeffrey N.; Pereyra, Florencia; Colombo, Sara; Brown, Elizabeth E.; Shupert, W. Lesley; Phair, John; Goedert, James J.; Buchbinder, Susan; Kirk, Gregory D.; Telenti, Amalio; Connors, Mark; O'Brien, Stephen J.; Walker, Bruce D.; Parham, Peter; Deeks, Steven G.; McVicar, Daniel W.; Carrington, Mary			Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1	NATURE GENETICS			English	Article							NATURAL-KILLER-CELLS; MAJOR HISTOCOMPATIBILITY COMPLEX; IMMUNOGLOBULIN-LIKE RECEPTOR; IMMUNODEFICIENCY-VIRUS TYPE-1; CLASS-I MOLECULES; MHC CLASS-I; INHIBITORY RECEPTORS; SELF-TOLERANCE; AIDS; INFECTION	Allotypes of the natural killer ( NK) cell receptor KIR3DL1 vary in both NK cell expression patterns and inhibitory capacity upon binding to their ligands, HLA-B Bw4 molecules, present on target cells. Using a sample size of over 1,500 human immunodeficiency virus (HIV)(+) individuals, we show that various distinct allelic combinations of the KIR3DL1 and HLA-B loci significantly and strongly influence both AIDS progression and plasma HIV RNA abundance in a consistent manner. These genetic data correlate very well with previously defined functional differences that distinguish KIR3DL1 allotypes. The various epistatic effects observed here for common, distinct KIR3DL1 and HLA-B Bw4 combinations are unprecedented with regard to any pair of genetic loci in human disease, and indicate that NK cells may have a critical role in the natural history of HIV infection.	Sci Applicat Int Corp Frederick Inc, NCI, Lab Genom Divers, Frederick, MD 21702 USA; Sci Applicat Int Corp Frederick Inc, NCI, Lab Expt Immunol, Frederick, MD 21702 USA; Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94105 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, AIDS Res Ctr, Boston, MA 02129 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Infect Dis Div, Boston, MA 02129 USA; Univ Lausanne, Inst Microbiol, CH-1011 Lausanne, Switzerland; NCI, Viral Epidemiol Branch, Div Canc Epidemiol & Genet, Rockville, MD 20852 USA; NIAID, Rocky Mt Lab, Hamilton, MT 59840 USA; Northwestern Univ, Sch Med, Dept Med, Chicago, IL 60611 USA; HIV Res Sect, San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; NIAID, Immunoregulat Lab, Bethesda, MD 20892 USA; Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA; San Francisco Gen Hosp, San Francisco, CA 94110 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Lausanne; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Northwestern University; San Francisco Department of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Stanford University; San Francisco General Hospital Medical Center	Carrington, M (corresponding author), Sci Applicat Int Corp Frederick Inc, NCI, Lab Genom Divers, POB B,Bldg 560, Frederick, MD 21702 USA.	carringt@ncifcrf.gov	Telenti, Amalio/AAY-1674-2021; VALLET, Yannick/F-9979-2011; McVicar, Daniel/G-1970-2015; Kirk, Gregory/A-8484-2009; OBRIEN, STEPHEN/ABD-1346-2020	McVicar, Daniel/0000-0002-1112-5111; OBRIEN, STEPHEN/0000-0001-7857-0757	NATIONAL CANCER INSTITUTE [Z01BC010791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000855] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [N01CO12400, N01-CO-12400] Funding Source: Medline; NIAID NIH HHS [P30 AI027763] Funding Source: Medline; NIDA NIH HHS [R56 DA004334, R01-DA04334, R01 DA004334] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Abi-Rached L, 2005, J EXP MED, V201, P1319, DOI 10.1084/jem.20042558; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Biron CA, 1999, ANNU REV IMMUNOL, V17, P189, DOI 10.1146/annurev.immunol.17.1.189; BUCHBINDER SP, 1994, AIDS, V8, P1123, DOI 10.1097/00002030-199408000-00014; Carr WH, 2005, J IMMUNOL, V175, P5222, DOI 10.4049/jimmunol.175.8.5222; Carrington M, 2005, J EXP MED, V201, P1069, DOI 10.1084/jem.20042158; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; CELLA M, 1994, J EXP MED, V180, P1235, DOI 10.1084/jem.180.4.1235; Colucci F, 2002, NAT IMMUNOL, V3, P807, DOI 10.1038/ni0902-807; Council of State and Territorial Epidemiologists, 1987, MMWR MORB MORTAL S1, V36, p1S; Dorfman JR, 1998, J EXP MED, V187, P609, DOI 10.1084/jem.187.4.609; Emu B, 2005, J VIROL, V79, P14169, DOI 10.1128/JVI.79.22.14169-14178.2005; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Gao XJ, 2005, NAT MED, V11, P1290, DOI 10.1038/nm1333; Gao XJ, 2001, NEW ENGL J MED, V344, P1668, DOI 10.1056/NEJM200105313442203; Gardiner CM, 2001, J IMMUNOL, V166, P2992, DOI 10.4049/jimmunol.166.5.2992; GOEDERT JJ, 1989, NEW ENGL J MED, V321, P1141, DOI 10.1056/NEJM198910263211701; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Gumperz JE, 1997, J IMMUNOL, V158, P5237; Held W, 1996, EUR J IMMUNOL, V26, P2286, DOI 10.1002/eji.1830261003; Jennes W, 2006, J IMMUNOL, V177, P6588, DOI 10.4049/jimmunol.177.10.6588; Khakoo SI, 2000, IMMUNITY, V12, P687, DOI 10.1016/S1074-7613(00)80219-8; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; KLEIN J, 1993, ANNU REV IMMUNOL, V11, P269, DOI 10.1146/annurev.immunol.11.1.269; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lopez-Vazquez A, 2005, HUM IMMUNOL, V66, P285, DOI 10.1016/j.humimm.2005.01.001; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; O'Brien SJ, 2001, TRENDS MOL MED, V7, P379, DOI 10.1016/S1471-4914(01)02131-1; Pando MJ, 2003, J IMMUNOL, V171, P6640, DOI 10.4049/jimmunol.171.12.6640; Parham P, 2006, IMMUNOL REV, V214, P155, DOI 10.1111/j.1600-065X.2006.00462.x; PHAIR J, 1992, J ACQ IMMUN DEF SYND, V5, P490; Qi Y, 2006, PLOS PATHOG, V2, P741, DOI 10.1371/journal.ppat.0020079; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Valiante NM, 1997, IMMUNITY, V7, P739, DOI 10.1016/S1074-7613(00)80393-3; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; Vlahov D, 1998, JAMA-J AM MED ASSOC, V279, P35, DOI 10.1001/jama.279.1.35; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884; Yawata M, 2002, CRIT REV IMMUNOL, V22, P463; Yokoyama WM, 2006, IMMUNITY, V24, P249, DOI 10.1016/j.immuni.2006.03.006	45	561	572	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2007	39	6					733	740		10.1038/ng2035	http://dx.doi.org/10.1038/ng2035			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17496894	Green Accepted, Green Published			2022-12-27	WOS:000246859100017
J	Ventura, JJ; Tenbaum, S; Perdiguero, E; Huth, M; Guerra, C; Barbacid, M; Pasparakis, M; Nebreda, AR				Ventura, Juan Jose; Tenbaum, Stephan; Perdiguero, Eusebio; Huth, Marion; Guerra, Carmen; Barbacid, Mariano; Pasparakis, Manolis; Nebreda, Angel R.			p38 alpha MAP kinase is essential in lung stem and progenitor cell proliferation and differentiation	NATURE GENETICS			English	Article							ACTIVATED PROTEIN-KINASE; K-RAS ONCOGENE; GENE-EXPRESSION; C/EBP-ALPHA; TUMOR-SUPPRESSOR; CYCLIN D1; CANCER; MICE; GROWTH; PHOSPHORYLATION	Stem cell function is central for the maintenance of normal tissue homeostasis. Here we show that deletion of p38 alpha mitogenactivated protein ( MAP) kinase in adult mice results in increased proliferation and defective differentiation of lung stem and progenitor cells both in vivo and in vitro. We found that p38a positively regulates factors such as CCAAT/enhancer-binding protein that are required for lung cell differentiation. In addition, p38a controls self-renewal of the lung stem and progenitor cell population by inhibiting proliferation-inducing signals, most notably epidermal growth factor receptor. As a consequence, the inactivation of p38a leads to an immature and hyperproliferative lung epithelium that is highly sensitized to K-RasG12V-induced tumorigenesis. Our results indicate that by coordinating proliferation and differentiation signals in lung stem and progenitor cells, p38a has a key role in the regulation of lung cell renewal and tumorigenesis.	CNIO, Spanish Natl Canc Ctr, E-28029 Madrid, Spain; European Mol Biol Lab, Mouse Biol Unit, I-00016 Monterotondo, Italy; Univ Cologne, Inst Genet, D-50674 Cologne, Germany	Centro Nacional de Investigaciones Oncologicas (CNIO); European Molecular Biology Laboratory (EMBL); University of Cologne	Nebreda, AR (corresponding author), CNIO, Spanish Natl Canc Ctr, Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.	jjventura@cnio.es; anebreda@cnio.es	Perdiguero, Eusebio/F-3178-2013; Ventura, Juan-Jose/J-7913-2016; Guerra, Carmen/K-5852-2014; Pasparakis, Manolis/N-4350-2019; Pasparakis, Manolis/H-9292-2017; Nebreda, Angel Rodriguez/R-9594-2019	Perdiguero, Eusebio/0000-0003-3529-8989; Ventura, Juan-Jose/0000-0002-9252-843X; Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; Guerra, Carmen/0000-0002-3891-046X	Medical Research Council [G0800346] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; Ambrosino C, 2006, BIOCHEM J, V396, P163, DOI 10.1042/BJ20051502; Bardeesy N, 2005, MOL CELL BIOL, V25, P4176, DOI 10.1128/MCB.25.10.4176-4188.2005; Basseres DS, 2006, MOL CELL BIOL, V26, P1109, DOI 10.1128/MCB.26.3.1109-1123.2006; Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; Bulavin DV, 2004, ADV CANCER RES, V92, P95, DOI 10.1016/S0065-230X(04)92005-2; Casanovas O, 2000, J BIOL CHEM, V275, P35091, DOI 10.1074/jbc.M006324200; Chen JP, 1999, FEBS LETT, V457, P162, DOI 10.1016/S0014-5793(99)01031-5; Cheng LC, 2005, NEURON, V46, P363, DOI 10.1016/j.neuron.2005.04.027; Coe BP, 2006, BRIT J CANCER, V94, P1927, DOI 10.1038/sj.bjc.6603167; Craxton A, 1998, J IMMUNOL, V161, P3225; DaSilva J, 2006, MOL CELL BIOL, V26, P1898, DOI 10.1128/MCB.26.5.1898-1907.2006; Deng JB, 2006, BIOCHEM BIOPH RES CO, V339, P923, DOI 10.1016/j.bbrc.2005.10.217; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Engelman JA, 1998, J BIOL CHEM, V273, P32111, DOI 10.1074/jbc.273.48.32111; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Halmos B, 2004, CANCER RES, V64, P4137, DOI 10.1158/0008-5472.CAN-03-4052; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lawson GW, 2002, AM J PATHOL, V160, P315, DOI 10.1016/S0002-9440(10)64375-1; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mailleux AA, 2001, MECH DEVELOP, V102, P81, DOI 10.1016/S0925-4773(01)00286-6; Martis PC, 2006, DEVELOPMENT, V133, P1155, DOI 10.1242/dev.02273; Meuwissen R, 2001, ONCOGENE, V20, P6551, DOI 10.1038/sj.onc.1204837; Mialon A, 2005, MOL CELL BIOL, V25, P5040, DOI 10.1128/MCB.25.12.5040-5051.2005; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Nystul TG, 2006, CURR OPIN GENET DEV, V16, P463, DOI 10.1016/j.gde.2006.08.003; Pirrotta V, 2006, CURR OPIN GENET DEV, V16, P443, DOI 10.1016/j.gde.2006.08.014; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; Sugahara K, 2001, CELL TISSUE RES, V306, P57, DOI 10.1007/s004410100420; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; Tang QQ, 2005, P NATL ACAD SCI USA, V102, P9766, DOI 10.1073/pnas.0503891102; Ventura JJ, 2006, MOL CELL, V21, P701, DOI 10.1016/j.molcel.2006.01.018; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2	45	239	246	0	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2007	39	6					750	758		10.1038/ng2037	http://dx.doi.org/10.1038/ng2037			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17468755				2022-12-27	WOS:000246859100019
J	Alcais, A; Alter, A; Antoni, G; Orlova, M; Van Thuc, N; Singh, M; Vanderborght, PR; Katoch, K; Mira, MT; Thai, VH; Huong, NT; Ba, NN; Moraes, M; Mehra, N; Schurr, E; Abel, L				Alcais, Alexandre; Alter, Andrea; Antoni, Guillemette; Orlova, Marianna; Van Thuc, Nguyen; Singh, Meenakshi; Vanderborght, Patricia R.; Katoch, Kiran; Mira, Marcelo T.; Thai, Vu Hong; Huong, Ngyuen Thu; Ba, Nguyen Ngoc; Moraes, Milton; Mehra, Narinder; Schurr, Erwin; Abel, Laurent			Stepwise replication identifies a low-producing lymphotoxin-alpha allele as a major risk factor for early-onset leprosy	NATURE GENETICS			English	Article							TUBERCULOID LEPROSY; GENETIC DISSECTION; BOVIS BCG; LT-ALPHA; SUSCEPTIBILITY; TNF; ASSOCIATIONS; INFECTION; IMMUNITY; MARKERS	Host genetics has an important role in leprosy, and variants in the shared promoter region of PARK2 and PACRG were the first major susceptibility factors identified by positional cloning(1,2). Here we report the linkage disequilibrium mapping of the second linkage peak of our previous genome- wide scan1, located close to the HLA complex. In both a Vietnamese familial sample and an Indian case- control sample, the lowproducing lymphotoxin-alpha (LTA)+80 A allele was significantly associated with an increase in leprosy risk (P = 0.007 and P 0.01, respectively). Analysis of an additional case- control sample from Brazil and an additional familial sample from Vietnam showed that the LTA+80 effect was much stronger in young individuals. In the combined sample of 298 Vietnamese familial trios, the odds ratio of leprosy for LTA+80 AA/AC versus CC subjects was 2.11 (P = 0.000024), which increased to 5.63 (P = 0.0000004) in the subsample of 121 trios of affected individuals diagnosed before 16 years of age. In addition to identifying LTA as a major gene associated with early- onset leprosy, our study highlights the critical role of case- and population- specific factors in the dissection of susceptibility variants in complex diseases.	INSERM, U550, Lab Genet Humaine Malad Infectieuses, F-75015 Paris, France; Univ Paris Rene Descartes, Fac Med Necker, F-75015 Paris, France; McGill Univ, Mcgill Ctr Study Host Resistence, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Human Genet, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Med, Montreal, PQ H3G 1A4, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3G 1A4, Canada; Hosp Dermatovenereol, Chi Minh City, Vietnam; All India Inst Med Sci, Dept Transplant Immunol & Immunogenet, New Delhi 110029, India; Fiocruz MS, Leprosy Lab, Trop Med Dept, Oswaldo Cruz Inst, BR-21040900 Rio De Janeiro, Brazil; Cent JALMA Inst Leprosy & Other Infect Dis, Agra 282001, Uttar Pradesh, India; Pontificia Univ Catolica Parana, Ctr Ciencias Biol & Saude, BR-80215901 Curitiba, Parana, Brazil	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; McGill University; McGill University; McGill University; McGill University; All India Institute of Medical Sciences (AIIMS) New Delhi; Fundacao Oswaldo Cruz; Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; Pontificia Universidade Catolica do Parana	Alcais, A (corresponding author), INSERM, U550, Lab Genet Humaine Malad Infectieuses, F-75015 Paris, France.	abel@necker.fr; erwin.schurr@mcgill.ca	Mira, Marcelo T/B-5046-2010; Moraes, Milton Ozório/G-9753-2011; Moraes, Milton/AFF-1842-2022; Abel, Laurent/H-8888-2017; Alcais, Alexandre/J-5882-2017	Mira, Marcelo T/0000-0002-8087-9400; Moraes, Milton Ozório/0000-0003-2653-0037; Orlova, Marianna/0000-0002-8108-938X; Abel, Laurent/0000-0001-7016-6493; Alcais, Alexandre/0000-0002-1012-2226				ABEL L, 1988, AM J HUM GENET, V42, P256; ABEL L, 1995, GENET EPIDEMIOL, V12, P63, DOI 10.1002/gepi.1370120107; Alcais A, 2005, CURR OPIN IMMUNOL, V17, P44, DOI 10.1016/j.coi.2004.11.006; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bell PA, 2002, BIOTECHNIQUES, P70; Bopst M, 2001, EUR J IMMUNOL, V31, P1935, DOI 10.1002/1521-4141(200106)31:6&lt;1935::AID-IMMU1935&gt;3.0.CO;2-N; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; DEVRIES RRP, 1980, TISSUE ANTIGENS, V16, P294, DOI 10.1111/j.1399-0039.1980.tb00309.x; Dupuis J, 1999, GENETICS, V151, P373; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Griffin TJ, 2000, TRENDS BIOTECHNOL, V18, P77, DOI 10.1016/S0167-7799(99)01401-8; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Jacobs M, 2000, CLIN IMMUNOL, V94, P192, DOI 10.1006/clim.2000.4835; Knight JC, 2004, NAT GENET, V36, P394, DOI 10.1038/ng1331; LEE LG, 1993, NUCLEIC ACIDS RES, V21, P3761, DOI 10.1093/nar/21.16.3761; Mira MT, 2006, MICROBES INFECT, V8, P1124, DOI 10.1016/j.micinf.2005.10.024; Mira MT, 2003, NAT GENET, V33, P412, DOI 10.1038/ng1096; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; Roach DR, 2001, J EXP MED, V193, P239, DOI 10.1084/jem.193.2.239; Schaid DJ, 1998, AM J HUM GENET, V63, P1492, DOI 10.1086/302094; Ware CF, 2005, ANNU REV IMMUNOL, V23, P787, DOI 10.1146/annurev.immunol.23.021704.115719; *WHO, 2006, WKLY EPIDEMIOL REC, V81, P309; Zerva L, 1996, J EXP MED, V183, P829, DOI 10.1084/jem.183.3.829	27	125	130	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2007	39	4					517	522		10.1038/ng2000	http://dx.doi.org/10.1038/ng2000			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17353895				2022-12-27	WOS:000245271200022
J	Stevanin, G; Santorelli, FM; Azzedine, H; Coutinho, P; Chomilier, J; Denora, PS; Martin, E; Ouvrard-Hernandez, AM; Tessa, A; Bouslam, N; Lossos, A; Charles, P; Loureiro, JL; Elleuch, N; Confavreux, C; Cruz, VT; Ruberg, M; Leguern, E; Grid, D; Tazir, M; Fontaine, B; Filla, A; Bertini, E; Durr, A; Brice, A				Stevanin, Giovanni; Santorelli, Filippo M.; Azzedine, Hamid; Coutinho, Paula; Chomilier, Jacques; Denora, Paola S.; Martin, Elodie; Ouvrard-Hernandez, Anne-Marie; Tessa, Alessandra; Bouslam, Naima; Lossos, Alexander; Charles, Perrine; Loureiro, Jose L.; Elleuch, Nizar; Confavreux, Christian; Cruz, Vitor T.; Ruberg, Merle; Leguern, Eric; Grid, Djamel; Tazir, Meriem; Fontaine, Bertrand; Filla, Alessandro; Bertini, Enrico; Durr, Alexandra; Brice, Alexis			Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum	NATURE GENETICS			English	Article							HYDROPHOBIC CLUSTER-ANALYSIS; GENETIC-HETEROGENEITY; MENTAL IMPAIRMENT; LOCUS; PROTEINS; LINKAGE	Autosomal recessive hereditary spastic paraplegia (ARHSP) with thin corpus callosum (TCC) is a common and clinically distinct form of familial spastic paraplegia that is linked to the SPG11 locus on chromosome 15 in most affected families. We analyzed 12 ARHSP-TCC families, refined the SPG11 candidate interval and identified ten mutations in a previously unidentified gene expressed ubiquitously in the nervous system but most prominently in the cerebellum, cerebral cortex, hippocampus and pineal gland. The mutations were either nonsense or insertions and deletions leading to a frameshift, suggesting a loss-of-function mechanism. The identification of the function of the gene will provide insight into the mechanisms leading to the degeneration of the corticospinal tract and other brain structures in this frequent form of ARHSP.	Hop La Pitie Salpetriere, INSERM, UMR679, Fed Inst Neurosci Res, Paris, France; Univ Paris 06, Pitie Salpetriere Hosp, UMR679, Paris, France; Hop La Pitie Salpetriere, APHP, Dept Cytogenet & Genet, Paris, France; Bambino Gesu Pediat Hosp, IRCCS, Mol Med Unit, Rome, Italy; Univ Porto, UnIGENe, P-4100 Oporto, Portugal; Hosp S Sebastiao, Dept Neurol, Santa Maria Feira, Portugal; Univ Paris 06, Inst Mineral & Phys Milieux Condenses, F-75252 Paris 05, France; Univ Paris 07, Inst Mineral & Phys Milieux Condenses, F-75221 Paris 05, France; CHU Grenoble, Dept Neurol, F-38043 Grenoble, France; Hebrew Univ Jerusalem, Hadassah Med Ctr, Agnes Ginges Ctr Human Neurogenet, Dept Neurol, IL-91905 Jerusalem, Israel; Hop Neurol & Neurochirurg P Wertheimer, Lyon, France; Genethon, Evry, France; Mustapha Hosp, Dept Neurol, Algiers, Algeria; Grp Hosp Pitie Salpetriere, INSERM, U546, F-75634 Paris, France; Hop La Pitie Salpetriere, APHP, Federat Neurol, Paris, France; Univ Paris 06, Pitie Salpetriere Med Sch, F-75252 Paris 05, France; Univ Naples Federico II, Dept Neurol Sci, Naples, Italy	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; IRCCS Bambino Gesu; Universidade do Porto; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paris Cite; CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Hebrew University of Jerusalem; Hadassah University Medical Center; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Naples Federico II	Stevanin, G (corresponding author), Hop La Pitie Salpetriere, INSERM, UMR679, Fed Inst Neurosci Res, Paris, France.	stevanin@ccr.jussieu.fr	MARTIN, Elodie/ABF-3563-2020; brice, alexis/AAE-8275-2019; Tessa, Alessandra/AAA-4442-2021; Stevanin, Giovanni/E-5038-2016; Cruz, Vítor Tedim/AAM-3014-2020; Santorelli, Filippo M/ABE-5124-2020; Bertini, Enrico/ABG-1278-2020; Bertini, Enrico/A-2284-2014; Brice, Alexis/A-2170-2009; Coutinho, Paula/K-6053-2013; Loureiro, José Leal/K-6379-2013; Tessa, Alessandra/K-2325-2016	MARTIN, Elodie/0000-0002-4494-9168; brice, alexis/0000-0002-0941-3990; Tessa, Alessandra/0000-0002-1445-6434; Stevanin, Giovanni/0000-0001-9368-8657; Cruz, Vítor Tedim/0000-0002-5333-4771; Santorelli, Filippo M/0000-0002-1359-9062; Bertini, Enrico/0000-0001-9276-4590; Loureiro, José Leal/0000-0002-6195-5412; Tessa, Alessandra/0000-0002-1445-6434; CHOMILIER, Jacques/0000-0002-4250-0762; Coutinho, Paula/0000-0002-3461-230X	Telethon [GGP06188] Funding Source: Medline	Telethon(Fondazione Telethon)		Al-Yahyaee S, 2006, NEUROLOGY, V66, P1230, DOI 10.1212/01.wnl.0000208501.52849.dd; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Casali C, 2004, NEUROLOGY, V62, P262, DOI 10.1212/WNL.62.2.262; Crosby AH, 2002, AM J HUM GENET, V71, P1009, DOI 10.1086/344206; Elleuch N, 2006, NEUROLOGY, V66, P654, DOI 10.1212/01.wnl.0000201185.91110.15; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; HARDING AE, 1983, LANCET, V1, P1151; Howard HC, 2002, NAT GENET, V32, P384, DOI 10.1038/ng1002; Hughes CA, 2001, NEUROLOGY, V56, P1230, DOI 10.1212/WNL.56.9.1230; Kikuno R, 2002, NUCLEIC ACIDS RES, V30, P166, DOI 10.1093/nar/30.1.166; Lossos A, 2006, ARCH NEUROL-CHICAGO, V63, P756, DOI 10.1001/archneur.63.5.756; MARTINEZ MF, 1999, NEUROLOGY, V53, P50; Moutsimilli L, 2005, NEUROPHARMACOLOGY, V49, P890, DOI 10.1016/j.neuropharm.2005.06.017; Mucchielli-Giorgi MHM, 2002, PROTEINS, V46, P243, DOI 10.1002/prot.10047; NAGANATHAN PB, 1995, PACKAGING TECHNOLOGY, V8, P85, DOI DOI 10.1002/PTS.2770080204; NAKAMURA A, 1995, J NEUROL SCI, V131, P35, DOI 10.1016/0022-510X(95)00028-Z; Olmez A, 2006, NEUROPEDIATRICS, V37, P59, DOI 10.1055/s-2006-923982; Orlacchio A, 2005, MOVEMENT DISORD, V20, P1055, DOI 10.1002/mds.20494; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Shibasaki Y, 2000, ANN NEUROL, V48, P108, DOI 10.1002/1531-8249(200007)48:1<108::AID-ANA17>3.3.CO;2-1; Simpson MA, 2003, AM J HUM GENET, V73, P1147, DOI 10.1086/379522; Stevanin G, 2006, NEUROGENETICS, V7, P149, DOI 10.1007/s10048-006-0044-2; Winner B, 2004, ARCH NEUROL-CHICAGO, V61, P117, DOI 10.1001/archneur.61.1.117; WOODCOCK S, 1992, PROTEIN ENG, V5, P629, DOI 10.1093/protein/5.7.629	24	235	252	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2007	39	3					366	372		10.1038/ng1980	http://dx.doi.org/10.1038/ng1980			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17322883				2022-12-27	WOS:000244480000019
J	Spielman, RS; Bastone, LA; Burdick, JT; Morley, M; Ewens, WJ; Cheung, VG				Spielman, Richard S.; Bastone, Laurel A.; Burdick, Joshua T.; Morley, Michael; Ewens, Warren J.; Cheung, Vivian G.			Common genetic variants account for differences in gene expression among ethnic groups	NATURE GENETICS			English	Article							HUMAN GENOME; POLYMORPHISMS; PIGMENTATION; PATTERNS; HUMANS	Variation in DNA sequence contributes to individual differences in quantitative traits, but in humans the specific sequence variants are known for very few traits. We characterized variation in gene expression in cells from individuals belonging to three major population groups. This quantitative phenotype differs significantly between European-derived and Asian-derived populations for 1,097 of 4,197 genes tested. For the phenotypes with the strongest evidence of cis determinants, most of the variation is due to allele frequency differences at cis-linked regulators. The results show that specific genetic variation among populations contributes appreciably to differences in gene expression phenotypes. Populations differ in prevalence of many complex genetic diseases, such as diabetes and cardiovascular disease. As some of these are probably influenced by the level of gene expression, our results suggest that allele frequency differences at regulatory polymorphisms also account for some population differences in prevalence of complex diseases.	Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Epidemiol & Biostat, Philadelphia, PA 19104 USA; Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania	Cheung, VG (corresponding author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	spielman@pobox.upenn.edu; vcheung@mail.med.upenn.edu	Cheung, Vivian G./AAT-3115-2020	Morley, Michael/0000-0002-0958-7376	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015733] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081930] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ES015733-03, R01 ES015733] Funding Source: Medline; NIGMS NIH HHS [R01 GM081930, R01 GM081930-08] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Knight JC, 2005, J MOL MED, V83, P97, DOI 10.1007/s00109-004-0603-7; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McEvoy B, 2006, HUM MOL GENET, V15, pR176, DOI 10.1093/hmg/ddl217; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Osada N, 2006, MOL BIOL EVOL, V23, P1585, DOI 10.1093/molbev/msl023; Pastinen T, 2004, PHYSIOL GENOMICS, V16, P184, DOI 10.1152/physiolgenomics.00163.2003; PAW BH, 1990, AM J HUM GENET, V47, P698; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tsui Lap-Chee, 1992, Human Mutation, V1, P197, DOI 10.1002/humu.1380010304; Westfall P.H., 1992, RESAMPLING BASED MUL; Wilson W, 2004, GENOMICS, V84, P707, DOI 10.1016/j.ygeno.2004.06.011; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545	20	359	376	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2007	39	2					226	231		10.1038/ng1955	http://dx.doi.org/10.1038/ng1955			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17206142	Green Accepted			2022-12-27	WOS:000244063900021
J	[Anonymous]				[Anonymous]			New handles on genomic structural variation	NATURE GENETICS			English	Editorial Material								Procedures for genotyping structural variants with SNP detection arrays now permit many of the larger and more common polymorphisms to be incorporated into association studies.											0	0	0	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2008	40	10					1143	1143		10.1038/ng1008-1143	http://dx.doi.org/10.1038/ng1008-1143			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18818712	Bronze			2022-12-27	WOS:000259651000001
J	Holt, KE; Parkhill, J; Mazzoni, CJ; Roumagnac, P; Weill, FX; Goodhead, I; Rance, R; Baker, S; Maskell, DJ; Wain, J; Dolecek, C; Achtman, M; Dougan, G				Holt, Kathryn E.; Parkhill, Julian; Mazzoni, Camila J.; Roumagnac, Philippe; Weill, Francois-Xavier; Goodhead, Ian; Rance, Richard; Baker, Stephen; Maskell, Duncan J.; Wain, John; Dolecek, Christiane; Achtman, Mark; Dougan, Gordon			High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi	NATURE GENETICS			English	Article							ENTERICA SEROVAR TYPHI; PATHOGENICITY ISLAND; VI EXOPOLYSACCHARIDE; STRAINS; RECOMBINATION; ACQUISITION; RESISTANCE; DIVERSITY; SANTIAGO; CARRIERS	Isolates of Salmonella enterica serovar Typhi (Typhi), a human-restricted bacterial pathogen that causes typhoid, show limited genetic variation. We generated whole-genome sequences for 19 Typhi isolates using 454 (Roche) and Solexa (Illumina) technologies. Isolates, including the previously sequenced CT18 and Ty2 isolates, were selected to represent major nodes in the phylogenetic tree. Comparative analysis showed little evidence of purifying selection, antigenic variation or recombination between isolates. Rather, evolution in the Typhi population seems to be characterized by ongoing loss of gene function, consistent with a small effective population size. The lack of evidence for antigenic variation driven by immune selection is in contrast to strong adaptive selection for mutations conferring antibiotic resistance in Typhi. The observed patterns of genetic isolation and drift are consistent with the proposed key role of asymptomatic carriers of Typhi as the main reservoir of this pathogen, highlighting the need for identification and treatment of carriers.	[Holt, Kathryn E.; Parkhill, Julian; Goodhead, Ian; Rance, Richard; Baker, Stephen; Wain, John; Dougan, Gordon] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Mazzoni, Camila J.; Achtman, Mark] Natl Univ Ireland Univ Coll Cork, Environm Res Inst, Cork, Ireland; [Mazzoni, Camila J.; Roumagnac, Philippe; Achtman, Mark] Max Planck Inst Infektionsbiol, Dept Mol Biol, D-10117 Berlin, Germany; [Roumagnac, Philippe] Aix Marseille Univ, Univ Mixte Rech Ctr Natl Rech Sci 6191, Commissariat Energie Atom, F-13108 St Paul Les Durance, France; [Weill, Francois-Xavier] Inst Pasteur, Lab Bacteries Pathogenes Enter, F-75724 Paris 15, France; [Baker, Stephen; Dolecek, Christiane] Univ Oxford, Clin Res Unit, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Maskell, Duncan J.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England	Wellcome Trust Sanger Institute; University College Cork; Max Planck Society; CEA; UDICE-French Research Universities; Aix-Marseille Universite; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Oxford; University of Cambridge	Holt, KE (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	kh2@sanger.ac.uk	Mazzoni, Camila J/L-3441-2014; Mazzoni, Camila/AAJ-9702-2020; Goodhead, Ian/ABC-9200-2020; Holt, Kathryn E/A-8108-2012; Wain, John/B-3446-2013; Parkhill, Julian/G-4703-2011	Mazzoni, Camila/0000-0001-6758-5427; Holt, Kathryn E/0000-0003-3949-2471; Wain, John/0000-0002-1257-1148; Parkhill, Julian/0000-0002-7069-5958; Weill, Francois-Xavier/0000-0001-9941-5799; Roumagnac, Philippe/0000-0001-5002-6039; Goodhead, Ian/0000-0002-3110-9442; Baker, Stephen/0000-0003-1308-5755; Achtman, Mark/0000-0001-6815-0070	Wellcome Trust [067321] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Andersson JO, 1999, MOL BIOL EVOL, V16, P1178, DOI 10.1093/oxfordjournals.molbev.a026208; Baker S, 2008, J CLIN MICROBIOL, V46, P1741, DOI 10.1128/JCM.02249-07; Bertram G, 2001, MICROBIOL-SGM, V147, P255, DOI 10.1099/00221287-147-2-255; Boyd EF, 2003, J CLIN MICROBIOL, V41, P3823, DOI 10.1128/JCM.41.8.3823-3828.2003; Bueno SM, 2004, J BACTERIOL, V186, P3202, DOI 10.1128/JB.186.10.3202-3213.2004; Chau TT, 2007, ANTIMICROB AGENTS CH, V51, P4315, DOI 10.1128/AAC.00294-07; Cho JC, 1999, FEMS MICROBIOL LETT, V170, P257, DOI 10.1111/j.1574-6968.1999.tb13382.x; Coburn B, 2007, IMMUNOL CELL BIOL, V85, P112, DOI 10.1038/sj.icb.7100007; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Deng W, 2003, J BACTERIOL, V185, P2330, DOI 10.1128/JB.185.7.2330-2337.2003; Didelot X, 2007, GENOME RES, V17, P61, DOI 10.1101/gr.5512906; Falush D, 2006, TRENDS MICROBIOL, V14, P353, DOI 10.1016/j.tim.2006.06.003; Gey van Pittius NC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-95; Gomes JP, 2007, GENOME RES, V17, P50, DOI 10.1101/gr.5674706; Hall N, 2007, J EXP BIOL, V210, P1518, DOI 10.1242/jeb.001370; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hiller NL, 2007, J BACTERIOL, V189, P8186, DOI 10.1128/JB.00690-07; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Le TAH, 2007, J CLIN MICROBIOL, V45, P3485, DOI 10.1128/JCM.00948-07; LEVINE MM, 1982, J INFECT DIS, V146, P724, DOI 10.1093/infdis/146.6.724; Lewis MD, 2005, CLIN INFECT DIS, V40, P554, DOI 10.1086/427503; Nair S, 2004, J BACTERIOL, V186, P3214, DOI 10.1128/JB.186.10.3214-3223.2004; Octavia S, 2007, J CLIN MICROBIOL, V45, P3795, DOI 10.1128/JCM.00720-07; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Pearson T, 2004, P NATL ACAD SCI USA, V101, P13536, DOI 10.1073/pnas.0403844101; Pickard D, 2003, J BACTERIOL, V185, P5055, DOI 10.1128/JB.185.17.5055-5065.2003; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Saurin W, 1999, J MOL EVOL, V48, P22, DOI 10.1007/PL00006442; SEARS SD, 1984, J INFECT DIS, V149, P640, DOI 10.1093/infdis/149.4.640; Sokurenko EV, 2006, NAT REV MICROBIOL, V4, P548, DOI 10.1038/nrmicro1446; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Thomson N, 2004, J MOL BIOL, V339, P279, DOI 10.1016/j.jmb.2004.03.058; Thomson NR, 2006, PLOS GENET, V2, P2039, DOI 10.1371/journal.pgen.0020206; Turner AK, 2006, J ANTIMICROB CHEMOTH, V58, P733, DOI 10.1093/jac/dkl333; Vaishnavi C, 2005, MICROBIOL IMMUNOL, V49, P107, DOI 10.1111/j.1348-0421.2005.tb03709.x; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; Webber MA, 2003, J ANTIMICROB CHEMOTH, V51, P9, DOI 10.1093/jac/dkg050	41	389	405	1	70	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2008	40	8					987	993		10.1038/ng.195	http://dx.doi.org/10.1038/ng.195			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18660809	Green Accepted			2022-12-27	WOS:000258026900015
J	McBride, CM; Alford, SH; Reid, RJ; Larson, EB; Baxevanis, AD; Brody, LC				McBride, Colleen M.; Alford, Sharon Hensley; Reid, Robert J.; Larson, Eric B.; Baxevanis, Andreas D.; Brody, Lawrence C.			Putting science over supposition in the arena of personalized genomics	NATURE GENETICS			English	Editorial Material							HEALTH BEHAVIOR-CHANGE; MEDICINE; DISEASES	We explore the process of going from genome discovery to evaluation of medical impact and discuss emerging challenges faced by the scientific community. the need to confront these challenges is heightened in a climate where unregulated genetic tests are being marketed directly to the general public(1,2). Specifically, we characterize the delicate balance involved in deciding when genomic discoveries such as gene-disease associations are 'ready' to be evaluated as potential tools to improve health. We recommend that a considerable research commitment be made now in order to successfully bridge the rapidly widening gap between gene-disease association research and the critical (but slower and more involved) investigations into public health and clinical utility. Lastly, we describe a large, ongoing, early-phase research project, the multiplex Initiative, which is examining issues related to the utility of genetic susceptibility testing for common health conditions.	[McBride, Colleen M.] Natl Genome Res Inst, Social & Behav Res Branch, NIH, Bethesda, MD 20892 USA; [Alford, Sharon Hensley] Henry Ford Hosp, Detroit, MI 48202 USA; [Reid, Robert J.; Larson, Eric B.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA; [Baxevanis, Andreas D.; Brody, Lawrence C.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Henry Ford Health System; Henry Ford Hospital; Group Health Cooperative; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	McBride, CM (corresponding author), Natl Genome Res Inst, Social & Behav Res Branch, NIH, Bethesda, MD 20892 USA.	cmcbride@mail.nih.gov; lbrody@helix.nih.gov		Baxevanis, Andy/0000-0002-5370-0014	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200344, Z01HG200345] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 HG200344-01] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Baird PA, 2002, PERSPECT BIOL MED, V45, P516, DOI 10.1353/pbm.2002.0061; Baker M, 2008, NATURE, V451, P516, DOI 10.1038/451516a; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; COOKEDEEGAN R, 1994, GENE WARS SCI POLITI; Haga SB, 2003, NAT GENET, V34, P347, DOI 10.1038/ng0803-347; Hammond D, 2007, AM J PREV MED, V32, P202, DOI 10.1016/j.amepre.2006.11.011; Hunter DJ, 2008, NEW ENGL J MED, V358, P105, DOI 10.1056/NEJMp0708162; Institute of Medicine, 2004, HLTH LIT; Katsanis SH, 2008, SCIENCE, V320, P53, DOI 10.1126/science.1156604; Khoury MJ, 2007, GENET MED, V9, P665, DOI 10.1097/GIM.0b013e31815699d0; Lunshof JE, 2006, PHARMACOGENOMICS, V7, P237, DOI 10.2217/14622416.7.2.237; McClure JB, 2002, AM J PREV MED, V22, P200, DOI 10.1016/S0749-3797(01)00425-1; Ory MG, 2002, HEALTH EDUC RES, V17, P500, DOI 10.1093/her/17.5.500; Roberts L, 2001, SCIENCE, V291, P1182; Satia JA, 2005, J AM DIET ASSOC, V105, P392, DOI 10.1016/j.jada.2004.12.006; Scheuner MT, 2008, JAMA-J AM MED ASSOC, V299, P1320, DOI 10.1001/jama.299.11.1320; Thrasher JF, 2007, ADDICT BEHAV, V32, P2916, DOI 10.1016/j.addbeh.2007.05.018; Zerhouni E, 2003, SCIENCE, V302, P63, DOI 10.1126/science.1091867	18	71	71	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					939	942		10.1038/ng0808-939	http://dx.doi.org/10.1038/ng0808-939			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18665132	Green Accepted			2022-12-27	WOS:000258026900006
J	Schormair, B; Kemlink, D; Roeske, D; Eckstein, G; Xiong, L; Lichtner, P; Ripke, S; Trenkwalder, C; Zimprich, A; Stiasny-Kolster, K; Oertel, W; Bachmann, CG; Paulus, W; Hogl, B; Frauscher, B; Gschliesser, V; Poewe, W; Peglau, I; Vodicka, P; Vavrova, J; Sonka, K; Nevsimalova, S; Montplaisir, J; Turecki, G; Rouleau, G; Gieger, C; Illig, T; Wichmann, HE; Holsboer, F; Mueller-Myhsok, B; Meitinger, T; Winkelmann, J				Schormair, Barbara; Kemlink, David; Roeske, Darina; Eckstein, Gertrud; Xiong, Lan; Lichtner, Peter; Ripke, Stephan; Trenkwalder, Claudia; Zimprich, Alexander; Stiasny-Kolster, Karin; Oertel, Wolfgang; Bachmann, Cornelius G.; Paulus, Walter; Hoegl, Birgit; Frauscher, Birgit; Gschliesser, Viola; Poewe, Werner; Peglau, Ines; Vodicka, Pavel; Vavrova, Jana; Sonka, Karel; Nevsimalova, Sona; Montplaisir, Jacques; Turecki, Gustavo; Rouleau, Guy; Gieger, Christian; Illig, Thomas; Wichmann, H-Erich; Holsboer, Florian; Mueller-Myhsok, Bertram; Meitinger, Thomas; Winkelmann, Juliane			PTPRD (protein tyrosine phosphatase receptor type delta) is associated with restless legs syndrome	NATURE GENETICS			English	Article							PERIODIC LIMB MOVEMENTS; GENETIC RISK-FACTOR; CHROMOSOME 9P; LINKAGE; LOCUS; CANCER; FAMILY; SLEEP	We identified association of restless legs syndrome (RLS) with PTPRD at 9p23-24 in 2,458 affected individuals and 4,749 controls from Germany, Austria, Czechia and Canada. Two independent SNPs in the 5' UTR of splice variants expressed predominantly in the central nervous system showed highly significant P values (rs4626664, P(nominal/lambda corrected) = 5.91 x 10(-10), odds ratio (OR) = 1.44; rs1975197, P(nominal/lambda corrected) = 5.81 x 10(-9), OR 1.31). This work identifies PTPRD as the fourth genome-wide significant locus for RLS.	[Schormair, Barbara; Kemlink, David; Eckstein, Gertrud; Lichtner, Peter; Meitinger, Thomas; Winkelmann, Juliane] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [Schormair, Barbara; Lichtner, Peter; Meitinger, Thomas; Winkelmann, Juliane] Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; [Kemlink, David; Eckstein, Gertrud; Sonka, Karel; Nevsimalova, Sona] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague 12000, Czech Republic; [Roeske, Darina; Ripke, Stephan; Holsboer, Florian; Mueller-Myhsok, Bertram; Winkelmann, Juliane] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Xiong, Lan] Univ Montreal, Hop Notre Dame de Bon Secours, Ctr Excellence Neurom, Montreal, PQ H2L 4M1, Canada; [Trenkwalder, Claudia] Paracelsus Elena Hosp, D-34128 Kassel, Germany; [Zimprich, Alexander] Med Univ Vienna, Dept Neurol, A-1090 Vienna, Austria; [Stiasny-Kolster, Karin; Oertel, Wolfgang] Philipps Univ, Dept Neurol, Ctr Nervous Dis, D-35039 Marburg, Germany; [Bachmann, Cornelius G.; Paulus, Walter] Univ Gottingen, Dept Clin Neurophysiol, D-37070 Gottingen, Germany; [Hoegl, Birgit; Frauscher, Birgit; Gschliesser, Viola; Poewe, Werner] Innsbruck Med Univ, Dept Neurol, A-6020 Innsbruck, Austria; [Peglau, Ines] Neurol Praxis, D-10969 Berlin, Germany; [Vodicka, Pavel] Acad Sci Czech Republic, Inst Expt Med, Prague, Czech Republic; [Montplaisir, Jacques] Hop Sacre Coeur, Ctr Etude Sommeil, Montreal, PQ H4J 1C5, Canada; [Montplaisir, Jacques] Univ Montreal, Ctr Rech Sci Neurol, Montreal, PQ H4J 1C5, Canada; [Turecki, Gustavo] McGill Univ, Douglas Hosp, Dept Psychiat, Verdun, PQ H4H 1R3, Canada; McGill Univ, Douglas Hosp, Dept Human Genet, Verdun, PQ H4H 1R3, Canada; [Illig, Thomas; Wichmann, H-Erich] Helmholtz Zentrum Munchen German Res Ctr Environm, Inst Epidemiol, D-85764 Munich, Germany; [Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, D-81377 Munich, Germany; [Winkelmann, Juliane] Tech Univ Munich, Neurol Klin & Poliklin, D-81675 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Charles University Prague; Max Planck Society; Universite de Montreal; Medical University of Vienna; Philipps University Marburg; University of Gottingen; Medical University of Innsbruck; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Universite de Montreal; Universite de Montreal; McGill University; McGill University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Technical University of Munich; University of Hamburg; University Medical Center Hamburg-Eppendorf	Winkelmann, J (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany.	meitinger@helmholtz-muenchen.de; winkelmann@lrz.tu-muenchen.de	Turecki, Gustavo/K-5100-2015; Vodicka, Pavel/H-3370-2014; Zimprich, Alexander/A-5232-2017; Ripke, Stephan/AAK-5486-2021; Wichmann, Heinz Erich/AAA-5695-2022; Trenkwalder, Claudia/AHD-1232-2022; Nevšímalová, Soňa/H-3533-2017; Paulus, Walter/A-3544-2009; Šonka, Karel/G-1801-2017; Kemlink, David/Q-3019-2019; Kemlink, David/F-9567-2017; Meitinger, Thomas/O-1318-2015; Trenkwalder, Claudia/ABD-6559-2021	Zimprich, Alexander/0000-0002-1668-5177; Trenkwalder, Claudia/0000-0001-6407-1199; Nevšímalová, Soňa/0000-0003-0083-3742; Paulus, Walter/0000-0001-5549-8377; Šonka, Karel/0000-0001-5773-9656; Kemlink, David/0000-0003-1398-5796; Vodicka, Pavel/0000-0003-2376-1243; Hogl, Birgit/0000-0003-1894-7641; ripke, stephan/0000-0003-3622-835X; Meitinger, Thomas/0000-0002-8838-8403; Gieger, Christian/0000-0001-6986-9554; Winkelmann, Juliane/0000-0003-2667-9691; Turecki, Gustavo/0000-0003-4075-2736				Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Bonnen PE, 2002, GENOME RES, V12, P1846, DOI 10.1101/gr.483802; Chen SH, 2004, AM J HUM GENET, V74, P876, DOI 10.1086/420772; Kemlink D, 2007, MOVEMENT DISORD, V22, P207, DOI 10.1002/mds.21254; Liebetanz KM, 2006, NEUROLOGY, V67, P320, DOI 10.1212/01.wnl.0000224886.65213.b5; Lohmann-Hedrich K, 2008, NEUROLOGY, V70, P686, DOI 10.1212/01.wnl.0000282760.07650.ba; Nair P, 2008, GENE CHROMOSOME CANC, V47, P197, DOI 10.1002/gcc.20521; PULIDO R, 1995, J BIOL CHEM, V270, P6722, DOI 10.1074/jbc.270.12.6722; Ray A, 2005, AM J HUM GENET, V76, P705, DOI 10.1086/429392; Sato M, 2005, GENE CHROMOSOME CANC, V44, P405, DOI 10.1002/gcc.20253; Stefansson H, 2007, NEW ENGL J MED, V357, P639, DOI 10.1056/NEJMoa072743; Uetani N, 2006, J NEUROSCI, V26, P5872, DOI 10.1523/JNEUROSCI.0386-06.2006; Vilarino-Guell C, 2008, NEW ENGL J MED, V358, P425, DOI 10.1056/NEJMc072518; Winkelmann J, 2007, MOVEMENT DISORD, V22, pS449, DOI 10.1002/mds.21587; Winkelmann J, 2007, NAT GENET, V39, P1000, DOI 10.1038/ng2099	15	190	195	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					946	948		10.1038/ng.190	http://dx.doi.org/10.1038/ng.190			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18660810				2022-12-27	WOS:000258026900008
J	Mueller, JL; Mahadevaiah, SK; Park, PJ; Warburton, PE; Page, DC; Turner, JMA				Mueller, Jacob L.; Mahadevaiah, Shantha K.; Park, Peter J.; Warburton, Peter E.; Page, David C.; Turner, James M. A.			The mouse X chromosome is enriched for multicopy testis genes showing postmeiotic expression	NATURE GENETICS			English	Article							DIFFERENTIAL EXPRESSION; SEX-CHROMOSOMES; HUMAN GENOME; INACTIVATION; HETEROCHROMATIN; CHROMATIN	According to the prevailing view, mammalian X chromosomes are enriched in spermatogenesis genes expressed before meiosis(1-3) and deficient in spermatogenesis genes expressed after meiosis(2,3).The paucity of postmeiotic genes on the X chromosome has been interpreted as a consequence of meiotic sex chromosome inactivation (MSCI)-the complete silencing of genes on the XY bivalent at meiotic prophase(4,5). Recent studies have concluded that MSCI-initiated silencing persists beyond meiosis(6-8) and that most genes on the X chromosome remain repressed in round spermatids(7). Here, we report that 33 multicopy gene families, representing similar to 273 mouse X-linked genes, are expressed in the testis and that this expression is predominantly in postmeiotic cells. RNA FISH and microarray analysis show that the maintenance of X chromosome postmeiotic repression is incomplete. Furthermore, X-linked multicopy genes exhibit a similar degree of expression as autosomal genes. Thus, not only is the mouse X chromosome enriched for spermatogenesis genes functioning before meiosis, but in addition, similar to 18% of mouse X-linked genes are expressed in postmeiotic cells.	[Mueller, Jacob L.; Page, David C.] Whitehead Inst, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Mueller, Jacob L.; Page, David C.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Mahadevaiah, Shantha K.; Turner, James M. A.] Natl Inst Med Res, MRC, Div Stem Cell Res & Dev Genet, London NW7 1AA, England; [Park, Peter J.] Harvard Partners Ctr Genet & Genom, Childrens Hosp Informat Program, Boston, MA 02115 USA; [Warburton, Peter E.] Mt Sinai Sch Med, Dept Human Genet, New York, NY 10029 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); MRC National Institute for Medical Research; Harvard University; Boston Children's Hospital; Icahn School of Medicine at Mount Sinai	Mueller, JL (corresponding author), Whitehead Inst, Howard Hughes Med Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jmueller@wi.mit.edu; jturner@nimr.mrc.ac.uk		Park, Peter/0000-0001-9378-960X; Mueller, Jacob L./0000-0003-1232-0303	Howard Hughes Medical Institute Funding Source: Medline; Medical Research Council [MC_U117588498] Funding Source: Medline; NICHD NIH HHS [F32 HD052379, F32HD052379, HD000257, F32 HD052379-02] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD052379] Funding Source: NIH RePORTER; MRC [MC_U117588498] Funding Source: UKRI	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Eichler EE, 2004, NAT REV GENET, V5, P345, DOI 10.1038/nrg1322; Govin J, 2007, J CELL BIOL, V176, P283, DOI 10.1083/jcb.200604141; Greaves IK, 2006, MOL CELL BIOL, V26, P5394, DOI 10.1128/MCB.00519-06; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Khil PP, 2004, NAT GENET, V36, P642, DOI 10.1038/ng1368; Kimura T, 2003, MOL CELL BIOL, V23, P1304, DOI 10.1128/MCB.23.4.1304-1315.2003; Mazeyrat S, 2001, NAT GENET, V29, P49, DOI 10.1038/ng717; MCKEE BD, 1993, CHROMOSOMA, V102, P71, DOI 10.1007/BF00356023; Mroz K, 1999, DEV BIOL, V207, P229, DOI 10.1006/dbio.1998.9160; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Reinke V, 2004, NAT GENET, V36, P548, DOI 10.1038/ng0604-548; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018; Turner JMA, 2006, DEV CELL, V10, P521, DOI 10.1016/j.devcel.2006.02.009; Wang PJ, 2005, HUM MOL GENET, V14, P2911, DOI 10.1093/hmg/ddi322; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Warburton PE, 2004, GENOME RES, V14, P1861, DOI 10.1101/gr.2542904; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Westbrook VA, 2006, MOL HUM REPROD, V12, P703, DOI 10.1093/molehr/gal079; Westbrook VA, 2000, BIOL REPROD, V63, P469, DOI 10.1093/biolreprod/63.2.469	21	220	223	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2008	40	6					794	799		10.1038/ng.126	http://dx.doi.org/10.1038/ng.126			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18454149	Green Accepted			2022-12-27	WOS:000256212000023
J	Ji, WZ; Foo, JN; O'Roak, BJ; Zhao, H; Larson, MG; Simon, DB; Newton-Cheh, C; State, MW; Levy, D; Lifton, RP				Ji, Weizhen; Foo, Jia Nee; O'Roak, Brian J.; Zhao, Hongyu; Larson, Martin G.; Simon, David B.; Newton-Cheh, Christopher; State, Matthew W.; Levy, Daniel; Lifton, Richard P.			Rare independent mutations in renal salt handling genes contribute to blood pressure variation	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; NA-CL COTRANSPORTER; CORONARY-HEART-DISEASE; BARTTERS-SYNDROME; HYPOKALEMIC ALKALOSIS; RISK; HYPERCALCIURIA; SUSCEPTIBILITY; MECHANISMS; EXPRESSION	The effects of alleles in many genes are believed to contribute to common complex diseases such as hypertension. Whether risk alleles comprise a small number of common variants or many rare independent mutations at trait loci is largely unknown. We screened members of the Framingham Heart Study (FHS) for variation in three genes-SLC12A3 (NCCT), SLC12A1 (NKCC2) and KCNJ1 (ROMK)- causing rare recessive diseases featuring large reductions in blood pressure. Using comparative genomics, genetics and biochemistry, we identified subjects with mutations proven or inferred to be functional. These mutations, all heterozygous and rare, produce clinically significant blood pressure reduction and protect from development of hypertension. Our findings implicate many rare alleles that alter renal salt handling in blood pressure variation in the general population, and identify alleles with health benefit that are nonetheless under purifying selection. These findings have implications for the genetic architecture of hypertension and other common complex traits.	[Ji, Weizhen; Foo, Jia Nee; O'Roak, Brian J.; Zhao, Hongyu; Simon, David B.; State, Matthew W.; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Ji, Weizhen; Foo, Jia Nee; Simon, David B.; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Zhao, Hongyu] Yale Univ, Sch Med, Dept Epidemiol & Publ Hlth, New Haven, CT 06510 USA; [Larson, Martin G.; Newton-Cheh, Christopher; Levy, Daniel] NHLBI, Framingham Heart Study, Framingham, MA 01702 USA; [Larson, Martin G.] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [State, Matthew W.] Yale Univ, Ctr Child Study, Sch Med, New Haven, CT 06520 USA; [Levy, Daniel] NHLBI, Bethesda, MD 20892 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Boston University; Yale University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Lifton, RP (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St, New Haven, CT 06510 USA.	richard.lifton@yale.edu	State, Matthew/W-2256-2019; Foo, Jia Nee/D-6069-2014; Levy, Daniel/ABF-6873-2021; Levy, Daniel/ABB-2752-2021	Foo, Jia Nee/0000-0001-9899-2308; Levy, Daniel/0000-0003-1843-8724; Larson, Martin/0000-0002-9631-1254; State, Matthew/0000-0003-1624-8302; O'Roak, Brian/0000-0002-4141-0095	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL055007, ZIAHL006001] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [N01-HC-25195, P50 HL055007, N01HC25195] Funding Source: Medline	DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		[Anonymous], 1967, J AMER MED ASSOC, V202, P1028, DOI 10.1001/jama.1967.03130240070013; Birkenhager R, 2001, NAT GENET, V29, P310, DOI 10.1038/ng752; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chanchevalap S, 2000, J BIOL CHEM, V275, P7811, DOI 10.1074/jbc.275.11.7811; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Cooper DN, 1995, METABOLIC MOL BASES, P259; Cruz DN, 2001, HYPERTENSION, V37, P1458, DOI 10.1161/01.HYP.37.6.1458; Cruz DN, 2001, NEPHROL DIAL TRANSPL, V16, P691, DOI 10.1093/ndt/16.4.691-a; De Jong JC, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000017904.77985.03; Franklin SS, 2001, CIRCULATION, V103, P1245; Franklin SS, 1997, CIRCULATION, V96, P308; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; He J, 1999, AM HEART J, V138, pS211, DOI 10.1016/S0002-8703(99)70312-1; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; KANNEL WB, 1970, J AMER MED ASSOC, V214, P301, DOI 10.1001/jama.214.2.301; KANNEL WB, 1969, DIS CHEST, V56, P43, DOI 10.1378/chest.56.1.43; Lemmink HH, 1998, KIDNEY INT, V54, P720, DOI 10.1046/j.1523-1755.1998.00070.x; Levy D, 2000, HYPERTENSION, V36, P477, DOI 10.1161/01.HYP.36.4.477; Lifton Richard P, 2004, Harvey Lect, V100, P71; Lifton RP, 2001, CELL, V104, P545, DOI 10.1016/S0092-8674(01)00241-0; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Murphy KM, 2003, EXPERT REV MOL DIAGN, V3, P811, DOI 10.1586/14737159.3.6.811; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; OHLSSON A, 1984, ACTA PAEDIATR SCAND, V73, P868, DOI 10.1111/j.1651-2227.1984.tb17793.x; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Riveira-Munoz E, 2007, J AM SOC NEPHROL, V18, P1271, DOI 10.1681/ASN.2006101095; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; RUDIN A, 1988, ACTA MED SCAND, V224, P165; Sabath E, 2004, AM J PHYSIOL-RENAL, V287, pF195, DOI 10.1152/ajprenal.00044.2004; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schwalbe RA, 1998, HUM MOL GENET, V7, P975, DOI 10.1093/hmg/7.6.975; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shaer AJ, 2001, AM J MED SCI, V322, P316, DOI 10.1097/00000441-200112000-00004; SIECK UV, 1984, OBSTET GYNECOL, V63, pS22; Simon DB, 1996, NAT GENET, V14, P152, DOI 10.1038/ng1096-152; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Syren Marie-Louise, 2002, Hum Mutat, V20, P78, DOI 10.1002/humu.9045; Takahashi N, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133604; Tchernitchko D, 2004, CLIN CHEM, V50, P1974, DOI 10.1373/clinchem.2004.036053; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Van Gestel S, 2000, BEHAV GENET, V30, P141, DOI 10.1023/A:1001907321955; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	46	588	631	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					592	599		10.1038/ng.118	http://dx.doi.org/10.1038/ng.118			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18391953	Green Accepted			2022-12-27	WOS:000255366700027
J	Leitch, CC; Zaghloul, NA; Davis, EE; Stoetzel, C; Diaz-Font, A; Rix, S; Al-Fadhel, M; Lewis, RA; Eyaid, W; Banin, E; Dollfus, H; Beales, PL; Badano, JL; Katsanis, N				Leitch, Carmen C.; Zaghloul, Norann A.; Davis, Erica E.; Stoetzel, Corinne; Diaz-Font, Anna; Rix, Suzanne; Al-Fadhel, Majid; Lewis, Richard Alan; Eyaid, Wafaa; Banin, Eyal; Dollfus, Helene; Beales, Philip L.; Badano, Jose L.; Katsanis, Nicholas			Hypomorphic mutations in syndromic encephalocele genes are associated with Bardet-Biedl syndrome	NATURE GENETICS			English	Article							MECKEL-GRUBER-SYNDROME; BASAL BODY PROTEIN; JOUBERT-SYNDROME; BBS LOCUS; DISSECTION; DISRUPTION; RPGRIP1L; CILIUM; MKS3	Meckel-Gruber syndrome (MKS) is a genetically heterogeneous, neonatally lethal malformation and the most common form of syndromic neural tube defect (NTD). To date, several MKS-associated genes have been identified whose protein products affect ciliary function(1-5). Here we show that mutations in MKS1, MKS3 and CEP290 (also known as NPHP6) either can cause Bardet-Biedl syndrome (BBS) or may have a potential epistatic effect on mutations in known BBS-associated loci. Five of six families with both MKS1 and BBS mutations manifested seizures, a feature that is not a typical component of either syndrome. Functional studies in zebrafish showed that mks1 is necessary for gastrulation movements and that it interacts genetically with known bbs genes. Similarly, we found two families with missense or splice mutations in MKS3, in one of which the affected individual also bears a homozygous nonsense mutation in CEP290 that is likely to truncate the C terminus of the protein. These data extend the genetic stratification of ciliopathies and suggest that BBS and MKS, although distinct clinically, are allelic forms of the same molecular spectrum.	[Leitch, Carmen C.; Zaghloul, Norann A.; Davis, Erica E.; Badano, Jose L.; Katsanis, Nicholas] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Stoetzel, Corinne; Dollfus, Helene] Univ Strasbourg 1, Fac Med Strasbourg, Med Genet Lab, Equipe Avenir INSERM EA 34390, F-67085 Strasbourg, France; [Diaz-Font, Anna; Rix, Suzanne; Beales, Philip L.] UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; [Lewis, Richard Alan; Banin, Eyal] King Fahad Hosp, Dept Pediat, Riyadh 11426, Saudi Arabia; [Lewis, Richard Alan] Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; [Lewis, Richard Alan] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Banin, Eyal] Hadassah Hebrew Univ Hosp, Dept Ophthalmol, IL-91120 Jerusalem, Israel; [Badano, Jose L.] Inst Pasteur, Montevideo 11400, Uruguay	Johns Hopkins University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of London; University College London; King Saud Bin Abdulaziz University for Health Sciences; King Fahad Hospital - National Guard; Baylor College of Medicine; Baylor College of Medicine; Hebrew University of Jerusalem; Hadassah University Medical Center; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo	Katsanis, N (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, 733 N Broadway, Baltimore, MD 21205 USA.	katsanis@jhmi.edu	Beales, Philip L/C-7367-2009; Katsanis, Nicholas/E-1837-2012	Katsanis, Nicholas/0000-0002-2480-0171; Badano, Jose/0000-0002-0706-8652; Davis, Erica/0000-0002-2412-8397; Dollfus, Helene/0000-0002-2249-895X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK079541, R01DK072301] Funding Source: NIH RePORTER; Medical Research Council [G0801843] Funding Source: Medline; NICHD NIH HHS [R01HD04260] Funding Source: Medline; NIDDK NIH HHS [F32 DK079541-01, R01DK072301] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome Trust)		Arts HH, 2007, NAT GENET, V39, P882, DOI 10.1038/ng2069; Baala L, 2007, AM J HUM GENET, V81, P170, DOI 10.1086/519494; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Badano JL, 2003, HUM MOL GENET, V12, P1651, DOI 10.1093/hmg/ddg188; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Beales PL, 1999, J MED GENET, V36, P437; Beales PL, 2003, AM J HUM GENET, V72, P1187, DOI 10.1086/375178; Davis EE, 2006, DEV CELL, V11, P9, DOI 10.1016/j.devcel.2006.06.009; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Delous M, 2007, NAT GENET, V39, P875, DOI 10.1038/ng2039; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Helou J, 2007, J MED GENET, V44, P657, DOI 10.1136/jmg.2007.052027; Karmous-Benailly H, 2005, AM J HUM GENET, V76, P493, DOI 10.1086/428679; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Katsanis N, 2000, NAT GENET, V26, P67, DOI 10.1038/79201; Khaddour Rana, 2007, Hum Mutat, V28, P523, DOI 10.1002/humu.9489; Kyttala M, 2006, NAT GENET, V38, P155, DOI 10.1038/ng1714; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Smith UM, 2006, NAT GENET, V38, P191, DOI 10.1038/ng1713; Stoetzel C, 2006, NAT GENET, V38, P521, DOI 10.1038/ng1771; Stoetzel C, 2007, AM J HUM GENET, V80, P1, DOI 10.1086/510256; Stone DL, 2000, NAT GENET, V25, P79, DOI 10.1038/75637; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715	28	302	312	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2008	40	4					443	448		10.1038/ng.97	http://dx.doi.org/10.1038/ng.97			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18327255				2022-12-27	WOS:000254388100015
J	Musaro, M; Ciapponi, L; Fasulo, B; Gatti, M; Cenci, G				Musaro, Mariarosaria; Ciapponi, Laura; Fasulo, Barbara; Gatti, Maurizio; Cenci, Giovanni			Unprotected Drosophila melanogaster telomeres activate the spindle assembly checkpoint	NATURE GENETICS			English	Article							DNA-DAMAGE; PATHWAYS; PROTEIN; MAINTENANCE; ATM; PROTECTION; PREVENT; STABILITY; MUTANTS; HOMOLOG	In both yeast and mammals, uncapped telomeres activate the DNA damage response (DDR) and undergo end-to-end fusion(1,2). Previous work has shown that the Drosophila HOAP protein, encoded by the caravaggio (cav) gene, is required to prevent telomeric fusions(3). Here we show that HOAP-depleted telomeres activate both the DDR and the spindle assembly checkpoint (SAC). The cell cycle arrest elicited by the DDR was alleviated by mutations in mei-41 (encoding ATR), mus304 (ATRIP), grp (Chk1) and rad50 but not by mutations in tefu (ATM). The SAC was partially overridden by mutations in zw10 (also known as mit(1) 15) and bubR1, and also by mutations in mei-41, mus304, rad50, grp and tefu. As expected from SAC activation, the SAC proteins Zw10, Zwilch, BubR1 and Cenp-meta (Cenp-E) accumulated at the kinetochores of cav mutant cells. Notably, BubR1 also accumulated at cav mutant telomeres in a mei-41-, mus304-, rad50-, grp- and tefu-dependent manner. Our results collectively suggest that recruitment of BubR1 by dysfunctional telomeres inhibits Cdc20-APC function, preventing the metaphase-to-anaphase transition.	[Musaro, Mariarosaria; Cenci, Giovanni] Univ Salento, Dipartimento Sci & Tecnol Biol Ambientali DiSTeBA, I-73100 Lecce, Italy; [Fasulo, Barbara] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Musaro, Mariarosaria; Ciapponi, Laura; Gatti, Maurizio] Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; [Musaro, Mariarosaria; Ciapponi, Laura; Gatti, Maurizio] Univ Roma La Sapienza, Ist Biol & Patol Mol, CNR, I-00185 Rome, Italy	University of Salento; University of California System; University of California Santa Cruz; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	Cenci, G (corresponding author), Univ Aquila, Dipartimento Biol Base Applicata, I-67010 Laquila, Italy.	giovanni.cenci@cc.univaq.it	Ciapponi, Laura/H-6867-2013; Gatti, Maurizio/S-2877-2019; Gatti, Maurizio/J-9703-2013	Gatti, Maurizio/0000-0003-3777-300X; Cenci, Giovanni/0000-0002-9628-1411; CIAPPONI, LAURA/0000-0002-0817-1862; fasulo, barbara/0000-0001-7000-2974	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom; Telethon [GGP07200] Funding Source: Medline	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Telethon(Fondazione Telethon)		Bast RC, 2000, INT J GYNECOL CANCER, V10, P2, DOI 10.1046/j.1525-1438.2000.99502.x; Bentley AM, 2002, J CELL SCI, V115, P949; Bi XL, 2005, P NATL ACAD SCI USA, V102, P15167, DOI 10.1073/pnas.0504981102; Bi XL, 2004, CURR BIOL, V14, P1348, DOI 10.1016/j.cub.2004.06.063; Brodsky MH, 2000, GENE DEV, V14, P666; Cenci G, 2005, CHROMOSOMA, V114, P135, DOI 10.1007/s00412-005-0005-9; Cenci G, 2003, NAT CELL BIOL, V5, P82, DOI 10.1038/ncb902; Cenci G, 1997, GENE DEV, V11, P863, DOI 10.1101/gad.11.7.863; Ciapponi L, 2004, CURR BIOL, V14, P1360, DOI 10.1016/j.cub.2004.07.019; Ciapponi L, 2006, GENETICS, V173, P1447, DOI 10.1534/genetics.106.058081; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Fanti L, 1998, MOL CELL, V2, P527, DOI 10.1016/S1097-2765(00)80152-5; Fogarty P, 1997, CURR BIOL, V7, P418, DOI 10.1016/S0960-9822(06)00189-8; HARI KL, 1995, CELL, V82, P815, DOI 10.1016/0092-8674(95)90478-6; Heeger S, 2005, GENE DEV, V19, P2041, DOI 10.1101/gad.347805; Karess R, 2005, TRENDS CELL BIOL, V15, P386, DOI 10.1016/j.tcb.2005.05.003; Lydall D, 2003, J CELL SCI, V116, P4057, DOI 10.1242/jcs.00765; Maringele L, 2002, GENE DEV, V16, P1919, DOI 10.1101/gad.225102; Mikhailov A, 2002, CURR BIOL, V12, P1797, DOI 10.1016/S0960-9822(02)01226-5; Miller KM, 2003, MOL CELL, V11, P303, DOI 10.1016/S1097-2765(03)00041-8; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Oikemus SR, 2006, PLOS GENET, V2, P693, DOI 10.1371/journal.pgen.0020071; Oikemus SR, 2004, GENE DEV, V18, P1850, DOI 10.1101/gad.1202504; Raffa GD, 2005, MOL CELL, V20, P821, DOI 10.1016/j.molcel.2005.12.003; Royou A, 2005, CURR BIOL, V15, P334, DOI 10.1016/j.cub.2005.02.026; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Silva E, 2004, CURR BIOL, V14, P1341, DOI 10.1016/j.cub.2004.06.056; Song YH, 2004, CURR BIOL, V14, P1354, DOI 10.1016/j.cub.2004.06.064; Williams BC, 1998, NAT GENET, V18, P30, DOI 10.1038/ng0198-30	29	35	37	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2008	40	3					362	366		10.1038/ng.2007.64	http://dx.doi.org/10.1038/ng.2007.64			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18246067				2022-12-27	WOS:000253548400030
J	Kwan, T; Benovoy, D; Dias, C; Gurd, S; Provencher, C; Beaulieu, P; Hudson, TJ; Sladek, R; Majewski, J				Kwan, Tony; Benovoy, David; Dias, Christel; Gurd, Scott; Provencher, Cathy; Beaulieu, Patrick; Hudson, Thomas J.; Sladek, Rob; Majewski, Jacek			Genome-wide analysis of transcript isoform variation in humans	NATURE GENETICS			English	Article							MESSENGER-RNA; GENE-EXPRESSION; LARGE-SCALE; POLYADENYLATION; ASSOCIATION; DISCOVERY; VARIANTS; DISEASE; MOUSE; IRF5	We have performed a genome- wide analysis of common genetic variation controlling differential expression of transcript isoforms in the CEU HapMap population using a comprehensive exon tiling microarray covering 17,897 genes. We detected 324 genes with significant associations between flanking SNPs and transcript levels. Of these, 39% reflected changes in whole gene expression and 55% reflected transcript isoform changes such as splicing variants (exon skipping, alternative splice site use, intron retention), differential 5' UTR (initiation of transcription) use, and differential 3' UTR (alternative polyadenylation) use. These results demonstrate that the regulatory effects of genetic variation in a normal human population are far more complex than previously observed. This extra layer of molecular diversity may account for natural phenotypic variation and disease susceptibility.	[Kwan, Tony; Benovoy, David; Dias, Christel; Gurd, Scott; Provencher, Cathy; Hudson, Thomas J.; Sladek, Rob; Majewski, Jacek] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1A4, Canada; [Kwan, Tony; Benovoy, David; Gurd, Scott; Provencher, Cathy; Hudson, Thomas J.; Sladek, Rob; Majewski, Jacek] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Beaulieu, Patrick] Hop St Justine, Div Hematol Oncol, Res Ctr, Montreal, PQ H3T 1C5, Canada; [Hudson, Thomas J.] MaRS Ctr, Ontario Inst Canc Res, Toronto, ON M5G 1L7, Canada	McGill University; Universite de Montreal; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Majewski, J (corresponding author), McGill Univ, Dept Human Genet, 740 Dr Penfield,Room 7210, Montreal, PQ H3A 1A4, Canada.	jacek.majewski@mcgill.ca	Sladek, Robert/R-2391-2019	Sladek, Robert/0000-0002-2730-1204				Alberts R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000622; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; CHURCHILL GA, 1994, GENETICS, V138, P963; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Field LL, 2005, DIABETES, V54, P1588, DOI 10.2337/diabetes.54.5.1588; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Graham DSC, 2007, HUM MOL GENET, V16, P579, DOI 10.1093/hmg/ddl469; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Hull J, 2007, PLOS GENET, V3, P1009, DOI 10.1371/journal.pgen.0030099; Kim H, 2004, NAT GENET, V36, P915, DOI 10.1038/ng0904-915; Kwan T, 2007, GENOME RES, V17, P1210, DOI 10.1101/gr.6281007; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Liu S, 2003, NUCLEIC ACIDS RES, V31, P4828, DOI 10.1093/nar/gkg668; Naef F, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.011906; Nembaware V, 2004, FEBS LETT, V577, P233, DOI 10.1016/j.febslet.2004.10.018; Nissim-Rafinia M, 2005, TRENDS GENET, V21, P480, DOI 10.1016/j.tig.2005.07.005; Qu HQ, 2007, DIABETES, V56, P270, DOI 10.2337/db06-0865; Rozen S, 2000, Methods Mol Biol, V132, P365; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Tian B, 2005, NUCLEIC ACIDS RES, V33, P201, DOI 10.1093/nar/gki158; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Yan J, 2005, GENOME RES, V15, P369, DOI 10.1101/gr.3109605; Zielenski J, 2000, RESPIRATION, V67, P117, DOI 10.1159/000029497	30	241	257	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					225	231		10.1038/ng.2007.57	http://dx.doi.org/10.1038/ng.2007.57			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18193047				2022-12-27	WOS:000252732900022
J	Willer, CJ; Sanna, S; Jackson, AU; Scuteri, A; Bonnycastle, LL; Clarke, R; Heath, SC; Timpson, NJ; Najjar, SS; Stringham, HM; Strait, J; Duren, WL; Maschio, A; Busonero, F; Mulas, A; Albai, G; Swift, AJ; Morken, MA; Narisu, N; Bennett, D; Parish, S; Shen, HQ; Galan, P; Meneton, P; Hercberg, S; Zelenika, D; Chen, WM; Li, Y; Scott, LJ; Scheet, PA; Sundvall, J; Watanabe, RM; Nagaraja, R; Ebrahim, S; Lawlor, DA; Ben-Shlomo, Y; Davey-Smith, G; Shuldiner, AR; Collins, R; Bergman, RN; Uda, M; Tuomilehto, J; Cao, A; Collins, FS; Lakatta, E; Lathrop, GM; Boehnke, M; Schlessinger, D; Mohlke, KL; Abecasis, GR				Willer, Cristen J.; Sanna, Serena; Jackson, Anne U.; Scuteri, Angelo; Bonnycastle, Lori L.; Clarke, Robert; Heath, Simon C.; Timpson, Nicholas J.; Najjar, Samer S.; Stringham, Heather M.; Strait, James; Duren, William L.; Maschio, Andrea; Busonero, Fabio; Mulas, Antonella; Albai, Giuseppe; Swift, Amy J.; Morken, Mario A.; Narisu, Narisu; Bennett, Derrick; Parish, Sarah; Shen, Haiqing; Galan, Pilar; Meneton, Pierre; Hercberg, Serge; Zelenika, Diana; Chen, Wei-Min; Li, Yun; Scott, Laura J.; Scheet, Paul A.; Sundvall, Jouko; Watanabe, Richard M.; Nagaraja, Ramaiah; Ebrahim, Shah; Lawlor, Debbie A.; Ben-Shlomo, Yoav; Davey-Smith, George; Shuldiner, Alan R.; Collins, Rory; Bergman, Richard N.; Uda, Manuela; Tuomilehto, Jaakko; Cao, Antonio; Collins, Francis S.; Lakatta, Edward; Lathrop, G. Mark; Boehnke, Michael; Schlessinger, David; Mohlke, Karen L.; Abecasis, Goncalo R.			Newly identified loci that influence lipid concentrations and risk of coronary artery disease	NATURE GENETICS			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; GENOME-WIDE ASSOCIATION; ISCHEMIC-HEART-DISEASE; NONFASTING TRIGLYCERIDES; MYOCARDIAL-INFARCTION; ANTIOXIDANT VITAMINS; GENETIC-VARIANTS; POPULATION; HYPERCHOLESTEROLEMIA; SU.VI.MAX	To identify genetic variants influencing plasma lipid concentrations, we first used genotype imputation and meta-analysis to combine three genome-wide scans totaling 8,816 individuals and comprising 6,068 individuals specific to our study (1,874 individuals from the FUSION study of type 2 diabetes and 4,184 individuals from the SardiNIA study of aging-associated variables) and 2,758 individuals from the Diabetes Genetics Initiative, reported in a companion study in this issue. We subsequently examined promising signals in 11,569 additional individuals. Overall, we identify strongly associated variants in eleven loci previously implicated in lipid metabolism (ABCA1, the APOA5-APOA4-APOC3-APOA1 and APOE-APOC clusters, APOB, CETP, GCKR, LDLR, LPL, LIPC, LIPG and PCSK9) and also in several newly identified loci (near MVK-MMAB and GALNT2, with variants primarily associated with high-density lipoprotein (HDL) cholesterol; near SORT1, with variants primarily associated with low-density lipoprotein (LDL) cholesterol; near TRIB1, MLXIPL and ANGPTL3, with variants primarily associated with triglycerides; and a locus encompassing several genes near NCAN, with variants strongly associated with both triglycerides and LDL cholesterol). Notably, the 11 independent variants associated with increased LDL cholesterol concentrations in our study also showed increased frequency in a sample of coronary artery disease cases versus controls.	[Willer, Cristen J.; Sanna, Serena; Jackson, Anne U.; Stringham, Heather M.; Duren, William L.; Chen, Wei-Min; Li, Yun; Scott, Laura J.; Scheet, Paul A.; Boehnke, Michael; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Sanna, Serena; Maschio, Andrea; Busonero, Fabio; Mulas, Antonella; Albai, Giuseppe; Uda, Manuela; Cao, Antonio] Citta Univ Monserrato, CNR, INN, I-09042 Cagliari, Italy; [Scuteri, Angelo; Najjar, Samer S.; Strait, James; Nagaraja, Ramaiah; Lakatta, Edward; Schlessinger, David] NIA, Gerontol Res Ctr, Baltimore, MD 21224 USA; [Scuteri, Angelo] Ist Patol Endocrina & Metab, Unita Operat Geriatr, Rome, Italy; [Bonnycastle, Lori L.; Swift, Amy J.; Morken, Mario A.; Narisu, Narisu; Collins, Francis S.] NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; [Clarke, Robert; Bennett, Derrick; Parish, Sarah; Collins, Rory] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Heath, Simon C.; Zelenika, Diana; Lathrop, G. Mark] Commissariat Energie Atom, Inst Genom, Ctr Natl Genotypage, F-91057 Evry, France; [Timpson, Nicholas J.; Lawlor, Debbie A.; Ben-Shlomo, Yoav; Davey-Smith, George] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; [Shen, Haiqing; Shuldiner, Alan R.] Univ Maryland, Sch Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 21201 USA; [Galan, Pilar] INSERM, U872, F-75270 Paris, France; [Galan, Pilar] Fac Med Rene Descartes, Dept Sante Publ & Informat Med, F-75270 Paris, France; [Meneton, Pierre; Hercberg, Serge] CRNH, F-93017 Bobigny, France; [Meneton, Pierre; Hercberg, Serge] INSERM, U557, F-93017 Bobigny, France; [Meneton, Pierre; Hercberg, Serge] INRA, U1125, F-93017 Bobigny, France; [Meneton, Pierre; Hercberg, Serge] Cnam, F-93017 Bobigny, France; [Meneton, Pierre; Hercberg, Serge] Univ Paris 13, F-93017 Bobigny, France; [Sundvall, Jouko] Natl Publ Hlth Inst, Dept Hlth & Funct Capac, Lab Analyt Biochem, SF-00300 Helsinki, Finland; [Watanabe, Richard M.; Bergman, Richard N.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Watanabe, Richard M.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; [Ebrahim, Shah] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; [Tuomilehto, Jaakko] Natl Publ Hlth Inst, Dept Hlth Promot & Chron Dis Prevent, Diabet Unit, SF-00300 Helsinki, Finland; [Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA	University of Michigan System; University of Michigan; Consiglio Nazionale delle Ricerche (CNR); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Oxford; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; University of Bristol; University System of Maryland; University of Maryland Baltimore; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; heSam Universite; Conservatoire National Arts & Metiers (CNAM); Universite Paris 13; Finland National Institute for Health & Welfare; University of Southern California; University of Southern California; University of London; London School of Hygiene & Tropical Medicine; Finland National Institute for Health & Welfare; University of North Carolina; University of North Carolina Chapel Hill	Abecasis, GR (corresponding author), Univ Michigan, Dept Biostat, Ctr Stat Genet, 1420 Washington Hts, Ann Arbor, MI 48109 USA.	mohlke@med.unc.edu; goncalo@umich.edu	, Bennett/O-7998-2019; Fox, Laura J/C-6249-2016; Attrill, Lauren/V-1688-2018; Uda, Manuela/AAC-2645-2019; Narisu, Narisu/T-6908-2019; Bennett, Derrick/AAH-1220-2022; Meneton, Pierre/T-1216-2019; Pilar, Galan/F-2908-2017; Davey Smith, George/A-7407-2013; Heath, Simon C/J-4138-2012; HERCBERG, Serge/B-4429-2008; Timpson, Nicholas John/O-7548-2015; Chen, Wei-Min/A-8469-2009; Abecasis, Goncalo R/B-7840-2010; sanna, serena/H-3009-2019; Ben-Shlomo, Yoav/ABD-2004-2021; Lakatta, Edward G/AAL-1447-2020; Maschio, Andrea/AAX-8185-2020; Serge, Hercberg/F-3038-2017; Mulas, Antonella/B-4231-2015; Bennett, Derrick/AFL-9254-2022	Uda, Manuela/0000-0002-4890-6456; Bennett, Derrick/0000-0002-9170-8447; Pilar, Galan/0000-0003-1706-3107; Davey Smith, George/0000-0002-1407-8314; Heath, Simon C/0000-0002-9550-0897; HERCBERG, Serge/0000-0002-3168-1350; Timpson, Nicholas John/0000-0002-7141-9189; sanna, serena/0000-0002-3768-1749; Ben-Shlomo, Yoav/0000-0001-6648-3007; Serge, Hercberg/0000-0002-3168-1350; Bennett, Derrick/0000-0002-9170-8447; SCUTERI, ANGELO/0000-0003-4784-5441; Willer, Cristen/0000-0001-5645-4966; Shuldiner, Alan/0000-0001-9921-4305; maschio, andrea/0000-0002-4238-9144; s, hema/0000-0002-3440-9475; Lawlor, Debbie A/0000-0002-6793-2262; Abecasis, Goncalo/0000-0003-1509-1825; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Lakatta, Edward/0000-0002-4772-0035; Mulas, Antonella/0000-0002-6856-1483	MRC [MC_U137686857, G0600705] Funding Source: UKRI; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [N01HG065403, ZIAHG000024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072193, R01DK029867] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000235, ZIAAG000675] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AG000235-01] Funding Source: Medline; Medical Research Council [G0600705, G9815508, MC_U137686857] Funding Source: Medline; NHGRI NIH HHS [N01HG65403, N01-HG-65403)] Funding Source: Medline; NIDDK NIH HHS [R01 DK072193, R01 DK029867] Funding Source: Medline; Wellcome Trust [076113] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome Trust)		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; BAINTON D, 1992, BRIT HEART J, V68, P60; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; Breslow JL, 2000, ANNU REV GENET, V34, P233, DOI 10.1146/annurev.genet.34.1.233; Burdick JT, 2006, NAT GENET, V38, P1002, DOI 10.1038/ng1863; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Clarke R, 2007, ARCH INTERN MED, V167, P1373, DOI 10.1001/archinte.167.13.1373; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; ELWOOD PC, 1984, J EPIDEMIOL COMMUN H, V38, P259, DOI 10.1136/jech.38.3.259; Georgiades C S, 2001, Tech Vasc Interv Radiol, V4, P193, DOI 10.1016/S1089-2516(01)90025-3; Gotto AM, 2004, J AM COLL CARDIOL, V43, P717, DOI 10.1016/j.jacc.2003.08.061; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hercberg S, 2004, ARCH INTERN MED, V164, P2335, DOI 10.1001/archinte.164.21.2335; Hercberg S, 1998, CONTROL CLIN TRIALS, V19, P336, DOI 10.1016/S0197-2456(98)00015-4; HUNT D, 1992, LANCET, V339, P753; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Keavney B, 2004, INT J EPIDEMIOL, V33, P1002, DOI 10.1093/ije/dyh275; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Koishi R, 2002, NAT GENET, V30, P151, DOI 10.1038/ng814; Kuivenhoven JA, 1997, J LIPID RES, V38, P191; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; Lawlor DA, 2003, J EPIDEMIOL COMMUN H, V57, P134, DOI 10.1136/jech.57.2.134; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lind S, 2004, J INTERN MED, V256, P406, DOI 10.1111/j.1365-2796.2004.01401.x; Mackay J, 2004, ATLAS HEART DIS STRO; Magrane J, 1999, FEBS LETT, V451, P56, DOI 10.1016/S0014-5793(99)00494-9; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Murphy C, 2007, BIOCHEM BIOPH RES CO, V355, P359, DOI 10.1016/j.bbrc.2007.01.155; Naoumova RP, 2005, ARTERIOSCL THROM VAS, V25, P2654, DOI 10.1161/01.ATV.0000190668.94752.ab; Nielsen MS, 1999, J BIOL CHEM, V274, P8832, DOI 10.1074/jbc.274.13.8832; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Pare G, 2007, AM J HUM GENET, V80, P673, DOI 10.1086/513286; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Pollin TI, 2004, ATHEROSCLEROSIS, V173, P89, DOI 10.1016/j.atherosclerosis.2003.11.012; Post W, 2007, CIRCULATION, V115, P717, DOI 10.1161/CIRCULATIONAHA.106.637512; Post W, 2007, HUM HERED, V64, P214, DOI 10.1159/000103630; Rauch U, 2001, CELL MOL LIFE SCI, V58, P1842, DOI 10.1007/PL00000822; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115	49	1274	1311	3	145	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					161	169		10.1038/ng.76	http://dx.doi.org/10.1038/ng.76			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18193043	Green Accepted, Green Submitted			2022-12-27	WOS:000252732900014
J	Pasqualucci, L; Bhagat, G; Jankovic, M; Compagno, M; Smith, P; Muramatsu, M; Honjo, T; Morse, HC; Nussenzweig, MC; Dalla-Favera, R				Pasqualucci, Laura; Bhagat, Govind; Jankovic, Mila; Compagno, Mara; Smith, Paula; Muramatsu, Masamichi; Honjo, Tasuku; Morse, Herbert C., III; Nussenzweig, Michel C.; Dalla-Favera, Riccardo			AID is required for germinal center-derived lymphomagenesis	NATURE GENETICS			English	Article							CYTIDINE DEAMINASE AID; CLASS SWITCH RECOMBINATION; SINGLE-STRANDED-DNA; CENTER B-CELLS; ANTIBODY DIVERSIFICATION; SOMATIC HYPERMUTATION; EXPRESSION; TRANSLOCATIONS; PHENOTYPE; REGION	Most human B cell non-Hodgkin's lymphomas (B-NHLs) derive from germinal centers (GCs), the structure in which B cells undergo somatic hypermutation (SHM) and class switch recombination (CSR) before being selected for high-affinity antibody production(1). The pathogenesis of B-NHL is associated with distinct genetic lesions, including chromosomal translocations and aberrant SHM, which arise from mistakes occurring during CSR and SHM2-4. A direct link between these DNA remodeling events and GC lymphoma development, however, has not been demonstrated. Here we have crossed three mouse models of B cell lymphoma driven by oncogenes (Myc, Bcl6 and Myc/Bcl6; refs. 5,6) with mice lacking activation-induced cytidine deaminase (AID), the enzyme required for both CSR and SHM7,8. We show that AID deficiency prevents Bcl6-dependent, GC-derived B-NHL, but has no impact on Myc-driven, pre-GC lymphomas. Accordingly, abrogation of AID is associated with the disappearance of CSR- and SHM-mediated structural alterations. These results show that AID is required for GC-derived lymphomagenesis, supporting the notion that errors in AID-mediated antigen-receptor gene modification processes are principal contributors to the pathogenesis of human B-NHL.	[Pasqualucci, Laura; Bhagat, Govind; Compagno, Mara; Smith, Paula; Dalla-Favera, Riccardo] Columbia Univ, Inst Canc Genet, Dept Pathol, New York, NY 10032 USA; [Pasqualucci, Laura; Bhagat, Govind; Compagno, Mara; Smith, Paula; Dalla-Favera, Riccardo] Columbia Univ, Inst Canc Genet, Dept Genet & Dev, New York, NY 10032 USA; [Pasqualucci, Laura; Bhagat, Govind; Compagno, Mara; Smith, Paula; Dalla-Favera, Riccardo] Columbia Univ, Inst Canc Genet, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Jankovic, Mila; Muramatsu, Masamichi] Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; [Muramatsu, Masamichi] Kanazawa Univ, Grad Sch Med Sci, Dept Mol Genet, Kanazawa, Ishikawa 9208640, Japan; [Honjo, Tasuku] Kyoto Univ, Grad Sch Med, Dept Immunol & Genom Med, Kyoto 6068501, Japan; [Morse, Herbert C., III] NIAID, NIH, Immunopathol Lab, Bethesda, MD 20892 USA; [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Columbia University; Columbia University; Columbia University; Rockefeller University; Kanazawa University; Kyoto University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Howard Hughes Medical Institute; Rockefeller University	Pasqualucci, L (corresponding author), Columbia Univ, Inst Canc Genet, Dept Pathol, New York, NY 10032 USA.	lp171@columbia.edu; rd10@columbia.edu	Honjo, Tasuku/N-4470-2016; Muramatsu, Masamichi/C-4339-2015; Bhagat, Govind/AAE-9493-2021; Nussenzweig, Michel/AAE-7292-2019	Muramatsu, Masamichi/0000-0002-0153-3533; Bhagat, Govind/0000-0001-6250-048X; Morse, Herbert/0000-0002-9331-3705	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000858, ZIAAI000858] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Cattoretti G, 2005, CANCER CELL, V7, P445, DOI 10.1016/j.ccr.2005.03.037; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; DALLAFAVERA R, 2004, NON HODGKINS LYMPHOM, P825; Di Noia J, 2002, NATURE, V419, P43, DOI 10.1038/nature00981; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Klein U, 2001, J EXP MED, V194, P1625, DOI 10.1084/jem.194.11.1625; Kotani A, 2007, P NATL ACAD SCI USA, V104, P1616, DOI 10.1073/pnas.0610732104; Kovalchuk AL, 2000, J EXP MED, V192, P1183, DOI 10.1084/jem.192.8.1183; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Lenz G, 2007, J EXP MED, V204, P633, DOI 10.1084/jem.20062041; Mollejo M, 2005, HEMATOL ONCOL, V23, P108, DOI 10.1002/hon.762; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nagaoka H, 2002, J EXP MED, V195, P529, DOI 10.1084/jem.20012144; Pasqualucci L, 2004, BLOOD, V104, P3318, DOI 10.1182/blood-2004-04-1558; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Phan RT, 2004, NATURE, V432, P635, DOI 10.1038/nature03147; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Ranuncolo SM, 2007, NAT IMMUNOL, V8, P705, DOI 10.1038/ni1478; Reina-San-Martin B, 2003, J EXP MED, V197, P1767, DOI 10.1084/jem.20030569; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Shaffer AL, 2002, NAT REV IMMUNOL, V2, P920, DOI 10.1038/nri953	30	284	294	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2008	40	1					108	112		10.1038/ng.2007.35	http://dx.doi.org/10.1038/ng.2007.35			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18066064				2022-12-27	WOS:000252118600026
J	Sulem, P; Gudbjartsson, DF; Stacey, SN; Helgason, A; Rafnar, T; Magnusson, KP; Manolescu, A; Karason, A; Palsson, A; Thorleifsson, G; Jakobsdottir, M; Steinberg, S; Palsson, S; Jonasson, F; Sigurgeirsson, B; Thorisdottir, K; Ragnarsson, R; Benediktsdottir, KR; Aben, KK; Kiemeney, LA; Olafsson, JH; Gulcher, J; Kong, A; Thorsteinsdottir, U; Stefansson, K				Sulem, Patrick; Gudbjartsson, Daniel F.; Stacey, Simon N.; Helgason, Agnar; Rafnar, Thorunn; Magnusson, Kristinn P.; Manolescu, Andrei; Karason, Ari; Palsson, Arnar; Thorleifsson, Gudmar; Jakobsdottir, Margret; Steinberg, Stacy; Palsson, Snaebjorn; Jonasson, Fridbert; Sigurgeirsson, Bardur; Thorisdottir, Kristin; Ragnarsson, Rafn; Benediktsdottir, Kristrun R.; Aben, Katja K.; Kiemeney, Lambertus A.; Olafsson, Jon H.; Gulcher, Jeffrey; Kong, Augie; Thorsteinsdottir, Unnur; Stefansson, Kari			Genetic determinants of hair, eye and skin pigmentation in Europeans	NATURE GENETICS			English	Article							RECENT POSITIVE SELECTION; GENOMIC CONTROL; CONFERS RISK; RED HAIR; COLOR; SIGNATURES; EVOLUTION; HAPLOTYPE; POLYMORPHISM; DIFFERENCE	Hair, skin and eye colors are highly heritable and visible traits in humans. We carried out a genome-wide association scan for variants associated with hair and eye pigmentation, skin sensitivity to sun and freckling among 2,986 Icelanders. We then tested the most closely associated SNPs from six regions-four not previously implicated in the normal variation of human pigmentation-and replicated their association in a second sample of 2,718 Icelanders and a sample of 1,214 Dutch. The SNPs from all six regions met the criteria for genome-wide significance. A variant in SLC24A4 is associated with eye and hair color, a variant near KITLG is associated with hair color, two coding variants in TYR are associated with eye color and freckles, and a variant on 6p25.3 is associated with freckles. The fifth region provided refinements to a previously reported association in OCA2, and the sixth encompasses previously described variants in MC1R.	DeCODE Genet, IS-101 Reykjavik, Iceland; Landspitali Univ Hosp, Dept Ophthalmol, Reykjavik, Iceland; Landspitali Univ Hosp, Dept Dermatol, Reykjavik, Iceland; Landspitali Univ Hosp, Dept Plast Surg, Reykjavik, Iceland; Landspitali Univ Hosp, Dept Anatomopathol, Reykjavik, Iceland; Radboud Univ Nijmegen, Comprehens Canc Ctr E, Dept Epidemiol & Biostat, Nijmegen, Netherlands; Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, Nijmegen, Netherlands	Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; Radboud University Nijmegen; Radboud University Nijmegen	Gudbjartsson, DF (corresponding author), DeCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	daniel.gudbjartsson@decode.is; kstefans@decode.is	Manolescu, Andrei/G-4565-2014; Magnusson, Kristinn/A-6479-2011; Helgason, Agnar/K-1522-2015; Aben, Katja KH/G-9686-2016; Kiemeney, Lambertus A./D-3357-2009; Jonasson, Fridbert/ABA-9889-2021; Sigurgeirsson, Bárður/B-6130-2011; Palsson, Arnar/M-2742-2015; Stefansson, Kari/AAE-7187-2019; Magnusson, Kristinn P Pétur/X-4907-2019; Palsson, Snaebjorn/J-9113-2012; Sigurgeirsson, Bardur/AAP-7755-2020	Manolescu, Andrei/0000-0002-0713-4664; Magnusson, Kristinn/0000-0003-4528-6826; Aben, Katja KH/0000-0002-0214-2147; Kiemeney, Lambertus A./0000-0002-2368-1326; Palsson, Arnar/0000-0002-6525-8112; Magnusson, Kristinn P Pétur/0000-0003-4528-6826; Gudbjartsson, Daniel/0000-0002-5222-9857; Helgason, Agnar/0000-0002-8545-3767; Palsson, Snaebjorn/0000-0002-4297-3500; Sigurgeirsson, Bardur/0000-0002-9733-9742; Kong, Augustine/0000-0001-8193-5438				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barsh GS, 2003, PLOS BIOL, V1, P19, DOI 10.1371/journal.pbio.0000027; Bataille V, 2000, JNCI-J NATL CANCER I, V92, P457, DOI 10.1093/jnci/92.6.457; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bonilla C, 2005, HUM GENET, V116, P402, DOI 10.1007/s00439-004-1251-2; BRAUER G, 1978, J ANTHROPOL ANZ, V36, P109; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Duffy DL, 2007, AM J HUM GENET, V80, P241, DOI 10.1086/510885; EIBERG H, 1987, CLIN GENET, V32, P125; Eiberg H, 1996, EUR J HUM GENET, V4, P237; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Frudakis T, 2003, GENETICS, V165, P2071; GALTON F, 1886, NATURE, V34, P137; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Harding RM, 2000, AM J HUM GENET, V66, P1351, DOI 10.1086/302863; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Hoekstra HE, 2006, HEREDITY, V97, P222, DOI 10.1038/sj.hdy.6800861; Izagirre N, 2006, MOL BIOL EVOL, V23, P1697, DOI 10.1093/molbev/msl030; Jablonski NG, 2000, J HUM EVOL, V39, P57, DOI 10.1006/jhev.2000.0403; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; Lao O, 2007, ANN HUM GENET, V71, P354, DOI 10.1111/j.1469-1809.2006.00341.x; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Makova K, 2005, PEPTIDES, V26, P1901, DOI 10.1016/j.peptides.2004.12.032; MANTEL N, 1959, J NATL CANCER I, V22, P719; McEvoy B, 2006, HUM MOL GENET, V15, pR176, DOI 10.1093/hmg/ddl217; Myles S, 2007, HUM GENET, V120, P613, DOI 10.1007/s00439-006-0256-4; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Posthuma D, 2006, BEHAV GENET, V36, P12, DOI 10.1007/s10519-005-9007-x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rees JL, 2004, AM J HUM GENET, V75, P739, DOI 10.1086/425285; Relethford JH, 1997, AM J PHYS ANTHROPOL, V104, P449, DOI 10.1002/(SICI)1096-8644(199712)104:4<449::AID-AJPA2>3.0.CO;2-N; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Seitz JJ, 1999, MAMM GENOME, V10, P710, DOI 10.1007/s003359901076; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Sturm RA, 2004, TRENDS GENET, V20, P327, DOI 10.1016/j.tig.2004.06.010; Sturm RA, 1998, BIOESSAYS, V20, P712, DOI 10.1002/(SICI)1521-1878(199809)20:9<712::AID-BIES4>3.0.CO;2-I; Sturm RA, 2006, TRENDS GENET, V22, P464, DOI 10.1016/j.tig.2006.06.010; VALVERDE P, 1995, NAT GENET, V11, P328, DOI 10.1038/ng1195-328; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wehrle-Haller B, 2003, PIGM CELL RES, V16, P287, DOI 10.1034/j.1600-0749.2003.00055.x; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090	50	509	534	1	142	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2007	39	12					1443	1452		10.1038/ng.2007.13	http://dx.doi.org/10.1038/ng.2007.13			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	17952075				2022-12-27	WOS:000251267400011
J	Wang, FD; Paradkar, PN; Custodio, AO; Ward, DM; Fleming, MD; Campagna, D; Roberts, KA; Boyartchuk, V; Dietrich, WF; Kaplan, J; Andrews, NC				Wang, Fudi; Paradkar, Prasad N.; Custodio, Angel O.; Ward, Diane Mcvey; Fleming, Mark D.; Campagna, Dean; Roberts, Kristina A.; Boyartchuk, Victor; Dietrich, William F.; Kaplan, Jerry; Andrews, Nancy C.			Genetic variation in Mon1a affects protein trafficking and modifies macrophage iron loading in mice	NATURE GENETICS			English	Article							RECEPTOR TYROSINE KINASE; HEREDITARY HEMOCHROMATOSIS; SACCHAROMYCES-CEREVISIAE; HOMEOSTASIS; HEPCIDIN; FERROPORTIN; MUTATIONS; MOUSE; HFE; IDENTIFICATION	We undertook a quantitative trait locus (QTL) analysis in mice to identify modifier genes that might influence the severity of human iron disorders. We identified a strong QTL on mouse chromosome 9 that differentially affected macrophage iron burden in C57BL/10J and SWR/J mice. A C57BL/10J missense allele of an evolutionarily conserved gene, Mon1a, cosegregated with the QTL in congenic mouse lines. We present evidence that Mon1a is involved in trafficking of ferroportin, the major mammalian iron exporter, to the surface of iron- recycling macrophages. Differences in amounts of surface ferroportin correlate with differences in cellular iron content. Mon1a is also important for trafficking of cell- surface and secreted molecules unrelated to iron metabolism, suggesting that it has a fundamental role in the mammalian secretory apparatus.	Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84132 USA; Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01655 USA; Novartis Inst Biomed Res, Models Dis Ctr, Cambridge, MA 02139 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah; Harvard University; Boston Children's Hospital; University of Massachusetts System; University of Massachusetts Worcester; Novartis	Andrews, NC (corresponding author), Childrens Hosp, Div Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	nandrews@enders.tch.harvard.edu	Paradkar, Prasad/ABA-5851-2020; Wang, Fudi/L-7888-2018	Paradkar, Prasad/0000-0002-6553-2214; Wang, Fudi/0000-0001-8730-0003; Andrews, Nancy/0000-0003-0243-4462; Custodio, Angel Omar/0000-0003-0916-2826; Fleming, Mark/0000-0003-0948-4024	NIDDK NIH HHS [R01 DK066373, R01 DK066373-04] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066373] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abboud S, 2000, J BIOL CHEM, V275, P19906, DOI 10.1074/jbc.M000713200; Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; Andrews NC, 2000, NAT REV GENET, V1, P208, DOI 10.1038/35042073; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Beutler E, 2002, CLIN CHEM, V48, P2232; Biasiotto G, 2004, BLOOD CELL MOL DIS, V33, P338, DOI 10.1016/j.bcmd.2004.08.002; Bonangelino CJ, 2002, MOL BIOL CELL, V13, P2486, DOI 10.1091/mbc.02-01-0005; Clothier B, 2000, BIOCHEM PHARMACOL, V59, P115, DOI 10.1016/S0006-2952(99)00306-8; Delaby C, 2005, BLOOD, V106, P3979, DOI 10.1182/blood-2005-06-2398; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Goswami T, 2006, J BIOL CHEM, V281, P28494, DOI 10.1074/jbc.C600197200; Grant GR, 2006, HEPATOLOGY, V44, P174, DOI 10.1002/hep.21233; Gu SY, 2005, MOL BIOL REP, V32, P247, DOI 10.1007/s11033-005-3005-1; Hoffman-Sommer M, 2005, BIOCHEM BIOPH RES CO, V329, P197, DOI 10.1016/j.bbrc.2005.01.107; LEBOEUF RC, 1995, J LAB CLIN MED, V126, P128; Lee P, 2002, BLOOD CELL MOL DIS, V29, P471, DOI 10.1006/bcmd.2002.0586; Lee PL, 2001, BLOOD CELL MOL DIS, V27, P783, DOI 10.1006/bcmd.2001.0445; Lee PL, 1999, BLOOD CELL MOL DIS, V25, P374, DOI 10.1006/bcmd.1999.0267; Levy JE, 1999, BLOOD, V94, P9, DOI 10.1182/blood.V94.1.9.413a43_9_11; Meiling-Wesse K, 2002, FEBS LETT, V530, P174, DOI 10.1016/S0014-5793(02)03456-7; Merryweather-Clarke AT, 2003, HUM MOL GENET, V12, P2241, DOI 10.1093/hmg/ddg225; Muraoka RS, 1999, J CLIN INVEST, V103, P1277, DOI 10.1172/JCI6091; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Persons DA, 1999, NAT GENET, V23, P159, DOI 10.1038/13787; Powell ND, 2005, J IMMUNOL, V175, P5611, DOI 10.4049/jimmunol.175.9.5611; Whitlock EP, 2006, ANN INTERN MED, V145, P209, DOI 10.7326/0003-4819-145-3-200608010-00009	26	54	58	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					1025	1032		10.1038/ng2059	http://dx.doi.org/10.1038/ng2059			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17632513				2022-12-27	WOS:000248446900022
J	Steinthorsdottir, V; Thorleifsson, G; Reynisdottir, I; Benediktsson, R; Jonsdottir, T; Walters, GB; Styrkarsdottir, U; Gretarsdottir, S; Emilsson, V; Ghosh, S; Baker, A; Snorradottir, S; Bjarnason, H; Ng, MCY; Hansen, T; Bagger, Y; Wilensky, RL; Reilly, MP; Adeyemo, A; Chen, YX; Zhou, J; Gudnason, V; Chen, GJ; Huang, HX; Lashley, K; Doumatey, A; So, WY; Ma, RCY; Andersen, G; Borch-Johnsen, K; Jorgensen, T; van Vliet-Ostaptchouk, JV; Hofker, MH; Wijmenga, C; Christiansen, C; Rader, DJ; Rotimi, C; Gurney, M; Chan, JCN; Pedersen, O; Sigurdsson, G; Gulcher, JR; Thorsteinsdottir, U; Kong, A; Stefansson, K				Steinthorsdottir, Valgerdur; Thorleifsson, Gudmar; Reynisdottir, Inga; Benediktsson, Rafn; Jonsdottir, Thorbjorg; Walters, G. Bragi; Styrkarsdottir, Unnur; Gretarsdottir, Solveig; Emilsson, Valur; Ghosh, Shyamali; Baker, Adam; Snorradottir, Steinunn; Bjarnason, Hjordis; Ng, Maggie C. Y.; Hansen, Torben; Bagger, Yu; Wilensky, Robert L.; Reilly, Muredach P.; Adeyemo, Adebowale; Chen, Yuanxiu; Zhou, Jie; Gudnason, Vilmundur; Chen, Guanjie; Huang, Hanxia; Lashley, Kerrie; Doumatey, Ayo; So, Wing-Yee; Ma, Ronald C. Y.; Andersen, Gitte; Borch-Johnsen, Knut; Jorgensen, Torben; van Vliet-Ostaptchouk, Jana V.; Hofker, Marten H.; Wijmenga, Cisca; Christiansen, Claus; Rader, Daniel J.; Rotimi, Charles; Gurney, Mark; Chan, Juliana C. N.; Pedersen, Oluf; Sigurdsson, Gunnar; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari			A variant in CDKAL1 influences insulin response and risk of type 2 diabetes	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CONFERS RISK; GENE; GLUCOSE; IDENTIFICATION; SECRETION; STROKE; IMPACT	We conducted a genome-wide association study for type 2 diabetes (T2D) in Icelandic cases and controls, and we found that a previously described variant in the transcription factor 7-like 2 gene (TCF7L2) gene conferred the most significant risk. In addition to confirming two recently identified risk variants(1), we identified a variant in the CDKAL1 gene that was associated with T2D in individuals of European ancestry (allele-specific odds ratio (OR) = 1.20 (95% confidence interval, 1.13 - 1.27), P = 7.7 x 10(-9)) and individuals from Hong Kong of Han Chinese ancestry (OR = 1.25 (1.11 - 1.40), P = 0.00018). The genotype OR of this variant suggested that the effect was substantially stronger in homozygous carriers than in heterozygous carriers. The ORs for homozygotes were 1.50 (1.31 - 1.72) and 1.55 (1.23 - 1.95) in the European and Hong Kong groups, respectively. The insulin response for homozygotes was approximately 20% lower than for heterozygotes or noncarriers, suggesting that this variant confers risk of T2D through reduced insulin secretion.	deCODE Genet, IS-101 Reykjavik, Iceland; Landspitali Univ Hosp, IS-101 Reykjavik, Iceland; Icelandic Heart Assoc, IS-201 Kopavogur, Iceland; Chinese Univ Hong Kong, Dept Med & Therapeut, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; Steno Diabet Ctr, DK-2820 Gentofte, Denmark; Ctr Clin & Basic Res AS, DK-2750 Ballerup, Denmark; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Howard Univ, Natl Human Genome Ctr, Dept Community & Family Med, Washington, DC 20060 USA; Aarhus Univ, Fac Hlth Sci, DK-8000 Aarhus, Denmark; Glostrup Univ Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; Maastricht Univ, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands; Univ Groningen, Med Ctr, Dept Pathol & Lab Med, NL-9700 RB Groningen, Netherlands; Univ Groningen, Med Ctr, Dept Genet, NL-9700 RB Groningen, Netherlands; Univ Utrecht, Med Ctr, Dept Biomed Genet, Complex Genet Sect, NL-3508 AB Utrecht, Netherlands	Landspitali National University Hospital; Icelandic Heart Association; Chinese University of Hong Kong; Prince of Wales Hospital; Steno Diabetes Center; Center Clinical & Basic Research; University of Pennsylvania; Howard University; Aarhus University; University of Copenhagen; Maastricht University; University of Groningen; University of Groningen; Utrecht University	Stefansson, K (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	vstein@decode.is; kstefans@decode.is	Benediktsson, Rafn/R-2457-2018; Chan, Juliana/B-7918-2016; Gudnason, Vilmundur/AAE-7126-2019; Pedersen, Oluf/Z-1731-2019; Ma, Ronald/C-2788-2009; Pedersen, Oluf/AAG-8015-2020; Wijmenga, Cisca/AAE-7719-2019; Wijmenga, Cisca/D-2173-2009; Jørgensen, Torben/Z-1335-2018; Walters, G. Bragi/L-4215-2013; Gudnason, Vilmundur/K-6885-2015; Stefansson, Kari/AAE-7187-2019	Benediktsson, Rafn/0000-0002-2954-9801; Chan, Juliana/0000-0003-1325-1194; Gudnason, Vilmundur/0000-0001-5696-0084; Pedersen, Oluf/0000-0002-3321-3972; Ma, Ronald/0000-0002-1227-803X; Wijmenga, Cisca/0000-0002-5635-1614; Walters, G. Bragi/0000-0002-5415-6487; Gudnason, Vilmundur/0000-0001-5696-0084; Emilsson, Valur/0000-0001-9982-0524; Reilly, Muredach/0000-0002-3035-9386; Jorgensen, Torben/0000-0001-9453-2830; Adeyemo, Adebowale/0000-0002-3105-3231; Kong, Augustine/0000-0001-8193-5438; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Reynisdottir, Inga/0000-0002-9730-7476; Hansen, Torben/0000-0001-8748-3831; van Vliet-Ostaptchouk, Jana/0000-0002-7943-3153; Styrkarsdottir, Unnur/0000-0001-8146-8278	FOGARTY INTERNATIONAL CENTER [T37TW000041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072128] Funding Source: NIH RePORTER; FIC NIH HHS [3T37TW00041-03S2] Funding Source: Medline; NCRR NIH HHS [RR03048] Funding Source: Medline; NIDDK NIH HHS [DK072128] Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Chimienti F, 2004, DIABETES, V53, P2330, DOI 10.2337/diabetes.53.9.2330; Ching YP, 2002, J BIOL CHEM, V277, P15237, DOI 10.1074/jbc.C200032200; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; Helgadottir A, 2006, NAT GENET, V38, P68, DOI 10.1038/ng1692; Helgason A, 2005, NAT GENET, V37, P90, DOI 10.1038/ng1492; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; MANTEL N, 1959, J NATL CANCER I, V22, P719; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Reynisdottir I, 2003, AM J HUM GENET, V73, P323, DOI 10.1086/377139; Rice J., 1995, MATH STAT DATA ANAL; Rotimi CN, 2001, ANN EPIDEMIOL, V11, P51, DOI 10.1016/S1047-2797(00)00180-0; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; SLUITER WJ, 1976, DIABETES, V25, P241, DOI 10.2337/diabetes.25.4.241; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Tanko LB, 2003, BONE, V32, P8, DOI 10.1016/S8756-3282(02)00918-3; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; Yang X, 2007, DIABETES CARE, V30, P65, DOI 10.2337/dc06-1273	26	793	847	0	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2007	39	6					770	775		10.1038/ng2043	http://dx.doi.org/10.1038/ng2043			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17460697	Green Published			2022-12-27	WOS:000246859100021
J	Liang, Y; Jansen, M; Aronow, B; Geiger, H; Van Zant, G				Liang, Ying; Jansen, Michael; Aronow, Bruce; Geiger, Hartmut; Van Zant, Gary			The quantitative trait gene latexin influences the size of the hematopoietic stem cell population in mice	NATURE GENETICS			English	Article							MAMMALIAN CARBOXYPEPTIDASE INHIBITOR; TAZAROTENE-INDUCED GENE-1; RETINOID RESPONSE GENE; IN-VIVO; REGIONAL SPECIFICATION; PROGENITOR CELLS; LIFE-SPAN; EXPRESSION; TIG1; FREQUENCY	We mapped quantitative trait loci that accounted for the variation in hematopoietic stem cell ( HSC) numbers between young adult C57BL/6 ( B6) and DBA/ 2 ( D2) mice. In reciprocal chromosome 3 congenic mice, introgressed D2 alleles increased HSC numbers owing to enhanced proliferation and self-renewal and reduced apoptosis, whereas B6 alleles had the opposite effects. Using oligonucleotide arrays, real-time PCR and protein blots, we identified latexin ( Lxn), a gene whose differential transcription and expression was associated with the allelic differences. Expression was inversely correlated with the number of HSCs; therefore, ectopic expression of Lxn using a retroviral vector decreased stem cell population size. We identified clusters of SNPs upstream of the Lxn transcriptional start site, at least two of which are associated with potential binding sites for transcription factors regulating stem cells. Thus, promoter polymorphisms between the B6 and D2 alleles may affect Lxn gene expression and consequently influence the population size of hematopoietic stem cells.	Univ Kentucky, Dept Internal Med, Lexington, KY 40536 USA; Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; Cincinnati Childrens Hosp, Med Ctr, Dept Biomed Informat, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA; Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Div Expt Hematol, Cincinnati, OH 45229 USA	University of Kentucky; University of Kentucky; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Van Zant, G (corresponding author), Univ Kentucky, Dept Internal Med, Lexington, KY 40536 USA.	gvzant1@uky.edu	Aronow, Bruce J/F-8438-2012		NIA NIH HHS [AG024950, AG022859, AG020917] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG024950, R01AG022859, R01AG020917] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aagaard A, 2005, STRUCTURE, V13, P309, DOI 10.1016/j.str.2004.12.013; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; ARIMATSU Y, 1994, J NEUROSCI, V14, P2020; ARIMATSU Y, 1992, P NATL ACAD SCI USA, V89, P8879, DOI 10.1073/pnas.89.19.8879; ARIMATSU Y, 1994, NEUROSCI RES, V20, P131, DOI 10.1016/0168-0102(94)90030-2; BAILEY DW, 1971, TRANSPLANTATION, V11, P325, DOI 10.1097/00007890-197103000-00013; Bradford GB, 1997, EXP HEMATOL, V25, P445; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; CALLAHAN G, 1999, FASEB J, pF637; Chen JC, 2000, EXP HEMATOL, V28, P442, DOI 10.1016/S0301-472X(99)00157-5; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; De Haan G, 1999, FASEB J, V13, P707, DOI 10.1096/fasebj.13.6.707; de Haan G, 1999, BLOOD, V93, P3294, DOI 10.1182/blood.V93.10.3294.410k07_3294_3301; deHaan G, 1997, BLOOD, V89, P1543, DOI 10.1182/blood.V89.5.1543.1543_1543_1550; deHaan G, 1997, J EXP MED, V186, P529, DOI 10.1084/jem.186.4.529; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Flint J, 2001, NAT REV GENET, V2, P437, DOI 10.1038/35076585; Geiger H, 2005, P NATL ACAD SCI USA, V102, P5102, DOI 10.1073/pnas.0408654102; Geiger H, 2002, NAT IMMUNOL, V3, P329, DOI 10.1038/ni0402-329; Geiger H, 2001, BLOOD, V98, P2966, DOI 10.1182/blood.V98.10.2966; Henckaerts E, 2004, J IMMUNOL, V173, P2486, DOI 10.4049/jimmunol.173.4.2486; Henckaerts E, 2002, BLOOD, V99, P3947, DOI 10.1182/blood.V99.11.3947; Jin MH, 1997, GENOMICS, V39, P419, DOI 10.1006/geno.1996.4469; Jing C, 2002, JNCI-J NATL CANCER I, V94, P482; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kwong J, 2005, INT J CANCER, V113, P386, DOI 10.1002/ijc.20593; Liang Y, 2003, CURR OPIN HEMATOL, V10, P195, DOI 10.1097/00062752-200305000-00001; Liu Q, 2000, MOL BIOL REP, V27, P241, DOI 10.1023/A:1010971219806; Markel P, 1997, NAT GENET, V17, P280, DOI 10.1038/ng1197-280; Morrison SJ, 2002, J IMMUNOL, V168, P635, DOI 10.4049/jimmunol.168.2.635; MullerSieburg CE, 1996, J EXP MED, V183, P1141, DOI 10.1084/jem.183.3.1141; Normant E, 1995, P NATL ACAD SCI USA, V92, P12225, DOI 10.1073/pnas.92.26.12225; SAUVAGEAU G, 1995, GENE DEV, V9, P1753, DOI 10.1101/gad.9.14.1753; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; VANDERSLUIJS JP, 1990, EXP HEMATOL, V18, P893; VANZANT G, 1990, J EXP MED, V171, P1547, DOI 10.1084/jem.171.5.1547; Wakeland E, 1997, IMMUNOL TODAY, V18, P472, DOI 10.1016/S0167-5699(97)01126-2; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140; Youssef EM, 2004, CANCER RES, V64, P2411, DOI 10.1158/0008-5472.CAN-03-0164; Zhang JM, 2004, ONCOGENE, V23, P2241, DOI 10.1038/sj.onc.1207328	42	77	84	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					178	188		10.1038/ng1938	http://dx.doi.org/10.1038/ng1938			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17220891				2022-12-27	WOS:000244063900015
J	Passador-Gurgel, G; Hsieh, WP; Hunt, P; Deighton, N; Gibson, G				Passador-Gurgel, Gisele; Hsieh, Wen-Ping; Hunt, Priscilla; Deighton, Nigel; Gibson, Greg			Quantitative trait transcripts for nicotine resistance in Drosophila melanogaster	NATURE GENETICS			English	Article							GENETIC ARCHITECTURE; EXPRESSION DATA; EGFR; GLUTAMATE; CAFFEINE; LINDANE; PATHWAY; MODELS; NUMBER; GABA	Although most genetic association studies are performed with the intention of detecting nucleotide polymorphisms that are correlated with a complex trait, transcript abundance should also be expected to associate with diseases or phenotypes. We performed a scan for such quantitative trait transcripts in adult female heads of the fruit fly ( Drosophila melanogaster) that might explain variation for nicotine resistance. The strongest association was seen for abundance of ornithine aminotransferase transcripts, implicating detoxification and neurotransmitter biosynthesis as mediators of the quantitative response to the drug. Subsequently, genetic analysis and metabolite profiling confirmed a complex role for ornithine and GABA levels in modification of survival time upon chronic nicotine exposure. Differences between populations from North Carolina and California suggest that the resistance mechanism may be an evolved response to environmental exposure.	N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; Natl Tsing Hua Univ, Dept Stat, Hsinchu 30013, Taiwan; N Carolina State Univ, Metabolom & Proteom Lab, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; National Tsing Hua University; University of North Carolina; North Carolina State University	Gibson, G (corresponding author), N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA.	ggibson@ncsu.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM045344] Funding Source: NIH RePORTER; NIGMS NIH HHS [P01-GM45344] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beleboni RO, 2004, CELL MOL NEUROBIOL, V24, P707, DOI 10.1007/s10571-004-6913-z; Carrillo R, 2002, GENET RES, V80, P205, DOI 10.1017/S0016672302005888; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; COHEN C, 1991, PHARMACOL BIOCHEM BE, V40, P121, DOI 10.1016/0091-3057(91)90331-U; de Koning DJ, 2005, TRENDS GENET, V21, P377, DOI 10.1016/j.tig.2005.05.004; De Luca M, 2003, NAT GENET, V34, P429, DOI 10.1038/ng1218; Dworkin I, 2003, CURR BIOL, V13, P1888, DOI 10.1016/j.cub.2003.10.001; Jain AN, 2002, GENOME RES, V12, P325, DOI 10.1101/gr.210902; Jessen A, 2005, DIABETES OBES METAB, V7, P327, DOI 10.1111/j.1463-1326.2004.00389.x; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Kelly A, 2001, MENT RETARD DEV D R, V7, P287, DOI 10.1002/mrdd.1040; Liotta L, 2000, NAT REV GENET, V1, P48, DOI 10.1038/35049567; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macdonald SJ, 2005, GENETICS, V171, P1741, DOI 10.1534/genetics.105.045344; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Palsson A, 2004, GENETICS, V167, P1199, DOI 10.1534/genetics.104.026252; Palsson A, 2004, GENETICS, V167, P1187, DOI 10.1534/genetics.103.021766; Parmar D, 2003, FOOD CHEM TOXICOL, V41, P1077, DOI 10.1016/S0278-6915(03)00045-0; Seiler Nikolaus, 2000, Current Drug Targets, V1, P119, DOI 10.2174/1389450003349254; SIVILOTTI L, 1991, PROG NEUROBIOL, V36, P35, DOI 10.1016/0301-0082(91)90036-Z; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tomfohr J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-225; Vale C, 1998, J NEUROSCI RES, V52, P276, DOI 10.1002/(SICI)1097-4547(19980501)52:3<276::AID-JNR4>3.0.CO;2-A; Wolf FW, 2003, J NEUROBIOL, V54, P161, DOI 10.1002/neu.10166; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Yang HP, 2003, MOL BIOL EVOL, V20, P800, DOI 10.1093/molbev/msg087; YONEDA Y, 1982, J NEUROCHEM, V38, P1686, DOI 10.1111/j.1471-4159.1982.tb06650.x	27	59	60	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2007	39	2					264	268		10.1038/ng1944	http://dx.doi.org/10.1038/ng1944			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17237783				2022-12-27	WOS:000244063900027
J	Conrad, DF; Jakobsson, M; Coop, G; Wen, XQ; Wall, JD; Rosenberg, NA; Pritchard, JK				Conrad, Donald F.; Jakobsson, Mattias; Coop, Graham; Wen, Xiaoquan; Wall, Jeffrey D.; Rosenberg, Noah A.; Pritchard, Jonathan K.			A worldwide survey of haplotype variation and linkage disequilibrium in the human genome	NATURE GENETICS			English	Article							HUMAN-POPULATIONS; HIGH-RESOLUTION; POLYMORPHISM DATA; WIDE ASSOCIATION; WHOLE-GENOME; DIVERSITY; PATTERNS; MAP; PORTABILITY; CHIMPANZEES	Recent genomic surveys have produced high-resolution haplotype information, but only in a small number of human populations. We report haplotype structure across 12 Mb of DNA sequence in 927 individuals representing 52 populations. The geographic distribution of haplotypes reflects human history, with a loss of haplotype diversity as distance increases from Africa. Although the extent of linkage disequilibrium (LD) varies markedly across populations, considerable sharing of haplotype structure exists, and inferred recombination hotspot locations generally match across groups. The four samples in the International HapMap Project contain the majority of common haplotypes found in most populations: averaging across populations, 83% of common 20-kb haplotypes in a population are also common in the most similar HapMap sample. Consequently, although the portability of tag SNPs based on the HapMap is reduced in low-LD Africans, the HapMap will be helpful for the design of genome-wide association mapping studies in nearly all human populations.	Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	University of Michigan System; University of Michigan; University of Southern California; University of Chicago	Rosenberg, NA (corresponding author), Univ Michigan, Dept Human Genet, 100 Washtenaw Ave, Ann Arbor, MI 48109 USA.	rnoah@umich.edu	Jakobsson, Mattias/A-6116-2011	Jakobsson, Mattias/0000-0001-7840-7853; Wen, Xiaoquan/0000-0001-8990-2737; Coop, Graham/0000-0001-8431-0302; Rosenberg, Noah/0000-0002-1829-8664				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Bonnen PE, 2006, NAT GENET, V38, P214, DOI 10.1038/ng1712; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Cann HM, 2002, SCIENCE, V296, P261; Cavalli-Sforza LL, 2005, NAT REV GENET, V6, P333, DOI 10.1038/nrg1579; DEBAKKER PI, 2006, PAC S BIOCOMPUT, V11, P478; Fearnhead P, 2005, AM J HUM GENET, V77, P781, DOI 10.1086/497579; Gonzalez-Neira A, 2006, GENOME RES, V16, P323, DOI 10.1101/gr.4138406; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Huang W, 2006, P NATL ACAD SCI USA, V103, P1418, DOI 10.1073/pnas.0510360103; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Montpetit A, 2006, PLOS GENET, V2, P282, DOI 10.1371/journal.pgen.0020027; MOUNTAIN JL, 1994, P NATL ACAD SCI USA, V91, P6515, DOI 10.1073/pnas.91.14.6515; Nielsen R, 2004, GENETICS, V168, P2373, DOI 10.1534/genetics.104.031039; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Plagnol V, 2006, PLOS GENET, V2, P972, DOI 10.1371/journal.pgen.0020105; Pritchard JK, 2000, GENETICS, V155, P945; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rogers AR, 1996, AM J HUM GENET, V58, P1033; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sawyer SL, 2005, EUR J HUM GENET, V13, P677, DOI 10.1038/sj.ejhg.5201368; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; Tishkoff SA, 1996, SCIENCE, V271, P1380, DOI 10.1126/science.271.5254.1380; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Willer CJ, 2006, GENET EPIDEMIOL, V30, P180, DOI 10.1002/gepi.20131; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Yoo YK, 2006, GENETICS, V174, P491, DOI 10.1534/genetics.105.052225; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	35	350	362	1	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2006	38	11					1251	1260		10.1038/ng1911	http://dx.doi.org/10.1038/ng1911			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17057719				2022-12-27	WOS:000241592700013
J	Moreno-Loshuertos, R; Acin-Perez, R; Fernandez-Silva, P; Movilla, N; Perez-Martos, A; de Cordoba, SR; Gallardo, ME; Enriquez, JA				Moreno-Loshuertos, Raquel; Acin-Perez, Rebeca; Fernandez-Silva, Patricio; Movilla, Nieves; Perez-Martos, Acisclo; de Cordoba, Santiago Rodriguez; Gallardo, M. Esther; Enriquez, Jose Antonio			Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variants	NATURE GENETICS			English	Article							OXIDATIVE STRESS; RESPIRATORY-FUNCTION; NADH DEHYDROGENASE; MTDNA HAPLOGROUPS; MAMMALIAN-CELLS; MUTATION; GENE; SELECTION; RNA; FIBROBLASTS	Common mitochondrial DNA (mtDNA) haplotypes in humans and mice have been associated with various phenotypes, including learning performance and disease penetrance. Notably, no influence of mtDNA haplotype in cell respiration has been demonstrated. Here, using cell lines carrying four different common mouse mtDNA haplotypes in an identical nuclear background, we show that the similar level of respiration among the cell lines is only apparent and is a consequence of compensatory mechanisms triggered by different production of reactive oxygen species. We observe that the respiration capacity per molecule of mtDNA in cells with the NIH3T3 or NZB mtDNA is lower than in those with the C57BL/6J, CBA/J or BALB/cJ mtDNA. In addition, we have determined the genetic element underlying these differences. Our data provide insight into the molecular basis of the complex phenotypes associated with common mtDNA variants and anticipate a relevant contribution of mtDNA single nucleotide polymorphisms to phenotypic variability in humans.	Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, E-50013 Zaragoza, Spain; CSIC, Ctr Invest Biol, Dept Inmunol, E-28040 Madrid, Spain	University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Enriquez, JA (corresponding author), Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Miguel Servet 177, E-50013 Zaragoza, Spain.	enriquez@unizar.es	Moreno-Loshuertos, Raquel/H-4545-2015; Enríquez, J.A./M-8468-2016; Gallardo, M. Esther/AFK-7298-2022; de Cordoba, Santiago Rodriguez/K-6727-2014; Acin-Perez, Rebeca/H-6160-2015; Silva, Patricio Fernandez/U-2256-2017; Acin-Perez, Rebeca/AAU-4913-2020	Enríquez, J.A./0000-0002-3671-2961; Gallardo, M. Esther/0000-0002-8699-8734; de Cordoba, Santiago Rodriguez/0000-0001-6401-1874; Acin-Perez, Rebeca/0000-0001-9553-8337; Silva, Patricio Fernandez/0000-0001-8971-7355; Acin-Perez, Rebeca/0000-0001-9553-8337; Moreno Loshuertos, Raquel/0000-0002-6600-1618				Acin-Perez R, 2004, MOL CELL, V13, P805, DOI 10.1016/S1097-2765(04)00124-8; Acin-Perez R, 2003, HUM MOL GENET, V12, P329, DOI 10.1093/hmg/ddg021; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Bai YD, 1998, EMBO J, V17, P4848, DOI 10.1093/emboj/17.16.4848; Battersby BJ, 2001, HUM MOL GENET, V10, P2469, DOI 10.1093/hmg/10.22.2469; Bayona-Bafaluy MP, 2003, NUCLEIC ACIDS RES, V31, P5349, DOI 10.1093/nar/gkg739; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown MD, 2002, HUM GENET, V110, P130, DOI 10.1007/s00439-001-0660-8; Carelli V, 2002, BBA-MOL BASIS DIS, V1588, P7, DOI 10.1016/S0925-4439(02)00097-2; CHOMYN A, 1994, AM J HUM GENET, V54, P966; De Benedictis G, 1999, FASEB J, V13, P1532, DOI 10.1096/fasebj.13.12.1532; DiMauro S, 2004, BBA-BIOENERGETICS, V1659, P107, DOI 10.1016/j.bbabio.2004.08.003; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Enriquez JA, 1996, EUR J BIOCHEM, V237, P601, DOI 10.1111/j.1432-1033.1996.0601p.x; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Gallardo ME, 2006, HUM MUTAT, V27, P575, DOI 10.1002/humu.20338; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; GARDNER PR, 1994, P NATL ACAD SCI USA, V91, P12248, DOI 10.1073/pnas.91.25.12248; Geromel V, 2001, HUM MOL GENET, V10, P1221, DOI 10.1093/hmg/10.11.1221; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; Herrnstadt C, 2004, MITOCHONDRION, V4, P791, DOI 10.1016/j.mito.2004.07.041; Hofhaus G, 1996, Methods Enzymol, V264, P476, DOI 10.1016/S0076-6879(96)64043-9; Howell N, 2003, AM J MED GENET A, V119A, P147, DOI 10.1002/ajmg.a.20135; Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93; Johnson KR, 2001, NAT GENET, V27, P191, DOI 10.1038/84831; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Lee HC, 2002, J BIOMED SCI, V9, P517, DOI 10.1007/BF02254978; Lee HC, 2005, INT J BIOCHEM CELL B, V37, P822, DOI 10.1016/j.biocel.2004.09.010; Liu CS, 2003, FREE RADICAL RES, V37, P1307, DOI 10.1080/10715760310001621342; LOVELAND B, 1990, CELL, V60, P971, DOI 10.1016/0092-8674(90)90345-F; Montiel-Sosa F, 2006, GENE, V368, P21, DOI 10.1016/j.gene.2005.09.015; Niemi AK, 2003, HUM GENET, V112, P29, DOI 10.1007/s00439-002-0843-y; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; Nulton-Persson AC, 2001, J BIOL CHEM, V276, P23357, DOI 10.1074/jbc.M100320200; PREZANT TR, 1993, NAT GENET, V4, P289, DOI 10.1038/ng0793-289; REID FM, 1994, HUM MUTAT, V3, P243, DOI 10.1002/humu.1380030311; Roubertoux PL, 2003, NAT GENET, V35, P65, DOI 10.1038/ng1230; Ruiz-Pesini E, 2004, SCIENCE, V303, P223, DOI 10.1126/science.1088434; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; Staden R, 2000, Methods Mol Biol, V132, P115; Tanaka M, 1998, LANCET, V351, P185, DOI 10.1016/S0140-6736(05)78211-8; Tretter L, 2000, J NEUROSCI, V20, P8972; Wallace DC, 2003, COLD SPRING HARB SYM, V68, P479; Wang H, 1999, FREE RADICAL BIO MED, V27, P612, DOI 10.1016/S0891-5849(99)00107-0; Zhao H, 2004, AM J HUM GENET, V74, P139, DOI 10.1086/381133	48	254	262	0	29	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2006	38	11					1261	1268		10.1038/ng1897	http://dx.doi.org/10.1038/ng1897			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17013393				2022-12-27	WOS:000241592700014
J	Hoffmann, R				Hoffmann, Robert			A wiki for the life sciences where authorship matters	NATURE GENETICS			English	Article							ANNOTATION; BIOLOGISTS; RESOURCES; DATABASE	WikiGenes is the first wiki system to combine the collaborative and largely altruistic possibilities of wikis with explicit authorship. In view of the extraordinary success of Wikipedia there remains no doubt about the potential of collaborative publishing, yet its adoption in science has been limited. Here I discuss a dynamic collaborative knowledge base for the life sciences that provides authors with due credit and that can evolve via continual revision and traditional peer review into a rigorous scientific tool.	MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Hoffmann, R (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, 32 Vassar St, Cambridge, MA 02139 USA.	hoffmann@wikigenes.org		Newman, Gregory/0000-0003-0503-5782	Society in Science	Society in Science	This work was supported in part by the Branco Weiss Fellowship, Society in Science. I am thankful to the Memorial Sloan-Kettering Cancer Center for hosting the iHOP information resource, C. Sander and M. Ramirez-Gaite for helpful discussion, and T. Berners-Lee and D. Weitzner for their support.	Adler B.T., 2007, P 16 INT C WORLD WID, P261, DOI DOI 10.1145/1242572.1242608; [Anonymous], 2007, NAT GENET, V39, P423; [Anonymous], 2005, NATURE, V438, P531, DOI 10.1038/438531a; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Baumgartner WA, 2007, BIOINFORMATICS, V23, pI41, DOI 10.1093/bioinformatics/btm229; Berners-Lee T, 2001, NATURE, V410, P1023, DOI 10.1038/35074206; Brooksbank C, 2005, NUCLEIC ACIDS RES, V33, pD46, DOI 10.1093/nar/gki026; Butler D, 2005, NATURE, V438, P548, DOI 10.1038/438548a; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Check E, 2007, NATURE, V448, P848, DOI 10.1038/448848a; Chen M., 2001, COMPUTING USING REPU, P154, DOI DOI 10.1145/501158.501175; Cokol M, 2007, EMBO REP, V8, P422, DOI 10.1038/sj.embor.7400970; Conte R., 2002, REPUTATION ARTIFICIA; Cotton RGH, 2007, NAT GENET, V39, P433, DOI 10.1038/ng2024; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Friedman EJ, 2001, J ECON MANAGE STRAT, V10, P173, DOI 10.1162/105864001300122476; Giles J, 2005, NATURE, V438, P900, DOI 10.1038/438900a; Giles J, 2006, NATURE, V443, P493, DOI 10.1038/443493a; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Heber J, 2008, NAT MATER, V7, P512, DOI 10.1038/nmat2215; Hoffmann R, 2005, BIOINFORMATICS, V21, P252, DOI 10.1093/bioinformatics/bti1142; Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664; Huss JW, 2008, PLOS BIOL, V6, P1398, DOI 10.1371/journal.pbio.0060175; KASSIRER JP, 1994, JAMA-J AM MED ASSOC, V272, P96, DOI 10.1001/jama.272.2.96; Kling Rob, 1996, COMPUTERIZATION CONT, V2nd; Lehmann S, 2006, NATURE, V444, P1003, DOI 10.1038/4441003a; Lipscomb CE, 2000, B MED LIBR ASSOC, V88, P265; Little P, 1998, NAT GENET, V19, P222, DOI 10.1038/896; MCKUSICK VA, 1989, GENOMICS, V5, P385, DOI 10.1016/0888-7543(89)90077-3; Mons B, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r89; Patterson SD, 2003, NAT GENET, V33, P311, DOI 10.1038/ng1106; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Resnick P, 2000, COMMUN ACM, V43, P45, DOI 10.1145/355112.355122; Roberts L, 2001, SCIENCE, V291, P1182; Rodriguez MA, 2006, J INF SCI, V32, P149, DOI 10.1177/0165551506062327; Salzberg SL, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-102; Searls DB, 2005, NAT REV DRUG DISCOV, V4, P45, DOI 10.1038/nrd1608; Spier Ray, 2002, Trends Biotechnol, V20, P357, DOI 10.1016/S0167-7799(02)01985-6; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Terry SF, 2007, NAT REV GENET, V8, P157, DOI 10.1038/nrg1991; von Bubnoff A, 2001, DEV BIOL, V239, P1, DOI 10.1006/dbio.2001.0388; Waldrop MM, 2008, SCI AM, V298, P68, DOI 10.1038/scientificamerican0508-68; Wang K, 2006, NATURE, V439, P534, DOI 10.1038/439534a; Westerhoff HV, 2004, NAT BIOTECHNOL, V22, P1249, DOI 10.1038/nbt1020; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; 2007, NAT GENET, V39, P931; 2005, NATURE, V436, P1066	48	118	119	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2008	40	9					1047	1051		10.1038/ng.f.217	http://dx.doi.org/10.1038/ng.f.217			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	18728691				2022-12-27	WOS:000258761200013
J	O'Donovan, MC; Craddock, N; Norton, N; Williams, H; Peirce, T; Moskvina, V; Nikolov, I; Hamshere, M; Carroll, L; Georgieva, L; Dwyer, S; Holmans, P; Marchini, JL; Spencer, CCA; Howie, B; Leung, HT; Hartmann, AM; Moller, HJ; Morris, DW; Shi, YY; Feng, GY; Hoffmann, P; Propping, P; Vasilescu, C; Maier, W; Rietschel, M; Zammit, S; Schumacher, J; Quinn, EM; Schulze, TG; Williams, NM; Giegling, I; Iwata, N; Ikeda, M; Darvasi, A; Shifman, S; He, L; Duan, J; Sanders, AR; Levinson, DF; Gejman, PV; Cichon, S; Nothen, MM; Gill, M; Corvin, A; Rujescu, D; Kirov, G; Owen, MJ				O'Donovan, Michael C.; Craddock, Nicholas; Norton, Nadine; Williams, Hywel; Peirce, Timothy; Moskvina, Valentina; Nikolov, Ivan; Hamshere, Marian; Carroll, Liam; Georgieva, Lyudmila; Dwyer, Sarah; Holmans, Peter; Marchini, Jonathan L.; Spencer, Chris C. A.; Howie, Bryan; Leung, Hin-Tak; Hartmann, Annette M.; Moeller, Hans-Juergen; Morris, Derek W.; Shi, YongYong; Feng, GuoYin; Hoffmann, Per; Propping, Peter; Vasilescu, Catalina; Maier, Wolfgang; Rietschel, Marcella; Zammit, Stanley; Schumacher, Johannes; Quinn, Emma M.; Schulze, Thomas G.; Williams, Nigel M.; Giegling, Ina; Iwata, Nakao; Ikeda, Masashi; Darvasi, Ariel; Shifman, Sagiv; He, Lin; Duan, Jubao; Sanders, Alan R.; Levinson, Douglas F.; Gejman, Pablo V.; Cichon, Sven; Noethen, Markus M.; Gill, Michael; Corvin, Aiden; Rujescu, Dan; Kirov, George; Owen, Michael J.		Mol Genetics Of Schizophrenia Coll	Identification of loci associated with schizophrenia by genome-wide association and follow-up	NATURE GENETICS			English	Article								We carried out a genome-wide association study of schizophrenia (479 cases, 2,937 controls) and tested loci with P < 10(-5) in up to 16,726 additional subjects. Of 12 loci followed up, 3 had strong independent support (P < 5 x 10(-4)), and the overall pattern of replication was unlikely to occur by chance (P < 9 x 10(-8)). Meta-analysis provided strongest evidence for association around ZNF804A (P = 1.61 x 10(-7)) and this strengthened when the affected phenotype included bipolar disorder (P = 9.96 x 10(-9)).	[O'Donovan, Michael C.; Craddock, Nicholas; Norton, Nadine; Williams, Hywel; Peirce, Timothy; Moskvina, Valentina; Nikolov, Ivan; Hamshere, Marian; Carroll, Liam; Georgieva, Lyudmila; Dwyer, Sarah; Holmans, Peter; Zammit, Stanley; Williams, Nigel M.; Kirov, George; Owen, Michael J.] Cardiff Univ, Sch Med, Dept Psychol Med, Cardiff CF14 4XN, England; [Marchini, Jonathan L.; Spencer, Chris C. A.; Howie, Bryan] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Leung, Hin-Tak] Univ Cambridge, Dept Med Genet, Wellcome Trust Diabet & Inflammat Lab, Juvenile Diabet Res Fdn, Cambridge CB2 0XY, England; [Hartmann, Annette M.; Giegling, Ina; Rujescu, Dan] Univ Munich, Div Mol & Clin Neurbiol, D-80336 Munich, Germany; [Moeller, Hans-Juergen] Univ Munich, Dept Psychiat, D-80336 Munich, Germany; [Morris, Derek W.; Quinn, Emma M.; Gill, Michael; Corvin, Aiden] Univ Dublin Trinity Coll, Sch Med, Neuropsychiat Genet Res Grp, Dublin 8, Ireland; [Shi, YongYong] Shanghai Jiao Tong Univ, BioX Ctr, Shanghai 200030, Peoples R China; [Feng, GuoYin] Shanghai Inst Mental Hlth, Shanghai 200030, Peoples R China; [Hoffmann, Per; Vasilescu, Catalina; Cichon, Sven; Noethen, Markus M.] Univ Bonn, Dept Gen, Life & Brain Ctr, D-53105 Bonn, Germany; [Propping, Peter; Cichon, Sven; Noethen, Markus M.] Univ Bonn, Inst Human Genet, D-53105 Bonn, Germany; [Maier, Wolfgang] Univ Bonn, Dept Psychiat, D-53105 Bonn, Germany; [Rietschel, Marcella] Cent Inst Mental Hlth, Div Genet Epidemiol Psychiat, D-68159 Mannheim, Germany; [Schumacher, Johannes; Schulze, Thomas G.] US Natl Inst Mental Hlth, Natl Inst Hlth, Bethesda, MD 20892 USA; [Iwata, Nakao; Ikeda, Masashi] Fujita Hlth Univ, Sch Med, Dept Psychiat, Aichi 4701192, Japan; [Iwata, Nakao; Ikeda, Masashi] Japan Sci & Technol Agcy, CREST, Saitama 3320012, Japan; [Darvasi, Ariel; Shifman, Sagiv] Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel; [He, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Shanghai 200031, Peoples R China; [Duan, Jubao; Sanders, Alan R.; Gejman, Pablo V.] Northwestern Univ, Ctr Psychiat Genet, Evanston, IL 60201 USA; [Duan, Jubao; Sanders, Alan R.; Gejman, Pablo V.] Northwestern Univ, Feinberg Sch Med, Evanston, IL 60201 USA; [Levinson, Douglas F.] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Cardiff University; University of Oxford; University of Cambridge; University of Munich; University of Munich; Trinity College Dublin; Shanghai Jiao Tong University; University of Bonn; University of Bonn; University of Bonn; Central Institute of Mental Health; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Fujita Health University; Japan Science & Technology Agency (JST); Hebrew University of Jerusalem; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Northwestern University; Northwestern University; Feinberg School of Medicine; Stanford University	O'Donovan, MC (corresponding author), Cardiff Univ, Sch Med, Dept Psychol Med, Cardiff CF14 4XN, England.	wpcmod@cf.ac.uk; wpcmjo@cf.ac.uk	Marchini, Jonathan/ABE-9024-2020; Hoffmann, Per/A-5149-2010; Giegling, Ina/ABA-3677-2021; Shi, Yongyong/GSO-1627-2022; Cichon, Sven/B-9618-2014; Schumacher, Johannes/F-4970-2015; Morris, Derek/AAW-8343-2021; Cichon, Sven/H-8803-2013; Hartmann, Annette/AAS-6331-2021; Schulze, Thomas G/H-2157-2013; Rujescu, Dan/GRS-3875-2022; Holmans, Peter/F-4518-2015; Williams, Hywel/AAL-2440-2021; Shifman, Sagiv/D-8749-2017; O'Donovan, Michael C/P-7005-2018; Nöthen, Markus/B-2027-2009; Mowry, Bryan/G-5046-2010	Marchini, Jonathan/0000-0003-0610-8322; Hoffmann, Per/0000-0002-6573-983X; Shi, Yongyong/0000-0003-1710-1505; Cichon, Sven/0000-0002-9475-086X; Schumacher, Johannes/0000-0001-9217-6457; Morris, Derek/0000-0002-3413-570X; Cichon, Sven/0000-0002-9475-086X; Holmans, Peter/0000-0003-0870-9412; Williams, Hywel/0000-0001-7758-0312; Shifman, Sagiv/0000-0003-4071-5361; O'Donovan, Michael C/0000-0001-7073-2379; Nöthen, Markus/0000-0002-8770-2464; Corvin, Aiden/0000-0001-6717-4089; Freedman, Robert/0000-0002-2181-2898; Black, Donald/0000-0001-8038-1971; Gill, Michael/0000-0003-0206-5337; Mowry, Bryan/0000-0002-4115-5645; Escott-Price, Valentina/0000-0003-1784-5483; Buccola, Nancy/0000-0003-1378-4636; Ikeda, Masashi/0000-0001-6237-2449; Zammit, Stanley/0000-0002-2647-9211; Walters, James/0000-0002-6980-4053; Kirov, George/0000-0002-3427-3950	MRC; Wellcome Trust; Science Foundation Ireland; Health Research Board (Ireland); National Genomic Network of the 'Bundesministerium fur Bildung und Forschung' (BMBF); Alfried Krupp von Bohlen und Halbach-Stiftung; GlaxoSmithKline.; Medical Research Council [G9810900] Funding Source: researchfish; MRC [G9810900] Funding Source: UKRI; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060879, U01MH046276] Funding Source: NIH RePORTER	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Health Research Board (Ireland); National Genomic Network of the 'Bundesministerium fur Bildung und Forschung' (BMBF)(Federal Ministry of Education & Research (BMBF)); Alfried Krupp von Bohlen und Halbach-Stiftung; GlaxoSmithKline.(GlaxoSmithKline); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The UK research was supported by grants from the MRC and the Wellcome Trust. We are grateful to the Wellcome Trust Case Control Consortium for access to control genotypes (and to the individuals acknowledged in that respect in ref. 4) and their contribution to the genome-wide study, and to the Welsh e-Science Centre at Cardiff University for access to computing resources for some of this work. In Dublin, the research was supported by Science Foundation Ireland, the Health Research Board (Ireland) and the Wellcome Trust. We are grateful to J. Waddington for sample recruitment. Irish controls were supplied by J. McPartlin and the Trinity College Biobank. In Bonn and Mannheim, the work was supported by the National Genomic Network of the 'Bundesministerium fur Bildung und Forschung' (BMBF) and the Alfried Krupp von Bohlen und Halbach-Stiftung. We also thank the Department of Psychiatry, LMU Munich for clinical characterization of the Munich subjects and the processing of the samples. Recruitment in Munich was partially supported by GlaxoSmithKline. The Ashkenazi samples are part of the Hebrew University Genetic Resource.	Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cardno AG, 2000, AM J MED GENET, V97, P12, DOI 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.3.CO;2-L; Craddock N, 2005, J MED GENET, V42, P193, DOI 10.1136/jmg.2005.030718; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; RISCH N, 1990, AM J HUM GENET, V46, P222; Ross CA, 2006, NEURON, V52, P139, DOI 10.1016/j.neuron.2006.09.015; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	10	817	851	2	80	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2008	40	9					1053	1055		10.1038/ng.201	http://dx.doi.org/10.1038/ng.201			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	18677311				2022-12-27	WOS:000258761200014
J	Dutrow, N; Nix, DA; Holt, D; Milash, B; Dalley, B; Westbroek, E; Parnell, TJ; Cairns, BR				Dutrow, Natalie; Nix, David A.; Holt, Derick; Milash, Brett; Dalley, Brian; Westbroek, Erick; Parnell, Timothy J.; Cairns, Bradley R.			Dynamic transcriptome of Schizosaccharomyces pombe shown by RNA-DNA hybrid mapping	NATURE GENETICS			English	Article							FISSION YEAST CENTROMERES; POLYMERASE-II; HUMAN GENOME; SEQUENCE; HETEROCHROMATIN; COMPLEX; IDENTIFICATION; ORGANIZATION; METHYLATION; TELOMERASE	We have determined the high-resolution strand-specific transcriptome of the fission yeast S. pombe under multiple growth conditions using a novel RNA-DNA hybridization mapping (HybMap) technique. HybMap uses an antibody against an RNA-DNA hybrid to detect RNA molecules hybridized to a high-density DNA oligonucleotide tiling microarray. HybMap showed exceptional dynamic range and reproducibility, and allowed us to identify strand-specific coding, noncoding and structural RNAs, as well as previously unknown RNAs conserved in distant yeast species. Notably, we found that virtually the entire euchromatic genome (including intergenics) is transcribed, with heterochromatin dampening intergenic transcription. We identified features including large numbers of condition-specific noncoding RNAs, extensive antisense transcription, new properties of antisense transcripts and induced divergent transcription. Furthermore, our HybMap data informed the efficiency and locations of RNA splicing genome-wide. Finally, we observed strand-specific transcription islands around tRNAs at heterochromatin boundaries inside centromeres. Here, we discuss these new features in terms of organism fitness and transcriptome evolution.	[Dutrow, Natalie; Holt, Derick; Westbroek, Erick; Parnell, Timothy J.; Cairns, Bradley R.] Univ Utah, Sch Med, Dept Oncol Sci, Salt Lake City, UT 84132 USA; [Dutrow, Natalie; Holt, Derick; Westbroek, Erick; Parnell, Timothy J.; Cairns, Bradley R.] Univ Utah, Sch Med, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; [Nix, David A.; Milash, Brett] Univ Utah, Sch Med, Huntsman Canc Inst, Bioinformat Core Facil, Salt Lake City, UT 84112 USA; [Dalley, Brian] Univ Utah, Sch Med, Huntsman Canc Inst, Microarray Core Facil, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Cairns, BR (corresponding author), Univ Utah, Sch Med, Dept Oncol Sci, Salt Lake City, UT 84132 USA.	brad.cairns@hci.utah.edu		Parnell, Timothy/0000-0002-3632-3691	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [CA24014] Funding Source: Medline; NIGMS NIH HHS [T32 GM007464] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007464] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALLSHIRE RC, 1994, CELL, V76, P157, DOI 10.1016/0092-8674(94)90180-5; BAUM M, 1994, MOL BIOL CELL, V5, P747, DOI 10.1091/mbc.5.7.747; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BOGUSLAWSKI SJ, 1986, J IMMUNOL METHODS, V89, P123, DOI 10.1016/0022-1759(86)90040-2; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; CLARKE L, 1986, P NATL ACAD SCI USA, V83, P8253, DOI 10.1073/pnas.83.21.8253; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Gordon M, 2007, MOL CELL BIOL, V27, P4058, DOI 10.1128/MCB.02044-06; Hu ZL, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl142; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; Kato H, 2005, SCIENCE, V309, P467, DOI 10.1126/science.1114955; Leonardi J, 2008, NAT STRUCT MOL BIOL, V15, P26, DOI 10.1038/nsmb1343; Lindsey-Boltz LA, 2007, P NATL ACAD SCI USA, V104, P13213, DOI 10.1073/pnas.0706316104; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; NAKASEKO Y, 1986, EMBO J, V5, P1011, DOI 10.1002/j.1460-2075.1986.tb04316.x; NAKASEKO Y, 1987, NUCLEIC ACIDS RES, V15, P4705, DOI 10.1093/nar/15.12.4705; Nicolas E, 2007, NAT STRUCT MOL BIOL, V14, P372, DOI 10.1038/nsmb1239; Noma KI, 2006, CELL, V125, P859, DOI 10.1016/j.cell.2006.04.028; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Partridge JF, 2002, CURR BIOL, V12, P1652, DOI 10.1016/S0960-9822(02)01177-6; Perocchi F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm683; Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183; Scott KC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001099; Steigele S, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-25; STEINER NC, 1993, MOL CELL BIOL, V13, P4578, DOI 10.1128/MCB.13.8.4578; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; TAKAHASHI K, 1992, MOL BIOL CELL, V3, P819, DOI 10.1091/mbc.3.7.819; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Webb CJ, 2008, NAT STRUCT MOL BIOL, V15, P34, DOI 10.1038/nsmb1354; Wiren M, 2005, EMBO J, V24, P2906, DOI 10.1038/sj.emboj.7600758; Wood V, 2002, NATURE, V415, P871, DOI 10.1038/nature724	38	78	79	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					977	986		10.1038/ng.196	http://dx.doi.org/10.1038/ng.196			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18641648	Green Accepted			2022-12-27	WOS:000258026900014
J	Franke, A; Balschun, T; Karlsen, TH; Hedderich, J; May, S; Lu, T; Schuldt, D; Nikolaus, S; Rosenstiel, P; Krawczak, M; Schreiber, S				Franke, Andre; Balschun, Tobias; Karlsen, Tom H.; Hedderich, Juergen; May, Sandra; Lu, Tim; Schuldt, Doerthe; Nikolaus, Susanna; Rosenstiel, Philip; Krawczak, Michael; Schreiber, Stefan			Replication of signals from recent studies of Crohn's disease identifies previously unknown disease loci for ulcerative colitis	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY; GENE; AUTOPHAGY; MULTIPLE	Following up on recent genome-wide association studies (GWAS) of Crohn's disease, we investigated 50 previously reported susceptibility loci in a German sample of individuals with Crohn's disease (n = 1,850) or ulcerative colitis (n = 1,103) and healthy controls (n = 1,817). Among these loci, we identified variants in 3p21.31, NKX2-3 and CCNY as susceptibility factors for both diseases, whereas variants in PTPN2, HERC2 and STAT3 were associated only with ulcerative colitis in our sample collection.	[Franke, Andre; Balschun, Tobias; May, Sandra; Schuldt, Doerthe; Rosenstiel, Philip; Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Karlsen, Tom H.] Univ Oslo, Rikshosp, Univ Hosp, Dept Med, N-0027 Oslo, Norway; [Hedderich, Juergen; Lu, Tim; Krawczak, Michael] Univ Kiel, Inst Med Informat & Stat, D-24105 Kiel, Germany; [Schuldt, Doerthe; Nikolaus, Susanna; Schreiber, Stefan] Univ Kiel, Dept Gen Internal Med, Univ Hosp Schleswig Holstein, D-24105 Kiel, Germany	University of Kiel; University of Oslo; National Hospital Norway; University of Kiel; University of Kiel; Schleswig Holstein University Hospital	Schreiber, S (corresponding author), Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany.	s.schreiber@mucosa.de	Franke, Andre/B-2151-2010; Rosenstiel, Philip/A-5137-2009; Balschun, Tobias/B-2356-2010; Krawczak, Michael/A-8964-2010	Franke, Andre/0000-0003-1530-5811; Rosenstiel, Philip/0000-0002-9692-8828; Krawczak, Michael/0000-0003-2603-1502				Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Franke A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000691; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Raelson JV, 2007, P NATL ACAD SCI USA, V104, P14747, DOI 10.1073/pnas.0706645104; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379	10	294	303	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2008	40	6					713	715		10.1038/ng.148	http://dx.doi.org/10.1038/ng.148			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18438405				2022-12-27	WOS:000256212000011
J	Rosendahl, J; Witt, H; Szmola, R; Bhatia, E; Ozsvari, B; Landt, O; Schulz, HU; Gress, TM; Pfuetzer, R; Loehr, M; Kovacs, P; Blueher, M; Stumvoll, M; Choudhuri, G; Hegyi, P; Morsche, RHT; Drenth, JP; Truninger, K; Macek, M; Puhl, G; Witt, U; Schmidt, H; Buening, C; Ockenga, J; Kage, A; Groneberg, DA; Nickel, R; Berg, T; Wiedenmann, B; Boedeker, H; Keim, V; Moessner, J; Teich, N; Sahin-Toth, M				Rosendahl, Jonas; Witt, Heiko; Szmola, Richard; Bhatia, Eesh; Ozsvari, Bela; Landt, Olfert; Schulz, Hans-Ulrich; Gress, Thomas M.; Pfuetzer, Roland; Loehr, Matthias; Kovacs, Peter; Blueher, Matthias; Stumvoll, Michael; Choudhuri, Gourdas; Hegyi, Peter; Morsche, Rene Hm te; Drenth, Joost P. H.; Truninger, Kaspar; Macek, Milan, Jr.; Puhl, Gero; Witt, Ulrike; Schmidt, Hartmut; Buening, Carsten; Ockenga, Johann; Kage, Andreas; Groneberg, David Alexander; Nickel, Renate; Berg, Thomas; Wiedenmann, Bertram; Boedeker, Hans; Keim, Volker; Moessner, Joachim; Teich, Niels; Sahin-Toth, Miklos			Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis	NATURE GENETICS			English	Article							CATIONIC TRYPSINOGEN GENE; TROPICAL CALCIFIC PANCREATITIS; HEREDITARY PANCREATITIS; MISSENSE MUTATIONS; INHIBITOR GENE; DEGRADATION; PRSS1	Chronic pancreatitis is a persistent inflammatory disease of the pancreas, in which the digestive protease trypsin has a fundamental pathogenetic role. Here we have analyzed the gene encoding the trypsin-degrading enzyme chymotrypsin C (CTRC) in German subjects with idiopathic or hereditary chronic pancreatitis. Two alterations in this gene, p.R254W and p.K247_R254del, were significantly overrepresented in the pancreatitis group, being present in 30 of 901 (3.3%) affected individuals but only 21 of 2,804 (0.7%) controls ( odds ratio (OR)=4.6; confidence interval (CI)=2.6 - 8.0; P=1.3x10(-7)). A replication study identified these two variants in 10 of 348 (2.9%) individuals with alcoholic chronic pancreatitis but only 3 of 432 ( 0.7%) subjects with alcoholic liver disease (OR=4.2; CI=1.2 - 15.5; P=0.02). CTRC variants were also found in 10 of 71 (14.1%) Indian subjects with tropical pancreatitis but only 1 of 84 (1.2%) healthy controls (OR=13.6; CI=1.7 - 109.2; P=0.0028). Functional analysis of the CTRC variants showed impaired activity and/or reduced secretion. The results indicate that loss-of-function alterations in CTRC predispose to pancreatitis by diminishing its protective trypsin-degrading activity.	[Szmola, Richard; Ozsvari, Bela; Sahin-Toth, Miklos] Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, Boston, MA 02118 USA; [Rosendahl, Jonas; Boedeker, Hans; Keim, Volker; Moessner, Joachim; Teich, Niels] Univ Leipzig, Dept Gastroenterol & Hepatol, D-04103 Leipzig, Germany; [Witt, Heiko; Berg, Thomas; Boedeker, Hans] Charite Univ Med Berlin, Dept Hepatol & Gastroenterol, D-13353 Berlin, Germany; [Bhatia, Eesh] Sanjay Gandhi Postgrad Inst Med Sci, Dept Endocrinol, Lucknow 226014, Uttar Pradesh, India; [Ozsvari, Bela; Hegyi, Peter] Univ Szeged, Dept Med 1, H-6720 Szeged, Hungary; [Landt, Olfert] TIB MOLBIOL, D-12103 Berlin, Germany; [Schulz, Hans-Ulrich] Otto VonGuericke Univ Magdegurg, Dept Surg, D-39120 Magdeburg, Germany; [Gress, Thomas M.] Univ Marburg, Fac Med, Dept Gastroenterol Endocrinol & Metab, D-35043 Marburg, Germany; [Pfuetzer, Roland] Univ Heidelberg, Med Fac Mannheim, Dept Med 2 Gastroenterol Hepatol Infect Dis, D-68167 Mannheim, Germany; [Loehr, Matthias] Karoliniska Univ Hosp, Karolinska Inst, Dept Clin Sci Intervent & Technol, SE-14186 Stockholm, Sweden; [Kovacs, Peter] Univ Leipzig, Interdisciplinary Ctr Clin Res Leipzig, D-04103 Leipzig, Germany; [Blueher, Matthias; Stumvoll, Michael] Univ Leipzig, Dept Endocrinol, D-04103 Leipzig, Germany; [Choudhuri, Gourdas] Sanjay Gandhi Postgrad Inst Med Sci, Dept Gastroenterol, Lucknow 226014, Uttar Pradesh, India; [Morsche, Rene Hm te; Drenth, Joost P. H.] Univ Nijmegen, Med Ctr, Div Gastroenterol & Hepatol, Dept Med, NL-6500 HB Nijmegen, Netherlands; [Truninger, Kaspar] Inselspital Bern, Gastroenterol Clin, CH-3010 Bern, Switzerland; [Macek, Milan, Jr.] Charles Univ Prague, Sch Med 2, CZ-15006 Prague 5, Czech Republic; [Macek, Milan, Jr.] Univ Hosp Motol, Inst Biol & Med Genet Cyst, CZ-15006 Prague 5, Czech Republic; [Puhl, Gero] Dept Surg Charie, Campus Virchow Klinikum, D-13353 Berlin, Germany; [Schmidt, Hartmut] Univ Hosp Munster, D-48149 Munster, Germany; [Buening, Carsten; Ockenga, Johann] Charite Univ Med Berlin, Dept Gastroenterol Hepatol Endocrinol, D-10008 Berlin, Germany; [Kage, Andreas] Charite Univ Med Berlin, Inst Lab Med & Pathobiochem, D-13353 Berlin, Germany; [Groneberg, David Alexander] Charite Univ Med Berlin, Inst Occupat Med, D-12207 Berlin, Germany; [Nickel, Renate] Charite Univ Med Berlin, Dept Pediat, D-13353 Berlin, Germany	Boston University; Leipzig University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Szeged University; Otto von Guericke University; Philipps University Marburg; Ruprecht Karls University Heidelberg; Karolinska Institutet; Karolinska University Hospital; Leipzig University; Leipzig University; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Radboud University Nijmegen; University of Bern; University Hospital of Bern; Charles University Prague; Motol University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Sahin-Toth, M (corresponding author), Boston Univ, Goldman Sch Dent Med, Dept Mol & Cell Biol, 715 Albany St,Evans St, Boston, MA 02118 USA.	miklos@bu.edu	Drenth, Joost/V-7436-2019; Teich, Niels/AAF-5104-2019; te Morsche, R/P-9143-2015; Drenth, J.P.H./H-8025-2014; Löhr, Matthias/A-3692-2012; Groneberg, David/A-5132-2018; Stumvoll, Michael/ABE-1121-2021	Löhr, Matthias/0000-0002-7647-198X; Groneberg, David/0000-0001-8551-6556; Stumvoll, Michael/0000-0001-6225-8240; Gress, Thomas/0000-0002-9333-5461; Wiedenmann, Bertram/0000-0002-7890-2552; Berg, Thomas/0000-0003-0003-6241; Kovacs, Peter/0000-0002-0290-5423; Sahin-Toth, Miklos/0000-0003-4513-9922	NIDDK NIH HHS [R01 DK058088, R01 DK058088-06, R01 DK058088-07] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058088] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bhatia E, 2002, GASTROENTEROLOGY, V123, P1020, DOI 10.1053/gast.2002.36028; Boulling A, 2007, EUR J HUM GENET, V15, P936, DOI 10.1038/sj.ejhg.5201873; Chandak GR, 2002, J MED GENET, V39, P347, DOI 10.1136/jmg.39.5.347; Gorry MC, 1997, GASTROENTEROLOGY, V113, P1063, DOI 10.1053/gast.1997.v113.pm9322498; JESSOP NW, 1980, IN VITRO CELL DEV B, V16, P212; Kiraly O, 2007, GUT, V56, P1433, DOI 10.1136/gut.2006.115725; Le Marechal C, 2006, NAT GENET, V38, P1372, DOI 10.1038/ng1904; Pfutzer RH, 2000, GASTROENTEROLOGY, V119, P615, DOI 10.1053/gast.2000.18017; Sahin-Toth M, 2006, ENDOCRIN METAB CLIN, V35, P303, DOI 10.1016/j.ecl.2006.02.002; Schneider A, 2002, GASTROENTEROLOGY, V123, P1026, DOI 10.1053/gast.2002.36059; Szmola R, 2007, P NATL ACAD SCI USA, V104, P11227, DOI 10.1073/pnas.0703714104; Teich N, 1998, HUM MUTAT, V12, P39, DOI 10.1002/(SICI)1098-1004(1998)12:1<39::AID-HUMU6>3.0.CO;2-P; Teich N, 2006, HUM MUTAT, V27, P721, DOI 10.1002/humu.20343; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Witt H, 2001, JAMA-J AM MED ASSOC, V285, P2716, DOI 10.1001/jama.285.21.2716-a; Witt H, 1999, GASTROENTEROLOGY, V117, P7, DOI 10.1016/S0016-5085(99)70543-3; Witt H, 2006, NAT GENET, V38, P668, DOI 10.1038/ng1797	18	263	275	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2008	40	1					78	82		10.1038/ng.2007.44	http://dx.doi.org/10.1038/ng.2007.44			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18059268	Green Accepted			2022-12-27	WOS:000252118600021
J	Lacefield, S; Murray, AW				Lacefield, Soni; Murray, Andrew W.			The spindle checkpoint rescues the meiotic segregation of chromosomes whose crossovers are far from the centromere	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; MEIOSIS-I; YEAST; RECOMBINATION; NONDISJUNCTION; PROGRESSION; DIVERSITY; SPO11P; MAD2	Improper meiotic chromosome segregation causes conditions such as Down's syndrome(1). Recombination promotes proper chromosome segregation in meiosis I; chromosomes without crossovers near the centromere are more likely to segregate to the same spindle pole (nondisjoin). Here we have used budding yeast to determine whether the spindle checkpoint promotes segregation of such chromosomes. In checkpoint-defective mad2 Delta cells, properly segregating chromosomes have more crossovers near the centromere than their wild-type counterparts, and an artificial tether that holds chromosomes together suppresses nondisjunction as long as the tether is near the centromere. The tether partially rescues the segregation of chromosomes that lack crossovers.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Lacefield, S (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divinity Ave, Cambridge, MA 02138 USA.	soni@mcb.harvard.edu	Grafström, Roland C/N-7217-2016		NIGMS NIH HHS [R37 GM043987, GM 055840] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043987] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bergerat A, 1997, NATURE, V386, P414, DOI 10.1038/386414a0; Blat Y, 1999, CELL, V98, P249, DOI 10.1016/S0092-8674(00)81019-3; Boumil RM, 2003, MOL GENET GENOMICS, V268, P750, DOI 10.1007/s00438-002-0796-9; Cha RS, 2000, GENE DEV, V14, P493; CHEN J, 1994, BIOCHEMISTRY-US, V33, P8728, DOI 10.1021/bi00195a014; Cherry JM, 1997, NATURE, V387, P67, DOI 10.1038/387s067; Cheslock PS, 2005, NAT GENET, V37, P756, DOI 10.1038/ng1588; Diaz RL, 2002, MOL CELL BIOL, V22, P1106, DOI 10.1128/MCB.22.4.1106-1115.2002; Gerton JL, 2005, NAT REV GENET, V6, P477, DOI 10.1038/nrg1614; Gilliland WD, 2005, CURR BIOL, V15, P672; Gu ZL, 2005, P NATL ACAD SCI USA, V102, P1092, DOI 10.1073/pnas.0409159102; KABACK DB, 1989, P NATL ACAD SCI USA, V86, P3694, DOI 10.1073/pnas.86.10.3694; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kemp B, 2004, GENE DEV, V18, P1946, DOI 10.1101/gad.1227304; Kiburz BM, 2005, GENE DEV, V19, P3017, DOI 10.1101/gad.1373005; Koehler KE, 1996, NAT GENET, V14, P406, DOI 10.1038/ng1296-406; KRAMER H, 1987, EMBO J, V6, P1481, DOI 10.1002/j.1460-2075.1987.tb02390.x; Lamb NE, 2005, CYTOGENET GENOME RES, V111, P250, DOI 10.1159/000086896; Lamb NE, 1996, NAT GENET, V14, P400, DOI 10.1038/ng1296-400; MORTIMER RK, 1989, YEAST, V5, P321, DOI 10.1002/yea.320050503; NICKLAS RB, 1967, CHROMOSOMA, V21, P17, DOI 10.1007/BF00330545; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Rockmill B, 2006, GENETICS, V174, P1745, DOI 10.1534/genetics.106.058933; Shonn MA, 2000, SCIENCE, V289, P300, DOI 10.1126/science.289.5477.300; Shonn MA, 2003, CURR BIOL, V13, P1979, DOI 10.1016/j.cub.2003.10.057; Straight AF, 1996, CURR BIOL, V6, P1599, DOI 10.1016/S0960-9822(02)70783-5; Tsubouchi T, 2005, SCIENCE, V308, P870, DOI 10.1126/science.1108283; WEINER BM, 1994, CELL, V77, P977, DOI 10.1016/0092-8674(94)90438-3; Winzeler EA, 2003, GENETICS, V163, P79	30	43	43	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2007	39	10					1273	1277		10.1038/ng2120	http://dx.doi.org/10.1038/ng2120			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17828265				2022-12-27	WOS:000249737400025
J	Magalhaes, JV; Liu, J; Guimaraes, CT; Lana, UGP; Alves, VMC; Wang, YH; Schaffert, RE; Hoekenga, OA; Pineros, MA; Shaff, JE; Klein, PE; Carneiro, NP; Coelho, CM; Trick, HN; Kochian, LV				Magalhaes, Jurandir V.; Liu, Jiping; Guimaraes, Claudia T.; Lana, Ubiraci G. P.; Alves, Vera M. C.; Wang, Yi-Hong; Schaffert, Robert E.; Hoekenga, Owen A.; Pineros, Miguel A.; Shaff, Jon E.; Klein, Patricia E.; Carneiro, Newton P.; Coelho, Cintia M.; Trick, Harold N.; Kochian, Leon V.			A gene in the multidrug and toxic compound extrusion (MATE) family confers aluminum tolerance in sorghum	NATURE GENETICS			English	Article							EFFLUX; TRANSPORTER; CITRATE; MEMBER; PLANTS; ROOTS	Crop yields are significantly reduced by aluminum toxicity on highly acidic soils, which comprise up to 50% of the world's arable land(1-3). Candidate aluminum tolerance proteins include organic acid efflux transporters, with the organic acids forming non- toxic complexes with rhizosphere aluminum(1,4). In this study, we used positional cloning to identify the gene encoding a member of the multidrug and toxic compound extrusion ( MATE) family, an aluminum- activated citrate transporter, as responsible for the major sorghum ( Sorghum bicolor) aluminum tolerance locus, Alt(SB)(5). Polymorphisms in regulatory regions of AltSB are likely to contribute to large allelic effects, acting to increase AltSB expression in the root apex of tolerant genotypes. Furthermore, aluminum- inducible AltSB expression is associated with induction of aluminum tolerance via enhanced root citrate exudation. These findings will allow us to identify superior AltSB haplotypes that can be incorporated via molecular breeding and biotechnology into acid soil breeding programs, thus helping to increase crop yields in developing countries where acidic soils predominate.	Embrapa Maize & Sorghum, BR-35701970 Sete Lagoas, MG, Brazil; Cornell Univ, US Plant Soil & Nutr Lab, USDA ARS, Ithaca, NY 14853 USA; Texas A&M Univ, Inst Plant Genom & Biotechnol, College Stn, TX 77843 USA; Texas A&M Univ, Dept Hort, College Stn, TX 77843 USA; Kansas State Univ, Dept Plant Pathol, Manhattan, KS 66506 USA	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Cornell University; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Kansas State University	Magalhaes, JV (corresponding author), Embrapa Maize & Sorghum, Rod Mg 424,Km 65, BR-35701970 Sete Lagoas, MG, Brazil.	jurandir@cnpms.embrapa.br; Leon.Kochian@ars.usda.gov	Magalhaes, Jurandir/AAH-4349-2020; Coelho, Cíntia M/M-9939-2017; Kochian, Leon/ABH-6148-2020	Magalhaes, Jurandir/0000-0002-6673-6497; Coelho, Cíntia M/0000-0002-8564-3587; Kochian, Leon/0000-0003-3416-089X; Hoekenga, Owen/0000-0003-4427-2000; LIU, JIPING/0000-0002-7558-0025; Pineros, Miguel/0000-0002-7166-1848; Trick, Harold/0000-0001-5255-5575				Brown MH, 1999, MOL MICROBIOL, V31, P394, DOI 10.1046/j.1365-2958.1999.01162.x; BUREAU TE, 1992, PLANT CELL, V4, P1283, DOI 10.1105/tpc.4.10.1283; Caniato FF, 2007, THEOR APPL GENET, V114, P863, DOI 10.1007/s00122-006-0485-x; Diener AC, 2001, PLANT CELL, V13, P1625, DOI 10.1105/tpc.13.7.1625; Durrett TP, 2007, PLANT PHYSIOL, V144, P197, DOI 10.1104/pp.107.097162; Green LS, 2004, PLANT PHYSIOL, V136, P2523, DOI 10.1104/pp.104.045633; He GX, 2004, J BACTERIOL, V186, P262, DOI 10.1128/JB.186.1.262-265.2004; Hoekenga OA, 2006, P NATL ACAD SCI USA, V103, P9738, DOI 10.1073/pnas.0602868103; Hvorup RN, 2003, EUR J BIOCHEM, V270, P799, DOI 10.1046/j.1432-1033.2003.03418.x; KOCHIAN LV, 1995, ANNU REV PLANT PHYS, V46, P237, DOI 10.1146/annurev.pp.46.060195.001321; Kochian LV, 2004, ANNU REV PLANT BIOL, V55, P459, DOI 10.1146/annurev.arplant.55.031903.141655; Li LG, 2002, J BIOL CHEM, V277, P5360, DOI 10.1074/jbc.M108777200; Lou Y, 2006, PLANT MOL BIOL, V60, P729, DOI 10.1007/s11103-005-5548-x; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Magalhaes JV, 2004, GENETICS, V167, P1905, DOI 10.1534/genetics.103.023580; MAGALHAES JV, 2003, THESIS CORNELL U; Morita Y, 1998, ANTIMICROB AGENTS CH, V42, P1778, DOI 10.1128/AAC.42.7.1778; Nguyen VT, 2001, THEOR APPL GENET, V102, P1002, DOI 10.1007/s001220000472; PATERSON AH, 1995, SCIENCE, V269, P1714, DOI 10.1126/science.269.5231.1714; Pineros MA, 2002, PLANT PHYSIOL, V129, P1194, DOI 10.1104/pp.002295; Raizada MN, 2001, PLANT J, V25, P79, DOI 10.1046/j.1365-313x.2001.00939.x; Raman H, 2005, GENOME, V48, P781, DOI 10.1139/g05-054; RYAN PR, 1993, J EXP BOT, V44, P437, DOI 10.1093/jxb/44.2.437; Sasaki T, 2004, PLANT J, V37, P645, DOI 10.1111/j.1365-313X.2003.01991.x; Uhde-Stone C, 2005, PLANT J, V44, P840, DOI 10.1111/j.1365-313X.2005.02573.x; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558; WESSLER SR, 1995, CURR OPIN GENET DEV, V5, P814, DOI 10.1016/0959-437X(95)80016-X; WOOD S, 2000, PILOT ANAL GLOB ECOS; Yang GJ, 2005, PLANT CELL, V17, P1559, DOI 10.1105/tpc.104.030528	29	516	564	11	154	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1156	1161		10.1038/ng2074	http://dx.doi.org/10.1038/ng2074			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17721535				2022-12-27	WOS:000249122400028
J	Kouznetsova, A; Lister, L; Nordenskjold, M; Herbert, M; Hoog, C				Kouznetsova, Anna; Lister, Lisa; Nordenskjold, Magnus; Herbert, Mary; Hoog, Christer			Bi-orientation of achiasmatic chromosomes in meiosis I oocytes contributes to aneuploidy in mice	NATURE GENETICS			English	Article							SPINDLE-CHECKPOINT; NONDISJUNCTION; ASSOCIATION; MECHANISM; TENSION; MAD2	The spindle assembly checkpoint guards against chromosomal missegregation but does not induce arrest in oocytes that contain a few achiasmatic chromosomes ( univalents). We followed the fate of univalents in oocytes during the first meiotic division, and although these preserved a meiotic kinetochore structure, they were also bi-oriented in a mitotic manner. The hybrid chromosomal configuration attained by univalents allows them to evade the spindle assembly checkpoint and contribute to aneuploidy in oocytes.	Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; Univ Newcastle, Int Ctr Life, Inst Human Genet, Newcastle Fertil Ctr, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England; Univ Newcastle, Int Ctr Life, N E England Stem Cell Inst, Newcastle Upon Tyne NE1 4EP, Tyne & Wear, England; Karolinska Univ Hosp, Dept Mol Med & Surg, S-17176 Solna, Sweden; Karolinska Univ Hosp, Ctr Mol Med, S-17176 Solna, Sweden	Karolinska Institutet; Newcastle University - UK; Newcastle University - UK; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Hoog, C (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden.	christer.hoog@ki.se	Kouznetsova, Anna/AAF-2312-2019	Kouznetsova, Anna/0000-0001-9059-4567; Herbert, Mary/0000-0002-8488-2770; Nordenskjold, Magnus/0000-0002-4974-425X				Ahonen LJ, 2005, CURR BIOL, V15, P1078, DOI 10.1016/j.cub.2005.05.026; Brunet S, 2003, REPRODUCTION, V126, P443, DOI 10.1530/rep.0.1260443; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Hauf S, 2004, CELL, V119, P317, DOI 10.1016/j.cell.2004.10.014; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Kallio M, 2000, DEV BIOL, V225, P112, DOI 10.1006/dbio.2000.9818; Kuliev A, 2004, HUM REPROD UPDATE, V10, P401, DOI 10.1093/humupd/dmh036; Lemaire-Adkins R, 1997, J CELL BIOL, V139, P1611, DOI 10.1083/jcb.139.7.1611; Lightfoot DA, 2006, DEV BIOL, V289, P384, DOI 10.1016/j.ydbio.2005.11.001; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Taylor SS, 2004, CHROMOSOME RES, V12, P599, DOI 10.1023/B:CHRO.0000036610.78380.51; Vaur S, 2005, CURR BIOL, V15, P2263, DOI 10.1016/j.cub.2005.11.034; Woods LM, 1999, J CELL BIOL, V145, P1395, DOI 10.1083/jcb.145.7.1395; Yuan L, 2002, SCIENCE, V296, P1115, DOI 10.1126/science.1070594	15	90	95	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					966	968		10.1038/ng2065	http://dx.doi.org/10.1038/ng2065			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17618286				2022-12-27	WOS:000248446900012
J	Pandit, B; Sarkozy, A; Pennacchio, LA; Carta, C; Oishi, K; Martinelli, S; Pogna, EA; Schackwitz, W; Ustaszewska, A; Landstrom, A; Bos, JM; Ommen, SR; Esposito, G; Lepri, F; Faul, C; Mundel, P; Siguero, JPL; Tenconi, R; Selicorni, A; Rossi, C; Mazzanti, L; Torrente, I; Marino, B; Digilio, MC; Zampino, G; Ackerman, MJ; Dallapiccola, B; Tartaglia, M; Gelb, BD				Pandit, Bhaswati; Sarkozy, Anna; Pennacchio, Len A.; Carta, Claudio; Oishi, Kimihiko; Martinelli, Simone; Pogna, Edgar A.; Schackwitz, Wendy; Ustaszewska, Anna; Landstrom, Andrew; Bos, J. Martijn; Ommen, Steve R.; Esposito, Giorgia; Lepri, Francesca; Faul, Christian; Mundel, Peter; Siguero, Juan P. Lopez; Tenconi, Romano; Selicorni, Angelo; Rossi, Cesare; Mazzanti, Laura; Torrente, Isabella; Marino, Bruno; Digilio, Maria C.; Zampino, Giuseppe; Ackerman, Michael J.; Dallapiccola, Bruno; Tartaglia, Marco; Gelb, Bruce D.			Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy	NATURE GENETICS			English	Article							CARDIAC-HYPERTROPHY; PHENOTYPE CORRELATION; GERMLINE MUTATIONS; SIGNALING PATHWAY; COSTELLO-SYNDROME; PTPN11 MUTATIONS; TRANSGENIC MICE; HUMAN CANCER; C-RAF; B-RAF	Noonan and LEOPARD syndromes are developmental disorders with overlapping features, including cardiac abnormalities, short stature and facial dysmorphia. Increased RAS signaling owing to PTPN11, SOS1 and KRAS mutations causes similar to 60% of Noonan syndrome cases(1-6), and PTPN11 mutations cause 90% of LEOPARD syndrome cases7. Here, we report that 18 of 231 individuals with Noonan syndrome without known mutations (corresponding to 3% of all affected individuals) and two of six individuals with LEOPARD syndrome without PTPN11 mutations have missense mutations in RAF1, which encodes a serine- threonine kinase that activates MEK1 and MEK2. Most mutations altered a motif flanking Ser259, a residue critical for autoinhibition of RAF1 through 14-3-3 binding. Of 19 subjects with a RAF1 mutation in two hotspots, 18 (or 95%) showed hypertrophic cardiomyopathy (HCM), compared with the 18% prevalence of HCM among individuals with Noonan syndrome in general. Ectopically expressed RAF1 mutants from the two HCM hotspots had increased kinase activity and enhanced ERK activation, whereas non-HCM-associated mutants were kinase impaired. Our findings further implicate increased RAS signaling in pathological cardiomyocyte hypertrophy.	CUNY Mt Sinai Sch Med, Dept Pediat, Ctr Mol Cardiol, New York, NY 10029 USA; CUNY Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA; CSS Mendel Inst, I-00198 Rome, Italy; CSS, Ist Ricovero & Cura Carattere Sci, San Giovanni Rotondo, Italy; Univ Roma La Sapienza, Dept Expt Med, I-00198 Rome, Italy; Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; US Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA; Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, I-00161 Rome, Italy; Mayo Clin, Coll Med, Dept Med, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Pediat, Rochester, MN 55905 USA; Mayo Clin, Coll Med, Dept Mol Pharmacol, Rochester, MN 55905 USA; CUNY Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; Hosp Materno Infantil, Malaga 29011, Spain; Univ Padua, Dipartimento Pediat, I-35128 Padua, Italy; Univ Milan, Pediat Clin, I-20122 Milan, Italy; Univ Bologna, Policlin S Orsola Malpighi, Dipartimento Pediat, I-40138 Bologna, Italy; Univ Roma La Sapienza, Policlin Umberto I, Dipartimento Pediat, I-00161 Rome, Italy; Osped Bambino Gesu, I-00165 Rome, Italy; Univ Cattolica Sacro Cuore, Ist Clin Pediat, I-00168 Rome, Italy	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; IRCCS Casa Sollievo Della Sofferenza; Sapienza University Rome; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Istituto Superiore di Sanita (ISS); Mayo Clinic; Mayo Clinic; Mayo Clinic; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; University of Padua; University of Milan; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; Sapienza University Rome; University Hospital Sapienza Rome; IRCCS Bambino Gesu; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Tartaglia, M (corresponding author), CUNY Mt Sinai Sch Med, Dept Pediat, Ctr Mol Cardiol, 1 Gustave L Levy Pl, New York, NY 10029 USA.	mtartaglia@iss.it; bruce.gelb@mssm.edu	Rossi, Cesare/AAC-2083-2022; Schackwitz, Wendy/GXH-9536-2022; Martinelli, Simone/J-9432-2018; Zampino, Giuseppe/AAC-2152-2019; Lepri, Francesca Romana/AAA-6115-2020; Digilio, Maria Cristina/AAI-2434-2019; Carta, Claudio/A-7305-2013; Tartaglia, Marco/K-2955-2018; Landstrom, Andrew/A-9221-2017; Faul, Christian/D-1549-2011; Dallapiccola, Bruno/K-8692-2016	Rossi, Cesare/0000-0003-1826-615X; Martinelli, Simone/0000-0002-5843-419X; Carta, Claudio/0000-0003-3545-198X; Tartaglia, Marco/0000-0001-7736-9672; Landstrom, Andrew/0000-0002-1878-9631; Lepri, Francesca Romana/0000-0001-5331-0473; Pennacchio, Len/0000-0002-8748-3732; Schackwitz, Wendy/0000-0002-3013-9180; Dallapiccola, Bruno/0000-0002-5031-1013; mazzanti, laura/0000-0002-7670-6494; Oishi, Kimihiko/0000-0001-9446-8912	NHLBI NIH HHS [HL066681, HL074728, HL71207] Funding Source: Medline; NICHD NIH HHS [HD042569, HD01294] Funding Source: Medline; NIDDK NIH HHS [DK57683] Funding Source: Medline; NIGMS NIH HHS [T32 GM072474] Funding Source: Medline; Telethon [GGP07115, GGP04172] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD042569] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD001294] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL074728, R01HL071207, U01HL066681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK057683] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM072474] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Telethon(Fondazione Telethon); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; BURCH M, 1993, J AM COLL CARDIOL, V22, P1189, DOI 10.1016/0735-1097(93)90436-5; Carta C, 2006, AM J HUM GENET, V79, P129, DOI 10.1086/504394; Digilio MC, 2002, AM J HUM GENET, V71, P389, DOI 10.1086/341528; Emuss V, 2005, CANCER RES, V65, P9719, DOI 10.1158/0008-5472.CAN-05-1683; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gripp KW, 2006, AM J MED GENET A, V140A, P1, DOI 10.1002/ajmg.a.31047; HUNTER JJ, 1995, J BIOL CHEM, V270, P23173, DOI 10.1074/jbc.270.39.23173; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Light Y, 2002, MOL CELL BIOL, V22, P4984, DOI 10.1128/MCB.22.14.4984-4996.2002; Merks JHM, 2005, AM J MED GENET A, V134A, P132, DOI 10.1002/ajmg.a.30603; Muslin AJ, 2005, TRENDS CARDIOVAS MED, V15, P225, DOI 10.1016/j.tcm.2005.06.008; Muslin AJ, 1996, CELL, V84, P889, DOI 10.1016/S0092-8674(00)81067-3; NILHORI T, 2006, NAT GENET, V38, P294; Patel R, 2001, CIRCULATION, V104, P317, DOI 10.1161/hc2801.094031; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Sarkozy A, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.013466; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Tartaglia M, 2006, AM J HUM GENET, V78, P279, DOI 10.1086/499925; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Ucar C, 2006, J PEDIAT HEMATOL ONC, V28, P123; Van Driest SL, 2004, J AM COLL CARDIOL, V44, P1903, DOI 10.1016/j.jacc.2004.07.045; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Yamaguchi O, 2004, J CLIN INVEST, V114, P937, DOI 10.1172/JCI200420317; Zebisch A, 2006, CANCER RES, V66, P3401, DOI 10.1158/0008-5472.CAN-05-0115	30	481	503	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					1007	1012		10.1038/ng2073	http://dx.doi.org/10.1038/ng2073			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17603483				2022-12-27	WOS:000248446900019
J	Dieterich, K; Rifo, RS; Faure, AK; Hennebicq, S; Ben Amar, B; Zahi, M; Perrin, J; Martinez, D; Sele, B; Jouk, PS; Ohlmann, T; Rousseaux, S; Lunardi, J; Ray, PF				Dieterich, Klaus; Rifo, Ricardo Soto; Faure, Anne Karen; Hennebicq, Sylviane; Ben Amar, Baha; Zahi, Mohamed; Perrin, Julia; Martinez, Delphine; Sele, Bernard; Jouk, Pierre-Simon; Ohlmann, Theophile; Rousseaux, Sophie; Lunardi, Joel; Ray, Pierre F.			Homozygous mutation of AURKC yields large-headed polyploid spermatozoa and causes male infertility	NATURE GENETICS			English	Article							AURORA-C KINASE; PROTEIN-KINASE; TAILED SPERMATOZOA; SPERM; CHROMOSOME; CLONING; SPERMATOGENESIS; OVEREXPRESSION; LOCALIZATION; EXPRESSION	The World Health Organization conservatively estimates that 80 million people suffer from infertility worldwide. Male factors are believed to be responsible for 20 - 50% of all infertility cases, but microdeletions of the Y chromosome are the only genetic defects altering human spermatogenesis that have been reported repeatedly(1). We focused our work on infertile men with a normal somatic karyotype but typical spermatozoa mainly characterized by large heads, a variable number of tails and an increased chromosomal content ( OMIM 243060)(2-4). We performed a genome-wide microsatellite scan on ten infertile men presenting this characteristic phenotype. In all of these men, we identified a common region of homozygosity harboring the aurora kinase C gene (AURKC) with a single nucleotide deletion in the AURKC coding sequence. In addition, we show that this founder mutation results in premature termination of translation, yielding a truncated protein that lacks the kinase domain. We conclude that the absence of AURKC causes male infertility owing to the production of large-headed multiflagellar polyploid spermatozoa.	CHU Grenoble, Dept Genet & Procreat, UF Biochim Genet & Mol, F-38700 La Tronche, France; Univ Grenoble 1, Fac Med Pharm, F-38700 Grenoble, France; INSERM, U758, F-69364 Lyon, France; Ecole Normale Super Lyon, Unite Virol Humaine, IFR 128, F-69364 Lyon, France; INSERM, U309, Inst Albert Bonniot, F-38700 Grenoble, France; Ctr FIV, Clin Alboustane, Rabat, Morocco; Ctr Prive Fecondat, Rabat, Morocco	CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Ray, PF (corresponding author), CHU Grenoble, Dept Genet & Procreat, UF Biochim Genet & Mol, F-38700 La Tronche, France.	pray@chu-grenoble.fr	Ray, Pierre F/D-7315-2019; dieterich, klaus/R-8418-2019; Soto Rifo, Ricardo/I-2850-2013; Rousseaux, Sophie/G-1697-2013; Ohlmann, Theophile/H-6522-2016; hennebicq, sylviane/A-6564-2012; Jouk, Pierre-Simon/M-7367-2014; Soto, Ricardo/AAJ-5510-2021; ohlmann, Theophile/M-4463-2014; Jouk, Pierre-Simon/AAB-5262-2022; Ray, Pierre/B-9326-2012	Ray, Pierre F/0000-0003-1544-7449; dieterich, klaus/0000-0002-4362-4062; Soto Rifo, Ricardo/0000-0003-0945-2970; Rousseaux, Sophie/0000-0001-5246-5350; hennebicq, sylviane/0000-0002-1851-6932; ohlmann, Theophile/0000-0002-2001-8916; Jouk, Pierre-Simon/0000-0001-8301-320X; 				Assou S, 2006, HUM REPROD, V21, P1705, DOI 10.1093/humrep/del065; Benzacken B, 2001, HUM REPROD, V16, P2646, DOI 10.1093/humrep/16.12.2646; Bernard M, 1998, GENOMICS, V53, P406, DOI 10.1006/geno.1998.5522; Bishop JD, 2002, J BIOL CHEM, V277, P27577, DOI 10.1074/jbc.C200307200; Chen HL, 2005, J BIOMED SCI, V12, P297, DOI 10.1007/s11373-005-0980-0; Devillard F, 2002, HUM REPROD, V17, P1292, DOI 10.1093/humrep/17.5.1292; ESCALIER D, 1983, BIOL CELL, V48, P65; Escalier D, 2002, MOL HUM REPROD, V8, P1, DOI 10.1093/molehr/8.1.1; GERMAN J, 1981, AM J HUM GENET, V33, pA64; Herbreteau CH, 2005, NAT STRUCT MOL BIOL, V12, P1001, DOI 10.1038/nsmb1011; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; Kimmins S, 2007, MOL ENDOCRINOL, V21, P726, DOI 10.1210/me.2006-0332; Kimura M, 1999, J BIOL CHEM, V274, P7334, DOI 10.1074/jbc.274.11.7334; Kozak M, 2001, NUCLEIC ACIDS RES, V29, P5226, DOI 10.1093/nar/29.24.5226; NISTAL M, 1977, VIRCHOWS ARCH B, V26, P111; Pieters MHEC, 1998, LANCET, V351, P957; Pryor JL, 1997, NEW ENGL J MED, V336, P534, DOI 10.1056/NEJM199702203360802; Sasai K, 2004, CELL MOTIL CYTOSKEL, V59, P249, DOI 10.1002/cm.20039; Tang CJC, 2006, DEV BIOL, V290, P398, DOI 10.1016/j.ydbio.2005.11.036; Tang CJC, 2001, J BIOL CHEM, V276, P19631, DOI 10.1074/jbc.M100170200; Tatsuka M, 1998, CANCER RES, V58, P4811; Tseng TC, 1998, DNA CELL BIOL, V17, P823, DOI 10.1089/dna.1998.17.823; Veld PAI, 1997, HUM REPROD, V12, P752; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th; Yan XM, 2005, GENES CELLS, V10, P617, DOI 10.1111/j.1365-2443.2005.00863.x; Yan XM, 2005, BIOCHEM BIOPH RES CO, V328, P353, DOI 10.1016/j.bbrc.2004.12.168	26	197	207	2	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2007	39	5					661	665		10.1038/ng2027	http://dx.doi.org/10.1038/ng2027			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17435757				2022-12-27	WOS:000245971300023
J	van der Heijden, GW; Derijck, AAHA; Posfai, E; Giele, M; Pelczar, P; Ramos, L; Wansink, DG; van der Vlag, J; Peters, AHFM; de Boer, P				van der Heijden, Godfried W.; Derijck, Alwin A. H. A.; Posfai, Eszter; Giele, Maud; Pelczar, Pawel; Ramos, Liliana; Wansink, Derick G.; van der Vlag, Johan; Peters, Antoine H. F. M.; de Boer, Peter			Chromosome-wide nucleosome replacement and H3.3 incorporation during mammalian meiotic sex chromosome inactivation	NATURE GENETICS			English	Article							HISTONE MODIFICATIONS; SYNAPTONEMAL COMPLEX; RNA-SYNTHESIS; XY BODY; MOUSE; CHROMATIN; MICE; SPERMATOCYTES; MEIOSIS; SPERMATOGENESIS	In mammalian males, the first meiotic prophase is characterized by formation of a separate chromatin domain called the sex body(1). In this domain, the X and Y chromosomes are partially synapsed and transcriptionally silenced, a process termed meiotic sex-chromosome inactivation ( MSCI)(2,3). Likewise, unsynapsed autosomal chromatin present during pachytene is also silenced ( meiotic silencing of unsynapsed chromatin, MSUC)(2,4,5). Although it is known that MSCI and MSUC are both dependent on histone H2A.X phosphorylation mediated by the kinase ATR, and cause repressive H3 Lys9 dimethylation(4), the mechanisms underlying silencing are largely unidentified. Here, we demonstrate an extensive replacement of nucleosomes within unsynapsed chromatin, depending on and initiated shortly after induction of MSCI and MSUC. Nucleosomal eviction results in the exclusive incorporation of the H3.3 variant, which to date has primarily been associated with transcriptional activity. Nucleosomal exchange causes loss and subsequent selective reacquisition of specific histone modifications. This process therefore provides a means for epigenetic reprogramming of sex chromatin presumably required for gene silencing in the male mammalian germ line.	Univ Nijmegen, Med Ctr, Dept Obstet & Gynaecol, NL-6500 HB Nijmegen, Netherlands; Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Cell Biol, Nijmegen, Netherlands; Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Nephrol Res Lab,Div Nephrol, Nijmegen, Netherlands; Univ Zurich, Inst Lab Anim Sci, CH-8091 Zurich, Switzerland	Radboud University Nijmegen; Friedrich Miescher Institute for Biomedical Research; Radboud University Nijmegen; Radboud University Nijmegen; University of Zurich	van der Heijden, GW (corresponding author), Univ Nijmegen, Med Ctr, Dept Obstet & Gynaecol, POB 9101, NL-6500 HB Nijmegen, Netherlands.		Van der Vlag, Johan/E-4636-2010; Wansink, Derick G./F-3404-2010; van der Heijden, Godfried/ABC-5623-2021; Ramos, L./L-4590-2015; Peters, Antoine/ABA-6283-2020	Van der Vlag, Johan/0000-0001-7843-5918; van der Heijden, Godfried/0000-0001-5894-7027; Posfai, Eszter/0000-0002-4871-6652; Peters, Antoine/0000-0002-0311-1887				Ashley T, 2004, CHROMOSOMA, V113, P126, DOI 10.1007/s00412-004-0293-5; Baarends WM, 2005, MOL CELL BIOL, V25, P1041, DOI 10.1128/MCB.25.3.1041-1053.2005; Baart EB, 2000, CHROMOSOMA, V109, P139, DOI 10.1007/s004120050422; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; DEBOER P, 1986, CHROMOSOMA, V93, P326, DOI 10.1007/BF00327591; DIETRICH AJJ, 1983, GENETICA, V61, P119, DOI 10.1007/BF00123222; Fernandez-Capetillo O, 2003, DEV CELL, V4, P497, DOI 10.1016/S1534-5807(03)00093-5; Greaves IK, 2006, MOL CELL BIOL, V26, P5394, DOI 10.1128/MCB.00519-06; Hake SB, 2005, P NATL ACAD SCI USA, V102, P6344, DOI 10.1073/pnas.0502413102; Handel MA, 2004, EXP CELL RES, V296, P57, DOI 10.1016/j.yexcr.2004.03.008; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Kamakaka RT, 2005, GENE DEV, V19, P295, DOI 10.1101/gad.1272805; Khalil AM, 2004, P NATL ACAD SCI USA, V101, P16583, DOI 10.1073/pnas.0406325101; KIERSZENBAUM AL, 1974, J CELL BIOL, V60, P39, DOI 10.1083/jcb.60.1.39; Kourmouli N, 2004, J CELL SCI, V117, P2491, DOI 10.1242/jcs.01238; Kramers K, 1996, J AUTOIMMUN, V9, P723, DOI 10.1006/jaut.1996.0094; Loppin B, 2005, NATURE, V437, P1386, DOI 10.1038/nature04059; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; MOENS PB, 1995, CHROMOSOMA, V104, P169, DOI 10.1007/BF00352181; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Nightingale KP, 2006, CURR OPIN GENET DEV, V16, P125, DOI 10.1016/j.gde.2006.02.015; OAKBERG EF, 1956, AM J ANAT, V99, P507, DOI 10.1002/aja.1000990307; Peters AHFM, 1997, CHROMOSOME RES, V5, P66, DOI 10.1023/A:1018445520117; SPEED RM, 1986, CHROMOSOMA, V93, P267, DOI 10.1007/BF00292748; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; TURNER JM, 2003, DEV CELL, V10, P521; Turner JMA, 2005, NAT GENET, V37, P41, DOI 10.1038/ng1484; Turner JMA, 2004, CURR BIOL, V14, P2135, DOI 10.1016/j.cub.2004.11.032; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; van der Heijden GW, 2005, MECH DEVELOP, V122, P1008, DOI 10.1016/j.mod.2005.04.009	30	175	177	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2007	39	2					251	258		10.1038/ng1949	http://dx.doi.org/10.1038/ng1949			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17237782				2022-12-27	WOS:000244063900025
J	Roberts, AE; Araki, T; Swanson, KD; Montgomery, KT; Schiripo, TA; Joshi, VA; Li, L; Yassin, Y; Tamburino, AM; Neel, BG; Kucherlapati, RS				Roberts, Amy E.; Araki, Toshiyuki; Swanson, Kenneth D.; Montgomery, Kate T.; Schiripo, Taryn A.; Joshi, Victoria A.; Li, Li; Yassin, Yosuf; Tamburino, Alex M.; Neel, Benjamin G.; Kucherlapati, Raju S.			Germline gain-of-function mutations in SOS1 cause Noonan syndrome	NATURE GENETICS			English	Article							RAS ACTIVATOR SON; FACIO-CUTANEOUS SYNDROME; SEVENLESS; MUTANTS; PATHWAY; DOMAIN; KRAS	Noonan syndrome, the most common single-gene cause of congenital heart disease, is characterized by short stature, characteristic facies, learning problems and leukemia predisposition(1). Gain-of-function mutations in PTPN11, encoding the tyrosine phosphatase SHP2, cause similar to 50% of Noonan syndrome cases. SHP2 is required for RAS-ERK MAP kinase (MAPK) cascade activation(2), and Noonan syndrome mutants enhance ERK activation ex vivo(3,4) and in mice(5). KRAS mutations account for < 5% of cases of Noonan syndrome(6), but the gene(s) responsible for the remainder are unknown. We identified missense mutations in SOS1, which encodes an essential RAS guanine nucleotide-exchange factor (RAS-GEF), in similar to 20% of cases of Noonan syndrome without PTPN11 mutation. The prevalence of specific cardiac defects differs in SOS1 mutation-associated Noonan syndrome. Noonan syndrome-associated SOS1 mutations are hypermorphs encoding products that enhance RAS and ERK activation. Our results identify SOS1 mutants as a major cause of Noonan syndrome, representing the first example of activating GEF mutations associated with human disease ;and providing new insights into RAS-GEF regulation.	Beth Israel Deaconess Med Ctr, Canc Biol Program, Div Hematol Oncol, Dept Med, Boston, MA 02115 USA; Harvard Partners Ctr Genet & Genom, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Childrens Hosp, Div Genet, Dept Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital	Neel, BG (corresponding author), Beth Israel Deaconess Med Ctr, Canc Biol Program, Div Hematol Oncol, Dept Med, Boston, MA 02115 USA.	bneel@bidmc.harvard.edu	Kucherlapati, Raju/ABC-8807-2021	Araki, Toshiyuki/0000-0002-1179-4534	NATIONAL CANCER INSTITUTE [R37CA049152] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR002172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016140] Funding Source: NIH RePORTER; NCI NIH HHS [R37CA49152] Funding Source: Medline; NCRR NIH HHS [M01-RR02172] Funding Source: Medline; NIDCR NIH HHS [DE16140] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Araki T, 2004, NAT MED, V10, P849, DOI 10.1038/nm1084; Bentires-Alj M, 2006, NAT MED, V12, P283, DOI 10.1038/nm0306-283; BOS JL, 1989, CANCER RES, V49, P4682; Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Godbey WT, 1999, GENE THER, V6, P1380, DOI 10.1038/sj.gt.3300976; Goi T, 1999, MOL CELL BIOL, V19, P1731; Hart TC, 2002, AM J HUM GENET, V70, P943, DOI 10.1086/339689; Keilhack H, 2005, J BIOL CHEM, V280, P30984, DOI 10.1074/jbc.M504699200; Kontaridis MI, 2006, J BIOL CHEM, V281, P6785, DOI 10.1074/jbc.M513068200; Lauchle JO, 2006, PEDIATR BLOOD CANCER, V46, P579, DOI 10.1002/pbc.20644; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Neel BG, 2003, TRENDS BIOCHEM SCI, V28, P284, DOI 10.1016/S0968-0004(03)00091-4; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; NIMNUAL A, 2002, SCI STKE, pPE36, DOI DOI 10.1126/STKE.2002.145; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Soisson SM, 1998, CELL, V95, P259, DOI 10.1016/S0092-8674(00)81756-0; Sondermann H, 2005, P NATL ACAD SCI USA, V102, P16632, DOI 10.1073/pnas.0508315102; Sondermann H, 2003, STRUCTURE, V11, P1583, DOI 10.1016/j.str.2003.10.015; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Tartaglia M, 2005, ANNU REV GENOM HUM G, V6, P45, DOI 10.1146/annurev.genom.6.080604.162305; VANDERBURGT I, 1994, AM J MED GENET, V53, P187, DOI 10.1002/ajmg.1320530213	23	415	438	4	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2007	39	1					70	74		10.1038/ng1926	http://dx.doi.org/10.1038/ng1926			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	17143285				2022-12-27	WOS:000243136500019
J	Fukami, M; Wada, Y; Miyabayashi, K; Nishino, I; Hasegawa, T; Camerino, G; Kretz, C; Buj-Bello, A; Laporte, J; Yamada, G; Morohashi, K; Ogata, T				Fukami, Maki; Wada, Yuka; Miyabayashi, Kanako; Nishino, Ichizo; Hasegawa, Tomonobu; Camerino, Giovanna; Kretz, Christine; Buj-Bello, Anna; Laporte, Jocelyn; Yamada, Gen; Morohashi, Ken-ichirou; Ogata, Tsutomu			CXorf6 is a causative gene for hypospadias	NATURE GENETICS			English	Article							LINKED MYOTUBULAR MYOPATHY; MALE HYPOGENITALISM; XQ28; MUTATIONS; MTM1; DELETION	46,XY disorders of sex development (DSD) refer to a wide range of abnormal genitalia, including hypospadias, which affects similar to 0.5% of male newborns. We identified three different nonsense mutations of CXorf6 in individuals with hypospadias and found that its mouse homolog was specifically expressed in fetal Sertoli and Leydig cells around the critical period for sex development. These data imply that CXorf6 is a causative gene for hypospadias.	Natl Inst Basic Biol, Div Sex Differentiat, Okazaki, Aichi 4448787, Japan; Natl Inst Neurosci, Dept Neuromuscular Res, Kodaira, Tokyo 1878502, Japan; Keio Univ, Sch Med, Dept Pediat, Tokyo 1608582, Japan; Univ Pavia, Dipartimento Patol Umana & Ereditaria, Sezione Biol Gen & Genet Med, I-27100 Pavia, Italy; Inst Genet & Biol Mol & Cellulaire, Dept Mol Pathol, F-67404 Illkirch Graffenstaden, France; Kumamoto Univ, Sch Med, Ctr Anim Resources & Dev, Kumamoto 860, Japan	National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); National Center for Neurology & Psychiatry - Japan; Keio University; University of Pavia; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Kumamoto University	Ogata, T (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Endocrinol & Metab, Tokyo 1578535, Japan.	tomogata@nch.go.jp	Fukami, Maki/ABE-4694-2020; BUJ-BELLO, Anna/J-7556-2013; Nishino, Ichizo/G-2676-2010; laporte, jocelyn/O-4888-2019; Hasegawa, Tomonobu/L-3331-2013; laporte, jocelyn/J-7008-2012; Laporte, Jocelyn/H-6801-2016	Fukami, Maki/0000-0001-9971-4035; Nishino, Ichizo/0000-0001-9452-112X; Ogata, Tsutomu/0000-0001-7178-9991; Nordenskjold, Agneta/0000-0001-6638-4631				Bartsch O, 1999, CYTOGENET CELL GENET, V85, P310, DOI 10.1159/000015284; Biancalana V, 2003, HUM GENET, V112, P135, DOI 10.1007/s00439-002-0869-1; Hentze MW, 1999, CELL, V96, P307, DOI 10.1016/S0092-8674(00)80542-5; Hu LJ, 1996, HUM MOL GENET, V5, P139, DOI 10.1093/hmg/5.1.139; Laporte J, 1997, GENOMICS, V41, P458, DOI 10.1006/geno.1997.4662; Laporte J, 1997, HUM MOL GENET, V6, P1505, DOI 10.1093/hmg/6.9.1505; Nomura M, 1998, J BIOCHEM, V124, P217, DOI 10.1093/oxfordjournals.jbchem.a022083; Tsai TC, 2005, NEUROMUSCULAR DISORD, V15, P245, DOI 10.1016/j.nmd.2004.12.005; WINTER JSD, 1976, J CLIN ENDOCR METAB, V42, P679, DOI 10.1210/jcem-42-4-679; [No title captured]	10	98	106	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2006	38	12					1369	1371		10.1038/ng1900	http://dx.doi.org/10.1038/ng1900			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110TR	17086185				2022-12-27	WOS:000242404200011
J	Smits, G; Mungall, AJ; Griffiths-Jones, S; Smith, P; Beury, D; Matthews, L; Rogers, J; Pask, AJ; Shaw, G; VandeBerg, JL; McCarrey, JR; Renfree, MB; Reik, W; Dunham, I				Smits, Guillaume; Mungall, Andrew J.; Griffiths-Jones, Sam; Smith, Paul; Beury, Delphine; Matthews, Lucy; Rogers, Jane; Pask, Andrew J.; Shaw, Geoff; VandeBerg, John L.; McCarrey, John R.; Renfree, Marilyn B.; Reik, Wolf; Dunham, Ian		SAVOIR Consortium	Conservation of the H19 noncoding RNA and H19-IGF2 imprinting mechanism in therians	NATURE GENETICS			English	Article							INSULATOR PROTEIN CTCF; DIFFERENTIAL METHYLATION; CHROMATIN INSULATOR; DNA METHYLATION; GENE; MOUSE; IGF2; EXPRESSION; MAMMALS; SEQUENCES	Comparisons between eutherians and marsupials suggest limited conservation of the molecular mechanisms that control genomic imprinting in mammals. We have studied the evolution of the imprinted IGF2-H19 locus in therians. Although marsupial orthologs of protein-coding exons were easily identified, the use of evolutionarily conserved regions and low-stringency Bl2seq comparisons was required to delineate a candidate H19 noncoding RNA sequence. The therian H19 orthologs show miR-675 and exon structure conservation, suggesting functional selection on both features. Transcription start site sequences and poly(A) signals are also conserved. As in eutherians, marsupial H19 is maternally expressed and paternal methylation upstream of the gene originates in the male germline, encompasses a CTCF insulator, and spreads somatically into the H19 gene. The conservation in all therians of the mechanism controlling imprinting of the IGF2-H19 locus suggests a sequential model of imprinting evolution.	[Smits, Guillaume; Smith, Paul; Beury, Delphine; Reik, Wolf] Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB22 3AT, England; [Mungall, Andrew J.; Matthews, Lucy; Rogers, Jane; Dunham, Ian] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Griffiths-Jones, Sam] Univ Manchester, Fac Life Sci, Manchester M13 9PL, England; [Pask, Andrew J.; Shaw, Geoff; Renfree, Marilyn B.] Univ Melbourne, Dept Zool, Victoria 3010, Australia; [VandeBerg, John L.] SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78227 USA; [McCarrey, John R.] Univ Texas San Antonio, Dept Biol, San Antonio, TX 78249 USA	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Wellcome Trust Sanger Institute; University of Manchester; University of Melbourne; Texas Biomedical Research Institute; University of Texas System; University of Texas at San Antonio (UTSA)	Reik, W (corresponding author), Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB22 3AT, England.	wolf.reik@bbsrc.ac.uk; dunham@ebi.ac.uk	Mungall, Andrew J./U-7067-2018; Shaw, Geoff/A-6916-2012; Reik, Wolf/I-6794-2012; Griffiths-Jones, Sam/H-2998-2014	Mungall, Andrew J./0000-0002-0905-2742; Shaw, Geoff/0000-0002-7421-7136; Pask, Andrew/0000-0002-1900-2263; Griffiths-Jones, Sam/0000-0001-6043-807X; Beury, Delphine/0000-0002-4163-0362; Renfree, Marilyn/0000-0002-4589-0436; Smits, Guillaume/0000-0003-2845-6758; Dunham, Ian/0000-0003-2525-5598; Reik, Wolf/0000-0003-0216-9881; Steward, Charles/0000-0001-8829-5349	MRC [G0400154] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C214, BBS/E/B/0000S119] Funding Source: Medline; Medical Research Council [G0400154] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Ager E, 2007, DEV BIOL, V309, P317, DOI 10.1016/j.ydbio.2007.07.025; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; Butler CM, 2008, J ANAT, V212, P55, DOI 10.1111/j.1469-7580.2007.00837.x; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Duret L, 2006, SCIENCE, V312, P1653, DOI 10.1126/science.1126316; Eddy SR, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-18; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Fedoriw AM, 2004, SCIENCE, V303, P238, DOI 10.1126/science.1090934; FERGUSONSMITH AC, 1993, NATURE, V362, P751, DOI 10.1038/362751a0; Gabory A, 2006, CYTOGENET GENOME RES, V113, P188, DOI 10.1159/000090831; Griffiths-Jones S, 2005, BIOINFORMATICS, V21, P257, DOI 10.1093/bioinformatics/bth489; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; HAO Y, 1993, NATURE, V365, P764, DOI 10.1038/365764a0; Ishihara K, 2006, MOL CELL, V23, P733, DOI 10.1016/j.molcel.2006.08.008; Jelinic P, 2006, PLOS BIOL, V4, P1910, DOI 10.1371/journal.pbio.0040355; Kaneda M, 2004, NATURE, V429, P900, DOI 10.1038/nature02633; Kato Y, 2007, HUM MOL GENET, V16, P2272, DOI 10.1093/hmg/ddm179; Killian JK, 2000, MOL CELL, V5, P707, DOI 10.1016/S1097-2765(00)80249-X; Killian JK, 2001, J EXP ZOOL, V291, P205, DOI 10.1002/jez.1070; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; La Salle S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-104; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Matouk IJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000845; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; O'Neill MJ, 2000, DEV GENES EVOL, V210, P18, DOI 10.1007/PL00008182; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Ovcharenko I, 2004, GENOME RES, V14, P472, DOI 10.1101/gr.2129504; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Rapkins RW, 2006, PLOS GENET, V2, P1666, DOI 10.1371/journal.pgen.0020182; Reese KJ, 2007, PLOS GENET, V3, P1407, DOI 10.1371/journal.pgen.0030137; Reik W, 2005, NAT REV GENET, V6, P403, DOI 10.1038/nrg1602; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Ro S, 2006, BIOCHEM BIOPH RES CO, V351, P756, DOI 10.1016/j.bbrc.2006.10.105; Saini HK, 2007, P NATL ACAD SCI USA, V104, P17719, DOI 10.1073/pnas.0703890104; Schmid J, 2003, COMP BIOCHEM PHYS A, V136, P903, DOI 10.1016/S1095-6433(03)00240-X; Schoenherr CJ, 2003, NAT GENET, V33, P66, DOI 10.1038/ng1057; Suzuki S, 2005, MECH DEVELOP, V122, P213, DOI 10.1016/j.mod.2004.10.003; Suzuki S, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030055; Webster KE, 2005, P NATL ACAD SCI USA, V102, P4068, DOI 10.1073/pnas.0500702102; Weidman JR, 2006, EPIGENETICS-US, V1, P49; Weidman JR, 2004, GENOME RES, V14, P1726, DOI 10.1101/gr.2774804; Wilkins JF, 2003, NAT REV GENET, V4, P359, DOI 10.1038/nrg1062; Wood AJ, 2007, PLOS GENET, V3, P192, DOI 10.1371/journal.pgen.0030020; Yokomine T, 2006, CYTOGENET GENOME RES, V113, P75, DOI 10.1159/000090817	50	139	149	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					971	976		10.1038/ng.168	http://dx.doi.org/10.1038/ng.168			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18587395				2022-12-27	WOS:000258026900013
J	Weinberger, LS; Dar, RD; Simpson, ML				Weinberger, Leor S.; Dar, Roy D.; Simpson, Michael L.			Transient-mediated fate determination in a transcriptional circuit of HIV	NATURE GENETICS			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; ESCHERICHIA-COLI; TYPE-1 INFECTION; GENE-EXPRESSION; T-CELLS; RESERVOIR; LATENCY; NOISE; TAT	Steady-state behavior and bistability have been proposed as mechanisms for decision making in gene circuits(1-3). However, transient gene expression has also been proposed to control cell fate(4,5), with the decision arbitrated by the duration of a transient gene expression pulse. Here, using an HIV-1 model system, we directly quantify transcriptional feedback strength and its effects on both the duration of HIV-1 Tat transcriptional pulses and the fate of HIV-infected cells. By measuring shifts in the autocorrelation of noise inherent to gene expression, we found that transcriptional positive feedback extends the single-cell Tat expression lifetime two-to sixfold for both minimal Tat circuits and full length, actively replicating HIV-1. Notably, artificial weakening of Tat positive feedback shortened the duration of Tat expression transients and biased the probability in favor of latency. Thus, transcriptional positive feedback can modulate transient expression lifetime to a greater extent than protein half-life modulation, and it has a critical role in the cell-fate decision in HIV.	[Weinberger, Leor S.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Dar, Roy D.; Simpson, Michael L.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN 37831 USA; [Dar, Roy D.] Univ Tennessee, Dept Phys & Astron, Knoxville, TN 37996 USA; [Simpson, Michael L.] Univ Tennessee, Dept Mat Sci & Engn, Knoxville, TN 37996 USA	University of California System; University of California San Diego; United States Department of Energy (DOE); Oak Ridge National Laboratory; Center for Nanophase Materials Sciences; University of Tennessee System; University of Tennessee Knoxville; University of Tennessee System; University of Tennessee Knoxville	Weinberger, LS (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, 9500 Gilman Dr 0314, La Jolla, CA 92093 USA.	lsw@ucsd.edu; simpsonml1@ornl.gov	Simpson, Michael/A-8410-2011	Simpson, Michael/0000-0002-3933-3457; Dar, Roy/0000-0002-6006-4888				Alon U, 2007, INTRO SYSTEMS BIOL D; Arkin A, 1998, GENETICS, V149, P1633; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Bagowski CP, 2001, CURR BIOL, V11, P1176, DOI 10.1016/S0960-9822(01)00330-X; BOHNLEIN E, 1988, CELL, V53, P827, DOI 10.1016/0092-8674(88)90099-2; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Cox CD, 2006, CHAOS, V16, DOI 10.1063/1.2204354; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; Han YF, 2007, NAT REV MICROBIOL, V5, P95, DOI 10.1038/nrmicro1580; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; KLOTMAN ME, 1991, P NATL ACAD SCI USA, V88, P5011, DOI 10.1073/pnas.88.11.5011; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; Lassen KG, 2006, PLOS PATHOG, V2, P650, DOI 10.1371/journal.ppat.0020068; Lin X, 2003, J VIROL, V77, P8227, DOI 10.1128/JVI.77.15.8227-8236.2003; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Ozbudak EM, 2004, NATURE, V427, P737, DOI 10.1038/nature02298; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Seth N, 2005, J IMMUNOL, V175, P6948, DOI 10.4049/jimmunol.175.10.6948; Simpson ML, 2003, P NATL ACAD SCI USA, V100, P4551, DOI 10.1073/pnas.0736140100; Suel GM, 2006, NATURE, V440, P545, DOI 10.1038/nature04588; TONGSTARKSEN SE, 1989, J IMMUNOL, V142, P702; Tyagi M, 2007, EMBO J, V26, P4985, DOI 10.1038/sj.emboj.7601928; Weinberger LS, 2007, PLOS BIOL, V5, P67, DOI 10.1371/journal.pbio.0050009; Weinberger LS, 2003, J VIROL, V77, P10028, DOI 10.1128/JVI.77.18.10028-10036.2003; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006	30	144	146	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2008	40	4					466	470		10.1038/ng.116	http://dx.doi.org/10.1038/ng.116			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18344999				2022-12-27	WOS:000254388100019
J	Genevieve, D; Proulle, V; Isidor, B; Bellais, S; Serre, V; Djouadi, F; Picard, C; Vignon-Savoye; Bader-Meunier, B; Blanche, S; de Vernejoul, MC; Legeai-Mallet, L; Fischer, AM; Le Merrer, M; Dreyfus, M; Gaussem, P; Munnich, A; Cormier-Daire, V				Genevieve, David; Proulle, Valerie; Isidor, Bertrand; Bellais, Samuel; Serre, Valerie; Djouadi, Fatima; Picard, Capucine; Vignon-Savoye, Capucine; Bader-Meunier, Brigitte; Blanche, Stephane; de Vernejoul, Marie-Christine; Legeai-Mallet, Laurence; Fischer, Anne-Marie; Le Merrer, Martine; Dreyfus, Marie; Gaussem, Pascale; Munnich, Arnold; Cormier-Daire, Valerie			Thromboxane synthase mutations in an increased bone density disorder (Ghosal syndrome)	NATURE GENETICS			English	Article							SYNTHETASE; CELLS	Studying consanguineous families with Ghosal hematodiaphyseal dysplasia syndrome (GHDD), a disorder of increased bone density, we identified mutations in TBXAS1, which encodes thromboxane synthase (TXAS). TXAS, an enzyme of the arachidonic acid cascade, produces thromboxane A(2) (TXA(2)). Platelets from subjects with GHDD showed a specific deficit in arachidonic acid-produced aggregation. We also found that TXAS and TXA2 modulated expression of TNFSF11 and TNFRSF11B (encoding RANKL and osteoprotegerin (OPG), respectively) in primary cultured osteoblasts.	[Genevieve, David; Isidor, Bertrand; Bellais, Samuel; Serre, Valerie; Legeai-Mallet, Laurence; Le Merrer, Martine; Munnich, Arnold; Cormier-Daire, Valerie] Univ Paris 05, AP HP,Hop Necker Enfants Malades, Dept Genet, INSERM,Unite U781, F-75015 Paris, France; [Proulle, Valerie; Dreyfus, Marie] Univ Paris Sud, Hop Kremlin Bicetre, AP HP,Lab Hematol, F-94275 Le Kremlin Bicetre, France; [Djouadi, Fatima] CNRS, UPR9078, F-75015 Paris, France; [Picard, Capucine; Blanche, Stephane] Hop Necker Enfants Malad, AP HP,Unite Immunohematol & Rhumatol, F-75015 Paris, France; [Vignon-Savoye, Capucine] Ctr Hosp Intercommunal Le Raincy Montfermeil, Serv Pediat, F-93370 Montfermeil, France; [Bader-Meunier, Brigitte] Hop Robert Debre, AP HP, Serv Hematol Pediat, F-75019 Paris, France; [de Vernejoul, Marie-Christine] Hop Lariboisiere, AP HP, Dept Rhumatol, F-75010 Paris, France; [Fischer, Anne-Marie; Gaussem, Pascale] Hop Europeen Georges Pompidou, AP HP, Lab Hematol, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Cormier-Daire, V (corresponding author), Univ Paris 05, AP HP,Hop Necker Enfants Malades, Dept Genet, INSERM,Unite U781, F-75015 Paris, France.	cormier@necker.fr	Gaussem, Pascale/AGY-9723-2022; Isidor, Bertrand/L-2435-2015; Picard, Capucine/H-3914-2017; Gaussem, P./ABA-1222-2020; Legeai-Mallet, Laurence/E-6112-2016; Gaussem, Pascale/ABA-2228-2020; Isidor, Bertrand/AAJ-3456-2021; DJOUADI, Fatima/C-6187-2019; proulle, valerie/A-5911-2018; cormier-daire, valerie/H-6520-2017	Isidor, Bertrand/0000-0001-6480-126X; Picard, Capucine/0000-0001-8788-5056; Gaussem, P./0000-0002-9139-2147; Legeai-Mallet, Laurence/0000-0003-4989-5856; Isidor, Bertrand/0000-0001-6480-126X; bader-meunier, brigitte/0000-0001-8476-8196; Djouadi, Fatima/0000-0003-0350-0935; cormier-daire, valerie/0000-0002-2839-9856; proulle, valerie/0000-0003-3620-9570				DAVIES P, 1984, ANNU REV IMMUNOL, V2, P335, DOI 10.1146/annurev.immunol.2.1.335; GHOSAL SP, 1988, J PEDIATR-US, V113, P49, DOI 10.1016/S0022-3476(88)80527-4; Gruber R, 2002, BONE, V30, P726, DOI 10.1016/S8756-3282(02)00697-X; Hsu PY, 2000, ARCH BIOCHEM BIOPHYS, V383, P119, DOI 10.1006/abbi.2000.2041; Isidor B, 2007, HUM GENET, V121, P269, DOI 10.1007/s00439-006-0311-1; JORGENSEN HR, 1988, ACTA ORTHOP SCAND, V4, P464; MESTEL F, 1980, LANCET, V1, P157; PILBEAN CC, 2002, PRINCIPLE BONE BIOL, pCH54; Raisz LG, 2003, PROSTAG OTH LIPID M, V71, P287, DOI 10.1016/S1098-8823(03)00049-2; Ralston SH, 2006, GENE DEV, V20, P2492, DOI 10.1101/gad.1449506; Shen RF, 1998, J BIOMED SCI, V5, P153, DOI 10.1007/BF02253465; TANIGUCHI S, 1989, KIDNEY INT, V36, P712, DOI 10.1038/ki.1989.251; Watkins BA, 2001, PROG LIPID RES, V40, P125, DOI 10.1016/S0163-7827(00)00016-3; WEISS HJ, 1977, LANCET, V1, P760; Yu IS, 2004, BLOOD, V104, P135, DOI 10.1182/blood-2003-10-3661	15	47	48	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2008	40	3					284	286		10.1038/ng.2007.66	http://dx.doi.org/10.1038/ng.2007.66			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18264100				2022-12-27	WOS:000253548400017
J	Hodges, E; Xuan, Z; Balija, V; Kramer, M; Molla, MN; Smith, SW; Middle, CM; Rodesch, MJ; Albert, TJ; Hannon, GJ; McCombie, WR				Hodges, Emily; Xuan, Zhenyu; Balija, Vivekanand; Kramer, Melissa; Molla, Michael N.; Smith, Steven W.; Middle, Christina M.; Rodesch, Matthew J.; Albert, Thomas J.; Hannon, Gregory J.; McCombie, W. Richard			Genome-wide in situ exon capture for selective resequencing	NATURE GENETICS			English	Article							HUMAN CANCER; SEQUENCES; PROTEINS	Increasingly powerful sequencing technologies are ushering in an era of personal genome sequences and raising the possibility of using such information to guide medical decisions. Genome resequencing also promises to accelerate the identification of disease-associated mutations. Roughly 98% of the human genome is composed of repeats and intergenic or non-proteincoding sequences. Thus, it is crucial to focus resequencing on high-value genomic regions. Protein-coding exons represent one such type of high-value target. We have developed a method of using flexible, high-density microarrays to capture any desired fraction of the human genome, in this case corresponding to more than 200,000 protein-coding exons. Depending on the precise protocol, up to 55-85% of the captured fragments are associated with targeted regions and up to 98% of intended exons can be recovered. This methodology provides an adaptable route toward rapid and efficient resequencing of any sizeable, non-repeat portion of the human genome.	Cold Spring Harbor Lab, Warson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY USA; NimbleGlen Syst Inc, Madison, WI 53711 USA	Cold Spring Harbor Laboratory; Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Roche Holding; Roche NimbleGen	McCombie, WR (corresponding author), Cold Spring Harbor Lab, Warson Sch Biol Sci, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	McCombie@cshl.edu	Hannon, Gregory/AAB-3568-2019	Hodges, Emily/0000-0001-6513-610X; McCombie, W. Richard/0000-0003-1899-0682; Xuan, Zhenyu/0000-0001-9344-8493				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bentley DR, 2006, CURR OPIN GENET DEV, V16, P545, DOI 10.1016/j.gde.2006.10.009; Cleary MA, 2004, NAT METHODS, V1, P241, DOI 10.1038/nmeth724; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Futreal PA, 2005, COLD SH Q B, V70, P43, DOI 10.1101/sqb.2005.70.015; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Morgulis A, 2006, BIOINFORMATICS, V22, P134, DOI 10.1093/bioinformatics/bti774; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Topol EJ, 2007, NAT GENET, V39, P439, DOI 10.1038/ng0407-439	17	463	546	1	77	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2007	39	12					1522	1527		10.1038/ng.2007.42	http://dx.doi.org/10.1038/ng.2007.42			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	17982454				2022-12-27	WOS:000251267400023
J	Sackton, TB; Lazzaro, BP; Schlenke, TA; Evans, JD; Hultmark, D; Clark, AG				Sackton, Timothy B.; Lazzaro, Brian P.; Schlenke, Todd A.; Evans, Jay D.; Hultmark, Dan; Clark, Andrew G.			Dynamic evolution of the innate immune system in Drosophila	NATURE GENETICS			English	Article							MOLECULAR POPULATION-GENETICS; DETECTING POSITIVE SELECTION; ANTIMICROBIAL PEPTIDES; TRANSMEMBRANE PROTEIN; ADAPTIVE EVOLUTION; SIGNALING PATHWAYS; GENES; FAMILY; PATTERN; PHAGOCYTOSIS	The availability of complete genome sequence from 12 Drosophila species presents the opportunity to examine how natural selection has affected patterns of gene family evolution and sequence divergence among different components of the innate immune system. We have identified orthologs and paralogs of 245 Drosophila melanogaster immune-related genes in these recently sequenced genomes. Genes encoding effector proteins, and to a lesser extent genes encoding recognition proteins, are much more likely to vary in copy number across species than genes encoding signaling proteins. Furthermore, we can trace the apparent recent origination of several evolutionarily novel immune-related genes and gene families. Using codon-based likelihood methods, we show that immune-system genes, and especially those encoding recognition proteins, evolve under positive darwinian selection. Positively selected sites within recognition proteins cluster in domains involved in recognition of microorganisms, suggesting that molecular interactions between hosts and pathogens may drive adaptive evolution in the Drosophila immune system.	Cornell Univ, New York, NY 14853 USA; Cornell Univ, Dept Entomol, Ithaca, NY 14853 USA; Emory Univ, Dept Biol, Atlanta, GA 30322 USA; USDA, Agr Res Serv Bee Res Lab, Beltsville, MD 20705 USA; Umea Univ, Umea Ctr Mol Pathogenesis, S-90187 Umea, Sweden; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University; Cornell University; Emory University; United States Department of Agriculture (USDA); Umea University; Cornell University	Sackton, TB (corresponding author), Cornell Univ, New York, NY 14853 USA.	tbs7@cornell.edu	Hultmark, Dan/C-5058-2013; Evans, Jay D/C-8408-2012	Hultmark, Dan/0000-0002-6506-5855; Evans, Jay D/0000-0002-0036-4651; Schlenke, Todd/0000-0003-3091-3057; Sackton, Timothy/0000-0003-1673-9216; Clark, Andrew/0000-0001-7159-8511	NIGMS NIH HHS [F32 GM067504] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM067504] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agaisse Herve, 2004, Immunol Rev, V198, P72, DOI 10.1111/j.0105-2896.2004.0133.x; Begun DJ, 2000, GENETICS, V154, P1231; Blandin S, 2004, MOL IMMUNOL, V40, P903, DOI 10.1016/j.molimm.2003.10.010; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Bulmer MS, 2006, MOL BIOL EVOL, V23, P317, DOI 10.1093/molbev/msj037; Chang CI, 2005, P NATL ACAD SCI USA, V102, P10279, DOI 10.1073/pnas.0504547102; CHEN CI, 2006, SCIENCE, V311, P1761; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Clark AG, 1997, GENETICS, V147, P713; Daibo S, 2001, GENE, V278, P177, DOI 10.1016/S0378-1119(01)00713-2; De Bie T, 2006, BIOINFORMATICS, V22, P1269, DOI 10.1093/bioinformatics/btl097; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; *DROS 12 GEN CONS, 2007, NATURE, DOI DOI 10.1038/06341; Evans CJ, 2003, DEV CELL, V5, P673, DOI 10.1016/S1534-5807(03)00335-6; Evans JD, 2006, INSECT MOL BIOL, V15, P645, DOI 10.1111/j.1365-2583.2006.00682.x; Hahn MW, 2005, GENOME RES, V15, P1153, DOI 10.1101/gr.3567505; Hotopp JCD, 2007, SCIENCE, V317, P1753, DOI 10.1126/science.1142490; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HULTMARK D, 1993, TRENDS GENET, V9, P178, DOI 10.1016/0168-9525(93)90165-E; Hultmark D, 2003, CURR OPIN IMMUNOL, V15, P12, DOI 10.1016/S0952-7915(02)00005-5; Jiggins FM, 2005, GENETICS, V171, P1847, DOI 10.1534/genetics.105.045435; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Kurucz E, 2003, P NATL ACAD SCI USA, V100, P2622, DOI 10.1073/pnas.0436940100; Kurucz E, 2007, CURR BIOL, V17, P649, DOI 10.1016/j.cub.2007.02.041; Lazzaro BP, 2003, MOL BIOL EVOL, V20, P914, DOI 10.1093/molbev/msg109; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levine MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000442; Little TJ, 2005, INSECT MOL BIOL, V14, P599, DOI 10.1111/j.1365-2583.2005.00588.x; Little TJ, 2004, J MOL EVOL, V59, P498, DOI 10.1007/s00239-004-2641-8; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Markow TA, 2007, GENETICS, V177, P1269, DOI 10.1534/genetics.107.074112; Meister M, 2003, CELL MICROBIOL, V5, P573, DOI 10.1046/j.1462-5822.2003.00302.x; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Ramet M, 2001, IMMUNITY, V15, P1027, DOI 10.1016/S1074-7613(01)00249-7; Ramos-Onsins S, 1998, GENETICS, V150, P157; Schlenke TA, 2003, GENETICS, V164, P1471; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Steiner H, 2004, IMMUNOL REV, V198, P83, DOI 10.1111/j.0105-2896.2004.0120.x; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Stroschein-Stevenson SL, 2006, PLOS BIOL, V4, P87, DOI 10.1371/journal.pbio.0040004; Tennessen JA, 2005, J EVOLUTION BIOL, V18, P1387, DOI 10.1111/j.1420-9101.2005.00925.x; Werner T, 2003, J BIOL CHEM, V278, P26319, DOI 10.1074/jbc.C300184200; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	50	310	319	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2007	39	12					1461	1468		10.1038/ng.2007.60	http://dx.doi.org/10.1038/ng.2007.60			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	17987029				2022-12-27	WOS:000251267400013
J	Karlsson, EK; Baranowska, I; Wade, CM; Salmon Hillbertz, NHC; Zody, MC; Anderson, N; Biagi, TM; Patterson, N; Pielberg, GR; Kulbokas, EJ; Comstock, KE; Keller, ET; Mesirov, JP; von Euler, H; Kampe, O; Hedhammar, A; Lander, ES; Andersson, R; Andersson, L; Lindblad-Toh, K				Karlsson, Elinor K.; Baranowska, Izabella; Wade, Claire M.; Salmon Hillbertz, Nicolette H. C.; Zody, Michael C.; Anderson, Nathan; Biagi, Tara M.; Patterson, Nick; Pielberg, Gerli Rosengren; Kulbokas, Edward J., III; Comstock, Kenine E.; Keller, Evan T.; Mesirov, Jill P.; von Euler, Henrik; Kampe, Olle; Hedhammar, Ake; Lander, Eric S.; Andersson, Ran; Andersson, Leif; Lindblad-Toh, Kerstin			Efficient mapping of mendelian traits in dogs through genome-wide association	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR GENE; WAARDENBURG-SYNDROME; DOMESTIC DOG; MITF; DIFFERENTIATION; PIGMENTATION; INHERITANCE; NEURULATION; MELANOCYTES; REGULATOR	With several hundred genetic diseases and an advantageous genome structure, dogs are ideal for mapping genes that cause disease. Here we report the development of a genotyping array with similar to 27,000 SNPs and show that genome-wide association mapping of mendelian traits in dog breeds can be achieved with only similar to 20 dogs. Specifically, we map two traits with mendelian inheritance: the major white spotting ( S) locus and the hair ridge in Rhodesian ridgebacks. For both traits, we map the loci to discrete regions of <1 Mb. Fine-mapping of the S locus in two breeds refines the localization to a region of similar to 100 kb contained within the pigmentation-related gene MITF. Complete sequencing of the white and solid haplotypes identifies candidate regulatory mutations in the melanocyte-specific promoter of MITF. Our results show that genome-wide association mapping within dog breeds, followed by fine-mapping across multiple breeds, will be highly efficient and generally applicable to trait mapping, providing insights into canine and human health.	MIT, Broad Inst Harvard, Cambridge, MA 02142 USA; Boston Univ, Bioinformat Program, Boston, MA 02215 USA; Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Biomed Ctr, SE-75124 Uppsala, Sweden; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Uppsala Univ, Dept Med Biochem, SE-75124 Uppsala, Sweden; Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; Swedish Univ Agr Sci, Dept Clin Sci, SE-75007 Uppsala, Sweden; Uppsala Univ, Univ Hosp, Dept Med Sci, SE-75185 Uppsala, Sweden; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Boston University; Swedish University of Agricultural Sciences; Harvard University; Massachusetts General Hospital; Uppsala University; University of Michigan System; University of Michigan; Swedish University of Agricultural Sciences; Uppsala University; Uppsala University Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Karlsson, EK (corresponding author), MIT, Broad Inst Harvard, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	elinor@broad.mit.edu; leif.andersson@imbim.uu.se; kersli@broad.mit.edu	Keller, Evan T/M-1446-2016; Fiumefreddo, Andrea/T-2977-2019; Ronnberg, HENRIK Paul Olof/AAP-9678-2021; Andersson, Goran/AAK-6564-2020; Mesirov, Jill/AGF-7626-2022	Keller, Evan T/0000-0002-7592-7535; Ronnberg, HENRIK Paul Olof/0000-0001-6098-5364; Andersson, Goran/0000-0001-5131-3144; Kampe, Olle/0000-0001-6091-9914; Wade, Claire/0000-0003-3413-4771; Karlsson, Elinor/0000-0002-4343-3776; Hedhammar, Ake/0000-0001-7048-3851				Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bondurand N, 2000, HUM MOL GENET, V9, P1907, DOI 10.1093/hmg/9.13.1907; BURNS M, 1966, GENETICWS DOG BASIS; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Dourmishev AL, 1999, INT J DERMATOL, V38, P656, DOI 10.1046/j.1365-4362.1999.00750.x; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Hart D. L., 2007, PRINCIPLES POPULATIO; Hillbertz NHCS, 2006, J SMALL ANIM PRACT, V47, P184, DOI 10.1111/j.1748-5827.2006.00016.x; Hillbertz NHCS, 2007, NAT GENET, V39, P1318, DOI 10.1038/ng.2007.4; Jacquemin P, 2001, BIOCHEM BIOPH RES CO, V285, P1200, DOI 10.1006/bbrc.2001.5294; Jordan SF, 2000, MECH DEVELOP, V92, P135, DOI 10.1016/S0925-4773(99)00332-9; Karabagli H, 2002, ANAT EMBRYOL, V205, P365, DOI 10.1007/s00429-002-0264-7; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Ladher RK, 2005, GENE DEV, V19, P603, DOI 10.1101/gad.1273605; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Little C., 1957, INHERITANCE COAT COL; METALLINOS D, 2000, GENOME BIOL, V1; MOTOHASHI H, 1994, HEARING RES, V80, P10, DOI 10.1016/0378-5955(94)90003-5; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saito H, 2002, J BIOL CHEM, V277, P28787, DOI 10.1074/jbc.M203719200; Smith SD, 2000, J MED GENET, V37, P446, DOI 10.1136/jmg.37.6.446; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Strain GM, 2004, VET J, V167, P23, DOI 10.1016/S1090-0233(03)00104-7; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; TASSABEHJI M, 1994, NAT GENET, V8, P251, DOI 10.1038/ng1194-251; TIETZ W, 1963, AM J HUM GENET, V15, P259; Udono T, 2000, BBA-GENE STRUCT EXPR, V1491, P205, DOI 10.1016/S0167-4781(00)00051-8; van Hagen MAE, 2004, J HERED, V95, P526, DOI 10.1093/jhered/esh083; Wade CM, 2006, COLD SPRING HARB MON, V44, P179; Widlund HR, 2003, ONCOGENE, V22, P3035, DOI 10.1038/sj.onc.1206443; Yoshida H, 1996, DEVELOPMENT, V122, P1207	36	409	422	1	122	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2007	39	11					1321	1328		10.1038/ng.2007.10	http://dx.doi.org/10.1038/ng.2007.10			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17906626				2022-12-27	WOS:000250575900016
J	Manolio, TA; Rodriguez, LL; Brooks, L; Abecasis, G; Ballinger, D; Daly, M; Donnelly, P; Faraone, SV; Frazer, K; Gabriel, S; Gejman, P; Guttmacher, A; Harris, EL; Insel, T; Kelsoe, JR; Lander, E; McCowin, N; Mailman, MD; Nabel, E; Ostell, J; Pugh, E; Sherry, S; Sullivan, PF; Thompson, JF; Warram, J; Study, G; Wholley, D; Milos, PM; Collins, FS				Manolio, Teri A.; Rodriguez, Laura Lyman; Brooks, Lisa; Abecasis, Goncalo; Ballinger, Dennis; Daly, Mark; Donnelly, Peter; Faraone, Stephen V.; Frazer, Kelly; Gabriel, Stacey; Gejman, Pablo; Guttmacher, Alan; Harris, Emily L.; Insel, Thomas; Kelsoe, John R.; Lander, Eric; McCowin, Norma; Mailman, Matthew D.; Nabel, Elizabeth; Ostell, James; Pugh, Elizabeth; Sherry, Stephen; Sullivan, Patrick F.; Thompson, John F.; Warram, James; Study, GoKinD; Wholley, David; Milos, Patrice M.; Collins, Francis S.		Gain Collaborative Res Grp; Collaborative Assoc Study; Int Multi-Center ADHD Genetics; Mol Genetics Schizophrenia Collab; Bipolar Genome Study; Major Depression Stage 1 Genomewid	New models of collaboration in genome-wide association studies: the Genetic Association Information Network	NATURE GENETICS			English	Editorial Material							BREAST-CANCER; SUSCEPTIBILITY; LOCI; VARIANTS; MULTIPLE; LINKAGE; SAMPLE; RISK	The Genetic Association Information Network ( GAIN) is a public- private partnership established to investigate the genetic basis of common diseases through a series of collaborative genome-wide association studies. GAIN has used new approaches for project selection, data deposition and distribution, collaborative analysis, publication and protection from premature intellectual property claims. These demonstrate a new commitment to shared scientific knowledge that should facilitate rapid advances in understanding the genetics of complex diseases.	US NIH, NHGRI, Bethesda, MD 20892 USA; Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; Perlegen Sci, Mountain View, CA 94043 USA; Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; Univ Oxford, Oxford OX1 3TG, England; SUNY Upstate Med Univ, Syracuse, NY 13210 USA; Scripps Res Inst, La Jolla, CA 92037 USA; Evanston NW Healthcare, Evanston, IL 60201 USA; Northwestern Univ, Evanston, IL 60201 USA; NIMH, NIH, Bethesda, MD 20892 USA; Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; Vet Admin San Diego Healthcare Syst, La Jolla, CA 92093 USA; Fdn NIH, Bethesda, MD 20892 USA; Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA; Natl Lib Med, NIH, Bethesda, MD 20892 USA; NHLBI, NIH, Bethesda, MD 20892 USA; Johns Hopkins Univ, Ctr Inherited Dis Res, Baltimore, MD 21224 USA; Univ N Carolina, Chapel Hill, NC 27599 USA; Pfizer Inc, Pharmacogenom Pfizer Global Res & Dev, Groton, CT 06340 USA; Joslin Diabet Ctr, Boston, MA 02215 USA; Helicos BioSci Corp, Cambridge, MA 02139 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Michigan System; University of Michigan; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Oxford; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Scripps Research Institute; NorthShore University Health System; Northwestern University; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; Eli Lilly; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; Pfizer; Harvard University; Joslin Diabetes Center, Inc.	Manolio, TA (corresponding author), US NIH, NHGRI, 31 Ctr Dr, Bethesda, MD 20892 USA.	manolio@nih.gov; manolio@nih.gov	Daly, Mark J/B-2453-2017; Faraone, Stephen V/O-7239-2018; Abecasis, Goncalo R/B-7840-2010; Peng, Bo/A-6920-2009; Faraone, Stephen/AAE-7334-2019	Daly, Mark J/0000-0002-0949-8752; Faraone, Stephen V/0000-0002-9217-3982; Peng, Bo/0000-0001-8225-2284; Faraone, Stephen/0000-0002-9217-3982; Thompson, John/0000-0001-8568-3311; Frazer, Kelly/0000-0002-6060-8902; Sherry, Stephen/0000-0002-7982-076X; Donnelly, Peter/0000-0001-9495-3408; Abecasis, Goncalo/0000-0003-1509-1825	NCRR NIH HHS [U54RR020278-01] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200334, Z01HG200334] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [Z01LM000160] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; *DEP HLTH HUM SERV, 2000, FED REGISTER, V67, P53270; *DEP HLTH HUM SERV, 2005, FED REGISTER, V70, P36325; *DEP HLTH HUM SERV, 2000, FED REGISTER, V65, P82818; Dick DM, 2003, AM J HUM GENET, V73, P107, DOI 10.1086/376562; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kuntsi Jonna, 2006, Behav Brain Funct, V2, P27, DOI 10.1186/1744-9081-2-27; McGuire AL, 2006, SCIENCE, V312, P370, DOI 10.1126/science.1125339; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Mueller PW, 2006, J AM SOC NEPHROL, V17, P1782, DOI 10.1681/ASN.2005080822; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; SCHLESSELMAN JJ, CASE CONTROL STUDIES; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Suarez BK, 2006, AM J HUM GENET, V78, P315, DOI 10.1086/500272; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	25	229	234	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1045	1051		10.1038/ng2127	http://dx.doi.org/10.1038/ng2127			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17728769				2022-12-27	WOS:000249122400003
J	Zhang, Y; Liu, JS				Zhang, Yu; Liu, Jun S.			Bayesian inference of epistatic interactions in case-control studies	NATURE GENETICS			English	Article							ASSOCIATION; STRATEGIES	Epistatic interactions among multiple genetic variants in the human genome may be important in determining individual susceptibility to common diseases. Although some existing computational methods for identifying genetic interactions have been effective for small- scale studies, we here propose a method, denoted ' bayesian epistasis association mapping' ( BEAM), for genome- wide case- control studies. BEAM treats the disease- associated markers and their interactions via a bayesian partitioning model and computes, via Markov chain Monte Carlo, the posterior probability that each marker set is associated with the disease. Testing this on an age- related macular degeneration genome- wide association data set, we demonstrate that the method is significantly more powerful than existing approaches and that genome- wide case- control epistasis mapping with many thousands of markers is both computationally and statistically feasible.	Harvard Univ, Dept Stat, Sci Ctr 715, Cambridge, MA 02138 USA; Penn State Univ, Dept Stat, University Pk, PA 16802 USA	Harvard University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Liu, JS (corresponding author), Harvard Univ, Dept Stat, Sci Ctr 715, 1 Oxford St, Cambridge, MA 02138 USA.	jliu@stat.harvard.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002518] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01HG002518-06] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Ccok NR, 2004, STAT MED, V23, P1439, DOI 10.1002/sim.1749; Cho YM, 2004, DIABETOLOGIA, V47, P549, DOI 10.1007/s00125-003-1321-3; Collins A, 1999, P NATL ACAD SCI USA, V96, P15173, DOI 10.1073/pnas.96.26.15173; Culverhouse R, 2004, GENET EPIDEMIOL, V27, P141, DOI 10.1002/gepi.20006; Culverhouse R, 2002, AM J HUM GENET, V70, P461, DOI 10.1086/338759; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kooperberg C, 2005, GENET EPIDEMIOL, V28, P157, DOI 10.1002/gepi.20042; Kruglyak L, 1999, NAT GENET, V22, P139, DOI 10.1038/9642; Liu J.S., 2001, MONTE CARLO STRATEGI; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Moore JH, 2002, ANN MED, V34, P88, DOI 10.1080/07853890252953473; Nelson MR, 2001, GENOME RES, V11, P458, DOI 10.1101/gr.172901; Ritchie MD, 2001, AM J HUM GENET, V69, P138, DOI 10.1086/321276; Tsai CT, 2004, CIRCULATION, V109, P1640, DOI 10.1161/01.CIR.0000124487.36586.26; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Williams SM, 2004, HUM HERED, V57, P28, DOI 10.1159/000077387; Zee R. Y. L., 2002, Pharmacogenomics Journal, V2, P197, DOI 10.1038/sj.tpj.6500101; Zheng T, 2006, HUM HERED, V62, P196, DOI 10.1159/000096995; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	19	352	369	1	30	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1167	1173		10.1038/ng2110	http://dx.doi.org/10.1038/ng2110			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17721534				2022-12-27	WOS:000249122400030
J	Douglas, J; Cilliers, D; Coleman, K; Tatton-Brown, K; Barker, K; Bernhard, B; Burn, J; Huson, S; Josifova, D; Lacombe, D; Malik, M; Mansour, S; Reid, E; Cormier-Daire, V; Cole, T; Rahman, N				Douglas, Jenny; Cilliers, Deirdre; Coleman, Kim; Tatton-Brown, Katrina; Barker, Karen; Bernhard, Brigitte; Burn, John; Huson, Susan; Josifova, Dragana; Lacombe, Didier; Malik, Mohsin; Mansour, Sahar; Reid, Evan; Cormier-Daire, Valerie; Cole, Trevor; Rahman, Nazneen			Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth	NATURE GENETICS			English	Article							INDIVIDUALS; DELETIONS	17q11 microdeletions that encompass NF1 cause 5%-10% of cases of neurofibromatosis type 1, and individuals with microdeletions are typically taller than individuals with intragenic NF1 mutations, suggesting that deletion of a neighboring gene might promote human growth. We identified mutations in RNF135, which is within the NF1 microdeletion region, in six families characterized by overgrowth, learning disability, dysmorphic features and variable additional features. These data identify RNF135 as causative of a new overgrowth syndrome and demonstrate that RNF135 haploinsufficiency contributes to the phenotype of NF1 microdeletion cases.	Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; St George Hosp, Sch Med, SW Thames Reg Genet Serv, London SW17 0RE, England; Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England; Guys Hosp, Dept Clin Genet, London SE1 9RT, England; Hop Pellegrin Enfants, Dept Med Genet, EA2406, Bordeaux, France; Queen Elizabeth Queen Mothers Hosp, Margate CT9 4AN, England; Addenbrookes Hosp, Dept Med Genet, Cambridge CB2 2QQ, England; Hop Necker Enfants Malad, Dept Med Genet, F-75015 Paris, France; Birmingham Womens Hosp, Clin Genet Unit, Birmingham B15 2TG, W Midlands, England	University of London; Institute of Cancer Research - UK; St Georges University London; Newcastle University - UK; University of Manchester; Guy's & St Thomas' NHS Foundation Trust; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Birmingham Women's Hospital	Rahman, N (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England.	nazneen.rahman@icr.ac.uk	Milani, Donatella/AAC-8430-2019; Reid, Evan/F-3250-2010; Rahman, Nazneen/B-8890-2012; cormier-daire, valerie/H-6520-2017; Rahman, Nazneen/D-2802-2013; Grasso, Marina/AAC-8722-2019	Milani, Donatella/0000-0002-3087-8514; Reid, Evan/0000-0003-1623-7304; Reardon, Willie/0000-0001-7329-9179; cormier-daire, valerie/0000-0002-2839-9856; Rahman, Nazneen/0000-0003-4376-0440; Lynch, Sally Ann/0000-0003-3540-1333; Grasso, Marina/0000-0001-5682-1789; FitzPatrick, David R./0000-0003-4861-969X; Burn, John/0000-0002-9823-2322; Lacombe, Didier/0000-0002-8956-2207; Silengo, Margherita/0000-0002-6255-1532	Medical Research Council [G0400188] Funding Source: Medline; MRC [G0400188] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646; De Raedt T, 2003, AM J HUM GENET, V72, P1288, DOI 10.1086/374821; De Raedt T, 2006, NAT GENET, V38, P1419, DOI 10.1038/ng1920; Devriendt Koen, 2004, Human Genomics, V1, P126; Ferner RE, 2007, J MED GENET, V44, P81, DOI 10.1136/jmg.2006.045906; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kluwe L, 2004, HUM MUTAT, V23, P111, DOI 10.1002/humu.10299; Messiaen LM, 2000, HUM MUTAT, V15, P541, DOI 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.3.CO;2-E; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Rhodes DA, 2005, IMMUNOLOGY, V116, P411, DOI 10.1111/j.1365-2567.2005.02248.x; Spiegel M, 2005, EUR J HUM GENET, V13, P883, DOI 10.1038/sj.ejhg.5201419; Tonsgard JH, 1997, AM J MED GENET, V73, P80, DOI 10.1002/(SICI)1096-8628(19971128)73:1<80::AID-AJMG16>3.0.CO;2-N; van Asperen CJ, 1998, J MED GENET, V35, P323, DOI 10.1136/jmg.35.4.323; Venturin M, 2004, J MED GENET, V41, P35, DOI 10.1136/jmg.2003.014761; Weksberg R., 2002, OVERGROWTH SYNDROMES	15	61	69	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					963	965		10.1038/ng2083	http://dx.doi.org/10.1038/ng2083			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17632510				2022-12-27	WOS:000248446900011
J	Kantarci, S; Al-Gazali, L; Hill, RS; Donnai, D; Black, GCM; Bieth, E; Chassaing, N; Lacombe, D; Devriendt, K; Teebi, A; Loscertales, M; Robson, C; Liu, TM; MacLaughlin, DT; Noonan, KM; Russell, MK; AWalsh, C; Donahoe, PK; Pober, BR				Kantarci, Sibel; Al-Gazali, Lihadh; Hill, R. Sean; Donnai, Dian; Black, Graeme C. M.; Bieth, Eric; Chassaing, Nicolas; Lacombe, Didier; Devriendt, Koen; Teebi, Ahmad; Loscertales, Maria; Robson, Caroline; Liu, Tianming; MacLaughlin, David T.; Noonan, Kristin M.; Russell, Meaghan K.; AWalsh, Christopher; Donahoe, Patricia K.; Pober, Barbara R.			Mutations in LRP2, which encodes the multiligand receptor megalin, cause Donnai-Barrow and facio-oculo-acoustico-renal syndromes	NATURE GENETICS			English	Article							DIAPHRAGMATIC-HERNIA; SONIC HEDGEHOG; ANIMAL-MODEL; DEAFNESS; MICE; HYPERTELORISM; PROTEINURIA; HYPOPLASIA; RETINOL; MYOPIA	Donnai-Barrow syndrome is associated with agenesis of the corpus callosum, congenital diaphragmatic hernia, facial dysmorphology, ocular anomalies, sensorineural hearing loss and developmental delay. By studying multiplex families, we mapped this disorder to chromosome 2q23.3-31.1 and identified LRP2 mutations in six families with Donnai-Barrow syndrome and one family with facio-oculo-acoustico-renal syndrome. LRP2 encodes megalin, a multiligand uptake receptor that regulates levels of diverse circulating compounds. This work implicates a pathway with potential pharmacological therapeutic targets.	Massachusetts Gen Hosp, Pediat Surg Res Lab, Boston, MA 02114 USA; United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pediat, Al Ain, U Arab Emirates; Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02215 USA; Univ Manchester, St Marys Hosp, Unit Med Genet, Manchester M13 0JH, Lancs, England; Hop Purpan, F-31059 Toulouse 9, France; CHU Pellegrin, Bordeaux, France; CHU Bordeaux, Hop Pellegrin, Gen Med Serv, Bordeaux, France; Catholic Univ Louvain, Ctr Human Genet, B-3000 Louvain, Belgium; Weill Cornell Med Coll, Dept Pediat, Doha, Qatar; Weill Cornell Med Coll, Dept Med Genet, Doha, Qatar; Hamad Med City, Doha, Qatar; Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; Childrens Hosp, Boston, MA 02115 USA; Brigham & Womens Hosp, Harvard Ctr Neurodegenerat & Repair, Ctr Bioinformat, Boston, MA 02115 USA; MassGen Hosp Children, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; United Arab Emirates University; Harvard University; Beth Israel Deaconess Medical Center; University of Manchester; CHU de Toulouse; CHU Bordeaux; CHU Bordeaux; Universite Catholique Louvain; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Hamad Medical Corporation; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Pober, BR (corresponding author), Massachusetts Gen Hosp, Pediat Surg Res Lab, Simches Res Bldg,185 Cambridge St, Boston, MA 02114 USA.	bpober@partners.org	Congregado, Miguel/B-9062-2009; Liu, Tianming/AAA-4602-2022; Liu, Tianming/A-2512-2008; wei, wei/HHR-8613-2022; Black, Graeme/K-7374-2015	Congregado, Miguel/0000-0002-2404-0176; Lacombe, Didier/0000-0002-8956-2207; Robson, Caroline/0000-0001-5592-249X; Black, Graeme/0000-0001-8727-6592	NICHD NIH HHS [R01 HD055150, R01 HD055150-02, R01 HD55150-01] Funding Source: Medline; NINDS NIH HHS [R37 NS35129, R37 NS035129] Funding Source: Medline; Wellcome Trust Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD055150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS035129] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Wellcome Trust(Wellcome TrustEuropean Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Chassaing N, 2003, AM J MED GENET A, V121A, P258, DOI 10.1002/ajmg.a.20266; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; Devriendt K, 1998, J MED GENET, V35, P70, DOI 10.1136/jmg.35.1.70; DONNAI D, 1993, AM J MED GENET, V47, P679, DOI 10.1002/ajmg.1320470518; Fisher CE, 2006, DEV BIOL, V296, P279, DOI 10.1016/j.ydbio.2006.06.007; HOLMES LB, 1972, J PEDIATR-US, V81, P552, DOI 10.1016/S0022-3476(72)80189-6; KLUTH D, 1990, J PEDIATR SURG, V25, P850, DOI 10.1016/0022-3468(90)90190-K; Leheste JR, 1999, AM J PATHOL, V155, P1361, DOI 10.1016/S0002-9440(10)65238-8; McCarthy RA, 2003, J CELL SCI, V116, P955, DOI 10.1242/jcs.00313; McCarthy RA, 2002, J BIOL CHEM, V277, P25660, DOI 10.1074/jbc.M201933200; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; Raila J, 2005, J NUTR, V135, P2512, DOI 10.1093/jn/135.11.2512; Unger S, 2003, AM J PATHOL, V162, P547, DOI 10.1016/S0002-9440(10)63848-5; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460	15	223	229	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2007	39	8					957	959		10.1038/ng2063	http://dx.doi.org/10.1038/ng2063			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17632512	Green Accepted			2022-12-27	WOS:000248446900009
J	Song, XJ; Huang, W; Shi, M; Zhu, MZ; Lin, HX				Song, Xian-Jun; Huang, Wei; Shi, Min; Zhu, Mei-Zhen; Lin, Hong-Xuan			A QTL for rice grain width and weight encodes a previously unknown RING-type E3 ubiquitin ligase	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCUS; ADVANCED BACKCROSS POPULATION; ORYZA-SATIVA; NEGATIVE REGULATOR; PHOTOPERIOD SENSITIVITY; CANCER SUSCEPTIBILITY; MORPHOLOGICAL TRAITS; YIELD COMPONENTS; SEED SIZE; GENE	Grain weight is one of the most important components of grain yield and is controlled by quantitative trait loci (QTLs) derived from natural variations in crops. However, the molecular roles of QTLs in the regulation of grain weight have not been fully elucidated. Here, we report the cloning and characterization of GW2, a new QTL that controls rice grain width and weight. Our data show that GW2 encodes a previously unknown RING-type protein with E3 ubiquitin ligase activity, which is known to function in the degradation by the ubiquitin-proteasome pathway. Loss of GW2 function increased cell numbers, resulting in a larger ( wider) spikelet hull, and it accelerated the grain milk filling rate, resulting in enhanced grain width, weight and yield. Our results suggest that GW2 negatively regulates cell division by targeting its substrate(s) to proteasomes for regulated proteolysis. The functional characterization of GW2 provides insight into the mechanism of seed development and is a potential tool for improving grain yield in crops.	Chinese Acad Sci, Shanghai Inst Biol Sci, Natl Key Lab Plant Mol Genet, Shanghai Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Lin, HX (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Natl Key Lab Plant Mol Genet, Shanghai Inst Plant Physiol & Ecol, 300 Fenglin Rd, Shanghai 200032, Peoples R China.	hxlin@sibs.ac.cn	Lin, Hong-Xuan/AEQ-6607-2022	Lin, Hong-Xuan/0000-0002-2818-023X				Albert TK, 2002, EMBO J, V21, P355, DOI 10.1093/emboj/21.3.355; Alonso-Blanco C, 1999, P NATL ACAD SCI USA, V96, P4710, DOI 10.1073/pnas.96.8.4710; Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; CHOJECKI AJS, 1986, ANN BOT-LONDON, V58, P809, DOI 10.1093/oxfordjournals.aob.a087263; Dasgupta A, 2004, J BIOL CHEM, V279, P26830, DOI 10.1074/jbc.M400894200; DENG XW, 1991, GENE DEV, V5, P1172, DOI 10.1101/gad.5.7.1172; Disch S, 2006, CURR BIOL, V16, P272, DOI 10.1016/j.cub.2005.12.026; Dornan D, 2004, NATURE, V429, P86, DOI 10.1038/nature02514; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; EVANS LT, 1972, RICE BREEDING; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; FREEMONT PS, 1991, CELL, V64, P483, DOI 10.1016/0092-8674(91)90229-R; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Huang N, 1997, MOL BREEDING, V3, P105, DOI 10.1023/A:1009683603862; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; LANDER ES, 1989, GENETICS, V121, P185; Li JM, 2004, GENETICS, V168, P2187, DOI 10.1534/genetics.104.034165; Lin HongXuan, 1995, Scientia Agricultura Sinica, V28, P1; Lin HX, 1996, THEOR APPL GENET, V92, P920, DOI 10.1007/BF00224031; Liu JP, 2002, P NATL ACAD SCI USA, V99, P13302, DOI 10.1073/pnas.162485999; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Luo M, 2005, P NATL ACAD SCI USA, V102, P17531, DOI 10.1073/pnas.0508418102; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Moon J, 2004, PLANT CELL, V16, P3181, DOI 10.1105/tpc.104.161220; Osterlund MT, 2000, NATURE, V405, P462, DOI 10.1038/35013076; REDDY VM, 1983, MAYDICA, V28, P339; Redona ED, 1998, THEOR APPL GENET, V96, P957, DOI 10.1007/s001220050826; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Saijo Y, 2003, GENE DEV, V17, P2642, DOI 10.1101/gad.1122903; Saurin AJ, 1996, TRENDS BIOCHEM SCI, V21, P208, DOI 10.1016/S0968-0004(96)80017-X; Schruff MC, 2006, DEVELOPMENT, V133, P251, DOI 10.1242/dev.02194; Stone SL, 2005, PLANT PHYSIOL, V137, P13, DOI 10.1104/pp.104.052423; Takahashi Y, 2001, P NATL ACAD SCI USA, V98, P7922, DOI 10.1073/pnas.111136798; Tan YF, 2000, THEOR APPL GENET, V101, P823, DOI 10.1007/s001220051549; TANKSLEY SD, 1993, ANNU REV GENET, V27, P205, DOI 10.1146/annurev.ge.27.120193.001225; Thomson MJ, 2003, THEOR APPL GENET, V107, P479, DOI 10.1007/s00122-003-1270-8; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Xie Q, 2002, NATURE, V419, P167, DOI 10.1038/nature00998; Xie XB, 2006, THEOR APPL GENET, V113, P885, DOI 10.1007/s00122-006-0348-5; Xu JianLong, 2002, Chinese Journal of Rice Science, V16, P6; Yano M, 2001, CURR OPIN PLANT BIOL, V4, P130, DOI 10.1016/S1369-5266(00)00148-5; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yoon DB, 2006, THEOR APPL GENET, V112, P1052, DOI 10.1007/s00122-006-0207-4; Zhang XR, 2005, GENE DEV, V19, P1532, DOI 10.1101/gad.1318705	49	1029	1352	32	414	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2007	39	5					623	630		10.1038/ng2014	http://dx.doi.org/10.1038/ng2014			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17417637				2022-12-27	WOS:000245971300017
J	Menne, TF; Goyenechea, B; Sanchez-Puig, N; Wong, CC; Tonkin, LM; Ancliff, PJ; Brost, RL; Costanzo, M; Boone, C; Warren, AJ				Menne, Tobias F.; Goyenechea, Beatriz; Sanchez-Puig, Nuria; Wong, Chi C.; Tonkin, Louise M.; Ancliff, Philip J.; Brost, Renee L.; Costanzo, Michael; Boone, Charles; Warren, Alan J.			The Shwachman-Bodian-Diamond syndrome protein mediates translational activation of ribosomes in yeast	NATURE GENETICS			English	Article							LINKED DYSKERATOSIS-CONGENITA; SACCHAROMYCES-CEREVISIAE; NUCLEAR EXPORT; DELETION MUTANTS; BLACKFAN ANEMIA; ORDERED ARRAYS; 60S SUBUNIT; GENE; RNA; MUTATIONS	The autosomal recessive disorder Shwachman-Diamond syndrome, characterized by bone marrow failure and leukemia predisposition, is caused by deficiency of the highly conserved Shwachman-Bodian-Diamond syndrome (SBDS) protein. Here, we identify the function of the yeast SBDS ortholog Sdo1, showing that it is critical for the release and recycling of the nucleolar shuttling factor Tif6 from pre-60S ribosomes, a key step in 60S maturation and translational activation of ribosomes. Using genome-wide synthetic genetic array mapping, we identified multiple TIF6 gain-of-function alleles that suppressed the pre-60S nuclear export defects and cytoplasmic mislocalization of Tif6 observed in sdo1D cells. Sdo1 appears to function within a pathway containing elongation factor-like 1, and together they control translational activation of ribosomes. Thus, our data link defective late 60S ribosomal subunit maturation to an inherited bone marrow failure syndrome associated with leukemia predisposition.	MRC, Mol Biol Lab, Cambridge CB2 0QH, England; Univ Cambridge, Dept Hematol, Cambridge CB2 2XY, England; Great Ormond St Hosp Sick Children, Camelia Botnar Labs, London WC1N 3JH, England; Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Dept Mol Genet & Microbiol, Toronto, ON M5S 3E1, Canada	MRC Laboratory Molecular Biology; University of Cambridge; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Toronto; University of Toronto	Warren, AJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	ajw@mrc-lmb.cam.ac.uk		Sanchez Puig, Nuria/0000-0002-8945-7001	Medical Research Council [MC_U105161083, G84/6468] Funding Source: Medline; MRC [MC_U105161083, G84/6468] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Ancliff PJ, 2006, BLOOD, V108, P2182, DOI 10.1182/blood-2006-01-010249; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Austin KM, 2005, BLOOD, V106, P1253, DOI 10.1182/blood-2005-02-0807; Basu U, 2001, MOL CELL BIOL, V21, P1453, DOI 10.1128/MCB.21.5.1453-1462.2001; Becam AM, 2001, MOL GENET GENOMICS, V266, P454, DOI 10.1007/s004380100548; BOOCOCK GR, 2006, GENOMICS; Boocock GRB, 2003, NAT GENET, V33, P97, DOI 10.1038/ng1062; Carr-Schmid A, 1999, MOL CELL BIOL, V19, P5257; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Davierwala AP, 2005, NAT GENET, V37, P1147, DOI 10.1038/ng1640; Dick FA, 1997, J BIOL CHEM, V272, P13372, DOI 10.1074/jbc.272.20.13372; Donadieu J, 2005, BONE MARROW TRANSPL, V36, P787, DOI 10.1038/sj.bmt.1705141; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; FOIANI M, 1991, MOL CELL BIOL, V11, P3203, DOI 10.1128/MCB.11.6.3203; Gazda HT, 2006, AM J HUM GENET, V79, P1110, DOI 10.1086/510020; Graindorge JS, 2005, J MOL BIOL, V352, P355, DOI 10.1016/j.jmb.2005.07.037; Groft CM, 2000, NAT STRUCT BIOL, V7, P1156; Hall GW, 2006, ARCH DIS CHILD, V91, P521, DOI 10.1136/adc.2003.046151; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; Ho JHN, 2000, J CELL BIOL, V151, P1057, DOI 10.1083/jcb.151.5.1057; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hung NJ, 2006, MOL CELL BIOL, V26, P3718, DOI 10.1128/MCB.26.10.3718-3727.2006; Hurt E, 1999, J CELL BIOL, V144, P389, DOI 10.1083/jcb.144.3.389; Jorgensen P, 2002, GENETICS, V162, P1091; Koonin EV, 2001, GENOME RES, V11, P240, DOI 10.1101/gr.162001; Kressler D, 1997, MOL CELL BIOL, V17, P7283, DOI 10.1128/MCB.17.12.7283; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Lafontaine DLJ, 1998, GENE DEV, V12, P527, DOI 10.1101/gad.12.4.527; Peng WT, 2003, CELL, V113, P919, DOI 10.1016/S0092-8674(03)00466-5; Rodnina MV, 1999, FEMS MICROBIOL REV, V23, P317, DOI 10.1016/S0168-6445(99)00010-8; Ruggero D, 2003, SCIENCE, V299, P259, DOI 10.1126/science.1079447; Sanvito F, 1999, J CELL BIOL, V144, P823, DOI 10.1083/jcb.144.5.823; Savchenko A, 2005, J BIOL CHEM, V280, P19213, DOI 10.1074/jbc.M414421200; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schroeder R, 2000, EMBO J, V19, P1, DOI 10.1093/emboj/19.1.1; Senger B, 2001, MOL CELL, V8, P1363, DOI 10.1016/S1097-2765(01)00403-8; Shammas C, 2005, J BIOL CHEM, V280, P19221, DOI 10.1074/jbc.M414656200; Spahn CMT, 2004, EMBO J, V23, P1008, DOI 10.1038/sj.emboj.7600102; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; WATSON KL, 1992, P NATL ACAD SCI USA, V89, P11302, DOI 10.1073/pnas.89.23.11302; West M, 2005, MOL CELL BIOL, V25, P3802, DOI 10.1128/MCB.25.9.3802-3813.2005; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wong JMY, 2006, GENE DEV, V20, P2848, DOI 10.1101/gad.1476206; Wu LF, 2002, NAT GENET, V31, P255, DOI 10.1038/ng906; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835; Zhang SY, 2006, MOL CELL BIOL, V26, P6656, DOI 10.1128/MCB.00091-06	50	233	239	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2007	39	4					486	495		10.1038/ng1994	http://dx.doi.org/10.1038/ng1994			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17353896				2022-12-27	WOS:000245271200018
J	Miyamoto, Y; Mabuchi, A; Shi, DQ; Kubo, T; Takatori, Y; Saito, S; Fujioka, M; Sudo, A; Uchida, A; Yamamoto, S; Ozaki, K; Takigawa, M; Tanaka, T; Nakamura, Y; Jiang, Q; Ikegawa, S				Miyamoto, Yoshinari; Mabuchi, Akihiko; Shi, Dongquan; Kubo, Toshikazu; Takatori, Yoshio; Saito, Susumu; Fujioka, Mikihiro; Sudo, Akihiro; Uchida, Atsumasa; Yamamoto, Seizo; Ozaki, Koichi; Takigawa, Masaharu; Tanaka, Toshihiro; Nakamura, Yusuke; Jiang, Qing; Ikegawa, Shiro			A functional polymorphism in the 5 ' UTR of GDF5 is associated with susceptibility to osteoarthritis	NATURE GENETICS			English	Article							CHONDROSARCOMA CELL-LINE; ACID REPEAT POLYMORPHISM; SEQUENCE POLYMORPHISMS; MORPHOGENETIC PROTEINS; KNEE-OSTEOARTHRITIS; HIP OSTEOARTHRITIS; GENE; MUTATION; CHONDRODYSPLASIA; CHONDROGENESIS	Osteoarthritis (MIM 165720), characterized by degeneration of articular cartilage, is the most common form of human arthritis and a major concern for aging societies worldwide(1-3). Epidemiological and genetic studies have shown that osteoarthritis is a polygenic disease(1,4,5). Here, we report that the gene encoding growth differentiation factor 5 (GDF5) is associated with osteoarthritis in Asian populations. A SNP in the 5' UTR of GDF5 (+104T/ C; rs143383) showed significant association (P = 1.8 x 10(-13)) with hip osteoarthritis in two independent Japanese populations. This association was replicated for knee osteoarthritis in Japanese (P = 0.0021) and Han Chinese (P = 0.00028) populations. This SNP, located in the GDF5 core promoter, exerts allelic differences on transcriptional activity in chondrogenic cells, with the susceptibility allele showing reduced activity. Our findings implicate GDF5 as a susceptibility gene for osteoarthritis and suggest that decreased GDF5 expression is involved in the pathogenesis of osteoarthritis.	RIKEN, SNP Res Ctr, Lab Bone & Joint Dis, Tokyo 1088639, Japan; Nanjing Univ, Sch Med, Drum Tower hosp, Ctr Diagnosis Treatment Joint Dis, Nanjing 210008, Jiangsu, Peoples R China; Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kyoto 6028566, Japan; Univ Tokyo, Dept Orthopaed Surg, Tokyo 1138655, Japan; Sumitorno Hosp, Dept Orthopaed Surg, Kita Ku, Osaka 5300005, Japan; Mie Univ, Fac Med, Dept Orthopaed Surg, Tsu, Mie 5148507, Japan; Tokyo Metropolitan Geriatr Hosp, Dept Orthopaed Surg, Itabashi Ku, Tokyo 1730015, Japan; RIKEN, Lab Cardiovasc Dis, SNP Res Ctr, Minato Ku, Tokyo 1088639, Japan; Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Biochem & Mol Dent, Okayama 7008525, Japan; RIKEN, Lab Genotyping, SNP Res Ctr, Minato Ku, Tokyo 1088639, Japan	RIKEN; Nanjing University; Kyoto Prefectural University of Medicine; University of Tokyo; Sumitomo Hospital; Mie University; RIKEN; Okayama University; RIKEN	Ikegawa, S (corresponding author), Osaka Rosai Hosp, Dept Orthopaed Surg, 1179-3 Nagasone Cho, Osaka 5918025, Japan.	sikegawa@ims.u-tokyo.ac.jp	Tanaka, Toshihiro/J-9310-2014; shi, dongquan/ABH-3078-2021; Ikegawa, Shiro/N-6895-2015; Shi, Dongquan/ABG-6949-2021; shi, dongquan/AAE-9956-2020	Tanaka, Toshihiro/0000-0001-6201-9784; shi, dongquan/0000-0002-4769-7816; Ikegawa, Shiro/0000-0003-0316-2147; Ozaki, Kouichi/0000-0003-0028-1570				Bobacz K, 2002, OSTEOARTHR CARTILAGE, V10, P394, DOI 10.1053/joca.2002.0522; CHANG SC, 1994, J BIOL CHEM, V269, P28227; Chano T, 1998, VIRCHOWS ARCH, V432, P529, DOI 10.1007/s004280050201; Erlacher L, 1998, J BONE MINER RES, V13, P383, DOI 10.1359/jbmr.1998.13.3.383; Faiyaz-Ul-Haque M, 2002, AM J MED GENET, V111, P31, DOI 10.1002/ajmg.10501; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; Francis-West PH, 1999, DEVELOPMENT, V126, P1305; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Hotten GC, 1996, GROWTH FACTORS, V13, P65, DOI 10.3109/08977199609034567; Ikeda T, 2001, J HUM GENET, V46, P538, DOI 10.1007/s100380170036; Jiang Q, 2006, J HUM GENET, V51, P1068, DOI 10.1007/s10038-006-0065-6; KELLGREN JH, 1952, BRIT MED J, V1, P181, DOI 10.1136/bmj.1.4751.181; KELLGREN JH, 1963, ANN RHEUM DIS, V22, P237, DOI 10.1136/ard.22.4.237; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Kunisada T, 1998, INT J CANCER, V77, P854, DOI 10.1002/(SICI)1097-0215(19980911)77:6<854::AID-IJC10>3.0.CO;2-1; Mabuchi A, 2001, J HUM GENET, V46, P456, DOI 10.1007/s100380170045; Merino R, 1999, DEV BIOL, V206, P33, DOI 10.1006/dbio.1998.9129; Mototani H, 2005, HUM MOL GENET, V14, P1009, DOI 10.1093/hmg/ddi093; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; OLIVERIA SA, 1995, ARTHRITIS RHEUM, V38, P1134, DOI 10.1002/art.1780380817; OTT J, 1977, ANN HUM GENET, V40, P443, DOI 10.1111/j.1469-1809.1977.tb02031.x; Savarirayan R, 2003, AM J MED GENET A, V117A, P136, DOI 10.1002/ajmg.a.10924; Stecher RM, 1941, AM J MED SCI, V201, P801, DOI 10.1097/00000441-194106000-00004; Storm EE, 1999, DEV BIOL, V209, P11, DOI 10.1006/dbio.1999.9241; STORM EE, 1994, NATURE, V368, P639, DOI 10.1038/368639a0; Sugiura T, 1999, BIOCHEM BIOPH RES CO, V263, P707, DOI 10.1006/bbrc.1999.1445; TAKIGAWA M, 1989, CANCER RES, V49, P3996; Thomas JT, 1996, NAT GENET, V12, P315, DOI 10.1038/ng0396-315; Tsumaki N, 1999, J CELL BIOL, V144, P161, DOI 10.1083/jcb.144.1.161; Wolfman NM, 1997, J CLIN INVEST, V100, P321, DOI 10.1172/JCI119537	30	338	365	0	63	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2007	39	4					529	533		10.1038/2005	http://dx.doi.org/10.1038/2005			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17384641				2022-12-27	WOS:000245271200024
J	He, XC; Yin, T; Grindley, JC; Tian, Q; Sato, T; Tao, WA; Dirisina, R; Porter-Westpfahl, KS; Hembree, M; Johnson, T; Wiedemann, LM; Barrett, TA; Hood, L; Wu, H; Li, LH				He, Xi C.; Yin, Tong; Grindley, Justin C.; Tian, Qiang; Sato, Toshiro; Tao, W. Andy; Dirisina, Raminarao; Porter-Westpfahl, Kimberly S.; Hembree, Mark; Johnson, Teri; Wiedemann, Leanne M.; Barrett, Terrence A.; Hood, Leroy; Wu, Hong; Li, Linheng			PTEN-deficient intestinal stem cells initiate intestinal polyposis	NATURE GENETICS			English	Article							BETA-CATENIN; GERMLINE MUTATIONS; JUVENILE POLYPOSIS; CRYPT FISSION; SELF-RENEWAL; PROTEIN-KINASE; CANCER CELLS; CYCLIN D1; PHOSPHORYLATION; EXPRESSION	Intestinal polyposis, a precancerous neoplasia, results primarily from an abnormal increase in the number of crypts, which contain intestinal stem cells ( ISCs). In mice, widespread deletion of the tumor suppressor Phosphatase and tensin homolog ( PTEN) generates hamartomatous intestinal polyps with epithelial and stromal involvement. Using this model, we have established the relationship between stem cells and polyp and tumor formation. PTEN helps govern the proliferation rate and number of ISCs and loss of PTEN results in an excess of ISCs. In PTEN-deficient mice, excess ISCs initiate de novo crypt formation and crypt fission, recapitulating crypt production in fetal and neonatal intestine. The PTEN-Akt pathway probably governs stem cell activation by helping control nuclear localization of the Wnt pathway effector beta-catenin. Akt phosphorylates beta-catenin at Ser552, resulting in a nuclear- localized form in ISCs. Our observations show that intestinal polyposis is initiated by PTEN- deficient ISCs that undergo excessive proliferation driven by Akt activation and nuclear localization of beta- catenin.	Stowers Inst Med Res, Kansas City, MO 64110 USA; Inst Syst Biol, Seattle, WA 98103 USA; Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; Northwestern Univ, Sch Med, Div Gastroenterol, Dept Med Microbiol & Immunol, Chicago, IL 60611 USA; Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; Univ Calif Los Angeles, Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	Stowers Institute for Medical Research; Institute for Systems Biology (ISB); Purdue University System; Purdue University; Purdue University West Lafayette Campus; Northwestern University; University of Kansas; University of Kansas Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Li, LH (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	lil@stowers-institute.org	Sato, Toshiro/J-3522-2014; Tao, Andy/N-1290-2019; Tao, Weiguo/AAL-2777-2020; Wiedemann, Leanne/E-3316-2010	Sato, Toshiro/0000-0001-8353-8137; Tao, Weiguo/0000-0002-5535-5517; Wiedemann, Leanne/0000-0002-0964-4676; Li, Linheng/0000-0001-9963-430X; Barrett, Terrence/0000-0001-6428-3271	NIAID NIH HHS [R01 AI061701, R01 AI061701-02] Funding Source: Medline; NIDDK NIH HHS [R01 DK070001] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070001] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Asai R, 2005, DEV GROWTH DIFFER, V47, P501, DOI 10.1111/j.1440-169X.2005.00825.x; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Brittan M, 2002, J PATHOL, V197, P492, DOI 10.1002/path.1155; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Gera JF, 2004, J BIOL CHEM, V279, P2737, DOI 10.1074/jbc.M309999200; Gottardi CJ, 2004, J CELL BIOL, V167, P339, DOI 10.1083/jcb.200402153; Greaves LC, 2006, P NATL ACAD SCI USA, V103, P714, DOI 10.1073/pnas.0505903103; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Huber AH, 1997, CELL, V90, P871, DOI 10.1016/S0092-8674(00)80352-9; Koike M, 2004, J BIOL CHEM, V279, P34038, DOI 10.1074/jbc.M405821200; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Megy S, 2005, PEPTIDES, V26, P227, DOI 10.1016/j.peptides.2004.09.021; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Persad S, 2001, J CELL BIOL, V153, P1161, DOI 10.1083/jcb.153.6.1161; Piedra J, 2001, J BIOL CHEM, V276, P20436, DOI 10.1074/jbc.M100194200; Potten CS, 2002, J CELL SCI, V115, P2381; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Preston SL, 2003, CANCER RES, V63, P3819; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sancho E, 2004, ANNU REV CELL DEV BI, V20, P695, DOI 10.1146/annurev.cellbio.20.010403.092805; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Shih LM, 2001, P NATL ACAD SCI USA, V98, P2640, DOI 10.1073/pnas.051629398; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stiles B, 2004, DEV BIOL, V273, P175, DOI 10.1016/j.ydbio.2004.06.008; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Tian Q, 2004, P NATL ACAD SCI USA, V101, P15370, DOI 10.1073/pnas.0406499101; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; Waite KA, 2003, HUM MOL GENET, V12, P679, DOI 10.1093/hmg/ddg069; Wasan HS, 1998, J PATHOL, V185, P246; Wirtzfeld DA, 2001, ANN SURG ONCOL, V8, P319, DOI 10.1245/aso.2001.8.4.319; Wong WM, 2002, GUT, V50, P212, DOI 10.1136/gut.50.2.212; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhou XP, 2001, AM J HUM GENET, V69, P704, DOI 10.1086/323703	50	340	357	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					189	198		10.1038/ng1928	http://dx.doi.org/10.1038/ng1928			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17237784	Green Accepted			2022-12-27	WOS:000244063900016
J	Durand, CM; Betancur, C; Boeckers, TM; Bockmann, J; Chaste, P; Fauchereau, F; Nygren, G; Rastam, M; Gillberg, IC; Anckarsater, H; Sponheim, E; Goubran-Botros, H; Delorme, R; Chabane, N; Mouren-Simeoni, MC; de Mas, P; Bieth, E; Roge, B; Heron, D; Burglen, L; Gillberg, C; Leboyer, M; Bourgeron, T				Durand, Christelle M.; Betancur, Catalina; Boeckers, Tobias M.; Bockmann, Juergen; Chaste, Pauline; Fauchereau, Fabien; Nygren, Gudrun; Rastam, Maria; Gillberg, I. Carina; Anckarsater, Henrik; Sponheim, Eili; Goubran-Botros, Hany; Delorme, Richard; Chabane, Nadia; Mouren-Simeoni, Marie-Christine; de Mas, Philippe; Bieth, Eric; Roge, Bernadette; Heron, Delphine; Burglen, Lydie; Gillberg, Christopher; Leboyer, Marion; Bourgeron, Thomas			Mutations in the gene encoding the synaptic scaffolding protein SHANK3 are associated with autism spectrum disorders	NATURE GENETICS			English	Article							POSTSYNAPTIC DENSITY; DELETION SYNDROME; IDENTIFICATION; SYNAPSES; COMPLEX; SPEECH; FAMILY	SHANK3 (also known as ProSAP2) regulates the structural organization of dendritic spines and is a binding partner of neuroligins; genes encoding neuroligins are mutated in autism and Asperger syndrome. Here, we report that a mutation of a single copy of SHANK3 on chromosome 22q13 can result in language and/or social communication disorders. These mutations concern only a small number of individuals, but they shed light on one gene dosage - sensitive synaptic pathway that is involved in autism spectrum disorders.	Inst Pasteur, Human Genet & Cognit Funct, Paris, France; Univ Paris 12, INSERM, U513, Creteil, France; Univ Ulm, Inst Anat & Cell Biol, Ulm, Germany; Univ Paris 07, Paris, France; Univ Gothenburg, Dept Child & Adolescent Psychiat, Gothenburg, Sweden; Univ Oslo, Ctr Child & Adolescent Psychiat, Oslo, Norway; Hop Robert Debre, Assistance Publ Hop Paris, Serv Psychopathol Enfant & Adolescent, F-75019 Paris, France; Purpan Hosp, Dept Med Genet, Toulouse, France; Univ Toulouse Le Mirail, Ctr Etud Rech & Psychopathp, Toulouse, France; Grp Hosp Pitie Salpetriere, Dept Genet, F-75634 Paris, France; Hop Trousseau, Assistance Publ Hop Paris, Serv Genet, F-75571 Paris, France; St Georges Hosp Med Sch, London, England; Grp Hosp Henri Mondor & Albert Chenevier, Assistance Publ Hop Paris, Dept Psychiat, Creteil, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Ulm University; UDICE-French Research Universities; Universite Paris Cite; University of Gothenburg; University of Oslo; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; CHU de Toulouse; Universite de Toulouse; Universite de Toulouse - Jean Jaures; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; St Georges University London; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Bourgeron, T (corresponding author), Inst Pasteur, Human Genet & Cognit Funct, Paris, France.	thomasb@pasteur.fr	Betancur, Catalina/K-3791-2017; Anckarsater, Henrik/C-2244-2009; Leboyer, Marion/AAW-3648-2021	Betancur, Catalina/0000-0002-3327-4804; Leboyer, Marion/0000-0001-5473-3697; Delorme, Richard/0000-0002-5614-3663; Bourgeron, Thomas/0000-0001-8164-9220				Baron MK, 2006, SCIENCE, V311, P531, DOI 10.1126/science.1118995; Boeckers TM, 2002, J NEUROCHEM, V81, P903, DOI 10.1046/j.1471-4159.2002.00931.x; Bonaglia MC, 2006, J MED GENET, V43, P822, DOI 10.1136/jmg.2005.038604; Bonaglia MC, 2001, AM J HUM GENET, V69, P261, DOI 10.1086/321293; Carlisle HJ, 2005, TRENDS NEUROSCI, V28, P182, DOI 10.1016/j.tins.2005.01.008; Folstein SE, 2001, NAT REV GENET, V2, P943, DOI 10.1038/35103559; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Lai CSL, 2001, NATURE, V413, P519, DOI 10.1038/35097076; Manning MA, 2004, PEDIATRICS, V114, P451, DOI 10.1542/peds.114.2.451; Meyer G, 2004, NEUROPHARMACOLOGY, V47, P724, DOI 10.1016/j.neuropharm.2004.06.023; Naisbitt S, 1999, NEURON, V23, P569, DOI 10.1016/S0896-6273(00)80809-0; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; Roussignol G, 2005, J NEUROSCI, V25, P3560, DOI 10.1523/JNEUROSCI.4354-04.2005; Somerville MJ, 2005, NEW ENGL J MED, V353, P1694, DOI 10.1056/NEJMoa051962; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757	15	1069	1127	6	142	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2007	39	1					25	27		10.1038/ng1933	http://dx.doi.org/10.1038/ng1933			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	17173049	Green Accepted, Green Submitted			2022-12-27	WOS:000243136500013
J	Volkman, SK; Sabeti, PC; DeCaprio, D; Neafsey, DE; Schaffner, SF; Milner, DA; Daily, JP; Sarr, O; Ndiaye, D; Ndir, O; Mboup, S; Duraisingh, MT; Lukens, A; Derr, A; Stange-Thomann, N; Waggoner, S; Onofrio, R; Ziaugra, L; Mauceli, E; Gnerre, S; Jaffe, DB; Zainoun, J; Wiegand, RC; Birren, BW; Hartl, DL; Galagan, JE; Lander, ES; Wirth, DF				Volkman, Sarah K.; Sabeti, Pardis C.; DeCaprio, David; Neafsey, Daniel E.; Schaffner, Stephen F.; Milner, Danny A., Jr.; Daily, Johanna P.; Sarr, Ousmane; Ndiaye, Daouda; Ndir, Omar; Mboup, Soulyemane; Duraisingh, Manoj T.; Lukens, Amanda; Derr, Alan; Stange-Thomann, Nicole; Waggoner, Skye; Onofrio, Robert; Ziaugra, Liuda; Mauceli, Evan; Gnerre, Sante; Jaffe, David B.; Zainoun, Joanne; Wiegand, Roger C.; Birren, Bruce W.; Hartl, Daniel L.; Galagan, James E.; Lander, Eric S.; Wirth, Dyann F.			A genome-wide map of diversity in Plasmodium falciparum	NATURE GENETICS			English	Article							MALARIA; SELECTION; SEQUENCE; ORIGIN; POLYMORPHISM; GENE	Genetic variation allows the malaria parasite Plasmodium falciparum to overcome chemotherapeutic agents, vaccines and vector control strategies and remain a leading cause of global morbidity and mortality(1). Here we describe an initial survey of genetic variation across the P. falciparum genome. We performed extensive sequencing of 16 geographically diverse parasites and identified 46,937 SNPs, demonstrating rich diversity among P. falciparum parasites (pi=1.16 x 10(-3)) and strong correlation with gene function. We identified multiple regions with signatures of selective sweeps in drug-resistant parasites, including a previously unidentified 160-kb region with extremely low polymorphism in pyrimethamine-resistant parasites. We further characterized 54 worldwide isolates by genotyping SNPs across 20 genomic regions. These data begin to define population structure among African, Asian and American groups and illustrate the degree of linkage disequilibrium, which extends over relatively short distances in African parasites but over longer distances in Asian parasites. We provide an initial map of genetic diversity in P. falciparum and demonstrate its potential utility in identifying genes subject to recent natural selection and in understanding the population genetics of this parasite.	Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; Cheikh Anta Diop Univ, Fac Med & Pharm, Dakar, Senegal; Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; MIT, Dept Biol, Cambridge, MA 02139 USA; Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University Cheikh Anta Diop Dakar; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Harvard Medical School	Wirth, DF (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA.	dfwirth@hsph.harvard.edu	Milner, Danny/K-3568-2019; Sabeti, Pardis/GQH-8610-2022; Schaffner, Stephen F/D-1189-2011	DeCaprio, Dave/0000-0001-8931-9461; Schaffner, Stephen/0000-0001-6699-3568; Galagan, James/0000-0003-0542-3291; Milner, Jr, Danny Arnold/0000-0002-6685-8208	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI054518] Funding Source: NIH RePORTER; NIAID NIH HHS [K23 AI054518] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baum J, 2003, GENETICS, V163, P1327; Conway DJ, 2000, MOL BIOCHEM PARASIT, V111, P163, DOI 10.1016/S0166-6851(00)00313-3; Delemarre B J, 1979, Ned Tijdschr Geneeskd, V123, P1981; Ferreira MU, 2003, GENE, V304, P65, DOI 10.1016/S0378-1119(02)01180-0; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Hughes AL, 2002, TRENDS PARASITOL, V18, P348, DOI 10.1016/S1471-4922(02)02290-0; Jeffares DC, 2007, NAT GENET, V39, P120, DOI 10.1038/ng1931; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; Kaneko O, 1999, EXP PARASITOL, V93, P116, DOI 10.1006/expr.1999.4441; LEWONTIN RC, 1988, GENETICS, V120, P849; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Mu JB, 2005, PLOS BIOL, V3, P1734, DOI 10.1371/journal.pbio.0030335; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Nair S, 2003, MOL BIOL EVOL, V20, P1526, DOI 10.1093/molbev/msg162; Polley SD, 2003, GENETICS, V165, P555; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rich SM, 1998, P NATL ACAD SCI USA, V95, P4425, DOI 10.1073/pnas.95.8.4425; ROBSON K J H, 1990, Proceedings of the Royal Society of London Series B Biological Sciences, V242, P205, DOI 10.1098/rspb.1990.0126; Roper C, 2003, LANCET, V361, P1174, DOI 10.1016/S0140-6736(03)12951-0; Roper C, 2004, SCIENCE, V305, P1124, DOI 10.1126/science.1098876; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Su XZ, 1999, SCIENCE, V286, P1351, DOI 10.1126/science.286.5443.1351; Volkman SK, 2002, SCIENCE, V298, P216, DOI 10.1126/science.1075642; Volkman SK, 2001, SCIENCE, V293, P482, DOI 10.1126/science.1059878; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; WHO Expert Committee on Malaria, 2000, WHO TECH REP SER, V892, P1; Wootton JC, 2002, NATURE, V418, P320, DOI 10.1038/nature00813	30	248	252	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2007	39	1					113	119		10.1038/ng1930	http://dx.doi.org/10.1038/ng1930			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	17159979				2022-12-27	WOS:000243136500026
J	Dorus, S; Busby, SA; Gerike, U; Shabanowitz, J; Hunt, DF; Karr, TL				Dorus, Steve; Busby, Scott A.; Gerike, Ursula; Shabanowitz, Jeffrey; Hunt, Donald F.; Karr, Timothy L.			Genomic and functional evolution of the Drosophila melanogaster sperm proteome	NATURE GENETICS			English	Article							REPRODUCTIVE PROTEINS; MOLECULAR EVOLUTION; GENES; EXPRESSION; SUBSTITUTION; CHROMOSOME; DATABASE; TESTIS; RATES	In addition to delivering a haploid genome to the egg, sperm have additional critical functions, including egg activation, origination of the zygote centrosome and delivery of paternal factors(1,2). Despite this, existing knowledge of the molecular basis of sperm form and function is limited. We used whole-sperm mass spectrometry to identify 381 proteins of the Drosophila melanogaster sperm proteome (DmSP). This approach identified mitochondrial, metabolic and cytoskeletal proteins, in addition to several new functional categories. We also observed nonrandom genomic clustering of sperm genes and underrepresentation on the X chromosome. Identification of widespread functional constraint on the proteome indicates that sexual selection has had a limited role in the overall evolution of D. melanogaster sperm. The relevance of the DmSP to the study of mammalian sperm function and fertilization mechanisms is demonstrated by the identification of substantial homology between the DmSP and proteins of the mouse axoneme accessory structure.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; Univ Virginia, Dept Pathol, Charlottesville, VA 22904 USA	University of Bath; University of Virginia; University of Virginia	Karr, TL (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	T.L.Karr@bath.ac.uk	Hunt, Donald F/I-6936-2012; Karr, Timothy L/G-1693-2011	Hunt, Donald F/0000-0003-2815-6368; 	NIGMS NIH HHS [F32 GM076913] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boutanaev AM, 2002, NATURE, V420, P666, DOI 10.1038/nature01216; Cao WL, 2006, MOL CELL PROTEOMICS, V5, P801, DOI 10.1074/mcp.M500322-MCP200; Challapalli KK, 2004, ELECTROPHORESIS, V25, P3040, DOI 10.1002/elps.200405979; Clark NL, 2005, PLOS GENET, V1, P335, DOI 10.1371/journal.pgen.0010035; Duret L, 2000, MOL BIOL EVOL, V17, P68, DOI 10.1093/oxfordjournals.molbev.a026239; Fay JC, 2002, NATURE, V415, P1024, DOI 10.1038/4151024a; Fernandez D, 2002, PEPTIDES, V23, P461, DOI 10.1016/S0196-9781(01)00622-2; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Jamieson B.G.M., 1999, INSECTS THEIR SPERMA; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; LI WH, 1993, J MOL EVOL, V36, P96, DOI 10.1007/BF02407308; Loppin B, 2005, CURR BIOL, V15, P87, DOI 10.1016/j.cub.2004.12.071; LOPPIN B, 2004, CO0MPREHENSIVE INSEC; Lu AQ, 2000, MECH DEVELOP, V94, P171, DOI 10.1016/S0925-4773(00)00262-8; Mitchell BF, 2005, MOL BIOL CELL, V16, P4509, DOI 10.1091/mbc.E05-04-0347; Mueller JL, 2005, GENETICS, V171, P131, DOI 10.1534/genetics.105.043844; Nurminsky DI, 1998, NATURE, V396, P572, DOI 10.1038/25126; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Parisi M, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-6-r40; Parisi M, 2003, SCIENCE, V299, P697, DOI 10.1126/science.1079190; Parsch J, 2001, MOL BIOL EVOL, V18, P801, DOI 10.1093/oxfordjournals.molbev.a003862; Perotti ME, 2001, MOL REPROD DEV, V60, P248, DOI 10.1002/mrd.1085; Sardiello M, 2003, NUCLEIC ACIDS RES, V31, P322, DOI 10.1093/nar/gkg123; Snook RR, 2000, GENETICS, V155, P167; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Swanson WJ, 2001, P NATL ACAD SCI USA, V98, P7375, DOI 10.1073/pnas.131568198; Togo T, 2004, MOL REPROD DEV, V67, P465, DOI 10.1002/mrd.20037; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Yeh SD, 2002, J BIOL CHEM, V277, P6311, DOI 10.1074/jbc.M106941200; ZHENG YX, 1991, CELL, V65, P817, DOI 10.1016/0092-8674(91)90389-G	30	208	208	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2006	38	12					1440	1445		10.1038/ng1915	http://dx.doi.org/10.1038/ng1915			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110TR	17099714				2022-12-27	WOS:000242404200023
J	Cai, ST; Lee, CC; Kohwi-Shigematsu, T				Cai, Shutao; Lee, Charles C.; Kohwi-Shigematsu, Terumi			SATB1 packages densely looped, transcriptionally active chromatin for coordinated expression of cytokine genes	NATURE GENETICS			English	Article							GLOBIN LOCUS REQUIRES; MAR-BINDING PROTEIN; HISTONE ACETYLATION; IN-VIVO; DIFFERENTIATION; CELLS; IDENTIFICATION; CONFORMATION; ORGANIZATION; SUFFICIENT	SATB1 (special AT-rich sequence binding protein 1) organizes cell type-specific nuclear architecture by anchoring specialized DNA sequences and recruiting chromatin remodeling factors to control gene transcription. We studied the role of SATB1 in regulating the coordinated expression of Il5, Il4 and Il13, located in the 200-kb T-helper 2 (T(H)2) cytokine locus on mouse chromosome 11. We show that on T(H)2 cell activation, SATB1 expression is rapidly induced to form a unique transcriptionally active chromatin structure at the cytokine locus. In this structure, chromatin is folded into numerous small loops, all anchored to SATB1 at their base. In addition, histone H3 is acetylated at Lys9 and Lys14, and the T(H)2-specific factors GATA3, STAT6 and c-Maf, the chromatin-remodeling enzyme Brg1 and RNA polymerase II are all bound across the 200-kb region. Before activation, the TH2 cytokine locus is already associated with GATA3 and STAT6, showing some looping, but these are insufficient to induce cytokine gene expression. Using RNA interference, we show that on cell activation, SATB1 is required not only for compacting chromatin into dense loops at the 200-kb cytokine locus but also for inducing Il4, Il5, Il13 and c-Maf expression. Thus, SATB1 is a necessary determinant for the hitherto unidentified higher-order, transcriptionally active chromatin structure that forms on TH2 cell activation.	Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Kohwi-Shigematsu, T (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA.	terumiks@lbl.gov						Alvarez JD, 2000, GENE DEV, V14, P521; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Baguet A, 2004, P NATL ACAD SCI USA, V101, P11410, DOI 10.1073/pnas.0403334101; Britanova O, 2005, EUR J NEUROSCI, V21, P658, DOI 10.1111/j.1460-9568.2005.03897.x; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Cook PR, 2002, NAT GENET, V32, P347, DOI 10.1038/ng1102-347; de Belle I, 1998, J CELL BIOL, V141, P335, DOI 10.1083/jcb.141.2.335; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Dobreva G, 2003, GENE DEV, V17, P3048, DOI 10.1101/gad.1153003; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; Fields PE, 2004, IMMUNITY, V21, P865, DOI 10.1016/j.immuni.2004.10.015; Fields PE, 2002, J IMMUNOL, V169, P647, DOI 10.4049/jimmunol.169.2.647; Glimcher LH, 2000, GENE DEV, V14, P1693; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Hager GL, 2006, CHROMOSOME RES, V14, P107, DOI 10.1007/s10577-006-1030-0; Ho IC, 1996, CELL, V85, P973, DOI 10.1016/S0092-8674(00)81299-4; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KAYE J, 1983, J EXP MED, V158, P836, DOI 10.1084/jem.158.3.836; Kohwi-Shigematsu T, 1998, METHOD CELL BIOL, V53, P323; KOHWISHIGEMATSU T, 1990, BIOCHEMISTRY-US, V29, P9551, DOI 10.1021/bi00493a009; Kosak ST, 2004, GENE DEV, V18, P1371, DOI 10.1101/gad.1209304; Kurata H, 1999, IMMUNITY, V11, P677, DOI 10.1016/S1074-7613(00)80142-9; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Lee CC, 2003, PHOTOCH PHOTOBIO SCI, V2, P145, DOI 10.1039/b207598a; Lee CD, 2002, MRS INTERNET J N S R, V7; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Liu Z, 2005, MOL CELL BIOL, V25, P3220, DOI 10.1128/MCB.25.8.3220-3231.2005; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Makar KW, 2003, NAT IMMUNOL, V4, P1183, DOI 10.1038/ni1004; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Palstra RJ, 2003, NAT GENET, V35, P190, DOI 10.1038/ng1244; Pavan KP, 2006, MOL CELL, V22, P231, DOI 10.1016/j.molcel.2006.03.010; Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739; Spilianakis CG, 2004, NAT IMMUNOL, V5, P1017, DOI 10.1038/ni1115; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Wen J, 2005, BLOOD, V105, P3330, DOI 10.1182/blood-2004-08-2988; Wilson CB, 2005, SEMIN IMMUNOL, V17, P105, DOI 10.1016/j.smim.2005.01.005; Wurtele H, 2006, CHROMOSOME RES, V14, P477, DOI 10.1007/s10577-006-1075-0; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084; Zhao KJ, 1998, CELL, V95, P625, DOI 10.1016/S0092-8674(00)81633-5; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2001, J IMMUNOL, V166, P7276, DOI 10.4049/jimmunol.166.12.7276	50	425	447	1	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2006	38	11					1278	1288		10.1038/ng1913	http://dx.doi.org/10.1038/ng1913			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17057718	Green Submitted			2022-12-27	WOS:000241592700016
J	Sung, LY; Gao, SR; Shen, HM; Yu, H; Song, YF; Smith, SL; Chang, CC; Inoue, K; Kuo, L; Lian, J; Li, A; Tian, XC; Tuck, DP; Weissman, SM; Yang, XZ; Cheng, T				Sung, Li-Ying; Gao, Shaorong; Shen, Hongmei; Yu, Hui; Song, Yifang; Smith, Sadie L.; Chang, Ching-Chien; Inoue, Kimiko; Kuo, Lynn; Lian, Jin; Li, Ao; Tian, X. Cindy; Tuck, David P.; Weissman, Sherman M.; Yang, Xiangzhong; Cheng, Tao			Differentiated cells are more efficient than adult stem cells for cloning by somatic cell nuclear transfer	NATURE GENETICS			English	Article							CLONED MICE; P21(CIP1/WAF1); P18(INK4C); GENOME; MOUSE	Since the creation of Dolly via somatic cell nuclear transfer (SCNT) 1, more than a dozen species of mammals have been cloned using this technology(2). One hypothesis for the limited success of cloning via SCNT (1%-5%) 3 is that the clones are likely to be derived from adult stem cells(4). Support for this hypothesis comes from the findings that the reproductive cloning efficiency for embryonic stem cells is five to ten times higher than that for somatic cells as donors(5,6) and that cloned pups cannot be produced directly from cloned embryos derived from differentiated B and T cells or neuronal cells(7-10). The question remains as to whether SCNT-derived animal clones can be derived from truly differentiated somatic cells. We tested this hypothesis with mouse hematopoietic cells at different differentiation stages: hematopoietic stem cells, progenitor cells and granulocytes. We found that cloning efficiency increases over the differentiation hierarchy, and terminally differentiated postmitotic granulocytes yield cloned pups with the greatest cloning efficiency.	Univ Pittsburgh, Inst Canc, Canc Stem Cell Program, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Radiat Oncol, Pittsburgh, PA 15213 USA; Univ Connecticut, Ctr Regenerat Biol, Storrs, CT 06269 USA; Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA; Univ Connecticut, Dept Stat, Storrs, CT 06269 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Connecticut; University of Connecticut; University of Connecticut; Yale University; Yale University	Yang, XZ (corresponding author), Univ Pittsburgh, Inst Canc, Canc Stem Cell Program, Pittsburgh, PA 15213 USA.	xiangzhong.yang@uconn.edu; chengt@upmc.edu	Li, aoyu/GXV-4925-2022; Pillay, Nischalan/F-9536-2012; Li, Ao/GRR-5311-2022; Kuo, Lynn/AAQ-6409-2021	Kuo, Lynn/0000-0002-1903-4425; SUNG, LI-YING/0000-0003-1221-2476; Cheng, Tao/0000-0002-5925-2769; Marjani, Sadie/0000-0003-1241-8538	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080424] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL70561, R01 HL070561-05A2, R01 HL070561] Funding Source: Medline; NIAID NIH HHS [R01 AI080424] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Campbell K H, 1999, Cloning, V1, P3, DOI 10.1089/15204559950020058; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Gao SR, 2003, CLONING STEM CELLS, V5, P287, DOI 10.1089/153623003772032790; Gao SR, 2003, BIOL REPROD, V68, P595, DOI 10.1095/biolreprod.102.005819; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hochedlinger K, 2002, CURR OPIN CELL BIOL, V14, P741, DOI 10.1016/S0955-0674(02)00380-0; Humpherys D, 2001, SCIENCE, V293, P95, DOI 10.1126/science.1061402; Inoue K, 2005, CURR BIOL, V15, P1114, DOI 10.1016/j.cub.2005.05.021; Inoue K, 2006, J CELL SCI, V119, P1985, DOI 10.1242/jcs.02913; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Li JS, 2005, CURR BIOL, V15, pR756, DOI 10.1016/j.cub.2005.09.010; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Smith AL, 2005, J GERONTOL A-BIOL, V60, P448, DOI 10.1093/gerona/60.4.448; Smyth MJ, 2005, J EXP MED, V201, P1973, DOI 10.1084/jem.20042280; Takano H, 2004, J EXP MED, V199, P295, DOI 10.1084/jem.20030929; Tian X Cindy, 2003, Reprod Biol Endocrinol, V1, P98, DOI 10.1186/1477-7827-1-98; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yanagimachi R, 2002, MOL CELL ENDOCRINOL, V187, P241, DOI 10.1016/S0303-7207(01)00697-9; Yu H, 2006, BLOOD, V107, P1200, DOI 10.1182/blood-2005-02-0685; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126	30	89	103	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2006	38	11					1323	1328		10.1038/ng1895	http://dx.doi.org/10.1038/ng1895			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17013394				2022-12-27	WOS:000241592700022
J	Pravenec, M; Churchill, PC; Churchill, MC; Viklicky, O; Kazdova, L; Aitman, TJ; Petretto, E; Hubner, N; Wallace, CA; Zimdahl, H; Zidek, V; Landa, V; Dunbar, J; Bidani, A; Griffin, K; Qi, N; Maxova, M; Kren, V; Mlejnek, P; Wang, J; Kurtz, TW				Pravenec, Michal; Churchill, Paul C.; Churchill, Monique C.; Viklicky, Ondrej; Kazdova, Ludmila; Aitman, Timothy J.; Petretto, Enrico; Hubner, Norbert; Wallace, Caroline A.; Zimdahl, Heike; Zidek, Vaclav; Landa, Vladimir; Dunbar, Joseph; Bidani, Anil; Griffin, Karen; Qi, Nathan; Maxova, Martina; Kren, Vladimir; Mlejnek, Petr; Wang, Jiaming; Kurtz, Theodore W.			Identification of renal Cd36 as a determinant of blood pressure and risk for hypertension	NATURE GENETICS			English	Article							NITRIC-OXIDE SYNTHASE; INSULIN-RESISTANCE; DEFICIENCY; EXPRESSION; GENES; ACID; RATS	To identify renally expressed genes that influence risk for hypertension, we integrated expression quantitative trait locus (QTL) analysis of the kidney with genome-wide correlation analysis of renal expression profiles and blood pressure in recombinant inbred strains derived from the spontaneously hypertensive rat (SHR). This strategy, together with renal transplantation studies in SHR progenitor, transgenic and congenic strains, identified deficient renal expression of Cd36 encoding fatty acid translocase as a genetically determined risk factor for spontaneous hypertension.	[Wang, Jiaming; Kurtz, Theodore W.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94107 USA; [Pravenec, Michal; Zidek, Vaclav; Landa, Vladimir; Kren, Vladimir; Mlejnek, Petr] Acad Sci Czech Republic, Inst Physiol, Prague 14220, Czech Republic; Acad Sci Czech Republic, Ctr Appl Genom, Prague 14220, Czech Republic; [Pravenec, Michal; Kren, Vladimir] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague 12800, Czech Republic; Charles Univ Prague, Gen Teaching Hosp, Prague 12800, Czech Republic; [Churchill, Paul C.; Churchill, Monique C.] Wayne State Univ, Dept Physiol, Sch Med, Detroit, MI 48201 USA; [Viklicky, Ondrej; Kazdova, Ludmila; Maxova, Martina] Inst Clin & Expt Med, Prague 14021, Czech Republic; [Aitman, Timothy J.; Petretto, Enrico; Wallace, Caroline A.] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, London W12 ONN, England; [Petretto, Enrico] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Epidemiol Publ Hlth & Primary Care, London W12 ONN, England; [Hubner, Norbert; Zimdahl, Heike] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Bidani, Anil; Griffin, Karen] Loyola Univ, Dept Internal Med, Maywood, IL 60153 USA; Hines VA Hosp, Maywood, IL 60153 USA; [Qi, Nathan] Univ Michigan, Sch Med, Dept Med, Ann Arbor, MI 48109 USA	University of California System; University of California San Francisco; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Czech Academy of Sciences; Charles University Prague; Charles University Prague; General University Hospital Prague; Wayne State University; Institute for Clinical & Experimental Medicine (IKEM); Imperial College London; Imperial College London; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Loyola University Chicago; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; University of Michigan System; University of Michigan	Kurtz, TW (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94107 USA.	KurtzT@Labmed2.ucsf.edu	Pravenec, Michal/B-1666-2012; Mlejnek, Petr/C-2305-2012; Landa, Vladimir/B-8908-2012; Zidek, Vaclav/C-6685-2012	Pravenec, Michal/0000-0001-9197-5871; Mlejnek, Petr/0000-0002-4218-8983; Viklicky, Ondrej/0000-0003-1049-2195; Aitman, Timothy/0000-0002-7875-4502	Howard Hughes Medical Institute Funding Source: Medline; Medical Research Council [MC_U120097112, MC_U120061454] Funding Source: Medline; MRC [MC_U120061454] Funding Source: UKRI	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; BORDESSOULE D, 1993, BRIT J HAEMATOL, V83, P370, DOI 10.1111/j.1365-2141.1993.tb04659.x; Glazier AM, 2002, SCIENCE, V298, P2345, DOI 10.1126/science.1076641; Hirano K, 2003, TRENDS CARDIOVAS MED, V13, P136, DOI 10.1016/S1050-1738(03)00026-4; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Kincer JF, 2002, J BIOL CHEM, V277, P23525, DOI 10.1074/jbc.M202465200; Koonen DPY, 2007, CIRCULATION, V116, P2139, DOI 10.1161/CIRCULATIONAHA.107.712901; Lifton Richard P, 2004, Harvey Lect, V100, P71; Miyaoka K, 2001, LANCET, V357, P686, DOI 10.1016/S0140-6736(00)04138-6; Passador-Gurgel G, 2007, NAT GENET, V39, P264, DOI 10.1038/ng1944; Pravenec M, 2003, PHYSIOL RES, V52, P681; Pravenec M, 1999, J CLIN INVEST, V103, P1651, DOI 10.1172/JCI6691; Pravenec M, 2001, NAT GENET, V27, P156, DOI 10.1038/84777; Zhu WF, 2005, J BIOL CHEM, V280, P29543, DOI 10.1074/jbc.M501238200; Zou A P, 1999, Curr Hypertens Rep, V1, P178, DOI 10.1007/s11906-999-0016-7	15	78	81	2	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					952	954		10.1038/ng.164	http://dx.doi.org/10.1038/ng.164			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18587397				2022-12-27	WOS:000258026900010
J	Shomura, A; Izawa, T; Ebana, K; Ebitani, T; Kanegae, H; Konishi, S; Yano, M				Shomura, Ayahiko; Izawa, Takeshi; Ebana, Kaworu; Ebitani, Takeshi; Kanegae, Hiromi; Konishi, Saeko; Yano, Masahiro			Deletion in a gene associated with grain size increased yields during rice domestication	NATURE GENETICS			English	Article							SELECTION; MUTATION; ORIGIN; WHEAT	The domestication of crops involves a complex process of selection in plant evolution and is associated with changes in the DNA regulating agronomically important traits. Here we report the cloning of a newly identified QTL, qSW5 (QTL for seed width on chromosome 5), involved in the determination of grain width in rice. Through fine mapping, complementation testing and association analysis, we found that a deletion in qSW5 resulted in a significant increase in sink size owing to an increase in cell number in the outer glume of the rice flower; this trait might have been selected by ancient humans to increase yield of rice grains. In addition, we mapped two other defective functional nucleotide polymorphisms of rice domestication-related genes with genome-wide RFLP polymorphisms of various rice landraces. These analyses show that the qSW5 deletion had an important historical role in artificial selection, propagation of cultivation and natural crossings in rice domestication, and shed light on how the rice genome was domesticated.	[Izawa, Takeshi; Konishi, Saeko] Natl Inst Agrobiol Sci, Plant Genome Res Unit, Tsukuba, Ibaraki 3058602, Japan; [Shomura, Ayahiko] Inst Soc Technoinnovat Agr Forestry & Fisheries, Tsukuba, Ibaraki 3050854, Japan; [Ebana, Kaworu; Kanegae, Hiromi; Yano, Masahiro] Natl Inst Agrobiol Sci, QTL Genom Res Ctr, Tsukuba, Ibaraki 3058602, Japan; [Ebitani, Takeshi] Toyama Agr Res Ctr, Toyama 9398153, Japan	National Institute of Agrobiological Sciences - Japan; National Institute of Agrobiological Sciences - Japan	Izawa, T (corresponding author), Natl Inst Agrobiol Sci, Plant Genome Res Unit, 2-1-2 Kannondai, Tsukuba, Ibaraki 3058602, Japan.	tizawa@nias.affrc.go.jp	Kanegae, Hiromi/AFS-0023-2022; Kajiya-Kanegae, Hiromi/AAA-2951-2020; Yano, Masahiro/AAC-5441-2019	Kanegae, Hiromi/0000-0002-5719-7559; Yano, Masahiro/0000-0003-1510-4622; Izawa, Takeshi/0000-0001-5109-0024				Cheng CY, 2003, MOL BIOL EVOL, V20, P67, DOI 10.1093/molbev/msg004; DARWIN C, 1857, VARIATIONS ANIMALS P; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Dubcovsky J, 2007, SCIENCE, V316, P1862, DOI 10.1126/science.1143986; Ehrenreich IM, 2006, AM J BOT, V93, P953, DOI 10.3732/ajb.93.7.953; Hong SK, 1996, DEVELOPMENT, V122, P2051; Isshiki M, 1998, PLANT J, V15, P133, DOI 10.1046/j.1365-313X.1998.00189.x; Kojima Y, 2005, BREEDING SCI, V55, P431, DOI 10.1270/jsbbs.55.431; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; Olsen KM, 2006, GENETICS, V173, P975, DOI 10.1534/genetics.106.056473; Olsen KM, 2002, GENETICS, V162, P941; Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104; Sang T, 2007, J INTEGR PLANT BIOL, V49, P760, DOI 10.1111/j.1744-7909.2007.00510.x; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Sweeney M, 2007, ANN BOT-LONDON, V100, P951, DOI 10.1093/aob/mcm128; Vitte C, 2004, MOL GENET GENOMICS, V272, P504, DOI 10.1007/s00438-004-1069-6; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891	23	637	777	13	251	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2008	40	8					1023	1028		10.1038/ng.169	http://dx.doi.org/10.1038/ng.169			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18604208				2022-12-27	WOS:000258026900021
J	Brown, KM; MacGregor, S; Montgomery, GW; Craig, DW; Zhao, ZZ; Iyadurai, K; Henders, AK; Homer, N; Campbell, MJ; Stark, M; Thomas, S; Schmid, H; Holland, EA; Gillanders, EM; Duffy, DL; Maskiell, JA; Jetann, J; Ferguson, M; Stephan, DA; Cust, AE; Whiteman, D; Green, A; Olsson, H; Puig, S; Ghiorzo, P; Hansson, J; Demenais, F; Goldstein, AM; Gruis, NA; Elder, DE; Bishop, JN; Kefford, RF; Giles, GG; Armstrong, BK; Aitken, JF; Hopper, JL; Martin, NG; Trent, JM; Mann, GJ; Hayward, NK				Brown, Kevin M.; MacGregor, Stuart; Montgomery, Grant W.; Craig, David W.; Zhao, Zhen Zhen; Iyadurai, Kelly; Henders, Anjali K.; Homer, Nils; Campbell, Megan J.; Stark, Mitchell; Thomas, Shane; Schmid, Helen; Holland, Elizabeth A.; Gillanders, Elizabeth M.; Duffy, David L.; Maskiell, Judith A.; Jetann, Jodie; Ferguson, Megan; Stephan, Dietrich A.; Cust, Anne E.; Whiteman, David; Green, Adele; Olsson, Hakan; Puig, Susana; Ghiorzo, Paola; Hansson, Johan; Demenais, Florence; Goldstein, Alisa M.; Gruis, Nelleke A.; Elder, David E.; Bishop, Julia Newton; Kefford, Richard F.; Giles, Graham G.; Armstrong, Bruce K.; Aitken, Joanne F.; Hopper, John L.; Martin, Nicholas G.; Trent, Jeffrey M.; Mann, Graham J.; Hayward, Nicholas K.			Common sequence variants on 20q11.22 confer melanoma susceptibility	NATURE GENETICS			English	Article							GENE; ASSOCIATION; PIGMENTATION; POLYMORPHISM; POPULATION; PHENOTYPE; ARRAYS; ASIP; RISK	We conducted a genome-wide association pooling study for cutaneous melanoma and performed validation in samples totaling 2,019 cases and 2,105 controls. Using pooling, we identified a new melanoma risk locus on chromosome 20 (rs910873 and rs1885120), with replication in two further samples (combined P < 1 x 10(-15)). The per allele odds ratio was 1.75 (1.53, 2.01), with evidence for stronger association in early-onset cases.	[MacGregor, Stuart; Montgomery, Grant W.; Zhao, Zhen Zhen; Henders, Anjali K.; Campbell, Megan J.; Stark, Mitchell; Thomas, Shane; Duffy, David L.; Whiteman, David; Green, Adele; Martin, Nicholas G.; Hayward, Nicholas K.] Queensland Inst Med Res, Populat Studies & Genet Div, Brisbane, Qld 4029, Australia; [Brown, Kevin M.] Translat Genom Res Inst, Integrated Canc Genom Div, Phoenix, AZ 85028 USA; [Craig, David W.; Stephan, Dietrich A.] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85028 USA; [Homer, Nils] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Schmid, Helen; Holland, Elizabeth A.; Kefford, Richard F.; Mann, Graham J.] Univ Sydney, Westmead Millennium Inst, Sydney Melanoma Unit, Westmead, NSW 2145, Australia; [Schmid, Helen; Holland, Elizabeth A.; Kefford, Richard F.; Mann, Graham J.] Univ Sydney, Westmead Inst Canc Res, Westmead, NSW 2145, Australia; [Gillanders, Elizabeth M.] NHGRI, Inherited Dis Res Branch, Natl Inst Hlth, Baltimore, MD 21224 USA; [Maskiell, Judith A.; Cust, Anne E.; Hopper, John L.] Univ Melbourne, Sch Populat Hlth, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic 3052, Australia; [Jetann, Jodie; Ferguson, Megan; Aitken, Joanne F.] Canc Council Queensland, Viertel Ctr Res Canc Control, Brisbane, Qld 4004, Australia; [Olsson, Hakan] Univ Hosp, Lund Canc Ctr, Dept Oncol, SE-22185 Lund, Sweden; [Puig, Susana] Univ Barcelona, Hosp Clin, Inst Invest Biomed August P & Sune, Dermatol Dept,Melanoma Unit, E-08036 Barcelona, Spain; [Ghiorzo, Paola] Univ Genoa, Dept Oncol Biol & Genet, I-16132 Genoa, Italy; [Hansson, Johan] Karolinska Inst, Dept Oncol Pathol, S-17176 Stockholm, Sweden; [Hansson, Johan] Karolinska Univ Hosp, S-17176 Stockholm, Sweden; [Demenais, Florence] Fdn Jean Dausset CEPH, INSERM, U794, F-75010 Paris, France; [Goldstein, Alisa M.] NCI, Div Canc Epidemiol & Genet, Genet Epidemiol Branch, Bethesda, MD 20892 USA; [Gruis, Nelleke A.] Leiden Univ, Med Ctr, Dept Dermatol, NL-2333 AL Leiden, Netherlands; [Elder, David E.] Univ Pennsylvania, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Bishop, Julia Newton] Univ Leeds, Leeds Inst Mol Med, Epidemiol & Biostat Sect, Leeds LS9 7TF, W Yorkshire, England; [Giles, Graham G.] Canc Council Victoria, Canc Epidemiol Ctr, Carlton, Vic 3053, Australia; [Armstrong, Bruce K.] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Trent, Jeffrey M.] Translat Genom Res Inst, Genet Basis Human Dis Div, Phoenix, AZ 85028 USA	QIMR Berghofer Medical Research Institute; Translational Genomics Research Institute; Translational Genomics Research Institute; University of California System; University of California Los Angeles; University of Sydney; Westmead Institute for Medical Research; University of Sydney; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Melbourne; Cancer Council Queensland; Lund University; Skane University Hospital; University of Barcelona; Hospital Clinic de Barcelona; University of Genoa; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Pennsylvania; University of Leeds; Cancer Council Victoria; University of Sydney; Translational Genomics Research Institute	MacGregor, S (corresponding author), Queensland Inst Med Res, Populat Studies & Genet Div, Brisbane, Qld 4029, Australia.	stuart.macgregor@qimr.edu.au	Ghiorzo, Paola/CAG-0673-2022; Craig, David Wesley/K-6961-2019; Macgregor, Stuart/C-6442-2009; Green, Adele C/B-5324-2011; Aitken, Joanne F/C-5289-2009; Cust, Anne/J-1797-2019; Montgomery, Grant W/B-7148-2008; Whiteman, David C/P-2728-2014; Stark, Mitchell/K-3874-2019; hayward, nicholas k/C-1367-2015; Stark, Mitchell S/E-3542-2010; Puig, Susana/AAB-2091-2020; hayward, nick/AAV-8802-2020; Green, Adele C/P-2736-2014; Duffy, David L/B-7392-2013; Armstrong, Bruce K/K-9464-2015; Stark, Mitchell/K-6794-2019; Mann, Graham J/G-4758-2014; Demenais, Florence/G-3298-2013; Henders, Anjali/E-3126-2017	Ghiorzo, Paola/0000-0002-3651-8173; Craig, David Wesley/0000-0003-2040-1955; Macgregor, Stuart/0000-0001-6731-8142; Cust, Anne/0000-0002-5331-6370; Montgomery, Grant W/0000-0002-4140-8139; Whiteman, David C/0000-0003-2563-9559; hayward, nicholas k/0000-0003-4760-1033; Stark, Mitchell S/0000-0002-4510-2161; Puig, Susana/0000-0003-1337-9745; Green, Adele C/0000-0002-2753-4841; Duffy, David L/0000-0001-7227-632X; Armstrong, Bruce K/0000-0001-8940-7525; Stark, Mitchell/0000-0002-4510-2161; Mann, Graham J/0000-0003-1301-405X; Demenais, Florence/0000-0001-8361-0936; Henders, Anjali/0000-0003-3672-1451; Bishop, Tim/0000-0002-8752-8785; Gruis, Nelleke/0000-0002-5210-9150; Giles, Graham/0000-0003-4946-9099; Kefford, Richard/0000-0001-9251-9229; Jetann, Jodie/0000-0002-9760-3099; Martin, Nicholas/0000-0003-4069-8020; Newton-Bishop, Julia/0000-0001-9147-6802; Olsson, Hakan/0000-0002-8794-9635; Campbell, Megan/0000-0002-6056-6140; Aitken, Joanne Frances/0000-0001-6859-2186	NATIONAL CANCER INSTITUTE [R01CA109544, R01CA088363, R01CA083115] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL086528] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA088363-07, R01 CA083115-08, R01 CA109544, R01 CA088363, CA083115, CA83115, CA88363, R01 CA083115, CA109544] Funding Source: Medline; NHLBI NIH HHS [HL086528, U01 HL086528] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baxter AJ, 2008, TWIN RES HUM GENET, V11, P183, DOI 10.1375/twin.11.2.183; Bonilla C, 2005, HUM GENET, V116, P402, DOI 10.1007/s00439-004-1251-2; de Snoo FA, 2005, CANCER LETT, V230, P153, DOI 10.1016/j.canlet.2004.12.033; Johansson P, 2007, PIGM CELL RES, V20, P216, DOI 10.1111/j.1600-0749.2007.00375.x; Kanetsky PA, 2002, AM J HUM GENET, V70, P770, DOI 10.1086/339076; Landi MT, 2005, J NATL CANCER I, V97, P998, DOI 10.1093/jnci/dji176; Lens MB, 2004, BRIT J DERMATOL, V150, P179, DOI 10.1111/j.1365-2133.2004.05708.x; Macgregor S, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl136; Macgregor S, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1060; Meziani R, 2005, J DERMATOL SCI, V40, P133, DOI 10.1016/j.jdermsci.2005.08.001; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711	11	169	172	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2008	40	7					838	840		10.1038/ng.163	http://dx.doi.org/10.1038/ng.163			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18488026	Green Accepted			2022-12-27	WOS:000257166500017
J	Wang, ZB; Zang, CZ; Rosenfeld, JA; Schones, DE; Barski, A; Cuddapah, S; Cui, KR; Roh, TY; Peng, WQ; Zhang, MQ; Zhao, KJ				Wang, Zhibin; Zang, Chongzhi; Rosenfeld, Jeffrey A.; Schones, Dustin E.; Barski, Artem; Cuddapah, Suresh; Cui, Kairong; Roh, Tae-Young; Peng, Weiqun; Zhang, Michael Q.; Zhao, Keji			Combinatorial patterns of histone acetylations and methylations in the human genome	NATURE GENETICS			English	Article							CHROMATIN DOMAINS; GENE-EXPRESSION; TRANSCRIPTION; ENHANCERS; LANGUAGE; COMPLEX	Histones are characterized by numerous posttranslational modifications that influence gene transcription(1,2). However, because of the lack of global distribution data in higher eukaryotic systems(3), the extent to which gene-specific combinatorial patterns of histone modifications exist remains to be determined. Here, we report the patterns derived from the analysis of 39 histone modifications in human CD4(+) T cells. Our data indicate that a large number of patterns are associated with promoters and enhancers. In particular, we identify a common modification module consisting of 17 modifications detected at 3,286 promoters. These modifications tend to colocalize in the genome and correlate with each other at an individual nucleosome level. Genes associated with this module tend to have higher expression, and addition of more modifications to this module is associated with further increased expression. Our data suggest that these histone modifications may act cooperatively to prepare chromatin for transcriptional activation.	[Wang, Zhibin; Schones, Dustin E.; Barski, Artem; Cuddapah, Suresh; Cui, Kairong; Roh, Tae-Young; Zhao, Keji] NHLBI, Lab Mol Immunol, US NIH, Bethesda, MD 20892 USA; [Zang, Chongzhi] George Washington Univ, Dept Phys, Washington, DC 20052 USA; [Rosenfeld, Jeffrey A.; Zhang, Michael Q.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; NYU, Dept Biol, New York, NY 10003 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); George Washington University; Cold Spring Harbor Laboratory; New York University	Zhao, KJ (corresponding author), NHLBI, Lab Mol Immunol, US NIH, Bethesda, MD 20892 USA.	zhaok@nhlbi.nih.gov	Zang, Chongzhi/D-1445-2011; /AAI-2516-2019; Cuddapah, Suresh/AAU-4288-2021	Zang, Chongzhi/0000-0003-4812-3627; Peng, Weiqun/0000-0001-5521-9091; Barski, Artem/0000-0002-1861-5316; Roh, Tae-Young/0000-0001-5833-0844; Cuddapah, Suresh/0000-0002-4556-2029	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006018, Z01HL005801] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG001696] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 HL005801-05] Funding Source: Medline; NHGRI NIH HHS [R01 HG001696, HG001696, R01 HG001696-05] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Agalioti T, 2002, CELL, V111, P381, DOI 10.1016/S0092-8674(02)01077-2; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bulger M, 2005, J BIOL CHEM, V280, P21689, DOI 10.1074/jbc.R500004200; Carey M, 2006, MOL CELL, V24, P481, DOI 10.1016/j.molcel.2006.09.012; Cho H, 1998, MOL CELL BIOL, V18, P5355, DOI 10.1128/MCB.18.9.5355; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Garcia BA, 2007, J BIOL CHEM, V282, P7641, DOI 10.1074/jbc.M607900200; Hatton RD, 2006, IMMUNITY, V25, P717, DOI 10.1016/j.immuni.2006.09.007; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Kim HP, 2005, J BIOL CHEM, V280, P34042, DOI 10.1074/jbc.M505833200; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Roh TY, 2007, GENOME RES, V17, P74, DOI 10.1101/gr.5767907; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Schreiber SL, 2002, CELL, V111, P771, DOI 10.1016/S0092-8674(02)01196-0; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Turner BM, 2000, BIOESSAYS, V22, P836, DOI 10.1002/1521-1878(200009)22:9<836::AID-BIES9>3.0.CO;2-X; Wade PA, 1997, TRENDS BIOCHEM SCI, V22, P128, DOI 10.1016/S0968-0004(97)01016-5; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301	30	1637	1673	1	130	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					897	903		10.1038/ng.154	http://dx.doi.org/10.1038/ng.154			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18552846	Green Accepted			2022-12-27	WOS:000257166500026
J	Morison, IM; Cramer Borde, EM; Cheesman, EJ; Cheong, PL; Holyoake, AJ; Fichelson, S; Weeks, RJ; Lo, A; Davies, SMK; Wilbanks, SM; Fagerlund, RD; Ludgate, MW; Tatley, FMDS; Coker, MSA; Bockett, NA; Hughes, G; Pippig, DA; Smith, MP; Capron, C; Ledgerwood, EC				Morison, Ian M.; Cramer Borde, Elisabeth M.; Cheesman, Emma J.; Cheong, Pak Leng; Holyoake, Andrew J.; Fichelson, Serge; Weeks, Robert J.; Lo, Alexandra; Davies, Stefan M. K.; Wilbanks, Sigurd M.; Fagerlund, Robert D.; Ludgate, Mathew W.; Tatley, Fernanda M. da Silva; Coker, Melanie S. A.; Bockett, Nicholas A.; Hughes, Gillian; Pippig, Diana A.; Smith, Mark P.; Capron, Claude; Ledgerwood, Elizabeth C.			A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia	NATURE GENETICS			English	Article							PLATELET FORMATION; BONE-MARROW; MEGAKARYOCYTES; ACTIVATION	We report the first identified mutation in the gene encoding human cytochrome c (CYCS). Glycine 41, invariant throughout eukaryotes, is substituted by serine in a family with autosomal dominant thrombocytopenia caused by dysregulated platelet formation. The mutation yields a cytochrome c variant with enhanced apoptotic activity in vitro. Notably, the family has no other phenotypic indication of abnormal apoptosis, implying that cytochrome c activity is not a critical regulator of most physiological apoptosis.	[Morison, Ian M.; Cheesman, Emma J.; Cheong, Pak Leng; Weeks, Robert J.; Lo, Alexandra; Davies, Stefan M. K.; Wilbanks, Sigurd M.; Fagerlund, Robert D.; Ludgate, Mathew W.; Tatley, Fernanda M. da Silva; Coker, Melanie S. A.; Bockett, Nicholas A.; Hughes, Gillian; Pippig, Diana A.; Ledgerwood, Elizabeth C.] Univ Otago, Dept Biochem, Dunedin 9054, New Zealand; [Cramer Borde, Elisabeth M.; Capron, Claude] Univ Versailles, Fac Med Paris Ilede France Ouest, St Quentin en Yvelines, France; [Cramer Borde, Elisabeth M.; Fichelson, Serge; Capron, Claude] INSERM, Inst Cochin, U567, F-75014 Paris, France; [Holyoake, Andrew J.] Pacific Edge Biotechnol Ltd, Dunedin 9054, New Zealand; [Fichelson, Serge] Univ Paris 05, Inst Cochin, CNRS, UMR 8104,INSERM U567, Paris, France; [Smith, Mark P.] Caanterbury District Hlth Board, Christchurch 8140, New Zealand	University of Otago; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Morison, IM (corresponding author), Univ Otago, Dept Biochem, POB 56, Dunedin 9054, New Zealand.	ian.morison@otago.ac.nz	Cheong, Pak Leng/D-3603-2013; Ledgerwood, Elizabeth/M-3939-2018; Capron, Claude/AAJ-2710-2021; Holyoake, Andrew/H-9570-2013; Weeks, Robert J/A-6876-2012; Morison, Ian M/A-1236-2008	Cheong, Pak Leng/0000-0002-0095-4459; Ledgerwood, Elizabeth/0000-0002-4956-6043; Weeks, Robert J/0000-0003-0474-9089; Morison, Ian M/0000-0003-3616-0025; Cramer Borde, Elisabeth/0000-0001-7595-0885; Fagerlund, Robert/0000-0002-3939-1489; Bockett, Nicholas/0000-0002-7630-7637; Wilbanks, Sigurd/0000-0001-7565-8913				Banci L, 1999, J BIOL INORG CHEM, V4, P824, DOI 10.1007/s007750050356; Briggs C, 2004, BRIT J HAEMATOL, V126, P93, DOI 10.1111/j.1365-2141.2004.04987.x; Cooper C. E., 1995, BIOENERGETICS PRACTI, P85; Cramer EM, 1997, BLOOD, V89, P2336, DOI 10.1182/blood.V89.7.2336; de Botton S, 2002, BLOOD, V100, P1310, DOI 10.1182/blood-2002-03-0686; Ekert PG, 2005, CURR OPIN CELL BIOL, V17, P626, DOI 10.1016/j.ceb.2005.09.001; Finsterer J, 2004, EUR J NEUROL, V11, P163, DOI 10.1046/j.1351-5101.2003.00728.x; Hao ZY, 2005, CELL, V121, P579, DOI 10.1016/j.cell.2005.03.016; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Olteanu A, 2003, BIOCHEM BIOPH RES CO, V312, P733, DOI 10.1016/j.bbrc.2003.10.182; Sabri S, 2006, BLOOD, V108, P134, DOI 10.1182/blood-2005-03-1219; Sharonov GV, 2005, APOPTOSIS, V10, P797, DOI 10.1007/s10495-005-0366-9; Yu TN, 2001, J BIOL CHEM, V276, P13034, DOI 10.1074/jbc.M009773200	15	130	133	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2008	40	4					387	389		10.1038/ng.103	http://dx.doi.org/10.1038/ng.103			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18345000				2022-12-27	WOS:000254388100006
J	Lee, I; Lehner, B; Crombie, C; Wong, W; Fraser, AG; Marcotte, EM				Lee, Insuk; Lehner, Ben; Crombie, Catriona; Wong, Wendy; Fraser, Andrew G.; Marcotte, Edward M.			A single gene network accurately predicts phenotypic effects of gene perturbation in Caenorhabditis elegans	NATURE GENETICS			English	Article							PROTEIN INTERACTION NETWORK; ENHANCED RNA INTERFERENCE; GENOME-WIDE PREDICTION; C-ELEGANS; SACCHAROMYCES-CEREVISIAE; INTERACTION DATASETS; FUNCTIONAL LINKAGES; LIFE-SPAN; DATABASE; YEAST	The fundamental aim of genetics is to understand how an organism's phenotype is determined by its genotype, and implicit in this is predicting how changes in DNA sequence alter phenotypes. A single network covering all the genes of an organism might guide such predictions down to the level of individual cells and tissues. To validate this approach, we computationally generated a network covering most C. elegans genes and tested its predictive capacity. Connectivity within this network predicts essentiality, identifying this relationship as an evolutionarily conserved biological principle. Critically, the network makes tissue-specific predictions-we accurately identify genes for most systematically assayed loss-of-function phenotypes, which span diverse cellular and developmental processes. Using the network, we identify 16 genes whose inactivation suppresses defects in the retinoblastoma tumor suppressor pathway, and we successfully predict that the dystrophin complex modulates EGF signaling. We conclude that an analogous network for human genes might be similarly predictive and thus facilitate identification of disease genes and rational therapeutic targets.	[Lehner, Ben; Crombie, Catriona; Wong, Wendy; Fraser, Andrew G.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Lee, Insuk; Marcotte, Edward M.] Univ Texas Austin, Inst Mol & Cellular Biol, Dept Chem & Biochem, Ctr Syst Synthet Biol, Austin, TX 78712 USA; [Lehner, Ben] Univ Pompeu Fabra, Ctr Genom Regulat, ICREA, Barcelona 08003, Spain; [Lehner, Ben] Univ Pompeu Fabra, EMBL, CRG, Syst Biol Unit, Barcelona 08003, Spain	Wellcome Trust Sanger Institute; University of Texas System; University of Texas Austin; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL)	Fraser, AG (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	agf@sanger.ac.uk; marcotte@icmb.utexas.edu	Lehner, Ben/L-3413-2014; Lee, Insuk/F-7722-2010; Lehner, Ben/ABH-6562-2020	Lehner, Ben/0000-0002-8817-1124; Lehner, Ben/0000-0002-8817-1124; Marcotte, Edward/0000-0001-8808-180X; Fraser, Andrew/0000-0001-9939-6014	ICREA Funding Source: Custom; NIGMS NIH HHS [GM06779-01] Funding Source: Medline; Wellcome Trust Funding Source: Medline	ICREA(ICREA); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bowers PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r35; Chen XH, 2005, CAN J STAT, V33, P389, DOI 10.1002/cjs.5540330306; Chen Y, 2004, NUCLEIC ACIDS RES, V32, P6414, DOI 10.1093/nar/gkh978; Chockalingam PS, 2002, AM J PHYSIOL-CELL PH, V283, pC500, DOI 10.1152/ajpcell.00529.2001; Cui MX, 2006, PLOS GENET, V2, P719, DOI 10.1371/journal.pgen.0020074; Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056; Date SV, 2003, NAT BIOTECHNOL, V21, P1055, DOI 10.1038/nbt861; Deplancke B, 2006, CELL, V125, P1193, DOI 10.1016/j.cell.2006.04.038; EFRON B, 1993, INTRO BOOTSTRAP, V439; Eppig JT, 2005, NUCLEIC ACIDS RES, V33, pD471, DOI 10.1093/nar/gki113; Famili I, 2003, P NATL ACAD SCI USA, V100, P13134, DOI 10.1073/pnas.2235812100; Gandhi TKB, 2006, NAT GENET, V38, P285, DOI 10.1038/ng1747; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gollub J, 2003, NUCLEIC ACIDS RES, V31, P94, DOI 10.1093/nar/gkg078; Gunsalus KC, 2005, NATURE, V436, P861, DOI 10.1038/nature03876; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hansen M, 2005, PLOS GENET, V1, P119, DOI 10.1371/journal.pgen.0010017; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000988; Lehner B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-r4; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Lund J, 2002, CURR BIOL, V12, P1566, DOI 10.1016/S0960-9822(02)01146-6; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Ramani AK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-5-R40; Reinke V, 2000, MOL CELL, V6, P605, DOI 10.1016/S1097-2765(00)00059-9; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Romagnolo B, 2002, DEV BIOL, V247, P127, DOI 10.1006/dbio.2002.0692; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Segal SS, 2005, MICROCIRCULATION, V12, P1, DOI 10.1080/10739680590907114; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; SUNDARAM MV, 2005, WORMBOOK, V1; Troyanskaya OG, 2003, P NATL ACAD SCI USA, V100, P8348, DOI 10.1073/pnas.0832373100; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Walker M G, 1999, Proc Int Conf Intell Syst Mol Biol, P282; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Wang J, 2003, DEVELOPMENT, V130, P1621, DOI 10.1242/dev.00363; Yochem J, 1997, MOL CELL BIOL, V17, P2716, DOI 10.1128/MCB.17.5.2716; Zhong WW, 2006, SCIENCE, V311, P1481, DOI 10.1126/science.1123287	50	225	229	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					181	188		10.1038/ng.2007.70	http://dx.doi.org/10.1038/ng.2007.70			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18223650				2022-12-27	WOS:000252732900016
J	Sekita, Y; Wagatsuma, H; Nakamura, K; Ono, R; Kagami, M; Wakisaka, N; Hino, T; Suzuki-Migishima, R; Kohda, T; Ogura, A; Ogata, T; Yokoyama, M; Kaneko-Ishino, T; Ishino, F				Sekita, Yoichi; Wagatsuma, Hirotaka; Nakamura, Kenji; Ono, Ryuichi; Kagami, Masayo; Wakisaka, Noriko; Hino, Toshiaki; Suzuki-Migishima, Rika; Kohda, Takashi; Ogura, Atsuo; Ogata, Tsutomu; Yokoyama, Minesuke; Kaneko-Ishino, Tomoko; Ishino, Fumitoshi			Role of retrotransposon-derived imprinted gene, Rtl1, in the feto-maternal interface of mouse placenta	NATURE GENETICS			English	Article							TRANSPOSABLE ELEMENTS; UNIPARENTAL DISOMY; JUNK DNA; MICE; MOUSE-CHROMOSOME-12; CHROMOSOME-12; EXPRESSION; EVOLUTION; SYNCYTIN; MAMMALS	Eutherian placenta, an organ that emerged in the course of mammalian evolution, provides essential architecture, the so-called feto-maternal interface, for fetal development by exchanging nutrition, gas and waste between fetal and maternal blood. Functional defects of the placenta cause several developmental disorders, such as intrauterine growth retardation in humans and mice. A series of new inventions and/ or adaptations must have been necessary to form and maintain eutherian chorioallantoic placenta, which consists of capillary endothelial cells and a surrounding trophoblast cell layer(s)(1). Although many placental genes have been identified(2), it remains unknown how the feto-maternal interface is formed and maintained during development, and how this novel design evolved. Here we demonstrate that retrotransposon-derived Rtl1 (retrotransposon-like 1), also known as Peg11 (paternally expressed 11), is essential for maintenance of the fetal capillaries, and that both its loss and its overproduction cause late-fetal and/or neonatal lethality in mice.	[Wakisaka, Noriko; Kaneko-Ishino, Tomoko] Tokai Univ, Sch Hlth Sci, Kanagawa 2591193, Japan; [Sekita, Yoichi; Ono, Ryuichi; Wakisaka, Noriko; Kohda, Takashi; Ishino, Fumitoshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Epigenet, Chiyoda Ku, Tokyo 1010062, Japan; [Wagatsuma, Hirotaka] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 2268501, Japan; [Nakamura, Kenji; Hino, Toshiaki; Suzuki-Migishima, Rika; Yokoyama, Minesuke] Mitsubishi Kagaku Inst Life Sci, Tokyo 1948511, Japan; [Kagami, Masayo; Ogata, Tsutomu] Natl Res Inst Child Hlth & Dev, Dept Endocrinol & Metab, Setagaya Ku, Tokyo 1578535, Japan; [Ogura, Atsuo] RIKEN, Bioresource Ctr, Tsukuba, Ibaraki 3050074, Japan	Tokai University; Tokyo Medical & Dental University (TMDU); Tokyo Institute of Technology; Mitsubishi Kagaku Institute of Life Sciences (MITILS); National Center for Child Health & Development - Japan; RIKEN	Kaneko-Ishino, T (corresponding author), Tokai Univ, Sch Hlth Sci, Kanagawa 2591193, Japan.	tkanekoi@is.icc.u-tokai.ac.jp; fishino.epgn@mri.tmd.ac.jp	Ogura, Atsuo/J-3916-2014; Ishino（Kaneko-Ishino）, Tomoko/AGY-0742-2022; Kohda, Takashi/C-2879-2014	Ogura, Atsuo/0000-0003-0447-1988; Kagami, Masayo/0000-0003-3020-455X; Ogata, Tsutomu/0000-0001-7178-9991; SEKITA, YOICHI/0000-0002-6230-8719; Kohda, Takashi/0000-0002-6856-5601				Angiolini E, 2006, PLACENTA, V27, pS98, DOI 10.1016/j.placenta.2005.12.008; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Biemont C, 2006, NATURE, V443, P521, DOI 10.1038/443521a; Brandt J, 2005, GENE, V345, P101, DOI 10.1016/j.gene.2004.11.022; BROSIUS J, 1992, P NATL ACAD SCI USA, V89, P10706, DOI 10.1073/pnas.89.22.10706; Butler M, 2001, J MOL EVOL, V52, P260, DOI 10.1007/s002390010154; CATTANACH BM, 1993, MOUSE GENOME, V91, P858; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Dupressoir A, 2005, P NATL ACAD SCI USA, V102, P725, DOI 10.1073/pnas.0406509102; Georgiades P, 2000, DEVELOPMENT, V127, P4719; Georgiades P, 2001, P NATL ACAD SCI USA, V98, P4522, DOI 10.1073/pnas.081540898; GOULD SJ, 1982, PALEOBIOLOGY, V8, P4, DOI 10.1017/S0094837300004310; Hernandez A, 2006, J CLIN INVEST, V116, P476, DOI 10.1172/JCI26240; KAGAMI M, 2008, NAT GENET       0106; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Lynch C, 2003, CURR BIOL, V13, P1518, DOI 10.1016/S0960-9822(03)00618-3; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Ono R, 2006, NAT GENET, V38, P101, DOI 10.1038/ng1699; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sekita Y, 2006, CYTOGENET GENOME RES, V113, P223, DOI 10.1159/000090836; Sibley CP, 2004, P NATL ACAD SCI USA, V101, P8204, DOI 10.1073/pnas.0402508101; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Tevendale M, 2006, CYTOGENET GENOME RES, V113, P215, DOI 10.1159/000090835; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; Youngson NA, 2005, J MOL EVOL, V61, P481, DOI 10.1007/s00239-004-0332-0	30	225	234	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					243	248		10.1038/ng.2007.51	http://dx.doi.org/10.1038/ng.2007.51			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18176565				2022-12-27	WOS:000252732900025
J	Plenge, RM; Cotsapas, C; Davies, L; Price, AL; Bakker, PIW; Maller, J; Pe'er, I; Burtt, NP; Blumenstiel, B; DeFelice, M; Parkin, M; Barry, R; Winslow, W; Healy, C; Graham, RR; Neale, BM; Izmailova, E; Roubenoff, R; Parker, AN; Glass, R; Karlson, EW; Maher, N; Hafler, DA; Lee, DM; Seldin, MF; Remmers, EF; Lee, AT; Padyukov, L; Alfredsson, L; Coblyn, J; Weinblatt, ME; Gabriel, SB; Purcell, S; Klareskog, L; Gregersen, PK; Shadick, NA; Daly, MJ; Altshuler, D				Plenge, Robert M.; Cotsapas, Chris; Davies, Leela; Price, Alkes L.; Bakker, Paul I. Wde; Maller, Julian; Pe'er, Itsik; Burtt, Noel P.; Blumenstiel, Brendan; DeFelice, Matt; Parkin, Melissa; Barry, Rachel; Winslow, Wendy; Healy, Claire; Graham, Robert R.; Neale, Benjamin M.; Izmailova, Elena; Roubenoff, Ronenn; Parker, Alexander N.; Glass, Roberta; Karlson, Elizabeth W.; Maher, Nancy; Hafler, David A.; Lee, David M.; Seldin, Michael F.; Remmers, Elaine F.; Lee, Annette T.; Padyukov, Leonid; Alfredsson, Lars; Coblyn, Jonathan; Weinblatt, Michael E.; Gabriel, Stacey B.; Purcell, Shaun; Klareskog, Lars; Gregersen, Peter K.; Shadick, Nancy A.; Daly, Mark J.; Altshuler, David			Two independent alleles at 6q23 associated with risk of rheumatoid arthritis	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; POPULATION-STRUCTURE; STRATIFICATION; VARIANT	To identify susceptibility alleles associated with rheumatoid arthritis, we genotyped 397 individuals with rheumatoid arthritis for 116,204 SNPs and carried out an association analysis in comparison to publicly available genotype data for 1,211 related individuals from the Framingham Heart Study(1). After evaluating and adjusting for technical and population biases, we identified a SNP at 6q23 ( rs10499194, similar to 150 kb from TNFAIP3 and OLIG3) that was reproducibly associated with rheumatoid arthritis both in the genome-wide association ( GWA) scan and in 5,541 additional case-control samples (P = 10(-3), GWA scan; P < 10(-6), replication; P = 10(-9), combined). In a concurrent study, the Wellcome Trust Case Control Consortium ( WTCCC) has reported strong association of rheumatoid arthritis susceptibility to a different SNP located 3.8 kb from rs10499194 ( rs6920220; P = 5 x 10(-6) in WTCCC)(2). We show that these two SNP associations are statistically independent, are each reproducible in the comparison of our data and WTCCC data, and define risk and protective haplotypes for rheumatoid arthritis at 6q23.	MIT, Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; Brigham & Womens Hosp, Harvard Med Sch, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; Massachusetts Gen Hosp, Harvard Med Sch, Dept Med, Ctr Human Genet Res, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Biol Mol, Boston, MA 02115 USA; Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; Columbia Univ, Dept Comp Sci, New York, NY 10027 USA; Coll London, London SE5 8AF, England; Millennium Pharmaceut Inc, Cambridge, MA 02139 USA; Brigham & Womens Hosp, Harvard Med Sch, Ctr Neurol Dis, Boston, MA 02115 USA; Univ Calif Davis, Rowe Program Genet, Davis, CA 95616 USA; NIAMSD, NIH, Genet Genom Branch, Bethesda, MD 20892 USA; N Shore Long Island Hlth Syst, Feinstein Inst Med Res, Manhasset, NY 11030 USA; Karilinska Univ Hosp Solna, Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Columbia University; University of London; University College London; Takeda Pharmaceutical Company Ltd; Millennium Pharmaceuticals; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of California System; University of California Davis; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Northwell Health; Karolinska Institutet; Karolinska Institutet	Plenge, RM (corresponding author), MIT, Broad Inst Harvard, Program Med & Populat Genet, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	rplenge@partners.org	Daly, Mark J/B-2453-2017; Altshuler, David M/A-4476-2009; maller, julian B/A-9323-2009; Padyukov, Leonid/A-4890-2009; de Bakker, Paul IW/B-8730-2009; Alfredsson, Lars/AAC-9007-2019	Daly, Mark J/0000-0002-0949-8752; Altshuler, David M/0000-0002-7250-4107; Padyukov, Leonid/0000-0003-2950-5670; de Bakker, Paul IW/0000-0001-7735-7858; Alfredsson, Lars/0000-0003-1688-6697; Izmailova, Elena/0000-0002-7150-1748; Maller, Julian/0000-0002-1565-9559; Healy, Claire M/0000-0001-7940-4611; Remmers, Elaine F/0000-0002-9522-1249; Roubenoff, Ronenn/0000-0002-3959-3179; Klareskog, Lars/0000-0001-9601-6186; Cotsapas, Chris/0000-0002-7772-5910	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI055314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [N01AR022263, R01AR044422, Z01AR041139] Funding Source: NIH RePORTER; NIAID NIH HHS [K08 AI055314-01A1, K08 AI055314, K08 AI055314-02, K08 AI055314-05, K08 AI055314-03, K08 AI055314-04, AI55314-3] Funding Source: Medline; NIAMS NIH HHS [N01-AR-2-2263, R01 AR044422, R01-AR44422] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; ELLIOTT MJ, 1994, LANCET, V344, P1105, DOI 10.1016/S0140-6736(94)90628-9; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Irigoyen P, 2005, ARTHRITIS RHEUM-US, V52, P3813, DOI 10.1002/art.21419; Jawaheer D, 2004, ARTHRITIS RHEUM-US, V50, P736, DOI 10.1002/art.20066; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; Muller T, 2005, GENE DEV, V19, P733, DOI 10.1101/gad.326105; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell S, 2007, BIOINFORMATICS, V23, P255, DOI 10.1093/bioinformatics/btl580; Sato M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1921; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; Stolt P, 2003, ANN RHEUM DIS, V62, P835, DOI 10.1136/ard.62.9.835; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	28	439	456	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2007	39	12					1477	1482		10.1038/ng.2007.27	http://dx.doi.org/10.1038/ng.2007.27			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	17982456	Green Accepted			2022-12-27	WOS:000251267400015
J	Gerdes, JM; Liu, Y; Zaghloul, NA; Leitch, CC; Lawson, SS; Kato, M; Beachy, PA; Beales, PL; Demartino, GN; Fisher, S; Badano, JL; Katsanis, N				Gerdes, Jantje M.; Liu, Yangfan; Zaghloul, Norann A.; Leitch, Carmen C.; Lawson, Shaneka S.; Kato, Masaki; Beachy, Philip A.; Beales, Philip L.; Demartino, George N.; Fisher, Shannon; Badano, Jose L.; Katsanis, Nicholas			Disruption of the basal body comprises proteasomal function and perturbs intracellular Wnt response	NATURE GENETICS			English	Article							BARDET-BIEDL-SYNDROME; PLANAR CELL POLARITY; INTRAFLAGELLAR TRANSPORT PROTEINS; NEURAL-TUBE DEFECTS; BETA-CATENIN; LOOP-TAIL; TRANSCRIPTION FACTORS; CONVERGENT EXTENSION; SIGNALING PATHWAYS; MOUSE	Primary cilia and basal bodies are evolutionarily conserved organelles that mediate communication between the intracellular and extracellular environments. Here we show that bbs1, bbs4 and mkks ( also known as bbs6), which encode basal body proteins, are required for convergence and extension in zebrafish and interact with wnt11 and wnt5b. Suppression of bbs1, bbs4 and mkks transcripts results in stabilization of beta-catenin with concomitant upregulation of T-cell factor ( TCF)-dependent transcription in both zebrafish embryos and mammalian ciliated cells, a defect phenocopied by the silencing of the axonemal kinesin subunit KIF3A but not by chemical disruption of the cytoplasmic microtubule network. These observations are attributable partly to defective degradation by the proteasome; suppression of BBS4 leads to perturbed proteasomal targeting and concomitant accumulation of cytoplasmic beta-catenin. Cumulatively, our data indicate that the basal body is an important regulator of Wnt signal interpretation through selective proteolysis and suggest that defects in this system may contribute to phenotypes pathognomonic of human ciliopathies.	Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; Stanford Univ, Sch Med, Howard Hughes Med Inst, Inst Stem Cell Biol & Regenerat Med,Dept Dev Biol, Stanford, CA 94305 USA; UCL, Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; Univ Texas, Southwestern Med Ctr, Dept Physiol, Dallas, TX 75390 USA; Inst Pasteur, Montevideo, Uruguay; Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Stanford University; University of London; University College London; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine	Katsanis, N (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA.	katsanis@jhmi.edu	Katsanis, Nicholas/E-1837-2012; Masaki, Kato/AAW-2603-2020; Beales, Philip L/C-7367-2009; Fisher, Shannon/K-7351-2012; Gerdes, Jantje Mareike/M-9868-2014; lawson, shaneka/AAV-1569-2021	Gerdes, Jantje Mareike/0000-0001-6885-5441; Katsanis, Nicholas/0000-0002-2480-0171; Badano, Jose/0000-0002-0706-8652	Medical Research Council [G0801843] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Badano JL, 2006, NATURE, V439, P326, DOI 10.1038/nature04370; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Chiang AP, 2006, P NATL ACAD SCI USA, V103, P6287, DOI 10.1073/pnas.0600158103; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Davis EE, 2006, DEV CELL, V11, P9, DOI 10.1016/j.devcel.2006.06.009; DeMartino GN, 2005, METHOD ENZYMOL, V398, P295, DOI 10.1016/S0076-6879(05)98024-5; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; DEVERAUX Q, 1995, J BIOL CHEM, V270, P23726, DOI 10.1074/jbc.270.40.23726; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Greene NDE, 1998, MECH DEVELOP, V73, P59, DOI 10.1016/S0925-4773(98)00029-X; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; ITOH K, 2005, J BIOL, V4, P1; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Keller R, 2002, SCIENCE, V298, P1950, DOI 10.1126/science.1079478; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kibar Z, 2001, GENOMICS, V72, P331, DOI 10.1006/geno.2000.6493; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Marlow F, 2004, DEVELOPMENT, V131, P203, DOI 10.1242/dev.00915; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Nojima H, 2004, MECH DEVELOP, V121, P371, DOI 10.1016/j.mod.2004.02.003; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; OLSON DJ, 1994, CELL GROWTH DIFFER, V5, P197; ROSENBAUM JL, 1967, J CELL BIOL, V34, P345, DOI 10.1083/jcb.34.1.345; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Slusarski DC, 1997, NATURE, V390, P410, DOI 10.1038/37138; THISSE C, 1993, DEVELOPMENT, V119, P1203; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Torban E, 2004, TRENDS GENET, V20, P570, DOI 10.1016/j.tig.2004.09.003; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Wessely O, 2001, DEV BIOL, V234, P161, DOI 10.1006/dbio.2001.0258; Wigley WC, 1999, J CELL BIOL, V145, P481; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498	50	309	318	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2007	39	11					1350	1360		10.1038/ng.2007.12	http://dx.doi.org/10.1038/ng.2007.12			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17906624				2022-12-27	WOS:000250575900019
J	Delous, M; Baala, L; Salomon, R; Laclef, C; Vierkotten, J; Tory, K; Golzio, C; Lacoste, T; Besse, L; Ozilou, C; Moutkine, I; Hellman, NE; Anselme, I; Silbermann, F; Vesque, C; Gerhardt, C; Rattenberry, E; Wolf, MTF; Gubler, MC; Martinovic, J; Encha-Razavi, F; Boddaert, N; Gonzales, M; Macher, MA; Nivet, H; Champion, G; Bertheleme, JP; Niaudet, P; McDonald, F; Hildebrandt, F; Johnson, CA; Vekemans, M; Antignac, C; Ruther, U; Schneider-Maunoury, S; Attie-Bitach, T; Saunier, S				Delous, Marion; Baala, Lekbir; Salomon, Remi; Laclef, Christine; Vierkotten, Jeanette; Tory, Kalman; Golzio, Christelle; Lacoste, Tiphanie; Besse, Laurianne; Ozilou, Catherine; Moutkine, Imane; Hellman, Nathan E.; Anselme, Isabelle; Silbermann, Flora; Vesque, Christine; Gerhardt, Christoph; Rattenberry, Eleanor; Wolf, Matthias T. F.; Gubler, Marie Claire; Martinovic, Jelena; Encha-Razavi, Ferechte; Boddaert, Nathalie; Gonzales, Marie; Macher, Marie Alice; Nivet, Hubert; Champion, Gerard; Bertheleme, Jean Pierre; Niaudet, Patrick; McDonald, Fiona; Hildebrandt, Friedhelm; Johnson, Colin A.; Vekemans, Michel; Antignac, Corinne; Ruether, Ulrich; Schneider-Maunoury, Sylvie; Attie-Bitach, Tania; Saunier, Sophie			The ciliary gene RPGRIP1L is mutated in cerebello-oculo-renal syndrome (Joubert syndrome type B) and Meckel syndrome	NATURE GENETICS			English	Article							LEBER CONGENITAL AMAUROSIS; MUTANT FUSED-TOES; JUVENILE NEPHRONOPHTHISIS; CENTROSOMAL PROTEIN; MUTATIONS; MOUSE; NPHP1; NEPHROCYSTIN-4; ENCODES; CILIUM	Cerebello- oculo- renal syndrome ( CORS), also called Joubert syndrome type B, and Meckel ( MKS) syndrome belong to the group of developmental autosomal recessive disorders that are associated with primary cilium dysfunction. Using SNP mapping, we identified missense and truncating mutations in RPGRIP1L ( KIAA1005) in both CORS and MKS, and we show that inactivation of the mouse ortholog Rpgrip1l ( Ftm) recapitulates the cerebral, renal and hepatic defects of CORS and MKS. In addition, we show that RPGRIP1L colocalizes at the basal body and centrosomes with the protein products of both NPHP6 and NPHP4, known genes associated with MKS, CORS and nephronophthisis ( a related renal disorder and ciliopathy). In addition, the RPGRIP1L missense mutations found in CORS individuals diminishes the interaction between RPGRIP1L and nephrocystin- 4. Our findings show that mutations in RPGRIP1L can cause the multiorgan phenotypic abnormalities found in CORS or MKS, which therefore represent a continuum of the same underlying disorder.	INSERM, Hop Necker Enfants Malad, U574, F-75015 Paris, France; Univ Paris 05, F-75006 Paris, France; Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France; Hop Necker Enfants Malad, APHP, F-75015 Paris, France; CNRS, UMR7622, Dev Biol Lab, F-75005 Paris, France; Univ Paris 06, F-75005 Paris, France; Univ Dusseldorf, Inst Entwicklungs & Mol Biol Tiere, EMT, D-40225 Dusseldorf, Germany; Hop Necker Enfants Malad, APHP, Dept Genet, F-75015 Paris, France; Womens Hosp Med Ctr, W Midlands Reg Genet, Birmingham B15 2TG, W Midlands, England; Univ Michigan, Dept Pediat & Human Genet, Ann Arbor, MI 48109 USA; Hop Necker Enfants Malad, F-75015 Paris, France; Hop Trousseau, Dept Foetopathol, F-75012 Paris, France; Hop Robert Debre, APHP, Dept Pediat, F-75019 Paris, France; CHU Bretonneau, Dept Nephrol & Clin Immunol, F-37000 Tours, France; CHU Angers, Dept Pediat Nephrol, F-49100 Angers, France; Ctr Perharidy, F-29680 Roscoff, France; St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds LS9 7TF, W Yorkshire, England	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Heinrich Heine University Dusseldorf; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Birmingham Women's Hospital; University of Michigan System; University of Michigan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Tours; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Saint James's University Hospital; University of Leeds	Saunier, S (corresponding author), INSERM, Hop Necker Enfants Malad, U574, F-75015 Paris, France.	saunier@necker.fr	ANTIGNAC, Corinne/H-8945-2017; Vesque, Christine/L-9839-2017; Gerhardt, Christoph/AAO-4596-2020; ATTIE-BITACH, Tania/K-1453-2017; Delous, Marion/H-3850-2017; Schneider-Maunoury, Sylvie/K-6795-2017; boddaert, nathalie/GWV-2865-2022; Saunier, Sophie/G-6044-2015; Delous, Marion/Q-1835-2019; Vesque, Christine/Q-8461-2019	ANTIGNAC, Corinne/0000-0002-9934-4940; Gerhardt, Christoph/0000-0002-6340-549X; ATTIE-BITACH, Tania/0000-0002-1155-3626; Delous, Marion/0000-0003-2666-4457; Schneider-Maunoury, Sylvie/0000-0002-0797-4735; Saunier, Sophie/0000-0002-1069-0047; Delous, Marion/0000-0003-2666-4457; boddaert, nathalie/0000-0003-0991-7774; Gubler, Marie-Claire/0000-0002-3526-5661; Vesque, Christine/0000-0001-7983-4953; Golzio, Christelle/0000-0002-4420-3921; legendre, flora/0000-0002-4149-1913	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068306] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK068306] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Anselme I, 2007, DEV BIOL, V304, P208, DOI 10.1016/j.ydbio.2006.12.025; BAALA L, IN PRESS AM J HUM GE; Baala L, 2007, AM J HUM GENET, V80, P186, DOI 10.1086/510499; Betz R, 2000, J PEDIATR-US, V136, P828, DOI 10.1067/mpd.2000.106225; Blacque OE, 2005, CURR BIOL, V15, P935, DOI 10.1016/j.cub.2005.04.059; Caridi G, 2006, KIDNEY INT, V70, P1342, DOI 10.1038/sj.ki.5001768; Chen DH, 2001, BIOCHEM BIOPH RES CO, V280, P99, DOI 10.1006/bbrc.2000.4087; Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459; Dryja TP, 2001, AM J HUM GENET, V68, P1295, DOI 10.1086/320113; Espinosa-Parrilla Y, 2002, MECH DEVELOP, V114, P187, DOI 10.1016/S0925-4773(02)00062-X; Ferland RJ, 2004, NAT GENET, V36, P1008, DOI 10.1038/ng1419; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; JOUBERT M, 1969, NEUROLOGY, V19, P813, DOI 10.1212/WNL.19.9.813; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Kyttala M, 2006, NAT GENET, V38, P155, DOI 10.1038/ng1714; Mollet G, 2005, HUM MOL GENET, V14, P645, DOI 10.1093/hmg/ddi061; Mollet G, 2002, NAT GENET, V32, P300, DOI 10.1038/ng996; Otto EA, 2003, NAT GENET, V34, P413, DOI 10.1038/ng1217; Parisi MA, 2004, AM J HUM GENET, V75, P82, DOI 10.1086/421846; Patel S, 2002, AM J NEURORADIOL, V23, P1074; Roepman R, 2005, P NATL ACAD SCI USA, V102, P18520, DOI 10.1073/pnas.0505774102; Saar K, 1999, AM J HUM GENET, V65, P1666, DOI 10.1086/302655; Saunier S, 2005, CURR OPIN GENET DEV, V15, P324, DOI 10.1016/j.gde.2005.04.012; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Smith A., 1996, Managing Information, V3, P38; Tory K, 2007, J AM SOC NEPHROL, V18, P1566, DOI 10.1681/ASN.2006101164; Valente EM, 2003, AM J HUM GENET, V73, P663, DOI 10.1086/378241; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; VANDERHOEVEN F, 1994, DEVELOPMENT, V120, P2601; Watnick T, 2003, NAT GENET, V34, P355, DOI 10.1038/ng0803-355	30	351	356	2	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2007	39	7					875	881		10.1038/ng2039	http://dx.doi.org/10.1038/ng2039			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17558409				2022-12-27	WOS:000247619800018
J	Wu, S; Ying, G; Wu, Q; Capecchi, MR				Wu, Sen; Ying, Guoxin; Wu, Qiang; Capecchi, Mario R.			Toward simpler and faster genome-wide mutagenesis in mice	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; GAMMA-PROTOCADHERINS; CHROMOSOME REARRANGEMENTS; DROSOPHILA-MELANOGASTER; DEVELOPMENTAL GENES; SPINAL-CORD; MOUSE; PIGGYBAC; TRANSPOSON; DISRUPTION	Here we describe a practical Cre- loxP and piggyBac transposon - based mutagenesis strategy to systematically mutate coding sequences and/ or the vast noncoding regions of the mouse genome for large- scale functional genomic analysis. To illustrate this approach, we first created loxP- containing loss-of-function alleles in the protocadherin alpha, beta and gamma gene clusters ( Pcdha, Pcdhb and Pcdhg). Using these alleles, we show that, under proper guidance, Cre- loxP site- specific recombination can mediate efficient trans- allelic recombination in vivo, facilitating the generation of large germline deletions and duplications including deletions of Pcdha, and Pcdha to Pcdhb, simply by breeding ( that is, at frequencies of 5.5% - 21.6%). The same breeding method can also generate designed germline translocations between nonhomologous chromosomes at unexpected frequencies of greater than 1%. By incorporating a piggyBac transposon to insert and to distribute loxP sites randomly throughout the mouse genome, we present a simple but comprehensive method for generating genome-wide deletions and duplications, in addition to insertional loss-of-function and conditional rescue alleles, again simply by breeding.	Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Capecchi, MR (corresponding author), Univ Utah, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA.	mario.capecchi@genetics.utah.edu	Wilson, Matthew H/K-3193-2013; Wu, Qiang/A-6751-2009	Wu, Qiang/0000-0003-3841-3591				Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Auwerx J, 2004, NAT GENET, V36, P925, DOI 10.1038/ng0904-925; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bejerano G, 2004, BIOINFORMATICS, V20, P40, DOI 10.1093/bioinformatics/bth946; Boffelli D, 2004, NAT REV GENET, V5, P456, DOI 10.1038/nrg1350; Bonin CP, 2004, GENETICS, V167, P1801, DOI 10.1534/genetics.104.027557; Boulet AM, 2004, DEVELOPMENT, V131, P299, DOI 10.1242/dev.00936; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; CARY LC, 1989, VIROLOGY, V172, P156, DOI 10.1016/0042-6822(89)90117-7; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; DeChiara TM, 2000, NAT GENET, V24, P271, DOI 10.1038/73488; Dermitzakis ET, 2005, NAT REV GENET, V6, P151, DOI 10.1038/nrg1527; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; DRACOPOLI NC, 2006, CURRENT PROTOCOL HUM; Economides KD, 2003, DEV BIOL, V256, P317, DOI 10.1016/S0012-1606(02)00137-9; Forster A, 2003, CANCER CELL, V3, P449, DOI 10.1016/S1535-6108(03)00106-5; Fraser MJ, 1996, INSECT MOL BIOL, V5, P141, DOI 10.1111/j.1365-2583.1996.tb00048.x; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Genoud N, 2004, P NATL ACAD SCI USA, V101, P4198, DOI 10.1073/pnas.0400131101; Golic KG, 1996, GENETICS, V144, P1693; Hambsch B, 2005, J BIOL CHEM, V280, P15888, DOI 10.1074/jbc.M414359200; Handler AM, 2001, INSECT BIOCHEM MOLEC, V31, P199, DOI 10.1016/S0965-1748(00)00119-3; Herault Y, 1998, NAT GENET, V20, P381, DOI 10.1038/3861; Jung JY, 2003, AM J PHYSIOL-RENAL, V285, pF1210, DOI 10.1152/ajprenal.00111.2003; Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189; Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Li X, 2005, INSECT MOL BIOL, V14, P17, DOI 10.1111/j.1365-2583.2004.00525.x; Liu PT, 2002, NAT GENET, V30, P66, DOI 10.1038/ng788; Margulies EH, 2005, P NATL ACAD SCI USA, V102, P3354, DOI 10.1073/pnas.0408539102; Mills AA, 2001, TRENDS GENET, V17, P331, DOI 10.1016/S0168-9525(01)02321-6; Phillips GR, 2003, J NEUROSCI, V23, P5096; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Schmidt EE, 2000, P NATL ACAD SCI USA, V97, P13702, DOI 10.1073/pnas.240471297; Spitz F, 2005, NAT GENET, V37, P889, DOI 10.1038/ng1597; Tang SHE, 2002, GENESIS, V32, P199, DOI 10.1002/gene.10030; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Vavouri T, 2006, TRENDS GENET, V22, P5, DOI 10.1016/j.tig.2005.10.005; Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5; Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101; Wu Q, 2001, GENOME RES, V11, P389, DOI 10.1101/gr.167301; Wu Q, 2005, GENETICS, V169, P2179, DOI 10.1534/genetics.104.037606; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Zakany J, 1999, NATURE, V401, P761, DOI 10.1038/44511; Zheng BH, 2000, MOL CELL BIOL, V20, P648, DOI 10.1128/MCB.20.2.648-655.2000; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	47	112	125	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39	7					922	930		10.1038/ng2060	http://dx.doi.org/10.1038/ng2060			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17572674				2022-12-27	WOS:000247619800025
J	Gudmundsson, J; Sulem, P; Manolescu, A; Amundadottir, LT; Gudbjartsson, D; Helgason, A; Rafnar, T; Bergthorsson, JT; Agnarsson, BA; Baker, A; Sigurdsson, A; Benediktsdottir, KR; Jakobsdottir, M; Xu, JF; Blondal, T; Kostic, J; Sun, JL; Ghosh, S; Stacey, SN; Mouy, M; Saemundsdottir, J; Backman, VM; Kristjansson, K; Tres, A; Partin, AW; Albers-Akkers, MT; Marcos, JGI; Walsh, PC; Swinkels, DW; Navarrete, S; Isaacs, SD; Aben, KK; Graif, T; Cashy, J; Ruiz-Echarri, M; Wiley, KE; Suarez, BK; Witjes, JA; Frigge, M; Ober, C; Jonsson, E; Einarsson, GV; Mayordomo, JI; Kiemeney, LA; Isaacs, WB; Catalona, WJ; Barkardottir, RB; Gulcher, JR; Thorsteinsdottir, U; Kong, A; Stefansson, K				Gudmundsson, Julius; Sulem, Patrick; Manolescu, Andrei; Amundadottir, Laufey T.; Gudbjartsson, Daniel; Helgason, Agnar; Rafnar, Thorunn; Bergthorsson, Jon T.; Agnarsson, Bjarni A.; Baker, Adam; Sigurdsson, Asgeir; Benediktsdottir, Kristrun R.; Jakobsdottir, Margret; Xu, Jianfeng; Blondal, Thorarinn; Kostic, Jelena; Sun, Jielin; Ghosh, Shyamali; Stacey, Simon N.; Mouy, Magali; Saemundsdottir, Jona; Backman, Valgerdur M.; Kristjansson, Kristleifur; Tres, Alejandro; Partin, Alan W.; Albers-Akkers, Marjo T.; Marcos, Javier Godino-Ivan; Walsh, Patrick C.; Swinkels, Dorine W.; Navarrete, Sebastian; Isaacs, Sarah D.; Aben, Katja K.; Graif, Theresa; Cashy, John; Ruiz-Echarri, Manuel; Wiley, Kathleen E.; Suarez, Brian K.; Witjes, J. Alfred; Frigge, Mike; Ober, Carole; Jonsson, Eirikur; Einarsson, Gudmundur V.; Mayordomo, Jose I.; Kiemeney, Lambertus A.; Isaacs, William B.; Catalona, William J.; Barkardottir, Rosa B.; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari			Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24	NATURE GENETICS			English	Article							CERVICAL-CARCINOMA; CONFERS RISK; METAANALYSIS; INTEGRATION; DISEASES; LOCUS	Prostate cancer is the most prevalent noncutaneous cancer in males in developed regions(1), with African American men having among the highest worldwide incidence and mortality rates(2). Here we report a second genetic variant in the 8q24 region that, in conjunction with another variant we recently discovered(3), accounts for about 11% - 13% of prostate cancer cases in individuals of European descent and 31% of cases in African Americans. We made the current discovery through a genome-wide association scan of 1,453 affected Icelandic individuals and 3,064 controls using the Illumina HumanHap 300 BeadChip followed by four replication studies. A key step in the discovery was the construction of a 14-SNP haplotype that efficiently tags a relatively uncommon (2% - 4%) susceptibility variant in individuals of European descent that happens to be very common (similar to 42%) in African Americans. The newly identified variant shows a stronger association with affected individuals who have an earlier age at diagnosis.	deCODE Genet, IS-101 Reykjavik, Iceland; Landspitali Univ Hosp, Dept Pathol, IS-101 Reykjavik, Iceland; Wake Forest Univ, Sch Med, Ctr Human Genom, Winston Salem, NC 27157 USA; Univ Zaragoza, Lozano Blesa Univ Hosp, Div Med Oncol, E-50009 Zaragoza, Spain; Johns Hopkins Med Inst, James Buchanan Brady Urol Inst, Dept Urol, Baltimore, MD 21209 USA; Thrombosis Serv, NL-6503 GM Nijmegen, Netherlands; Inst Hlth Sci, Nanotechnol Inst Aragon, Zaragoza 50009, Spain; Radboud Univ Nijmegen Med Ctr, Dept Clin Chem, Nijmegen, Netherlands; Univ Hosp, Div Radiat Oncol, Zaragoza, Spain; Ctr Comprehens Canc E, NL-6501 BG Nijmegen, Netherlands; Radboud Univ Nijmegen, Nigmegen Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Radboud Univ Nijmegen, Nigmegen Med Ctr, Dept Urol, NL-6500 HB Nijmegen, Netherlands; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Landspital Univ Hosp, Dept Urol, IS-101 Reykjavik, Iceland; Radboud Univ Nijmegen, Nigmegen Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands	Landspitali National University Hospital; Wake Forest University; Lozano Blesa University Clinical Hospital; University of Zaragoza; Johns Hopkins University; Johns Hopkins Medicine; Radboud University Nijmegen; Miguel Servet University Hospital; Radboud University Nijmegen; Northwestern University; Feinberg School of Medicine; Washington University (WUSTL); Radboud University Nijmegen; University of Chicago; Landspitali National University Hospital; Radboud University Nijmegen	Stefansson, K (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	augustine.kong@decode.is; kstefans@decode.is	Backman, Vadim/B-6689-2009; Swinkels, Dorine W./H-8098-2014; Mayordomo, Jose/K-3453-2013; Amundadottir, Laufey T/L-7656-2016; Aben, Katja KH/G-9686-2016; Helgason, Agnar/K-1522-2015; Stefansson, Kari/AAE-7187-2019; Witjes, Fred/N-9665-2013; Manolescu, Andrei/G-4565-2014; Kiemeney, Lambertus A./D-3357-2009	Swinkels, Dorine W./0000-0002-1040-9446; Amundadottir, Laufey T/0000-0003-1859-8971; Aben, Katja KH/0000-0002-0214-2147; Manolescu, Andrei/0000-0002-0713-4664; Kiemeney, Lambertus A./0000-0002-2368-1326; Gudbjartsson, Daniel/0000-0002-5222-9857; Ober, Carole/0000-0003-4626-9809; Bergthorsson, Jon Thor/0000-0002-0560-2639; Kong, Augustine/0000-0001-8193-5438; Helgason, Agnar/0000-0002-8545-3767				Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Baudis M, 2001, BIOINFORMATICS, V17, P1228, DOI 10.1093/bioinformatics/17.12.1228; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Ferber MJ, 2003, ONCOGENE, V22, P7233, DOI 10.1038/sj.onc.1207006; Ferber MJ, 2004, CANCER GENET CYTOGEN, V154, P1, DOI 10.1016/j.cancergencyto.2004.01.028; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; MANTEL N, 1959, J NATL CANCER I, V22, P719; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; REES LAG, 2006, SEER CANC STAT REV 1; Taylor ML, 2005, FAM MED, V37, P506; Trikalinos TA, 2004, EUR J HUM GENET, V12, P762, DOI 10.1038/sj.ejhg.5201227; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322	22	674	712	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2007	39	5					631	637		10.1038/ng1999	http://dx.doi.org/10.1038/ng1999			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17401366				2022-12-27	WOS:000245971300018
J	Herring, CD; Raghunathan, A; Honisch, C; Patel, T; Applebee, MK; Joyce, AR; Albert, TJ; Blattner, FR; van den Boom, D; Cantor, CR; Palsson, BO				Herring, Christopher D.; Raghunathan, Anu; Honisch, Christiane; Patel, Trina; Applebee, M. Kenyon; Joyce, Andrew R.; Albert, Thomas J.; Blattner, Frederick R.; van den Boom, Dirk; Cantor, Charles R.; Palsson, Bernhard O.			Comparative genome sequencing of Escherichia coli allows observation of bacterial evolution on a laboratory timescale	NATURE GENETICS			English	Article							ADAPTIVE EVOLUTION; GLYCEROL KINASE; GROWTH PHENOTYPES; ADAPTATION; MUTATIONS; PROTEIN; DISSIMILATION; POPULATION; VIRUS	We applied whole-genome resequencing of Escherichia coli to monitor the acquisition and fixation of mutations that conveyed a selective growth advantage during adaptation to a glycerol-based growth medium. We identified 13 different de novo mutations in five different E. coli strains and monitored their fixation over a 44-d period of adaptation. We obtained proof that the observed spontaneous mutations were responsible for improved fitness by creating single, double and triple site-directed mutants that had growth rates matching those of the evolved strains. The success of this new genome-scale approach indicates that real-time evolution studies will now be practical in a wide variety of contexts.	Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; Univ Calif San Diego, Bioinformat Program, La Jolla, CA 92093 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Nimblegan Syst Inc, Madison, WI 53711 USA; Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; CUNY Mt Sinai Sch Med, Div Infect Dis, New York, NY 10029 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Palsson, BO (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	bpalsson@bioeng.ucsd.edu		Herring, Christopher/0000-0003-1621-5906; Palsson, Bernhard/0000-0003-2357-6785	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062791, F32GM074590] Funding Source: NIH RePORTER; NIGMS NIH HHS [1F32GM074590-01, GM62791] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Albert TJ, 2005, NAT METHODS, V2, P951, DOI 10.1038/NMETH805; Bansal A, 2002, P NATL ACAD SCI USA, V99, P16871, DOI 10.1073/pnas.262671399; Barker CS, 2004, J BACTERIOL, V186, P7529, DOI 10.1128/JB.186.22.7529-7537.2004; Dobrindt U, 2002, CURR TOP MICROBIOL, V264, P157; Dominique SA, 2004, RES MICROBIOL, V155, P319, DOI 10.1016/j.resmic.2003.12.008; Elena SF, 2003, NAT REV GENET, V4, P457, DOI 10.1038/nrg1088; Eppler T, 2002, J BACTERIOL, V184, P3044, DOI 10.1128/JB.184.11.3044-3052.2002; Ferguson GP, 1998, ARCH MICROBIOL, V170, P209, DOI 10.1007/s002030050635; Fong SS, 2005, GENOME RES, V15, P1365, DOI 10.1101/gr.3832305; Fong SS, 2005, BIOTECHNOL BIOENG, V91, P643, DOI 10.1002/bit.20542; Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Herring CD, 2003, GENE, V311, P153, DOI 10.1016/S0378-1119(03)00585-7; Holtman CK, 2001, J BACTERIOL, V183, P3336, DOI 10.1128/JB.183.11.3336-3344.2001; Honisch C, 2004, GENOME RES, V14, P2495, DOI 10.1101/gr.2977704; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; JANSON CA, 1974, J BIOL CHEM, V249, P2562; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; King T, 2004, J BACTERIOL, V186, P5614, DOI 10.1128/JB.186.17.5614-5620.2004; Lawson CL, 2004, CURR OPIN STRUC BIOL, V14, P10, DOI 10.1016/j.sbi.2004.01.012; LIN ECC, 1976, ANNU REV MICROBIOL, V30, P535, DOI 10.1146/annurev.mi.30.100176.002535; LIU WZ, 1994, BIOCHEMISTRY-US, V33, P10120, DOI 10.1021/bi00199a040; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Miller BG, 2004, BIOCHEMISTRY-US, V43, P6387, DOI 10.1021/bi049424m; Pelosi L, 2006, GENETICS, V173, P1851, DOI 10.1534/genetics.105.049619; Rokyta DR, 2005, NAT GENET, V37, P441, DOI 10.1038/ng1535; Ross P, 2000, BIOTECHNIQUES, V29, P620, DOI 10.2144/00293rr05; ROTH JR, 1996, ESCHERICHIA COLI SAL, P2256; Saier MH, 1996, ESCHERICHIA COLI SAL, V1, P1325; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; Zeyl C, 2005, GENETICS, V169, P1825, DOI 10.1534/genetics.104.027102; ZWAIG N, 1970, J BACTERIOL, V102, P753, DOI 10.1128/JB.102.3.753-759.1970	35	278	292	0	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2006	38	12					1406	1412		10.1038/ng1906	http://dx.doi.org/10.1038/ng1906			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110TR	17086184	Bronze			2022-12-27	WOS:000242404200017
J	Feng, JQ; Ward, LM; Liu, SG; Lu, YB; Xie, YX; Yuan, BZ; Yu, XJ; Rauch, F; Davis, SI; Zhang, SB; Rios, H; Drezner, MK; Quarles, LD; Bonewald, LF; White, KE				Feng, Jian Q.; Ward, Leanne M.; Liu, Shiguang; Lu, Yongbo; Xie, Yixia; Yuan, Baozhi; Yu, Xijie; Rauch, Frank; Davis, Siobhan I.; Zhang, Shubin; Rios, Hector; Drezner, Marc K.; Quarles, L. Darryl; Bonewald, Lynda F.; White, Kenneth E.			Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism	NATURE GENETICS			English	Article							DENTIN MATRIX PROTEIN-1; BONE MINERALIZATION; HYPOPHOSPHATEMIA; EXPRESSION; CARTILAGE; CHICKEN	The osteocyte, a terminally differentiated cell comprising 90%-95% of all bone cells(1,2), may have multiple functions, including acting as a mechanosensor in bone (re) modeling(3). Dentin matrix protein 1 (encoded by DMP1) is highly expressed in osteocytes(4) and, when deleted in mice, results in a hypomineralized bone phenotype(5). We investigated the potential for this gene not only to direct skeletal mineralization but also to regulate phosphate (Pi) homeostasis. Both Dmp1-null mice and individuals with a newly identified disorder, autosomal recessive hypophosphatemic rickets, manifest rickets and osteomalacia with isolated renal phosphate-wasting associated with elevated fibroblast growth factor 23 (FGF23) levels and normocalciuria. Mutational analyses showed that autosomal recessive hypophosphatemic rickets family carried a mutation affecting the DMP1 start codon, and a second family carried a 7-bp deletion disrupting the highly conserved DMP1 C terminus. Mechanistic studies using Dmp1-null mice demonstrated that absence of DMP1 results in defective osteocyte maturation and increased FGF23 expression, leading to pathological changes in bone mineralization. Our findings suggest a bone-renal axis that is central to guiding proper mineral metabolism.	Univ Kansas, Med Ctr, Dept Internal Med, Kidney Inst, Kansas City, KS 66160 USA; Univ Kansas, Med Ctr, Div Nephrol, Kansas City, KS 66160 USA; Univ Ottawa, Childrens Hosp Eastern Ontario, Dept Pediat, Ottawa, ON K1H 8L1, Canada; Univ Missouri, Kansas City, MO 64108 USA; Indiana Univ, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; Univ Wisconsin, Dept Med, Madison, WI USA; McGill Univ, Shriners Hosp Children, Montreal, PQ H3G 1A6, Canada	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center; University of Ottawa; Children's Hospital of Eastern Ontario; University of Missouri System; University of Missouri Kansas City; Indiana University System; Indiana University-Purdue University Indianapolis; University of Wisconsin System; University of Wisconsin Madison; McGill University	Ward, LM (corresponding author), Univ Kansas, Med Ctr, Dept Internal Med, Kidney Inst, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	Lward@cheo.on.ca; dquarles@kumc.edu	Rauch, Frank/D-1554-2009; Ward, Leanne Marie/AAF-8482-2020; Yu, Xijie/H-4124-2011; Bonewald, Lynda/Q-3638-2019	Ward, Leanne Marie/0000-0003-1557-9185; Yu, Xijie/0000-0002-3504-7664; Quarles, L. Darryl/0000-0002-5082-7896; Rauch, Frank/0000-0002-6261-0360; Lu, Yongbo/0000-0003-3692-1736	NIAMS NIH HHS [R56 AR027032, R01 AR051587, R56 AR045955, P01 AR046798, R01 AR027032, AR046798, R01 AR045955, AR051587, AR-45955, AR027032] Funding Source: Medline; NIDCR NIH HHS [R29 DE013480, DE13480] Funding Source: Medline; NIDDK NIH HHS [R01 DK063934, DK063934] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR045955, R56AR027032, R01AR027032, R01AR051587, R01AR045955, P01AR046798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R29DE013480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063934] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Butler WT, 2002, CONNECT TISSUE RES, V43, P301, DOI 10.1080/03008200290000682; DSouza RN, 1997, J BONE MINER RES, V12, P2040, DOI 10.1359/jbmr.1997.12.12.2040; EICHER EM, 1976, P NATL ACAD SCI USA, V73, P4667, DOI 10.1073/pnas.73.12.4667; Feng JQ, 2003, J DENT RES, V82, P776, DOI 10.1177/154405910308201003; Feng JQ, 2002, J BONE MINER RES, V17, P1822, DOI 10.1359/jbmr.2002.17.10.1822; Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; FROST HM, 1960, J BONE JOINT SURG AM, V42, P138, DOI 10.2106/00004623-196042010-00011; Glorieux FH, 2000, BONE, V26, P103, DOI 10.1016/S8756-3282(99)00257-4; Ito N, 2005, J BONE MINER METAB, V23, P435, DOI 10.1007/s00774-005-0625-4; Ling YF, 2005, J BONE MINER RES, V20, P2169, DOI 10.1359/JBMR.050815; Liu SG, 2006, AM J PHYSIOL-ENDOC M, V291, pE38, DOI 10.1152/ajpendo.00008.2006; MARIE PJ, 1983, CALCIFIED TISSUE INT, V35, P443, DOI 10.1007/BF02405074; MCKEE MD, 1992, ANAT REC, V234, P479, DOI 10.1002/ar.1092340404; PALUMBO C, 1990, ACTA ANAT, V137, P350; PEAD MJ, 1989, CALCIFIED TISSUE INT, V45, P34, DOI 10.1007/BF02556658; Rowe PSN, 2000, GENOMICS, V67, P54, DOI 10.1006/geno.2000.6235; SMITH R, 1976, LANCET, V1, P40; Tenenhouse HS, 1999, NEPHROL DIAL TRANSPL, V14, P333, DOI 10.1093/ndt/14.2.333; Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Ye L, 2005, J BIOL CHEM, V280, P6197, DOI 10.1074/jbc.M412911200; Ye L, 2004, J BIOL CHEM, V279, P19141, DOI 10.1074/jbc.M400490200; Zhang KQ, 2006, MOL CELL BIOL, V26, P4539, DOI 10.1128/MCB.02120-05	24	844	899	0	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2006	38	11					1310	1315		10.1038/ng1905	http://dx.doi.org/10.1038/ng1905			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17033621	Green Accepted			2022-12-27	WOS:000241592700020
J	Seal, S; Thompson, D; Renwick, A; Elliott, A; Kelly, P; Barfoot, R; Chagtai, T; Jayatilake, H; Ahmed, M; Spanova, K; North, B; McGuffog, L; Evans, DG; Eccles, D; Easton, DF; Stratton, MR; Rahman, N				Seal, Sheila; Thompson, Deborah; Renwick, Anthony; Elliott, Anna; Kelly, Patrick; Barfoot, Rita; Chagtai, Tasnim; Jayatilake, Hiran; Ahmed, Munaza; Spanova, Katarina; North, Bernard; McGuffog, Lesley; Evans, D. Gareth; Eccles, Diana; Easton, Douglas F.; Stratton, Michael R.; Rahman, Nazneen		BCS Collaboration	Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles	NATURE GENETICS			English	Article							BRCA2 MUTATIONS; HELICASE BRIP1; BACH1; PROTEIN; PREDISPOSITION	We identified constitutional truncating mutations of the BRCA1-interacting helicase BRIP1 in 9/1,212 individuals with breast cancer from BRCA1/BRCA2 mutation-negative families but in only 2/2,081 controls (P = 0.0030), and we estimate that BRIP1 mutations confer a relative risk of breast cancer of 2.0 (95% confidence interval = 1.2-3.2, P = 0.012). Biallelic BRIP1 mutations were recently shown to cause Fanconi anemia complementation group J. Thus, inactivating truncating mutations of BRIP1, similar to those in BRCA2, cause Fanconi anemia in biallelic carriers and confer susceptibility to breast cancer in monoallelic carriers.	Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Univ Cambridge, Strangeways Res Labs, Canc Res UK Genet Epidemiol Unit, Cambridge CB1 8RN, England; St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England; Princess Anne Hosp, Wessex Clin Genet Serv, Southampton SO16 6YA, Hants, England; Wellcome Trust Sanger Inst, Canc Genome Project, Hixton CB10 1SA, Cambs, England	University of London; Institute of Cancer Research - UK; Cancer Research UK; University of Cambridge; University of Manchester; Wellcome Trust Sanger Institute	Rahman, N (corresponding author), Inst Canc Res, Sect Canc Genet, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England.	nazneen.rahman@icr.ac.uk	Eccles, Diana/K-6327-2019; Evans, D Gareth/AAB-4308-2022; Rahman, Nazneen/B-8890-2012; Rahman, Nazneen/D-2802-2013	Eccles, Diana/0000-0002-9935-3169; Evans, D Gareth/0000-0002-8482-5784; Rahman, Nazneen/0000-0003-4376-0440	MRC [G0000934] Funding Source: UKRI; Medical Research Council [G0000934] Funding Source: Medline; Wellcome Trust [068545/Z/02] Funding Source: Medline; Breast Cancer Now [2003:592] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Breast Cancer Now		Antoniou AC, 2001, GENET EPIDEMIOL, V21, P1, DOI 10.1002/gepi.1014; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Cantor SB, 2006, CELL CYCLE, V5, P164, DOI 10.4161/cc.5.2.2338; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; Peng M, 2006, ONCOGENE, V25, P2245, DOI 10.1038/sj.onc.1209257; Reid S, 2005, J MED GENET, V42, P147, DOI 10.1136/jmg.2004.022673; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Seal S, 2003, CANCER RES, V63, P8596; SWIFT M, 1980, J NATL CANCER I, V65, P863; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240	15	527	542	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2006	38	11					1239	1241		10.1038/ng1902	http://dx.doi.org/10.1038/ng1902			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17033622				2022-12-27	WOS:000241592700009
J	Franke, A; Balschun, T; Karlsen, TH; Sventoraityte, J; Nikolaus, S; Mayr, G; Domingues, FS; Albrecht, M; Nothnagel, M; Ellinghaus, D; Sina, C; Onnie, CM; Weersma, RK; Stokkers, PCF; Wijmenga, C; Gazouli, M; Strachan, D; McArdle, WL; Vermeire, S; Rutgeerts, P; Rosenstiel, P; Krawczak, M; Vatn, MH; Mathew, CG; Schreiber, S				Franke, Andre; Balschun, Tobias; Karlsen, Tom H.; Sventoraityte, Jurgita; Nikolaus, Susanna; Mayr, Gabriele; Domingues, Francisco S.; Albrecht, Mario; Nothnagel, Michael; Ellinghaus, David; Sina, Christian; Onnie, Clive M.; Weersma, Rinse K.; Stokkers, Pieter C. F.; Wijmenga, Cisca; Gazouli, Maria; Strachan, David; McArdle, Wendy L.; Vermeire, Severine; Rutgeerts, Paul; Rosenstiel, Philip; Krawczak, Michael; Vatn, Morten H.; Mathew, Christopher G.; Schreiber, Stefan		IBSEN Study Grp	Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; CYTOKINE GENE POLYMORPHISMS; GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; IL-10 GENE; TNF-ALPHA; INTERLEUKIN-10; METAANALYSIS; PHENOTYPE; IBD	Inflammatory bowel disease (IBD) typically manifests as either ulcerative colitis (UC) or Crohn's disease (CD). Systematic identification of susceptibility genes for IBD has thus far focused mainly on CD, and little is known about the genetic architecture of UC. Here we report a genome-wide association study with 440,794 SNPs genotyped in 1,167 individuals with UC and 777 healthy controls. Twenty of the most significantly associated SNPs were tested for replication in three independent European case-control panels comprising a total of 1,855 individuals with UC and 3,091 controls. Among the four consistently replicated markers, SNP rs3024505 immediately flanking the IL10 (interleukin 10) gene on chromosome 1q32.1 showed the most significant association in the combined verification samples (P = 1.35 x 10(-12); OR = 1.46 (1.31-1.62)). The other markers were located in ARPC2 and in the HLA-BTNL2 region. Association between rs3024505 and CD (1,848 cases, 1,804 controls) was weak (P = 0.013; OR = 1.17 (1.01-1.34)). IL10 is an immunosuppressive cytokine that has long been proposed to influence IBD pathophysiology. Our findings strongly suggest that defective IL10 function is central to the pathogenesis of the UC subtype of IBD.	[Franke, Andre; Balschun, Tobias; Sventoraityte, Jurgita; Ellinghaus, David; Rosenstiel, Philip; Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Karlsen, Tom H.; Vatn, Morten H.] Rikshosp Univ Hosp, Dept Med, N-0027 Oslo, Norway; [Nikolaus, Susanna; Sina, Christian] Univ Kiel, Poppgen Biobank, D-24105 Kiel, Germany; [Nikolaus, Susanna; Sina, Christian; Schreiber, Stefan] Univ Kiel, Univ Hosp Schleswig Holstein, Dept Gen Internal Med, D-24105 Kiel, Germany; [Mayr, Gabriele; Domingues, Francisco S.; Albrecht, Mario] Max Planck Inst Informat, D-66123 Saarbrucken, Germany; [Nothnagel, Michael; Krawczak, Michael] Univ Kiel, Inst Med Informat & Stat, D-24105 Kiel, Germany; [Onnie, Clive M.; Mathew, Christopher G.] Kings Coll London, Sch Med, Dept Med & Mol Genet, London SE1 9RT, England; [Weersma, Rinse K.] Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, NL-9700 RB Groningen, Netherlands; [Weersma, Rinse K.; Wijmenga, Cisca] Univ Groningen, NL-9700 RB Groningen, Netherlands; [Stokkers, Pieter C. F.] Acad Med Ctr, Dept Gastroenterol & Hepatol, NL-1105 AZ Amsterdam, Netherlands; [Wijmenga, Cisca] Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Gazouli, Maria] Univ Athens, Sch Med, Dept Biol, GR-11527 Athens, Greece; [Strachan, David] St Georgess Univ, Div Community Hlth Sci, London SW17 0RE, England; [McArdle, Wendy L.] Univ Bristol, Dept Social Med, ALSPAC, Bristol BS8 1TQ, Avon, England; [Vermeire, Severine; Rutgeerts, Paul] Univ Hosp Gasthuisberg, Dept Gastroenterol, B-3000 Louvain, Belgium; [Vatn, Morten H.] Akershus Univ Hosp, Fac Med, N-1474 Oslo, Norway	University of Kiel; University of Oslo; National Hospital Norway; University of Kiel; University of Kiel; Schleswig Holstein University Hospital; Max Planck Society; University of Kiel; University of London; King's College London; University of Groningen; University of Groningen; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; Athens Medical School; National & Kapodistrian University of Athens; St Georges University London; University of Bristol; KU Leuven; University Hospital Leuven; University of Oslo	Schreiber, S (corresponding author), Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany.	s.schreiber@mucosa.de	Balschun, Tobias/B-2356-2010; Nothnagel, Michael/H-6887-2012; Weersma, Rinse/ABE-3807-2021; Wijmenga, Cisca/D-2173-2009; Ellinghaus, David/G-4467-2012; Rosenstiel, Philip/A-5137-2009; Gazouli, Maria/I-2572-2018; Nothnagel, Michael/A-7759-2011; Franke, Andre/B-2151-2010; Ellinghaus, David/ABC-3610-2020; Albrecht, Mario/B-6694-2008; Krawczak, Michael/A-8964-2010; Mathew, Christopher G/G-3434-2015; Wijmenga, Cisca/AAE-7719-2019; Gazouli, Maria/W-6245-2019; Nothnagel, Michael/G-6545-2014; Sina, Christian/D-5348-2014; Nothnagel, Michael/L-7187-2019	Rosenstiel, Philip/0000-0002-9692-8828; Gazouli, Maria/0000-0002-3295-6811; Franke, Andre/0000-0003-1530-5811; Ellinghaus, David/0000-0002-4332-6110; Albrecht, Mario/0000-0002-3103-9624; Krawczak, Michael/0000-0003-2603-1502; Mathew, Christopher G/0000-0003-4178-1838; Wijmenga, Cisca/0000-0002-5635-1614; Gazouli, Maria/0000-0002-3295-6811; Nothnagel, Michael/0000-0001-8305-7114; Domingues, Francisco/0000-0003-4567-4562; Vermeire, Severine/0000-0001-9942-3019	German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN); popgen biobank; DFG; British Birth Cohort collection; UK MRC [G0000934]; Wellcome Trust [068545/Z/02]; CORE (UK); MRC [G0000934, MC_qA137934] Funding Source: UKRI; Medical Research Council [MC_qA137934, G0000934] Funding Source: researchfish	German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN)(Federal Ministry of Education & Research (BMBF)); popgen biobank; DFG(German Research Foundation (DFG)); British Birth Cohort collection; UK MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); CORE (UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We wish to thank all individuals with IBD, families and physicians for their cooperation. We gratefully acknowledge the cooperation of the German Crohn and Colitis Foundation (Deutsche Morbus Crohn und Colitis Vereinigung e. V.), the BMBF competence network "IBD'' and of the contributing gastroenterologists. Finally, we wish to thank T. Wesse, T. Henke, A. Dietsch, R. Vogler, C.v.d. Lancken and M. Friskovec for expert technical help. We thank T. Wienker and M. Steffens (IMBIE, University of Bonn) for performing the quality control of the GWAS datasets. We thank B. A. Lie and the Norwegian Bone Marrow Donor Registry at Rikshospitalet University Hospital, Oslo, for contributing the healthy Norwegian control population. This study was supported by the German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN), the popgen biobank and the SFB617 "Molecular Mechanisms of Epithelial Defense.'' The project received infrastructure support through the DFG excellence cluster "Inflammation at Interfaces.'' We acknowledge use of DNA from the 1958 British Birth Cohort collection (R. Jones, S. Ring, W. McArdle and M. Pembrey), funded by the UK MRC (grant G0000934) and The Wellcome Trust (grant 068545/Z/02). C. G. M. and C.M.O. were supported by The Wellcome Trust and CORE (UK).	Aithal GP, 2001, DIGEST DIS SCI, V46, P1520, DOI 10.1023/A:1010604307776; Balding J, 2004, MEDIAT INFLAMM, V13, P181, DOI 10.1080/09511920410001713529; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Cantor MJ, 2005, AM J GASTROENTEROL, V100, P1134, DOI 10.1111/j.1572-0241.2005.40979.x; Castro-Santos P, 2006, AM J GASTROENTEROL, V101, P1039, DOI 10.1111/j.1572-0241.2006.00501.x; Celik Y, 2006, SCAND J GASTROENTERO, V41, P559, DOI 10.1080/00365520500349523; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fernandez L, 2005, INFLAMM BOWEL DIS, V11, P739, DOI 10.1097/01.MIB.0000173457.64868.20; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Franke A, 2008, NAT GENET, V40, P713, DOI 10.1038/ng.148; Hu XY, 2007, J LEUKOCYTE BIOL, V82, P237, DOI 10.1189/jlb.1206763; Kim Tae Ho, 2003, Korean J Gastroenterol, V42, P377; Klein W, 2000, ELECTROPHORESIS, V21, P3578, DOI 10.1002/1522-2683(200011)21:17<3578::AID-ELPS3578>3.3.CO;2-Q; Kolbe D, 2004, GENOME RES, V14, P700, DOI 10.1101/gr.1976004; Koss K, 2000, GENES IMMUN, V1, P185, DOI 10.1038/sj.gene.6363657; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Marangoni F, 2007, J EXP MED, V204, P369, DOI 10.1084/jem.20061334; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; Mitsuyama K, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/26875; Parkes M, 1998, CLIN EXP IMMUNOL, V113, P28, DOI 10.1046/j.1365-2249.1998.00625.x; Schreiber S, 1998, GASTROENTEROLOGY, V114, pA1080; SCHREIBER S, 1995, GASTROENTEROLOGY, V108, P1434, DOI 10.1016/0016-5085(95)90692-4; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Stokkers PCF, 1999, GUT, V45, P395, DOI 10.1136/gut.45.3.395; Tagore A, 1999, TISSUE ANTIGENS, V54, P386, DOI 10.1034/j.1399-0039.1999.540408.x; Trikalinos TA, 2004, EUR J HUM GENET, V12, P762, DOI 10.1038/sj.ejhg.5201227; van der Linde K, 2005, DIGEST LIVER DIS, V37, P330, DOI 10.1016/j.dld.2004.12.009; van Heel DA, 2004, HUM MOL GENET, V13, P763, DOI 10.1093/hmg/ddh090; WEBB MC, 1993, TRANSPLANTATION, V56, P1585	30	446	461	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1319	1323		10.1038/ng.221	http://dx.doi.org/10.1038/ng.221			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18836448				2022-12-27	WOS:000260501500024
J	Jin, J; Huang, W; Gao, JP; Yang, J; Shi, M; Zhu, MZ; Luo, D; Lin, HX				Jin, Jian; Huang, Wei; Gao, Ji-Ping; Yang, Jun; Shi, Min; Zhu, Mei-Zhen; Luo, Da; Lin, Hong-Xuan			Genetic control of rice plant architecture under domestication	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCUS; ZINC-FINGER PROTEINS; TOMATO FRUIT; EVOLUTION; ORIGIN; MAIZE; ARABIDOPSIS; ENCODES; SIZE; DNA	The closely related wild rice species Oryza rufipogon is considered the progenitor of cultivated rice (Oryza sativa)(1-5). The transition from the characteristic plant architecture of wild rice to that of cultivated rice was one of the most important events in rice domestication; however, the molecular basis of this key domestication transition has not been elucidated. Here we show that the PROG1 gene controls aspects of wild-rice plant architecture, including tiller angle and number of tillers. The gene encodes a newly identified zinc-finger nuclear transcription factor with transcriptional activity and is mapped on chromosome 7. PROG1 is predominantly expressed in the axillary meristems, the site of tiller bud formation. Rice transformation experiments demonstrate that artificial selection of an amino acid substitution in the PROG1 protein during domestication led to the transition from the plant architecture of wild rice to that of domesticated rice.	[Jin, Jian; Huang, Wei; Gao, Ji-Ping; Yang, Jun; Shi, Min; Zhu, Mei-Zhen; Luo, Da; Lin, Hong-Xuan] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, Shanghai 200032, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Lin, HX (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Plant Physiol & Ecol, Natl Key Lab Plant Mol Genet, 300 Fenglin Rd, Shanghai 200032, Peoples R China.	hxlin@sibs.ac.cn	Lin, Hong-Xuan/AEQ-6607-2022	Lin, Hong-Xuan/0000-0002-2818-023X; Gao, Ji-Ping/0000-0002-8968-4423	Ministry of Science and Technology of China; National Natural Science Foundation of China; Chinese Academy of Sciences; Shanghai Science and Technology Development Fund	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Science and Technology Development Fund	We thank Z.-Z. Piao and X.-M. Li for technical assistance. We thank S. Luan for critically reading the manuscript. This work was supported by grants from the Ministry of Science and Technology of China, the National Natural Science Foundation of China, the Chinese Academy of Sciences and the Shanghai Science and Technology Development Fund to H.-X.L.	CHANT S, 1995, GENDER PLACE CULT, V2, P147; Cheng CY, 2003, MOL BIOL EVOL, V20, P67, DOI 10.1093/molbev/msg004; COEN ES, 1990, CELL, V63, P1311, DOI 10.1016/0092-8674(90)90426-F; Cong B, 2008, NAT GENET, V40, P800, DOI 10.1038/ng.144; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Hao Wei, 2006, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V32, P354; HIEI Y, 1994, PLANT J, V6, P271, DOI 10.1046/j.1365-313X.1994.6020271.x; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li PJ, 2007, CELL RES, V17, P402, DOI 10.1038/cr.2007.38; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Lin RC, 2007, SCIENCE, V318, P1302, DOI 10.1126/science.1146281; Liu JP, 2002, P NATL ACAD SCI USA, V99, P13302, DOI 10.1073/pnas.162485999; MILLER J, 1985, EMBO J, V4, P1609, DOI 10.1002/j.1460-2075.1985.tb03825.x; Oka H. I., 1988, Origin of cultivated rice.; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ren ZH, 2005, NAT GENET, V37, P1141, DOI 10.1038/ng1643; Sakamoto H, 2004, PLANT PHYSIOL, V136, P2734, DOI 10.1104/pp.104.046599; Sharma SD, 2000, RICE BREEDING AND GENETICS, P349; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; Vaughan DA, 2003, CURR OPIN PLANT BIOL, V6, P139, DOI 10.1016/S1369-5266(03)00009-8; Vitte C, 2004, MOL GENET GENOMICS, V272, P504, DOI 10.1007/s00438-004-1069-6; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Yu BS, 2007, PLANT J, V52, P891, DOI 10.1111/j.1365-313X.2007.03284.x	30	283	354	13	182	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1365	1369		10.1038/ng.247	http://dx.doi.org/10.1038/ng.247			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18820696				2022-12-27	WOS:000260501500032
J	Rahimov, F; Marazita, ML; Visel, A; Cooper, ME; Hitchler, MJ; Rubini, M; Domann, FE; Govil, M; Christensen, K; Bille, C; Melbye, M; Jugessur, A; Lie, RT; Wilcox, AJ; Fitzpatrick, DR; Green, ED; Mossey, PA; Little, J; Steegers-Theunissen, RP; Pennacchio, LA; Schutte, BC; Murray, JC				Rahimov, Fedik; Marazita, Mary L.; Visel, Axel; Cooper, Margaret E.; Hitchler, Michael J.; Rubini, Michele; Domann, Frederick E.; Govil, Manika; Christensen, Kaare; Bille, Camille; Melbye, Mads; Jugessur, Astanand; Lie, Rolv T.; Wilcox, Allen J.; Fitzpatrick, David R.; Green, Eric D.; Mossey, Peter A.; Little, Julian; Steegers-Theunissen, Regine P.; Pennacchio, Len A.; Schutte, Brian C.; Murray, Jeffrey C.		NISC Comparative Sequencing Pr	Disruption of an AP-2 alpha binding site in an IRF6 enhancer is associated with cleft lip	NATURE GENETICS			English	Article							OROFACIAL CLEFTS; ORAL CLEFTS; PALATE; GENE; POPULATION; SEQUENCES; POLYMORPHISMS; CONTRIBUTES; EXPRESSION; MUTATIONS	Previously we have shown that nonsyndromic cleft lip with or without cleft palate (NSCL/P)(1) is strongly associated with SNPs in IRF6 (interferon regulatory factor 6)(2). Here, we use multispecies sequence comparisons to identify a common SNP (rs642961, G>A) in a newly identified IRF6 enhancer. The A allele is significantly overtransmitted (P = 1 x 10(-11)) in families with NSCL/P, in particular those with cleft lip but not cleft palate. Further, there is a dosage effect of the A allele, with a relative risk for cleft lip of 1.68 for the AG genotype and 2.40 for the AA genotype. EMSA and ChIP assays demonstrate that the risk allele disrupts the binding site of transcription factor AP-2a and expression analysis in the mouse localizes the enhancer activity to craniofacial and limb structures. Our findings place IRF6 and AP-2a in the same developmental pathway and identify a high-frequency variant in a regulatory element contributing substantially to a common, complex disorder.	[Rahimov, Fedik; Schutte, Brian C.; Murray, Jeffrey C.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA; [Marazita, Mary L.; Cooper, Margaret E.; Govil, Manika] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Ctr Craniofacial & Dent Genet, Pittsburgh, PA 15219 USA; [Visel, Axel; Pennacchio, Len A.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Genome Div, Berkeley, CA 94720 USA; [Hitchler, Michael J.; Domann, Frederick E.] Univ Iowa, Dept Radiat Oncol, Iowa City, IA 52242 USA; [Rubini, Michele] Univ Ferrara, Med Genet Unit, Dept Expt Diagnost Med, I-44100 Ferrara, Italy; [Christensen, Kaare; Bille, Camille] Univ So Denmark, Inst Publ Hlth, Ctr Prevent Congenital Malinformat, DK-5000 Odense C, Denmark; [Melbye, Mads] Danish Epidemiol Sci Ctr, State Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Jugessur, Astanand; Lie, Rolv T.] Univ Bergen, Dept Publ Hlth & Primary Hlth Care, Sect Epidemiol & Med Stat, N-5018 Bergen, Norway; [Wilcox, Allen J.] NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC 27709 USA; [Fitzpatrick, David R.] Western Gen Hosp, Med Res Council Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Green, Eric D.; NISC Comparative Sequencing Pr] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Green, Eric D.; NISC Comparative Sequencing Pr] NHGRI, US Natl Inst Hlth Intramural Sequencing Ctr, NIH, Bethesda, MD 20892 USA; [Mossey, Peter A.] Univ Dundee, Dent Hosp & Sch, Dundee DD1 4HR, Scotland; [Little, Julian] Univ Ottawa, Dept Epidemiol & Community Med, Ottawa, ON K1H 8M5, Canada; [Steegers-Theunissen, Regine P.] Univ Med Ctr, NL-3015 GD Rotterdam, Netherlands	University of Iowa; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Iowa; University of Ferrara; University of Southern Denmark; Aarhus University; Statens Serum Institut; University of Bergen; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Edinburgh; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Dundee; University of Ottawa	Murray, JC (corresponding author), Univ Iowa, Dept Pediat, 2182 ML,S Grand Ave, Iowa City, IA 52242 USA.	jeff-murray@uiowa.edu	Visel, Axel/A-9398-2009; Christensen, Kaare/C-2360-2009; Little, Julian/AAR-6117-2020; Rahimov, Fedik/H-2685-2013; Rubini, Michele/AFF-8477-2022; FitzPatrick, David R/C-7301-2013; Wilcox, Allen J/C-7723-2019	Visel, Axel/0000-0002-4130-7784; Christensen, Kaare/0000-0002-5429-5292; Little, Julian/0000-0001-5026-5531; Rubini, Michele/0000-0003-1448-9516; Wilcox, Allen J/0000-0002-3376-1311; Pennacchio, Len/0000-0002-8748-3732; FitzPatrick, David R./0000-0003-4861-969X; Mossey, Peter/0000-0002-9914-6901; melbye, mads/0000-0001-8264-6785; Rahimov, Fedik/0000-0001-6519-7404; Domann, Frederick/0000-0002-0489-2179	National Institutes of Health (NIH) [P50 DE16215, P30 ES05605, R37 DE08559, R01-DE13513, 1 UL1 RR024979-01, R01-CA73612, R01-HG003988]; Intramural Research Program of the National Human Genome Research Institute; Intramural Research Program of the NIH; National Institute of Environmental Health Sciences; European Commission FP5; EUROCRAN [QLG1-CT-2000-01019]; American Heart Association;  [DE-AC02-05CH11231];  [T32 CA078586]; NATIONAL CANCER INSTITUTE [R01CA073612, T32CA078586] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003988, ZIAHG000060, ZIBHG000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016148, R37DE008559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE008559, P50DE009170, R01DE013513, P50DE016215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605, R01ES010876, ZIAES049027] Funding Source: NIH RePORTER; Medical Research Council [MC_U127561093] Funding Source: researchfish; MRC [MC_U127561093] Funding Source: UKRI	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of the National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); European Commission FP5(European CommissionEuropean Commission Joint Research Centre); EUROCRAN; American Heart Association(American Heart Association); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank A. Kinoshita, K. Frees, A. Mansilla, J. L'Heureux, M. Johnson, H. Morrison, G. Wehby, N. Rorick, K. Bedell and L. Powers for technical assistance and S. McConnell, D. Benton and M. DeVore for their administrative assistance. We would also like to thank A. Klingelhutz (University of Iowa) for kindly providing us with HFK cell line. This work was supported by grants from the National Institutes of Health (NIH): P50 DE16215 (J.C.M., M.L.M., B.C.S.), P30 ES05605 (J.C.M.), R37 DE08559 (J.C.M., M.L.M.), R01-DE13513 (B.C.S.), 1 UL1 RR024979-01 (J.C.M., B.C.S.), R01-CA73612 (F.E.D.), R01-HG003988 administered under Department of Energy Contract DE-AC02-05CH11231 (L.A.P.) as well as by the Intramural Research Program of the National Human Genome Research Institute (E.D.G.), in part by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (A.J.W.), and European Commission FP5: EUROCRAN Project (contract no. QLG1-CT-2000-01019) (M.R., P.A.M., J.L., R.P.S.-T.). A.V. was supported by the American Heart Association. M.J.H. received salary support from T32 CA078586.	Bille C, 2007, EUR J EPIDEMIOL, V22, P173, DOI 10.1007/s10654-006-9099-5; Blanton SH, 2005, AM J MED GENET A, V137A, P259, DOI 10.1002/ajmg.a.30887; Cirulli ET, 2007, HUM MOL GENET, V16, P1931, DOI 10.1093/hmg/ddm140; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Ghassibe M, 2005, EUR J HUM GENET, V13, P1239, DOI 10.1038/sj.ejhg.5201486; Graham RR, 2007, P NATL ACAD SCI USA, V104, P6758, DOI 10.1073/pnas.0701266104; Harville EW, 2005, AM J EPIDEMIOL, V162, P448, DOI 10.1093/aje/kwi214; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Jugessur A, 2005, CURR OPIN GENET DEV, V15, P270, DOI 10.1016/j.gde.2005.03.003; Knight AS, 2006, DEV DYNAM, V235, P1441, DOI 10.1002/dvdy.20598; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Marazita ML, 2004, AM J HUM GENET, V75, P161, DOI 10.1086/422475; Margulies EH, 2003, GENOME RES, V13, P2507, DOI 10.1101/gr.1602203; Milunsky JM, 2008, AM J HUM GENET, V82, P1171, DOI 10.1016/j.ajhg.2008.03.005; Mitchell LE, 2002, CLEFT PALATE-CRAN J, V39, P93, DOI 10.1597/1545-1569(2002)039<0093:GFTDAA>2.0.CO;2; Mossey P, 2007, ORTHOD CRANIOFAC RES, V10, P114, DOI 10.1111/j.1601-6343.2007.00398.x; Nguyen RHN, 2007, ANN EPIDEMIOL, V17, P763, DOI 10.1016/j.annepidem.2007.04.008; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Park JW, 2007, GENET MED, V9, P219, DOI 10.1097/GIM.0b013e3180423cca; Poulin F, 2005, GENOMICS, V85, P774, DOI 10.1016/j.ygeno.2005.03.003; Provenzano MJ, 2007, EXP MOL PATHOL, V83, P277, DOI 10.1016/j.yexmp.2007.06.001; Riley BM, 2007, P NATL ACAD SCI USA, V104, P4512, DOI 10.1073/pnas.0607956104; Scapoli L, 2005, AM J HUM GENET, V76, P180, DOI 10.1086/427344; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Schwartz S, 2003, NUCLEIC ACIDS RES, V31, P3518, DOI 10.1093/nar/gkg579; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Thomas JW, 2003, NATURE, V424, P788, DOI 10.1038/nature01858; Vieira AR, 2005, PLOS GENET, V1, P651, DOI 10.1371/journal.pgen.0010064; Weinberg CR, 1999, AM J HUM GENET, V65, P229, DOI 10.1086/302466; Zucchero TM, 2004, NEW ENGL J MED, V351, P769, DOI 10.1056/NEJMoa032909	30	314	331	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1341	1347		10.1038/ng.242	http://dx.doi.org/10.1038/ng.242			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18836445	Green Accepted			2022-12-27	WOS:000260501500028
J	Chambers, JC; Elliott, P; Zabaneh, D; Zhang, WH; Li, Y; Froguel, P; Balding, D; Scott, J; Kooner, JS				Chambers, John C.; Elliott, Paul; Zabaneh, Delilah; Zhang, Weihua; Li, Yun; Froguel, Philippe; Balding, David; Scott, James; Kooner, Jaspal S.			Common genetic variation near MC4R is associated with waist circumference and insulin resistance	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; OBESITY; DISEASE; EXPRESSION; RISK	We carried out a genome-wide association study (318,237 SNPs) for insulin resistance and related phenotypes in 2,684 Indian Asians, with further testing in 11,955 individuals of Indian Asian or European ancestry. We found associations of rs12970134 near MC4R with waist circumference (P = 1.7 x 10(-9)) and, independently, with insulin resistance. Homozygotes for the risk allele of rs12970134 have similar to 2 cm increased waist circumference. Common genetic variation near MC4R is associated with risk of adiposity and insulin resistance.	[Scott, James; Kooner, Jaspal S.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Natl Heart & Lung Inst, London W12 0NN, England; [Chambers, John C.; Elliott, Paul; Zabaneh, Delilah; Zhang, Weihua; Balding, David] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Li, Yun] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sect Genom Med, London W12 0NN, England; Inst Pasteur, Ctr Natl Rech Sci, Inst Biol 8090, F-59019 Lille, France	Imperial College London; Imperial College London; University of Michigan System; University of Michigan; Imperial College London; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille	Kooner, JS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Natl Heart & Lung Inst, Du Cane Rd, London W12 0NN, England.	j.kooner@imperial.ac.uk	Balding, David/G-9898-2011; FROGUEL, Philippe/O-6799-2017; zhang, weihua/GXV-1334-2022	Balding, David/0000-0002-1480-6115; FROGUEL, Philippe/0000-0003-2972-0784; 	British Heart Foundation [SP/04/002] Funding Source: Medline; Medical Research Council [G0700931, G0600331, G0601966] Funding Source: Medline; Wellcome Trust [066786] Funding Source: Medline; MRC [G0600331, G0601966, G0700931] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kooner JS, 2008, NAT GENET, V40, P149, DOI 10.1038/ng.2007.61; Kooner JS, 1998, ARTERIOSCL THROM VAS, V18, P1021, DOI 10.1161/01.ATV.18.7.1021; Lopez AD, 1998, NAT MED, V4, P1241, DOI 10.1038/3218; MCKEIGUE PM, 1991, LANCET, V337, P382, DOI 10.1016/0140-6736(91)91164-P; Nogueiras R, 2007, J CLIN INVEST, V117, P3475, DOI 10.1172/JCI31743; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Schones DE, 2008, NAT REV GENET, V9, P179, DOI 10.1038/nrg2270; Trevaskis JL, 2007, OBESITY, V15, P2664, DOI 10.1038/oby.2007.318; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76	15	379	392	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2008	40	6					716	718		10.1038/ng.156	http://dx.doi.org/10.1038/ng.156			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18454146	Green Submitted			2022-12-27	WOS:000256212000012
J	Zeggini, E; Scott, LJ; Saxena, R; Voight, BF; Marchini, JL; Hu, T; de Bakker, PIW; Abecasis, GR; Almgren, P; Andersen, G; Ardlie, K; Bostroem, KB; Bergman, RN; Bonnycastle, LL; Borch-Johnsen, K; Burtt, NP; Chen, H; Chines, PS; Daly, MJ; Deodhar, P; Ding, CJ; Doney, ASF; Duren, WL; Elliott, KS; Erdos, MR; Frayling, TM; Freathy, RM; Gianniny, L; Grallert, H; Grarup, N; Groves, CJ; Guiducci, C; Hansen, T; Herder, C; Hitman, GA; Hughes, TE; Isomaa, B; Jackson, AU; Jorgensen, T; Kong, A; Kubalanza, K; Kuruvilla, FG; Kuusisto, J; Langenberg, C; Lango, H; Lauritzen, T; Li, Y; Lindgren, CM; Lyssenko, V; Marvelle, AF; Meisinger, C; Midthjell, K; Mohlke, KL; Morken, MA; Morris, AD; Narisu, N; Nilsson, P; Owen, KR; Palmer, CNA; Payne, F; Perry, JRB; Pettersen, E; Platou, C; Prokopenko, I; Qi, L; Qin, L; Rayner, NW; Rees, M; Roix, JJ; Sandbaek, A; Shields, B; Sjogren, M; Steinthorsdottir, V; Stringham, HM; Swift, AJ; Thorleifsson, G; Thorsteinsdottir, U; Timpson, NJ; Tuomi, T; Tuomilehto, J; Walker, M; Watanabe, RM; Weedon, MN; Willer, CJ; Illig, T; Hveem, K; Hu, FB; Laakso, M; Stefansson, K; Pedersen, O; Wareham, NJ; Barroso, I; Hattersley, AT; Collins, FS; Groop, L; McCarthy, MI; Boehnke, M; Altshuler, D				Zeggini, Eleftheria; Scott, Laura J.; Saxena, Richa; Voight, Benjamin F.; Marchini, Jonathan L.; Hu, Tianle; de Bakker, Paul I. W.; Abecasis, Goncalo R.; Almgren, Peter; Andersen, Gitte; Ardlie, Kristin; Bostroem, Kristina Bengtsson; Bergman, Richard N.; Bonnycastle, Lori L.; Borch-Johnsen, Knut; Burtt, Noel P.; Chen, Hong; Chines, Peter S.; Daly, Mark J.; Deodhar, Parimal; Ding, Chia-Jen; Doney, Alex S. F.; Duren, William L.; Elliott, Katherine S.; Erdos, Michael R.; Frayling, Timothy M.; Freathy, Rachel M.; Gianniny, Lauren; Grallert, Harald; Grarup, Niels; Groves, Christopher J.; Guiducci, Candace; Hansen, Torben; Herder, Christian; Hitman, Graham A.; Hughes, Thomas E.; Isomaa, Bo; Jackson, Anne U.; Jorgensen, Torben; Kong, Augustine; Kubalanza, Kari; Kuruvilla, Finny G.; Kuusisto, Johanna; Langenberg, Claudia; Lango, Hana; Lauritzen, Torsten; Li, Yun; Lindgren, Cecilia M.; Lyssenko, Valeriya; Marvelle, Amanda F.; Meisinger, Christa; Midthjell, Kristian; Mohlke, Karen L.; Morken, Mario A.; Morris, Andrew D.; Narisu, Narisu; Nilsson, Peter; Owen, Katharine R.; Palmer, Colin N. A.; Payne, Felicity; Perry, John R. B.; Pettersen, Elin; Platou, Carl; Prokopenko, Inga; Qi, Lu; Qin, Li; Rayner, Nigel W.; Rees, Matthew; Roix, Jeffrey J.; Sandbaek, Anelli; Shields, Beverley; Sjogren, Marketa; Steinthorsdottir, Valgerdur; Stringham, Heather M.; Swift, Amy J.; Thorleifsson, Gudmar; Thorsteinsdottir, Unnur; Timpson, Nicholas J.; Tuomi, Tiinamaija; Tuomilehto, Jaakko; Walker, Mark; Watanabe, Richard M.; Weedon, Michael N.; Willer, Cristen J.; Illig, Thomas; Hveem, Kristian; Hu, Frank B.; Laakso, Markku; Stefansson, Kari; Pedersen, Oluf; Wareham, Nicholas J.; Barroso, Ines; Hattersley, Andrew T.; Collins, Francis S.; Groop, Leif; McCarthy, Mark I.; Boehnke, Michael; Altshuler, David		DIAGRAM Consortium; Wellcome Trust Case Control Consor	Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes	NATURE GENETICS			English	Article							PROSTATE-CANCER; RISK LOCI; VARIANTS; GENES	Genome-wide association (GWA) studies have identified multiple loci at which common variants modestly but reproducibly influence risk of type 2 diabetes (T2D)(1-11). Established associations to common and rare variants explain only a small proportion of the heritability of T2D. As previously published analyses had limited power to identify variants with modest effects, we carried out meta-analysis of three T2D GWA scans comprising 10,128 individuals of European descent and similar to 2.2 million SNPs (directly genotyped and imputed), followed by replication testing in an independent sample with an effective sample size of up to 53,975. We detected at least six previously unknown loci with robust evidence for association, including the JAZF1 (P=5.0 x 10(-14)), CDC123-CAMK1D (P=1.2 x 10(-10)), TSPAN8-LGR5 (P=1.1 x 10(-9)), THADA (P=1.1 x 10(-9)), ADAMTS9 (P=1.2 x 10(-8)) and NOTCH2 (P=4.1 x 10(-8)) gene regions. Our results illustrate the value of large discovery and follow-up samples for gaining further insights into the inherited basis of T2D.	[Marchini, Jonathan L.; Elliott, Katherine S.; Lindgren, Cecilia M.; Prokopenko, Inga; Rayner, Nigel W.; Roix, Jeffrey J.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Scott, Laura J.; Hu, Tianle; Andersen, Gitte; Bostroem, Kristina Bengtsson; Ding, Chia-Jen; Duren, William L.; Erdos, Michael R.; Freathy, Rachel M.; Jackson, Anne U.; Li, Yun; Meisinger, Christa; Stringham, Heather M.; Watanabe, Richard M.; Willer, Cristen J.; Barroso, Ines] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Scott, Laura J.; Andersen, Gitte; Bostroem, Kristina Bengtsson; Duren, William L.; Erdos, Michael R.; Jackson, Anne U.; Li, Yun; Meisinger, Christa; Stringham, Heather M.; Watanabe, Richard M.; Willer, Cristen J.; Barroso, Ines] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Saxena, Richa; Voight, Benjamin F.; Ardlie, Kristin; Borch-Johnsen, Knut; Burtt, Noel P.; Deodhar, Parimal; Duren, William L.; Gianniny, Lauren; Guiducci, Candace; Hughes, Thomas E.; Kuruvilla, Finny G.; Lauritzen, Torsten] Broad Inst Harvard, Cambridge, MA 02142 USA; [Saxena, Richa; Voight, Benjamin F.; de Bakker, Paul I. W.; Ardlie, Kristin; Kuruvilla, Finny G.; Altshuler, David] MIT, Cambridge, MA 02142 USA; [Saxena, Richa; Voight, Benjamin F.; Daly, Mark J.; Altshuler, David] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Saxena, Richa; Voight, Benjamin F.; Abecasis, Goncalo R.; Daly, Mark J.; Altshuler, David] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Saxena, Richa; Kuruvilla, Finny G.; Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Saxena, Richa; Voight, Benjamin F.; de Bakker, Paul I. W.; Daly, Mark J.; Altshuler, David] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Saxena, Richa; Altshuler, David] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Marchini, Jonathan L.] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [de Bakker, Paul I. W.] Brigham & Womens Hosp, Harvard Partners Ctr Genet & Genom, Boston, MA 02115 USA; [Chines, Peter S.; Lyssenko, Valeriya; Nilsson, Peter; Sjogren, Marketa; Groop, Leif] Lund Univ, Dept Clin Sci, Diabet & Endocrinol Res Unit, Malmo Univ Hosp, S-20502 Malmo, Sweden; [Andersen, Gitte; Borch-Johnsen, Knut; Grarup, Niels; Hansen, Torben; Pedersen, Oluf] Steno Diabet Ctr, DK-2820 Copenhagen, Denmark; [Bostroem, Kristina Bengtsson] Skaraborg Inst, S-54130 Skovde, Sweden; [Bergman, Richard N.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 90033 USA; [Bonnycastle, Lori L.; Chines, Peter S.; Deodhar, Parimal; Erdos, Michael R.; Kubalanza, Kari; Morken, Mario A.; Narisu, Narisu; Rees, Matthew; Swift, Amy J.; Collins, Francis S.] NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; [Borch-Johnsen, Knut; Sandbaek, Anelli; Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, DK-8000 Aarhus, Denmark; [Chen, Hong; Hughes, Thomas E.; Roix, Jeffrey J.] Novartis Inst Biomed Res, Diabet & Metab Dis Area, Cambridge, MA 02139 USA; [Doney, Alex S. F.] Ninewells Hosp & Med Sch, Diabet Res Grp, Div Med & Therapeut, Dundee DD1 9SY, Scotland; [Frayling, Timothy M.; Freathy, Rachel M.; Lango, Hana; Perry, John R. B.; Weedon, Michael N.; Hattersley, Andrew T.] Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX1 2LU, Devon, England; [Frayling, Timothy M.; Freathy, Rachel M.; Lango, Hana; Perry, John R. B.; Shields, Beverley; Weedon, Michael N.; Hattersley, Andrew T.] Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England; [Grallert, Harald; Meisinger, Christa; Illig, Thomas] Gesell Strahlenforsch Natl Res Ctr Environm & Hlt, Inst Epidemiol, D-85764 Neuherberg, Germany; [Groves, Christopher J.; Lindgren, Cecilia M.; Owen, Katharine R.; Prokopenko, Inga; Rayner, Nigel W.] Univ Oxford, Oxford Ctr Diabetes Endocrinol & Metab, Oxford OX3 7LJ, England; [Herder, Christian] Univ Dusseldorf, Inst Clin Diabet Res, German Diabetes Ctr, Leiden Inst, D-40225 Dusseldorf, Germany; [Hitman, Graham A.] Royal London Hosp, Ctr Diabet & Metab Med, London E1 1BB, England; [Isomaa, Bo] Malmska Municipal Hlth Ctr & Hosp, FIN-68601 Pietarsaari, Finland; [Isomaa, Bo] Folkhalsan Res Ctr, FIN-00014 Helsinki, Finland; [Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; [Kong, Augustine; Steinthorsdottir, Valgerdur; Thorleifsson, Gudmar; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Kuusisto, Johanna; Laakso, Markku] Univ Kuopio, Dept Med, SF-70210 Kuopio, Finland; [Kuusisto, Johanna] Kuopio Univ Hosp, SF-70210 Kuopio, Finland; [Langenberg, Claudia; Wareham, Nicholas J.] Addenbrookes Hosp, MRC Epidemiol Unit, Inst Metab Sci, Cambridge CB2 0QQ, England; [Lauritzen, Torsten] Univ Aarhus, Dept Gen Practice, DK-8000 Aarhus, Denmark; [Marvelle, Amanda F.; Mohlke, Karen L.; Qin, Li] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Midthjell, Kristian; Platou, Carl; Hveem, Kristian] Norwegian Univ Sci & Technol, HUNT Res Ctr, Dept Publ Hlth & Gen Practice, Fac Med, N-7650 Verdal, Norway; [Palmer, Colin N. A.] Ninewells Hosp & Med Sch, Populat Pharmacogenet Grp, Biomed Res Ctr, Dundee DD1 9SY, Scotland; [Payne, Felicity; Barroso, Ines] Wellcome Trust Sanger Inst, Metab Dis Grp, Cambridge CB10 1SA, England; [Qi, Lu; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Qi, Lu; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Qi, Lu] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Qi, Lu; Hu, Frank B.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Timpson, Nicholas J.] Univ Bristol, MRC Ctr Causal Analyses Translat Epidemiol, Bristol BS2 8PR, Avon, England; [Tuomi, Tiinamaija; Groop, Leif] Univ Helsinki, Helsinki Univ Hosp, Dept Med, FIN-00300 Helsinki, Finland; [Tuomilehto, Jaakko; Altshuler, David] Natl Publ Hlth Inst, Diabet Unit, Dept Epidemiol & Hlth Promot, SF-00300 Helsinki, Finland; [Tuomilehto, Jaakko] Univ Helsinki, Dept Publ Hlth, Helsinki 00014, Finland; [Tuomilehto, Jaakko] S Ostrobothnia Cent Hosp, Seinajoki 60220, Finland; [Walker, Mark] Newcastle Univ, Diabet Res Grp, Sch Clin Med Sci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Watanabe, Richard M.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; Massachusetts Gen Hosp, Diabet Unit, Boston, MA 02114 USA; [Pettersen, Elin] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7600 Levanger, Norway	University of Oxford; Wellcome Centre for Human Genetics; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Oxford; Harvard University; Brigham & Women's Hospital; Lund University; Skane University Hospital; Steno Diabetes Center; University of Southern California; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Aarhus University; Novartis; University of Dundee; University of Exeter; University of Exeter; University of Oxford; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Barts Health NHS Trust; Royal London Hospital; Folkhalsan Research Center; University of Copenhagen; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Aarhus University; University of North Carolina; University of North Carolina Chapel Hill; Norwegian University of Science & Technology (NTNU); University of Dundee; Wellcome Trust Sanger Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Bristol; University of Helsinki; Helsinki University Central Hospital; Finland National Institute for Health & Welfare; University of Helsinki; Newcastle University - UK; University of Southern California; Harvard University; Massachusetts General Hospital; Norwegian University of Science & Technology (NTNU)	McCarthy, MI (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	mark.mccarthy@drl.ox.ac.uk; boehnke@umich.edu; altshuler@molbio.mgh.harvard.edu	Doney, Alexander SF/P-7437-2017; Marchini, Jonathan/ABE-9024-2020; Grarup, Niels/K-2807-2015; Allen, Hana Lango/G-9026-2012; Daly, Mark J/B-2453-2017; Prokopenko, Inga/AAU-9895-2020; Saxena, Richa/AAG-7279-2020; Langenberg, Claudia/ABG-9067-2021; Meisinger, Christine/B-5358-2014; Voight, Benjamin/F-1775-2011; Stefansson, Kari/AAE-7187-2019; Timpson, Nicholas John/O-7548-2015; Palmer, Colin NA/C-7053-2008; Pedersen, Oluf/Z-1731-2019; Morris, Andrew D/C-2837-2009; Jørgensen, Torben/Z-1335-2018; Hu, Tianle/H-9105-2012; Prokopenko, Inga/H-3241-2014; Grallert, Harald/B-3424-2013; Abecasis, Goncalo R/B-7840-2010; Altshuler, David M/A-4476-2009; Hveem, Kristian/AFV-4683-2022; de Bakker, Paul IW/B-8730-2009; Study, GoDARTS/K-9448-2016; Attrill, Lauren/V-1688-2018; Fox, Laura J/C-6249-2016; Payne, Felicity/GKF-2573-2022; Pedersen, Oluf/AAG-8015-2020; Narisu, Narisu/T-6908-2019	Doney, Alexander SF/0000-0002-6210-5620; Marchini, Jonathan/0000-0003-0610-8322; Grarup, Niels/0000-0001-5526-1070; Allen, Hana Lango/0000-0002-7803-8688; Daly, Mark J/0000-0002-0949-8752; Langenberg, Claudia/0000-0002-5017-7344; Timpson, Nicholas John/0000-0002-7141-9189; Palmer, Colin NA/0000-0002-6415-6560; Pedersen, Oluf/0000-0002-3321-3972; Prokopenko, Inga/0000-0003-1624-7457; Altshuler, David M/0000-0002-7250-4107; de Bakker, Paul IW/0000-0001-7735-7858; Payne, Felicity/0000-0003-4228-581X; Hattersley, Andrew/0000-0001-5620-473X; Kong, Augustine/0000-0001-8193-5438; Hansen, Torben/0000-0001-8748-3831; Freathy, Rachel/0000-0003-4152-2238; Bergman, Richard/0000-0003-1539-4471; Weedon, Michael/0000-0002-6174-6135; Saxena, Richa/0000-0003-2233-1065; Lindgren, Cecilia/0000-0002-4903-9374; Jorgensen, Torben/0000-0001-9453-2830; Voight, Benjamin/0000-0002-6205-9994; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Zeggini, Eleftheria/0000-0003-4238-659X; Tuomi, Tiinamaija/0000-0002-8306-6202; Barroso, Ines/0000-0001-5800-4520	MRC [G0600705, G0601261] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL084729] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004171, ZIAHG000024, U01HG004399, Z01HG000024, R01HG002651, N01HG065403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058845, R01DK029867, R01DK072193, U01DK062370, R01DK062370, R56DK062370, P30DK040561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA021519] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 HG000024] Funding Source: Medline; Medical Research Council [G0600705, MC_U106179471, G0000649, G0601261] Funding Source: Medline; NCI NIH HHS [CA87969, P01 CA087969] Funding Source: Medline; NHGRI NIH HHS [U01 HG004399, R01 HG002651, U01 HG004171, N01HG65403, HG002651] Funding Source: Medline; NHLBI NIH HHS [HL084729, U01 HL084729] Funding Source: Medline; NIDA NIH HHS [U54 DA021519] Funding Source: Medline; NIDDK NIH HHS [R01 DK062370, R01 DK058845, R01 DK029867, DK062370, R01 DK072193, P30 DK040561, DK58845, DK072193, U01 DK062370, P30 DK040561-12, R56 DK062370] Funding Source: Medline; Wellcome Trust [076113, 072960, GR072960, 079557, 077016, 090532] Funding Source: Medline; Department of Health [DHCS/07/07/008] Funding Source: Medline; National Institute for Health Research [DHCS/07/07/008] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome Trust); Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Bieganowski P, 2004, J BIOL CHEM, V279, P44656, DOI 10.1074/jbc.M406151200; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Collins LL, 2004, P NATL ACAD SCI USA, V101, P15058, DOI 10.1073/pnas.0405700101; Drieschner N, 2006, THYROID, V16, P1091, DOI 10.1089/thy.2006.16.1091; Drieschner N, 2007, GENE, V403, P110, DOI 10.1016/j.gene.2007.06.029; Florez JC, 2007, DIABETES, V56, P3063, DOI 10.2337/db07-0451; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Hanson RL, 2007, DIABETES, V56, P3045, DOI 10.2337/db07-0462; Hayes MG, 2007, DIABETES, V56, P3033, DOI 10.2337/db07-0482; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Lammert E, 2000, MECH DEVELOP, V94, P199, DOI 10.1016/S0925-4773(00)00317-8; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; McCarthy MI, 2007, TRENDS PHARMACOL SCI, V28, P598, DOI 10.1016/j.tips.2007.10.008; Nakajima T, 2004, NUCLEIC ACIDS RES, V32, P4194, DOI 10.1093/nar/gkh741; Rampersaud E, 2007, DIABETES, V56, P3053, DOI 10.2337/db07-0457; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Salonen JT, 2007, AM J HUM GENET, V81, P338, DOI 10.1086/520599; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	27	1425	1475	1	155	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					638	645		10.1038/ng.120	http://dx.doi.org/10.1038/ng.120			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18372903	Green Submitted, Green Accepted			2022-12-27	WOS:000255366700033
J	Tran, PV; Haycraft, CJ; Besschetnova, TY; Turbe-Doan, A; Stottmann, RW; Herron, BJ; Chesebro, AL; Qiu, H; Scherz, PJ; Shah, JV; Yoder, BK; Beier, DR				Tran, Pamela V.; Haycraft, Courtney J.; Besschetnova, Tatiana Y.; Turbe-Doan, Annick; Stottmann, Rolf W.; Herron, Bruce J.; Chesebro, Allyson L.; Qiu, Haiyan; Scherz, Paul J.; Shah, Jagesh V.; Yoder, Bradley K.; Beier, David R.			THM1 negatively modulates mouse sonic hedgehog signal transduction and affects retrograde intraflagellar transport in cilia	NATURE GENETICS			English	Article							REPRESSOR FUNCTIONS; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTORS; VERTEBRATE LIMB; SPINAL-CORD; PROTEIN; GLI3; ACTIVATOR; CHAIN; CHLAMYDOMONAS	Characterization of previously described intraflagellar transport (IFT) mouse mutants has led to the proposition that normal primary cilia are required for mammalian cells to respond to the sonic hedgehog (SHH) signal. Here we describe an N-ethyl-N-nitrosourea-induced mutant mouse, alien (aln), which has abnormal primary cilia and shows overactivation of the SHH pathway. The aln locus encodes a novel protein, THM1 (tetratricopeptide repeat-containing hedgehog modulator-1), which localizes to cilia. aln-mutant cilia have bulb-like structures at their tips in which IFT proteins (such as IFT88) are sequestered, characteristic of Chlamydomonas reinhardtii and Caenorhabditis elegans retrograde IFT mutants. RNA-interference knockdown of Ttc21b (which we call Thm1 and which encodes THM1) in mouse inner medullary collecting duct cells expressing an IFT88-enhanced yellow fluorescent protein fusion recapitulated the aln-mutant cilial phenotype, and live imaging of these cells revealed impaired retrograde IFT. In contrast to previously described IFT mutants, Smoothened and full-length glioblastoma (GLI) proteins localize to aln-mutant cilia. We hypothesize that the aln retrograde IFT defect causes sequestration of IFT proteins in aln-mutant cilia and leads to the overactivated SHH signaling phenotype. Specifically, the aln mutation uncouples the roles of anterograde and retrograde transport in SHH signaling, suggesting that anterograde IFT is required for GLI activation and that retrograde IFT modulates this event.	[Tran, Pamela V.; Turbe-Doan, Annick; Stottmann, Rolf W.; Herron, Bruce J.; Chesebro, Allyson L.; Qiu, Haiyan; Beier, David R.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Haycraft, Courtney J.; Yoder, Bradley K.] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA; [Besschetnova, Tatiana Y.; Shah, Jagesh V.] Harvard Univ, Sch Med, Harvard Inst Med, Div Renal,Brigham & Womens Hosp, Boston, MA 02115 USA; [Scherz, Paul J.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Alabama System; University of Alabama Birmingham; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Beier, DR (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Genet, New Res Bldg,77 Ave Louis Pasteur, Boston, MA 02115 USA.	beier@receptor.med.harvard.edu	Stottmann, Rolf/U-6589-2019; Stottmann, Rolf/GRO-3453-2022	Stottmann, Rolf/0000-0003-4512-6806; Chesebro, Allyson/0000-0002-9880-2743	NICHD NIH HHS [R01HD056030, R01 HD036404, F32 HD053198, R01 HD056030, F32 HD053198-01A2, R01HD36404, F32 HD053198-02] Funding Source: Medline; NIDDK NIH HHS [P50 DK074030-019001, P50DK074030, P30 DK074038, P50 DK074030-029001, P50 DK074030] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD036404, R01HD056030] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [F32HD053198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK074030, P30DK074038] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ansley SJ, 2003, NATURE, V425, P628, DOI 10.1038/nature02030; Blacque OE, 2006, MOL BIOL CELL, V17, P5053, DOI 10.1091/mbc.E06-06-0571; Caspary T, 2007, DEV CELL, V12, P767, DOI 10.1016/j.devcel.2007.03.004; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Ding Q, 1998, DEVELOPMENT, V125, P2533; Eggenschwiler JT, 2001, NATURE, V412, P194, DOI 10.1038/35084089; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; Haycraft CJ, 2001, DEVELOPMENT, V128, P1493; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Houde C, 2006, DEV BIOL, V300, P523, DOI 10.1016/j.ydbio.2006.09.001; Huangfu D, 2005, P NATL ACAD SCI USA, V102, P11325, DOI 10.1073/pnas.0505328102; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Iomini C, 2001, J CELL BIOL, V153, P13, DOI 10.1083/jcb.153.1.13; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; KARLIN S, 1985, P NATL ACAD SCI USA, V82, P8597, DOI 10.1073/pnas.82.24.8597; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; May SR, 2005, DEV BIOL, V287, P378, DOI 10.1016/j.ydbio.2005.08.050; Mo R, 1997, DEVELOPMENT, V124, P113; Moran JL, 2006, GENOME RES, V16, P436, DOI 10.1101/gr.4563306; MORGENSTERN JP, 1990, NUCLEIC ACIDS RES, V18, P3587, DOI 10.1093/nar/18.12.3587; Ogden SK, 2006, J BIOL CHEM, V281, P7237, DOI 10.1074/jbc.M510169200; Pazour GJ, 1998, J CELL BIOL, V141, P979, DOI 10.1083/jcb.141.4.979; PERKINS LA, 1986, DEV BIOL, V117, P456, DOI 10.1016/0012-1606(86)90314-3; Perrone CA, 2003, MOL BIOL CELL, V14, P2041, DOI 10.1091/mbc.e02-10-0682; Persson M, 2002, GENE DEV, V16, P2865, DOI 10.1101/gad.243402; Piperno G, 1998, J CELL BIOL, V143, P1591, DOI 10.1083/jcb.143.6.1591; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Schafer JC, 2003, MOL BIOL CELL, V14, P2057, DOI 10.1091/mbc.E02-10-0677; Sloboda RD, 2005, J CELL BIOCHEM, V94, P266, DOI 10.1002/jcb.20323; Snell WJ, 2004, CELL, V117, P693, DOI 10.1016/j.cell.2004.05.019; Vierkotten J, 2007, DEVELOPMENT, V134, P2569, DOI 10.1242/dev.003715; Villavicencio EH, 2000, AM J HUM GENET, V67, P1047, DOI 10.1016/S0002-9297(07)62934-6; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang CB, 2007, DEV BIOL, V305, P460, DOI 10.1016/j.ydbio.2007.02.029; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3; Zhou Q, 2000, NEURON, V25, P331, DOI 10.1016/S0896-6273(00)80898-3	45	242	246	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2008	40	4					403	410		10.1038/ng.105	http://dx.doi.org/10.1038/ng.105			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18327258	Green Accepted			2022-12-27	WOS:000254388100010
J	Owusu-Ansah, E; Yavari, A; Mandal, S; Banerjee, U				Owusu-Ansah, Edward; Yavari, Amir; Mandal, Sudip; Banerjee, Utpal			Distinct mitochondrial retrograde signals control the G1-S cell cycle checkpoint	NATURE GENETICS			English	Article							TRANSCRIPTION FACTOR FOXO3A; DROSOPHILA EYE; OXIDATIVE STRESS; PROLIFERATION; APOPTOSIS; OXYGEN; JNK; SUPEROXIDE; ACTIVATION; EXPRESSION	During electron transport, the mitochondrion generates ATP and reactive oxygen species (ROS), a group of partially reduced and highly reactive metabolites of oxygen(1). In this in vivo genetic analysis in Drosophila melanogaster, we establish that disruption of complex I of the mitochondrial electron transport chain specifically retards the cell cycle during the G1-S transition. The mechanism involves a specific signaling cascade initiated by ROS and transduced by ASK-1, JNK, FOXO and the Drosophila p27 homolog, Dacapo. On the basis of our data combined with previous analyses of the system(2), we conclude that mitochondrial dysfunction activates at least two retrograde signals to specifically enforce a G1-S cell cycle checkpoint. One such signal involves an increase in AMP production and downregulation of cyclin E protein; another independent pathway involves increased ROS and upregulation of Dacapo. Thus, our results indicate that the mitochondrion can use AMP and ROS at sublethal concentrations as independent signaling molecules to modulate cell cycle progression.	[Owusu-Ansah, Edward; Yavari, Amir; Mandal, Sudip; Banerjee, Utpal] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Banerjee, Utpal] Univ Calif Los Angeles, Dept Biol Chem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Banerjee, U (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	banerjee@mbi.ucla.edu		Mandal, Sudip/0000-0002-2211-483X	NATIONAL EYE INSTITUTE [R01EY008152] Funding Source: NIH RePORTER; NEI NIH HHS [R01-EY00852, R01 EY008152] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Baker NE, 2001, SEMIN CELL DEV BIOL, V12, P499, DOI 10.1006/scdb.2001.0274; Baonza A, 2005, DEV CELL, V8, P529, DOI 10.1016/j.devcel.2005.01.019; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; DENOOIJ JC, 1995, SCIENCE, V270, P983, DOI 10.1126/science.270.5238.983; Edgar BA, 1996, SCIENCE, V274, P1646, DOI 10.1126/science.274.5293.1646; EDWARD EOA, 2008, NAT PROTOC; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; Grivennikova VG, 2006, BBA-BIOENERGETICS, V1757, P553, DOI 10.1016/j.bbabio.2006.03.013; Jasper H, 2002, DEV CELL, V3, P511, DOI 10.1016/S1534-5807(02)00297-6; Karim FD, 1998, DEVELOPMENT, V125, P1; Kim HP, 2006, ANNU REV PHARMACOL, V46, P411, DOI 10.1146/annurev.pharmtox.46.120604.141053; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Kuzin B, 1996, CELL, V87, P639, DOI 10.1016/S0092-8674(00)81384-7; Mandal S, 2005, DEV CELL, V9, P843, DOI 10.1016/j.devcel.2005.11.006; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Newsome TP, 2000, DEVELOPMENT, V127, P851; Robinson KM, 2006, P NATL ACAD SCI USA, V103, P15038, DOI 10.1073/pnas.0601945103; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wingrove JA, 1999, CELL, V98, P105, DOI 10.1016/S0092-8674(00)80610-8; WOLFF T, 1991, DEVELOPMENT, V113, P841; Xu WM, 2004, NAT CELL BIOL, V6, P1129, DOI 10.1038/ncb1188	28	270	275	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2008	40	3					356	361		10.1038/ng.2007.50	http://dx.doi.org/10.1038/ng.2007.50			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18246068				2022-12-27	WOS:000253548400029
J	Shimomura, Y; Wajid, M; Ishii, Y; Shapiro, L; Petukhova, L; Gordon, D; Christiano, AM				Shimomura, Yutaka; Wajid, Muhammad; Ishii, Yoshiyuki; Shapiro, Lawrence; Petukhova, Lynn; Gordon, Derek; Christiano, Angela M.			Disruption of P2RY5, an orphan G protein-coupled receptor, underlies autosomal recessive woolly hair	NATURE GENETICS			English	Article							RETINOBLASTOMA SUSCEPTIBILITY GENE; LYSOPHOSPHATIDIC ACID; IDENTIFICATION; CARDIOMYOPATHY; KERATODERMA; MUTATION; ENCODES; DISEASE; SHAPE; 6H1	The genetic determinants of hair texture in humans are largely unknown. Several human syndromes exist in which woolly hair comprises a part of the phenotype; however, simple autosomal recessive inheritance of isolated woolly hair has only rarely been reported(1,2). To identify a gene involved in controlling hair texture, we performed genetic linkage analysis in six families of Pakistani origin with autosomal recessive woolly hair (ARWH; OMIM 278150). All six families showed linkage to chromosome 13q14.2-14.3 (Z = 17.97). In all cases, we discovered pathogenic mutations in P2RY5, which encodes a G protein-coupled receptor and is a nested gene residing within intron 17 of the retinoblastoma 1 (RB1) gene. P2RY5 is expressed in both Henle's and Huxley's layers of the inner root sheath of the hair follicle. Our findings indicate that disruption of P2RY5 underlies ARWH and, more broadly, uncover a new gene involved in determining hair texture in humans.	[Shimomura, Yutaka; Wajid, Muhammad; Ishii, Yoshiyuki; Petukhova, Lynn; Christiano, Angela M.] Columbia Univ Coll Phys & Surg, Dept Dermatol, New York, NY 10032 USA; [Shapiro, Lawrence] Columbia Univ Coll Phys & Surg, Dept Ophthalmol, New York, NY 10032 USA; [Shapiro, Lawrence] Columbia Univ Coll Phys & Surg, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Gordon, Derek] Rutgers State Univ, Dept Genet, Piscataway, NJ 08854 USA; [Christiano, Angela M.] Columbia Univ Coll Phys & Surg, Dept Genet & Dev, New York, NY 10032 USA	Columbia University; Columbia University; Columbia University; Rutgers State University New Brunswick; Columbia University	Christiano, AM (corresponding author), Columbia Univ Coll Phys & Surg, Dept Dermatol, 630 W 168th St,VC15 204A, New York, NY 10032 USA.	amc65@columbia.edu	Petukhova, Lynn/W-6858-2019; Shapiro, Lawrence/AAE-7172-2019; Gordon, Derek/AAU-2281-2020; Wajid, Muhammad/F-5087-2015	Gordon, Derek/0000-0003-2945-1748; 	NIAMS NIH HHS [R01AR44924] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044924] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Bernard BA, 2003, J AM ACAD DERMATOL, V48, pS120, DOI 10.1067/mjd.2003.279; Chien AJ, 2006, J AM ACAD DERMATOL, V54, pS35, DOI 10.1016/j.jaad.2005.01.092; GOODRICH DW, 1993, BIOCHIM BIOPHYS ACTA, V1155, P43, DOI 10.1016/0304-419X(93)90021-4; Greig AVH, 2003, J INVEST DERMATOL, V120, P1007, DOI 10.1046/j.1523-1747.2003.12261.x; Herzog H, 1996, GENOME RES, V6, P858, DOI 10.1101/gr.6.9.858; HRDY D, 1973, AM J PHYS ANTHROPOL, V39, P7, DOI 10.1002/ajpa.1330390103; HUTCHINSON P E, 1974, Transactions of the St. John's Hospital Dermatological Society, V60, P160; Kazantseva A, 2006, SCIENCE, V314, P982, DOI 10.1126/science.1133276; Lee S, 2007, P NATL ACAD SCI USA, V104, P13732, DOI 10.1073/pnas.0701771104; Levy-Nissenbaum E, 2003, NAT GENET, V34, P151, DOI 10.1038/ng1163; Li Q, 1997, BIOCHEM BIOPH RES CO, V236, P455, DOI 10.1006/bbrc.1997.6984; McKoy G, 2000, LANCET, V355, P2119, DOI 10.1016/S0140-6736(00)02379-5; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Norgett EE, 2000, HUM MOL GENET, V9, P2761, DOI 10.1093/hmg/9.18.2761; Robben JH, 2005, AM J PHYSIOL-RENAL, V289, pF265, DOI 10.1152/ajprenal.00404.2004; SALAMON T, 1963, Hautarzt, V14, P540; Schweizer J, 2007, EXP CELL RES, V313, P2010, DOI 10.1016/j.yexcr.2007.02.032; Song HL, 2006, CANCER RES, V66, P10220, DOI 10.1158/0008-5472.CAN-06-2222; Sonoda H, 2002, J BIOL CHEM, V277, P34254, DOI 10.1074/jbc.M201659200; Stratigos AJ, 2001, ARCH DERMATOL, V137, P1465; Thibaut S, 2005, BRIT J DERMATOL, V152, P632, DOI 10.1111/j.1365-2133.2005.06521.x; VULPE C, 1993, NAT GENET, V3, P7, DOI 10.1038/ng0193-7; Webb TE, 1996, BIOCHEM BIOPH RES CO, V219, P105, DOI 10.1006/bbrc.1996.0189; Weeda G, 1997, AM J HUM GENET, V60, P320; Yu P, 2005, GENOMICS, V86, P414, DOI 10.1016/j.ygeno.2005.06.008	25	161	173	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2008	40	3					335	339		10.1038/ng.100	http://dx.doi.org/10.1038/ng.100			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18297072				2022-12-27	WOS:000253548400025
J	Hillbertz, NHCS; Isaksson, M; Karlsson, EK; Hellmen, E; Pielberg, GR; Savolainen, P; Wade, CM; Von Euler, H; Gustafson, U; Hedhammar, K; Nilsson, M; Lindblad-Toh, K; Andersson, L; Andersson, G				Hillbertz, Nicolette H. C. Salmon; Isaksson, Magnus; Karlsson, Elinor K.; Hellmen, Eva; Pielberg, Gerli Rosengren; Savolainen, Peter; Wade, Claire M.; Von Euler, Henrik; Gustafson, Ulla; Hedhammar, Ake; Nilsson, Mats; Lindblad-Toh, Kerstin; Andersson, Leif; Andersson, Goran			Duplication of FGF3, FGF4, FGF19 and ORAOV1 causes hair ridge and predisposition to dermoid sinus in Ridgeback dogs	NATURE GENETICS			English	Article							EXPRESSION; GENE	The dorsal hair ridge in Rhodesian and Thai Ridgeback dogs is caused by a dominant mutation that also predisposes to the congenital developmental disorder dermoid sinus. Here we show that the causative mutation is a 133-kb duplication involving three fibroblast growth factor (FGF) genes. FGFs play a crucial role in development, suggesting that the ridge and dermoid sinus are caused by dysregulation of one or more of the three FGF genes during development.	Swedish Univ Agr Sci, Ctr Biomed, Dept Anim Breeding & Genet, SE-75124 Uppsala, Sweden; Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden; Broad Inst Harvard, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Boston Univ, Bioinformat Program, Boston, MA 02215 USA; SLU, Dept Physiol Anat & Biochem, SE-75007 Uppsala, Sweden; Uppsala Univ, Dept Med Biochem & Microbiol, SE-75124 Uppsala, Sweden; AlbaNova Univ Ctr, Royal Inst Technol, Sch Biotechnol, SE-10691 Stockholm, Sweden; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; SLU, Dept Clin Sci, SE-75007 Uppsala, Sweden	Swedish University of Agricultural Sciences; Uppsala University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Boston University; Swedish University of Agricultural Sciences; Uppsala University; Royal Institute of Technology; Harvard University; Massachusetts General Hospital; Swedish University of Agricultural Sciences	Andersson, L (corresponding author), Swedish Univ Agr Sci, Ctr Biomed, Dept Anim Breeding & Genet, Box 597, SE-75124 Uppsala, Sweden.	leif.andersson@imbim.uu.se; goran.andersson@hgen.slu.se	Ronnberg, HENRIK Paul Olof/AAP-9678-2021; Andersson, Goran/AAK-6564-2020; Fiumefreddo, Andrea/T-2977-2019	Ronnberg, HENRIK Paul Olof/0000-0001-6098-5364; Andersson, Goran/0000-0001-5131-3144; Karlsson, Elinor/0000-0002-4343-3776; Wade, Claire/0000-0003-3413-4771; Hedhammar, Ake/0000-0001-7048-3851				Ackerman LL, 2003, PEDIATRICS, V112, P641, DOI 10.1542/peds.112.3.641; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; ELTON S, 2001, NEUROSURG FOCUS, V10, P1; HALL S, 2003, DOGS AFRICA, P123; Hillbertz NHCS, 2006, J SMALL ANIM PRACT, V47, P184, DOI 10.1111/j.1748-5827.2006.00016.x; Hillbertz NHCS, 2005, J SMALL ANIM PRACT, V46, P71, DOI 10.1111/j.1748-5827.2005.tb00295.x; Huang X, 2002, P NATL ACAD SCI USA, V99, P11369, DOI 10.1073/pnas.172285799; ISAKSSONM, 2007, NUCLEIC ACIDS RES, DOI DOI 10.1093/NAR/GKM651; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Ornitz DM, 2001, GENOME BIOL, V2; Padmanabhan Rengasamy, 2006, Congenital Anomalies, V46, P55, DOI 10.1111/j.1741-4520.2006.00104.x; Powles N, 2004, DEV DYNAM, V230, P44, DOI 10.1002/dvdy.20028; Rosenquist TA, 1996, DEV DYNAM, V205, P379, DOI 10.1002/(SICI)1097-0177(199604)205:4<379::AID-AJA2>3.0.CO;2-F; Wang YS, 2006, P NATL ACAD SCI USA, V103, P19800, DOI 10.1073/pnas.0609712104; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005	15	154	158	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2007	39	11					1318	1320		10.1038/ng.2007.4	http://dx.doi.org/10.1038/ng.2007.4			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17906623				2022-12-27	WOS:000250575900015
J	Pinkston-Gosse, J; Kenyon, C				Pinkston-Gosse, Julie; Kenyon, Cynthia			DAF-16/FOXO targets genes that regulate tumor growth in Caenorhabditis elegans	NATURE GENETICS			English	Article							LIFE-SPAN; SUPPRESSOR GENE; CELL-GROWTH; CANCER; OVEREXPRESSION; PROLIFERATION; DOWNSTREAM; LONGEVITY; TRANSPORT; ADENOSINE	Cancer is an age-related disease, and inhibiting insulin/insulinlike growth factor 1 (IGF-1) signaling extends lifespan and increases tumor resistance in C. elegans and mammals. To investigate how the insulin/IGF-1 pathway couples these two processes, we analyzed putative transcriptional targets of the C. elegans FOXO transcription factor DAF-16, which promotes both longevity and tumor resistance. Twenty-nine of 734 genes tested influenced germline-tumor cell proliferation or p53-dependent apoptosis. About half of these genes also affected normal aging, thereby linking these two processes mechanistically. Many of these 29 genes are orthologs of known human tumor suppressors or oncogenes, suggesting that others may be as well. Our findings implicate nuclear-pore modification in p53-dependent cell death, because inhibiting nuclear-pore genes that are upregulated by DAF-16 blocks p53-dependent cell death in the tumor, but not normal, p53-independent, germline cell death.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Kenyon, C (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	ckenyon@biochem.ucsf.edu		Kenyon, Cynthia/0000-0003-3446-2636				Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; DELPUECH O, 2007, MOL CELL BIOL; Fahrenkrog B, 2006, CAN J PHYSIOL PHARM, V84, P279, DOI 10.1139/Y05-100; FRANCIS R, 1995, GENETICS, V139, P579; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garigan D, 2002, GENETICS, V161, P1101; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kenyon C, 2006, NAT GENET, V38, P397, DOI 10.1038/ng0406-397; LAWLESS JF, 1998, MODELS METHODS LIFET; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Li CM, 2006, CANCER RES, V66, P665, DOI 10.1158/0008-5472.CAN-05-1553; Madi L, 2004, CLIN CANCER RES, V10, P4472, DOI 10.1158/1078-0432.CCR-03-0651; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; Milner AE, 1997, ONCOGENE, V15, P1815, DOI 10.1038/sj.onc.1201355; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Ohana G, 2001, J CELL PHYSIOL, V186, P19, DOI 10.1002/1097-4652(200101)186:1<19::AID-JCP1011>3.0.CO;2-3; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pinkston JM, 2006, SCIENCE, V313, P971, DOI 10.1126/science.1121908; Qi J, 2005, BIOCHEM BIOPH RES CO, V328, P517, DOI 10.1016/j.bbrc.2005.01.014; Ramsey MM, 2002, ENDOCRINOLOGY, V143, P4139, DOI 10.1210/en.2002-220717; Ren CZ, 2004, CANCER RES, V64, P969, DOI 10.1158/0008-5472.CAN-03-2592; Schumacher B, 2001, CURR BIOL, V11, P1722, DOI 10.1016/S0960-9822(01)00534-6; Shimada H, 2000, BLOOD, V96, P655; Singh AP, 2007, CANCER RES, V67, P433, DOI 10.1158/0008-5472.CAN-06-3114; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Wechsler DS, 1997, CANCER RES, V57, P4905; Zhou L, 2007, EUR J CANCER, V43, P809, DOI 10.1016/j.ejca.2006.10.025	30	106	157	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2007	39	11					1403	1409		10.1038/ng.2007.1	http://dx.doi.org/10.1038/ng.2007.1			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17934462				2022-12-27	WOS:000250575900026
J	Nicot, AS; Toussaint, A; Tosch, V; Kretz, C; Wallgren-Pettersson, C; Iwarsson, E; Kingston, H; Garnier, JM; Biancalana, V; Oldfors, A; Mandel, JL; Laporte, J				Nicot, Anne-Sophie; Toussaint, Anne; Tosch, Valerie; Kretz, Christine; Wallgren-Pettersson, Carina; Iwarsson, Erik; Kingston, Helen; Garnier, Jean-Marie; Biancalana, Valerie; Oldfors, Anders; Mandel, Jean-Louis; Laporte, Jocelyn			Mutations in amphiphysin 2 (BIN1) disrupt interaction with dynamin 2 and cause autosomal recessive centronuclear myopathy	NATURE GENETICS			English	Article							TUMOR-SUPPRESSOR BIN1; MEMBRANE CURVATURE; SKELETAL-MUSCLE; SH3 DOMAIN; BAR; PHOSPHOINOSITIDES; MYOTUBULARINS; PHOSPHATASE; ENDOCYTOSIS; DOMINANT	Centronuclear myopathies are characterized by muscle weakness and abnormal centralization of nuclei in muscle fibers not secondary to regeneration. The severe neonatal X- linked form ( myotubular myopathy) is due to mutations in the phosphoinositide phosphatase myotubularin ( MTM1)(1), whereas mutations in dynamin 2 ( DNM2) have been found in some autosomal dominant cases(2). By direct sequencing of functional candidate genes, we identified homozygous mutations in amphiphysin 2 ( BIN1) in three families with autosomal recessive inheritance. Two missense mutations affecting the BAR ( Bin1/ amphiphysin/ RVS167) domain disrupt its membrane tubulation properties in transfected cells, and a partial truncation of the C- terminal SH3 domain abrogates the interaction with DNM2 and its recruitment to the membrane tubules. Our results suggest that mutations in BIN1 cause centronuclear myopathy by interfering with remodeling of T tubules and/ or endocytic membranes, and that the functional interaction between BIN1 and DNM2 is necessary for normal muscle function and positioning of nuclei.	IGBMC, Dept Mol Pathol, F-67400 Illkirch Graffenstaden, France; INSERM, U596, F-67400 Illkirch Graffenstaden, France; CNRS, UMR7104, F-67400 Illkirch Graffenstaden, France; Univ Strasbourg 1, F-67000 Strasbourg, France; Coll France, Chaire Genet Humaine, F-67400 Illkirch Graffenstaden, France; Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; Folkhalsan Inst Genet, Biomed, FIN-00014 Helsinki, Finland; Karolinska Univ Hosp, Dept Mol Med & Surg, Clin Genet Unit, S-17176 Stockholm, Sweden; Acad Unit Med Genet, Manchester M13 0JH, Lancs, England; Cent Manchester & Manchester Childrens Univ Hosp, Reg Genet Serv, Manchester M13 0JH, Lancs, England; Univ Strasbourg 1, Fac Med, CHRU, Lab Diagnost Genet, F-67085 Strasbourg, France; Univ Strasbourg 1, Med Genet Lab, EA3949, F-67085 Strasbourg, France; Sahlgrens Univ Hosp, Dept Pathol, SE-41345 Gothenburg, Sweden	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; PSL Research University Paris; College de France; University of Helsinki; Karolinska Institutet; Karolinska University Hospital; University of Manchester; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Sahlgrenska University Hospital	Laporte, J (corresponding author), IGBMC, Dept Mol Pathol, F-67400 Illkirch Graffenstaden, France.	mtm@igbmc.u-strasbg.fr	Laporte, Jocelyn/H-6801-2016; laporte, jocelyn/O-4888-2019; Nicot, Anne-Sophie/GSE-6467-2022; Biancalana, Valerie/O-2351-2016; laporte, jocelyn/J-7008-2012; Iwarsson, Erik/J-4677-2019; Mandel, Jean Louis/Q-2668-2016	Iwarsson, Erik/0000-0002-3827-0263; Mandel, Jean Louis/0000-0002-0535-6589; Oldfors, Anders/0000-0002-5758-7397				Bitoun M, 2005, NAT GENET, V37, P1207, DOI 10.1038/ng1657; Buj-Bello A, 2002, P NATL ACAD SCI USA, V99, P15060, DOI 10.1073/pnas.212498399; Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355; Dang H, 2004, MOL BIOL CELL, V15, P189, DOI 10.1091/mbc.E03-08-0605; Engel A., 2004, MYOLOGY BASIC CLIN; Ge K, 1999, P NATL ACAD SCI USA, V96, P9689, DOI 10.1073/pnas.96.17.9689; Ge K, 2000, INT J CANCER, V85, P376; GREEN S, 1988, NUCLEIC ACIDS RES, V16, P369, DOI 10.1093/nar/16.1.369; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Jeannet PY, 2004, NEUROLOGY, V62, P1484, DOI 10.1212/01.WNL.0000124388.67003.56; Kojima C, 2004, EMBO J, V23, P4413, DOI 10.1038/sj.emboj.7600442; KORSHUNOV A, 2006, ACTA NEUROPATHOL BER; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Lee EY, 2002, SCIENCE, V297, P1193, DOI 10.1126/science.1071362; MANDEL JL, 2002, STRUCTURAL MOL BASIS, P124; Muller AJ, 2003, MOL CELL BIOL, V23, P4295, DOI 10.1128/MCB.23.12.4295-4306.2003; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Pierson CR, 2005, J NEUROPATH EXP NEUR, V64, P555, DOI 10.1097/01.jnen.0000171653.17213.2e; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Ramjaun AR, 1997, J BIOL CHEM, V272, P16700, DOI 10.1074/jbc.272.26.16700; Razzaq A, 2001, GENE DEV, V15, P2967, DOI 10.1101/gad.207801; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; Sakamuro D, 1996, NAT GENET, V14, P69, DOI 10.1038/ng0996-69; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tosch V, 2006, HUM MOL GENET, V15, P3098, DOI 10.1093/hmg/ddl250; WALLGRENPETTERSSON C, 1995, J MED GENET, V32, P673, DOI 10.1136/jmg.32.9.673; Wechsler-Reya RJ, 1998, MOL CELL BIOL, V18, P566, DOI 10.1128/MCB.18.1.566; WechslerReya R, 1997, J BIOL CHEM, V272, P31453, DOI 10.1074/jbc.272.50.31453	29	258	268	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1134	1139		10.1038/ng2086	http://dx.doi.org/10.1038/ng2086			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17676042				2022-12-27	WOS:000249122400024
J	Dunoyer, P; Himber, C; Ruiz-Ferrer, V; Alioua, A; Voinnet, O				Dunoyer, Patrice; Himber, Christophe; Ruiz-Ferrer, Virginia; Alioua, Abdelmalek; Voinnet, Olivier			Intra- and intercellular RNA interference in Arabidopsis thaliana requires components of the microRNA and heterochromatic silencing pathways	NATURE GENETICS			English	Article							DICER-LIKE PROTEINS; TRANS-ACTING SIRNAS; DOUBLE-STRANDED-RNA; DNA METHYLATION; BIOGENESIS; ACCUMULATION; IV; DICER-LIKE-4; SUPPRESSION; ARGONAUTE1	In RNA interference ( RNAi), double- stranded RNA ( dsRNA) is processed into short interfering RNA ( siRNA) to mediate sequence-specific gene knockdown. The genetics of plant RNAi is not understood, nor are the bases for its spreading between cells. Here, we unravel the requirements for biogenesis and action of siRNAs directing RNAi in Arabidopsis thaliana and show how alternative routes redundantly mediate this process under extreme dsRNA dosages. We found that SMD1 and SMD2, required for intercellular but not intracellular RNAi, are allelic to RDR2 and NRPD1a, respectively, previously implicated in siRNA- directed heterochromatin formation through the action of DCL3 and AGO4. However, neither DCL3 nor AGO4 is required for non - cell autonomous RNAi, uncovering a new pathway for RNAi spreading or detection in recipient cells. Finally, we show that the genetics of RNAi is distinct from that of antiviral silencing and propose that this experimental silencing pathway has a direct endogenous plant counterpart.	CNRS, Inst Biol Mol Plantes, UPR2357, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Voinnet, O (corresponding author), CNRS, Inst Biol Mol Plantes, UPR2357, 12 Rue Gen Zimmer, F-67084 Strasbourg, France.	olivier.voinnet@ibmp-ulp.u-strasbg.fr		Voinnet, Olivier/0000-0001-6982-9544; Ruiz-Ferrer, Virginia/0000-0002-7840-297X				Adenot X, 2006, CURR BIOL, V16, P927, DOI 10.1016/j.cub.2006.03.035; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bechtold N, 1998, METH MOL B, V82, P259; Beclin C, 2002, CURR BIOL, V12, P684, DOI 10.1016/S0960-9822(02)00792-3; Blevins T, 2006, NUCLEIC ACIDS RES, V34, P6233, DOI 10.1093/nar/gkl886; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Dalmay T, 2000, PLANT CELL, V12, P369, DOI 10.1105/tpc.12.3.369; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Dunoyer P, 2006, NAT GENET, V38, P258, DOI 10.1038/ng1722; Finnegan EJ, 2003, CURR BIOL, V13, P236, DOI 10.1016/S0960-9822(03)00010-1; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Fusaro AF, 2006, EMBO REP, V7, P1168, DOI 10.1038/sj.embor.7400837; Havelda Z, 2003, J VIROL, V77, P6082, DOI 10.1128/JVI.77.10.6082-6086.2003; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Hiraguri A, 2005, PLANT MOL BIOL, V57, P173, DOI 10.1007/s11103-004-6853-5; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Kasschau KD, 2007, PLOS BIOL, V5, P479, DOI 10.1371/journal.pbio.0050057; Kavi HH, 2005, FEBS LETT, V579, P5940, DOI 10.1016/j.febslet.2005.08.069; Kurihara Y, 2006, RNA, V12, P206, DOI 10.1261/rna.2146906; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Moissiard G, 2006, P NATL ACAD SCI USA, V103, P19593, DOI 10.1073/pnas.0604627103; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Voinnet O, 2005, NAT REV GENET, V6, P206, DOI 10.1038/nrg1555; Wassenegger M, 2006, TRENDS PLANT SCI, V11, P142, DOI 10.1016/j.tplants.2006.01.003; Wu FJ, 2007, PLANT CELL, V19, P914, DOI 10.1105/tpc.106.048637; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zaratiegui M, 2007, CELL, V128, P763, DOI 10.1016/j.cell.2007.02.016; Zhang XR, 2006, GENE DEV, V20, P3255, DOI 10.1101/gad.1495506; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zilberman D, 2003, SCIENCE, V299, P716, DOI 10.1126/science.1079695	50	165	175	5	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39	7					848	856		10.1038/ng2081	http://dx.doi.org/10.1038/ng2081			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17558406				2022-12-27	WOS:000247619800014
J	Dumas, ME; Wilder, SP; Bihoreau, MT; Barton, RH; Fearnside, JF; Argoud, K; D'Amato, L; Wallis, RH; Blancher, C; Keun, HC; Baunsgaard, D; Scott, J; Sidelmann, UG; Nicholson, JK; Gauguier, D				Dumas, Marc-Emmanuel; Wilder, Steven P.; Bihoreau, Marie-Therese; Barton, Richard H.; Fearnside, Jane F.; Argoud, Karene; D'Amato, Lisa; Wallis, Robert H.; Blancher, Christine; Keun, Hector C.; Baunsgaard, Dorrit; Scott, James; Sidelmann, Ulla Grove; Nicholson, Jeremy K.; Gauguier, Dominique			Direct quantitative trait locus mapping of mammalian metabolic phenotypes in diabetic and normoglycemic rat models	NATURE GENETICS			English	Article							GOTO-KAKIZAKI RATS; BROWN-NORWAY; METABONOMICS; GENOME; EXPRESSION; ASSOCIATION; GENETICS; DISEASE; CROSSES; SYSTEMS	Characterizing the relationships between genomic and phenotypic variation is essential to understanding disease etiology. Information-dense data sets derived from pathophysiological(1), proteomic(2,3) and transcriptomic(4) profiling have been applied to map quantitative trait loci (QTLs). Metabolic traits, already used in QTL studies in plants(5), are essential phenotypes in mammalian genetics to define disease biomarkers. Using a complex mammalian system, here we show chromosomal mapping of untargeted plasma metabolic fingerprints derived from NMR spectroscopic analysis(6) in a cross between diabetic and control rats. We propose candidate metabolites for the most significant QTLs. Metabolite profiling in congenic strains provided evidence of QTL replication. Linkage to a gut microbial metabolite ( benzoate) can be explained by deletion of a uridine diphosphate glucuronosyltransferase. Mapping metabotypic QTLs provides a practical approach to understanding genome-phenotype relationships in mammals and may uncover deeper biological complexity, as extended genome(7) (microbiome) perturbations that affect disease processes through transgenomic effects(8) may influence QTL detection.	Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Biomol Med, Div Surg Oncol Reprod Biol & Anaesthet, London SW7 2AZ, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; NovoNordisk AS, DK-2760 Malov, Denmark; Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Fac Med, London SW7 2AZ, England	Imperial College London; University of Oxford; Wellcome Centre for Human Genetics; Novo Nordisk; Imperial College London	Nicholson, JK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Biomol Med, Div Surg Oncol Reprod Biol & Anaesthet, Sir Alexander Fleming Bldg,Exhibit Rd, London SW7 2AZ, England.	j.nicholson@imperial.ac.uk; gdomi@well.ox.ac.uk	Dumas, Marc-Emmanuel/C-1736-2008; Nicholson, Jeremy K/B-3395-2012; Gauguier, Dominique/G-2190-2016	Dumas, Marc-Emmanuel/0000-0001-9523-7024; Nicholson, Jeremy K/0000-0002-8123-8349; Gauguier, Dominique/0000-0001-6156-9530; Barton, Richard H./0000-0001-7469-2845; Wilder, Steven/0000-0001-8049-2559				Argoud K, 2006, DIABETOLOGIA, V49, P2679, DOI 10.1007/s00125-006-0396-z; Bihoreau MT, 1997, GENOME RES, V7, P434, DOI 10.1101/gr.7.5.434; BRIDGES JW, 1970, BIOCHEM J, V118, P47, DOI 10.1042/bj1180047; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Collins SC, 2006, MAMM GENOME, V17, P538, DOI 10.1007/s00335-005-0168-y; DAMERVAL C, 1994, GENETICS, V137, P289; Dudbridge F, 2004, AM J HUM GENET, V75, P424, DOI 10.1086/423738; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Gauguier D, 1996, NAT GENET, V12, P38, DOI 10.1038/ng0196-38; GAUGUIER D, 2006, ENCY GENETICS, V3, P1154; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Keurentjes JJB, 2006, NAT GENET, V38, P842, DOI 10.1038/ng1815; Klose J, 2002, NAT GENET, V30, P385, DOI 10.1038/ng861; Lederberg J, 2000, SCIENCE, V288, P287, DOI 10.1126/science.288.5464.287; Lindon JC, 2000, CONCEPT MAGNETIC RES, V12, P289, DOI 10.1002/1099-0534(2000)12:5<289::AID-CMR3>3.0.CO;2-W; Morreel K, 2006, PLANT J, V47, P224, DOI 10.1111/j.1365-313X.2006.02786.x; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Nicholson JK, 2004, NAT BIOTECHNOL, V22, P1268, DOI 10.1038/nbt1015; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Schauer N, 2006, NAT BIOTECHNOL, V24, P447, DOI 10.1038/nbt1192; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Watanabe TK, 2005, CLIN EXP PHARMACOL P, V32, P355, DOI 10.1111/j.1440-1681.2005.04196.x; Wilder SP, 2004, GENOME RES, V14, P758, DOI 10.1101/gr.2001604	30	121	125	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2007	39	5					666	672		10.1038/ng2026	http://dx.doi.org/10.1038/ng2026			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17435758				2022-12-27	WOS:000245971300024
J	Hampe, J; Franke, A; Rosenstiel, P; Till, A; Teuber, M; Huse, K; Albrecht, M; Mayr, G; De La Vega, FM; Briggs, J; Gunther, S; Prescott, NJ; Onnie, CM; Hasler, R; Sipos, B; Folsch, UR; Lengauer, T; Platzer, M; Mathew, CG; Krawczak, M; Schreiber, S				Hampe, Jochen; Franke, Andre; Rosenstiel, Philip; Till, Andreas; Teuber, Markus; Huse, Klaus; Albrecht, Mario; Mayr, Gabriele; De La Vega, Francisco M.; Briggs, Jason; Guenther, Simone; Prescott, Natalie J.; Onnie, Clive M.; Haesler, Robert; Sipos, Bence; Foelsch, Ulrich R.; Lengauer, Thomas; Platzer, Matthias; Mathew, Christopher G.; Krawczak, Michael; Schreiber, Stefan			A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; GENETIC-VARIATION; NOD2; POLYMORPHISM; MUTATION; VISUALIZATION; POPULATIONS; APG16L; SYSTEM	We performed a genome-wide association study of 19,779 nonsynonymous SNPs in 735 individuals with Crohn disease and 368 controls. A total of 7,159 of these SNPs were informative. We followed up on all 72 SNPs with P <= 0.01 with an allele- based disease association test in 380 independent Crohn disease trios, 498 Crohn disease singleton cases and 1,032 controls. Disease association of rs2241880 in the autophagy- related 16- like 1 gene ( ATG16L1) was replicated in these samples ( P 4.0 X 10(-8)) and confirmed in a UK case-control sample ( P =0.0004). By haplotype and regression analysis, we found that marker rs2241880, a coding SNP ( T300A), carries virtually all the disease risk exerted by the ATG16L1 locus. The ATG16L1 gene encodes a protein in the autophagosome pathway that processes intracellular bacteria. We found a statistically significant interaction with respect to Crohn disease risk between rs2241880 and the established CARD15 susceptibility variants ( P =0.039). Together with the lack of association between rs2241880 and ulcerative colitis ( P > 0.4), these data suggest that the underlying biological process may be specific to Crohn disease.	Univ Kiel, Inst Clin Mol Biol, Univ Hosp Schleswig Holstein, D-24105 Kiel, Germany; Fritz Lipmann Inst EV, Genome Anal Grp, Leibniz Inst Age Res, D-07745 Jena, Germany; Max Planck Inst Informat, D-66123 Saarbrucken, Germany; Appl Biosyst Inc, Foster City, CA 94404 USA; Kings Coll London, Sch Med, Dept Med & Mol Genet, London SE1 9RT, England; Univ Kiel, Dept Pathol, Univ Hosp Schleswig Holstein, D-24105 Kiel, Germany; Univ Kiel, Inst Med Informat & Stat, Univ Hosp Schleswig Holstein, D-24105 Kiel, Germany; Max Planck Inst Mol Genet, D-14195 Berlin, Germany	University of Kiel; Schleswig Holstein University Hospital; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Max Planck Society; Thermo Fisher Scientific; Applied Biosystems; University of London; King's College London; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Max Planck Society	Hampe, J (corresponding author), Univ Kiel, Inst Clin Mol Biol, Univ Hosp Schleswig Holstein, D-24105 Kiel, Germany.	jhampe@1med.uni-kiel.de; s.schreiber@mucosa.de	Albrecht, Mario/B-6694-2008; Prescott, Natalie J/F-6490-2011; Hampe, Jochen/A-2555-2010; Franke, Andre/B-2151-2010; Rosenstiel, Philip/A-5137-2009; Till, Andreas/E-9661-2013; Häsler, Robert/A-4908-2009; Krawczak, Michael/A-8964-2010; Till, Andreas/AAO-6375-2021; Mathew, Christopher G/G-3434-2015	Albrecht, Mario/0000-0002-3103-9624; Prescott, Natalie J/0000-0002-5901-7371; Hampe, Jochen/0000-0002-2421-6127; Franke, Andre/0000-0003-1530-5811; Rosenstiel, Philip/0000-0002-9692-8828; Till, Andreas/0000-0002-0139-9143; Häsler, Robert/0000-0003-4174-8229; Krawczak, Michael/0000-0003-2603-1502; Mathew, Christopher G/0000-0003-4178-1838; Huse, Klaus/0000-0003-3854-1884	MRC [G0000934] Funding Source: UKRI; Medical Research Council [G0000934] Funding Source: Medline; Wellcome Trust [068545/Z/02] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Brant SR, 2003, AM J HUM GENET, V73, P1282, DOI 10.1086/379927; Croucher PJP, 2003, EUR J HUM GENET, V11, P6, DOI 10.1038/sj.ejhg.5200897; DUBRIDGE F, 2003, GENET EPIDEMIOL, V25, P115; Duerr RH, 2000, AM J HUM GENET, V66, P1857, DOI 10.1086/302947; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Franke A, 2006, HUM MUTAT, V27, P583, DOI 10.1002/humu.20306; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Hampe J, 2001, BIOINFORMATICS, V17, P654, DOI 10.1093/bioinformatics/17.7.654; Hampe J, 2002, P NATL ACAD SCI USA, V99, P321, DOI 10.1073/pnas.261567999; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Hampe J, 2001, LANCET, V357, P1925, DOI 10.1016/S0140-6736(00)05063-7; Ho GT, 2006, HUM MOL GENET, V15, P797, DOI 10.1093/hmg/ddi494; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Manaster C, 2005, HUM MUTAT, V26, P11, DOI 10.1002/humu.20188; McGovern DPB, 2005, HUM MOL GENET, V14, P1245, DOI 10.1093/hmg/ddi135; Mizushima N, 2003, J CELL SCI, V116, P1679, DOI 10.1242/jcs.00381; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Schwab M, 2003, GASTROENTEROLOGY, V124, P26, DOI 10.1053/gast.2003.50010; Shaw SH, 2003, HUM GENET, V113, P514, DOI 10.1007/s00439-003-1020-7; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Stoll M, 2004, NAT GENET, V36, P476, DOI 10.1038/ng1345; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Zheng HR, 2004, DNA SEQUENCE, V15, P303, DOI 10.1080/10425170400004104	30	1432	1484	2	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2007	39	2					207	211		10.1038/ng1954	http://dx.doi.org/10.1038/ng1954			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17200669				2022-12-27	WOS:000244063900018
J	Oishi, I; Kawakami, Y; Raya, A; Callol-Massot, C; Belmonte, JCI				Oishi, Isao; Kawakami, Yasuhiko; Raya, Angel; Callol-Massot, Carles; Belmonte, Juan Carlos Izpisua			Regulation of primary cilia formation and left-right patterning in zebrafish by a noncanonical Wnt signaling mediator, duboraya	NATURE GENETICS			English	Article							LEFT-RIGHT ASYMMETRY; PLANAR CELL POLARITY; KUPFFERS VESICLE; GASTRULATION; EMBRYO; ESTABLISHMENT; VERTEBRATES; FRIZZLED-2; ACTIVATION; MECHANISMS	Primary cilia are microtubule-based organelles that project from the surface of nearly every animal cell(1). Although important functions of primary cilia in morphogenesis and tissue homeostasis have been identified2,3, the mechanisms that control the formation of primary cilia are not understood. Here we characterize a zebrafish gene, termed duboraya ( dub), that is essential for ciliogenesis. Knockdown of dub in zebrafish embryos results in both defects in primary cilia formation in Kupffer's vesicle and randomization of left-right organ asymmetries. We show that, at the molecular level, the function of dub in ciliogenesis is regulated by phosphorylation, which in turn depends on Frizzled-2-mediated noncanonical Wnt signaling. We also provide evidence that, at the cellular level, dub function is essential for actin organization in the cells lining Kupffer's vesicle. Taken together, our findings identify a molecular factor that links noncanonical Wnt signaling with the control of left-right axis specification, and provide an entry point for analyzing the mechanisms that regulate primary cilia formation.	Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; ICREA, Barcelona 08003, Spain; Ctr Regenerat Med Barcelona, Barcelona 08003, Spain	Salk Institute; ICREA; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Oishi, Isao/L-8639-2018; Raya, Angel/E-6205-2010	Oishi, Isao/0000-0003-3682-5349; Raya, Angel/0000-0003-2189-9775; Kawakami, Yasuhiko/0000-0002-0043-9705	ICREA Funding Source: Custom	ICREA(ICREA)		Ahumada A, 2002, SCIENCE, V298, P2006, DOI 10.1126/science.1073776; Bisgrove BW, 2003, ANNU REV GENOM HUM G, V4, P1, DOI 10.1146/annurev.genom.4.070802.110428; Capdevila J, 2000, CELL, V101, P9, DOI 10.1016/S0092-8674(00)80619-4; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Eyers CE, 2005, BIOCHEM J, V389, P127, DOI 10.1042/BJ20050387; Germino GG, 2005, NAT GENET, V37, P455, DOI 10.1038/ng0505-455; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hammerschmidt M, 1996, DEVELOPMENT, V123, P143; Huang CJ, 2003, DEV DYNAM, V228, P30, DOI 10.1002/dvdy.10356; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Liu XX, 1999, P NATL ACAD SCI USA, V96, P14383, DOI 10.1073/pnas.96.25.14383; Matsui T, 2005, GENE DEV, V19, P164, DOI 10.1101/gad.1253605; Ng JK, 2002, DEVELOPMENT, V129, P5161; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Praetorius HA, 2005, ANNU REV PHYSIOL, V67, P515, DOI 10.1146/annurev.physiol.67.040403.101353; Raya A, 2006, NAT REV GENET, V7, P283, DOI 10.1038/nrg1830; Raya A, 2003, GENE DEV, V17, P1213, DOI 10.1101/gad.1084403; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Sumanas S, 2001, GENESIS, V30, P114, DOI 10.1002/gene.1043; Tada M, 2000, DEVELOPMENT, V127, P2227; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wheatley DN, 1995, PATHOBIOLOGY, V63, P222, DOI 10.1159/000163955	30	96	98	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2006	38	11					1316	1322		10.1038/ng1892	http://dx.doi.org/10.1038/ng1892			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17013396				2022-12-27	WOS:000241592700021
J	To, MD; Wong, CE; Karnezis, AN; Del Rosario, R; Di Lauro, R; Balmain, A				To, Minh D.; Wong, Christine E.; Karnezis, Anthony N.; Del Rosario, Reyno; Di Lauro, Roberto; Balmain, Allan			Kras regulatory elements and exon 4A determine mutation specificity in lung cancer	NATURE GENETICS			English	Article							K-RAS 4A; MOUSE SKIN CARCINOGENESIS; TUMOR SUSCEPTIBILITY; HA-RAS; N-RAS; MICE; GENE; PROGRESSION; ACTIVATION; EXPRESSION	Kras is the most frequently mutated ras family member in lung carcinomas(1,2), whereas Hras mutations are common in tumors from stratified epithelia such as the skin. Using a Hras knock-in mouse model(3), we demonstrate that specificity for Kras mutations in lung and Hras mutations in skin tumors is determined by local regulatory elements in the target ras genes. Although the Kras 4A isoform is dispensable for mouse development(4,5), it is the most important isoform for lung carcinogenesis in vivo and for the inhibitory effect of wild-type (WT) Kras on the mutant allele(6,7). Kras 4A expression is detected in a subpopulation of normal lung epithelial cells, but at very low levels in lung tumors, suggesting that it may not be required for tumor progression. The two Kras isoforms undergo different post-translational modifications(8); therefore, these findings can have implications for the design of therapeutic strategies for inhibiting oncogenic Kras activity in human cancers.	[To, Minh D.; Wong, Christine E.; Karnezis, Anthony N.; Del Rosario, Reyno; Balmain, Allan] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Canc Res Inst, San Francisco, CA 94115 USA; [Karnezis, Anthony N.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94115 USA; [Di Lauro, Roberto] Staz Zool Anton Dohrn, I-80121 Naples, Italy; [Di Lauro, Roberto] Inst Genet Res Gaetano Salvatore IRGS, I-83031 Ariano Irpino, Italy	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; Stazione Zoologica Anton Dohrn di Napoli	Balmain, A (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Canc Res Inst, San Francisco, CA 94115 USA.	abalmain@cc.ucsf.edu	Di Lauro, Roberto/A-2746-2012	Di Lauro, Roberto/0000-0001-9493-3036	Sandler Foundation Postdoctoral Research Fellowship [CA111834, CA084244]; Swiss National Science Foundation (SNSF); Associazione Italiana per la ricerca sul cancro (AIRC); Bruce and Davina Isackson Foundation; NATIONAL CANCER INSTITUTE [U01CA084244, R01CA111834] Funding Source: NIH RePORTER	Sandler Foundation Postdoctoral Research Fellowship; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); Associazione Italiana per la ricerca sul cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Bruce and Davina Isackson Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by CA111834 and CA084244 (A. B.). M. D. T. was supported in part by a Sandler Foundation Postdoctoral Research Fellowship. C. E. W. was supported by the Swiss National Science Foundation (SNSF). R. D. L. was supported by a grant of Associazione Italiana per la ricerca sul cancro (AIRC). A. B. acknowledges support from the Bruce and Davina Isackson Foundation and from the Barbara Bass Bakar Chair of Cancer Genetics. Phospho-Akt was provided by D. Stokoe (University of California San Francisco), and primary antibodies against CCA/CC10 were a gift from A. Mukherjee (National Institute of Child Health and Human Development, US National Institutes of Health).	BALMAIN A, 1983, NATURE, V303, P72, DOI 10.1038/303072a0; BOS JL, 1989, CANCER RES, V49, P4682; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Diaz R, 2005, INT J CANCER, V113, P241, DOI 10.1002/ijc.20563; GUERRERO I, 1985, P NATL ACAD SCI USA, V82, P7810, DOI 10.1073/pnas.82.23.7810; Hancock JF, 2003, NAT REV MOL CELL BIO, V4, P373, DOI 10.1038/nrm1105; Ise K, 2000, ONCOGENE, V19, P2951, DOI 10.1038/sj.onc.1203600; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Konstantinopoulos PA, 2007, NAT REV DRUG DISCOV, V6, P540, DOI 10.1038/nrd2221; Li J, 2003, ONCOGENE, V22, P1243, DOI 10.1038/sj.onc.1206192; Li WQ, 2004, J BIOL CHEM, V279, P37398, DOI 10.1074/jbc.M405730200; Mao JH, 2004, GENE DEV, V18, P1800, DOI 10.1101/gad.1213804; Nagase H, 2003, CANCER RES, V63, P4849; NELSON MA, 1992, P NATL ACAD SCI USA, V89, P6398, DOI 10.1073/pnas.89.14.6398; Patek CE, 2008, EXP CELL RES, V314, P1105, DOI 10.1016/j.yexcr.2007.11.004; Pells S, 1997, ONCOGENE, V15, P1781, DOI 10.1038/sj.onc.1201354; Plowman SJ, 2006, J EXP CLIN CANC RES, V25, P259; Plowman SJ, 2003, MOL CELL BIOL, V23, P9245, DOI 10.1128/MCB.23.24.9245-9250.2003; Potenza N, 2005, EMBO REP, V6, P432, DOI 10.1038/sj.embor.7400397; QUINTANILLA M, 1986, NATURE, V322, P78, DOI 10.1038/322078a0; To MD, 2006, NAT GENET, V38, P926, DOI 10.1038/ng1836; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Voice JK, 1999, J BIOL CHEM, V274, P17164, DOI 10.1074/jbc.274.24.17164; Wang M, 2005, EXP LUNG RES, V31, P165, DOI 10.1080/01902140490495543; Wang Y, 2001, EXP LUNG RES, V27, P255, DOI 10.1080/019021401300054028; YOU M, 1989, P NATL ACAD SCI USA, V86, P3070, DOI 10.1073/pnas.86.9.3070; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721	30	95	96	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2008	40	10					1240	1244		10.1038/ng.211	http://dx.doi.org/10.1038/ng.211			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18758463	Green Accepted			2022-12-27	WOS:000259651000026
J	McGowan, KA; Li, JZ; Park, CY; Beaudry, V; Tabor, HK; Sabnis, AJ; Zhang, W; Fuchs, H; de Angelis, MH; Myers, RM; Attardi, LD; Barsh, GS				McGowan, Kelly A.; Li, Jun Z.; Park, Christopher Y.; Beaudry, Veronica; Tabor, Holly K.; Sabnis, Amit J.; Zhang, Weibin; Fuchs, Helmut; de Angelis, Martin Hrabe; Myers, Richard M.; Attardi, Laura D.; Barsh, Gregory S.			Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects	NATURE GENETICS			English	Article							DIAMOND-BLACKFAN ANEMIA; PROTEIN S19; P53-DEPENDENT CHECKPOINT; DROSOPHILA-MELANOGASTER; CRE RECOMBINASE; MOUSE; MICE; GENE; PROLIFERATION; P53	Mutations in genes encoding ribosomal proteins cause the Minute phenotype in Drosophila and mice, and Diamond-Blackfan syndrome in humans. Here we report two mouse dark skin (Dsk) loci caused by mutations in Rps19 (ribosomal protein S19) and Rps20 (ribosomal protein S20). We identify a common pathophysiologic program in which p53 stabilization stimulates Kit ligand expression, and, consequently, epidermal melanocytosis via a paracrine mechanism. Accumulation of p53 also causes reduced body size and erythrocyte count. These results provide a mechanistic explanation for the diverse collection of phenotypes that accompany reduced dosage of genes encoding ribosomal proteins, and have implications for understanding normal human variation and human disease.	[McGowan, Kelly A.; Li, Jun Z.; Tabor, Holly K.; Sabnis, Amit J.; Zhang, Weibin; Myers, Richard M.; Attardi, Laura D.; Barsh, Gregory S.] Stanford Univ, Div Radiat & Canc Biol, Dept Genet, Stanford, CA 94305 USA; [Li, Jun Z.; Tabor, Holly K.; Myers, Richard M.] Stanford Univ, Stanford Human Genome Ctr, Div Radiat & Canc Biol, Stanford, CA 94305 USA; [Park, Christopher Y.] Stanford Univ, Dept Pathol, Div Radiat & Canc Biol, Stanford, CA 94305 USA; [Beaudry, Veronica; Attardi, Laura D.] Stanford Univ, Dept Radiat Oncol, Div Radiat & Canc Biol, Stanford, CA 94305 USA; [Fuchs, Helmut; de Angelis, Martin Hrabe] Helmholtz Zentrum Muenchen, German Res Ctr Environm Hlth, Inst Expt Genet, D-85764 Neuherberg, Germany; [Barsh, Gregory S.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Stanford University	Barsh, GS (corresponding author), Stanford Univ, Div Radiat & Canc Biol, Dept Genet, Stanford, CA 94305 USA.	gbarsh@stanford.edu	de Angelis, Martin Hrabe/F-5531-2012; Fuchs, Helmut/M-7347-2014	de Angelis, Martin Hrabe/0000-0002-7898-2353; Fuchs, Helmut/0000-0002-5143-2677; Sabnis, Amit/0000-0002-2061-5139; Li, Jun/0000-0001-6727-0812	NIGMS NIH HHS [R01 GM068882] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068882] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alizadeh A, 2008, PIGM CELL MELANOMA R, V21, P63, DOI 10.1111/j.1755-148X.2007.00425.x; Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Angelini M, 2007, HUM MOL GENET, V16, P1720, DOI 10.1093/hmg/ddm120; BARAK Y, 1993, EMBO J, V12, P461, DOI 10.1002/j.1460-2075.1993.tb05678.x; BECKMAN G, 1994, HUM HERED, V44, P266, DOI 10.1159/000154228; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; CABLE J, 1995, MECH DEVELOP, V50, P139, DOI 10.1016/0925-4773(94)00331-G; Chan EL, 2007, MOL CARCINOGEN, V46, P49, DOI 10.1002/mc.20192; Cmejla R, 2007, HUM MUTAT, V28, P1178, DOI 10.1002/humu.20608; Cui RT, 2007, CELL, V128, P853, DOI 10.1016/j.cell.2006.12.045; de Angelis MH, 2000, NAT GENET, V25, P444, DOI 10.1038/78146; Draptchinskaia N, 1999, NAT GENET, V21, P169, DOI 10.1038/5951; Ellis SR, 2008, CURR TOP DEV BIOL, V82, P217, DOI 10.1016/S0070-2153(07)00008-7; Ellisen LW, 2002, MOL CELL, V10, P995, DOI 10.1016/S1097-2765(02)00706-2; Fitch KR, 2003, GENE DEV, V17, P214, DOI 10.1101/gad.1023703; Flygare J, 2007, BLOOD, V109, P3152, DOI 10.1182/blood-2006-09-001222; Fromont-Racine M, 2003, GENE, V313, P17, DOI 10.1016/S0378-1119(03)00629-2; Gazda HT, 2006, AM J HUM GENET, V79, P1110, DOI 10.1086/510020; Gazda HT, 2006, BRIT J HAEMATOL, V135, P149, DOI 10.1111/j.1365-2141.2006.06268.x; Hirobe T, 2005, PIGM CELL RES, V18, P2, DOI 10.1111/j.1600-0749.2004.00198.x; HIROBE T, 1984, ANAT REC, V208, P589, DOI 10.1002/ar.1092080414; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Johnson TM, 2005, NAT GENET, V37, P145, DOI 10.1038/ng1498; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Kunisada T, 1998, DEVELOPMENT, V125, P2915; Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X; Leger-Silvestre I, 2005, J BIOL CHEM, V280, P38177, DOI 10.1074/jbc.M506916200; Loonstra A, 2001, P NATL ACAD SCI USA, V98, P9209, DOI 10.1073/pnas.161269798; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; Matsson H, 2006, BLOOD CELL MOL DIS, V36, P259, DOI 10.1016/j.bcmd.2005.12.002; Matsson H, 2004, MOL CELL BIOL, V24, P4032, DOI 10.1128/MCB.24.9.4032-4037.2004; MAYER TC, 1973, DEV BIOL, V34, P39, DOI 10.1016/0012-1606(73)90337-0; MCCULLOC.EA, 1965, BLOOD-J HEMATOL, V26, P399, DOI 10.1182/blood.V26.4.399.399; Miyake K, 2008, STEM CELLS, V26, P323, DOI 10.1634/stemcells.2007-0569; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; NISHIKAWA S, 1991, EMBO J, V10, P2111, DOI 10.1002/j.1460-2075.1991.tb07744.x; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Panic L, 2006, MOL CELL BIOL, V26, P8880, DOI 10.1128/MCB.00751-06; Ramirez A, 2004, GENESIS, V39, P52, DOI 10.1002/gene.20025; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Schultz J, 1929, GENETICS, V14, P366; SJALANDER A, 1995, HUM HERED, V45, P144, DOI 10.1159/000154275; Slominski A, 2005, ENDOCRINOLOGY, V146, P1245, DOI 10.1210/en.2004-0733; STEEL KP, 1992, DEVELOPMENT, V115, P1111; Strehlow ANT, 2007, HUM MOL GENET, V16, P391, DOI 10.1093/hmg/ddl467; Sulic S, 2005, GENE DEV, V19, P3070, DOI 10.1101/gad.359305; Van Raamsdonk CD, 2004, NAT GENET, V36, P961, DOI 10.1038/ng1412; Volarevic S, 2000, SCIENCE, V288, P2045, DOI 10.1126/science.288.5473.2045; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147	50	269	275	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					963	970		10.1038/ng.188	http://dx.doi.org/10.1038/ng.188			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18641651	Green Accepted			2022-12-27	WOS:000258026900012
J	Bhangale, TR; Rieder, MJ; Nickerson, DA				Bhangale, Tushar R.; Rieder, Mark J.; Nickerson, Deborah A.			Estimating coverage and power for genetic association studies using near-complete variation data	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LOCI	Although studies suggest that SNPs derived from HapMap provide promising coverage and power for association studies, the lack of alternative variation datasets limits independent analysis. Using near-complete variation data for 76 genes resequenced in HapMap samples, we find that coverage of common variation by commercial genotyping arrays is substantially lower compared to the HapMap-based estimates. We quantify the power offered by these arrays for a range of disease models.	[Bhangale, Tushar R.; Rieder, Mark J.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Bhangale, TR (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	tushar@u.washington.edu; debnick@u.washington.edu			NHLBI NIH HHS [HL66642, HL66682] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066682, U01HL066642] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; de Bakker PIW, 2006, NAT GENET, V38, P1298, DOI 10.1038/ng1899; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Kaiser J, 2008, SCIENCE, V319, P395, DOI 10.1126/science.319.5862.395; Ke XY, 2005, HUM MOL GENET, V14, P2757, DOI 10.1093/hmg/ddi309; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schork NJ, 2002, AM J HUM GENET, V70, P1480, DOI 10.1086/340788; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Servin B, 2007, PLOS GENET, V3, P1296, DOI 10.1371/journal.pgen.0030114; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	14	66	68	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					841	843		10.1038/ng.180	http://dx.doi.org/10.1038/ng.180			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18568023				2022-12-27	WOS:000257166500018
J	Gudbjartsson, DF; Sulem, P; Stacey, SN; Goldstein, AM; Rafnar, T; Sigurgeirsson, B; Benediktsdottir, KR; Thorisdottir, K; Ragnarsson, R; Sveinsdottir, SG; Magnusson, V; Lindblom, A; Kostulas, K; Botella-Estrada, R; Soriano, V; Juberias, P; Grasa, M; Saez, B; Andres, R; Scherer, D; Rudnai, P; Gurzau, E; Koppova, K; Kiemeney, LA; Jakobsdottir, M; Steinberg, S; Helgason, A; Gretarsdottir, S; Tucker, MA; Mayordomo, JI; Nagore, E; Kumar, R; Hansson, J; Olafsson, JH; Gulcher, J; Kong, A; Thorsteinsdottir, U; Stefansson, K				Gudbjartsson, Daniel F.; Sulem, Patrick; Stacey, Simon N.; Goldstein, Alisa M.; Rafnar, Thorunn; Sigurgeirsson, Bardur; Benediktsdottir, Kristrun R.; Thorisdottir, Kristin; Ragnarsson, Rafn; Sveinsdottir, Steinunn G.; Magnusson, Veronica; Lindblom, Annika; Kostulas, Konstantinos; Botella-Estrada, Rafael; Soriano, Virtudes; Juberias, Pablo; Grasa, Matilde; Saez, Berta; Andres, Raquel; Scherer, Dominique; Rudnai, Peter; Gurzau, Eugene; Koppova, Kvetoslava; Kiemeney, Lambertus A.; Jakobsdottir, Margret; Steinberg, Stacy; Helgason, Agnar; Gretarsdottir, Solveig; Tucker, Margaret A.; Mayordomo, Jose I.; Nagore, Eduardo; Kumar, Rajiv; Hansson, Johan; Olafsson, Jon H.; Gulcher, Jeffrey; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari			ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma	NATURE GENETICS			English	Article							MELANOCORTIN-1 RECEPTOR MC1R; NONMELANOMA SKIN-CANCER; RISK-FACTORS; GENE VARIANTS; CONFERS RISK; EYE-COLOR; POLYMORPHISM; AGOUTI; HAIR; SUSCEPTIBILITY	Fair color increases risk of cutaneous melanoma (CM) and basal cell carcinoma (BCC). Recent genome-wide association studies have identified variants affecting hair, eye and skin pigmentation in Europeans. Here, we assess the effect of these variants on risk of CM and BCC in European populations comprising 2,121 individuals with CM, 2,163 individuals with BCC and over 40,000 controls. A haplotype near ASIP, known to affect a similar spectrum of pigmentation traits as MC1R variants, conferred significant risk of CM (odds ratio (OR) 1.45, P = 1.2 x 10(-9)) and BCC (OR = 1.33, P = 1.2 x 10(-6)). The variant in TYR encoding the R402Q amino acid substitution, previously shown to affect eye color and tanning response, conferred risk of CM (OR = 1.21, P = 2.8 x 10(-7)) and BCC (OR = 1.14, P = 6.1 x 10(-4)). An eye color variant in TYRP1 was associated with risk of CM (OR = 1.15, P = 4.6 x 10(-4)). The association of all three variants is robust with respect to adjustment for the effect of pigmentation.	[Gudbjartsson, Daniel F.; Sulem, Patrick; Stacey, Simon N.; Rafnar, Thorunn; Jakobsdottir, Margret; Steinberg, Stacy; Helgason, Agnar; Gretarsdottir, Solveig; Gulcher, Jeffrey; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Goldstein, Alisa M.; Tucker, Margaret A.] NCI, Genet Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,Dept Hlth & Human Services, Bethesda, MD 20892 USA; [Sigurgeirsson, Bardur; Benediktsdottir, Kristrun R.; Thorisdottir, Kristin; Olafsson, Jon H.] Landspitali Univ Hosp, Dept Dermatol, IS-101 Reykjavik, Iceland; [Sigurgeirsson, Bardur; Benediktsdottir, Kristrun R.; Thorisdottir, Kristin; Olafsson, Jon H.] Landspitali Univ Hosp, Dept Pathol, IS-101 Reykjavik, Iceland; [Benediktsdottir, Kristrun R.; Thorisdottir, Kristin] Landspitali Univ Hosp, Dept Plast Surg, IS-101 Reykjavik, Iceland; [Sveinsdottir, Steinunn G.] Clin Res Ctr, IS-110 Reykjavik, Iceland; [Magnusson, Veronica] Karolinska Univ Hosp Solna, Karolinska Inst, Canc Ctr Karolinska, Dept Oncol Pathol, S-17176 Stockholm, Sweden; [Lindblom, Annika] Karolinska Inst, Dept Mol Med, S-17176 Stockholm, Sweden; [Kostulas, Konstantinos] Karolinska Univ Hosp, Karolinska Inst, Dept Neurol, S-14186 Huddinge, Sweden; [Botella-Estrada, Rafael] Inst Valenciano Oncol, Dept Dermatol, Valencia 46009, Spain; [Soriano, Virtudes; Nagore, Eduardo] Inst Valenciano Oncol, Dept Oncol, Valencia 46009, Spain; [Juberias, Pablo; Grasa, Matilde] Univ Hosp, Div Dermatol, Zaragoza 50009, Spain; [Saez, Berta] Hlth Sci Inst, Zaragoza 50009, Spain; [Andres, Raquel; Mayordomo, Jose I.] Hlth Sci Inst, Div Med Oncol, Zaragoza 50009, Spain; [Scherer, Dominique; Kumar, Rajiv] German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany; [Rudnai, Peter] Natl Inst Environm Hlth, H-1450 Budapest, Hungary; [Gurzau, Eugene] Ctr Environm Hlth, RO Cluj Napoca, Romania; [Koppova, Kvetoslava] State Hlth Inst, SK-97576 Banska Bystr, Slovakia; [Kiemeney, Lambertus A.] Ctr Comprehens Canc, NL-6501 BG Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Urol, NL-6500 HB Nijmegen, Netherlands	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Instituto Valenciano De Oncologia; Instituto Valenciano De Oncologia; Miguel Servet University Hospital; Helmholtz Association; German Cancer Research Center (DKFZ); Radboud University Nijmegen; Radboud University Nijmegen	Gudbjartsson, DF (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	daniel.gudbjartsson@decode.is; kstefans@decode.is	Sigurgeirsson, Bárður/B-6130-2011; Tucker, Margaret A/B-4297-2015; Sigurgeirsson, Bardur/AAP-7755-2020; Höiom, Veronica/F-4153-2012; Mayordomo, Jose/K-3453-2013; Nagore, Eduardo/Z-2126-2019; Stefansson, Kari/AAE-7187-2019; Kiemeney, Lambertus A./D-3357-2009; Kumar, Rajiv/H-6431-2019; Helgason, Agnar/K-1522-2015	Nagore, Eduardo/0000-0003-3433-8707; Kiemeney, Lambertus A./0000-0002-2368-1326; Kumar, Rajiv/0000-0002-6093-0395; Gudbjartsson, Daniel/0000-0002-5222-9857; Helgason, Agnar/0000-0002-8545-3767; Sigurgeirsson, Bardur/0000-0002-9733-9742; Kong, Augustine/0000-0001-8193-5438; Gurzau, Eugen/0000-0002-8688-6118	Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [N02-CP-91026] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bastiaens MT, 2001, AM J HUM GENET, V68, P884, DOI 10.1086/319500; Box NF, 2001, J INVEST DERMATOL, V116, P224, DOI 10.1046/j.1523-1747.2001.01224.x; Duffy DL, 2007, AM J HUM GENET, V80, P241, DOI 10.1086/510885; Frudakis T, 2003, GENETICS, V165, P2071; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Han JL, 2006, INT J EPIDEMIOL, V35, P1514, DOI 10.1093/ije/dyl197; Han JL, 2006, INT J CANCER, V119, P1976, DOI 10.1002/ijc.22074; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kanetsky PA, 2002, AM J HUM GENET, V70, P770, DOI 10.1086/339076; Kennedy C, 2001, J INVEST DERMATOL, V117, P294, DOI 10.1046/j.0022-202x.2001.01421.x; KING RA, 1991, J CLIN INVEST, V87, P1046, DOI 10.1172/JCI115064; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Landi MT, 2005, J NATL CANCER I, V97, P998, DOI 10.1093/jnci/dji176; Madan V, 2006, BRIT J DERMATOL, V154, P5, DOI 10.1111/j.1365-2133.2006.07229.x; Markovic SN, 2007, MAYO CLIN PROC, V82, P364; Meziani R, 2005, J DERMATOL SCI, V40, P133, DOI 10.1016/j.jdermsci.2005.08.001; MILLER DL, 1994, J AM ACAD DERMATOL, V30, P774, DOI 10.1016/S0190-9622(08)81509-5; Oliveria SA, 2006, ARCH DIS CHILD, V91, P131, DOI 10.1136/adc.2005.086918; Palmer JS, 2000, AM J HUM GENET, V66, P176, DOI 10.1086/302711; Rees J, 2006, J INVEST DERMATOL, V126, P1691, DOI 10.1038/sj.jid.5700345; Scherer D, 2008, INT J CANCER, V122, P1787, DOI 10.1002/ijc.23257; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Sturm RA, 2004, TRENDS GENET, V20, P327, DOI 10.1016/j.tig.2004.06.010; SULEM P, NAT GENET       0525; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Suzuki I, 1997, J INVEST DERMATOL, V108, P838, DOI 10.1111/1523-1747.ep12292572; Valverde P, 1996, HUM MOL GENET, V5, P1663, DOI 10.1093/hmg/5.10.1663; Voisey J, 2002, PIGM CELL RES, V15, P10, DOI 10.1034/j.1600-0749.2002.00039.x; Wong TH, 2005, PEPTIDES, V26, P1965, DOI 10.1016/j.peptides.2004.11.021	30	250	260	1	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					886	891		10.1038/ng.161	http://dx.doi.org/10.1038/ng.161			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18488027				2022-12-27	WOS:000257166500024
J	Dibbens, LM; Tarpey, PS; Hynes, K; Bayly, MA; Scheffer, IE; Smith, R; Bomar, J; Sutton, E; Vandeleur, L; Shoubridge, C; Edkins, S; Turner, SJ; Stevens, C; O'Meara, S; Tofts, C; Barthorpe, S; Buck, G; Cole, J; Halliday, K; Jones, D; Lee, R; Madison, M; Mironenko, T; Varian, J; West, S; Widaa, S; Wray, P; Teague, J; Dicks, E; Butler, A; Menzies, A; Jenkinson, A; Shepherd, R; Gusella, JF; Afawi, Z; Mazarib, A; Neufeld, MY; Kivity, S; Lev, D; Lerman-Sagie, T; Korczyn, AD; Derry, CP; Sutherland, GR; Friend, K; Shaw, M; Corbett, M; Kim, HG; Geschwind, DH; Thomas, P; Haan, E; Ryan, S; McKee, S; Berkovic, SF; Futreal, PA; Stratton, MR; Mulley, JC; Gecz, J				Dibbens, Leanne M.; Tarpey, Patrick S.; Hynes, Kim; Bayly, Marta A.; Scheffer, Ingrid E.; Smith, Raffaella; Bomar, Jamee; Sutton, Edwina; Vandeleur, Lucianne; Shoubridge, Cheryl; Edkins, Sarah; Turner, Samantha J.; Stevens, Claire; O'Meara, Sarah; Tofts, Calli; Barthorpe, Syd; Buck, Gemma; Cole, Jennifer; Halliday, Kelly; Jones, David; Lee, Rebecca; Madison, Mark; Mironenko, Tatiana; Varian, Jennifer; West, Sofie; Widaa, Sara; Wray, Paul; Teague, John; Dicks, Ed; Butler, Adam; Menzies, Andrew; Jenkinson, Andrew; Shepherd, Rebecca; Gusella, James F.; Afawi, Zaid; Mazarib, Aziz; Neufeld, Miriam Y.; Kivity, Sara; Lev, Dorit; Lerman-Sagie, Tally; Korczyn, Amos D.; Derry, Christopher P.; Sutherland, Grant R.; Friend, Kathryn; Shaw, Marie; Corbett, Mark; Kim, Hyung-Goo; Geschwind, Daniel H.; Thomas, Paul; Haan, Eric; Ryan, Stephen; McKee, Shane; Berkovic, Samuel F.; Futreal, P. Andrew; Stratton, Michael R.; Mulley, John C.; Gecz, Jozef			X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairment	NATURE GENETICS			English	Article							CADHERIN SUPERFAMILY; CONVULSIVE DISORDER; FAMILIAL FORM; EXPRESSION; BRAIN; GENES; ORGANIZATION; DIVERSITY; MEMBERS	Epilepsy and mental retardation limited to females (EFMR) is a disorder with an X-linked mode of inheritance and an unusual expression pattern. Disorders arising from mutations on the X chromosome are typically characterized by affected males and unaffected carrier females. In contrast, EFMR spares transmitting males and affects only carrier females. Aided by systematic resequencing of 737 X chromosome genes, we identified different protocadherin 19 (PCDH19) gene mutations in seven families with EFMR. Five mutations resulted in the introduction of a premature termination codon. Study of two of these demonstrated nonsense-mediated decay of PCDH19 mRNA. The two missense mutations were predicted to affect adhesiveness of PCDH19 through impaired calcium binding. PCDH19 is expressed in developing brains of human and mouse and is the first member of the cadherin superfamily to be directly implicated in epilepsy or mental retardation.	[Dibbens, Leanne M.; Hynes, Kim; Bayly, Marta A.; Vandeleur, Lucianne; Shoubridge, Cheryl; Sutherland, Grant R.; Friend, Kathryn; Shaw, Marie; Corbett, Mark; Haan, Eric; Mulley, John C.; Gecz, Jozef] Womens & Childrens Hosp, Dept Med Genet, Adelaide, SA 5006, Australia; [Dibbens, Leanne M.; Sutherland, Grant R.; Mulley, John C.; Gecz, Jozef] Univ Adelaide, Sch Paediat & Reprod Hlth, Adelaide, SA 5005, Australia; [Tarpey, Patrick S.; Smith, Raffaella; Edkins, Sarah; Stevens, Claire; O'Meara, Sarah; Tofts, Calli; Barthorpe, Syd; Buck, Gemma; Cole, Jennifer; Halliday, Kelly; Jones, David; Lee, Rebecca; Madison, Mark; Mironenko, Tatiana; Varian, Jennifer; West, Sofie; Widaa, Sara; Wray, Paul; Teague, John; Dicks, Ed; Butler, Adam; Menzies, Andrew; Jenkinson, Andrew; Shepherd, Rebecca; Futreal, P. Andrew; Stratton, Michael R.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Hynes, Kim; Sutton, Edwina; Sutherland, Grant R.; Thomas, Paul; Haan, Eric; Mulley, John C.; Gecz, Jozef] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA 5005, Australia; [Scheffer, Ingrid E.; Turner, Samantha J.; Derry, Christopher P.; Berkovic, Samuel F.] Univ Melbourne, Epilepsy Res Ctr, Heidelberg Repatriat Hosp, Heidelberg West, Vic 3081, Australia; [Scheffer, Ingrid E.; Turner, Samantha J.; Derry, Christopher P.; Berkovic, Samuel F.] Univ Melbourne, Dept Med, Heidelberg Repatriat Hosp, Heidelberg West, Vic 3081, Australia; [Scheffer, Ingrid E.] Univ Melbourne, Dept Paediat, Royal Childrens Hosp, Parkville, Vic 3052, Australia; [Bomar, Jamee; Geschwind, Daniel H.] Univ Calif Los Angeles, Program Neurogenet & Neurobehav Genet, Dept Neurol, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Bomar, Jamee; Geschwind, Daniel H.] Univ Calif Los Angeles, Semel Inst Neurosci & Behav, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Gusella, James F.; Korczyn, Amos D.; Kim, Hyung-Goo] Massachusetts Gen Hosp, Mol Neurogenet Unit, Ctr Human Genet Res, Boston, MA 02114 USA; [Gusella, James F.; Korczyn, Amos D.; Kim, Hyung-Goo] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Afawi, Zaid; Mazarib, Aziz; Neufeld, Miriam Y.] Tel Aviv Sourasky Med Ctr, Dept Neurol, IL-64239 Tel Aviv, Israel; [Kivity, Sara] Schneider Childrens Med Ctr, Dept Neurol, IL-49202 Petaq Tikvah, Israel; [Lev, Dorit; Lerman-Sagie, Tally] Wolfson Med Ctr, Metab Neurogenet Clin, IL-58100 Holon, Israel; [Ryan, Stephen] AstraZeneca, Wilmington, DE 19803 USA; [McKee, Shane] Belfast City Hosp, No Ireland Reg Genet Serv, Belfast BT9 7AB, Antrim, North Ireland	Womens & Childrens Hospital Australia; University of Adelaide; Wellcome Trust Sanger Institute; University of Adelaide; University of Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; AstraZeneca; Belfast City Hospital	Dibbens, LM (corresponding author), Womens & Childrens Hosp, Dept Med Genet, Level 9 Rieger Bldg,72 King William Rd, Adelaide, SA 5006, Australia.	leanne.dibbens@cywhs.sa.gov.au; jozef.gecz@adelaide.edu.au	Scheffer, Ingrid E/G-1668-2013; Corbett, Mark/A-8063-2010; Bayly, Marta A/F-3977-2013; Gecz, Jozef/X-3469-2019; jiang, yu/HGU-0029-2022; Thomas, Paul Q/K-4497-2012; Afawi, Zaid/AAE-7848-2022; Shoubridge, Cheryl/A-1571-2016; Korczyn, Amos/C-3461-2017; Hynes, Kim/O-3874-2015	Scheffer, Ingrid E/0000-0002-2311-2174; Corbett, Mark/0000-0001-9298-3072; Gecz, Jozef/0000-0002-7884-6861; Shoubridge, Cheryl/0000-0002-0157-3084; Korczyn, Amos/0000-0003-0125-2579; Berkovic, Samuel/0000-0003-4580-841X; Bayly, Marta/0000-0002-6011-4478; Jenkinson, Andrew/0000-0002-0703-6984; Dibbens, Leanne/0000-0002-5824-3342; Buck, Gemma/0000-0001-5289-1050; Hynes, Kim/0000-0001-8679-4400	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM061354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH064547] Funding Source: NIH RePORTER; NICHD NIH HHS [N01-HD-4-3383, N01-HD-4-3368] Funding Source: Medline; NIGMS NIH HHS [P01 GM061354, GM061354] Funding Source: Medline; NIMH NIH HHS [R01 MH064547-05, R01 MH064547, R01 MH064547-02, R01 MH064547-01, R01 MH 64547, R01 MH064547-02S1, R01 MH064547-03, R01 MH064547-04, R01 MH064547-01S1] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Arnold AP, 2004, NAT REV NEUROSCI, V5, P701, DOI 10.1038/nrn1494; Bauer R, 2006, EXP MOL PATHOL, V81, P224, DOI 10.1016/j.yexmp.2006.07.002; Blanco P, 2000, MAMM GENOME, V11, P906, DOI 10.1007/s003350010177; Durand CM, 2006, AM J MED GENET B, V141B, P67, DOI 10.1002/ajmg.b.30229; FABISIAK K, 1990, CLIN GENET, V38, P353; Gaitan Y, 2006, GENE EXPR PATTERNS, V6, P893, DOI 10.1016/j.modgep.2006.03.001; JUBERG RC, 1971, J PEDIATR-US, V79, P726, DOI 10.1016/S0022-3476(71)80382-7; Kim SY, 2007, NEUROSCIENCE, V147, P996, DOI 10.1016/j.neuroscience.2007.03.052; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Morishita H, 2006, J BIOL CHEM, V281, P33650, DOI 10.1074/jbc.M603298200; Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046; Ryan SG, 1997, NAT GENET, V17, P92, DOI 10.1038/ng0997-92; Scheffer IE, 2008, BRAIN, V131, P918, DOI 10.1093/brain/awm338; Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043; Teramitsu I, 2004, J NEUROSCI, V24, P3152, DOI 10.1523/JNEUROSCI.5589-03.2004; Uemura M, 2007, NAT NEUROSCI, V10, P1151, DOI 10.1038/nn1960; Vanhalst K, 2005, CELL MOL LIFE SCI, V62, P1247, DOI 10.1007/s00018-005-5021-7; Wieland I, 2004, AM J HUM GENET, V74, P1209, DOI 10.1086/421532; Wilson LD, 2005, GENE EXPR PATTERNS, V5, P305, DOI 10.1016/j.modgep.2004.10.005; Wolverton T, 2001, GENOMICS, V76, P66, DOI 10.1006/geno.2001.6592; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Yagi T, 2000, GENE DEV, V14, P1169; Yang X, 2006, GENOME RES, V16, P995, DOI 10.1101/gr.5217506	24	302	323	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2008	40	6					776	781		10.1038/ng.149	http://dx.doi.org/10.1038/ng.149			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18469813	Green Accepted			2022-12-27	WOS:000256212000020
J	Behmoaras, J; Bhangal, G; Smith, J; McDonald, K; Mutch, B; Lai, PC; Domin, J; Game, L; Salama, A; Foxwell, BM; Pusey, CD; Cook, HT; Aitman, TJ				Behmoaras, Jacques; Bhangal, Gurjeet; Smith, Jennifer; McDonald, Kylie; Mutch, Brenda; Lai, Ping Chin; Domin, Jan; Game, Laurence; Salama, Alan; Foxwell, Brian M.; Pusey, Charles D.; Cook, H. Terence; Aitman, Timothy J.			Jund is a determinant of macrophage activation and is associated with glomerulonephritis susceptibility	NATURE GENETICS			English	Article							ANTI-GBM GLOMERULONEPHRITIS; CRESCENTIC GLOMERULONEPHRITIS; INSULIN-RESISTANCE; HYPERTENSIVE-RATS; AP-1 ACTIVATION; PATHOGENIC ROLE; RENAL INJURY; EXPRESSION; CELLS	Crescentic glomerulonephritis is an important cause of human kidney failure for which the underlying molecular basis is largely unknown. In previous studies, we mapped several susceptibility loci, Crgn1-Crgn7, for crescentic glomerulonephritis in the Wistar Kyoto ( WKY) rat(1). Here we show by combined congenic, linkage and microarray studies that the activator protein-1 ( AP-1) transcription factor JunD is a major determinant of macrophage activity and is associated with glomerulonephritis susceptibility. Introgression of Crgn2 from the nonsusceptible Lewis strain onto the WKY background leads to significant reductions in crescent formation, macrophage infiltration, Fc receptor-mediated macrophage activation and cytokine production. Haplotype analysis restricted the Crgn2 linkage interval to a 430-kb interval containing Jund, which is markedly overexpressed in WKY macrophages and glomeruli. Jund knockdown in rat and human primary macrophages led to significantly reduced macrophage activity and cytokine secretion, indicating conservation of JunD function in macrophage activation in rats and humans and suggesting in vivo inhibition of Jund as a possible new therapeutic strategy for diseases characterized by inflammation and macrophage activation.	[Behmoaras, Jacques; McDonald, Kylie; Aitman, Timothy J.] MRC, Ctr Clin Sci, Physiol Genom & Med Grp, London W12 0NN, England; [Mutch, Brenda; Foxwell, Brian M.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Kennedy Inst, Div Rheumatol, London W6 8LH, England; [Lai, Ping Chin] Chang Gung Univ, Sch Med, Dept Nephrol, Chang Gung Mem Hosp,Kidney Inst, Taipei, Taiwan; [Game, Laurence] Univ London Imperial Coll Sci Technol & Med, Microarray Ctr, Ctr Clin Sci, London W12 0NN, England; [Cook, H. Terence] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Histopathol, London W12 0NN, England; [Aitman, Timothy J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sect Mol Genet & Rheumatol, London W12 0NN, England	Imperial College London; University of Oxford; Chang Gung Memorial Hospital; Chang Gung University; Imperial College London; Imperial College London; Imperial College London	Aitman, TJ (corresponding author), MRC, Ctr Clin Sci, Physiol Genom & Med Grp, Du Cane Rd, London W12 0NN, England.	t.aitman@imperial.ac.uk		Aitman, Timothy/0000-0002-7875-4502	MRC [G0500936, G0400116, MC_U120061454] Funding Source: UKRI; Medical Research Council [G0500936, G0400116, MC_U120061454] Funding Source: Medline; Wellcome Trust [081462] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; Andersson A, 2004, J LEUKOCYTE BIOL, V76, P1118, DOI 10.1189/jlb.0704385; BHAN AK, 1978, J EXP MED, V148, P246, DOI 10.1084/jem.148.1.246; CATTELL V, 1994, KIDNEY INT, V45, P945, DOI 10.1038/ki.1994.128; Cook HT, 1999, KIDNEY INT, V55, P1319, DOI 10.1046/j.1523-1755.1999.00354.x; COOK HT, 1989, AM J PATHOL, V134, P431; Duffield JS, 2005, AM J PATHOL, V167, P1207, DOI 10.1016/S0002-9440(10)61209-6; Flanc RS, 2007, KIDNEY INT, V72, P698, DOI 10.1038/sj.ki.5002404; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Ikezumi Y, 2004, J AM SOC NEPHROL, V15, P1775, DOI 10.1097/01.ASN.0000131272.06958.DE; Isome M, 2004, NEPHROL DIAL TRANSPL, V19, P2997, DOI 10.1093/ndt/gfh558; Kluth DC, 2007, KIDNEY INT, V72, P234, DOI 10.1038/sj.ki.5002332; Lai PC, 2001, J AM SOC NEPHROL, V12, P2310, DOI 10.1681/ASN.V12112310; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; Meixner A, 2004, EMBO J, V23, P1325, DOI 10.1038/sj.emboj.7600133; PFARR CM, 1994, CELL, V76, P747, DOI 10.1016/0092-8674(94)90513-4; Pravenec M, 2001, NAT GENET, V27, P156, DOI 10.1038/84777; Sakurai H, 1998, BIOCHEM MOL BIOL INT, V45, P831; Sakurai H, 1997, BBA-MOL BASIS DIS, V1362, P252, DOI 10.1016/S0925-4439(97)00068-9; Smith J, 2007, J AM SOC NEPHROL, V18, P1816, DOI 10.1681/ASN.2006070733; Tam FWK, 1999, NEPHROL DIAL TRANSPL, V14, P1658, DOI 10.1093/ndt/14.7.1658; Wang Y, 2007, KIDNEY INT, V72, P290, DOI 10.1038/sj.ki.5002275; Weitzman JB, 2000, MOL CELL, V6, P1109, DOI 10.1016/S1097-2765(00)00109-X; Williams L, 2004, J IMMUNOL, V172, P567, DOI 10.4049/jimmunol.172.1.567	25	68	70	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2008	40	5					553	559		10.1038/ng.137	http://dx.doi.org/10.1038/ng.137			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18443593	Green Published, Green Accepted			2022-12-27	WOS:000255366700021
J	Kooner, JS; Chambers, JC; Aguilar-Salinas, CA; Hinds, DA; Hyde, CL; Warnes, GR; Perez, FJG; Frazer, KA; Elliott, P; Scott, J; Milos, PM; Cox, DR; Thompson, JF				Kooner, Jaspal S.; Chambers, John C.; Aguilar-Salinas, Carlos A.; Hinds, David A.; Hyde, Craig L.; Warnes, Gregory R.; Gomez Perez, Francisco J.; Frazer, Kelly A.; Elliott, Paul; Scott, James; Milos, Patrice M.; Cox, David R.; Thompson, John F.			Genome-wide scan identifies variation in MLXIPL associated with plasma triglycerides	NATURE GENETICS			English	Article							GENE; OBESITY; CHREBP; HDL	We tested over 267,000 SNPs in 1,005 Northern Europeans and 248,000 in 1,006 Indian Asians for association with triglycerides and HDL cholesterol, with replication in 10,536 subjects. We found association of a nonsynonymous SNP (rs3812316, G771C, Gln241His) in MLXIPL with plasma triglyceride levels (combined P = 1.4 x 10(-10)). MLXIPL coordinates transcriptional regulation of enzymes that channel glycolytic end-products into lipogenesis and energy storage, making MLXIPL a plausible 'thrifty gene'.	[Kooner, Jaspal S.; Scott, James] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Chambers, John C.; Elliott, Paul] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London SW7 2AZ, England; [Aguilar-Salinas, Carlos A.; Gomez Perez, Francisco J.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City 14000, DF, Mexico; [Hinds, David A.; Frazer, Kelly A.; Cox, David R.] Perlegen Sci Inc, Mountain View, CA 94043 USA; [Hyde, Craig L.; Warnes, Gregory R.; Milos, Patrice M.] Pfizer Global Res & Dev, Groton, CT 06340 USA	Imperial College London; Imperial College London; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Pfizer	Scott, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England.	j.scott@imperial.ac.uk	Salinas, Carlos A Aguilar/AAL-4491-2020	Hinds, David/0000-0002-4911-803X; Elliott, Paul/0000-0002-7511-5684; Frazer, Kelly/0000-0002-6060-8902; Thompson, John/0000-0001-8568-3311	MRC [G0700931, G0601966] Funding Source: UKRI; Medical Research Council [G0700931, G0601966] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bacanu SA, 2000, AM J HUM GENET, V66, P1933, DOI 10.1086/302929; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Diamond J, 2003, NATURE, V423, P599, DOI 10.1038/423599a; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; Li MV, 2006, DIABETES, V55, P1179, DOI 10.2337/db05-0822; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Ordovas JM, 2002, CARDIOVASC DRUG THER, V16, P273, DOI 10.1023/A:1021769523568; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	15	258	266	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2008	40	2					149	151		10.1038/ng.2007.61	http://dx.doi.org/10.1038/ng.2007.61			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18193046				2022-12-27	WOS:000252732900010
J	Graham, DSC; Graham, RR; Manku, H; Wong, AK; Whittaker, JC; Gaffney, PM; Moser, KL; Rioux, JD; Altshuler, D; Behrens, TW; Vyse, TJ				Graham, Deborah S. Cunninghame; Graham, Robert R.; Manku, Harinder; Wong, Andrew K.; Whittaker, John C.; Gaffney, Patrick M.; Moser, Kathy L.; Rioux, John D.; Altshuler, David; Behrens, Timothy W.; Vyse, Timothy J.			Polymorphism at the TNF superfamily gene TNFSF4 confers susceptibility to systemic lupus erythematosus	NATURE GENETICS			English	Article							OX40 LIGAND; T-CELLS; LINKAGE DISEQUILIBRIUM; OX-40 LIGAND; HAPLOTYPE; EXPRESSION; IDENTIFICATION; ASSOCIATION; GENOME; FAMILY	Systemic lupus erythematosus (SLE) is a multisystem complex autoimmune disease of uncertain etiology (OMIM 152700). Over recent years a genetic component to SLE susceptibility has been established(1 - 3). Recent successes with association studies in SLE have identified genes including IRF5 (refs. 4,5) and FCGR3B(6). Two tumor necrosis factor (TNF) superfamily members located within intervals showing genetic linkage with SLE are TNFSF4 (also known as OX40L; 1q25), which is expressed on activated antigen-presenting cells (APCs)(7,8) and vascular endothelial cells(9), and also its unique receptor, TNFRSF4 ( also known as OX40; 1p36), which is primarily expressed on activated CD4(+) T cells(10). TNFSF4 produces a potent co-stimulatory signal for activated CD4(+) T cells after engagement of TNFRSF4 (ref. 11). Using both a family-based and a case-control study design, we show that the upstream region of TNFSF4 contains a single risk haplotype for SLE, which is correlated with increased expression of both cell-surface TNFSF4 and the TNFSF4 transcript. We hypothesize that increased expression of TNFSF4 predisposes to SLE either by quantitatively augmenting T cell - APC interaction or by influencing the functional consequences of T cell activation via TNFRSF4.	[Graham, Deborah S. Cunninghame; Manku, Harinder; Wong, Andrew K.; Vyse, Timothy J.] Hammersmith Hosp, Imperial Coll Fac Med, Sect Mol Genet & Rheumatol, London W12 0NN, England; [Graham, Robert R.; Altshuler, David] MIT, Cambridge, MA 02142 USA; [Graham, Robert R.; Altshuler, David] Broad Inst Harvard, Programme Med & Populat Genet, Cambridge, MA 02142 USA; [Whittaker, John C.] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England; [Gaffney, Patrick M.; Behrens, Timothy W.] Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55455 USA; [Rioux, John D.] Univ Montreal, Montreal, PQ H1T 1C8, Canada; [Rioux, John D.] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Rioux, John D.] Broad Inst MIT & Harvard, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Moser, Kathy L.] Genentech Inc, San Francisco, CA 94080 USA	Imperial College London; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of London; London School of Hygiene & Tropical Medicine; University of Minnesota System; University of Minnesota Twin Cities; Universite de Montreal; Universite de Montreal; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Roche Holding; Genentech	Vyse, TJ (corresponding author), Hammersmith Hosp, Imperial Coll Fac Med, Sect Mol Genet & Rheumatol, Du Cane Rd, London W12 0NN, England.	t.vyse@imperial.ac.uk	Whittaker, John C/B-8609-2012; Rioux, John D/A-9599-2015; Altshuler, David M/A-4476-2009; Wong, Andrew/M-8899-2016; Wong, Andrew/AAE-6995-2019	Whittaker, John C/0000-0002-3529-2379; Rioux, John D/0000-0001-7560-8326; Altshuler, David M/0000-0002-7250-4107; Wong, Andrew/0000-0003-2079-4779; Wong, Andrew/0000-0003-2079-4779; Gaffney, Patrick/0000-0002-1580-869X	NCRR NIH HHS [U54 RR020278-01, U54 RR020278] Funding Source: Medline; NIAID NIH HHS [P01 AI065687, AI067152, AI065687, U19 AI067152] Funding Source: Medline; NIDDK NIH HHS [R01 DK064869, DK064869, U01 DK062432, DK062432] Funding Source: Medline; Wellcome Trust [051276, 068545/Z/02] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI065687, U19AI067152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064869, U01DK062432] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boyum A, 1968, Scand J Clin Lab Invest Suppl, V97, P7; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; DEAPEN D, 1992, ARTHRITIS RHEUM, V35, P311; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Fisher R. A., 1954, STAT METHODS RES WOR, DOI DOI 10.1007/BF01603396; Forabosco P, 2006, GENES IMMUN, V7, P609, DOI 10.1038/sj.gene.6364338; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; GODFREY WR, 1994, J EXP MED, V180, P757, DOI 10.1084/jem.180.2.757; Graham DSC, 2006, HUM MOL GENET, V15, P3195, DOI 10.1093/hmg/ddl395; Graham DSC, 2007, HUM MOL GENET, V16, P579, DOI 10.1093/hmg/ddl469; Graham RR, 2006, NAT GENET, V38, P550, DOI 10.1038/ng1782; Gramaglia I, 1998, J IMMUNOL, V161, P6510; HILL WG, 1994, AM J HUM GENET, V54, P705; Ikushima S, 1997, P NATL ACAD SCI USA, V94, P2609, DOI 10.1073/pnas.94.6.2609; Imura A, 1996, J EXP MED, V183, P2185, DOI 10.1084/jem.183.5.2185; Ito T, 2006, P NATL ACAD SCI USA, V103, P13138, DOI 10.1073/pnas.0603107103; Kruglyak L, 1998, J COMPUT BIOL, V5, P1, DOI 10.1089/cmb.1998.5.1; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; LATZA U, 1994, EUR J IMMUNOL, V24, P677, DOI 10.1002/eji.1830240329; LEWONTIN RC, 1964, GENETICS, V49, P49; Ohshima Y, 1997, J IMMUNOL, V159, P3838; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Storm Niels, 2003, Methods Mol Biol, V212, P241; STUBER E, 1995, IMMUNITY, V2, P507, DOI 10.1016/1074-7613(95)90031-4; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Vyse TJ, 1996, CELL, V85, P311, DOI 10.1016/S0092-8674(00)81110-1; Wang XS, 2005, NAT GENET, V37, P365, DOI 10.1038/ng1524	28	164	173	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2008	40	1					83	89		10.1038/ng.2007.47	http://dx.doi.org/10.1038/ng.2007.47			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18059267	Green Accepted			2022-12-27	WOS:000252118600022
J	Muse, GW; Gilchrist, DA; Nechaev, S; Shah, R; Parker, JS; Grissom, SF; Zeitlinger, J; Adelman, K				Muse, Ginger W.; Gilchrist, Daniel A.; Nechaev, Sergei; Shah, Ruchir; Parker, Joel S.; Grissom, Sherry F.; Zeitlinger, Julia; Adelman, Karen			RNA polymerase is poised for activation across the genome	NATURE GENETICS			English	Article							TRANSCRIPTION ELONGATION; IN-VIVO; DROSOPHILA-MELANOGASTER; HSP70 GENE; HEAT-SHOCK; PROMOTER; COMPLEX; CELLS; NELF; INITIATION	Regulation of gene expression is integral to the development and survival of all organisms. Transcription begins with the assembly of a pre-initiation complex at the gene promoter(1), followed by initiation of RNA synthesis and the transition to productive elongation(2-4). In many cases, recruitment of RNA polymerase II ( Pol II) to a promoter is necessary and sufficient for activation of genes. However, there are a few notable exceptions to this paradigm, including heat shock genes and several proto-oncogenes, whose expression is attenuated by regulated stalling of polymerase elongation within the promoter-proximal region(5-13). To determine the importance of polymerase stalling for transcription regulation, we carried out a genome-wide search for Drosophila melanogaster genes with Pol II stalled within the promoter-proximal region. Our data show that stalling is widespread, occurring at hundreds of genes that respond to stimuli and developmental signals. This finding indicates a role for regulation of polymerase elongation in the transcriptional responses to dynamic environmental and developmental cues.	Natl Inst Hlth, Natl Inst Environm Hlth Sci, Mol Carcinogenesis Lab, Res Triangle Pk, NC 27709 USA; Constella Grp, Durham, NC 27713 USA; Natl Inst Hlth, Natl Inst Environm Hlth Sci, Microarray Grp, Res Triangle Pk, NC 27709 USA; Express Anal, Durham, NC 27713 USA; Whitehead Inst Biomed Res, Nine Cambridge Ctr, Cambridge, MA 02142 USA; Stowers Inst Med Res, Kansas City, MO 64110 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Massachusetts Institute of Technology (MIT); Whitehead Institute; Stowers Institute for Medical Research	Adelman, K (corresponding author), Natl Inst Hlth, Natl Inst Environm Hlth Sci, Mol Carcinogenesis Lab, Res Triangle Pk, NC 27709 USA.	adelmank@niehs.nih.gov	Parker, Joel/AAG-1108-2019; Nechaev, Sergei/AAQ-3450-2021	Gilchrist, Daniel/0000-0003-1668-2790; Adelman, Karen/0000-0001-5364-334X	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101987] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 ES101987-02] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; Aiyar SE, 2004, GENE DEV, V18, P2134, DOI 10.1101/gad.1214104; Boehm AK, 2003, MOL CELL BIOL, V23, P7628, DOI 10.1128/MCB.23.21.7628-7637.2003; Fujinaga K, 1998, J VIROL, V72, P7154, DOI 10.1128/JVI.72.9.7154-7159.1998; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; KRUMM A, 1995, GENE DEV, V9, P559, DOI 10.1101/gad.9.5.559; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; Law A, 1998, NUCLEIC ACIDS RES, V26, P919, DOI 10.1093/nar/26.4.919; Lee CY, 2003, CURR BIOL, V13, P350, DOI 10.1016/S0960-9822(03)00085-X; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lis J, 1998, COLD SPRING HARB SYM, V63, P347, DOI 10.1101/sqb.1998.63.347; Luse DS, 1998, COLD SPRING HARB SYM, V63, P289, DOI 10.1101/sqb.1998.63.289; Narita T, 2003, MOL CELL BIOL, V23, P1863, DOI 10.1128/MCB.23.6.1863-1873.2003; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Qi Y, 2006, NAT BIOTECHNOL, V24, P963, DOI 10.1038/nbt1233; Raschke EE, 1999, J IMMUNOL, V163, P4375; RASMUSSEN EB, 1995, J MOL BIOL, V252, P522, DOI 10.1006/jmbi.1995.0517; RASMUSSEN EB, 1993, P NATL ACAD SCI USA, V90, P7923, DOI 10.1073/pnas.90.17.7923; Roeder RG, 2005, FEBS LETT, V579, P909, DOI 10.1016/j.febslet.2004.12.007; ROUGVIE AE, 1990, MOL CELL BIOL, V10, P6041, DOI 10.1128/MCB.10.11.6041; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; Shilatifard A, 2003, ANNU REV BIOCHEM, V72, P693, DOI 10.1146/annurev.biochem.72.121801.161551; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; STROBL LJ, 1992, EMBO J, V11, P3307, DOI 10.1002/j.1460-2075.1992.tb05409.x; Wang XL, 2007, GENE DEV, V21, P1031, DOI 10.1101/gad.1521207; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002	30	559	569	2	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2007	39	12					1507	1511		10.1038/ng.2007.21	http://dx.doi.org/10.1038/ng.2007.21			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	17994021	Green Accepted, Green Submitted			2022-12-27	WOS:000251267400020
J	Batada, NN; Hurst, LD				Batada, Nizar N.; Hurst, Laurence D.			Evolution of chromosome organization driven by selection for reduced gene expression noise	NATURE GENETICS			English	Article							GENOME-WIDE; YEAST; ORDER; HAPLOINSUFFICIENCY; IDENTIFICATION; ARCHITECTURE; LEVEL	The distribution of genes on eukaryotic chromosomes is nonrandom, but the reasons behind this are not well understood. The commonly observed clustering of essential genes is a case in point. Here we model and test a new hypothesis. Essential proteins are unusual in that random fluctuations in abundance (noise) can be highly deleterious. We hypothesize that persistently open chromatin domains are sinks for essential genes, as they enable reduced noise by avoidance of transcriptional bursting associated with chromatin remodeling. Simulation of the model captures clustering and correctly predicts that (i) essential gene clusters are associated with low nucleosome occupancy (ii) noise- sensitive nonessential genes cluster with essential genes (iii) nonessential genes of similar knockout fitness are physically linked (iv) genes in domains rich in essential genes have low noise (v) essential genes are rare subtelomerically and (vi) essential gene clusters are preferentially conserved. We conclude that different noise characteristics of different genomic domains favors nonrandom gene positioning. This has implications for gene therapy and understanding transgenic phenotypes.	Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England	University of Bath	Batada, NN (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	nizar.batada@gmail.com; l.d.hurst@bath.ac.uk	Batada, Nizar/D-5605-2009; Hurst, Laurence/F-9215-2010	Hurst, Laurence/0000-0002-1002-1054; Batada, Nizar/0000-0002-8007-1487	MRC [G0300415] Funding Source: UKRI; Medical Research Council [G0300415] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; BATADA NN, IN PRESS TRENDS GENE; Becskei A, 2005, NAT GENET, V37, P937, DOI 10.1038/ng1616; Cook DL, 1998, P NATL ACAD SCI USA, V95, P15641, DOI 10.1073/pnas.95.26.15641; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Fischer G, 2006, PLOS GENET, V2, P253, DOI 10.1371/journal.pgen.0020032; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Gilbert N, 2004, CELL, V118, P555, DOI 10.1016/j.cell.2004.08.011; Gustafson AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-265; Hentges KE, 2007, PLOS GENET, V3, P661, DOI 10.1371/journal.pgen.0030072; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Knop M, 2006, BIOESSAYS, V28, P696, DOI 10.1002/bies.20435; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796; NEI M, 1967, GENETICS, V57, P625; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Pal C, 2003, NAT GENET, V33, P392, DOI 10.1038/ng1111; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891; Seoighe C, 2000, P NATL ACAD SCI USA, V97, P14433, DOI 10.1073/pnas.240462997; Spellman Paul T, 2002, J Biol, V1, P5, DOI 10.1186/1475-4924-1-5	25	145	146	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					945	949		10.1038/ng2071	http://dx.doi.org/10.1038/ng2071			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17660811				2022-12-27	WOS:000248446900006
J	Lee, C; Iafrate, AJ; Brothman, AR				Lee, Charles; Iafrate, A. John; Brothman, Arthur R.			Copy number variations and clinical cytogenetic diagnosis of constitutional disorders	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; SEGMENTAL ANEUPLOIDY; WHOLE-GENOME; REARRANGEMENTS; GENE; MICROARRAY; DELETION; POLYMORPHISM; RETARDATION; IMBALANCE	The recent appreciation of widespread copy number variation in the genomes of healthy human beings has presented a significant challenge to clinical cytogeneticists who wish to use genome-wide array comparative genomic hybridization (CGH) assays for clinical diagnostic purposes. Clinical cytogeneticists need to differentiate between copy number variants (CNVs) that are likely to be pathogenic and CNVs that are less likely to contribute to an affected individual's clinical presentation. Unfortunately, our knowledge of the phenotypic effects of most CNVs is minimal, leading to the classification of many CNVs as genomic imbalances of unknown clinical significance. This has caused many laboratories to resist the use of higher-resolution genome-wide array CGH assays for clinical purposes. Ironically, the accumulation and annotation of such array CGH data can lead to the rapid identification of pathogenic CNVs and the definition of new genomic syndromes that, in turn, are useful for accurate clinical genetic diagnoses.	[Lee, Charles; Iafrate, A. John] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Lee, Charles; Iafrate, A. John] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Brothman, Arthur R.] Univ Utah, Dept Pediat, Salt Lake City, UT 84132 USA; [Brothman, Arthur R.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84132 USA; [Brothman, Arthur R.] Univ Utah, Dept Pathol, Salt Lake City, UT 84132 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Lee, C (corresponding author), Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.	clee@rics.bwh.harvard.edu						Bejjani BA, 2006, J MOL DIAGN, V8, P528, DOI 10.2353/jmoldx.2006.060029; Brewer C, 1999, AM J HUM GENET, V64, P1702, DOI 10.1086/302410; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; DELACHAPELLE A, 1974, AM J HUM GENET, V26, P746; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Flint J, 2003, CURR OPIN GENET DEV, V13, P310, DOI 10.1016/S0959-437X(03)00049-2; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Friedman JM, 2006, AM J HUM GENET, V79, P500, DOI 10.1086/507471; Hansson K, 2007, AM J MED GENET A, V143A, P1354, DOI 10.1002/ajmg.a.31783; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Knight SJL, 2000, AM J HUM GENET, V67, P320, DOI 10.1086/302998; Knight SJL, 1999, LANCET, V354, P1676, DOI 10.1016/S0140-6736(99)03070-6; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; LINDSLEY DL, 1972, GENETICS, V71, P157; Martin CL, 2002, J MED GENET, V39, P734, DOI 10.1136/jmg.39.10.734; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Menten B, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039453; Ning Y, 1996, NAT GENET, V14, P86, DOI 10.1038/ng0996-86; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Ravnan JB, 2006, J MED GENET, V43, P478, DOI 10.1136/jmg.2005.036350; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Saunier S, 1997, HUM MOL GENET, V6, P2317, DOI 10.1093/hmg/6.13.2317; SCHAFFER LG, 2005, ISCN 2005 INT SYSTEM, pCH7; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Veltman JA, 2006, J MOL DIAGN, V8, P534, DOI 10.2353/jmoldx.2006.060131; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; WANG Y, 2005, NUCLEIC ACIDS RES, V38, P183, DOI DOI 10.1039/NAR/GNI177	37	265	292	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39			7			S48	S54		10.1038/ng2092	http://dx.doi.org/10.1038/ng2092			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	274AO	17597782				2022-12-27	WOS:000253974400009
J	Ori, N; Cohen, AR; Etzioni, A; Brand, A; Yanai, O; Shleizer, S; Menda, N; Amsellem, Z; Efroni, I; Pekker, I; Alvarez, JP; Blum, E; Zamir, D; Eshed, Y				Ori, Naomi; Cohen, Aya Refael; Etzioni, Adi; Brand, Arnon; Yanai, Osnat; Shleizer, Sharona; Menda, Naama; Amsellem, Ziva; Efroni, Idan; Pekker, Irena; Alvarez, John Paul; Blum, Eyal; Zamir, Dani; Eshed, Yuval			Regulation of LANCEOLATE by miR319 is required for compound-leaf development in tomato	NATURE GENETICS			English	Article							MICRORNAS; GROWTH; MUTANT; LOCUS; GENE; MORPHOGENESIS; SHAPE; FORM	Plant leaves show pronounced plasticity of size and form. In the classical, partially dominant mutation Lanceolate ( La) 1, the large compound leaves of tomato (Solanum lycopersicum) are converted into small simple ones. We show that LA encodes a transcription factor from the TCP family(2,3) containing an miR319-binding site(4). Five independent La isolates are gain-offunction alleles that result from point mutations within the miR319-binding site and confer partial resistance of the La transcripts to microRNA (miRNA)-directed inhibition. The reduced sensitivity to miRNA regulation leads to elevated LA expression in very young La leaf primordia and to precocious differentiation of leaf margins. In contrast, downregulation of several LA-like genes using ectopic expression of miR319 resulted in larger leaflets and continuous growth of leaf margins. Our results imply that regulation of LA by miR319 defines a flexible window of morphogenetic competence along the developing leaf margin that is required for leaf elaboration.	Hebrew Univ Jerusalem, Fac Agr, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel; Hebrew Univ Jerusalem, Fac Agr, Otto Warburg Minerva Ctr Agr Biotechnol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Dept Plant Sci, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Weizmann Institute of Science	Ori, N (corresponding author), Hebrew Univ Jerusalem, Fac Agr, Robert H Smith Inst Plant Sci & Genet Agr, POB 12, IL-76100 Rehovot, Israel.	ori@agri.huji.ac.il; yuval.eshed@weizmann.ac.il	Menda, Naama/G-2915-2012	Eshed, Yuval/0000-0001-8290-0018; Efroni, Idan/0000-0002-0219-8685				Alvarez JP, 2006, PLANT CELL, V18, P1134, DOI 10.1105/tpc.105.040725; Baker CC, 2005, CURR BIOL, V15, P303, DOI 10.1016/j.cub.2005.02.017; Bharathan G, 2002, SCIENCE, V296, P1858, DOI 10.1126/science.1070343; BOYNTON JE, 1965, TOMATO GENET COOP RE, V15, P24; CARUSO JL, 1968, AM J BOT, V55, P1169, DOI 10.2307/2440737; Chen JJ, 1997, PLANT CELL, V9, P1289, DOI 10.1105/tpc.9.8.1289; Cubas P, 1999, PLANT J, V18, P215, DOI 10.1046/j.1365-313X.1999.00444.x; DENGLER NG, 1984, BOT GAZ, V145, P66, DOI 10.1086/337428; Dengler NG, 2001, INT J PLANT SCI, V162, P459, DOI 10.1086/320145; Hagemann W, 1996, PLANT SYST EVOL, V199, P121, DOI 10.1007/BF00984901; Hareven D, 1996, CELL, V84, P735, DOI 10.1016/S0092-8674(00)81051-X; Hay A, 2006, NAT GENET, V38, P942, DOI 10.1038/ng1835; Holtan HEE, 2003, GENETICS, V165, P1541; Kessler S, 2001, INT J PLANT SCI, V162, P475, DOI 10.1086/320136; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li CX, 2005, P NATL ACAD SCI USA, V102, P12978, DOI 10.1073/pnas.0504039102; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; LIFSCHYTZ E, 1969, GENETICS, V62, P353; MATHAN DS, 1960, SCIENCE, V131, P36, DOI 10.1126/science.131.3392.36; MATHAN DS, 1962, AM J BOT, V49, P504, DOI 10.2307/2439421; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Menda N, 2004, PLANT J, V38, P861, DOI 10.1111/j.1365-313X.2004.02088.x; Nath U, 2003, SCIENCE, V299, P1404, DOI 10.1126/science.1079354; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Parnis A, 1997, PLANT CELL, V9, P2143, DOI 10.1105/tpc.9.12.2143; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Stadler LJ, 1930, J HERED, V21, P3, DOI 10.1093/oxfordjournals.jhered.a103249; STETTLER RF, 1964, AM J BOT, V51, P253, DOI 10.2307/2440294; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Valoczi A, 2006, PLANT J, V47, P140, DOI 10.1111/j.1365-313X.2006.02766.x	30	354	396	7	120	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2007	39	6					787	791		10.1038/ng2036	http://dx.doi.org/10.1038/ng2036			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17486095				2022-12-27	WOS:000246859100024
J	Lahortiga, I; De Keersmaecker, K; Van Vlierberghe, P; Graux, C; Cauwelier, B; Lambert, F; Mentens, N; Beverloo, HB; Pieters, R; Speleman, F; Odero, MD; Bauters, M; Froyen, G; Marynen, P; Vandenberghe, P; Wlodarska, I; Meijerink, JPP; Cools, J				Lahortiga, Idoya; De Keersmaecker, Kim; Van Vlierberghe, Pieter; Graux, Carlos; Cauwelier, Barbara; Lambert, Frederic; Mentens, Nicole; Beverloo, H. Berna; Pieters, Rob; Speleman, Frank; Odero, Maria D.; Bauters, Marijke; Froyen, Guy; Marynen, Peter; Vandenberghe, Peter; Wlodarska, Iwona; Meijerink, Jules P. P.; Cools, Jan			Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia	NATURE GENETICS			English	Article							C-MYB; CANCER	We identified a duplication of the MYB oncogene in 8.4% of individuals with T cell acute lymphoblastic leukemia (T-ALL) and in five T-ALL cell lines. The duplication is associated with a threefold increase in MYB expression, and knockdown of MYB expression initiates T cell differentiation. Our results identify duplication of MYB as an oncogenic event and suggest that MYB could be a therapeutic target in human T-ALL.	VIV, Dept Mol & Dev Genet, Human Genome Lab, Louvain, Belgium; Katholieke Univ Leuven, Ctr Human Genet, Human Genome Lab, Louvain, Belgium; Univ Navarra, Div Oncol, Ctr Appl Med Res, E-31080 Pamplona, Spain; Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Pediat Oncol Hematol, Rotterdam, Netherlands; Catholic Univ Louvain, Clin Univ, Dept Hematol, Yvoir, Belgium; Ghent Univ Hosp, Ctr Genet Med, B-9000 Ghent, Belgium; Univ Liege, Dept Human Genet, Ctr Biomed Integrated Genoproteom, Liege, Belgium; Erasmus MC, Dept Clin Genet, Rotterdam, Netherlands	KU Leuven; University of Navarra; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Universite Catholique Louvain; Ghent University; Ghent University Hospital; University of Liege; Erasmus University Rotterdam; Erasmus MC	Cools, J (corresponding author), VIV, Dept Mol & Dev Genet, Human Genome Lab, Louvain, Belgium.	jan.cools@med.kuleuven.be	Van Vlierberghe, Pieter/G-8894-2013; Meijerink, Jules P/D-4393-2017; speleman, frank/AAR-5184-2020; De Keersmaecker, Kim/W-9702-2018; Odero/ABG-9860-2020	Van Vlierberghe, Pieter/0000-0001-9063-7205; Meijerink, Jules P/0000-0002-6860-798X; speleman, frank/0000-0002-6628-8559; De Keersmaecker, Kim/0000-0002-7420-9531; Odero/0000-0002-8858-2054; Cools, Jan/0000-0001-6626-5843; Vandenberghe, Peter/0000-0003-4719-1935				Bender TP, 2004, NAT IMMUNOL, V5, P721, DOI 10.1038/ni1085; De Keersmaecker K, 2005, HAEMATOLOGICA, V90, P1116; Grabher C, 2006, NAT REV CANCER, V6, P347, DOI 10.1038/nrc1880; Graux C, 2004, NAT GENET, V36, P1084, DOI 10.1038/ng1425; Hess JL, 2006, BLOOD, V108, P297, DOI 10.1182/blood-2005-12-5014; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Lund AH, 2002, NAT GENET, V32, P160, DOI 10.1038/ng956; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Sakamoto H, 2006, BLOOD, V108, P896, DOI 10.1182/blood-2005-09-3846; Speicher MR, 2005, NAT REV GENET, V6, P782, DOI 10.1038/nrg1692; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160	14	197	201	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2007	39	5					593	595		10.1038/ng2025	http://dx.doi.org/10.1038/ng2025			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17435759				2022-12-27	WOS:000245971300013
J	Kitamura, T; Kometani, K; Hashida, H; Matsunaga, A; Miyoshi, H; Hosogi, H; Aoki, M; Oshima, M; Hattori, M; Takabayashi, A; Minato, N; Taketo, MM				Kitamura, Takanori; Kometani, Kohei; Hashida, Hiroki; Matsunaga, Akihiro; Miyoshi, Hiroyuki; Hosogi, Hisahiro; Aoki, Masahiro; Oshima, Masanobu; Hattori, Masakazu; Takabayashi, Arimichi; Minato, Nagahiro; Taketo, Makoto M.			SMAD4-deficient intestinal tumors recruit CCR1(+) myeloid cells that promote invasion	NATURE GENETICS			English	Article							TGF-BETA; BONE-MARROW; COLORECTAL-CANCER; CC-CHEMOKINE; MICROSATELLITE INSTABILITY; STROMAL FIBROBLASTS; MAMMARY-TUMORS; CD34(+) CELLS; COLON-CANCER; RECEPTOR	Inactivation of TGF-beta family signaling is implicated in colorectal tumor progression. Using cis-Apc(+/Delta 716) Smad4(+/-) mutant mice (referred to as cis-Apc/Smad4), a model of invasive colorectal cancer in which TGF-b family signaling is blocked, we show here that a new type of immature myeloid cell (iMC) is recruited from the bone marrow to the tumor invasion front. These CD34(+) iMCs express the matrix metalloproteinases MMP9 and MMP2 and the CC-chemokine receptor 1 (CCR1) and migrate toward the CCR1 ligand CCL9. In adenocarcinomas, expression of CCL9 is increased in the tumor epithelium. By deleting Ccr1 in the background of the cis-Apc/Smad4 mutant, we further show that lack of CCR1 prevents accumulation of CD34(+) iMCs at the invasion front and suppresses tumor invasion. These results indicate that loss of transforming growth factor-beta family signaling in tumor epithelium causes accumulation of iMCs that promote tumor invasion.	Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan; Kyoto Univ, Grad Sch Biostudies, Dept Immunol & Cell Biol, Kyoto 6068501, Japan; Kitano Hosp, Dept Gastroenterol Surg & Oncol, Osaka 5308480, Japan	Kyoto University; Kyoto University; Kitano Hospital	Taketo, MM (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan.	taketo@mfour.med.kyoto-u.ac.jp	Matsunaga, Akihiro/AAU-3255-2021; Aoki, Masahiro/A-5149-2016; Oshima, Masanobu/F-9958-2014; Hosogi, Hisahiro/AAK-2585-2020	Aoki, Masahiro/0000-0003-4316-9490; Oshima, Masanobu/0000-0002-3304-0004; Kitamura, Takanori/0000-0003-2032-3918; Miyoshi, Hiroyuki/0000-0001-7400-0714; Hashida, Hiroki/0000-0001-8044-9366; Kometani, Kohei/0000-0003-4281-4371				Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bhowmick NA, 2004, NATURE, V432, P332, DOI 10.1038/nature03096; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; BRUBAKER PL, 1987, ENDOCRINOLOGY, V120, P1976, DOI 10.1210/endo-120-5-1976; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Collins HM, 2001, BRIT J CANCER, V84, P1664, DOI 10.1054/bjoc.2001.1831; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; Forssmann U, 1997, FEBS LETT, V408, P211, DOI 10.1016/S0014-5793(97)00408-0; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gao JL, 1997, J EXP MED, V185, P1959, DOI 10.1084/jem.185.11.1959; Garmy-Susini B, 2005, BRIT J CANCER, V93, P855, DOI 10.1038/sj.bjc.6602808; Grady WM, 1998, CANCER RES, V58, P3101; Greaves DR, 2000, MICROBES INFECT, V2, P331, DOI 10.1016/S1286-4579(00)00293-8; Han IS, 2003, MOL CELLS, V15, P176; Ishiguro K, 2006, GUT, V55, P695, DOI 10.1136/gut.2005.079459; Janowska-Wieczorek A, 1999, BLOOD, V93, P3379, DOI 10.1182/blood.V93.10.3379.410k09_3379_3390; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Krause DS, 1996, BLOOD, V87, P1; Kusmartsev S, 2006, CANCER IMMUNOL IMMUN, V55, P237, DOI 10.1007/s00262-005-0048-z; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Markowitz S, 2000, BBA-REV CANCER, V1470, pM13, DOI 10.1016/S0304-419X(99)00031-1; Matsuo SE, 2006, J ENDOCRINOL, V190, P141, DOI 10.1677/joe.1.06713; Mook ORF, 2004, BBA-REV CANCER, V1705, P69, DOI 10.1016/j.bbcan.2004.09.006; Mook ORF, 2003, J HISTOCHEM CYTOCHEM, V51, P821, DOI 10.1177/002215540305100613; Mori Y, 2001, CANCER RES, V61, P6046; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Olumi AF, 1999, CANCER RES, V59, P5002; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Oshima H, 2004, EMBO J, V23, P1669, DOI 10.1038/sj.emboj.7600170; Oshima H, 1997, CANCER RES, V57, P1644; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; Paglinawan R, 2003, GLIA, V44, P219, DOI 10.1002/glia.10286; PARSONS R, 1995, CANCER RES, V55, P5548; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Robinson SC, 2003, CANCER RES, V63, P8360; Salovaara R, 2002, GUT, V51, P56, DOI 10.1136/gut.51.1.56; Scotton C, 2001, BRIT J CANCER, V85, P891, DOI 10.1054/bjoc.2001.2020; Seno H, 2002, CANCER RES, V62, P506; Takaku K, 1998, CELL, V92, P645, DOI 10.1016/S0092-8674(00)81132-0; Wyckoff J, 2004, CANCER RES, V64, P7022, DOI 10.1158/0008-5472.CAN-04-1449; Yang MH, 2005, CYTOKINE, V31, P94, DOI 10.1016/j.cyto.2005.04.001; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhao XY, 2003, J IMMUNOL, V171, P2797, DOI 10.4049/jimmunol.171.6.2797	50	210	217	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2007	39	4					467	475		10.1038/ng1997	http://dx.doi.org/10.1038/ng1997			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17369830				2022-12-27	WOS:000245271200016
J	Romeo, S; Pennacchio, LA; Fu, YX; Boerwinkle, E; Tybjaerg-Hansen, A; Hobbs, HH; Cohen, JC				Romeo, Stefano; Pennacchio, Len A.; Fu, Yunxin; Boerwinkle, Eric; Tybjaerg-Hansen, Anne; Hobbs, Helen H.; Cohen, Jonathan C.			Population-based resequencing of ANGPTL4 uncovers variations that reduce triglycerides and increase HDL	NATURE GENETICS			English	Article							ANGIOPOIETIN-LIKE PROTEIN-4; HEPATIC STEATOSIS; LIPOPROTEIN; OVEREXPRESSION; HYPERLIPIDEMIA; GENETICS	Resequencing genes provides the opportunity to assess the full spectrum of variants that influence complex traits. Here we report the first application of resequencing to a large population (n = 3,551) to examine the role of the adipokine ANGPTL4 in lipid metabolism. Nonsynonymous variants in ANGPTL4 were more prevalent in individuals with triglyceride levels in the lowest quartile than in individuals with levels in the highest quartile (P = 0.016). One variant (E40K), present in similar to 3% of European Americans, was associated with significantly lower plasma levels of triglyceride and higher levels of highdensity lipoprotein cholesterol in European Americans from the Atherosclerosis Risk in Communities Study and in Danes from the Copenhagen City Heart Study. The ratio of nonsynonymous to synonymous variants was higher in European Americans than in African Americans (4:1 versus 1.3:1), suggesting population- specific relaxation of purifying selection. Thus, resequencing of ANGPTL4 in a multiethnic population allowed analysis of the phenotypic effects of both rare and common variants while taking advantage of genetic variation arising from ethnic differences in population history.	Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA; Lawrence Berkeley Natl Lab, Genom Div, Berkeley, CA 94720 USA; US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; Univ Texas, Hlth Sci Ctr, Ctr Human Genet, Houston, TX 77030 USA; Univ Texas, Hlth Sci Ctr, Inst Mol Med, Houston, TX 77030 USA; Univ Copenhagen Hosp, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; Univ Texas, SW Med Ctr, Howard Hughes Med Ctr, Dallas, TX 75216 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Rigshospitalet; University of Copenhagen; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Hobbs, HH (corresponding author), Univ Texas, SW Med Ctr, Donald W Reynolds Cardiovasc Clin Res Ctr, Eugene McDermott Ctr Human Growth & Dev, Dallas, TX 75390 USA.	helen.hobbs@utsouthwestern.edu; jonathan.cohen@utsouthwestern.edu	Romeo, Stefano/L-6861-2015	Romeo, Stefano/0000-0001-9168-4898; Pennacchio, Len/0000-0002-8748-3732	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RL1HL092550, U01HL066681] Funding Source: NIH RePORTER; NHLBI NIH HHS [RL1 HL092550, HL066681, U01 HL066681, RL1 HL092550-02] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, P NATL ACAD SCI USA, V103, P1810, DOI 10.1073/pnas.0508483103; Collins FS, 2004, NATURE, V429, P475, DOI 10.1038/nature02628; FU YX, 1993, GENETICS, V133, P693; Gibbs R, 2005, NATURE, V437, P1233, DOI 10.1038/4371233a; Grundy SM, 1998, AM J CARDIOL, V81, p18B, DOI 10.1016/S0002-9149(98)00033-2; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Li C, 2006, CURR OPIN LIPIDOL, V17, P152, DOI 10.1097/01.mol.0000217896.67444.05; Mandard S, 2006, J BIOL CHEM, V281, P934, DOI 10.1074/jbc.M506519200; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; Rondinone CM, 2006, ENDOCRINE, V29, P81, DOI 10.1385/ENDO:29:1:81; Schnohr P, 2001, EUR HEART J SUPPL, V3, pH1; TAJIMA F, 1989, GENETICS, V123, P585; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200; Yu XX, 2005, P NATL ACAD SCI USA, V102, P1767, DOI 10.1073/pnas.0409564102	21	411	421	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2007	39	4					513	516		10.1038/ng1984	http://dx.doi.org/10.1038/ng1984			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17322881	Green Accepted			2022-12-27	WOS:000245271200021
J	Zilberman, D; Gehring, M; Tran, RK; Ballinger, T; Henikoff, S				Zilberman, Daniel; Gehring, Mary; Tran, Robert K.; Ballinger, Tracy; Henikoff, Steven			Genome-wide analysis of Arabidopsis thaliana DNA methylation uncovers an interdependence between methylation and transcription	NATURE GENETICS			English	Article							TRANSPOSABLE ELEMENTS; GENE-EXPRESSION; CHROMOSOME-WIDE; CG METHYLATION; POLYCOMB GENE; ELONGATION; CHROMATIN; INITIATION; SITES	Cytosine methylation, a common form of DNA modification that antagonizes transcription, is found at transposons and repeats in vertebrates, plants and fungi. Here we have mapped DNA methylation in the entire Arabidopsis thaliana genome at high resolution. DNA methylation covers transposons and is present within a large fraction of A. thaliana genes. Methylation within genes is conspicuously biased away from gene ends, suggesting a dependence on RNA polymerase transit. Genic methylation is strongly influenced by transcription: moderately transcribed genes are most likely to be methylated, whereas genes at either extreme are least likely. In turn, transcription is influenced by methylation: short methylated genes are poorly expressed, and loss of methylation in the body of a gene leads to enhanced transcription. Our results indicate that genic transcription and DNA methylation are closely interwoven processes.	Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Henikoff, S (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N, Seattle, WA 98109 USA.	steveh@fhcrc.org		Henikoff, Steven/0000-0002-7621-8685; Zilberman, Daniel/0000-0002-0123-8649				BARRY C, 1993, P NATL ACAD SCI USA, V90, P4557, DOI 10.1073/pnas.90.10.4557; Belotserkovskaya R, 2004, BBA-GENE STRUCT EXPR, V1677, P87, DOI 10.1016/j.bbaexp.2003.09.017; Berardini TZ, 2004, PLANT PHYSIOL, V135, P745, DOI 10.1104/pp.104.040071; BESTOR TH, 1990, PHILOS T ROY SOC B, V326, P179, DOI 10.1098/rstb.1990.0002; BIRD AP, 1995, TRENDS GENET, V11, P94, DOI 10.1016/S0168-9525(00)89009-5; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Field LM, 2004, INSECT MOL BIOL, V13, P109, DOI 10.1111/j.0962-1075.2004.00470.x; Freitag M, 2005, CURR OPIN GENET DEV, V15, P191, DOI 10.1016/j.gde.2005.02.003; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gilfillan GD, 2006, GENE DEV, V20, P858, DOI 10.1101/gad.1399406; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Hohn T, 1996, P NATL ACAD SCI USA, V93, P8334, DOI 10.1073/pnas.93.16.8334; Jacobsen SE, 2000, CURR BIOL, V10, P179, DOI 10.1016/S0960-9822(00)00324-9; Johnson LM, 2002, CURR BIOL, V12, P1360, DOI 10.1016/S0960-9822(02)00976-4; Jullien PE, 2006, PLANT CELL, V18, P1360, DOI 10.1105/tpc.106.041178; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kakutani T, 2004, COLD SPRING HARB SYM, V69, P139, DOI 10.1101/sqb.2004.69.139; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Kato M, 2004, GENETICS, V168, P961, DOI 10.1534/genetics.104.029637; Kato M, 2003, CURR BIOL, V13, P421, DOI 10.1016/S0960-9822(03)00106-4; Kinoshita T, 2004, SCIENCE, V303, P521, DOI 10.1126/science.1089835; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; Liu CL, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-19; Lorincz MC, 2004, NAT STRUCT MOL BIOL, V11, P1068, DOI 10.1038/nsmb840; Mason PB, 2003, MOL CELL BIOL, V23, P8323, DOI 10.1128/MCB.23.22.8323-8333.2003; Rountree MR, 1997, GENE DEV, V11, P2383, DOI 10.1101/gad.11.18.2383; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schwabish MA, 2006, MOL CELL, V22, P415, DOI 10.1016/j.molcel.2006.03.014; Selker EU, 2004, COLD SPRING HARB SYM, V69, P119, DOI 10.1101/sqb.2004.69.119; Simmen MW, 1999, SCIENCE, V283, P1164, DOI 10.1126/science.283.5405.1164; Singer T, 2001, GENE DEV, V15, P591, DOI 10.1101/gad.193701; Soppe WJJ, 2000, MOL CELL, V6, P791, DOI 10.1016/S1097-2765(05)00090-0; Svejstrup JQ, 2003, SCIENCE, V301, P1053, DOI 10.1126/science.1088901; Thibaud-Nissen F, 2006, PLANT J, V47, P152, DOI 10.1111/j.1365-313X.2006.02770.x; Tran RK, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r90; Tran RK, 2005, CURR BIOL, V15, P154, DOI 10.1016/j.cub.2005.01.008; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Xiao WY, 2003, DEV CELL, V5, P891, DOI 10.1016/S1534-5807(03)00361-7; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-249	41	990	1067	8	167	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2007	39	1					61	69		10.1038/ng1929	http://dx.doi.org/10.1038/ng1929			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	17128275				2022-12-27	WOS:000243136500018
J	De Raedt, T; Stephens, M; Heyns, I; Brems, H; Thijs, D; Messiaen, L; Stephens, K; Lazaro, C; Wimmer, K; Kehrer-Sawatzki, H; Vidaud, D; Kluwe, L; Marynen, P; Legius, E				De Raedt, Thomas; Stephens, Matthew; Heyns, Ine; Brems, Hilde; Thijs, Daisy; Messiaen, Ludwine; Stephens, Karen; Lazaro, Conxi; Wimmer, Katharina; Kehrer-Sawatzki, Hildegard; Vidaud, Dominique; Kluwe, Lan; Marynen, Peter; Legius, Eric			Conservation of hotspots for recombination in low-copy repeats associated with the NF1 microdeletion	NATURE GENETICS			English	Article							HAPLOTYPE RECONSTRUCTION; POLYMORPHISM DATA; HOT-SPOTS; GENE; CHIMPANZEES; MOSAICISM; HUMANS; REGION; RATES	Several large-scale studies of human genetic variation have provided insights into processes such as recombination that have shaped human diversity. However, regions such as low-copy repeats (LCRs) have proven difficult to characterize, hindering efforts to understand the processes operating in these regions. We present a detailed study of genetic variation and underlying recombination processes in two copies of an LCR (NF1REPa and NF1REPc) on chromosome 17 involved in the generation of NF1 microdeletions and in a third copy (REP19) on chromosome 19 from which the others originated over 6.7 million years ago. We find evidence for shared hotspots of recombination among the LCRs. REP19 seems to contain hotspots in the same place as the nonallelic recombination hotspots in NF1REPa and NF1REPc. This apparent conservation of patterns of recombination hotspots in moderately diverged paralogous regions contrasts with recent evidence that these patterns are not conserved in less-diverged orthologous regions of chimpanzees.	Catholic Univ Louvain, Dept Human Genet, Louvain, Belgium; Univ Washington, Dept Stat, Seattle, WA 98195 USA; Univ Alabama Birmingham, Dept Genet, Med Genet Lab, Birmingham, AL USA; Univ Washington, Dept Med, Seattle, WA 98195 USA; Hosp Llobregat, Inst Biomed, Inst Catala Oncol, Barcelona, Spain; Univ Vienna, Dept Human Genet, Vienna, Austria; Univ Ulm, Dept Human Genet, Ulm, Germany; Univ Paris 05, INSERM, Mol Genet Lab, U745, Paris, France; Univ Hamburg, Hosp Eppendorf, Lab Tumor Biol & Dev & Malformat, D-20246 Hamburg, Germany	Universite Catholique Louvain; University of Washington; University of Washington Seattle; University of Alabama System; University of Alabama Birmingham; University of Washington; University of Washington Seattle; Catalan Institute of Oncology; University of Barcelona; University of Vienna; Ulm University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Hamburg	Legius, E (corresponding author), Catholic Univ Louvain, Dept Human Genet, Louvain, Belgium.	Eric.Legius@uz.kuleuven.ac.be	Legius, Eric/H-1735-2011; GARCIA, CONXI LAZARO/Q-2410-2016; De Raedt, Thomas/AAC-3172-2021; Brems, Hilde/AAN-4075-2020; VIDAUD, Dominique/O-7357-2017	GARCIA, CONXI LAZARO/0000-0002-7198-5906; De Raedt, Thomas/0000-0002-7492-851X; Vermeesch, Joris/0000-0002-3071-1191	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002585] Funding Source: NIH RePORTER; NHGRI NIH HHS [1R01HG/LM02585-01] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Correa CL, 2000, AM J HUM GENET, V66, P1969, DOI 10.1086/302920; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; De Raedt T, 2004, GENOMICS, V84, P346, DOI 10.1016/j.ygeno.2004.03.006; Fearnhead P, 2004, GENETICS, V167, P2067, DOI 10.1534/genetics.103.021584; Fearnhead P, 2005, AM J HUM GENET, V77, P781, DOI 10.1086/497579; Forbes SH, 2004, GENE CHROMOSOME CANC, V41, P12, DOI 10.1002/gcc.20065; Hudson RR, 2001, GENETICS, V159, P1805; Jeffreys AJ, 2004, NAT GENET, V36, P151, DOI 10.1038/ng1287; Jeffreys AJ, 2005, NAT GENET, V37, P601, DOI 10.1038/ng1565; Kehrer-Sawatzki H, 2004, AM J HUM GENET, V75, P410, DOI 10.1086/423624; Li N, 2003, GENETICS, V165, P2213; Lopez-Correa C, 2001, HUM MOL GENET, V10, P1387, DOI 10.1093/hmg/10.13.1387; Marchini J, 2006, AM J HUM GENET, V78, P437, DOI 10.1086/500808; Neumann R, 2006, HUM MOL GENET, V15, P1401, DOI 10.1093/hmg/ddl063; Petek E, 2003, J MED GENET, V40, P520, DOI 10.1136/jmg.40.7.520; Ptak SE, 2004, PLOS BIOL, V2, P849, DOI 10.1371/journal.pbio.0020155; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Reiter LT, 1998, AM J HUM GENET, V62, P1023, DOI 10.1086/301827; Repping S, 2002, AM J HUM GENET, V71, P906, DOI 10.1086/342928; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322	22	67	69	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2006	38	12					1419	1423		10.1038/ng1920	http://dx.doi.org/10.1038/ng1920			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110TR	17115058				2022-12-27	WOS:000242404200019
J	Barton, A; Thomson, W; Ke, X; Eyre, S; Hinks, A; Bowes, J; Plant, D; Gibbons, LJ; Wilson, AG; Bax, DE; Morgan, AW; Emery, P; Steer, S; Hocking, L; Reid, DM; Wordsworth, P; Harrison, P; Worthington, J				Barton, Anne; Thomson, Wendy; Ke, Xiayi; Eyre, Steve; Hinks, Anne; Bowes, John; Plant, Darren; Gibbons, Laura J.; Wilson, Anthony G.; Bax, Deborah E.; Morgan, Ann W.; Emery, Paul; Steer, Sophia; Hocking, Lynne; Reid, David M.; Wordsworth, Paul; Harrison, Pille; Worthington, Jane		Wellcome Trust Case Control Consor; Year Consortium; BIRAC Consortium	Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; EXPRESSION; PATHWAY; 6Q23; RISK	The WTCCC study identified 49 SNPs putatively associated with rheumatoid arthritis at P = 1 x 10(-4) - 1 x 10(-5) (tier 3). Here we show that three of these SNPs, mapping to chromosome 10p15 (rs4750316), 12q13 (rs1678542) and 22q13 (rs3218253), are also associated (trend P = 4 x 10(-5), P = 4 x 10(-4) and P = 4 x 10(-4), respectively) in a validation study of 4,106 individuals with rheumatoid arthritis and an expanded reference group of 11,238 subjects, confirming them as true susceptibility loci in individuals of European ancestry.	[Barton, Anne; Thomson, Wendy; Ke, Xiayi; Eyre, Steve; Hinks, Anne; Bowes, John; Plant, Darren; Gibbons, Laura J.; Worthington, Jane] Univ Manchester, Arthritis Res Campaign Epidemiol Unit, Manchester, Lancs, England; [Wilson, Anthony G.; Bax, Deborah E.] Univ Sheffield, Sch Med & Biomed Sci, Sheffield S10 2JF, S Yorkshire, England; [Morgan, Ann W.; Emery, Paul] Chapel Allerton Hosp, Acad Unit Musculoskeletal Dis, Leeds LS7 4SA, W Yorkshire, England; [Steer, Sophia] Kings Coll Hosp London, Natl Hlth Serv Fdn Trust, London SE5 9RS, England; [Hocking, Lynne; Reid, David M.] Univ Aberdeen, Dept Med & Therapeut, Bone Res Grp, Aberdeen AB25 2ZD, Scotland; [Wordsworth, Paul; Harrison, Pille] Univ Oxford, Inst Musculoskeletal Sci, Botnar Res Ctr, Oxford OX3 7LD, England	University of Manchester; University of Sheffield; Chapel Allerton Hospital; University of Leeds; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Aberdeen; University of Oxford	Barton, A (corresponding author), Univ Manchester, Arthritis Res Campaign Epidemiol Unit, Stopford Bldg, Manchester, Lancs, England.	anne.barton@manchester.ac.uk	Ke, Xiayi/C-7674-2009; eyre, stephen/K-3776-2017; Dominiczak, Anna F/P-9390-2017; Worthington, Jane/M-9770-2014; Breen, Gerome/Y-2706-2019; emery, paul/B-3560-2013; Hinks, Anne/E-1853-2015; Breen, Gerome D/A-5540-2010; Barton, Anne/N-2053-2014; Bowes, John/B-3472-2015; Yuldasheva, Dr. Nadira Yusupovna/GXM-9013-2022	eyre, stephen/0000-0002-1251-6974; Dominiczak, Anna F/0000-0003-4913-3608; Worthington, Jane/0000-0003-0544-042X; Breen, Gerome/0000-0003-2053-1792; Hinks, Anne/0000-0001-8843-3967; Breen, Gerome D/0000-0003-2053-1792; Barton, Anne/0000-0003-3316-2527; Bowes, John/0000-0003-4659-031X; Yuldasheva, Dr. Nadira Yusupovna/0000-0001-6213-6358; Morgan, Ann/0000-0003-1109-624X; Parkes, Miles/0000-0002-6467-0631; Hensor, Elizabeth/0000-0002-5245-4755; Munroe, Patricia/0000-0002-4176-2947; Zeggini, Eleftheria/0000-0003-4238-659X; Gaffney, Karl/0000-0002-7863-9176; Conaghan, Philip/0000-0002-3478-5665; Lindgren, Cecilia/0000-0002-4903-9374; McInnes, Iain/0000-0002-6462-4280; Weedon, Michael/0000-0002-6174-6135; Hocking, Lynne J/0000-0002-2414-2826; Dunger, Professor David/0000-0002-2566-9304; Wilson, Anthony Gerard/0000-0003-4855-3926; Packham, Jon/0000-0001-5531-1680; Lango Allen, Hana/0000-0002-7803-8688; Potter, Simon/0000-0003-4208-4102; Thomson, Wendy/0000-0002-9022-5179; Young-Min, Steven/0000-0001-8270-6207; Harrison, Pille/0000-0003-4117-6910; Hyrich, Kimme/0000-0001-8242-9262; Hattersley, Andrew/0000-0001-5620-473X; Lees, Charlie/0000-0002-0732-8215	Arthritis Research Campaign [17552]; National Health Service (NHS) Research and Development; Guy's and St Thomas' and Lewisham NHS Trusts; Medical Research Council [G0000934]; Wellcome Trust [068545/Z/02]; European Community's Sixth Framework Programme Autocure; MRC [G0600329, G0000934] Funding Source: UKRI; Medical Research Council [G0600329] Funding Source: researchfish; Chief Scientist Office [CZB/4/540] Funding Source: researchfish	Arthritis Research Campaign(Versus Arthritis); National Health Service (NHS) Research and Development; Guy's and St Thomas' and Lewisham NHS Trusts; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); European Community's Sixth Framework Programme Autocure(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office	We thank the Arthritis Research Campaign for their support (arc grant reference no. 17552). We would also like to acknowledge the National Health Service (NHS) Research and Development Support Fund for Guy's and St Thomas' and Lewisham NHS Trusts. We acknowledge use of DNA from the British 1958 Birth Cohort collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. We thank the YEAR consortium for allowing us access to their DNA collection. D. P. is supported by the European Community's Sixth Framework Programme Autocure funding. Information-technology support was provided by P. Steer and technical support by P. Gilbert, B. Lad and S. G. Martin. Nursing support was provided by J. Grumley, J. Shotton and C. Farrar.	Barton A, 2008, HUM MOL GENET, V17, P2274, DOI 10.1093/hmg/ddn128; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Fichera M, 2004, NEUROLOGY, V63, P1108, DOI 10.1212/01.WNL.0000138731.60693.D2; Hayashi K, 2007, PHARMACOL RES, V55, P537, DOI 10.1016/j.phrs.2007.04.009; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Niiro H, 2003, IMMUNITY, V19, P637, DOI 10.1016/S1074-7613(03)00303-0; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Wang Y, 2005, J BIOL CHEM, V280, P10955, DOI 10.1074/jbc.M412808200	12	123	127	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2008	40	10					1156	1159		10.1038/ng.218	http://dx.doi.org/10.1038/ng.218			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18794857	Green Accepted			2022-12-27	WOS:000259651000012
J	McCarroll, SA; Kuruvilla, FG; Korn, JM; Cawley, S; Nemesh, J; Wysoker, A; Shapero, MH; de Bakker, PIW; Maller, JB; Kirby, A; Elliott, AL; Parkin, M; Hubbell, E; Webster, T; Mei, R; Veitch, J; Collins, PJ; Handsaker, R; Lincoln, S; Nizzari, M; Blume, J; Jones, KW; Rava, R; Daly, MJ; Gabriel, SB; Altshuler, D				McCarroll, Steven A.; Kuruvilla, Finny G.; Korn, Joshua M.; Cawley, Simon; Nemesh, James; Wysoker, Alec; Shapero, Michael H.; de Bakker, Paul I. W.; Maller, Julian B.; Kirby, Andrew; Elliott, Amanda L.; Parkin, Melissa; Hubbell, Earl; Webster, Teresa; Mei, Rui; Veitch, James; Collins, Patrick J.; Handsaker, Robert; Lincoln, Steve; Nizzari, Marcia; Blume, John; Jones, Keith W.; Rava, Rich; Daly, Mark J.; Gabriel, Stacey B.; Altshuler, David			Integrated detection and population-genetic analysis of SNPs and copy number variation	NATURE GENETICS			English	Article							STRUCTURAL VARIATION; LINKAGE DISEQUILIBRIUM; POLYMORPHISMS; HAPLOTYPE; VARIANTS	Dissecting the genetic basis of disease risk requires measuring all forms of genetic variation, including SNPs and copy number variants (CNVs), and is enabled by accurate maps of their locations, frequencies and population-genetic properties. We designed a hybrid genotyping array (Affymetrix SNP 6.0) to simultaneously measure 906,600 SNPs and copy number at 1.8 million genomic locations. By characterizing 270 HapMap samples, we developed a map of human CNV (at 2-kb breakpoint resolution) informed by integer genotypes for 1,320 copy number polymorphisms (CNPs) that segregate at an allele frequency >1%. More than 80% of the sequence in previously reported CNV regions fell outside our estimated CNV boundaries, indicating that large (>100 kb) CNVs affect much less of the genome than initially reported. Approximately 80% of observed copy number differences between pairs of individuals were due to common CNPs with an allele frequency >5%, and more than 99% derived from inheritance rather than new mutation. Most common, diallelic CNPs were in strong linkage disequilibrium with SNPs, and most low-frequency CNVs segregated on specific SNP haplotypes.	[McCarroll, Steven A.; Kuruvilla, Finny G.; Korn, Joshua M.; Nemesh, James; Wysoker, Alec; de Bakker, Paul I. W.; Elliott, Amanda L.; Parkin, Melissa; Handsaker, Robert; Nizzari, Marcia; Daly, Mark J.; Gabriel, Stacey B.; Altshuler, David] MIT, Broad Inst, Program Med & Populat Genet & Genet Anal Platform, Cambridge, MA 02142 USA; [McCarroll, Steven A.; Kuruvilla, Finny G.; Korn, Joshua M.; Nemesh, James; Wysoker, Alec; de Bakker, Paul I. W.; Elliott, Amanda L.; Parkin, Melissa; Handsaker, Robert; Nizzari, Marcia; Daly, Mark J.; Gabriel, Stacey B.; Altshuler, David] Harvard Univ, Cambridge, MA 02142 USA; [McCarroll, Steven A.; Kuruvilla, Finny G.; Korn, Joshua M.; Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [McCarroll, Steven A.; Kuruvilla, Finny G.; Korn, Joshua M.; Maller, Julian B.; Kirby, Andrew; Daly, Mark J.; Altshuler, David] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [McCarroll, Steven A.; Kuruvilla, Finny G.; de Bakker, Paul I. W.; Daly, Mark J.; Altshuler, David] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Korn, Joshua M.] Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Korn, Joshua M.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Cawley, Simon; Shapero, Michael H.; Hubbell, Earl; Webster, Teresa; Mei, Rui; Veitch, James; Collins, Patrick J.; Lincoln, Steve; Blume, John; Jones, Keith W.; Rava, Rich] Affymetrix Inc, Santa Clara, CA 95051 USA; [de Bakker, Paul I. W.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [de Bakker, Paul I. W.] Harvard Univ, Sch Med, Partners HealthCare Syst Ctr Genet & Genom, Boston, MA 02115 USA; [Daly, Mark J.; Altshuler, David] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Affymetrix; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Partners Healthcare System; Harvard University; Massachusetts General Hospital	McCarroll, SA (corresponding author), MIT, Broad Inst, Program Med & Populat Genet & Genet Anal Platform, Cambridge, MA 02142 USA.	smccarro@broad.mit.edu; altshuler@molbio.mgh.harvard.edu	McCarroll, Steven A/A-8433-2009; Daly, Mark J/B-2453-2017; Elliott, Amanda/G-5120-2012; Altshuler, David M/A-4476-2009; de Bakker, Paul IW/B-8730-2009; maller, julian B/A-9323-2009; Handsaker, Bob/AAX-9095-2021	Daly, Mark J/0000-0002-0949-8752; Altshuler, David M/0000-0002-7250-4107; de Bakker, Paul IW/0000-0001-7735-7858; Handsaker, Bob/0000-0002-3128-3547; Blume, John/0000-0003-3026-953X; Maller, Julian/0000-0002-1565-9559; Hubbell, Earl/0000-0001-7301-3759; McCarroll, Steven/0000-0002-6954-8184				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Antipova AA, 2002, GENOME BIOL, V3; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McCarroll SA, 2008, NAT GENET, V40, P5, DOI 10.1038/ng0108-5; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Shen F, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-27; Smemo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000287; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916	29	692	725	0	73	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2008	40	10					1166	1174		10.1038/ng.238	http://dx.doi.org/10.1038/ng.238			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18776908				2022-12-27	WOS:000259651000015
J	Benzinou, M; Creemers, JWM; Choquet, H; Lobbens, S; Dina, C; Durand, E; Guerardel, A; Boutin, P; Jouret, B; Heude, B; Balkau, B; Tichet, J; Marre, M; Potoczna, N; Horber, F; Le Stunff, C; Czernichow, S; Sandbaek, A; Lauritzen, T; Borch-Johnsen, K; Andersen, G; Kiess, W; Korner, A; Kovacs, P; Jacobson, P; Carlsson, LMS; Walley, AJ; Jorgensen, T; Hansen, T; Pedersen, O; Meyre, D; Froguel, P				Benzinou, Michael; Creemers, John W. M.; Choquet, Helene; Lobbens, Stephane; Dina, Christian; Durand, Emmanuelle; Guerardel, Audrey; Boutin, Philippe; Jouret, Beatrice; Heude, Barbara; Balkau, Beverley; Tichet, Jean; Marre, Michel; Potoczna, Natascha; Horber, Fritz; Le Stunff, Catherine; Czernichow, Sebastien; Sandbaek, Annelli; Lauritzen, Torsten; Borch-Johnsen, Knut; Andersen, Gitte; Kiess, Wieland; Koerner, Antje; Kovacs, Peter; Jacobson, Peter; Carlsson, Lena M. S.; Walley, Andrew J.; Jorgensen, Torben; Hansen, Torben; Pedersen, Oluf; Meyre, David; Froguel, Philippe			Common nonsynonymous variants in PCSK1 confer risk of obesity	NATURE GENETICS			English	Article							GENOME-WIDE SCAN; SUSCEPTIBILITY LOCUS; HYPERPHAGIA; CAUCASIANS	Mutations in PCSK1 cause monogenic obesity. To assess the contribution of PCSK1 to polygenic obesity risk, we genotyped tag SNPs in a total of 13,659 individuals of European ancestry from eight independent case-control or family-based cohorts. The nonsynonymous variants rs6232, encoding N221D, and rs6234-rs6235, encoding the Q665E-S690T pair, were consistently associated with obesity in adults and children (P = 7.27 x 10(-8) and P = 2.31 x 10(-12), respectively). Functional analysis showed a significant impairment of the N221D-mutant PC1/3 protein catalytic activity.	[Benzinou, Michael; Walley, Andrew J.; Froguel, Philippe] Hammersmith Hosp, Imperial Coll London, London W12 0NN, England; [Benzinou, Michael; Choquet, Helene; Lobbens, Stephane; Dina, Christian; Durand, Emmanuelle; Guerardel, Audrey; Boutin, Philippe; Meyre, David; Froguel, Philippe] CNRS 8090, Inst Biol, Inst Pasteur, F-59000 Lille, France; [Creemers, John W. M.] Univ Louvain, Dept Human Genet, B-3000 Louvain, Belgium; [Jouret, Beatrice] Childrens Hosp, INSERM, U563, Inst Nacl Sante & Rech Med, F-31000 Toulouse, France; [Heude, Barbara; Balkau, Beverley] INSERM, U780, IFR69, Villejuif, France; Univ Paris Sud, Fac Med, F-94270 Le Kremlin Bicetre, France; [Tichet, Jean; Potoczna, Natascha] Reg Inst Hlth, F-37000 Tours, France; [Marre, Michel] INSERM, U695, F-75018 Paris, France; Univ Paris 07, F-75018 Paris, France; [Marre, Michel] Hop Bichat Claude Bernard, Dept Endocrinol Diabetol & Nutr, F-75870 Paris, France; [Horber, Fritz] Klin Lindberg, CH-8400 Winterthur, Switzerland; [Le Stunff, Catherine] Univ Paris 05, Hop St Vincent de Paul, Dept Pediat Endocrinol, F-75014 Paris, France; Univ Paris 05, Hop St Vincent de Paul, INSERM, U561, F-75014 Paris, France; [Czernichow, Sebastien] Univ Paris 13, INSERM, U557, Inst Sci Rech Agronom INRA,U1125,CNAM EA3200, F-93017 Bobigny, France; Hop Avicenne, AP HP, F-93017 Bobigny, France; [Sandbaek, Annelli; Lauritzen, Torsten] Univ Aarhus, Dept Gen Practice, DK-8000 Aarhus, Denmark; [Borch-Johnsen, Knut; Andersen, Gitte; Jorgensen, Torben; Hansen, Torben] Steno Diabet Ctr, DK-2820 Copenhagen, Denmark; [Borch-Johnsen, Knut; Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, DK-8000 Aarhus, Denmark; [Kiess, Wieland; Koerner, Antje] Univ Leipzig, Univ Hosp Children & Adolescents, D-04109 Leipzig, Germany; [Kovacs, Peter] Univ Leipzig, Interdisciplinary Ctr Clin Res, Dept Internal Med 3, D-04109 Leipzig, Germany; [Jacobson, Peter; Carlsson, Lena M. S.] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Mol & Clin Med, SE-431 Gothenburg, Sweden; [Hansen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark	Imperial College London; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Aarhus University; Steno Diabetes Center; Aarhus University; Leipzig University; Leipzig University; University of Gothenburg; University of Copenhagen	Froguel, P (corresponding author), Hammersmith Hosp, Imperial Coll London, London W12 0NN, England.	p.froguel@imperial.ac.uk	Dina, Christian R/D-3535-2015; Pedersen, Oluf/Z-1731-2019; Carlsson, Lena/F-7570-2018; FROGUEL, Philippe/O-6799-2017; Jouret, Béatrice/AAC-8146-2019; Körner, Antje/B-3988-2015; Heude, Barbara/G-3095-2016; Walley, Andrew J/D-2573-2009; horber, Fritz/AAL-5419-2020; Jørgensen, Torben/Z-1335-2018; Pedersen, Oluf/AAG-8015-2020; Heude, Barbara/GLU-9626-2022; LE STUNFF, CATHERINE/Y-3270-2018; Meyre, David/D-7315-2011	Dina, Christian R/0000-0002-7722-7348; Pedersen, Oluf/0000-0002-3321-3972; Carlsson, Lena/0000-0003-4145-6242; FROGUEL, Philippe/0000-0003-2972-0784; Körner, Antje/0000-0001-6001-0356; Heude, Barbara/0000-0002-1565-1629; Walley, Andrew J/0000-0001-7707-7549; Heude, Barbara/0000-0002-1565-1629; LE STUNFF, CATHERINE/0000-0001-8419-0451; Meyre, David/0000-0003-4850-7444; Jacobson, Peter/0000-0002-1769-1827; Jorgensen, Torben/0000-0001-9453-2830; Hansen, Torben/0000-0001-8748-3831; Kovacs, Peter/0000-0002-0290-5423; Choquet, Helene/0000-0001-9839-8667; Marre, Michel/0000-0002-3071-1837	Medical Research Council [G0600331] Funding Source: Medline; MRC [G0600331] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Balkau B, 1996, REV EPIDEMIOL SANTE, V44, P373; Bell CG, 2004, DIABETES, V53, P1857, DOI 10.2337/diabetes.53.7.1857; Chagnon YC, 2001, J APPL PHYSIOL, V90, P1777, DOI 10.1152/jappl.2001.90.5.1777; Chen G, 2005, INT J OBESITY, V29, P255, DOI 10.1038/sj.ijo.0802873; Farooqi IS, 2007, J CLIN ENDOCR METAB, V92, P3369, DOI 10.1210/jc.2007-0687; Hager J, 1998, NAT GENET, V20, P304, DOI 10.1038/3123; Jackson RS, 2003, J CLIN INVEST, V112, P1550, DOI 10.1172/JCI18784; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Lloyd DJ, 2006, HUM MOL GENET, V15, P1884, DOI 10.1093/hmg/ddl111; ZHOU Y, 1994, J BIOL CHEM, V269, P18408	10	216	225	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					943	945		10.1038/ng.177	http://dx.doi.org/10.1038/ng.177			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18604207				2022-12-27	WOS:000258026900007
J	Allen, NC; Bagade, S; McQueen, MB; Ioannidis, JPA; Kavvoura, FK; Khoury, MJ; Tanzi, RE; Bertram, L				Allen, Nicole C.; Bagade, Sachin; McQueen, Matthew B.; Ioannidis, John P. A.; Kavvoura, Fotini K.; Khoury, Muin J.; Tanzi, Rudolph E.; Bertram, Lars			Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database	NATURE GENETICS			English	Article							PUBLISHED RESEARCH; BIPOLAR DISORDER; COMMON MUTATION; RISK-FACTOR; SUSCEPTIBILITY; COMPLEX; POLYMORPHISMS; HETEROGENEITY; CANDIDATE; VALIDITY	In an effort to pinpoint potential genetic risk factors for schizophrenia, research groups worldwide have published over 1,000 genetic association studies with largely inconsistent results. To facilitate the interpretation of these findings, we have created a regularly updated online database of all published genetic association studies for schizophrenia ('SzGene'). For all polymorphisms having genotype data available in at least four independent case-control samples, we systematically carried out random-effects meta-analyses using allelic contrasts. Across 118 meta-analyses, a total of 24 genetic variants in 16 different genes (APOE, COMT, DAO, DRD1, DRD2, DRD4, DTNBP1, GABRB2, GRIN2B, HP, IL1B, MTHFR, PLXNA2, SLC6A4, TP53 and TPH1) showed nominally significant effects with average summary odds ratios of similar to 1.23. Seven of these variants had not been previously meta-analyzed. According to recently proposed criteria for the assessment of cumulative evidence in genetic association studies, four of the significant results can be characterized as showing 'strong' epidemiological credibility. Our project represents the first comprehensive online resource for systematically synthesized and graded evidence of genetic association studies in schizophrenia. As such, it could serve as a model for field synopses of genetic associations in other common and genetically complex disorders.	[Allen, Nicole C.; Bagade, Sachin; Tanzi, Rudolph E.; Bertram, Lars] Massachusetts Gen Hosp, MIND, Dept Neurol, Genet & Aging Res Unit, Charlestown, MA 02129 USA; [McQueen, Matthew B.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Ioannidis, John P. A.; Kavvoura, Fotini K.] Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, Clin & Mol Epidemiol Unit, GR-45110 Ioannina, Greece; [Ioannidis, John P. A.] Fdn Res & Technol Hellas, Inst Biomed Res, Ioannina 45110, Greece; [Ioannidis, John P. A.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02110 USA; [Khoury, Muin J.] Ctr Dis Control & Prevent, Natl Off Publ Hlth Gen, Atlanta, GA 30341 USA	Harvard University; Massachusetts General Hospital; University of Colorado System; University of Colorado Boulder; University of Ioannina; Foundation for Research & Technology - Hellas (FORTH); Tufts University; Centers for Disease Control & Prevention - USA	Bertram, L (corresponding author), Massachusetts Gen Hosp, MIND, Dept Neurol, Genet & Aging Res Unit, Charlestown, MA 02129 USA.	bertram@helix.mgh.harvard.edu	Ioannidis, John P. A./G-9836-2011; Tanzi, Rudolph/AAE-9622-2019; McQueen, Matthew/X-5845-2019; Bertram, Lars/K-3889-2015	Tanzi, Rudolph/0000-0002-7032-1454; Bertram, Lars/0000-0002-0108-124X	NICHD NIH HHS [R01 HD060726] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060726] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Badner JA, 2002, MOL PSYCHIATR, V7, P405, DOI 10.1038/sj.mp.4001012; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Evangelou E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000196; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Fujii T, 2007, PROG NEURO-PSYCHOPH, V31, P873, DOI 10.1016/j.pnpbp.2007.01.027; Harbord RM, 2006, STAT MED, V25, P3443, DOI 10.1002/sim.2380; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Ioannidis JPA, 2007, CLIN TRIALS, V4, P245, DOI 10.1177/1740774507079441; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ioannidis JPA, 2005, J CLIN EPIDEMIOL, V58, P543, DOI 10.1016/j.jclinepi.2004.10.019; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Ioannidis JPA, 2006, NAT GENET, V38, P3, DOI 10.1038/ng0106-3; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Lencz T, 2007, MOL PSYCHIATR, V12, P572, DOI 10.1038/sj.mp.4001983; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Li DW, 2007, GENET MED, V9, P4, DOI 10.1097/01.gim.0000250507.96760.4b; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Mah S, 2006, MOL PSYCHIATR, V11, P471, DOI 10.1038/sj.mp.4001785; MCGORRY PD, 1995, AM J PSYCHIAT, V152, P220; Missale C, 2006, CURR TOP MED CHEM, V6, P801, DOI 10.2174/156802606777057562; Mueser KT, 2004, LANCET, V363, P2063, DOI 10.1016/S0140-6736(04)16458-1; Munafo MR, 2006, MOL PSYCHIATR, V11, P539, DOI 10.1038/sj.mp.4001817; Owen MJ, 2005, TRENDS GENET, V21, P518, DOI 10.1016/j.tig.2005.06.011; Roffman JL, 2008, BIOL PSYCHIAT, V63, P42, DOI 10.1016/j.biopsych.2006.12.017; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Tauscher J, 2004, AM J PSYCHIAT, V161, P1620, DOI 10.1176/appi.ajp.161.9.1620; Thakkinstian A, 2006, HUM MOL GENET, V15, P2784, DOI 10.1093/hmg/ddl220; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Weickert CS, 2004, ARCH GEN PSYCHIAT, V61, P544, DOI 10.1001/archpsyc.61.6.544; Williams NM, 2005, SCHIZOPHRENIA BULL, V31, P800, DOI 10.1093/schbul/sbi061	39	806	845	3	97	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					827	834		10.1038/ng.171	http://dx.doi.org/10.1038/ng.171			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18583979				2022-12-27	WOS:000257166500015
J	Fritsche, LG; Loenhardt, T; Janssen, A; Fisher, SA; Rivera, A; Keilhauer, CN; Weber, BHF				Fritsche, Lars G.; Loenhardt, Thomas; Janssen, Andreas; Fisher, Sheila A.; Rivera, Andrea; Keilhauer, Claudia N.; Weber, Bernhard H. F.			Age-related macular degeneration is associated with an unstable ARMS2 (LOC387715) mRNA	NATURE GENETICS			English	Article							COMPLEMENT FACTOR-H; X-LINKED RETINOSCHISIS; MACULOPATHY; HTRA1; SUSCEPTIBILITY; POLYMORPHISM; HAPLOTYPE; DISEASE; VARIANT; GENE	Age-related macular degeneration (AMD) is a prevalent multifactorial disorder of the central retina(1-3). Genetic variants at two chromosomal loci, 1q31 and 10q26, confer major disease risks, together accounting for more than 50% of AMD pathology(4-9). Signals at 10q26 center over two nearby genes, ARMS2 (age-related maculopathy susceptibility 2, also known as LOC387715)(8,9) and HTRA1 (high-temperature requirement factor A1)(10,11), suggesting two equally probable candidates. Here we show that a deletion-insertion polymorphism in ARMS2 (NM_001099667.1: c.*372_815del443ins54) is strongly associated with AMD, directly affecting the transcript by removing the polyadenylation signal and inserting a 54-bp element known to mediate rapid mRNA turnover. As a consequence, expression of ARMS2 in homozygous carriers of the indel variant is not detectable. Confirming previous findings(12), we demonstrate a mitochondrial association of the normal protein and further define its retinal localization to the ellipsoid region of the photoreceptors. Our data suggest that ARMS2 has a key role in AMD, possibly through mitochondria-related pathways.	[Fritsche, Lars G.; Loenhardt, Thomas; Janssen, Andreas; Rivera, Andrea; Weber, Bernhard H. F.] Univ Regensburg, Inst Human Genet, D-93053 Regensburg, Germany; [Fisher, Sheila A.] St Thomas Hosp, London WC2R 2LS, England; [Fisher, Sheila A.] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Keilhauer, Claudia N.] Univ Wurzburg, Dept Ophthalmol, D-97080 Wurzburg, Germany	University of Regensburg; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Wurzburg	Weber, BHF (corresponding author), Univ Regensburg, Inst Human Genet, Franz Josef Str Allee 11, D-93053 Regensburg, Germany.	bweb@klinik.uni-regensburg.de	Fritsche, Lars G/AAF-9387-2019	Fritsche, Lars G/0000-0002-2110-1690; Weber, Bernhard H.F./0000-0002-8808-7723				Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; DUDBRIDGE F, 2006, 5 MRC BIOST UN; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fernandez-Vizarra E, 2002, METHODS, V26, P292, DOI 10.1016/S1046-2023(02)00034-8; Fisher SA, 2007, HUM MUTAT, V28, P406, DOI 10.1002/humu.20464; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; GEYSEN HM, 1987, J IMMUNOL METHODS, V102, P259, DOI 10.1016/0022-1759(87)90085-8; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Khabar KSA, 2005, J INTERF CYTOK RES, V25, P1, DOI 10.1089/jir.2005.25.1; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; MITCHELL P, 1995, OPHTHALMOLOGY, V102, P1450; Molday LL, 2001, INVEST OPHTH VIS SCI, V42, P816; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Wu WWH, 2003, J BIOL CHEM, V278, P28139, DOI 10.1074/jbc.M302464200; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zeviani M, 2007, CURR OPIN NEUROL, V20, P564, DOI 10.1097/WCO.0b013e3282ef58cd	28	306	319	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					892	896		10.1038/ng.170	http://dx.doi.org/10.1038/ng.170			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18511946				2022-12-27	WOS:000257166500025
J	Cong, B; Barrero, LS; Tanksley, SD				Cong, Bin; Barrero, Luz S.; Tanksley, Steven D.			Regulatory change in YABBY-like transcription factor led to evolution of extreme fruit size during tomato domestication	NATURE GENETICS			English	Article							FLOWER DEVELOPMENT; LYCOPERSICON; EXPRESSION; PLANTS; CROSS; RICE; GENE	Plant domestication represents an accelerated form of evolution, resulting in exaggerated changes in the tissues and organs of greatest interest to humans ( for example, seeds, roots and tubers). One of the most extreme cases has been the evolution of tomato fruit. Cultivated tomato plants produce fruit as much as 1,000 times larger than those of their wild progenitors. Quantitative trait mapping studies have shown that a relatively small number of genes were involved in this dramatic transition, and these genes control two processes: cell cycle and organ number determination(1). The key gene in the first process has been isolated and corresponds to fw2.2, a negative regulator of cell division(2,3). However, until now, nothing was known about the molecular basis of the second process. Here, we show that the second major step in the evolution of extreme fruit size was the result of a regulatory change of a YABBY-like transcription factor (fasciated) that controls carpel number during flower and/or fruit development.	[Cong, Bin; Barrero, Luz S.; Tanksley, Steven D.] Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY 14853 USA; [Cong, Bin; Barrero, Luz S.; Tanksley, Steven D.] Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Tanksley, SD (corresponding author), Cornell Univ, Dept Genet & Plant Breeding, Ithaca, NY 14853 USA.	sdt4@cornell.edu						Barrero LS, 2004, THEOR APPL GENET, V109, P669, DOI 10.1007/s00122-004-1676-y; COEN ES, 1990, CELL, V63, P1311, DOI 10.1016/0092-8674(90)90426-F; Cong B, 2002, P NATL ACAD SCI USA, V99, P13606, DOI 10.1073/pnas.172520999; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; ESHED Y, 1995, GENETICS, V141, P1147; Fourquin C, 2005, P NATL ACAD SCI USA, V102, P4649, DOI 10.1073/pnas.0409577102; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Jang S, 2004, PLANT MOL BIOL, V56, P133, DOI 10.1007/s11103-004-2648-y; Jones Jonathan D. G., 1992, Transgenic Research, V1, P285, DOI 10.1007/BF02525170; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Kosambi D. D., 1944, ANN EUGENICS, V12, P172; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lippman Z, 2001, GENETICS, V158, P413; Nesbitt TC, 2002, GENETICS, V162, P365; ROE JL, 1993, CELL, V75, P939, DOI 10.1016/0092-8674(93)90537-Z; Tanksley SD, 2004, PLANT CELL, V16, pS181, DOI 10.1105/tpc.018119	17	273	303	9	170	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2008	40	6					800	804		10.1038/ng.144	http://dx.doi.org/10.1038/ng.144			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18469814				2022-12-27	WOS:000256212000024
J	Finberg, KE; Heeney, MM; Campagna, DR; Aydinok, Y; Pearson, HA; Hartman, KR; Mayo, MM; Samuel, SM; Strouse, JJ; Markianos, K; Andrews, NC; Fleming, MD				Finberg, Karin E.; Heeney, Matthew M.; Campagna, Dean R.; Aydinok, Yesim; Pearson, Howard A.; Hartman, Kip R.; Mayo, Mary M.; Samuel, Stewart M.; Strouse, John J.; Markianos, Kyriacos; Andrews, Nancy C.; Fleming, Mark D.			Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)	NATURE GENETICS			English	Article							MICROCYTIC ANEMIA; MALABSORPTION; METABOLISM; HEPCIDIN	Iron deficiency is usually attributed to chronic blood loss or inadequate dietary intake. Here, we show that iron deficiency anemia refractory to oral iron therapy can be caused by germline mutations in TMPRSS6, which encodes a type II transmembrane serine protease produced by the liver that regulates the expression of the systemic iron regulatory hormone hepcidin. These findings demonstrate that TMPRSS6 is essential for normal systemic iron homeostasis in humans.	[Finberg, Karin E.] Massachusetts Gen Hosp, Pathol Serv, Boston, MA 02114 USA; [Heeney, Matthew M.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Campagna, Dean R.] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Aydinok, Yesim] Ege Univ, Fac Med, Dept Pediat Hematol, TR-35100 Izmir, Turkey; [Pearson, Howard A.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06520 USA; [Hartman, Kip R.] Uniformed Serv Univ Hlth Sci, Dept Pediat, Bethesda, MD 20814 USA; [Mayo, Mary M.] St Louis Univ, Sch Med, Dept Pathol, St Louis, MO 63104 USA; [Samuel, Stewart M.] Pediat Hlth Associates PC, New York, NY 11803 USA; [Strouse, John J.] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Pediat Hematol, Baltimore, MD 21205 USA; [Markianos, Kyriacos] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Markianos, Kyriacos; Andrews, Nancy C.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Fleming, Mark D.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Finberg, Karin E.; Heeney, Matthew M.; Andrews, Nancy C.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Ege University; Yale University; Uniformed Services University of the Health Sciences - USA; Saint Louis University; Johns Hopkins University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	Andrews, NC (corresponding author), Duke Univ, Sch Med, Dept Pathol, Durham, NC 27710 USA.	Nancy.Andrews@duke.edu; Mark.Fleming@childrens.harvard.edu	Strouse, J/A-2690-2008; Aydinok, Yesim/G-5410-2010; Heeney, Matthew/J-6838-2015	Strouse, J/0000-0003-0341-1457; Markianos, Kyriacos/0000-0003-0214-6014; Fleming, Mark/0000-0003-0948-4024; Andrews, Nancy/0000-0003-0243-4462; Heeney, Matthew/0000-0002-1104-6843	NCI NIH HHS [T32 CA009216] Funding Source: Medline; NHLBI NIH HHS [K12 HL087164] Funding Source: Medline; NIDDK NIH HHS [R01 DK066373, DK053813, R01 DK080011, R01 DK053813, R01 DK053813-10] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009216] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL087164] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053813, R01DK066373, R01DK080011] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andrews NC, 1997, YALE J BIOL MED, V70, P219; BROWN AC, 1988, AM J HEMATOL, V27, P1, DOI 10.1002/ajh.2830270102; BUCHANAN GR, 1981, J PEDIATR-US, V98, P723, DOI 10.1016/S0022-3476(81)80831-1; Hartman KR, 1996, AM J HEMATOL, V51, P269, DOI 10.1002/(SICI)1096-8652(199604)51:4<269::AID-AJH4>3.0.CO;2-U; Kemna EHJM, 2007, CLIN CHEM, V53, P620, DOI 10.1373/clinchem.2006.079186; Mayo M M, 2001, Clin Lab Sci, V14, P135; Nemeth E, 2006, ANNU REV NUTR, V26, P323, DOI 10.1146/annurev.nutr.26.061505.111303; Pearson HA, 1999, J PEDIAT HEMATOL ONC, V21, P412, DOI 10.1097/00043426-199909000-00014; Velasco G, 2002, J BIOL CHEM, V277, P37637, DOI 10.1074/jbc.M203007200	9	480	514	0	26	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					569	571		10.1038/ng.130	http://dx.doi.org/10.1038/ng.130			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18408718	Green Accepted			2022-12-27	WOS:000255366700023
J	Guryev, V; Saar, K; Adamovic, T; Verheul, M; Van Heesch, SAAC; Cook, S; Pravenec, M; Aitman, T; Jacob, H; Shull, JD; Hubner, N; Cuppen, E				Guryev, Victor; Saar, Kathrin; Adamovic, Tatjana; Verheul, Mark; Van Heesch, Sebastiaan A. A. C.; Cook, Stuart; Pravenec, Michal; Aitman, Timothy; Jacob, Howard; Shull, James D.; Hubner, Norbert; Cuppen, Edwin			Distribution and functional impact of DNA copy number variation in the rat	NATURE GENETICS			English	Article							RECENT SEGMENTAL DUPLICATIONS; STRUCTURAL VARIATION; POLYMORPHISM; SEQUENCE; INSIGHTS; TRAITS	The abundance and dynamics of copy number variants ( CNVs) in mammalian genomes poses new challenges in the identification of their impact on natural and disease phenotypes. We used computational and experimental methods to catalog CNVs in rat and found that they share important functional characteristics with those in human. In addition, 113 one-to-one orthologous genes overlap CNVs in both human and rat, 80 of which are implicated in human disease. CNVs are nonrandomly distributed throughout the genome. Chromosome 18 is a cold spot for CNVs as well as evolutionary rearrangements and segmental duplications, suggesting stringent selective mechanisms underlying CNV genesis or maintenance. By exploiting gene expression data available for rat recombinant inbred lines, we established the functional relationship of CNVs underlying 22 expression quantitative trait loci. These characteristics make the rat an excellent model for studying phenotypic effects of structural variation in relation to human complex traits and disease.	[Guryev, Victor; Verheul, Mark; Van Heesch, Sebastiaan A. A. C.; Cuppen, Edwin] Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Saar, Kathrin; Hubner, Norbert] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Adamovic, Tatjana; Jacob, Howard] Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA; [Cook, Stuart; Aitman, Timothy] Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, London W12 0NN, England; [Cook, Stuart] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England; [Pravenec, Michal] Acad Sci Czech Republ, Inst Physiol, CR-14220 Prague, Czech Republic; [Pravenec, Michal] Charles Univ Prague, Inst Biol & Med Genet, Fac Med 1, Prague 12800 2, Czech Republic; [Shull, James D.] Univ Nebraska, Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Helmholtz Association; Max Delbruck Center for Molecular Medicine; Medical College of Wisconsin; Imperial College London; Imperial College London; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague; University of Nebraska System; University of Nebraska Medical Center	Cuppen, E (corresponding author), Royal Netherlands Acad Arts & Sci, Hubrecht Inst, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	e.cuppen@niob.knaw.nl	Pravenec, Michal/B-1666-2012; Cook, Stuart/G-9567-2011; Cuppen, Edwin/H-2389-2016; van Heesch, Sebastiaan/AAT-6595-2020; Cuppen, Edwin/F-5696-2011	Pravenec, Michal/0000-0001-9197-5871; Cuppen, Edwin/0000-0002-0400-9542; van Heesch, Sebastiaan/0000-0001-9593-1980; Cuppen, Edwin/0000-0002-0400-9542; Guryev, Victor/0000-0002-5810-6022; Saar, Kathrin/0000-0002-4483-1557; Cook, Stuart/0000-0001-6628-194X; Aitman, Timothy/0000-0002-7875-4502	MRC [MC_U120085815, MC_U120061454] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA077876] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; Medical Research Council [MC_U120085815, MC_U120061454] Funding Source: Medline; NCI NIH HHS [R01 CA077876, CA77876] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Berriz GF, 2003, BIOINFORMATICS, V19, P2502, DOI 10.1093/bioinformatics/btg363; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Cutler G, 2007, GENOME RES, V17, P1743, DOI 10.1101/gr.6754607; Drake TA, 2006, MAMM GENOME, V17, P466, DOI 10.1007/s00335-005-0175-z; Dumas L, 2007, GENOME RES, V17, P1266, DOI 10.1101/gr.6557307; Egan CM, 2007, NAT GENET, V39, P1384, DOI 10.1038/ng.2007.19; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Glazier AN, 2002, MAMM GENOME, V13, P108, DOI 10.1007/s00335-001-2132-9; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Hubner N, 2006, NAT GENET, V38, P140, DOI 10.1038/ng0206-140; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Irizarry RA, 2003, STAT APPL GENET MOL, V2, DOI DOI 10.2202/1544-6115.1002; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Kwitek AE, 2006, PHYSIOL GENOMICS, V25, P303, DOI 10.1152/physiolgenomics.00288.2005; Lee JA, 2006, ANN NEUROL, V59, P398, DOI 10.1002/ana.20732; Li JZ, 2004, NAT GENET, V36, P952, DOI 10.1038/ng1417; Malek RL, 2006, NAT GENET, V38, P234, DOI 10.1038/ng1693; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Petretto E, 2006, PLOS GENET, V2, P1625, DOI 10.1371/journal.pgen.0020172; Pravenec M, 2005, EXP PHYSIOL, V90, P273, DOI 10.1113/expphysiol.2004.029322; PRAVENEC M, 1989, J HYPERTENS, V7, P217; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Snijders AM, 2005, GENOME RES, V15, P302, DOI 10.1101/gr.2902505; Somerville MJ, 2005, NEW ENGL J MED, V353, P1694, DOI 10.1056/NEJMoa051962; *STAT CONS, 2008, NAT GENET, DOI DOI 10.1038/NG.124; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Tuzun E, 2004, GENOME RES, V14, P493, DOI 10.1101/gr.1907504; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310	42	167	172	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					538	545		10.1038/ng.141	http://dx.doi.org/10.1038/ng.141			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18443591				2022-12-27	WOS:000255366700019
J	Saal, LH; Gruvberger-Saal, SK; Persson, C; Loevgren, K; Jumppanen, M; Staaf, J; Jonsson, G; Pires, MM; Maurer, M; Holm, K; Koujak, S; Subramaniyam, S; Vallon-Christersson, J; Olsson, H; Su, T; Memeo, L; Ludwig, T; Ethier, SP; Krogh, M; Szabolcs, M; Murty, VV; Isola, J; Hibshoosh, H; Parsons, R; Borg, A				Saal, Lao H.; Gruvberger-Saal, Sofia K.; Persson, Camilla; Loevgren, Kristina; Jumppanen, Mervi; Staaf, Johan; Jonsson, Goeran; Pires, Maira M.; Maurer, Matthew; Holm, Karolina; Koujak, Susan; Subramaniyam, Shivakumar; Vallon-Christersson, Johan; Olsson, Hakan; Su, Tao; Memeo, Lorenzo; Ludwig, Thomas; Ethier, Stephen P.; Krogh, Morten; Szabolcs, Matthias; Murty, Vundavalli V. V. S.; Isola, Jorma; Hibshoosh, Hanina; Parsons, Ramon; Borg, Ake			Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair	NATURE GENETICS			English	Article							CELL-LINES; PROSTATE-CANCER; BRCA1; INSTABILITY; PHENOTYPE; CARCINOMA; PATTERNS; SUBTYPES; MICE	Basal-like breast cancer (BBC) is a subtype of breast cancer with poor prognosis(1 - 3). Inherited mutations of BRCA1, a cancer susceptibility gene involved in double-strand DNA break (DSB) repair, lead to breast cancers that are nearly always of the BBC subtype(3 - 5); however, the precise molecular lesions and oncogenic consequences of BRCA1 dysfunction are poorly understood. Here we show that heterozygous inactivation of the tumor suppressor gene Pten leads to the formation of basal-like mammary tumors in mice, and that loss of PTEN expression is significantly associated with the BBC subtype in human sporadic and BRCA1-associated hereditary breast cancers. In addition, we identify frequent gross PTEN mutations, involving intragenic chromosome breaks, inversions, deletions and micro copy number aberrations, specifically in BRCA1-deficient tumors. These data provide an example of a specific and recurrent oncogenic consequence of BRCA1-dependent dysfunction in DNA repair and provide insight into the pathogenesis of BBC with therapeutic implications. These findings also argue that obtaining an accurate census of genes mutated in cancer will require a systematic examination for gross gene rearrangements, particularly in tumors with deficient DSB repair.	[Saal, Lao H.] Columbia Univ, Coll Phys & Surg, New York, NY 10032 USA; [Persson, Camilla; Loevgren, Kristina; Staaf, Johan; Jonsson, Goeran; Holm, Karolina; Vallon-Christersson, Johan; Olsson, Hakan; Borg, Ake] Lund Univ, Dept Clin Sci, Div Oncol, S-22185 Lund, Sweden; [Jumppanen, Mervi] Seinajoki Cent Hosp, Dept Pathol, Seinajoki 60220, Finland; [Jumppanen, Mervi; Isola, Jorma] Tampere Univ, Inst Med Technol, Tampere 33014, Finland; [Pires, Maira M.] Columbia Univ, Dept Biochem, New York, NY 10032 USA; [Maurer, Matthew; Parsons, Ramon] Columbia Univ, Dept Med, New York, NY 10032 USA; [Subramaniyam, Shivakumar; Ludwig, Thomas; Szabolcs, Matthias; Murty, Vundavalli V. V. S.; Hibshoosh, Hanina; Parsons, Ramon] Columbia Univ, Dept Pathol, New York, NY 10032 USA; [Su, Tao; Hibshoosh, Hanina; Parsons, Ramon] Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA; [Memeo, Lorenzo] Mediterranean Inst Oncol, Pathol Unit, I-95029 Catania, Italy; [Ethier, Stephen P.] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA; [Krogh, Morten] Lund Univ, Dept Theoret, S-22362 Lund, Sweden; [Borg, Ake] Lund Univ, Lund Strateg Ctr Stem Cell Biol & Cell Therapy, S-22185 Lund, Sweden; [Saal, Lao H.; Gruvberger-Saal, Sofia K.; Maurer, Matthew; Koujak, Susan; Murty, Vundavalli V. V. S.; Parsons, Ramon] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA	Columbia University; Lund University; Seinajoki Central Hospital; Tampere University; Columbia University; Columbia University; Columbia University; Columbia University; Mediterranean Institute of Oncology; Barbara Ann Karmanos Cancer Institute; Wayne State University; Lund University; Lund University; Columbia University	Parsons, R (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10032 USA.	rep15@columbia.edu	SUBRAMANIYAM, SHIVAKUMAR/HCI-4231-2022; Califano, Andrea/F-7239-2012; Su, Tao/T-4411-2019; Saal, Lao H/A-2919-2011; Ludwig, Thomas/Q-6484-2016; Jönsson, Göran/D-1212-2014	Su, Tao/0000-0002-9148-6127; Saal, Lao H/0000-0002-0815-1896; Ludwig, Thomas/0000-0003-3461-2585; Vallon-Christersson, Johan/0000-0002-2195-0385; Memeo, Lorenzo/0000-0003-4251-7203; Parsons, Ramon/0000-0002-6656-3514; Olsson, Hakan/0000-0002-8794-9635	NATIONAL CANCER INSTITUTE [R01CA082783, P01CA097403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007367] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA082783-08, R01 CA082783-06, P01 CA097403, R01 CA082783-07, R01 CA082783, CA097403, CA082783] Funding Source: Medline; NIGMS NIH HHS [5T32 GM07367-29, T32 GM007367] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baker SJ, 2007, CELL, V128, P25, DOI 10.1016/j.cell.2006.12.023; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Evers B, 2006, ONCOGENE, V25, P5885, DOI 10.1038/sj.onc.1209871; GIOVANELLA BC, 1974, JNCI-J NATL CANCER I, V52, P921, DOI 10.1093/jnci/52.3.921; Greenblatt MS, 2001, CANCER RES, V61, P4092; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Janzen V, 2006, NATURE, V441, P418, DOI 10.1038/441418b; Jasin M, 2002, ONCOGENE, V21, P8981, DOI 10.1038/sj.onc.1206176; Jonsson G, 2007, GENE CHROMOSOME CANC, V46, P543, DOI 10.1002/gcc.20438; Laakso M, 2005, MODERN PATHOL, V18, P1321, DOI 10.1038/modpathol.3800456; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Loman N, 2001, JNCI-J NATL CANCER I, V93, P1215, DOI 10.1093/jnci/93.16.1215; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Podsypanina K, 1999, P NATL ACAD SCI USA, V96, P1563, DOI 10.1073/pnas.96.4.1563; Puc J, 2005, CANCER CELL, V7, P193, DOI 10.1016/j.ccr.2005.01.009; Saal LH, 2007, P NATL ACAD SCI USA, V104, P7564, DOI 10.1073/pnas.0702507104; Saal LH, 2002, GENOME BIOL, V3; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; SILVA LD, 2007, J CLIN PATHOL   0511; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; STAAF J, IN PRESS HUM MUTAT; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlinson GE, 1998, CANCER RES, V58, P3237; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096	30	273	283	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2008	40	1					102	107		10.1038/ng.2007.39	http://dx.doi.org/10.1038/ng.2007.39			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18066063	Green Accepted, Green Published			2022-12-27	WOS:000252118600025
J	Jiang, Z; Tang, H; Ventura, M; Cardone, MF; Marques-Bonet, T; She, X; Pevzner, PA; Eichler, EE				Jiang, Zhaoshi; Tang, Haixu; Ventura, Mario; Cardone, Maria Francesca; Marques-Bonet, Tomas; She, Xinwei; Pevzner, Pavel A.; Eichler, Evan E.			Ancestral reconstruction of segmental duplications reveals punctuated cores of human genome evolution	NATURE GENETICS			English	Article							HOMINOID EVOLUTION; GENE FAMILY; SEQUENCE; EXPANSION; REARRANGEMENTS; TRANSPOSITION; ORGANIZATION; EMERGENCE; INSIGHTS; DELETION	Human segmental duplications are hotspots for nonallelic homologous recombination leading to genomic disorders, copy-number polymorphisms and gene and transcript innovations. The complex structure and history of these regions have precluded a global evolutionary analysis. Combining a modified A-Bruijn graph algorithm with comparative genome sequence data, we identify the origin of 4,692 ancestral duplication loci and use these to cluster 437 complex duplication blocks into 24 distinct groups. The sequence-divergence data between ancestral-derivative pairs and a comparison with the chimpanzee and macaque genome support a `punctuated' model of evolution. Our analysis reveals that human segmental duplications are frequently organized around `core' duplicons, which are enriched for transcripts and, in some cases, encode primate-specific genes undergoing positive selection. We hypothesize that the rapid expansion and fixation of some intrachromosomal segmental duplications during great-ape evolution has been due to the selective advantage conferred by these genes and transcripts embedded within these core duplications.	Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; Howard Hughes Med Inst, Seattle, WA 98195 USA; Indiana Univ, Sch Informat, Bloomington, IN 47408 USA; Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN 47408 USA; Univ Bari, Dept Genet & Microbiol, I-70126 Bari, Italy; Univ Calif Santa Cruz, Dept Comp Sci & Engn, La Jolla, CA 92093 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Universita degli Studi di Bari Aldo Moro; University of California System; University of California Santa Cruz	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, 1705 NE Pacific St, Seattle, WA 98195 USA.	eee@gs.washington.edu	Cardone, Maria Francesca/G-8818-2012; Marques-Bonet, Tomas/ABF-3734-2020; Marques-Bonet, Tomas/I-4618-2014; Ventura, Mario/E-6420-2011	Cardone, Maria Francesca/0000-0002-7597-7313; Marques-Bonet, Tomas/0000-0002-5597-3075; Marques-Bonet, Tomas/0000-0002-5597-3075; Ventura, Mario/0000-0001-7762-8777				Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bowers PM, 2004, SCIENCE, V306, P2246, DOI 10.1126/science.1103330; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Ciccarelli FD, 2005, GENOME RES, V15, P343, DOI 10.1101/gr.3266405; Eichler EE, 2001, J HERED, V92, P462, DOI 10.1093/jhered/92.6.462; Eichler EE, 1996, HUM MOL GENET, V5, P899, DOI 10.1093/hmg/5.7.899; Eichler EE, 1997, HUM MOL GENET, V6, P991, DOI 10.1093/hmg/6.7.991; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gu X, 2002, NAT GENET, V31, P205, DOI 10.1038/ng902; Horvath JE, 2005, GENOME RES, V15, P914, DOI 10.1101/gr.3916405; Horvath JE, 2003, MOL BIOL EVOL, V20, P1463, DOI 10.1093/molbev/msg158; Horvath JE, 2000, HUM MOL GENET, V9, P113, DOI 10.1093/hmg/9.1.113; Horvath JE, 2000, GENOME RES, V10, P839, DOI 10.1101/gr.10.6.839; Hurles M E, 2001, BMC Genomics, V2, P11, DOI 10.1186/1471-2164-2-11; Jackson MS, 2005, AM J HUM GENET, V77, P824, DOI 10.1086/497704; Jackson MS, 1999, HUM MOL GENET, V8, P205, DOI 10.1093/hmg/8.2.205; Johnson ME, 2006, P NATL ACAD SCI USA, V103, P17626, DOI 10.1073/pnas.0605426103; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Lake JA, 2004, MOL BIOL EVOL, V21, P681, DOI 10.1093/molbev/msh061; Linardopoulou EV, 2005, NATURE, V437, P94, DOI 10.1038/nature04029; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Locke DP, 2005, CYTOGENET GENOME RES, V108, P73, DOI 10.1159/000080804; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Orti R, 1998, CYTOGENET CELL GENET, V83, P262, DOI 10.1159/000015201; Paulding CA, 2003, P NATL ACAD SCI USA, V100, P2507, DOI 10.1073/pnas.0437015100; Pavlicek A, 2005, GENOME RES, V15, P1487, DOI 10.1101/gr.4281205; Pevzner PA, 2004, GENOME RES, V14, P1786, DOI 10.1101/gr.2395204; Potier MC, 1998, GENOMICS, V51, P417, DOI 10.1006/geno.1998.5389; Regnier V, 1997, HUM MOL GENET, V6, P9, DOI 10.1093/hmg/6.1.9; Rivera MC, 2004, NATURE, V431, P152, DOI 10.1038/nature02848; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; She XW, 2006, GENOME RES, V16, P576, DOI 10.1101/gr.4949406; She XW, 2004, NATURE, V430, P857, DOI 10.1038/nature02806; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Vandepoele K, 2005, MOL BIOL EVOL, V22, P2265, DOI 10.1093/molbev/msi222; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	41	145	147	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2007	39	11					1361	1368		10.1038/ng.2007.9	http://dx.doi.org/10.1038/ng.2007.9			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17922013				2022-12-27	WOS:000250575900020
J	Goring, HHH; Curran, JE; Johnson, MP; Dyer, TD; Charlesworth, J; Cole, SA; Jowett, JBM; Abraham, LJ; Rainwater, DL; Comuzzie, AG; Mahaney, MC; Almasy, L; MacCluer, JW; Kissebah, AH; Collier, GR; Moses, EK; Blangero, J				Goering, Harald H. H.; Curran, Joanne E.; Johnson, Matthew P.; Dyer, Thomas D.; Charlesworth, Jac; Cole, Shelley A.; Jowett, Jeremy B. M.; Abraham, Lawrence J.; Rainwater, David L.; Comuzzie, Anthony G.; Mahaney, Michael C.; Almasy, Laura; MacCluer, Jean W.; Kissebah, Ahmed H.; Collier, Gregory R.; Moses, Eric K.; Blangero, John			Discovery of expression QTLs using large-scale transcriptional profiling in human lymphocytes	NATURE GENETICS			English	Article							HUMAN GENE-EXPRESSION; LINKAGE ANALYSIS; HUMAN GENOME; YEAST; IDENTIFICATION; ASSOCIATION; SEGREGATION; POPULATIONS; NUCLEOTIDE; PHENOTYPES	Quantitative differences in gene expression are thought to contribute to phenotypic differences between individuals. We generated genome-wide transcriptional profiles of lymphocyte samples from 1,240 participants in the San Antonio Family Heart Study. The expression levels of 85% of the 19,648 detected autosomal transcripts were significantly heritable. Linkage analysis uncovered > 1,000 cis-regulated transcripts at a false discovery rate of 5% and showed that the expression quantitative trait loci with the most significant linkage evidence are often located at the structural locus of a given transcript. To highlight the usefulness of this much- enlarged map of cis-regulated transcripts for the discovery of genes that influence complex traits in humans, as an example we selected high-density lipoprotein cholesterol concentration as a phenotype of clinical importance, and identified the cis-regulated vanin 1 (VNN1) gene as harboring sequence variants that influence high-density lipoprotein cholesterol concentrations.	SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78245 USA; Int Diab Inst, Caulfield, Vic 3162, Australia; ChemGenex Pharmaceut, Geelong, Vic 3216, Australia; Univ Western Australia, Sch Biomed Biomol & Chem Sci, Nedlands, WA 6009, Australia; Med Coll Wisconsin, TOPS Ctr Obes & Metab Res, Milwaukee, WI 53226 USA; Deakin Univ, Sch Hlth Sci, Metab Res Unit, Waurn Ponds, Vic 3216, Australia	Texas Biomedical Research Institute; University of Western Australia; Medical College of Wisconsin; Deakin University	Goring, HHH (corresponding author), SW Fdn Biomed Res, Dept Genet, San Antonio, TX 78245 USA.	hgoring@sfbrgenetics.org	Blangero, John/ABA-7175-2021; Almasy, Laura/V-3156-2019; Jowett, Jeremy/A-3809-2009; Charlesworth, Jac/J-7661-2014; Moses, Eric/A-3101-2010	Charlesworth, Jac/0000-0001-6201-3518; Moses, Eric/0000-0001-7781-4465; Curran, Joanne/0000-0002-6898-155X	NCRR NIH HHS [RR013556] Funding Source: Medline; NHLBI NIH HHS [HL045222] Funding Source: Medline; NIMH NIH HHS [MH059490] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR013556] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059490, R01MH059490] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blangero J, 2005, HUM BIOL, V77, P541, DOI 10.1353/hub.2006.0003; BOEHNKE M, 1991, AM J HUM GENET, V48, P22; BOERWINKLE E, 1986, ANN HUM GENET, V50, P181, DOI 10.1111/j.1469-1809.1986.tb01037.x; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Chekmenev DS, 2005, NUCLEIC ACIDS RES, V33, pW432, DOI 10.1093/nar/gki441; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; DAUSSET J, 1990, GENOMICS, V6, P575, DOI 10.1016/0888-7543(90)90491-C; de Koning DJ, 2005, TRENDS GENET, V21, P377, DOI 10.1016/j.tig.2005.05.004; Deutsch S, 2005, HUM MOL GENET, V14, P3741, DOI 10.1093/hmg/ddi404; Goring HHH, 2001, AM J HUM GENET, V69, P1357, DOI 10.1086/324471; Heath SC, 1997, AM J HUM GENET, V61, P748, DOI 10.1086/515506; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Jin W, 2001, NAT GENET, V29, P389, DOI 10.1038/ng766; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Kent JW, 2007, GENET EPIDEMIOL, V31, P173, DOI 10.1002/gepi.20200; Kirst M, 2004, PLANT PHYSIOL, V135, P2368, DOI 10.1104/pp.103.037960; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; LI YC, 1991, MOL CELL BIOL, V11, P1883, DOI 10.1128/MCB.11.4.1883; McPeek MS, 2000, AM J HUM GENET, V66, P1076, DOI 10.1086/302800; Mitchell BD, 1996, CIRCULATION, V94, P2159, DOI 10.1161/01.CIR.94.9.2159; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Pant PVK, 2006, GENOME RES, V16, P331, DOI 10.1101/gr.4559106; Pastinen T, 2006, HUM MOL GENET, V15, pR9, DOI 10.1093/hmg/ddl044; Perez-Enciso M, 2004, GENETICS, V166, P547, DOI 10.1534/genetics.166.1.547; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Sobel E, 1996, AM J HUM GENET, V58, P1323; Sobel E, 2002, AM J HUM GENET, V70, P496, DOI 10.1086/338920; Storey JD, 2005, PLOS BIOL, V3, P1380, DOI 10.1371/journal.pbio.0030267; Storey JD, 2007, AM J HUM GENET, V80, P502, DOI 10.1086/512017; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Turner J, 1999, TRENDS BIOCHEM SCI, V24, P236, DOI 10.1016/S0968-0004(99)01406-1; WARNICK GR, 1982, CLIN CHEM, V28, P1379; Wayne ML, 2002, P NATL ACAD SCI USA, V99, P14903, DOI 10.1073/pnas.222549199; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; Williams JT, 1999, ANN HUM GENET, V63, P545, DOI 10.1017/S0003480099007848; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Yamazaki K, 2002, BIOCHEM BIOPH RES CO, V290, P1114, DOI 10.1006/bbrc.2001.6319; Young Christine E, 2004, Cardiol Rev, V12, P107, DOI 10.1097/01.crd.0000097140.29929.8a; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	50	387	404	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2007	39	10					1208	1216		10.1038/ng2119	http://dx.doi.org/10.1038/ng2119			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17873875				2022-12-27	WOS:000249737400016
J	Mailman, MD; Feolo, M; Jin, Y; Kimura, M; Tryka, K; Bagoutdinov, R; Hao, L; Kiang, A; Paschall, J; Phan, L; Popova, N; Pretel, S; Ziyabari, L; Lee, M; Shao, Y; Wang, ZY; Sirotkin, K; Ward, M; Kholodov, M; Zbicz, K; Beck, J; Kimelman, M; Shevelev, S; Preuss, D; Yaschenko, E; Graeff, A; Ostell, J; Sherry, ST				Mailman, Matthew D.; Feolo, Michael; Jin, Yumi; Kimura, Masato; Tryka, Kimberly; Bagoutdinov, Rinat; Hao, Luning; Kiang, Anne; Paschall, Justin; Phan, Lon; Popova, Natalia; Pretel, Stephanie; Ziyabari, Lora; Lee, Moira; Shao, Yu; Wang, Zhen Y.; Sirotkin, Karl; Ward, Minghong; Kholodov, Michael; Zbicz, Kerry; Beck, Jeffrey; Kimelman, Michael; Shevelev, Sergey; Preuss, Don; Yaschenko, Eugene; Graeff, Alan; Ostell, James; Sherry, Stephen T.			The NCBI dbGaP database of genotypes and phenotypes	NATURE GENETICS			English	Editorial Material							GENOMIC CONTROL; ASSOCIATION	The National Center for Biotechnology Information has created the dbGaP public repository for individual-level phenotype, exposure, genotype and sequence data and the associations between them. dbGaP assigns stable, unique identifiers to studies and subsets of information from those studies, including documents, individual phenotypic variables, tables of trait data, sets of genotype data, computed phenotype-genotype associations, and groups of study subjects who have given similar consents for use of their data.	Natl Ctr Biotechnol Informat, NIH, Natl Lib Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Sherry, ST (corresponding author), Natl Ctr Biotechnol Informat, NIH, Natl Lib Med, Bethesda, MD 20892 USA.	sherry@ncbi.nlm.nih.gov		Sherry, Stephen/0000-0002-7982-076X; Beck, Jeffrey/0000-0002-1798-9797; Tryka, Kimberly/0000-0002-5399-4235	NATIONAL LIBRARY OF MEDICINE [Z01LM000160] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 LM999999] Funding Source: Medline	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		BRAY T, 2006, EXTENSIBEL MARKUP LA; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; HAROLD ER, 2001, XML BIBLE; Lowrance WW, 2007, SCIENCE, V317, P600, DOI 10.1126/science.1147699; Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127	6	746	758	2	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2007	39	10					1181	1186		10.1038/ng1007-1181	http://dx.doi.org/10.1038/ng1007-1181			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17898773	Green Submitted, Green Accepted			2022-12-27	WOS:000249737400003
J	Haygood, R; Fedrigo, O; Hanson, B; Yokoyama, KD; Awray, G				Haygood, Ralph; Fedrigo, Olivier; Hanson, Brian; Yokoyama, Ken-Daigoro; Awray, Gregory			Promoter regions of many neural- and nutrition-related genes have experienced positive selection during human evolution	NATURE GENETICS			English	Article							HUMAN GENOME; NATURAL-SELECTION; CHIMPANZEE GENOME; SEQUENCES; INSIGHTS; LINEAGE; MOUSE	Surveys of protein- coding sequences for evidence of positive selection in humans or chimpanzees have flagged only a few genes known to function in neural or nutritional processes(1-5), despite pronounced differences between humans and chimpanzees in behavior, cognition and diet(6-8). It may be that most such differences are due to changes in gene regulation rather than protein structure(9). Here, we present the first survey of promoter ( 5'- flanking) regions, which are rich in cis-regulatory sequences, for evidence of positive selection in humans. Our results indicate that positive selection has targeted the regulation of many genes known to be involved in neural development and function, both in the brain and elsewhere in the nervous system, and in nutrition, particularly in glucose metabolism.	Duke Univ, Dept Biol, Durham, NC 27708 USA; Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA	Duke University; Duke University	Haygood, R (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	rhaygood@duke.edu						Arcadi AC, 2005, CURR BIOL, V15, pR884, DOI 10.1016/j.cub.2005.10.020; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Clark AG, 2003, SCIENCE, V302, P1960, DOI 10.1126/science.1088821; Crawford GE, 2006, GENOME RES, V16, P123, DOI 10.1101/gr.4074106; Hellmann I, 2003, GENOME RES, V13, P831, DOI 10.1101/gr.944903; Johnson-Frey SH, 2003, NEURON, V39, P201, DOI 10.1016/S0896-6273(03)00424-0; Keightley PD, 2005, PLOS BIOL, V3, P282, DOI 10.1371/journal.pbio.0030042; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Loftus SK, 2005, PLOS GENET, V1, P369, DOI 10.1371/journal.pgen.0010038; Majewski J, 2002, GENOME RES, V12, P1827, DOI 10.1101/gr.606402; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Olson MV, 2003, NAT REV GENET, V4, P20, DOI 10.1038/nrg981; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Rockman MV, 2005, PLOS BIOL, V3, P2208, DOI 10.1371/journal.pbio.0030387; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sorek R, 2003, GENOME RES, V13, P1631, DOI 10.1101/gr.1208803; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Ungar P.S, 2007, EVOLUTION HUMAN DIET; Vallender EJ, 2004, HUM MOL GENET, V13, pR245, DOI 10.1093/hmg/ddh253; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; Wong WSW, 2004, GENETICS, V167, P949, DOI 10.1534/genetics.102.010959; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; Yu XJ, 2006, GENOMICS, V88, P745, DOI 10.1016/j.ygeno.2006.05.008; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237	30	211	216	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2007	39	9					1140	1144		10.1038/ng2104	http://dx.doi.org/10.1038/ng2104			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17694055				2022-12-27	WOS:000249122400025
J	Single, RM; Martin, MP; Gao, XJ; Meyer, DG; Yeager, M; Kidd, JR; Kidd, KK; Carrington, M				Single, Richard M.; Martin, Maureen P.; Gao, Xiaojiang; Meyer, Diogo; Yeager, Meredith; Kidd, Judith R.; Kidd, Kenneth K.; Carrington, Mary			Global diversity and evidence for coevolution of KIR and HLA	NATURE GENETICS			English	Article							NATURAL-SELECTION; SIGNATURES; MOLECULES; EVOLUTION; HISTORY; GENES	The killer immunoglobulin- like receptor ( KIR) gene cluster shows extensive genetic diversity, as do the HLA class I loci, which encode ligands for KIR molecules. We genotyped 1,642 individuals from 30 geographically distinct populations to examine population- level evidence for coevolution of these two functionally related but unlinked gene clusters. We observed strong negative correlations between the presence of activating KIR genes and their corresponding HLA ligand groups across populations, especially KIR3DS1 and its putative HLA- B Bw4-80I ligands ( r=- 0.66, P 0.038). In contrast, we observed weak positive relationships between the various inhibitory KIR genes and their ligands. We observed a negative correlation between distance from East Africa and frequency of activating KIR genes and their corresponding ligands, suggesting a balance between selection on HLA and KIR loci. Most KIR- HLA genetic association studies indicate a primary influence of activating KIR- HLA genotypes in disease risk(1,2); concomitantly, activating receptor- ligand pairs in this study show the strongest signature of coevolution of these two complex genetic systems as compared with inhibitory receptor- ligand pairs.	NCI, SAIC Frederick, Lab Genom Divers, Ft Detrick, MD 21702 USA; Univ Vermont, Dept Math & Stat, Burlington, VT 05405 USA; Univ Sao Paulo, Dept Genet & Biol Evolut, BR-05608900 Sao Paulo, SP, Brazil; NCI, SAIC Frederick Inc, Adv Technol Program, Core Genotyping Facil, Ft Detrick, MD 21702 USA; NCI, US Natl Inst Hlth, Div Canc Epidemiol & Genet, Dept Hlth & Human Serv, Rockville, MD 20852 USA; Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; University of Vermont; Universidade de Sao Paulo; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yale University	Carrington, M (corresponding author), NCI, SAIC Frederick, Lab Genom Divers, Ft Detrick, MD 21702 USA.	carringt@ncifcrf.gov	Meyer, Diogo/A-1868-2008; Yeager, Meredith/AAA-5322-2020		NATIONAL CANCER INSTITUTE [Z01BC010792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035326] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [N01-CO-12400] Funding Source: Medline; NIGMS NIH HHS [GM35326] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Apanius V, 1997, CRIT REV IMMUNOL, V17, P179, DOI 10.1615/CritRevImmunol.v17.i2.40; Bamshad M, 2003, NAT REV GENET, V4, P99, DOI 10.1038/nrg999; Borghans JAM, 2004, IMMUNOGENETICS, V55, P732, DOI 10.1007/s00251-003-0630-5; Carr WH, 2005, J IMMUNOL, V175, P5222, DOI 10.4049/jimmunol.175.8.5222; Carrim ZI, 2005, PHLEBOLOGY, V20, P196, DOI 10.1258/026835505774964919; Carrington M, 2006, CURR TOP MICROBIOL, V298, P225; CELLA M, 1994, J EXP MED, V180, P1235, DOI 10.1084/jem.180.4.1235; Cramer H., 1946, MATH METHODS STAT; Fisher R., 1970, STAT METHODS RES WOR; Gumperz JE, 1997, J IMMUNOL, V158, P5237; HEDRICK PW, 1991, P NATL ACAD SCI USA, V88, P5897, DOI 10.1073/pnas.88.13.5897; Hedrick PW, 2002, EVOLUTION, V56, P1902, DOI 10.1111/j.0014-3820.2002.tb00116.x; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; Khakoo SI, 2006, IMMUNOL REV, V214, P186, DOI 10.1111/j.1600-065X.2006.00459.x; Khakoo SI, 2000, IMMUNITY, V12, P687, DOI 10.1016/S1074-7613(00)80219-8; Lancaster Alex, 2003, Pac Symp Biocomput, P514; Lopez-Vazquez A, 2005, J INFECT DIS, V192, P162, DOI 10.1086/430351; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Martin MP, 2002, J IMMUNOL, V169, P2818, DOI 10.4049/jimmunol.169.6.2818; MARTIN MP, IN PRESS METHODS MOL; Meyer D, 2006, GENETICS, V173, P2121, DOI 10.1534/genetics.105.052837; Osier MV, 2002, AM J PHYS ANTHROPOL, V119, P77, DOI 10.1002/ajpa.10094; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; Qi Y, 2006, PLOS PATHOG, V2, P741, DOI 10.1371/journal.ppat.0020079; Salamon H, 1999, GENETICS, V152, P393; SINGLE RM, 2007, IMMUNOBIOLOGY HUMAN; Su B, 2000, P NATL ACAD SCI USA, V97, P8225, DOI 10.1073/pnas.97.15.8225; Vilches C, 2002, ANNU REV IMMUNOL, V20, P217, DOI 10.1146/annurev.immunol.20.092501.134942; WILLIAMS RC, 1986, AM J HUM GENET, V39, P409	30	173	183	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1114	1119		10.1038/ng2077	http://dx.doi.org/10.1038/ng2077			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17694058				2022-12-27	WOS:000249122400021
J	Lupski, JR				Lupski, James R.			Genomic rearrangements and sporadic disease	NATURE GENETICS			English	Article							COPY-NUMBER VARIATION; MARIE-TOOTH-DISEASE; CHROMOSOMAL REARRANGEMENTS; HOMOLOGOUS RECOMBINATION; STRUCTURAL VARIATION; CONGENITAL-MALFORMATIONS; CONSTITUTIONAL T(11/22); SEGMENTAL DUPLICATIONS; SPONTANEOUS MUTATION; DNA REARRANGEMENTS	Many clinical phenotypes occur sporadically despite genetics contributing partly or entirely to their cause. To what extent are de novo mutations the cause of sporadic traits? Locus-specific mutation rates for genomic rearrangements appear to be two to four orders of magnitude greater than nucleotide-specific rates for base substitutions. Widespread implementation of high-resolution genome analyses to detect de novo copy-number variation may identify the cause of traits previously intractable to conventional genetic analyses.	[Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Baylor Univ, Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor University	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Pl,604B, Houston, TX 77030 USA.	jlupski@bcm.tmc.edu						BAIRD PA, 1988, AM J HUM GENET, V42, P677; Bejjani BA, 2005, AM J MED GENET A, V134A, P259, DOI 10.1002/ajmg.a.30621; Bi WM, 2003, AM J HUM GENET, V73, P1302, DOI 10.1086/379979; Bort S, 1997, AM J HUM GENET, V60, P230; Brewer C, 1999, AM J HUM GENET, V64, P1702, DOI 10.1086/302410; Brewer C, 1998, AM J HUM GENET, V63, P1153, DOI 10.1086/302041; Chen KS, 1997, NAT GENET, V17, P154, DOI 10.1038/ng1097-154; Cheung SW, 2005, GENET MED, V7, P422, DOI 10.1097/01.GIM.0000170992.63691.32; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Crow JF, 2006, J RADIAT RES, V47, pB75, DOI 10.1269/jrr.47.B75; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; Edelmann L, 2001, AM J HUM GENET, V68, P1, DOI 10.1086/316952; Eichler EE, 2001, GENOME RES, V11, P653, DOI 10.1101/gr.188901; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; Goriely A, 2003, SCIENCE, V301, P643, DOI 10.1126/science.1085710; Haldane JBS, 1935, J GENET, V31, P317, DOI 10.1007/BF02982403; HOOGENDIJK JE, 1992, LANCET, V339, P1081, DOI 10.1016/0140-6736(92)90668-S; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; KALTER H, 1983, NEW ENGL J MED, V308, P424, DOI 10.1056/NEJM198302243080804; KALTER H, 1983, NEW ENGL J MED, V308, P491, DOI 10.1056/NEJM198303033080904; Kato T, 2006, SCIENCE, V311, P971, DOI 10.1126/science.1121452; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Kurahashi H, 2000, HUM MOL GENET, V9, P1665, DOI 10.1093/hmg/9.11.1665; Kurahashi H, 2001, NAT GENET, V29, P139, DOI 10.1038/ng1001-139; Lam KWG, 2006, P NATL ACAD SCI USA, V103, P8921, DOI 10.1073/pnas.0602690103; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Lee JA, 2006, HUM MOL GENET, V15, P2250, DOI 10.1093/hmg/ddl150; Lu XY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000327; Lupski JR, 2007, NEW ENGL J MED, V356, P1169, DOI 10.1056/NEJMcibr067658; Lupski JR, 2006, NAT GENET, V38, P974, DOI 10.1038/ng0906-974; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Lupski JR, 2003, AM J HUM GENET, V72, P246, DOI 10.1086/346217; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; Lupski JR, 2001, METABOLIC MOL BASES, P5759; Lupski JR, 2005, PERIPHERAL NEUROPATH, P1659, DOI DOI 10.1016/B978-0-7216-9491-7.50073-9; Marques W, 2005, J NEUROL, V252, P972, DOI 10.1007/s00415-005-0797-9; Nachman MW, 2000, GENETICS, V156, P297; Nelis E, 1996, EUR J HUM GENET, V4, P25; Newman TL, 2005, GENOME RES, V15, P1344, DOI 10.1101/gr.4338005; Potocki L, 1999, AM J HUM GENET, V64, P471, DOI 10.1086/302240; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Shaffer UG, 2006, J PEDIATR-US, V149, P98, DOI 10.1016/j.jpeds.2006.02.006; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2007, HUM MOL GENET, V16, P567, DOI 10.1093/hmg/ddm016; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw CJ, 2004, AM J HUM GENET, V75, P75, DOI 10.1086/422016; Shaw CJ, 2004, HUM MOL GENET, V13, pR57, DOI 10.1093/hmg/ddh073; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; SHY ME, 2005, PERIPHERAL NEUROPATH, V1, P1623; SKRE H, 1974, CLIN GENET, V6, P98; Stankiewicz P, 2003, AM J HUM GENET, V72, P1101, DOI 10.1086/374385; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stankiewicz P, 2006, GENOMIC DISORDERS: THE GENOMIC BASIS OF DISEASE, P179, DOI 10.1007/978-1-59745-039-3_12; Szigeti K, 2006, GENET MED, V8, P86, DOI 10.1097/01.gim.0000200160.29385.73; van Ommen GJB, 2005, NAT GENET, V37, P333, DOI 10.1038/ng0405-333; Vorstman JAS, 2006, MOL PSYCHIATR, V11, P18, DOI 10.1038/sj.mp.4001757; White S, 2002, AM J HUM GENET, V71, P365, DOI 10.1086/341942; WISE CA, 1993, AM J HUM GENET, V53, P853; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560	69	315	375	1	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39			7			S43	S47		10.1038/ng2084	http://dx.doi.org/10.1038/ng2084			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	274AO	17597781				2022-12-27	WOS:000253974400008
J	van Heel, DA; Franke, L; Hunt, KA; Gwilliam, R; Zhernakova, A; Inouye, M; Wapenaar, MC; Barnardo, MCNM; Bethel, G; Holmes, GKT; Feighery, C; Jewell, D; Kelleher, D; Kumar, P; Travis, S; Walters, JRF; Sanders, DS; Howdle, P; Swift, J; Playford, RJ; McLaren, WM; Mearin, ML; Mulder, CJ; McManus, R; McGinnis, R; Cardon, LR; Deloukas, P; Wijmenga, C				van Heel, David A.; Franke, Lude; Hunt, Karen A.; Gwilliam, Rhian; Zhernakova, Alexandra; Inouye, Mike; Wapenaar, Martin C.; Barnardo, Martin C. N. M.; Bethel, Graeme; Holmes, Geoffrey K. T.; Feighery, Con; Jewell, Derek; Kelleher, Dermot; Kumar, Parveen; Travis, Simon; Walters, Julian R. F.; Sanders, David S.; Howdle, Peter; Swift, Jill; Playford, Raymond J.; McLaren, William M.; Mearin, M. Luisa; Mulder, Chris J.; McManus, Ross; McGinnis, Ralph; Cardon, Lon R.; Deloukas, Panos; Wijmenga, Cisca			A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21	NATURE GENETICS			English	Article							INTERLEUKIN-2 GENE	We tested 310,605 SNPs for association in 778 individuals with celiac disease and 1,422 controls. Outside the HLA region, the most significant finding ( rs13119723; P = 2.0 x 10(-7)) was in the KIAA1109- TENR- IL2- IL21 linkage disequilibrium block. We independently confirmed association in two further collections ( strongest association at rs6822844, 24 kb 5' of IL21; meta-analysis P = 1.3 x 10(- 14), odds ratio 0.63), suggesting that genetic variation in this region predisposes to celiac disease.	Queen Mary Univ London, Inst Cell & Mol Sci, Ctr Gastroenterol, London E1 2AT, England; Univ Utrecht, Med Ctr, Ctr Biomed Genet, Complex Genet Sect, NL-3584 CG Utrecht, Netherlands; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Groningen, Med Ctr, Dept Genet, NL-9700 RB Groningen, Netherlands; Churchill Hosp, Oxford Transplant Ctr, Oxford OX3 7LJ, England; Derbyshire Royal Infirm, Dept Gastroenterol, Derby DE1 2QY, England; Univ Dublin Trinity Coll, Inst Mol Med, Dept Clin Med, Dublin 2, Ireland; Univ Dublin Trinity Coll, Inst Mol Med, Dept Immunol, Dublin 2, Ireland; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Oxford, Gastroenterol Unit, Oxford OX3 7BN, England; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Gastroenterol Sect, London W12 0HS, England; Royal Hallamshire Hosp, Dept Gastroenterol, Sheffield S10 2JF, S Yorkshire, England; Royal Hallamshire Hosp, Liver Unit, Sheffield S10 2JF, S Yorkshire, England; St James Univ Hosp, Dept Gastroenterol, Leeds LS9 7TF, W Yorkshire, England; Llandough Hosp, Dept Gastroenterol, Penarth CF64 2XX, S Glam, Wales; Leiden Univ, Med Ctr, Dept Paediat Gastroenterol, NL-2300 RC Leiden, Netherlands; Vrije Univ Amsterdam, Med Ctr, Dept Pediat Gastroenterol, NL-1007 MB Amsterdam, Netherlands; Vrije Univ Amsterdam, Med Ctr, Dept Gastroenterol, NL-1007 MB Amsterdam, Netherlands	University of London; Queen Mary University London; Utrecht University; Wellcome Trust Sanger Institute; University of Groningen; University of Oxford; Trinity College Dublin; Trinity College Dublin; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Imperial College London; University of Sheffield; University of Sheffield; Saint James's University Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	van Heel, DA (corresponding author), Queen Mary Univ London, Inst Cell & Mol Sci, Ctr Gastroenterol, London E1 2AT, England.	d.vanheel@qmul.ac.uk	Wijmenga, Cisca/AAE-7719-2019; Franke, Lude/P-7036-2016; Zhernakova, Alexandra/ABA-9372-2020; McManus, Ross/AAE-9236-2020; Walters, Julian/D-5189-2009; Deloukas, Panos/B-2922-2013; Wijmenga, Cisca/D-2173-2009	Wijmenga, Cisca/0000-0002-5635-1614; Franke, Lude/0000-0002-5159-8802; Walters, Julian/0000-0001-9720-5835; Deloukas, Panos/0000-0001-9251-070X; Playford, Raymond/0000-0003-1235-8504; Zhernakova, Alexandra/0000-0002-4574-0841; McGinnis, Ralph/0000-0003-4540-9857; McManus, Ross/0000-0002-0529-9617; Travis, Simon/0000-0002-2690-4361; van Heel, David/0000-0002-0637-2265; McLaren, William/0000-0001-6218-1116; Inouye, Michael/0000-0001-9413-6520	Medical Research Council [G0000934] Funding Source: Medline; Wellcome Trust [068545/Z/02, GR068094MA, 068094] Funding Source: Medline; MRC [G0000934] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; He QY, 2006, BIOINFORMATICS, V22, P2189, DOI 10.1093/bioinformatics/btl123; Hunt KA, 2005, EUR J HUM GENET, V13, P440, DOI 10.1038/sj.ejhg.5201357; Karell K, 2003, HUM IMMUNOL, V64, P469, DOI 10.1016/S0198-8859(03)00027-2; Monsuur AJ, 2005, NAT GENET, V37, P1341, DOI 10.1038/ng1680; Monteleone G, 2005, GASTROENTEROLOGY, V128, P687, DOI 10.1053/j.gastro.2004.12.042; Nistico L, 2006, GUT, V55, P803, DOI 10.1136/gut.2005.083964; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; SADLACK B, 1993, CELL, V75, P253, DOI 10.1016/0092-8674(93)80067-O; van Heel DA, 2006, GUT, V55, P1037, DOI 10.1136/gut.2005.075119; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958	12	496	509	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2007	39	7					827	829		10.1038/ng2058	http://dx.doi.org/10.1038/ng2058			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17558408	Green Accepted, Green Submitted			2022-12-27	WOS:000247619800009
J	Theodorou, V; Kimm, MA; Boer, M; Wessels, L; Theelen, W; Jonkers, J; Hilkens, J				Theodorou, Vassiliki; Kimm, Melanie A.; Boer, Mandy; Wessels, Lodewyk; Theelen, Wendy; Jonkers, Jos; Hilkens, John			MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer	NATURE GENETICS			English	Article							TUMOR VIRUS; HUMAN BREAST; TUMORIGENESIS; ACTIVATION; EXPRESSION; MICE; PROTOONCOGENES; CARCINOGENESIS; ONCOGENE; KINASE	We performed a high-throughput retroviral insertional mutagenesis screen in mouse mammary tumor virus (MMTV)-induced mammary tumors and identified 33 common insertion sites, of which 17 genes were previously not known to be associated with mammary cancer and 13 had not previously been linked to cancer in general. Although members of the Wnt and fibroblast growth factors ( Fgf) families were frequently tagged, our exhaustive screening for MMTV insertion sites uncovered a new repertoire of candidate breast cancer oncogenes. We validated one of these genes, Rspo3, as an oncogene by overexpression in a p53-deficient mammary epithelial cell line. The human orthologs of the candidate oncogenes were frequently deregulated in human breast cancers and associated with several tumor parameters. Computational analysis of all MMTV-tagged genes uncovered specific gene families not previously associated with cancer and showed a significant overrepresentation of protein domains and signaling pathways mainly associated with development and growth factor signaling. Comparison of all tagged genes in MMTV and Moloney murine leukemia virus - induced malignancies showed that both viruses target mostly different genes that act predominantly in distinct pathways.	Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute	Hilkens, J (corresponding author), Netherlands Canc Inst, Div Mol Genet, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	j.hilkens@nki.nl	Jonkers, Jos/AAG-3246-2019; Theodorou, Vasiliki/GON-4996-2022; Theodorou, Vasiliki/H-1576-2016	Jonkers, Jos/0000-0002-9264-9792; Theodorou, Vasiliki/0000-0003-1614-700X; Hilkens, John/0000-0002-0932-7793				Adams NC, 2002, DEVELOPMENT, V129, P965; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Callahan R, 2000, ONCOGENE, V19, P992, DOI 10.1038/sj.onc.1203276; Ceci JD, 1997, GENE DEV, V11, P688, DOI 10.1101/gad.11.6.688; Chatterjee G, 2002, AM J PATHOL, V161, P2241, DOI 10.1016/S0002-9440(10)64500-2; Chen JZ, 2002, MOL BIOL REP, V29, P287, DOI 10.1023/A:1020479301379; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DEVON RS, 1995, NUCLEIC ACIDS RES, V23, P1644, DOI 10.1093/nar/23.9.1644; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Erny KM, 1996, ONCOGENE, V13, P2015; GALLAHAN D, 1987, J VIROL, V61, P66, DOI 10.1128/JVI.61.1.66-74.1987; Gallahan D, 1997, ONCOGENE, V14, P1883, DOI 10.1038/sj.onc.1201035; HYNES NE, 1980, COLD SPRING HARB SYM, V44, P1161, DOI 10.1101/SQB.1980.044.01.125; Johansson FK, 2004, P NATL ACAD SCI USA, V101, P11334, DOI 10.1073/pnas.0402716101; Jonkers J, 1996, BBA-REV CANCER, V1287, P29, DOI 10.1016/0304-419X(95)00020-G; Kazanskaya O, 2004, DEV CELL, V7, P525, DOI 10.1016/j.devcel.2004.07.019; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; KWAN H, 1992, MOL CELL BIOL, V12, P147, DOI 10.1128/MCB.12.1.147; LAMMIE GA, 1992, ONCOGENE, V7, P2381; LAZO PA, 1990, P NATL ACAD SCI USA, V87, P170, DOI 10.1073/pnas.87.1.170; Liu YJ, 2006, ONCOGENE, V25, P2452, DOI 10.1038/sj.onc.1209287; Lowther W, 2005, J VIROL, V79, P10093, DOI 10.1128/JVI.79.15.10093-10096.2005; MERLO GR, 1993, ANN NY ACAD SCI, V698, P108, DOI 10.1111/j.1749-6632.1993.tb17195.x; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Pavlidis P, 2003, METHODS, V31, P282, DOI 10.1016/S1046-2023(03)00157-9; Payton M, 2002, ONCOGENE, V21, P8529, DOI 10.1038/sj.onc.1206035; PENAULTLLORCA F, 1995, INT J CANCER, V61, P170, DOI 10.1002/ijc.2910610205; PETERS G, 1986, NATURE, V320, P628, DOI 10.1038/320628a0; Prasad V, 2005, CANCER RES, V65, P8655, DOI 10.1158/0008-5472.CAN-05-0026; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Sakatani T, 2005, SCIENCE, V307, P1976, DOI 10.1126/science.1108080; SHACKLEFORD GM, 1993, P NATL ACAD SCI USA, V90, P740, DOI 10.1073/pnas.90.2.740; Sheskin D.J., 1997, HDB PARAMETRIC NONPA; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sourvinos G, 1999, ONCOGENE, V18, P4968, DOI 10.1038/sj.onc.1202891; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takeuchi JK, 2003, DEVELOPMENT, V130, P2729, DOI 10.1242/dev.00474; Theodorou V, 2004, ONCOGENE, V23, P6047, DOI 10.1038/sj.onc.1207816; Tlsty TD, 2001, SEMIN CANCER BIOL, V11, P97, DOI 10.1006/scbi.2000.0361; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Roozendaal CEP, 1998, FEBS LETT, V437, P107, DOI 10.1016/S0014-5793(98)01211-3; VANDERVALK MA, 1981, MAMMARY TUMORS MOUSE, P45; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Zagha E, 2005, J BIOL CHEM, V280, P18853, DOI 10.1074/jbc.M410613200; Zhang SL, 2003, ONCOGENE, V22, P2285, DOI 10.1038/sj.onc.1206257	49	153	164	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2007	39	6					759	769		10.1038/ng2034	http://dx.doi.org/10.1038/ng2034			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17468756				2022-12-27	WOS:000246859100020
J	Haiman, CA; Patterson, N; Freedman, ML; Myers, SR; Pike, MC; Waliszewska, A; Neubauer, J; Tandon, A; Schirmer, C; McDonald, GJ; Greenway, SC; Stram, DO; Le Marchand, L; Kolonel, LN; Frasco, M; Wong, D; Pooler, LC; Ardlie, K; Oakley-Girvan, I; Whittemore, AS; Cooney, KA; John, EM; Ingles, SA; Altshuler, D; Henderson, BE; Reich, D				Haiman, Christopher A.; Patterson, Nick; Freedman, Matthew L.; Myers, Simon R.; Pike, Malcolm C.; Waliszewska, Alicja; Neubauer, Julie; Tandon, Arti; Schirmer, Christine; McDonald, Gavin J.; Greenway, Steven C.; Stram, Daniel O.; Le Marchand, Loic; Kolonel, Laurence N.; Frasco, Melissa; Wong, David; Pooler, Loreall C.; Ardlie, Kristin; Oakley-Girvan, Ingrid; Whittemore, Alice S.; Cooney, Kathleen A.; John, Esther M.; Ingles, Sue A.; Altshuler, David; Henderson, Brian E.; Reich, David			Multiple regions within 8q24 independently affect risk for prostate cancer	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; AFRICAN-AMERICAN MEN; VITAMIN-D-RECEPTOR; POLYMORPHISMS; LOCUS	After the recent discovery that common genetic variation in 8q24 influences inherited risk of prostate cancer, we genotyped 2,973 SNPs in up to 7,518 men with and without prostate cancer from five populations. We identified seven risk variants, five of them previously undescribed, spanning 430 kb and each independently predicting risk for prostate cancer (P = 7.9 x 10(-19) for the strongest association, and P < 1.5 x 10(-4) for five of the variants, after controlling for each of the others). The variants define common genotypes that span a more than fivefold range of susceptibility to cancer in some populations. None of the prostate cancer risk variants aligns to a known gene or alters the coding sequence of an encoded protein.	Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Brigham & Womens Hosp, Ctr Neurol Dis, Lab Mol Immunol, Boston, MA 02115 USA; Univ Hawaii, Canc Res Ctr, Program Epidemiol, Honolulu, HI 96813 USA; Genom Collaborat, Cambridge, MA 02139 USA; No Calif Canc Ctr, Fremont, CA 94538 USA; Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA; Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Urol, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Southern California; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Cancer Research Center of Hawaii; University of Hawaii System; Stanford University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Reich, D (corresponding author), Harvard Univ, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA.	reich@genetics.med.harvard.edu	Greenway, Steven C/S-7777-2019; Myers, Simon R/A-6792-2015; Altshuler, David M/A-4476-2009	Myers, Simon R/0000-0002-2585-9626; Altshuler, David M/0000-0002-7250-4107; Frasco, Melissa/0000-0002-3437-1518; Cooney, Kathleen/0000-0003-3831-6943	NCI NIH HHS [R01 CA063464-09S1, CA54281, CA79596, CA84979, R01 CA084979, CA63464, R01 CA063464, CA67044, R01 CA054281, U01 CA063464, R01 CA079596, R01 CA067044, R37 CA054281, P50 CA069568, CA69568, U01 CA067044] Funding Source: Medline; NHGRI NIH HHS [HG02758, K01 HG002758] Funding Source: Medline; NICHD NIH HHS [HD00850, K12 HD000850] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U01CA063464, R37CA054281, R01CA054281, R01CA067044, P50CA069568, R01CA084979, R01CA079596, U01CA067044, R01CA063464] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [K01HG002758] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Cooney KA, 2001, UROLOGY, V57, P91, DOI 10.1016/S0090-4295(00)00873-6; Cooney KA, 1997, J NATL CANCER I, V89, P955, DOI 10.1093/jnci/89.13.955; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Fan JB, 2003, COLD SPRING HARB SYM, V68, P69, DOI 10.1101/sqb.2003.68.69; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Hosono S, 2003, GENOME RES, V13, P954, DOI 10.1101/gr.816903; John EM, 2005, CANCER RES, V65, P5470, DOI 10.1158/0008-5472.CAN-04-3134; Kataria, 2016, SAUDI J SPORTS MED, V16, P139; Kolonel LN, 2000, AM J EPIDEMIOL, V151, P346, DOI 10.1093/oxfordjournals.aje.a010213; LEE LG, 1993, NUCLEIC ACIDS RES, V21, P3761, DOI 10.1093/nar/21.16.3761; Oakley-Girvan I, 2004, CANCER EPIDEM BIOMAR, V13, P1325; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Tang K, 1999, P NATL ACAD SCI USA, V96, P10016, DOI 10.1073/pnas.96.18.10016; van Duin M, 2005, GENE CHROMOSOME CANC, V44, P438, DOI 10.1002/gcc.20259; VISAKORPI T, 1995, CANCER RES, V55, P342	17	515	550	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2007	39	5					638	644		10.1038/ng2015	http://dx.doi.org/10.1038/ng2015			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17401364	Green Accepted			2022-12-27	WOS:000245971300019
J	Perlstein, EO; Ruderfer, DM; Roberts, DC; Schreiber, SL; Kruglyak, L				Perlstein, Ethan O.; Ruderfer, Douglas M.; Roberts, David C.; Schreiber, Stuart L.; Kruglyak, Leonid			Genetic basis of individual differences in the response to small-molecule drugs in yeast	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCUS; SACCHAROMYCES-CEREVISIAE; CELL-LINES; PHOSPHATE TRANSPORTER; CANCER; POLYMORPHISMS; CYTOTOXICITY; EXPRESSION; RESISTANCE; DISCOVERY	Individual response to small-molecule drugs is variable; a drug that provides a cure for some may confer no therapeutic benefit or trigger an adverse reaction in others. To begin to understand such differences systematically, we treated 104 genotyped segregants from a cross between two yeast strains with a collection of 100 diverse small molecules. We used linkage analysis to identify 124 distinct linkages between genetic markers and response to 83 compounds. The linked markers clustered at eight genomic locations, or quantitative-trait locus 'hotspots', that contain one or more polymorphisms that affect response to multiple small molecules. We also experimentally verified that a deficiency in leucine biosynthesis caused by a deletion of LEU2 underlies sensitivity to niguldipine, which is structurally related to therapeutic calcium channel blockers, and that a natural coding-region polymorphism in the inorganic phosphate transporter PHO84 underlies sensitivity to two polychlorinated phenols that uncouple oxidative phosphorylation. Our results provide a step toward a systematic understanding of small-molecule drug action in genetically distinct individuals.	Harvard Univ, Broad Inst, Howard Hughes Med Inst, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; Los Alamos Natl Lab, Theoret Div, Los Alamos, NM 87544 USA; Los Alamos Natl Lab, Ctr Nonlinear Studies, Los Alamos, NM 87544 USA; Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Princeton University; Princeton University; United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; Harvard University	Schreiber, SL (corresponding author), Harvard Univ, Broad Inst, Howard Hughes Med Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	stuart_schreiber@harvard.edu; leonid@genomics.princeton.edu	Ruderfer, Douglas M/M-5795-2016	Ruderfer, Douglas M/0000-0002-2365-386X; Perlstein, Ethan/0000-0002-4734-4391	NIGMS NIH HHS [P50GM071508] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BENARI G, 2006, IN PRESS PLOS GENET; Bolster DR, 2004, J NUTR, V134, P1704, DOI 10.1093/jn/134.7.1704; Borisy AA, 2003, P NATL ACAD SCI USA, V100, P7977, DOI 10.1073/pnas.1337088100; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; BUNYA M, 1991, MOL CELL BIOL, V11, P3229, DOI 10.1128/MCB.11.6.3229; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Cordes FS, 2002, J MOL BIOL, V323, P951, DOI 10.1016/S0022-2836(02)01006-9; Deutschbauer AM, 2005, NAT GENET, V37, P1333, DOI 10.1038/ng1674; Dolan ME, 2004, CANCER RES, V64, P4353, DOI 10.1158/0008-5472.CAN-04-0340; FOGEL S, 1988, J BASIC MICROB, V28, P147, DOI 10.1002/jobm.3620280302; Foury F, 1997, GENE, V195, P1, DOI 10.1016/S0378-1119(97)00140-6; Hohmann S, 2005, CURR OPIN BIOTECH, V16, P356, DOI 10.1016/j.copbio.2005.04.006; Jensen LT, 2003, J BIOL CHEM, V278, P42036, DOI 10.1074/jbc.M307413200; Le Morvan V, 2006, PHARMACOGENOMICS, V7, P843, DOI 10.2217/14622416.7.6.843; MARO B, 1982, EMBO J, V1, P1347, DOI 10.1002/j.1460-2075.1982.tb01321.x; Marton MJ, 1997, MOL CELL BIOL, V17, P4474, DOI 10.1128/MCB.17.8.4474; Moisan F, 2006, BRIT J CANCER, V95, P906, DOI 10.1038/sj.bjc.6603361; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Ooi SL, 2006, TRENDS GENET, V22, P56, DOI 10.1016/j.tig.2005.11.003; Outeiro Tiago Fleming, 2006, Biotechnology Journal, V1, P258, DOI 10.1002/biot.200500043; Perlstein EO, 2006, CHEM BIOL, V13, P319, DOI 10.1016/j.chembiol.2006.01.010; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Ruderfer DM, 2006, NAT GENET, V38, P1077, DOI 10.1038/ng1859; Shukla SJ, 2005, PHARMACOGENOMICS, V6, P303, DOI 10.1517/14622416.6.3.303; Sinha H, 2006, PLOS GENET, V2, P140, DOI 10.1371/journal.pgen.0020013; SOMERVILLE L, 1986, XENOBIOTICA, V16, P1017, DOI 10.3109/00498258609038980; Staunton JE, 2001, P NATL ACAD SCI USA, V98, P10787, DOI 10.1073/pnas.191368598; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Stoehlmacher J, 2004, BRIT J CANCER, V91, P344, DOI 10.1038/sj.bjc.6601975; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; Tamura KI, 2004, J BIOSCI BIOENG, V98, P159, DOI 10.1016/S1389-1723(04)00260-9; Tenreiro S, 2002, BIOCHEM BIOPH RES CO, V292, P741, DOI 10.1006/bbrc.2002.6703; Thomas MR, 2005, P NATL ACAD SCI USA, V102, P9565, DOI 10.1073/pnas.0501122102; Urban TJ, 2006, GENOME RES, V16, P223, DOI 10.1101/gr.4356206; Watters JW, 2004, P NATL ACAD SCI USA, V101, P11809, DOI 10.1073/pnas.0404580101; WEINBACH EUGENE C., 1957, PROC NATL ACAD SCI, V43, P393, DOI 10.1073/pnas.43.5.393; Weinstein JN, 1997, SCIENCE, V275, P343, DOI 10.1126/science.275.5298.343; Yarosh DB, 2005, BIOMARKERS, V10, P188, DOI 10.1080/13547500500138732; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zhou XF, 2005, DRUG METAB DISPOS, V33, P1220, DOI 10.1124/dmd.104.003558	45	88	93	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2007	39	4					496	502		10.1038/ng1991	http://dx.doi.org/10.1038/ng1991			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17334364				2022-12-27	WOS:000245271200019
J	Szatmari, P; Paterson, AD; Zwaigenbaum, L; Roberts, W; Brian, J; Liu, XQ; Vincent, JB; Skaug, JL; Thompson, AP; Senman, L; Feuk, L; Qian, C; Bryson, SE; Jones, MB; Marshall, CR; Scherer, SW; Vieland, VJ; Bartlett, C; Mangin, LV; Goedken, R; Segre, A; Pericak-Vance, MA; Cuccaro, ML; Gilbert, JR; Wright, HH; Abramson, RK; Betancur, C; Bourgeron, T; Gillberg, C; Leboyer, M; Buxbaum, JD; Davis, KL; Hollander, E; Silverman, JM; Hallmayer, J; Lotspeich, L; Sutcliffe, JS; Haines, JL; Folstein, SE; Piven, J; Wassink, TH; Sheffield, V; Geschwind, DH; Bucan, M; Brown, WT; Cantor, RM; Constantino, JN; Gilliam, TC; Herbert, M; LaJonchere, C; Ledbetter, DH; Lese-Martin, C; Miller, J; Nelson, S; Samango-Sprouse, CA; Spence, S; State, M; Tanzi, RE; Coon, H; Dawson, G; Devlin, B; Estes, A; Flodman, P; Klei, L; McMahon, WM; Minshew, N; Munson, J; Korvatska, E; Rodier, PM; Schellenberg, GD; Smith, M; Spence, MA; Stodgell, C; Tepper, PG; Wijsman, EM; Yu, CE; Roge, B; Mantoulan, C; Wittemeyer, K; Poustka, A; Felder, B; Klauck, SM; Schuster, C; Poustka, F; Bolte, S; Feineis-Matthews, S; Herbrecht, E; Schmotzer, G; Tsiantis, J; Papanikolaou, K; Maestrini, E; Bacchelli, E; Blasi, F; Carone, S; Toma, C; Van Engeland, H; de Jonge, M; Kemner, C; Koop, F; Langemeijer, M; Hijimans, C; Staal, WG; Baird, G; Bolton, PF; Rutter, ML; Weisblatt, E; Green, J; Aldred, C; Wilkinson, JA; Pickles, A; Le Couteur, A; Berney, T; McConachie, H; Bailey, AJ; Francis, K; Honeyman, G; Hutchinson, A; Parr, JR; Wallace, S; Monaco, AP; Barnby, G; Kobayashi, K; Lamb, JA; Sousa, I; Sykes, N; Cook, EH; Guter, SJ; Leventhal, BL; Salt, J; Lord, C; Corsello, C; Hus, V; Weeks, DE; Volkmar, F; Tauber, M; Fombonne, E; Shih, A				Szatmari, Peter; Paterson, Andrew D.; Zwaigenbaum, Lonnie; Roberts, Wendy; Brian, Jessica; Liu, Xiao-Qing; Vincent, John B.; Skaug, Jennifer L.; Thompson, Ann P.; Senman, Lili; Feuk, Lars; Qian, Cheng; Bryson, Susan E.; Jones, Marshall B.; Marshall, Christian R.; Scherer, Stephen W.; Vieland, Veronica J.; Bartlett, Christopher; Mangin, La Vonne; Goedken, Rhinda; Segre, Alberto; Pericak-Vance, Margaret A.; Cuccaro, Michael L.; Gilbert, John R.; Wright, Harry H.; Abramson, Ruth K.; Betancur, Catalina; Bourgeron, Thomas; Gillberg, Christopher; Leboyer, Marion; Buxbaum, Joseph D.; Davis, Kenneth L.; Hollander, Eric; Silverman, Jeremy M.; Hallmayer, Joachim; Lotspeich, Linda; Sutcliffe, James S.; Haines, Jonathan L.; Folstein, Susan E.; Piven, Joseph; Wassink, Thomas H.; Sheffield, Val; Geschwind, Daniel H.; Bucan, Maja; Brown, W. Ted; Cantor, Rita M.; Constantino, John N.; Gilliam, T. Conrad; Herbert, Martha; LaJonchere, Clara; Ledbetter, David H.; Lese-Martin, Christa; Miller, Janet; Nelson, Stan; Samango-Sprouse, Carol A.; Spence, Sarah; State, Matthew; Tanzi, Rudolph E.; Coon, Hilary; Dawson, Geraldine; Devlin, Bernie; Estes, Annette; Flodman, Pamela; Klei, Lambertus; McMahon, William M.; Minshew, Nancy; Munson, Jeff; Korvatska, Elena; Rodier, Patricia M.; Schellenberg, Gerard D.; Smith, Moyra; Spence, M. Anne; Stodgell, Chris; Tepper, Ping Guo; Wijsman, Ellen M.; Yu, Chang-En; Roge, Bernadette; Mantoulan, Carine; Wittemeyer, Kerstin; Poustka, Annemarie; Felder, Barbel; Klauck, Sabine M.; Schuster, Claudia; Poustka, Fritz; Boelte, Sven; Feineis-Matthews, Sabine; Herbrecht, Evelyn; Schmoetzer, Gabi; Tsiantis, John; Papanikolaou, Katerina; Maestrini, Elena; Bacchelli, Elena; Blasi, Francesca; Carone, Simona; Toma, Claudio; Van Engeland, Herman; de Jonge, Maretha; Kemner, Chantal; Koop, Frederike; Langemeijer, Marjolijn; Hijimans, Channa; Staal, Wouter G.; Baird, Gillian; Bolton, Patrick F.; Rutter, Michael L.; Weisblatt, Emma; Green, Jonathan; Aldred, Catherine; Wilkinson, Julie-Anne; Pickles, Andrew; Le Couteur, Ann; Berney, Tom; McConachie, Helen; Bailey, Anthony J.; Francis, Kostas; Honeyman, Gemma; Hutchinson, Aislinn; Parr, Jeremy R.; Wallace, Simon; Monaco, Anthony P.; Barnby, Gabrielle; Kobayashi, Kazuhiro; Lamb, Janine A.; Sousa, Ines; Sykes, Nuala; Cook, Edwin H.; Guter, Stephen J.; Leventhal, Bennett L.; Salt, Jeff; Lord, Catherine; Corsello, Christina; Hus, Vanessa; Weeks, Daniel E.; Volkmar, Fred; Tauber, Maite; Fombonne, Eric; Shih, Andy			Mapping autism risk loci using genetic linkage and chromosomal rearrangements	NATURE GENETICS			English	Article							GLUTAMATE; NEUROLIGINS; DISORDERS; DISSECTION; MUTATIONS; FREQUENCY; PROGRAM; NLGN4; TWIN	Autism spectrum disorders (ASDs) are common, heritable neurodevelopmental conditions. The genetic architecture of ASDs is complex, requiring large samples to overcome heterogeneity. Here we broaden coverage and sample size relative to other studies of ASDs by using Affymetrix 10K SNP arrays and 1,168 families with at least two affected individuals, performing the largest linkage scan to date while also analyzing copy number variation in these families. Linkage and copy number variation analyses implicate chromosome 11p12-p13 and neurexins, respectively, among other candidate loci. Neurexins team with previously implicated neuroligins for glutamatergic synaptogenesis, highlighting glutamate-related genes as promising candidates for contributing to ASDs.	McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON L8N 3Z5, Canada; Hosp Sick Children, Ctr Appl Genom, Toronto, ON M5G 1X8, Canada; Hosp Sick Children, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; McMaster Univ, Dept Pediat, Hamilton, ON L8N 3Z5, Canada; Hosp Sick Children, Autism Res Unit, Toronto, ON M5G 1X8, Canada; Univ Toronto, Clarke Inst, Ctr Addist & Mental Hlth, Toronto, ON M5G 1X8, Canada; Univ Toronto, Clarke Inst, Dept Psychiat, Toronto, ON M5G 1X8, Canada; Dalhousie Univ, Izaak Walton Killam Hlth Ctr, Dept Pediat, Halifax, NS B3K 6R8, Canada; Dalhousie Univ, Izaak Walton Killam Hlth Ctr, Dept Psychol, Halifax, NS B3K 6R8, Canada; Penn State Univ, Coll Med, Dept Neural & Behav Sci, Hershey, PA 17033 USA; Columbus Childrens Res Inst, Ctr Quantitat & Computat Biol, Columbus, OH 43205 USA; Univ Iowa, Dept Comp Sci, Iowa City, IA 52242 USA; Univ Miami, Miller Sch Med, Inst Human Genet, Miami, FL 33101 USA; Univ S Carolina, Columbia, SC 29208 USA; Univ Paris 12, INSERM, U513, F-94000 Creteil, France; Inst Pasteur, F-75013 Paris, France; Univ Gothenburg, Dept Child & Adolescent Psychiat, S-41119 Gothenburg, Sweden; Grp Hosp Henri Mondor Albert Chenevier, APHP, Dept Psychiat, F-94000 Creteil, France; Mt Sinai Sch Med, Seaver Autism Res Ctr, Dept Psychiat, New York, NY 10029 USA; Mt Sinai Sch Med, Greater New York Autism Ctr Excellence, Dept Psychiat, New York, NY 10029 USA; Stanford Univ, Dept Psychiat, Palo Alto, CA 94304 USA; Vanderbilt Univ, Ctr Mol Neurosci, Nashville, TN 37232 USA; Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37232 USA; Johns Hopkins Univ, Dept Psychiat, Baltimore, MD 21287 USA; Univ N Carolina, Chapel Hill, NC 27599 USA; Univ Iowa, Iowa City, IA 52242 USA; Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90095 USA; Univ Penn, Philadelphia, PA 19104 USA; New York State Inst Basic Res Dev Disabil, Staten Isl, NY 10314 USA; Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; Washington Univ, Sch Med, St Louis, MO 63130 USA; Univ Chicago, Chicago, IL 60637 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; Cure Autism Now, Los Angeles, CA 90036 USA; Emory Univ, Atlanta, GA 30322 USA; George Washington Univ, Washington, DC 20052 USA; Univ Calif Los Angeles, Los Angeles, CA 90095 USA; Yale Univ, Ctr Child Study, New Haven, CT 06520 USA; Massachusetts Gen Hosp, Boston, MA 02114 USA; Univ Utah, Sch Med, Dept Psychiat, Salt Lake City, UT 84112 USA; Univ Washington, Dept Psychol, Seattle, WA 98195 USA; Univ Washington, Ctr Human Dev & Disabil, Seattle, WA 98195 USA; Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA 15213 USA; Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA; Pugent Sound VA Hlth Care Syst, Ctr Geriatr Res Educ & Clin, Seattle, WA 98108 USA; Univ Washington, Dept Med, Seattle, WA 98104 USA; Univ Rochester, Med Ctr, Dept OB GYN, Rochester, NY 14642 USA; Univ Washington, Dept Neurol, Seattle, WA 98195 USA; Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; Univ Washington, Dept Biostat, Seattle, WA 98195 USA; Univ Toulouse Le Mirail, Ctr Etud & Rech Psychopathol, CERPP, F-31058 Toulouse, France; Deutsch Krebsforschungszentrum, Div Mol Genome Anal, DKFZ, D-69120 Heidelberg, Germany; Goethe Univ Frankfurt, Klin Psychiat & Psychotherapy Kindes & Jugendalte, D-60528 Frankfurt, Germany; Univ Athens, Aghia Sophia Childrens Hosp, Dept Child Psychiat, Athens 11526, Greece; Univ Bologna, Dept Biol, I-40126 Bologna, Italy; Univ Utrecht, Med Ctr, Dept Child & Adolescent Psychiat, NL-3508 GA Utrecht, Netherlands; Guys Hosp, Newcomen Ctr, London SE1 9RT, England; Inst Psychiat, Dept Child & Adolescent Psychiat, London, England; SGDP, Inst Psychiat, London SE5 8AF, England; Univ Cambridge, Sch Clin, Cambridge CB2 2AH, England; Univ Manchester, Booth Hall Childrens Hosp, Dept Child Psychiat, Manchester M9 7AA, Lancs, England; Univ Manchester, Sch Epidemiol & Hlth Sci, Manchester M13 9P, Lancs, England; Univ Newcastle, Sir James Space Inst, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Univ Oxford, Dept Psychiat, Oxford OX3 7LQ, England; Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Illinois, Inst Juvenile Res, Dept Psychiat, Chicago, IL 60608 USA; Univ Michigan, Autism & Communicat Disorders Ctr, UMACC, Ann Arbor, MI 48109 USA; Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA 15213 USA; CHU Toulouse, Serv Pediat & Genet Med, Toulouse, France; McGill Univ, Montreal Childrens Hosp, Montreal, PQ H3H 1P3, Canada; Autism Speeks, New York, NY 10016 USA	McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; Dalhousie University; Dalhousie University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University System of Ohio; Ohio State University; University of Iowa; University of Miami; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Gothenburg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Stanford University; Vanderbilt University; Vanderbilt University; Johns Hopkins University; University of North Carolina; University of North Carolina Chapel Hill; University of Iowa; University of California System; University of California Los Angeles; University of Pennsylvania; Institute for Basic Research in Developmental Disabilities; University of California System; University of California Los Angeles; Washington University (WUSTL); University of Chicago; Harvard University; Harvard Medical School; Emory University; George Washington University; University of California System; University of California Los Angeles; Yale University; Harvard University; Massachusetts General Hospital; Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Irvine; Geriatric Research Education & Clinical Center; University of Washington; University of Washington Seattle; University of Rochester; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Universite de Toulouse; Universite de Toulouse - Jean Jaures; Helmholtz Association; German Cancer Research Center (DKFZ); Goethe University Frankfurt; National & Kapodistrian University of Athens; The Aghia Sophia Children's Hospital; University of Bologna; Utrecht University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; King's College London; University of Cambridge; Royal Manchester Children's Hospital; University of Manchester; University of Manchester; Newcastle University - UK; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Michigan System; University of Michigan; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; CHU de Toulouse; McGill University	Scherer, SW (corresponding author), McMaster Univ, Dept Psychiat & Behav Neurosci, Hamilton, ON L8N 3Z5, Canada.	swscherer@sickkids.ca; devlinbj@upmc.edu	State, Matthew/W-2256-2019; Bartlett, Christopher/AAD-8813-2022; Buxbaum, Joseph D/G-6001-2010; bacchelli, elena/R-3675-2016; Warfield, Simon/B-3352-2009; De Jonge, Maretha V/F-4942-2013; Staal, W.G./L-4665-2015; Volkmar, Fred/AEB-0666-2022; Weeks, Daniel E/B-2995-2012; Rutter, Michael/C-8570-2013; Bal, Vanessa Hus/AAN-2381-2020; Segre, Alberto M/B-1734-2009; Monaco, Anthony P/A-4495-2010; Tanzi, Rudolph/AAE-9622-2019; Kobayashi, Kazuhiro/AAH-8638-2021; Toma, Claudio/L-7853-2014; Bailey, Anthony/J-2860-2014; Stodgell, Christopher/A-1161-2007; Nelson, Stanley F/D-4771-2009; Staal, Wouter G/A-3099-2013; Sutcliffe, James S/C-1348-2012; Maestrini, Elena/K-7508-2012; Paterson, Andrew D/A-4088-2011; Scherer, Stephen W./B-3785-2013; Betancur, Catalina/K-3791-2017; Fombonne, Eric/M-4893-2018; Brown, William/GXN-2777-2022; Pickles, Andrew/A-9625-2011; Bartlett, Christopher/B-4958-2009; Haines, Jonathan/C-3374-2012; Bölte, Sven/AAH-8675-2019; Paterson, Andrew/AAQ-7511-2020; Leboyer, Marion/AAW-3648-2021; Papanikolaou, Katerina/AAB-4771-2020; Silverman, Jeremy M./AAO-4268-2020	Bartlett, Christopher/0000-0001-7837-6348; bacchelli, elena/0000-0001-8800-9568; Warfield, Simon/0000-0002-7659-3880; Weeks, Daniel E/0000-0001-9410-7228; Bal, Vanessa Hus/0000-0003-0750-823X; Monaco, Anthony P/0000-0001-7480-3197; Tanzi, Rudolph/0000-0002-7032-1454; Kobayashi, Kazuhiro/0000-0001-7801-147X; Toma, Claudio/0000-0003-3901-7507; Bailey, Anthony/0000-0003-4257-972X; Nelson, Stanley F/0000-0002-2082-3114; Sutcliffe, James S/0000-0001-5200-6007; Maestrini, Elena/0000-0001-5924-3179; Paterson, Andrew D/0000-0002-9169-118X; Scherer, Stephen W./0000-0002-8326-1999; Betancur, Catalina/0000-0002-3327-4804; Fombonne, Eric/0000-0002-8605-3538; Pickles, Andrew/0000-0003-1283-0346; Bartlett, Christopher/0000-0001-7837-6348; Haines, Jonathan/0000-0002-4351-4728; Bölte, Sven/0000-0002-4579-4970; Paterson, Andrew/0000-0002-9169-118X; Leboyer, Marion/0000-0001-5473-3697; Sheffield, Val/0000-0002-6282-0835; Girao Meireles de Sousa, Ines/0000-0001-6983-8870; Bourgeron, Thomas/0000-0001-8164-9220; Buxbaum, Joseph/0000-0001-8898-8313; Simpson, Nuala/0000-0003-3390-9993; State, Matthew/0000-0003-1624-8302; Liu, Xiao-Qing/0000-0002-4034-5156; Lamb, Janine/0000-0002-7248-0539; Wassink, Thomas/0000-0002-0952-8333; Stodgell, Christopher/0000-0002-1666-5299; Green, Andrew/0000-0002-1077-7417; Wijsman, Ellen/0000-0002-2725-6669; Dawson, Geraldine/0000-0003-1410-2764; Estes, Annette/0000-0003-2687-4155; Rutter, Michael Llewellyn/0000-0003-1577-7405; Guter, Stephen/0000-0002-4476-2045; Green, Jonathan/0000-0002-0143-181X	MRC [G0601030] Funding Source: UKRI; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD055784] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U19HD035482, U19HD035476] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000064, M01RR006022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061009, U54MH066673, K02MH001389, R01MH093725, R01MH057881, R37MH057881, R01MH055135, R01MH081754, R01MH052708, R01MH064547, R10MH055135, K05MH001196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS026630, R01NS043550, R01NS049261, R01NS042165] Funding Source: NIH RePORTER; Medical Research Council [G0601030] Funding Source: Medline; NCRR NIH HHS [M01 RR000064, M01 RR06022, M01-RR00064, M01 RR006022] Funding Source: Medline; NICHD NIH HHS [U19 HD035476, U19HD34565, 5 U19 HD035476, P50 HD055784, U19 HD35482, U19 HD035482] Funding Source: Medline; NIMH NIH HHS [U54 MH066673, U54 MH066673-020001, R01 MH081754, R01 MH064547, MH52708, K02 MH01389, MH061009, MH64547, R01 MH057881, R01 MH061009, K05 MH01196, R01 MH093725, MH057881, R37 MH057881, MH066673, MH55135] Funding Source: Medline; NINDS NIH HHS [R01 NS049261, R01 NS042165, NS042165, NS026630, P01 NS026630, NS043550, NS036738, R01 NS043550, NS049261] Funding Source: Medline; Telethon [GGP030227] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Autism Speaks [AS1489] Funding Source: Medline; Fondazione Telethon Funding Source: Custom	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Telethon(Fondazione Telethon); Wellcome Trust(Wellcome Trust); Autism Speaks; Fondazione Telethon(Fondazione Telethon)		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; *AM PSYCHOL ASS, 1994, DIAGN STAT MAN MENT; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; Belmonte MK, 2006, NAT NEUROSCI, V9, P1221, DOI 10.1038/nn1765; Camp NJ, 2001, ANN HUM GENET, V65, P577, DOI [10.1046/j.1469-1809.2001.6560577.x, 10.1017/S0003480001008922]; Chakrabarti S, 2005, AM J PSYCHIAT, V162, P1133, DOI 10.1176/appi.ajp.162.6.1133; Chubykin AA, 2005, J BIOL CHEM, V280, P22365, DOI 10.1074/jbc.M410723200; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; FALCONER DS, 2006, INTRO QUANTITATIVE G, V38, P904; Feng JN, 2006, NEUROSCI LETT, V409, P10, DOI 10.1016/j.neulet.2006.08.017; Freitag CM, 2007, MOL PSYCHIATR, V12, P2, DOI 10.1038/sj.mp.4001896; Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hallmayer J, 2002, AM J HUM GENET, V71, P941, DOI 10.1086/342990; Houlden H, 2006, NEUROMOL MED, V8, P43, DOI 10.1385/NMM:8:1:43; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jalil MA, 2005, J BIOL CHEM, V280, P31333, DOI 10.1074/jbc.M505286200; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; JONES MB, 1988, J AUTISM DEV DISORD, V18, P31, DOI 10.1007/BF02211816; Kong X, 2004, AM J HUM GENET, V75, P1143, DOI 10.1086/426405; Kugler P, 2004, HIPPOCAMPUS, V14, P975, DOI 10.1002/hipo.20015; Lamb JA, 2005, J MED GENET, V42, P132, DOI 10.1136/jmg.2004.025668; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; Lange C, 2002, GENET EPIDEMIOL, V23, P165, DOI 10.1002/gepi.209; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; LI C, 2001, ANAL GENE EXPRESSION; McPeek MS, 2004, BIOMETRICS, V60, P359; McQueen MB, 2006, AM J HUM GENET, V78, P914, DOI 10.1086/503920; Moog U, 2004, GENET COUNSEL, V15, P73; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; PICKLES A, 1995, AM J HUM GENET, V57, P717; Piven J, 2001, AM J MED GENET, V105, P34, DOI 10.1002/1096-8628(20010108)105:1<34::AID-AJMG1052>3.0.CO;2-D; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell AE, 2001, NEUROLOGY, V57, P1618, DOI 10.1212/WNL.57.9.1618; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rinaldo A, 2005, GENET EPIDEMIOL, V28, P193, DOI 10.1002/gepi.20056; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; Risi S, 2006, J AM ACAD CHILD PSY, V45, P1094, DOI 10.1097/01.chi.0000227880.42780.0e; RITVO ER, 1989, AM J PSYCHIAT, V146, P194; Schellenberg GD, 2006, MOL PSYCHIATR, V11, P1049, DOI 10.1038/sj.mp.4001874; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shinohe A, 2006, PROG NEURO-PSYCHOPH, V30, P1472, DOI 10.1016/j.pnpbp.2006.06.013; Stone JL, 2004, AM J HUM GENET, V75, P1117, DOI 10.1086/426034; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003; Veenstra-VanderWeele J, 2004, ANNU REV GENOM HUM G, V5, P379, DOI 10.1146/annurev.genom.5.061903.180050; Xu Jie, 2004, Current Genomics, V5, P347, DOI 10.2174/1389202043349246	50	1032	1070	0	162	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2007	39	3					319	328		10.1038/ng1985	http://dx.doi.org/10.1038/ng1985			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17322880	Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000244480000013
J	Flynt, AS; Li, N; Thatcher, EJ; Solnica-Krezel, L; Patton, JG				Flynt, Alex S.; Li, Nan; Thatcher, Elizabeth J.; Solnica-Krezel, Lilianna; Patton, James G.			Zebrafish miR-214 modulates Hedgehog signaling to specify muscle cell fate	NATURE GENETICS			English	Article							FLOOR PLATE; EXPRESSION; EMBRYO; GENE; SPECIFICATION; MORPHOGENESIS; INDUCTION; MICRORNAS	Numerous microRNAs ( miRNAs) have been discovered in the genomes of higher eukaryotes, and functional studies indicate that they are important during development. However, little is known concerning the function of individual miRNAs. We approached this problem in zebrafish by combining identification of miRNA expression, functional analyses and experimental validation of potential targets. We show that miR-214 is expressed during early segmentation stages in somites and that varying its expression alters the expression of genes regulated by Hedgehog signaling. Inhibition of miR-214 results in a reduction or loss of slow-muscle cell types. We show that su(fu) mRNA, encoding a negative regulator of Hedgehog signaling, is targeted by miR-214. Through regulation of su( fu), miR-214 enables precise specification of muscle cell types by sharpening cellular responses to Hedgehog.	Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	Vanderbilt University	Patton, JG (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	james.g.patton@vanderbilt.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075790, T32GM008554] Funding Source: NIH RePORTER; NICHD NIH HHS [T32 HD007502] Funding Source: Medline; NIGMS NIH HHS [R01 GM075790-01, GM 075790, T32 GM008554, R01 GM075790, T32 GM 008554, R01 GM075790-02] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barnfield PC, 2005, DIFFERENTIATION, V73, P397, DOI 10.1111/j.1432-0436.2005.00042.x; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Dunaeva M, 2003, J BIOL CHEM, V278, P5116, DOI 10.1074/jbc.M209492200; Feng XS, 2006, DEV BIOL, V300, P736, DOI 10.1016/j.ydbio.2006.08.056; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Henry CA, 2004, DEV CELL, V7, P917, DOI 10.1016/j.devcel.2004.09.017; Ingham PW, 2005, EXP CELL RES, V306, P336, DOI 10.1016/j.yexcr.2005.03.019; Koudijs MJ, 2005, PLOS GENET, V1, P223, DOI 10.1371/journal.pgen.0010019; Lewis KE, 1999, DEV BIOL, V216, P469, DOI 10.1006/dbio.1999.9519; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Park HC, 2004, DEVELOPMENT, V131, P5959, DOI 10.1242/dev.01456; Roy S, 2001, GENE DEV, V15, P1563, DOI 10.1101/gad.195801; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Schaffer M, 2005, MECH DEVELOP, V122, P43, DOI 10.1016/j.mod.2004.09.002; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Sernpere LF, 2003, DEV BIOL, V259, P9, DOI 10.1016/S0012-1606(03)00208-2; THISSE C, 1993, DEVELOPMENT, V119, P1203; Topczewska JM, 2001, GENE DEV, V15, P2483, DOI 10.1101/gad.907401; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5	22	252	285	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					259	263		10.1038/ng1953	http://dx.doi.org/10.1038/ng1953			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17220889	Green Accepted			2022-12-27	WOS:000244063900026
J	Widschwendter, M; Fiegl, H; Egle, D; Mueller-Holzner, E; Spizzo, G; Marth, C; Weisenberger, DJ; Campan, M; Young, J; Jacobs, I; Laird, PW				Widschwendter, Martin; Fiegl, Heidi; Egle, Daniel; Mueller-Holzner, Elisabeth; Spizzo, Gilbert; Marth, Christian; Weisenberger, Daniel J.; Campan, Mihaela; Young, Joanne; Jacobs, Ian; Laird, Peter W.			Epigenetic stem cell signature in cancer	NATURE GENETICS			English	Article							PROMOTER METHYLATION; POLYCOMB; GENOME; HYPERMETHYLATION; BIOLOGY; ORIGIN	Embryonic stem cells rely on Polycomb group proteins to reversibly repress genes required for differentiation. We report that stem cell Polycomb group targets are up to 12-fold more likely to have cancer- specific promoter DNA hypermethylation than non-targets, supporting a stem cell origin of cancer in which reversible gene repression is replaced by permanent silencing, locking the cell into a perpetual state of self-renewal and thereby predisposing to subsequent malignant transformation.	Univ So Calif, Norris Comprehens Canc Ctr, Dept Surg, Los Angeles, CA 90033 USA; Univ So Calif, Norris Comprehens Canc Ctr, Dept Biochem, Los Angeles, CA USA; Univ So Calif, Norris Comprehens Canc Ctr, Dept Biol Mol, Los Angeles, CA USA; UCL, Inst Womens Hlth, Dept Gynecol Oncol, London WC1E 6DH, England; Innsbruck Med Univ, Dept Obstet & Gynecol, Innsbruck, Austria; Innsbruck Med Univ, Dept Internal Med, Innsbruck, Austria; Queensland Inst Med Res, Mol Canc Epidemiol Lab, Brisbane, Qld 4006, Australia	University of Southern California; University of Southern California; University of Southern California; University of London; University College London; Medical University of Innsbruck; Medical University of Innsbruck; QIMR Berghofer Medical Research Institute	Laird, PW (corresponding author), Univ So Calif, Norris Comprehens Canc Ctr, Dept Surg, Los Angeles, CA 90033 USA.	M.Widschwendter@ucl.ac.uk; plaird@usc.edu	Spizzo, Gilbert/Q-6707-2016; Young, Joanne P/B-9981-2011; Laird, Peter W/G-8683-2012; Weisenberger, Daniel/AAA-8314-2020; Young, Joanne P/H-7774-2014; Fiegl, Heidi/K-4445-2017	Laird, Peter W/0000-0001-9117-3641; Weisenberger, Daniel/0000-0001-8303-2603; Fiegl, Heidi/0000-0002-1236-6806; Young, Joanne/0000-0002-1514-1522; Widschwendter, Martin/0000-0002-7778-8380; Spizzo, Gilbert/0000-0003-4121-0146; Jacobs, Ian/0000-0002-5005-2672	NCI NIH HHS [R01 CA096958, R01 CA001815, R01 CA075090] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA075090, R01CA096958, R01CA001815] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Eads CA, 2000, CANCER RES, V60, P5021; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Hatada I, 2006, ONCOGENE, V25, P3059, DOI 10.1038/sj.onc.1209331; HOUGHTON J, 2006, SEMIN CANCER BIOL, DOI DOI 10.1016/J.SEMICANCER.2006.04.003; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Passegue E, 2006, NATURE, V442, P754, DOI 10.1038/442754a; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Schuebel K, 2006, NAT GENET, V38, P738, DOI 10.1038/ng0706-738; Shen LL, 2005, JNCI-J NATL CANCER I, V97, P1330, DOI 10.1093/jnci/dji275; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834	15	808	846	2	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					157	158		10.1038/ng1941	http://dx.doi.org/10.1038/ng1941			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17200673				2022-12-27	WOS:000244063900010
J	Hinkes, B; Wiggins, RC; Gbadegesin, R; Vlangos, CN; Seelow, D; Nurnberg, G; Garg, P; Verma, R; Chaib, H; Hoskins, BE; Ashraf, S; Becker, C; Hennies, HC; Goyal, M; Wharram, BL; Schachter, AD; Mudumana, S; Drummond, I; Kerjaschki, D; Waldherr, R; Dietrich, A; Ozaltin, F; Bakkaloglu, A; Cleper, R; Basel-Vanagaite, L; Pohl, M; Griebel, M; Tsygin, AN; Soylu, A; Muller, D; Sorli, CS; Bunney, TD; Katan, M; Liu, JH; Attanasio, M; O'Toole, JF; Hasselbacher, K; Mucha, B; Otto, EA; Airik, R; Kispert, A; Kelley, GG; Smrcka, AV; Gudermann, T; Holzman, LB; Nurnberg, P; Hildebrandt, F				Hinkes, Bernward; Wiggins, Roger C.; Gbadegesin, Rasheed; Vlangos, Christopher N.; Seelow, Dominik; Nuernberg, Gudrun; Garg, Puneet; Verma, Rakesh; Chaib, Hassan; Hoskins, Bethan E.; Ashraf, Shazia; Becker, Christian; Hennies, Hans Christian; Goyal, Meera; Wharram, Bryan L.; Schachter, Asher D.; Mudumana, Sudha; Drummond, Iain; Kerjaschki, Dontscho; Waldherr, Ruediger; Dietrich, Alexander; Ozaltin, Fatih; Bakkaloglu, Aysin; Cleper, Roxana; Basel-Vanagaite, Lina; Pohl, Martin; Griebel, Martin; Tsygin, Alexey N.; Soylu, Alper; Mueller, Dominik; Sorli, Caroline S.; Bunney, Tom D.; Katan, Matilda; Liu, Jinhong; Attanasio, Massimo; O'Toole, John F.; Hasselbacher, Katrin; Mucha, Bettina; Otto, Edgar A.; Airik, Rannar; Kispert, Andreas; Kelley, Grant G.; Smrcka, Alan V.; Gudermann, Thomas; Holzman, Lawrence B.; Nuernberg, Peter; Hildebrandt, Friedhelm			Positional cloning uncovers mutations in PLCE1 responsible for a nephrotic syndrome variant that may be reversible	NATURE GENETICS			English	Article							PHOSPHOLIPASE-C-EPSILON; PODOCYTE DEPLETION; GLOMERULAR PROTEIN; DRASH-SYNDROME; NEPHRIN; GLOMERULOSCLEROSIS; PODOCALYXIN; EXPRESSION; IQGAP1; GENE	Nephrotic syndrome, a malfunction of the kidney glomerular filter, leads to proteinuria, edema and, in steroid-resistant nephrotic syndrome, end-stage kidney disease. Using positional cloning, we identified mutations in the phospholipase C epsilon gene (PLCE1) as causing early-onset nephrotic syndrome with end-stage kidney disease. Kidney histology of affected individuals showed diffuse mesangial sclerosis (DMS). Using immunofluorescence, we found PLC epsilon 1 expression in developing and mature glomerular podocytes and showed that DMS represents an arrest of normal glomerular development. We identified IQ motif-containing GTPase-activating protein 1 as a new interaction partner of PLC epsilon 1. Two siblings with a missense mutation in an exon encoding the PLCe1 catalytic domain showed histology characteristic of focal segmental glomerulosclerosis. Notably, two other affected individuals responded to therapy, making this the first report of a molecular cause of nephrotic syndrome that may resolve after therapy. These findings, together with the zebrafish model of human nephrotic syndrome generated by plce1 knockdown, open new inroads into pathophysiology and treatment mechanisms of nephrotic syndrome.	Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA; Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; Univ Cologne, Cologne Ctr Genom, Cologne, Germany; RZPD Deutsches Ressourcenzentrum Genomforsch GmbH, Berlin, Germany; Univ Cologne, Inst Genet, Cologne, Germany; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Childrens Hosp, Boston, MA 02129 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Renal Unit, Boston, MA 02129 USA; Univ Vienna, Clin Inst Pathol, A-1090 Vienna, Austria; Gerneinschaftspraxis Pathol, D-69115 Heidelberg, Germany; Univ Marburg, Dept Pharmacol & Toxicol, Marburg, Germany; Hacettepe Univ, Fac Med, Dept Pediat Nephrol, TR-06100 Ankara, Turkey; Schneider Childrens Med Ctr, Dept Med Genet, Petah Tiqwa, Israel; Rabin Med Ctr, Petah Tiqwa, Israel; Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; Univ Freiburg, Dept Pediat, D-79106 Freiburg, Germany; Tech Univ Munich, Childrens Hosp, Schwabing, Germany; Sci Ctr Childrens Hlth, Moscow, Russia; Dokuz Eylul Univ, Dept Pediat, Izmir, Turkey; Charite Childrens Hosp, Dept Pediat Nephrol, Berlin, Germany; Inst Canc Res, Chester Beatty Labs, Ctr Cell & Mol Biol, Canc Res UK, London SW3 6JB, England; Hannover Med Sch, Inst Mol Biol, D-30625 Hannover, Germany; SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA; Univ Rochester, Sch Med, Dept Pharmacol & Physiol, Rochester, NY 14642 USA; Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Cologne; University of Cologne; Harvard University; Boston Children's Hospital; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Vienna; Philipps University Marburg; Hacettepe University; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; University of Freiburg; Technical University of Munich; Dokuz Eylul University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Cancer Research UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Hannover Medical School; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Rochester; University of Michigan System; University of Michigan	Hildebrandt, F (corresponding author), Univ Michigan, Dept Pediat, Ann Arbor, MI 48109 USA.	fhilde@umich.edu	Airik, Rannar/AAS-7810-2021; Soylu, Alper/AAR-7694-2020; Dietrich, Alexander/G-8619-2013; Hennies, Hans C/G-9424-2014; Seelow, Dominik/HGB-3124-2022	Airik, Rannar/0000-0002-7055-6325; Soylu, Alper/0000-0002-5901-7398; Dietrich, Alexander/0000-0002-1168-8707; Hennies, Hans C/0000-0001-7210-2389; Seelow, Dominik/0000-0002-9746-4412; Otto, Edgar/0000-0002-2387-9973; Bunney, Tom/0000-0002-0281-8813; Mucha, Bettina/0000-0002-6410-7320; Wiggins, Roger/0000-0002-1166-2849; Alexey, Tsygin/0000-0001-6301-9313; Basel-Vanagaite, Vanagaite, Lina/0000-0002-9076-8157; Garg, Puneet/0000-0001-7439-459X; Attanasio, Massimo/0000-0002-1278-3650; Holzman, Lawrence/0000-0002-8961-234X	NIDDK NIH HHS [R01-DK56294, R01-DK53093, P50-DK039255, DK46073] Funding Source: Medline; NIGMS NIH HHS [R01-GM053536] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK039255, R01DK053093, R56DK046073, R01DK046073, R01DK056294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053536] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 1981, KIDNEY INT, V20, P765; Antignac C, 2005, NEFROLOGIA, V25, P25; Barbaux S, 1997, NAT GENET, V17, P467, DOI 10.1038/ng1297-467; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; BRODEHL J, 1988, LANCET, V1, P380; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Habib R, 1993, Adv Nephrol Necker Hosp, V22, P43; HABIB R, 1993, PEDIATR NEPHROL, V7, P347, DOI 10.1007/BF00857534; HABIB R, 1985, CLIN NEPHROL, V24, P269; Hasselbacher K, 2006, KIDNEY INT, V70, P1008, DOI 10.1038/sj.ki.5001679; HOLMBERG C, 2004, PEDIAT NEPHROLOGY; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; KERJASCHKI D, 1984, J CELL BIOL, V98, P1591, DOI 10.1083/jcb.98.4.1591; KERSHAW DB, 1995, J BIOL CHEM, V270, P29439, DOI 10.1074/jbc.270.49.29439; KESTILA M, 1994, GENOMICS, V19, P570, DOI 10.1006/geno.1994.1109; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kim YH, 2001, KIDNEY INT, V60, P957, DOI 10.1046/j.1523-1755.2001.060003957.x; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Kriz W, 2002, MICROSC RES TECHNIQ, V57, P189, DOI 10.1002/jemt.10072; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Lehtonen S, 2005, P NATL ACAD SCI USA, V102, P9814, DOI 10.1073/pnas.0504166102; Liu XL, 2005, FEBS J, V272, P228, DOI 10.1111/j.1432-1033.2004.04408.x; Mucha B, 2006, PEDIATR RES, V59, P325, DOI 10.1203/01.pdr.0000196717.94518.f0; Ransom RF, 2004, CONTRIB NEPHROL, V141, P189; Reiser J, 2005, NAT GENET, V37, P739, DOI 10.1038/ng1592; Ruf RG, 2004, J AM SOC NEPHROL, V15, P722, DOI 10.1097/01.ASN.0000113552.59155.72; SCHNABEL E, 1989, EUR J CELL BIOL, V48, P313; Somlo S, 2000, NAT GENET, V24, P333, DOI 10.1038/74139; Sorli SC, 2005, ONCOGENE, V24, P90, DOI 10.1038/sj.onc.1208168; Strauch K, 2003, AM J HUM GENET, V73, P615; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Wang H, 2005, CIRC RES, V97, P1305, DOI 10.1161/01.RES.0000196578.15385.bb; Westerfield M, 1994, ZEBRAFISH BOOK; Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055; Wiggins JE, 2005, J AM SOC NEPHROL, V16, P2953, DOI 10.1681/ASN.2005050488; Wing Michele R, 2003, Mol Interv, V3, P273, DOI 10.1124/mi.3.5.273; Winn MP, 2005, SCIENCE, V308, P1801, DOI 10.1126/science.1106215; Yang YX, 1999, AM J PATHOL, V154, P181, DOI 10.1016/S0002-9440(10)65264-9; Zenker M, 2004, HUM MOL GENET, V13, P2625, DOI 10.1093/hmg/ddh284	41	382	425	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2006	38	12					1397	1405		10.1038/ng1918	http://dx.doi.org/10.1038/ng1918			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110TR	17086182				2022-12-27	WOS:000242404200016
J	Ben-Porath, I; Thomson, MW; Carey, VJ; Ge, R; Bell, GW; Regev, A; Weinberg, RA				Ben-Porath, Ittai; Thomson, Matthew W.; Carey, Vincent J.; Ge, Ruping; Bell, George W.; Regev, Aviv; Weinberg, Robert A.			An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors	NATURE GENETICS			English	Article							BREAST-CANCER PATIENTS; BASAL-LIKE SUBTYPE; C-MYC; METAANALYSIS; CARCINOMAS; SUBCLASSES; POLYCOMB; PATTERNS; RENEWAL; GRADE	Cancer cells possess traits reminiscent of those ascribed to normal stem cells. It is unclear, however, whether these phenotypic similarities reflect the activity of common molecular pathways. Here, we analyze the enrichment patterns of gene sets associated with embryonic stem ( ES) cell identity in the expression profiles of various human tumor types. We find that histologically poorly differentiated tumors show preferential overexpression of genes normally enriched in ES cells, combined with preferential repression of Polycomb- regulated genes. Moreover, activation targets of Nanog, Oct4, Sox2 and c-Myc are more frequently overexpressed in poorly differentiated tumors than in well-differentiated tumors. In breast cancers, this ES-like signature is associated with high-grade estrogen receptor ( ER)-negative tumors, often of the basal-like subtype, and with poor clinical outcome. The ES signature is also present in poorly differentiated glioblastomas and bladder carcinomas. We identify a subset of ES cell-associated transcription regulators that are highly expressed in poorly differentiated tumors. Our results reveal a previously unknown link between genes associated with ES cell identity and the histopathological traits of tumors and support the possibility that these genes contribute to stem cell-like phenotypes shown by many tumors.	[Ben-Porath, Ittai; Thomson, Matthew W.; Regev, Aviv; Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Ben-Porath, Ittai; Weinberg, Robert A.] MIT, Ludwig Ctr Canc Res, Cambridge, MA 02142 USA; [Thomson, Matthew W.; Regev, Aviv] MIT, Broad Inst Harvard, Cambridge, MA 02142 USA; [Carey, Vincent J.] Harvard Univ, Sch Med, Channing Lab, Brigham & Womens Hosp,Dana Farber Canc Inst, Boston, MA 02115 USA; [Carey, Vincent J.] Harvard Univ, Sch Med, Dept Med Oncol, Brigham & Womens Hosp,Dana Farber Canc Inst, Boston, MA 02115 USA; [Carey, Vincent J.] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp,Dana Farber Canc Inst, Boston, MA 02115 USA; [Ben-Porath, Ittai; Ge, Ruping; Bell, George W.; Weinberg, Robert A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Massachusetts Institute of Technology (MIT); Whitehead Institute	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu			NATIONAL CANCER INSTITUTE [R01CA078461] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P41HG004059] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA078461-10A1, R01 CA078461] Funding Source: Medline; NHGRI NIH HHS [P41 HG004059, P41 HG 004059] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		ANDRES AC, 1988, GENE DEV, V2, P1486, DOI 10.1101/gad.2.11.1486; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Beachy PA, 2004, NATURE, V432, P324, DOI 10.1038/nature03100; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Gidekel S, 2003, CANCER CELL, V4, P361, DOI 10.1016/S1535-6108(03)00270-8; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li XL, 2004, INT J ONCOL, V24, P257; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Livasy CA, 2006, MODERN PATHOL, V19, P264, DOI 10.1038/modpathol.3800528; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rhodes DR, 2005, NAT GENET, V37, pS31, DOI 10.1038/ng1570; Rodriguez-Pinilla SM, 2007, MODERN PATHOL, V20, P474, DOI 10.1038/modpathol.3800760; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Santagata S, 2007, AM J SURG PATHOL, V31, P836, DOI 10.1097/PAS.0b013e31802e708a; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Shachaf CM, 2004, NATURE, V431, P1112, DOI 10.1038/nature03043; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wei CL, 2005, STEM CELLS, V23, P166, DOI 10.1634/stemcells.2004-0162; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	50	1855	1921	4	130	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					499	507		10.1038/ng.127	http://dx.doi.org/10.1038/ng.127			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18443585	Green Accepted			2022-12-27	WOS:000255366700013
J	Boyden, LM; Lewis, JM; Barbee, SD; Bas, A; Girardi, M; Hayday, AC; Tigelaar, RE; Lifton, RP				Boyden, Lynn M.; Lewis, Julia M.; Barbee, Susannah D.; Bas, Anna; Girardi, Michael; Hayday, Adrian C.; Tigelaar, Robert E.; Lifton, Richard P.			Skint1, the prototype of a newly identified immunoglobulin superfamily gene cluster, positively selects epidermal gamma delta T cells	NATURE GENETICS			English	Article							ANTIGEN RECEPTORS; VIRUS-INFECTION; BOVINE SKIN; IMMUNITY; MICE; LYMPHOCYTES; REPERTOIRE; GENOME	B cells, alpha beta T cells and gamma delta T cells are conserved lymphocyte subtypes encoding their antigen receptors from somatically rearranged genes. ab T cells undergo positive selection in the thymus by engagement of their T cell receptors (TCRs) with self-peptides presented by major histocompatibility complex molecules(1). The molecules that select gamma delta T cells are unknown(2-4). V gamma 5(+)V delta 1(+) cells comprise 90% of mouse epidermal gamma delta T cells(4). By mapping and genetic complementation using a strain showing loss of Vc5(+)Vd1(+) cells due to a failure of thymic selection, we show that this defect is caused by mutation in Skint1, a newly identified gene expressed in thymus and skin that encodes a protein with immunoglobulin-like and transmembrane domains. Skint1 is the prototypic member of a rapidly evolving family of at least 11 genes in mouse, with greatest similarity to the butyrophilin genes. These findings define a new family of proteins mediating key epithelial-immune interactions.	[Boyden, Lynn M.; Lifton, Richard P.] Yale Univ, Sch Med, Dept Genet, New Haven, CT 06510 USA; [Lewis, Julia M.; Girardi, Michael; Tigelaar, Robert E.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Barbee, Susannah D.; Bas, Anna; Hayday, Adrian C.] Kings Coll London, Sch Med, Peter Gorer Dept Immunobiol, Guys Hosp, London SE1 9RT, England; [Tigelaar, Robert E.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA; [Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Lifton, Richard P.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Lifton, Richard P.] Yale Univ, Sch Med, Dept Mol Biophys & Biochem, New Haven, CT 06510 USA	Yale University; Yale University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Lifton, RP (corresponding author), Yale Univ, Sch Med, Dept Genet, 333 Cedar St,SHM 1-308, New Haven, CT 06510 USA.	richard.lifton@yale.edu		Girardi, Michael/0000-0003-1887-9343; HAYDAY, ADRIAN/0000-0002-9495-5793	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007149] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA102703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR002072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079310] Funding Source: NIH RePORTER; Medical Research Council [G0600698B] Funding Source: researchfish; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA102703] Funding Source: Medline; NIAMS NIH HHS [K08 AR002072] Funding Source: Medline; NICHD NIH HHS [T32 HD007149] Funding Source: Medline; NIDDK NIH HHS [P30 DK079310] Funding Source: Medline; Wellcome Trust [071534] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission)		ALLISON JP, 1991, ANNU REV IMMUNOL, V9, P679, DOI 10.1146/annurev.iy.09.040191.003335; BOS JD, 1990, J INVEST DERMATOL, V94, P37, DOI 10.1111/1523-1747.ep12873333; DSouza CD, 1997, J IMMUNOL, V158, P1217; Ebert LM, 2006, J IMMUNOL, V176, P4331, DOI 10.4049/jimmunol.176.7.4331; Fujiwara K, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-39; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Girardi M, 2002, J EXP MED, V195, P855, DOI 10.1084/jem.20012000; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Hayday AC, 2000, ANNU REV IMMUNOL, V18, P975, DOI 10.1146/annurev.immunol.18.1.975; Hein WR, 1997, IMMUNOLOGY, V91, P58, DOI 10.1046/j.1365-2567.1997.00224.x; Holtmeier V, 2001, J INVEST DERMATOL, V116, P275, DOI 10.1046/j.1523-1747.2001.01250.x; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Janeway CA, 2001, IMMUNOBIOLOGY; King DP, 1999, J IMMUNOL, V162, P5033; Kuhnlein P, 1996, EUR J IMMUNOL, V26, P3092, DOI 10.1002/eji.1830261240; Lewis JM, 2006, NAT IMMUNOL, V7, P843, DOI 10.1038/ni1363; MOMBAERTS P, 1993, NATURE, V365, P53, DOI 10.1038/365053a0; Moore TA, 2000, J IMMUNOL, V165, P2643, DOI 10.4049/jimmunol.165.5.2643; Peng SL, 1996, J IMMUNOL, V157, P5689; Rhodes DA, 2001, GENOMICS, V71, P351, DOI 10.1006/geno.2000.6406; Roberts SJ, 1996, P NATL ACAD SCI USA, V93, P11774, DOI 10.1073/pnas.93.21.11774; Selin LK, 2001, J IMMUNOL, V166, P6784, DOI 10.4049/jimmunol.166.11.6784; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Shiohara T, 1996, J EXP MED, V183, P1483, DOI 10.1084/jem.183.4.1483; TIGELAAR RE, 1990, J INVEST DERMATOL, V94, pS58, DOI 10.1111/1523-1747.ep12875138; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Van Rhijn I, 2007, J LEUKOCYTE BIOL, V81, P968, DOI 10.1189/jlb.0506331; Wang T, 2006, J IMMUNOL, V177, P1825, DOI 10.4049/jimmunol.177.3.1825; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Zachariadis O, 2006, INFECT IMMUN, V74, P1837, DOI 10.1128/IAI.74.3.1837-1845.2006	30	217	234	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					656	662		10.1038/ng.108	http://dx.doi.org/10.1038/ng.108			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18408721	Green Accepted			2022-12-27	WOS:000255366700036
J	Park, CC; Ahn, S; Bloom, JS; Lin, A; Wang, RT; Wu, T; Sekar, A; Khan, AH; Farr, CJ; Lusis, AJ; Leahy, RM; Lange, K; Smith, DJ				Park, Christopher C.; Ahn, Sangtae; Bloom, Joshua S.; Lin, Andy; Wang, Richard T.; Wu, Tongtong; Sekar, Aswin; Khan, Arshad H.; Farr, Christine J.; Lusis, Aldons J.; Leahy, Richard M.; Lange, Kenneth; Smith, Desmond J.			Fine mapping of regulatory loci for mammalian gene expression using radiation hybrids	NATURE GENETICS			English	Article							FALSE DISCOVERY RATE; MAXIMUM-LIKELIHOOD; LINKAGE ANALYSIS; MICROARRAY DATA; EM ALGORITHM; WHOLE GENOME; MOUSE GENOME; YEAST; MAP; IDENTIFICATION	We mapped regulatory loci for nearly all protein-coding genes in mammals using comparative genomic hybridization and expression array measurements from a panel of mouse-hamster radiation hybrid cell lines. The large number of breaks in the mouse chromosomes and the dense genotyping of the panel allowed extremely sharp mapping of loci. As the regulatory loci result from extra gene dosage, we call them copy number expression quantitative trait loci, or ceQTLs. The -2log(10)P support interval for the ceQTLs was <150 kb, containing an average of <2-3 genes. We identified 29,769 trans ceQTLs with -log(10)P>4, including 13 hotspots each regulating >100 genes in trans. Further, this work identifies 2,761 trans ceQTLs harboring no known genes, and provides evidence for a mode of gene expression autoregulation specific to the X chromosome.	[Park, Christopher C.; Bloom, Joshua S.; Lin, Andy; Wang, Richard T.; Sekar, Aswin; Khan, Arshad H.; Smith, Desmond J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Ahn, Sangtae; Leahy, Richard M.] Univ So Calif, Viterbi Sch Engn, Dept Elect Engn, Inst Signal & Image Proc, Los Angeles, CA 90089 USA; [Wu, Tongtong] Univ Calif Los Angeles, Sch Publ Hlth, Dept Biostat, Los Angeles, CA 90095 USA; [Farr, Christine J.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Lusis, Aldons J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Dept Med, Los Angeles, CA 90095 USA; [Lusis, Aldons J.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Lange, Kenneth] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Southern California; University of California System; University of California Los Angeles; University of Cambridge; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Smith, DJ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	DSmith@mednet.ucla.edu		Farr, Christine/0000-0002-5357-5962; Park, Christopher/0000-0002-2579-6039; Wang, Richard/0000-0002-2483-3205	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL030568, P01HL028481] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002536] Funding Source: NIH RePORTER; NHGRI NIH HHS [T32 HG002536] Funding Source: Medline; NHLBI NIH HHS [P01 HL030568, P01 HL028481-25, P01 HL030568-220009, P01 HL028481] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Avner P, 2001, NAT GENET, V29, P194, DOI 10.1038/ng1001-194; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Behboudi A, 2002, GENOMICS, V79, P844, DOI 10.1006/geno.2002.6785; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Carlborg O, 2005, BIOINFORMATICS, V21, P2383, DOI 10.1093/bioinformatics/bti241; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; CHURCHILL GA, 1994, GENETICS, V138, P963; Cusick ME, 2005, HUM MOL GENET, V14, pR171, DOI 10.1093/hmg/ddi335; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; GOSS SJ, 1975, NATURE, V255, P680, DOI 10.1038/255680a0; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Hudson TJ, 2001, NAT GENET, V29, P201, DOI 10.1038/ng1001-201; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; JANSEN RC, 1993, BIOMETRICS, V49, P227, DOI 10.2307/2532616; Kirst M, 2004, PLANT PHYSIOL, V135, P2368, DOI 10.1104/pp.103.037960; LEHMANN E. L., 2005, TESTING STAT HYPOTHE; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; McCarthy LC, 1997, GENOME RES, V7, P1153, DOI 10.1101/gr.7.12.1153; McCarthy LC, 1996, TRENDS GENET, V12, P491, DOI 10.1016/S0168-9525(96)30110-8; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Olivier M, 2001, SCIENCE, V291, P1298, DOI 10.1126/science.1057437; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Perlstein EO, 2007, NAT GENET, V39, P496, DOI 10.1038/ng1991; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Prandini P, 2007, AM J HUM GENET, V81, P252, DOI 10.1086/519248; REDNER RA, 1984, SIAM REV, V26, P195, DOI 10.1137/1026034; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Storey JD, 2005, PLOS BIOL, V3, P1380, DOI 10.1371/journal.pbio.0030267; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Wayne ML, 2002, P NATL ACAD SCI USA, V99, P14903, DOI 10.1073/pnas.222549199; Yoshida K, 1998, GENOMICS, V49, P458, DOI 10.1006/geno.1998.5271; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	42	25	25	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2008	40	4					421	429		10.1038/ng.113	http://dx.doi.org/10.1038/ng.113			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18362883	Green Published, Green Accepted			2022-12-27	WOS:000254388100012
J	Onouchi, Y; Gunji, T; Burns, JC; Shimizu, C; Newburger, JW; Yashiro, M; Nakamura, Y; Yanagawa, H; Wakui, K; Fukushima, Y; Kishi, F; Hamamoto, K; Terai, M; Sato, Y; Ouchi, K; Saji, T; Nariai, A; Kaburagi, Y; Yoshikawa, T; Suzuki, K; Tanaka, T; Nagai, T; Cho, H; Fujino, A; Sekine, A; Nakamichi, R; Tsunoda, T; Kawasaki, T; Nakamura, Y; Hata, A				Onouchi, Yoshihiro; Gunji, Tomohiko; Burns, Jane C.; Shimizu, Chisato; Newburger, Jane W.; Yashiro, Mayumi; Nakamura, Yoshikazu; Yanagawa, Hiroshi; Wakui, Keiko; Fukushima, Yoshimitsu; Kishi, Fumio; Hamamoto, Kunihiro; Terai, Masaru; Sato, Yoshitake; Ouchi, Kazunobu; Saji, Tsutomu; Nariai, Akiyoshi; Kaburagi, Yoichi; Yoshikawa, Tetsushi; Suzuki, Kyoko; Tanaka, Takeo; Nagai, Toshiro; Cho, Hideo; Fujino, Akihiro; Sekine, Akihiro; Nakamichi, Reiichiro; Tsunoda, Tatsuhiko; Kawasaki, Tomisaku; Nakamura, Yusuke; Hata, Akira			ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms	NATURE GENETICS			English	Article							BASE-PAIR SUBSTITUTIONS; T-LYMPHOCYTES; HUMAN GENES; REGULATORY ELEMENTS; SIGNAL-TRANSDUCTION; MESSENGER; RNA; CONSEQUENCES; PREDICTION; EXPRESSION	Kawasaki disease is a pediatric systemic vasculitis of unknown etiology for which a genetic influence is suspected. We identified a functional SNP (itpkc_3) in the inositol 1,4,5-trisphosphate 3-kinase C (ITPKC) gene on chromosome 19q13.2 that is significantly associated with Kawasaki disease susceptibility and also with an increased risk of coronary artery lesions in both Japanese and US children. Transfection experiments showed that the C allele of itpkc_3 reduces splicing efficiency of the ITPKC mRNA. ITPKC acts as a negative regulator of T-cell activation through the Ca2+/NFAT signaling pathway, and the C allele may contribute to immune hyper-reactivity in Kawasaki disease. This finding provides new insights into the mechanisms of immune activation in Kawasaki disease and emphasizes the importance of activated T cells in the pathogenesis of this vasculitis.	[Onouchi, Yoshihiro; Gunji, Tomohiko; Hata, Akira] RIKEN, SNP Res Ctr, Lab Gastrointestinal Dis, Kanagawa 2300045, Japan; [Gunji, Tomohiko] Tokyo Med & Dent Univ, Grad Sch, Dept Hard Tissue Engn, Tokyo 1138549, Japan; [Burns, Jane C.; Shimizu, Chisato] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Shimizu, Chisato] Rady Childrens Hosp, La Jolla, CA 92093 USA; [Newburger, Jane W.] Boston Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Yashiro, Mayumi; Nakamura, Yoshikazu] Jichi Med Sch, Dept Publ Hlth, Minamimaki, Tochigi 3290498, Japan; [Yanagawa, Hiroshi] Saitama Prefectural Univ, Koshigaya, Saitama 3438540, Japan; [Wakui, Keiko; Fukushima, Yoshimitsu] Shinshu Univ, Sch Med, Dept Prevent Med, Matsumoto, Nagano 3908621, Japan; [Kishi, Fumio] Kawasaki Med Sch, Dept Mol Genet, Kurashiki, Okayama 7010192, Japan; [Hamamoto, Kunihiro] Fukuoka Univ, Sch Med, Dept Pediat, Fukuoka 8318501, Japan; [Terai, Masaru] Tokyo Womens Med Univ, Yachiyo Med Ctr, Dept Pediat, Chiba 2768524, Japan; [Sato, Yoshitake] Fuji Heavy Ind Co Ltd, Dept Pediat, Fuji Heavy Ind Ltd, Gunma 3738585, Japan; [Ouchi, Kazunobu] Kawasaki Med Sch, Dept Pediat, Okayama 7010192, Japan; [Saji, Tsutomu] Toho Univ, Sch Med, Dept Pediat, Tokyo 1438541, Japan; [Nariai, Akiyoshi; Kaburagi, Yoichi] Yokohama Minami Kyousai Hosp, Dept Pediat, Yokohama, Kanagawa 2360037, Japan; [Yoshikawa, Tetsushi] Fujita Hlth Univ, Dept Pediat, Toyoake, Aichi 4701192, Japan; [Suzuki, Kyoko] Toyokawa Citizens Hosp, Dept Pediat, Aichi 4428561, Japan; [Tanaka, Takeo] Kure Med Ctr, NAtl Hosp Org, Dept Pediat, Okayama 7370023, Japan; [Nagai, Toshiro] Dokkyo Med Univ, Koshigaya Hosp, Dept Pediat, Koshigaya, Saitama 3438555, Japan; [Cho, Hideo] Kawasaki Municipal Hosp, Dept Pediat, Kawasaki, Kanagawa 2100013, Japan; [Fujino, Akihiro] Keio Univ, Sch Med, Dept Surg, Tokyo 1608582, Japan; [Sekine, Akihiro] RIKEN, Lab Genotyping, Kanagawa 2300045, Japan; [Nakamichi, Reiichiro; Tsunoda, Tatsuhiko] RIKEN, SNP Res Ctr, Lab Med Informat, Kanagawa 2300045, Japan; [Kawasaki, Tomisaku] Japan Kawasaki Dis Res Ctr, Tokyo 1110031, Japan; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo 1088639, Japan; [Nakamura, Yusuke] RIKEN, SNP Res Ctr, Kanagawa 2300045, Japan	RIKEN; Tokyo Medical & Dental University (TMDU); University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Harvard University; Boston Children's Hospital; Jichi Medical University; Shinshu University; Kawasaki Medical School; Fukuoka University; Tokyo Women's Medical University; Subaru Corporation; Kawasaki Medical School; Toho University; Fujita Health University; Dokkyo Medical University; Keio University; RIKEN; RIKEN; University of Tokyo; RIKEN	Onouchi, Y (corresponding author), RIKEN, SNP Res Ctr, Lab Gastrointestinal Dis, Kanagawa 2300045, Japan.	onouchi@src.riken.jp	Burns, Jane C/J-6167-2015; Shimizu, Chisato/J-6516-2015; Tsunoda, Tatsuhiko/K-2061-2014; Fujino, Akihiro/AAH-2243-2019	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Fujino, Akihiro/0000-0003-2987-5081; Shimizu, Chisato/0000-0002-3149-2699	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069413] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL069413-08, R01 HL069413, HL69413] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ayusawa M, 2005, PEDIATR INT, V47, P232, DOI 10.1111/j.1442-200x.2005.02033.x; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Brown TJ, 2001, J INFECT DIS, V184, P940, DOI 10.1086/323155; Buratti E, 2004, MOL CELL BIOL, V24, P10505, DOI 10.1128/MCB.24.24.10505-10514.2004; Burns JC, 2005, GENES IMMUN, V6, P438, DOI 10.1038/sj.gene.6364225; Cogan JD, 1997, HUM MOL GENET, V6, P909, DOI 10.1093/hmg/6.6.909; COOK DH, 1989, CAN J CARDIOL, V5, P389; Dergun M, 2005, ARCH PEDIAT ADOL MED, V159, P876, DOI 10.1001/archpedi.159.9.876; Dewaste V, 2000, BIOCHEM J, V352, P343, DOI 10.1042/0264-6021:3520343; Egami K, 2006, J PEDIATR-US, V149, P237, DOI 10.1016/j.jpeds.2006.03.050; FUJITA Y, 1989, PEDIATRICS, V84, P666; Fukunishi M, 2000, J PEDIATR-US, V137, P172, DOI 10.1067/mpd.2000.104815; HARNICK DJ, 1995, J BIOL CHEM, V270, P2833, DOI 10.1074/jbc.270.6.2833; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; IMBODEN JB, 1987, J CLIN INVEST, V79, P1538, DOI 10.1172/JCI112986; Kato H, 1996, CIRCULATION, V94, P1379, DOI 10.1161/01.CIR.94.6.1379; KATO H, 1975, J PEDIATR-US, V86, P892, DOI 10.1016/S0022-3476(75)80220-4; Kawasaki T., 1967, PEDIATR INFECT DIS J, V16, P178; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Kobayashi T, 2006, CIRCULATION, V113, P2606, DOI 10.1161/CIRCULATIONAHA.105.592865; KRAWCZAK M, 1992, HUM GENET, V90, P41; Krawczak M, 2007, HUM MUTAT, V28, P150, DOI 10.1002/humu.20400; Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497; Louie E, 2003, GENOME RES, V13, P2594, DOI 10.1101/gr.1317703; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Majewski J, 2002, GENOME RES, V12, P1827, DOI 10.1101/gr.606402; McCullough AJ, 1997, MOL CELL BIOL, V17, P4562, DOI 10.1128/MCB.17.8.4562; MORISAKI H, 1993, J CLIN INVEST, V91, P2275, DOI 10.1172/JCI116455; Onouchi Y, 2007, J HUM GENET, V52, P179, DOI 10.1007/s10038-006-0092-3; Raman V, 2001, PEDIATR INFECT DIS J, V20, P635, DOI 10.1097/00006454-200106000-00022; Sano T, 2007, EUR J PEDIATR, V166, P131, DOI 10.1007/s00431-006-0223-z; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Uehara R, 2003, ACTA PAEDIATR, V92, P694, DOI 10.1080/08035320310002768; Ueijma H, 2000, NAT GENET, V25, P375, DOI 10.1038/78040; Varani L, 1999, P NATL ACAD SCI USA, V96, P8229, DOI 10.1073/pnas.96.14.8229; von Ahsen N, 2004, BLOOD, V103, P586, DOI 10.1182/blood-2003-02-0419; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Yeo G, 2004, P NATL ACAD SCI USA, V101, P15700, DOI 10.1073/pnas.0404901101; Yoshioka T, 1999, IMMUNOLOGY, V96, P465, DOI 10.1046/j.1365-2567.1999.00695.x	40	315	335	3	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2008	40	1					35	42		10.1038/ng.2007.59	http://dx.doi.org/10.1038/ng.2007.59			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18084290	Green Accepted			2022-12-27	WOS:000252118600016
J	St Onge, RP; Mani, R; Oh, J; Proctor, M; Fung, E; Davis, RW; Nislow, C; Roth, FP; Giaever, G				St Onge, Robert P.; Mani, Ramamurthy; Oh, Julia; Proctor, Michael; Fung, Eula; Davis, Ronald W.; Nislow, Corey; Roth, Frederick P.; Giaever, Guri			Systematic pathway analysis using high-resolution fitness profiling of combinatorial gene deletions	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; DELETERIOUS MUTATIONS; DNA-REPAIR; HOMOLOGOUS RECOMBINATION; INTERACTION NETWORKS; YEAST; REPLICATION; PROTEINS; HELICASE; MUTANTS	Systematic genetic interaction studies have illuminated many cellular processes. Here we quantitatively examine genetic interactions among 26 Saccharomyces cerevisiae genes conferring resistance to the DNA- damaging agent methyl methanesulfonate ( MMS), as determined by chemogenomic fitness profiling of pooled deletion strains. We constructed 650 double- deletion strains, corresponding to all pairings of these 26 deletions. The fitness of single- and double- deletion strains were measured in the presence and absence of MMS. Genetic interactions were defined by combining principles from both statistical and classical genetics. The resulting network predicts that the Mph1 helicase has a role in resolving homologous recombination - derived DNA intermediates that is similar to ( but distinct from) that of the Sgs1 helicase. Our results emphasize the utility of small molecules and multifactorial deletion mutants in uncovering functional relationships and pathway order.	Harvard Univ, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; Univ Toronto, Dept Pharmaceut Chem, Leslie Dan Fac Pharm, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; Ctr Canc Syst Biol, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Stanford University; University of Toronto; Harvard University; Dana-Farber Cancer Institute	Roth, FP (corresponding author), Harvard Univ, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	froth@hms.harvard.edu; guri.giaever@utoronto.ca	Roth, Frederick P/H-6308-2011	Nislow, Corey/0000-0002-4016-8874; Roth, Frederick/0000-0002-6628-649X	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003224] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG003224-02, R01 HG003224-03, R01 HG003224-01A2, R01 HG003224] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; AVERY L, 1992, TRENDS GENET, V8, P312, DOI 10.1016/0168-9525(92)90263-4; Bai Y, 1996, GENE DEV, V10, P2025, DOI 10.1101/gad.10.16.2025; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Davierwala AP, 2005, NAT GENET, V37, P1147, DOI 10.1038/ng1640; Drees BL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-4-r38; Elena SF, 1997, NATURE, V390, P395, DOI 10.1038/37108; ELLIS NA, 1995, CELL, V83, P655, DOI 10.1016/0092-8674(95)90105-1; Erdeniz N, 1997, GENOME RES, V7, P1174, DOI 10.1101/gr.7.12.1174; Fabre F, 2002, P NATL ACAD SCI USA, V99, P16887, DOI 10.1073/pnas.252652399; Friedl AA, 2001, MUTAT RES-DNA REPAIR, V486, P137, DOI 10.1016/S0921-8777(01)00086-6; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Huang ME, 2003, P NATL ACAD SCI USA, V100, P11529, DOI 10.1073/pnas.2035018100; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; JANA S, 1972, THEOR APPL GENET, V42, P119, DOI 10.1007/BF00583413; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; Klein H, 2001, GENETICS, V157, P557; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lee W, 2005, PLOS GENET, V1, P235, DOI 10.1371/journal.pgen.0010024; Liberi G, 2005, GENE DEV, V19, P339, DOI 10.1101/gad.322605; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Maisnier-Patin S, 2005, NAT GENET, V37, P1376, DOI 10.1038/ng1676; McEachern MJ, 2006, ANNU REV BIOCHEM, V75, P111, DOI 10.1146/annurev.biochem.74.082803.133234; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Ooi SL, 2006, TRENDS GENET, V22, P56, DOI 10.1016/j.tig.2005.11.003; Ooi SL, 2003, NAT GENET, V35, P277, DOI 10.1038/ng1258; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Phillips PC, 1998, GENETICS, V149, P1167; PHILLIPS PC, 2000, AVERAGE EVOLUTIONARY, P20; Prakash R, 2005, J BIOL CHEM, V280, P7854, DOI 10.1074/jbc.M413898200; PUNNETT RC, 1913, MENDELISM; Rose MD., 1990, METHODS YEAST GENETI; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schurer KA, 2004, GENETICS, V166, P1673, DOI 10.1534/genetics.166.4.1673; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Szafraniec K, 2003, GENET RES, V82, P19, DOI 10.1017/S001667230300630X; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Ulrich HD, 2000, EMBO J, V19, P3388, DOI 10.1093/emboj/19.13.3388; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wong SL, 2005, TRENDS GENET, V21, P424, DOI 10.1016/j.tig.2005.06.006; Wong SL, 2004, P NATL ACAD SCI USA, V101, P15682, DOI 10.1073/pnas.0406614101; Ye P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-270	48	231	234	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2007	39	2					199	206		10.1038/ng1948	http://dx.doi.org/10.1038/ng1948			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17206143	Green Accepted			2022-12-27	WOS:000244063900017
J	Jeffares, DC; Pain, A; Berry, A; Cox, AV; Stalker, J; Ingle, CE; Thomas, A; Quail, MA; Siebenthall, K; Uhlemann, AC; Kyes, S; Krishna, S; Newbold, C; Dermitzakis, ET; Berriman, M				Jeffares, Daniel C.; Pain, Arnab; Berry, Andrew; Cox, Anthony V.; Stalker, James; Ingle, Catherine E.; Thomas, Alan; Quail, Michael A.; Siebenthall, Kyle; Uhlemann, Anne-Catrin; Kyes, Sue; Krishna, Sanjeev; Newbold, Chris; Dermitzakis, Emmanouil T.; Berriman, Matthew			Genome variation and evolution of the malaria parasite Plasmodium falciparum	NATURE GENETICS			English	Article							PROTEINS; SEQUENCE; ONTOLOGY; REVEAL; GENES	Infections with the malaria parasite Plasmodium falciparum result in more than 1 million deaths each year worldwide(1). Deciphering the evolutionary history and genetic variation of P. falciparum is critical for understanding the evolution of drug resistance, identifying potential vaccine candidates and appreciating the effect of parasite variation on prevalence and severity of malaria in humans. Most studies of natural variation in P. falciparum have been either in depth over small genomic regions (up to the size of a small chromosome(2)) or genome wide but only at low resolution(3). In an effort to complement these studies with genome-wide data, we undertook shotgun sequencing of a Ghanaian clinical isolate (with fivefold coverage), the IT laboratory isolate (with onefold coverage) and the chimpanzee parasite P. reichenowi (with twofold coverage). We compared these sequences with the fully sequenced P. falciparum 3D7 isolate genome(4). We describe the most salient features of P. falciparum polymorphism and adaptive evolution with relation to gene function, transcript and protein expression and cellular localization. This analysis uncovers the primary evolutionary changes that have occurred since the P. falciparum-P. reichenowi speciation and changes that are occurring within P. falciparum.	Wellcome Trust Sanger Inst, Div Informat, Hinxton CB10 1SA, England; Wellcome Trust Sanger Inst, Pathogen Sequencing Unit, Hinxton CB10 1SA, England; Biomed Primate Res Ctr, NL-2280 GH Rijswijk, Netherlands; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; St Georges Univ London, London SW17 0RE, England; Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Oxford OX3 9DS, England	Wellcome Trust Sanger Institute; Wellcome Trust Sanger Institute; Cornell University; St Georges University London; University of Oxford	Dermitzakis, ET (corresponding author), Wellcome Trust Sanger Inst, Div Informat, Hinxton CB10 1SA, England.	md4@sanger.ac.uk; mb4@sanger.ac.uk	Quail, michael/ABE-6131-2020; Pain, Arnab/L-5766-2015; Jeffares, Daniel/N-2632-2018; Dermitzakis, Emmanouil/B-7687-2013; Berriman, Matthew/A-7618-2011	Pain, Arnab/0000-0002-1755-2819; Jeffares, Daniel/0000-0001-7320-0706; Berriman, Matthew/0000-0002-9581-0377; Berry, Andrew/0000-0001-5096-7701; Newbold, Chris/0000-0002-9274-3789; Krishna, Sanjeev/0000-0003-0066-0634	Wellcome Trust [079643, 077046] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Anderson Tim J. C., 2004, Current Drug Targets - Infectious Disorders, V4, P65, DOI 10.2174/1568005043480943; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bowman S, 1999, NATURE, V400, P532, DOI 10.1038/22964; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Carret CK, 2005, MOL BIOCHEM PARASIT, V144, P177, DOI 10.1016/j.molbiopara.2005.08.010; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Garnham PCC, 1996, MALARIA PARASITES OT; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Horrocks P, 2004, MOL BIOCHEM PARASIT, V134, P193, DOI 10.1016/j.molbiopara.2003.11.016; Korenromp E, 2005, WORLD MALARIA REPORT; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; Li FW, 2004, J BIOL CHEM, V279, P26635, DOI 10.1074/jbc.M401385200; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Martin MJ, 2005, P NATL ACAD SCI USA, V102, P12819, DOI 10.1073/pnas.0503819102; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Mu JB, 2002, NATURE, V418, P323, DOI 10.1038/nature00836; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Rocha EPC, 2006, TRENDS GENET, V22, P412, DOI 10.1016/j.tig.2006.06.004; Volkman SK, 2007, NAT GENET, V39, P113, DOI 10.1038/ng1930; Volkman SK, 2002, SCIENCE, V298, P216, DOI 10.1126/science.1075642; Winter G, 2005, J EXP MED, V201, P1853, DOI 10.1084/jem.20041392; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Young JA, 2005, MOL BIOCHEM PARASIT, V143, P67, DOI 10.1016/j.molbiopara.2005.05.007	30	162	166	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2007	39	1					120	125		10.1038/ng1931	http://dx.doi.org/10.1038/ng1931			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	17159978	Green Accepted			2022-12-27	WOS:000243136500027
J	Cooper, JD; Smyth, DJ; Smiles, AM; Plagnol, V; Walker, NM; Allen, JE; Downes, K; Barrett, JC; Healy, BC; Mychaleckyj, JC; Warram, JH; Todd, JA				Cooper, Jason D.; Smyth, Deborah J.; Smiles, Adam M.; Plagnol, Vincent; Walker, Neil M.; Allen, James E.; Downes, Kate; Barrett, Jeffrey C.; Healy, Barry C.; Mychaleckyj, Josyf C.; Warram, James H.; Todd, John A.			Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci	NATURE GENETICS			English	Article							LARGE-SCALE; PKC-THETA; DISEASES; REGION; BACH2	We carried out a meta-analysis of data from three genome-wide association (GWA) studies of type 1 diabetes (T1D), testing 305,090 SNPs in 3,561 T1D cases and 4,646 controls of European ancestry. We obtained further support for 4q27 (IL2-IL21, P = 1.9 x 10(-8)) and, after genotyping an additional 6,225 cases, 6,946 controls and 2,828 families, convincing evidence for four previously unknown and distinct risk loci in chromosome regions 6q15 (BACH2, P = 4.7 x 10(-12)), 10p15 (PRKCQ, P = 3.7 x 10(-9)), 15q24 (CTSH, P = 3.2 x 10(-15)) and 22q13 (C1QTNF6, P = 2.0 x 10(-8)).	[Cooper, Jason D.; Smyth, Deborah J.; Plagnol, Vincent; Walker, Neil M.; Allen, James E.; Downes, Kate; Barrett, Jeffrey C.; Healy, Barry C.; Todd, John A.] Univ Cambridge, Addenbrookes Hosp, Juvenile Diabet Res Fdn,Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab,Dept Med Ge, Cambridge CB2 0XY, England; [Smiles, Adam M.; Warram, James H.] Joslin Diabet Ctr, Div Res, Boston, MA 02215 USA; [Mychaleckyj, Josyf C.] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA 22908 USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Harvard University; Joslin Diabetes Center, Inc.; University of Virginia	Cooper, JD (corresponding author), Univ Cambridge, Addenbrookes Hosp, Juvenile Diabet Res Fdn,Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab,Dept Med Ge, Cambridge CB2 0XY, England.	jason.cooper@cimr.cam.ac.uk	Todd, John A/A-3542-2010; Plagnol, Vincent/A-5667-2011; Allen, James/B-2457-2009	Todd, John A/0000-0003-2740-8148; smyth, deborah/0000-0002-6330-2669; Allen, James/0000-0002-3894-4854; Plagnol, Vincent/0000-0002-5597-9215; Walker, Neil/0000-0001-9796-7688	Juvenile Diabetes Research Foundation International; Wellcome Trust; National Institute for Health Research Cambridge Biomedical Centre; Wellcome Trust Strategic Award [079895]; Wellcome Trust [076113]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059587, R01MH059588, R01MH061675, R01MH067257, R01MH059586, R01MH059565, R01MH060879, R01MH060870, R01MH059571, R01MH059566, R01MH063420] Funding Source: NIH RePORTER; Medical Research Council [G0000934] Funding Source: researchfish; MRC [G0000934] Funding Source: UKRI	Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research Cambridge Biomedical Centre(National Institute for Health Research (NIHR)); Wellcome Trust Strategic Award(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the Juvenile Diabetes Research Foundation International, the Wellcome Trust and the National Institute for Health Research Cambridge Biomedical Centre. The Cambridge Institute for Medical Research (CIMR) is in receipt of a Wellcome Trust Strategic Award (079895). We thank all study participants and family members. We gratefully acknowledge D. Clayton for methodology advice and comments on the manuscript. We acknowledge use of DNA from the British 1958 Birth Cohort collection, funded by the Medical Research Council and the Wellcome Trust. We thank The Avon Longitudinal Study of Parents and Children laboratory in Bristol and the British 1958 Birth Cohort team, including S. Ring, R. Jones, M. Pembrey, W. McArdle, D. Strachan and P. Burton, for preparing and providing the control DNA samples. We also thank H. Stevens, P. Clarke, G. Coleman, S. Duley, D. Harrison, S. Hawkins, M. Maisuria, T. Mistry and N. Taylor for preparation of DNA samples. We acknowledge use of DNA from the Human Biological Data Interchange and Diabetes UK for the USA and UK multiplex families, respectively; the Norwegian Study Group for Childhood Diabetes (D. Undlien and K. Ronningen) for the Norwegian families; D. Savage, C. Patterson, D. Carson and P. Maxwell for the Northern Irish families; the Genetics of Type 1 Diabetes in Finland (GET1FIN); J. Tuomilehto, L. Kinnunen, E. Tuomilehto-Wolf, V. Harjutsalo and T. Valle for the Finnish families; and C. Guja and C. Ionescu-Tirgoviste for the Romanian families. WTCCC: This study makes use of data generated by the Wellcome Trust Case Control Consortium. A full list of the investigators who contributed to the generation of the data are available from http://www.wtccc.org.uk/. Funding for the project was provided by the Wellcome Trust under award 076113 (see ref. 1). NIMH: We gratefully acknowledge the National Institute of Mental Health for generously allowing the use of their control CEL and genotype data. Control subjects from the National Institute of Mental Health Schizophrenia Genetics Initiative (NIMH-GI), data and biomaterials are being collected by the "Molecular Genetics of Schizophrenia II'' (MGS-2) collaboration. The investigators and co-investigators are as follows: P.V. Gejman (Collaboration coordinator) and A. R. Sanders (ENH/Northwestern University, MH059571); F. Amin (Emory University School of Medicine, MH59587); N. Buccola (Louisiana State University Health Sciences Center, MH067257); W. Byerley (University of California-Irvine, MH60870); C. R. Cloninger (Washington University, St. Louis, U01, MH060879); R. Crowe (PI) and D. Black (University of Iowa, MH59566); R. Freedman (University of Colorado, MH059565); D. Levinson (University of Pennsylvania, MH061675); B. Mowry (University of Queensland, MH059588); and J. Silverman (Mt. Sinai School of Medicine, MH59586). The samples were collected by V.L. Nimgaonkar's group at the University of Pittsburgh as part of a multi-institutional collaborative research project with J. Smoller and P. Sklar (Massachusetts General Hospital) (grant MH 63420). GoKinD: We acknowledge the National Institutes of Health for allowing the use of their control allele signal intensity and genotype data. The dataset(s) used for the analyses described in this manuscript were obtained from the GAIN Database, controlled through dbGaP accession number phs000018.v1.p1.	Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chaudhary D, 2006, CURR OPIN INVEST DR, V7, P432; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Concannon P, 2008, DIABETES, V57, P2858, DOI 10.2337/db08-0753; Hakonarson H, 2008, DIABETES, V57, P1143, DOI 10.2337/db07-1305; Hayashi K, 2007, PHARMACOL RES, V55, P537, DOI 10.1016/j.phrs.2007.04.009; Hong SW, 2008, BIOCHEM BIOPH RES CO, V365, P426, DOI 10.1016/j.bbrc.2007.10.183; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Manolio TA, 2007, NAT GENET, V39, P1045, DOI 10.1038/ng2127; Mueller PW, 2006, J AM SOC NEPHROL, V17, P1782, DOI 10.1681/ASN.2005080822; Muto A, 1998, EMBO J, V17, P5734, DOI 10.1093/emboj/17.19.5734; Smyth DJ, 2008, DIABETES, V57, P1730, DOI 10.2337/db07-1131; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068	15	373	383	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2008	40	12					1399	1401		10.1038/ng.249	http://dx.doi.org/10.1038/ng.249			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	18978792	Green Accepted			2022-12-27	WOS:000261215900012
J	Hennies, HC; Kornak, U; Zhang, HK; Egerer, J; Zhang, X; Seifert, W; Kuhnisch, J; Budde, B; Natebus, M; Brancati, F; Wilcox, WR; Muller, D; Kaplan, PB; Rajab, A; Zampino, G; Fodale, V; Dallapiccola, B; Newman, W; Metcalfe, K; Clayton-Smith, J; Tassabehji, M; Steinmann, B; Barr, FA; Nurnberg, P; Wieacker, P; Mundlos, S				Hennies, Hans Christian; Kornak, Uwe; Zhang, Haikuo; Egerer, Johannes; Zhang, Xin; Seifert, Wenke; Kuehnisch, Jirko; Budde, Birgit; Naetebus, Marc; Brancati, Francesco; Wilcox, William R.; Mueller, Dietmar; Kaplan, Paige B.; Rajab, Anna; Zampino, Giuseppe; Fodale, Valentina; Dallapiccola, Bruno; Newman, William; Metcalfe, Kay; Clayton-Smith, Jill; Tassabehji, May; Steinmann, Beat; Barr, Francis A.; Nuernberg, Peter; Wieacker, Peter; Mundlos, Stefan			Gerodermia osteodysplastica is caused by mutations in SCYL1BP1, a Rab-6 interacting golgin	NATURE GENETICS			English	Article							SPINOCEREBELLAR NEURODEGENERATION; RECESSIVE FORM; GENE; TRANSPORT; APPARATUS	Gerodermia osteodysplastica is an autosomal recessive disorder characterized by wrinkly skin and osteoporosis. Here we demonstrate that gerodermia osteodysplastica is caused by loss-of-function mutations in SCYL1BP1, which is highly expressed in skin and osteoblasts. The protein localizes to the Golgi apparatus and interacts with Rab6, identifying SCYL1BP1 as a golgin. These results associate abnormalities of the secretory pathway with age-related changes in connective tissues.	[Kornak, Uwe; Zhang, Haikuo; Zhang, Xin; Seifert, Wenke; Kuehnisch, Jirko; Mundlos, Stefan] Charite, Inst Med Genet, D-13353 Berlin, Germany; [Hennies, Hans Christian; Seifert, Wenke; Budde, Birgit; Naetebus, Marc; Nuernberg, Peter] Univ Cologne, CCG, D-50674 Cologne, Germany; [Hennies, Hans Christian] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Kornak, Uwe; Zhang, Haikuo; Egerer, Johannes; Zhang, Xin; Mundlos, Stefan] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Egerer, Johannes; Barr, Francis A.] Max Planck Inst Biochem, D-82152 Munich, Germany; [Brancati, Francesco; Dallapiccola, Bruno] San Giovanni Rotondo & CSS Mendel Inst, IRCCS CSS, I-00198 Rome, Italy; [Brancati, Francesco; Dallapiccola, Bruno] CeSI G Annunzio Univ Fdn, Dept Biomed Sci, Chieti, Italy; [Brancati, Francesco; Dallapiccola, Bruno] CeSI G Annunzio Univ Fdn, Aging Res Ctr, Chieti, Italy; [Wilcox, William R.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Mueller, Dietmar] Klinikum Chemnitz, Inst Med Genet, D-09116 Chemnitz, Germany; [Kaplan, Paige B.] Univ Penn, Childrens Hosp Philadelphia, Sect Metab Dis, Philadelphia, PA 19104 USA; [Rajab, Anna] Minist Hlth, Directorate Gen Hlth Affairs, Genet Unit, Muscat 113, Oman; [Zampino, Giuseppe] Univ Cattolica Sacro Cuore, Ist Clin Pediat, I-00168 Rome, Italy; [Fodale, Valentina] Ist Super Sanita, Dipartimento Biol Cellulare & Neurosci, I-00161 Rome, Italy; [Newman, William; Metcalfe, Kay; Clayton-Smith, Jill; Tassabehji, May] Univ Manchester, St Marys Hosp, Manchester M13 0JH, Lancs, England; [Steinmann, Beat] Univ Childrens Hosp, Div Metab & Mol Pediat, CH-8032 Zurich, Switzerland; [Barr, Francis A.] Univ Liverpool, Canc Res Ctr, Liverpool L3 9TA, Merseyside, England; [Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Wieacker, Peter] Univ Munster, Inst Humangenet, D-48149 Munster, Germany; [Mundlos, Stefan] Berlin Brandenburg Ctr Regenerat Therapies, D-14195 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Cologne; University of Cologne; Max Planck Society; Max Planck Society; IRCCS Casa Sollievo Della Sofferenza; Istituto CSS Mendel; Cedars Sinai Medical Center; Chemnitz Clinic; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Istituto Superiore di Sanita (ISS); University of Manchester; University Children's Hospital Zurich; University of Liverpool; University of Cologne; University of Munster; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Mundlos, S (corresponding author), Charite, Inst Med Genet, D-13353 Berlin, Germany.	stefan.mundlos@charite.de	Hennies, Hans C/G-9424-2014; Seifert, Wenke/B-8772-2011; Kühnisch, Jirko/M-3744-2019; Mundlos, Stefan/ABH-9585-2020; Kühnisch, Jirko/L-7761-2013; Zampino, Giuseppe/AAC-2152-2019; Brancati, Francesco/AAC-3778-2022; Dallapiccola, Bruno/K-8692-2016	Hennies, Hans C/0000-0001-7210-2389; Kühnisch, Jirko/0000-0003-4744-5421; Brancati, Francesco/0000-0003-3624-2354; Newman, William/0000-0002-6382-4678; Dallapiccola, Bruno/0000-0002-5031-1013; Barr, Francis/0000-0001-7518-253X; Seifert, Wenke/0000-0003-1432-9862; Mundlos, Stefan/0000-0002-9788-3166; Budde, Birgit/0000-0001-9385-4168	German Federal Ministry of Education and Research; Ministry for Innovation, Science, Research, and Technology of the Land Nordrhein Westfalen; Deutsche Forschungsgemeinschaft; Italian Telethon; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER	German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Ministry for Innovation, Science, Research, and Technology of the Land Nordrhein Westfalen; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Italian Telethon(Fondazione Telethon); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We are grateful to all participants in this study. We thank J. Evans, B.N. Chodirker and K. Wrogemann for their support. We wish to thank F. Andre, B. Fischer, S. Kolberg and N. Wittstruck for technical assistance. This work was funded by grants from the German Federal Ministry of Education and Research and the Ministry for Innovation, Science, Research, and Technology of the Land Nordrhein Westfalen to H.C.H. and by funds from the Deutsche Forschungsgemeinschaft (collaborative research centre 577) to U. K. The sample IG was obtained from the "Cell line and DNA Bank from patients affected by Genetic Diseases'' collection (http://www.gaslini.org/labdppm.htm) supported by Italian Telethon grants. We thank H. Zentgraf for the generation of monoclonal antibodies.	Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Burman JL, 2008, J BIOL CHEM, V283, P22774, DOI 10.1074/jbc.M801869200; Di YJ, 2003, J HUM GENET, V48, P315, DOI 10.1007/s10038-003-0031-5; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; HUNTER AGW, 1988, J MED GENET, V25, P854, DOI 10.1136/jmg.25.12.854; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Martin GM, 2005, CELL, V120, P523, DOI 10.1016/j.cell.2005.01.031; Pedersen AG, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P226; Rajab A, 2008, AM J MED GENET A, V146A, P965, DOI 10.1002/ajmg.a.32143; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Schmidt WM, 2007, EMBO REP, V8, P691, DOI 10.1038/sj.embor.7401001; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Sun Y, 2007, MOL BIOL CELL, V18, P4129, DOI 10.1091/mbc.E07-01-0080; Wu XH, 2004, NAT MED, V10, P518, DOI 10.1038/nm1041	15	119	126	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1410	1412		10.1038/ng.252	http://dx.doi.org/10.1038/ng.252			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	18997784	Green Accepted			2022-12-27	WOS:000261215900016
J	Tan, LB; Li, XR; Liu, FX; Sun, XY; Li, CG; Zhu, ZF; Fu, YC; Cai, HW; Wang, XK; Xie, DX; Sun, CQ				Tan, Lubin; Li, Xianran; Liu, Fengxia; Sun, Xianyou; Li, Chenggang; Zhu, Zuofeng; Fu, Yongcai; Cai, Hongwei; Wang, Xiangkun; Xie, Daoxin; Sun, Chuanqing			Control of a key transition from prostrate to erect growth in rice domestication	NATURE GENETICS			English	Article							ORYZA-RUFIPOGON; PLANT; GENE; GRAVITROPISM; EVOLUTION; PROTEIN; ORIGIN; MAIZE; LAZY1	The transition from the prostrate growth of ancestral wild rice (O. rufipogon Griff.) to the erect growth of Oryza sativa cultivars was one of the most critical events in rice domestication. This evolutionary step importantly improved plant architecture and increased grain yield. Here we find that prostrate growth of wild rice from Yuanjiang County in China is controlled by a semi-dominant gene, PROG1 (PROSTRATE GROWTH 1), on chromosome 7 that encodes a single Cys(2)-His(2) zinc-finger protein. prog1 variants identified in O. sativa disrupt the prog1 function and inactivate prog1 expression, leading to erect growth, greater grain number and higher grain yield in cultivated rice. Sequence comparison shows that 182 varieties of cultivated rice, including 87 indica and 95 japonica cultivars from 17 countries, carry identical mutations in the prog1 coding region that may have become fixed during rice domestication.	[Tan, Lubin; Li, Xianran; Liu, Fengxia; Sun, Xianyou; Li, Chenggang; Zhu, Zuofeng; Fu, Yongcai; Cai, Hongwei; Wang, Xiangkun; Sun, Chuanqing] China Agr Univ, Dept Genet & Plant Breeding, Natl Ctr Evaluat Agr Wild Plants Rice, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China; [Xie, Daoxin] Tsinghua Univ, Dept Biol Sci & Biotechnol, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China	China Agricultural University; Tsinghua University	Sun, CQ (corresponding author), China Agr Univ, Dept Genet & Plant Breeding, Natl Ctr Evaluat Agr Wild Plants Rice, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China.	daoxin@tsinghua.edu.cn; suncq@cau.edu.cn	Li, Xianran/I-5651-2012; xie, daoxin d/C-8646-2017; Li, Xianran/AAH-1070-2019; Tan, Lubin/H-9270-2017	Li, Xianran/0000-0002-4252-6911; Tan, Lubin/0000-0003-3775-7720	National Natural Science Foundation; Ministry of Agriculture; Ministry of Science and Technology of China	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	We thank N. Harberd for comments on the manuscript, Y. Wang for assisting in cross sections, and the International Rice Research Institute, Chinese Rice Research Institute, Institute of Crop Sciences of Chinese Academy of Agricultural Sciences, Guangxi Academy of Agricultural Sciences and Guangdong Academy of Agricultural Sciences for providing the wild rice and cultivated rice samples. This research was supported by the National Natural Science Foundation, the Ministry of Agriculture and the Ministry of Science and Technology of China.	Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Hiratsu K, 2002, FEBS LETT, V514, P351, DOI 10.1016/S0014-5793(02)02435-3; Khush GS, 1997, PLANT MOL BIOL, V35, P25, DOI 10.1023/A:1005810616885; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li PJ, 2007, CELL RES, V17, P402, DOI 10.1038/cr.2007.38; Li XR, 2008, BIOTECHNOL LETT, V30, P555, DOI 10.1007/s10529-007-9558-4; Lin ZW, 2007, PLANTA, V226, P11, DOI 10.1007/s00425-006-0460-4; Scarpella E, 2003, DEVELOPMENT, V130, P645, DOI 10.1242/dev.00243; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; Takatsuji H, 1999, PLANT MOL BIOL, V39, P1073, DOI 10.1023/A:1006184519697; Tan LB, 2007, J INTEGR PLANT BIOL, V49, P871, DOI 10.1111/j.1744-7909.2007.00497.x; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; WAISEL Y, 1987, OECOLOGIA, V73, P630, DOI 10.1007/BF00379428; Yoshihara T, 2007, PLANT CELL PHYSIOL, V48, P678, DOI 10.1093/pcp/pcm042; Yu BS, 2007, PLANT J, V52, P891, DOI 10.1111/j.1365-313X.2007.03284.x; Yuan QP, 2003, NUCLEIC ACIDS RES, V31, P229, DOI 10.1093/nar/gkg059	21	303	365	15	228	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1360	1364		10.1038/ng.197	http://dx.doi.org/10.1038/ng.197			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18820699				2022-12-27	WOS:000260501500031
J	Bodmer, W; Bonilla, C				Bodmer, Walter; Bonilla, Carolina			Common and rare variants in multifactorial susceptibility to common diseases	NATURE GENETICS			English	Article; Proceedings Paper	Meeting on the Genomics of Common Diseases	JUL 07-10, 2007	Wellcome Trust Sanger Inst, Cambridge, ENGLAND		Wellcome Trust Sanger Inst		GENOME-WIDE ASSOCIATION; DEPENDENT DIABETES-MELLITUS; COLORECTAL-CANCER; RISK LOCUS; HL-A; GENE; APC; RESISTANCE; ADENOMAS; FAMILY	Here, we give a historical overview of the search for genetic variants that influence the susceptibility of an individual to a chronic disease, from RA Fisher's seminal work to the current excitement of whole-genome association studies (WGAS). We then discuss the concepts behind the identification of common variants as disease causal factors and contrast them to the basic ideas that underlie the rare variant hypothesis. The identification of rare variants involves the careful selection of candidate genes to examine, the availability of highly efficient resequencing techniques and the appropriate assessment of the functional consequences of the implicated variant. We believe that this strategy can be successfully applied at present in order to unravel the contribution of rare variants to the multifactorial inheritance of common diseases, which could lead to the implementation of much needed preventative screening schemes.	[Bodmer, Walter; Bonilla, Carolina] Univ Oxford, Canc & Immunogenet Lab, John Radcliffe Hosp, Oxford OX3 9DS, England	University of Oxford	Bodmer, W (corresponding author), Univ Oxford, Canc & Immunogenet Lab, John Radcliffe Hosp, Oxford OX3 9DS, England.	walter.bodmer@hertford.ox.ac.uk	Bonilla, Carolina/U-9263-2018	Bonilla, Carolina/0000-0002-9972-6383; Bodmer, Walter/0000-0001-6244-9792	Cancer Research UK [A6426] Funding Source: Medline	Cancer Research UK(Cancer Research UK)		AIRD I, 1953, BRIT MED J, V1, P799, DOI 10.1136/bmj.1.4814.799; Amiel J.L, 1967, HISTOCOMPAT TEST, V1967, P79; BODMER JG, 1989, LANCET, V1, P1455; Bodmer W, 1999, CYTOGENET CELL GENET, V86, P99, DOI 10.1159/000015360; BODMER W, 1981, BIOL MANIPULATION LI, P217; BODMER W, 1972, NATL CANC I MONOGR, V36, P127; Bodmer WF, 2006, J HUM GENET, V51, P391, DOI 10.1007/s10038-006-0373-x; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cavalli-Sforza LL., 1999, GENETICS HUMAN POPUL; CLARKE C, 1961, PROGR MED GENETICS, V1; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Fearnhead NS, 2005, CELL CYCLE, V4, P521, DOI 10.4161/cc.4.4.1591; Fearnhead NS, 2004, P NATL ACAD SCI USA, V101, P15992, DOI 10.1073/pnas.0407187101; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Felix R, 2006, MUTAT RES-FUND MOL M, V602, P175, DOI 10.1016/j.mrfmmm.2006.09.004; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Fisher RA, 1932, GENETICS, V17, P0107; Frayling IM, 1998, P NATL ACAD SCI USA, V95, P10722, DOI 10.1073/pnas.95.18.10722; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Haldane J. B. S, 1949, RICERCA SCIENTIFIC S, V19, P3; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; LILLY F, 1964, LANCET, V2, P1207; Lovelock PK, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1826; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; MCDEVITT HO, 1974, LANCET, V1, P1269; SINGAL DP, 1973, DIABETES, V22, P429, DOI 10.2337/diab.22.6.429; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; THODAY JM, 1961, NATURE, V191, P368, DOI 10.1038/191368a0; THOMSEN M, 1975, TRANSPLANT REV-DENMA, V22, P125; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; WINEARLS BC, 1984, TISSUE ANTIGENS, V24, P234, DOI 10.1111/j.1399-0039.1984.tb02132.x; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	34	822	863	0	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2008	40	6					695	701		10.1038/ng.f.136	http://dx.doi.org/10.1038/ng.f.136			7	Genetics & Heredity	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18509313	Bronze, Green Accepted			2022-12-27	WOS:000256212000007
J	Lettre, G; Jackson, AU; Gieger, C; Schumacher, FR; Berndt, SI; Sanna, S; Eyheramendy, S; Voight, BF; Butler, JL; Guiducci, C; Illig, T; Hackett, R; Heid, IM; Jacobs, KB; Lyssenko, V; Uda, M; Boehnke, M; Chanock, SJ; Groop, LC; Hu, FB; Isomaa, B; Kraft, P; Peltonen, L; Salomaa, V; Schlessinger, D; Hunter, DJ; Hayes, RB; Abecasis, GR; Wichmann, HE; Mohlke, KL; Hirschhorn, JN				Lettre, Guillaume; Jackson, Anne U.; Gieger, Christian; Schumacher, Fredrick R.; Berndt, Sonja I.; Sanna, Serena; Eyheramendy, Susana; Voight, Benjamin F.; Butler, Johannah L.; Guiducci, Candace; Illig, Thomas; Hackett, Rachel; Heid, Iris M.; Jacobs, Kevin B.; Lyssenko, Valeriya; Uda, Manuela; Boehnke, Michael; Chanock, Stephen J.; Groop, Leif C.; Hu, Frank B.; Isomaa, Bo; Kraft, Peter; Peltonen, Leena; Salomaa, Veikko; Schlessinger, David; Hunter, David J.; Hayes, Richard B.; Abecasis, Goncalo R.; Wichmann, H-Erich; Mohlke, Karen L.; Hirschhorn, Joel N.		Diabet Genetics Initiative; FUSION; KORA; Prostate Lung Colorectal Ovarian C; Nurses' Hlth Study; SardiNIA	Identification of ten loci associated with height highlights new biological pathways in human growth	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; FTO GENE; PROLIFERATION; LINKAGE; ADULT; LET-7; HMGA2; RISK; DIFFERENTIATION	Height is a classic polygenic trait, reflecting the combined influence of multiple as-yet- undiscovered genetic factors. We carried out a meta-analysis of genome-wide association study data of height from 15,821 individuals at 2.2 million SNPs, and followed up the strongest findings in 410,000 subjects. Ten newly identified and two previously reported loci were strongly associated with variation in height (P values from 4 x 10(-7) to 8 x 10(-22)). Together, these 12 loci account for similar to 2% of the population variation in height. Individuals with <= 8 height-increasing alleles and >= 16 height-increasing alleles differ in height by similar to 3.5 cm. The newly identified loci, along with several additional loci with strongly suggestive associations, encompass both strong biological candidates and unexpected genes, and highlight several pathways (let-7 targets, chromatin remodeling proteins and Hedgehog signaling) as important regulators of human stature. These results expand the picture of the biological regulation of human height and of the genetic architecture of this classical complex trait.	[Lettre, Guillaume; Voight, Benjamin F.; Guiducci, Candace; Hackett, Rachel; Peltonen, Leena; Hunter, David J.; Hirschhorn, Joel N.] MIT, Program Med & Populat Genet, Broad Inst, Cambridge, MA 02142 USA; [Lettre, Guillaume; Butler, Johannah L.; Hirschhorn, Joel N.] Childrens Hosp, Div Genet & Endocrinol, Boston, MA 02115 USA; [Lettre, Guillaume; Butler, Johannah L.; Hirschhorn, Joel N.] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Jackson, Anne U.; Sanna, Serena; Boehnke, Michael; Abecasis, Goncalo R.] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Gieger, Christian; Eyheramendy, Susana; Illig, Thomas; Heid, Iris M.; Wichmann, H-Erich] GSF Natl Res Ctr Environm & Hlth, Inst Epidemiol, D-85764 Neuherberg, Germany; [Gieger, Christian; Eyheramendy, Susana; Heid, Iris M.; Wichmann, H-Erich] Univ Munich, Dept Epidemiol, Inst Med Informat Biometry & Epidemiol, D-81377 Munich, Germany; [Schumacher, Fredrick R.; Hu, Frank B.; Hunter, David J.] Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; [Schumacher, Fredrick R.; Hu, Frank B.; Hunter, David J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Schumacher, Fredrick R.; Hu, Frank B.; Kraft, Peter; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Dept Epidemiol, Boston, MA 02115 USA; [Berndt, Sonja I.; Hayes, Richard B.] NCI, Occupat & Environm Epidemiol Branch, Div Canc Epidemiol & Genet, NIH,DHHS, Bethesda, MD 20892 USA; [Sanna, Serena; Uda, Manuela] Cittadella Univ Monserrato, INN, Consiglio Nazl Ric, I-09042 Cagliari, Italy; [Voight, Benjamin F.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Jacobs, Kevin B.] Bioinformed Consulting Serv, Gaithersburg, MD 20877 USA; [Lyssenko, Valeriya; Groop, Leif C.] Lund Univ, Dept Clin Sci Diabetes & Endocrinol, Malmo Univ Hosp, S-20502 Malmo, Sweden; [Chanock, Stephen J.] NCI, NIH, DHHS, Lab Translat Genom,Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Groop, Leif C.] Univ Helsinki, Dept Med, Helsinki Univ Cent Hosp, Helsinki, Finland; [Groop, Leif C.] Univ Helsinki, Res Program Mol Med, Helsinki, Finland; [Hu, Frank B.; Hunter, David J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Isomaa, Bo] Malmska Municipal Hlth Ctr & Hosp, Pietarsaari, Finland; [Isomaa, Bo] Folkhalsan Res Ctr, Helsinki, Finland; [Peltonen, Leena] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Peltonen, Leena] Univ Helsinki, Dept Mol Med, Natl Publ Hlth Inst, FI-00014 Helsinki, Finland; [Peltonen, Leena] Univ Helsinki, Dept Mol Med, Dept Med Genet, FI-00014 Helsinki, Finland; [Salomaa, Veikko] Natl Publ Hlth Inst, Dept Epidemiol & Hlth Promot, FI-00300 Helsinki, Finland; [Schlessinger, David] NIA, Gerontol Res Ctr, Baltimore, MD 21224 USA; [Mohlke, Karen L.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; University of Michigan System; University of Michigan; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Consiglio Nazionale delle Ricerche (CNR); University of Cagliari; Harvard University; Massachusetts General Hospital; Lund University; Skane University Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Harvard University; Harvard T.H. Chan School of Public Health; Folkhalsan Research Center; Wellcome Trust Sanger Institute; Finland National Institute for Health & Welfare; University of Helsinki; Finland National Institute for Health & Welfare; University of Helsinki; Finland National Institute for Health & Welfare; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Harvard Medical School	Hirschhorn, JN (corresponding author), MIT, Program Med & Populat Genet, Broad Inst, Cambridge, MA 02142 USA.	joelh@broad.mit.edu	Uda, Manuela/AAC-2645-2019; Berndt, Sonja I/J-8423-2016; Abecasis, Goncalo R/B-7840-2010; sanna, serena/H-3009-2019; Lai, Sandra/AAY-4176-2020; Schumacher, Fredrick/R-6043-2019; Piras, Maria Grazia/P-2061-2018; Dei, Mariano/AAY-3870-2020; Genetic Epidemiology, Innsbruck Med.Univ./C-2095-2008; Voight, Benjamin/F-1775-2011; Wichmann, Heinz Erich/AAA-5695-2022	Uda, Manuela/0000-0002-4890-6456; sanna, serena/0000-0002-3768-1749; Schumacher, Fredrick/0000-0002-3073-7463; Piras, Maria Grazia/0000-0001-9004-0900; Eyheramendy, Susana/0000-0003-4723-9660; Voight, Benjamin/0000-0002-6205-9994; Dei, Mariano/0000-0002-7404-508X; Hayes, Richard/0000-0002-0918-661X; Jacobs, Kevin/0000-0002-4657-6473; Gieger, Christian/0000-0001-6986-9554; Abecasis, Goncalo/0000-0003-1509-1825	NATIONAL CANCER INSTITUTE [U01CA049449, U01CA098233, R01CA049449, P01CA087969, Z01CP010152] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL084729] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062370, U01DK062370, R01DK072193, R01DK075787, R56DK062370] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000675] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [5U01CA098233, U01 CA049449, CA49449, R01 CA049449, 5P01CA087969, U01 CA098233, P01 CA087969] Funding Source: Medline; NHGRI NIH HHS [R01 HG002651, HG02651] Funding Source: Medline; NHLBI NIH HHS [U01 HL084729, HL084729] Funding Source: Medline; NIDDK NIH HHS [R01 DK072193, DK62370, U01 DK062370, DK72193, R01 DK062370, R56 DK062370, R01 DK075787, 5 R01 DK 075787] Funding Source: Medline; Wellcome Trust [089061] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Asp J, 2006, GENE CHROMOSOME CANC, V45, P820, DOI 10.1002/gcc.20346; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Chikuda H, 2004, GENE DEV, V18, P2418, DOI 10.1101/gad.1224204; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gunnell D, 2001, EPIDEMIOL REV, V23, P313, DOI 10.1093/oxfordjournals.epirev.a000809; Guo YQ, 2006, GENE, V384, P51, DOI 10.1016/j.gene.2006.07.011; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirschhorn JN, 2001, AM J HUM GENET, V69, P106, DOI 10.1086/321287; HIRSCHHORN JN, 2005, NATURE REV GENETICS, V6, P108; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Mathias RA, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S36; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Vartiainen E, 2000, INT J EPIDEMIOL, V29, P49, DOI 10.1093/ije/29.1.49; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821	40	448	463	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					584	591		10.1038/ng.125	http://dx.doi.org/10.1038/ng.125			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18391950	Green Submitted, Green Accepted			2022-12-27	WOS:000255366700026
J	Katajisto, P; Vaahtomeri, K; Ekman, N; Ventela, E; Ristimaki, A; Bardeesy, N; Feil, R; DePinho, RA; Makela, TP				Katajisto, Pekka; Vaahtomeri, Kari; Ekman, Niklas; Ventela, Eeva; Ristimaki, Ari; Bardeesy, Nabeel; Feil, Robert; DePinho, Ronald A.; Makela, Tomi P.			LKB1 signaling in mesenchymal cells required for suppression of gastrointestinal polyposis	NATURE GENETICS			English	Article							PEUTZ-JEGHERS-SYNDROME; SMOOTH-MUSCLE; GROWTH-FACTORS; TGF-BETA; DIFFERENTIATION; FIBROBLASTS; CANCER; MYOFIBROBLASTS; LUNG	Germline mutations in STK11 (also known as LKB1) are found in individuals with Peutz-Jeghers syndrome (PJS)(1) manifesting with gastrointestinal polyps that contain a prominent stromal component. Epithelia in polyps of Stk11(+/-) mice can retain a functional copy of Stk11 (refs. 2,3), and loss of heterozygosity is not an obligate feature of human polyps(4), raising the possibility of non-epithelial origins in tumorigenesis. Here we show that either monoallelic or biallelic loss of murine Stk11 limited to Tagln-expressing mesenchymal cells results in premature postnatal death as a result of gastrointestinal polyps indistinguishable from those in PJS. Stk11-deficient mesenchymal cells produced less TGF beta, and defective TGF beta signaling to epithelial cells coincided with epithelial proliferation. We also noted TGF beta signaling defects in polyps of individuals with PJS, suggesting that the identified stromal-derived mechanism of tumor suppression is also relevant in PJS.	[Katajisto, Pekka; Vaahtomeri, Kari; Ekman, Niklas; Ventela, Eeva; Ristimaki, Ari; Makela, Tomi P.] Univ Helsinki, Genome Scale Biol Program, FIN-00014 Helsinki, Finland; [Katajisto, Pekka; Vaahtomeri, Kari; Ekman, Niklas; Ventela, Eeva; Ristimaki, Ari; Makela, Tomi P.] Univ Helsinki, Inst Biomed, FIN-00014 Helsinki, Finland; [Ristimaki, Ari] Univ Helsinki, Cent Hosp, Dept Pathol, Helsinki, Finland; [Bardeesy, Nabeel] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Massachusetts Gen Hosp Canc Ctr, Boston, MA 02114 USA; [Feil, Robert] Univ Tubingen, Interfak Inst Biochem, D-72076 Tubingen, Germany; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol,Ctr Appl Canc Sci Belfer Inst Inno, Boston, MA 02115 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med,Ctr Appl Canc Sci Belfer Inst Innovat Ca, Boston, MA 02115 USA; [DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Genet,Ctr Appl Canc Sci Belfer Inst Innovat, Boston, MA 02115 USA	University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Eberhard Karls University of Tubingen; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Makela, TP (corresponding author), Univ Helsinki, Genome Scale Biol Program, FIN-00014 Helsinki, Finland.	tomi.makela@helsinki.fi	makela, tomi/B-3734-2009; Feil, Robert/B-8918-2014	makela, tomi/0000-0002-4869-8044; Feil, Robert/0000-0002-7335-4841; Katajisto, Pekka/0000-0002-3033-4189; Vaahtomeri, Kari/0000-0001-7829-3518; DePinho, Ronald/0000-0002-5625-577X				ABE M, 1994, ANAL BIOCHEM, V216, P276, DOI 10.1006/abio.1994.1042; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Boesten LSM, 2006, CELL DEATH DIFFER, V13, P2089, DOI 10.1038/sj.cdd.4401973; Entius MM, 1997, GUT, V41, P320, DOI 10.1136/gut.41.3.320; Entius MM, 2001, J CLIN PATHOL, V54, P126, DOI 10.1136/jcp.54.2.126; Halttunen T, 1996, GASTROENTEROLOGY, V111, P1252, DOI 10.1053/gast.1996.v111.pm8898639; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hernan I, 2004, CLIN GENET, V66, P58, DOI 10.1111/j.0009-9163.2004.00266.x; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kim BG, 2006, NATURE, V441, P1015, DOI 10.1038/nature04846; Kuemmerle JF, 1997, GASTROENTEROLOGY, V113, P817, DOI 10.1016/S0016-5085(97)70176-8; Kuhbandner S, 2000, GENESIS, V28, P15, DOI 10.1002/1526-968X(200009)28:1<15::AID-GENE20>3.0.CO;2-C; KUROKOWA M, 1987, BIOCHEM BIOPH RES CO, V142, P775, DOI 10.1016/0006-291X(87)91481-1; Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Powell DW, 2005, AM J PHYSIOL-GASTR L, V289, pG2, DOI 10.1152/ajpgi.00075.2005; Rossi DJ, 2002, P NATL ACAD SCI USA, V99, P12327, DOI 10.1073/pnas.192301399; RUSSELL WE, 1988, P NATL ACAD SCI USA, V85, P5126, DOI 10.1073/pnas.85.14.5126; Sanchez-Cespedes M, 2002, CANCER RES, V62, P3659; Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074	25	84	92	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2008	40	4					455	459		10.1038/ng.98	http://dx.doi.org/10.1038/ng.98			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18311138				2022-12-27	WOS:000254388100017
J	Turner, DJ; Miretti, M; Rajan, D; Fiegler, H; Carter, NP; Blayney, ML; Beck, S; Hurles, ME				Turner, Daniel J.; Miretti, Marcos; Rajan, Diana; Fiegler, Heike; Carter, Nigel P.; Blayney, Martyn L.; Beck, Stephan; Hurles, Matthew E.			Germline rates of de novo meiotic deletions and duplications causing several genomic disorders	NATURE GENETICS			English	Article							EXPRESSIVE-LANGUAGE DELAY; RECOMBINATION HOT-SPOT; WILLIAMS-BEUREN LOCUS; COPY NUMBER VARIATION; HUMAN Y-CHROMOSOME; HOMOLOGOUS RECOMBINATION; DEVELOPMENTAL DELAY; REARRANGEMENTS; HOTSPOT; REGION	Meiotic recombination between highly similar duplicated sequences (nonallelic homologous recombination, NAHR) generates deletions, duplications, inversions and translocations, and it is responsible for genetic diseases known as 'genomic disorders', most of which are caused by altered copy number of dosage-sensitive genes. NAHR hot spots have been identified within some duplicated sequences. We have developed sperm-based assays to measure the de novo rate of reciprocal deletions and duplications at four NAHR hot spots. We used these assays to dissect the relative rates of NAHR between different pairs of duplicated sequences. We show that (i) these NAHR hot spots are specific to meiosis, (ii) deletions are generated at a higher rate than their reciprocal duplications in the male germline and (iii) some of these genomic disorders are likely to have been underascertained clinically, most notably that resulting from the duplication of 7q11, the reciprocal of the deletion causing Williams-Beuren syndrome.	[Turner, Daniel J.; Miretti, Marcos; Rajan, Diana; Fiegler, Heike; Carter, Nigel P.; Hurles, Matthew E.] Wellcome Trust Genom Campus, Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Blayney, Martyn L.] Bourn Hall Clin, Cambridge CB23 2TN, England; [Beck, Stephan] UCL, Inst Canc, London WC1E 6DD, England	Wellcome Trust Sanger Institute; University of London; University College London	Hurles, ME (corresponding author), Wellcome Trust Genom Campus, Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	meh@sanger.ac.uk	Miretti, Marcos M./AAY-5895-2020	Miretti, Marcos M./0000-0001-8179-1606	Wellcome Trust [077008, 077014] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; Blanco P, 2000, J MED GENET, V37, P752, DOI 10.1136/jmg.37.10.752; Bosch E, 2003, HUM MOL GENET, V12, P341, DOI 10.1093/hmg/ddg031; CHANG FY, 1994, IEEE T COMPON PACK B, V17, P3, DOI 10.1109/96.296425; Edelmann L, 1999, HUM MOL GENET, V8, P1157, DOI 10.1093/hmg/8.7.1157; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; Han LL, 2000, HUM MOL GENET, V9, P1881, DOI 10.1093/hmg/9.12.1881; Hurles ME, 2006, GENOMIC DISORDERS: THE GENOMIC BASIS OF DISEASE, P341, DOI 10.1007/978-1-59745-039-3_24; Infante J, 2001, MUSCLE NERVE, V24, P1149, DOI 10.1002/mus.1126; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Jeffreys AJ, 1998, MOL CELL, V2, P267, DOI 10.1016/S1097-2765(00)80138-0; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kirchhoff M, 2007, EUR J MED GENET, V50, P33, DOI 10.1016/j.ejmg.2006.10.002; Kriek M, 2006, EUR J HUM GENET, V14, P180, DOI 10.1038/sj.ejhg.5201540; Kumar N, 1999, ANN NY ACAD SCI, V883, P344, DOI 10.1111/j.1749-6632.1999.tb08596.x; Lindsay SJ, 2006, AM J HUM GENET, V79, P890, DOI 10.1086/508709; Long FL, 1998, J MED GENET, V35, P425, DOI 10.1136/jmg.35.5.425; Lopes J, 1998, HUM MOL GENET, V7, P141, DOI 10.1093/hmg/7.1.141; Lupski JR, 2005, PLOS GENET, V1, P627, DOI 10.1371/journal.pgen.0010049; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; May CA, 2002, NAT GENET, V31, P272, DOI 10.1038/ng918; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Potocki L, 2000, NAT GENET, V24, P84, DOI 10.1038/71743; Potocki L, 2007, AM J HUM GENET, V80, P633, DOI 10.1086/512864; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reiter LT, 1996, NAT GENET, V12, P288, DOI 10.1038/ng0396-288; Shaw CJ, 2004, AM J HUM GENET, V75, P75, DOI 10.1086/422016; Somerville MJ, 2005, NEW ENGL J MED, V353, P1694, DOI 10.1056/NEJMoa051962; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Thomas NS, 2006, EUR J HUM GENET, V14, P831, DOI 10.1038/sj.ejhg.5201617; Tiemann-Boege I, 2006, PLOS GENET, V2, P682, DOI 10.1371/journal.pgen.0020070; Torniero C, 2007, EUR J HUM GENET, V15, P62, DOI 10.1038/sj.ejhg.5201730	32	227	233	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2008	40	1					90	95		10.1038/ng.2007.40	http://dx.doi.org/10.1038/ng.2007.40			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18059269	Green Accepted			2022-12-27	WOS:000252118600023
J	Yadava, RS; Frenzel-McCardell, CD; Yu, Q; Srinivasan, V; Tucker, AL; Puymirat, J; Thornton, CA; Prall, OW; Harvey, RP; Mahadevan, MS				Yadava, Ramesh S.; Frenzel-McCardell, Carla D.; Yu, Qing; Srinivasan, Varadamurthy; Tucker, Amy L.; Puymirat, Jack; Thornton, Charles A.; Prall, Owen W.; Harvey, Richard P.; Mahadevan, Mani S.			RNA toxicity in myotonic muscular dystrophy induces NKX2-5 expression	NATURE GENETICS			English	Article							CONGENITAL HEART-DISEASE; CARDIAC CONDUCTION; SKELETAL-MUSCLE; TRANSGENIC MICE; GAP-JUNCTIONS; TRANSCRIPTION; DIFFERENTIATION; MUTATION; CELLS; MODEL	Myotonic muscular dystrophy (DM1) is the most common inherited neuromuscular disorder in adults and is considered the first example of a disease caused by RNA toxicity. Using a reversible transgenic mouse model of RNA toxicity in DM1, we provide evidence that DM1 is associated with induced NKX2-5 expression. Transgene expression resulted in cardiac conduction defects, increased expression of the cardiac-specific transcription factor NKX2-5 and profound disturbances in connexin 40 and connexin 43. Notably, overexpression of the DMPK 3' UTR mRNA in mouse skeletal muscle also induced transcriptional activation of Nkx2-5 and its targets. In human muscles, these changes were specific to DM1 and were not present in other muscular dystrophies. The effects on NKX2-5 and its downstream targets were reversed by silencing toxic RNA expression. Furthermore, using Nkx2-5(+/-) mice, we show that NKX2-5 is the first genetic modifier of DM1-associated RNA toxicity in the heart.	[Yadava, Ramesh S.; Frenzel-McCardell, Carla D.; Yu, Qing; Srinivasan, Varadamurthy; Mahadevan, Mani S.] Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA; [Tucker, Amy L.] Univ Virginia, Dept Med, Charlottesville, VA 22908 USA; [Puymirat, Jack] Univ Laval, Human Genet Res Unit, Quebec City, PQ G1V 4G2, Canada; [Thornton, Charles A.] Univ Rochester, Dept Neurol, Rochester, NY 14642 USA; [Prall, Owen W.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia	University of Virginia; University of Virginia; Laval University; University of Rochester; Victor Chang Cardiac Research Institute	Mahadevan, MS (corresponding author), Univ Virginia, Dept Pathol, Charlottesville, VA 22908 USA.	mahadevan@virginia.edu	Yadava, Ramesh S/AAZ-3099-2021	Yadava, Ramesh S/0000-0002-0092-5033; Harvey, Richard/0000-0002-9950-9792	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049077, R01AR052771, R01AR045992] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR045992, AR052771, R01 AR052771-03, R01 AR049077, R01 AR052771] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Akazawa H, 2005, PHARMACOL THERAPEUT, V107, P252, DOI 10.1016/j.pharmthera.2005.03.005; Amack JD, 1999, HUM MOL GENET, V8, P1975, DOI 10.1093/hmg/8.11.1975; Amack JD, 2002, J CELL BIOL, V159, P419, DOI 10.1083/jcb.200206020; Araya R, 2005, J CELL SCI, V118, P27, DOI 10.1242/jcs.01553; Berul CI, 2000, J INTERV CARD ELECTR, V4, P351, DOI 10.1023/A:1009842114968; Berul CI, 1999, J CLIN INVEST, V103, pR1, DOI 10.1172/JCI5346; Biben C, 2000, CIRC RES, V87, P888, DOI 10.1161/01.RES.87.10.888; Brown CO, 2004, J BIOL CHEM, V279, P10659, DOI 10.1074/jbc.M301648200; Bruneau BG, 2001, CELL, V106, P709, DOI 10.1016/S0092-8674(01)00493-7; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Chen ZF, 2002, INORG CHEM COMMUN, V5, P35, DOI 10.1016/S1387-7003(01)00341-0; Elliott DA, 2006, DEVELOPMENT, V133, P1311, DOI 10.1242/dev.02305; Furling D, 2001, NEUROMUSCULAR DISORD, V11, P728, DOI 10.1016/S0960-8966(01)00226-7; Gaussin V, 2004, ANAT REC PART A, V280A, P1022, DOI 10.1002/ar.a.20074; Gorbe A, 2005, HISTOCHEM CELL BIOL, V123, P573, DOI 10.1007/s00418-004-0745-2; Harper P.S., 1989, MYOTONIC DYSTROPHY; Jay PY, 2004, J CLIN INVEST, V113, P1130, DOI 10.1172/JCI200419846; Kasahara H, 2001, J CLIN INVEST, V108, P189, DOI 10.1172/JCI200112694; Kasahara H, 2003, J MOL CELL CARDIOL, V35, P243, DOI 10.1016/S0022-2828(03)00002-6; Kasahara H, 1998, CIRC RES, V82, P936, DOI 10.1161/01.RES.82.9.936; Langlois MA, 2003, MOL THER, V7, P670, DOI 10.1016/S1525-0016(03)00068-6; Liberatore CM, 2002, DEV BIOL, V244, P243, DOI 10.1006/dbio.2002.0604; Lien CL, 1999, DEVELOPMENT, V126, P75; Linhares VLF, 2004, CARDIOVASC RES, V64, P402, DOI 10.1016/j.cardiores.2004.09.021; LINTS TJ, 1993, DEVELOPMENT, V119, P419; Liquori CL, 2001, SCIENCE, V293, P864, DOI 10.1126/science.1062125; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo CW, 2000, CIRC RES, V87, P346; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; Mahadevan MS, 2006, NAT GENET, V38, P1066, DOI 10.1038/ng1857; Mankodi A, 2000, SCIENCE, V289, P1769, DOI 10.1126/science.289.5485.1769; Mankodi A, 2005, CIRC RES, V97, P1152, DOI 10.1161/01.RES.0000193598.89753.e3; Mankodi A, 2003, ANN NEUROL, V54, P760, DOI 10.1002/ana.10763; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Pashmforoush M, 2004, CELL, V117, P373, DOI 10.1016/S0092-8674(04)00405-2; Pelargonio G, 2002, HEART, V88, P665, DOI 10.1136/heart.88.6.665; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; Ranum LPW, 2004, AM J HUM GENET, V74, P793, DOI 10.1086/383590; Riazi AM, 2005, J BIOL CHEM, V280, P10716, DOI 10.1074/jbc.M500028200; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Schwartz RJ, 1999, DEVELOPMENT, V126, P4187; Tanaka M, 2002, COLD SPRING HARB SYM, V67, P317, DOI 10.1101/sqb.2002.67.317; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Tapscott SJ, 2001, SCIENCE, V293, P816, DOI 10.1126/science.1063517; Teunissen BEJ, 2003, GENE, V322, P123, DOI 10.1016/j.gene.2003.08.011; Timchenko NA, 2001, MOL CELL BIOL, V21, P6927, DOI 10.1128/MCB.21.20.6927-6938.2001; Wakimoto H, 2003, GENESIS, V37, P144, DOI 10.1002/gene.10236; Wakimoto H, 2002, J CARDIOVASC ELECTR, V13, P682, DOI 10.1046/j.1540-8167.2002.00682.x	50	59	65	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2008	40	1					61	68		10.1038/ng.2007.28	http://dx.doi.org/10.1038/ng.2007.28			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18084293	Green Accepted			2022-12-27	WOS:000252118600019
J	Guo, DC; Pannu, H; Tran-Fadulu, V; Papke, CL; Yu, RK; Avidan, N; Bourgeois, S; Estrera, AL; Safi, HJ; Sparks, E; Amor, D; Ades, L; McConnell, V; Willoughby, CE; Abuelo, D; Willing, M; Lewis, RA; Kim, DH; Scherer, S; Tung, PP; Ahn, C; Buja, LM; Raman, CS; Shete, SS; Milewicz, DM				Guo, Dong-Chuan; Pannu, Hariyadarshi; Tran-Fadulu, Van; Papke, Christina L.; Yu, Robert K.; Avidan, Nili; Bourgeois, Scott; Estrera, Anthony L.; Safi, Hazim J.; Sparks, Elizabeth; Amor, David; Ades, Lesley; McConnell, Vivienne; Willoughby, Colin E.; Abuelo, Dianne; Willing, Marcia; Lewis, Richard A.; Kim, Dong H.; Scherer, Steve; Tung, Poyee P.; Ahn, Chul; Buja, L. Maximilian; Raman, C. S.; Shete, Sanjay S.; Milewicz, Dianna M.			Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections	NATURE GENETICS			English	Article							FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; GENETIC-BASIS; PROTEINS; BINDING; MYOSIN; MYOPATHY	The major function of vascular smooth muscle cells ( SMCs) is contraction to regulate blood pressure and flow. SMC contractile force requires cyclic interactions between SMC alpha-actin ( encoded by ACTA2) and the beta-myosin heavy chain ( encoded by MYH11). Here we show that missense mutations in ACTA2 are responsible for 14% of inherited ascending thoracic aortic aneurysms and dissections ( TAAD). Structural analyses and immunofluorescence of actin filaments in SMCs derived from individuals heterozygous for ACTA2 mutations illustrate that these mutations interfere with actin filament assembly and are predicted to decrease SMC contraction. Aortic tissues from affected individuals showed aortic medial degeneration, focal areas of medial SMC hyperplasia and disarray, and stenotic arteries in the vasa vasorum due to medial SMC proliferation. These data, along with the previously reported MYH11 mutations causing familial TAAD(1), indicate the importance of SMC contraction in maintaining the structural integrity of the ascending aorta.	Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA; Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; Univ Texas Hlth Sci Ctr Houston, Dept Cardiothorac & Vasc Surg, Houston, TX 77030 USA; Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; Royal Childrens Hosp, Genet Hlth Serv Victoria, Clin Genet Res Grp, Parkville, Vic 3052, Australia; Univ Sydney, Childrens Hosp Westmead, Dept Pediat & Child Hlth, Sydney, NSW 2006, Australia; No Ireland Reg Genet Serv, Dept Genet, Hosp Trust, Belfast BT97 AB, Antrim, North Ireland; Queens Univ Belfast, Sch Biomed Sci, Ctr Vis Sci, Belfast BT12 6BA, Antrim, North Ireland; Rhode Isl Hosp, Dept Pediat, Providence, RI 02903 USA; Univ Iowa Hosp & Clin, Dept Pediat, Iowa City, IA 52242 USA; Baylor Coll Med, Dept Ophthalmol, Houston, TX 77030 USA; Brigham & Womens Hosp, Harvard Med Sch, Dept Neurosurg, Boston, MA 02115 USA; Baylor Coll Med, Human Genome Sequencing Ctr, Dept Human Mol Genet, Houston, TX 77030 USA; Univ Texas Hlth Sci Ctr Houston, Dept Pathol & Lab Med, Houston, TX 77030 USA; Univ Texas Hlth Sci Ctr Houston, Struct Biol Ctr, Dept Biochem, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University System of Ohio; Ohio State University; Royal Children's Hospital Melbourne; University of Sydney; Queens University Belfast; Lifespan Health Rhode Island; Rhode Island Hospital; University of Iowa; Baylor College of Medicine; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Milewicz, DM (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX 77030 USA.	dianna.m.milewicz@uth.tmc.edu	Estrera, Anthony/ABG-4175-2021; Amor, David J/A-6478-2018	Amor, David J/0000-0001-7191-8511; Kim, Dong/0000-0002-1523-6396; Rui, Yanning/0000-0002-4482-5579; Raman, C. S./0000-0002-1036-3193; Willoughby, Colin/0000-0002-1246-4166; Buja, Louis Maximilian/0000-0001-8386-7029	NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062594, P50HL083794] Funding Source: NIH RePORTER; NCRR NIH HHS [RR024148] Funding Source: Medline; NHLBI NIH HHS [P50HL083794-01, R01 HL62594] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; Biddinger A, 1997, J VASC SURG, V25, P506, DOI 10.1016/S0741-5214(97)70261-1; Bixler D, 1976, Birth Defects Orig Artic Ser, V12, P229; Crawford K, 2002, MOL CELL BIOL, V22, P5887, DOI 10.1128/MCB.22.16.5887-5896.2002; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; FATIGATI V, 1984, J BIOL CHEM, V259, P4383; FINKBOHNER R, 1995, CIRCULATION, V91, P728, DOI 10.1161/01.CIR.91.3.728; GEISTERFERLOWRANCE AAT, 1990, CELL, V62, P999, DOI 10.1016/0092-8674(90)90274-I; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Guo DC, 2001, CIRCULATION, V103, P2461; He RM, 2006, J THORAC CARDIOV SUR, V131, P671, DOI 10.1016/j.jtcvs.2005.09.018; Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005; Klenchin VA, 2003, NAT STRUCT BIOL, V10, P1058, DOI 10.1038/nsb1006; LEWIS RA, 1995, ARCH OPHTHALMOL-CHIC, V113, P1330, DOI 10.1001/archopht.1995.01100100118041; Loeys BL, 2006, NEW ENGL J MED, V355, P788, DOI 10.1056/NEJMoa055695; MCHUGH KM, 1991, DEV BIOL, V148, P442, DOI 10.1016/0012-1606(91)90263-3; Nowak KJ, 1999, NAT GENET, V23, P208, DOI 10.1038/13837; Nowak KJ, 2007, ANN NEUROL, V61, P175, DOI 10.1002/ana.21035; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Page R, 1998, J MOL BIOL, V280, P463, DOI 10.1006/jmbi.1998.1879; Pannu H, 2005, CIRCULATION, V112, P513, DOI 10.1161/CIRCULATIONAHA.105.537340; Pannu H, 2007, HUM MOL GENET, V16, P2453, DOI 10.1093/hmg/ddm201; Pannu H, 2006, ANN NY ACAD SCI, V1085, P242, DOI 10.1196/annals.1383.024; Poindexter Brian J, 2005, J Burns Wounds, V4, pe7; Schildmeyer LA, 2000, FASEB J, V14, P2213, DOI 10.1096/fj.99-0927com; Small JV, 1998, ACTA PHYSIOL SCAND, V164, P341; Sparrow JC, 2003, NEUROMUSCULAR DISORD, V13, P519, DOI 10.1016/S0960-8966(03)00101-9; Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5; VANDEKERCKHOVE J, 1978, J MOL BIOL, V126, P783, DOI 10.1016/0022-2836(78)90020-7; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	30	561	582	0	38	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2007	39	12					1488	1493		10.1038/ng.2007.6	http://dx.doi.org/10.1038/ng.2007.6			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	17994018				2022-12-27	WOS:000251267400017
J	Razzaque, MA; Nishizawa, T; Komoike, Y; Yagi, H; Furutani, M; Amo, R; Kamisago, M; Momma, K; Katayama, H; Nakagawa, M; Fujiwara, Y; Matsushima, M; Mizuno, K; Tokuyama, M; Hirota, H; Muneuchi, J; Higashinakagawa, T; Matsuoka, R				Razzaque, M. Abdur; Nishizawa, Tsutomu; Komoike, Yuta; Yagi, Hisato; Furutani, Michiko; Amo, Ryunosuke; Kamisago, Mitsuhiro; Momma, Kazuo; Katayama, Hiroshi; Nakagawa, Masao; Fujiwara, Yuko; Matsushima, Masaki; Mizuno, Katsumi; Tokuyama, Mika; Hirota, Hamao; Muneuchi, Jun; Higashinakagawa, Toru; Matsuoka, Rumiko			Germline gain-of-function mutations in RAF1 cause Noonan syndrome	NATURE GENETICS			English	Article							FACIO-CUTANEOUS SYNDROME; PROTEIN-KINASE-A; CARDIAC-HYPERTROPHY; SIGNALING PATHWAY; C-RAF; B-RAF; DISORDERS; PHENOTYPE; KRAS; ACTIVATION	Noonan syndrome is characterized by short stature, facial dysmorphia and a wide spectrum of congenital heart defects1,2. Mutations of PTPN11, KRAS and SOS1 in the RAS- MAPK pathway cause similar to 60% of cases of Noonan syndrome3-9. However, the gene(s) responsible for the remainder are unknown. We have identified five different mutations in RAF1 in ten individuals with Noonan syndrome; those with any of four mutations causing changes in the CR2 domain of RAF1 had hypertrophic cardiomyopathy (HCM), whereas affected individuals with mutations leading to changes in the CR3 domain did not. Cells transfected with constructs containing Noonan syndrome - associated RAF1 mutations showed increased in vitro kinase and ERK activation, and zebrafish embryos with morpholino knockdown of raf1 demonstrated the need for raf1 for the development of normal myocardial structure and function. Thus, our findings implicate RAF1 gain-of-function mutations as a causative agent of a human developmental disorder, representing a new genetic mechanism for the activation of the MAPK pathway.	Tokyo Womens Med Univ, IREIIMS, Tokyo 1628666, Japan; Waseda Univ, Sch Educ, Dept Biol, Tokyo, Japan; Tokyo Womens Med Univ, Grad Sch Med, Inst Adv Biomed Engn & Sci, Tokyo 1628666, Japan; Tokyo Womens Med Univ, Div Pediat Cardiol, Tokyo 1628666, Japan; Osaka Med Coll, Dept Pediat, Osaka, Japan; Shiga Univ Med Sci, Dept Pediat, Shiga, Japan; Jikei Univ, Dept Pediat, Tokyo, Japan; Social Insurance Chukyo Hosp, Dept Pediat Cardiol, Aichi, Japan; Chiba Childrens Hosp, Dept Neonatol, Chiba, Japan; Toho Univ, Dept Pediat, Tokyo, Japan; Kitasato Univ, Dept Pediat, Kanagawa, Japan; Kyushu Univ, Dept Pediat, Fukuoka 812, Japan	Tokyo Women's Medical University; Waseda University; Tokyo Women's Medical University; Tokyo Women's Medical University; Osaka Medical College; Shiga University of Medical Science; Jikei University; Chiba Children's Hospital; Toho University; Kitasato University; Kyushu University	Matsuoka, R (corresponding author), Tokyo Womens Med Univ, IREIIMS, Tokyo 1628666, Japan.	rumiko@imcir.twmu.ac.jp		Amo, Ryunosuke/0000-0001-8644-2296; Yagi, Hisato/0000-0003-1460-4043; Razzaque, Md Abdur/0000-0002-5932-3432				ALLANSON JE, 1987, J MED GENET, V24, P9, DOI 10.1136/jmg.24.1.9; Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Bentires-Alj M, 2006, NAT MED, V12, P283, DOI 10.1038/nm0306-283; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Carta C, 2006, AM J HUM GENET, V79, P129, DOI 10.1086/504394; Chan EYW, 2002, MOL CARCINOGEN, V33, P189, DOI 10.1002/mc.10031; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Emuss V, 2005, CANCER RES, V65, P9719, DOI 10.1158/0008-5472.CAN-05-1683; Fragale A, 2004, HUM MUTAT, V23, P267, DOI 10.1002/humu.20005; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Gelb BD, 2006, HUM MOL GENET, V15, pR220, DOI 10.1093/hmg/ddl197; Harris IS, 2004, CIRCULATION, V110, P718, DOI 10.1161/01.CIR.0000138190.50127.6A; HEIDECKER G, 1990, MOL CELL BIOL, V10, P2503, DOI 10.1128/MCB.10.6.2503; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Komoike Y, 2005, BIOCHEM BIOPH RES CO, V328, P858, DOI 10.1016/j.bbrc.2005.01.031; Kratz CP, 2006, CELL CYCLE, V5, P1607, DOI 10.4161/cc.5.15.3128; MARSHALL CJ, 1994, CURR OPIN GENET DEV, V4, P82, DOI 10.1016/0959-437X(94)90095-7; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; NOONAN JA, 1968, AM J DIS CHILD, V116, P373, DOI 10.1001/archpedi.1968.02100020377005; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2002, AM J HUM GENET, V70, P1555, DOI 10.1086/340847; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Yamazaki T, 1997, J MOL CELL CARDIOL, V29, P2491, DOI 10.1006/jmcc.1997.0488; Zebisch A, 2006, CANCER RES, V66, P3401, DOI 10.1158/0008-5472.CAN-05-0115	28	340	357	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					1013	1017		10.1038/ng2078	http://dx.doi.org/10.1038/ng2078			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17603482				2022-12-27	WOS:000248446900020
J	Cartolano, M; Castillo, R; Efremova, N; Kuckenberg, M; Zethof, J; Gerats, T; Schwarz-Sommer, Z; Vandenbussche, M				Cartolano, Maria; Castillo, Rosa; Efremova, Nadia; Kuckenberg, Markus; Zethof, Jan; Gerats, Tom; Schwarz-Sommer, Zsuzsanna; Vandenbussche, Michiel			A conserved microRNA module exerts homeotic control over Petunia hybrida and Antirrhinum majus floral organ identity	NATURE GENETICS			English	Article							ARABIDOPSIS; FLOWER; GENES; EXPRESSION; MORPHOGENESIS; FIMBRIATA; ELEMENTS; STYLOSA	It is commonly thought that deep phylogenetic conservation of plant microRNAs ( miRNAs) and their targets(1,2) indicates conserved regulatory functions. We show that the blind ( bl) mutant of Petunia hybrida(3) and the fistulata ( fis) mutant of Antirrhinum majus(4,5), which have similar homeotic phenotypes, are recessive alleles of two homologous miRNA- encoding genes. The BL and FIS genes control the spatial restriction of homeotic class C genes(6,7) to the inner floral whorls, but their ubiquitous early floral expression patterns are in contradiction with a potential role in patterning C gene expression. We provide genetic evidence for the unexpected function of the MIRFIS and MIRBL genes in the center of the flower and propose a dynamic mechanism underlying their regulatory role. Notably, Arabidopsis thaliana, a more distantly related species, also contains this miRNA module but does not seem to use it to confine early C gene expression to the center of the flower.	Max Planck Inst Zuchtungsforsch, Plant Mol Genet Dept, D-50829 Cologne, Germany; Radboud Univ Nijmegen, Inst Wetlands & Water Res, NL-6525 ED Nijmegen, Netherlands	Max Planck Society; Radboud University Nijmegen	Schwarz-Sommer, Z (corresponding author), Max Planck Inst Zuchtungsforsch, Plant Mol Genet Dept, Carl Von Linne Weg 10, D-50829 Cologne, Germany.	schwarzs@mpiz-koeln.mpg.de	Gerats, Tom/A-3528-2012	VANDENBUSSCHE, Michiel/0000-0002-4192-7369; Cartolano, Maria/0000-0001-9830-988X				Axtell MJ, 2005, PLANT CELL, V17, P1658, DOI 10.1105/tpc.105.032185; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Davies B, 1999, EMBO J, V18, P4023, DOI 10.1093/emboj/18.14.4023; Davies B, 2006, ADV BOT RES, V44, P279, DOI 10.1016/S0065-2296(06)44007-6; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; Gomez-Mena C, 2005, DEVELOPMENT, V132, P429, DOI 10.1242/dev.01600; Gusmaroli G, 2002, GENE, V283, P41, DOI 10.1016/S0378-1119(01)00833-2; Hong RL, 2003, PLANT CELL, V15, P1296, DOI 10.1105/tpc.009548; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; INGRAM GC, 1995, PLANT CELL, V7, P1501, DOI 10.1105/tpc.7.9.1501; Ingram GC, 1997, EMBO J, V16, P6521, DOI 10.1093/emboj/16.21.6521; Jack T, 2004, PLANT CELL, V16, pS1, DOI 10.1105/tpc.017038; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kater MM, 1998, PLANT CELL, V10, P171, DOI 10.1105/tpc.10.2.171; Keck E, 2003, EMBO J, V22, P1058, DOI 10.1093/emboj/cdg097; Maes T, 2001, PLANT CELL, V13, P229, DOI 10.1105/tpc.13.2.229; McSteen PCM, 1998, DEVELOPMENT, V125, P2359; Mlotshwa S, 2006, PLANT MOL BIOL, V61, P781, DOI 10.1007/s11103-006-0049-0; Motte P, 1998, DEVELOPMENT, V125, P71; Navarro C, 2004, DEVELOPMENT, V131, P3649, DOI 10.1242/dev.01205; Nikovics K, 2006, PLANT CELL, V18, P2929, DOI 10.1105/tpc.106.045617; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shigyo M, 2006, GENE, V366, P256, DOI 10.1016/j.gene.2005.08.009; VALLADE J, 1987, CAN J BOT, V65, P761, DOI 10.1139/b87-101; Valoczi A, 2006, PLANT J, V47, P140, DOI 10.1111/j.1365-313X.2006.02766.x; Van den Broeck D, 1998, PLANT J, V13, P121, DOI 10.1046/j.1365-313X.1998.00004.x; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943	28	122	146	2	41	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39	7					901	905		10.1038/ng2056	http://dx.doi.org/10.1038/ng2056			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17589508	Green Published			2022-12-27	WOS:000247619800022
J	Heintzman, ND; Stuart, RK; Hon, G; Fu, YT; Ching, CW; Hawkins, RD; Barrera, LO; Van Calcar, S; Qu, CX; Ching, KA; Wang, W; Weng, ZP; Green, RD; Crawford, GE; Ren, B				Heintzman, Nathaniel D.; Stuart, Rhona K.; Hon, Gary; Fu, Yutao; Ching, Christina W.; Hawkins, R. David; Barrera, Leah O.; Van Calcar, Sara; Qu, Chunxu; Ching, Keith A.; Wang, Wei; Weng, Zhiping; Green, Roland D.; Crawford, Gregory E.; Ren, Bing			Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome	NATURE GENETICS			English	Article							SYSTEMIC CARNITINE DEFICIENCY; HISTONE MODIFICATIONS; WIDE ANALYSIS; MOLECULAR-CLONING; TRANSPORTER OCTN2; GENE-EXPRESSION; CODE; ORGANIZATION; ACETYLATION; ACTIVATION	Eukaryotic gene transcription is accompanied by acetylation and methylation of nucleosomes near promoters, but the locations and roles of histone modifications elsewhere in the genome remain unclear. We determined the chromatin modification states in high resolution along 30 Mb of the human genome and found that active promoters are marked by trimethylation of Lys4 of histone H3 (H3K4), whereas enhancers are marked by monomethylation, but not trimethylation, of H3K4. We developed computational algorithms using these distinct chromatin signatures to identify new regulatory elements, predicting over 200 promoters and 400 enhancers within the 30-Mb region. This approach accurately predicted the location and function of independently identified regulatory elements with high sensitivity and specificity and uncovered a novel functional enhancer for the carnitine transporter SLC22A5 (OCTN2). Our results give insight into the connections between chromatin modifications and transcriptional regulatory activity and provide a new tool for the functional annotation of the human genome.	Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Biomed Sci Grad Program, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Program Bioinformat, La Jolla, CA 92093 USA; Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; Boston Univ, Bioinformat Program, Boston, MA 02215 USA; Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; NimbleGen Syst Inc, Madison, WI 53711 USA; Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; Duke Univ, Dept Pediat, Durham, NC 27708 USA	Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Boston University; University of California System; University of California San Diego; Boston University; Roche Holding; Roche NimbleGen; Duke University; Duke University	Ren, B (corresponding author), Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, 9500 Gilman Dr, La Jolla, CA 92093 USA.	biren@ucsd.edu	Li, Yapeng/N-1042-2017	Li, Yapeng/0000-0002-5042-6881; Soriaga, Leah/0000-0001-5852-741X; Stuart, Rhona/0000-0001-5916-9693				Barrera LO, 2006, CURR OPIN CELL BIOL, V18, P291, DOI 10.1016/j.ceb.2006.04.002; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Blanchette M, 2006, GENOME RES, V16, P656, DOI 10.1101/gr.4866006; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Felsenfeld G, 1996, CELL, V86, P13, DOI 10.1016/S0092-8674(00)80073-2; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Hatzis P, 2002, MOL CELL, V10, P1467, DOI 10.1016/S1097-2765(02)00786-4; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kouskouti A, 2005, EMBO J, V24, P347, DOI 10.1038/sj.emboj.7600516; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Nezu JI, 1999, NAT GENET, V21, P91, DOI 10.1038/5030; Nightingale KP, 2006, CURR OPIN GENET DEV, V16, P125, DOI 10.1016/j.gde.2006.02.015; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Schomig E, 1998, FEBS LETT, V425, P79, DOI 10.1016/S0014-5793(98)00203-8; Sekine T, 1998, BIOCHEM BIOPH RES CO, V251, P586, DOI 10.1006/bbrc.1998.9521; Shoji Y, 1998, AM J HUM GENET, V63, P101, DOI 10.1086/301911; Smale ST, 2003, ANNU REV BIOCHEM, V72, P449, DOI 10.1146/annurev.biochem.72.121801.161520; Stanley CA, 2004, ANN NY ACAD SCI, V1033, P42, DOI 10.1196/annals.1320.004; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tamai I, 1998, J BIOL CHEM, V273, P20378, DOI 10.1074/jbc.273.32.20378; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang YH, 1999, P NATL ACAD SCI USA, V96, P2356, DOI 10.1073/pnas.96.5.2356; Wu X, 1998, BIOCHEM BIOPH RES CO, V246, P589, DOI 10.1006/bbrc.1998.8669	35	2327	2371	5	162	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2007	39	3					311	318		10.1038/ng1966	http://dx.doi.org/10.1038/ng1966			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17277777				2022-12-27	WOS:000244480000012
J	Shima, N; Alcaraz, A; Liachko, I; Buske, TR; Andrews, CA; Munroe, RJ; Hartford, SA; Tye, BK; Schimenti, JC				Shima, Naoko; Alcaraz, Ana; Liachko, Ivan; Buske, Tavanna R.; Andrews, Catherine A.; Munroe, Robert J.; Hartford, Suzanne A.; Tye, Bik K.; Schimenti, John C.			A viable allele of Mcm4 causes chromosome instability and mammary adenocarcinomas in mice	NATURE GENETICS			English	Article							DNA-REPLICATION; GENOMIC INSTABILITY; MINICHROMOSOME MAINTENANCE; PROTEINS; MUTANTS; COMPLEX; CEREVISIAE; ACTIVATION; CHECKPOINT; CANDIDATE	Mcm4 (minichromosome maintenance-deficient 4 homolog) encodes a subunit of the MCM2-7 complex (also known as MCM2-MCM7), the replication licensing factor and presumptive replicative helicase. Here, we report that the mouse chromosome instability mutation Chaos3 (chromosome aberrations occurring spontaneously 3), isolated in a forward genetic screen, is a viable allele of Mcm4. Mcm4(Chaos3) encodes a change in an evolutionarily invariant amino acid (F345I), producing an apparently destabilized MCM4. Saccharomyces cerevisiae strains that we engineered to contain a corresponding allele (resulting in an F391I change) showed a classical minichromosome loss phenotype. Whereas homozygosity for a disrupted Mcm4 allele (Mcm4(-)) caused preimplantation lethality, Mcm(Chaos3/-) embryos died late in gestation, indicating that Mcm4Chaos3 is hypomorphic. Mutant embryonic fibroblasts were highly susceptible to chromosome breaks induced by the DNA replication inhibitor aphidicolin. Most notably, > 80% of Mcm4(Chaos3/Chaos3) females succumbed to mammary adenocarcinomas with a mean latency of 12 months. These findings suggest that hypomorphic alleles of the genes encoding the subunits of the MCM2-7 complex may increase breast cancer risk.	Univ Minnesota, Coll Biol Sci, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; Jackson Lab, Bar Harbor, ME 04609 USA; Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	University of Minnesota System; University of Minnesota Twin Cities; Cornell University; Jackson Laboratory; Cornell University	Shima, N (corresponding author), Univ Minnesota, Coll Biol Sci, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	shima023@umn.edu; jcs92@cornell.edu		Hartford, Suzanne/0000-0001-8816-8585; Shima, Naoko/0000-0001-5927-8451	NIGMS NIH HHS [R01 GM45415] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045415] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Cardiff RD, 2000, ONCOGENE, V19, P968, DOI 10.1038/sj.onc.1203277; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; DARZYNKIEWICZ Z, 1997, ANAL DNA CONTENT BRD; Dertinger SD, 1996, MUTAT RES-GENET TOX, V371, P283, DOI 10.1016/S0165-1218(96)90117-2; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Fletcher RJ, 2003, NAT STRUCT BIOL, V10, P160, DOI 10.1038/nsb893; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Glover TW, 2005, HUM MOL GENET, V14, pR197, DOI 10.1093/hmg/ddi265; Gonzalez MA, 2005, NAT REV CANCER, V5, P135, DOI 10.1038/nrc1548; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Keays DA, 2006, MAMM GENOME, V17, P230, DOI 10.1007/s00335-005-0101-4; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lei M, 2005, CURR CANCER DRUG TAR, V5, P365, DOI 10.2174/1568009054629654; Lei M, 1996, MOL CELL BIOL, V16, P5081; Lengronne A, 2002, MOL CELL, V9, P1067, DOI 10.1016/S1097-2765(02)00513-0; Liang DT, 1999, J CELL SCI, V112, P559; MAINE GT, 1984, GENETICS, V106, P365; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Reinholdt Laura, 2004, Methods Mol Biol, V262, P87; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; Shetty A, 2005, BRIT J CANCER, V93, P1295, DOI 10.1038/sj.bjc.6602829; Shima N, 2003, GENETICS, V163, P1031; Sidorova JM, 2003, MUTAT RES-FUND MOL M, V532, P5, DOI 10.1016/j.mrfmmm.2003.08.006; Snyder M, 2005, P NATL ACAD SCI USA, V102, P14539, DOI 10.1073/pnas.0507479102; Stoeber K, 2001, J CELL SCI, V114, P2027; Tye BK, 1999, METHODS, V18, P329, DOI 10.1006/meth.1999.0793; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108	30	227	230	2	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2007	39	1					93	98		10.1038/ng1936	http://dx.doi.org/10.1038/ng1936			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	17143284				2022-12-27	WOS:000243136500023
J	Berezikov, E; Thuemmler, F; van Laake, LW; Kondova, I; Bontrop, R; Cuppen, E; Plasterk, RHA				Berezikov, Eugene; Thuemmler, Fritz; van Laake, Linda W.; Kondova, Ivanela; Bontrop, Ronald; Cuppen, Edwin; Plasterk, Ronald H. A.			Diversity of microRNAs in human and chimpanzee brain	NATURE GENETICS			English	Article							IDENTIFICATION; SEQUENCES; RNAS; PATHWAY; GENES	We used massively parallel sequencing to compare the microRNA (miRNA) content of human and chimpanzee brains, and we identified 447 new miRNA genes. Many of the new miRNAs are not conserved beyond primates, indicating their recent origin, and some miRNAs seem species specific, whereas others are expanded in one species through duplication events. These data suggest that evolution of miRNAs is an ongoing process and that along with ancient, highly conserved miRNAs, there are a number of emerging miRNAs.	KNAW, Hubrecht Lab, NL-3584 CT Utrecht, Netherlands; Vertis Biotechnol AG, D-85354 Freising Weihenstephan, Germany; Univ Utrecht, Med Ctr, Dept Cardiol, NL-3508 GA Utrecht, Netherlands; Biomed Primate Res Ctr, Rijswijk, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University	Plasterk, RHA (corresponding author), KNAW, Hubrecht Lab, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	plasterk@niob.knaw.nl	Cuppen, Edwin/F-5696-2011; Bontrop, Ronald E/J-3628-2012; Bontrop, Ronald E./D-4844-2011; Cuppen, Edwin/H-2389-2016; Berezikov, Eugene/D-3363-2013	Cuppen, Edwin/0000-0002-0400-9542; Bontrop, Ronald E/0000-0003-0874-6467; Cuppen, Edwin/0000-0002-0400-9542; Berezikov, Eugene/0000-0002-1145-2884				Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Bonnet E, 2004, BIOINFORMATICS, V20, P2911, DOI 10.1093/bioinformatics/bth374; Enard W, 2002, SCIENCE, V296, P340, DOI 10.1126/science.1068996; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Stein AJ, 2005, CELL, V121, P529, DOI 10.1016/j.cell.2005.03.009; Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333	15	383	407	0	30	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2006	38	12					1375	1377		10.1038/ng1914	http://dx.doi.org/10.1038/ng1914			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110TR	17072315				2022-12-27	WOS:000242404200013
J	Chen, K; Rajewsky, N				Chen, Kevin; Rajewsky, Nikolaus			Natural selection on human microRNA binding sites inferred from SNP data	NATURE GENETICS			English	Article							POLYMORPHISM; RNA; IMPACT	A fundamental problem in biology is understanding how natural selection has shaped the evolution of gene regulation. Here we use SNP genotype data and techniques from population genetics to study an entire layer of short, cis-regulatory sites in the human genome. MicroRNAs (miRNAs) are a class of small noncoding RNAs that post-transcriptionally repress mRNA through cis-regulatory sites in 3 ' UTRs. We show that negative selection in humans is stronger on computationally predicted conserved miRNA binding sites than on other conserved sequence motifs in 3 ' UTRs, thus providing independent support for the target prediction model and explicitly demonstrating the contribution of miRNAs to darwinian fitness. Our techniques extend to nonconserved miRNA binding sites, and we estimate that 30%-50% of these are functional when the mRNA and miRNA are endogenously coexpressed. As we show that polymorphisms in predicted miRNA binding sites are likely to be deleterious, they are candidates for causal variants of human disease. We believe that our approach can be extended to studying other classes of cis-regulatory sites.	NYU, Dept Biol, Ctr Comparat Funct Genom, New York, NY 10003 USA; Max Delbruck Ctr Mol Med, Berlin, Germany	New York University; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Rajewsky, N (corresponding author), NYU, Dept Biol, Ctr Comparat Funct Genom, New York, NY 10003 USA.	rajewsky@mdc-berlin.de		Rajewsky, Nikolaus/0000-0002-4785-4332				Abelson JF, 2005, SCIENCE, V310, P317, DOI 10.1126/science.1116502; Akashi H, 1999, GENETICS, V151, P221; Allen E, 2005, NATURE, V438, P224, DOI 10.1038/nature04256; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Fairbrother WG, 2004, PLOS BIOL, V2, P1388, DOI 10.1371/journal.pbio.0020268; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Gottwein E, 2006, J VIROL, V80, P5321, DOI 10.1128/JVI.02734-05; Griffiths-Jones S, 2005, NUCLEIC ACIDS RES, V33, pD121, DOI 10.1093/nar/gki081; Hartl :D. L, 2000, PRIMER POPULATION GE; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Iwai N, 2005, BIOCHEM BIOPH RES CO, V331, P1439, DOI 10.1016/j.bbrc.2005.04.051; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Lu R, 2004, P NATL ACAD SCI USA, V101, P15201, DOI 10.1073/pnas.0404995101; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rockman MV, 2005, PLOS BIOL, V3, P2208, DOI 10.1371/journal.pbio.0030387; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; SAWYER SA, 1992, GENETICS, V132, P1161; Sood P, 2006, P NATL ACAD SCI USA, V103, P2746, DOI 10.1073/pnas.0511045103; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	30	350	378	0	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2006	38	12					1452	1456		10.1038/ng1910	http://dx.doi.org/10.1038/ng1910			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110TR	17072316				2022-12-27	WOS:000242404200025
J	Wang, Y; Baskerville, S; Shenoy, A; Babiarz, JE; Baehner, L; Blelloch, R				Wang, Yangming; Baskerville, Scott; Shenoy, Archana; Babiarz, Joshua E.; Baehner, Lauren; Blelloch, Robert			Embryonic stem cell-specific microRNAs regulate the G1-S transition and promote rapid proliferation	NATURE GENETICS			English	Article							DNA METHYLATION; DIFFERENTIATION; CYCLE; TARGETS; BIOGENESIS; DIVISION; PATHWAY; GENES	Dgcr8 knockout embryonic stem (ES) cells lack microprocessor activity and hence all canonical microRNAs (miRNAs). These cells proliferate slowly and accumulate in G1 phase of the cell cycle(1). Here, by screening a comprehensive library of individual miRNAs in the background of the Dgcr8 knockout ES cells, we report that multiple ES cell-specific miRNAs, members of the miR-290 family, rescue the ES cell proliferation defect. Furthermore, rescued cells no longer accumulate in the G1 phase of the cell cycle. These miRNAs function by suppressing several key regulators of the G1-S transition. These results show that post-transcriptional regulation by miRNAs promotes the G1-S transition of the ES cell cycle, enabling rapid proliferation of these cells. Our screening strategy provides an alternative and powerful approach for uncovering the role of individual miRNAs in biological processes, as it overcomes the common problem of redundancy and saturation in the miRNA system.	[Wang, Yangming; Shenoy, Archana; Babiarz, Joshua E.; Baehner, Lauren; Blelloch, Robert] Univ Calif San Francisco, Inst Regenerat Med, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Baskerville, Scott] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA; [Baskerville, Scott] Dharmacon Technol, Thermo Fisher Sci, Lafayette, CO 80026 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Thermo Fisher Scientific	Blelloch, R (corresponding author), Univ Calif San Francisco, Inst Regenerat Med, Ctr Reprod Sci, San Francisco, CA 94143 USA.	BlellochR@stemcell.ucsf.edu	Wang, Yangming/J-8939-2015	Wang, Yangming/0000-0001-6974-6060	US National Institutes of Health [K08 NS48118, R01 NS057221]; Stem Cell Research Foundation; Pew Charitable Trust; California Institute of Regenerative Medicine Training Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057221, K08NS048118] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stem Cell Research Foundation; Pew Charitable Trust; California Institute of Regenerative Medicine Training Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank A. D. Sharma and K. Okamura for their technical assistance with the immunoblot assay; M. Grskovic and C. Chaivorapol for their technical assistance with the luciferase reporter assay; M. Sachs for help in developing the overexpression construct; and M. Conti, M. Ramalho-Santos, J. Reiter and members of the Blelloch laboratory for critical reading of the manuscript. This work was supported by funds to R. B. from the US National Institutes of Health (K08 NS48118 and R01 NS057221), the Stem Cell Research Foundation and the Pew Charitable Trust. Y. W. is supported by a California Institute of Regenerative Medicine Training Grant.	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P268, DOI 10.1038/nsmb.1399; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Chen CF, 2007, MAMM GENOME, V18, P316, DOI 10.1007/s00335-007-9032-6; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Houbaviy HB, 2005, RNA, V11, P1245, DOI 10.1261/rna.2890305; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Kato Jun-ya, 1999, Frontiers in Bioscience, V4, pd787, DOI 10.2741/Kato; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Lee MH, 2003, CANCER METAST REV, V22, P435, DOI 10.1023/A:1023785332315; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li YF, 2003, ONCOGENE, V22, P4398, DOI 10.1038/sj.onc.1206603; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Sabapathy K, 1997, EMBO J, V16, P6217, DOI 10.1093/emboj/16.20.6217; Savatier P, 1996, ONCOGENE, V12, P309; Shcherbata HR, 2006, CELL CYCLE, V5, P172, DOI 10.4161/cc.5.2.2343; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Sorrentino E, 2007, GENE EXPR PATTERNS, V7, P714, DOI 10.1016/j.modgep.2007.02.002; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.e04-12-1056; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131	28	501	531	3	46	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2008	40	12					1478	1483		10.1038/ng.250	http://dx.doi.org/10.1038/ng.250			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	18978791	Green Accepted			2022-12-27	WOS:000261215900026
J	Miyagawa, T; Kawashima, M; Nishida, N; Ohashi, J; Kimura, R; Fujimoto, A; Shimada, M; Morishita, S; Shigeta, T; Lin, L; Hong, SC; Faraco, J; Shin, YK; Jeong, JH; Okazaki, Y; Tsuji, S; Honda, M; Honda, Y; Mignot, E; Tokunaga, K				Miyagawa, Taku; Kawashima, Minae; Nishida, Nao; Ohashi, Jun; Kimura, Ryosuke; Fujimoto, Akihiro; Shimada, Mihoko; Morishita, Shinichi; Shigeta, Takashi; Lin, Ling; Hong, Seung-Chul; Faraco, Juliette; Shin, Yoon-Kyung; Jeong, Jong-Hyun; Okazaki, Yuji; Tsuji, Shoji; Honda, Makoto; Honda, Yutaka; Mignot, Emmanuel; Tokunaga, Katsushi			Variant between CPT1B and CHKB associated with susceptibility to narcolepsy	NATURE GENETICS			English	Article							OREXIN NEURONS; DEFICIENCY; MICE; HYPOCRETIN/OREXIN; POLYMORPHISMS; OXIDATION; MUTATION	Narcolepsy (hypocretin deficiency), a sleep disorder characterized by sleepiness, cataplexy and rapid eye movement (REM) sleep abnormalities, is tightly associated with HLA-DRB1*1501 (M17378) and HLA-DQB1*0602 (M20432). Susceptibility genes other than those in the HLA region are also likely involved. We conducted a genome-wide association study using 500K SNP microarrays in 222 Japanese individuals with narcolepsy and 389 Japanese controls, with replication of top hits in 159 Japanese individuals with narcolepsy and 190 Japanese controls, followed by the testing of 424 Koreans, 785 individuals of European descent and 184 African Americans. rs5770917, a SNP located between CPT1B and CHKB, was associated with narcolepsy in Japanese (rs5770917[C], odds ratio (OR) = 1.79, combined P = 4.4 x 10(-7)) and other ancestry groups (OR = 1.40, P = 0.02). Real-time quantitative PCR assays in white blood cells indicated decreased CPT1B and CHKB expression in subjects with the C allele, suggesting that a genetic variant regulating CPT1B or CHKB expression is associated with narcolepsy. Either of these genes is a plausible candidate, as CPT1B regulates beta-oxidation, a pathway involved in regulating theta frequency during REM sleep, and CHKB is an enzyme involved in the metabolism of choline, a precursor of the REM- and wake-regulating neurotransmitter acetylcholine.	[Miyagawa, Taku; Kawashima, Minae; Nishida, Nao; Ohashi, Jun; Kimura, Ryosuke; Fujimoto, Akihiro; Shimada, Mihoko; Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo 1130033, Japan; [Kawashima, Minae] Univ Tokyo, Grad Sch Med, Dept Sleep Disorder Res, Tokyo 1130033, Japan; [Kimura, Ryosuke] Tokai Univ, Sch Med, Dept Forens Med, Isehara 259100, Japan; [Morishita, Shinichi; Shigeta, Takashi] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol, Kashiwa, Chiba 2770000, Japan; [Lin, Ling; Faraco, Juliette; Mignot, Emmanuel] Stanford Univ, Sch Med, Ctr Narcolepsy, Stanford, CA 94305 USA; [Hong, Seung-Chul; Shin, Yoon-Kyung; Jeong, Jong-Hyun] Catholic Univ Korea, St Vincents Hosp, Dept Neuropsychiat, Suwon 442723, South Korea; [Okazaki, Yuji] Tokyo Metropolitan Matsuzawa Hosp, Tokyo 1560057, Japan; [Tsuji, Shoji] Univ Tokyo, Grad Sch Med, Dept Neurol, Tokyo 1130033, Japan; [Tsuji, Shoji] Univ Tokyo, Grad Sch Med, Ctr Integrated Brain Med Sci, 21st Century COE Program, Tokyo 1130033, Japan; [Honda, Makoto] Tokyo Inst Psychiat, Dept Sleep Disorders Res, Tokyo 1568585, Japan; [Honda, Makoto; Honda, Yutaka] Japan Somnol Ctr, Neuropsychiat Res Inst, Tokyo 1510053, Japan; [Mignot, Emmanuel] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	University of Tokyo; University of Tokyo; Tokai University; University of Tokyo; Stanford University; Catholic University of Korea; University of Tokyo; University of Tokyo; Tokyo Institute of Psychiatry; Howard Hughes Medical Institute; Stanford University	Tokunaga, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo 1130033, Japan.	tokunaga@m.u-tokyo.ac.jp	Kimura, Ryosuke/B-3354-2015; OHASHI, JUN/G-5907-2015	Jeong, Jong-Hyun/0000-0003-3570-7607; Morishita, Shinichi/0000-0002-6201-8885	Ministry of Education, Culture, Sports, Science and Technology of Japan,; JSPS; US National Institutes of Health [NS 23724]	Ministry of Education, Culture, Sports, Science and Technology of Japan,(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to express our sincere thanks to the study participants. This study was supported by Grants-in-Aid for Scientific Research on Priority Areas "Comprehensive Genomics'' and "Applied Genomics'' from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Grant-in-Aid for JSPS fellows, and US National Institutes of Health grant NS 23724 to E. Mignot, a Howard Hughes Investigator.	Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Chemelli RM, 1999, CELL, V98, P437, DOI 10.1016/S0092-8674(00)81973-X; Dixon CE, 1997, J NEUROTRAUM, V14, P161, DOI 10.1089/neu.1997.14.161; Fioravanti M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000269.pub3; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; Gencik M, 2001, NEUROLOGY, V56, P115, DOI 10.1212/WNL.56.1.115; Hara J, 2001, NEURON, V30, P345, DOI 10.1016/S0896-6273(01)00293-8; Hungs M, 2001, NEUROLOGY, V57, P1893, DOI 10.1212/WNL.57.10.1893; JUJI T, 1984, TISSUE ANTIGENS, V24, P316, DOI 10.1111/j.1399-0039.1984.tb02144.x; Kent C, 1997, BBA-LIPID LIPID MET, V1348, P79, DOI 10.1016/S0005-2760(97)00112-4; Kuwajima M, 2007, ENDOCR J, V54, P911, DOI 10.1507/endocrj.K07-044; LANGDON N, 1984, LANCET, V2, P1178; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Liu JK, 2002, P NATL ACAD SCI USA, V99, P2356, DOI 10.1073/pnas.261709299; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; Mignot E, 2005, SLEEP, V28, P754, DOI 10.1093/sleep/28.6.754; Mignot E, 1998, NEUROLOGY, V50, pS16, DOI 10.1212/WNL.50.2_Suppl_1.S16; Mignot E, 2001, AM J HUM GENET, V68, P686, DOI 10.1086/318799; Nishida N, 2007, ANAL BIOCHEM, V364, P78, DOI 10.1016/j.ab.2007.02.005; Nishino S, 1997, PROG NEUROBIOL, V52, P27, DOI 10.1016/S0301-0082(96)00070-6; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Olafsdottir BR, 2001, NEUROLOGY, V57, P1896, DOI 10.1212/WNL.57.10.1896; Overeem S, 2001, J CLIN NEUROPHYSIOL, V18, P78, DOI 10.1097/00004691-200103000-00002; Peyron C, 2000, NAT MED, V6, P991, DOI 10.1038/79690; Rao KVR, 1997, CAN J PHYSIOL PHARM, V75, P423, DOI 10.1139/cjpp-75-5-423; Tafti M, 2003, NAT GENET, V34, P320, DOI 10.1038/ng1174; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Yoshida G, 2006, NEUROSCI RES, V55, P78, DOI 10.1016/j.neures.2006.02.003; Zweigner J, 2004, J EXP MED, V200, P99, DOI 10.1084/jem.20032100	30	111	113	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2008	40	11					1324	1328		10.1038/ng.231	http://dx.doi.org/10.1038/ng.231			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18820697				2022-12-27	WOS:000260501500025
J	Stark, KL; Xu, B; Bagchi, A; Lai, WS; Liu, H; Hsu, R; Wan, X; Pavlidis, P; Mills, AA; Karayiorgou, M; Gogos, JA				Stark, Kimberly L.; Xu, Bin; Bagchi, Anindya; Lai, Wen-Sung; Liu, Hui; Hsu, Ruby; Wan, Xiang; Pavlidis, Paul; Mills, Alea A.; Karayiorgou, Maria; Gogos, Joseph A.			Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model	NATURE GENETICS			English	Article							22Q11 DELETION SYNDROME; CARDIO-FACIAL SYNDROME; PREPULSE INHIBITION; GENETIC-VARIATION; SYNDROME REGION; MICE; SCHIZOPHRENIA; MEMORY; DISORDER; SYSTEM	Individuals with 22q11.2 microdeletions show behavioral and cognitive deficits and are at high risk of developing schizophrenia. We analyzed an engineered mouse strain carrying a chromosomal deficiency spanning a segment syntenic to the human 22q11.2 locus. We uncovered a previously unknown alteration in the biogenesis of microRNAs (miRNAs) and identified a subset of brain miRNAs affected by the microdeletion. We provide evidence that the abnormal miRNA biogenesis emerges because of haploinsufficiency of the Dgcr8 gene, which encodes an RNA-binding moiety of the 'microprocessor' complex and contributes to the behavioral and neuronal deficits associated with the 22q11.2 microdeletion.	[Xu, Bin; Lai, Wen-Sung; Gogos, Joseph A.] Columbia Univ, Dept Physiol & Cellular Biophys, Coll Phys & Surg, New York, NY 10032 USA; [Stark, Kimberly L.; Liu, Hui; Karayiorgou, Maria] Columbia Univ, Dept Psychiat, Coll Phys & Surg, New York, NY 10032 USA; [Bagchi, Anindya; Mills, Alea A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Hsu, Ruby; Gogos, Joseph A.] Columbia Univ, Dept Neurosci, Coll Phys & Surg, New York, NY 10032 USA; [Wan, Xiang; Pavlidis, Paul] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 1Z4, Canada; [Wan, Xiang; Pavlidis, Paul] Univ British Columbia, Bioinformat Ctr, Vancouver, BC V6T 1Z4, Canada	Columbia University; Columbia University; Cold Spring Harbor Laboratory; Columbia University; University of British Columbia; University of British Columbia	Gogos, JA (corresponding author), Columbia Univ, Dept Physiol & Cellular Biophys, Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA.	jag90@columbia.edu	Pavlidis, Paul/H-8406-2013	Pavlidis, Paul/0000-0002-0426-5028; Lai, Wen-Sung/0000-0001-6918-5531	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067068, R01MH077235] Funding Source: NIH RePORTER; NIMH NIH HHS [MH067068, MH077235] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Botto LD, 2003, PEDIATRICS, V112, P101, DOI 10.1542/peds.112.1.101; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Edelmann L, 1999, AM J HUM GENET, V64, P1076, DOI 10.1086/302343; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Gogos JA, 1999, NAT GENET, V21, P434, DOI 10.1038/7777; Gothelf D, 2004, AM J MED GENET B, V126B, P99, DOI 10.1002/ajmg.b.20124; Gothelf D, 2005, NAT NEUROSCI, V8, P1500, DOI 10.1038/nn1572; Gothelf D, 2004, AM J MED GENET B, V126B, P116, DOI 10.1002/ajmg.b.20144; Green MF, 2004, BIOL PSYCHIAT, V56, P301, DOI 10.1016/j.biopsych.2004.06.023; Jones MW, 2005, PLOS BIOL, V3, P2187, DOI 10.1371/journal.pbio.0030402; Jurata LW, 2006, SCHIZOPHR RES, V88, P251, DOI 10.1016/j.schres.2006.07.017; KARAYIORGOU P, 1995, P NATL ACAD SCI USA, V92, P7612, DOI 10.1073/pnas.92.17.7612; Kellendonk C, 2006, NEURON, V49, P603, DOI 10.1016/j.neuron.2006.01.023; Kimber WL, 1999, HUM MOL GENET, V8, P2229, DOI 10.1093/hmg/8.12.2229; Koike H, 2006, P NATL ACAD SCI USA, V103, P3693, DOI 10.1073/pnas.0511189103; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lindsay EA, 1999, NATURE, V401, P379, DOI 10.1038/43900; Liu H, 2002, P NATL ACAD SCI USA, V99, P16859, DOI 10.1073/pnas.232186099; Liu H, 2002, P NATL ACAD SCI USA, V99, P3717, DOI 10.1073/pnas.042700699; Long JM, 2006, NEUROGENETICS, V7, P247, DOI 10.1007/s10048-006-0054-0; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McDonald-McGinn DM, 2001, GENET MED, V3, P23, DOI 10.1097/00125817-200101000-00006; Meechan DW, 2006, MOL CELL NEUROSCI, V33, P412, DOI 10.1016/j.mcn.2006.09.001; Merscher S, 2001, CELL, V104, P619, DOI 10.1016/S0092-8674(01)00247-1; Mukai J, 2004, NAT GENET, V36, P725, DOI 10.1038/ng1375; Paterlini M, 2005, NAT NEUROSCI, V8, P1586, DOI 10.1038/nn1562; Paylor R, 1997, PSYCHOPHARMACOLOGY, V132, P169, DOI 10.1007/s002130050333; Paylor R, 2001, HUM MOL GENET, V10, P2645, DOI 10.1093/hmg/10.23.2645; Paylor R, 2006, P NATL ACAD SCI USA, V103, P7729, DOI 10.1073/pnas.0600206103; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; PULVER AE, 1994, J NERV MENT DIS, V182, P476, DOI 10.1097/00005053-199408000-00010; Raux G, 2007, HUM MOL GENET, V16, P83, DOI 10.1093/hmg/ddl443; Schratt GM, 2006, NATURE, V441, P902, DOI 10.1038/nature04909; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Sivagnanasundaram S, 2007, BRAIN RES, V1139, P48, DOI 10.1016/j.brainres.2007.01.014; Sobin C, 2005, CHILD NEUROPSYCHOL, V11, P39, DOI 10.1080/09297040590911167; Swerdlow NR, 2001, PSYCHOPHARMACOLOGY, V156, P194, DOI 10.1007/s002130100799; Tomari Y, 2005, CURR BIOL, V15, pR61, DOI 10.1016/j.cub.2004.12.057; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wheeler G, 2006, FEBS LETT, V580, P2195, DOI 10.1016/j.febslet.2006.03.019; Williams NM, 2008, HUM MOL GENET, V17, P555, DOI 10.1093/hmg/ddm330; Woodin M, 2001, GENET MED, V3, P34, DOI 10.1097/00125817-200101000-00008; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030; Zheng BH, 1999, NUCLEIC ACIDS RES, V27, P2354, DOI 10.1093/nar/27.11.2354	50	438	456	0	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2008	40	6					751	760		10.1038/ng.138	http://dx.doi.org/10.1038/ng.138			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18469815	Green Submitted			2022-12-27	WOS:000256212000017
J	Eeles, RA; Kote-Jarai, Z; Giles, GG; Al Olama, AA; Guy, M; Jugurnauth, SK; Mulholland, S; Leongamornlert, DA; Edwards, SM; Morrison, J; Field, HI; Southey, MC; Severi, G; Donovan, JL; Hamdy, FC; Dearnaley, DP; Muir, KR; Smith, C; Bagnato, M; Ardern-Jones, AT; Hall, AL; O'Brien, LT; Gehr-Swain, BN; Wilkinson, RA; Cox, A; Lewis, S; Brown, PM; Jhavar, SG; Tymrakiewicz, M; Lophatananon, A; Bryant, SL; Horwich, A; Huddart, RA; Khoo, VS; Parker, CC; Woodhouse, CJ; Thompson, A; Christmas, T; Ogden, C; Fisher, C; Jamieson, C; Cooper, CS; English, DR; Hopper, JL; Neal, DE; Easton, DF				Eeles, Rosalind A.; Kote-Jarai, Zsofia; Giles, Graham G.; Al Olama, Ali Amin; Guy, Michelle; Jugurnauth, Sarah K.; Mulholland, Shani; Leongamornlert, Daniel A.; Edwards, Stephen M.; Morrison, Jonathan; Field, Helen I.; Southey, Melissa C.; Severi, Gianluca; Donovan, Jenny L.; Hamdy, Freddie C.; Dearnaley, David P.; Muir, Kenneth R.; Smith, Charmaine; Bagnato, Melisa; Ardern-Jones, Audrey T.; Hall, Amanda L.; O'Brien, Lynne T.; Gehr-Swain, Beatrice N.; Wilkinson, Rosemary A.; Cox, Angie; Lewis, Sarah; Brown, Paul M.; Jhavar, Sameer G.; Tymrakiewicz, Malgorzata; Lophatananon, Artitaya; Bryant, Sarah L.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Woodhouse, Christopher J.; Thompson, Alan; Christmas, Tim; Ogden, Chris; Fisher, Cyril; Jamieson, Charles; Cooper, Colin S.; English, Dallas R.; Hopper, John L.; Neal, David E.; Easton, Douglas F.		Uk Genetic Prostate Canc Study Col; British Assoc Urological Surg Sect; Uk ProtecT Study Collaborators	Multiple newly identified loci associated with prostate cancer susceptibility	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; AUSTRALIAN CASE-CONTROL; RADICAL PROSTATECTOMY; ANTIGEN LEVELS; RISK LOCUS; GENE; MEN; POLYMORPHISMS; VARIANTS; PROMOTER	Prostate cancer is the most common cancer affecting males in developed countries. It shows consistent evidence of familial aggregation, but the causes of this aggregation are mostly unknown. To identify common alleles associated with prostate cancer risk, we conducted a genome-wide association study (GWAS) using blood DNA samples from 1,854 individuals with clinically detected prostate cancer diagnosed at <= 60 years or with a family history of disease, and 1,894 population-screened controls with a low prostate-specific antigen (PSA) concentration (< 0.5 ng/ml). We analyzed these samples for 541,129 SNPs using the Illumina Infinium platform. Initial putative associations were confirmed using a further 3,268 cases and 3,366 controls. We identified seven loci associated with prostate cancer on chromosomes 3, 6, 7, 10, 11, 19 and X (P = 2.7 x 10(-8) to P = 8.7 x 10(-29)). We confirmed previous reports of common loci associated with prostate cancer at 8q24 and 17q. Moreover, we found that three of the newly identified loci contain candidate susceptibility genes: MSMB, LMTK2 and KLK3.	[Eeles, Rosalind A.; Kote-Jarai, Zsofia; Guy, Michelle; Jugurnauth, Sarah K.; Mulholland, Shani; Leongamornlert, Daniel A.; Edwards, Stephen M.; Dearnaley, David P.; Hall, Amanda L.; O'Brien, Lynne T.; Gehr-Swain, Beatrice N.; Wilkinson, Rosemary A.; Jhavar, Sameer G.; Tymrakiewicz, Malgorzata; Bryant, Sarah L.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Cooper, Colin S.] Inst Canc Res, Sutton SM2 5NG, Surrey, England; [Eeles, Rosalind A.; Dearnaley, David P.; Ardern-Jones, Audrey T.; Hall, Amanda L.; Gehr-Swain, Beatrice N.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Woodhouse, Christopher J.; Thompson, Alan; Christmas, Tim; Ogden, Chris; Fisher, Cyril; Jamieson, Charles] Royal Marsden NHS Fdn Trust, Sutton SM2 5PT, Surrey, England; [Eeles, Rosalind A.; Dearnaley, David P.; Ardern-Jones, Audrey T.; Hall, Amanda L.; Gehr-Swain, Beatrice N.; Horwich, Alan; Huddart, Robert A.; Khoo, Vincent S.; Parker, Christopher C.; Woodhouse, Christopher J.; Thompson, Alan; Christmas, Tim; Ogden, Chris; Fisher, Cyril; Jamieson, Charles] Royal Marsden NHS Fdn Trust, London SW3 6JJ, England; [Giles, Graham G.; Severi, Gianluca; Smith, Charmaine; Bagnato, Melisa] Canc Epidemiol Ctr, Canc Council Vic, Melbourne, Vic 3053, Australia; [Giles, Graham G.; Severi, Gianluca; English, Dallas R.; Hopper, John L.] Univ Melbourne, Ctr Mol Environm Genet & Analyt Epidemiol, Melbourne, Vic 3053, Australia; [Al Olama, Ali Amin; Morrison, Jonathan; Easton, Douglas F.] Univ Cambridge, Strangeways Lab, Canc Res UK Genet Epidemiol Unit, Cambridge CB1 8RN, England; [Field, Helen I.] Univ Cambridge, Strangeways Lab, Dept Oncol, Cambridge CB1 8RN, England; [Southey, Melissa C.] Univ Melbourne, Dept Pathol, Genet Epidemiol Lab, Parkville, Vic 3052, Australia; [Donovan, Jenny L.; Lewis, Sarah] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; [Hamdy, Freddie C.; Cox, Angie] Univ Sheffield, Acad Urol Unit, Sheffield S10 2JF, S Yorkshire, England; [Muir, Kenneth R.; Lophatananon, Artitaya] Univ Nottingham, Sch Med, Queens Med Ctr, Nottingham NG7 2UH, England; [Brown, Paul M.; Neal, David E.] Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Cambridge CB2 2QQ, England; [Brown, Paul M.; Neal, David E.] Univ Cambridge, Addenbrookes Hosp, Dept Surg, Cambridge CB2 2QQ, England; [Neal, David E.] Canc Res UK Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England	University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; Royal Marsden NHS Foundation Trust; Cancer Council Victoria; University of Melbourne; Cancer Research UK; University of Cambridge; University of Cambridge; University of Melbourne; University of Bristol; University of Sheffield; University of Nottingham; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cancer Research UK; CRUK Cambridge Institute	Eeles, RA (corresponding author), Inst Canc Res, 15 Cotswold Rd, Sutton SM2 5NG, Surrey, England.	rosalind.eeles@icr.ac.uk	Severi, Gianluca/Q-1824-2019; McNicholas, Tom A/C-2268-2014; English, Dallas/AAH-5005-2019; Severi, Gianluca/H-3774-2018; Dearnaley, David P/J-2318-2014	Severi, Gianluca/0000-0001-7157-419X; McNicholas, Tom A/0000-0001-9971-8765; English, Dallas/0000-0001-7828-8188; Severi, Gianluca/0000-0001-7157-419X; Dearnaley, David P/0000-0002-3954-2806; Eeles, Rosalind/0000-0002-3698-6241; Leongamornlert, Daniel/0000-0002-3486-3168; Hamdy, Freddie/0000-0003-2627-2154; Neal, David/0000-0002-6033-5086; Giles, Graham/0000-0003-4946-9099; Southey, Melissa/0000-0002-6313-9005; huddart, robert/0000-0003-3604-1990; Cox, Angela/0000-0002-5138-1099; Lewis, Sarah/0000-0003-4311-6890	MRC [G0500966, G0501019] Funding Source: UKRI; Cancer Research UK [10118] Funding Source: Medline; Medical Research Council [G0500966, G0501019] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayton D, 2007, HUM HERED, V64, P45, DOI 10.1159/000101422; Cramer SD, 2003, JNCI-J NATL CANCER I, V95, P1044, DOI 10.1093/jnci/95.14.1044; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Edwards SM, 2004, AM J MED GENET C, V129C, P65, DOI 10.1002/ajmg.c.30027; Edwards SM, 2003, AM J HUM GENET, V72, P1, DOI 10.1086/345310; Eeles RA, 1999, PROSTATE CANCER P D, V2, P9, DOI 10.1038/sj.pcan.4500279; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Giles GG, 2002, CANCER EPIDEM BIOMAR, V11, P549; Giles GG, 2001, ANN ONCOL, V12, P761, DOI 10.1023/A:1011131105617; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hidaka K, 2002, J BIOL CHEM, V277, P32730, DOI 10.1074/jbc.M205476200; Kawa S, 2004, GENES CELLS, V9, P219, DOI 10.1111/j.1356-9597.2004.00714.x; Lai J, 2007, CARCINOGENESIS, V28, P1032, DOI 10.1093/carcin/bgl236; Lilja H, 2007, J CLIN ONCOL, V25, P431, DOI 10.1200/JCO.2006.06.9351; MacInnis RJ, 2003, CANCER EPIDEM BIOMAR, V12, P1417; Reeves JR, 2006, CLIN CANCER RES, V12, P6018, DOI 10.1158/1078-0432.CCR-06-0625; Severi G, 2006, CANCER EPIDEM BIOMAR, V15, P86, DOI 10.1158/1055-9965.EPI-05-0633; Severi G, 2003, J NATL CANCER I, V95, P818, DOI 10.1093/jnci/95.11.818; Severi G, 2006, CANCER EPIDEM BIOMAR, V15, P1142, DOI 10.1158/1055-9965.EPI-05-0984; Steuber T, 2006, INT J CANCER, V118, P1234, DOI 10.1002/ijc.21474; Steuber T, 2007, WORLD J UROL, V25, P111, DOI 10.1007/s00345-007-0160-0; Thomas DC, 2005, AM J HUM GENET, V77, P337, DOI 10.1086/432962; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	28	672	695	0	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2008	40	3					316	321		10.1038/ng.90	http://dx.doi.org/10.1038/ng.90			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18264097				2022-12-27	WOS:000253548400022
J	Wittkopp, PJ; Haerum, BK; Clark, AG				Wittkopp, Patricia J.; Haerum, Belinda K.; Clark, Andrew G.			Regulatory changes underlying expression differences within and between Drosophila species	NATURE GENETICS			English	Article							GENE-EXPRESSION; INTERSPECIFIC HYBRIDS; MELANOGASTER; EVOLUTION; CIS; TRANS	Differences in gene expression are an important source of phenotypic variation, and can be caused by changes in cis and/or trans regulation. cis-regulatory variants alter allele-specific expression, whereas trans-regulatory variants influence expression of both alleles in a diploid cell. Because of this difference, we hypothesize that natural selection may favor one type of change over the other. Here, we investigate contributions of cis- and trans-regulatory changes to variable intra- and interspecific gene expression using four strains of Drosophila melanogaster, three strains of D. simulans and a total of 78 genes. We show that cis- regulatory changes account for a greater proportion of the expression differences observed between rather than within species. These data are inconsistent with a neutral model assuming equal probabilities of fixation for cis- and trans-regulatory polymorphisms, suggesting that natural selection influences the molecular mechanisms underlying divergent gene expression. Specifically, cis- regulatory changes seem to accumulate preferentially over time.	[Wittkopp, Patricia J.; Haerum, Belinda K.; Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA; [Wittkopp, Patricia J.; Haerum, Belinda K.] Univ Michigan, Dept Mol Cellular & Dev Biol, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	Cornell University; University of Michigan System; University of Michigan	Wittkopp, PJ (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	wittkopp@umich.edu		Clark, Andrew/0000-0001-7159-8511				Akritas MG, 1996, ASTROPHYS J, V470, P706, DOI 10.1086/177901; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Denver DR, 2005, NAT GENET, V37, P544, DOI 10.1038/ng1554; Gibson G, 2004, GENETICS, V167, P1791, DOI 10.1534/genetics.104.026583; Landry CR, 2007, SCIENCE, V317, P118, DOI 10.1126/science.1140247; Landry CR, 2005, GENETICS, V171, P1813, DOI 10.1534/genetics.105.047449; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; Meiklejohn CD, 2003, P NATL ACAD SCI USA, V100, P9894, DOI 10.1073/pnas.1630690100; Michalak P, 2003, MOL BIOL EVOL, V20, P1070, DOI 10.1093/molbev/msg119; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Osada N, 2006, MOL BIOL EVOL, V23, P1585, DOI 10.1093/molbev/msl023; Powell J. R., 1997, PROGR PROSPECTS EVOL; Ranz JM, 2004, GENOME RES, V14, P373, DOI 10.1101/gr.2019804; Ranz JM, 2003, SCIENCE, V300, P1742, DOI 10.1126/science.1085881; Rifkin SA, 2003, NAT GENET, V33, P138, DOI 10.1038/ng1086; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; West MAL, 2007, GENETICS, V175, P1441, DOI 10.1534/genetics.106.064972; Wittkopp PJ, 2006, GENETICS, V173, P1817, DOI 10.1534/genetics.105.054684; Wittkopp PJ, 2004, NATURE, V430, P85, DOI 10.1038/nature02698; Wittkopp PJ, 2005, CELL MOL LIFE SCI, V62, P1779, DOI 10.1007/s00018-005-5064-9; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	24	267	270	0	59	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2008	40	3					346	350		10.1038/ng.77	http://dx.doi.org/10.1038/ng.77			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18278046				2022-12-27	WOS:000253548400027
J	Aragones, J; Schneider, M; Van Geyte, K; Fraisl, P; Dresselaers, T; Mazzone, M; Dirkx, R; Zacchigna, S; Lemieux, H; Jeoung, NH; Lambrechts, D; Bishop, T; Lafuste, P; Diez-Juan, A; Harten, SK; Van Noten, P; De Bock, K; Willam, C; Tjwa, M; Grosfeld, A; Navet, R; Moons, L; Vandendriessche, T; Deroose, C; Wijeyekoon, B; Nuyts, J; Jordan, B; Silasi-Mansat, R; Lupu, F; Dewerchin, M; Pugh, C; Salmon, P; Mortelmans, L; Gallez, B; Gorus, F; Buyse, J; Sluse, F; Harris, RA; Gnaiger, E; Hespel, P; Van Hecke, P; Schuit, F; Van Veldhoven, P; Ratcliffe, P; Baes, M; Maxwell, P; Carmeliet, P				Aragones, Julian; Schneider, Martin; Van Geyte, Katie; Fraisl, Peter; Dresselaers, Tom; Mazzone, Massimiliano; Dirkx, Ruud; Zacchigna, Serena; Lemieux, Helene; Jeoung, Nam Ho; Lambrechts, Diether; Bishop, Tammie; Lafuste, Peggy; Diez-Juan, Antonio; Harten, Sarah K.; Van Noten, Pieter; De Bock, Katrien; Willam, Carsten; Tjwa, Marc; Grosfeld, Alexandra; Navet, Rachel; Moons, Lieve; Vandendriessche, Thierry; Deroose, Christophe; Wijeyekoon, Bhathiya; Nuyts, Johan; Jordan, Benedicte; Silasi-Mansat, Robert; Lupu, Florea; Dewerchin, Mieke; Pugh, Chris; Salmon, Phil; Mortelmans, Luc; Gallez, Bernard; Gorus, Frans; Buyse, Johan; Sluse, Francis; Harris, Robert A.; Gnaiger, Erich; Hespel, Peter; Van Hecke, Paul; Schuit, Frans; Van Veldhoven, Paul; Ratcliffe, Peter; Baes, Myriam; Maxwell, Patrick; Carmeliet, Peter			Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism	NATURE GENETICS			English	Article							SKELETAL-MUSCLE; EXPRESSION; ALPHA; HIF; INCREASES; MICE; RESPIRATION; HIF-1-ALPHA; HOMEOSTASIS; ADAPTATION	HIF prolyl hydroxylases (PHD1-3) are oxygen sensors that regulate the stability of the hypoxia-inducible factors (HIFs) in an oxygen-dependent manner. Here, we show that loss of Phd1 lowers oxygen consumption in skeletal muscle by reprogramming glucose metabolism from oxidative to more anaerobic ATP production through activation of a Ppar alpha pathway. This metabolic adaptation to oxygen conservation impairs oxidative muscle performance in healthy conditions, but it provides acute protection of myofibers against lethal ischemia. Hypoxia tolerance is not due to HIF-dependent angiogenesis, erythropoiesis or vasodilation, but rather to reduced generation of oxidative stress, which allows Phd1-deficient myofibers to preserve mitochondrial respiration. Hypoxia tolerance relies primarily on Hif-2 alpha and was not observed in heterozygous Phd2-deficient or homozygous Phd3-deficient mice. Of medical importance, conditional knockdown of Phd1 also rapidly induces hypoxia tolerance. These findings delineate a new role of Phd1 in hypoxia tolerance and offer new treatment perspectives for disorders characterized by oxidative stress.	[Aragones, Julian; Schneider, Martin; Van Geyte, Katie; Fraisl, Peter; Mazzone, Massimiliano; Zacchigna, Serena; Lambrechts, Diether; Lafuste, Peggy; Diez-Juan, Antonio; Tjwa, Marc; Moons, Lieve; Vandendriessche, Thierry; Dewerchin, Mieke; Carmeliet, Peter] Katholieke Univ Leuven, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium; [Aragones, Julian; Schneider, Martin; Van Geyte, Katie; Fraisl, Peter; Mazzone, Massimiliano; Zacchigna, Serena; Lemieux, Helene; Lambrechts, Diether; Lafuste, Peggy; Diez-Juan, Antonio; Tjwa, Marc; Moons, Lieve; Vandendriessche, Thierry; Dewerchin, Mieke; Carmeliet, Peter] Katholieke Univ Leuven VIB, Dept Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium; [Dresselaers, Tom; Van Hecke, Paul] Katholieke Univ Leuven, Biomed MRI Unit, B-3000 Louvain, Belgium; [Dirkx, Ruud; Baes, Myriam] Katholieke Univ Leuven, Lab Cell Metab, B-3000 Louvain, Belgium; [Lemieux, Helene; Gnaiger, Erich] Med Univ Innsbruck, Dept Transplant Surg, D Swarovski Res Lab, A-6020 Innsbruck, Austria; [Jeoung, Nam Ho; Harris, Robert A.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Bishop, Tammie; Willam, Carsten; Grosfeld, Alexandra; Wijeyekoon, Bhathiya; Pugh, Chris; Ratcliffe, Peter] Henry Wellcome Bldg Mol Physiol, Oxford OX3 7BN, England; [Harten, Sarah K.; Maxwell, Patrick] Univ London Imperial Coll Sci Technol & Med, Div Med, London W12 0NN, England; [Van Noten, Pieter; De Bock, Katrien; Hespel, Peter] Katholieke Univ Leuven, Fac Kinesiol & Rehabil Sci, Exercise & Hlth Lab, B-3001 Louvain, Belgium; [Navet, Rachel; Sluse, Francis] Univ Liege, Dept Life Sci, Lab Bioenerget & Mol Physiol, B-4000 Liege, Belgium; [Deroose, Christophe; Nuyts, Johan; Mortelmans, Luc] Katholieke Univ Leuven, Univ Hosp, Dept Nucl Med, B-3000 Louvain, Belgium; [Jordan, Benedicte; Gallez, Bernard] Catholic Univ Louvain, Biomed Magnet Resonance Unit, B-1200 Brussels, Belgium; [Silasi-Mansat, Robert; Lupu, Florea] Oklahoma Med Res Fdn, Cardiovasc Res Program, Oklahoma City, OK 73104 USA; [Salmon, Phil] Skyscan NV, B-2630 Aartselaar, Belgium; [Gorus, Frans] Free Univ Brussels, Diabet Res Ctr, B-1090 Brussels, Belgium; [Buyse, Johan] Katholieke Univ Leuven, Dept Biosyst, Lab Physiol Immunol & Genet Domest Anim, B-3001 Louvain, Belgium; [Schuit, Frans] Katholieke Univ Leuven, Dept Mol Cell Biol, Gene Express Unit, B-3000 Louvain, Belgium; [Van Veldhoven, Paul] Katholieke Univ Leuven, Lab Lipid Biochem & Prot Interact, Dept Mol Cell Biol, B-3000 Louvain, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; KU Leuven; KU Leuven; Medical University of Innsbruck; Indiana University System; Indiana University-Purdue University Indianapolis; University of Oxford; Imperial College London; KU Leuven; University of Liege; KU Leuven; Universite Catholique Louvain; Oklahoma Medical Research Foundation; Universite Libre de Bruxelles; Vrije Universiteit Brussel; KU Leuven; KU Leuven; KU Leuven	Carmeliet, P (corresponding author), Katholieke Univ Leuven, Ctr Transgene Technol & Gene Therapy, B-3000 Louvain, Belgium.	peter.carmeliet@med.kuleuven.be	De Bock, Katrien/B-7208-2012; Grosfeld, Alexandra/R-1404-2017; Verdrengh, Evelien/H-4571-2012; Schneider, Martin/H-3745-2011; Carmeliet, Peter/AAQ-5140-2020; Lupu, Florea/AAV-3257-2021; Lupu, Florea/C-3162-2009; De Bock, Katrien/L-2273-2013; Deroose, Christophe/AAG-7385-2020; , Van Veldhoven Paul/U-6359-2019; Maxwell, Patrick H/C-5557-2008; Lambrechts, Diether/AAJ-3167-2020; Diez Juan, Antonio/D-3695-2018; Grosfeld, Alexandra/AAH-3510-2020; ZACCHIGNA, SERENA/E-9496-2017; Diez-Juan, Antonio/H-5464-2015	Grosfeld, Alexandra/0000-0002-9508-036X; Carmeliet, Peter/0000-0001-7961-1821; Lupu, Florea/0000-0003-1249-9278; Lupu, Florea/0000-0003-1249-9278; De Bock, Katrien/0000-0001-8232-4663; Deroose, Christophe/0000-0002-6080-1577; , Van Veldhoven Paul/0000-0002-4478-2564; Maxwell, Patrick H/0000-0002-0338-2679; Lambrechts, Diether/0000-0002-3429-302X; Vandendriessche, Thierry/0000-0003-4230-745X; Jeoung, Nam Ho/0000-0002-7584-3761; ZACCHIGNA, SERENA/0000-0001-6705-3076; Aragones Lopez, Julian/0000-0002-0193-4679; Pugh, Chris/0000-0002-5170-1662; Gnaiger, Erich/0000-0003-3647-5895; Nuyts, Johan/0000-0003-1923-6198; Wilkinson, Sarah/0000-0002-1912-8384; Mazzone, Massimiliano/0000-0001-8824-4015; Bishop, Tammie/0000-0003-3308-9139; Gorus, Frans/0000-0002-9007-6177; Diez-Juan, Antonio/0000-0002-0166-1869; Dresselaers, Tom/0000-0002-0884-5142; Wijeyekoon, Jananath/0000-0003-3414-4304; Lafuste, Peggy/0000-0001-8239-3482; Ratcliffe, Peter/0000-0002-2853-806X; Silasi, Robert/0000-0001-9590-6160; Moons, Lieve (Godelieve)/0000-0003-0186-1411; Hespel, Peter/0000-0003-1283-2229; Baes, Myriam/0000-0002-2525-2269	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047844] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037704] Funding Source: NIH RePORTER; MRC [G84/6411] Funding Source: UKRI; Medical Research Council [G84/6411] Funding Source: Medline; NIDDK NIH HHS [12R01DK47844] Funding Source: Medline; NIGMS NIH HHS [5R01GM037704] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andrews MT, 2004, BIOCHEM SOC T, V32, P1021, DOI 10.1042/BST0321021; Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Becker LB, 1999, AM J PHYSIOL-HEART C, V277, pH2240, DOI 10.1152/ajpheart.1999.277.6.H2240; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Boushel R, 2007, DIABETOLOGIA, V50, P790, DOI 10.1007/s00125-007-0594-3; Bracken CP, 2003, CELL MOL LIFE SCI, V60, P1376, DOI 10.1007/s00018-003-2370-y; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Brusselmans K, 2003, J CLIN INVEST, V111, P1519, DOI 10.1172/JCI200315496; Buck MJ, 2002, PHYSIOL GENOMICS, V8, P5, DOI 10.1152/physiolgenomics.00076.2001; Buyse J, 1998, BRIT POULTRY SCI, V39, P264, DOI 10.1080/00071669889231; Clanton TL, 2007, J APPL PHYSIOL, V102, P2379, DOI 10.1152/japplphysiol.01298.2006; Doege K, 2005, BLOOD, V106, P2311, DOI 10.1182/blood-2005-03-1138; Elson DA, 2001, GENE DEV, V15, P2520, DOI 10.1101/gad.914801; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; Fiskum G, 2004, J BIOENERG BIOMEMBR, V36, P347, DOI 10.1023/B:JOBB.0000041766.71376.81; Gardner PR, 2002, METHOD ENZYMOL, V349, P9, DOI 10.1016/S0076-6879(02)49317-2; Gnaiger E, 2003, ADV EXP MED BIOL, V543, P39; Haddad GG, 2006, EXP PHYSIOL, V91, P277, DOI 10.1113/expphysiol.2005.030767; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Hochachka PW, 1998, J EXP BIOL, V201, P1243; Imai H, 2003, FREE RADICAL BIO MED, V34, P56, DOI 10.1016/S0891-5849(02)01180-2; Jeoung NH, 2006, BIOCHEM J, V397, P417, DOI 10.1042/BJ20060125; Jordan BF, 2002, CANCER RES, V62, P3555; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Kotani K, 2004, J CLIN INVEST, V114, P1666, DOI 10.1172/JCI200421341; Kuznetsov AV, 2004, AM J PHYSIOL-HEART C, V286, pH1633, DOI 10.1152/ajpheart.00701.2003; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Luttun A, 2002, NAT MED, V8, P831, DOI 10.1038/nm731; Magalhaes J, 2005, J APPL PHYSIOL, V99, P1247, DOI 10.1152/japplphysiol.01324.2004; Mason SD, 2004, PLOS BIOL, V2, P1540, DOI 10.1371/journal.pbio.0020288; McMahon JM, 2001, GENE THER, V8, P1264, DOI 10.1038/sj.gt.3301522; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; RERNIREZ JM, 2007, ANNU REV PHYSIOL, V69, P113; Schuler M, 2006, CELL METAB, V4, P407, DOI 10.1016/j.cmet.2006.10.003; Scortegagna M, 2003, NAT GENET, V35, P331, DOI 10.1038/ng1266; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sloniger MA, 1997, J APPL PHYSIOL, V83, P2073, DOI 10.1152/jappl.1997.83.6.2073; Sugden Mary C., 2006, Archives of Physiology and Biochemistry, V112, P139, DOI 10.1080/13813450600935263; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Takeda K, 2006, MOL CELL BIOL, V26, P8336, DOI 10.1128/MCB.00425-06; Thomas S, 1998, EUR J BIOCHEM, V258, P956, DOI 10.1046/j.1432-1327.1998.2580956.x; Wallace DC, 1999, SCIENCE, V283, P1482, DOI 10.1126/science.283.5407.1482; Willam C, 2002, P NATL ACAD SCI USA, V99, P10423, DOI 10.1073/pnas.162119399; Wouters BG, 2004, DRUG RESIST UPDATE, V7, P25, DOI 10.1016/j.drup.2003.12.004; Wu PF, 2001, BIOCHEM BIOPH RES CO, V287, P391, DOI 10.1006/bbrc.2001.5608; Zaccagnini G, 2004, CIRCULATION, V109, P2917, DOI 10.1161/01.CIR.0000129309.58874.0F	49	380	393	3	64	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					170	180		10.1038/ng.2007.62	http://dx.doi.org/10.1038/ng.2007.62			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18176562	Green Accepted, Green Published			2022-12-27	WOS:000252732900015
J	Kozyrev, SV; Abelson, AK; Wojcik, J; Zaghlool, A; Reddy, MVPL; Sanchez, E; Gunnarsson, I; Svenungsson, E; Sturfelt, G; Jonsen, A; Truedsson, L; Pons-Estel, BA; Witte, T; D'Alfonso, S; Barrizzone, N; Danieli, MG; Gutierrez, C; Suarez, A; Junker, P; Laustrup, H; Gonzalez-Escribano, MF; Martin, J; Abderrahim, H; Alarcon-Riquelme, ME				Kozyrev, Sergey V.; Abelson, Anna-Karin; Wojcik, Jerome; Zaghlool, Ammar; Reddy, M. V. Prasad Linga; Sanchez, Elena; Gunnarsson, Iva; Svenungsson, Elisabet; Sturfelt, Gunnar; Jonsen, Andreas; Truedsson, Lennart; Pons-Estel, Bernardo A.; Witte, Torsten; D'Alfonso, Sandra; Barrizzone, Nadia; Danieli, Maria Giovanna; Gutierrez, Carmen; Suarez, Ana; Junker, Peter; Laustrup, Helle; Gonzalez-Escribano, Maria Francisca; Martin, Javier; Abderrahim, Hadi; Alarcon-Riquelme, Marta E.			Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus	NATURE GENETICS			English	Article							SIGNAL-TRANSDUCTION; HAPLOTYPE RECONSTRUCTION; LYN; RECEPTOR; PHOSPHORYLATION; ACTIVATION; EXPRESSION; SEQUENCE	Systemic lupus erythematosus (SLE) is a prototypical autoimmune disease characterized by production of autoantibodies and complex genetic inheritance(1-3). In a genome-wide scan using 85,042 SNPs, we identified an association between SLE and a nonsynonymous substitution (rs10516487, R61H) in the B-cell scaffold protein with ankyrin repeats gene, BANK1. We replicated the association in four independent case-control sets (combined P = 3.7 x 10(-10); OR = 1.38). We analyzed BANK1 cDNA and found two isoforms, one full-length and the other alternatively spliced and lacking exon 2 (Delta 2), encoding a protein without a putative IP3R-binding domain. The transcripts were differentially expressed depending on a branch point-site SNP, rs17266594, in strong linkage disequilibrium (LD) with rs10516487. A third associated variant was found in the ankyrin domain (rs3733197, A383T). Our findings implicate BANK1 as a susceptibility gene for SLE, with variants affecting regulatory sites and key functional domains. The disease-associated variants could contribute to sustained B cell-receptor signaling and B-cell hyperactivity characteristic of this disease.	[Kozyrev, Sergey V.; Abelson, Anna-Karin; Zaghlool, Ammar; Reddy, M. V. Prasad Linga; Alarcon-Riquelme, Marta E.] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, S-75185 Uppsala, Sweden; [Wojcik, Jerome; Abderrahim, Hadi] Merck Serono, CH-12202 Geneva, Switzerland; [Sanchez, Elena; Martin, Javier] Inst Biomed Lopez Neyra, Granada 18100, Spain; [Gunnarsson, Iva; Svenungsson, Elisabet] Karolinska Univ Hosp, Rheumatol Unit, Dept Med, S-17176 Solna, Sweden; [Sturfelt, Gunnar; Jonsen, Andreas] Lund Univ, Dept Rheumatol, S-22200 Lund, Sweden; [Truedsson, Lennart] Lund Univ, Dept Clin Immunol & Microbiol, S-22200 Lund, Sweden; [Pons-Estel, Bernardo A.] Sanatorio Parque, RA-2000 Rosario, Santa Fe, Argentina; [Witte, Torsten] Hannover Med Sch, D-30625 Hannover, Germany; [D'Alfonso, Sandra; Barrizzone, Nadia] Univ Piemonte Orientale, IRCAD, I-13100 Novara, Italy; [D'Alfonso, Sandra; Barrizzone, Nadia] Univ Piemonte Orientale, Dept Med Sci, I-13100 Novara, Italy; [Danieli, Maria Giovanna] Univ Politecn Marche, Dipartimento Sci Med & Chirurg, I-60121 Ancona, Italy; [Gutierrez, Carmen; Suarez, Ana] Univ Oviedo, Hosp Univ Cent Asturias, Dept Funct Biol, E-33006 Oviedo, Spain; [Junker, Peter; Laustrup, Helle] Odense Univ Hosp, Rheumatol Sect, Dept Internal Med C, DK-5000 Odense, Denmark; [Gonzalez-Escribano, Maria Francisca] Hosp Virgen Rocio, Dept Immunol, Seville 41013, Spain	Uppsala University; Merck KGaA; EMD Serono Inc.; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Karolinska Institutet; Karolinska University Hospital; Lund University; Lund University; Hannover Medical School; University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Marche Polytechnic University; Central University Hospital Asturias; University of Oviedo; University of Southern Denmark; Odense University Hospital; Virgen del Rocio University Hospital	Alarcon-Riquelme, ME (corresponding author), Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, S-75185 Uppsala, Sweden.	marta.alarcon@genpat.uu.se	REDDY, M.V. PRASAD LINGA/H-6330-2012; Sanchez, Elena/AAC-1985-2021; Witte, Torsten/B-5783-2016; Martín, Javier/AAV-5209-2021; Alarcón-Riquelme, Marta E./ABF-8163-2020; González-Escribano, María Francisca/X-5554-2019; Martín, María/HDL-9512-2022; Suarez, Ana/F-4492-2015; Martin, Javier/B-8141-2008; Sanchez, Elena/B-4140-2017; D'Alfonso, Sandra/K-7295-2014	Alarcón-Riquelme, Marta E./0000-0002-7632-4154; Suarez, Ana/0000-0002-4452-7539; Martin, Javier/0000-0002-2202-0622; Sanchez, Elena/0000-0002-7041-5485; D'Alfonso, Sandra/0000-0002-3983-9925; Danieli, Maria Giovanna/0000-0002-9608-2252; Svenungsson, Elisabet/0000-0003-3396-3244; Rapa, Anna/0000-0002-5523-5224; Abelson, Anna-Karin/0000-0002-4205-3456; Kozyrev, Sergey/0000-0001-6209-4100; Laustrup, Helle/0000-0002-4421-9907; Pons-Estel, Bernardo/0000-0003-2518-0266				Aiba Y, 2006, IMMUNITY, V24, P259, DOI 10.1016/j.immuni.2006.01.002; Alarcon-Riquelme ME, 2006, SPRINGER SEMIN IMMUN, V28, P109, DOI 10.1007/s00281-006-0033-4; Anolik Jennifer, 2003, Curr Rheumatol Rep, V5, P350, DOI 10.1007/s11926-003-0020-x; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Burge CB, 1999, RNA WORLD, P525; Cornall RJ, 1998, IMMUNITY, V8, P497, DOI 10.1016/S1074-7613(00)80554-3; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P115, DOI 10.1002/gepi.10252; Flores-Borja F, 2005, ARTHRITIS RHEUM-US, V52, P3955, DOI 10.1002/art.21416; Forner K, 2008, HUM HERED, V65, P183, DOI 10.1159/000112365; Guedj M, 2006, HUM HERED, V61, P210, DOI 10.1159/000094776; Hibbs ML, 2002, J EXP MED, V196, P1593, DOI 10.1084/jem.20020515; Hucka S, 2001, AUTOIMMUNITY, V33, P213, DOI 10.3109/08916930109008048; Jordan MS, 2003, NAT IMMUNOL, V4, P110, DOI 10.1038/ni0203-110; Kozyrev SV, 2007, ARTHRITIS RHEUM, V56, P1234, DOI 10.1002/art.22497; Kurosaki T, 2002, NAT REV IMMUNOL, V2, P354, DOI 10.1038/nri801; Li M, 2000, J BIOL CHEM, V275, P18079, DOI 10.1074/jbc.M910197199; Liossis SNC, 1996, J CLIN INVEST, V98, P2549, DOI 10.1172/JCI119073; Liossis SNC, 2001, J INVEST MED, V49, P157, DOI 10.2310/6650.2001.34042; Mohler PJ, 2003, NATURE, V421, P634, DOI 10.1038/nature01335; Okada T, 2000, IMMUNITY, V13, P817, DOI 10.1016/S1074-7613(00)00079-0; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Purcell S, 2007, BIOINFORMATICS, V23, P255, DOI 10.1093/bioinformatics/btl580; Sestak AL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2176; Sherer Y, 2004, SEMIN ARTHRITIS RHEU, V34, P501, DOI 10.1016/j.semarthrit.2004.07.002; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Yokoyama K, 2002, EMBO J, V21, P83, DOI 10.1093/emboj/21.1.83	28	362	374	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					211	216		10.1038/ng.79	http://dx.doi.org/10.1038/ng.79			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18204447				2022-12-27	WOS:000252732900020
J	Stratton, MR; Rahman, N				Stratton, Michael R.; Rahman, Nazneen			The emerging landscape of breast cancer susceptibility	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; COLORECTAL-CANCER; ATAXIA-TELANGIECTASIA; PROSTATE-CANCER; BRCA2; MUTATIONS; GENE; VARIANT; PROTEIN; RISK	The genetic basis of inherited predisposition to breast cancer has been assiduously investigated for the past two decades and has been the subject of several recent discoveries. Three reasonably well-defined classes of breast cancer susceptibility alleles with different levels of risk and prevalence in the population have become apparent: rare high-penetrance alleles, rare moderate-penetrance alleles and common low-penetrance alleles. The contribution of each component to breast cancer predisposition is still to be fully explored, as are the phenotypic characteristics of the cancers associated with them, the ways in which they interact, much of their biology and their clinical utility. These recent advances herald a new chapter in the exploration of susceptibility to breast cancer and are likely to provide insights relevant to other common, heterogeneous diseases.	[Stratton, Michael R.] Wellcome Trust Genome Campus, Wellcome Trust Sange Inst, Canc Genom Project, Cambridge CB10 1SA, England; [Stratton, Michael R.; Rahman, Nazneen] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England	Wellcome Trust Sanger Institute; University of London; Institute of Cancer Research - UK	Stratton, MR (corresponding author), Wellcome Trust Genome Campus, Wellcome Trust Sange Inst, Canc Genom Project, 15 Cotswold Rd, Cambridge CB10 1SA, England.	nazneen.rahman@icr.ac.uk	Rahman, Nazneen/B-8890-2012; Rahman, Nazneen/D-2802-2013	Rahman, Nazneen/0000-0003-4376-0440				Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Antoniou AC, 2006, ONCOGENE, V25, P5898, DOI 10.1038/sj.onc.1209879; Beral V, 2002, LANCET, V360, P187, DOI 10.1016/S0140-6736(02)09454-0; Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Domchek SM, 2006, ONCOGENE, V25, P5825, DOI 10.1038/sj.onc.1209881; Easton D, 2004, AM J HUM GENET, V74, P1175, DOI 10.1086/421251; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Erkko H, 2007, NATURE, V446, P316, DOI 10.1038/nature05609; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Heikkinen K, 2006, CARCINOGENESIS, V27, P1593, DOI 10.1093/carcin/bgi360; Honrado E, 2006, CRIT REV ONCOL HEMAT, V59, P27, DOI 10.1016/j.critrevonc.2006.01.006; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; Meijers-Heijboer H, 2002, NAT GENET, V31, P55, DOI 10.1038/ng879; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Peng M, 2006, ONCOGENE, V25, P2245, DOI 10.1038/sj.onc.1209257; Peto J, 2000, NAT GENET, V26, P411, DOI 10.1038/82533; Peto J, 1999, J NATL CANCER I, V91, P943, DOI 10.1093/jnci/91.11.943; Pharoah P, 2006, JNCI-J NATL CANCER I, V98, P1382, DOI 10.1093/jnci/djj374; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Pollock PM, 2007, ONCOGENE, V26, P7158, DOI 10.1038/sj.onc.1210529; Ponder BAJ, 2000, BRIT J CANCER, V83, P1301; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Reid S, 2005, J MED GENET, V42, P147, DOI 10.1136/jmg.2004.022673; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Seal S, 2003, CANCER RES, V63, P8596; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Smith P, 2006, GENE CHROMOSOME CANC, V45, P646, DOI 10.1002/gcc.20330; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Thompson D, 2005, JNCI-J NATL CANCER I, V97, P813, DOI 10.1093/jnci/dji141; Thompson D, 2004, J MAMMARY GLAND BIOL, V9, P221, DOI 10.1023/B:JOMG.0000048770.90334.3b; Thompson D, 2002, JNCI-J NATL CANCER I, V94, P1358, DOI 10.1093/jnci/94.18.1358; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tommiska J, 2006, INT J CANCER, V118, P2911, DOI 10.1002/ijc.21738; Vahteristo P, 2002, AM J HUM GENET, V71, P432, DOI 10.1086/341943; van Puijenbroek M, 2005, J PATHOL, V206, P198, DOI 10.1002/path.1764; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	55	346	358	1	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2008	40	1					17	22		10.1038/ng.2007.53	http://dx.doi.org/10.1038/ng.2007.53			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18163131				2022-12-27	WOS:000252118600011
J	Cortina, C; Palomo-Ponce, S; Iglesias, M; Fernandez-Masip, JL; Vivancos, A; Whissell, G; Huma, M; Peiro, N; Gallego, L; Jonkheer, S; Davy, A; Lloreta, J; Sancho, E; Batlle, E				Cortina, Carme; Palomo-Ponce, Sergio; Iglesias, Mar; Fernandez-Masip, Juan Luis; Vivancos, Ana; Whissell, Gavin; Huma, Mireia; Peiro, Nerea; Gallego, Lourdes; Jonkheer, Suzanne; Davy, Alice; Lloreta, Josep; Sancho, Elena; Batlle, Eduard			EphB ephrin-B interactions suppress colorectal cancer progression by compartmentalizing tumor cells	NATURE GENETICS			English	Article							EXPRESSION; RECEPTORS; EPHB/EPHRINB; EPITHELIUM; MICE	The genes encoding tyrosine kinase receptors EphB2 and EphB3 are beta-catenin and Tcf4 target genes in colorectal cancer (CRC) and in normal intestinal cells(1,2). In the intestinal epithelium, EphB signaling controls the positioning of cell types along the crypt-villus axis(1). In CRC, EphB activity suppresses tumor progression beyond the earliest stages(3,4). Here we show that EphB receptors compartmentalize the expansion of CRC cells through a mechanism dependent on E-cadherin-mediated adhesion. We demonstrate that EphB-mediated compartmentalization restricts the spreading of EphB-expressing tumor cells into ephrin-B1-positive territories in vitro and in vivo. Our results indicate that CRC cells must silence EphB expression to avoid repulsive interactions imposed by normal ephrin-B1-expressing intestinal cells at the onset of tumorigenesis.	Inst Res Biomed IRB, Oncol Programme, Glassboro, NJ 08028 USA; Univ Autonoma Barcelona, Hosp Univ Mar, Dept Pathol, E-08193 Barcelona, Spain; UPS, CNRS, Ctr Dev Biol, F-31062 Toulouse, France	Autonomous University of Barcelona; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Batlle, E (corresponding author), Inst Res Biomed IRB, Oncol Programme, Josep Samitier 1 5, Glassboro, NJ 08028 USA.	eduard.batlle@irbbarcelona.org	Lloreta-Trull, Josep/GRR-9682-2022; Vivancos, Ana/AAG-8331-2019; Lloreta-Trull, Josep/AAZ-1229-2020; Cortina Duran, Carme/K-7203-2017; Sancho, Elena/ABH-4867-2020; Batlle, Eduard/K-8080-2014; Palomo-Ponce, Sergio/L-2749-2017; Lloreta, J/I-2112-2014	Vivancos, Ana/0000-0003-2888-6512; Cortina Duran, Carme/0000-0003-3477-4322; Sancho, Elena/0000-0002-8182-513X; Batlle, Eduard/0000-0003-2422-0326; Palomo-Ponce, Sergio/0000-0002-3371-6457; Lloreta, J/0000-0003-1644-9470				Barrios A, 2003, CURR BIOL, V13, P1571, DOI 10.1016/j.cub.2003.08.030; Batlle E, 2005, NATURE, V435, P1126, DOI 10.1038/nature03626; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Clevers H, 2006, CANCER RES, V66, P2, DOI 10.1158/0008-5472.CAN-05-3849; Davy A, 2004, GENE DEV, V18, P572, DOI 10.1101/gad.1171704; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fuller T, 2003, J CELL SCI, V116, P2461, DOI 10.1242/jcs.00426; Guo DL, 2006, CARCINOGENESIS, V27, P454, DOI 10.1093/carcin/bgi259; Hanawa H, 2002, MOL THER, V5, P242, DOI 10.1006/mthe.2002.0549; Huusko P, 2004, NAT GENET, V36, P979, DOI 10.1038/ng1408; Jubb AM, 2005, CLIN CANCER RES, V11, P5181, DOI 10.1158/1078-0432.CCR-05-0143; Lugli A, 2005, CLIN CANCER RES, V11, P6450, DOI 10.1158/1078-0432.CCR-04-2458; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Noren NK, 2006, NAT CELL BIOL, V8, P815, DOI 10.1038/ncb1438; Oshima H, 1997, CANCER RES, V57, P1644; Shih LM, 2001, P NATL ACAD SCI USA, V98, P2640, DOI 10.1073/pnas.051629398; Taketo MM, 2006, CANCER SCI, V97, P355, DOI 10.1111/j.1349-7006.2006.00190.x; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Xu QL, 1999, NATURE, V399, P267, DOI 10.1038/20452; Yamada Y, 2002, CANCER RES, V62, P6367	21	208	212	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2007	39	11					1376	1383		10.1038/ng.2007.11	http://dx.doi.org/10.1038/ng.2007.11			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17906625				2022-12-27	WOS:000250575900022
J	Gregory, SG; Schmidt, S; Seth, P; Oksenberg, JR; Hart, J; Prokop, A; Caillier, SJ; Ban, M; Goris, A; Barcellos, LF; Lincoln, R; McCauley, JL; Sawcer, SJ; Compston, DAS; Dubois, B; Hauser, SL; Garcia-Blanco, MA; Pericak-Vance, MA; Haines, JL				Gregory, Simon G.; Schmidt, Silke; Seth, Puneet; Oksenberg, Jorge R.; Hart, John; Prokop, Angela; Caillier, Stacy J.; Ban, Maria; Goris, An; Barcellos, Lisa F.; Lincoln, Robin; McCauley, Jacob L.; Sawcer, Stephen J.; Compston, D. A. S.; Dubois, Benedicte; Hauser, Stephen L.; Garcia-Blanco, Mariano A.; Pericak-Vance, Margaret A.; Haines, Jonathan L.		Multiple Sclerosis Genetics Grp	Interleukin 7 receptor a chain (IL7R) shows allelic and functional association with multiple sclerosis	NATURE GENETICS			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; THYMIC STROMAL LYMPHOPOIETIN; FAMILY-BASED TESTS; GENE-EXPRESSION; LINKAGE DISEQUILIBRIUM; DISEASE; IDENTIFICATION; RISK; SUSCEPTIBILITY; HOMEOSTASIS	Multiple sclerosis is a demyelinating neurodegenerative disease with a strong genetic component. Previous genetic risk studies have failed to identify consistently linked regions or genes outside of the major histocompatibility complex on chromosome 6p. We describe allelic association of a polymorphism in the gene encoding the interleukin 7 receptor a chain ( IL7R) as a significant risk factor for multiple sclerosis in four independent family- based or case- control data sets ( overall P 2.9 x 10(-7)). Further, the likely causal SNP, rs6897932, located within the alternatively spliced exon 6 of IL7R, has a functional effect on gene expression. The SNP influences the amount of soluble and membrane- bound isoforms of the protein by putatively disrupting an exonic splicing silencer.	Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, Nashville, TN 37232 USA; Duke Univ, Med Ctr, Ctr Human Genet, Durham, NC 27710 USA; Duke Univ, Med Ctr, Ctr RNA Biol, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; Katholieke Univ Leuven, Sect Expt Neurol, B-3000 Louvain, Belgium; Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; Univ Miami, Sch Med, Miami Inst Human Genom, Miami, FL 33136 USA	Vanderbilt University; Duke University; Duke University; Duke University; University of California System; University of California San Francisco; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; KU Leuven; University of California System; University of California Berkeley; University of Miami	Haines, JL (corresponding author), Vanderbilt Univ, Med Ctr, Ctr Human Genet Res, 221 Kirkland Hall, Nashville, TN 37232 USA.	MPericak@med.miami.edu; jonathan@chgr.mc.vanderbilt.edu	Goris, An/F-2943-2010; Haines, Jonathan/C-3374-2012; Goris, An/L-5852-2019; Hauser, Stephen L/J-2978-2016; Dubois, Benedicte/A-4338-2019	Goris, An/0000-0002-1276-6682; Haines, Jonathan/0000-0002-4351-4728; Goris, An/0000-0002-1276-6682; Gregory, Simon/0000-0002-7805-1743; Dubois, Benedicte/0000-0003-0604-8702	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026799, R01NS049477, R01NS032830] Funding Source: NIH RePORTER; MRC [G0000934] Funding Source: UKRI; Medical Research Council [G0000934] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2000, BIOINFORMATICS, V16, P182, DOI 10.1093/bioinformatics/16.2.182; Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Al-Shami A, 2004, J EXP MED, V200, P159, DOI 10.1084/jem.20031975; Baraniak AP, 2003, MOL CELL BIOL, V23, P9327, DOI 10.1128/MCB.23.24.9327-9337.2003; Barcellos LF, 2004, ANN NEUROL, V55, P793, DOI 10.1002/ana.20092; Bomprezzi R, 2003, HUM MOL GENET, V12, P2191, DOI 10.1093/hmg/ddg221; Booth DR, 2005, J MOL MED, V83, P822, DOI 10.1007/s00109-005-0684-y; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Carstens RP, 1998, MOL CELL BIOL, V18, P2205, DOI 10.1128/MCB.18.4.2205; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Correale J, 2006, NEUROLOGY, V67, P652, DOI 10.1212/01.wnl.0000233834.09743.3b; Cox AL, 2005, EUR J IMMUNOL, V35, P3332, DOI 10.1002/eji.200535075; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Ebers GC, 1996, NAT GENET, V13, P472, DOI 10.1038/ng0896-472; Fernald GH, 2005, J NEUROIMMUNOL, V167, P157, DOI 10.1016/j.jneuroim.2005.06.032; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Giedraitis V, 2003, GENES IMMUN, V4, P559, DOI 10.1038/sj.gene.6364024; GOODWIN RG, 1990, CELL, V60, P941, DOI 10.1016/0092-8674(90)90342-C; Haines JL, 1996, NAT GENET, V13, P469, DOI 10.1038/ng0896-469; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Haines JL, 1998, HUM MOL GENET, V7, P1229, DOI 10.1093/hmg/7.8.1229; Hauser MA, 2003, HUM MOL GENET, V12, P671, DOI 10.1093/hmg/ddg070; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Huston DP, 2006, CURR ALLERGY ASTHM R, V6, P372, DOI 10.1007/s11882-996-0006-7; Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853; Kenealy SJ, 2003, J NEUROIMMUNOL, V143, P7, DOI [10.1016/j.jneuroim.2003.08.005, 10.1016/j.jneuroim.2003.08.009]; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Koyama K, 2007, BIOCHEM BIOPH RES CO, V357, P99, DOI 10.1016/j.bbrc.2007.03.081; Malmestrom C, 2006, J NEUROIMMUNOL, V175, P176, DOI 10.1016/j.jneuroim.2006.03.004; Martin ER, 2000, AM J HUM GENET, V67, P146, DOI 10.1086/302957; Monks SA, 2000, AM J HUM GENET, V66, P576, DOI 10.1086/302745; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Oturai A, 1999, ANN NEUROL, V46, P612, DOI 10.1002/1531-8249(199910)46:4<612::AID-ANA9>3.3.CO;2-N; Ramanathan M, 2001, J NEUROIMMUNOL, V116, P213, DOI 10.1016/S0165-5728(01)00308-3; Roxburgh RHSR, 2005, NEUROLOGY, V64, P1144, DOI 10.1212/01.WNL.0000156155.19270.F8; Schmidt S, 2006, GENES IMMUN, V7, P384, DOI 10.1038/sj.gene.6364311; Sham PC, 2004, BEHAV GENET, V34, P207, DOI 10.1023/B:BEGE.0000013734.39266.a3; SUNDVALL M, 1995, NAT GENET, V10, P313, DOI 10.1038/ng0795-313; Teutsch SM, 2003, EUR J HUM GENET, V11, P509, DOI 10.1038/sj.ejhg.5200994; Traggiai E, 2001, J NEUROIMMUNOL, V121, P111, DOI 10.1016/S0165-5728(01)00433-7; van Horssen J, 2006, NEUROPATH APPL NEURO, V32, P585, DOI 10.1111/j.1365-2990.2006.00766.x; Willer CJ, 2003, P NATL ACAD SCI USA, V100, P12877, DOI 10.1073/pnas.1932604100; Xu H, 2005, BIOINFORMATICS, V21, P4181, DOI 10.1093/bioinformatics/bti682; ZAYKIN D, 1995, GENETICA, V96, P169, DOI 10.1007/BF01441162; Zhang Z, 2005, GENES IMMUN, V6, P145, DOI 10.1038/sj.gene.6364171	50	474	489	2	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1083	1091		10.1038/ng2103	http://dx.doi.org/10.1038/ng2103			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17660817				2022-12-27	WOS:000249122400017
J	Yang, H; Bell, TA; Churchill, GA; de Villena, FPM				Yang, Hyuna; Bell, Timothy A.; Churchill, Gary A.; de Villena, Fernando Pardo-Manuel			On the subspecific origin of the laboratory mouse	NATURE GENETICS			English	Article							MUS-MUSCULUS-MOLOSSINUS; INBRED STRAINS; HOUSE MOUSE; MITOCHONDRIAL-DNA; GENETIC-VARIATION; Y-CHROMOSOME; REPRODUCTIVE ISOLATION; INTELLECTUAL HISTORY; HAPLOTYPE DIVERSITY; COMPLEX TRAITS	The genome of the laboratory mouse is thought to be a mosaic of regions with distinct subspecific origins. We have developed a high- resolution map of the origin of the laboratory mouse by generating 25,400 phylogenetic trees at 100- kb intervals spanning the genome. On average, 92% of the genome is of Mus musculus domesticus origin, and the distribution of diversity is markedly nonrandom among the chromosomes. There are large regions of extremely low diversity, which represent blind spots for studies of natural variation and complex traits, and hot spots of diversity. In contrast with the mosaic model, we found that most of the genome has intermediate levels of variation of intrasubspecific origin. Finally, mouse strains derived from the wild that are supposed to represent different mouse subspecies show substantial intersubspecific introgression, which has strong implications for evolutionary studies that assume these are pure representatives of a given subspecies.	Univ N Carolina, Dept Genet, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA; Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; Jackson Lab, Bar Harbor, ME 04609 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Jackson Laboratory	de Villena, FPM (corresponding author), Univ N Carolina, Dept Genet, Carolina Ctr Genome Sci, Chapel Hill, NC 27599 USA.	fernando@med.unc.edu	Churchill, Gary/AAY-7496-2020	Churchill, Gary/0000-0001-9190-9284	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076468] Funding Source: NIH RePORTER; NIGMS NIH HHS [1P50 GM076468] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abe K, 2004, GENOME RES, V14, P2439, DOI 10.1101/gr.2899304; AUFFRAY JC, 1990, BIOL J LINN SOC, V41, P13, DOI 10.1111/j.1095-8312.1990.tb00818.x; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; BISHOP CE, 1985, NATURE, V315, P70, DOI 10.1038/315070a0; Boissinot S, 1997, GENETICS, V146, P1019; BONHOMME F, 1987, BIOL J LINN SOC, V30, P51, DOI 10.1111/j.1095-8312.1987.tb00288.x; Bonhomme F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r80; Boursot P, 2006, GENOME RES, V16, P1191, DOI 10.1101/gr.5541806; Churchill G, 2004, NAT GENET, V36, P1133, DOI 10.1038/ng1104-1133; CHURCHILL GA, 1989, B MATH BIOL, V51, P79; Dai JG, 2005, J EXP BIOL, V208, P4445, DOI 10.1242/jeb.01920; Din W, 1996, J EVOLUTION BIOL, V9, P519, DOI 10.1046/j.1420-9101.1996.9050519.x; FERRIS SD, 1983, P NATL ACAD SCI-BIOL, V80, P2290, DOI 10.1073/pnas.80.8.2290; FERRIS SD, 1982, NATURE, V295, P163, DOI 10.1038/295163a0; Forejt J, 1996, TRENDS GENET, V12, P412, DOI 10.1016/0168-9525(96)10040-8; Frazer KA, 2004, GENOME RES, V14, P1493, DOI 10.1101/gr.2627804; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Harr B, 2006, GENOME RES, V16, P730, DOI 10.1101/gr.5045006; Harr B, 2006, GENOME RES, V16, P1193, DOI 10.1101/gr.5787706; Ideraabdullah FY, 2004, GENOME RES, V14, P1880, DOI 10.1101/gr.2519704; Keightley PD, 2005, PLOS BIOL, V3, P282, DOI 10.1371/journal.pbio.0030042; Li JZ, 2004, NAT GENET, V36, P952, DOI 10.1038/ng1417; LYON MF, 1996, GENETIC VARIANTS STR; NAGAMINE CM, 1992, MAMM GENOME, V3, P84, DOI 10.1007/BF00431251; Oka A, 2007, GENETICS, V175, P185, DOI 10.1534/genetics.106.062976; Paigen K, 2003, GENETICS, V163, P1227; Paigen K, 2003, GENETICS, V163, P1; Patil N, 2001, SCIENCE, V294, P1719, DOI 10.1126/science.1065573; Payseur BA, 2005, GENETICS, V171, P1905, DOI 10.1534/genetics.105.046193; Petkov PM, 2005, PLOS GENET, V1, P312, DOI 10.1371/journal.pgen.0010033; Pletcher MT, 2004, PLOS BIOL, V2, P2159, DOI 10.1371/journal.pbio.0020393; Prager EM, 1998, GENETICS, V150, P835; Sakai T, 2005, MAMM GENOME, V16, P11, DOI 10.1007/s00344-004-3013-9; Snijders AM, 2005, GENOME RES, V15, P302, DOI 10.1101/gr.2902505; Trachtulec Z, 2005, BIOL J LINN SOC, V84, P637, DOI 10.1111/j.1095-8312.2005.00460.x; TUCKER PK, 1992, MAMM GENOME, V3, P254, DOI 10.1007/BF00292153; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Wade CM, 2005, NAT GENET, V37, P1175, DOI 10.1038/ng1666; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Wiltshire T, 2003, P NATL ACAD SCI USA, V100, P3380, DOI 10.1073/pnas.0130101100; Yalcin B, 2004, P NATL ACAD SCI USA, V101, P9734, DOI 10.1073/pnas.0401189101; YONEKAWA H, 1988, MOL BIOL EVOL, V5, P63; Zhang JH, 2005, GENOME RES, V15, P241, DOI 10.1101/gr.2901705	44	235	239	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1100	1107		10.1038/ng2087	http://dx.doi.org/10.1038/ng2087			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17660819				2022-12-27	WOS:000249122400019
J	Hui, LJ; Bakiri, L; Mairhorfer, A; Schweifer, N; Haslinger, C; Kenner, L; Komnenovic, V; Scheuch, H; Beug, H; Wagner, EF				Hui, Lijian; Bakiri, Latifa; Mairhorfer, Andreas; Schweifer, Norbert; Haslinger, Christian; Kenner, Lukas; Komnenovic, Vukoslav; Scheuch, Harald; Beug, Hartmut; Wagner, Erwin F.			p38 alpha suppresses normal and cancer cell proliferation by antagonizing the JNK-c-Jun pathway	NATURE GENETICS			English	Article							ACTIVATED PROTEIN-KINASE; P38 MAP KINASE; SIGNAL-REGULATED KINASE; CYCLIN D1 EXPRESSION; PHOSPHORYLATION; PROGRESSION; INDUCTION; DEATH; HPK1	yThe mitogen-activated protein kinase (MAPK) p38a controls inflammatory responses and cell proliferation. Using mice carrying conditional Mapk14 ( also known as p38a) alleles, we investigated its function in postnatal development and tumorigenesis. When we specifically deleted Mapk14 in the mouse embryo, fetuses developed to term but died shortly after birth, probably owing to lung dysfunction. Fetal hematopoietic cells and embryonic fibroblasts deficient in p38a showed increased proliferation resulting from sustained activation of the c-Jun N-terminal kinase (JNK)-c-Jun pathway. Notably, in chemical-induced liver cancer development, mice with liver-specific deletion of Mapk14 showed enhanced hepatocyte proliferation and tumor development that correlated with upregulation of the JNK-c-Jun pathway. Furthermore, inactivation of JNK or c-Jun suppressed the increased proliferation of Mapk14-deficient hepatocytes and tumor cells. These results demonstrate a new mechanism whereby p38a negatively regulates cell proliferation by antagonizing the JNK-c-Jun pathway in multiple cell types and in liver cancer development.	Res Inst Mol Pathol, A-1030 Vienna, Austria; Boehringer Ingelheim KG, A-1121 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Boehringer Ingelheim	Wagner, EF (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	wagner@imp.ac.at	Bakiri, Latifa/AAP-1674-2020; Bakiri, Latifa/N-5780-2014	Wagner, Erwin F/0000-0001-7872-0196; bakiri, latifa/0000-0002-6300-2420; Kenner, Lukas/0000-0003-2184-1338	Austrian Science Fund (FWF) [F 2802] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		Adams RH, 2000, MOL CELL, V6, P109, DOI 10.1016/S1097-2765(00)00012-5; Aguirre-Ghiso JA, 2004, CANCER RES, V64, P7336, DOI 10.1158/0008-5472.CAN-04-0113; Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; Bakiri L, 2000, EMBO J, V19, P2056, DOI 10.1093/emboj/19.9.2056; Behrens A, 1999, NAT GENET, V21, P326, DOI 10.1038/6854; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Bulavin DV, 2004, ADV CANCER RES, V92, P95, DOI 10.1016/S0065-230X(04)92005-2; Bulavin DV, 2004, NAT GENET, V36, P343, DOI 10.1038/ng1317; Bulavin DV, 2003, MOL CELL BIOL, V23, P3859, DOI 10.1128/MCB.23.11.3859-3871.2003; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Eferl R, 2003, CELL, V112, P181, DOI 10.1016/S0092-8674(03)00042-4; Engel FB, 2005, GENE DEV, V19, P1175, DOI 10.1101/gad.1306705; Hochedlinger K, 2002, ONCOGENE, V21, P2441, DOI 10.1038/sj.onc.1205348; Ihle JN, 2000, CELL, V102, P131, DOI 10.1016/S0092-8674(00)00017-9; Iyoda K, 2003, CANCER-AM CANCER SOC, V97, P3017, DOI 10.1002/cncr.11425; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E; Kiefer F, 1996, EMBO J, V15, P7013, DOI 10.1002/j.1460-2075.1996.tb01093.x; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Lizundia R, 2006, CANCER RES, V66, P6105, DOI 10.1158/0008-5472.CAN-05-3861; Ma WB, 2001, ONCOGENE, V20, P1703, DOI 10.1038/sj.onc.1204224; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Maekawa T, 1999, J BIOL CHEM, V274, P17813, DOI 10.1074/jbc.274.25.17813; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Papa S, 2004, NAT CELL BIOL, V6, P146, DOI 10.1038/ncb1093; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Puri PL, 2000, GENE DEV, V14, P574; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Schreiber M, 1999, GENE DEV, V13, P607, DOI 10.1101/gad.13.5.607; Schwabe RF, 2003, HEPATOLOGY, V37, P824, DOI 10.1053/jhep.2003.50135; Stepniak E, 2006, GENE DEV, V20, P2306, DOI 10.1101/gad.390506; Sun PQ, 2007, CELL, V128, P295, DOI 10.1016/j.cell.2006.11.050; Tamura K, 2000, CELL, V102, P221, DOI 10.1016/S0092-8674(00)00027-1; von Lindern M, 2001, ONCOGENE, V20, P3651, DOI 10.1038/sj.onc.1204494; Wada T, 2004, NAT CELL BIOL, V6, P215, DOI 10.1038/ncb1098; Wang WP, 2002, MOL CELL BIOL, V22, P3389, DOI 10.1128/MCB.22.10.3389-3403.2002	42	288	308	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2007	39	6					741	749		10.1038/ng2033	http://dx.doi.org/10.1038/ng2033			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17468757				2022-12-27	WOS:000246859100018
J	Sun, T; Gao, Y; Tan, W; Ma, SF; Shi, YK; Yao, JR; Guo, YL; Yang, M; Zhang, XM; Zhang, QR; Zeng, CQ; Lin, DX				Sun, Tong; Gao, Yang; Tan, Wen; Ma, Sufang; Shi, Yuankai; Yao, Jiarui; Guo, Yongli; Yang, Ming; Zhang, Xuemei; Zhang, Qingrun; Zeng, Changqing; Lin, Dongxin			A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers	NATURE GENETICS			English	Article							INDUCED CELL-DEATH; PATHWAY GENES FAS; SINGLE NUCLEOTIDE POLYMORPHISM; BREAST-CANCER; CASPASE-8 GENE; INACTIVATING MUTATIONS; ESOPHAGEAL CANCER; SIGNALING COMPLEX; COMMON VARIANT; REDUCED RISK	Caspases are important in the life and death of immune cells and therefore influence immune surveillance of malignancies. We tested whether genetic variants in CASP8, CASP10 and CFLAR, three genes important for death receptor - induced cell killing residing in tandem order on chromosome 2q33, are associated with cancer susceptibility. Using a haplotype-tagging SNP approach, we identified a six-nucleotide deletion ( - 652 6N del) variant in the CASP8 promoter associated with decreased risk of lung cancer. The deletion destroys a stimulatory protein 1 binding site and decreases CASP8 transcription. Biochemical analyses showed that T lymphocytes with the deletion variant had lower caspase-8 activity and activation-induced cell death upon stimulation with cancer cell antigens. Case-control analyses of 4,995 individuals with cancer and 4,972 controls in a Chinese population showed that this genetic variant is associated with reduced susceptibility to multiple cancers, including lung, esophageal, gastric, colorectal, cervical and breast cancers, acting in an allele dose - dependent manner. These results support the hypothesis that genetic variants influencing immune status modify cancer susceptibility.	Chinese Acad Med Sci, Dept Etiol & Carcinogenesis, Canc Inst & Hosp, Beijing 100037, Peoples R China; Peking Union Med Coll, Beijing, Peoples R China; Chinese Acad Sci, Beijing Genom Inst, Beijing, Peoples R China; Chinese Acad Med Sci, Dept Med Oncol, Canc Inst & Hosp, Beijing 100037, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Beijing Genomics Institute (BGI); Chinese Academy of Sciences; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS	Lin, DX (corresponding author), Chinese Acad Med Sci, Dept Etiol & Carcinogenesis, Canc Inst & Hosp, Beijing 100037, Peoples R China.	czeng@genomics.org.cn; dlin@public.bta.net.cn	Yang, Ming/G-4705-2012	Yang, Ming/0000-0002-7722-7487				Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Breckenridge DG, 2002, P NATL ACAD SCI USA, V99, P4331, DOI 10.1073/pnas.072088099; Buetow KH, 2001, P NATL ACAD SCI USA, V98, P581, DOI 10.1073/pnas.021506298; Carlson CS, 2004, NATURE, V429, P446, DOI 10.1038/nature02623; Chappell DB, 1998, CANCER IMMUNOL IMMUN, V47, P65, DOI 10.1007/s002620050505; Couzin J, 2006, SCIENCE, V312, P1131, DOI 10.1126/science.312.5777.1131; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Frank B, 2006, CARCINOGENESIS, V27, P606, DOI 10.1093/carcin/bgi248; Frank B, 2005, J NATL CANCER I, V97, P1012, DOI 10.1093/jnci/dji178; Gratas C, 1998, CANCER RES, V58, P2057; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Gutierrez LS, 1999, BREAST CANCER RES TR, V54, P245, DOI 10.1023/A:1006102601215; Himeji D, 2002, BLOOD, V99, P4070, DOI 10.1182/blood.V99.11.4070; Ho PK, 2005, FEBS J, V272, P5436, DOI 10.1111/j.1742-4658.2005.04966.x; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Kase S, 2002, INT J ONCOL, V20, P291; Kim HS, 2003, GASTROENTEROLOGY, V125, P708, DOI 10.1016/S0016-5085(03)01059-X; Krippl P, 2004, J NATL CANCER I, V96, P1478, DOI 10.1093/jnci/djh289; Lee SH, 1999, ONCOGENE, V18, P3754, DOI 10.1038/sj.onc.1202769; Liedtke C, 2003, J BIOL CHEM, V278, P27593, DOI 10.1074/jbc.M304077200; Liu F, 2006, GASTROENTEROLOGY, V130, P1975, DOI 10.1053/j.gastro.2006.03.021; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; MacPherson G, 2004, JNCI-J NATL CANCER I, V96, P1866, DOI 10.1093/jnci/dji001; Maher S, 2002, IMMUNOL CELL BIOL, V80, P131, DOI 10.1046/j.1440-1711.2002.01068.x; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Muzio M, 1996, CELL, V85, P817, DOI 10.1016/S0092-8674(00)81266-0; Park WS, 2001, GASTROENTEROLOGY, V121, P1219, DOI 10.1053/gast.2001.28663; Reesink-Peters N, 2005, GYNECOL ONCOL, V96, P705, DOI 10.1016/j.ygyno.2004.10.046; Scaffidi C, 1997, J BIOL CHEM, V272, P26953, DOI 10.1074/jbc.272.43.26953; Shin MS, 2001, CANCER RES, V61, P4942; Sibley K, 2003, CANCER RES, V63, P4327; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809; Soung YH, 2005, CANCER RES, V65, P815; Soung YH, 2005, ONCOGENE, V24, P141, DOI 10.1038/sj.onc.1208244; Sun T, 2004, JNCI-J NATL CANCER I, V96, P1030, DOI 10.1093/jnci/djh187; Sun T, 2005, J EXP MED, V202, P967, DOI 10.1084/jem.20050707; Sun T, 2004, CARCINOGENESIS, V25, P2225, DOI 10.1093/carcin/bgh244; TAN W, 2006, CARCINOGENESIS  1206, DOI DOI 10.1093/CARCIN/BGL242; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Thorburn A, 2004, CELL SIGNAL, V16, P139, DOI 10.1016/j.cellsig.2003.08.007; Yu P, 2006, LAB INVEST, V86, P231, DOI 10.1038/labinvest.3700389; Zhang X, 2005, J MED GENET, V42, P479, DOI 10.1136/jmg.2004.030106; Zhang XM, 2005, GASTROENTEROLOGY, V129, P565, DOI 10.1053/j.gastro.2005.05.003	47	223	237	0	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2007	39	5					605	613		10.1038/ng2030	http://dx.doi.org/10.1038/ng2030			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17450141				2022-12-27	WOS:000245971300015
J	Yeager, M; Orr, N; Hayes, RB; Jacobs, KB; Kraft, P; Wacholder, S; Minichiello, MJ; Fearnhead, P; Yu, K; Chatterjee, N; Wang, ZM; Welch, R; Staats, BJ; Calle, EE; Feigelson, HS; Thun, MJ; Rodriguez, C; Albanes, D; Virtamo, J; Weinstein, S; Schumacher, FR; Giovannucci, E; Willett, WC; Cancel-Tassin, G; Cussenot, O; Valeri, A; Andriole, GL; Gelmann, EP; Tucker, M; Gerhard, DS; Fraumeni, JF; Hoover, R; Hunter, DJ; Chanock, SJ; Thomas, G				Yeager, Meredith; Orr, Nick; Hayes, Richard B.; Jacobs, Kevin B.; Kraft, Peter; Wacholder, Sholom; Minichiello, Mark J.; Fearnhead, Paul; Yu, Kai; Chatterjee, Nilanjan; Wang, Zhaoming; Welch, Robert; Staats, Brian J.; Calle, Eugenia E.; Feigelson, Heather Spencer; Thun, Michael J.; Rodriguez, Carmen; Albanes, Demetrius; Virtamo, Jarmo; Weinstein, Stephanie; Schumacher, Fredrick R.; Giovannucci, Edward; Willett, Walter C.; Cancel-Tassin, Geraldine; Cussenot, Olivier; Valeri, Antoine; Andriole, Gerald L.; Gelmann, Edward P.; Tucker, Margaret; Gerhard, Daniela S.; Fraumeni, Joseph F., Jr.; Hoover, Robert; Hunter, David J.; Chanock, Stephen J.; Thomas, Gilles			Genome-wide association study of prostate cancer identifies a second risk locus at 8q24	NATURE GENETICS			English	Article							GENETIC ALTERATIONS; ATTRIBUTABLE RISK	Recently, common variants on human chromosome 8q24 were found to be associated with prostate cancer risk. While conducting a genome-wide association study in the Cancer Genetic Markers of Susceptibility project with 550,000 SNPs in a nested case-control study ( 1,172 cases and 1,157 controls of European origin), we identified a new association at 8q24 with an independent effect on prostate cancer susceptibility. The most significant signal is 70 kb centromeric to the previously reported SNP, rs1447295, but shows little evidence of linkage disequilibrium with it. A combined analysis with four additional studies ( total: 4,296 cases and 4,299 controls) confirms association with prostate cancer for rs6983267 in the centromeric locus ( P = 9.42 x 10(-13;) heterozygote odds ratio (OR): 1.26, 95% confidence interval ( c. i.): 1.13 - 1.41; homozygote OR: 1.58, 95% c. i.: 1.40 - 1.78). Each SNP remained significant in a joint analysis after adjusting for the other ( rs1447295 P = 1.41 x 10(-11); rs6983267 P = 6.62 x 10(-10)). These observations, combined with compelling evidence for a recombination hotspot between the two markers, indicate the presence of at least two independent loci within 8q24 that contribute to prostate cancer in men of European ancestry. We estimate that the population attributable risk of the new locus, marked by rs6983267, is higher than the locus marked by rs1447295 ( 21% versus 9%).	NCI, Div Canc Epidemiol & Genet, Ctr Canc Res, NIH,DHHS, Bethesda, MD 20892 USA; NCI, Pediat Oncol Branch, Ctr Canc Res, NIH,DHHS, Bethesda, MD 20892 USA; NCI, SAIC Frederick, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA; Bioinformed Consulting Serv, Gaithersburg, MD 20877 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Lancaster, Dept Math & Stat, Lancaster LA1 4YF, England; Amer Canc Soc, Dept Epidemiol & Surveillance Res, Atlanta, GA 30329 USA; Natl Inst Publ Hlth, Dept Hlth Promot & Chron Dis Prevent, FIN-00300 Helsinki, Finland; Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; Hop Tenon, AP HP, CeRePP, F-75970 Paris, France; Washington Univ, Sch Med, Div Urol Surg, St Louis, MO 63108 USA; Columbia Univ, Div Hematol & Oncol, New York, NY 10032 USA; NCI, Off Canc Genom, NIH, DHHS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Harvard University; Harvard T.H. Chan School of Public Health; Wellcome Trust Sanger Institute; Lancaster University; American Cancer Society; Finland National Institute for Health & Welfare; Harvard University; Harvard T.H. Chan School of Public Health; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Washington University (WUSTL); Columbia University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Center for Cancer Genomics (CCG)	Chanock, SJ (corresponding author), NCI, Div Canc Epidemiol & Genet, Ctr Canc Res, NIH,DHHS, Bethesda, MD 20892 USA.	chanocks@mail.nih.gov	Weinstein, Stephanie J/P-1627-2017; Tucker, Margaret A/B-4297-2015; Albanes, Demetrius/B-9749-2015; Yeager, Meredith/AAA-5322-2020; Fearnhead, Paul/A-1653-2008; Schumacher, Fredrick/R-6043-2019; Fearnhead, Paul/A-5938-2015; Wang, Zhaoming/R-5527-2018	Weinstein, Stephanie J/0000-0002-3834-1535; Fearnhead, Paul/0000-0002-9386-2341; Schumacher, Fredrick/0000-0002-3073-7463; Fearnhead, Paul/0000-0002-9386-2341; Wang, Zhaoming/0000-0001-7556-3869; Hayes, Richard/0000-0002-0918-661X; Cancel-Tassin, Geraldine/0000-0002-9583-6382; Jacobs, Kevin/0000-0002-4657-6473; cussenot, olivier/0000-0002-9912-0533; Staats, Brian/0000-0002-3818-3792	CCR NIH HHS [N01-RC-37004, N01-RC-45035] Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [T32 CA 09001, U01 CA098710, 5U01CA098233-04, CA55075, N01-CN-45165] Funding Source: Medline; Wellcome Trust Funding Source: Medline; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN045165] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009001, U01CA098710, U01CA098233, Z01SC010083] Funding Source: NIH RePORTER	CCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome TrustEuropean Commission); DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; *ATBC CANC PREV ST, 1994, ANN EPIDEMIOL, V4, P1; BRUZZI P, 1985, AM J EPIDEMIOL, V122, P904, DOI 10.1093/oxfordjournals.aje.a114174; Calle EE, 2002, CANCER-AM CANCER SOC, V94, P2490, DOI 10.1002/cncr.101970; Chen YC, 2005, CANCER RES, V65, P11771, DOI 10.1158/0008-5472.CAN-05-2078; Cher ML, 1996, CANCER RES, V56, P3091; Crawford ED, 2003, UROLOGY, V62, P3, DOI 10.1016/j.urology.2003.10.013; Fearnhead P, 2006, BIOINFORMATICS, V22, P3061, DOI 10.1093/bioinformatics/btl540; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Gohagan JK, 2000, CONTROL CLIN TRIALS, V21, p251S, DOI 10.1016/S0197-2456(00)00097-0; Minichiello MJ, 2006, AM J HUM GENET, V79, P910, DOI 10.1086/508901; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Nupponen NN, 1998, AM J PATHOL, V153, P141, DOI 10.1016/S0002-9440(10)65554-X; Parkin DM, 2002, CANC INCIDENCE 5 CON; Phillips MS, 2003, NAT GENET, V33, P382, DOI 10.1038/ng1100; Prorok PC, 2000, CONTROL CLIN TRIALS, V21, p273S, DOI 10.1016/S0197-2456(00)00098-2; Saarela J, 2006, PLOS GENET, V2, P364, DOI 10.1371/journal.pgen.0020042; SCHUMACHER FR, IN PRESS CANC RES; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; STEINBERG GD, 1990, PROSTATE, V17, P337, DOI 10.1002/pros.2990170409; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Valeri A, 2003, ANN HUM GENET, V67, P125, DOI 10.1046/j.1469-1809.2003.00022.x; WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P303, DOI 10.1093/oxfordjournals.aje.a117252; Willer CJ, 2006, GENET EPIDEMIOL, V30, P180, DOI 10.1002/gepi.20131	26	909	958	1	43	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2007	39	5					645	649		10.1038/ng2022	http://dx.doi.org/10.1038/ng2022			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17401363				2022-12-27	WOS:000245971300020
J	Jeon, J; Park, SY; Chi, MH; Choi, J; Park, J; Rho, HS; Kim, S; Goh, J; Yoo, S; Choi, J; Park, JY; Yi, M; Yang, S; Kwon, MJ; Han, SS; Kim, BR; Khang, CH; Park, B; Lim, SE; Jung, K; Kong, S; Karunakaran, M; Oh, HS; Kim, H; Kim, S; Park, J; Kang, S; Choi, WB; Kang, S; Lee, YH				Jeon, Junhyun; Park, Sook-Young; Chi, Myoung-Hwan; Choi, Jaehyuk; Park, Jongsun; Rho, Hee-Sool; Kim, Soonok; Goh, Jaeduk; Yoo, Sungyong; Choi, Jinhee; Park, Ju-Young; Yi, Mihwa; Yang, Seonyoung; Kwon, Min-Jung; Han, Seong-Sook; Kim, Byeong Ryun; Khang, Chang Hyun; Park, Bongsoo; Lim, Se-Eun; Jung, Kyongyong; Kong, Sunghyung; Karunakaran, Maruthachalam; Oh, Hong-Sik; Kim, Hyojeong; Kim, Seryun; Park, Jaejin; Kang, Soyoung; Choi, Woo-Bong; Kang, Seogchan; Lee, Yong-Hwan			Genome-wide functional analysis of pathogenicity genes in the rice blast fungus	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; MAGNAPORTHE-GRISEA; PLANT INFECTION; DRAFT SEQUENCE; RNAI; TRANSFORMATION; PENETRATION; ARABIDOPSIS; PATHWAY; BIOLOGY	Rapid translation of genome sequences into meaningful biological information hinges on the integration of multiple experimental and informatics methods into a cohesive platform. Despite the explosion in the number of genome sequences available(1), such a platform does not exist for filamentous fungi. Here we present the development and application of a functional genomics and informatics platform for a model plant pathogenic fungus, Magnaporthe oryzae(2). In total, we produced 21,070 mutants through large-scale insertional mutagenesis using Agrobacterium tumefaciens mediated transformation(3). We used a high-throughput phenotype screening pipeline to detect disruption of seven phenotypes encompassing the fungal life cycle and identified the mutated gene and the nature of mutation for each mutant. Comparative analysis of phenotypes and genotypes of the mutants uncovered 202 new pathogenicity loci. Our findings demonstrate the effectiveness of our platform and provide new insights on the molecular basis of fungal pathogenesis. Our approach promises comprehensive functional genomics in filamentous fungi and beyond.	Seoul Natl Univ, Dept Agr Biotechnol, Ctr Fungal Genet Resources, Seoul 151921, South Korea; Seoul Natl Univ, Ctr Agr Biomat, Seoul 151921, South Korea; Rural Dev Adm, Natl Inst Crop Sci, Seoul 441857, South Korea; Penn State Univ, Dept Plant Pathol, University Pk, PA 16802 USA; Dong Eui Univ, Dept Biotechnol & Bioengn, Pusan 614714, South Korea	Seoul National University (SNU); Seoul National University (SNU); Rural Development Administration (RDA), Republic of Korea; National Institute of Crop Science; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Dong-Eui University	Lee, YH (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Ctr Fungal Genet Resources, Seoul 151921, South Korea.	yonglee@snu.ac.kr	Khang, Chang Hyun/ABH-5124-2020	Khang, Chang Hyun/0000-0001-7954-4841; Kang, Seogchan/0000-0003-2291-5634; Park, Jongsun/0000-0003-0786-4701				Andres AJ, 2004, TRENDS ENDOCRIN MET, V15, P243, DOI 10.1016/j.tem.2004.06.010; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Baker EJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-11; Berns K, 2004, NATURE, V428, P431, DOI 10.1038/nature02371; Bevan M, 2005, GENOME RES, V15, P1632, DOI 10.1101/gr.3723405; Bhambra GK, 2006, MOL MICROBIOL, V61, P46, DOI 10.1111/j.1365-2958.2006.05209.x; Chen CB, 2004, MOL MICROBIOL, V51, P1493, DOI 10.1111/j.1365-2958.2003.03932.x; Couch BC, 2002, MYCOLOGIA, V94, P683, DOI 10.2307/3761719; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Donofrio N, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-94; Foster AJ, 2003, EMBO J, V22, P225, DOI 10.1093/emboj/cdg018; Galagan JE, 2005, GENOME RES, V15, P1620, DOI 10.1101/gr.3767105; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Hirochika H, 2004, PLANT MOL BIOL, V54, P325, DOI 10.1023/B:PLAN.0000036368.74758.66; Idnurm A, 2001, MOL PLANT PATHOL, V2, P241, DOI 10.1046/j.1464-6722.2001.00070.x; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; Kwon-Chung J.K., 1992, MED MYCOL; LEE KS, 1992, MOL CELL BIOL, V12, P172, DOI 10.1128/MCB.12.1.172; LIU YG, 1995, GENOMICS, V25, P674, DOI 10.1016/0888-7543(95)80010-J; Mullins ED, 2001, CELL MOL LIFE SCI, V58, P2043, DOI 10.1007/PL00000835; Rho HS, 2001, MOL CELLS, V12, P407; ROGERS SO, 1985, PLANT MOL BIOL, V5, P69, DOI 10.1007/BF00020088; SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; Tani S, 2001, CURR GENET, V39, P10, DOI 10.1007/s002940000175; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xu JR, 1998, P NATL ACAD SCI USA, V95, P12713, DOI 10.1073/pnas.95.21.12713; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001	30	180	193	0	55	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2007	39	4					561	565		10.1038/ng2002	http://dx.doi.org/10.1038/ng2002			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17353894				2022-12-27	WOS:000245271200030
J	Rogaeva, E; Meng, Y; Lee, JH; Gu, Y; Kawarai, T; Zou, F; Katayama, T; Baldwin, CT; Cheng, R; Hasegawa, H; Chen, F; Shibata, N; Lunetta, KL; Pardossi-Piquard, R; Bohm, C; Wakutani, Y; Cupples, LA; Cuenco, KT; Green, RC; Pinessi, L; Rainero, I; Sorbi, S; Bruni, A; Duara, R; Friedland, RP; Inzelberg, R; Hampe, W; Bujo, H; Song, YQ; Andersen, OM; Willnow, TE; Graff-Radford, N; Petersen, RC; Dickson, D; Der, SD; Fraser, PE; Schmitt-Ulms, G; Younkin, S; Mayeux, R; Farrer, LA; St George-Hyslop, P				Rogaeva, Ekaterina; Meng, Yan; Lee, Joseph H.; Gu, Yongjun; Kawarai, Toshitaka; Zou, Fanggeng; Katayama, Taiichi; Baldwin, Clinton T.; Cheng, Rong; Hasegawa, Hiroshi; Chen, Fusheng; Shibata, Nobuto; Lunetta, Kathryn L.; Pardossi-Piquard, Raphaelle; Bohm, Christopher; Wakutani, Yosuke; Cupples, L. Adrienne; Cuenco, Karen T.; Green, Robert C.; Pinessi, Lorenzo; Rainero, Innocenzo; Sorbi, Sandro; Bruni, Amalia; Duara, Ranjan; Friedland, Robert P.; Inzelberg, Rivka; Hampe, Wolfgang; Bujo, Hideaki; Song, You-Qiang; Andersen, Olav M.; Willnow, Thomas E.; Graff-Radford, Neill; Petersen, Ronald C.; Dickson, Dennis; Der, Sandy D.; Fraser, Paul E.; Schmitt-Ulms, Gerold; Younkin, Steven; Mayeux, Richard; Farrer, Lindsay A.; St George-Hyslop, Peter			The neuronal sortilin-related receptor SORL1 is genetically associated with Alzheimer disease	NATURE GENETICS			English	Article							AMYLOID PRECURSOR PROTEIN; FAMILY-BASED ASSOCIATION; APOLIPOPROTEIN-E GENOTYPE; MISSENSE MUTATIONS; BETA PRODUCTION; TESTS; GENE; COMPLEX; SUSCEPTIBILITY; INFORMATION	The recycling of the amyloid precursor protein ( APP) from the cell surface via the endocytic pathways plays a key role in the generation of amyloid beta peptide ( A beta) in Alzheimer disease. We report here that inherited variants in the SORL1 neuronal sorting receptor are associated with late- onset Alzheimer disease. These variants, which occur in at least two different clusters of intronic sequences within the SORL1 gene ( also known as LR11 or SORLA) may regulate tissue- specific expression of SORL1. We also show that SORL1 directs trafficking of APP into recycling pathways and that when SORL1 is underexpressed, APP is sorted into A beta- generating compartments. These data suggest that inherited or acquired changes in SORL1 expression or function are mechanistically involved in causing Alzheimer disease.	Columbia Univ, Taub Inst Alzheimers Dis & Aging Brain, New York, NY USA; Columbia Univ, Gertrude H Sergievsky Ctr, Coll Phys & Surg, New York, NY USA; Univ Toronto, Ctr Res Neurodegenerat Dis, Dept Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada; Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; Toronto Western Hosp, Res Inst, Toronto, ON M5S 3H2, Canada; Boston Univ, Sch Med, Dept Epidemiol, Dept Med,Genet Program,Dept Neurol,Dept Genet & G, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA; Mayo Clin Jacksonville, Dept Neurosci, Jacksonville, FL 32224 USA; Mayo Clin Jacksonville, Dept Neurol, Jacksonville, FL 32224 USA; Mayo Clin Rochester, Dept Neurol, Rochester, MN 55905 USA; Univ Turin, Dept Neurosci, I-10126 Turin, Italy; Univ Florence, Dept Neurol & Psychiat Sci, Ctr Res Transfer & High Educ Chron Inflammat Dege, I-50139 Florence, Italy; Reg Ctr Neurogenet, I-88046 Lamezia Terme, CZ, Italy; Mt Sinai Med Ctr, Wien Ctr Alzheimers Dis & Mem Disorders, Miami Beach, FL 33140 USA; Univ Miami, Sch Med, Dept Psychiat, Miami Beach, FL 33140 USA; Univ Miami, Sch Med, Dept Behav Sci & Med, Miami Beach, FL 33140 USA; Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; Meir Hosp, Kfar Saba & Rappaport Fac Med, IL-47441 Haifa, Israel; Univ Med Ctr Hamburg Eppendorf, Dept Mol Cell Biol, D-20246 Hamburg, Germany; Chiba Univ, Grad Sch Med, Dept Genome Res & Clin Applicat M6, Chuo Ku, Chiba 2608670, Japan; Univ Hong Kong, Dept Biochem, Dept Orthopaed Surg, Hong Kong, Hong Kong, Peoples R China; Univ Hong Kong, Genome Res Ctr, Hong Kong, Hong Kong, Peoples R China; Max Delbruck Ctr Mol Med, Dept Mol Cardiovasc Res, D-13125 Berlin, Germany	Columbia University; Columbia University; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Boston University; Boston University; Columbia University; Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Turin; University of Florence; Mount Sinai Medical Center; University of Miami; University of Miami; Case Western Reserve University; Tel Aviv University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Chiba University; University of Hong Kong; University of Hong Kong; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Mayeux, R (corresponding author), Columbia Univ, Taub Inst Alzheimers Dis & Aging Brain, New York, NY USA.	rpm2@columbia.edu; farrer@bu.edu; p.hyslop@utoronto.ca	Shibata, Nobuto/AAB-9366-2020; Pardossi-Piquard, Raphaëlle/ABA-4472-2021; Friedland, Robert/A-2834-2010; Mayeux, Richard/E-9788-2013; Lee, Joseph H/D-2441-2012; Pardossi-Piquard, Raphaëlle/D-6263-2012; Kawarai, Toshitaka/C-2822-2013; Inzelberg, Rivka/E-5861-2010; Song, You-qiang/C-4401-2009; Farrer, Lindsay/AAS-1035-2020; Song, You-Qiang/E-5207-2011; Andersen, Olav/N-2777-2017; Bruni, Amalia/K-5038-2016	Pardossi-Piquard, Raphaëlle/0000-0001-5292-4414; Friedland, Robert/0000-0001-5721-1843; Mayeux, Richard/0000-0001-6519-9696; Lee, Joseph H/0000-0002-2000-4821; Kawarai, Toshitaka/0000-0003-4547-8131; Inzelberg, Rivka/0000-0002-0720-0502; sorbi, sandro/0000-0002-0380-6670; Song, You-Qiang/0000-0001-9407-2256; Andersen, Olav/0000-0003-4226-3354; Farrer, Lindsay/0000-0001-5533-4225; Cupples, L. Adrienne/0000-0003-0273-7965; Lunetta, Kathryn/0000-0002-9268-810X; St George-Hyslop, Peter/0000-0003-0796-7209; Baldwin, Clinton/0000-0002-3275-9463; Dickson, Dennis W/0000-0001-7189-7917; Bruni, Amalia/0000-0003-3471-3343; Willnow, Thomas/0000-0001-9515-7921	NATIONAL INSTITUTE ON AGING [U01AG006786, R37AG015473, P01AG007232, R01AG017173, R01AG009029, P50AG016574, P30AG013846] Funding Source: NIH RePORTER; NIA NIH HHS [R37 AG015473-07, U01 AG006786, U01-AG06786, P30-AG13846, R01-AG017173, R01 AG017173, R37-AG15473, R37 AG015473, P50-AG16574, P01 AG007232, R37 AG015473-06, P30 AG013846, R37 AG015473-08, R37 AG015473-09, P01-AG07232, R01-HG/AG02213, P50 AG016574, R01 AG009029, R01-AG09029, R37 AG015473-10] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Athan ES, 2001, JAMA-J AM MED ASSOC, V286, P2257, DOI 10.1001/jama.286.18.2257; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Bayer TA, 2001, BRAIN PATHOL, V11, P1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Bowirrat A, 2001, EUR J NEUROL, V8, P119, DOI 10.1046/j.1468-1331.2001.00183.x; Chen FS, 2001, NAT CELL BIOL, V3, P751, DOI 10.1038/35087069; Dodson SE, 2006, J NEUROPATH EXP NEUR, V65, P866, DOI 10.1097/01.jnen.0000228205.19915.20; Ertekin-Taner N, 2005, HUM MOL GENET, V14, P447, DOI 10.1093/hmg/ddi041; Ertekin-Taner N, 2004, HUM MUTAT, V23, P334, DOI 10.1002/humu.20016; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Farrer LA, 2003, HUM MOL GENET, V12, P415, DOI 10.1093/hmg/ddg037; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; Graff-Radford NR, 2002, ARCH NEUROL-CHICAGO, V59, P594, DOI 10.1001/archneur.59.4.594; Green RC, 2002, JAMA-J AM MED ASSOC, V287, P329, DOI 10.1001/jama.287.3.329; Gu YJ, 2004, J BIOL CHEM, V279, P31329, DOI 10.1074/jbc.M401548200; HAASS C, 1993, CELL, V75, P1039, DOI 10.1016/0092-8674(93)90312-E; Hasegawa H, 2004, J BIOL CHEM, V279, P46455, DOI 10.1074/jbc.M406289200; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; Horvath S, 2004, GENET EPIDEMIOL, V26, P61, DOI 10.1002/gepi.10295; Jannot AS, 2003, GENET EPIDEMIOL, V25, P158, DOI 10.1002/gepi.10256; Kinoshita A, 2003, J CELL SCI, V116, P3339, DOI 10.1242/jcs.00643; Lange C, 2003, BIOSTATISTICS, V4, P195, DOI 10.1093/biostatistics/4.2.195; Lange C, 2002, AM J HUM GENET, V71, P575, DOI 10.1086/342406; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Lee JH, 2004, MOL PSYCHIATR, V9, P1042, DOI 10.1038/sj.mp.4001538; Lin S, 2004, NAT GENET, V36, P1181, DOI 10.1038/ng1457; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Offe K, 2006, J NEUROSCI, V26, P1596, DOI 10.1523/JNEUROSCI.4946-05.2006; Owen MJ, 2005, TRENDS GENET, V21, P518, DOI 10.1016/j.tig.2005.06.011; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2002, HUM MOL GENET, V11, P2417, DOI 10.1093/hmg/11.20.2417; Rabinowitz D, 2000, HUM HERED, V50, P211, DOI 10.1159/000022918; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rogaeva E, 1998, JAMA-J AM MED ASSOC, V280, P614, DOI 10.1001/jama.280.7.614; Rogaeva EA, 1999, NAT GENET, V22, P19, DOI 10.1038/8729; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Scherzer CR, 2004, ARCH NEUROL-CHICAGO, V61, P1200, DOI 10.1001/archneur.61.8.1200; Seaman MNJ, 2005, TRENDS CELL BIOL, V15, P68, DOI 10.1016/j.tcb.2004.12.004; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Terwilliger JD, 1998, CURR OPIN BIOTECH, V9, P578, DOI 10.1016/S0958-1669(98)80135-3; Van Steen K, 2005, NAT GENET, V37, P683, DOI 10.1038/ng1582; Vermeire S, 2005, GENES IMMUN, V6, P637, DOI 10.1038/sj.gene.6364257; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009	49	853	889	1	74	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					168	177		10.1038/ng1943	http://dx.doi.org/10.1038/ng1943			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17220890	Green Accepted			2022-12-27	WOS:000244063900014
J	Fischer, J; Lefevre, C; Morava, E; Mussini, JM; Laforet, P; Negre-Salvayre, A; Lathrop, M; Salvayre, R				Fischer, Judith; Lefevre, Caroline; Morava, Eva; Mussini, Jean-Marie; Laforet, Pascal; Negre-Salvayre, Anne; Lathrop, Mark; Salvayre, Robert			The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy	NATURE GENETICS			English	Article							CHANARIN-DORFMAN-SYNDROME; FAMILY-MEMBERS; LIPOLYSIS; METABOLISM; EXPRESSION; PROTEIN; CGI-58	Neutral lipid storage disease comprises a heterogeneous group of autosomal recessive disorders characterized by systemic accumulation of triglycerides in cytoplasmic droplets. Here we report a neutral lipid storage disease subgroup characterized by mild myopathy, absence of ichthyosis and mutations in both alleles of adipose triglyceride lipase (PNPLA2, also known as ATGL). Three of these mutations are predicted to lead to a truncated ATGL protein with an intact patatin domain containing the active site, but with defects in the hydrophobic domain. The block in triglyceride degradation was mimicked by short interfering RNA directed against ATGL. NLSDM is distinct from Chanarin-Dorfman syndrome, which is characterized by neutral lipid storage disease with ichthyosis, mild myopathy and hepatomegaly due to mutations in ABHD5 (also known as CGI-58).	Ctr Natl Genotypage, F-91057 Evry, France; Radboud Univ Nijmegen, Ctr Med, Dept Pediat, NL-6500 HB Nijmegen, Netherlands; Univ Nantes, Ctr Hosp, Dept Internal Med, F-44093 Nantes, France; Grp Hosp Pitie Salpetriere, AP HP, Inst Myol, Ctr Ref Pathol Neuromusc, F-75651 Paris 13, France; CHU Rangueil, IFR 31, F-31432 Toulouse 04, France; Univ Toulouse 3, INSERM, U446, F-31432 Toulouse 04, France	CEA; UDICE-French Research Universities; Universite Paris Saclay; Radboud University Nijmegen; Nantes Universite; CHU de Nantes; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Fischer, J (corresponding author), Ctr Natl Genotypage, F-91057 Evry, France.	fischer@cng.fr; salvayre@toulouse.inserm.fr	Morava, E./L-4529-2015; Fischer, Judith/E-6327-2016	Fischer, Judith/0000-0002-8580-8118; Negre-Salvayre, Anne/0000-0003-2136-5706				CHANARIN I, 1975, BRIT MED J, V1, P553, DOI 10.1136/bmj.1.5957.553; DORFMAN ML, 1974, ARCH DERMATOL, V110, P261, DOI 10.1001/archderm.110.2.261; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; JORDANS GHW, 1953, ACTA MED SCAND, V145, P419; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Lake AC, 2005, J LIPID RES, V46, P2477, DOI 10.1194/jlr.M500290-JLR200; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lefevre C, 2001, AM J HUM GENET, V69, P1002, DOI 10.1086/324121; RADOM J, 1987, EUR J BIOCHEM, V164, P703, DOI 10.1111/j.1432-1033.1987.tb11183.x; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Zechner R, 2005, CURR OPIN LIPIDOL, V16, P333, DOI 10.1097/01.mol.0000169354.20395.1c; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	15	332	353	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2007	39	1					28	30		10.1038/ng1951	http://dx.doi.org/10.1038/ng1951			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	17187067				2022-12-27	WOS:000243136500014
J	Gros-Louis, F; Dupre, N; Dion, P; Fox, MA; Laurent, S; Verreault, S; Sanes, JR; Bouchard, JP; Rouleau, GA				Gros-Louis, Francois; Dupre, Nicolas; Dion, Patrick; Fox, Michael A.; Laurent, Sandra; Verreault, Steve; Sanes, Joshua R.; Bouchard, Jean-Pierre; Rouleau, Guy A.			Mutations in SYNE1 lead to a newly discovered form of autosomal recessive cerebellar ataxia	NATURE GENETICS			English	Article							NEUROMUSCULAR-JUNCTION; PROTEIN; GENE; NUCLEI; MSP-300; REPEAT; MUTANT	The past decade has seen great advances in unraveling the biological basis of hereditary ataxias. Molecular studies of spinocerebellar ataxias (SCA) have extended our understanding of dominant ataxias(1). Causative genes have been identified for a few autosomal recessive ataxias: Friedreich's ataxia(2), ataxia with vitamin E deficiency(3), ataxia telangiectasia(4), recessive spastic ataxia of Charlevoix-Saguenay(5) and ataxia with oculomotor apraxia type 1 (refs. 6,7) and type 2 (ref. 8). Nonetheless, genes remain unidentified for most recessive ataxias. Additionally, pure cerebellar ataxias, which represent up to 20% of all ataxias, remain poorly studied with only two causative dominant genes being described: CACNA1A (ref. 9) and SPTBN2 (ref. 10). Here, we report a newly discovered form of recessive ataxia in a French-Canadian cohort and show that SYNE1 mutations are causative in all of our kindreds, making SYNE1 the first identified gene responsible for a recessively inherited pure cerebellar ataxia.	Univ Montreal, Cent Hosp, Ctr Study Brain Dis, Montreal, PQ H2L 4M1, Canada; Univ Montreal, Cent Hosp Univ Ste Justine, Montreal, PQ H2L 4M1, Canada; Univ Quebec, Hop Enfants Jesus, Fac Med, Laval Univ,Dept Neurol Sci, Quebec City, PQ G1J 1Z4, Canada; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Universite de Montreal; Universite de Montreal; Laval University; University of Quebec; Harvard University	Rouleau, GA (corresponding author), Univ Montreal, Cent Hosp, Ctr Study Brain Dis, Montreal, PQ H2L 4M1, Canada.	guy.rouleau@umontreal.ca	Dupre, Nicolas/Y-1828-2019	Fox, Michael/0000-0002-1649-7782				Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Cottrell JR, 2004, NEURON, V44, P677, DOI 10.1016/j.neuron.2004.10.025; Date H, 2001, NAT GENET, V29, P184, DOI 10.1038/ng1001-184; Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769; Grady RM, 2005, P NATL ACAD SCI USA, V102, P4359, DOI 10.1073/pnas.0500711102; HOLMES A, 1908, BRAIN, V30, P466; Ikeda Y, 2006, NAT GENET, V38, P184, DOI 10.1038/ng1728; Ishikawa K, 2005, AM J HUM GENET, V77, P280, DOI 10.1086/432518; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; Parkinson NJ, 2001, NAT GENET, V29, P61, DOI 10.1038/ng710; RosenbergHasson Y, 1996, MECH DEVELOP, V60, P83, DOI 10.1016/S0925-4773(96)00602-8; Sanes JR, 2001, NAT REV NEUROSCI, V2, P791, DOI 10.1038/35097557; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Schols L, 2004, LANCET NEUROL, V3, P291, DOI 10.1016/S1474-4422(04)00737-9; Starr DA, 2002, SCIENCE, V298, P406, DOI 10.1126/science.1075119; Zhang QP, 2002, GENOMICS, V80, P473, DOI 10.1006/geno.2002.6859; Zhuchenko O, 1997, NAT GENET, V15, P62, DOI 10.1038/ng0197-62	22	221	228	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2007	39	1					80	85		10.1038/ng1927	http://dx.doi.org/10.1038/ng1927			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	17159980				2022-12-27	WOS:000243136500021
J	Castle, JC; Zhang, CL; Shah, JK; Kulkarni, AV; Kalsotra, A; Cooper, TA; Johnson, JM				Castle, John C.; Zhang, Chaolin; Shah, Jyoti K.; Kulkarni, Amit V.; Kalsotra, Auinash; Cooper, Thomas A.; Johnson, Jason M.			Expression of 24,426 human alternative splicing events and predicted cis regulation in 48 tissues and cell lines	NATURE GENETICS			English	Article							BIVATUZUMAB MERTANSINE; RNA; IDENTIFICATION; FOX-1; ENHANCERS; SEQUENCES; ELEMENTS; PROTEIN; HOMOLOGS	Alternative pre-messenger RNA splicing influences development, physiology and disease, but its regulation in humans is not well understood, partially because of the limited scale at which the expression of specific splicing events has been measured. We generated the first genome-scale expression compendium of human alternative splicing events using custom whole-transcript microarrays monitoring expression of 24,426 alternative splicing events in 48 diverse human samples. Over 11,700 genes and 9,500 splicing events were differentially expressed, providing a rich resource for studying splicing regulation. An unbiased, systematic screen of 21,760 4-mer to 7-mer words for cis-regulatory motifs identified 143 RNA 'words' enriched near regulated cassette exons, including six clusters of motifs represented by UCUCU, UGCAUG, UGCU, UGUGU, UUUU and AGGG, which map to trans-acting regulators PTB, Fox, Muscleblind, CELF/CUG-BP, TIA-1 and hnRNP F/H, respectively. Each cluster showed a distinct pattern of genomic location and tissue specificity. For example, UCUCU occurs 110 to 35 nucleotides preceding cassette exons upregulated in brain and striated muscle but depleted in other tissues. UCUCU and UGCAUG seem to have similar function but independent action, occurring 5' and 3', respectively, of 33% of the cassette exons upregulated in skeletal muscle but co-occurring for only 2%.	[Castle, John C.; Shah, Jyoti K.; Kulkarni, Amit V.; Johnson, Jason M.] Rosetta Inpharmat LLC, Seattle, WA 98109 USA; [Zhang, Chaolin] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Kalsotra, Auinash; Cooper, Thomas A.] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA; [Cooper, Thomas A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Merck & Company; Cold Spring Harbor Laboratory; Baylor College of Medicine; Baylor College of Medicine	Castle, JC (corresponding author), Rosetta Inpharmat LLC, Seattle, WA 98109 USA.	john_castle@merck.com; jason_johnson@merck.com		Kalsotra, Auinash/0000-0002-1011-0006	 [R01GM076493]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076493, R01GM074688] Funding Source: NIH RePORTER	; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Armour, C. Raymond, D. Haynor, V. Emilsson, P. Garrett-Engele, F. Roth, P. Loerch, R. Chen, C. Rohl, M. Tompa, E. Schadt and L. Lim for input, Rosetta's Gene Expression Laboratory microarray hybridization facility for microarray data, and S. Carlson for project management. Funding for T.A.C. provided by R01GM076493.	Brudno M, 2001, NUCLEIC ACIDS RES, V29, P2338, DOI 10.1093/nar/29.11.2338; Castle J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r66; CHAN RC, 1995, MOL CELL BIOL, V15, P6377; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Das D, 2007, NUCLEIC ACIDS RES, V35, P4845, DOI 10.1093/nar/gkm485; Duncan PI, 1997, MOL CELL BIOL, V17, P5996, DOI 10.1128/MCB.17.10.5996; Fagnani M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r108; Fairbrother WG, 2004, PLOS BIOL, V2, P1388, DOI 10.1371/journal.pbio.0020268; Fairbrother WG, 2004, NUCLEIC ACIDS RES, V32, pW187, DOI 10.1093/nar/gkh393; Fairbrother WG, 2002, SCIENCE, V297, P1007, DOI 10.1126/science.1073774; Faustino NA, 2005, MOL CELL BIOL, V25, P879, DOI 10.1128/MCB.25.3.879-887.2005; Fehlbaum P, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni047; Florea L, 1998, GENOME RES, V8, P967, DOI 10.1101/gr.8.9.967; Forch P, 2000, MOL CELL, V6, P1089, DOI 10.1016/S1097-2765(00)00107-6; Gooding C, 1998, RNA, V4, P85; Goren A, 2006, MOL CELL, V22, P769, DOI 10.1016/j.molcel.2006.05.008; Griffith M, 2008, NAT METHODS, V5, P118, DOI 10.1038/nmeth0208-118; Han K, 2005, PLOS BIOL, V3, P843, DOI 10.1371/journal.pbio.0030158; Ho TH, 2004, EMBO J, V23, P3103, DOI 10.1038/sj.emboj.7600300; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Jensen KB, 2000, P NATL ACAD SCI USA, V97, P5740, DOI 10.1073/pnas.090553997; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; KAN Z, 2004, PAC S BIOCOMPUT, V9, P42; Kuroyanagi H, 2007, MOL CELL BIOL, V27, P8612, DOI 10.1128/MCB.01508-07; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Liu HX, 1998, GENE DEV, V12, P1998, DOI 10.1101/gad.12.13.1998; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Minovitsky S, 2005, NUCLEIC ACIDS RES, V33, P714, DOI 10.1093/nar/gki210; Nakahata S, 2005, NUCLEIC ACIDS RES, V33, P2078, DOI 10.1093/nar/gki338; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Perez I, 1997, RNA, V3, P764; Riechelmann H, 2008, ORAL ONCOL, V44, P823, DOI 10.1016/j.oraloncology.2007.10.009; Rupp U, 2007, ANTI-CANCER DRUG, V18, P477, DOI 10.1097/CAD.0b013e32801403f4; SINGH R, 1995, SCIENCE, V268, P1173, DOI 10.1126/science.7761834; Sugnet CW, 2006, PLOS COMPUT BIOL, V2, P22, DOI 10.1371/journal.pcbi.0020004; TAYLOR JR, 1982, INTRO ERROR ANAL, V270; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; Underwood JG, 2005, MOL CELL BIOL, V25, P10005, DOI 10.1128/MCB.25.22.10005-10016.2005; Voelker RB, 2007, GENOME RES, V17, P1023, DOI 10.1101/gr.6017807; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Yeo GW, 2007, PLOS COMPUT BIOL, V3, P1951, DOI 10.1371/journal.pcbi.0030196; Yeo GW, 2007, PLOS GENET, V3, P814, DOI 10.1371/journal.pgen.0030085; Yeo GW, 2005, P NATL ACAD SCI USA, V102, P2850, DOI 10.1073/pnas.0409742102; Zhang CL, 2008, GENE DEV, V22, P2550, DOI 10.1101/gad.1703108; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16	49	231	235	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1416	1425		10.1038/ng.264	http://dx.doi.org/10.1038/ng.264			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	18978788	Green Accepted			2022-12-27	WOS:000261215900018
J	Budde, BS; Namavar, Y; Barth, PG; Poll-The, BT; Nurnberg, G; Becker, C; van Ruissen, F; Weterman, MAJ; Fluiter, K; Beek, ETT; Aronica, E; van der Knaap, MS; Hohne, W; Toliat, MR; Crow, YJ; Steinlin, M; Voit, T; Roelens, F; Brussel, W; Brockmann, K; Kyllerman, M; Boltshauser, E; Hammersen, G; Willemsen, M; Basel-Vanagaite, L; Krageloh-Mann, I; de Vries, LS; Sztriha, L; Muntoni, F; Ferrie, CD; Battini, R; Hennekam, RCM; Grillo, E; Beemer, FA; Stoets, LME; Wollnik, B; Nurnberg, P; Baas, F				Budde, Birgit S.; Namavar, Yasmin; Barth, Peter G.; Poll-The, Bwee Tien; Nuernberg, Gudrun; Becker, Christian; van Ruissen, Fred; Weterman, Marian A. J.; Fluiter, Kees; Beek, Erik T. te; Aronica, Eleonora; van der Knaap, Marjo S.; Hoehne, Wolfgang; Toliat, Mohammad Reza; Crow, Yanick J.; Steinlin, Maja; Voit, Thomas; Roelens, Filip; Brussel, Wim; Brockmann, Knut; Kyllerman, Marten; Boltshauser, Eugen; Hammersen, Gerhard; Willemsen, Michel; Basel-Vanagaite, Lina; Kraegeloh-Mann, Ingeborg; de Vries, Linda S.; Sztriha, Laszlo; Muntoni, Francesco; Ferrie, Colin D.; Battini, Roberta; Hennekam, Raoul C. M.; Grillo, Eugenio; Beemer, Frits A.; Stoets, Loes M. E.; Wollnik, Bernd; Nuernberg, Peter; Baas, Frank			tRNA splicing endonuclease mutations cause pontocerebellar hypoplasia	NATURE GENETICS			English	Article							LINKAGE ANALYSIS; OLIVOPONTOCEREBELLAR HYPOPLASIA; FETAL-ONSET; PEDIGREES; SPECTRUM; DISEASE; TYPE-2; TOOL; FORM	Pontocerebellar hypoplasias (PCH) represent a group of neurodegenerative autosomal recessive disorders with prenatal onset, atrophy or hypoplasia of the cerebellum, hypoplasia of the ventral pons, microcephaly, variable neocortical atrophy and severe mental and motor impairments. In two subtypes, PCH2 and PCH4, we identified mutations in three of the four different subunits of the tRNA-splicing endonuclease complex. Our findings point to RNA processing as a new basic cellular impairment in neurological disorders.	[Namavar, Yasmin; van Ruissen, Fred; Weterman, Marian A. J.; Fluiter, Kees; Beek, Erik T. te; Baas, Frank] Univ Amsterdam, Dept Neurogenet, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Budde, Birgit S.; Nuernberg, Gudrun; Becker, Christian; Toliat, Mohammad Reza; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50674 Cologne, Germany; [Budde, Birgit S.; Nuernberg, Gudrun; Becker, Christian; Toliat, Mohammad Reza; Nuernberg, Peter] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Namavar, Yasmin; Barth, Peter G.; Poll-The, Bwee Tien] Univ Amsterdam, Div Pediat Neurol, Emma Childrens Hosp, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Aronica, Eleonora] Univ Amsterdam, Dept Pathol, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [van der Knaap, Marjo S.] Vrije Univ Amsterdam, Med Ctr, Dept Pediat & Child Neurol, NL-1081 HV Amsterdam, Netherlands; [Hoehne, Wolfgang] Charite Univ Med Berlin, Inst Biochem, D-10117 Berlin, Germany; [Crow, Yanick J.] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Steinlin, Maja] Univ Hosp Bern, Dept Pediat Neurol, CH-3010 Bern, Switzerland; [Voit, Thomas] Grp Hosp Pitie Salpetriere, Inst Myol, F-75651 Paris 13, France; [Roelens, Filip] Heilig Hartziekenhuis, Dept Pediat, B-8800 Roeselare, Belgium; [Brussel, Wim] Rijnstate Hosp, Dept Pediat, NL-6815 AD Arnhem, Netherlands; [Brockmann, Knut] Univ Gottingen, Dept Paediat & Child Neurol, D-37075 Gottingen, Germany; [Kyllerman, Marten] Sahlgrens Univ Hosp, Queen Silvia Childrens Hosp, Dept Paediat, S-41685 Gothenburg, Sweden; [Boltshauser, Eugen] Univ Childrens Hosp, CH-8032 Zurich, Switzerland; [Hammersen, Gerhard] CNOPFsche Kinderklin, D-90419 Nurnberg, Germany; [Willemsen, Michel] Radboud Univ Nijmegen, Med Ctr, Dept Pediat Neurol, NL-6500 HB Nijmegen, Netherlands; [Basel-Vanagaite, Lina] Schneider Childrens Med Ctr Israel, IL-49100 Petah Tiqwa, Israel; [Basel-Vanagaite, Lina] Raphael Recanati Genet Inst, Rabin Med Ctr, IL-49100 Petah Tiqwa, Israel; [Kraegeloh-Mann, Ingeborg] Univ Tubingen, Dept Paediat Neurol & Dev Med, D-72076 Tubingen, Germany; [de Vries, Linda S.] Univ Med Ctr, Wilhelmina Childrens Hosp, Dept Neonatol, NL-3584 AE Utrecht, Netherlands; [Sztriha, Laszlo] Univ Szeged, Dept Paediat, H-6726 Szeged, Hungary; [Muntoni, Francesco; Hennekam, Raoul C. M.] UCL, Great Ormond St Hosp Children, Inst Child Hlth, London WC1N 1EH, England; [Ferrie, Colin D.] Gen Infirm, Leeds LS1 3EX, W Yorkshire, England; [Battini, Roberta] Univ Pisa, Stella Maris Sci Inst, Div Child Neurol & Psychiat, I-56018 Calambrone Pisa, Italy; [Hennekam, Raoul C. M.] Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands; [Grillo, Eugenio] Hosp Infantil Joana de Gusmao, Dept Neurol, BR-88025301 Florianopolis, SC, Brazil; [Beemer, Frits A.] Univ Med Ctr Utrecht, Dept Med Genet, NL-3584 AE Utrecht, Netherlands; [Stoets, Loes M. E.] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands; [Wollnik, Bernd; Nuernberg, Peter] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50674 Cologne, Germany; [Wollnik, Bernd; Nuernberg, Peter] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Wollnik, Bernd] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Wollnik, Bernd] Istanbul Univ, Istanbul Fac Med, Dept Med Genet, TR-34390 Istanbul, Turkey	University of Amsterdam; Academic Medical Center Amsterdam; University of Cologne; University of Cologne; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Saint James's University Hospital; University of Leeds; University of Bern; University Hospital of Bern; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Rijnstate Hospital; University of Gottingen; Queen Silvia Children's Hospital; Sahlgrenska University Hospital; University Children's Hospital Zurich; Radboud University Nijmegen; Rabin Medical Center; Eberhard Karls University of Tubingen; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Szeged University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Leeds General Infirmary; IRCCS Fondazione Stella Maris; University of Pisa; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Cologne; University of Cologne; University of Cologne; Istanbul University	Baas, F (corresponding author), Univ Amsterdam, Dept Neurogenet, Acad Med Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	f.baas@amc.uva.nl	de Vries, Linda S/AAB-6454-2021; Patterson, Marc/AAI-5056-2020; battini, roberta/P-9095-2017; Crow, Yanick J/N-6120-2014; Steinlin, Maja/G-5991-2010; Wollnik, Bernd/GRY-6062-2022; Fluiter, Kees/H-2828-2015; Patterson, Marc C./H-5331-2019; Baas, Frank/F-9574-2010; Willemsen, Michel A.A.P./H-8119-2014	battini, roberta/0000-0002-7889-1355; Crow, Yanick J/0000-0001-7211-7564; Wollnik, Bernd/0000-0003-2589-0364; Fluiter, Kees/0000-0003-0898-7260; Baas, Frank/0000-0003-3912-5428; Aronica, Eleonora/0000-0002-3542-3770; Grillo, Eugenio/0000-0002-1002-6613; Poll-The, Bwee Tien/0000-0002-8118-5419; Budde, Birgit/0000-0001-9385-4168; Namavar, Yasmin/0000-0002-0176-5959; van Ruissen, Fred/0000-0002-9458-7505; Basel-Vanagaite, Vanagaite, Lina/0000-0002-9076-8157				ALBRECHT S, 1993, ACTA NEUROPATHOL, V85, P394, DOI 10.1007/BF00334450; Barth PG, 2007, ACTA NEUROPATHOL, V114, P373, DOI 10.1007/s00401-007-0263-0; BARTH PG, 1995, NEUROLOGY, V45, P311, DOI 10.1212/WNL.45.2.311; BARTH PG, 1993, BRAIN DEV-JPN, V15, P411, DOI 10.1016/0387-7604(93)90080-R; Edvardson S, 2007, AM J HUM GENET, V81, P857, DOI 10.1086/521227; GOUTIERES F, 1977, J NEUROL NEUROSUR PS, V40, P370, DOI 10.1136/jnnp.40.4.370; Hopper AK, 2003, GENE DEV, V17, P162, DOI 10.1101/gad.1049103; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Muntoni F, 1999, NEUROPEDIATRICS, V30, P243, DOI 10.1055/s-2007-973498; Patel MS, 2006, AM J MED GENET A, V140A, P594, DOI 10.1002/ajmg.a.31095; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; Rajab A, 2003, NEUROLOGY, V60, P1664, DOI 10.1212/01.WNL.0000068548.58498.41; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; Strauch K, 2000, AM J HUM GENET, V66, P1945, DOI 10.1086/302911; Sztriha L, 2005, AM J MED GENET A, V135A, P134, DOI 10.1002/ajmg.a.30701; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Trotta CR, 2006, NATURE, V441, P375, DOI 10.1038/nature04741; van der Knaap MS, 2002, ANN NEUROL, V51, P264, DOI 10.1002/ana.10112	19	162	168	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2008	40	9					1113	1118		10.1038/ng.204	http://dx.doi.org/10.1038/ng.204			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	18711368				2022-12-27	WOS:000258761200026
J	Monti, J; Fischer, J; Paskas, S; Heinig, M; Schulz, H; Gosele, C; Heuser, A; Fischer, R; Schmidt, C; Schirdewan, A; Gross, V; Hummel, O; Maatz, H; Patone, G; Saar, K; Vingron, M; Weldon, SM; Lindpaintner, K; Hammock, BD; Rohde, K; Dietz, R; Cook, SA; Schunck, WH; Luft, FC; Hubner, N				Monti, Jan; Fischer, Judith; Paskas, Svetlana; Heinig, Matthias; Schulz, Herbert; Goesele, Claudia; Heuser, Arnd; Fischer, Robert; Schmidt, Cosima; Schirdewan, Alexander; Gross, Volkmar; Hummel, Oliver; Maatz, Henrike; Patone, Giannino; Saar, Kathrin; Vingron, Martin; Weldon, Steven M.; Lindpaintner, Klaus; Hammock, Bruce D.; Rohde, Klaus; Dietz, Rainer; Cook, Stuart A.; Schunck, Wolf-Hagen; Luft, Friedrich C.; Hubner, Norbert			Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease	NATURE GENETICS			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; BLOOD-PRESSURE REGULATION; GENE-EXPRESSION; CARDIAC-HYPERTROPHY; EJECTION FRACTION; NERVOUS-SYSTEM; IDENTIFICATION; MOUSE; MICE; ASSOCIATION	We aimed to identify genetic variants associated with heart failure by using a rat model of the human disease. We performed invasive cardiac hemodynamic measurements in F-2 crosses between spontaneously hypertensive heart failure ( SHHF) rats and reference strains. We combined linkage analyses with genome-wide expression profiling and identified Ephx2 as a heart failure susceptibility gene in SHHF rats. Specifically, we found that cis variation at Ephx2 segregated with heart failure and with increased transcript expression, protein expression and enzyme activity, leading to a more rapid hydrolysis of cardioprotective epoxyeicosatrienoic acids. To confirm our results, we tested the role of Ephx2 in heart failure using knockout mice. Ephx2 gene ablation protected from pressure overload-induced heart failure and cardiac arrhythmias. We further demonstrated differential regulation of EPHX2 in human heart failure, suggesting a cross-species role for Ephx2 in this complex disease.	[Monti, Jan; Fischer, Judith; Paskas, Svetlana; Heinig, Matthias; Schulz, Herbert; Goesele, Claudia; Heuser, Arnd; Fischer, Robert; Schmidt, Cosima; Gross, Volkmar; Hummel, Oliver; Maatz, Henrike; Patone, Giannino; Saar, Kathrin; Rohde, Klaus; Dietz, Rainer; Schunck, Wolf-Hagen; Luft, Friedrich C.; Hubner, Norbert] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Monti, Jan; Heuser, Arnd; Fischer, Robert; Schirdewan, Alexander; Dietz, Rainer] Charite Univ Med Berlin, HELIOS, Franz Volhard Clin, Dept Clin & Mol Cardiol, D-13125 Berlin, Germany; [Heinig, Matthias; Vingron, Martin] Max Planck Inst Mol Genet, Dept Bioinformat, D-14195 Berlin, Germany; [Weldon, Steven M.] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA; [Lindpaintner, Klaus] F Hoffmann La Roche, CH-4070 Basel, Switzerland; [Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Hammock, Bruce D.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Hammock, Bruce D.] Univ Calif Davis, Canc Res Ctr, Davis, CA 95616 USA; [Cook, Stuart A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England; [Luft, Friedrich C.] Charite Univ Med Berlin, HELIOS, Franz Volhard Clin, Dept Nephrol Hypertens, D-13125 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Franz-Volhard Clinical Research Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Boehringer Ingelheim; Roche Holding; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Imperial College London; Franz-Volhard Clinical Research Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hubner, N (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	nhuebner@mdc-berlin.de	Cook, Stuart/G-9567-2011	Heinig, Matthias/0000-0002-5612-1720; Paskas, Svetlana/0000-0002-1206-5376; Saar, Kathrin/0000-0002-4483-1557; Fischer-Sternjak, Judith/0000-0003-0398-7720; Heuser, Arnd/0000-0002-3334-960X; Luft, Friedrich/0000-0002-8635-1199; Cook, Stuart/0000-0001-6628-194X	MRC [MC_U120085815] Funding Source: UKRI; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES002710] Funding Source: NIH RePORTER; British Heart Foundation Funding Source: Medline; Medical Research Council [MC_U120085815] Funding Source: Medline; NIEHS NIH HHS [R37 ES002710, R37 ES02710] Funding Source: Medline; Department of Health Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Department of Health		Ai D, 2007, P NATL ACAD SCI USA, V104, P9018, DOI 10.1073/pnas.0703229104; BAAN J, 1984, CIRCULATION, V70, P812, DOI 10.1161/01.CIR.70.5.812; Baurand A, 2007, CIRC RES, V100, P1353, DOI 10.1161/01.RES.0000266605.63681.5a; Bergman MR, 1999, AM J PHYSIOL-HEART C, V277, pH543, DOI 10.1152/ajpheart.1999.277.2.H543; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Chien KR, 2000, NATURE, V407, P227, DOI 10.1038/35025196; Cingolani OH, 2003, HYPERTENSION, V41, P249, DOI 10.1161/01.HYP.0000052832.96564.0B; DAHLOF B, 1991, LANCET, V338, P1281, DOI 10.1016/0140-6736(91)92589-T; Fiala-Beer E, 2007, INT J BIOCHEM CELL B, V39, P1235, DOI 10.1016/j.biocel.2007.03.019; Frantz S, 2003, CARDIOVASC RES, V57, P749, DOI 10.1016/S0008-6363(02)00723-X; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Gross V, 2005, AM J PHYSIOL-REG I, V288, pR1134, DOI 10.1152/ajpregu.00246.2004; Grupe A, 2001, SCIENCE, V292, P1915, DOI 10.1126/science.1058889; HAMMOCK BD, 1980, LIFE SCI, V27, P1635, DOI 10.1016/0024-3205(80)90636-0; Heyen JRR, 2002, AM J PHYSIOL-HEART C, V283, pH1775, DOI 10.1152/ajpheart.00305.2002; Holycross BJ, 1997, AM J PHYSIOL-HEART C, V273, pH228, DOI 10.1152/ajpheart.1997.273.1.H228; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Hunt SA, 2001, J AM COLL CARDIOL, V38, P2101, DOI 10.1016/S0735-1097(01)01683-7; Imig JD, 2002, HYPERTENSION, V39, P690, DOI 10.1161/hy0202.103788; Imig JD, 2006, CARDIOVASC DRUG REV, V24, P169, DOI 10.1111/j.1527-3466.2006.00169.x; KANNEL WB, 1991, AM HEART J, V121, P951, DOI 10.1016/0002-8703(91)90225-7; Karp CL, 2000, NAT IMMUNOL, V1, P221, DOI 10.1038/79759; Klose J, 2002, NAT GENET, V30, P385, DOI 10.1038/ng861; Kostis JB, 1997, JAMA-J AM MED ASSOC, V278, P212; Lee DS, 2006, NEW ENGL J MED, V355, P138, DOI 10.1056/NEJMoa052948; Levy D, 2002, NEW ENGL J MED, V347, P1397, DOI 10.1056/NEJMoa020265; Liao GC, 2004, SCIENCE, V306, P690, DOI 10.1126/science.1100636; Luria A, 2007, J BIOL CHEM, V282, P2891, DOI 10.1074/jbc.M608057200; McCune SA, 1990, ILAR J, V32, P23; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Monks SA, 2004, AM J HUM GENET, V75, P1094, DOI 10.1086/426461; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; PFEFFER MA, 1973, CIRC RES, V32, P28; Reffelmann T, 2003, BASIC RES CARDIOL, V98, P275, DOI 10.1007/s00395-003-0401-3; Sack MN, 1996, CIRCULATION, V94, P2837, DOI 10.1161/01.CIR.94.11.2837; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Seubert J, 2004, CIRC RES, V95, P506, DOI 10.1161/01.RES.0000139436.89654.c8; Seubert JM, 2006, CIRC RES, V99, P442, DOI 10.1161/01.RES.0000237390.92932.37; Shorofsky SR, 1999, CIRC RES, V84, P424, DOI 10.1161/01.RES.84.4.424; Slama M, 2004, AM J PHYSIOL-HEART C, V286, pH181, DOI 10.1152/ajpheart.00642.2003; Solomon SD, 2005, CIRCULATION, V112, P3738, DOI 10.1161/CIRCULATIONAHA.105.561423; Spector AA, 2004, PROG LIPID RES, V43, P55, DOI 10.1016/S0163-7827(03)00049-3; Spiecker M, 2005, ARCH BIOCHEM BIOPHYS, V433, P413, DOI 10.1016/j.abb.2004.10.009; Watkins H, 2006, NAT REV GENET, V7, P163, DOI 10.1038/nrg1805; Xu D, 2006, P NATL ACAD SCI USA, V103, P18733, DOI 10.1073/pnas.0609158103	49	141	150	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					529	537		10.1038/ng.129	http://dx.doi.org/10.1038/ng.129			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18443590	Green Accepted			2022-12-27	WOS:000255366700018
J	Weedon, MN; Lango, H; Lindgren, CM; Wallace, C; Evans, DM; Mangino, M; Freathy, RM; Perry, JRB; Stevens, S; Hall, AS; Samani, NJ; Shields, B; Prokopenko, I; Farrall, M; Dominiczak, A; Johnson, T; Bergmann, S; Beckmann, JS; Vollenweider, P; Waterworth, DM; Mooser, V; Palmer, CNA; Morris, AD; Ouwehand, WH; Caulfield, M; Munroe, PB; Hattersley, AT; McCarthy, MI; Frayling, TM				Weedon, Michael N.; Lango, Hana; Lindgren, Cecilia M.; Wallace, Chris; Evans, David M.; Mangino, Massimo; Freathy, Rachel M.; Perry, John R. B.; Stevens, Suzanne; Hall, Alistair S.; Samani, Nilesh J.; Shields, Beverly; Prokopenko, Inga; Farrall, Martin; Dominiczak, Anna; Johnson, Toby; Bergmann, Sven; Beckmann, Jacques S.; Vollenweider, Peter; Waterworth, Dawn M.; Mooser, Vincent; Palmer, Colin N. A.; Morris, Andrew D.; Ouwehand, Willem H.; Caulfield, Mark; Munroe, Patricia B.; Hattersley, Andrew T.; McCarthy, Mark I.; Frayling, Timothy M.		Diabet Genetics Initiat; Wellcome Trust Case Control Consor; Cambridge GEM Consortium	Genome-wide association analysis identifies 20 loci that influence adult height	NATURE GENETICS			English	Article							GENETIC ASSOCIATION; BODY HEIGHT; SUSCEPTIBILITY; POPULATION; STRATIFICATION; OSTEOARTHRITIS; HERITABILITY; EXPRESSION; STATURE; COHORTS	Adult height is a model polygenic trait, but there has been limited success in identifying the genes underlying its normal variation. To identify genetic variants influencing adult human height, we used genome-wide association data from 13,665 individuals and genotyped 39 variants in an additional 16,482 samples. We identified 20 variants associated with adult height ( P < 5 x 10(-7), with 10 reaching P < 1 iota x 10(-10)). Combined, the 20 SNPs explain similar to 3% of height variation, with a similar to 5 cm difference between the 6.2% of people with iota 7 or fewer 'tall' alleles compared to the 5.5% with 27 or more 'tall' alleles. The loci we identified implicate genes in Hedgehog signaling ( IHH, HHIP, PTCH1), extracellular matrix ( EFEMP1, ADAMTSL3, ACAN) and cancer ( CDK6, HMGA2, DLEU7) pathways, and provide new insights into human growth and developmental processes. Finally, our results provide insights into the genetic architecture of a classic quantitative trait.	[Weedon, Michael N.; Lango, Hana; Freathy, Rachel M.; Perry, John R. B.; Hattersley, Andrew T.; Frayling, Timothy M.] Penn Med Sch, Inst Biomed & Clin Sci, Exeter EX1 2LU, Devon, England; [Weedon, Michael N.; Lango, Hana; Freathy, Rachel M.; Perry, John R. B.; Shields, Beverly; Hattersley, Andrew T.; Frayling, Timothy M.] Penn Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England; [Lindgren, Cecilia M.; Prokopenko, Inga; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Lindgren, Cecilia M.; Prokopenko, Inga; McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Med, Oxford OX3 7LJ, England; [Wallace, Chris; Munroe, Patricia B.] Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, Clin Pharmacol & Barts & London Genome Ctr, London EC1M 6BQ, England; [Evans, David M.] Univ Bristol, Dept Social Med, MRC, Ctr Causal Anal Translat Epidemiol, Bristol BS8 2PR, Avon, England; [Mangino, Massimo; Stevens, Suzanne; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester LE3 9QP, Leics, England; [Hall, Alistair S.] Univ Leeds, Fac Med & Hlth, Leeds Inst Genet Hlth & Therapeut, Leeds LS2 9JT, W Yorkshire, England; [Farrall, Martin] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Dominiczak, Anna] Univ Glasgow, British Heart Fdn Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland; [Johnson, Toby; Bergmann, Sven; Beckmann, Jacques S.] Univ Lausanne, Dept Med Genet, CH-1011 Lausanne, Switzerland; [Bergmann, Sven] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Johnson, Toby] CHU Vaudois, Inst Univ Med Sociale & Prevent, CH-1011 Lausanne, Switzerland; [Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Vollenweider, Peter] CHU Vaudois, Dept Med, CH-1011 Lausanne, Switzerland; [Waterworth, Dawn M.; Mooser, Vincent] GlaxoSmithKline Inc, Med Genet Clin Pharmacol & Discovery Med, King Of Prussia, PA 19406 USA; [Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Populat Pharmacogenet Grp, Biomed Res Ctr, Dundee DD1 9SY, Scotland; [Morris, Andrew D.] Univ Dundee, Ninewells Hosp & Med Sch, Diabet Res Grp, Div Med & Therapeut, Dundee DD1 9SY, Scotland; [Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge CB2 2BT, England; [Ouwehand, Willem H.] Cambridge Ctr, Natl Hlth Serv Blood & Transplant, Cambridge CB2 2BT, England	University of Exeter; University of Exeter; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of London; Queen Mary University London; University of Bristol; University of Leicester; University of Leeds; University of Oxford; Wellcome Centre for Human Genetics; University of Glasgow; University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); GlaxoSmithKline; University of Dundee; University of Dundee; University of Cambridge; NHS Blood & Transplant (NHSBT)	Frayling, TM (corresponding author), Penn Med Sch, Inst Biomed & Clin Sci, Genet Complex Traits,Magdalen Rd, Exeter EX1 2LU, Devon, England.	Tim.Frayling@pms.ac.uk	Dominiczak, Anna F/P-9390-2017; Evans, David M/H-6325-2013; Prokopenko, Inga/AAU-9895-2020; Cambridge, G/N-3776-2015; Hall, Alistair/K-1953-2019; Mangino, Massimo/F-5134-2011; Allen, Hana Lango/G-9026-2012; Prokopenko, Inga/H-3241-2014; Study, GoDARTS/K-9448-2016; Colaus, PsyColaus/K-6607-2013; Palmer, Colin NA/C-7053-2008; Dominiczak, Anna F/D-2262-2009; Beckmann, Jacques S/A-9772-2008; Morris, Andrew D/C-2837-2009; Deloukas, Panos/B-2922-2013; Loos, Ruth/Q-2862-2016; McCarthy, Mark/M-3763-2015	Dominiczak, Anna F/0000-0003-4913-3608; Evans, David M/0000-0003-0663-4621; Cambridge, G/0000-0002-6022-6322; Mangino, Massimo/0000-0002-2167-7470; Allen, Hana Lango/0000-0002-7803-8688; Prokopenko, Inga/0000-0003-1624-7457; Palmer, Colin NA/0000-0002-6415-6560; Beckmann, Jacques S/0000-0002-9741-1900; Deloukas, Panos/0000-0001-9251-070X; Bergmann, Sven/0000-0002-6785-9034; Caulfield, Mark/0000-0001-9295-3594; Lindgren, Cecilia/0000-0002-4903-9374; Frayling, Timothy/0000-0001-8362-2603; Inouye, Michael/0000-0001-9413-6520; Johnson, Toby/0000-0002-5998-3270; Wallace, Chris/0000-0001-9755-1703; Hall, Alistair/0000-0003-0306-7887; Weedon, Michael/0000-0002-6174-6135; Munroe, Patricia/0000-0002-4176-2947; Loos, Ruth/0000-0002-8532-5087; McCarthy, Mark/0000-0002-4393-0510; Soranzo, Nicole/0000-0003-1095-3852; Hattersley, Andrew/0000-0001-5620-473X; Barroso, Ines/0000-0001-5800-4520; Freathy, Rachel/0000-0003-4152-2238; Wheeler, Eleanor/0000-0002-8616-6444	British Heart Foundation [PG02/128, PG/02/128/14470, FS/05/061/19501] Funding Source: Medline; Medical Research Council [G0701863, MC_U106188470, G9521010(63660), G0600705, G9521010D, G9521010] Funding Source: Medline; Wellcome Trust [077016, 076113, 090532, 077011] Funding Source: Medline; MRC [MC_U106188470, G0701863, G9521010, G0600705] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Caulfield M, 2003, LANCET, V361, P2118, DOI 10.1016/S0140-6736(03)13722-1; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Fisher R. A., 1918, PHILOS T ROYAL SOC E, V52, DOI DOI 10.1017/S0080456800012163; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Knight B, 2006, PAEDIATR PERINAT EP, V20, P172, DOI 10.1111/j.1365-3016.2006.00701.x; LETTRE G, 2008, NAT GENET; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Macgregor S, 2006, HUM GENET, V120, P571, DOI 10.1007/s00439-006-0240-z; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; MARQUESVIDAL P, 2007, EUR J CLIN NUTR ADV; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Palmert MR, 2003, MOL GENET METAB, V80, P1, DOI 10.1016/S1096-7192(03)00107-0; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Preece MA, 1996, HORM RES, V45, P56, DOI 10.1159/000184849; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Silventoinen K, 2000, AM J PUBLIC HEALTH, V90, P627, DOI 10.2105/AJPH.90.4.627; Southam L, 2007, HUM MOL GENET, V16, P2226, DOI 10.1093/hmg/ddm174; STIRLING WD, 1982, STATISTICIAN, V31, P211; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	27	609	627	3	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2008	40	5					575	583		10.1038/ng.121	http://dx.doi.org/10.1038/ng.121			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18391952	Green Accepted, Green Published			2022-12-27	WOS:000255366700025
J	Gudmundsson, J; Sulem, P; Rafnar, T; Bergthorsson, JT; Manolescu, A; Gudbjartsson, D; Agnarsson, BA; Sigurdsson, A; Benediktsdottir, KR; Blondal, T; Jakobsdottir, M; Stacey, SN; Kostic, J; Kristinsson, KT; Birgisdottir, B; Ghosh, S; Magnusdottir, DN; Thorlacius, S; Thorleifsson, G; Zheng, SL; Sun, J; Chang, BL; Elmore, JB; Breyer, JP; McReynolds, KM; Bradley, KM; Yaspan, BL; Wiklund, F; Stattin, P; Lindstrom, S; Adami, HO; McDonnell, SK; Schaid, DJ; Cunningham, JM; Wang, L; Cerhan, JR; St Sauver, JL; Isaacs, SD; Wiley, KE; Partin, AW; Walsh, PC; Polo, S; Ruiz-Echarri, M; Navarrete, S; Fuertes, F; Saez, B; Godino, J; Weijerman, PC; Swinkels, DW; Aben, KK; Witjes, JA; Suarez, BK; Helfand, BT; Frigge, ML; Kristjansson, K; Ober, C; Jonsson, E; Einarsson, GV; Xu, JF; Gronberg, H; Smith, JR; Thibodeau, SN; Isaacs, WB; Catalona, WJ; Mayordomo, JI; Kiemeney, LA; Barkardottir, RB; Gulcher, JR; Thorsteinsdottir, U; Kong, A; Stefansson, K				Gudmundsson, Julius; Sulem, Patrick; Rafnar, Thorunn; Bergthorsson, Jon T.; Manolescu, Andrei; Gudbjartsson, Daniel; Agnarsson, Bjarni A.; Sigurdsson, Asgeir; Benediktsdottir, Kristrun R.; Blondal, Thorarinn; Jakobsdottir, Margret; Stacey, Simon N.; Kostic, Jelena; Kristinsson, Kari T.; Birgisdottir, Birgitta; Ghosh, Shyamali; Magnusdottir, Droplaug N.; Thorlacius, Steinunn; Thorleifsson, Gudmar; Zheng, S. Lilly; Sun, Jielin; Chang, Bao-Li; Elmore, J. Bradford; Breyer, Joan P.; McReynolds, Kate M.; Bradley, Kevin M.; Yaspan, Brian L.; Wiklund, Fredrik; Stattin, Par; Lindstrom, Sara; Adami, Hans-Olov; McDonnell, Shannon K.; Schaid, Daniel J.; Cunningham, Julie M.; Wang, Liang; Cerhan, James R.; St Sauver, Jennifer L.; Isaacs, Sara D.; Wiley, Kathleen E.; Partin, Alan W.; Walsh, Patrick C.; Polo, Sonia; Ruiz-Echarri, Manuel; Navarrete, Sebastian; Fuertes, Fernando; Saez, Berta; Godino, Javier; Weijerman, Philip C.; Swinkels, Dorine W.; Aben, Katja K.; Witjes, J. Alfred; Suarez, Brian K.; Helfand, Brian T.; Frigge, Michael L.; Kristjansson, Kristleifur; Ober, Carole; Jonsson, Eirikur; Einarsson, Gudmundur V.; Xu, Jianfeng; Gronberg, Henrik; Smith, Jeffrey R.; Thibodeau, Stephen N.; Isaacs, William B.; Catalona, William J.; Mayordomo, Jose I.; Kiemeney, Lambertus A.; Barkardottir, Rosa B.; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari			Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer	NATURE GENETICS			English	Article							P75 NEUROTROPHIN RECEPTOR; PROTEIN; RISK; NRAGE	We conducted a genome-wide SNP association study on prostate cancer on over 23,000 Icelanders, followed by a replication study including over 15,500 individuals from Europe and the United States. Two newly identified variants were shown to be associated with prostate cancer: rs5945572 on Xp11.22 and rs721048 on 2p15 (odds ratios (OR) = 1.23 and 1.15; P = 3.9 x 10(-13) and 7.7 x 10(-9), respectively). The 2p15 variant shows a significantly stronger association with more aggressive, rather than less aggressive, forms of the disease.	[Gudmundsson, Julius; Sulem, Patrick; Rafnar, Thorunn; Bergthorsson, Jon T.; Manolescu, Andrei; Gudbjartsson, Daniel; Sigurdsson, Asgeir; Blondal, Thorarinn; Jakobsdottir, Margret; Stacey, Simon N.; Kostic, Jelena; Kristinsson, Kari T.; Birgisdottir, Birgitta; Ghosh, Shyamali; Magnusdottir, Droplaug N.; Thorlacius, Steinunn; Thorleifsson, Gudmar; Frigge, Michael L.; Kristjansson, Kristleifur; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Agnarsson, Bjarni A.; Benediktsdottir, Kristrun R.; Barkardottir, Rosa B.] Landspitali Univ Hosp, Dept Pathol, IS-101 Reykjavik, Iceland; [Zheng, S. Lilly; Sun, Jielin; Chang, Bao-Li; Xu, Jianfeng] Wake Forest Univ, Sch Med, Ctr Human Genome, Winston Salem, NC 27157 USA; [Elmore, J. Bradford; Breyer, Joan P.; McReynolds, Kate M.; Bradley, Kevin M.; Yaspan, Brian L.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Dept Med, Nashville, TN 37232 USA; [Lindstrom, Sara; Adami, Hans-Olov] Karolinska Inst, Dept Med Epidemiol & Biostat, S-17177 Stockholm, Sweden; [Stattin, Par] Umea Univ Hosp, Dept Urol, S-90185 Umea, Sweden; [Adami, Hans-Olov] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [McDonnell, Shannon K.; Schaid, Daniel J.; Cerhan, James R.; St Sauver, Jennifer L.] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Cunningham, Julie M.; Wang, Liang; Thibodeau, Stephen N.] Mayo Clin, Dept Lab Med & Pathol, Rochester, MN 55905 USA; [Isaacs, Sara D.; Wiley, Kathleen E.; Partin, Alan W.; Walsh, Patrick C.; Isaacs, William B.] Johns Hopkins Med Inst, Brady Urol Inst, Baltimore, MD 21209 USA; [Polo, Sonia] Quiron Hosp, Div Radiat Oncol, Zaragoza 50009, Spain; [Ruiz-Echarri, Manuel; Mayordomo, Jose I.] Univ Zaragoza, Lozano Blesa Univ Hosp, Div Med Oncol, E-50009 Zaragoza, Spain; [Navarrete, Sebastian; Fuertes, Fernando] Univ Zaragoza, Lozano Blesa Univ Hosp, Div Radiat Oncol, E-50009 Zaragoza, Spain; [Saez, Berta; Godino, Javier; Mayordomo, Jose I.] Hlth Sci Inst, Zaragoza 50009, Spain; [Saez, Berta; Mayordomo, Jose I.] Nanotechnol Inst Aragon, Zaragoza 50009, Spain; [Weijerman, Philip C.] Rijinstate Hosp, Dept Urol, NL-6800 TA Arnhem, Netherlands; [Swinkels, Dorine W.] Radboud Univ Nijmegen, Med Ctr, Dept Clin Chem, NL-6500 HB Nijmegen, Netherlands; [Aben, Katja K.; Kiemeney, Lambertus A.] Comprehens Canc Ctr E, NL-6501 BG Nijmegen, Netherlands; [Aben, Katja K.] Radboud Univ Nijmegen, Dept Epidemiol & Biostat, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Witjes, J. Alfred; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6500 HB Nijmegen, Netherlands; [Suarez, Brian K.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Helfand, Brian T.; Catalona, William J.] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Ober, Carole] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Jonsson, Eirikur; Einarsson, Gudmundur V.] Landspitali Univ Hosp, Dept Urol, Reykjavik 101, Iceland; [Smith, Jeffrey R.] VA Tennessee Valley Hlthcare Syst, Med Res Serv, Nashville, TN 37212 USA	Landspitali National University Hospital; Wake Forest University; Vanderbilt University; Karolinska Institutet; Umea University; Harvard University; Harvard T.H. Chan School of Public Health; Mayo Clinic; Mayo Clinic; Johns Hopkins University; Johns Hopkins Medicine; Lozano Blesa University Clinical Hospital; University of Zaragoza; Lozano Blesa University Clinical Hospital; University of Zaragoza; Rijnstate Hospital; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Washington University (WUSTL); Northwestern University; Feinberg School of Medicine; University of Chicago; Landspitali National University Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Gudmundsson, J (corresponding author), deCODE Genet, IS-101 Reykjavik, Iceland.	julius@decode.is; kstefans@decode.is	Swinkels, Dorine W./H-8098-2014; Manolescu, Andrei/G-4565-2014; Stefansson, Kari/AAE-7187-2019; Smith, Jeff/C-3484-2012; Godino, Javier/M-3753-2018; Aben, Katja KH/G-9686-2016; Kiemeney, Lambertus A./D-3357-2009; Witjes, Fred/N-9665-2013; Mayordomo, Jose/K-3453-2013	Swinkels, Dorine W./0000-0002-1040-9446; Manolescu, Andrei/0000-0002-0713-4664; Godino, Javier/0000-0002-5653-2722; Aben, Katja KH/0000-0002-0214-2147; Kiemeney, Lambertus A./0000-0002-2368-1326; Saez, Berta/0000-0003-0753-1165; St Sauver, Jennifer/0000-0002-9789-8544; Gudbjartsson, Daniel/0000-0002-5222-9857; Ober, Carole/0000-0003-4626-9809; Cerhan, James/0000-0002-7482-178X; Yaspan, Brian/0000-0002-3787-2510; Smith, Jeffrey/0000-0001-8424-910X; Kong, Augustine/0000-0001-8193-5438; McDonnell, Shannon/0000-0001-6201-369X; Bergthorsson, Jon Thor/0000-0002-0560-2639	NATIONAL CANCER INSTITUTE [R01CA105055, P50CA058236, R01CA112517, U01CA086323, R01CA095052, R01CA106523] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA095052, CA106523, R01 CA112517, R01 CA106523, CA86323, CA58236, U01 CA086323, CA105055, R01 CA112517-01A1, P50 CA058236, CA112517, CA95052, R01 CA105055] Funding Source: Medline; NCRR NIH HHS [UL1 RR025741] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Dubois E, 2002, J BIOL CHEM, V277, P23755, DOI 10.1074/jbc.M202206200; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hidaka K, 2002, J BIOL CHEM, V277, P32730, DOI 10.1074/jbc.M205476200; MONROE KR, 1995, NAT MED, V1, P827, DOI 10.1038/nm0895-827; Morrison BH, 2001, J BIOL CHEM, V276, P24965, DOI 10.1074/jbc.M101161200; NAROD SA, 1995, NAT MED, V1, P99, DOI 10.1038/nm0295-99; Salehi AH, 2000, NEURON, V27, P279, DOI 10.1016/S0896-6273(00)00036-2; Salehi AH, 2002, J BIOL CHEM, V277, P48043, DOI 10.1074/jbc.M205324200; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	13	298	316	1	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2008	40	3					281	283		10.1038/ng.89	http://dx.doi.org/10.1038/ng.89			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18264098	Green Accepted			2022-12-27	WOS:000253548400016
J	Helgadottir, A; Thorleifsson, G; Magnusson, KP; Gretarsdottir, S; Steinthorsdottir, V; Manolescu, A; Jones, GT; Rinkel, GJE; Blankensteijn, JD; Ronkainen, A; Jaaskelainen, JE; Kyo, Y; Lenk, GM; Sakalihasan, N; Kostulas, K; Gottsater, A; Flex, A; Stefansson, H; Hansen, T; Andersen, G; Weinsheimer, S; Borch-Johnsen, K; Jorgensen, T; Shah, SH; Quyyumi, AA; Granger, CB; Reilly, MP; Austin, H; Levey, AI; Vaccarino, V; Palsdottir, E; Walters, GB; Jonsdottir, T; Snorradottir, S; Magnusdottir, D; Gudmundsson, G; Ferrell, RE; Sveinbjornsdottir, S; Hernesniemi, J; Niemela, M; Limet, R; Andersen, K; Sigurdsson, G; Benediktsson, R; Verhoeven, ELG; Teijink, JAW; Grobbee, DE; Rader, DJ; Collier, DA; Pedersen, O; Pola, R; Hillert, J; Lindblad, B; Valdimarsson, EM; Magnadottir, HB; Wijmenga, C; Tromp, G; Baas, AF; Ruigrok, YM; van Rij, AM; Kuivaniemi, H; Powell, JT; Matthiasson, SE; Gulcher, JR; Thorgeirsson, G; Kong, A; Thorsteinsdottir, U; Stefansson, K				Helgadottir, Anna; Thorleifsson, Gudmar; Magnusson, Kristinn P.; Gretarsdottir, Solveig; Steinthorsdottir, Valgerdur; Manolescu, Andrei; Jones, Gregory T.; Rinkel, Gabriel J. E.; Blankensteijn, Jan D.; Ronkainen, Antti; Jaaskelainen, Juha E.; Kyo, Yoshiki; Lenk, Guy M.; Sakalihasan, Natzi; Kostulas, Konstantinos; Gottsater, Anders; Flex, Andrea; Stefansson, Hreinn; Hansen, Torben; Andersen, Gitte; Weinsheimer, Shantel; Borch-Johnsen, Knut; Jorgensen, Torben; Shah, Svati H.; Quyyumi, Arshed A.; Granger, Christopher B.; Reilly, Muredach P.; Austin, Harland; Levey, Allan I.; Vaccarino, Viola; Palsdottir, Ebba; Walters, G. Bragi; Jonsdottir, Thorbjorg; Snorradottir, Steinunn; Magnusdottir, Dana; Gudmundsson, Gudmundur; Ferrell, Robert E.; Sveinbjornsdottir, Sigurlaug; Hernesniemi, Juha; Niemela, Mika; Limet, Raymond; Andersen, Karl; Sigurdsson, Gunnar; Benediktsson, Rafn; Verhoeven, Eric L. G.; Teijink, Joep A. W.; Grobbee, Diederick E.; Rader, Daniel J.; Collier, David A.; Pedersen, Oluf; Pola, Roberto; Hillert, Jan; Lindblad, Bengt; Valdimarsson, Einar M.; Magnadottir, Hulda B.; Wijmenga, Cisca; Tromp, Gerard; Baas, Annette F.; Ruigrok, Ynte M.; van Rij, Andre M.; Kuivaniemi, Helena; Powell, Janet T.; Matthiasson, Stefan E.; Gulcher, Jeffrey R.; Thorgeirsson, Gudmundur; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari			The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; ISCHEMIC-STROKE; SHEAR-STRESS; DISEASE; RISK; ATHEROSCLEROSIS; POLYMORPHISMS; VALIDATION; BEHAVIOR; GENES	Recently, two common sequence variants on 9p21, tagged by rs10757278-G and rs10811661-T, were reported to be associated with coronary artery disease (CAD)(1-4) and type 2 diabetes (T2D)(5-7), respectively. We proceeded to further investigate the contributions of these variants to arterial diseases and T2D. Here we report that rs10757278-G is associated with, in addition to CAD, abdominal aortic aneurysm (AAA; odds ratio (OR) 1.31, P = 1.2 x 10(-12)) and intracranial aneurysm (OR = 1.29, P = 2.5 x 10(-6)), but not with T2D. This variant is the first to be described that affects the risk of AAA and intracranial aneurysm in many populations. The association of rs10811661-T to T2D replicates in our samples, but the variant does not associate with any of the five arterial diseases examined. These findings extend our insight into the role of the sequence variant tagged by rs10757278-G and show that it is not confined to atherosclerotic diseases.	[Helgadottir, Anna; Thorleifsson, Gudmar; Magnusson, Kristinn P.; Gretarsdottir, Solveig; Steinthorsdottir, Valgerdur; Manolescu, Andrei; Stefansson, Hreinn; Palsdottir, Ebba; Walters, G. Bragi; Jonsdottir, Thorbjorg; Snorradottir, Steinunn; Magnusdottir, Dana; Gudmundsson, Gudmundur; Gulcher, Jeffrey R.; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Jones, Gregory T.; van Rij, Andre M.] Univ Otago Sch Med, Vasc Res Grp, Dunedin 9054, New Zealand; [Rinkel, Gabriel J. E.; Ruigrok, Ynte M.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, NL-3584 CX Utrecht, Netherlands; [Blankensteijn, Jan D.] Radboud Univ Med Ctr, Dept Vasc Surg, NL-6500 HB Nijmegen, Netherlands; [Ronkainen, Antti; Jaaskelainen, Juha E.] Kuopio Univ Hosp, Dept Neurosurg, SF-70210 Kuopio, Finland; [Kyo, Yoshiki; Lenk, Guy M.; Weinsheimer, Shantel; Tromp, Gerard; Kuivaniemi, Helena] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI 48201 USA; [Sakalihasan, Natzi; Limet, Raymond] Univ Hosp Liege, Dept Cardiovasc Surg, B-4000 Liege, Belgium; [Kostulas, Konstantinos; Hillert, Jan] Karolinska Univ Hosp, Karolinska Inst, Dept Neurol, S-14186 Huddinge, Sweden; [Gottsater, Anders; Hernesniemi, Juha; Lindblad, Bengt] Lund Univ, Malmo Univ Hosp, Dept Vasc Dis, S-20502 Malmo, Sweden; [Flex, Andrea; Pola, Roberto] A Gemelli Univ Hosp, Dept Med, I-00168 Rome, Italy; [Hansen, Torben; Andersen, Gitte; Borch-Johnsen, Knut; Pedersen, Oluf] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Borch-Johnsen, Knut; Pedersen, Oluf] Aarhus Univ, Fac Hlth Sci, DK-8000 Aarhus, Denmark; [Borch-Johnsen, Knut; Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; [Shah, Svati H.; Granger, Christopher B.] Duke Univ, Sch Med, Durham, NC 27710 USA; [Quyyumi, Arshed A.; Austin, Harland; Levey, Allan I.; Vaccarino, Viola] Emory Univ, Sch Med, Atlanta, GA 30322 USA; [Reilly, Muredach P.; Rader, Daniel J.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Ferrell, Robert E.] Univ Pittsburgh, Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Sveinbjornsdottir, Sigurlaug; Andersen, Karl; Sigurdsson, Gunnar; Benediktsson, Rafn; Valdimarsson, Einar M.; Magnadottir, Hulda B.; Thorgeirsson, Gudmundur] Landspitali Univ Hosp, IS-101 Reykjavik, Iceland; [Hernesniemi, Juha; Niemela, Mika] Univ Helsinki, Cent Hosp, Dept Neurosurg, FI-00029 Helsinki, Finland; [Sigurdsson, Gunnar; Benediktsson, Rafn] Iceland Heart Assoc, IS-201 Kopavogur, Iceland; [Verhoeven, Eric L. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, NL-9700 RB Groningen, Netherlands; [Teijink, Joep A. W.] Atrium Med Ctr, Dept Surg, NL-6401 CX Heerlen, Netherlands; [Grobbee, Diederick E.; Baas, Annette F.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, NL-3508 GA Utrecht, Netherlands; [Collier, David A.] Inst Psychiat, Div Psychol Med & Social Genet, London SE5 8AF, England; [Collier, David A.] Inst Psychiat, Dev Psychiat Ctr, London SE5 8AF, England; [Wijmenga, Cisca] UMCG, Dept Genet, NL-9700 Groningen, Netherlands; [Wijmenga, Cisca] Univ Med Ctr Utrecht, Dept Biomed Genet, Complex Genet Sect, NL-3508 AB Utrecht, Netherlands; [Powell, Janet T.] Imperial Coll Charing Cross, Vasc Surg Res Grp, London W6 8RP, England; [Matthiasson, Stefan E.; Thorgeirsson, Gudmundur; Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Sch Med, IS-101 Reykjavik, Iceland	University of Otago; Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen; Kuopio University Hospital; University of Eastern Finland; Wayne State University; University of Liege; Karolinska Institutet; Karolinska University Hospital; Lund University; Skane University Hospital; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Steno Diabetes Center; Aarhus University; University of Copenhagen; Duke University; Emory University; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Landspitali National University Hospital; University of Helsinki; Helsinki University Central Hospital; Icelandic Heart Association; University of Groningen; Atrium Medical Center; Utrecht University; Utrecht University Medical Center; University of London; King's College London; University of London; King's College London; University of Groningen; Utrecht University; Utrecht University Medical Center; Imperial College London; University of Iceland	Stefansson, K (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	unnur.thorsteinsdottir@decode.is; kstefans@decode.is	Flex, Andrea/K-7305-2016; Lenk, Guy M./Q-1226-2016; Magnusson, Kristinn P Pétur/X-4907-2019; Blankensteijn, Jan D/Q-9291-2016; Niemelä, Mika R/F-2539-2015; Wijmenga, Cisca/AAE-7719-2019; , Viola/AAW-5600-2020; Tromp, Gerard/B-2677-2017; Collier, David A/D-1649-2011; Powell, Janet/AAW-8669-2021; Walters, G. Bragi/L-4215-2013; Granger, Christopher B/D-3458-2014; Pedersen, Oluf/Z-1731-2019; Pedersen, Oluf/AAG-8015-2020; Wijmenga, Cisca/D-2173-2009; Jørgensen, Torben/Z-1335-2018; Stefansson, Kari/AAE-7187-2019; Grobbee, Diederick/C-7651-2014; Levey, Allan/F-2104-2011; Magnusson, Kristinn/A-6479-2011; Kuivaniemi, Helena/Q-8178-2019; Benediktsson, Rafn/R-2457-2018; Manolescu, Andrei/G-4565-2014	Flex, Andrea/0000-0003-2664-4165; Lenk, Guy M./0000-0001-8092-1405; Magnusson, Kristinn P Pétur/0000-0003-4528-6826; Blankensteijn, Jan D/0000-0002-2062-8749; Niemelä, Mika R/0000-0003-1526-0684; Wijmenga, Cisca/0000-0002-5635-1614; Tromp, Gerard/0000-0002-7761-0806; Collier, David A/0000-0003-4087-1559; Powell, Janet/0000-0002-3905-1468; Walters, G. Bragi/0000-0002-5415-6487; Granger, Christopher B/0000-0002-0045-3291; Pedersen, Oluf/0000-0002-3321-3972; Grobbee, Diederick/0000-0003-4472-4468; Levey, Allan/0000-0002-3153-502X; Magnusson, Kristinn/0000-0003-4528-6826; Kuivaniemi, Helena/0000-0001-5753-8766; Benediktsson, Rafn/0000-0002-2954-9801; Manolescu, Andrei/0000-0002-0713-4664; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Reilly, Muredach/0000-0002-3035-9386; Kong, Augustine/0000-0001-8193-5438; Hansen, Torben/0000-0001-8748-3831; Jorgensen, Torben/0000-0001-9453-2830; Weinsheimer, Shantel/0000-0001-7486-9110; Jones, Gregory T/0000-0002-6950-4210; Pola, Roberto/0000-0001-5224-2931; Stefansson, Hreinn/0000-0002-9331-6666	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044682, R01HL064310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034395] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL044682, HL064310] Funding Source: Medline; NINDS NIH HHS [NS034395] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barani J, 2005, J VASC SURG, V42, P75, DOI 10.1016/j.jvs.2005.03.025; Brady AR, 2004, CIRCULATION, V110, P16, DOI 10.1161/01.CIR.0000133279.07468.9F; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chatzizisis YS, 2007, J AM COLL CARDIOL, V49, P2379, DOI 10.1016/j.jacc.2007.02.059; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Flex A, 2002, EUR J VASC ENDOVASC, V24, P264, DOI 10.1053/ejvs.2002.1711; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Hashimoto T, 2006, NEUROL RES, V28, P372, DOI 10.1179/016164106X14973; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Jones GT, 2007, CLIN CHEM, V53, P679, DOI 10.1373/clinchem.2006.079947; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Lederle FA, 2000, ARCH INTERN MED, V160, P1425, DOI 10.1001/archinte.160.10.1425; Lederle FA, 2001, J VASC SURG, V34, P122, DOI 10.1067/mva.2001.115275; MANTEL N, 1959, J NATL CANCER I, V22, P719; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; MOORE JE, 1994, ATHEROSCLEROSIS, V110, P225, DOI 10.1016/0021-9150(94)90207-0; Ogata T, 2005, J VASC SURG, V41, P1036, DOI 10.1016/j.jvs.2005.02.020; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schievink WI, 1997, NEW ENGL J MED, V336, P28, DOI 10.1056/NEJM199701023360106; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; STJEAN PL, 1995, ANN HUM GENET, V59, P17; Thompson RW, 2002, CARDIOVASC SURG, V10, P389, DOI 10.1016/S0967-2109(02)00042-X; Weinsheimer S, 2007, STROKE, V38, P2670, DOI 10.1161/STROKEAHA.107.486225; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	30	549	564	0	51	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					217	224		10.1038/ng.72	http://dx.doi.org/10.1038/ng.72			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18176561				2022-12-27	WOS:000252732900021
J	Santoro, MM; Samuel, T; Mitchell, T; Reed, JC; Stainier, DYR				Santoro, Massimo M.; Samuel, Temesgen; Mitchell, Tracy; Reed, John C.; Stainier, Didier Y. R.			Birc2 (cIap1) regulates endothelial cell integrity and blood vessel homeostasis	NATURE GENETICS			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; VASCULAR DEVELOPMENT; APOPTOSIS PROTEINS; SIGNALING COMPLEX; UBIQUITINATION; ANGIOGENESIS; INHIBITOR; CASPASES; PATHWAY	Integrity of the blood vessel wall is essential for vascular homeostasis and organ function(1,2).A dynamic balance between endothelial cell survival and apoptosis contributes to this integrity during vascular development and pathological angiogenesis(3-6). The genetic and molecular mechanisms regulating these processes in vivo are still largely unknown. Here, we show that Birc2 ( also known as clap1) is essential for maintaining endothelial cell survival and blood vessel homeostasis during vascular development. Using a forward-genetic approach, we identified a zebrafish null mutant for birc2, which shows severe hemorrhage and vascular regression due to endothelial cell integrity defects and apoptosis. Using genetic and molecular approaches, we show that Birc2 positively regulates the formation of the TNF receptor complex I in endothelial cells, thereby promoting NF- kappa B activation and maintaining vessel integrity and stabilization. In the absence of Birc2, a caspase-8-dependent apoptotic program takes place that leads to vessel regression. Our findings identify Birc2 and TNF signaling components as critical regulators of vascular integrity and endothelial cell survival, thereby providing an additional target pathway for the control of angiogenesis and blood vessel homeostasis during embryogenesis, regeneration and tumorigenesis.	Univ Calif San Francisco, Program Dev Biol, Dept Biochem & Biophys, San Francisco, CA 94158 USA; Univ Calif San Francisco, Genet Program, Dept Biochem & Biophys, San Francisco, CA 94158 USA; Univ Calif San Francisco, Program Human Genet, Dept Biochem & Biophys, San Francisco, CA 94158 USA; Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94158 USA; Univ Piemonte Orientale, Dept Environm & Life Sci, I-15100 Alessandria, Italy; Burnham Inst Med Res, La Jolla, CA 92037 USA; Tuskegee Univ, Coll Vet Med Nursing & Allied Hlth, Tuskegee, AL 36088 USA; Wyeth Res, Osteoarthritis Res Grp, Cambridge, MA 02140 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Eastern Piedmont Amedeo Avogadro; Sanford Burnham Prebys Medical Discovery Institute; Tuskegee University; Pfizer	Santoro, MM (corresponding author), Univ Calif San Francisco, Program Dev Biol, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	massimo.santoro@ucsf.edu; didier.stainier@biochem.ucsf.edu		SANTORO, Massimo Mattia/0000-0003-4605-5085; Stainier, Didier/0000-0002-0382-0026	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL054737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015402] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-54737] Funding Source: Medline; NIA NIH HHS [AG-15402] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Baud V, 2001, TRENDS CELL BIOL, V11, P372, DOI 10.1016/S0962-8924(01)02064-5; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479; de Martin R, 2000, ARTERIOSCL THROM VAS, V20, pE83; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Dimmeler S, 2000, CIRC RES, V87, P434; Duval Helene, 2003, Angiogenesis, V6, P171, DOI 10.1023/B:AGEN.0000021390.09275.bc; Eckelman BP, 2006, J BIOL CHEM, V281, P3254, DOI 10.1074/jbc.M510863200; Eckelman BP, 2006, EMBO REP, V7, P988, DOI 10.1038/sj.embor.7400795; Eimon PM, 2006, CELL DEATH DIFFER, V13, P1619, DOI 10.1038/sj.cdd.4402015; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jin SW, 2007, DEV BIOL, V307, P29, DOI 10.1016/j.ydbio.2007.03.526; Kisseleva T, 2006, J CLIN INVEST, V116, P2955, DOI 10.1172/JCI27392; Li XM, 2002, NATURE, V416, P345, DOI 10.1038/416345a; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Rajagopalan S, 2004, BLOOD, V103, P3677, DOI 10.1182/blood-2003-09-3198; Red-Horse K, 2007, DEV CELL, V12, P181, DOI 10.1016/j.devcel.2007.01.013; Rothe M, 1995, CELL, V83, P1243, DOI 10.1016/0092-8674(95)90149-3; Samuel T, 2006, J BIOL CHEM, V281, P1080, DOI 10.1074/jbc.M509381200; Sebban H, 2006, TRENDS CELL BIOL, V16, P569, DOI 10.1016/j.tcb.2006.09.004; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Tang ED, 2003, J BIOL CHEM, V278, P37297, DOI 10.1074/jbc.M303389200; Tricot O, 2000, CIRCULATION, V101, P2450, DOI 10.1161/01.CIR.101.21.2450; Weinstein BM, 2002, SEMIN CELL DEV BIOL, V13, P515, DOI 10.1016/S1084952102001052; Winn RK, 2005, J THROMB HAEMOST, V3, P1815, DOI 10.1111/j.1538-7836.2005.01378.x	30	112	121	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2007	39	11					1397	1402		10.1038/ng.2007.8	http://dx.doi.org/10.1038/ng.2007.8			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17934460				2022-12-27	WOS:000250575900025
J	Brault, AC; Huang, CYH; Langevin, SA; Kinney, RM; Bowen, RA; Ramey, WN; Panella, NA; Holmes, EC; Powers, AM; Miller, BR				Brault, Aaron C.; Huang, Claire Y-H; Langevin, Stanley A.; Kinney, Richard M.; Bowen, Richard A.; Ramey, Wanichaya N.; Panella, Nicholas A.; Holmes, Edward C.; Powers, Ann M.; Miller, Barry R.			A single positively selected West Nile viral mutation confers increased virogenesis in American crows	NATURE GENETICS			English	Article							VIRUS-STRAINS; NEW-YORK; VIRULENCE; BIRDS; TRANSMISSION; DISEASE; EUROPE; HOST; EPIDEMIOLOGY; ENCEPHALITIS	West Nile virus ( WNV), first recognized in North America in 1999, has been responsible for the largest arboviral epiornitic and epidemic of human encephalitis in recorded history. Despite the well- described epidemiological patterns of WNV in North America, the basis for the emergence of WNV-associated avian pathology, particularly in the American crow ( AMCR) sentinel species, and the large scale of the North American epidemic and epiornitic is uncertain. We report here that the introduction of a T249P amino acid substitution in the NS3 helicase ( found in North American WNV) in a lowvirulence strain was sufficient to generate a phenotype highly virulent to AMCRs. Furthermore, comparative sequence analyses of full- length WNV genomes demonstrated that the same site ( NS3- 249) was subject to adaptive evolution. These phenotypic and evolutionary results provide compelling evidence for the positive selection of a mutation encoding increased viremia potential and virulence in the AMCR sentinel bird species.	Univ Calif Davis, Ctr Vector Borne Dis, Sch Vet Med, Davis, CA 95616 USA; Univ Calif Davis, Dept Pathol Microbiol & Immunol, Sch Vet Med, Davis, CA 95616 USA; US Dept HHS, Ctr Dis Control & Prevent, Div Vector Borne Infect Dis, Ft Collins, CO 80522 USA; Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; Penn State Univ, Dept Biol, University Pk, PA 16802 USA; NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA	University of California System; University of California Davis; University of California System; University of California Davis; Centers for Disease Control & Prevention - USA; Colorado State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC)	Brault, AC (corresponding author), Univ Calif Davis, Ctr Vector Borne Dis, Sch Vet Med, Davis, CA 95616 USA.	acbrault@ucdavis.edu	Holmes, Edward/Y-2789-2019; Holmes, Edward/GVR-9499-2022; Pacific-Southwest, RCE/B-6155-2009	Holmes, Edward/0000-0001-9596-3552; 	NIAID NIH HHS [U54 AI065359-010001, R01 AI061822, U54 AI065359, R01 AI061822-01, AI061822] Funding Source: Medline; NCPDCID CDC HHS [R01 CI000235, CI000235] Funding Source: Medline; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID) [R01CI000235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061822, U54AI065359] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCPDCID CDC HHS; NATIONAL CENTER FOR INFECTIOUS DISEASES (NCID)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bakonyi T, 2005, EMERG INFECT DIS, V11, P225, DOI 10.3201/eid1102.041028; Brault AC, 2004, EMERG INFECT DIS, V10, P2161, DOI 10.3201/eid1012.040486; Charrel RN, 2003, VIROLOGY, V315, P381, DOI 10.1016/S0042-6822(03)00536-1; DAY JF, 1983, J PARASITOL, V69, P163, DOI 10.2307/3281292; DAY JF, 1984, COMP BIOCHEM PHYS A, V77, P447, DOI 10.1016/0300-9629(84)90210-X; Deardorff E, 2006, EMERG INFECT DIS, V12, P314, DOI 10.3201/eid1202.050871; Eidson M, 2001, ANN NY ACAD SCI, V951, P38; EWALD PW, 1983, ANNU REV ECOL SYST, V14, P465, DOI 10.1146/annurev.es.14.110183.002341; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Kinney RM, 2006, J GEN VIROL, V87, P3611, DOI 10.1099/vir.0.82299-0; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Kramer LD, 2001, CURR OPIN INFECT DIS, V14, P519, DOI 10.1097/00001432-200110000-00004; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Langevin SA, 2005, AM J TROP MED HYG, V72, P99, DOI 10.4269/ajtmh.2005.72.99; Langevin SA, 2003, AM J TROP MED HYG, V69, P78, DOI 10.4269/ajtmh.2003.69.78; Lipsitch M, 1997, TRENDS MICROBIOL, V5, P31, DOI 10.1016/S0966-842X(97)81772-6; Malkinson M, 2002, CURR TOP MICROBIOL, V267, P309; Miller BR, 2000, AM J TROP MED HYG, V62, P240, DOI 10.4269/ajtmh.2000.62.240; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Reisen WK, 2005, J MED ENTOMOL, V42, P367, DOI 10.1603/0022-2585(2005)042[0367:AHAMDC]2.0.CO;2; Reisen WK, 2006, J MED ENTOMOL, V43, P356, DOI 10.1603/0022-2585(2006)043[0356:ROCIEO]2.0.CO;2; Sejvar JJ, 2004, NEUROLOGY, V63, P206, DOI 10.1212/01.WNL.0000130361.62281.69; Solomon T, 2003, LANCET INFECT DIS, V3, P189, DOI 10.1016/S1473-3099(03)00574-7; Steele KE, 2000, VET PATHOL, V37, P208, DOI 10.1354/vp.37-3-208; SWOFFORD D, 2003, PHYLOGENETICS ANAL U; Weiss D, 2001, EMERG INFECT DIS, V7, P654, DOI 10.3201/eid0704.010409; WORK TH, 1955, AM J TROP MED HYG, V4, P872, DOI 10.4269/ajtmh.1955.4.872; WORK TH, 1953, P SOC EXP BIOL MED, V84, P719, DOI 10.3181/00379727-84-20764	28	254	262	0	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2007	39	9					1162	1166		10.1038/ng2097	http://dx.doi.org/10.1038/ng2097			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17694056	Green Accepted			2022-12-27	WOS:000249122400029
J	Franco-Zorrilla, JM; Valli, A; Todesco, M; Mateos, I; Puga, MI; Rubio-Somoza, I; Leyva, A; Weigel, D; Garcia, JA; Paz-Ares, J				Franco-Zorrilla, Jose Manuel; Valli, Adrian; Todesco, Marco; Mateos, Isabel; Puga, Maria Isabel; Rubio-Somoza, Ignacio; Leyva, Antonio; Weigel, Detlef; Garcia, Juan Antonio; Paz-Ares, Javier			Target mimicry provides a new mechanism for regulation of microRNA activity	NATURE GENETICS			English	Article							PHOSPHATE-STARVATION; SIRNA BIOGENESIS; PLANTS; ARABIDOPSIS; EXPRESSION; GENE; PATHWAY; SHOOTS; ROOTS; ROLES	MicroRNAs (miRNA) regulate key aspects of development and physiology in animals and plants. These regulatory RNAs act as guides of effector complexes to recognize specific mRNA sequences based on sequence complementarity, resulting in translational repression or site-specific cleavage1,2. In plants, most miRNA targets are cleaved and show almost perfect complementarity with the miRNAs around the cleavage site3-8. Here, we examined the non -protein coding gene IPS1 (INDUCED BY PHOSPHATE STARVATION1) from Arabidopsis thaliana. IPS1 contains a motif with sequence complementarity to the phosphate (Pi) starvation -induced miRNA miR-399, but the pairing is interrupted by a mismatched loop at the expected miRNA cleavage site. We show that IPS1 RNA is not cleaved but instead sequesters miR-399. Thus, IPS1 overexpression results in increased accumulation of the miR-399 target PHO2 mRNA and, concomitantly, in reduced shoot P-i content5-8. Engineering of IPS1 to be cleavable abolishes its inhibitory activity on miR-399. We coin the term 'target mimicry' to define this mechanism of inhibition of miRNA activity. Target mimicry can be generalized beyond the control of Pi homeostasis, as demonstrated using artificial target mimics.	CSIC, Ctr Nacl Biotecnol, Dept Plant Mol Genet, E-28049 Madrid, Spain; Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Max Planck Society	Paz-Ares, J (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Plant Mol Genet, Campus Cantoblanco, E-28049 Madrid, Spain.	jpazares@cnb.uam.es	Todesco, Marco/HCH-3494-2022; Leyva, Antonio/C-9040-2013; Somoza, Ignacio Rubio/L-6139-2014; Garcia, Juan Antonio/N-3723-2014; Franco-Zorrilla, Jose/M-8361-2015; Valli, Adrian/H-6738-2012; Mateos, Isabel/B-7127-2014; Weigel, Detlef/AAR-3312-2021; Franco-Zorrilla, Jose Manuel/ABD-5092-2021; Weigel, Detlef/C-1418-2008; Weigel, Detlef/GSJ-0799-2022	Leyva, Antonio/0000-0001-7617-0418; Somoza, Ignacio Rubio/0000-0003-0754-816X; Garcia, Juan Antonio/0000-0002-4861-9609; Franco-Zorrilla, Jose/0000-0001-6769-7349; Valli, Adrian/0000-0002-3266-7200; Franco-Zorrilla, Jose Manuel/0000-0001-6769-7349; Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Todesco, Marco/0000-0002-6227-4096; Paz-Ares, Javier/0000-0003-0553-9745; puga, maria isabel/0000-0001-7498-2236				Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Ames B. N., 1966, METHOD ENZYMOL, P115, DOI DOI 10.1016/0076-6879(66)08014-5; Aung K, 2006, PLANT PHYSIOL, V141, P1000, DOI 10.1104/pp.106.078063; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Bari R, 2006, PLANT PHYSIOL, V141, P988, DOI 10.1104/pp.106.079707; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BAULCOMBE DC, 1986, NATURE, V321, P446, DOI 10.1038/321446a0; BECHTOLD N, 1993, CR ACAD SCI PARIS LI, V316, P15; Burleigh SH, 1999, PLANT PHYSIOL, V119, P241, DOI 10.1104/pp.119.1.241; Burleigh SH, 1997, PLANT MOL BIOL, V34, P199, DOI 10.1023/A:1005841119665; CHIROU TJ, 2006, PLANT CELL, V18, P412; Franco-Zorrilla JM, 2005, PLANT PHYSIOL, V138, P847, DOI 10.1104/pp.105.060517; Franco-Zorrilla JM, 2004, J EXP BOT, V55, P285, DOI 10.1093/jxb/erh009; Fujii H, 2005, CURR BIOL, V15, P2038, DOI 10.1016/j.cub.2005.10.016; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Liu CM, 1997, PLANT MOL BIOL, V33, P867, DOI 10.1023/A:1005729309569; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Martin AC, 2000, PLANT J, V24, P559, DOI 10.1046/j.1365-313x.2000.00893.x; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Poirier Y, 2002, ARABIDOPSIS BOOK; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Shin H, 2006, PLANT J, V45, P712, DOI 10.1111/j.1365-313X.2005.02629.x; Simon-Mateo C, 2006, J VIROL, V80, P2429, DOI 10.1128/JVI.80.5.2429-2436.2006; Ticconi CA, 2004, TRENDS PLANT SCI, V9, P548, DOI 10.1016/j.tplants.2004.09.003; Vaucheret H, 2004, GENE DEV, V18, P1187, DOI 10.1101/gad.1201404; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Wu G, 2006, DEVELOPMENT, V133, P3539, DOI 10.1242/dev.02521	28	1369	1489	17	347	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					1033	1037		10.1038/ng2079	http://dx.doi.org/10.1038/ng2079			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17643101				2022-12-27	WOS:000248446900023
J	Conrad, DF; Hurles, ME				Conrad, Donald F.; Hurles, Matthew E.			The population genetics of structural variation	NATURE GENETICS			English	Article							COPY-NUMBER VARIATION; HUMAN GENOME; LINKAGE DISEQUILIBRIUM; SEGMENTAL DUPLICATIONS; POSITIVE SELECTION; DELETION POLYMORPHISMS; RECURRENT DUPLICATION; FINITE POPULATION; NATURAL-SELECTION; HIGH-RESOLUTION	Population genetics is central to our understanding of human variation, and by linking medical and evolutionary themes, it enables us to understand the origins and impacts of our genomic differences. Despite current limitations in our knowledge of the locations, sizes and mutational origins of structural variants, our characterization of their population genetics is developing apace, bringing new insights into recent human adaptation, genome biology and disease. We summarize recent dramatic advances, describe the diverse mutational origins of chromosomal rearrangements and argue that their complexity necessitates a re-evaluation of existing population genetic methods.	[Hurles, Matthew E.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Conrad, Donald F.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA	Wellcome Trust Sanger Institute; University of Chicago	Hurles, ME (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	meh@sanger.ac.uk			Wellcome Trust [077014] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Andolfatto P, 1998, GENETICS, V148, P1397; Armour JAL, 1996, NAT GENET, V13, P154, DOI 10.1038/ng0696-154; Bacolla A, 2004, P NATL ACAD SCI USA, V101, P14162, DOI 10.1073/pnas.0405974101; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Barbujani G, 1997, P NATL ACAD SCI USA, V94, P4516, DOI 10.1073/pnas.94.9.4516; Bayes M, 2003, AM J HUM GENET, V73, P131, DOI 10.1086/376565; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Brewer C, 1999, AM J HUM GENET, V64, P1702, DOI 10.1086/302410; Bubb KL, 2006, GENETICS, V173, P2165, DOI 10.1534/genetics.106.055715; Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Fernandes S, 2004, AM J HUM GENET, V74, P180, DOI 10.1086/381132; Feuk L, 2005, PLOS GENET, V1, P489, DOI 10.1371/journal.pgen.0010056; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; FLINT J, 1986, NATURE, V321, P744, DOI 10.1038/321744a0; Fredman D, 2004, NAT GENET, V36, P861, DOI 10.1038/ng1401; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Han LL, 2000, HUM MOL GENET, V9, P1881, DOI 10.1093/hmg/9.12.1881; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; HUDSON RR, 1994, GENETICS, V136, P1329; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Jobling MA, 1996, HUM MOL GENET, V5, P1767, DOI 10.1093/hmg/5.11.1767; Johnson ME, 2006, P NATL ACAD SCI USA, V103, P17626, DOI 10.1073/pnas.0605426103; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; KIMURA M, 1969, P NATL ACAD SCI USA, V63, P1181, DOI 10.1073/pnas.63.4.1181; KIMURA M, 1964, GENETICS, V49, P725; Kurahashi H, 2001, NAT GENET, V29, P139, DOI 10.1038/ng1001-139; Li N, 2003, GENETICS, V165, P2213; Linardopoulou EV, 2005, NATURE, V437, P94, DOI 10.1038/nature04029; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Newman TL, 2006, HUM MOL GENET, V15, P1159, DOI 10.1093/hmg/ddl031; Nguyen DQ, 2006, PLOS GENET, V2, P198, DOI 10.1371/journal.pgen.0020020; Nielsen R, 2003, THEOR POPUL BIOL, V63, P245, DOI 10.1016/S0040-5809(03)00005-4; OHTA T, 1973, GENET RES, V22, P201, DOI 10.1017/S0016672300012994; Perry GH, 2006, P NATL ACAD SCI USA, V103, P8006, DOI 10.1073/pnas.0602318103; Popesco MC, 2006, SCIENCE, V313, P1304, DOI 10.1126/science.1127980; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2000, GENETICS, V155, P945; Przeworski M, 2000, TRENDS GENET, V16, P296, DOI 10.1016/S0168-9525(00)02030-8; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schmutz J, 2004, NATURE, V431, P268, DOI 10.1038/nature02919; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Slatkin M, 2000, ANNU REV GENOM HUM G, V1, P225, DOI 10.1146/annurev.genom.1.1.225; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Turner DJ, 2006, NAT METHODS, V3, P439, DOI 10.1038/NMETH881; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; VALDES AM, 1993, GENETICS, V133, P737; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Voight BF, 2005, P NATL ACAD SCI USA, V102, P18508, DOI 10.1073/pnas.0507325102; WARBURTON D, 1991, AM J HUM GENET, V49, P995; Watkins WS, 2003, GENOME RES, V13, P1607, DOI 10.1101/gr.894603; Weber JL, 2002, AM J HUM GENET, V71, P854, DOI 10.1086/342727; WONG Z, 1990, GENOMICS, V7, P222, DOI 10.1016/0888-7543(90)90544-5; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	74	141	147	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39			7			S30	S36		10.1038/ng2042	http://dx.doi.org/10.1038/ng2042			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	274AO	17597779	Green Accepted			2022-12-27	WOS:000253974400006
J	Parkes, M; Barrett, JC; Prescott, NJ; Tremelling, M; Anderson, CA; Fisher, SA; Roberts, RG; Nimmo, ER; Cummings, FR; Soars, D; Drummond, H; Lees, CW; Khawaja, SA; Bagnall, R; Burke, DA; Todhunter, CE; Ahmad, T; Onnie, CM; McArdle, W; Strachan, D; Bethel, G; Bryan, C; Lewis, CM; Deloukas, P; Forbes, A; Sanderson, J; Jewell, DP; Satsangi, J; Mansfield, JC; Cardon, L; Mathew, CG				Parkes, Miles; Barrett, Jeffrey C.; Prescott, Natalie J.; Tremelling, Mark; Anderson, Carl A.; Fisher, Sheila A.; Roberts, Roland G.; Nimmo, Elaine R.; Cummings, Fraser R.; Soars, Dianne; Drummond, Hazel; Lees, Charlie W.; Khawaja, Saud A.; Bagnall, Richard; Burke, Denis A.; Todhunter, Catherine E.; Ahmad, Tariq; Onnie, Clive M.; McArdle, Wendy; Strachan, David; Bethel, Graeme; Bryan, Claire; Lewis, Cathryn M.; Deloukas, Panos; Forbes, Alastair; Sanderson, Jeremy; Jewell, Derek P.; Satsangi, Jack; Mansfield, John C.; Cardon, Lon; Mathew, Christopher G.		Wellcome Trust Case Control Consor	Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RESISTANCE; EXPRESSION; IL23R	A genome- wide association scan in individuals with Crohn's disease by the Wellcome Trust Case Control Consortium detected strong association at four novel loci. We tested 37 SNPs from these and other loci for association in an independent case- control sample. We obtained replication for the autophagy- inducing IRGM gene on chromosome 5q33.1 ( replication P = 6.6 x 10(-4), combined P = 2.1 x 10(-10)) and for nine other loci, including NKX2- 3, PTPN2 and gene deserts on chromosomes 1q and 5p13.	Addenbrookes Hosp, Inflammatory Bowel Dis Res Grp, Cambridge CB2 2QQ, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Kings Coll London, Guys Hosp, Sch Med, Dept Med & Mol Genet, London SE1 9RT, England; Univ Edinburgh, Western Gen Hosp, Sch Mol & Clin Med, Div Med Sci,Gastrointestinal Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Univ Oxford, Radcliffe Infirm, Gastroenterol Unit, Oxford OX2 6HE, England; Univ Newcastle Upon Tyne, Royal Victoria Infirm, Dept Gastroenterol & Hepatol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Univ Bristol, ALSPAC, Bristol BS8 1TQ, Avon, England; St Georges Univ London, Div Community Hlth Serv, London SW17 0RE, England; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; UCL, Hosp Trust, Inst Digest Dis, London NW1 2BU, England; Guys & St Thomas NHS Fdn Trust, Dept Gastroenterol, London SE1 7EH, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Edinburgh; Radcliffe Infirmary; University of Oxford; Newcastle University - UK; University of Bristol; St Georges University London; Wellcome Trust Sanger Institute; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust	Parkes, M (corresponding author), Addenbrookes Hosp, Inflammatory Bowel Dis Res Grp, Hills Rd, Cambridge CB2 2QQ, England.	miles.parkes@addenbrookes.nhs.uk	Anderson, Carl A/B-8327-2013; Prescott, Natalie J/F-6490-2011; Mathew, Christopher G/G-3434-2015; Brown, Matthew A/E-5749-2010; Roberts, Roland G/C-3596-2009; Lewis, Cathryn M/A-5225-2010; Deloukas, Panos/B-2922-2013; Lewis, Cathryn/M-8766-2019	Anderson, Carl A/0000-0003-1719-7009; Prescott, Natalie J/0000-0002-5901-7371; Mathew, Christopher G/0000-0003-4178-1838; Brown, Matthew A/0000-0003-0538-8211; Lewis, Cathryn M/0000-0002-8249-8476; Deloukas, Panos/0000-0001-9251-070X; Lewis, Cathryn/0000-0002-8249-8476; Khawaja, Saud Ahmed/0000-0001-5349-6087; Roberts, Roland/0000-0001-6636-1579; Bagnall, Richard/0000-0002-2476-9864; Parkes, Miles/0000-0002-6467-0631; Barrett, Jeffrey/0000-0002-1152-370X; Forbes, Alastair/0000-0001-7416-9843; Lees, Charlie/0000-0002-0732-8215; Cummings, Fraser/0000-0002-9659-3247; Morgan, Ann/0000-0003-1109-624X	MRC [G0000934] Funding Source: UKRI; Medical Research Council [G0000934] Funding Source: Medline; Wellcome Trust [072029, 068545/Z/02] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Bekpen C, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r92; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Collazo CM, 2001, J EXP MED, V194, P181, DOI 10.1084/jem.194.2.181; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Pabst O, 2000, EMBO J, V19, P2015, DOI 10.1093/emboj/19.9.2015; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Todd JA, 2007, NAT GENET; Zwiers A, 2004, GENES IMMUN, V5, P675, DOI 10.1038/sj.gene.6364131	15	897	926	4	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2007	39	7					830	832		10.1038/ng2061	http://dx.doi.org/10.1038/ng2061			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17554261	Green Accepted			2022-12-27	WOS:000247619800010
J	Sandilands, A; Terron-Kwiatkowski, A; Hull, PR; O'Regan, GM; Clayton, TH; Watson, RM; Carrick, T; Evans, AT; Liao, HH; Zhao, YW; Campbell, LE; Schmuth, M; Gruber, R; Janecke, AR; Elias, PM; van Steensel, MAM; Nagtzaam, I; van Geel, M; Steijlen, PM; Munro, CS; Bradley, DG; Palmer, CNA; Smith, FJD; McLean, WHI; Irvine, AD				Sandilands, Aileen; Terron-Kwiatkowski, Ana; Hull, Peter R.; O'Regan, Grainne M.; Clayton, Timothy H.; Watson, Rosemarie M.; Carrick, Thomas; Evans, Alan T.; Liao, Haihui; Zhao, Yiwei; Campbell, Linda E.; Schmuth, Matthias; Gruber, Robert; Janecke, Andreas R.; Elias, Peter M.; van Steensel, Maurice A. M.; Nagtzaam, Ivo; van Geel, Michel; Steijlen, Peter M.; Munro, Colin S.; Bradley, Daniel G.; Palmer, Colin N. A.; Smith, Frances J. D.; McLean, W. H. Irwin; Irvine, Alan D.			Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema	NATURE GENETICS			English	Article							OF-FUNCTION MUTATIONS; PREDISPOSE; DERMATITIS; POLYMORPHISMS; PROFILAGGRIN; BARRIER; COMPLEX	We recently reported two common filaggrin (FLG) null mutations that cause ichthyosis vulgaris(1) and predispose to eczema and secondary allergic diseases(2). We show here that these common European mutations are ancestral variants carried on conserved haplotypes. To facilitate comprehensive analysis of other populations, we report a strategy for full sequencing of this large, highly repetitive gene, and we describe 15 variants, including seven that are prevalent. All the variants are either nonsense or frameshift mutations that, in representative cases, resulted in loss of filaggrin production in the epidermis. In an Irish case-control study, the five most common European mutations showed a strong association with moderate-to-severe childhood eczema (chi(2) test: P = 2.12 x 10(-51); Fisher's exact test: heterozygote odds ratio (OR) = 7.44 (95% confidence interval (c. i.) = 4.9 - 11.3), and homozygote OR 151 (95% c. i. = 20 - 1,136)). We found three additional rare null mutations in this case series, suggesting that the genetic architecture of filaggrin-related atopic dermatitis consists of both prevalent and rare risk alleles.	Univ Dundee, Ninewells Hosp & Med Sch, Epithelial Genet Grp, Human Genet Unit,Div Pathol & Neurosci, Dundee DD1 9SY, Scotland; Our Ladys Hosp Sick Children, Dept Paediat Dermatol, Dublin 12, Ireland; Tayside Univ Hosp NHS Trust, Ninewells Hosp & Med Sch, Dept Genet, Dundee DD1 9SY, Scotland; Tayside Univ Hosp NHS Trust, Ninewells Hosp & Med Sch, Dept Pathol, Dundee DD1 9SY, Scotland; Innsbruck Med Univ, Dept Dermatol, Innsbruck, Austria; Innsbruck Med Univ, Dept Med Genet Mol & Clin Pharmacol, Innsbruck, Austria; Vet Affairs Med Ctr, Dermatol & Metab Med Serv, San Francisco, CA 94121 USA; Univ Hosp Maastricht, Dept Dermatol, Maastricht, Netherlands; So Gen Hosp, Dept Dermatol, Glasgow G51 4TF, Lanark, Scotland; Univ Dublin Trinity Coll, Dept Genet, Dublin 2, Ireland; Univ Dundee, Ninewells Hosp & Med Sch, Populat Pharmacogenet Grp, Ctr Biomed Res, Dundee DD1 9SY, Scotland; Univ Dublin Trinity Coll, Dept Clin Med, Dublin 2, Ireland	University of Dundee; Our Ladys Children Hospital Crumlin; University of Dundee; University of Dundee; Medical University of Innsbruck; Medical University of Innsbruck; US Department of Veterans Affairs; Veterans Health Administration (VHA); Maastricht University; Maastricht University Medical Centre (MUMC); University of Glasgow; Trinity College Dublin; University of Dundee; Trinity College Dublin	McLean, WHI (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Epithelial Genet Grp, Human Genet Unit,Div Pathol & Neurosci, Dundee DD1 9SY, Scotland.	w.h.i.mclean@dundee.ac.uk; irvinea@tcd.ie	Bradley, Daniel G/A-3240-2012; McLean, William HI/C-6352-2009; Palmer, Colin NA/C-7053-2008; Janecke, Andreas/AAA-5227-2019; Irvine, Alan D/A-3982-2008; van Steensel, Maurice A.M./V-3852-2019; Steijlen, Peter/X-2729-2019	Palmer, Colin NA/0000-0002-6415-6560; Irvine, Alan D/0000-0002-9048-2044; van Steensel, Maurice/0000-0002-7507-2442; Schmuth, Matthias/0000-0002-4064-1334; Bradley, Daniel G/0000-0001-7335-7092; Janecke, Andreas/0000-0001-7155-0315; McLean, William Henry Irwin/0000-0001-5539-5757; Hull, Peter/0000-0002-3896-9373	MRC [G0700314] Funding Source: UKRI; Medical Research Council [G0700314] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Barker JNWN, 2007, J INVEST DERMATOL, V127, P564, DOI 10.1038/sj.jid.5700587; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Cookson WOCM, 2001, NAT GENET, V27, P372, DOI 10.1038/86867; GAN SQ, 1990, BIOCHEMISTRY-US, V29, P9432, DOI 10.1021/bi00492a018; Gruber R, 2007, EUR J HUM GENET, V15, P179, DOI 10.1038/sj.ejhg.5201742; Irvine AD, 2007, J INVEST DERMATOL, V127, P504, DOI 10.1038/sj.jid.5700695; Irvine AD, 2006, J INVEST DERMATOL, V126, P1200, DOI 10.1038/sj.jid.5700365; JUDGE MR, 2004, ROOKS TXB DERMATOLOG, V1; Katagiri C, 2003, J DERMATOL SCI, V31, P29, DOI 10.1016/S0923-1811(02)00137-8; Marenholz I, 2006, J ALLERGY CLIN IMMUN, V118, P866, DOI 10.1016/j.jaci.2006.07.026; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; Morar N, 2007, J INVEST DERMATOL, V127, P1667, DOI 10.1038/sj.jid.5700739; Nomura T, 2007, J ALLERGY CLIN IMMUN, V119, P434, DOI 10.1016/j.jaci.2006.12.646; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Presland RB, 2000, J INVEST DERMATOL, V115, P1072, DOI 10.1046/j.1523-1747.2000.00178.x; Rawlings A.V., 2004, DERMATOL THER S1, V17, P43, DOI [10.1111/j.1396-0296.2004.04s1005.x, DOI 10.1111/J.1396-0296.2004.04S1005.X]; Ruether A, 2006, BRIT J DERMATOL, V155, P1093, DOI 10.1111/j.1365-2133.2006.07500.x; Sandilands A, 2006, J INVEST DERMATOL, V126, P1770, DOI 10.1038/sj.jid.5700459; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Stemmler S, 2007, J INVEST DERMATOL, V127, P722, DOI 10.1038/sj.jid.5700579; Takahashi M, 1996, ARCH BIOCHEM BIOPHYS, V329, P123, DOI 10.1006/abbi.1996.0199; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P214, DOI 10.1016/j.jaci.2006.05.004; Weidinger S, 2007, J INVEST DERMATOL, V127, P724, DOI 10.1038/sj.jid.5700630	24	447	469	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2007	39	5					650	654		10.1038/ng2020	http://dx.doi.org/10.1038/ng2020			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17417636				2022-12-27	WOS:000245971300021
J	Weber, M; Hellmann, I; Stadler, MB; Ramos, L; Paabo, S; Rebhan, M; Schubeler, D				Weber, Michael; Hellmann, Ines; Stadler, Michael B.; Ramos, Liliana; Paabo, Svante; Rebhan, Michael; Schubeler, Dirk			Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome	NATURE GENETICS			English	Article							CPG-BINDING-PROTEIN; GENE-EXPRESSION; GERM-CELL; ISLANDS; WIDE; PATTERNS; PROFILE; CANCER; MOUSE; HYPOMETHYLATION	To gain insight into the function of DNA methylation at cis-regulatory regions and its impact on gene expression, we measured methylation, RNA polymerase occupancy and histone modifications at 16,000 promoters in primary human somatic and germline cells. We find CpG-poor promoters hypermethylated in somatic cells, which does not preclude their activity. This methylation is present in male gametes and results in evolutionary loss of CpG dinucleotides, as measured by divergence between humans and primates. In contrast, strong CpG island promoters are mostly unmethylated, even when inactive. Weak CpG island promoters are distinct, as they are preferential targets for de novo methylation in somatic cells. Notably, most germline-specific genes are methylated in somatic cells, suggesting additional functional selection. These results show that promoter sequence and gene function are major predictors of promoter methylation states. Moreover, we observe that inactive unmethylated CpG island promoters show elevated levels of dimethylation of Lys4 of histone H3, suggesting that this chromatin mark may protect DNA from methylation.	Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland; Max Planck Inst Evolutionary Anthropol, D-04103 Leipzig, Germany; Univ Copenhagen, DK-2100 Copenhagen, Denmark; Radboud Univ Nijmegen Med Ctr, Dept Obstet & Gynaecol, NL-6500 HB Nijmegen, Netherlands	Friedrich Miescher Institute for Biomedical Research; Max Planck Society; University of Copenhagen; Radboud University Nijmegen	Schubeler, D (corresponding author), Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.	dirk@fmi.ch	Ramos, L./L-4590-2015; Weber, Michael/P-1914-2016	Weber, Michael/0000-0003-3484-5821				Assou S, 2006, HUM REPROD, V21, P1705, DOI 10.1093/humrep/del065; Ayton PM, 2004, MOL CELL BIOL, V24, P10470, DOI 10.1128/MCB.24.23.10470-10478.2004; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; BIRD AP, 1995, TRENDS GENET, V11, P94, DOI 10.1016/S0168-9525(00)89009-5; Bock C, 2006, PLOS GENET, V2, P243, DOI 10.1371/journal.pgen.0020026; BOYES J, 1992, EMBO J, V11, P327, DOI 10.1002/j.1460-2075.1992.tb05055.x; BRANDEIS M, 1993, BIOESSAYS, V15, P709, DOI 10.1002/bies.950151103; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; CHOI YC, 1991, J BIOL CHEM, V266, P20504; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; De Smet C, 2004, MOL CELL BIOL, V24, P4781, DOI 10.1128/MCB.24.11.4781-4790.2004; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Egger G, 2004, NATURE, V429, P457, DOI 10.1038/nature02625; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Hendrich B, 1999, NATURE, V401, P301, DOI 10.1038/45843; HSIEH CL, 1994, MOL CELL BIOL, V14, P5487, DOI 10.1128/MCB.14.8.5487; Hwang DG, 2004, P NATL ACAD SCI USA, V101, P13994, DOI 10.1073/pnas.0404142101; Ioshikhes IP, 2000, NAT GENET, V26, P61, DOI 10.1038/79189; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Koslowski M, 2004, CANCER RES, V64, P5988, DOI 10.1158/0008-5472.CAN-04-1187; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; LI E, 1993, NATURE, V366, P362, DOI 10.1038/366362a0; Li ZR, 2003, P NATL ACAD SCI USA, V100, P8164, DOI 10.1073/pnas.1332764100; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; Muller F, 2004, EMBO J, V23, P2, DOI 10.1038/sj.emboj.7600027; NEDDERMANN P, 1993, J BIOL CHEM, V268, P21218; Peters AHFM, 2005, CURR OPIN CELL BIOL, V17, P230, DOI 10.1016/j.ceb.2005.02.006; Pohlers M, 2005, CURR BIOL, V15, P1051, DOI 10.1016/j.cub.2005.04.060; Riesewijk AM, 1997, GENOMICS, V42, P236, DOI 10.1006/geno.1997.4731; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Rollins RA, 2006, GENOME RES, V16, P157, DOI 10.1101/gr.4262006; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Schubeler D, 2000, MOL CELL BIOL, V20, P9103, DOI 10.1128/MCB.20.24.9103-9112.2000; SHEN JC, 1994, NUCLEIC ACIDS RES, V22, P972, DOI 10.1093/nar/22.6.972; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Singal R, 2000, BIOL REPROD, V63, P1237, DOI 10.1095/biolreprod63.5.1237; Smiraglia DJ, 2001, HUM MOL GENET, V10, P1413, DOI 10.1093/hmg/10.13.1413; Song F, 2005, P NATL ACAD SCI USA, V102, P3336, DOI 10.1073/pnas.0408436102; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Warnecke PM, 1999, MOL CELL BIOL, V19, P164; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598	50	1563	1642	10	136	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2007	39	4					457	466		10.1038/ng1990	http://dx.doi.org/10.1038/ng1990			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17334365				2022-12-27	WOS:000245271200015
J	Yang, XZ; Smith, SL; Tian, XC; Lewin, HA; Renard, JP; Wakayama, T				Yang, Xiangzhong; Smith, Sadie L.; Tian, X. Cindy; Lewin, Harris A.; Renard, Jean-Paul; Wakayama, Teruhiko			Nuclear reprogramming of cloned embryos and its implications for therapeutic cloning	NATURE GENETICS			English	Article							X-CHROMOSOME INACTIVATION; ADULT SOMATIC-CELLS; STEM-CELLS; GENE-EXPRESSION; MITOCHONDRIAL-DNA; IMPRINTED GENES; PREIMPLANTATION EMBRYOS; MAMMALIAN DEVELOPMENT; METHYLATION PATTERNS; ABERRANT	Therapeutic cloning, whereby somatic cell nuclear transfer (SCNT) is used to generate patient-specific embryonic stem cells (ESCs) from blastocysts cloned by nuclear transfer (ntESCs), holds great promise for the treatment of many human diseases. ntESCs have been derived in mice and cattle, but thus far there are no credible reports of human ntESCs. Here we review the recent literature on nuclear reprogramming by SCNT, including studies of gene expression, DNA methylation, chromatin remodeling, genomic imprinting and X chromosome inactivation. Reprogramming of genes expressed in the inner cell mass, from which ntESCs are derived, seems to be highly efficient. Defects in the extraembryonic lineage are probably the major cause of the low success rate of reproductive cloning but are not expected to affect the derivation of ntESCs. We remain optimistic that human therapeutic cloning is achievable and that the derivation of patient-specific ntESC lines will have great potential for regenerative medicine.	Univ Connecticut, Ctr Regenerat Biol, Storrs, CT 06269 USA; Univ Connecticut, Dept Anim Sci, Storrs, CT 06269 USA; Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; INRA, Unite Mixte Rech Biol Dev & Reprod, F-78532 Jouy En Josas, France; RIKEN, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan	University of Connecticut; University of Connecticut; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; INRAE; UDICE-French Research Universities; Universite Paris Saclay; RIKEN	Yang, XZ (corresponding author), Univ Connecticut, Ctr Regenerat Biol, Storrs, CT 06269 USA.	xiangzhong.yang@uconn.edu	Pillay, Nischalan/F-9536-2012; LEWIN, HARRIS/HGC-6543-2022	LEWIN, HARRIS/0000-0002-1043-7287; Marjani, Sadie/0000-0003-1241-8538				Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Bourc'his D, 2001, CURR BIOL, V11, P1542, DOI 10.1016/S0960-9822(01)00480-8; BRAMBRINK T, 2006, P NATL ACAD SCI; Cardoso MC, 1999, J CELL BIOL, V147, P25, DOI 10.1083/jcb.147.1.25; Chavatte-Palmer P, 2002, BIOL REPROD, V66, P1596, DOI 10.1095/biolreprod66.6.1596; Chen Y, 2003, CELL RES, V13, P251, DOI 10.1038/sj.cr.7290170; Cibelli JB, 1998, NAT BIOTECHNOL, V16, P642, DOI 10.1038/nbt0798-642; Cibelli JB, 2002, NAT BIOTECHNOL, V20, P13, DOI 10.1038/nbt0102-13; CIBELLI JB, 2002, PRINCIPLES CLONING; Constant F, 2006, BIOL REPROD, V75, P122, DOI 10.1095/biolreprod.106.051581; Daniels R, 2000, BIOL REPROD, V63, P1034, DOI 10.1095/biolreprod63.4.1034; De La Fuente R, 1999, BIOL REPROD, V60, P769, DOI 10.1095/biolreprod60.3.769; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Dean W, 2003, SEMIN CELL DEV BIOL, V14, P93, DOI 10.1016/S1084-9521(02)00141-6; DeBaun MR, 2003, AM J HUM GENET, V72, P156, DOI 10.1086/346031; Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368; Dyce PW, 2006, NAT CELL BIOL, V8, P384, DOI 10.1038/ncb1388; Eakin GS, 2003, DEV DYNAM, V228, P751, DOI 10.1002/dvdy.10363; Eggan E, 2004, NATURE, V428, P44, DOI 10.1038/nature02375; Eggan K, 2000, SCIENCE, V290, P1578, DOI 10.1126/science.290.5496.1578; Enright BP, 2005, BIOL REPROD, V72, P944, DOI 10.1095/biolreprod.104.033225; Evans MJ, 1999, NAT GENET, V23, P90, DOI 10.1038/12696; Farin PW, 2006, THERIOGENOLOGY, V65, P178, DOI 10.1016/j.theriogenology.2005.09.022; Han YM, 2003, THERIOGENOLOGY, V59, P33, DOI 10.1016/S0093-691X(02)01271-2; Hashizume Kazuyoshi, 2002, Cloning and Stem Cells, V4, P197, DOI 10.1089/15362300260339485; Hemberger M, 2002, CYTOGENET GENOME RES, V99, P210, DOI 10.1159/000071595; Hill JR, 2002, BIOL REPROD, V67, P55, DOI 10.1095/biolreprod67.1.55; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hochedlinger K, 2003, NEW ENGL J MED, V349, P275, DOI 10.1056/NEJMra035397; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Humphreys D, 2002, P NATL ACAD SCI USA, V99, P12889, DOI 10.1073/pnas.192433399; Illmensee K, 2006, FERTIL STERIL, V85, P1248, DOI 10.1016/j.fertnstert.2005.10.026; Inoue K, 2002, SCIENCE, V295, P297, DOI 10.1126/science.295.5553.297; Inoue K, 2006, J CELL SCI, V119, P1985, DOI 10.1242/jcs.02913; Iwasaki S, 2000, BIOL REPROD, V62, P470, DOI 10.1095/biolreprod62.2.470; Jouneau A, 2006, DEVELOPMENT, V133, P1597, DOI 10.1242/dev.02317; Kang YK, 2002, EMBO J, V21, P1092, DOI 10.1093/emboj/21.5.1092; Kennedy Donald, 2006, Science, V311, P335; Kim HR, 2005, PROTEOMICS, V5, P4264, DOI 10.1002/pmic.200401297; Kishigami S, 2006, BIOCHEM BIOPH RES CO, V340, P183, DOI 10.1016/j.bbrc.2005.11.164; Koo DB, 2002, BIOL REPROD, V67, P487, DOI 10.1095/biolreprod67.2.487; Kruip TAM, 1997, THERIOGENOLOGY, V47, P43, DOI 10.1016/S0093-691X(96)00338-X; Latham KE, 1999, CURR TOP DEV BIOL, V43, P1; Lee JB, 2006, NATURE, V440, pE2, DOI 10.1038/nature04686; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li JS, 2004, NATURE, V428, P393, DOI 10.1038/nature02433; Li XP, 2005, MOL REPROD DEV, V72, P152, DOI 10.1002/mrd.20346; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Monk M, 2001, MOL CELL ENDOCRINOL, V183, pS35, DOI 10.1016/S0303-7207(01)00575-5; Morgan HD, 2005, HUM MOL GENET, V14, pR47, DOI 10.1093/hmg/ddi114; Munsie MJ, 2000, CURR BIOL, V10, P989, DOI 10.1016/S0960-9822(00)00648-5; NAGY A, 1990, DEVELOPMENT, V110, P815; Nolen LD, 2005, DEV BIOL, V279, P525, DOI 10.1016/j.ydbio.2005.01.016; Okamoto I, 2005, NATURE, V438, P369, DOI 10.1038/nature04155; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Pfister-Genskow M, 2005, BIOL REPROD, V72, P546, DOI 10.1095/biolreprod.104.031799; Reik W, 2003, PHILOS T R SOC B, V358, P1403, DOI 10.1098/rstb.2003.1326; Rybouchkin A, 2006, BIOL REPROD, V74, P1083, DOI 10.1095/biolreprod.105.047456; Santos F, 2003, CURR BIOL, V13, P1116, DOI 10.1016/S0960-9822(03)00419-6; Scott LA, 2006, CYTOGENET GENOME RES, V112, P261, DOI 10.1159/000089880; Senda S, 2004, BIOCHEM BIOPH RES CO, V321, P38, DOI 10.1016/j.bbrc.2004.06.096; Simerly C, 2003, SCIENCE, V300, P297, DOI 10.1126/science.1082091; Smith SL, 2005, P NATL ACAD SCI USA, V102, P17582, DOI 10.1073/pnas.0508952102; Somers J, 2006, REPRODUCTION, V131, P1073, DOI 10.1530/rep.1.00967; Steinborn R, 2000, NAT GENET, V25, P255, DOI 10.1038/77000; Suemizu H, 2003, DEV BIOL, V253, P36, DOI 10.1006/dbio.2002.0870; Suteevun T, 2006, J ANIM SCI, V84, P2065, DOI 10.2527/jas.2005-695; Tada T, 2000, DEVELOPMENT, V127, P3101; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; TAKAGI N, 1982, CHROMOSOMA, V85, P275, DOI 10.1007/BF00294971; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tamashiro KLK, 2002, NAT MED, V8, P262, DOI 10.1038/nm0302-262; Thorvaldsen JL, 2006, DEV BIOL, V298, P344, DOI 10.1016/j.ydbio.2006.07.011; Tycko B, 2002, J CELL PHYSIOL, V192, P245, DOI 10.1002/jcp.10129; Wagschal A, 2006, CYTOGENET GENOME RES, V113, P90, DOI 10.1159/000090819; Wakayama S, 2005, J REPROD DEVELOP, V51, P765, DOI 10.1262/jrd.17061; Wakayama S, 2005, BIOL REPROD, V72, P932, DOI 10.1095/biolreprod.104.035105; Wakayama S, 2005, P NATL ACAD SCI USA, V102, P29, DOI 10.1073/pnas.0408548102; Wakayama S, 2006, STEM CELLS, V24, P2023, DOI 10.1634/stemcells.2005-0537; Wakayama T, 2001, SCIENCE, V292, P740, DOI 10.1126/science.1059399; Wang L, 2005, BIOL REPROD, V73, P149, DOI 10.1095/biolreprod.104.037150; Wilkins JF, 2003, NAT REV GENET, V4, P359, DOI 10.1038/nrg1062; Winger QA, 2000, MOL REPROD DEV, V56, P458, DOI 10.1002/1098-2795(200008)56:4&lt;458::AID-MRD3&gt;3.0.CO;2-L; Wrenzycki C, 2001, BIOL REPROD, V65, P309, DOI 10.1095/biolreprod65.1.309; Xue F, 2002, NAT GENET, V31, P216, DOI 10.1038/ng900; Yang L, 2005, MOL REPROD DEV, V71, P431, DOI 10.1002/mrd.20311; Young LE, 1998, REV REPROD, V3, P155, DOI 10.1530/revreprod/3.3.155; Zhu J, 2002, BIOL REPROD, V66, P635, DOI 10.1095/biolreprod66.3.635; Zuccotti M, 2000, J ENDOCRINOL INVEST, V23, P623, DOI 10.1007/BF03343786	93	441	489	4	88	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2007	39	3					295	302		10.1038/ng1973	http://dx.doi.org/10.1038/ng1973			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17325680				2022-12-27	WOS:000244480000010
J	Hartong, DT; Dange, M; Mcgee, TL; Berson, EL; Dryja, TP; Colman, RF				Hartong, Dyonne T.; Dange, Mayura; McGee, Terri L.; Berson, Eliot L.; Dryja, Thaddeus P.; Colman, Roberta F.			Insights from retinitis pigmentosa into the roles of isocitrate dehydrogenases in the Krebs cycle	NATURE GENETICS			English	Article							POSITIONAL CLONING; BETA-SUBUNIT; PIG-HEART; GENE; MUTATIONS; IDENTIFICATION	Here we describe two families with retinitis pigmentosa, a hereditary neurodegeneration of rod and cone photoreceptors in the retina. Affected family members were homozygous for loss-of-function mutations in IDH3B, encoding the beta-subunit of NAD-specific isocitrate dehydrogenase (NAD-IDH, or IDH3), which is believed to catalyze the oxidation of isocitrate to a-ketoglutarate in the citric acid cycle. Cells from affected individuals had a substantial reduction of NAD-IDH activity, with about a 300-fold increase in the Km for NAD. NADP-specific isocitrate dehydrogenase (NADP-IDH, or IDH2), an enzyme that catalyzes the same reaction, was normal in affected individuals, and they had no health problems associated with the enzyme deficiency except for retinitis pigmentosa. These findings support the hypothesis that mitochondrial NADP-IDH, rather than NAD-IDH, serves as the main catalyst for this reaction in the citric acid cycle outside the retina, and that the retina has a particular requirement for NAD-IDH.	[Hartong, Dyonne T.; McGee, Terri L.; Dryja, Thaddeus P.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Ocular Mol Genet Inst, Boston, MA 02114 USA; [Dange, Mayura; Colman, Roberta F.] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA; [Berson, Eliot L.] Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Berman Gund Lab Study Retinal Degenerat, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; University of Delaware; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary	Dryja, TP (corresponding author), Harvard Univ, Massachusetts Eye & Ear Infirm, Sch Med, Ocular Mol Genet Inst, 243 Charles St, Boston, MA 02114 USA.	thaddeus.dryja@novartis.com			NEI NIH HHS [NIH-EY00169, P30-EY014104, R01 EY000169, P30 EY014104, NIH-EY08683, R37 EY000169, R01 EY008683, R01 EY000169-36] Funding Source: Medline; NHLBI NIH HHS [NIH-HL67774, R01 HL067774] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY000169, R37EY000169, P30EY014104, R01EY008683] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067774] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chakarova CF, 2002, HUM MOL GENET, V11, P87, DOI 10.1093/hmg/11.1.87; COHEN PF, 1972, BIOCHEMISTRY-US, V11, P1501, DOI 10.1021/bi00758a027; Daiger Stephen P, 2004, Novartis Found Symp, V255, P17; DOLPHIN D, 1987, PYRIDINE NUCLEOTID B, V606; Dybbs M, 2005, PLOS GENET, V1, P6, DOI 10.1371/journal.pgen.0010002; GARRETT RH, 2004, BIOCHEMISTRY, V618; Gu JJ, 1997, J BIOL CHEM, V272, P4458, DOI 10.1074/jbc.272.7.4458; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; HOEK JB, 1988, BIOCHEM J, V254, P1; Huusko P, 2004, NAT GENET, V36, P979, DOI 10.1038/ng1408; Kim YO, 1999, CYTOGENET CELL GENET, V86, P240, DOI 10.1159/000015348; LOSSON R, 1979, P NATL ACAD SCI USA, V76, P5134, DOI 10.1073/pnas.76.10.5134; McKie AB, 2001, HUM MOL GENET, V10, P1555, DOI 10.1093/hmg/10.15.1555; Meindl A, 1996, NAT GENET, V13, P35, DOI 10.1038/ng0596-35; MOYLE J, 1973, BIOCHEM J, V132, P571, DOI 10.1042/bj1320571; Noensie EN, 2001, NAT BIOTECHNOL, V19, P434, DOI 10.1038/88099; RAMACHANDRAN N, 1980, J BIOL CHEM, V255, P8859; Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; SMITH CM, 1979, EUR J BIOCHEM, V97, P283, DOI 10.1111/j.1432-1033.1979.tb13113.x; Soundar S, 2003, J BIOL CHEM, V278, P52146, DOI 10.1074/jbc.M306178200; Vithana EN, 2001, MOL CELL, V8, P375, DOI 10.1016/S1097-2765(01)00305-7; Warburg O, 1942, BIOCHEM Z, V310, P384	23	112	118	0	15	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2008	40	10					1230	1234		10.1038/ng.223	http://dx.doi.org/10.1038/ng.223			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18806796	Green Accepted			2022-12-27	WOS:000259651000024
J	Suzuki, A; Yamada, R; Kochi, Y; Sawada, T; Okada, Y; Matsuda, K; Kamatani, Y; Mori, M; Shimane, K; Hirabayashi, Y; Takahashi, A; Tsunoda, T; Miyatake, A; Kubo, M; Kamatani, N; Nakamura, Y; Yamamoto, K				Suzuki, Akari; Yamada, Ryo; Kochi, Yuta; Sawada, Tetsuji; Okada, Yukinori; Matsuda, Koichi; Kamatani, Yoichiro; Mori, Mikako; Shimane, Kenichi; Hirabayashi, Yasuhiko; Takahashi, Atsushi; Tsunoda, Tatsuhiko; Miyatake, Akihiko; Kubo, Michiaki; Kamatani, Naoyuki; Nakamura, Yusuke; Yamamoto, Kazuhiko			Functional SNPs in CD244 increase the risk of rheumatoid arthritis in a Japanese population	NATURE GENETICS			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; AUTOIMMUNE-DISEASES; ASSOCIATION; SUSCEPTIBILITY; PTPN22; PADI4; POLYMORPHISM; METAANALYSIS; NUCLEOTIDE; FAMILIES	Rheumatoid arthritis is a chronic autoimmune inflammatory disease with a complex genetic etiology. Members of the signaling lymphocyte activation molecule (SLAM) family carry out pivotal functions in innate immunity and in conventional lymphocytes. We identified a linkage disequilibrium block associated with rheumatoid arthritis in the chromosome 1q region containing multiple SLAM family genes. In this block, the association peaked at two functional SNPs (rs3766379 and rs6682654) in CD244 in two independent rheumatoid arthritis cohorts from Japan (P = 3.23 x 10(-8) and P = 7.45 x 10(-8)). We also identified a Japanese cohort with systemic lupus erythematosus that had a similar genotype distribution as the rheumatoid arthritis cohorts. We demonstrated that the rheumatoid arthritis-susceptible alleles of rs3766379 and rs6682654 and their haplotype increased their expression in luciferase and allele-specific transcript quantification assays. CD244 is a genetic risk factor for rheumatoid arthritis and may have a role in the autoimmune process shared by rheumatoid arthritis and systemic lupus erythematosus.	[Suzuki, Akari; Yamada, Ryo; Kochi, Yuta; Mori, Mikako; Shimane, Kenichi; Yamamoto, Kazuhiko] RIKEN, Ctr Genom Med, Lab Autoimmune Dis, Tsurumi Ku, Kanagawa 2300045, Japan; [Yamada, Ryo; Okada, Yukinori] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Funct Genom,Minato Ku, Tokyo 1088639, Japan; [Sawada, Tetsuji; Mori, Mikako; Shimane, Kenichi; Yamamoto, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Bunkyo Ku, Tokyo 1130033, Japan; [Hirabayashi, Yasuhiko] Tohoku Univ, Grad Sch Med, Dept Rheumatol & Hematol, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Takahashi, Atsushi; Kamatani, Naoyuki] RIKEN, Lab Stat Anal, Tsurumi Ku, Kanagawa 2300045, Japan; [Tsunoda, Tatsuhiko] RIKEN, Lab Med Informat, Tsurumi Ku, Kanagawa 2300045, Japan; [Miyatake, Akihiko] Miyatake Asthma Clin, Chuo Ku, Osaka 5420086, Japan; [Kubo, Michiaki] RIKEN, Lab Genotyping, Tsurumi Ku, Kanagawa 2300045, Japan	RIKEN; University of Tokyo; University of Tokyo; Tohoku University; RIKEN; RIKEN; RIKEN	Yamamoto, K (corresponding author), RIKEN, Ctr Genom Med, Lab Autoimmune Dis, Tsurumi Ku, 1-7-22 Suehirocho, Kanagawa 2300045, Japan.	yamamoto-tky@umin.ac.jp	Tsunoda, Tatsuhiko/K-2061-2014; Kamatani, Yoichiro/N-5513-2015; Suzuki, Akari/N-5389-2015; Kubo, Michiaki/N-7947-2015; Yamamoto, Kazuhiko/N-5096-2015; Sawed, Tetsuji/GRX-6582-2022; Matsuda, Koichi/D-4597-2011	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Matsuda, Koichi/0000-0001-7292-2686; Yamada, Ryo/0000-0002-1587-630X	BioBank Japan Project; Japanese Millennium Project; Japanese Ministry of Health, Labor and Welfare	BioBank Japan Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Millennium Project; Japanese Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan)	We thank K. Kobayashi, M. Ohtake-Yamanaka, E. Kanno and all members of the rheumatoid arthritis team for their advice and technical assistance; H. Kawakami and T. Kawaguchi for their expertise in computer programming; and members of the Center for Genomic Medicine of RIKEN and the Biomedical Research Laboratories of Sankyo Co. Ltd. for helpful discussions and assistance in various aspects of this study. We are also grateful to members of the Rotary Club of Osaka-Midosuji District 2660 Rotary International in Japan, the Pharma SNP Consortium in Japan and the BioBank Japan Project for supporting our study. This work was supported by grants from the Japanese Millennium Project and the Japanese Ministry of Health, Labor and Welfare.	Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Begovich AB, 2004, AM J HUM GENET, V75, P330, DOI 10.1086/422827; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Claus M, 2008, FRONT BIOSCI-LANDMRK, V13, P956, DOI 10.2741/2735; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Cornelis F, 1998, P NATL ACAD SCI USA, V95, P10746, DOI 10.1073/pnas.95.18.10746; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Graham DSC, 2008, GENES IMMUN, V9, P93, DOI 10.1038/sj.gene.6364453; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Iwamoto T, 2006, RHEUMATOLOGY, V45, P804, DOI 10.1093/rheumatology/kel023; Jawaheer D, 2001, AM J HUM GENET, V68, P927, DOI 10.1086/319518; Kochi Y, 2005, NAT GENET, V37, P478, DOI 10.1038/ng1540; Lee YH, 2007, RHEUMATOLOGY, V46, P49, DOI 10.1093/rheumatology/kel170; MacKay K, 2002, ARTHRITIS RHEUM, V46, P632, DOI 10.1002/art.10147; Mori M, 2005, J HUM GENET, V50, P264, DOI 10.1007/s10038-005-0246-8; Nakajima H, 2000, HUM IMMUNOL, V61, P39, DOI 10.1016/S0198-8859(99)00170-6; Pajukanta P, 2004, NAT GENET, V36, P371, DOI 10.1038/ng1320; Plenge RM, 2005, AM J HUM GENET, V77, P1044, DOI 10.1086/498651; Remmers EF, 2007, NEW ENGL J MED, V357, P977, DOI 10.1056/NEJMoa073003; Scofield RH, 2003, BLOOD, V101, P992, DOI 10.1182/blood-2002-04-1003; Seldin MF, 1999, ARTHRITIS RHEUM, V42, P1071, DOI 10.1002/1529-0131(199906)42:6<1071::AID-ANR1>3.0.CO;2-8; Shiozawa S, 1998, INT IMMUNOL, V10, P1891, DOI 10.1093/intimm/10.12.1891; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Tokuhiro S, 2003, NAT GENET, V35, P341, DOI 10.1038/ng1267; Tregouet DA, 2007, BIOINFORMATICS, V23, P1038, DOI 10.1093/bioinformatics/btm058; Yamada R, 2005, MUTAT RES-FUND MOL M, V573, P136, DOI 10.1016/j.mrfmmm.2004.06.061; Yamamoto K, 2007, NEW ENGL J MED, V357, P1250, DOI 10.1056/NEJMe078174	30	89	91	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2008	40	10					1224	1229		10.1038/ng.205	http://dx.doi.org/10.1038/ng.205			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18794858				2022-12-27	WOS:000259651000023
J	Rock, MJ; Prenen, J; Funari, VA; Funari, TL; Merriman, B; Nelson, SF; Lachman, RS; Wilcox, WR; Reyno, S; Quadrelli, R; Vaglio, A; Owsianik, G; Janssens, A; Voets, T; Ikegawa, S; Nagai, T; Rimoin, DL; Nilius, B; Cohn, DH				Rock, Matthew J.; Prenen, Jean; Funari, Vincent A.; Funari, Tara L.; Merriman, Barry; Nelson, Stanley F.; Lachman, Ralph S.; Wilcox, William R.; Reyno, Soraya; Quadrelli, Roberto; Vaglio, Alicia; Owsianik, Grzegorz; Janssens, Annelies; Voets, Thomas; Ikegawa, Shiro; Nagai, Toshiro; Rimoin, David L.; Nilius, Bernd; Cohn, Daniel H.			Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmia	NATURE GENETICS			English	Article							CATION CHANNEL TRPV4; GENETIC-DISORDERS; DIFFERENTIATION; CHONDROCYTES; MODULATION; ACTIVATION; EXPRESSION; DYSPLASIA; SKELETON	The brachyolmias constitute a clinically and genetically heterogeneous group of skeletal dysplasias characterized by a short trunk, scoliosis and mild short stature(1). Here, we identify a locus for an autosomal dominant form of brachyolmia on chromosome 12q24.1-12q24.2. Among the genes in the genetic interval, we selected TRPV4, which encodes a calcium permeable cation channel of the transient receptor potential (TRP) vanilloid family, as a candidate gene because of its cartilage-selective gene expression pattern. In two families with the phenotype, we identified point mutations in TRPV4 that encoded R616Q and V620I substitutions, respectively. Patch clamp studies of transfected HEK cells showed that both mutations resulted in a dramatic gain of function characterized by increased constitutive activity and elevated channel activation by either mechano-stimulation or agonist stimulation by arachidonic acid or the TRPV4-specific agonist 4 alpha-phorbol 12,13-didecanoate (4 alpha PDD). This study thus defines a previously unknown mechanism, activation of a calcium-permeable TRP ion channel, in skeletal dysplasia pathogenesis.	[Rock, Matthew J.; Funari, Vincent A.; Funari, Tara L.; Lachman, Ralph S.; Wilcox, William R.; Rimoin, David L.; Cohn, Daniel H.] Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Prenen, Jean; Owsianik, Grzegorz; Janssens, Annelies; Voets, Thomas; Nilius, Bernd] Katholieke Univ Leuven, Dept Mol Cell Biol, Lab Ion Channel Res, B-3000 Louvain, Belgium; [Merriman, Barry; Nelson, Stanley F.; Rimoin, David L.; Cohn, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Nelson, Stanley F.; Lachman, Ralph S.; Wilcox, William R.; Rimoin, David L.; Cohn, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Lachman, Ralph S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiol Sci, Los Angeles, CA 90095 USA; [Reyno, Soraya] Hosp Pereira Rossel, Serv Traumatol & Ortopedia, Montevideo, Uruguay; [Quadrelli, Roberto; Vaglio, Alicia] Hosp Italiano, Inst Med Genet, Montevideo, Uruguay; [Ikegawa, Shiro] RIKEN, SNP Res Ctr, Lab Bone & Joint Dis, Tokyo, Japan; [Nagai, Toshiro] Dokkyo Univ, Koshigaya Hosp, Dept Pediat, Saitama, Japan; [Rimoin, David L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA USA	Cedars Sinai Medical Center; KU Leuven; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; RIKEN; Dokkyo Medical University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cohn, DH (corresponding author), Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA.	dan.cohn@cshs.org	Nelson, Stanley F/D-4771-2009; Voets, Thomas/E-2466-2012; Ikegawa, Shiro/N-6895-2015; Voets, Thomas/AAD-4389-2019	Nelson, Stanley F/0000-0002-2082-3114; Voets, Thomas/0000-0001-5526-5821; Ikegawa, Shiro/0000-0003-0316-2147; Voets, Thomas/0000-0001-5526-5821; Janssens, Annelies/0000-0002-6735-8248	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NICHD NIH HHS [P01 HD022657-25, P01 HD022657, HD22657] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Becker D, 2005, J CELL SCI, V118, P2435, DOI 10.1242/jcs.02372; Chikuda H, 2004, GENE DEV, V18, P2418, DOI 10.1101/gad.1224204; D'hoedt D, 2008, J BIOL CHEM, V283, P6272, DOI 10.1074/jbc.M706386200; Fontaine G, 1975, Arch Fr Pediatr, V32, P493; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Funari VA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-165; GARDI C, 1994, THORAX, V49, P312, DOI 10.1136/thx.49.4.312; Giamarchi A, 2006, EMBO REP, V7, P787, DOI 10.1038/sj.embor.7400745; HORTON WA, 1983, AM J MED GENET, V16, P201, DOI 10.1002/ajmg.1320160210; HUNZIKER EB, 1994, MICROSC RES TECHNIQ, V28, P505, DOI 10.1002/jemt.1070280606; Kornak U, 2003, AM J HUM GENET, V73, P447, DOI 10.1086/377110; Lange K, 2001, AM J HUM GENET, V69, P504; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Muramatsu S, 2007, J BIOL CHEM, V282, P32158, DOI 10.1074/jbc.M706158200; Nilius B, 2004, AM J PHYSIOL-CELL PH, V286, pC195, DOI 10.1152/ajpcell.00365.2003; Nilius B, 2003, PFLUG ARCH EUR J PHY, V446, P298, DOI 10.1007/s00424-003-1028-9; Nilius B, 2001, PFLUG ARCH EUR J PHY, V443, P227, DOI 10.1007/s004240100676; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; OLSEN BR, 2005, ORAL BIOSCI MED, V2, P57; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; SHOHAT M, 1989, AM J MED GENET, V33, P209, DOI 10.1002/ajmg.1320330214; Superti-Furga A, 2001, AM J MED GENET, V106, P282, DOI 10.1002/ajmg.10233; Suzuki M, 2003, J BIOL CHEM, V278, P22664, DOI 10.1074/jbc.M302561200; TOLEDO SPA, 1978, AM J MED GENET, V2, P385, DOI 10.1002/ajmg.1320020408; Vriens J, 2007, J BIOL CHEM, V282, P12796, DOI 10.1074/jbc.M610485200; Wang Y, 2007, J BIOL CHEM, V282, P36561, DOI 10.1074/jbc.M703903200; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Watanabe H, 2003, CELL CALCIUM, V33, P489, DOI 10.1016/S0143-4160(03)00064-2; Watanabe H, 2002, J BIOL CHEM, V277, P13569, DOI 10.1074/jbc.M200062200; Xiao ZS, 2006, J BIOL CHEM, V281, P30884, DOI 10.1074/jbc.M604772200	30	167	181	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2008	40	8					999	1003		10.1038/ng.166	http://dx.doi.org/10.1038/ng.166			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18587396	Green Published, Green Accepted			2022-12-27	WOS:000258026900017
J	Sangiorgi, E; Capecchi, MR				Sangiorgi, Eugenio; Capecchi, Mario R.			Bmi1 is expressed in vivo in intestinal stem cells	NATURE GENETICS			English	Article							GENE; MICE; CRE; PROGENITORS; IDENTIFICATION; RECOMBINASE; MAINTENANCE; TISSUES; CANCER; MOUSE	Bmi1 plays an essential part in the self-renewal of hematopoietic and neural stem cells. To investigate its role in other adult stem cell populations, we generated a mouse expressing a tamoxifen-inducible Cre from the Bmi1 locus. We found that Bmi1 is expressed in discrete cells located near the bottom of crypts in the small intestine, predominantly four cells above the base of the crypt (+4 position). Over time, these cells proliferate, expand, self-renew and give rise to all the differentiated cell lineages of the small intestine epithelium. The induction of a stable form of beta-catenin in these cells was sufficient to rapidly generate adenomas. Moreover, ablation of Bmi1+ cells using a Rosa26 conditional allele, expressing diphtheria toxin, led to crypt loss. These experiments identify Bmi1 as an intestinal stem cell marker in vivo. Unexpectedly, the distribution of Bmi1-expressing stem cells along the length of the small intestine suggested that mammals use more than one molecularly distinguishable adult stem cell subpopulation to maintain organ homeostasis.	[Capecchi, Mario R.] Univ Utah, Sch Med, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA; Univ Utah, Sch Med, Dept Human Genet, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Capecchi, MR (corresponding author), Univ Utah, Sch Med, Howard Hughes Med Inst, Salt Lake City, UT 84112 USA.	mario.capecchi@genetics.utah.edu	Sangiorgi, Eugenio/AAP-9836-2020	Sangiorgi, Eugenio/0000-0001-9079-9175	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021168] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM021168-34, R01 GM021168] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Akasaka T, 2001, DEVELOPMENT, V128, P1587; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bjerknes M, 2005, AM J PHYSIOL-GASTR L, V289, pG381, DOI 10.1152/ajpgi.00160.2005; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Bjerknes M, 2006, METHOD ENZYMOL, V419, P337, DOI 10.1016/S0076-6879(06)19014-X; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Potten CS, 2002, J CELL SCI, V115, P2381; Potten CS, 2004, RADIAT RES, V161, P123, DOI 10.1667/RR3104; Preston SL, 2003, CANCER RES, V63, P3819; Seaberg RM, 2003, TRENDS NEUROSCI, V26, P125, DOI 10.1016/S0166-2236(03)00031-6; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shih LM, 2001, P NATL ACAD SCI USA, V98, P2640, DOI 10.1073/pnas.051629398; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wong MH, 2000, P NATL ACAD SCI USA, V97, P12601, DOI 10.1073/pnas.230237997; Wong MH, 1999, GASTROENTEROLOGY, V116, P208, DOI 10.1016/S0016-5085(99)70245-3; Wu S, 2006, DEVELOPMENT, V133, P581, DOI 10.1242/dev.02236	29	893	921	1	53	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					915	920		10.1038/ng.165	http://dx.doi.org/10.1038/ng.165			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18536716	Green Accepted			2022-12-27	WOS:000257166500029
J	Tischler, J; Lehner, B; Fraser, AG				Tischler, Julia; Lehner, Ben; Fraser, Andrew G.			Evolutionary plasticity of genetic interaction networks	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; GENOME	Non-additive genetic interactions contribute to many genetic disorders, but they are extremely difficult to predict. Here we show that genetic interactions identified in yeast, unlike gene functions or protein interactions, are not highly conserved in animals. Genetic interactions are therefore unlikely to represent simple redundancy between genes or pathways, and genetic interactions from yeast do not directly predict genetic interactions in higher eukaryotes, including humans.	[Tischler, Julia; Fraser, Andrew G.] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Lehner, Ben] Univ Pompeu Fabra, Ctr Genom Regulat, European Mol Biol Lab, Ctr Genom Regulat Syst Biol Unit, Barcelona 08003, Spain	Wellcome Trust Sanger Institute; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); European Molecular Biology Laboratory (EMBL)	Fraser, AG (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England.	agf@sanger.ac.uk	Lehner, Ben/ABH-6562-2020; Lehner, Ben/L-3413-2014	Lehner, Ben/0000-0002-8817-1124; Lehner, Ben/0000-0002-8817-1124; Fraser, Andrew/0000-0001-9939-6014	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Byrne Alexandra B, 2007, J Biol, V6, P8, DOI 10.1186/jbiol58; Davierwala AP, 2005, NAT GENET, V37, P1147, DOI 10.1038/ng1640; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hartman JL, 2001, SCIENCE, V291, P1001, DOI 10.1126/science.291.5506.1001; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Tischler J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r69; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317	11	98	99	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2008	40	4					390	391		10.1038/ng.114	http://dx.doi.org/10.1038/ng.114			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18362882				2022-12-27	WOS:000254388100007
J	Shinohara, M; Oh, SD; Hunter, N; Shinohara, A				Shinohara, Miki; Oh, Steve D.; Hunter, Neil; Shinohara, Akira			Crossover assurance and crossover interference are distinctly regulated by the ZMM proteins during yeast meiosis	NATURE GENETICS			English	Article							MEIOTIC CHROMOSOME SYNAPSIS; DOUBLE-STRAND-BREAK; SYNAPTONEMAL COMPLEX-FORMATION; SACCHAROMYCES-CEREVISIAE; CROSSING-OVER; HOLLIDAY JUNCTIONS; CHIASMA FORMATION; RECA HOMOLOGS; MUTS HOMOLOG; RECOMBINATION	Meiotic crossing-over is highly regulated such that each homolog pair typically receives at least one crossover (assurance) and adjacent crossovers are widely spaced (interference). Here we provide evidence that interference and assurance are mechanistically distinct processes that are separated by mutations in a new ZMM (Zip, Msh, Mer) protein from Saccharomyces cerevisiae, Spo16. Like other zmm mutants, spo16 cells have defects in both crossing-over and synaptonemal complex formation. Unlike in previously characterized zmm mutants, the residual crossovers in spo16 cells show interference comparable to that in the wild type. Spo16 interacts with a second ZMM protein, Spo22 (also known as Zip4), and spo22 mutants also show normal interference. Notably, assembly of the MutS homologs Msh4 and Msh5 on chromosomes occurs in both spo16 and spo22, but not in other zmm mutants. We suggest that crossover interference requires the normal assembly of recombination complexes containing Msh4 and Msh5 but does not require Spo16- and Spo22-dependent extension of synaptonemal complexes. In contrast, crossover assurance requires all ZMM proteins and full-length synaptonemal complexes.	[Shinohara, Miki; Shinohara, Akira] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; [Oh, Steve D.; Hunter, Neil] Univ Calif Davis, Microbiol Sect, Davis, CA 95616 USA; [Oh, Steve D.; Hunter, Neil] Univ Calif Davis, Sect Mol & Cellular Biol, Davis, CA 95616 USA; [Shinohara, Akira] Osaka Univ, Grad Sch Sci, Suita, Osaka 5650871, Japan	Osaka University; University of California System; University of California Davis; University of California System; University of California Davis; Osaka University	Shinohara, A (corresponding author), Osaka Univ, Inst Prot Res, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	ashino@protein.osaka-u.ac.jp	Shinohara, Miki/E-7151-2013	Shinohara, Miki/0000-0002-7413-8235	NIGMS NIH HHS [GM074223] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074223] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Cheng CH, 2006, GENE DEV, V20, P2067, DOI 10.1101/gad.1430406; Chua PR, 1998, CELL, V93, P349, DOI 10.1016/S0092-8674(00)81164-2; De Antoni A, 2000, GENE, V246, P179, DOI 10.1016/S0378-1119(00)00083-4; Fung JC, 2004, CELL, V116, P795, DOI 10.1016/S0092-8674(04)00249-1; Hayase A, 2004, CELL, V119, P927, DOI 10.1016/j.cell.2004.10.031; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; ISUBOUCHI I, 2005, SCIENCE, V308, P870; ISUBOUCHI T, 2006, DEV CELL, V10, P809; JONES G H, 1987, P213; Keeney S, 2001, CURR TOP DEV BIOL, V52, P1, DOI 10.1016/S0070-2153(01)52008-6; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; KING JS, 1990, GENETICS, V126, P1127; Kleckner N, 2006, CHROMOSOMA, V115, P175, DOI 10.1007/s00412-006-0055-7; MALAVASIC MJ, 1990, MOL CELL BIOL, V10, P2809, DOI 10.1128/MCB.10.6.2809; Malkova A, 2004, GENETICS, V168, P49, DOI 10.1534/genetics.104.027961; Mazina OM, 2004, CELL, V117, P47, DOI 10.1016/S0092-8674(04)00294-6; Miyazaki T, 2004, EMBO J, V23, P939, DOI 10.1038/sj.emboj.7600091; Muller HJ, 1916, AM NAT, V50, P193, DOI 10.1086/279534; Nakagawa T, 1999, EMBO J, V18, P5714, DOI 10.1093/emboj/18.20.5714; Novak JE, 2001, GENETICS, V158, P1013; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; PADMORE R, 1991, CELL, V66, P1239, DOI 10.1016/0092-8674(91)90046-2; Page SL, 2001, GENE DEV, V15, P3130, DOI 10.1101/gad.935001; PAPAZIAN HP, 1952, GENETICS, V37, P175; Perry J, 2005, P NATL ACAD SCI USA, V102, P17594, DOI 10.1073/pnas.0508581102; ROCKMILL B, 1995, GENE DEV, V9, P2684, DOI 10.1101/gad.9.21.2684; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara M, 2000, P NATL ACAD SCI USA, V97, P10814, DOI 10.1073/pnas.97.20.10814; Shinohara M, 2003, GENETICS, V164, P855; Shinohara M, 2003, GENETICS, V163, P1273; Smith AV, 1997, J CELL BIOL, V136, P957, DOI 10.1083/jcb.136.5.957; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; Storlazzi A, 1996, P NATL ACAD SCI USA, V93, P9043, DOI 10.1073/pnas.93.17.9043; STORLAZZI A, 1995, P NATL ACAD SCI USA, V92, P8512, DOI 10.1073/pnas.92.18.8512; SYM M, 1993, CELL, V72, P365, DOI 10.1016/0092-8674(93)90114-6; SYM M, 1994, CELL, V79, P283, DOI 10.1016/0092-8674(94)90197-X; SZOSTAK JW, 1983, CELL, V33, P25, DOI 10.1016/0092-8674(83)90331-8; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Zickler D, 1999, ANNU REV GENET, V33, P603, DOI 10.1146/annurev.genet.33.1.603	49	136	140	1	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2008	40	3					299	309		10.1038/ng.83	http://dx.doi.org/10.1038/ng.83			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18297071				2022-12-27	WOS:000253548400020
J	Delneri, D; Hoyle, DC; Gkargkas, K; Cross, EJM; Rash, B; Zeef, L; Leong, HS; Davey, HM; Hayes, A; Kell, DB; Griffith, GW; Oliver, SG				Delneri, Daniela; Hoyle, David C.; Gkargkas, Konstantinos; Cross, Emma J. M.; Rash, Bharat; Zeef, Leo; Leong, Hui-Sun; Davey, Hazel M.; Hayes, Andrew; Kell, Douglas B.; Griffith, Gareth W.; Oliver, Stephen G.			Identification and characterization of high-flux-control genes of yeast through competition analyses in continuous cultures	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE GENOME; HAPLOINSUFFICIENCY; ONTOLOGY; DELETION; STRAINS	Using competition experiments in continuous cultures grown in different nutrient environments (glucose limited, ammonium limited, phosphate limited and white grape juice), we identified genes that show haploinsufficiency phenotypes (reduced growth rate when hemizygous) or haploproficiency phenotypes (increased growth rate when hemizygous). Haploproficient genes (815, 1,194, 733 and 654 in glucose-limited, ammonium-limited, phosphate-limited and white grape juice environments, respectively) frequently show that phenotype in a specific environmental context. For instance, genes encoding components of the ubiquitination pathway or the proteasome show haploproficiency in nitrogen-limited conditions where protein conservation may be beneficial. Haploinsufficiency is more likely to be observed in all environments, as is the case with genes determining polar growth of the cell. Haploproficient genes seem randomly distributed in the genome, whereas haploinsufficient genes (685, 765, 1,277 and 217 in glucose-limited, ammonium-limited, phosphate-limited and white grape juice environments, respectively) are over-represented on chromosome III. This chromosome determines a yeast's mating type, and the concentration of haploinsufficient genes there may be a mechanism to prevent its loss.	Univ Manchester, Sch Med, NIBHI, Manchester M13 9PT, Lancs, England; Univ Wales, Inst Biol Sci, Aberystwyth SY23 3DA, Dyfed, Wales; Univ Manchester, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; Univ Manchester, Sch Chem, Manchester M1 7DN, Lancs, England; Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester; Aberystwyth University; University of Manchester; University of Manchester; University of Manchester	Oliver, SG (corresponding author), Univ Cambridge, Dept Biochem, Sanger Bldg,Tennis Court Rd, Cambridge, England.	steve.oliver@bioc.cam.ac.uk	Griffith, Gareth W./A-1970-2009; Kell, Douglas/E-8318-2011; Davey, Hazel/C-9055-2009; Oliver, Stephen/AAQ-5992-2021; Zeef, Leo/D-6922-2011	Griffith, Gareth W./0000-0001-6914-3745; Kell, Douglas/0000-0001-5838-7963; Oliver, Stephen/0000-0003-3410-6439; Delneri, Daniela/0000-0001-8070-411X; Hayes, Andy/0000-0002-9525-0306; Davey, Hazel/0000-0001-9185-0761; Hoyle, David/0000-0003-3483-5885	Natural Environment Research Council [NE/B500190/1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BB/C505140/1, BB/C505140/2] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baganz F, 1998, YEAST, V14, P1417, DOI 10.1002/(SICI)1097-0061(199811)14:15<1417::AID-YEA334>3.0.CO;2-N; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; Colson I, 2004, EMBO REP, V5, P392, DOI 10.1038/sj.embor.7400123; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Eason RG, 2004, P NATL ACAD SCI USA, V101, P11046, DOI 10.1073/pnas.0403672101; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Glover CVC, 1998, PROG NUCLEIC ACID RE, V59, P95; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; HEINRICH R, 1974, EUR J BIOCHEM, V42, P89, DOI 10.1111/j.1432-1033.1974.tb03318.x; Kacser H, 1973, Symp Soc Exp Biol, V27, P65; MORTIMER RK, 1994, YEAST, V10, P1543, DOI 10.1002/yea.320101203; Oliver SG, 2006, PHILOS T R SOC B, V361, P477, DOI 10.1098/rstb.2005.1805; OLIVER SG, 1991, BIOTECHNOLOGY HDB SA, P213; PAQUIN C, 1983, NATURE, V302, P495, DOI 10.1038/302495a0; Sherman F., 1981, METHODS YEAST GENETI; Veitia RA, 2002, BIOESSAYS, V24, P175, DOI 10.1002/bies.10023; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zeeberg BR, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r28	21	79	79	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2008	40	1					113	117		10.1038/ng.2007.49	http://dx.doi.org/10.1038/ng.2007.49			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18157128				2022-12-27	WOS:000252118600027
J	Lee-Kirsch, MA; Gong, M; Chowdhury, D; Senenko, L; Engel, K; Lee, YA; de Silva, U; Bailey, SL; Witte, T; Vyse, TJ; Kere, J; Pfeiffer, C; Harvey, S; Wong, A; Koskenmies, S; Hummel, O; Rohde, K; Schmidt, RE; Dominiczak, AF; Gahr, M; Hollis, T; Perrino, FW; Lieberman, J; Hubner, N				Lee-Kirsch, Min Ae; Gong, Maolian; Chowdhury, Dipanjan; Senenko, Lydia; Engel, Kerstin; Lee, Young-Ae; de Silva, Udesh; Bailey, Suzanna L.; Witte, Torsten; Vyse, Timothy J.; Kere, Juha; Pfeiffer, Christiane; Harvey, Scott; Wong, Andrew; Koskenmies, Sari; Hummel, Oliver; Rohde, Klaus; Schmidt, Reinhold E.; Dominiczak, Anna F.; Gahr, Manfred; Hollis, Thomas; Perrino, Fred W.; Lieberman, Judy; Huebner, Norbert			Mutations in the gene encoding the 3 '-5 ' DNA exonuclease TREX1 are associated with systemic lupus erythematosus	NATURE GENETICS			English	Article							NUCLEAR-BODIES	TREX1 acts in concert with the SET complex in granzyme A - mediated apoptosis, and mutations in TREX1 cause Aicardi-Goutieres syndrome and familial chilblain lupus. Here, we report monoallelic frameshift or missense mutations and one 3' UTR variant of TREX1 present in 9/ 417 individuals with systemic lupus erythematosus but absent in 1,712 controls (P= 4.1x10(-7)). We demonstrate that two mutant TREX1 alleles alter subcellular targeting. Our findings implicate TREX1 in the pathogenesis of SLE.	Tech Univ Dresden, Klin Kinder & Jugendmed, D-01307 Dresden, Germany; Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; Harvard Univ, Sch Med, Dept Pediat, CBR Inst Biomed Res, Boston, MA 02125 USA; Charite Univ Med Berlin, D-13353 Berlin, Germany; Wake Forest Univ Hlth Sci, Dept Biochem, Ctr Struct Biol, Winston Salem, NC 27157 USA; Hannover Med Sch, Klin Immunol, D-30625 Hannover, Germany; Hammersmith Hosp, Imperial Coll, Fac Med, Sect Rheumatol & Mol Genet, London W12 0NN, England; Karolinska Inst, Dept Biosci & Nutr, S-14157 Huddinge, Sweden; Clin Res Ctr, S-14157 Huddinge, Sweden; Tech Univ Dresden, Dermatol Klin, D-01307 Dresden, Germany; Wake Forest Univ Hlth Sci, Dept Biochem, Winston Salem, NC 27157 USA; Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland; Univ Helsinki, Dept Dermatol, FIN-00014 Helsinki, Finland; Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland	Technische Universitat Dresden; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Wake Forest University; Wake Forest University School of Medicine; Hannover Medical School; Imperial College London; Karolinska Institutet; Technische Universitat Dresden; Wake Forest University; Wake Forest University School of Medicine; University of Helsinki; University of Helsinki; University of Glasgow	Lee-Kirsch, MA (corresponding author), Tech Univ Dresden, Klin Kinder & Jugendmed, D-01307 Dresden, Germany.	minae.lee-kirsch@uniklinikum-dresden.de; nhuebner@mdc-berlin.de	Dominiczak, Anna F/P-9390-2017; Kere, Juha/A-9179-2008; Wong, Andrew/AAE-6995-2019; Wong, Andrew/M-8899-2016; Witte, Torsten/B-5783-2016; Lieberman, Judy/A-2717-2015; Kere, Juha/AAX-9117-2021; Dominiczak, Anna F/D-2262-2009; Lee-Kirsch, Min Ae/C-5769-2018	Dominiczak, Anna F/0000-0003-4913-3608; Kere, Juha/0000-0003-1974-0271; Wong, Andrew/0000-0003-2079-4779; Wong, Andrew/0000-0003-2079-4779; Kere, Juha/0000-0003-1974-0271; 	NIAID NIH HHS [AI45587] Funding Source: Medline; NIGMS NIH HHS [GM069962] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045587, R56AI045587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069962] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Boe SO, 2006, J CELL SCI, V119, P3284, DOI 10.1242/jcs.03068; Chowdhury D, 2006, MOL CELL, V23, P133, DOI 10.1016/j.molcel.2006.06.005; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; de Silva U, 2007, J BIOL CHEM, V282, P10537, DOI 10.1074/jbc.M700039200; James JA, 2001, CURR OPIN RHEUMATOL, V13, P370, DOI 10.1097/00002281-200109000-00005; Kawane K, 2006, NATURE, V443, P998, DOI 10.1038/nature05245; Laan M, 1997, NAT GENET, V17, P435, DOI 10.1038/ng1297-435; Mazur DJ, 1999, J BIOL CHEM, V274, P19655, DOI 10.1074/jbc.274.28.19655; Mendell JT, 2001, CELL, V107, P411, DOI 10.1016/S0092-8674(01)00583-9; Morita M, 2004, MOL CELL BIOL, V24, P6719, DOI 10.1128/MCB.24.15.6719-6727.2004; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; Regad T, 2001, ONCOGENE, V20, P7274, DOI 10.1038/sj.onc.1204854; Rice G, 2007, AM J HUM GENET, V80, P811, DOI 10.1086/513443; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070	15	479	495	1	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1065	1067		10.1038/ng2091	http://dx.doi.org/10.1038/ng2091			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17660818				2022-12-27	WOS:000249122400013
J	Gudmundsson, J; Sulem, P; Steinthorsdottir, V; Bergthorsson, JT; Thorleifsson, G; Manolescu, A; Rafnar, T; Gudbjartsson, D; Agnarsson, BA; Baker, A; Sigurdsson, A; Benediktsdottir, KR; Jakobsdottir, M; Blondal, T; Stacey, SN; Helgason, A; Gunnarsdottir, S; Olafsdottir, A; Kristinsson, KT; Birgisdottir, B; Ghosh, S; Thorlacius, S; Magnusdottir, D; Stefansdottir, G; Kristjansson, K; Bagger, Y; Wilensky, RL; Reilly, MP; Morris, AD; Kimber, CH; Adeyemo, A; Chen, Y; Zhou, J; So, WY; Tong, PCY; Ng, MCY; Hansen, T; Andersen, G; Borch-Johnsen, K; Jorgensen, T; Tres, A; Fuertes, F; Ruiz-Echarri, M; Asin, L; Saez, B; van Boven, E; Klaver, S; Swinkels, DW; Aben, KK; Graif, T; Cashy, J; Suarez, BK; van Vierssen, O; Frigge, ML; Ober, C; Hofker, MH; Wijmenga, C; Christiansen, C; Rader, DJ; Palmer, CNA; Rotimi, C; Chan, JCN; Pedersen, O; Sigurdsson, G; Benediktsson, R; Jonsson, E; Einarsson, GV; Mayordomo, JI; Catalona, WJ; Kiemeney, LA; Barkardottir, RB; Gulcher, JR; Thorsteinsdottir, U; Kong, A; Stefansson, K				Gudmundsson, Julius; Sulem, Patrick; Steinthorsdottir, Valgerdur; Bergthorsson, Jon T.; Thorleifsson, Gudmar; Manolescu, Andrei; Rafnar, Thorunn; Gudbjartsson, Daniel; Agnarsson, Bjarni A.; Baker, Adam; Sigurdsson, Asgeir; Benediktsdottir, Kristrun R.; Jakobsdottir, Margret; Blondal, Thorarinn; Stacey, Simon N.; Helgason, Agnar; Gunnarsdottir, Steinunn; Olafsdottir, Adalheidur; Kristinsson, Kari T.; Birgisdottir, Birgitta; Ghosh, Shyamali; Thorlacius, Steinunn; Magnusdottir, Dana; Stefansdottir, Gerdur; Kristjansson, Kristleifur; Bagger, Yu; Wilensky, Robert L.; Reilly, Muredach P.; Morris, Andrew D.; Kimber, Charlotte H.; Adeyemo, Adebowale; Chen, Yuanxiu; Zhou, Jie; So, Wing-Yee; Tong, Peter C. Y.; Ng, Maggie C. Y.; Hansen, Torben; Andersen, Gitte; Borch-Johnsen, Knut; Jorgensen, Torben; Tres, Alejandro; Fuertes, Fernando; Ruiz-Echarri, Manuel; Asin, Laura; Saez, Berta; van Boven, Erica; Klaver, Siem; Swinkels, Dorine W.; Aben, Katja K.; Graif, Theresa; Cashy, John; Suarez, Brian K.; van Vierssen, Onco; Frigge, Michael L.; Ober, Carole; Hofker, Marten H.; Wijmenga, Cisca; Christiansen, Claus; Rader, Daniel J.; Palmer, Colin N. A.; Rotimi, Charles; Chan, Juliana C. N.; Pedersen, Oluf; Sigurdsson, Gunnar; Benediktsson, Rafn; Jonsson, Eirikur; Einarsson, Gudmundur V.; Mayordomo, Jose I.; Catalona, William J.; Kiemeney, Lambertus A.; Barkardottir, Rosa B.; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari			Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes	NATURE GENETICS			English	Article							HEPATOCYTE NUCLEAR FACTOR-1-BETA; LINKAGE; ASSOCIATION; FAMILIES; MUTATIONS; GENES; GENETICS; UNCOMMON; BRCA1; SCAN	We performed a genome-wide association scan to search for sequence variants conferring risk of prostate cancer using 1,501 Icelandic men with prostate cancer and 11,290 controls. Follow-up studies involving three additional case-control groups replicated an association of two variants on chromosome 17 with the disease. These two variants, 33 Mb apart, fall within a region previously implicated by family-based linkage studies on prostate cancer. The risks conferred by these variants are moderate individually ( allele odds ratio of about 1.20), but because they are common, their joint population attributable risk is substantial. One of the variants is in TCF2 ( HNF1 beta), a gene known to be mutated in individuals with maturity-onset diabetes of the young type 5. Results from eight case-control groups, including one West African and one Chinese, demonstrate that this variant confers protection against type 2 diabetes.	deCODE Genet, IS-101 Reykjavik, Iceland; Landspitali Univ Hosp, Dept Pathol, IS-101 Reykjavik, Iceland; Ctr Clin & Basic Res AS, DK-2750 Ballerup, Denmark; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Univ Dundee, Ninewells Hosp & Med Sch, Div Med & Therapeut, Dundee DD1 9SY, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Populat Pharmacogenet Grp, Biomed Res Ctr, Dundee DD1 9SY, Scotland; Howard Univ, Natl Human Genome Ctr, Dept Community & Family Med, Washington, DC 20060 USA; Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; Steno Diabet Ctr, DK-2820 Copenhagen, Denmark; Univ Aarhus, Fac Hlth Sci, DK-8000 Aarhus, Denmark; Glostrup Univ Hosp, Ctr Res Prevent & Hlth, DK-2600 Glostrup, Denmark; Univ Zaragoza, Lozano Blesa Univ Hosp, Div Med Oncol, E-50009 Zaragoza, Spain; Nanotechnol Inst Aragon, Inst Hlth Sci, Zaragoza 50009, Spain; Univ Zaragoza, Lozano Blesa Univ Hosp, Div Radiat Oncol, E-50009 Zaragoza, Spain; Maas Ziekenhuis, Dept Urol, NL-5830 AB Boxmeer, Netherlands; Radboud Univ Nijmegen Med Ctr, Dept Clin Chem, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; Comprehens Canc Ctr E, NL-6501 BG Nijmegen, Netherlands; Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Gelderse Vallei Hosp, Dept Urol, NL-6716 RP Ede, Netherlands; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Lab Med, NL-9700 RB Groningen, Netherlands; Maastricht Univ, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands; Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; Univ Med Ctr Utrecht, Dept Biomed Genet, Complex Genet Sect, NL-3508 AB Utrecht, Netherlands; Iceland Heart Assoc, IS-201 Kopavogur, Iceland; Landspitali Univ Hosp, Dept Urol, IS-101 Reykjavik, Iceland; Radboud Univ Nijmegen Med Ctr, Dept Urol, NL-6500 HB Nijmegen, Netherlands	Landspitali National University Hospital; Center Clinical & Basic Research; University of Pennsylvania; University of Dundee; University of Dundee; Howard University; Chinese University of Hong Kong; Prince of Wales Hospital; Steno Diabetes Center; Aarhus University; University of Copenhagen; Lozano Blesa University Clinical Hospital; University of Zaragoza; Lozano Blesa University Clinical Hospital; University of Zaragoza; Radboud University Nijmegen; Radboud University Nijmegen; Northwestern University; Feinberg School of Medicine; Washington University (WUSTL); Gelderse Vallei Hospital; University of Chicago; University of Groningen; Maastricht University; University of Groningen; Utrecht University; Utrecht University Medical Center; Icelandic Heart Association; Landspitali National University Hospital; Radboud University Nijmegen	Gudmundsson, J (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	julius.gudmundsson@decode.is; kstefans@decode.is	Helgason, Agnar/K-1522-2015; Wijmenga, Cisca/D-2173-2009; Benediktsson, Rafn/R-2457-2018; Swinkels, Dorine W./H-8098-2014; Kiemeney, Lambertus A./D-3357-2009; Wijmenga, Cisca/AAE-7719-2019; Chan, Juliana/B-7918-2016; Aben, Katja KH/G-9686-2016; Mayordomo, Jose/K-3453-2013; Manolescu, Andrei/G-4565-2014; Stefansson, Kari/AAE-7187-2019; Morris, Andrew D/C-2837-2009; Palmer, Colin NA/C-7053-2008; Study, GoDARTS/K-9448-2016; ASIN, LAURA/H-7276-2017; Jørgensen, Torben/Z-1335-2018; Pedersen, Oluf/Z-1731-2019; Pedersen, Oluf/AAG-8015-2020	Benediktsson, Rafn/0000-0002-2954-9801; Swinkels, Dorine W./0000-0002-1040-9446; Kiemeney, Lambertus A./0000-0002-2368-1326; Wijmenga, Cisca/0000-0002-5635-1614; Chan, Juliana/0000-0003-1325-1194; Aben, Katja KH/0000-0002-0214-2147; Manolescu, Andrei/0000-0002-0713-4664; Palmer, Colin NA/0000-0002-6415-6560; ASIN, LAURA/0000-0003-0641-3407; Pedersen, Oluf/0000-0002-3321-3972; Kong, Augustine/0000-0001-8193-5438; Ober, Carole/0000-0003-4626-9809; Adeyemo, Adebowale/0000-0002-3105-3231; Saez, Berta/0000-0003-0753-1165; Jorgensen, Torben/0000-0001-9453-2830; Bergthorsson, Jon Thor/0000-0002-0560-2639; Gudbjartsson, Daniel/0000-0002-5222-9857; Helgason, Agnar/0000-0002-8545-3767; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Reilly, Muredach/0000-0002-3035-9386; Hansen, Torben/0000-0001-8748-3831	FOGARTY INTERNATIONAL CENTER [T37TW000041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072128] Funding Source: NIH RePORTER; FIC NIH HHS [3T37TW00041-03S2] Funding Source: Medline; NCRR NIH HHS [RR03048] Funding Source: Medline; NIDDK NIH HHS [DK072128] Funding Source: Medline; Wellcome Trust Funding Source: Medline	FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission)		Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Bellanne-Chantelot C, 2005, DIABETES, V54, P3126, DOI 10.2337/diabetes.54.11.3126; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Edghill EL, 2006, J MED GENET, V43, P84, DOI 10.1136/jmg.2005.032854; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hill-Harfe KL, 2005, AM J HUM GENET, V76, P663, DOI 10.1086/429254; KASPER JS, 2006, BIOMARKERS PREV, V15, P2056; Kraft P, 2005, PLOS GENET, V1, P603, DOI 10.1371/journal.pgen.0010068; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Lange EM, 2003, PROSTATE, V57, P326, DOI 10.1002/pros.10307; Lange EM, 2007, HUM GENET, V121, P49, DOI 10.1007/s00439-006-0274-2; MANTEL N, 1959, J NATL CANCER I, V22, P719; RISCH N, 1990, AM J HUM GENET, V46, P222; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; White KA, 2006, PROSTATE CANCER P D, V9, P298, DOI 10.1038/sj.pcan.4500878; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202; Xu JF, 2005, AM J HUM GENET, V77, P219, DOI 10.1086/432377; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zuhlke KA, 2004, CLIN CANCER RES, V10, P5975, DOI 10.1158/1078-0432.CCR-04-0554	23	565	590	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2007	39	8					977	983		10.1038/ng2062	http://dx.doi.org/10.1038/ng2062			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17603485				2022-12-27	WOS:000248446900014
J	Rioux, JD; Xavier, RJ; Taylor, KD; Silverberg, MS; Goyette, P; Huett, A; Green, T; Kuballa, P; Barmada, MM; Datta, LW; Shugart, YY; Griffiths, AM; Targan, SR; Ippoliti, AF; Bernard, EJ; Mei, L; Nicolae, DL; Regueiro, M; Schumm, LP; Steinhart, AH; Rotter, JI; Duerr, RH; Cho, JH; Daly, MJ; Brant, SR				Rioux, John D.; Xavier, Ramnik J.; Taylor, Kent D.; Silverberg, Mark S.; Goyette, Philippe; Huett, Alan; Green, Todd; Kuballa, Petric; Barmada, M. Michael; Datta, Lisa Wu; Shugart, Yin Yao; Griffiths, Anne M.; Targan, Stephan R.; Ippoliti, Andrew F.; Bernard, Edmond-Jean; Mei, Ling; Nicolae, Dan L.; Regueiro, Miguel; Schumm, L. Philip; Steinhart, A. Hillary; Rotter, Jerome I.; Duerr, Richard H.; Cho, Judy H.; Daly, Mark J.; Brant, Steven R.			Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; DENDRITIC CELLS; NADPH OXIDASE; GENE; COMPLEX; ANTIGEN; LOCALIZATION; CONCORDANCE; EXPRESSION; VARIANTS	We present a genome-wide association study of ileal Crohn disease and two independent replication studies that identify several new regions of association to Crohn disease. Specifically, in addition to the previously established CARD15 and IL23R associations, we identified strong and significantly replicated associations ( combined P < 10(-10)) with an intergenic region on 10q21.1 and a coding variant in ATG16L1, the latter of which was also recently reported by another group. We also report strong associations with independent replication to variation in the genomic regions encoding PHOX2B, NCF4 and a predicted gene on 16q24.1 (FAM92B). Finally, we demonstrate that ATG16L1 is expressed in intestinal epithelial cell lines and that functional knockdown of this gene abrogates autophagy of Salmonella typhimurium. Together, these findings suggest that autophagy and host cell responses to intracellular microbes are involved in the pathogenesis of Crohn disease.	Univ Montreal, Montreal, PQ H1T 1C8, Canada; Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada; MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; Cedars Sinai Med Ctr, Ctr Inflammatory Bowel Dis, Los Angeles, CA 90048 USA; Univ Toronto, Mt Sinai Hosp, IBD Ctr, Toronto, ON M5G 1X5, Canada; Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; Johns Hopkins Univ, Dept Med, Harvey M & Lyn P Meyerhoff Inflammatory Bowel Dis, Baltimore, MD 21231 USA; Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; Hosp Sick Children, Dept Pediat, Toronto, ON M5G 1X8, Canada; Univ Montreal, Montreal, PQ H2W 1V1, Canada; CHUM, Hotel Dieu, Montreal, PQ H2W 1V1, Canada; Univ Chicago, Dept Med, Chicago, IL 60637 USA; Univ Pittsburgh, Med Ctr, Sch Med, Dept Med,Div Gastroenterol Hepatol & Nutr, Pittsburgh, PA 15213 USA; Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; Yale Univ, Dept Med, Div Gastroenterol, Inflammatory Bowel Dis Ctr, New Haven, CT 06519 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA	Universite de Montreal; Universite de Montreal; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Universite de Montreal; Laval University; Universite de Montreal; University of Chicago; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Chicago; Yale University; Harvard University; Harvard Medical School; Massachusetts General Hospital	Rioux, JD (corresponding author), Univ Montreal, 5000 Rue Belanger, Montreal, PQ H1T 1C8, Canada.	rioux@broad.mit.edu	Huett, Alan/AAI-7998-2020; Rioux, John D/A-9599-2015; Duerr, Richard H/B-4188-2009; Rotter, Jerome/AAY-6598-2021; Silverberg, Mark/B-4183-2008; Daly, Mark J/B-2453-2017	Huett, Alan/0000-0001-7385-5585; Rioux, John D/0000-0001-7560-8326; Duerr, Richard H/0000-0001-6586-3905; Daly, Mark J/0000-0002-0949-8752; Schumm, Phil/0000-0002-3050-2429; Barmada, M Michael/0000-0002-3604-6460; Nicolae, Dan/0000-0002-0918-4630; YAO, YIN/0000-0003-3053-8429	NIAID NIH HHS [AI062773, R01 AI062773] Funding Source: Medline; NIDDK NIH HHS [U01 DK062431, DK43351, U01 DK062432, DK62431, U01 DK062432-06, P30 DK040561, P30 DK043351, DK62423, DK62432, P30 DK040561-12, P30 DK063491-029004, P30 DK063491-019004, DK 46763, U01 DK062423, P30 DK063491-049004, U01 DK062420, P01 DK046763, DK62422, U01 DK062422, P30 DK063491, DK62420, DK62429, DK62413, P30 DK063491-039004, U01 DK062413, U01 DK062429] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062431, U01DK062422, U24DK062429, U01DK062432, P30DK040561, P30DK063491, U01DK062429, U01DK062413, P30DK043351, P01DK046763, U01DK062420, U01DK062423] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amer AO, 2005, AUTOPHAGY, V1, P53, DOI 10.4161/auto.1.1.1589; Bayless TM, 1996, GASTROENTEROLOGY, V111, P573, DOI 10.1053/gast.1996.v111.pm8780559; Beuzon CR, 2000, EMBO J, V19, P3235, DOI 10.1093/emboj/19.13.3235; Birmingham CL, 2006, J BIOL CHEM, V281, P11374, DOI 10.1074/jbc.M509157200; Brunet JF, 2002, CURR OPIN GENET DEV, V12, P435, DOI 10.1016/S0959-437X(02)00322-2; Cargnin F, 2005, J BIOL CHEM, V280, P37439, DOI 10.1074/jbc.M508368200; Dalwadi H, 2001, IMMUNITY, V15, P149, DOI 10.1016/S1074-7613(01)00164-9; Daly MJ, 2004, INFLAMM BOWEL DIS, V10, P312, DOI 10.1097/00054725-200405000-00020; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Deretic V, 2005, TRENDS IMMUNOL, V26, P523, DOI 10.1016/j.it.2005.08.003; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Economou M, 2004, AM J GASTROENTEROL, V99, P2393, DOI 10.1111/j.1572-0241.2004.40304.x; Ellson CD, 2006, J EXP MED, V203, P1927, DOI 10.1084/jem.20052069; Halfvarson J, 2003, GASTROENTEROLOGY, V124, P1767, DOI 10.1016/S0016-5085(03)00385-8; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kuma A, 2002, J BIOL CHEM, V277, P18619, DOI 10.1074/jbc.M111889200; Lee HK, 2007, SCIENCE, V315, P1398, DOI 10.1126/science.1136880; LIBIOULLE C, 2007, PLOS GENET      0305, DOI DOI 10.1371/JOURNAL.PGEN.0030058.EOR; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Maison SF, 2003, J COMP NEUROL, V455, P406, DOI 10.1002/cne.10490; Matsue H, 2003, J IMMUNOL, V171, P3010, DOI 10.4049/jimmunol.171.6.3010; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nakahira K, 2006, J EXP MED, V203, P2377, DOI 10.1084/jem.20060845; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Pasqualetti M, 2001, CURR OPIN NEUROL, V14, P177, DOI 10.1097/00019052-200104000-00007; Pattyn A, 1999, NATURE, V399, P366, DOI 10.1038/20700; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Rioux JD, 2005, NATURE, V435, P584, DOI 10.1038/nature03723; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Silverberg MS, 2007, EUR J HUM GENET, V15, P328, DOI 10.1038/sj.ejhg.5201756; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Suh CI, 2006, J EXP MED, V203, P1915, DOI 10.1084/jem.20052085; Swanson MS, 2006, J IMMUNOL, V177, P4945, DOI 10.4049/jimmunol.177.8.4945; Thompson NP, 1996, BRIT MED J, V312, P95; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Zhan SX, 1996, BLOOD, V88, P2714, DOI 10.1182/blood.V88.7.2714.bloodjournal8872714	43	1388	1434	2	101	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2007	39	5					596	604		10.1038/ng2032	http://dx.doi.org/10.1038/ng2032			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17435756	Green Accepted			2022-12-27	WOS:000245971300014
J	Tong, JJY; Schriner, SE; McCleary, D; Day, BJ; Wallace, DC				Tong, James Jiayuan; Schriner, Samuel E.; McCleary, David; Day, Brian J.; Wallace, Douglas C.			Life extension through neurofibromin mitochondrial regulation and antioxidant therapy for neurofibromatosis-1 in Drosophila melanogaster	NATURE GENETICS			English	Article							SUPEROXIDE-DISMUTASE; OXIDATIVE DAMAGE; ADENYLYL-CYCLASE; CAMP CASCADE; COMPLEX-I; SPAN; OVEREXPRESSION; MUTATIONS; PHOSPHORYLATION; EXPRESSION	We investigated the pathophysiology of neurofibromatosis-1 (NF1) in Drosophila melanogaster by inactivation or overexpression of the NF1 gene. NF1 gene mutants had shortened life spans and increased vulnerability to heat and oxidative stress in association with reduced mitochondrial respiration and elevated reactive oxygen species (ROS) production. Flies overexpressing NF1 had increased life spans, improved reproductive fitness, increased resistance to oxidative and heat stress in association with increased mitochondrial respiration and a 60% reduction in ROS production. These phenotypic effects proved to be modulated by the adenylyl cyclase/cyclic AMP (cAMP)/protein kinase A pathway, not the Ras/Raf pathway. Treatment of wild-type D. melanogaster with cAMP analogs increased their life span, and treatment of NF1 mutants with metalloporphyrin catalytic antioxidant compounds restored their life span. Thus, neurofibromin regulates longevity and stress resistance through cAMP regulation of mitochondrial respiration and ROS production, and NF1 may be treatable using catalytic antioxidants.	Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; Univ Calif Irvine, Dept Pediat, Irvine, CA 92697 USA; Univ Calif Irvine, Multidisciplinary Exercise Program, Irvine, CA 92697 USA; Natl Jewish Med & Res Ctr, Denver, CO 80206 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; National Jewish Health	Wallace, DC (corresponding author), Univ Calif Irvine, Ctr Mol & Mitochondrial Med & Genet, Irvine, CA 92697 USA.	dwallace@uci.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR047752] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073691] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U54ES015678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021328, R01NS041850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013154, P01AG001751, R01AG024373] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-47752] Funding Source: Medline; NIA NIH HHS [AG13154, AG01751, AG24373] Funding Source: Medline; NIDDK NIH HHS [DK73691] Funding Source: Medline; NIEHS NIH HHS [U54 ES015678] Funding Source: Medline; NINDS NIH HHS [NS21328, NS41850] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arun D, 2004, CURR OPIN NEUROL, V17, P101, DOI 10.1097/00019052-200404000-00004; Barrientos A, 2002, METHODS, V26, P307, DOI 10.1016/S1046-2023(02)00036-1; BEAUCHAMP C, 1987, ANAL BIOCHEM, V44, P276; BEERS RF, 1952, J BIOL CHEM, V195, P133; Bellomo F, 2006, ANTIOXID REDOX SIGN, V8, P495, DOI 10.1089/ars.2006.8.495; Brandon M, 2006, ONCOGENE, V25, P4647, DOI 10.1038/sj.onc.1209607; BURDON RH, 1995, FREE RADICAL BIO MED, V18, P775, DOI 10.1016/0891-5849(94)00198-S; BUS JS, 1984, ENVIRON HEALTH PERSP, V55, P37, DOI 10.2307/3429690; Chen RM, 2004, J BIOL CHEM, V279, P26036, DOI 10.1074/jbc.M402710200; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Das N, 2001, BIOCHEM J, V360, P209, DOI 10.1042/0264-6021:3600209; Day BJ, 2004, DRUG DISCOV TODAY, V9, P557, DOI 10.1016/S1359-6446(04)03139-3; Day BJ, 1995, J PHARMACOL EXP THER, V275, P1227; Friedman JM, 1999, AM J MED GENET, V89, P1; GERSHMAN B, 2006, PHYSL GENOMICS; Guo HF, 2000, NATURE, V403, P895, DOI 10.1038/35002593; Guo HF, 1997, SCIENCE, V276, P795, DOI 10.1126/science.276.5313.795; Harrisingh MC, 2004, CELL CYCLE, V3, P1255, DOI 10.4161/cc.3.10.1182; Kachadourian R, 2004, BIOCHEM PHARMACOL, V67, P77, DOI 10.1016/j.bcp.2003.08.036; Korf B R, 2000, Oncologist, V5, P477, DOI 10.1634/theoncologist.5-6-477; Kurtz A, 2004, MOL CANCER RES, V2, P433; Li QY, 2001, J NEUROCHEM, V78, P746, DOI 10.1046/j.1471-4159.2001.00457.x; Magwere T, 2006, MECH AGEING DEV, V127, P356, DOI 10.1016/j.mad.2005.12.009; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Papa S, 2002, BIOSCIENCE REP, V22, P3, DOI 10.1023/A:1016004921277; Parkes TL, 1998, NAT GENET, V19, P171, DOI 10.1038/534; Patel M, 1999, TRENDS PHARMACOL SCI, V20, P359, DOI 10.1016/S0165-6147(99)01336-X; Petros JA, 2005, P NATL ACAD SCI USA, V102, P719, DOI 10.1073/pnas.0408894102; Phillips JP, 2000, EXP GERONTOL, V35, P1157, DOI 10.1016/S0531-5565(00)00117-0; Piccoli C, 2006, FEBS LETT, V580, P4539, DOI 10.1016/j.febslet.2006.06.085; Pocsfalvi G, 2007, MOL CELL PROTEOMICS, V6, P231, DOI 10.1074/mcp.M600268-MCP200; Sun JT, 2004, MECH AGEING DEV, V125, P341, DOI 10.1016/j.mad.2004.01.009; Sun JT, 2002, GENETICS, V161, P661; Technikova-Dobrova Z, 2001, BIOCHEMISTRY-US, V40, P13941, DOI 10.1021/bi011066p; The I, 1997, SCIENCE, V276, P791, DOI 10.1126/science.276.5313.791; Tong JY, 2002, NAT NEUROSCI, V5, P95, DOI 10.1038/nn792; Velsor LW, 2004, TOXICOL APPL PHARM, V199, P10, DOI 10.1016/j.taap.2004.03.005; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Williams JA, 2001, SCIENCE, V293, P2251, DOI 10.1126/science.1063097; Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168; Yohay Kaleb H, 2006, Semin Pediatr Neurol, V13, P21, DOI 10.1016/j.spen.2006.01.007; ZHONG Y, 1992, J NEUROSCI, V12, P644	44	81	85	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2007	39	4					476	485		10.1038/ng2004	http://dx.doi.org/10.1038/ng2004			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17369827				2022-12-27	WOS:000245271200017
J	Thomas, RK; Baker, AC; DeBiasi, RM; Winckler, W; LaFramboise, T; Lin, WM; Wang, M; Feng, W; Zander, T; MacConnaill, LE; Lee, JC; Nicoletti, R; Hatton, C; Goyette, M; Girard, L; Majmudar, K; Ziaugra, L; Wong, KK; Gabriel, S; Beroukhim, R; Peyton, M; Barretina, J; Dutt, A; Emery, C; Greulich, H; Shah, K; Sasaki, H; Gazdar, A; Minna, J; Armstrong, SA; Mellinghoff, IK; Hodi, FS; Dranoff, G; Mischel, PS; Cloughesy, TF; Nelson, SF; Liau, LM; Mertz, K; Rubin, MA; Moch, H; Loda, M; Catalona, W; Fletcher, J; Signoretti, S; Kaye, F; Anderson, KC; Demetri, GD; Dummer, R; Wagner, S; Herlyn, M; Sellers, WR; Meyerson, M; Garraway, LA				Thomas, Roman K.; Baker, Alissa C.; DeBiasi, Ralph M.; Winckler, Wendy; LaFramboise, Thomas; Lin, William M.; Wang, Meng; Feng, Whei; Zander, Thomas; MacConnaill, Laura E.; Lee, Jeffrey C.; Nicoletti, Rick; Hatton, Charlie; Goyette, Mary; Girard, Luc; Majmudar, Kuntal; Ziaugra, Liuda; Wong, Kwok-Kin; Gabriel, Stacey; Beroukhim, Rameen; Peyton, Michael; Barretina, Jordi; Dutt, Amit; Emery, Caroline; Greulich, Heidi; Shah, Kinjal; Sasaki, Hidefumi; Gazdar, Adi; Minna, John; Armstrong, Scott A.; Mellinghoff, Ingo K.; Hodi, F. Stephen; Dranoff, Glenn; Mischel, Paul S.; Cloughesy, Tim F.; Nelson, Stan F.; Liau, Linda M.; Mertz, Kirsten; Rubin, Mark A.; Moch, Holger; Loda, Massimo; Catalona, William; Fletcher, Jonathan; Signoretti, Sabina; Kaye, Frederic; Anderson, Kenneth C.; Demetri, George D.; Dummer, Reinhard; Wagner, Stephan; Herlyn, Meenhard; Sellers, William R.; Meyerson, Matthew; Garraway, Levi A.			High-throughput oncogene mutation profiling in human cancer	NATURE GENETICS			English	Article							GASTROINTESTINAL STROMAL TUMORS; TYROSINE KINASE JAK2; OF-FUNCTION MUTATION; MYELOPROLIFERATIVE DISORDERS; ACTIVATING MUTATIONS; LUNG ADENOCARCINOMA; POLYCYTHEMIA-VERA; GENE; SENSITIVITY; GEFITINIB	Systematic efforts are underway to decipher the genetic changes associated with tumor initiation and progression(1,2). However, widespread clinical application of this information is hampered by an inability to identify critical genetic events across the spectrum of human tumors with adequate sensitivity and scalability. Here, we have adapted high-throughput genotyping to query 238 known oncogene mutations across 1,000 human tumor samples. This approach established robust mutation distributions spanning 17 cancer types. Of 17 oncogenes analyzed, we found 14 to be mutated at least once, and 298 (30%) samples carried at least one mutation. Moreover, we identified previously unrecognized oncogene mutations in several tumor types and observed an unexpectedly high number of co-occurring mutations. These results offer a new dimension in tumor genetics, where mutations involving multiple cancer genes may be interrogated simultaneously and in 'real time' to guide cancer classification and rational therapeutic intervention.	Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; MIT, Broad Inst, Cambridge, MA 02142 USA; Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; Univ Texas, SW Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA; Nagoya City Univ, Sch Med, Dept Surg 2, Nagoya, Aichi 4678601, Japan; Univ Texas, SW Med Ctr, Dept Pathol, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Internal Med, Dallas, TX 75390 USA; Univ Texas, SW Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol & Med, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; Northwestern Univ, Feinberg Sch Med, Chicago, IL 60637 USA; NCI, Genet Branch, Ctr Canc Res, Bethesda, MD 20892 USA; USN, Natl Med Ctr, Bethesda, MD 20084 USA; Dana Farber Canc Inst, Ludwig Ctr Canc Res, Boston, MA 02115 USA; Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland; Med Univ Vienna, Austrian Acad Sci, Dept Dermatol, Div Immunol Allergy & Infect Dis, A-1090 Vienna, Austria; Austrian Acad Sci, Ctr Mol Med, A-1090 Vienna, Austria; Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; Novartis Inst BioMed Res, Cambridge, MA 02139 USA; Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Melanoma Program Med Oncol, Boston, MA 02115 USA; Max Planck Soc, Max Planck Inst Neurol Res, Klaus Joachim Zulch Labs, D-50931 Cologne, Germany; Univ Cologne, Fac Med, D-50931 Cologne, Germany; Univ Cologne, Ctr Integrated Oncol, D-50931 Cologne, Germany; Univ Cologne, Dept Internal Med 1, D-50931 Cologne, Germany	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Nagoya City University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Zurich; University Zurich Hospital; Northwestern University; Feinberg School of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Defense; United States Navy; Harvard University; Dana-Farber Cancer Institute; University of Zurich; University Zurich Hospital; Austrian Academy of Sciences; Medical University of Vienna; Austrian Academy of Sciences; The Wistar Institute; Novartis; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Max Planck Society; University of Cologne; University of Cologne; University of Cologne	Garraway, LA (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	levi_garraway@dfci.harvard.edu	Meyerson, Matthew L/E-7123-2012; Mertz, Kirsten/AAY-1660-2020; Cloughesy, Timothy Francis/AGV-1013-2022; kaye, frederic/E-2437-2011; Nelson, Stanley F/D-4771-2009; Dutt, Amit/I-1911-2013; Peyton, Michael/A-8728-2008; Barretina, Jordi/A-7192-2013	Mertz, Kirsten/0000-0002-3074-6925; Nelson, Stanley F/0000-0002-2082-3114; Dutt, Amit/0000-0002-1119-4774; Hatton, Charlie/0000-0001-9903-4291; Liau, Linda/0000-0002-4053-0052; Barretina, Jordi/0000-0002-3478-4080; wong, kwok kin/0000-0001-6323-235X; Wagner, Stephan/0000-0003-4941-7029; Rubin, Mark/0000-0002-8321-9950	NCI NIH HHS [P50CA70907, P50 CA070907] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA070907, ZIASC007256, Z01SC007256] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bansal A, 2002, P NATL ACAD SCI USA, V99, P16871, DOI 10.1073/pnas.262671399; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Chesi M, 1997, NAT GENET, V16, P260, DOI 10.1038/ng0797-260; Heinrich MC, 2003, J CLIN ONCOL, V21, P4342, DOI 10.1200/JCO.2003.04.190; Heinrich MC, 2006, J CLIN ONCOL, V24, P4764, DOI 10.1200/JCO.2006.06.2265; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; JIANG J, 2004, BLOOD; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lee JC, 2006, PLOS MED, V3, P2264, DOI 10.1371/journal.pmed.0030485; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Nakahara M, 1998, GASTROENTEROLOGY, V115, P1090, DOI 10.1016/S0016-5085(98)70079-4; Naoki K, 2002, CANCER RES, V62, P7001; *NAT HUM GEN RES I, 2006, CANC SEQ; National Cancer Institute National Human Genome Research Institute, 2006, CANC GEN ATL; Paez JG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh069; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Thomas RK, 2005, COLD SH Q B, V70, P73, DOI 10.1101/sqb.2005.70.056; Thomas RK, 2006, NAT MED, V12, P852, DOI 10.1038/nm1437; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558; Werner M, 2002, HUM MUTAT, V20, P57, DOI 10.1002/humu.10094	27	836	870	0	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2007	39	3					347	351		10.1038/ng1975	http://dx.doi.org/10.1038/ng1975			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17293865				2022-12-27	WOS:000244480000016
J	Tishkoff, SA; Reed, FA; Ranciaro, A; Voight, BF; Babbitt, CC; Silverman, JS; Powell, K; Mortensen, HM; Hirbo, JB; Osman, M; Ibrahim, M; Omar, SA; Lema, G; Nyambo, TB; Ghori, J; Bumpstead, S; Pritchard, JK; Wray, GA; Deloukas, P				Tishkoff, Sarah A.; Reed, Floyd A.; Ranciaro, Alessia; Voight, Benjamin F.; Babbitt, Courtney C.; Silverman, Jesse S.; Powell, Kweli; Mortensen, Holly M.; Hirbo, Jibril B.; Osman, Maha; Ibrahim, Muntaser; Omar, Sabah A.; Lema, Godfrey; Nyambo, Thomas B.; Ghori, Jilur; Bumpstead, Suzannah; Pritchard, Jonathan K.; Wray, Gregory A.; Deloukas, Panos			Convergent adaptation of human lactase persistence in Africa and Europe	NATURE GENETICS			English	Article							RECENT POSITIVE SELECTION; LINKAGE DISEQUILIBRIUM; TRANSCRIPTIONAL REGULATION; HAPLOTYPE DIVERSITY; POLYMORPHISM; DNA; RECOMBINATION; GENE; SUSCEPTIBILITY; EVOLUTION	A SNP in the gene encoding lactase (LCT) (C/T-13910) is associated with the ability to digest milk as adults ( lactase persistence) in Europeans, but the genetic basis of lactase persistence in Africans was previously unknown. We conducted a genotype-phenotype association study in 470 Tanzanians, Kenyans and Sudanese and identified three SNPs (G/C-14010, T/G-13915 and C/G-13907) that are associated with lactase persistence and that have derived alleles that significantly enhance transcription from the LCT promoter in vitro. These SNPs originated on different haplotype backgrounds from the European C/T-13910 SNP and from each other. Genotyping across a 3-Mb region demonstrated haplotype homozygosity extending > 2.0 Mb on chromosomes carrying C-14010, consistent with a selective sweep over the past similar to 7,000 years. These data provide a marked example of convergent evolution due to strong selective pressure resulting from shared cultural traits - animal domestication and adult milk consumption.	Univ Maryland, Dept Biol, College Pk, MD 20742 USA; Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; Univ Ferrara, Dept Biol, I-44100 Ferrara, Italy; Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; Duke Univ, Dept Biol, Durham, NC 27708 USA; Univ Khartoum, Inst Endem Dis, Dept Mol Biol, Khartoum, Sudan; Kenya Govt Med Res Ctr, Ctr Biotechnol Res & Dev, Nairobi 54840, Kenya; Muhimbili Univ, Coll Hlth Sci, Dept Biochem, Dar Es Salaam, Tanzania; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University System of Maryland; University of Maryland College Park; University of Chicago; University of Ferrara; Duke University; Duke University; University of Khartoum; Kenya Medical Research Institute; Wellcome Trust Sanger Institute	Tishkoff, SA (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	Tishkoff@umd.edu	Deloukas, Panos/B-2922-2013; Reed, Floyd/B-3586-2009; Voight, Benjamin/F-1775-2011	Deloukas, Panos/0000-0001-9251-070X; Osman, Maha/0000-0002-8557-1464; Voight, Benjamin/0000-0002-6205-9994; Hirbo, Jibril/0000-0002-8932-7311; Reed, Floyd/0000-0003-4703-530X	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG003801, R01HG002772] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076637] Funding Source: NIH RePORTER; NHGRI NIH HHS [F32HG03801, F32 HG003801, HG002772-1, R01 HG002772] Funding Source: Medline; NIGMS NIH HHS [R01GM076637, R01 GM076637] Funding Source: Medline; Wellcome Trust [076113] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ambrose SH, 1998, J ARCHAEOL SCI, V25, P377, DOI 10.1006/jasc.1997.0277; AROLA H, 1994, SCAND J GASTROENTERO, V29, P26, DOI 10.3109/00365529409091742; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Coelho M, 2005, HUM GENET, V117, P329, DOI 10.1007/s00439-005-1322-z; COOK GC, 1978, MAN, V13, P418, DOI 10.2307/2801938; Di Rienzo A, 2005, TRENDS GENET, V21, P596, DOI 10.1016/j.tig.2005.08.007; Durham W. H., 1992, COEVOLUTION GENES CU, DOI DOI 10.1098/rstb.2016.0428; Ehret C., 1983, CULTURE HIST SO SUDA, P19; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Gifford-Gonzalez D., 2005, AFRICAN ARCHAEOLOGY, P187; Hogenauer C, 2005, EUR J GASTROEN HEPAT, V17, P371; Hollox EJ, 2001, AM J HUM GENET, V68, P160, DOI 10.1086/316924; HOLLOX EJ, 2002, GENETIC BASIS COMMON, P250; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kuokkanen M, 2003, GUT, V52, P647, DOI 10.1136/gut.52.5.647; Lewinsky RH, 2005, HUM MOL GENET, V14, P3945, DOI 10.1093/hmg/ddi418; Li N, 2003, GENETICS, V165, P2213; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Mulcare CA, 2004, AM J HUM GENET, V74, P1102, DOI 10.1086/421050; Myles S, 2005, HUM GENET, V117, P34, DOI 10.1007/s00439-005-1266-3; Newman J. L., 1995, PEOPLING AFRICA; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Olds LC, 2003, HUM MOL GENET, V12, P2333, DOI 10.1093/hmg/ddg244; Poulter M, 2003, ANN HUM GENET, V67, P298, DOI 10.1046/j.1469-1809.2003.00048.x; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 1999, MOL BIOL EVOL, V16, P1791, DOI 10.1093/oxfordjournals.molbev.a026091; Reed FA, 2005, EVOLUTION, V59, P1280, DOI 10.1111/j.0014-3820.2005.tb01778.x; Reed FA, 2006, TRENDS GENET, V22, P479, DOI 10.1016/j.tig.2006.07.005; Ridefelt P, 2005, SCAND J GASTROENTERO, V40, P822, DOI 10.1080/00365520510015764; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; SIMOONS FJ, 1978, AM J DIG DIS, V23, P963, DOI 10.1007/BF01263095; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Spencer CCA, 2004, BIOINFORMATICS, V20, P3673, DOI 10.1093/bioinformatics/bth417; Star S.A., 1949, STUDIES SOCIAL PSYCH, V1; Swallow DM, 2003, ANNU REV GENET, V37, P197, DOI 10.1146/annurev.genet.37.110801.143820; Tishkoff SA, 2003, ANNU REV GENOM HUM G, V4, P293, DOI 10.1146/annurev.genom.4.070802.110226; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Troelsen JT, 2003, GASTROENTEROLOGY, V125, P1686, DOI 10.1053/j.gastro.2003.09.031; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WANG YX, 1995, HUM MOL GENET, V4, P657, DOI 10.1093/hmg/4.4.657; WHITTAKER P, 2006, CELL BIOL LAB HDB; Wiuf C, 2001, GENETICS, V159, P749; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140	49	888	917	12	466	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2007	39	1					31	40		10.1038/ng1946	http://dx.doi.org/10.1038/ng1946			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	17159977	Green Accepted			2022-12-27	WOS:000243136500015
J	Tomlins, SA; Mehra, R; Rhodes, DR; Cao, XH; Wang, L; Dhanasekaran, SM; Kalyana-Sundaram, S; Wei, JT; Rubin, MA; Pienta, KJ; Shah, RB; Chinnaiyan, AM				Tomlins, Scott A.; Mehra, Rohit; Rhodes, Daniel R.; Cao, Xuhong; Wang, Lei; Dhanasekaran, Saravana M.; Kalyana-Sundaram, Shanker; Wei, John T.; Rubin, Mark A.; Pienta, Kenneth J.; Shah, Rajal B.; Chinnaiyan, Arul M.			Integrative molecular concept modeling of prostate cancer progression	NATURE GENETICS			English	Article							GENE-EXPRESSION; HIGH-GRADE; INTRAEPITHELIAL NEOPLASIA; CARCINOMA; TRANSCRIPTOME; PROFILES; MARKERS; CARCINOGENESIS; ADENOCARCINOMA; TMPRSS2	Despite efforts to profile prostate cancer, the genetic alterations and biological processes that correlate with the observed histological progression are unclear. Using laser-capture microdissection to isolate 101 cell populations, we have profiled prostate cancer progression from benign epithelium to metastatic disease. By analyzing expression signatures in the context of over 14,000 'molecular concepts', or sets of biologically connected genes, we generated an integrative model of progression. Molecular concepts that demarcate critical transitions in progression include protein biosynthesis, E26 transformation-specific (ETS) family transcriptional targets, androgen signaling and cell proliferation. Of note, relative to low-grade prostate cancer (Gleason pattern 3), high-grade cancer (Gleason pattern 4) shows an attenuated androgen signaling signature, similar to metastatic prostate cancer, which may reflect dedifferentiation and explain the clinical association of grade with prognosis. Taken together, these data show that analyzing gene expression signatures in the context of a compendium of molecular concepts is useful in understanding cancer biology.	Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Bioinformat Program, Ann Arbor, MI 48109 USA; Univ Michigan, Sch Med, Dept Urol, Ann Arbor, MI 48109 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Michigan System; University of Michigan	Chinnaiyan, AM (corresponding author), Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI 48109 USA.	arul@umich.edu	Kalyana-Sundaram, Shanker/F-6860-2012; Wei, John T/E-8967-2012; Pienta, Kenneth/E-7679-2015	Rubin, Mark/0000-0002-8321-9950; Tomlins, Scott/0000-0001-8661-9821; Dhanasekaran, saravana mohan/0000-0002-0489-2224; Kalyana-Sundaram, Shanker/0000-0002-7309-3848; Pienta, Kenneth/0000-0002-4138-2186	NCI NIH HHS [UO1 CA111275-01, P50CA69568, R01 CA102872, 5P30 CA46592] Funding Source: Medline; NIDA NIH HHS [U54 DA021519-01A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA069568, P30CA046592, U01CA111275, R01CA102872] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [U54DA021519] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Ashida S, 2004, CANCER RES, V64, P5963, DOI 10.1158/0008-5472.CAN-04-0020; Best CJM, 2003, DIAGN MOL PATHOL, V12, P63, DOI 10.1097/00019606-200306000-00001; Bostwick DG, 2004, MODERN PATHOL, V17, P360, DOI 10.1038/modpathol.3800053; Chen L, 2004, NEW ASTRON, V10, P39, DOI 10.1016/j.newast.2004.04.008; De Marzo AM, 2004, J CELL BIOCHEM, V91, P459, DOI 10.1002/jcb.10747; De Marzo AM, 1999, AM J PATHOL, V155, P1985, DOI 10.1016/S0002-9440(10)65517-4; DeMarzo AM, 2003, LANCET, V361, P955, DOI 10.1016/S0140-6736(03)12779-1; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; Fischer AH, 2004, J CELL BIOCHEM, V91, P170, DOI 10.1002/jcb.10735; GLEASON DF, 1974, J UROLOGY, V111, P58, DOI 10.1016/S0022-5347(17)59889-4; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Hendriksen PJM, 2006, CANCER RES, V66, P5012, DOI 10.1158/0008-5472.CAN-05-3082; Humphrey PA, 2004, MODERN PATHOL, V17, P292, DOI 10.1038/modpathol.3800054; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Konishi N, 2005, PATHOL INT, V55, P531, DOI 10.1111/j.1440-1827.2005.01865.x; Koyabu Y, 2001, J BIOL CHEM, V276, P6889, DOI 10.1074/jbc.C000773200; Kristiansen G, 2005, J PATHOL, V205, P359, DOI 10.1002/path.1676; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Lin BY, 1999, CANCER RES, V59, P4180; Moore S, 2005, INT J CANCER, V114, P563, DOI 10.1002/ijc.20773; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nelson Peter S, 2004, J Urol, V172, pS28, DOI 10.1097/01.ju.0000142067.17181.68; Nupponen NN, 1998, AM J PATHOL, V153, P141, DOI 10.1016/S0002-9440(10)65554-X; Paris PL, 2004, HUM MOL GENET, V13, P1303, DOI 10.1093/hmg/ddh155; Quinn DI, 2005, EUR J CANCER, V41, P858, DOI 10.1016/j.ejca.2004.12.035; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rhodes DR, 2005, NAT GENET, V37, pS31, DOI 10.1038/ng1570; Rhodes DR, 2005, NAT GENET, V37, P579, DOI 10.1038/ng1578; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Sato K, 1999, JNCI-J NATL CANCER I, V91, P1574, DOI 10.1093/jnci/91.18.1574; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stuart RO, 2004, P NATL ACAD SCI USA, V101, P615, DOI 10.1073/pnas.2536479100; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sumitomo M, 2004, CANCER CELL, V5, P67, DOI 10.1016/S1535-6108(03)00331-3; Tomlins SA, 2006, CANCER RES, V66, P3396, DOI 10.1158/0008-5472.CAN-06-0168; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2006, ANNU REV PATHOL-MECH, V1, P243, DOI 10.1146/annurev.pathol.1.110304.100047; Tomlins SA, 2006, NEOPLASIA, V8, P153, DOI 10.1593/neo.05754; TRAN H, 2003, SCI STKE, pRE5, DOI DOI 10.1126/STKE.2003.172.RE5; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; True L, 2006, P NATL ACAD SCI USA, V103, P10991, DOI 10.1073/pnas.0603678103; Vaillancourt L, 1996, AM J SURG PATHOL, V20, P86, DOI 10.1097/00000478-199601000-00010; Vanaja DK, 2003, CANCER RES, V63, P3877; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Welsh JB, 2001, CANCER RES, V61, P5974	50	687	731	1	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2007	39	1					41	51		10.1038/ng1935	http://dx.doi.org/10.1038/ng1935			11	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	17173048				2022-12-27	WOS:000243136500016
J	Eckhardt, F; Lewin, J; Cortese, R; Rakyan, VK; Attwood, J; Burger, M; Burton, J; Cox, TV; Davies, R; Down, TA; Haefliger, C; Horton, R; Howe, K; Jackson, DK; Kunde, J; Koenig, C; Liddle, J; Niblett, D; Otto, T; Pettett, R; Seemann, S; Thompson, C; West, T; Rogers, J; Olek, A; Berlin, K; Beck, S				Eckhardt, Florian; Lewin, Joern; Cortese, Rene; Rakyan, Vardhman K.; Attwood, John; Burger, Matthias; Burton, John; Cox, Tony V.; Davies, Rob; Down, Thomas A.; Haefliger, Carolina; Horton, Roger; Howe, Kevin; Jackson, David K.; Kunde, Jan; Koenig, Christoph; Liddle, Jennifer; Niblett, David; Otto, Thomas; Pettett, Roger; Seemann, Stefanie; Thompson, Christian; West, Tony; Rogers, Jane; Olek, Alex; Berlin, Kurt; Beck, Stephan			DNA methylation profiling of human chromosomes 6, 20 and 22	NATURE GENETICS			English	Article							CPG-ISLANDS; HISTONE MODIFICATIONS; CYTOSINE METHYLATION; GENE-EXPRESSION; HUMAN GENOME; BINDING; CANCER; SITES; MOUSE; CELLS	DNA methylation is the most stable type of epigenetic modification modulating the transcriptional plasticity of mammalian genomes. Using bisulfite DNA sequencing, we report high-resolution methylation profiles of human chromosomes 6, 20 and 22, providing a resource of about 1.9 million CpG methylation values derived from 12 different tissues. Analysis of six annotation categories showed that evolutionarily conserved regions are the predominant sites for differential DNA methylation and that a core region surrounding the transcriptional start site is an informative surrogate for promoter methylation. We find that 17% of the 873 analyzed genes are differentially methylated in their 5 ' UTRs and that about one-third of the differentially methylated 5 ' UTRs are inversely correlated with transcription. Despite the fact that our study controlled for factors reported to affect DNA methylation such as sex and age, we did not find any significant attributable effects. Our data suggest DNA methylation to be ontogenetically more stable than previously thought.	Epigenom AG, D-10178 Berlin, Germany; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	Wellcome Trust Sanger Institute	Eckhardt, F (corresponding author), Epigenom AG, Kleine Prasidentstr 1, D-10178 Berlin, Germany.	florian.eckhardt@epigenomics.com; beck@sanger.ac.uk	Otto, Thomas/ABE-7632-2020	Howe, Kevin/0000-0002-1751-9226; Cortese, Rene/0000-0001-9262-7828	Wellcome Trust [084071] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Ashurst JL, 2005, NUCLEIC ACIDS RES, V33, pD459, DOI 10.1093/nar/gki135; BERLIN K, 2005, Patent No. 2005038051; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bjornsson HT, 2004, TRENDS GENET, V20, P350, DOI 10.1016/j.tig.2004.06.009; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Clark SJ, 1997, GENE, V195, P67, DOI 10.1016/S0378-1119(97)00164-9; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Costello JF, 2002, METHODS, V27, P144, DOI 10.1016/S1046-2023(02)00067-1; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; DUNCAN BK, 1980, NATURE, V287, P560, DOI 10.1038/287560a0; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Fraga MF, 2005, P NATL ACAD SCI USA, V102, P10604, DOI 10.1073/pnas.0500398102; Frigola J, 2006, NAT GENET, V38, P540, DOI 10.1038/ng1781; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; Futscher BW, 2002, NAT GENET, V31, P175, DOI 10.1038/ng886; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Grunau C, 2000, HUM MOL GENET, V9, P2651, DOI 10.1093/hmg/9.18.2651; HARRINGTON MA, 1988, P NATL ACAD SCI USA, V85, P2066, DOI 10.1073/pnas.85.7.2066; Hayward BE, 1998, P NATL ACAD SCI USA, V95, P10038, DOI 10.1073/pnas.95.17.10038; HOLLER M, 1988, GENE DEV, V2, P1127, DOI 10.1101/gad.2.9.1127; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Jones PA, 2005, CANCER RES, V65, P11241, DOI 10.1158/0008-5472.CAN-05-3865; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; KALSCHEUER VM, 1993, NAT GENET, V5, P74, DOI 10.1038/ng0993-74; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lewin J, 2004, BIOINFORMATICS, V20, P3005, DOI 10.1093/bioinformatics/bth346; Mancini DN, 1999, ONCOGENE, V18, P4108, DOI 10.1038/sj.onc.1202764; Murrell A, 2005, HUM MOL GENET, V14, pR3, DOI 10.1093/hmg/ddi110; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Schumacher A, 2006, NUCLEIC ACIDS RES, V34, P528, DOI 10.1093/nar/gkj461; Shiota K, 2002, GENES CELLS, V7, P961, DOI 10.1046/j.1365-2443.2002.00574.x; Shiota K, 2004, CYTOGENET GENOME RES, V105, P325, DOI 10.1159/000078205; Smiraglia DJ, 2001, HUM MOL GENET, V10, P1413, DOI 10.1093/hmg/10.13.1413; Song F, 2005, P NATL ACAD SCI USA, V102, P3336, DOI 10.1073/pnas.0408436102; Strichman-Almashanu LZ, 2002, GENOME RES, V12, P543, DOI 10.1101/gr.224102; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Verhaagh S, 1999, GENOMICS, V55, P209, DOI 10.1006/geno.1998.5639; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Widschwendter M, 2004, CANCER RES, V64, P3807, DOI 10.1158/0008-5472.CAN-03-3852; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zeng WH, 2004, EXP HEMATOL, V32, P806, DOI 10.1016/j.exphem.2004.06.004	47	974	1048	2	92	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2006	38	12					1378	1385		10.1038/ng1909	http://dx.doi.org/10.1038/ng1909			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110TR	17072317	Green Accepted			2022-12-27	WOS:000242404200014
J	Miyamoto, Y; Shi, D; Nakajima, M; Ozaki, K; Sudo, A; Kotani, A; Uchida, A; Tanaka, T; Fukui, N; Tsunoda, T; Takahashi, A; Nakamura, Y; Jiang, Q; Ikegawa, S				Miyamoto, Yoshinari; Shi, Dongquan; Nakajima, Masahiro; Ozaki, Kouichi; Sudo, Akihiro; Kotani, Akihiro; Uchida, Atsumasa; Tanaka, Toshihiro; Fukui, Naoshi; Tsunoda, Tatsuhiko; Takahashi, Atsushi; Nakamura, Yusuke; Jiang, Qing; Ikegawa, Shiro			Common variants in DVWA on chromosome 3p24.3 are associated with susceptibility to knee osteoarthritis	NATURE GENETICS			English	Article							ACID REPEAT POLYMORPHISM; POPULATION STRATIFICATION; SEQUENCE POLYMORPHISMS; HIP OSTEOARTHRITIS; GENE; IDENTIFICATION; PATHOGENESIS; JAPANESE; GENOME; CALM1	Susceptibility to osteoarthritis, the most common human arthritis, is known to be influenced by genetic factors(1,2). Through a genome-wide association study using B100,000 SNPs, we have identified a previously unknown gene on chromosome 3p24.3, DVWA, which is associated with susceptibility to knee osteoarthritis. Expressed specifically in cartilage, DVWA encodes a 276-amino-acid protein with two regions corresponding to the von Willebrand factor type A domain (VWA domain)3. Several DVWA SNPs are significantly associated with knee osteoarthritis in two independent Japanese case-control cohorts. This association was replicated in a Japanese population cohort and a Han Chinese case-control cohort (combined P = 7.3 x 10(-11)). DVWA protein binds to beta-tubulin, and the binding is influenced by two highly associated missense SNPs (rs11718863 and rs7639618) located in the VWA domain. The Tyr169-Cys260 isoform of DVWA, which is overrepresented in knee osteoarthritis, showed weaker interaction. Our findings reveal a new paradigm for study of osteoarthritis etiology and pathogenesis.	[Miyamoto, Yoshinari; Nakajima, Masahiro; Ikegawa, Shiro] RIKEN, Ctr Genom Med, Lab Bone & Joint Dis, Minato Ku, Tokyo 1088639, Japan; [Shi, Dongquan; Jiang, Qing] Nanjing Univ, Sch Med, Drum Tower Hosp, Ctr Diag & Treatment Joint Dis, Jiangsu 210008, Peoples R China; [Ozaki, Kouichi; Tanaka, Toshihiro] RIKEN, Ctr Genom Med, Lab Cardiovasc Dis, Tsurumi Ku, Kanagawa 2300045, Japan; [Sudo, Akihiro; Uchida, Atsumasa] Mie Univ, Dept Orthopaed Surg, Fac Med, Tsu, Mie 5148507, Japan; [Kotani, Akihiro] Kyorin Univ, Sch Med, Dept Orthopaed Surg, Tokyo 1818611, Japan; [Fukui, Naoshi] Sagamihara Natl Hosp, Natl Hosp Org, Dept Pathomech, Clin Res Ctr Rheumatol & Allergy, Sagamihara, Kanagawa 2288522, Japan; [Tsunoda, Tatsuhiko] RIKEN, Lab Med Informat, Ctr Genom Med, Tsurumi Ku, Kanagawa 2300045, Japan; [Takahashi, Atsushi] RIKEN, Ctr Genom Med, Lab Stat Anal, Minato Ku, Tokyo 1088639, Japan; [Nakamura, Yusuke] RIKEN, Ctr Genom Med, Lab Genotyping, Minato Ku, Tokyo 1088639, Japan	RIKEN; Nanjing University; RIKEN; Mie University; Kyorin University; RIKEN; RIKEN; RIKEN	Ikegawa, S (corresponding author), RIKEN, Ctr Genom Med, Lab Bone & Joint Dis, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	sikegawa@ims.u-tokyo.ac.jp	Tsunoda, Tatsuhiko/K-2061-2014; shi, dongquan/AAE-9956-2020; Ikegawa, Shiro/N-6895-2015; shi, dongquan/ABH-3078-2021; Shi, Dongquan/ABG-6949-2021; Tanaka, Toshihiro/J-9310-2014	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Ikegawa, Shiro/0000-0003-0316-2147; shi, dongquan/0000-0002-4769-7816; Tanaka, Toshihiro/0000-0001-6201-9784; Ozaki, Kouichi/0000-0003-0028-1570				Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Capin-Gutierrez N, 2004, HISTOL HISTOPATHOL, V19, P1125, DOI 10.14670/HH-19.1125; Celikel R, 1998, NAT STRUCT BIOL, V5, P189, DOI 10.1038/nsb0398-189; Dieppe PA, 2005, LANCET, V365, P965, DOI 10.1016/S0140-6736(05)71086-2; Farquharson C, 1999, BONE, V25, P405, DOI 10.1016/S8756-3282(99)00187-8; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Gupta S, 2005, RHEUMATOLOGY, V44, P1531, DOI 10.1093/rheumatology/kei049; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Hunter DJ, 2006, BMJ-BRIT MED J, V332, P639, DOI 10.1136/bmj.332.7542.639; Ikeda T, 2001, J HUM GENET, V46, P538, DOI 10.1007/s100380170036; Ikegawa S, 2007, CURR OPIN RHEUMATOL, V19, P429, DOI 10.1097/BOR.0b013e32825b079d; Jiang Q, 2006, J HUM GENET, V51, P1068, DOI 10.1007/s10038-006-0065-6; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Kubo M, 2007, NAT GENET, V39, P212, DOI 10.1038/ng1945; Loughlin J, 2004, P NATL ACAD SCI USA, V101, P9757, DOI 10.1073/pnas.0403456101; Mabuchi A, 2001, J HUM GENET, V46, P456, DOI 10.1007/s100380170045; Mabuchi Akihiko, 2004, Hum Mutat, V24, P439, DOI 10.1002/humu.9286; Miyamoto Y, 2007, NAT GENET, V39, P529, DOI 10.1038/2005; Mototani H, 2005, HUM MOL GENET, V14, P1009, DOI 10.1093/hmg/ddi093; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Pollard B, 2006, CURR OPIN RHEUMATOL, V18, P531, DOI 10.1097/01.bor.0000240368.39713.e6; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Spector TD, 1996, BRIT MED J, V312, P940; SPECTOR TD, 2004, OSTEOARTHRITIS CAR S, VA, pS39; Stefansson SE, 2003, AM J HUM GENET, V72, P1448, DOI 10.1086/375556; Tregouet DA, 2007, BIOINFORMATICS, V23, P1038, DOI 10.1093/bioinformatics/btm058; Valdes AM, 2007, ARTHRITIS RHEUM-US, V56, P137, DOI 10.1002/art.22301; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259	29	100	106	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2008	40	8					994	998		10.1038/ng.176	http://dx.doi.org/10.1038/ng.176			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18622395				2022-12-27	WOS:000258026900016
J	Blewitt, ME; Gendrel, AV; Pang, ZY; Sparrow, DB; Whitelaw, N; Craig, JM; Apedaile, A; Hilton, DJ; Dunwoodie, SL; Brockdorff, N; Kay, GF; Whitelaw, E				Blewitt, Marnie E.; Gendrel, Anne-Valerie; Pang, Zhenyi; Sparrow, Duncan B.; Whitelaw, Nadia; Craig, Jeffrey M.; Apedaile, Anwyn; Hilton, Douglas J.; Dunwoodie, Sally L.; Brockdorff, Neil; Kay, Graham F.; Whitelaw, Emma			SmcHD1, containing a structural-maintenance-of-chromosomes hinge domain, has a critical role in X inactivation	NATURE GENETICS			English	Article							TROPHOBLAST GIANT-CELLS; DOSAGE COMPENSATION; CONDENSIN SUBUNIT; MOUSE; GENE; METHYLATION; DNA; PROTEIN; DEFICIENT; COMPLEX	X-chromosome inactivation is the mammalian dosage compensation mechanism by which transcription of X-linked genes is equalized between females and males. In an N-ethyl-N-nitrosourea (ENU) mutagenesis screen on mice for modifiers of epigenetic reprogramming, we identified the MommeD1 (modifier of murine metastable epialleles) mutation as a semidominant suppressor of variegation. MommeD1 shows homozygous female-specific mid-gestation lethality and hypomethylation of the X-linked gene Hprt1, suggestive of a defect in X inactivation(1). Here we report that the causative point mutation lies in a previously uncharacterized gene, Smchd1 (structural maintenance of chromosomes hinge domain containing 1). We find that SmcHD1 is not required for correct Xist expression, but localizes to the inactive X and has a role in the maintenance of X inactivation and the hypermethylation of CpG islands associated with the inactive X. This finding links a group of proteins normally associated with structural aspects of chromosome biology with epigenetic gene silencing.	[Pang, Zhenyi; Whitelaw, Nadia; Kay, Graham F.; Whitelaw, Emma] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Blewitt, Marnie E.; Hilton, Douglas J.] Walter & Eliza Hall Inst Med Res, Div Mol Med, Melbourne, Vic 3050, Australia; [Blewitt, Marnie E.; Hilton, Douglas J.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3050, Australia; [Gendrel, Anne-Valerie; Apedaile, Anwyn; Brockdorff, Neil] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London SW7 2AZ, England; [Gendrel, Anne-Valerie; Apedaile, Anwyn; Brockdorff, Neil] Univ London Imperial Coll Sci Technol & Med, MRC, Fac Med, London SW7 2AZ, England; [Sparrow, Duncan B.] Univ New S Wales, Victor Chang Cardiac Res Inst, Sydney, NSW 2010, Australia; [Whitelaw, Nadia] Univ Queensland, Sch Med, Brisbane, Qld 4072, Australia; [Craig, Jeffrey M.] Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia	QIMR Berghofer Medical Research Institute; Walter & Eliza Hall Institute; University of Melbourne; Imperial College London; Imperial College London; University of New South Wales Sydney; Victor Chang Cardiac Research Institute; University of Queensland; Murdoch Children's Research Institute	Whitelaw, E (corresponding author), Queensland Inst Med Res, Brisbane, Qld 4006, Australia.	emma.whitelaw@qimr.edu.au	Blewitt, Marnie/B-1796-2012; Sparrow, Duncan/B-3994-2008; Kay, Graham F/A-4130-2011; Dunwoodie, Sally L/M-4019-2018; Gendrel, Anne-Valerie/E-5584-2017; Hilton, Douglas J/C-7250-2013; Craig, Jeffrey M/B-3484-2012	Sparrow, Duncan/0000-0002-1141-6613; Dunwoodie, Sally L/0000-0002-2069-7349; Gendrel, Anne-Valerie/0000-0003-4510-0024; Hilton, Douglas J/0000-0002-7698-2392; Craig, Jeffrey M/0000-0003-3979-7849; Blewitt, Marnie/0000-0002-2984-1474; Brockdorff, Neil/0000-0003-4838-2653	MRC [MC_U120031757] Funding Source: UKRI; Medical Research Council [MC_U120031757] Funding Source: Medline; Wellcome Trust [081385] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Adams DJ, 2004, NAT GENET, V36, P867, DOI 10.1038/ng1388; Anderson DE, 2002, J CELL BIOL, V156, P419, DOI 10.1083/jcb.200111002; Bhalla N, 2002, MOL BIOL CELL, V13, P632, DOI 10.1091/mbc.01-05-0264; Blewitt ME, 2005, P NATL ACAD SCI USA, V102, P7629, DOI 10.1073/pnas.0409375102; CHUANG PT, 1994, CELL, V79, P459, DOI 10.1016/0092-8674(94)90255-0; Dej KJ, 2004, GENETICS, V168, P895, DOI 10.1534/genetics.104.030908; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; FARIA TN, 1991, BIOL REPROD, V44, P327, DOI 10.1095/biolreprod44.2.327; FitzPatrick DR, 2002, HUM MOL GENET, V11, P3249, DOI 10.1093/hmg/11.26.3249; Geiman TM, 2004, NUCLEIC ACIDS RES, V32, P2716, DOI 10.1093/nar/gkh589; Hadjantonakis AK, 1998, NAT GENET, V19, P220, DOI 10.1038/896; Haering CH, 2002, MOL CELL, V9, P773, DOI 10.1016/S1097-2765(02)00515-4; Hakimi MA, 2002, J BIOL CHEM, V277, P36909, DOI 10.1074/jbc.C200434200; Hansen RS, 2000, HUM MOL GENET, V9, P2575, DOI 10.1093/hmg/9.18.2575; Heard E, 2005, CURR OPIN GENET DEV, V15, P482, DOI 10.1016/j.gde.2005.08.009; Hirano M, 2002, EMBO J, V21, P5733, DOI 10.1093/emboj/cdf575; KANNO T, 2008, NAT GENET; Lieb JD, 1996, SCIENCE, V274, P1732, DOI 10.1126/science.274.5293.1732; LOCK LF, 1987, CELL, V48, P39, DOI 10.1016/0092-8674(87)90353-9; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Marahrens Y, 1998, CELL, V92, P657, DOI 10.1016/S0092-8674(00)81133-2; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; Oda M, 2006, GENE DEV, V20, P3382, DOI 10.1101/gad.1470906; Sado T, 2000, DEV BIOL, V225, P294, DOI 10.1006/dbio.2000.9823; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; VARMUZA S, 1988, DEVELOPMENT, V102, P127; Wang JB, 2001, NAT GENET, V28, P371, DOI 10.1038/ng574	28	1415	1433	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2008	40	5					663	669		10.1038/ng.142	http://dx.doi.org/10.1038/ng.142			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18425126				2022-12-27	WOS:000255366700037
J	Pasternack, SM; von Kugelgen, I; Al Aboud, K; Lee, YA; Ruschendorf, F; Voss, K; Hillmer, AM; Molderings, GJ; Franz, T; Ramirez, A; Nuernberg, P; Nothen, MM; Betz, RC				Pasternack, Sandra M.; von Kuegelgen, Ivar; Al Aboud, Khalid; Lee, Young-Ae; Rueschendorf, Franz; Voss, Katrin; Hillmer, Axel M.; Molderings, Gerhard J.; Franz, Thomas; Ramirez, Alfredo; Nuernberg, Peter; Noethen, Markus M.; Betz, Regina C.			G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth	NATURE GENETICS			English	Article							LYSOPHOSPHATIDIC ACID; INTERNATIONAL UNION; GENE; IDENTIFICATION; HYPOTRICHOSIS; PHARMACOLOGY; MUTATIONS; GPR92; 6H1	Hypotrichosis simplex is a group of nonsyndromic human alopecias. We mapped an autosomal recessive form of this disorder to chromosome 13q14.11-13q21.33, and identified homozygous truncating mutations in P2RY5, which encodes an orphan G protein-coupled receptor. Furthermore, we identified oleoyl-L-alpha-lysophosphatidic acid (LPA), a bioactive lipid, as a ligand for P2Y5 in reporter gene and radioligand binding experiments. Homology and studies of signaling transduction pathways suggest that P2Y5 is a member of a subgroup of LPA receptors, which also includes LPA4 and LPA5. Our study is the first to implicate a G protein-coupled receptor as essential for and specific to the maintenance of human hair growth. This finding may provide opportunities for new therapeutic approaches to the treatment of hair loss in humans.	[Pasternack, Sandra M.; Noethen, Markus M.; Betz, Regina C.] Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany; [Pasternack, Sandra M.; Molderings, Gerhard J.] Univ Bonn, Dept Pharmacol, D-53113 Bonn, Germany; [Al Aboud, Khalid] King Faisal Hosp, Dept Dermatol, Mecca 5592, Saudi Arabia; [Lee, Young-Ae] Humboldt Univ, Charite, Dept Pediat Pneumol & Immunol, D-13353 Berlin, Germany; [Lee, Young-Ae; Rueschendorf, Franz] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany; [Voss, Katrin] Univ Wurzburg, Dept Human Genet, D-97074 Wurzburg, Germany; [Hillmer, Axel M.; Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, D-53127 Bonn, Germany; [Franz, Thomas] Univ Bonn, Dept Anat, D-53115 Bonn, Germany; [Ramirez, Alfredo] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Ramirez, Alfredo] Univ Cologne, Inst Human Genet, D-50931 Cologne, Germany; [Ramirez, Alfredo; Nuernberg, Peter] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, D-50674 Cologne, Germany	University of Bonn; University of Bonn; King Faisal Specialist Hospital & Research Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Wurzburg; University of Bonn; University of Bonn; University of Cologne; University of Cologne; University of Cologne; University of Cologne	Betz, RC (corresponding author), Univ Bonn, Inst Human Genet, D-53111 Bonn, Germany.	regina.betz@uni-bonn.de	Hillmer, Axel M/B-7485-2015; Betz, Regina C/E-8591-2011; Ramirez, Alfredo/S-5126-2019; von Kügelgen, Ivar/D-2989-2019; Nöthen, Markus/B-2027-2009; Hillmer, Axel M/N-2927-2014	Hillmer, Axel M/0000-0002-3381-7266; Betz, Regina C/0000-0001-5024-3623; Ramirez, Alfredo/0000-0003-4991-763X; von Kügelgen, Ivar/0000-0002-2021-4028; Nöthen, Markus/0000-0002-8770-2464; Hillmer, Axel M/0000-0002-3381-7266	Direct For Biological Sciences [0749004] Funding Source: National Science Foundation; Division Of Environmental Biology [0746560] Funding Source: National Science Foundation	Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Ahmad W, 1998, SCIENCE, V279, P720, DOI 10.1126/science.279.5351.720; Al Aboud D, 2005, SUDAN J DERMATOL, V3, P128; Al Aboud K, 2002, CLIN EXP DERMATOL, V27, P654, DOI 10.1046/j.1365-2230.2002.01088.x; BETZ RC, 2006, PROGR MONOGENIC HAIR, P43; Chun J, 2002, PHARMACOL REV, V54, P265, DOI 10.1124/pr.54.2.265; Cichon S, 1998, HUM MOL GENET, V7, P1671, DOI 10.1093/hmg/7.11.1671; Herzog H, 1996, GENOME RES, V6, P858, DOI 10.1101/gr.6.9.858; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Kazantseva A, 2006, SCIENCE, V314, P982, DOI 10.1126/science.1133276; Kljuic A, 2003, CELL, V113, P249, DOI 10.1016/S0092-8674(03)00273-3; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Levy-Nissenbaum E, 2003, NAT GENET, V34, P151, DOI 10.1038/ng1163; Li Q, 1997, BIOCHEM BIOPH RES CO, V236, P455, DOI 10.1006/bbrc.1997.6984; Miller J, 2001, J INVEST DERMATOL, V117, P612, DOI 10.1046/j.0022-202x.2001.01438.x; Molderings GJ, 2007, NEUROCHEM INT, V51, P476, DOI 10.1016/j.neuint.2007.04.022; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; Pin JP, 2007, PHARMACOL REV, V59, P5, DOI 10.1124/pr.59.1.5; Sobel E, 1996, AM J HUM GENET, V58, P1323; Tabata KI, 2007, BIOCHEM BIOPH RES CO, V363, P861, DOI 10.1016/j.bbrc.2007.09.063; Takahashi T, 2003, J INVEST DERMATOL, V121, P448, DOI 10.1046/j.1523-1747.2003.12426.x; von Kugelgen I, 2006, PHARMACOL THERAPEUT, V110, P415, DOI 10.1016/j.pharmthera.2005.08.014; Wali A, 2007, CLIN GENET, V72, P23, DOI 10.1111/j.1399-0004.2007.00818.x; Wang DA, 2001, J BIOL CHEM, V276, P49213, DOI 10.1074/jbc.M107301200; Webb TE, 1996, BIOCHEM BIOPH RES CO, V219, P105, DOI 10.1006/bbrc.1996.0189; zu Heringdorf DM, 2007, BBA-BIOMEMBRANES, V1768, P923, DOI 10.1016/j.bbamem.2006.09.026	30	310	326	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2008	40	3					329	334		10.1038/ng.84	http://dx.doi.org/10.1038/ng.84			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18297070				2022-12-27	WOS:000253548400024
J	Kornak, U; Reynders, E; Dimopoulou, A; van Reeuwijk, J; Fischer, B; Rajab, A; Budde, B; Nurnberg, P; Foulquier, F; Lefeber, D; Urban, Z; Gruenewald, S; Annaert, W; Brunner, HG; van Bokhoven, H; Wevers, R; Morava, E; Matthijs, G; Van Maldergem, L; Mundlos, S				Kornak, Uwe; Reynders, Ellen; Dimopoulou, Aikaterini; van Reeuwijk, Jeroen; Fischer, Bjoern; Rajab, Anna; Budde, Birgit; Nurnberg, Peter; Foulquier, Francois; Lefeber, Dirk; Urban, Zsolt; Gruenewald, Stephanie; Annaert, Wim; Brunner, Han G.; van Bokhoven, Hans; Wevers, Ron; Morava, Eva; Matthijs, Gert; Van Maldergem, Lionel; Mundlos, Stefan		ARCL Debre-type Study Grp	Impaired glycosylation and cutis laxa caused by mutations in the vesicular H+-ATPase subunit ATP6V0A2	NATURE GENETICS			English	Article							CONGENITAL DISORDER; DEFICIENCY REVEALS; COMPLEX-FORMATION; V-ATPASE; DEFECTS; PATHWAY; PH	We identified loss-of-function mutations in ATP6V0A2, encoding the a2 subunit of the V-type H+ ATPase, in several families with autosomal recessive cutis laxa type II or wrinkly skin syndrome. The mutations result in abnormal glycosylation of serum proteins (CDG-II) and cause an impairment of Golgi trafficking in fibroblasts from affected individuals. These results indicate that the a2 subunit of the proton pump has an important role in Golgi function.	[Kornak, Uwe; Dimopoulou, Aikaterini; Fischer, Bjoern; Mundlos, Stefan] Charite Univ Med Berlin, Inst Med Genet, Berlin, Germany; [Kornak, Uwe; Dimopoulou, Aikaterini; Fischer, Bjoern; Mundlos, Stefan] Max Planck Inst Mol Genet, Berlin, Germany; [Reynders, Ellen; Annaert, Wim] Katholieke Univ Leuven, Ctr Human Genet, Lab Membrane Trafficking, B-3000 Louvain, Belgium; [Reynders, Ellen; Annaert, Wim] Katholieke Univ Leuven VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [van Reeuwijk, Jeroen; Brunner, Han G.; van Bokhoven, Hans] Radboud Univ Nijmegen Med Ctr, Dept Human Genet, NL-3525 GA Nijmegen, Netherlands; [Rajab, Anna] Minist Hlth, Directorate Gen Hlth Affairs, Genet Unit, Muscat 113, Oman; [Budde, Birgit; Nurnberg, Peter] Univ Cologne, CCG, D-50674 Cologne, Germany; [Budde, Birgit; Nurnberg, Peter] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Foulquier, Francois; Matthijs, Gert; Mundlos, Stefan] Katholieke Univ Leuven, Ctr Human Genet, Lab Mol Diagnost, B-3000 Louvain, Belgium; [Lefeber, Dirk; Wevers, Ron; Morava, Eva] Univ Med Ctr Nijmegen, Lab Peiat & Neurol, Dept Pediat, NL-6525 GA Nijmegen, Netherlands; [Urban, Zsolt] Washington Univ, Dept Pediat, St Louis, MO 63110 USA; [Urban, Zsolt] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Gruenewald, Stephanie] Great Ormond St Hosp Children Trust NHS, London WC1N 3JH, England; [Van Maldergem, Lionel] Univ Liege, CHU Sart Tilman, Ctr Genet Humaine, B-4000 Liege, Belgium	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; KU Leuven; Flanders Institute for Biotechnology (VIB); KU Leuven; Radboud University Nijmegen; University of Cologne; University of Cologne; KU Leuven; Radboud University Nijmegen; Washington University (WUSTL); Washington University (WUSTL); University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Liege	Kornak, U (corresponding author), Charite Univ Med Berlin, Inst Med Genet, Berlin, Germany.	uwe.kornak@charite.de	Mundlos, Stefan/ABH-9585-2020; FOULQUIER, FRANCOIS/AAI-1182-2021; lefeber, dirk/G-5063-2012; van Bokhoven, Hans/D-8764-2012; Lefeber, Dirk DJ/A-2146-2014; Wevers, Ron A./H-8116-2014; Urban, Zsolt/A-2018-2013; Van Maldergem, Lionel/O-3242-2019; Van Maldergem, Lionel/G-9849-2017; Urban, Zsolt/B-1977-2008; Bokhoven, J.H.L.M. van van/H-8015-2014; Brunner, Han/C-9928-2013; Morava, E./L-4529-2015; Fischer-Zirnsak, Björn/D-7487-2013; foulquier, francois/ABE-5886-2020; van Reeuwijk, Jeroen/P-8665-2015; Nanda, Arti/H-8565-2019; Salih, Mustafa/C-1222-2014	Wevers, Ron A./0000-0003-2278-9746; Urban, Zsolt/0000-0003-3890-1843; Van Maldergem, Lionel/0000-0001-8880-5214; Van Maldergem, Lionel/0000-0001-8880-5214; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Fischer-Zirnsak, Björn/0000-0002-1075-7571; foulquier, francois/0000-0002-6551-3240; van Reeuwijk, Jeroen/0000-0002-0658-4399; Mundlos, Stefan/0000-0002-9788-3166; Leao Teles, Elisa/0000-0002-3011-0249; Budde, Birgit/0000-0001-9385-4168; Quelhas, Dulce/0000-0001-9989-9236; Salih, Mustafa/0000-0002-4379-2111; Nanda, Arti/0000-0002-1223-3181; Foulquier, Francois/0000-0001-5084-4015; Dobyns, William/0000-0002-7681-2844; Basel-Vanagaite, Vanagaite, Lina/0000-0002-9076-8157; Matthijs, Gert/0000-0001-6710-1912				Axelsson MAB, 2001, GLYCOBIOLOGY, V11, P633, DOI 10.1093/glycob/11.8.633; Foulquier F, 2006, P NATL ACAD SCI USA, V103, P3764, DOI 10.1073/pnas.0507685103; Foulquier F, 2007, HUM MOL GENET, V16, P717, DOI 10.1093/hmg/ddl476; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Gilchrist A, 2006, CELL, V127, P1265, DOI 10.1016/j.cell.2006.10.036; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Morava E, 2005, EUR J HUM GENET, V13, P414, DOI 10.1038/sj.ejhg.5201361; MORAVA E, IN PRESS EUR J HUM G; Nishi T, 2002, NAT REV MOL CELL BIO, V3, P94, DOI 10.1038/nrm729; Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; RAJAB A, IN PRESS AM J MED GE; Wu XH, 2004, NAT MED, V10, P518, DOI 10.1038/nm1041	15	259	268	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2008	40	1					32	34		10.1038/ng.2007.45	http://dx.doi.org/10.1038/ng.2007.45			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18157129				2022-12-27	WOS:000252118600015
J	Kaeser, SA; Herzig, MC; Coomaraswamy, J; Kilger, E; Selenica, ML; Winkler, DT; Staufenbiel, M; Levy, E; Grubb, A; Jucker, M				Kaeser, Stephan A.; Herzig, Martin C.; Coomaraswamy, Janaky; Kilger, Ellen; Selenica, Maj-Linda; Winkler, David T.; Staufenbiel, Matthias; Levy, Efrat; Grubb, Anders; Jucker, Mathias			Cystatin C modulates cerebral beta-amyloidosis	NATURE GENETICS			English	Article							ONSET ALZHEIMER-DISEASE; GENETIC ASSOCIATION; VARIANT; HEMORRHAGE	The CST3 Thr25 allele of CST3, which encodes cystatin C, leads to reduced cystatin C secretion and conveys susceptibility to Alzheimer's disease. Here we show that overexpression of human cystatin C in brains of APP-transgenic mice reduces cerebral amyloid-beta deposition and that cystatin C binds amyloid-beta and inhibits its fibril formation. Our results suggest that cystatin C concentrations modulate cerebral amyloidosis risk and provide an opportunity for genetic risk assessment and therapeutic interventions.	Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, D-72076 Tubingen, Germany; Univ Lund Hosp, Dept Clin Chem, S-22185 Lund, Sweden; Univ Basel, Inst Pathol, Dept Neuropathol, CH-4003 Basel, Switzerland; Novartis Inst Biomed Res Basel, CH-4002 Basel, Switzerland; NYU, Sch Med, Dept Pharmacol & Psychiat, New York, NY 10016 USA; Nathan S Kline Inst, New York, NY 10962 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Lund University; Skane University Hospital; University of Basel; Novartis; New York University; Nathan Kline Institute for Psychiatric Research	Jucker, M (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Cellular Neurol, Otfried Muller Str 27, D-72076 Tubingen, Germany.	mathias.jucker@uni-tuebingen.de	; Herzig, Martin/R-4601-2016	Grubb, Anders/0000-0002-0125-3662; Herzig, Martin/0000-0002-0500-353X				BALBIN M, 1992, BIOL CHEM H-S, V373, P471, DOI 10.1515/bchm3.1992.373.2.471; Benussi L, 2003, NEUROBIOL DIS, V13, P15, DOI 10.1016/S0969-9961(03)00012-3; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bjarnadottir M, 2001, AMYLOID, V8, P1, DOI 10.3109/13506120108993809; Cathcart HM, 2005, NEUROLOGY, V64, P755, DOI 10.1212/01.WNL.0000151980.42337.44; Chuo LJ, 2007, DEMENT GERIATR COGN, V23, P251, DOI 10.1159/000100021; Eriksson P, 2004, ARTERIOSCL THROM VAS, V24, P551, DOI 10.1161/01.ATV.0000117180.57731.36; Filler G, 2005, CLIN BIOCHEM, V38, P1, DOI 10.1016/j.clinbiochem.2004.09.025; Finckh U, 2000, ARCH NEUROL-CHICAGO, V57, P1579, DOI 10.1001/archneur.57.11.1579; Ghidoni R, 2007, NEUROBIOL AGING, V28, P371, DOI 10.1016/j.neurobiolaging.2006.01.007; Herzig MC, 2004, NAT NEUROSCI, V7, P954, DOI 10.1038/nn1302; Levy E, 2006, BRAIN PATHOL, V16, P60, DOI 10.1111/j.1750-3639.2006.tb00562.x; Paraoan L, 2004, TRAFFIC, V5, P884, DOI 10.1111/j.1600-0854.2004.00230.x; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Selenica ML, 2007, SCAND J CLIN LAB INV, V67, P179, DOI 10.1080/00365510601009738	15	135	139	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2007	39	12					1437	1439		10.1038/ng.2007.23	http://dx.doi.org/10.1038/ng.2007.23			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	18026102				2022-12-27	WOS:000251267400009
J	Khetchoumian, K; Teletin, M; Tisserand, J; Mark, M; Herquel, B; Ignat, M; Zucman-Rossi, J; Cammas, F; Lerouge, T; Thibault, C; Metzger, D; Chambon, P; Losson, R				Khetchoumian, Konstantin; Teletin, Marius; Tisserand, Johan; Mark, Manuel; Herquel, Benjamin; Ignat, Mihaela; Zucman-Rossi, Jessica; Cammas, Florence; Lerouge, Thierry; Thibault, Christelle; Metzger, Daniel; Chambon, Pierre; Losson, Regine			Loss of Trim24 (Tif1 alpha) gene function confers oncogenic activity to retinoic acid receptor alpha	NATURE GENETICS			English	Article							NUCLEAR RECEPTORS; HEPATOCELLULAR-CARCINOMA; RAR-ALPHA; LIVER; CHEMOPREVENTION; EXPRESSION; PROTEIN; FAMILY; MEMBER; TIF1	Hepatocellular carcinoma ( HCC) is a major cause of death worldwide. Here, we provide evidence that the ligand-dependent nuclear receptor co-regulator Trim24 ( also known as Tif1 alpha) functions in mice as a liver-specific tumor suppressor. In Trim24-null mice, hepatocytes fail to execute proper cell cycle withdrawal during the neonatal-to-adult transition and continue to cycle in adult livers, becoming prone to a continuum of cellular alterations that progress toward metastatic HCC. Using pharmacological approaches, we show that inhibition of retinoic acid signaling markedly reduces hepatocyte proliferation in Trim24(-/-) mice. We further show that deletion of a single retinoic acid receptor alpha ( Rara) allele in a Trim24-null background suppresses HCC development and restores wild-type expression of retinoic acid-responsive genes in the liver, thus demonstrating that in this genetic background Rara expresses an oncogenic activity correlating with a dysregulation of the retinoic acid signaling pathway. Our results not only provide genetic evidence that Trim24 and Rara co-regulate hepatocarcinogenesis in an antagonistic manner but also suggest that aberrant activation of Rara is deleterious to liver homeostasis.	Univ Strasbourg 1, Coll France, Inst Genet Biol Mol & Cellulaire, Dept Funct Genom,Ctr Natl Rech Sci,Inst Natl Sant, F-67070 Illkirch Graffenstaden, France; Inst Univ Hematol, INSERM, U674, Ctr Polymorphisme Human, F-75010 Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Losson, R (corresponding author), Univ Strasbourg 1, Coll France, Inst Genet Biol Mol & Cellulaire, Dept Funct Genom,Ctr Natl Rech Sci,Inst Natl Sant, BP 10142, F-67070 Illkirch Graffenstaden, France.	losson@igbmc.u-strasbg.fr	zucman-rossi, Jessica/B-5098-2009; Cammas, florence m/D-1823-2017; j, zucman-rossi/AAV-3594-2021; TELETIN, Marius/P-6460-2016; TELETIN, Marius/AAS-2241-2020	zucman-rossi, Jessica/0000-0002-5687-0334; Cammas, florence m/0000-0003-4117-8182; j, zucman-rossi/0000-0002-5687-0334; TELETIN, Marius/0000-0002-3286-8125; TELETIN, Marius/0000-0002-3286-8125; Metzger, Daniel/0000-0002-5555-046X; Thibault-Carpentier, Christelle/0000-0003-1562-1451; Ignat, Mihaela/0000-0002-0250-3280				Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Chapellier B, 2002, GENESIS, V32, P87, DOI 10.1002/gene.10071; Di Bisceglie AM, 2005, J LAB CLIN MED, V145, P134, DOI 10.1016/j.lab.2005.01.003; Fausto N, 1999, SEMIN LIVER DIS, V19, P243, DOI 10.1055/s-2007-1007114; FRITH CH, 1994, PATHOLOGY TUMORS LAB, V2, P223; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Khetchoumian K, 2004, J BIOL CHEM, V279, P48329, DOI 10.1074/jbc.M404779200; LE DB, 1996, EMBO J, V15, P6701; Ledda-Columbano GM, 2004, CARCINOGENESIS, V25, P2061, DOI 10.1093/carcin/bgh221; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; LUFKIN T, 1993, P NATL ACAD SCI USA, V90, P7225, DOI 10.1073/pnas.90.15.7225; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Sano K, 2003, CLIN CANCER RES, V9, P3679; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Soprano DR, 2004, ANNU REV NUTR, V24, P201, DOI 10.1146/annurev.nutr.24.012003.132407; Sun SY, 2002, CRIT REV ONCOL HEMAT, V41, P41, DOI 10.1016/S1040-8428(01)00144-5; Teyssier C, 2006, MOL ENDOCRINOL, V20, P1276, DOI 10.1210/me.2005-0393; Venturini L, 1999, ONCOGENE, V18, P1209, DOI 10.1038/sj.onc.1202655; Wu H, 1996, GENE DEV, V10, P245, DOI 10.1101/gad.10.3.245; Zhong S, 1999, NAT GENET, V23, P287, DOI 10.1038/15463	22	122	124	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2007	39	12					1500	1506		10.1038/ng.2007.15	http://dx.doi.org/10.1038/ng.2007.15			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	18026104				2022-12-27	WOS:000251267400019
J	Egan, CM; Sridhar, S; Wigler, M; Hall, IM				Egan, Chris M.; Sridhar, Srinath; Wigler, Michael; Hall, Ira M.			Recurrent DNA copy number variation in the laboratory mouse	NATURE GENETICS			English	Article							OLIGONUCLEOTIDE MICROARRAY ANALYSIS; PRIMATE SEGMENTAL DUPLICATIONS; HUMAN GENOME; LINKAGE DISEQUILIBRIUM; ARRAY CGH; POLYMORPHISM; DELETION; RATES; MECHANISMS; FREQUENCY	Different species, populations and individuals vary considerably in the copy number of discrete segments of their genomes. The manner and frequency with which these genetic differences arise over generational time is not well understood. Taking advantage of divergence among lineages sharing a recent common ancestry, we have conducted a genome-wide analysis of spontaneous copy number variation (CNV) in the laboratory mouse. We used high-resolution microarrays to identify 38 CNVs among 14 colonies of the C57BL/6 strain spanning similar to 967 generations of inbreeding, and we examined these loci in 12 additional strains. It is clear from our results that many CNVs arise through a highly nonrandom process: 18 of 38 were the product of recurrent mutation, and rates of change varied roughly four orders of magnitude across different loci. Recurrent CNVs are found throughout the genome, affect 43 genes and fluctuate in copy number over mere hundreds of generations, observations that raise questions about their contribution to natural variation.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA	Cold Spring Harbor Laboratory; Carnegie Mellon University	Hall, IM (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	hall@cshl.edu		Wigler, Michael/0000-0003-4396-1971				Bailey JA, 2006, NAT REV GENET, V7, P552, DOI 10.1038/nrg1895; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Drake JW, 1998, GENETICS, V148, P1667; Haldane JBS, 1936, J GENET, V32, P375, DOI 10.1007/BF02982522; Han LL, 2000, HUM MOL GENET, V9, P1881, DOI 10.1093/hmg/9.12.1881; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hollies CR, 2001, EUR J HUM GENET, V9, P143, DOI 10.1038/sj.ejhg.5200590; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Huang Y, 2004, BIOINFORMATICS, V20, P460, DOI 10.1093/bioinformatics/btg429; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kipling D, 1996, NAT GENET, V13, P78, DOI 10.1038/ng0596-78; Lakshmi B, 2006, P NATL ACAD SCI USA, V103, P11234, DOI 10.1073/pnas.0602984103; Li JZ, 2004, NAT GENET, V36, P952, DOI 10.1038/ng1417; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lucito R, 2003, GENOME RES, V13, P2291, DOI 10.1101/gr.1349003; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Perry GH, 2006, P NATL ACAD SCI USA, V103, P8006, DOI 10.1073/pnas.0602318103; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; She XW, 2006, GENOME RES, V16, P576, DOI 10.1101/gr.4949406; Snijders AM, 2005, GENOME RES, V15, P302, DOI 10.1101/gr.2902505; TUSIELUNA MT, 1995, P NATL ACAD SCI USA, V92, P10796, DOI 10.1073/pnas.92.23.10796; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; van Ommen GJB, 2005, NAT GENET, V37, P333, DOI 10.1038/ng0405-333	30	114	119	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2007	39	11					1384	1389		10.1038/ng.2007.19	http://dx.doi.org/10.1038/ng.2007.19			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17965714				2022-12-27	WOS:000250575900023
J	Winkelmann, J; Schormair, B; Lichtner, P; Ripke, S; Xiong, L; Jalilzadeh, S; Fulda, S; Putz, B; Eckstein, G; Hauk, S; Trenkwalder, C; Zimprich, A; Stiasny-Kolster, K; Oertel, W; Bachmann, CG; Paulus, W; Peglau, I; Eisensehr, I; Montplaisir, J; Turecki, G; Rouleau, G; Gieger, C; Illig, T; Wichmann, E; Holsboer, F; Muller-Myhsok, B; Meitinger, T				Winkelmann, Juliane; Schormair, Barbara; Lichtner, Peter; Ripke, Stephan; Xiong, Lan; Jalilzadeh, Shapour; Fulda, Stephany; Putz, Benno; Eckstein, Gertrud; Hauk, Stephanie; Trenkwalder, Claudia; Zimprich, Alexander; Stiasny-Kolster, Karin; Oertel, Wolfgang; Bachmann, Cornelius G.; Paulus, Walter; Peglau, Ines; Eisensehr, Ilonka; Montplaisir, Jacques; Turecki, Gustavo; Rouleau, Guy; Gieger, Christian; Illig, Thomas; Wichmann, Erich; Holsboer, Florian; Muller-Myhsok, Bertram; Meitinger, Thomas			Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions	NATURE GENETICS			English	Article							POPULATION; ERK5	Restless legs syndrome (RLS) is a frequent neurological disorder characterized by an imperative urge to move the legs during night, unpleasant sensation in the lower limbs, disturbed sleep and increased cardiovascular morbidity. In a genome- wide association study we found highly significant associations between RLS and intronic variants in the homeobox gene MEIS1, the BTBD9 gene encoding a BTB(POZ) domain as well as variants in a third locus containing the genes encoding mitogen- activated protein kinase MAP2K5 and the transcription factor LBXCOR1 on chromosomes 2p, 6p and 15q, respectively. Two independent replications confirmed these association signals. Each genetic variant was associated with a more than 50% increase in risk for RLS, with the combined allelic variants conferring more than half of the risk. MEIS1 has been implicated in limb development, raising the possibility that RLS has components of a developmental disorder.	GSF Natl Res Ctr Environm & Hlth, Inst Human Genet, D-85764 Neuherberg, Germany; Max Planck Inst Psychiat, D-80804 Munich, Germany; Tech Univ Munich, Inst Human Genet, D-81675 Munich, Germany; Univ Montreal, Notre Dame Hosp, Ctr Rech CHUM, Lab Etude Maladies Cerveau, Montreal, PQ H2L 4M1, Canada; Paracelsus Elena Hosp, D-34128 Kassel, Germany; Med Univ Vienna, Dept Neurol, A-1090 Vienna, Austria; Univ Marburg, Dept Neurol, D-35039 Marburg, Germany; Univ Gottingen, Dept Clin Neurophysiol, D-37070 Gottingen, Germany; Neurol Praxis, D-10969 Berlin, Germany; Neurol Praxis, D-80331 Munich, Germany; Hop Sacre Coeur, Ctr Etud Sommeil, Montreal, PQ H4J 1C5, Canada; Univ Montreal, Ctr Rech Sci Neurol, Montreal, PQ H4J 1C5, Canada; McGill Univ, Dept Psychiat, Douglas Hosp, Verdun, PQ H4H 1R3, Canada; McGill Univ, Dept Human Genet, Douglas Hosp, Verdun, PQ H4H 1R3, Canada; GSF Natl Res Ctr Environm & Hlth, Inst Epidemiol, D-85764 Neuherberg, Germany; Univ Munich, Inst Med Informat Biometry & Epidemiol, D-81377 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Max Planck Society; Technical University of Munich; Universite de Montreal; Medical University of Vienna; Philipps University Marburg; University of Gottingen; Universite de Montreal; Universite de Montreal; McGill University; McGill University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Winkelmann, J (corresponding author), GSF Natl Res Ctr Environm & Hlth, Inst Human Genet, D-85764 Neuherberg, Germany.	janew@mpipsykl.mpg.de; meitinger@gsf.de	Trenkwalder, Claudia/ABD-6559-2021; Ripke, Stephan/AAK-5486-2021; Meitinger, Thomas/O-1318-2015; Paulus, Walter/A-3544-2009; Müller-Myhsok, Bertram/A-3289-2013; Zimprich, Alexander/A-5232-2017; Trenkwalder, Claudia/AHD-1232-2022; Pütz, Benno/P-2630-2016; Turecki, Gustavo/K-5100-2015; Fulda, Stephany/C-6867-2013	Paulus, Walter/0000-0001-5549-8377; Zimprich, Alexander/0000-0002-1668-5177; Trenkwalder, Claudia/0000-0001-6407-1199; Pütz, Benno/0000-0002-2208-209X; Meitinger, Thomas/0000-0002-8838-8403; Gieger, Christian/0000-0001-6986-9554; Winkelmann, Juliane/0000-0003-2667-9691; Turecki, Gustavo/0000-0003-4075-2736; ripke, stephan/0000-0003-3622-835X; Fulda, Stephany/0000-0001-8416-2610				*ALL I BRAINSCI, 2004, ALL BRAIN ATL; Allen RP, 2003, SLEEP MED, V4, P101, DOI 10.1016/S1389-9457(03)00010-8; Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; Bara-Jimenez W, 2000, NEUROLOGY, V54, P1609, DOI 10.1212/WNL.54.8.1609; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barriere G, 2005, PROG NEUROBIOL, V77, P139, DOI 10.1016/j.pneurobio.2005.10.007; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cavanaugh JE, 2006, J NEUROSCI RES, V84, P1367, DOI 10.1002/jnr.21024; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Dinev D, 2001, EMBO REP, V2, P829, DOI 10.1093/embo-reports/kve177; DUBDRIDGE F, 2006, 20065 MRC BIOST UN C; GODT D, 1993, DEVELOPMENT, V119, P799; Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6; Kemlink D, 2007, MOVEMENT DISORD, V22, P207, DOI 10.1002/mds.21254; Maeda R, 2001, ONCOGENE, V20, P1329, DOI 10.1038/sj.onc.1204250; Mercader N, 1999, NATURE, V402, P425, DOI 10.1038/46580; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Plagnol V, 2007, PLOS GENET, V3, P759, DOI 10.1371/journal.pgen.0030074; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rajaram SS, 2004, SLEEP, V27, P767; RAO S, 2007, RESTLESS LEGS SYNDRO, P111; Rowe AK, 2004, AM J PREV MED, V26, P243, DOI 10.1016/j.amepre.2003.12.007; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Walters AS, 1996, NEUROLOGY, V46, P92, DOI 10.1212/WNL.46.1.92; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Winkelman JW, 2006, SLEEP MED, V7, P545, DOI 10.1016/j.sleep.2006.01.004; WINKELMANN J, 2007, MOV DISORD	30	474	488	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2007	39	8					1000	1006		10.1038/ng2099	http://dx.doi.org/10.1038/ng2099			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17637780				2022-12-27	WOS:000248446900018
J	Loudet, O; Saliba-Colombani, V; Camilleri, C; Calenge, F; Gaudon, V; Koprivova, A; North, KA; Kopriva, S; Daniel-Vedele, F				Loudet, Olivier; Saliba-Colombani, Vera; Camilleri, Christine; Calenge, Fanny; Gaudon, Virginie; Koprivova, Anna; North, Kathryn A.; Kopriva, Stanislav; Daniel-Vedele, Francoise			Natural variation for sulfate content in Arabidopsis thaliana is highly controlled by APR2	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; ADENOSINE 5'-PHOSPHOSULFATE REDUCTASE; HETEROGENEOUS INBRED FAMILY; SULFUR METABOLISM; NITROGEN; GLUTATHIONE; PLANTS; TRANSFORMATION; BIOSYNTHESIS; ASSIMILATION	Most agronomic traits of importance, whether physiological ( such as nutrient use efficiency) or developmental ( such as flowering time), are controlled simultaneously by multiple genes and their interactions with the environment. Here, we show that variation in sulfate content between wild Arabidopsis thaliana accessions Bay- 0 and Shahdara is controlled by a major quantitative trait locus that results in a strong interaction with nitrogen availability in the soil. Combining genetic and biochemical results and using a candidate gene approach, we have cloned the underlying gene, showing how a single - amino acid substitution in a key enzyme of the assimilatory sulfate reduction pathway, adenosine 5'- phosphosulfate reductase, is responsible for a decrease in enzyme activity, leading to sulfate accumulation in the plant. This work illustrates the potential of natural variation as a source of new alleles of known genes, which can aid in the study of gene function and metabolic pathway regulation. Our new insights on sulfate assimilation may have an impact on sulfur fertilizer use and stress defense improvement.	INRA, SGAP, F-78026 Versailles, France; INRA, Lab Nutr Azotee Plantes, NAP, F-78026 Versailles, France; John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England	INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Loudet, O (corresponding author), INRA, SGAP, Rte St Cyr, F-78026 Versailles, France.	loudet@versailles.inra.fr	Kopriva, Stanislav/C-7401-2013; Loudet, Olivier/CAF-7559-2022; Loudet, Olivier/K-8266-2012	Kopriva, Stanislav/0000-0002-7416-6551; Loudet, Olivier/0000-0003-3717-0137; CALENGE, Fanny/0000-0003-3529-3387				Brunold C., 1990, METHODS PLANT BIOCH, P339; CHURCHILL GA, 1994, GENETICS, V138, P963; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Creissen G, 1999, PLANT CELL, V11, P1277, DOI 10.1105/tpc.11.7.1277; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; Hawkesford MJ, 2006, PLANT CELL ENVIRON, V29, P382, DOI 10.1111/j.1365-3040.2005.01470.x; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hesse H, 2004, J EXP BOT, V55, P1283, DOI 10.1093/jxb/erh136; Koornneef M, 2004, ANNU REV PLANT BIOL, V55, P141, DOI 10.1146/annurev.arplant.55.031903.141605; Kopriva S, 2004, J EXP BOT, V55, P1775, DOI 10.1093/jxb/erh185; Koprivova A, 2000, PLANT PHYSIOL, V122, P737, DOI 10.1104/pp.122.3.737; Loudet O, 2005, THEOR APPL GENET, V110, P742, DOI 10.1007/s00122-004-1900-9; Loudet O, 2003, GENETICS, V163, P711; Loudet O, 2003, PLANT PHYSIOL, V131, P345, DOI 10.1104/pp.102.010785; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; Mackay TFC, 2004, NAT GENET, V36, P1145, DOI 10.1038/ng1104-1145; McGrath SP, 1996, J AGR SCI, V126, P53, DOI 10.1017/S0021859600088808; McKhann HI, 2004, PLANT J, V38, P193, DOI 10.1111/j.1365-313X.2004.02034.x; Mejlhede N, 2006, PLANT BREEDING, V125, P461, DOI 10.1111/j.1439-0523.2006.01226.x; Noctor G, 1998, J EXP BOT, V49, P623, DOI 10.1093/jexbot/49.321.623; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; STROHM M, 1995, PLANT J, V7, P141, DOI 10.1046/j.1365-313X.1995.07010141.x; Tuinstra MR, 1997, THEOR APPL GENET, V95, P1005, DOI 10.1007/s001220050654; Vauclare P, 2002, PLANT J, V31, P729, DOI 10.1046/j.1365-313X.2002.01391.x; Weigel D, 2005, PLANT PHYSIOL, V138, P567, DOI 10.1104/pp.104.900157	28	116	121	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39	7					896	900		10.1038/ng2050	http://dx.doi.org/10.1038/ng2050			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17589509				2022-12-27	WOS:000247619800021
J	Marchini, J; Howie, B; Myers, S; McVean, G; Donnelly, P				Marchini, Jonathan; Howie, Bryan; Myers, Simon; McVean, Gil; Donnelly, Peter			A new multipoint method for genome-wide association studies by imputation of genotypes	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; POPULATION-STRUCTURE; GENETIC ASSOCIATION; LARGE-SCALE; MODEL; LOCI; DISEASES; TCF7L2; RISK	Genome- wide association studies are set to become the method of choice for uncovering the genetic basis of human diseases. A central challenge in this area is the development of powerful multipoint methods that can detect causal variants that have not been directly genotyped. We propose a coherent analysis framework that treats the problem as one involving missing or uncertain genotypes. Central to our approach is a model- based imputation method for inferring genotypes at observed or unobserved SNPs, leading to improved power over existing methods for multipoint association mapping. Using real genome- wide association study data, we show that our approach ( i) is accurate and well calibrated, ( ii) provides detailed views of associated regions that facilitate follow- up studies and ( iii) can be used to validate and correct data at genotyped markers. A notable future use of our method will be to boost power by combining data from genome- wide scans that use different SNP sets.	Univ Oxford, Dept Stat, Oxford OX1 3TG, England	University of Oxford	Donnelly, P (corresponding author), Univ Oxford, Dept Stat, 1 S Pk Rd, Oxford OX1 3TG, England.	donnelly@stats.ox.ac.uk	Myers, Simon R/A-6792-2015; Peng, Bo/A-6920-2009; Marchini, Jonathan/ABE-9024-2020	Myers, Simon R/0000-0002-2585-9626; Peng, Bo/0000-0001-8225-2284; Marchini, Jonathan/0000-0003-0610-8322; Donnelly, Peter/0000-0001-9495-3408	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Conrad DF, 2006, NAT GENET, V38, P1251, DOI 10.1038/ng1911; Cordell HJ, 2006, GENET EPIDEMIOL, V30, P259, DOI 10.1002/gepi.20142; Crawford DC, 2004, NAT GENET, V36, P700, DOI 10.1038/ng1376; de Bakker PIW, 2006, NAT GENET, V38, P1298, DOI 10.1038/ng1899; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Eyheramendy S, 2007, GENOME RES, V17, P88, DOI 10.1101/gr.5675406; Falush D, 2003, GENETICS, V164, P1567; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Groves CJ, 2006, DIABETES, V55, P2640, DOI 10.2337/db06-0355; Kraft P, 2005, GENET EPIDEMIOL, V28, P261, DOI 10.1002/gepi.20061; LANDER ES, 1987, P NATL ACAD SCI USA, V84, P2363, DOI 10.1073/pnas.84.8.2363; Li N, 2003, GENETICS, V165, P2213; Marchini J, 2005, NAT GENET, V37, P413, DOI 10.1038/ng1537; Morris AP, 2005, GENET EPIDEMIOL, V29, P91, DOI 10.1002/gepi.20080; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; RISCH N, 1996, SCIENCE, V273, P1517; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Sen S, 2001, GENETICS, V159, P371; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Zollner S, 2005, GENETICS, V169, P1071, DOI 10.1534/genetics.104.031799	27	1909	1939	1	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2007	39	7					906	913		10.1038/ng2088	http://dx.doi.org/10.1038/ng2088			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17572673				2022-12-27	WOS:000247619800023
J	Todd, JA; Walker, NM; Cooper, JD; Smyth, DJ; Downes, K; Plagnol, V; Bailey, R; Nejentsev, S; Field, SF; Payne, F; Lowe, CE; Szeszko, JS; Hafler, JP; Zeitels, L; Yang, JHM; Vella, A; Nutland, S; Stevens, HE; Schuilenburg, H; Coleman, G; Maisuria, M; Meadows, W; Smink, LJ; Healy, B; Burren, OS; Lam, AAC; Ovington, NR; Allen, J; Adlem, E; Leung, HT; Wallace, C; Howson, JMM; Guja, C; Ionescu-Tirgoviste, C; Simmonds, MJ; Heward, JM; Gough, SCL; Dunger, DB; Wicker, LS; Clayton, DG				Todd, John A.; Walker, Neil M.; Cooper, Jason D.; Smyth, Deborah J.; Downes, Kate; Plagnol, Vincent; Bailey, Rebecca; Nejentsev, Sergey; Field, Sarah F.; Payne, Felicity; Lowe, Christopher E.; Szeszko, Jeffrey S.; Hafler, Jason P.; Zeitels, Lauren; Yang, Jennie H. M.; Vella, Adrian; Nutland, Sarah; Stevens, Helen E.; Schuilenburg, Helen; Coleman, Gillian; Maisuria, Meeta; Meadows, William; Smink, Luc J.; Healy, Barry; Burren, Oliver S.; Lam, Alex A. C.; Ovington, Nigel R.; Allen, James; Adlem, Ellen; Leung, Hin-Tak; Wallace, Chris; Howson, Joanna M. M.; Guja, Cristian; Ionescu-Tirgoviste, Constantin; Simmonds, Matthew J.; Heward, Joanne M.; Gough, Stephen C. L.; Dunger, David B.; Wicker, Linda S.; Clayton, David G.		Genetics Type 1 Diabet Finland; Wellcome Trust Case Control Consor	Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes	NATURE GENETICS			English	Article							TYROSINE-PHOSPHATASE; GENE; DISEASE; LOCUS; SNPS; SUSCEPTIBILITY; POLYMORPHISMS; AUTOIMMUNITY	The Wellcome Trust Case Control Consortium ( WTCCC) primary genome- wide association ( GWA) scan(1) on seven diseases, including the multifactorial autoimmune disease type 1 diabetes ( T1D), shows associations at P < 5 x 10(-7) between T1D and six chromosome regions: 12q24, 12q13, 16p13, 18p11, 12p13 and 4q27. Here, we attempted to validate these and six other top findings in 4,000 individuals with T1D, 5,000 controls and 2,997 family trios independent of the WTCCC study. We confirmed unequivocally the associations of 12q24, 12q13, 16p13 and 18p11 ( P(follow- up) <= 1.35 similar to 10(-9); P(overall) <= 1.15 x 10(-14)), leaving eight regions with small effects or false- positive associations. We also obtained evidence for chromosome 18q22 ( P(overall) 1.38 x 10(-8)) from a GWA study of nonsynonymous SNPs. Several regions, including 18q22 and 18p11, showed association with autoimmune thyroid disease. This study increases the number of T1D loci with compelling evidence from six to at least ten.	Univ Cambridge, Addenbrookes Hosp, Med Res Inst,Dept Med Genet, Juvenile Diabet Res Fdn,Wellcome Trust Diabet & I, Cambridge CB2 0XY, England; Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, Dept Clin Pharmacol, London EC1M 6BQ, England; Inst Diabet Endocrinol & Metab Dis, Diabet Clin, Nutr & Metab Dis N Paulescu, Bucharest 79811, Romania; Natl Publ Hlth Inst, Genet Type Diabet Finland 1, GET1FIN, Dept Hlth Promot & Chron Dis Prevent,Diabet Unit, Helsinki, Finland; Univ Birmingham, Div Med Sci, Birmingham B15 2TT, W Midlands, England; Univ Cambridge, Wellcome Trust Case Control Consortium, Cambridge CB2 0XY, England; Univ Cambridge, Addenbrookes Hosp, Dept Paediat, Cambridge CB2 0QY, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; Queen Mary University London; National Institute of Endocrinology C.I. Parhon; Finland National Institute for Health & Welfare; University of Birmingham; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Todd, JA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Med Res Inst,Dept Med Genet, Juvenile Diabet Res Fdn,Wellcome Trust Diabet & I, Cambridge CB2 0XY, England.	john.todd@cimr.cam.ac.uk	Wicker, Linda S/F-7384-2010; Plagnol, Vincent/A-5667-2011; Guja, Cristian/K-2334-2019; Todd, John A/A-3542-2010; Brown, Matthew A/E-5749-2010; Payne, Felicity/GKF-2573-2022; Allen, James/B-2457-2009	Todd, John A/0000-0003-2740-8148; Brown, Matthew A/0000-0003-0538-8211; Payne, Felicity/0000-0003-4228-581X; Wallace, Chris/0000-0001-9755-1703; Simmonds, Matt/0000-0003-3154-3510; Plagnol, Vincent/0000-0002-5597-9215; Morgan, Ann/0000-0003-1109-624X; Burren, Oliver/0000-0002-3388-5760; Walker, Neil/0000-0001-9796-7688; Allen, James/0000-0002-3894-4854; Dunger, Professor David/0000-0002-2566-9304; Howson, Joanna/0000-0001-7618-0050; smyth, deborah/0000-0002-6330-2669; Schuilenburg, Helen/0000-0002-0040-6591; Schofield, Ellen/0000-0003-0648-1418	MRC [G0000934] Funding Source: UKRI; Medical Research Council [G0000934] Funding Source: Medline; Wellcome Trust [089989, 061859, 061858] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Bottini N, 2006, SEMIN IMMUNOL, V18, P207, DOI 10.1016/j.smim.2006.03.008; Brand OJ, 2007, CLIN ENDOCRINOL, V66, P508, DOI 10.1111/j.1365-2265.2007.02762.x; Brassat D, 2006, GENES IMMUN, V7, P310, DOI 10.1038/sj.gene.6364299; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Clayton D, 2007, HUM HERED, V64, P45, DOI 10.1159/000101422; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Dardalhon V, 2005, J IMMUNOL, V175, P1558, DOI 10.4049/jimmunol.175.3.1558; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Hardenbol P, 2005, GENOME RES, V15, P269, DOI 10.1101/gr.3185605; Hulbert EM, 2007, NUCLEIC ACIDS RES, V35, pD742, DOI 10.1093/nar/gkl933; Hyttinen V, 2003, DIABETES, V52, P1052, DOI 10.2337/diabetes.52.4.1052; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Lowe CE, 2004, GENES IMMUN, V5, P301, DOI 10.1038/sj.gene.6364064; PLAGNOL V, 2007, PLOS GENET; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Todd JA, 2006, NAT GENET, V38, P731, DOI 10.1038/ng0706-731; TODD JA, 1991, DIABETIC MED, V8, P906, DOI 10.1111/j.1464-5491.1991.tb01528.x; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Zelensky AN, 2005, FEBS J, V272, P6179, DOI 10.1111/j.1742-4658.2005.05031.x	30	1111	1149	0	54	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2007	39	7					857	864		10.1038/ng2068	http://dx.doi.org/10.1038/ng2068			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17554260	Green Accepted			2022-12-27	WOS:000247619800015
J	Bourdon, A; Minai, L; Serre, V; Jais, JP; Sarzi, E; Aubert, S; Chretien, D; de Lonlay, P; Paquis-Flucklinger, V; Arakawa, H; Nakamura, Y; Munnich, A; Rotig, A				Bourdon, Alice; Minai, Limor; Serre, Valerie; Jais, Jean-Philippe; Sarzi, Emmanuelle; Aubert, Sophie; Chretien, Dominique; de Lonlay, Pascale; Paquis-Flucklinger, Veronique; Arakawa, Hirofumi; Nakamura, Yusuke; Munnich, Arnold; Rotig, Agnes			Mutation of RRM2B, encoding p53-controlled ribonucleotide reductase (p53R2), causes severe mitochondrial DNA depletion	NATURE GENETICS			English	Article							SWISS-MODEL; R2 PROTEIN; DNTP POOLS; GENE; ENCEPHALOMYOPATHY; CLUSPRO; DOCKING; KINASE; DAMAGE; CELLS	Mitochondrial DNA (mtDNA) depletion syndrome (MDS; MIM 251880) is a prevalent cause of oxidative phosphorylation disorders characterized by a reduction in mtDNA copy number. The hitherto recognized disease mechanisms alter either mtDNA replication (POLG (ref. 1)) or the salvage pathway of mitochondrial deoxyribonucleosides 5'- triphosphates (dNTPs) for mtDNA synthesis (DGUOK (ref. 2), TK2 (ref. 3) and SUCLA2 (ref. 4)). A last gene, MPV17 ( ref. 5), has no known function. Yet the majority of cases remain unexplained. Studying seven cases of profound mtDNA depletion (1-2% residual mtDNA in muscle) in four unrelated families, we have found nonsense, missense and splice-site mutations and in-frame deletions of the RRM2B gene, encoding the cytosolic p53-inducible ribonucleotide reductase small subunit. Accordingly, severe mtDNA depletion was found in various tissues of the Rrm2b(-/-) mouse. The mtDNA depletion triggered by p53R2 alterations in both human and mouse implies that p53R2 has a crucial role in dNTP supply for mtDNA synthesis.	Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France; Hop Necker Enfants Malad, Serv Genet, F-75015 Paris, France; Univ Paris 07, F-75005 Paris, France; Univ Paris 05, Hop Necker Enfants Malad, Fac Med, Serv Biostat & Informat, F-75015 Paris, France; Archet 2 Hosp, Dept Med Genet, F-06107 Nice, France; Univ Tokyo, Inst Med Sci, Human Genome Ctr, Minato Ku, Tokyo 1088639, Japan	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; CHU Nice; University of Tokyo	Rotig, A (corresponding author), Hop Necker Enfants Malad, INSERM, U781, 149 Rue Sevres, F-75015 Paris, France.	roetig@necker.fr	Rötig, Agnès/G-9592-2017; Arakawa, Hirofumi/L-3459-2013; JAIS, Jean-Philippe/B-2993-2009	Rötig, Agnès/0000-0003-0589-0703; Arakawa, Hirofumi/0000-0001-6077-0638; JAIS, Jean-Philippe/0000-0002-0708-8776; Sarzi, Emmanuelle/0000-0002-7623-6699				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Butow RA, 2004, MOL CELL, V14, P1, DOI 10.1016/S1097-2765(04)00179-0; Chabes AL, 2003, P NATL ACAD SCI USA, V100, P3925, DOI 10.1073/pnas.0330774100; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Eklund H, 2001, PROG BIOPHYS MOL BIO, V77, P177, DOI 10.1016/S0079-6107(01)00014-1; Elpeleg O, 2005, AM J HUM GENET, V76, P1081, DOI 10.1086/430843; Ferrari G, 2005, BRAIN, V128, P723, DOI 10.1093/brain/awh410; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; Kimura T, 2003, NAT GENET, V34, P440, DOI 10.1038/ng1212; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613; LYCKSELL PO, 1994, BIOCHEMISTRY-US, V33, P2838, DOI 10.1021/bi00176a013; Mandel H, 2001, NAT GENET, V29, P337, DOI 10.1038/ng746; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; PAQUISFLUCKLINGER V, 1995, EUR J PEDIATR, V154, P557, DOI 10.1007/BF02074834; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; SARZI E, IN PRESS J PEDIATR; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Spinazzola A, 2006, NAT GENET, V38, P570, DOI 10.1038/ng1765; Tanaka H, 2000, NATURE, V404, P42, DOI 10.1038/35003506; Zhou BS, 2003, CANCER RES, V63, P6583	26	418	433	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2007	39	6					776	780		10.1038/ng2040	http://dx.doi.org/10.1038/ng2040			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17486094				2022-12-27	WOS:000246859100022
J	Svistoonoff, S; Creff, A; Reymond, M; Sigoillot-Claude, C; Ricaud, L; Blanchet, A; Nussaume, L; Desnos, T				Svistoonoff, Sergio; Creff, Audrey; Reymond, Matthieu; Sigoillot-Claude, Cecile; Ricaud, Lilian; Blanchet, Aline; Nussaume, Laurent; Desnos, Thierry			Root tip contact with low-phosphate media reprograms plant root architecture	NATURE GENETICS			English	Article							SYSTEM ARCHITECTURE; ARABIDOPSIS; AVAILABILITY; STARVATION; ADAPTATION; COMPONENT; OXIDASES; LACCASE	Plant roots are able to sense soil nutrient availability. In order to acquire heterogeneously distributed water and minerals(1-3), they optimize their root architecture. One poorly understood plant response to soil phosphate ( Pi) deficiency is a reduction in primary root growth with an increase in the number and length of lateral roots(4-12). Here we show that physical contact of the Arabidopsis thaliana primary root tip with low-P-i medium is necessary and sufficient to arrest root growth. We further show that loss-of-function mutations in Low Phosphate Root1 (LPR1) and its close paralog LPR2 strongly reduce this inhibition. LPR1 was previously mapped as a major quantitative trait locus (QTL)(12); the molecular origin of this QTL is explained by the differential allelic expression of LPR1 in the root cap. These results provide strong evidence for the involvement of the root cap in sensing nutrient deficiency, responding to it, or both. LPR1 and LPR2 encode multicopper oxidases (MCOs), highlighting the essential role of MCOs for plant development.	Univ Aix Marseille 2, CNRS, CEA, UMR 6191,Lab Biol Dev Plantes,Dept Ecophysiol Veg, F-13108 St Paul Les Durance, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Desnos, T (corresponding author), Univ Aix Marseille 2, CNRS, CEA, UMR 6191,Lab Biol Dev Plantes,Dept Ecophysiol Veg, F-13108 St Paul Les Durance, France.	thierry.desnos@cea.fr	SVISTOONOFF, Sergio/X-9659-2019; NUSSAUME, Laurent/AAA-5980-2022; NUSSAUME, Laurent/AAB-8312-2020	SVISTOONOFF, Sergio/0000-0001-8554-2922; NUSSAUME, Laurent/0000-0002-9445-2563; DESNOS, Thierry/0000-0002-6585-1362				Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Chevalier F, 2003, PLANT CELL ENVIRON, V26, P1839, DOI 10.1046/j.1365-3040.2003.01100.x; CHIDAMBARAM MV, 1984, J INORG BIOCHEM, V22, P231, DOI 10.1016/0162-0134(84)85008-4; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; CURZON G, 1960, BIOCHEM J, V77, P66, DOI 10.1042/bj0770066; DECAMPILLO E, 2004, PLANT MOL BIOL, V56, P309; Enguita FJ, 2003, J BIOL CHEM, V278, P19416, DOI 10.1074/jbc.M301251200; Forde B, 2001, PLANT SOIL, V232, P51, DOI 10.1023/A:1010329902165; Franco-Zorrilla JM, 2005, PLANT PHYSIOL, V138, P847, DOI 10.1104/pp.105.060517; Herbette S, 2006, BIOCHIMIE, V88, P1751, DOI 10.1016/j.biochi.2006.04.018; Hinsinger P, 2001, PLANT SOIL, V237, P173, DOI 10.1023/A:1013351617532; Kramer EM, 2006, TRENDS PLANT SCI, V11, P382, DOI 10.1016/j.tplants.2006.06.002; Lopez-Bucio J, 2003, CURR OPIN PLANT BIOL, V6, P280, DOI 10.1016/S1369-5266(03)00035-9; Lopez-Bucio J, 2002, PLANT PHYSIOL, V129, P244, DOI 10.1104/pp.010934; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; Lynch JP, 2001, PLANT SOIL, V237, P225, DOI 10.1023/A:1013324727040; Malamy JE, 2005, PLANT CELL ENVIRON, V28, P67, DOI 10.1111/j.1365-3040.2005.01306.x; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; Misson J, 2004, PLANT MOL BIOL, V55, P727, DOI 10.1007/s11103-004-1965-5; Naito K, 2005, GENETICS, V169, P881, DOI 10.1534/genetics.104.033654; Nakamura K, 2005, CELL MOL LIFE SCI, V62, P2050, DOI 10.1007/s00018-004-5076-x; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; Reymond M, 2006, PLANT CELL ENVIRON, V29, P115, DOI 10.1111/j.1365-3040.2005.01405.x; Sanchez-Calderon L, 2006, PLANT PHYSIOL, V140, P879, DOI 10.1104/pp.105.073825; Sanchez-Calderon L, 2005, PLANT CELL PHYSIOL, V46, P174, DOI 10.1093/pcp/pci011; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; Ticconi CA, 2004, TRENDS PLANT SCI, V9, P548, DOI 10.1016/j.tplants.2004.09.003; Tsugeki R, 1999, P NATL ACAD SCI USA, V96, P12941, DOI 10.1073/pnas.96.22.12941; Williamson LC, 2001, PLANT PHYSIOL, V126, P875, DOI 10.1104/pp.126.2.875; Witte CP, 2004, PLANT MOL BIOL, V55, P135, DOI 10.1007/s11103-004-0501-y	30	416	448	3	150	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2007	39	6					792	796		10.1038/ng2041	http://dx.doi.org/10.1038/ng2041			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17496893				2022-12-27	WOS:000246859100025
J	Julien, SG; Dube, N; Read, M; Penney, J; Paquet, M; Han, YX; Kennedy, BP; Muller, WJ; Tremblay, ML				Julien, Sofi G.; Dube, Nadia; Read, Michelle; Penney, Janice; Paquet, Marilene; Han, Yongxin; Kennedy, Brian P.; Muller, William J.; Tremblay, Michel L.			Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis	NATURE GENETICS			English	Article							HUMAN BREAST-CANCER; TRANSGENIC MICE; NEU ONCOGENE; CYCLIN D1; SIGNALING PATHWAY; EPITHELIAL-CELLS; POINT MUTATION; ERBB RECEPTORS; TRANSFORMATION; KINASE	We investigated the role of protein tyrosine phosphatase 1B (PTP1B) in mammary tumorigenesis using both genetic and pharmacological approaches. It has been previously shown that transgenic mice with a deletion mutation in the region of Erbb2 encoding its extracellular domain (referred to as NDL2 mice, for 'Neu deletion in extracellular domain 2') develop mammary tumors that progress to lung metastasis. However, deletion of PTP1B activity in the NDL2 transgenic mice either by breeding with Ptpn1-deficient mice or by treatment with a specific PTP1B inhibitor results in significant mammary tumor latency and resistance to lung metastasis. In contrast, specific overexpression of PTP1B in the mammary gland leads to spontaneous breast cancer development. The regulation of ErbB2-induced mammary tumorigenesis by PTB1B occurs through the attenuation of both the MAP kinase (MAPK) and Akt pathways. This report provides a rationale for the development of PTP1B as a new therapeutic target in breast cancer.	McGill Univ, Ctr Canc, Montreal, PQ H3G 1Y6, Canada; McGill Univ, Vet Pathol Serv, Montreal, PQ H3G 1Y6, Canada; Merck Frosst Ctr Therapeut Res, Pointe Claire, PQ H9R 4P8, Canada; McGill Univ, Royal Victoria Hosp, Mol Oncol Grp, Montreal, PQ H3A 1A1, Canada; McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; Merck & Company; McGill University; Royal Victoria Hospital; McGill University	Tremblay, ML (corresponding author), McGill Univ, Ctr Canc, 3655 Sir William Osler Promenade, Montreal, PQ H3G 1Y6, Canada.	michel.tremblay@mcgill.ca	Paquet, Marilene/L-3414-2019	Paquet, Marilene/0000-0002-3562-4636; Julien, Sophie/0000-0003-2694-7211				Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Andrechek ER, 2003, CANCER RES, V63, P4920; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BARGMANN CI, 1988, EMBO J, V7, P2043, DOI 10.1002/j.1460-2075.1988.tb03044.x; Baselga J, 2002, CANCER CELL, V1, P319, DOI 10.1016/S1535-6108(02)00066-1; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Bjorge JD, 2000, J BIOL CHEM, V275, P41439, DOI 10.1074/jbc.M004852200; Bourdeau A, 2005, CURR OPIN CELL BIOL, V17, P203, DOI 10.1016/j.ceb.2005.02.001; BROWNSHIMER S, 1992, CANCER RES, V52, P478; Cheng A, 2001, J BIOL CHEM, V276, P25848, DOI 10.1074/jbc.M009734200; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Dube N, 2005, CANCER RES, V65, P10088, DOI 10.1158/0008-5472.CAN-05-1353; Dube N, 2004, P NATL ACAD SCI USA, V101, P1834, DOI 10.1073/pnas.0304242101; Dube N, 2004, CELL CYCLE, V3, P550; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Freiss G, 2004, CRIT REV ONCOL HEMAT, V52, P9, DOI 10.1016/j.critrevonc.2004.05.004; Hutchinson JN, 2000, ONCOGENE, V19, P6130, DOI 10.1038/sj.onc.1203970; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Kaminski R, 2006, CANCER RES, V66, P5757, DOI 10.1158/0008-5472.CAN-05-3536; Kwong KY, 1998, MOL CARCINOGEN, V23, P62, DOI 10.1002/(SICI)1098-2744(199810)23:2<62::AID-MC2>3.0.CO;2-O; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Lane HA, 2000, MOL CELL BIOL, V20, P3210, DOI 10.1128/MCB.20.9.3210-3223.2000; Lee RJ, 2000, MOL CELL BIOL, V20, P672, DOI 10.1128/MCB.20.2.672-683.2000; Lenferink AEG, 2001, CANCER RES, V61, P6583; Lin HJ, 2005, BRIT J CANCER, V93, P1372, DOI 10.1038/sj.bjc.6602862; Liu F, 1998, MOL CELL BIOL, V18, P250, DOI 10.1128/MCB.18.1.250; Liu H, 2006, P NATL ACAD SCI USA, V103, P4134, DOI 10.1073/pnas.0511342103; Montalibet J, 2006, J BIOL CHEM, V281, P5258, DOI 10.1074/jbc.M511546200; Muraoka RS, 2002, MOL CELL BIOL, V22, P2204, DOI 10.1128/MCB.22.7.2204-2219.2002; Neve RM, 2000, ONCOGENE, V19, P1647, DOI 10.1038/sj.onc.1203470; Normanno N, 2003, ENDOCR-RELAT CANCER, V10, P1, DOI 10.1677/erc.0.0100001; Ostman A, 2001, TRENDS CELL BIOL, V11, P258, DOI 10.1016/S0962-8924(01)01990-0; Perez-Nadales E, 2004, BREAST CANCER RES, V6, P137, DOI 10.1186/bcr792; Rowland BD, 2005, NAT CELL BIOL, V7, P1074, DOI 10.1038/ncb1314; Siegel PM, 1999, EMBO J, V18, P2149, DOI 10.1093/emboj/18.8.2149; SIEGEL PM, 1994, MOL CELL BIOL, V14, P7068, DOI 10.1128/MCB.14.11.7068; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Slamon DJ, 2004, ONCOLOGIST, V9, P1, DOI 10.1634/theoncologist.9-suppl_3-1; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Tamir I, 2000, IMMUNITY, V12, P347, DOI 10.1016/S1074-7613(00)80187-9; WIENER JR, 1994, AM J OBSTET GYNECOL, V170, P1177, DOI 10.1016/S0002-9378(94)70118-0; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; ZHAI YF, 1993, CANCER RES, V53, P2272; Zhao MM, 2006, MOL CELL BIOL, V26, P2479, DOI 10.1128/MCB.26.7.2479-2489.2006	44	258	270	1	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2007	39	3					338	346		10.1038/ng1963	http://dx.doi.org/10.1038/ng1963			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17259984				2022-12-27	WOS:000244480000015
J	Schlesinger, Y; Straussman, R; Keshet, I; Farkash, S; Hecht, M; Zimmerman, J; Eden, E; Yakhini, Z; Ben-Shushan, E; Reubinoff, BE; Bergman, Y; Simon, I; Cedar, H				Schlesinger, Yeshayahu; Straussman, Ravid; Keshet, Ilana; Farkash, Shlomit; Hecht, Merav; Zimmerman, Joseph; Eden, Eran; Yakhini, Zohar; Ben-Shushan, Etti; Reubinoff, Benjamin E.; Bergman, Yehudit; Simon, Itamar; Cedar, Howard			Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer	NATURE GENETICS			English	Article							DNA METHYLATION; CPG ISLAND; DEVELOPMENTAL REGULATORS; METHYLTRANSFERASES; INACTIVATION; EXPRESSION; LYSINE-27; OCT-3/4; GENOME; SUZ12	Many genes associated with CpG islands undergo de novo methylation in cancer. Studies have suggested that the pattern of this modification may be partially determined by an instructive mechanism that recognizes specifically marked regions of the genome(1). Using chromatin immunoprecipitation analysis, here we show that genes methylated in cancer cells are specifically packaged with nucleosomes containing histone H3 trimethylated on Lys27. This chromatin mark is established on these unmethylated CpG island genes early in development and then maintained in differentiated cell types by the presence of an EZH2- containing Polycomb complex(2,3). In cancer cells(4), as opposed to normal cells, the presence of this complex brings about the recruitment of DNA methyl transferases, leading to de novo methylation. These results suggest that tumor-specific targeting of de novo methylation is pre-programmed by an established epigenetic system that normally has a role in marking embryonic genes for repression(2).	Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Cellular Biochem & Human Genet, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Mol Biol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Gastroenterol, IL-91120 Jerusalem, Israel; Technion Israel Inst Technol, Dept Comp Sci, IL-32000 Haifa, Israel; Agilent Technol, IL-43527 Tel Aviv, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Obstet & Gynecol, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Goldyn Savad Inst Genet Therapy, IL-91120 Jerusalem, Israel; Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Expt Med, IL-91120 Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Technion Israel Institute of Technology; Agilent Technologies; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem	Cedar, H (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Cellular Biochem & Human Genet, IL-91120 Jerusalem, Israel.	cedar@md.huji.ac.il		Yakhini, Zohar/0000-0002-0420-5412; Reubinoff, Benjamin/0000-0003-0353-1299; Simon, Itamar/0000-0002-8517-1903				Alaminos M, 2004, JNCI-J NATL CANCER I, V96, P1208, DOI 10.1093/jnci/djh224; Bestor TH, 2000, HUM MOL GENET, V9, P2395, DOI 10.1093/hmg/9.16.2395; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; De Marzo AM, 1999, CANCER RES, V59, P3855; Di Croce L, 2002, SCIENCE, V295, P1079, DOI 10.1126/science.1065173; Esteller M, 2001, HUM MOL GENET, V10, P3001, DOI 10.1093/hmg/10.26.3001; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Feltus FA, 2003, P NATL ACAD SCI USA, V100, P12253, DOI 10.1073/pnas.2037852100; Gidekel S, 2002, J BIOL CHEM, V277, P34521, DOI 10.1074/jbc.M203338200; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; LOCK LF, 1987, CELL, V48, P39, DOI 10.1016/0092-8674(87)90353-9; McGarvey KM, 2006, CANCER RES, V66, P3541, DOI 10.1158/0008-5472.CAN-05-2481; Nguyen C, 2001, J NATL CANCER I, V93, P1465, DOI 10.1093/jnci/93.19.1465; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Robertson KD, 1999, NUCLEIC ACIDS RES, V27, P2291, DOI 10.1093/nar/27.11.2291; Rush LJ, 2002, ANAL BIOCHEM, V307, P191, DOI 10.1016/S0003-2697(02)00033-7; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wong DJ, 1999, MOL CELL BIOL, V19, P5642; Zardo G, 2002, NAT GENET, V32, P453, DOI 10.1038/ng1007	30	897	945	0	49	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					232	236		10.1038/ng1950	http://dx.doi.org/10.1038/ng1950			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17200670				2022-12-27	WOS:000244063900022
J	Liu, F; Thirumangalathu, S; Gallant, NM; Yang, SH; Stoick-Cooper, CL; Reddy, ST; Andl, T; Taketo, MM; Dlugosz, AA; Moon, RT; Barlow, LA; Millar, SE				Liu, Fei; Thirumangalathu, Shoba; Gallant, Natalie M.; Yang, Steven H.; Stoick-Cooper, Cristi L.; Reddy, Seshamma T.; Andl, Thomas; Taketo, Makoto M.; Dlugosz, Andrzej A.; Moon, Randall T.; Barlow, Linda A.; Millar, Sarah E.			Wnt-beta-catenin signaling initiates taste papilla development	NATURE GENETICS			English	Article							HAIR FOLLICLE MORPHOGENESIS; BUD DEVELOPMENT; RECEPTOR-CELLS; DIFFERENTIATION; EXPRESSION; PATTERN; GENE; MICE; COMPLEXES; MOUSE	Fungiform taste papillae form a regular array on the dorsal tongue. Taste buds arise from papilla epithelium(1) and, unusually for epithelial derivatives, synapse with neurons, release neurotransmitters and generate receptor and action potentials(2,3). Despite the importance of taste as one of our five senses, genetic analyses of taste papilla and bud development are lacking. We demonstrate that Wnt-beta-catenin signaling is activated in developing fungiform placodes and taste bud cells. A dominant stabilizing mutation of epithelial beta-catenin causes massive overproduction of enlarged fungiform papillae and taste buds. Likewise, genetic deletion of epithelial beta-catenin or inhibition of Wnt-beta-catenin signaling by ectopic dickkopf1 (Dkk1)(4-6) blocks initiation of fungiform papilla morphogenesis. Ectopic papillae are innervated in the stabilizing beta-catenin mutant, whereas ectopic Dkk1 causes absence of lingual epithelial innervation. Thus, Wnt-beta-catenin signaling is critical for fungiform papilla and taste bud development. Altered regulation of this pathway may underlie evolutionary changes in taste papilla patterning.	Univ Penn, Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; Univ Colorado, Hlth Sci Ctr, Dept Cell & Dev Biol, Aurora, CO 80045 USA; Univ Michigan, Dept Dermatol, Ann Arbor, MI 48109 USA; Univ Washington, Sch Med, Dept Pharmacol, Howard Hughes Med Inst, Seattle, WA 98195 USA; Univ Washington, Sch Med, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068501, Japan	University of Pennsylvania; University of Pennsylvania; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Kyoto University	Barlow, LA (corresponding author), Univ Penn, Sch Med, Dept Dermatol, Philadelphia, PA 19104 USA.	Linda.Barlow@uchsc.edu; millars@mail.med.upenn.edu	Moon, Randall/M-5605-2019; Moon, Randall T/B-1743-2014	Moon, Randall/0000-0002-9352-1408; Moon, Randall T/0000-0002-9352-1408; Andl, Thomas/0000-0002-5555-468X; Liu, Fei/0000-0002-7398-2274	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007505] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045973, T32AR007465, R01AR047709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015342] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003947] Funding Source: NIH RePORTER; NHLBI NIH HHS [T32-HL007312] Funding Source: Medline; NIAMS NIH HHS [R01 AR045973, R01-AR47709, R01 AR045973-08, R01-AR45973, T32-AR007465] Funding Source: Medline; NICHD NIH HHS [T32-HD007505] Funding Source: Medline; NIDCD NIH HHS [R01-DC003947] Funding Source: Medline; NIDCR NIH HHS [R01-DE015342] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Barlow LA, 1997, DEVELOPMENT, V124, P949; Brault V, 2001, DEVELOPMENT, V128, P1253; BYRNE C, 1994, DEVELOPMENT, V120, P2369; Cadigan KM, 2006, J CELL SCI, V119, P395, DOI 10.1242/jcs.02826; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Fritzsch B, 1997, INT J DEV NEUROSCI, V15, P563, DOI 10.1016/S0736-5748(96)00111-6; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Hall JM, 1999, J COMP NEUROL, V406, P143, DOI 10.1002/(SICI)1096-9861(19990405)406:2<143::AID-CNE1>3.0.CO;2-X; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Jiang TX, 2004, INT J DEV BIOL, V48, P117, DOI 10.1387/ijdb.15272377; JOHNSON KR, 1993, EXP CELL RES, V207, P252, DOI 10.1006/excr.1993.1191; Mbiene JP, 1997, ACTA ANAT, V160, P139; MISTRETTA CM, 1991, TASTE SMELL HLTH DIS, P35; Miura H, 2003, GENE EXPR PATTERNS, V3, P427, DOI 10.1016/S1567-133X(03)00081-4; Noramly S, 1999, DEVELOPMENT, V126, P3509; Northcutt RG, 1998, TRENDS NEUROSCI, V21, P38, DOI 10.1016/S0166-2236(97)01146-6; Okubo T, 2006, GENE DEV, V20, P2654, DOI 10.1101/gad.1457106; Parker MA, 2004, DEV DYNAM, V230, P630, DOI 10.1002/dvdy.20086; ROPER S, 1983, SCIENCE, V220, P1311, DOI 10.1126/science.6857254; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STONE LM, 1995, P NATL ACAD SCI USA, V92, P1916, DOI 10.1073/pnas.92.6.1916; SUGIMOTO K, 1990, J GEN PHYSIOL, V96, P809, DOI 10.1085/jgp.96.4.809; Zhang GH, 2006, ANAT EMBRYOL, V211, P625, DOI 10.1007/s00429-006-0112-2; Zhou YQ, 2006, DEV BIOL, V297, P198, DOI 10.1016/j.ydbio.2006.05.022; Zorn AM, 2001, CURR BIOL, V11, pR592, DOI 10.1016/S0960-9822(01)00360-8	30	116	120	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2007	39	1					106	112		10.1038/ng1932	http://dx.doi.org/10.1038/ng1932			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	17128274				2022-12-27	WOS:000243136500025
J	Tarpey, P; Thomas, S; Sarvananthan, N; Mallya, U; Lisgo, S; Talbot, CJ; Roberts, EO; Awan, M; Surendran, M; McLean, RJ; Reinecke, RD; Langmann, A; Lindner, S; Koch, M; Jain, S; Woodruff, G; Gale, RP; Degg, C; Droutsas, K; Asproudis, I; Zubcov, AA; Pieh, C; Veal, CD; Machado, RD; Backhouse, OC; Baumber, L; Constantinescu, CS; Brodsky, MC; Hunter, DG; Hertle, RW; Read, RJ; Edkins, S; O'Meara, S; Parker, A; Stevens, C; Teague, J; Wooster, R; Futreal, PA; Trembath, RC; Stratton, MR; Raymond, FL; Gottlob, I				Tarpey, Patrick; Thomas, Shery; Sarvananthan, Nagini; Mallya, Uma; Lisgo, Steven; Talbot, Chris J.; Roberts, Eryl O.; Awan, Musarat; Surendran, Mylvaganam; McLean, Rebecca J.; Reinecke, Robert D.; Langmann, Andrea; Lindner, Susanne; Koch, Martina; Jain, Sunila; Woodruff, Geoffrey; Gale, Richard P.; Degg, Chris; Droutsas, Konstantinos; Asproudis, Ioannis; Zubcov, Alina A.; Pieh, Christina; Veal, Colin D.; Machado, Rajiv D.; Backhouse, Oliver C.; Baumber, Laura; Constantinescu, Cris S.; Brodsky, Michael C.; Hunter, David G.; Hertle, Richard W.; Read, Randy J.; Edkins, Sarah; O'Meara, Sarah; Parker, Adrian; Stevens, Claire; Teague, Jon; Wooster, Richard; Futreal, P. Andrew; Trembath, Richard C.; Stratton, Michael R.; Raymond, F. Lucy; Gottlob, Irene			Mutations in FRMD7, a newly identified member of the FERM family, cause X-linked idiopathic congenital nystagmus	NATURE GENETICS			English	Article							MOTOR NYSTAGMUS; MODEL; GENE	Idiopathic congenital nystagmus is characterized by involuntary, periodic, predominantly horizontal oscillations of both eyes. We identified 22 mutations in FRMD7 in 26 families with X-linked idiopathic congenital nystagmus. Screening of 42 singleton cases of idiopathic congenital nystagmus (28 male, 14 females) yielded three mutations (7%). We found restricted expression of FRMD7 in human embryonic brain and developing neural retina, suggesting a specific role in the control of eye movement and gaze stability.	Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 2XY, England; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Leicester, Sch Med, Ophthalmol Grp, Leicester LE2 7LX, Leics, England; Univ Newcastle Upon Tyne, Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; Wills Eye Hosp & Res Inst, Foerderer Eye Movement Ctr Children, Philadelphia, PA 19107 USA; Med Univ Graz, Dept Ophthalmol, A-8036 Graz, Austria; Royal Preston Hosp, Preston PR2 9HT, Lancs, England; Leeds Gen Infirm, Dept Ophthalmol, Leeds LS2 9NS, W Yorkshire, England; Univ Hosp Leicester, Dept Med Phys, Leicester LE1 5WW, Leics, England; Univ Giessen, Dept Ophthalmol, D-35392 Giessen, Germany; Univ Hosp Ioannina, Fac Med, Dept Ophthalmol, GR-45110 Ioannina, Greece; Univ Frankfurt, Hosp Eye, D-60590 Frankfurt, Germany; Univ Freiburg, Dept Ophthalmol, Freiburg, Germany; Kings Coll London, Div Med & Mol Genet, London SE1 9RT, England; Univ Nottingham, Sch Med & Surg Sci, Div Clin Neurol, Nottingham NG7 2UH, England; Univ Arkansas Med Sci, Dept Ophthalmol, Little Rock, AR 72202 USA; Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72202 USA; Harvard Univ, Childrens Hosp, Sch Med, Dept Ophthalmol, Boston, MA 02115 USA; Univ Pittsburgh, Childrens Hosp Pittsburgh, Med Ctr, Div Paediat Ophthalmol, Pittsburgh, PA 15213 USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; University of Leicester; Newcastle University - UK; University of Leicester; Jefferson University; Medical University of Graz; Royal Preston Hospital; Leeds General Infirmary; University of Leeds; University Hospitals of Leicester NHS Trust; University of Leicester; Justus Liebig University Giessen; University Hospital Ioannina; Goethe University Frankfurt; University of Freiburg; University of London; King's College London; University of Nottingham; University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; Harvard University; Boston Children's Hospital; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Read, RJ (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 2XY, England.	flr24@cam.ac.uk; ig15@leicester.ac.uk	Machado, Rajiv D./AAD-7813-2019; Read, Randy J/L-1418-2013; Southgate, Laura/H-7924-2019	Machado, Rajiv D./0000-0001-9247-0744; Read, Randy J/0000-0001-8273-0047; Southgate, Laura/0000-0002-2090-1450; Lisgo, Steven/0000-0001-5186-3971; Hunter, David/0000-0002-4587-4794; Trembath, Richard/0000-0003-0550-3400; Thomas, Shery/0000-0002-4722-9182; Talbot, Christopher/0000-0001-7406-8962; Constantinescu, Cris/0000-0003-2066-7585; Veal, Colin/0000-0002-9840-2512	Medical Research Council [G9900837, G9826762] Funding Source: Medline; Wellcome Trust [050211] Funding Source: Medline; MRC [G9826762, G9900837] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Cabot A, 1999, AM J HUM GENET, V64, P1141, DOI 10.1086/302324; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gottlob I, 2001, CURR OPIN OPHTHALMOL, V12, P378, DOI 10.1097/00055735-200110000-00010; Han BG, 2000, NAT STRUCT BIOL, V7, P871; Jacobs JB, 2004, J VISION, V4, P604, DOI 10.1167/4.7.7; Kerrison J B, 2001, Ophthalmic Genet, V22, P241, DOI 10.1076/opge.22.4.241.2216; Kerrison JB, 1999, AM J HUM GENET, V64, P600, DOI 10.1086/302244; Kubo T, 2002, J NEUROSCI, V22, P8504; Pilling RF, 2005, BRIT J OPHTHALMOL, V89, P1278, DOI 10.1136/bjo.2005.070045; STAYTE M, 1993, BRIT J OPHTHALMOL, V77, P228, DOI 10.1136/bjo.77.4.228; Tarpey P, 2004, AM J HUM GENET, V75, P318, DOI 10.1086/422703; Toyofuku T, 2005, NAT NEUROSCI, V8, P1712, DOI 10.1038/nn1596; Zhang BR, 2005, HUM GENET, V116, P128, DOI 10.1007/s00439-004-1188-5	14	130	145	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2006	38	11					1242	1244		10.1038/ng1893	http://dx.doi.org/10.1038/ng1893			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17013395	Green Accepted, Green Published			2022-12-27	WOS:000241592700010
J	Zhao, Z; Tavoosidana, G; Sjolinder, M; Gondor, A; Mariano, P; Wang, S; Kanduri, C; Lezcano, M; Sandhu, KS; Singh, U; Pant, V; Tiwari, V; Kurukuti, S; Ohlsson, R				Zhao, Zhihu; Tavoosidana, Gholamreza; Sjolinder, Mikael; Gondor, Anita; Mariano, Piero; Wang, Sha; Kanduri, Chandrasekhar; Lezcano, Magda; Sandhu, Kuljeet Singh; Singh, Umashankar; Pant, Vinod; Tiwari, Vijay; Kurukuti, Sreenivasulu; Ohlsson, Rolf			Circular chromosome conformation capture (4C) uncovers extensive networks of epigenetically regulated intra- and interchromosomal interactions	NATURE GENETICS			English	Article							GENES; IGF2; CTCF; H19; COLOCALIZATION; INACTIVATION; ASSOCIATION; METHYLATION; EXPRESSION; PARENT	Accumulating evidence converges on the possibility that chromosomes interact with each other to regulate transcription in trans. To systematically explore the epigenetic dimension of such interactions, we devised a strategy termed circular chromosome conformation capture (4C). This approach involves a circularization step that enables high-throughput screening of physical interactions between chromosomes without a preconceived idea of the interacting partners. Here we identify 114 unique sequences from all autosomes, several of which interact primarily with the maternally inherited H19 imprinting control region. Imprinted domains were strongly overrepresented in the library of 4C sequences, further highlighting the epigenetic nature of these interactions. Moreover, we found that the direct interaction between differentially methylated regions was linked to epigenetic regulation of transcription in trans. Finally, the patterns of interactions specific to the maternal H19 imprinting control region underwent reprogramming during in vitro maturation of embryonic stem cells. These observations shed new light on development, cancer epigenetics and the evolution of imprinting.	Uppsala Univ, Dept Genet & Dev, Evolut Biol Ctr, SE-75136 Uppsala, Sweden	Uppsala University	Ohlsson, R (corresponding author), Uppsala Univ, Dept Genet & Dev, Evolut Biol Ctr, SE-75136 Uppsala, Sweden.	rolf.ohlsson@ebc.uu.se	kurukuti, sreenivasulu/AAI-5663-2020; Singh, Umashankar/ABE-3830-2020; Mariano, Pier Nilsson/AAP-5562-2021; Tavoosidana, Gholamreza/AAV-3893-2020	Singh, Umashankar/0000-0001-8578-8201; Tavoosidana, Gholamreza/0000-0002-1079-7434; Sandhu, Kuljeet/0000-0001-7632-6339; Kanduri, Chandrasekhar/0000-0001-6271-9078; Pant, Vinod/0000-0002-3286-1804; Gondor, Anita/0000-0002-1523-4411; Tiwari, Vijay/0000-0003-0292-6635				Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Dean W, 1998, DEVELOPMENT, V125, P2273; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Kono T, 2004, NATURE, V428, P860, DOI 10.1038/nature02402; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Ling JQ, 2006, SCIENCE, V312, P269, DOI 10.1126/science.1123191; Luedi PP, 2005, GENOME RES, V15, P875, DOI 10.1101/gr.3303505; Massey JB, 2006, CURR OPIN LIPIDOL, V17, P296, DOI 10.1097/01.mol.0000226123.17629.ab; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Ohlsson R, 2001, TRENDS GENET, V17, P136, DOI 10.1016/S0168-9525(00)02211-3; Okamura K, 2004, DNA RES, V11, P381, DOI 10.1093/dnares/11.6.381; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Pant V, 2003, GENE DEV, V17, P586, DOI 10.1101/gad.254903; Sakatani T, 2005, SCIENCE, V307, P1976, DOI 10.1126/science.1108080; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Wurtele H, 2006, CHROMOSOME RES, V14, P477, DOI 10.1007/s10577-006-1075-0	19	612	652	0	81	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2006	38	11					1341	1347		10.1038/ng1891	http://dx.doi.org/10.1038/ng1891			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17033624				2022-12-27	WOS:000241592700025
J	Nadeau, JH; Topol, EJ				Nadeau, Joseph H.; Topol, Eric J.			The genetics of health	NATURE GENETICS			English	Editorial Material							COMPLEMENT FACTOR-H; GERM-CELL TUMORS; MACULAR DEGENERATION; DEFICIENT MICE; HEARING-LOSS; DISEASE SEVERITY; MODIFIER LOCUS; BODY-WEIGHT; ATHEROSCLEROSIS; SUSCEPTIBILITY	Recent experience with several high-profile drugs demonstrates the great challenges in developing effective and safe therapeutics. A complementary approach to the popular paradigm of disease genetics is based on inherited factors that reduce the incidence and severity of disease among individuals who are genetically predisposed to disease. We propose testing specifically for modifier genes and protective alleles among at-risk individuals and studying the efficacy of therapeutics based on the genetics of health.	Case Western Reserve Univ, Sch Med, Dept Genet, Cleveland, OH 44106 USA	Case Western Reserve University	Nadeau, JH (corresponding author), Case Western Reserve Univ, Sch Med, Dept Genet, 2109 Adelbert Rd, Cleveland, OH 44106 USA.	jhn4@case.edu; ejt9@case.edu		Topol, Eric/0000-0002-1478-4729	NATIONAL CANCER INSTITUTE [R01CA075056] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR012305] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL077101] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA75056] Funding Source: Medline; NCRR NIH HHS [P40 RR12305] Funding Source: Medline; NHLBI NIH HHS [P50 HL077101] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abenhaim L, 1996, NEW ENGL J MED, V335, P609, DOI 10.1056/NEJM199608293350901; Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; Buchner DA, 2003, SCIENCE, V301, P967, DOI 10.1126/science.1086187; Collin GB, 2005, PHYSIOL GENOMICS, V22, P182, DOI 10.1152/physiolgenomics.00208.2003; Collin GB, 1996, MAMM GENOME, V7, P68, DOI 10.1007/s003359900017; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; Cormier RT, 1997, NAT GENET, V17, P88, DOI 10.1038/ng0997-88; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Dansky HM, 2002, GENETICS, V160, P1599; DIETRICH WF, 1993, CELL, V75, P631, DOI 10.1016/0092-8674(93)90484-8; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Fisher, 1958, GENETICAL THEORY NAT; Floyd JA, 2003, NAT GENET, V35, P221, DOI 10.1038/ng1247; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Ikeda A, 2002, NAT GENET, V30, P401, DOI 10.1038/ng838; Kardys I, 2006, J AM COLL CARDIOL, V47, P1568, DOI 10.1016/j.jacc.2005.11.076; Kerkela R, 2006, NAT MED, V12, P908, DOI 10.1038/nm1446; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MALKIN D, 1998, GENETIC BASIS HUMAN, P393; Matin A, 2001, TRENDS GENET, V17, P727, DOI 10.1016/S0168-9525(01)02528-8; Muller AJ, 2000, P NATL ACAD SCI USA, V97, P8421, DOI 10.1073/pnas.140208197; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; Noben-Trauth K, 2003, NAT GENET, V35, P21, DOI 10.1038/ng1226; Perls T, 2002, J AM GERIATR SOC, V50, P359, DOI 10.1046/j.1532-5415.2002.49283.x; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Rozmahel R, 1996, NAT GENET, V12, P280, DOI 10.1038/ng0396-280; Rutherford SL, 2000, BIOESSAYS, V22, P1095, DOI 10.1002/1521-1878(200012)22:12&lt;1095::AID-BIES7&gt;3.0.CO;2-A; Schultz JM, 2005, NEW ENGL J MED, V352, P1557, DOI 10.1056/NEJMoa043899; Seidelmann SB, 2005, ARTERIOSCL THROM VAS, V25, P204, DOI 10.1161/01.ATV.0000149146.32385.1b; Sierra S, 2006, SEMIN REPROD MED, V24, P17, DOI 10.1055/s-2006-931797; Smith JD, 2003, ARTERIOSCL THROM VAS, V23, P117, DOI 10.1161/01.ATV.0000047461.18902.80; Smith JD, 2001, ANN NY ACAD SCI, V947, P247; Stoehr JP, 2004, DIABETES, V53, P245, DOI 10.2337/diabetes.53.1.245; Todd JA, 2006, NAT GENET, V38, P731, DOI 10.1038/ng0706-731; Topol EJ, 2005, JAMA-J AM MED ASSOC, V293, P366, DOI 10.1001/jama.293.3.366; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Weinshilboum R, 2003, NEW ENGL J MED, V348, P529, DOI 10.1056/NEJMra020021; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426; Zheng QY, 2001, HEARING RES, V154, P45, DOI 10.1016/S0378-5955(01)00215-5; Zielenski J, 1999, NAT GENET, V22, P128, DOI 10.1038/9635	50	37	38	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2006	38	10					1095	1098		10.1038/ng1006-1095	http://dx.doi.org/10.1038/ng1006-1095			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	094PJ	17006459				2022-12-27	WOS:000241251100004
J	Jeong, Y; Leskow, FC; El-Jaick, K; Roessler, E; Muenke, M; Yocum, A; Dubourg, C; Li, X; Geng, X; Oliver, G; Epstein, DJ				Jeong, Yongsu; Leskow, Federico Coluccio; El-Jaick, Kenia; Roessler, Erich; Muenke, Maximilian; Yocum, Anastasia; Dubourg, Christele; Li, Xue; Geng, Xin; Oliver, Guillermo; Epstein, Douglas J.			Regulation of a remote Shh forebrain enhancer by the Six3 homeoprotein	NATURE GENETICS			English	Article							VENTRAL FOREBRAIN; EYE DEVELOPMENT; GENE; EXPRESSION; MUTATIONS; REPRESSION; MEMBERS; FAMILY; RISK; FACE	In humans, SHH haploinsufficiency results in holoprosencephaly (HPE), a defect in anterior midline formation(1,2). Despite the importance of maintaining SHH transcript levels above a critical threshold, we know little about the upstream regulators of SHH expression in the forebrain. Here we describe a rare nucleotide variant located 460 kb upstream of SHH in an individual with HPE that resulted in the loss of Shh brain enhancer-2 (SBE2) activity in the hypothalamus of transgenic mouse embryos. Using a DNA affinity-capture assay, we screened the SBE2 sequence for DNA-binding proteins and identified members of the Six3 and Six6 homeodomain family as candidate regulators of Shh transcription. Six3 showed reduced binding affinity for the mutant compared to the wild-type SBE2 sequence. Moreover, Six3 with HPE-causing alterations failed to bind and activate SBE2. These data suggest a direct link between Six3 and Shh regulation during normal forebrain development and in the pathogenesis of HPE.	[Jeong, Yongsu; Leskow, Federico Coluccio; Epstein, Douglas J.] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA; [El-Jaick, Kenia; Roessler, Erich; Muenke, Maximilian] NHGRI, Med Genet Branch, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA; [Yocum, Anastasia] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Dubourg, Christele] Univ Rennes 1, CNRS, UMR 6061, F-35043 Rennes, France; [Li, Xue] Harvard Univ, Sch Med, Childrens Hosp, Dept Urol Surg, Boston, MA 02115 USA; [Geng, Xin; Oliver, Guillermo] St Jude Childrens Res Hosp, Dept Genet, Memphis, TN 38105 USA	University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Pennsylvania; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; Harvard University; Boston Children's Hospital; Harvard Medical School; St Jude Children's Research Hospital	Epstein, DJ (corresponding author), Univ Penn, Sch Med, Dept Genet, 415 Curie Blvd, Philadelphia, PA 19104 USA.	epsteind@mail.med.upenn.edu	Jeong, Yongsu/AAK-7397-2020; El-Jaick, Kenia/P-1303-2014	El-Jaick, Kenia/0000-0003-3316-9323; Jeong, Yongsu/0000-0002-0008-9928; Muenke, Maximilian/0000-0002-7719-6545	NINDS [R01 NS39421, R01 NS052386]; March of Dimes [1-FY05-112]; Pew Scholar Award in the Biomedical Sciences; Cancer Center [CA-21765]; American Lebanese Syrian Associated Charities (ALSAC); Division of Intramural Research; National Human Genome Research Institute; National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000209, ZIAHG000175] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039421, R01NS052386] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); March of Dimes(March of Dimes); Pew Scholar Award in the Biomedical Sciences; Cancer Center; American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank the families for their participation in these studies. We also thank J. Richa and his staff at the University of Pennsylvania Transgenic and Mouse Chimeric Facility for their assistance in transgenic mouse production. We are grateful to V. Cheung, D. Kessler and T. Kadesch for their helpful comments on the manuscript. We are also grateful to K. Ewens and W. Ankener (R. Spielman laboratory) for the control human genotyping data and P. Bovolenta (Instituto Cajal, CSIC, Madrid, Spain) for kindly providing the human Six3 and Six6 expression constructs. This work was supported by NIH grants R01 NS39421 from NINDS (D.J.E.), R01 NS052386 (G.O.), March of Dimes grant # 1-FY05-112 (D.J.E.), a Pew Scholar Award in the Biomedical Sciences (D.J.E.), Cancer Center Support CA-21765 (G.O.), the American Lebanese Syrian Associated Charities (ALSAC) (G.O.) and the Division of Intramural Research, National Human Genome Research Institute, National Institutes of Health (M.M.).	Carl M, 2002, DEVELOPMENT, V129, P4057; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Chiang C, 1996, NATURE, V383, P407, DOI 10.1038/383407a0; Conte I, 2005, DEV DYNAM, V234, P718, DOI 10.1002/dvdy.20463; Cordero D, 2004, J CLIN INVEST, V114, P485, DOI 10.1172/JCI200419596; Del Bene F, 2004, NATURE, V427, P745, DOI 10.1038/nature02292; Dubourg C, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-8; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Fuccillo M, 2004, DEVELOPMENT, V131, P5031, DOI 10.1242/dev.01349; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Geng X, 2008, DEV CELL, V15, P236, DOI 10.1016/j.devcel.2008.07.003; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Helms JA, 2005, DEVELOPMENT, V132, P851, DOI 10.1242/dev.01705; Hu D, 2003, DEVELOPMENT, V130, P1749, DOI 10.1242/dev.00397; Jean D, 1999, MECH DEVELOP, V84, P31, DOI 10.1016/S0925-4773(99)00068-4; Jeong YS, 2006, DEVELOPMENT, V133, P761, DOI 10.1242/dev.02239; Lagutin OV, 2003, GENE DEV, V17, P368, DOI 10.1101/gad.1059403; Li X, 2002, SCIENCE, V297, P1180; Liu W, 2006, EMBO J, V25, P5383, DOI 10.1038/sj.emboj.7601398; Lopez-Rios J, 2003, DEVELOPMENT, V130, P185, DOI 10.1242/dev.00185; Marcucio RS, 2005, DEV BIOL, V284, P48, DOI 10.1016/j.ydbio.2005.04.030; Ming JE, 2002, AM J HUM GENET, V71, P1017, DOI 10.1086/344412; Park SS, 2005, ANAL BIOCHEM, V344, P152, DOI 10.1016/j.ab.2005.05.019; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Roessler E, 2003, P NATL ACAD SCI USA, V100, P13424, DOI 10.1073/pnas.2235734100; Shimamura K, 1997, DEVELOPMENT, V124, P2709; Treier M, 2001, DEVELOPMENT, V128, P377; Wallis DE, 1999, NAT GENET, V22, P196, DOI 10.1038/9718; Zhu CQC, 2002, DEVELOPMENT, V129, P2835	30	133	137	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1348	1353		10.1038/ng.230	http://dx.doi.org/10.1038/ng.230			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18836447	Green Accepted			2022-12-27	WOS:000260501500029
J	Kopp, JB; Smith, MW; Nelson, GW; Johnson, RC; Freedman, BI; Bowden, DW; Oleksyk, T; McKenzie, LM; Kajiyama, H; Ahuja, TS; Berns, JS; Briggs, W; Cho, ME; Dart, RA; Kimmel, PL; Korbet, SM; Michel, DM; Mokrzycki, MH; Schelling, JR; Simon, E; Trachtman, H; Vlahov, D; Winkler, CA				Kopp, Jeffrey B.; Smith, Michael W.; Nelson, George W.; Johnson, Randall C.; Freedman, Barry I.; Bowden, Donald W.; Oleksyk, Taras; McKenzie, Louise M.; Kajiyama, Hiroshi; Ahuja, Tejinder S.; Berns, Jeffrey S.; Briggs, William; Cho, Monique E.; Dart, Richard A.; Kimmel, Paul L.; Korbet, Stephen M.; Michel, Donna M.; Mokrzycki, Michele H.; Schelling, Jeffrey R.; Simon, Eric; Trachtman, Howard; Vlahov, David; Winkler, Cheryl A.			MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis	NATURE GENETICS			English	Article							STAGE RENAL-DISEASE; HYPERTENSIVE NEPHROSCLEROSIS; AFRICAN-AMERICAN; GENOME-SCAN; KIDNEY-DISEASE; ADMIXTURE; LOCUS; DISPARITIES; MUTATIONS; ESRD	The increased burden of chronic kidney and end-stage kidney diseases (ESKD) in populations of African ancestry has been largely unexplained. To identify genetic variants predisposing to idiopathic and HIV-1-associated focal segmental glomerulosclerosis (FSGS), we carried out an admixture-mapping linkage-disequilibrium genome scan on 190 African American individuals with FSGS and 222 controls. We identified a chromosome 22 region with a genome-wide logarithm of the odds (lod) score of 9.2 and a peak lod of 12.4 centered on MYH9, a functional candidate gene expressed in kidney podocytes. Multiple MYH9 SNPs and haplotypes were recessively associated with FSGS, most strongly a haplotype spanning exons 14 through 23 (OR = 5.0, 95% CI 3.5-7.1; P = 4 x 10(-23), n = 852). This association extended to hypertensive ESKD (OR = 2.2, 95% CI = 1.5-3.4; n = 433), but not type 2 diabetic ESKD (n 476). Genetic variation at the MYH9 locus substantially explains the increased burden of FSGS and hypertensive ESKD among African Americans.	[Smith, Michael W.; Nelson, George W.; Johnson, Randall C.; Oleksyk, Taras; McKenzie, Louise M.; Winkler, Cheryl A.] NCI, Lab Genom Divers, SAIC Frederick, Frederick, MD 21702 USA; [Kopp, Jeffrey B.; Kajiyama, Hiroshi; Cho, Monique E.] NIDDK, Kidney Dis Sect, NIH, Bethesda, MD 20892 USA; [Freedman, Barry I.; Bowden, Donald W.] Wake Forest Univ, Bowman Gray Sch Med, Nephrol Sect, Winston Salem, NC 27157 USA; [Ahuja, Tejinder S.] Univ Texas Galveston, Med Branch, Galveston, TX 77555 USA; [Berns, Jeffrey S.] Univ Penn, Sch Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; [Briggs, William] William Beaumont Hosp, Royal Oak, MI 48073 USA; [Dart, Richard A.] Marshfield Clin Fdn Med Res & Educ, Dept Hypertens & Nephrol, Marshfield, WI 54449 USA; [Kimmel, Paul L.] George Washington Univ, Med Ctr, Div Renal Dis & Hypertens, Dept Med, Washington, DC 20037 USA; [Korbet, Stephen M.] Rush Univ, Med Ctr, Dept Med, Chicago, IL 60612 USA; [Michel, Donna M.] Hypertens & Kidney Specialists, Lancaster, PA 17601 USA; [Mokrzycki, Michele H.] Albert Einstein Coll Med, Div Nephrol, Bronx, NY 10461 USA; [Schelling, Jeffrey R.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44109 USA; [Simon, Eric] Tulane Univ, Sch Med, Nephrol Sect, New Orleans, LA 70112 USA; [Trachtman, Howard] Schneider Childrens Hosp Syst, Div Nephrol, Dept Pediat, New Hyde Pk, NY 11040 USA; [Vlahov, David] New York Acad Med, New York, NY 10029 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Wake Forest University; Wake Forest Baptist Medical Center; University of Texas System; University of Texas Medical Branch Galveston; University of Pennsylvania; Beaumont Health; Marshfield Clinic; George Washington University; Rush University; Yeshiva University; Albert Einstein College of Medicine; Case Western Reserve University; Tulane University; New York Academy of Medicine	Winkler, CA (corresponding author), NCI, Lab Genom Divers, SAIC Frederick, Frederick, MD 21702 USA.	winkler@ncifcrf.gov	Smith, Michael/B-5341-2012; Trachtman, Howard/GSE-2340-2022; Taras, Oleksyk/J-8805-2013; Johnson, Randall C/B-1517-2014; Kopp, Jeffrey B/O-2681-2015	Taras, Oleksyk/0000-0002-8148-3918; Johnson, Randall C/0000-0001-7754-0847; Kopp, Jeffrey B/0000-0001-9052-186X; Trachtman, Howard/0000-0001-7447-9489; NOIRI, Eisei/0000-0002-9515-7582	NATIONAL CANCER INSTITUTE [ZIABC010297, ZIABC010022] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK043308, ZIADK075029] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 DK043308, Z01 DK043308-12] Funding Source: Medline; NCI NIH HHS [N01CO12400, N01-CO-12400] Funding Source: Medline; NIDDK NIH HHS [R01 DK072348-04, R01 DK072348, R01 DK059997-04, R01 DK067528-05, ZO-1 DK043308, R01 DK070941, R01 DK059997] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arrondel C, 2002, J AM SOC NEPHROL, V13, P65, DOI 10.1681/ASN.V13165; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Barisoni L, 2007, CLIN J AM SOC NEPHRO, V2, P529, DOI 10.2215/CJN.04121206; Bowden DW, 2004, KIDNEY INT, V66, P1517, DOI 10.1111/j.1523-1755.2004.00915.x; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; COWIE CC, 1989, NEW ENGL J MED, V321, P1074, DOI 10.1056/NEJM198910193211603; Dong F, 2005, BRIT J HAEMATOL, V130, P620, DOI 10.1111/j.1365-2141.2005.05658.x; Eggers PW, 2004, J AM SOC NEPHROL, V15, P2477, DOI 10.1097/01.ASN.0000138546.53152.A7; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Fernandez M, 2007, ARTHRIT RHEUM-ARTHR, V57, P576, DOI 10.1002/art.22672; Fogo A, 1997, KIDNEY INT, V51, P244, DOI 10.1038/ki.1997.29; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; FREEDMAN BI, 1995, AM J KIDNEY DIS, V25, P207, DOI 10.1016/0272-6386(95)90001-2; Freedman BI, 2004, J AM SOC NEPHROL, V15, P2719, DOI 10.1097/01.ASN.0000141312.39483.4F; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ghiggeri GM, 2003, AM J KIDNEY DIS, V41, P95, DOI 10.1053/ajkd.2003.50028; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kiberd BA, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000014251.87778.01; Kim JM, 2003, SCIENCE, V300, P1298, DOI 10.1126/science.1081068; Kitiyakara C, 2004, AM J KIDNEY DIS, V44, P815, DOI 10.1016/S0272-6386(04)01081-9; Kitiyakara C, 2003, SEMIN NEPHROL, V23, P172, DOI 10.1053/snep.2003.50025; Kopp JB, 2003, KIDNEY INT, V63, P43, DOI 10.1046/j.1523-1755.63.s83.39.x; Marcantoni C, 2002, KIDNEY INT, V62, P172, DOI 10.1046/j.1523-1755.2002.00420.x; Matsushita T, 2004, BIOCHEM BIOPH RES CO, V325, P1163, DOI 10.1016/j.bbrc.2004.10.147; McKenzie LM, 2007, J AM SOC NEPHROL, V18, P2987, DOI 10.1681/ASN.2007030319; Nalls MA, 2008, AM J HUM GENET, V82, P81, DOI 10.1016/j.ajhg.2007.09.003; O'Brien SJ, 2004, NAT GENET, V36, P565, DOI 10.1038/ng1369; Orloff MS, 2005, PHYSIOL GENOMICS, V21, P212, DOI 10.1152/physiolgenomics.00201.2004; Patterson N, 2004, AM J HUM GENET, V74, P979, DOI 10.1086/420871; Powe NR, 2003, KIDNEY INT, V64, P763, DOI 10.1046/j.1523-1755.2003.00138.x; Price AL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0030236; Reich D, 2005, NAT GENET, V37, P1113, DOI 10.1038/ng1646; Reich D, 2005, PHILOS T ROY SOC B, V360, P1605, DOI 10.1098/rstb.2005.1691; Reich D, 2007, AM J HUM GENET, V80, P716, DOI 10.1086/513206; Schwartz EJ, 1998, SEMIN NEPHROL, V18, P436; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; Smith MW, 2004, AM J HUM GENET, V74, P1001, DOI 10.1086/420856; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; Toto RD, 2004, KIDNEY INT, V66, pS102, DOI 10.1111/j.1523-1755.2004.09224.x; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Winn MP, 2003, NEPHROL DIAL TRANSPL, V18, P14, DOI 10.1093/ndt/gfg1070; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zarif L, 2000, NEPHROL DIAL TRANSPL, V15, P1801, DOI 10.1093/ndt/15.11.1801; Zhu XF, 2005, NAT GENET, V37, P177, DOI 10.1038/ng1510; Zhu XF, 2008, ADV GENET, V60, P547, DOI 10.1016/S0065-2660(07)00419-1	50	529	557	2	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2008	40	10					1175	1184		10.1038/ng.226	http://dx.doi.org/10.1038/ng.226			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18794856	Green Accepted			2022-12-27	WOS:000259651000016
J	Korn, JM; Kuruvilla, FG; McCarroll, SA; Wysoker, A; Nemesh, J; Cawley, S; Hubbell, E; Veitch, J; Collins, PJ; Darvishi, K; Lee, C; Nizzari, MM; Gabriel, SB; Purcell, S; Daly, MJ; Altshuler, D				Korn, Joshua M.; Kuruvilla, Finny G.; McCarroll, Steven A.; Wysoker, Alec; Nemesh, James; Cawley, Simon; Hubbell, Earl; Veitch, Jim; Collins, Patrick J.; Darvishi, Katayoon; Lee, Charles; Nizzari, Marcia M.; Gabriel, Stacey B.; Purcell, Shaun; Daly, Mark J.; Altshuler, David			Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs	NATURE GENETICS			English	Article							HUMAN GENOME; ALGORITHM; LIKELIHOOD; ACCURATE; ARRAYS	Accurate and complete measurement of single nucleotide (SNP) and copy number (CNV) variants, both common and rare, will be required to understand the role of genetic variation in disease. We present Birdsuite, a four-stage analytical framework instantiated in software for deriving integrated and mutually consistent copy number and SNP genotypes. The method sequentially assigns copy number across regions of common copy number polymorphisms (CNPs), calls genotypes of SNPs, identifies rare CNVs via a hidden Markov model (HMM), and generates an integrated sequence and copy number genotype at every locus (for example, including genotypes such as A-null, AAB and BBB in addition to AA, AB and BB calls). Such genotypes more accurately depict the underlying sequence of each individual, reducing the rate of apparent mendelian inconsistencies. The Birdsuite software is applied here to data from the Affymetrix SNP 6.0 array. Additionally, we describe a method, implemented in PLINK, to utilize these combined SNP and CNV genotypes for association testing with a phenotype.	[Korn, Joshua M.; Kuruvilla, Finny G.; McCarroll, Steven A.; Wysoker, Alec; Nemesh, James; Nizzari, Marcia M.; Gabriel, Stacey B.; Purcell, Shaun; Daly, Mark J.; Altshuler, David] Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; [Korn, Joshua M.; Kuruvilla, Finny G.; McCarroll, Steven A.; Wysoker, Alec; Nemesh, James; Nizzari, Marcia M.; Gabriel, Stacey B.; Purcell, Shaun; Daly, Mark J.; Altshuler, David] MIT, Cambridge, MA 02142 USA; [Korn, Joshua M.] Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Korn, Joshua M.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Korn, Joshua M.; Kuruvilla, Finny G.; McCarroll, Steven A.; Altshuler, David] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Korn, Joshua M.; Kuruvilla, Finny G.; McCarroll, Steven A.; Purcell, Shaun; Daly, Mark J.; Altshuler, David] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kuruvilla, Finny G.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Cawley, Simon; Hubbell, Earl; Veitch, Jim; Collins, Patrick J.] Affymetrix Inc, Santa Clara, CA 95051 USA; [Darvishi, Katayoon; Lee, Charles] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Daly, Mark J.; Altshuler, David] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Affymetrix; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Korn, JM (corresponding author), Harvard Univ, Broad Inst, Cambridge, MA 02142 USA.	jkorn@broad.mit.edu; altshuler@molbio.mgh.harvard.edu	McCarroll, Steven A/A-8433-2009; Altshuler, David M/A-4476-2009; Daly, Mark J/B-2453-2017	Altshuler, David M/0000-0002-7250-4107; Daly, Mark J/0000-0002-0949-8752; Hubbell, Earl/0000-0001-7301-3759; McCarroll, Steven/0000-0002-6954-8184	Lilly Life Sciences Research Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313] Funding Source: NIH RePORTER	Lilly Life Sciences Research Fellowship; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We wish to thank G. Getz for discussions on algorithms and comments regarding the supplemental methods. We also thank E. Lander and J. Hirschhorn for their readings and feedback. Finally, we are indebted to the testing labs that provided us with many replicates of HapMap samples run on the Affymetrix SNP 6.0 array. S. A. M. was supported by a Lilly Life Sciences Research Fellowship.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; *INT SCHIZ CONS, 2008, NATURE          0830, DOI DOI 10.1038/NATURE07239; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Laframboise T, 2007, BIOSTATISTICS, V8, P323, DOI 10.1093/biostatistics/kxl012; MacConaill LE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-211; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Nicolae DL, 2006, BIOINFORMATICS, V22, P1942, DOI 10.1093/bioinformatics/btl341; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rabbee N, 2006, BIOINFORMATICS, V22, P7, DOI 10.1093/bioinformatics/bti741; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974	21	584	608	0	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2008	40	10					1253	1260		10.1038/ng.237	http://dx.doi.org/10.1038/ng.237			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18776909	Green Published, Green Accepted			2022-12-27	WOS:000259651000028
J	Barrett, JC; Hansoul, S; Nicolae, DL; Cho, JH; Duerr, RH; Rioux, JD; Brant, SR; Silverberg, MS; Taylor, KD; Barmada, MM; Bitton, A; Dassopoulos, T; Datta, LW; Green, T; Griffiths, AM; Kistner, EO; Murtha, MT; Regueiro, MD; Rotter, JI; Schumm, LP; Steinhart, AH; Targan, SR; Xavier, RJ; Libioulle, C; Sandor, C; Lathrop, M; Belaiche, J; Dewit, O; Gut, I; Heath, S; Laukens, D; Mni, M; Rutgeerts, P; Van Gossum, A; Zelenika, D; Franchimont, D; Hugot, JP; de Vos, M; Vermeire, S; Louis, E; Cardon, LR; Anderson, CA; Drummond, H; Nimmo, E; Ahmad, T; Prescott, NJ; Onnie, CM; Fisher, SA; Marchini, J; Ghori, J; Bumpstead, S; Gwilliam, R; Tremelling, M; Deloukas, P; Mansfield, J; Jewell, D; Satsangi, J; Mathew, CG; Parkes, M; Georges, M; Daly, MJ				Barrett, Jeffrey C.; Hansoul, Sarah; Nicolae, Dan L.; Cho, Judy H.; Duerr, Richard H.; Rioux, John D.; Brant, Steven R.; Silverberg, Mark S.; Taylor, Kent D.; Barmada, M. Michael; Bitton, Alain; Dassopoulos, Themistocles; Datta, Lisa Wu; Green, Todd; Griffiths, Anne M.; Kistner, Emily O.; Murtha, Michael T.; Regueiro, Miguel D.; Rotter, Jerome I.; Schumm, L. Philip; Steinhart, A. Hillary; Targan, Stephan R.; Xavier, Ramnik J.; Libioulle, Cecile; Sandor, Cynthia; Lathrop, Mark; Belaiche, Jacques; Dewit, Olivier; Gut, Ivo; Heath, Simon; Laukens, Debby; Mni, Myriam; Rutgeerts, Paul; Van Gossum, Andre; Zelenika, Diana; Franchimont, Denis; Hugot, Jean-Pierre; de Vos, Martine; Vermeire, Severine; Louis, Edouard; Cardon, Lon R.; Anderson, Carl A.; Drummond, Hazel; Nimmo, Elaine; Ahmad, Tariq; Prescott, Natalie J.; Onnie, Clive M.; Fisher, Sheila A.; Marchini, Jonathan; Ghori, Jilur; Bumpstead, Suzannah; Gwilliam, Rhian; Tremelling, Mark; Deloukas, Panos; Mansfield, John; Jewell, Derek; Satsangi, Jack; Mathew, Christopher G.; Parkes, Miles; Georges, Michel; Daly, Mark J.		NIDDK IBD Genetics Consortium; Belgian-French IBD Consortium; Wellcome Trust Case Control	Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease	NATURE GENETICS			English	Article							LARGE-SCALE; NONSYNONYMOUS SNPS; GENETIC-VARIATION; VARIANTS; CELLS; EXPRESSION; IL-23; MULTIPLE; COLITIS; RISK	Several risk factors for Crohn's disease have been identified in recent genome-wide association studies. To advance gene discovery further, we combined data from three studies on Crohn's disease ( a total of 3,230 cases and 4,829 controls) and carried out replication in 3,664 independent cases with a mixture of population-based and family-based controls. The results strongly confirm 11 previously reported loci and provide genome-wide significant evidence for 21 additional loci, including the regions containing STAT3, JAK2, ICOSLG, CDKAL1 and ITLN1. The expanded molecular understanding of the basis of this disease offers promise for informed therapeutic development.	[Rioux, John D.; Green, Todd] MIT, Broad Inst, Cambridge, MA 02142 USA; [Barrett, Jeffrey C.; Cardon, Lon R.; Anderson, Carl A.] Univ Oxford, Wellcome Trust Ctr Human Genet, Bioinformat & Stat Genet, Oxford OX3 7BN, England; [Hansoul, Sarah; Libioulle, Cecile; Sandor, Cynthia] Univ Liege, Unit Anim Genom, GIGA R, B-4000 Liege, Belgium; Univ Liege, Fac Vet Med, B-4000 Liege, Belgium; [Nicolae, Dan L.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Cho, Judy H.; Murtha, Michael T.] Yale Univ, Dept Med, Div Gastroenterol, Inflammatory Bowel Dis Ctr, New Haven, CT 06519 USA; Yale Univ, Dept Genet, Div Gastroenterol, Inflammatory Bowel Dis Ctr, New Haven, CT 06519 USA; [Duerr, Richard H.] Univ Pittsburgh, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr,Univ Pittsburgh, Pittsburgh, PA 15213 USA; [Duerr, Richard H.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Rioux, John D.] Univ Montreal, Montreal, PQ H1T 1C8, Canada; Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Brant, Steven R.; Dassopoulos, Themistocles] Johns Hopkins Univ, Dept Med, Harvey M & Lyn P Meyerhoff Inflammatory Bowel Dis, Baltimore, MD 21231 USA; [Brant, Steven R.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Silverberg, Mark S.; Steinhart, A. Hillary] Univ Toronto, Mt Sinai Hosp, IBD Ctr, Toronto, ON M5G 1X5, Canada; [Taylor, Kent D.; Rotter, Jerome I.; Targan, Stephan R.] Cedars Sinai Med Ctr, Med Genet Inst Inflammatory Bowel Dis Ctr, Los Angeles, CA 90048 USA; [Bitton, Alain] McGill Univ, Royal Victoria Hosp, Dept Med, Montreal, PQ H3A 1A1, Canada; [Griffiths, Anne M.] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Kistner, Emily O.] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Lathrop, Mark; Gut, Ivo; Heath, Simon; Zelenika, Diana] Ctr Natl Genotypage, Evry, France; Univ Liege, CHU Liege, B-4000 Liege, Belgium; [Dewit, Olivier] Clin Univ St Luc, Dept Gastroenterol, UCL, B-1200 Brussels, Belgium; [Laukens, Debby; de Vos, Martine] Ghent Univ Hosp, Dept Gastroenterol & Hepatol, Ghent, Belgium; [Rutgeerts, Paul; Vermeire, Severine] Katholieke Univ Leuven Hosp, Dept Gastroenterol, Louvain, Belgium; [Van Gossum, Andre; Franchimont, Denis] Free Univ Brussels, Erasmus Hosp, Dept Gastroenterol, B-1050 Brussels, Belgium; [Hugot, Jean-Pierre] INSERM, F-75654 Paris 13, France; Univ Paris Diderot, Paris, France; Hosp Robert Debre, Paris, France; [Drummond, Hazel; Nimmo, Elaine; Satsangi, Jack] Univ Edinburgh, Western Gen Hosp, Sch Mol & Clin Med, Div Med Sci,Gastrointestinal Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Ahmad, Tariq] Peninsula Med Sch, Exeter EX2 5DW, Devon, England; [Prescott, Natalie J.; Onnie, Clive M.; Fisher, Sheila A.; Mathew, Christopher G.] Kings Coll London, Sch Med, Dept Med & Mol Genet, London SE1 9RT, England; [Marchini, Jonathan] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Bumpstead, Suzannah; Gwilliam, Rhian; Deloukas, Panos] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Tremelling, Mark; Parkes, Miles] Univ Cambridge, Addenbrookes Hosp, IBD Res Grp, Cambridge CB2 2QQ, England; [Mansfield, John] Univ Newcastle Upon Tyne, Dept Gastroenterol & Hepatol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; [Jewell, Derek] Univ Oxford, Dept Infirm, Gastroenterol Unit, Oxford OX2 6HE, England; [Daly, Mark J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Oxford; Wellcome Centre for Human Genetics; University of Liege; University of Liege; University of Chicago; Yale University; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Universite de Montreal; Universite de Montreal; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Cedars Sinai Medical Center; McGill University; Royal Victoria Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Chicago; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Liege; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Ghent University; Ghent University Hospital; Flanders Institute for Biotechnology (VIB); KU Leuven; University Hospital Leuven; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Edinburgh; University of Exeter; University of London; King's College London; University of Oxford; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Newcastle University - UK; University of Oxford; Harvard University; Harvard Medical School; Massachusetts General Hospital	Daly, MJ (corresponding author), MIT, Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	mjdaly@chgr.mgh.harvard.edu	Deloukas, Panos/B-2922-2013; Rioux, John D/A-9599-2015; Heath, Simon C/J-4138-2012; Mathew, Christopher G/G-3434-2015; Silverberg, Mark/B-4183-2008; Anderson, Carl A/B-8327-2013; Rotter, Jerome/AAY-6598-2021; Marchini, Jonathan/ABE-9024-2020; Duerr, Richard H/B-4188-2009; Prescott, Natalie J/F-6490-2011; Gut, Ivo/ABF-3188-2020; Daly, Mark J/B-2453-2017; Hugot, Jean-Pierre/F-6594-2012	Deloukas, Panos/0000-0001-9251-070X; Rioux, John D/0000-0001-7560-8326; Heath, Simon C/0000-0002-9550-0897; Mathew, Christopher G/0000-0003-4178-1838; Anderson, Carl A/0000-0003-1719-7009; Marchini, Jonathan/0000-0003-0610-8322; Duerr, Richard H/0000-0001-6586-3905; Prescott, Natalie J/0000-0002-5901-7371; Gut, Ivo/0000-0001-7219-632X; Daly, Mark J/0000-0002-0949-8752; Barrett, Jeffrey/0000-0002-1152-370X; Parkes, Miles/0000-0002-6467-0631; Hugot, Jean-Pierre/0000-0002-8446-6056; Georges, Michel/0000-0003-4124-2375; Vermeire, Severine/0000-0001-9942-3019; Schumm, Phil/0000-0002-3050-2429; Laukens, Debby/0000-0002-1984-5850; Nicolae, Dan/0000-0002-0918-4630; Barmada, M Michael/0000-0002-3604-6460	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK062422, P30DK040561, R01DK064869, U01DK062413, U01DK062420, U01DK062423, U01DK062429, U01DK062432, U01DK062431, P30DK063491] Funding Source: NIH RePORTER; MRC [G0000934, G0600329] Funding Source: UKRI; Medical Research Council [G0800759, G0000934, G0600329] Funding Source: Medline; NIAID NIH HHS [R01 AI062773-02, AI06277, R01 AI062773] Funding Source: Medline; NIDDK NIH HHS [DK62423, U01 DK062423, P30 DK063491-029004, P30 DK063491-019004, U01 DK062420-06, U01 DK062420-03, P30 DK063491-049004, DK62432, U01 DK062420, U01 DK062431-06, U01 DK062431, U01 DK062422, P30 DK040561-13, U01 DK062429, U01 DK062432, DK064869, DK62422, U01 DK062420-02, U01 DK062423-06, U01 DK062420-04, U01 DK062429-07, P30 DK063491-05, U01 DK062422-07, P30 DK063491, U01 DK062413, DK62413, R01 DK064869-04, DK62431, U01 DK062420-05, R01 DK064869, U01 DK062413-06, P30 DK063491-039004, DK62429, DK62420, P30 DK040561, U01 DK062420-01] Funding Source: Medline; Wellcome Trust [068545/Z/02] Funding Source: Medline; Chief Scientist Office [CZB/4/540] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome Trust); Chief Scientist Office		Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Bottini N, 2004, NAT GENET, V36, P337, DOI 10.1038/ng1323; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Criswell LA, 2005, AM J HUM GENET, V76, P561, DOI 10.1086/429096; Dinarello CA, 2007, SEMIN NEPHROL, V27, P98, DOI 10.1016/j.semnephrol.2006.09.013; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Facco M, 2007, J LEUKOCYTE BIOL, V82, P946, DOI 10.1189/jlb.0307133; Goyette P, 2008, MUCOSAL IMMUNOL, V1, P131, DOI 10.1038/mi.2007.15; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Ito T, 2007, J EXP MED, V204, P105, DOI 10.1084/jem.20061660; Kazeem GR, 2005, ANN HUM GENET, V69, P329, DOI 10.1046/j.1529-8817.2005.00156.x; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Li Y, 2006, AM J HUM GENET S, VS79, P2290; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Nakazawa A, 2004, GASTROENTEROLOGY, V126, P1347, DOI 10.1053/j.gastro.2004.02.004; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Oppmann B, 2000, IMMUNITY, V13, P715, DOI 10.1016/S1074-7613(00)00070-4; Parham C, 2002, J IMMUNOL, V168, P5699, DOI 10.4049/jimmunol.168.11.5699; Parkes M, 2007, NAT GENET, V39, P830, DOI 10.1038/ng2061; Pe'er I, 2008, GENET EPIDEMIOL, V32, P381, DOI 10.1002/gepi.20303; Peltekova VD, 2004, NAT GENET, V36, P471, DOI 10.1038/ng1339; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rieck M, 2007, J IMMUNOL, V179, P4704, DOI 10.4049/jimmunol.179.7.4704; Rioux JD, 2001, NAT GENET, V29, P223, DOI 10.1038/ng1001-223; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Salazar-Gonzalez RM, 2006, IMMUNITY, V24, P623, DOI 10.1016/j.immuni.2006.02.015; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Tsuji S, 2001, J BIOL CHEM, V276, P23456, DOI 10.1074/jbc.M103162200; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020; Wedemeyer J, 1999, GUT, V44, P629, DOI 10.1136/gut.44.5.629; Wrackmeyer U, 2006, BIOCHEMISTRY-US, V45, P9188, DOI 10.1021/bi060570x; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	50	2003	2057	2	162	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2008	40	8					955	962		10.1038/ng.175	http://dx.doi.org/10.1038/ng.175			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	331QF	18587394	Green Accepted			2022-12-27	WOS:000258026900011
J	Zhang, Y; Goss, AM; Cohen, ED; Kadzik, R; Lepore, JJ; Muthukumaraswamy, K; Yang, J; DeMayo, FJ; AWhitsett, J; Parmacek, MS; Morrisey, EE				Zhang, Yuzhen; Goss, Ashley M.; Cohen, Ethan David; Kadzik, Rachel; Lepore, John J.; Muthukumaraswamy, Karthika; Yang, Jifu; DeMayo, Francesco J.; AWhitsett, Jeffrey; Parmacek, Michael S.; Morrisey, Edward E.			A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration	NATURE GENETICS			English	Article							LUNG MORPHOGENESIS; REGULATES DIFFERENTIATION; RESPIRATORY-TRACT; GENE-EXPRESSION; GATA-6; WNT; PROLIFERATION; KINASE; TRANSCRIPTION; INACTIVATION	Epithelial organs, including the lung, are known to possess regenerative abilities through activation of endogenous stem cell populations, but the molecular pathways regulating stem cell expansion and regeneration are not well understood. Here we show that Gata6 regulates the temporal appearance and number of bronchioalveolar stem cells (BASCs) in the lung, its absence in Gata6-null lung epithelium leading to the precocious appearance of BASCs and concurrent loss in epithelial differentiation. This expansion of BASCs was the result of a pronounced increase in canonical Wnt signaling in lung epithelium upon loss of Gata6. Expression of the noncanonical Wnt receptor Fzd2 was downregulated in Gata6 mutants and increased Fzd2 or decreased beta-catenin expression rescued, in part, the lung epithelial defects in Gata6 mutants. During lung epithelial regeneration, canonical Wnt signaling was activated in the niche containing BASCs and forced activation of Wnt signaling led to a large increase in BASC numbers. Moreover, Gata6 was required for proper lung epithelial regeneration, and postnatal loss of Gata6 led to increased BASC expansion and decreased differentiation. Together, these data demonstrate that Gata6-regulated Wnt signaling controls the balance between progenitor expansion and epithelial differentiation required for both lung development and regeneration.	[Zhang, Yuzhen; Cohen, Ethan David; Lepore, John J.; Muthukumaraswamy, Karthika; Yang, Jifu; Parmacek, Michael S.; Morrisey, Edward E.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Goss, Ashley M.; Kadzik, Rachel; Morrisey, Edward E.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [DeMayo, Francesco J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [AWhitsett, Jeffrey] Cincinnatis Childrens Hosp, Div Pulm Biol, Cincinnati, OH 45229 USA; [AWhitsett, Jeffrey] Med Ctr, Cincinnati, OH 45229 USA; [Parmacek, Michael S.; Morrisey, Edward E.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Parmacek, Michael S.; Morrisey, Edward E.] Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Baylor College of Medicine; Cincinnati Children's Hospital Medical Center; University of Pennsylvania; University of Pennsylvania	Morrisey, EE (corresponding author), Univ Penn, Dept Med, 956 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.	emorrise@mail.med.upenn.edu	DeMayo, Francesco/C-6255-2019	DeMayo, Francesco/0000-0002-9480-7336; Parmacek, Michael/0000-0003-1449-4665	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075215, R01HL064632, R01HL087825] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL064632, P01 HL075215, P01 HL075215-01A10002, HL075215, HL064632, HL087825, R01 HL087825] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahumada A, 2002, SCIENCE, V298, P2006, DOI 10.1126/science.1073776; Besson A, 2007, GENE DEV, V21, P1731, DOI 10.1101/gad.1556607; BLENKINSOPP WK, 1967, EXP CELL RES, V46, P144, DOI 10.1016/0014-4827(67)90416-8; Brault V, 2001, DEVELOPMENT, V128, P1253; Bruno MD, 2000, J BIOL CHEM, V275, P1043, DOI 10.1074/jbc.275.2.1043; Cardoso WV, 2001, ANNU REV PHYSIOL, V63, P471, DOI 10.1146/annurev.physiol.63.1.471; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; COHEN RE, 1994, SUPRAMOL SCI, V1, P117; Dave V, 2008, AM J RESP CELL MOL, V38, P337, DOI 10.1165/rcmb.2007-0182OC; Fathke C, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-4; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Iwanaga K, 2008, CANCER RES, V68, P1119, DOI 10.1158/0008-5472.CAN-07-3117; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Lepore JJ, 2005, ARTERIOSCL THROM VAS, V25, P309, DOI 10.1161/01.ATV.0000152725.76020.3c; Lepore JJ, 2006, J CLIN INVEST, V116, P929, DOI 10.1172/JCi27363; Li H, 2004, MOL PHARMACOL, V65, P45, DOI 10.1124/mol.65.1.45; Lin LZ, 2007, P NATL ACAD SCI USA, V104, P9313, DOI 10.1073/pnas.0700923104; Liu C, 2002, AM J PHYSIOL-LUNG C, V283, pL468, DOI 10.1152/ajplung.00044.2002; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Minoo P, 1999, DEV BIOL, V209, P60, DOI 10.1006/dbio.1999.9234; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Mucenski ML, 2005, AM J PHYSIOL-LUNG C, V289, pL971, DOI 10.1152/ajplung.00172.2005; Okubo Tadashi, 2004, J Biol, V3, P11, DOI 10.1186/jbiol3; Perl AKT, 2002, TRANSGENIC RES, V11, P21, DOI 10.1023/A:1013986627504; PLOPPER CG, 1992, J PHARMACOL EXP THER, V261, P353; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Sheldahl LC, 2003, J CELL BIOL, V161, P769, DOI 10.1083/jcb.200211094; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Shu WG, 2001, J BIOL CHEM, V276, P27488, DOI 10.1074/jbc.M100636200; Shu WG, 2002, DEVELOPMENT, V129, P4831; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Tichelaar JW, 2000, J BIOL CHEM, V275, P11858, DOI 10.1074/jbc.275.16.11858; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Wan HJ, 2005, J BIOL CHEM, V280, P13809, DOI 10.1074/jbc.M414122200; Weidenfeld J, 2002, J BIOL CHEM, V277, P21061, DOI 10.1074/jbc.M111702200; Yanagi S, 2007, J CLIN INVEST, V117, P2929, DOI 10.1172/JCI31854; Yang HH, 2002, DEVELOPMENT, V129, P2233; Yin Z, 2006, AM J PHYSIOL-LUNG C, V291, pL191, DOI 10.1152/ajplung.00385.2005; Yokoyama H, 2007, DEV BIOL, V306, P170, DOI 10.1016/j.ydbio.2007.03.014; Zhang YZ, 2007, DEVELOPMENT, V134, P189, DOI 10.1242/dev.02720	48	201	211	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					862	870		10.1038/ng.157	http://dx.doi.org/10.1038/ng.157			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18536717	Green Accepted			2022-12-27	WOS:000257166500021
J	Saitsu, H; Kato, M; Mizuguchi, T; Hamada, K; Osaka, H; Tohyama, J; Uruno, K; Kumada, S; Nishiyama, K; Nishimura, A; Okada, I; Yoshimura, Y; Hirai, S; Kumada, T; Hayasaka, K; Fukuda, A; Ogata, K; Matsumoto, N				Saitsu, Hirotomo; Kato, Mitsuhiro; Mizuguchi, Takeshi; Hamada, Keisuke; Osaka, Hitoshi; Tohyama, Jun; Uruno, Katsuhisa; Kumada, Satoko; Nishiyama, Kiyomi; Nishimura, Akira; Okada, Ippei; Yoshimura, Yukiko; Hirai, Syu-ichi; Kumada, Tatsuro; Hayasaka, Kiyoshi; Fukuda, Atsuo; Ogata, Kazuhiro; Matsumoto, Naomichi			De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy	NATURE GENETICS			English	Article							EARLY MYOCLONIC ENCEPHALOPATHY; IDIOPATHIC MENTAL-RETARDATION; SYNAPTIC VESICLE DOCKING; OHTAHARA-SYNDROME; POLYALANINE EXPANSION; WEST-SYNDROME; SECRETION; SYNTAXIN; COMPLEX; PROTEIN	Early infantile epileptic encephalopathy with suppression-burst (EIEE), also known as Ohtahara syndrome, is one of the most severe and earliest forms of epilepsy(1). Using array-based comparative genomic hybridization, we found a de novo 2.0-Mb microdeletion at 9q33.3-q34.11 in a girl with EIEE. Mutation analysis of candidate genes mapped to the deletion revealed that four unrelated individuals with EIEE had heterozygous missense mutations in the gene encoding syntaxin binding protein 1 (STXBP1). STXBP1 (also known as MUNC18-1) is an evolutionally conserved neuronal Sec1/Munc-18 (SM) protein that is essential in synaptic vesicle release in several species(2-4). Circular dichroism melting experiments revealed that a mutant form of the protein was significantly thermolabile compared to wild type. Furthermore, binding of the mutant protein to syntaxin was impaired. These findings suggest that haploinsufficiency of STXBP1 causes EIEE.	[Saitsu, Hirotomo; Mizuguchi, Takeshi; Nishiyama, Kiyomi; Nishimura, Akira; Okada, Ippei; Yoshimura, Yukiko; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Kato, Mitsuhiro; Hayasaka, Kiyoshi] Yamagata Univ, Sch Med, Dept Pediat, Yamagata 9909585, Japan; [Hamada, Keisuke; Ogata, Kazuhiro] Yokohama City Univ, Grad Sch Med, Dept Biochem, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Osaka, Hitoshi] Kanagawa Childrens Med Ctr, Clin Res Inst, Div Neurol, Minami Ku, Yokohama, Kanagawa 2328555, Japan; [Tohyama, Jun] Nishi Niigata Chuo Natl Hosp, Dept Pediat, Epilepsy Ctr, Nishi Ku, Niigata 9502085, Japan; [Uruno, Katsuhisa] Yamagata Natl Hosp, Epilepsy Ctr, Yamagata 9900876, Japan; [Kumada, Satoko] Tokyo Metropolitan Neurol Hosp, Dept Neuropediat, Fuchu, Tokyo 1830042, Japan; [Hirai, Syu-ichi] Yokohama City Univ, Grad Sch Med, Dept Mol Biol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan; [Kumada, Tatsuro; Fukuda, Atsuo] Hamamatsu Univ Sch Med, Dept Physiol, Hamamatsu, Shizuoka 4313192, Japan	Yokohama City University; Yamagata University; Yokohama City University; Tokyo Metropolitan Institute for Neuroscience; Yokohama City University; Hamamatsu University School of Medicine	Saitsu, H (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Human Genet, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	hsaitsu@yokohama-cu.ac.jp; naomat@yokohama-cu.ac.jp	Saitsu, Hirotomo/AAM-7131-2021; Fukuda, Atsuo/ABA-6843-2020; Hayasaka, Kiyoshi/H-5340-2012; Kumada, Tatsuro/AAY-9117-2020	Fukuda, Atsuo/0000-0001-7112-4834; Saitsu, Hirotomo/0000-0003-0723-0960; Kato, Mitsuhiro/0000-0003-1485-8553				Djukic A, 2006, EPILEPSY RES, V70, pS68, DOI 10.1016/j.eplepsyres.2005.11.022; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Feuk L, 2006, HUM MOL GENET, V15, pR57, DOI 10.1093/hmg/ddl057; Garcia CC, 2004, J MED GENET, V41, P183, DOI 10.1136/jmg.2003.013680; GARCIA EP, 1994, P NATL ACAD SCI USA, V91, P2003, DOI 10.1073/pnas.91.6.2003; Gurnett CA, 2007, ARCH NEUROL-CHICAGO, V64, P324, DOI 10.1001/archneur.64.3.324; Harada N, 2004, J MED GENET, V41, P130, DOI 10.1136/jmg.2003.014639; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Kalidas S, 2000, ACTA NEUROPATHOL, V99, P191, DOI 10.1007/PL00007424; Kato M, 2003, NEUROLOGY, V61, P267, DOI 10.1212/01.WNL.0000068012.69928.92; Kato M, 2007, AM J HUM GENET, V81, P361, DOI 10.1086/518903; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Miyake N, 2006, AM J MED GENET A, V140A, P205, DOI 10.1002/ajmg.a.31098; Ohtahara S, 1976, NO TO HATTATSU, V8, P270, DOI DOI 10.11251/OJJSCN1969.8.270; Ohtahara S, 2006, EPILEPSY RES, V70, pS58, DOI 10.1016/j.eplepsyres.2005.11.021; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Rizo J, 2002, NAT REV NEUROSCI, V3, P641, DOI 10.1038/nrn898; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; SPREAFICO R, 1993, EPILEPSIA, V34, P800, DOI 10.1111/j.1528-1157.1993.tb02093.x; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tohyama J, 2008, BRAIN DEV-JPN, V30, P349, DOI 10.1016/j.braindev.2007.10.006; Toonen RFG, 2007, TRENDS NEUROSCI, V30, P564, DOI 10.1016/j.tins.2007.08.008; Toonen RFG, 2006, P NATL ACAD SCI USA, V103, P18332, DOI 10.1073/pnas.0608507103; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Vissers LELM, 2005, HUM MOL GENET, V14, pR215, DOI 10.1093/hmg/ddi268; Weimer RM, 2005, CURR TOP DEV BIOL, V65, P83; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; YANG JT, 1986, METHOD ENZYMOL, V130, P208	30	390	408	0	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2008	40	6					782	788		10.1038/ng.150	http://dx.doi.org/10.1038/ng.150			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18469812				2022-12-27	WOS:000256212000021
J	Doring, A; Gieger, C; Mehta, D; Gohlke, H; Prokisch, H; Coassin, S; Fischer, G; Henke, K; Klopp, N; Kronenberg, F; Paulweber, B; Pfeufer, A; Rosskopf, D; Voelzke, H; Illig, T; Meitinger, T; Wichmann, HE; Meisinger, C				Doering, Angela; Gieger, Christian; Mehta, Divya; Gohlke, Henning; Prokisch, Holger; Coassin, Stefan; Fischer, Guido; Henke, Kathleen; Klopp, Norman; Kronenberg, Florian; Paulweber, Bernhard; Pfeufer, Arne; Rosskopf, Dieter; Voelzke, Henry; Illig, Thomas; Meitinger, Thomas; Wichmann, H-Erich; Meisinger, Christa			SLC2A9 influences uric acid concentrations with pronounced sex-specific effects	NATURE GENETICS			English	Article							GENE; ASSOCIATION; TRANSPORTER; POPULATION; FRUCTOSE; URATE; EXPRESSION; DISEASE; LINKAGE; FAMILY	Serum uric acid concentrations are correlated with gout and clinical entities such as cardiovascular disease and diabetes. In the genome-wide association study KORA (Kooperative Gesundheitsforschung in der Region Augsburg) F3 500K (n = 1,644), the most significant SNPs associated with uric acid concentrations mapped within introns 4 and 6 of SLC2A9, a gene encoding a putative hexose transporter (effects: -0.23 to -0.36 mg/dl per copy of the minor allele). We replicated these findings in three independent samples from Germany (KORA S4 and SHIP (Study of Health in Pomerania)) and Austria (SAPHIR; Salzburg Atherosclerosis Prevention Program in Subjects at High Individual Risk), with P values ranging from 1.2 x 10(-8) to 1.0 x 10(-32). Analysis of whole blood RNA expression profiles from a KORA F3 500K subgroup (n = 117) showed a significant association between the SLC2A9 isoform 2 and urate concentrations. The SLC2A9 genotypes also showed significant association with self-reported gout. The proportion of the variance of serum uric acid concentrations explained by genotypes was about 1.2% in men and 6% in women, and the percentage accounted for by expression levels was 3.5% in men and 15% in women.	[Doering, Angela; Gieger, Christian; Gohlke, Henning; Fischer, Guido; Klopp, Norman; Illig, Thomas; Wichmann, H-Erich; Meisinger, Christa] German Res Ctr Environm Hlth, Inst Epidemiol, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany; [Gieger, Christian; Klopp, Norman; Wichmann, H-Erich] Univ Munich, Inst Med Informat Biometry & Epidemiol, D-81377 Munich, Germany; [Mehta, Divya; Prokisch, Holger; Pfeufer, Arne; Meitinger, Thomas] German Res Ctr Environm Hlth, Inst Human Genet, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany; [Prokisch, Holger; Pfeufer, Arne; Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-81765 Munich, Germany; [Coassin, Stefan; Kronenberg, Florian] Innsbruck Med Univ, Dept Med Genet, Div Genet Epidemiol, A-6020 Innsbruck, Austria; [Henke, Kathleen; Rosskopf, Dieter] Ernst Moritz Arndt Univ Greifswald, Dept Pharmacol, D-17487 Greifswald, Germany; [Paulweber, Bernhard] Paracelsus Private Med Univ, Dept Internal Med 1, St Johann Spital, A-5020 Salzburg, Austria; [Voelzke, Henry] Ernst Moritz Arndt Univ Greifswald, Inst Community Med, D-17487 Greifswald, Germany; [Meisinger, Christa] KORA Kooperat Gesundheitsforsch Reg Augsburg Myoc, MONICA Monitoring Trends & Determinants Cardiovas, Cent Hosp Augsburg, D-86156 Augsburg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Medical University of Innsbruck; Ernst Moritz Arndt Universitat Greifswald; Paracelsus Private Medical University; Ernst Moritz Arndt Universitat Greifswald	Meisinger, C (corresponding author), German Res Ctr Environm Hlth, Inst Epidemiol, Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany.	christa.meisinger@helmholtz-muenchen.de	Kronenberg, Florian/B-1736-2008; Meisinger, Christine/B-5358-2014; Coassin, Stefan/J-2611-2018; Prokisch, Holger/N-8964-2013; Meitinger, Thomas/O-1318-2015; Wichmann, Heinz Erich/AAA-5695-2022; Mehta, Divya/ABD-4551-2021; Pfeufer, Arne/B-6634-2013	Kronenberg, Florian/0000-0003-2229-1120; Coassin, Stefan/0000-0001-5677-8979; Prokisch, Holger/0000-0003-2379-6286; Gieger, Christian/0000-0001-6986-9554; Mehta, Divya/0000-0001-7971-7255; Mehta, Divya Deepak/0000-0002-7359-348X; Meitinger, Thomas/0000-0002-8838-8403; Meisinger, Christa/0000-0002-9026-6544				Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; BURANT CF, 1992, J BIOL CHEM, V267, P14523; Cheng LSC, 2004, AM J HUM GENET, V75, P498, DOI 10.1086/423429; Fang J, 2000, JAMA-J AM MED ASSOC, V283, P2404, DOI 10.1001/jama.283.18.2404; Graessler J, 2006, ARTHRITIS RHEUM, V54, P292, DOI 10.1002/art.21499; HALLFRISCH J, 1990, FASEB J, V4, P2652, DOI 10.1096/fasebj.4.9.2189777; Heid IM, 2006, DIABETES, V55, P375, DOI 10.2337/diabetes.55.02.06.db05-0747; John U, 2001, SOZ PRAVENTIV MED, V46, P186, DOI 10.1007/BF01324255; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; Keembiyehetty C, 2006, MOL ENDOCRINOL, V20, P686, DOI 10.1210/me.2005-0010; Lake SL, 2003, HUM HERED, V55, P56, DOI 10.1159/000071811; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Richardson S, 2003, OSTEOARTHR CARTILAGE, V11, P92, DOI 10.1053/joca.2002.0858; Roddy E, 2007, NAT CLIN PRACT RHEUM, V3, P443, DOI 10.1038/ncprheum0556; Scheepers A, 2005, MOL MEMBR BIOL, V22, P339, DOI 10.1080/09687860500166143; Shima Y, 2006, LIFE SCI, V79, P2234, DOI 10.1016/j.lfs.2006.07.030; STIRPE F, 1970, LANCET, V2, P1310; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS26, DOI 10.1055/s-2005-858226; Wilk JB, 2000, HUM GENET, V106, P355, DOI 10.1007/s004390051050; Yang Q, 2005, METABOLISM, V54, P1435, DOI 10.1016/j.metabol.2005.05.007; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	23	301	323	2	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2008	40	4					430	436		10.1038/ng.107	http://dx.doi.org/10.1038/ng.107			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18327256				2022-12-27	WOS:000254388100013
J	Sharp, AJ; Mefford, HC; Li, K; Baker, C; Skinner, C; Stevenson, RE; Schroer, RJ; Novara, F; De Gregori, M; Ciccone, R; Broomer, A; Casuga, I; Wang, Y; Xiao, C; Barbacioru, C; Gimelli, G; Bernardina, BD; Torniero, C; Giorda, R; Regan, R; Murday, V; Mansour, S; Fichera, M; Castiglia, L; Failla, P; Ventura, M; Jiang, ZS; Cooper, GM; Knight, SJL; Romano, C; Zuffardi, O; Chen, CF; Schwartz, CE; Eichler, EE				Sharp, Andrew J.; Mefford, Heather C.; Li, Kelly; Baker, Carl; Skinner, Cindy; Stevenson, Roger E.; Schroer, Richard J.; Novara, Francesca; De Gregori, Manuela; Ciccone, Roberto; Broomer, Adam; Casuga, Iris; Wang, Yu; Xiao, Chunlin; Barbacioru, Catalin; Gimelli, Giorgio; Bernardina, Bernardo Dalla; Torniero, Claudia; Giorda, Roberto; Regan, Regina; Murday, Victoria; Mansour, Sahar; Fichera, Marco; Castiglia, Lucia; Failla, Pinella; Ventura, Mario; Jiang, Zhaoshi; Cooper, Gregory M.; Knight, Samantha J. L.; Romano, Corrado; Zuffardi, Orsetta; Chen, Caifu; Schwartz, Charles E.; Eichler, Evan E.			A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures	NATURE GENETICS			English	Article							COPY-NUMBER VARIATION; ARRAY-CGH; MOLECULAR CHARACTERIZATION; SEGMENTAL DUPLICATIONS; STRUCTURAL VARIATION; ANGELMAN-SYNDROME; REARRANGEMENTS; ARCHITECTURE; POLYMORPHISM; 15Q11-Q13	We report a recurrent microdeletion syndrome causing mental retardation, epilepsy and variable facial and digital dysmorphisms. We describe nine affected individuals, including six probands: two with de novo deletions, two who inherited the deletion from an affected parent and two with unknown inheritance. The proximal breakpoint of the largest deletion is contiguous with breakpoint 3 (BP3) of the Prader-Willi and Angelman syndrome region, extending 3.95 Mb distally to BP5. A smaller 1.5-Mb deletion has a proximal breakpoint within the larger deletion (BP4) and shares the same distal BP5. This recurrent 1.5-Mb deletion contains six genes, including a candidate gene for epilepsy (CHRNA7) that is probably responsible for the observed seizure phenotype. The BP4-BP5 region undergoes frequent inversion, suggesting a possible link between this inversion polymorphism and recurrent deletion. The frequency of these microdeletions in mental retardation cases is similar to 0.3% (6/2,082 tested), a prevalence comparable to that of Williams, Angelman and Prader-Willi syndromes.	[Sharp, Andrew J.; Mefford, Heather C.; Baker, Carl; Jiang, Zhaoshi; Cooper, Gregory M.; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Li, Kelly; Broomer, Adam; Casuga, Iris; Wang, Yu; Xiao, Chunlin; Barbacioru, Catalin; Chen, Caifu] Appl Biosyst Inc, Assays Arrays R&D, Foster City, CA 94404 USA; [Skinner, Cindy; Stevenson, Roger E.; Schroer, Richard J.; Schwartz, Charles E.] Greenwood Genet Ctr, JC Self Res Inst, Greenwood, SC 29646 USA; [Novara, Francesca; De Gregori, Manuela; Ciccone, Roberto; Zuffardi, Orsetta] Univ Pavia, I-27100 Pavia, Italy; [Gimelli, Giorgio] Ist Giannina Gaslini, I-16147 Genoa, Italy; [Bernardina, Bernardo Dalla; Torniero, Claudia] Univ Verona, Policlin GB Rossi, Servizio Neuropsichiatr Infantile, I-37134 Verona, Italy; [Giorda, Roberto] IRCCS E Medea, I-23842 Bosisio Parini, Italy; [Regan, Regina; Knight, Samantha J. L.] Churchill Hosp, Wellcome Trust Ctr Human Genet, Oxford Natl Inst Hlth Res NIHR Biomed Res Ctr, Oxford OX3 7BN, England; [Murday, Victoria] Duncan Guthrie Inst Med Genet, Dept Med Genet, Glasgow G3 8SJ, Lanark, Scotland; [Mansour, Sahar] St George Hosp, SW Reg Genet Serv, London SW17 0RE, England; [Fichera, Marco; Castiglia, Lucia; Failla, Pinella; Romano, Corrado] IRCCS, Assoc Oasi Maria Santissima, I-94018 Troina, Italy; [Ventura, Mario] Univ Bari, Dipartimento Genet & Microbiol, I-27100 Pavia, Italy; [Zuffardi, Orsetta] Fdn IRCCS Policlin San Matteo, I-27100 Pavia, Italy; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Thermo Fisher Scientific; Applied Biosystems; Greenwood Genetic Center; University of Pavia; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; IRCCS Eugenio Medea; University of Oxford; Wellcome Centre for Human Genetics; St Georges University London; IRCCS Oasi Maria SS; Universita degli Studi di Bari Aldo Moro; IRCCS Fondazione San Matteo; Howard Hughes Medical Institute	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, 1705 NE Pacific St, Seattle, WA 98195 USA.	eee@gs.washington.edu	Giorda, Roberto/Q-6010-2019; Giorda, Roberto/J-1052-2014; Castiglia, Lucia/D-8563-2017; Ventura, Mario/E-6420-2011; Romano, Corrado/B-9695-2008; Fichera, Marco/K-9220-2016; De Gregori, Manuela/J-1039-2014; Failla, Pinella/AAE-9963-2019; Cooper, Gregory/D-6914-2011	Giorda, Roberto/0000-0001-8175-9606; Giorda, Roberto/0000-0001-8175-9606; Castiglia, Lucia/0000-0002-3261-8847; Ventura, Mario/0000-0001-7762-8777; Romano, Corrado/0000-0003-1049-0683; Fichera, Marco/0000-0002-8225-6880; De Gregori, Manuela/0000-0002-3507-497X; Failla, Pinella/0000-0003-3969-7266; Cooper, Gregory/0000-0001-5509-9923; Knight, Samantha/0000-0002-6047-3462; Novara, Francesca/0000-0003-1216-0231; zuffardi, orsetta/0000-0002-1466-4559	Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [U01 HL069757] Funding Source: Medline; NICHD NIH HHS [HD043569, R01 HD043569] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043569] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL069757] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; Elmslie FV, 1997, HUM MOL GENET, V6, P1329, DOI 10.1093/hmg/6.8.1329; Erdogan F, 2007, AM J MED GENET A, V143A, P172, DOI 10.1002/ajmg.a.31541; Gimelli G, 2003, HUM MOL GENET, V12, P849, DOI 10.1093/hmg/ddg101; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jiang Z, 2007, NAT GENET, V39, P1361, DOI 10.1038/ng.2007.9; Kurotaki N, 2005, HUM MOL GENET, V14, P535, DOI 10.1093/hmg/ddi050; LARSON SA, 2001, AM J MENT RETARD, V106, P231; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lupski JR, 2006, NAT GENET, V38, P974, DOI 10.1038/ng0906-974; Neubauer BA, 1998, NEUROLOGY, V51, P1608, DOI 10.1212/WNL.51.6.1608; OrrUrtreger A, 1997, J NEUROSCI, V17, P9165; Osborne LR, 2001, NAT GENET, V29, P321, DOI 10.1038/ng753; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Sahoo T, 2005, AM J MED GENET A, V139A, P106, DOI 10.1002/ajmg.a.31000; Sahoo T, 2007, EUR J HUM GENET, V15, P943, DOI 10.1038/sj.ejhg.5201859; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2006, ANNU REV GENOM HUM G, V7, P407, DOI 10.1146/annurev.genom.7.080505.115618; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Stevenson RE, 2003, AM J MED GENET A, V123A, P29, DOI 10.1002/ajmg.a.20492; STEVENSON RE, 1996, P GREENW GEN CTR; Wang NJ, 2004, AM J HUM GENET, V75, P267, DOI 10.1086/422854; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Zody MC, 2006, NATURE, V440, P671, DOI 10.1038/nature04601; Zogopoulos G, 2007, HUM GENET, V122, P345, DOI 10.1007/s00439-007-0404-5	30	431	439	2	28	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2008	40	3					322	328		10.1038/ng.93	http://dx.doi.org/10.1038/ng.93			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18278044	Green Accepted			2022-12-27	WOS:000253548400023
J	Zeitlinger, J; Stark, A; Kellis, M; Hong, JW; Nechaev, S; Adelman, K; Levine, M; Young, RA				Zeitlinger, Julia; Stark, Alexander; Kellis, Manolis; Hong, Joung-Woo; Nechaev, Sergei; Adelman, Karen; Levine, Michael; Young, Richard A.			RNA polymerase stalling at developmental control genes in the Drosophila melanogaster embryo	NATURE GENETICS			English	Article							TRANSCRIPTION ELONGATION; MESODERM DEVELOPMENT; PROXIMAL REGION; TARGET GENES; DORSAL; PROMOTER; EXPRESSION; PROTEIN; SNAIL; RECRUITMENT	It is widely assumed that the key rate-limiting step in gene activation is the recruitment of RNA polymerase II ( Pol II) to the core promoter(1). Although there are well-documented examples in which Pol II is recruited to a gene but stalls(2-12), a general role for Pol II stalling in development has not been established. We have carried out comprehensive Pol II chromatin immunoprecipitation microarray ( ChIP-chip) assays in Drosophila embryos and identified three distinct Pol II binding behaviors: active ( uniform binding across the entire transcription unit), no binding, and stalled ( binding at the transcription start site). The notable feature of the similar to 10% genes that are stalled is that they are highly enriched for developmental control genes, which are either repressed or poised for activation during later stages of embryogenesis. We propose that Pol II stalling facilitates rapid temporal and spatial changes in gene activity during development.	Univ Calif Berkeley, Ctr Integrat Genom, Dept Mol Cell Biol, Berkeley, CA 94720 USA; Whitehead Inst Biomed Res, Nine Cambridge Ctr, Cambridge, MA 02142 USA; Broad Inst Massachustts Inst Technol & Harvard, Cambridge, MA 02141 USA; MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; NIH, Natl Inst Environm Hlth Sci, Mol Carcinogenesis Lab, Res Triangle Pk, NC 27709 USA; MIT, Dept Biol, Cambridge, MA 02139 USA	University of California System; University of California Berkeley; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Massachusetts Institute of Technology (MIT)	Levine, M (corresponding author), Univ Calif Berkeley, Ctr Integrat Genom, Dept Mol Cell Biol, Berkeley, CA 94720 USA.	mlevine@berkeley.edu	Nechaev, Sergei/AAQ-3450-2021; Young, Richard A/F-6495-2012; Hong, Joung-Woo/AAG-1173-2021; Kellis, Manolis/ABE-7385-2020; Stark, Alexander/D-1473-2012	Young, Richard A/0000-0001-8855-8647; Hong, Joung-Woo/0000-0001-6511-7881; Kellis, Manolis/0000-0001-7113-9630; Stark, Alexander/0000-0003-2611-0841; Levine, Michael/0000-0001-7629-0081; Adelman, Karen/0000-0001-5364-334X	Intramural NIH HHS [Z01 ES101987-02] Funding Source: Medline; NHGRI NIH HHS [R01 HG004037, R01 HG004037-01A1, HG002668, R01 HG002668] Funding Source: Medline; NIGMS NIH HHS [GM34431, R01 GM069676, R37 GM046638, GM069676, R01 GM046638] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668, R01HG004037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034431, R37GM046638, R01GM046638, R01GM069676] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENDER TP, 1987, SCIENCE, V237, P1473, DOI 10.1126/science.3498214; Biemar F, 2006, P NATL ACAD SCI USA, V103, P12763, DOI 10.1073/pnas.0604484103; BOULAY JL, 1987, NATURE, V330, P395, DOI 10.1038/330395a0; Cheng CH, 2003, MOL CELL BIOL, V23, P1961, DOI 10.1128/MCB.23.6.1961-1967.2003; Conaway JW, 2000, TRENDS BIOCHEM SCI, V25, P375, DOI 10.1016/S0968-0004(00)01615-7; Furlong EE, 2004, CURR OPIN GENET DEV, V14, P343, DOI 10.1016/j.gde.2004.06.011; Furlong EEM, 2001, SCIENCE, V293, P1629, DOI 10.1126/science.1062660; GILMOUR DS, 1986, MOL CELL BIOL, V6, P3984, DOI 10.1128/MCB.6.11.3984; Huang AM, 1997, GENE DEV, V11, P1963, DOI 10.1101/gad.11.15.1963; KOSMAN D, 1991, SCIENCE, V254, P118, DOI 10.1126/science.1925551; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; LASPIA MF, 1993, J MOL BIOL, V232, P732, DOI 10.1006/jmbi.1993.1427; LEPTIN M, 1991, GENE DEV, V5, P1568, DOI 10.1101/gad.5.9.1568; LIS J, 1993, CELL, V74, P1, DOI 10.1016/0092-8674(93)90286-Y; Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Reppas NB, 2006, MOL CELL, V24, P747, DOI 10.1016/j.molcel.2006.10.030; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981; SCHNEIDER DS, 1991, GENE DEV, V5, P797, DOI 10.1101/gad.5.5.797; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Stathopoulos A, 2002, CELL, V111, P687, DOI 10.1016/S0092-8674(02)01087-5; STROBL LJ, 1992, EMBO J, V11, P3307, DOI 10.1002/j.1460-2075.1992.tb05409.x; TOMANCAK P, 2002, GENOME BIOL, V3; Wang XL, 2007, GENE DEV, V21, P1031, DOI 10.1101/gad.1521207; Zeitlinger J, 2007, GENE DEV, V21, P385, DOI 10.1101/gad.1509607	30	572	583	2	29	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2007	39	12					1512	1516		10.1038/ng.2007.26	http://dx.doi.org/10.1038/ng.2007.26			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	17994019	Green Accepted			2022-12-27	WOS:000251267400021
J	Shukla, V; Coumoul, X; Wang, RH; Kim, HS; Deng, CX				Shukla, Vivek; Coumoul, Xavier; Wang, Rui-Hong; Kim, Hyun-Seok; Deng, Chu-Xia			RNA interference and inhibition of MEK-ERK signaling prevent abnormal skeletal phenotypes in a mouse model of craniosynostosis	NATURE GENETICS			English	Article							MUTATIONS; FGFR2; ACTIVATION; EXPRESSION; RECEPTORS; PATHWAY; ROLES; CELLS; FGF-2	Premature fusion of one or more of the cranial sutures ( craniosynostosis) in humans causes over 100 skeletal diseases, which occur in 1 of approximate to 2,500 live births(1-3). Among them is Apert syndrome, one of the most severe forms of craniosynostosis, primarily caused by missense mutations leading to amino acid changes S252W or P253R in fibroblast growth factor receptor 2 ( FGFR2)(4-6). Here we show that a small hairpin RNA targeting the dominant mutant form of Fgfr2 ( Fgfr2(S252W)) completely prevents Apert- like syndrome in mice. Restoration of normal FGFR2 signaling is manifested by an alteration of the activity of extracellular signal- regulated kinases 1 and 2 ( ERK1/ 2), implicating the gene encoding ERK and the genes downstream of it in disease expressivity. Furthermore, treatment of the mutant mice with U0126, an inhibitor of mitogen- activated protein ( MAP) kinase kinase 1 and 2 ( MEK1/ 2) that blocks phosphorylation and activation of ERK1/ 2, significantly inhibits craniosynostosis. These results illustrate a pathogenic role for ERK activation in craniosynostosis resulting from FGFR2 with the S252W substitution and introduce a new concept of small- molecule inhibitor - mediated prevention and therapy for diseases caused by gain- of- function mutations in the human genome.	NIDDKD, US Natl Inst Hlth, Genet Dev & Dis Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Deng, CX (corresponding author), NIDDKD, US Natl Inst Hlth, Genet Dev & Dis Branch, 10 Ctr Dr, Bethesda, MD 20892 USA.	chuxiad@bdg10.niddk.nih.gov	deng, chuxia/N-6713-2016; COUMOUL, Xavier/AAR-3649-2020	COUMOUL, Xavier/0000-0003-2928-9648	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [Z01DK056004, ZIADK056004] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Cabrita MA, 2003, THROMB HAEMOSTASIS, V90, P586, DOI 10.1160/TH03-04-0217; Chaudhary LR, 1997, BIOCHEM BIOPH RES CO, V238, P134, DOI 10.1006/bbrc.1997.7256; Chen L, 2003, BONE, V33, P169, DOI 10.1016/S8756-3282(03)00222-9; Chen L, 2005, FRONT BIOSCI-LANDMRK, V10, P1961, DOI 10.2741/1671; Chikazu D, 2000, J BIOL CHEM, V275, P31444, DOI 10.1074/jbc.M910132199; Coumoul X, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni100; Coumoul X, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh083; Coumoul Xavier, 2003, Birth Defects Research, V69, P286, DOI 10.1002/bdrc.10025; Eswarakumar VP, 2006, P NATL ACAD SCI USA, V103, P18603, DOI 10.1073/pnas.0609157103; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Furthauer M, 2002, NAT CELL BIOL, V4, P170, DOI 10.1038/ncb750; Ibrahimi OA, 2005, PLAST RECONSTR SURG, V115, P264, DOI 10.1097/01.PRS.0000146703.08958.95; Katzen JT, 2000, OTOLARYNG CLIN N AM, V33, P1257, DOI 10.1016/S0030-6665(05)70280-2; Kim HJ, 2003, DEV DYNAM, V227, P335, DOI 10.1002/dvdy.10319; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; McIntosh I, 2000, CELL STRUCT FUNCT, V25, P85, DOI 10.1247/csf.25.85; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; MUENKE M, 1995, TRENDS GENET, V11, P308, DOI 10.1016/S0168-9525(00)89088-5; Ornitz DM, 2001, GENOME BIOL, V2; PARK WJ, 1995, AM J HUM GENET, V57, P321; Perlyn CA, 2006, NEUROSURGERY, V59, P210, DOI 10.1227/01.NEU.0000224323.53866.1E; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; Renier D, 2000, CHILD NERV SYST, V16, P645, DOI 10.1007/s003810000320; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Smith TG, 2005, DEVELOPMENT, V132, P1305, DOI 10.1242/dev.01699; Spector JA, 2005, PLAST RECONSTR SURG, V115, P838, DOI 10.1097/01.PRS.0000153035.73507.7B; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Yang X, 2001, J CELL BIOL, V153, P35, DOI 10.1083/jcb.153.1.35	30	147	163	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1145	1150		10.1038/ng2096	http://dx.doi.org/10.1038/ng2096			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17694057				2022-12-27	WOS:000249122400026
J	Jasnos, L; Korona, R				Jasnos, Lukasz; Korona, Ryszard			Epistatic buffering of fitness loss in yeast double deletion strains	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; DELETERIOUS MUTATIONS; SEXUAL REPRODUCTION; METABOLIC NETWORK; RECOMBINATION; EVOLUTION; GENOME; SELECTION; GENES	Interactions between deleterious mutations have been insufficiently studied(1,2), despite the fact that their strength and direction are critical for understanding the evolution of genetic recombination(3,4) and the buildup of mutational load in populations(5,6). We compiled a list of 758 yeast gene deletions causing growth defects ( from the Munich Information Center for Protein Sequences database and ref. 7). Using BY4741 and BY4742 single- deletion strains, we carried out 639 random crosses and assayed growth curves of the resulting progeny. We show that the maximum growth rate averaged over strains lacking deletions and those with double deletions is higher than that of strains with single deletions, indicating a positive epistatic effect. This tendency is shared by genes belonging to a variety of functional classes. Based on our data and former theoretical work(8-10), we suggest that epistasis is likely to diminish the negative effects of mutations when the ability to produce biomass at high rates contributes significantly to fitness.	Jagiellonian Univ, Inst Environm Sci, PL-30387 Krakow, Poland	Jagiellonian University	Korona, R (corresponding author), Jagiellonian Univ, Inst Environm Sci, Gronostajowa 7, PL-30387 Krakow, Poland.	korona@eko.uj.edu.pl	Korona, Ryszard/J-7154-2015	Korona, Ryszard/0000-0002-4329-5908				Azevedo RBR, 2006, NATURE, V440, P87, DOI 10.1038/nature04488; Baganz F, 1997, YEAST, V13, P1563, DOI 10.1002/(SICI)1097-0061(199712)13:16<1563::AID-YEA240>3.3.CO;2-Y; BARTON NH, 1995, GENET RES, V65, P123, DOI 10.1017/S0016672300033140; Burgard AP, 2004, GENOME RES, V14, P301, DOI 10.1101/gr.1926504; CHARLESWORTH D, 1993, GENET RES, V61, P39, DOI 10.1017/S0016672300031086; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; CROW JF, 1979, P NATL ACAD SCI USA, V76, P396, DOI 10.1073/pnas.76.1.396; Famili I, 2003, P NATL ACAD SCI USA, V100, P13134, DOI 10.1073/pnas.2235812100; FELDMAN MW, 1980, P NATL ACAD SCI-BIOL, V77, P4838, DOI 10.1073/pnas.77.8.4838; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Jasnos L, 2005, ANAL BIOCHEM, V344, P138, DOI 10.1016/j.ab.2005.04.034; Keightley PD, 1996, J THEOR BIOL, V182, P311, DOI 10.1006/jtbi.1996.0169; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; KIMURA M, 1966, GENETICS, V54, P1337; KONDRASHOV AS, 1988, NATURE, V336, P435, DOI 10.1038/336435a0; Kouyos RD, 2006, GENETICS, V173, P589, DOI 10.1534/genetics.105.053108; Moore JH, 2005, BIOESSAYS, V27, P637, DOI 10.1002/bies.20236; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Roeder GS, 1997, GENE DEV, V11, P2600, DOI 10.1101/gad.11.20.2600; Sanjuan R, 2004, P NATL ACAD SCI USA, V101, P15376, DOI 10.1073/pnas.0404125101; Sanjuan R, 2006, P NATL ACAD SCI USA, V103, P14402, DOI 10.1073/pnas.0604543103; Scherens B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-229; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Sliwa P, 2005, P NATL ACAD SCI USA, V102, P17670, DOI 10.1073/pnas.0505517102; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; SZATHMARY E, 1993, GENETICS, V133, P127; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Warringer J, 2003, YEAST, V20, P53, DOI 10.1002/yea.931	30	93	94	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2007	39	4					550	554		10.1038/ng1986	http://dx.doi.org/10.1038/ng1986			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17322879				2022-12-27	WOS:000245271200028
J	Benetti, R; Garcia-Cao, M; Blasco, MA				Benetti, Roberta; Garcia-Cao, Marta; Blasco, Maria A.			Telomere length regulates the epigenetic status of mammalian telomeres and subtelomeres	NATURE GENETICS			English	Article							CONSTITUTIVE HETEROCHROMATIN; HISTONE METHYLTRANSFERASES; CHROMOSOMAL INSTABILITY; DNA-DAMAGE; CELLS; MICE; STABILITY/; PROTEINS; COMPLEX; FAMILY	Mammalian telomeres have epigenetic marks of constitutive heterochromatin. Here, we study the impact of telomere length on the maintenance of heterochromatin domains at telomeres. Telomerase-deficient Terc(-/-) mice with short telomeres show decreased trimethylation of histone 3 at Lys9 ( H3K9) and histone 4 at Lys20 ( H4K20) in telomeric and subtelomeric chromatin as well as decreased CBX3 binding accompanied by increased H3 and H4 acetylation at these regions. Subtelomeric DNA methylation is also decreased in conjunction with telomere shortening in Terc(-/-) mice. In contrast, telomere repeat factors 1 and 2 show normal binding to telomeres independent of telomere length. These results indicate that loss of telomeric repeats leads to a change in the architecture of telomeric and subtelomeric chromatin consisting of loss of heterochromatic features leading to a more 'open' chromatin state. These observations highlight the importance of telomere repeats in the establishment of constitutive heterochromatin at mammalian telomeres and subtelomeres and point to histone modifications as important in counting telomere repeats.	Spanish Natl Canc Ctr, Mol Oncol Program, Telomeres & Telomerase Grp, Madrid 28029, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Blasco, MA (corresponding author), Spanish Natl Canc Ctr, Mol Oncol Program, Telomeres & Telomerase Grp, Madrid 28029, Spain.	mblasco@cnio.es	Blasco, Maria A./M-1694-2014	Blasco, Maria A./0000-0002-4211-233X; BENETTI, Roberta/0000-0001-8863-0821				Bailey SM, 2001, SCIENCE, V293, P2462, DOI 10.1126/science.1062560; Baur JA, 2001, SCIENCE, V292, P2075, DOI 10.1126/science.1062329; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chan SWL, 2002, ONCOGENE, V21, P553, DOI 10.1038/sj.onc.1205082; Chang S, 2003, GENE DEV, V17, P88, DOI 10.1101/gad.1029903; CHIEN CT, 1993, CELL, V75, P531, DOI 10.1016/0092-8674(93)90387-6; COCKELL M, 1995, J CELL BIOL, V129, P909, DOI 10.1083/jcb.129.4.909; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Espejel S, 2002, EMBO J, V21, P2207, DOI 10.1093/emboj/21.9.2207; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Garcia-Cao M, 2002, NAT GENET, V32, P415, DOI 10.1038/ng1011; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Gonzalo S, 2005, NAT CELL BIOL, V7, P420, DOI 10.1038/ncb1235; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Koering CE, 2002, EMBO REP, V3, P1055, DOI 10.1093/embo-reports/kvf215; Kourmouli N, 2004, J CELL SCI, V117, P2491, DOI 10.1242/jcs.01238; Lustig AJ, 1998, CURR OPIN GENET DEV, V8, P233, DOI 10.1016/S0959-437X(98)80146-9; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Muntoni A, 2005, HUM MOL GENET, V14, pR191, DOI 10.1093/hmg/ddi266; Niida H, 2000, MOL CELL BIOL, V20, P4115, DOI 10.1128/MCB.20.11.4115-4127.2000; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Samper E, 2001, EMBO REP, V2, P800, DOI 10.1093/embo-reports/kve174; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Steinert S, 2004, MOL CELL BIOL, V24, P4571, DOI 10.1128/MCB.24.10.4571-4580.2004; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4	29	274	288	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2007	39	2					243	250		10.1038/ng1952	http://dx.doi.org/10.1038/ng1952			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17237781				2022-12-27	WOS:000244063900024
J	Bhangale, TR; Stephens, M; Nickerson, DA				Bhangale, Tushar R.; Stephens, Matthew; Nickerson, Deborah A.			Automating resequencing-based detection of insertion-deletion polymorphisms	NATURE GENETICS			English	Article							HUMAN GENOME; LINKAGE-DISEQUILIBRIUM; STRUCTURAL VARIATION; SEQUENCE VARIATION; SNPS; RISK; GENE; TOOL; IDENTIFICATION; PROMOTER	Structural and insertion-deletion (indel) variants have received considerable recent attention, partly because of their phenotypic consequences. Among these variants, the most common are small indels (similar to 1-30 bp). Identifying and genotyping indels using sequence traces obtained from diploid samples requires extensive manual review, which makes large-scale studies inconvenient. We report a new algorithm, implemented in available software (PolyPhred version 6.0), to help automate detection and genotyping of indels from sequence traces. The algorithm identifies heterozygous individuals, which permits the discovery of low-frequency indels. It finds 80% of all indel polymorphisms with almost no false positives and finds 97% with a false discovery rate of 10%. Additionally, genotyping accuracy exceeds 99%, and it correctly infers indel length in 96% of the cases. Using this approach, we identify indels in the HapMap ENCODE regions, providing the first report of these polymorphisms in this data set.	Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; Univ Washington, Dept Stat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bhangale, TR (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	tushar@u.washington.edu; debnick@u.washington.edu			NHGRI NIH HHS [HG/LM02585] Funding Source: Medline; NHLBI NIH HHS [HL66682] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066682] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002585] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AHN J, 1995, NAT GENET, V11, P137, DOI 10.1038/ng1095-137; ALBERTINI AM, 1982, CELL, V29, P319, DOI 10.1016/0092-8674(82)90148-9; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bhangale TR, 2005, HUM MOL GENET, V14, P59, DOI 10.1093/hmg/ddi006; Carlson CS, 2003, NAT GENET, V33, P518, DOI 10.1038/ng1128; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; de Sanctis L, 2004, J CLIN ENDOCR METAB, V89, P5669, DOI 10.1210/jc.2004-0398; Eichler EE, 2006, NAT GENET, V38, P9, DOI 10.1038/ng0106-9; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Karban AS, 2004, HUM MOL GENET, V13, P35, DOI 10.1093/hmg/ddh008; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kruglyak L, 2001, NAT GENET, V27, P234, DOI 10.1038/85776; Lin SC, 2004, J ORAL PATHOL MED, V33, P323, DOI 10.1111/j.1600-0714.2004.00214.x; Livingston RJ, 2004, GENOME RES, V14, P1821, DOI 10.1101/gr.2730004; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Manaster C, 2005, HUM MUTAT, V26, P11, DOI 10.1002/humu.20188; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Newman TL, 2006, HUM MOL GENET, V15, P1159, DOI 10.1093/hmg/ddl031; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Othman M, 2005, BLOOD, V105, P4330, DOI 10.1182/blood-2002-09-2942; Rockman MV, 2004, CURR BIOL, V14, P1531, DOI 10.1016/j.cub.2004.08.051; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Stephens M, 2006, NAT GENET, V38, P375, DOI 10.1038/ng1746; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Weber JL, 2002, AM J HUM GENET, V71, P854, DOI 10.1086/342727; Weckx S, 2005, GENOME RES, V15, P436, DOI 10.1101/gr.2754005	32	71	76	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2006	38	12					1457	1462		10.1038/ng1925	http://dx.doi.org/10.1038/ng1925			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110TR	17115056				2022-12-27	WOS:000242404200026
J	Lorenz-Depiereux, B; Bastepe, M; Benet-Pages, A; Amyere, M; Wagenstaller, J; Muller-Barth, U; Badenhoop, K; Kaiser, SM; Rittmaster, RS; Shlossberg, AH; Olivares, JL; Loris, C; Ramos, FJ; Glorieux, F; Vikkula, M; Juppner, H; Strom, TM				Lorenz-Depiereux, Bettina; Bastepe, Murat; Benet-Pages, Anna; Amyere, Mustapha; Wagenstaller, Janine; Mueller-Barth, Ursula; Badenhoop, Klaus; Kaiser, Stephanie M.; Rittmaster, Roger S.; Shlossberg, Alan H.; Olivares, Jose L.; Loris, Cesar; Ramos, Feliciano J.; Glorieux, Francis; Vikkula, Miikka; Juppner, Harald; Strom, Tim M.			DMP1 mutations in autosomal recessive hypophosphatemia implicate a bone matrix protein in the regulation of phosphate homeostasis	NATURE GENETICS			English	Article							PHEX; MINERALIZATION; IDENTIFICATION; ROLES; GENE	Hypophosphatemia is a genetically heterogeneous disease. Here, we mapped an autosomal recessive form (designated ARHP) to chromosome 4q21 and identified homozygous mutations in DMP1 (dentin matrix protein 1), which encodes a non-collagenous bone matrix protein expressed in osteoblasts and osteocytes. Intact plasma levels of the phosphaturic protein FGF23 were clearly elevated in two of four affected individuals, providing a possible explanation for the phosphaturia and inappropriately normal 1,25(OH) 2D levels and suggesting that DMP1 may regulate FGF23 expression.	GSF, Inst Human Genet, Natl Res Ctr Environm & Hlth, D-85764 Neuherberg, Germany; Harvard Univ, Sch Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; Catholic Univ Louvain, B-1200 Brussels, Belgium; Christian Duve Inst, B-1200 Brussels, Belgium; Med Genet, D-63450 Hanau, Germany; Univ Hosp, Div Endocrinol Diabet & Metab, D-60590 Frankfurt, Germany; Queen Elizabeth 2 Hlth Sci Ctr, Div Endocrinol & Metab, Halifax, NS, Canada; Univ Zaragoza, Fac Med, Univ Hosp Lozano Blesa, Dept Pediat, E-50009 Zaragoza, Spain; Univ Zaragoza, Childrens Hosp Miguel Servet, Serv Nephrol, E-50009 Zaragoza, Spain; Shriners Hosp Children, Genet Unit, Montreal, PQ, Canada; Massachusetts Gen Hosp, Pediat Nephrol Unit, Boston, MA 02114 USA; Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-81675 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Universite Catholique Louvain; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Queen Elizabeth II Health Sciences Centre; Lozano Blesa University Clinical Hospital; University of Zaragoza; Miguel Servet University Hospital; University of Zaragoza; McGill University; Harvard University; Massachusetts General Hospital; Technical University of Munich	Juppner, H (corresponding author), GSF, Inst Human Genet, Natl Res Ctr Environm & Hlth, D-85764 Neuherberg, Germany.	jueppner@helix.mgh.harvard.edu; TimStrom@gsf.de	Bastepe, Murat/GQQ-3389-2022; Ramos, Feliciano J./ABH-8920-2020; Vikkula, Miikka/Q-1038-2018	Ramos, Feliciano J./0000-0002-5732-2209; Vikkula, Miikka/0000-0002-6236-338X; Bastepe, Murat/0000-0002-2643-3504	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075856, R37DK046718, P30DK040561] Funding Source: NIH RePORTER; NIDDK NIH HHS [R21 DK075856, R21 DK075856-01, R37 DK046718, P30 DK040561, P30 DK040561-11, R01 DK046718] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Boileau G, 2001, BIOCHEM J, V355, P707, DOI 10.1042/bj3550707; Bowe AE, 2001, BIOCHEM BIOPH RES CO, V284, P977, DOI 10.1006/bbrc.2001.5084; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Jonsson KB, 2003, NEW ENGL J MED, V348, P1656, DOI 10.1056/NEJMoa020881; Ling YF, 2005, J BONE MINER RES, V20, P2169, DOI 10.1359/JBMR.050815; Narayanan K, 2003, J BIOL CHEM, V278, P17500, DOI 10.1074/jbc.M212700200; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Qin CL, 2003, J BIOL CHEM, V278, P34700, DOI 10.1074/jbc.M305315200; Rowe PSN, 2005, BONE, V36, P33, DOI 10.1016/j.bone.2004.09.015; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Steiglitz BM, 2004, J BIOL CHEM, V279, P980, DOI 10.1074/jbc.M310179200; White KE, 2001, J CLIN ENDOCR METAB, V86, P497, DOI 10.1210/jc.86.2.497; White KE, 2001, KIDNEY INT, V60, P2079, DOI 10.1046/j.1523-1755.2001.00064.x; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Ye L, 2005, J BIOL CHEM, V280, P6197, DOI 10.1074/jbc.M412911200	15	388	402	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2006	38	11					1248	1250		10.1038/ng1868	http://dx.doi.org/10.1038/ng1868			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17033625	Green Accepted			2022-12-27	WOS:000241592700012
J	Capaldi, AP; Kaplan, T; Liu, Y; Habib, N; Regev, A; Friedman, N; O'Shea, EK				Capaldi, Andrew P.; Kaplan, Tommy; Liu, Ying; Habib, Naomi; Regev, Aviv; Friedman, Nir; O'Shea, Erin K.			Structure and function of a transcriptional network activated by the MAPK Hog1	NATURE GENETICS			English	Article							DEPENDENT OSMOTIC REGULATION; SACCHAROMYCES-CEREVISIAE; NUCLEAR-LOCALIZATION; PROTEIN-KINASE; EXPRESSION PROFILES; REGULATORY NETWORK; GENE-EXPRESSION; REDUNDANT ROLES; STRESS; GENOME	Cells regulate gene expression using a complex network of signaling pathways, transcription factors and promoters. To gain insight into the structure and function of these networks, we analyzed gene expression in single- and multiple-mutant strains to build a quantitative model of the Hog1 MAPK-dependent osmotic stress response in budding yeast. Our model reveals that the Hog1 and general stress (Msn2/4) pathways interact, at both the signaling and promoter level, to integrate information and create a context-dependent response. This study lays out a path to identifying and characterizing the role of signal integration and processing in other gene regulatory networks.	[Capaldi, Andrew P.; Liu, Ying; O'Shea, Erin K.] Harvard Univ, Fac Arts & Sci Ctr, Ctr Syst Biol, Howard Hughes Med Inst,Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Capaldi, Andrew P.; Liu, Ying; O'Shea, Erin K.] Harvard Univ, Fac Arts & Sci Ctr, Ctr Syst Biol,Northwest Labs, Howard Hughes Med Inst,Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Kaplan, Tommy; Habib, Naomi; Friedman, Nir] Hebrew Univ Jerusalem, Sch Comp Sci & Engn, IL-91904 Jerusalem, Israel; [Kaplan, Tommy; Habib, Naomi] Hebrew Univ Jerusalem, Fac Med, Dept Mol Genet & Biotechnol, IL-91120 Jerusalem, Israel; [Regev, Aviv] MIT, Dept Biol, Cambridge, MA 02142 USA; [Regev, Aviv] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; Howard Hughes Medical Institute; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	O'Shea, EK (corresponding author), Harvard Univ, Fac Arts & Sci Ctr, Ctr Syst Biol, Howard Hughes Med Inst,Dept Mol & Cellular Biol, 52 Oxford St, Cambridge, MA 02138 USA.	erin_oshea@harvard.edu	Habib, Naomi/AAA-8937-2020; Kaplan, Tommy/T-2528-2017; Friedman, Nir/H-9692-2012	Kaplan, Tommy/0000-0002-1892-5461; Friedman, Nir/0000-0002-9678-3550	HHMI; Human Frontiers Science Program	HHMI(Howard Hughes Medical Institute); Human Frontiers Science Program(Human Frontier Science Program)	We thank D. Steger, D. Wykoff, A. Carroll and C. Hopkins from Agilent for advice regarding microarray, ChIP and other procedures; T. Lee and R. Young for sharing their tiling-array design and hybridization protocol before publication; H. Margalit and members of the O'Shea, Friedman and Regev laboratories for helpful discussions; and P. Grosu for help with Rosetta Resolver. We are also grateful to E. Lander, D. Pe'er, D. Koller, R. Losick, M. Brenner and B. Stern for reading the manuscript before publication. A. P. C. was a Howard Hughes Medical Institute (HHMI) Fellow of the Life Sciences Research Foundation and A. R. was supported by a Career Award at the Scientific Interface from the Burroughs Wellcome Fund. This work was supported by HHMI (E.K.O.) and a grant from the Human Frontiers Science Program (E.K.O., A.R. and N.F.).	Alon U, 2007, INTRO SYSTEMS BIOL D; AVERY L, 1992, TRENDS GENET, V8, P312, DOI 10.1016/0168-9525(92)90263-4; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; BOHLANDER SK, 1992, GENOMICS, V13, P1322, DOI 10.1016/0888-7543(92)90057-Y; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; de Nadal E, 2003, MOL CELL BIOL, V23, P229, DOI 10.1128/MCB.23.1.229-237.2003; De Wever V, 2005, EMBO J, V24, P4115, DOI 10.1038/sj.emboj.7600871; Durchschlag E, 2004, J BIOL CHEM, V279, P55425, DOI 10.1074/jbc.M407264200; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Erasmus DJ, 2003, FEMS YEAST RES, V3, P375, DOI 10.1016/S1567-1356(02)00203-9; Garreau H, 2000, MICROBIOL-UK, V146, P2113, DOI 10.1099/00221287-146-9-2113; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; HOROVITZ A, 1992, J MOL BIOL, V224, P733, DOI 10.1016/0022-2836(92)90557-Z; Hu ZZ, 2007, NAT GENET, V39, P683, DOI 10.1038/ng2012; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Lee TI, 2000, NATURE, V405, P701, DOI 10.1038/35015104; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Nevitt T, 2004, BIOCHEM J, V379, P367, DOI 10.1042/BJ20031127; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; Proft M, 2005, EUKARYOT CELL, V4, P1343, DOI 10.1128/EC.4.8.1343-1352.2005; Proft M, 2004, CELL, V118, P351, DOI 10.1016/j.cell.2004.07.016; Proft M, 1999, MOL CELL BIOL, V19, P537; Reiser V, 2003, J CELL BIOL, V161, P1035, DOI 10.1083/jcb.200301099; Reiser V, 1999, MOL BIOL CELL, V10, P1147, DOI 10.1091/mbc.10.4.1147; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Rep M, 1999, MOL CELL BIOL, V19, P5474; Rep M, 2001, MOL MICROBIOL, V40, P1067, DOI 10.1046/j.1365-2958.2001.02384.x; Roberts CJ, 2000, SCIENCE, V287, P873, DOI 10.1126/science.287.5454.873; Robyr D, 2004, METHOD ENZYMOL, V376, P289; Van Driessche N, 2005, NAT GENET, V37, P471, DOI 10.1038/ng1545; [No title captured]	35	166	174	1	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2008	40	11					1300	1306		10.1038/ng.235	http://dx.doi.org/10.1038/ng.235			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18931682	Green Accepted			2022-12-27	WOS:000260501500021
J	Wang, E; Wang, J; Zhu, XD; Hao, W; Wang, LY; Li, Q; Zhang, LX; He, W; Lu, BR; Lin, HX; Ma, H; Zhang, GQ; He, ZH				Wang, Ertao; Wang, Jianjun; Zhu, Xudong; Hao, Wei; Wang, Linyou; Li, Qun; Zhang, Lixia; He, Wei; Lu, Baorong; Lin, Hongxuan; Ma, Hong; Zhang, Guiquan; He, Zuhua			Control of rice grain-filling and yield by a gene with a potential signature of domestication	NATURE GENETICS			English	Article							CELL-WALL INVERTASE; QUANTITATIVE TRAIT LOCI; ENCODES; SELECTION; WEIGHT; PLANT; ENDOSPERM; GENOME; WIDTH; QTL	Grain-filling, an important trait that contributes greatly to grain weight, is regulated by quantitative trait loci and is associated with crop domestication syndrome(1-4). However, the genes and underlying molecular mechanisms controlling crop grain-filling remain elusive. Here we report the isolation and functional analysis of the rice GIF1 (GRAIN INCOMPLETE FILLING 1) gene that encodes a cell-wall invertase required for carbon partitioning during early grain-filling. The cultivated GIF1 gene shows a restricted expression pattern during grain-filling compared to the wild rice allele, probably a result of accumulated mutations in the gene's regulatory sequence through domestication. Fine mapping with introgression lines revealed that the wild rice GIF1 is responsible for grain weight reduction. Ectopic expression of the cultivated GIF1 gene with the 35S or rice Waxy promoter resulted in smaller grains, whereas overexpression of GIF1 driven by its native promoter increased grain production. These findings, together with the domestication signature that we identified by comparing nucleotide diversity of the GIF1 loci between cultivated and wild rice, strongly suggest that GIF1 is a potential domestication gene and that such a domestication-selected gene can be used for further crop improvement.	[Wang, Ertao; Hao, Wei; Li, Qun; Lin, Hongxuan; He, Zuhua] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai 200032, Peoples R China; [Wang, Ertao; Zhu, Xudong] China Natl Rice Res Inst, Hangzhou 31006, Zhejiang, Peoples R China; [Wang, Jianjun; Wang, Linyou; Zhang, Lixia] Zhenjiang Acad Agr Sci, Hangzhou 310021, Zhejiang, Peoples R China; [Lu, Baorong] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China; [Ma, Hong] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Ma, Hong] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA; [Zhang, Guiquan] S China Agr Univ, Coll Agr, Guangzhou 510642, Guangdong, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Jiangsu Academy of Agricultural Sciences; Zhejiang Academy of Agricultural Sciences; Fudan University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; South China Agricultural University	He, ZH (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, 300 Fenglin Rd, Shanghai 200032, Peoples R China.	zhhe@sibs.ac.cn	WANG, TAO ER/GYV-0174-2022; cxzhou, cxzhou/AEO-7639-2022; Wang, Ertao/GYU-4506-2022; Lu, Bao-Rong/C-3130-2009; Lin, Hong-Xuan/AEQ-6607-2022; Ma, Hong/W-5251-2018	Wang, Ertao/0000-0002-5178-3530; Lu, Bao-Rong/0000-0002-0214-2390; Lin, Hong-Xuan/0000-0002-2818-023X; Ma, Hong/0000-0001-8717-4422; He, Zuhua/0000-0002-6098-7893	Ministry of Science and Technology of China [2007AA02Z162, 2006AA10A102, 2007AA10Z187]; National Natural Science Foundation of China [30721061, 30623006]; Reproductive Development Project of the Shanghai Institutes for Biological Sciences; Direct For Biological Sciences [1120417] Funding Source: National Science Foundation; Division Of Integrative Organismal Systems [1026094] Funding Source: National Science Foundation	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Reproductive Development Project of the Shanghai Institutes for Biological Sciences; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J.Y. Li, T. Sang and J.M. Li for critical reading of the manuscript and helpful suggestions; B. Han for the rice BAC clone; Z.Y. Wang for the Waxy promoter; D. Luo for help with in situ hybridization; X.Y. Gao and X. S. Gao for assistance with scanning electron microscopy and confocal laser microscopy; X.M. Zhang, L.J. Zeng and S.H. Ye for rice growth; and H.Q. Zheng for assistance with sugar measurement. This work was supported by grants from the Ministry of Science and Technology of China (2007AA02Z162, 2006AA10A102 and 2007AA10Z187), grants from the National Natural Science Foundation of China (30721061 and 30623006) and the Reproductive Development Project of the Shanghai Institutes for Biological Sciences.	Ashikari M, 2005, SCIENCE, V309, P741, DOI 10.1126/science.1113373; Caicedo AL, 2007, PLOS GENET, V3, P1745, DOI 10.1371/journal.pgen.0030163; Cheng WH, 1996, PLANT CELL, V8, P971, DOI 10.1105/tpc.8.6.971; Cho JI, 2005, PLANT CELL REP, V24, P225, DOI 10.1007/s00299-004-0910-z; Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Fridman E, 2004, SCIENCE, V305, P1786, DOI 10.1126/science.1101666; Hao Wei, 2006, Zhiwu Shengli yu Fenzi Shengwuxue Xuebao, V32, P354; Kang HG, 2005, PLANT J, V42, P901, DOI 10.1111/j.1365-313X.2005.02423.x; Konishi S, 2006, SCIENCE, V312, P1392, DOI 10.1126/science.1126410; Krishnan S, 2003, J BIOSCIENCES, V28, P455, DOI 10.1007/BF02705120; Li CB, 2006, SCIENCE, V311, P1936, DOI 10.1126/science.1123604; Li JM, 2004, GENETICS, V168, P2187, DOI 10.1534/genetics.104.034165; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Nagata K, 2001, PLANT PROD SCI, V4, P173, DOI 10.1626/pps.4.173; Olsen KM, 2006, GENETICS, V173, P975, DOI 10.1534/genetics.106.056473; Roitsch T, 2004, TRENDS PLANT SCI, V9, P606, DOI 10.1016/j.tplants.2004.10.009; Song XJ, 2007, NAT GENET, V39, P623, DOI 10.1038/ng2014; Sturm A, 1999, TRENDS PLANT SCI, V4, P401, DOI 10.1016/S1360-1385(99)01470-3; Sweeney M, 2007, ANN BOT-LONDON, V100, P951, DOI 10.1093/aob/mcm128; Sweeney MT, 2006, PLANT CELL, V18, P283, DOI 10.1105/tpc.105.038430; Takai T, 2005, J EXP BOT, V56, P2107, DOI 10.1093/jxb/eri209; Tang GQ, 1999, PLANT CELL, V11, P177, DOI 10.1105/tpc.11.2.177; Wang H, 2005, NATURE, V436, P714, DOI 10.1038/nature03863; Wang RL, 1999, NATURE, V398, P236, DOI 10.1038/18435; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Xue WY, 2008, NAT GENET, V40, P761, DOI 10.1038/ng.143; Yano M, 2001, CURR OPIN PLANT BIOL, V4, P130, DOI 10.1016/S1369-5266(00)00148-5; Zhu YY, 2006, PLANT CELL, V18, P442, DOI 10.1105/tpc.105.038455	30	516	639	11	303	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2008	40	11					1370	1374		10.1038/ng.220	http://dx.doi.org/10.1038/ng.220			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18820698				2022-12-27	WOS:000260501500033
J	Park, TJ; Mitchell, BJ; Abitua, PB; Kintner, C; Wallingford, JB				Park, Tae Joo; Mitchell, Brian J.; Abitua, Philip B.; Kintner, Chris; Wallingford, John B.			Dishevelled controls apical docking and planar polarization of basal bodies in ciliated epithelial cells	NATURE GENETICS			English	Article							NEURAL-TUBE DEFECTS; SUBCELLULAR-LOCALIZATION; INTRAFLAGELLAR TRANSPORT; CENTRIOLE FORMATION; SIGNALING PATHWAYS; QUAIL OVIDUCT; POLARITY; CILIOGENESIS; WNT; EMBRYOS	The planar cell polarity (PCP) signaling system governs many aspects of polarized cell behavior. Here, we use an in vivo model of vertebrate mucociliary epithelial development to show that Dishevelled (Dvl) is essential for the apical positioning of basal bodies. We find that Dvl and Inturned mediate the activation of the Rho GTPase specifically at basal bodies, and that these three proteins together mediate the docking of basal bodies to the apical plasma membrane. Moreover, we find that this docking involves a Dvl-dependent association of basal bodies with membrane-bound vesicles and the vesicle-trafficking protein, Sec8. Once docked, basal bodies again require Dvl and Rho for the planar polarization that underlies directional beating of cilia. These results demonstrate previously undescribed functions for PCP signaling components and suggest that a common signaling apparatus governs both apical docking and planar polarization of basal bodies.	[Park, Tae Joo; Abitua, Philip B.; Wallingford, John B.] Univ Texas, Dept Mol Cell & Dev Biol, Austin, TX 78712 USA; [Park, Tae Joo; Abitua, Philip B.; Wallingford, John B.] Univ Texas, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Mitchell, Brian J.; Kintner, Chris] Salk Inst Biol Studies, La Jolla, CA 92186 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Salk Institute	Wallingford, JB (corresponding author), Univ Texas, Dept Mol Cell & Dev Biol, Austin, TX 78712 USA.	wallingford@mail.utexas.edu	Park, Tae Joo/G-1460-2011	Park, Tae Joo/0000-0003-3176-177X; Abitua, Philip/0000-0002-8264-0807; Mitchell, Brian/0000-0001-6281-1536	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076507, R01GM074104] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM076507, R01 GM074104-04, R01 GM074104-04S1, R01 GM076507-04, R01 GM074104] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adler PN, 2004, CURR BIOL, V14, P2046, DOI 10.1016/j.cub.2004.11.007; Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; ASSHETON R, 1896, Q J MICROSC SCI, V38, P465; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Benink HA, 2005, J CELL BIOL, V168, P429, DOI 10.1083/jcb.200411109; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; BOISVIEUXULRICH E, 1990, CELL TISSUE RES, V259, P443, DOI 10.1007/BF01740770; BOISVIEUXULRICH E, 1985, BIOL CELL, V55, P147, DOI 10.1111/j.1768-322X.1985.tb00417.x; Capelluto DGS, 2002, NATURE, V419, P726, DOI 10.1038/nature01056; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Chilvers M A, 2000, Paediatr Respir Rev, V1, P27, DOI 10.1053/prrv.2000.0009; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; COHEN E, 1988, BIOL CELL, V62, P165, DOI 10.1016/0248-4900(88)90033-0; Dawe HR, 2007, J CELL SCI, V120, P7, DOI 10.1242/jcs.03305; FRISCH D, 1968, ANAT REC, V162, P221, DOI 10.1002/ar.1091620209; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gomperts BN, 2004, J CELL SCI, V117, P1329, DOI 10.1242/jcs.00978; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hayes JM, 2007, DEV BIOL, V312, P115, DOI 10.1016/j.ydbio.2007.09.031; Huang T, 2003, J CELL SCI, V116, P4935, DOI 10.1242/jcs.00830; Jekely G, 2006, BIOESSAYS, V28, P191, DOI 10.1002/bies.20369; Kibar Z, 2007, NEW ENGL J MED, V356, P1432, DOI 10.1056/NEJMoa060651; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Kishida S, 2007, GENES CELLS, V12, P49, DOI 10.1111/j.1365-2443.2006.01030.x; KONIG G, 1993, DEV BIOL, V160, P355, DOI 10.1006/dbio.1993.1312; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Lanzetti L, 2007, CURR OPIN CELL BIOL, V19, P453, DOI 10.1016/j.ceb.2007.04.017; Mitchell B, 2007, NATURE, V447, P97, DOI 10.1038/nature05771; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nokhbatolfoghahai M, 2005, J NAT HIST, V39, P887, DOI 10.1080/00222930400002937; Oishi I, 2006, NAT GENET, V38, P1316, DOI 10.1038/ng1892; Pan JH, 2007, J CELL SCI, V120, P1868, DOI 10.1242/jcs.005306; Panizzi JR, 2007, DEVELOPMENT, V134, P921, DOI 10.1242/dev.02776; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; Park TJ, 2005, CURR BIOL, V15, P1039, DOI 10.1016/j.cub.2005.04.062; Raji AR, 2007, ANAT HISTOL EMBRYOL, V36, P10, DOI 10.1111/j.1439-0264.2006.00709.x; Ross AJ, 2005, NAT GENET, V37, P1135, DOI 10.1038/ng1644; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Scholey JM, 2006, CELL, V125, P439, DOI 10.1016/j.cell.2006.04.013; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; SIVE HL, 2000, EARLY DEV XENOPUS IA; SOROKIN SP, 1968, J CELL SCI, V3, P207; STEINMAN RM, 1968, AM J ANAT, V122, P19, DOI 10.1002/aja.1001220103; Toskala E, 2005, AM J PHYSIOL-LUNG C, V289, pL454, DOI 10.1152/ajplung.00036.2005; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wallingford JB, 2000, NATURE, V405, P81, DOI 10.1038/35011077; Wallingford JB, 2006, HUM MOL GENET, V15, pR227, DOI 10.1093/hmg/ddl216; Yu A, 2007, DEV CELL, V12, P129, DOI 10.1016/j.devcel.2006.10.015	50	334	341	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUL	2008	40	7					871	879		10.1038/ng.104	http://dx.doi.org/10.1038/ng.104			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18552847	Green Accepted			2022-12-27	WOS:000257166500022
J	Campbell, PJ; Stephens, PJ; Pleasance, ED; O'Meara, S; Li, H; Santarius, T; Stebbings, LA; Leroy, C; Edkins, S; Hardy, C; Teague, JW; Menzies, A; Goodhead, I; Turner, DJ; Clee, CM; Quail, MA; Cox, A; Brown, C; Durbin, R; Hurles, ME; Edwards, PAW; Bignell, GR; Stratton, MR; Futreal, PA				Campbell, Peter J.; Stephens, Philip J.; Pleasance, Erin D.; O'Meara, Sarah; Li, Heng; Santarius, Thomas; Stebbings, Lucy A.; Leroy, Catherine; Edkins, Sarah; Hardy, Claire; Teague, Jon W.; Menzies, Andrew; Goodhead, Ian; Turner, Daniel J.; Clee, Christopher M.; Quail, Michael A.; Cox, Antony; Brown, Clive; Durbin, Richard; Hurles, Matthew E.; Edwards, Paul A. W.; Bignell, Graham R.; Stratton, Michael R.; Futreal, P. Andrew			Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing	NATURE GENETICS			English	Article							PARTIAL TANDEM DUPLICATION; PROSTATE-CANCER; LUNG-CANCER; FUSION; GENES; TRANSLOCATIONS; TRANSCRIPTS; INVOLVE; LOCUS	Human cancers often carry many somatically acquired genomic rearrangements, some of which may be implicated in cancer development. However, conventional strategies for characterizing rearrangements are laborious and low-throughput and have low sensitivity or poor resolution. We used massively parallel sequencing to generate sequence reads from both ends of short DNA fragments derived from the genomes of two individuals with lung cancer. By investigating read pairs that did not align correctly with respect to each other on the reference human genome, we characterized 306 germline structural variants and 103 somatic rearrangements to the base-pair level of resolution. The patterns of germline and somatic rearrangement were markedly different. Many somatic rearrangements were from amplicons, although rearrangements outside these regions, notably including tandem duplications, were also observed. Some somatic rearrangements led to abnormal transcripts, including two from internal tandem duplications and two fusion transcripts created by interchromosomal rearrangements. Germline variants were predominantly mediated by retrotransposition, often involving AluY and LINE elements. The results demonstrate the feasibility of systematic, genome-wide characterization of rearrangements in complex human cancer genomes, raising the prospect of a new harvest of genes associated with cancer using this strategy.	[Campbell, Peter J.; Stephens, Philip J.; Pleasance, Erin D.; O'Meara, Sarah; Li, Heng; Santarius, Thomas; Stebbings, Lucy A.; Leroy, Catherine; Edkins, Sarah; Hardy, Claire; Teague, Jon W.; Menzies, Andrew; Goodhead, Ian; Turner, Daniel J.; Clee, Christopher M.; Quail, Michael A.; Cox, Antony; Brown, Clive; Durbin, Richard; Hurles, Matthew E.; Bignell, Graham R.; Stratton, Michael R.; Futreal, P. Andrew] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Edwards, Paul A. W.] Univ Cambridge, Hutchison Med Res Council, Res Ctr, Cambridge CB2 0XZ, England; [Edwards, Paul A. W.] Univ Cambridge, Dept Pathol, Cambridge CB2 0XZ, England; [Santarius, Thomas] Univ Cambridge, Dept Neurosurg, Cambridge CB2 2QQ, England	Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; University of Cambridge	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England.	mrs@sanger.ac.uk; paf@sanger.ac.uk	Quail, michael/ABE-6131-2020; Goodhead, Ian/ABC-9200-2020; Edwards, Paul A/M-8291-2014; Durbin, Richard/AAE-7178-2019; Li, Heng/D-9344-2011	Edwards, Paul A/0000-0002-4789-3374; Durbin, Richard/0000-0002-9130-1006; Li, Heng/0000-0003-4874-2874; Santarius, Thomas/0000-0002-1416-9566; Goodhead, Ian/0000-0002-3110-9442	Wellcome Trust [088340, 077012] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Basecke J, 2006, BRIT J HAEMATOL, V135, P438, DOI 10.1111/j.1365-2141.2006.06301.x; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bignell GR, 2007, GENOME RES, V17, P1296, DOI 10.1101/gr.6522707; Cahill D, 2006, FRONT BIOSCI-LANDMRK, V11, P1958, DOI 10.2741/1938; CORY S, 1985, EMBO J, V4, P675, DOI 10.1002/j.1460-2075.1985.tb03682.x; Dorrance AM, 2006, J CLIN INVEST, V116, P2707, DOI 10.1172/JCI25546; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gazdar AF, 1996, J CELL BIOCHEM, P1; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Grigorova M, 2005, CANCER GENET CYTOGEN, V162, P1, DOI 10.1016/j.cancergencyto.2005.03.007; HOWARTH KD, 2007, ONCOGENE ADV, DOI DOI 10.1038/SJ.ONC.1210993; HUPPI K, 1994, INT J CANCER, V59, P848, DOI 10.1002/ijc.2910590623; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Mitelman F, 2004, NAT GENET, V36, P331, DOI 10.1038/ng1335; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Robinson KO, 2005, MAMM GENOME, V16, P32, DOI 10.1007/s00335-004-2423-z; Rozier L, 2004, ONCOGENE, V23, P6872, DOI 10.1038/sj.onc.1207809; Ruan YJ, 2007, GENOME RES, V17, P828, DOI 10.1101/gr.6018607; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Volik S, 2003, P NATL ACAD SCI USA, V100, P7696, DOI 10.1073/pnas.1232418100; Wu GJ, 2000, CANCER RES, V60, P5371	24	603	682	3	34	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2008	40	6					722	729		10.1038/ng.128	http://dx.doi.org/10.1038/ng.128			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18438408	Green Accepted			2022-12-27	WOS:000256212000014
J	Gudbjartsson, DF; Walters, GB; Thorleifsson, G; Stefansson, H; Halldorsson, BV; Zusmanovich, P; Sulem, P; Thorlacius, S; Gylfason, A; Steinberg, S; Helgadottir, A; Ingason, A; Steinthorsdottir, V; Olafsdottir, EJ; Olafsdottir, GH; Jonsson, T; Borch-Johnsen, K; Hansen, T; Andersen, G; Jorgensen, T; Pedersen, O; Aben, KK; Witjes, JA; Swinkels, DW; den Heijer, M; Franke, B; Verbeek, ALM; Becker, DM; Yanek, LR; Becker, LC; Tryggvadottir, L; Rafnar, T; Gulcher, J; Kiemeney, LA; Kong, A; Thorsteinsdottir, U; Stefansson, K				Gudbjartsson, Daniel F.; Walters, G. Bragi; Thorleifsson, Gudmar; Stefansson, Hreinn; Halldorsson, Bjarni V.; Zusmanovich, Pasha; Sulem, Patrick; Thorlacius, Steinunn; Gylfason, Arnaldur; Steinberg, Stacy; Helgadottir, Anna; Ingason, Andres; Steinthorsdottir, Valgerdur; Olafsdottir, Elinborg J.; Olafsdottir, Gudridur H.; Jonsson, Thorvaldur; Borch-Johnsen, Knut; Hansen, Torben; Andersen, Gitte; Jorgensen, Torben; Pedersen, Oluf; Aben, Katja K.; Witjes, J. Alfred; Swinkels, Dorine W.; den Heijer, Martin; Franke, Barbara; Verbeek, Andre L. M.; Becker, Diane M.; Yanek, Lisa R.; Becker, Lewis C.; Tryggvadottir, Laufey; Rafnar, Thorunn; Gulcher, Jeffrey; Kiemeney, Lambertus A.; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari			Many sequence variants affecting diversity of adult human height	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; POPULATION; DATABASE; STATURE; MODEL; DNA	Adult human height is one of the classical complex human traits(1). We searched for sequence variants that affect height by scanning the genomes of 25,174 Icelanders, 2,876 Dutch, 1,770 European Americans and 1,148 African Americans. We then combined these results with previously published results from the Diabetes Genetics Initiative on 3,024 Scandinavians(2) and tested a selected subset of SNPs in 5,517 Danes. We identified 27 regions of the genome with one or more sequence variants showing significant association with height. The estimated effects per allele of these variants ranged between 0.3 and 0.6 cm and, taken together, they explain around 3.7% of the population variation in height. The genes neighboring the identified loci cluster in biological processes related to skeletal development and mitosis. Association to three previously reported loci are replicated in our analyses(3-5), and the strongest association was with SNPs in the ZBTB38 gene.	[Gudbjartsson, Daniel F.; Walters, G. Bragi; Thorleifsson, Gudmar; Stefansson, Hreinn; Halldorsson, Bjarni V.; Zusmanovich, Pasha; Sulem, Patrick; Thorlacius, Steinunn; Gylfason, Arnaldur; Steinberg, Stacy; Helgadottir, Anna; Ingason, Andres; Steinthorsdottir, Valgerdur; Rafnar, Thorunn; Gulcher, Jeffrey; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE, IS-101 Reykjavik, Iceland; [Halldorsson, Bjarni V.] Reykjavik Univ, IS-103 Reykjavik, Iceland; [Olafsdottir, Elinborg J.; Olafsdottir, Gudridur H.; Tryggvadottir, Laufey] Iceland Canc Registry, IS-105 Reykjavik, Iceland; [Jonsson, Thorvaldur] Univ Hosp, Dept Surg, IS-101 Reykjavik, Iceland; [Hansen, Torben; Andersen, Gitte; Pedersen, Oluf] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Borch-Johnsen, Knut; Pedersen, Oluf] Univ Aarhus, Fac Hlth Sci, DK-8000 Aarhus, Denmark; [Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; [Aben, Katja K.; Kiemeney, Lambertus A.] Comprehens Canc Ctr E, NL-6500 HB Nijmegen, Netherlands; [Witjes, J. Alfred; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Dept Urol, NL-6500 HB Nijmegen, Netherlands; [Swinkels, Dorine W.] Radboud Univ Nijmegen, Dept Clin Chem, NL-6500 HB Nijmegen, Netherlands; [den Heijer, Martin] Radboud Univ Nijmegen, Dept Endocrinol, NL-6500 HB Nijmegen, Netherlands; [Franke, Barbara] Radboud Univ Nijmegen, Dept Genet, NL-6500 HB Nijmegen, Netherlands; [Verbeek, Andre L. M.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Dept Epidemiol & Biostat, Med Ctr, NL-6500 HB Nijmegen, Netherlands; [Becker, Diane M.; Yanek, Lisa R.; Becker, Lewis C.] Johns Hopkins Sch Med, Johns Hopkins Sibling & Family Heart Study, Baltimore, MD 21205 USA	Reykjavik University; Landspitali National University Hospital; Steno Diabetes Center; Aarhus University; University of Copenhagen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Johns Hopkins University; Johns Hopkins Medicine	Stefansson, K (corresponding author), deCODE, IS-101 Reykjavik, Iceland.	daniel.gudbjartsson@decode.is; kstefans@decode.is	Walters, G. Bragi/L-4215-2013; Jørgensen, Torben/Z-1335-2018; Ingason, Andres/G-6817-2012; Franke, Barbara/D-4836-2009; Stefansson, Kari/AAE-7187-2019; Pedersen, Oluf/Z-1731-2019; Swinkels, Dorine W./H-8098-2014; Witjes, Fred/N-9665-2013; Verbeek, A.L.M./H-8103-2014; Aben, Katja KH/G-9686-2016; Pedersen, Oluf/AAG-8015-2020; Kiemeney, Lambertus A./D-3357-2009; den Heijer, Martin/J-8036-2015	Walters, G. Bragi/0000-0002-5415-6487; Franke, Barbara/0000-0003-4375-6572; Pedersen, Oluf/0000-0002-3321-3972; Swinkels, Dorine W./0000-0002-1040-9446; Verbeek, A.L.M./0000-0002-2319-5002; Aben, Katja KH/0000-0002-0214-2147; Kiemeney, Lambertus A./0000-0002-2368-1326; Halldorsson, Bjarni/0000-0003-0756-0767; Gudbjartsson, Daniel/0000-0002-5222-9857; Tryggvadottir, Laufey/0000-0001-8067-9030; den Heijer, Martin/0000-0003-3620-5617; Hansen, Torben/0000-0001-8748-3831; Stefansson, Hreinn/0000-0002-9331-6666; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Jorgensen, Torben/0000-0001-9453-2830; Kong, Augustine/0000-0001-8193-5438				Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; CARMICHAEL CM, 1995, J GERONTOL A-BIOL, V50, pB237, DOI 10.1093/gerona/50A.4.B237; Devlin B, 2004, NAT GENET, V36, P1129, DOI 10.1038/ng1104-1129; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Filion GJP, 2006, MOL CELL BIOL, V26, P169, DOI 10.1128/MCB.26.1.169-181.2006; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Gulcher JR, 2000, EUR J HUM GENET, V8, P739, DOI 10.1038/sj.ejhg.5200530; Kiefer H, 2005, MOL CELL BIOL, V25, P1713, DOI 10.1128/MCB.25.5.1713-1729.2005; Kim KS, 2004, OBES RES, V12, P1981, DOI 10.1038/oby.2004.249; Kuno K, 2000, FEBS LETT, V478, P241, DOI 10.1016/S0014-5793(00)01854-8; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Malecot G., 1948, MATH HEREDITE; Mamada M, 2007, HUM GENET, V120, P733, DOI 10.1007/s00439-006-0263-5; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; MILEWICZ DM, 1995, J CLIN INVEST, V95, P2373, DOI 10.1172/JCI117930; Ogden CL, 2004, ADV DATA VITAL HLTH, V347; Palmert MR, 2003, MOL GENET METAB, V80, P1, DOI 10.1016/S1096-7192(03)00107-0; Perola M, 2007, PLOS GENET, V3, P1019, DOI 10.1371/journal.pgen.0030097; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Sanna S, 2008, NAT GENET, V40, P198, DOI 10.1038/ng.74; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Silventoinen K, 2003, TWIN RES, V6, P399, DOI 10.1375/twin.6.5.399; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; van der Eerden BCJ, 2003, ENDOCR REV, V24, P782, DOI 10.1210/er.2002-0033; Weedon MN, 2007, NAT GENET, V39, P1245, DOI 10.1038/ng2121	30	495	503	2	44	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					609	615		10.1038/ng.122	http://dx.doi.org/10.1038/ng.122			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18391951				2022-12-27	WOS:000255366700029
J	Haigis, KM; Kendall, KR; Wang, YF; Cheung, A; Haigis, MC; Glickman, JN; Niwa-Kawakita, M; Sweet-Cordero, A; Sebolt-Leopold, J; Shannon, KM; Settleman, J; Giovannini, M; Jacks, T				Haigis, Kevin M.; Kendall, Krystle R.; Wang, Yufang; Cheung, Ann; Haigis, Marcia C.; Glickman, Jonathan N.; Niwa-Kawakita, Michiko; Sweet-Cordero, Alejandro; Sebolt-Leopold, Judith; Shannon, Kevin M.; Settleman, Jeffrey; Giovannini, Marco; Jacks, Tyler			Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon	NATURE GENETICS			English	Article							INTESTINAL EPITHELIUM; PROTEIN-KINASE; STEM-CELL; IN-VIVO; H-RAS; CANCER; GROWTH; MOUSE; MICE; IDENTIFICATION	Kras is commonly mutated in colon cancers, but mutations in Nras are rare. We have used genetically engineered mice to determine whether and how these related oncogenes regulate homeostasis and tumorigenesis in the colon. Expression of K-Ras(G12D) in the colonic epithelium stimulated hyperproliferation in a Mek-dependent manner. N-Ras(G12D) did not alter the growth properties of the epithelium, but was able to confer resistance to apoptosis. In the context of an Apc-mutant colonic tumor, activation of K-Ras led to defects in terminal differentiation and expansion of putative stem cells within the tumor epithelium. This K-Ras tumor phenotype was associated with attenuated signaling through the MAPK pathway, and human colon cancer cells expressing mutant K-Ras were hypersensitive to inhibition of Raf, but not Mek. These studies demonstrate clear phenotypic differences between mutant Kras and Nras, and suggest that the oncogenic phenotype of mutant K-Ras might be mediated by noncanonical signaling through Ras effector pathways.	[Haigis, Kevin M.; Cheung, Ann; Jacks, Tyler] MIT, Ctr Canc Res, Cambridge, MA 02139 USA; [Haigis, Kevin M.; Cheung, Ann; Jacks, Tyler] MIT, Dept Biol, Cambridge, MA 02139 USA; [Haigis, Kevin M.; Kendall, Krystle R.; Wang, Yufang; Settleman, Jeffrey] Massachusetts Gen Hosp, Canc Res Ctr, Charlestown, MA 02129 USA; [Haigis, Kevin M.; Kendall, Krystle R.; Wang, Yufang; Settleman, Jeffrey] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Haigis, Marcia C.] Harvard Univ, Sch Med, Dept Pathol, Paul F Glenn Labs, Boston, MA 02115 USA; [Glickman, Jonathan N.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Niwa-Kawakita, Michiko; Giovannini, Marco] Ctr Etude Polymorphisme Humain, Fdn Jean Dausset, INSERM, U674, Paris, France; [Niwa-Kawakita, Michiko; Giovannini, Marco] Inst Univ Hematol, Paris, France; [Sweet-Cordero, Alejandro] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Sweet-Cordero, Alejandro] Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA; [Sebolt-Leopold, Judith] JS Leopold Consulting, Ann Arbor, MI 48105 USA; [Shannon, Kevin M.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Jacks, Tyler] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Foundation Jean Dausset-CEPH; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Stanford University; Stanford University; University of California System; University of California San Francisco; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Jacks, T (corresponding author), MIT, Ctr Canc Res, Cambridge, MA 02139 USA.	tjacks@mit.edu		Kawakita, Michiko/0000-0002-9450-583X	NATIONAL CANCER INSTITUTE [K01CA118425, U01CA084306, R01CA072614, P30CA014051, U01CA084221, U54CA112967, P50CA127003, R37CA072614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088827] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA072614-05S1, U01 CA084306, R01 CA072614-08, P30 CA014051, P30 CA014051-33, U01 CA084221-07, U01-CA84221, U01 CA084221-06, U54 CA112967-040002, R01 CA072614-07, U01 CA084221-02, K01 CA118425-01A1, R01 CA072614-04S1, R01 CA072614-03, U01 CA084306-02, P30-CA14051, P30 CA014051-34, U01-CA84306, R01 CA072614-04, U54 CA112967, K01 CA118425-02, U01 CA084221, U01 CA084221-05, U01 CA084306-04, R01 CA072614-06, K01 CA118425, U54 CA112967-010002, U54-CA112967, R01 CA072614-09, U01 CA084221-08, R01 CA072614, U01 CA084306-03, R01 CA072614-10, P30 CA014051-36, P30 CA014051-35, R37 CA072614, U01 CA084306-05, U01 CA084306-01, R01-CA72614, R01 CA072614-05, U54 CA112967-020002, P50 CA127003, U54 CA112967-030002, P50-CA127003, U01 CA084221-04, K01-CA118425, U01 CA084221-01, U01 CA084221-09, U01 CA084221-03] Funding Source: Medline; NIGMS NIH HHS [R01 GM088827] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Colnot S, 2004, LAB INVEST, V84, P1619, DOI 10.1038/labinvest.3700180; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Esteban LM, 2001, MOL CELL BIOL, V21, P1444, DOI 10.1128/MCB.21.5.1444-1452.2001; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Haigis K, 2006, J BIOL CHEM, V281, P638, DOI 10.1074/jbc.M509053200; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Holt KH, 1996, MOL CELL BIOL, V16, P577; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Janssen KP, 2002, GASTROENTEROLOGY, V123, P492, DOI 10.1053/gast.2002.34786; Johnson L, 1997, GENE DEV, V11, P2468, DOI 10.1101/gad.11.19.2468; Keller JW, 2007, ONCOGENE, V26, P3051, DOI 10.1038/sj.onc.1210103; Keller JW, 2007, J CELL PHYSIOL, V210, P740, DOI 10.1002/jcp.20898; Leicht DT, 2007, BBA-MOL CELL RES, V1773, P1196, DOI 10.1016/j.bbamcr.2007.05.001; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Parikh C, 2007, CANCER RES, V67, P7139, DOI 10.1158/0008-5472.CAN-07-0778; Potenza N, 2005, EMBO REP, V6, P432, DOI 10.1038/sj.embor.7400397; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Pouyssegur J, 2002, BIOCHEM PHARMACOL, V64, P755, DOI 10.1016/S0006-2952(02)01135-8; Rinehart J, 2004, J CLIN ONCOL, V22, P4456, DOI 10.1200/JCO.2004.01.185; Saam JR, 1999, J BIOL CHEM, V274, P38071, DOI 10.1074/jbc.274.53.38071; Sansom OJ, 2006, P NATL ACAD SCI USA, V103, P14122, DOI 10.1073/pnas.0604130103; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Voice JK, 1999, J BIOL CHEM, V274, P17164, DOI 10.1074/jbc.274.24.17164; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Wolfman JC, 2002, MOL CELL BIOL, V22, P1589, DOI 10.1128/MCB.22.5.1589-1606.2002; Wong MH, 2000, P NATL ACAD SCI USA, V97, P12601, DOI 10.1073/pnas.230237997	36	438	444	0	24	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2008	40	5					600	608		10.1038/ng.115	http://dx.doi.org/10.1038/ng.115			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18372904	Green Accepted			2022-12-27	WOS:000255366700028
J	Petretto, E; Sarwar, R; Grieve, I; Lu, H; Kumaran, MK; Muckett, PJ; Mangion, J; Schroen, B; Benson, M; Punjabi, PP; Prasad, SK; Pennell, DJ; Kiesewetter, C; Tasheva, ES; Corpuz, LM; Webb, MD; Conrad, GW; Kurtz, TW; Kren, V; Fischer, J; Hubner, N; Pinto, YM; Pravenec, M; Aitman, TJ; Cook, SA				Petretto, Enrico; Sarwar, Rizwan; Grieve, Ian; Lu, Han; Kumaran, Mande K.; Muckett, Phillip J.; Mangion, Jonathan; Schroen, Blanche; Benson, Matthew; Punjabi, Prakash P.; Prasad, Sanjay K.; Pennell, Dudley J.; Kiesewetter, Chris; Tasheva, Elena S.; Corpuz, Lolita M.; Webb, Megan D.; Conrad, Gary W.; Kurtz, Theodore W.; Kren, Vladimir; Fischer, Judith; Hubner, Norbert; Pinto, Yigal M.; Pravenec, Michal; Aitman, Timothy J.; Cook, Stuart A.			Integrated genomic approaches implicate osteoglycin (Ogn) in the regulation of left ventricular mass	NATURE GENETICS			English	Article							QUANTITATIVE TRAIT LOCI; CARDIAC-HYPERTROPHY; HEART-FAILURE; PRESSURE; DISEASE; ECHOCARDIOGRAPHY; IDENTIFICATION; HERITABILITY; TRANSCRIPTS; STRESS	Left ventricular mass ( LVM) and cardiac gene expression are complex traits regulated by factors both intrinsic and extrinsic to the heart. To dissect the major determinants of LVM, we combined expression quantitative trait locus(1) and quantitative trait transcript(2) ( QTT) analyses of the cardiac transcriptome in the rat. Using these methods and in vitro functional assays, we identified osteoglycin ( Ogn) as a major candidate regulator of rat LVM, with increased Ogn protein expression associated with elevated LVM. We also applied genome-wide QTT analysis to the human heart and observed that, out of similar to 22,000 transcripts, OGN transcript abundance had the highest correlation with LVM. We further confirmed a role for Ogn in the in vivo regulation of LVM in Ogn knockout mice. Taken together, these data implicate Ogn as a key regulator of LVM in rats, mice and humans, and suggest that Ogn modifies the hypertrophic response to extrinsic factors such as hypertension and aortic stenosis.	[Petretto, Enrico; Sarwar, Rizwan; Grieve, Ian; Lu, Han; Kumaran, Mande K.; Muckett, Phillip J.; Mangion, Jonathan; Schroen, Blanche; Benson, Matthew; Aitman, Timothy J.; Cook, Stuart A.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, MRC,Clin Sci Ctr, London W12 0NN, England; [Petretto, Enrico] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Epidemiol Publ Hlth & Primary Care, London W2 1PG, England; [Punjabi, Prakash P.; Prasad, Sanjay K.; Pennell, Dudley J.; Kiesewetter, Chris; Cook, Stuart A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW3 6LY, England; [Tasheva, Elena S.; Corpuz, Lolita M.; Webb, Megan D.; Conrad, Gary W.] Kansas State Univ, Div Biol, Manhattan, KS 66506 USA; [Kurtz, Theodore W.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Kren, Vladimir; Pravenec, Michal] Acad Sci Czech Republic, Inst Physiol, CR-14220 Prague 4, Czech Republic; [Kren, Vladimir; Pravenec, Michal] Ctr Appl Genom, Prague 14220 4, Czech Republic; [Kren, Vladimir; Pravenec, Michal] Charles Univ Prague, Inst Biol & Med Genet, Fac Med 1, Prague 12800 2, Czech Republic; [Kren, Vladimir; Pravenec, Michal] Gen Teaching Hosp, Prague 12800 2, Czech Republic; [Fischer, Judith; Hubner, Norbert] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Pinto, Yigal M.] Univ Amsterdam, Acad Med Ctr, Heart Failure Res Ctr, NL-1105 AZ Amsterdam, Netherlands; [Aitman, Timothy J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sect Mol Genet & Rheumatol, London W12 0NN, England; [Aitman, Timothy J.] Univ London Imperial Coll Sci Technol & Med, Fac Med, London W12 0NN, England	Imperial College London; Imperial College London; Imperial College London; Kansas State University; University of California System; University of California San Francisco; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Charles University Prague; General University Hospital Prague; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Amsterdam; Academic Medical Center Amsterdam; Imperial College London; Imperial College London	Aitman, TJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Fac Med, MRC,Clin Sci Ctr, Du Cane Rd, London W12 0NN, England.	t.aitman@csc.mrc.ac.uk; stuart.cook@imperial.ac.uk	Pravenec, Michal/B-1666-2012; Cook, Stuart/G-9567-2011; Punjabi, Prakash P/AAG-8724-2019	Pravenec, Michal/0000-0001-9197-5871; Punjabi, Prakash P/0000-0002-6587-1603; Cook, Stuart/0000-0001-6628-194X; Pennell, Dudley/0000-0001-5523-1314; Fischer-Sternjak, Judith/0000-0003-0398-7720; Benson, Matthew/0000-0003-4459-0439; Aitman, Timothy/0000-0002-7875-4502	NATIONAL EYE INSTITUTE [R01EY000952, R01EY013395] Funding Source: NIH RePORTER; British Heart Foundation Funding Source: Medline; Howard Hughes Medical Institute Funding Source: Medline; Medical Research Council [MC_U120061454, MC_U120097112, MC_U120085815] Funding Source: Medline; NEI NIH HHS [R01 EY013395, EY13395, EY000952, R01 EY000952] Funding Source: Medline; Wellcome Trust [066780] Funding Source: Medline; Department of Health Funding Source: Medline; MRC [MC_U120085815, MC_U120061454] Funding Source: UKRI	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); British Heart Foundation(British Heart Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Wellcome Trust(Wellcome Trust); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Caruthers SD, 2003, CIRCULATION, V108, P2236, DOI 10.1161/01.CIR.0000095268.47282.A1; Cerutti C, 2006, PHYSIOL GENOMICS, V27, P295, DOI 10.1152/physiolgenomics.00318.2005; Cheitlin MD, 2003, J AM SOC ECHOCARDIOG, V16, P1091, DOI 10.1016/S0894-7317(03)00685-0; Cook SA, 2003, CIRCULATION, V108, P664, DOI 10.1161/01.CIR.0000086978.95976.41; Cook SA, 1999, CIRC RES, V85, P940; de Koning DJ, 2005, TRENDS GENET, V21, P377, DOI 10.1016/j.tig.2005.05.004; Devereux RB, 1997, CIRCULATION, V96, P1416, DOI 10.1161/01.CIR.96.5.1416; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Hashimoto J, 2007, AM J HYPERTENS, V20, P378, DOI 10.1016/j.amjhyper.2006.09.019; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Hoshijima M, 2002, J CLIN INVEST, V109, P849, DOI 10.1172/JCI15380; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Kresse H, 2001, J CELL PHYSIOL, V189, P266, DOI 10.1002/jcp.10030; Lorell BH, 2000, CIRCULATION, V102, P470; O'Connell TD, 2003, J CLIN INVEST, V111, P1783, DOI 10.1172/JCI200316100; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Passador-Gurgel G, 2007, NAT GENET, V39, P264, DOI 10.1038/ng1944; Petretto E, 2006, PLOS GENET, V2, P1625, DOI 10.1371/journal.pgen.0020172; Post WS, 1997, HYPERTENSION, V30, P1025, DOI 10.1161/01.HYP.30.5.1025; PRAVENEC M, 1995, J CLIN INVEST, V96, P1973, DOI 10.1172/JCI118244; Schroen B, 2004, CIRC RES, V95, P515, DOI 10.1161/01.RES.0000141019.20332.3e; Schroen B, 2007, J EXP MED, V204, P1227, DOI 10.1084/jem.20070145; Tasheva ES, 2002, MOL VIS, V8, P407; Tasheva ES, 1997, J BIOL CHEM, V272, P32551, DOI 10.1074/jbc.272.51.32551; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Yoshioka J, 2004, CIRCULATION, V109, P2581, DOI 10.1161/01.CIR.0000129771.32215.44; Zhang D, 2000, NAT MED, V6, P556, DOI 10.1038/75037	30	130	137	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2008	40	5					546	552		10.1038/ng.134	http://dx.doi.org/10.1038/ng.134			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18443592	Green Accepted			2022-12-27	WOS:000255366700020
J	Saar, K; Beck, A; Bihoreau, MT; Birney, E; Brocklebank, D; Chen, Y; Cuppen, E; Demonchy, S; Dopazo, J; Flicek, P; Foglio, M; Fujiyama, A; Gut, IG; Gauguier, D; Guigo, R; Guryev, V; Heinig, M; Hummel, O; Jahn, N; Klages, S; Kren, V; Kube, M; Kuhl, H; Kuramoto, T; Kuroki, Y; Lechner, D; Lee, YA; Lopez-Bigas, N; Lathrop, GM; Mashimo, T; Medina, I; Mott, R; Patone, G; Perrier-Cornet, JA; Platzer, M; Pravenec, M; Reinhardt, R; Sakaki, Y; Schilhabel, M; Schulz, H; Serikawa, T; Shikhagaie, M; Tatsumoto, S; Taudien, S; Toyoda, A; Voigt, B; Zelenika, D; Zimdahl, H; Hubner, N				Saar, Kathrin; Beck, Alfred; Bihoreau, Marie-Therese; Birney, Ewan; Brocklebank, Denise; Chen, Yuan; Cuppen, Edwin; Demonchy, Stephanie; Dopazo, Joaquin; Flicek, Paul; Foglio, Mario; Fujiyama, Asao; Gut, Ivo G.; Gauguier, Dominique; Guigo, Roderic; Guryev, Victor; Heinig, Matthias; Hummel, Oliver; Jahn, Niels; Klages, Sven; Kren, Vladimir; Kube, Michael; Kuhl, Heiner; Kuramoto, Takashi; Kuroki, Yoko; Lechner, Doris; Lee, Young-Ae; Lopez-Bigas, Nuria; Lathrop, G. Mark; Mashimo, Tomoji; Medina, Ignacio; Mott, Richard; Patone, Giannino; Perrier-Cornet, Jeanne-Antide; Platzer, Matthias; Pravenec, Michal; Reinhardt, Richard; Sakaki, Yoshiyuki; Schilhabel, Markus; Schulz, Herbert; Serikawa, Tadao; Shikhagaie, Medya; Tatsumoto, Shouji; Taudien, Stefan; Toyoda, Atsushi; Voigt, Birger; Zelenika, Diana; Zimdahl, Heike; Hubner, Norbert		STAR Consortium	SNP and haplotype mapping for genetic analysis in the rat	NATURE GENETICS			English	Article							WISTAR-KYOTO RATS; SEQUENCE; MOUSE; MAP; STRAINS; SET	The laboratory rat is one of the most extensively studied model organisms. Inbred laboratory rat strains originated from limited Rattus norvegicus founder populations, and the inherited genetic variation provides an excellent resource for the correlation of genotype to phenotype. Here, we report a survey of genetic variation based on almost 3 million newly identified SNPs. We obtained accurate and complete genotypes for a subset of 20,238 SNPs across 167 distinct inbred rat strains, two rat recombinant inbred panels and an F-2 intercross. Using 81% of these SNPs, we constructed high-density genetic maps, creating a large dataset of fully characterized SNPs for disease gene mapping. Our data characterize the population structure and illustrate the degree of linkage disequilibrium. We provide a detailed SNP map and demonstrate its utility for mapping of quantitative trait loci. This community resource is openly available and augments the genetic tools for this workhorse of physiological studies.	[Saar, Kathrin; Heinig, Matthias; Hummel, Oliver; Lee, Young-Ae; Patone, Giannino; Schulz, Herbert; Zimdahl, Heike; Hubner, Norbert] Max Delbruck Ctr Mol Med, D-14195 Berlin, Germany; [Beck, Alfred; Klages, Sven; Kube, Michael; Kuhl, Heiner; Mott, Richard] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Bihoreau, Marie-Therese; Brocklebank, Denise; Gauguier, Dominique; Mott, Richard] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Birney, Ewan; Chen, Yuan; Flicek, Paul] European Bioinformat Inst, Cambridge CB10 1SD, England; [Cuppen, Edwin; Guryev, Victor] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Demonchy, Stephanie; Foglio, Mario; Gut, Ivo G.; Lechner, Doris; Lathrop, G. Mark; Perrier-Cornet, Jeanne-Antide; Zelenika, Diana] Ctr Natl Genotypage, Inst Genom, Commissariat Energie Atom, F-91057 Evry, France; [Dopazo, Joaquin; Medina, Ignacio] Ctr Invest Principe Felipe, Dept Bioinformat & Funct Genom Node, Valencia 46012, Spain; [Fujiyama, Asao; Kuroki, Yoko; Sakaki, Yoshiyuki; Tatsumoto, Shouji; Toyoda, Atsushi] RIKEN, Genom Sci Ctr, Tsurumi Ku, Kanagawa 2300045, Japan; [Fujiyama, Asao] Res Org Informat & Syst, Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan; [Guigo, Roderic; Lopez-Bigas, Nuria] Ctr Genom Regulat, Barcelona 08003, Catalonia, Spain; [Guigo, Roderic; Lopez-Bigas, Nuria; Shikhagaie, Medya] Univ Pompeu Fabra, Expt & Hlth Sci Dept, Barcelona 08003, Catalonia, Spain; [Jahn, Niels; Platzer, Matthias; Schilhabel, Markus; Taudien, Stefan] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany; [Kren, Vladimir; Pravenec, Michal] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague 12800 2, Czech Republic; [Kren, Vladimir; Pravenec, Michal] Acad Sci Czech Republ, Inst Physiol, CR-14220 Prague 4, Czech Republic; [Kuramoto, Takashi; Mashimo, Tomoji; Serikawa, Tadao; Voigt, Birger] Kyoto Univ, Grad Sch Med, Inst Lab Anim, Sakyo Ku, Kyoto 6068501, Japan; [Lee, Young-Ae] Charite, Pediat Pneumol & Immunol, D-13353 Berlin, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Max Planck Society; University of Oxford; Wellcome Centre for Human Genetics; European Molecular Biology Laboratory (EMBL); Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Prince Felipe Research Center; RIKEN; Research Organization of Information & Systems (ROIS); National Institute of Informatics (NII) - Japan; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Charles University Prague; Czech Academy of Sciences; Institute of Physiology of the Czech Academy of Sciences; Kyoto University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hubner, N (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-14195 Berlin, Germany.	nhuebner@mdc-berlin.de	Lopez-Bigas, Nuria/F-6193-2011; Kuhl, Heiner/L-2737-2019; Cuppen, Edwin/F-5696-2011; Cuppen, Edwin/H-2389-2016; Gauguier, Dominique/G-2190-2016; Dopazo, Joaquin/A-9270-2014; Medina, Ignacio/B-3045-2011; Guigo, Roderic/D-1303-2010; Pravenec, Michal/B-1666-2012; Foglio, mary A./B-9149-2012; Gut, Ivo/ABF-3188-2020; Gasull, Martina/J-4076-2019	Lopez-Bigas, Nuria/0000-0003-4925-8988; Cuppen, Edwin/0000-0002-0400-9542; Cuppen, Edwin/0000-0002-0400-9542; Gauguier, Dominique/0000-0001-6156-9530; Dopazo, Joaquin/0000-0003-3318-120X; Guigo, Roderic/0000-0002-5738-4477; Pravenec, Michal/0000-0001-9197-5871; Foglio, mary A./0000-0001-7715-4452; Gut, Ivo/0000-0001-7219-632X; Shikhagaie, Medya Mara/0000-0003-1978-8048; Reinhardt, Richard/0000-0001-9376-2132; Heinig, Matthias/0000-0002-5612-1720; Mott, Richard/0000-0002-1022-9330; Saar, Kathrin/0000-0002-4483-1557; Flicek, Paul/0000-0002-3897-7955; Guryev, Victor/0000-0002-5810-6022; Birney, Ewan/0000-0001-8314-8497; Medina, Ignacio/0000-0003-0095-670X				Arbiza L, 2006, J MOL BIOL, V358, P1390, DOI 10.1016/j.jmb.2006.02.067; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bihoreau MT, 1997, GENOME RES, V7, P434, DOI 10.1101/gr.7.5.434; Blanco E, 2006, PLOS COMPUT BIOL, V2, P403, DOI 10.1371/journal.pcbi.0020049; Broman KW, 2005, GENETICS, V169, P1133, DOI 10.1534/genetics.104.035212; Dumas ME, 2007, NAT GENET, V39, P666, DOI 10.1038/ng2026; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Fujiyama A, 2002, SCIENCE, V295, P131, DOI 10.1126/science.1065199; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gauguier D, 1996, NAT GENET, V12, P38, DOI 10.1038/ng0196-38; GAUGUIER D, 2006, ENCY GENETICS, V3, P1154; Goni JR, 2004, NUCLEIC ACIDS RES, V32, P354, DOI 10.1093/nar/gkh188; Grupe A, 2001, SCIENCE, V292, P1915, DOI 10.1126/science.1058889; Guryev V, 2004, GENOME RES, V14, P1438, DOI 10.1101/gr.2154304; Guryev V, 2006, PLOS GENET, V2, P1111, DOI 10.1371/journal.pgen.0020121; Hardenbol P, 2005, GENOME RES, V15, P269, DOI 10.1101/gr.3185605; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; HEDRICH HJ, 1990, GENETIC MONITORING I; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Jensen-Seaman MI, 2004, GENOME RES, V14, P528, DOI 10.1101/gr.1970304; KURTZ TW, 1989, HYPERTENSION, V13, P188, DOI 10.1161/01.HYP.13.2.188; KURTZ TW, 1987, HYPERTENSION, V10, P127, DOI 10.1161/01.HYP.10.1.127; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Mashimo T, 2005, J APPL PHYSIOL, V98, P371, DOI 10.1152/japplphysiol.01006.2004; Mashimo T, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-19; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Oliphant A, 2002, BIOTECHNIQUES, P56; OLIPHANT A, 2002, BIOTECHNIQUES S, V56, P60; Payseur BA, 2007, GENETICS, V175, P1999, DOI 10.1534/genetics.106.067868; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Shisa H, 1997, MAMM GENOME, V8, P324, DOI 10.1007/s003359900432; Smits BMG, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-170; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thomas MA, 2003, MAMM GENOME, V14, P61, DOI 10.1007/s00335-002-2204-5; Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115; Wade CM, 2002, NATURE, V420, P574, DOI 10.1038/nature01252; Yang H, 2007, NAT GENET, V39, P1100, DOI 10.1038/ng2087; Zimdahl H, 2004, SCIENCE, V303, P807, DOI 10.1126/science.1092427	41	141	142	0	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					560	566		10.1038/ng.124	http://dx.doi.org/10.1038/ng.124			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18443594	Green Accepted			2022-12-27	WOS:000255366700022
J	Charlier, C; Coppieters, W; Rollin, F; Desmecht, D; Agerholm, JS; Cambisano, N; Carta, E; Dardano, S; Dive, M; Fasquelle, C; Frennet, JC; Hanset, R; Hubin, X; Jorgensen, C; Karim, L; Kent, M; Harvey, K; Pearce, BR; Simon, P; Tama, N; Nie, H; Vandeputte, S; Lien, S; Longeri, M; Fredholm, M; Harvey, RJ; Georges, M				Charlier, Carole; Coppieters, Wouter; Rollin, Frederic; Desmecht, Daniel; Agerholm, Jorgen S.; Cambisano, Nadine; Carta, Eloisa; Dardano, Sabrina; Dive, Marc; Fasquelle, Corinne; Frennet, Jean-Claude; Hanset, Roger; Hubin, Xavier; Jorgensen, Claus; Karim, Latifa; Kent, Matthew; Harvey, Kirsten; Pearce, Brian R.; Simon, Patricia; Tama, Nico; Nie, Haisheng; Vandeputte, Sebastien; Lien, Sigbjorn; Longeri, Maria; Fredholm, Merete; Harvey, Robert J.; Georges, Michel			Highly effective SNP-based association mapping and management of recessive defects in livestock	NATURE GENETICS			English	Article							HARLEQUIN ICHTHYOSIS; TRANSPORTER ABCA12; NONSENSE MUTATION; SKELETAL-MUSCLE; CA2+ ATPASE; GENE; IDENTIFICATION; UNDERLIE; TRAITS; ION	The widespread use of elite sires by means of artificial insemination in livestock breeding leads to the frequent emergence of recessive genetic defects, which cause significant economic and animal welfare concerns. Here we show that the availability of genome-wide, high-density SNP panels, combined with the typical structure of livestock populations, markedly accelerates the positional identification of genes and mutations that cause inherited defects. We report the fine-scale mapping of five recessive disorders in cattle and the molecular basis for three of these: congenital muscular dystony (CMD) types 1 and 2 in Belgian Blue cattle and ichthyosis fetalis in Italian Chianina cattle. Identification of these causative mutations has an immediate translation into breeding practice, allowing marker assisted selection against the defects through avoidance of at-risk matings.	[Charlier, Carole; Coppieters, Wouter; Cambisano, Nadine; Fasquelle, Corinne; Hanset, Roger; Karim, Latifa; Simon, Patricia; Tama, Nico; Nie, Haisheng; Georges, Michel] Univ Liege, Fac Vet Med, Unit Anim Genom, GIGA Res, B-4000 Liege, Belgium; [Charlier, Carole; Coppieters, Wouter; Cambisano, Nadine; Fasquelle, Corinne; Hanset, Roger; Karim, Latifa; Simon, Patricia; Tama, Nico; Nie, Haisheng] Univ Liege, Fac Vet Med, Dept Anim Sci, B-4000 Liege, Belgium; [Rollin, Frederic; Vandeputte, Sebastien] Univ Liege, Fac Vet Med, Dept Large Anim Internal Med, B-4000 Liege, Belgium; [Desmecht, Daniel] Univ Liege, Fac Vet Med, Unit Pathol, Dept Morphol & Pathol, B-4000 Liege, Belgium; [Agerholm, Jorgen S.] Univ Copenhagen, Fac Life Sci, Dept Vet Pathobiol, DK-1870 Frederiksberg, Denmark; [Carta, Eloisa; Harvey, Kirsten; Pearce, Brian R.; Harvey, Robert J.] Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; [Dardano, Sabrina; Longeri, Maria] Univ Milan, Fac Vet Med, Dept Anim Sci, I-20133 Milan, Italy; [Hubin, Xavier] Rech & Dev Assoc Wallonne Elevage, B-5590 Ciney, Belgium; [Jorgensen, Claus; Fredholm, Merete] Univ Copenhagen, Fac Life Sci, Dept Anim & Vet Basic Sci, Div Genet & Bioinformat, DK-1870 Frederiksberg C, Denmark; [Kent, Matthew; Lien, Sigbjorn] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, Ctr Integrat Genet, N-1432 As, Norway	University of Liege; University of Liege; University of Liege; University of Liege; University of Copenhagen; University of London; University College London; University of London School of Pharmacy; University of Milan; University of Copenhagen; Norwegian University of Life Sciences	Georges, M (corresponding author), Univ Liege, Fac Vet Med, Unit Anim Genom, GIGA Res, B34,1 Ave Hop, B-4000 Liege, Belgium.	michel.georges@ulg.ac.be	Jorgensen, Claus B./GXH-7925-2022; Coppieters, Wouter/AAF-5030-2021; Harvey, Robert/D-3994-2016; Agerholm, Jørgen/GRX-7427-2022; Longeri, Maria/L-1557-2017	Jorgensen, Claus B./0000-0003-4749-5306; Coppieters, Wouter/0000-0001-8109-7825; Harvey, Robert/0000-0001-5956-6664; Longeri, Maria/0000-0001-7863-1855; Agerholm, Jorgen Steen/0000-0003-1653-4552; Fredholm, Merete/0000-0002-3563-7648; Charlier, Carole/0000-0002-9694-094X; Georges, Michel/0000-0003-4124-2375	Medical Research Council [G0601585(79887), G0601585] Funding Source: Medline; MRC [G0601585] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agerholm JS, 2007, APMIS, V115, P1, DOI 10.1111/j.1600-0463.2007.apm_v115_s122.x; Akiyama M, 2005, J CLIN INVEST, V115, P1777, DOI 10.1172/JCI24834; Akiyama M, 2007, DERMATOLOGY, V215, P155, DOI 10.1159/000104269; Akiyama M, 2006, ARCH DERMATOL, V142, P914, DOI 10.1001/archderm.142.7.914; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; Hayes BJ, 2003, GENOME RES, V13, P635, DOI 10.1101/gr.387103; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kelsell DP, 2005, AM J HUM GENET, V76, P794; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; Lefevre C, 2003, HUM MOL GENET, V12, P2369, DOI 10.1093/hmg/ddg235; Ma HL, 2005, BIOCHEMISTRY-US, V44, P8090, DOI 10.1021/bi050332m; Molteni L, 2006, VET REC, V158, P412, DOI 10.1136/vr.158.12.412; Odermatt A, 1996, NAT GENET, V14, P191, DOI 10.1038/ng1096-191; Peelman F, 2003, J MOL BIOL, V325, P259, DOI 10.1016/S0022-2836(02)01105-1; Pierce KD, 2001, MOL CELL NEUROSCI, V17, P354, DOI 10.1006/mcne.2000.0934; Rees MI, 2006, NAT GENET, V38, P801, DOI 10.1038/ng1814; Rude H, 2005, J COMP PATHOL, V132, P303, DOI 10.1016/j.jcpa.2004.11.005; SHUSTER DE, 1992, P NATL ACAD SCI USA, V89, P9225, DOI 10.1073/pnas.89.19.9225; THOMAS AC, BR J DERMATOL, V158, P611; Thomas AC, 2006, J INVEST DERMATOL, V126, P2408, DOI 10.1038/sj.jid.5700455; Thomsen B, 2006, GENOME RES, V16, P97, DOI 10.1101/gr.3690506; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; VANDEPUTTE S, 2006, P 24 WORLD BUIATR C; Young CW, 1996, J DAIRY SCI, V79, P502, DOI 10.3168/jds.S0022-0302(96)76392-0	25	205	219	2	57	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2008	40	4					449	454		10.1038/ng.96	http://dx.doi.org/10.1038/ng.96			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18344998	Green Published			2022-12-27	WOS:000254388100016
J	Cree, LM; Samuels, DC; Lopes, SCDS; Rajasimha, HK; Wonnapinij, P; Mann, JR; Dahl, HHM; Chinnery, PF				Cree, Lynsey M.; Samuels, David C.; Lopes, Susana Chuva de Sousa; Rajasimha, Harsha Karur; Wonnapinij, Passorn; Mann, Jeffrey R.; Dahl, Hans-Henrik M.; Chinnery, Patrick F.			A reduction of mitochondrial DNA molecules during embryogenesis explains the rapid segregation of genotypes	NATURE GENETICS			English	Article							HEREDITARY OPTIC NEUROPATHY; PRIMORDIAL GERM-CELLS; RANDOM GENETIC DRIFT; MOUSE EMBRYOS; D-LOOP; MTDNA; OOCYTES; MICE; PROLIFERATION; HETEROPLASMY	Mammalian mitochondrial DNA (mtDNA) is inherited principally down the maternal line, but the mechanisms involved are not fully understood. Females harboring a mixture of mutant and wild-type mtDNA (heteroplasmy) transmit a varying proportion of mutant mtDNA to their offspring. In humans with mtDNA disorders, the proportion of mutated mtDNA inherited from the mother correlates with disease severity(1-4). Rapid changes in allele frequency can occur in a single generation(5,6). This could be due to a marked reduction in the number of mtDNA molecules being transmitted from mother to offspring (the mitochondrial genetic bottleneck), to the partitioning of mtDNA into homoplasmic segregating units, or to the selection of a group of mtDNA molecules to re-populate the next generation. Here we show that the partitioning of mtDNA molecules into different cells before and after implantation, followed by the segregation of replicating mtDNA between proliferating primordial germ cells, is responsible for the different levels of heteroplasmy seen in the offspring of heteroplasmic female mice.	[Cree, Lynsey M.; Chinnery, Patrick F.] Univ Newcastle, Mitrochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Samuels, David C.; Rajasimha, Harsha Karur; Wonnapinij, Passorn] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Lopes, Susana Chuva de Sousa] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Mann, Jeffrey R.] City Hope Natl Med Ctr, Div Biol, Duarte, CA 91010 USA; [Dahl, Hans-Henrik M.] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Dahl, Hans-Henrik M.] Univ Melbourne, Royal Childrens Hosp, Dept Paediat, Parkville, Vic 3052, Australia; [Chinnery, Patrick F.] Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK; Virginia Polytechnic Institute & State University; University of Cambridge; City of Hope; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Royal Children's Hospital Melbourne; University of Melbourne; Newcastle University - UK	Chinnery, PF (corresponding author), Univ Newcastle, Mitrochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	p.f.chinnery@ncl.ac.uk	Samuels, David/C-1365-2012; Samuels, David C/A-5393-2008; Samuels, David/AHC-8381-2022	Samuels, David C/0000-0003-3529-7791; Samuels, David/0000-0003-3529-7791; Cree, Lynsey/0000-0003-2090-1589; Chinnery, Patrick/0000-0002-7065-6617	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Bendall KE, 1996, AM J HUM GENET, V59, P1276; Bergstrom CT, 1998, GENETICS, V149, P2135; Blok RB, 1997, AM J HUM GENET, V60, P1495, DOI 10.1086/515453; BOLHUIS PA, 1990, BIOCHEM BIOPH RES CO, V170, P994, DOI 10.1016/0006-291X(90)90490-E; Brown DT, 2001, AM J HUM GENET, V68, P533, DOI 10.1086/318190; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Chinnery PF, 2000, TRENDS GENET, V16, P500, DOI 10.1016/S0168-9525(00)02120-X; DOWNS KM, 1993, DEVELOPMENT, V118, P1255; GINSBURG M, 1990, DEVELOPMENT, V110, P521; Hogan B, 1994, MANIPULATING MOUSE E; HOLT IJ, 1989, J MED GENET, V26, P739, DOI 10.1136/jmg.26.12.739; HOWELL N, 1992, HUM GENET, V90, P117; Jenuth JP, 1997, NAT GENET, V16, P93, DOI 10.1038/ng0597-93; Jenuth JP, 1996, NAT GENET, V14, P146, DOI 10.1038/ng1096-146; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; LARSSON NG, 1992, AM J HUM GENET, V51, P1201; MANN JR, 1990, CELL, V62, P251, DOI 10.1016/0092-8674(90)90363-J; MCGRATH J, 1983, SCIENCE, V220, P1300, DOI 10.1126/science.6857250; McLaren A, 2005, DIFFERENTIATION, V73, P435, DOI 10.1111/j.1432-0436.2005.00049.x; OLIVO PD, 1983, NATURE, V306, P400, DOI 10.1038/306400a0; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; PIKO L, 1987, DEV BIOL, V123, P364, DOI 10.1016/0012-1606(87)90395-2; Poulton J, 1998, AM J HUM GENET, V62, P752, DOI 10.1086/301811; Spiropoulos J, 2002, MOL HUM REPROD, V8, P719, DOI 10.1093/molehr/8.8.719; Steuerwald N, 2000, ZYGOTE, V8, P209, DOI 10.1017/S0967199400001003; STREFFER C, 1980, CELL TISSUE KINET, V13, P135, DOI 10.1111/j.1365-2184.1980.tb00456.x; TAM PPL, 1981, J EMBRYOL EXP MORPH, V64, P133; UPHOLT WB, 1977, CELL, V11, P571, DOI 10.1016/0092-8674(77)90075-7; VILKKI J, 1990, AM J HUM GENET, V47, P95; Wright S., 1969, EVOLUTION GENETICS P	30	347	354	1	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2008	40	2					249	254		10.1038/ng.2007.63	http://dx.doi.org/10.1038/ng.2007.63			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18223651				2022-12-27	WOS:000252732900026
J	Huang, G; Zhang, P; Hirai, H; Elf, S; Yan, X; Chen, Z; Koschmieder, S; Okuno, Y; Dayaram, T; Growney, JD; Shivdasani, RA; Gilliland, DG; Speck, NA; Nimer, SD; Tenen, DG				Huang, Gang; Zhang, Pu; Hirai, Hideyo; Elf, Shannon; Yan, Xiaomei; Chen, Zhao; Koschmieder, Steffen; Okuno, Yutaka; Dayaram, Tajhal; Growney, Joseph D.; Shivdasani, Ramesh A.; Gilliland, D. Gary; Speck, Nancy A.; Nimer, Stephen D.; Tenen, Daniel G.			PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis	NATURE GENETICS			English	Article							ACUTE MYELOID-LEUKEMIA; TRANSCRIPTION FACTOR PU.1; STEM-CELLS; LINEAGE COMMITMENT; POINT MUTATIONS; GENE; EXPRESSION; MICE; DIFFERENTIATION; DOMAIN	Both PU.1 (also called SFPI1), an Ets-family transcription factor, and AML1 (also called RUNX1), a DNA-binding subunit of the CBF transcription factor family, are crucial for the generation of all hematopoietic lineages, and both act as tumor suppressors in leukemia. An upstream regulatory element (URE) of PU.1 has both enhancer and repressor activity and tightly regulates PU.1 expression. Here we show that AML1 binds to functionally important sites within the PU.1 upstream regulatory element and regulates PU.1 expression at both embryonic and adult stages of development. Analysis of mice carrying conditional AML1 knockout alleles and knock-in mice carrying mutations in all three AML1 sites of the URE proximal region demonstrated that AML1 regulates PU.1 both positively and negatively in a lineage dependent manner. Dysregulation of PU.1 expression contributed to each of the phenotypes observed in these mice, and restoration of proper PU.1 expression rescued or partially rescued each phenotype. Thus, our data demonstrate that PU.1 is a major downstream target gene of AML1.	[Huang, Gang; Zhang, Pu; Hirai, Hideyo; Koschmieder, Steffen; Okuno, Yutaka; Dayaram, Tajhal; Tenen, Daniel G.] Harvard Univ, Sch Med, Harvard Inst Med, Div Hematol Oncol, Boston, MA 02115 USA; [Huang, Gang; Yan, Xiaomei] Mem Sloan Kettering Canc Ctr, Div Hematol Oncol, New York, NY 10021 USA; [Hirai, Hideyo; Nimer, Stephen D.] Kyoto Prefectural Univ Med, Dept Microbiol, Kyoto 6028566, Japan; [Chen, Zhao; Shivdasani, Ramesh A.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Growney, Joseph D.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Speck, Nancy A.] Dartmouth Coll, Sch Med, Dept Biochem, Hanover, NH 03755 USA	Harvard University; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Kyoto Prefectural University of Medicine; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Dartmouth College	Tenen, DG (corresponding author), Harvard Univ, Sch Med, Harvard Inst Med, Div Hematol Oncol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	dtenen@bidmc.harvard.edu		Koschmieder, Steffen/0000-0002-1011-8171; Tenen, Daniel/0000-0002-6423-3888	NCI NIH HHS [CA66996, CA41456] Funding Source: Medline; NIDDK NIH HHS [DK52208] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA066996, R01CA041456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052208, R56DK052208] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Anderson MK, 2002, IMMUNITY, V16, P285, DOI 10.1016/S1074-7613(02)00277-7; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bystrykh L, 2005, NAT GENET, V37, P225, DOI 10.1038/ng1497; Canon J, 2000, SEMIN CELL DEV BIOL, V11, P327, DOI 10.1006/scdb.2000.0185; Canon J, 2003, GENE DEV, V17, P838, DOI 10.1101/gad.1064803; CHEN HM, 1995, ONCOGENE, V11, P1549; Chen Z, 2007, BLOOD, V109, P1451, DOI 10.1182/blood-2006-08-038901; Cook WD, 2004, BLOOD, V104, P3437, DOI 10.1182/blood-2004-06-2234; de Bruijn MFTR, 2004, ONCOGENE, V23, P4238, DOI 10.1038/sj.onc.1207763; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Du Y, 2005, BLOOD, V106, P2498, DOI 10.1182/blood-2004-12-4840; Flores GV, 1998, DEVELOPMENT, V125, P3681; Flores GV, 2000, CELL, V103, P75, DOI 10.1016/S0092-8674(00)00106-9; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Harada H, 2004, BLOOD, V103, P2316, DOI 10.1182/blood-2003-09-3074; Higuchi M, 2002, CANCER CELL, V1, P63, DOI 10.1016/S1535-6108(02)00016-8; Huang G, 2004, BLOOD, V103, P3200, DOI 10.1182/blood-2003-07-2188; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Iwasaki H, 2005, BLOOD, V106, P1590, DOI 10.1182/blood-2005-03-0860; Koschmieder S, 2005, INT J HEMATOL, V81, P368, DOI 10.1532/IJH97.05051; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Li YL, 2001, BLOOD, V98, P2958, DOI 10.1182/blood.V98.10.2958; Li Z, 2005, NAT GENET, V37, P613, DOI 10.1038/ng1566; Liu YZ, 2006, CANCER CELL, V9, P249, DOI 10.1016/j.ccr.2006.03.012; Lorsbach RB, 2004, BLOOD, V103, P2522, DOI 10.1182/blood-2003-07-2439; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; MoreauGachelin F, 1996, MOL CELL BIOL, V16, P2453; MOREAUGACHELIN F, 1988, NATURE, V331, P277, DOI 10.1038/331277a0; North TE, 2004, STEM CELLS, V22, P158, DOI 10.1634/stemcells.22-2-158; Nutt SL, 2005, J EXP MED, V201, P221, DOI 10.1084/jem.20041535; Okada H, 1998, ONCOGENE, V17, P2287, DOI 10.1038/sj.onc.1202151; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; Okuno Y, 2005, MOL CELL BIOL, V25, P2832, DOI 10.1128/MCB.25.7.2832-2845.2005; Osato M, 2004, ONCOGENE, V23, P4284, DOI 10.1038/sj.onc.1207779; Osato M, 1999, BLOOD, V93, P1817, DOI 10.1182/blood.V93.6.1817.406k36_1817_1824; Peterson LF, 2004, ONCOGENE, V23, P4255, DOI 10.1038/sj.onc.1207727; Putz G, 2006, ONCOGENE, V25, P929, DOI 10.1038/sj.onc.1209136; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Rosenbauer F, 2004, NAT GENET, V36, P624, DOI 10.1038/ng1361; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Suraweera N, 2005, ONCOGENE, V24, P3678, DOI 10.1038/sj.onc.1208422; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Vangala RK, 2003, BLOOD, V101, P270, DOI 10.1182/blood-2002-04-1288; Villeval JL, 1997, BLOOD, V90, P4369; Walter MJ, 2005, P NATL ACAD SCI USA, V102, P12513, DOI 10.1073/pnas.0504247102; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Zhang DE, 1996, MOL CELL BIOL, V16, P1231; Zhu J, 2002, ONCOGENE, V21, P3295, DOI 10.1038/sj.onc.1205318	49	173	181	1	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2008	40	1					51	60		10.1038/ng.2007.7	http://dx.doi.org/10.1038/ng.2007.7			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	17994017				2022-12-27	WOS:000252118600018
J	Chuck, G; Meeley, R; Irish, E; Sakai, H; Hake, S				Chuck, George; Meeley, Robert; Irish, Erin; Sakai, Hajime; Hake, Sarah			The maize tasselseed4 microRNA controls sex determination and meristem cell fate by targeting Tasselseed6/indeterminate spikelet1	NATURE GENETICS			English	Article							FLORAL ORGAN IDENTITY; GENES; EXPRESSION; MUTANTS; PROTEIN; BOUNDARY; APETALA2; ENCODES; DOMAIN	In maize ( Zea mays), sex determination occurs through abortion of female carpels in the tassel and arrest of male stamens in the ear. The Tasselseed6 ( Ts6) and tasselseed4 ( ts4) mutations permit carpel development in the tassel while increasing meristem branching, showing that sex determination and acquisition of meristem fate share a common pathway. We show that ts4 encodes a mir172 microRNA that targets APETALA2 floral homeotic transcription factors. Three lines of evidence suggest that indeterminate spikelet1 ( ids1), an APETALA2 gene required for spikelet meristem determinacy, is a key target of ts4. First, loss of ids1 suppresses the ts4 sex determination and branching defects. Second, Ts6 mutants phenocopy ts4 and possess mutations in the microRNA binding site of ids1. Finally, IDS1 protein is expressed more broadly in ts4 mutants compared to wild type. Our results demonstrate that sexual identity in maize is acquired by limiting floral growth through negative regulation of the floral homeotic pathway.	Univ Calif Albany, USDA Agr Res Serv, Plant Gene Express Ctr, Albany, CA 94710 USA; Pioneer A DuPont Co, Johnston, IA 50131 USA; Univ Iowa, Dept Sci Biol, Iowa City, IA 52242 USA; Dupont Crop Genet, Wilmington, DE 19880 USA	United States Department of Agriculture (USDA); DuPont; University of Iowa; DuPont	Chuck, G (corresponding author), Univ Calif Albany, USDA Agr Res Serv, Plant Gene Express Ctr, Albany, CA 94710 USA.	gchuck@nature.berkeley.edu	Irish, Erin/C-7331-2016	Irish, Erin/0000-0003-4244-7938				Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; BENSEN RJ, 1995, PLANT CELL, V7, P75, DOI 10.1105/tpc.7.1.75; Bortiri E, 2006, PLANT CELL, V18, P574, DOI 10.1105/tpc.105.039032; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; CHENG PC, 1983, AM J BOT, V70, P450, DOI 10.2307/2443252; Chuck G, 1998, GENE DEV, V12, P1145, DOI 10.1101/gad.12.8.1145; DELONG A, 1993, CELL, V74, P757, DOI 10.1016/0092-8674(93)90522-R; Irish EE, 1997, AM J BOT, V84, P1502, DOI 10.2307/2446611; IRISH EE, 1994, DEV GENET, V15, P155, DOI 10.1002/dvg.1020150206; JACKSON D, 1994, DEVELOPMENT, V120, P405; Jackson DP, 1991, MOL PLANT PATHOL, P163; Kaplinsky NJ, 2003, DEVELOPMENT, V130, P1149, DOI 10.1242/dev.00336; Lauter N, 2005, P NATL ACAD SCI USA, V102, P9412, DOI 10.1073/pnas.0503927102; MIZUKAMI Y, 1992, CELL, V71, P119, DOI 10.1016/0092-8674(92)90271-D; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; NICKERSON NORTON H., 1959, ANN MISSOURI BOT GARD, V46, P19, DOI 10.2307/2394566; Okamuro JK, 1997, PLANT CELL, V9, P37, DOI 10.1105/tpc.9.1.37; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Phipps IF, 1928, J HERED, V19, P399, DOI 10.1093/oxfordjournals.jhered.a103030; POSTLETHEWAIT SN, 1964, AM J BOT, V51, P238, DOI 10.2307/2440292; Reeves R, 1996, BIOCHEMISTRY-US, V35, P5063, DOI 10.1021/bi952424p; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; VEIT B, 1993, PLANT CELL, V5, P1205, DOI 10.1105/tpc.5.10.1205; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Zhao L, 2007, PLANT J, V51, P840, DOI 10.1111/j.1365-313X.2007.03181.x	26	276	306	5	62	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2007	39	12					1517	1521		10.1038/ng.2007.20	http://dx.doi.org/10.1038/ng.2007.20			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	18026103				2022-12-27	WOS:000251267400022
J	Thomson, W; Barton, A; Ke, X; Eyre, S; Hinks, A; Bowes, J; Donn, R; Symmons, D; Hider, S; Bruce, IN; Wilson, AG; Marinou, I; Morgan, A; Emery, P; Carter, A; Steer, S; Hocking, L; Reid, DM; Wordsworth, P; Harrison, P; Strachan, D; Worthington, J				Thomson, Wendy; Barton, Anne; Ke, Xiayi; Eyre, Steve; Hinks, Anne; Bowes, John; Donn, Rachelle; Symmons, Deborah; Hider, Samantha; Bruce, Ian N.; Wilson, Anthony G.; Marinou, Ioanna; Morgan, Ann; Emery, Paul; Carter, Angela; Steer, Sophia; Hocking, Lynne; Reid, David M.; Wordsworth, Paul; Harrison, Pille; Strachan, David; Worthington, Jane		Consortium, WTCC; Consortium, Y	Rheumatoid arthritis association at 6q23	NATURE GENETICS			English	Article							NF-KAPPA-B; POPULATION; RESPONSES; PTPN22; RISK; GENE; A20	The Wellcome Trust Case Control Consortium (WTCCC) identified nine single SNPs putatively associated with rheumatoid arthritis at P = 1 x 10(-5)-5 x 10(-7) in a genome-wide association screen. One, rs6920220, was unequivocally replicated ( trend P = 1.1 x 10(-8)) in a validation study, as described here. This SNP maps to 6q23, between the genes oligodendrocyte lineage transcription factor 3 (OLIG3) and tumor necrosis factor-alpha-induced protein 3 ( TNFAIP3).	Univ Manchester, Arthritis Res Campaign Epidemiol Unit, Manchester M13 9PT, Lancs, England; Univ Sheffield, Sch Med & Biomed Sci, Sheffield S10 2JF, S Yorkshire, England; Chapel Allerton Hosp, Acad Unit Musculoskeletal Dis, Leeds LS7 4SA, W Yorkshire, England; Univ Leeds, Inst Genet, Acad Unit Mol Vasc Med, Hlth & Therapeut Labs, Leeds LS2 9JT, W Yorkshire, England; Kings Coll Hosp London, Natl Hlth Serv Fdn Trust, London SE5 9RS, England; Univ Aberdeen, Dept Med & Therapeut, Bone Res Grp, Aberdeen AB25 2ZD, Scotland; Univ Oxford, Botnar Res Ctr, Inst Musculoskeletal Sci, Oxford OX3 7LD, England; St Georges Univ London, Div Community Hlth Sci, London SW17 0RE, England	University of Manchester; University of Sheffield; Chapel Allerton Hospital; University of Leeds; University of Leeds; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Aberdeen; University of Oxford; St Georges University London	Worthington, J (corresponding author), Univ Manchester, Arthritis Res Campaign Epidemiol Unit, Manchester M13 9PT, Lancs, England.	jane.worthington@manchester.ac.uk	Bowes, John/B-3472-2015; eyre, stephen/K-3776-2017; Brown, Matthew A/E-5749-2010; Timpson, Nicholas John/O-7548-2015; Yuldasheva, Dr. Nadira Yusupovna/GXM-9013-2022; Worthington, Jane/M-9770-2014; Dominiczak, Anna F/P-9390-2017; Hinks, Anne/E-1853-2015; emery, paul/B-3560-2013; Barton, Anne/N-2053-2014; Attrill, Lauren/V-1688-2018; Ke, Xiayi/C-7674-2009; O'Donovan, Michael C/P-7005-2018; McCarthy, Mark/M-3763-2015; Evans, David/H-6325-2013; Prescott, Natalie/F-6490-2011; dobson, richard/C-9269-2011; Robinson, James/D-9096-2016	Bowes, John/0000-0003-4659-031X; eyre, stephen/0000-0002-1251-6974; Brown, Matthew A/0000-0003-0538-8211; Timpson, Nicholas John/0000-0002-7141-9189; Yuldasheva, Dr. Nadira Yusupovna/0000-0001-6213-6358; Worthington, Jane/0000-0003-0544-042X; Dominiczak, Anna F/0000-0003-4913-3608; Hinks, Anne/0000-0001-8843-3967; Barton, Anne/0000-0003-3316-2527; O'Donovan, Michael C/0000-0001-7073-2379; Caulfield, Mark/0000-0001-9295-3594; Symmons, Deborah/0000-0002-8625-1200; Harrison, Pille/0000-0003-4117-6910; Jones, Lisa/0000-0002-5122-8334; Dunger, Professor David/0000-0002-2566-9304; Wilson, Anthony Gerard/0000-0003-4855-3926; Bishop, Tim/0000-0002-8752-8785; Tobin, Martin/0000-0002-3596-7874; Donn, Rachelle/0000-0001-6976-9828; Grozeva, Detelina/0000-0003-3239-8415; Munroe, Patricia/0000-0002-4176-2947; McCarthy, Mark/0000-0002-4393-0510; Evans, David/0000-0003-0663-4621; Bruce, Ian/0000-0003-3047-500X; Prescott, Natalie/0000-0002-5901-7371; Newport, Melanie/0000-0002-8946-7525; Lango Allen, Hana/0000-0002-7803-8688; Parkes, Miles/0000-0002-6467-0631; dobson, richard/0000-0003-4224-9245; Walker, Neil/0000-0001-9796-7688; Robinson, James/0000-0001-5425-7520; Lees, Charlie/0000-0002-0732-8215; Lindgren, Cecilia/0000-0002-4903-9374; Conaghan, Philip/0000-0002-3478-5665; Hensor, Elizabeth/0000-0002-5245-4755; Hocking, Lynne J/0000-0002-2414-2826; Zeggini, Eleftheria/0000-0003-4238-659X; Hall, Alistair/0000-0003-0306-7887; Morgan, Ann/0000-0003-1109-624X; Thomson, Wendy/0000-0002-9022-5179; Weedon, Michael/0000-0002-6174-6135; Hattersley, Andrew/0000-0001-5620-473X	MRC [G0000934] Funding Source: UKRI; Arthritis Research UK [17552] Funding Source: Medline; Medical Research Council [G0000934, G0000934(68341)] Funding Source: Medline; Wellcome Trust [076113, 068545, 090532, 068545/Z/02] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Filippi A, 2005, P NATL ACAD SCI USA, V102, P4377, DOI 10.1073/pnas.0407284102; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Harrison P, 2006, RHEUMATOLOGY, V45, P1009, DOI 10.1093/rheumatology/kei250; Hinks A, 2005, ARTHRITIS RHEUM-US, V52, P1694, DOI 10.1002/art.21049; Huizinga TWJ, 2005, ARTHRITIS RHEUM, V52, P3433, DOI 10.1002/art.21385; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Steer S, 2005, ARTHRITIS RHEUM, V52, P358, DOI 10.1002/art.20737; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Zheng DY, 2007, GENOME RES, V17, P839, DOI 10.1101/gr.5586307	13	317	323	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2007	39	12					1431	1433		10.1038/ng.2007.32	http://dx.doi.org/10.1038/ng.2007.32			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	17982455	Green Accepted			2022-12-27	WOS:000251267400007
J	Maller, JB; Fagerness, JA; Reynolds, RC; Neale, BM; Daly, MJ; Seddon, JM				Maller, Julian B.; Fagerness, Jesen A.; Reynolds, Robyn C.; Neale, Benjamin M.; Daly, Mark J.; Seddon, Johanna M.			Variation in complement factor 3 is associated with risk of age-related macular degeneration	NATURE GENETICS			English	Article							FACTOR-H POLYMORPHISM; VARIANT; CFH; GENES; Y402H	The association of variants in complement factors H and B with age-related macular degeneration has led to more intense genetic and functional analysis of the complement pathway. We identify a nonsynonymous coding change in complement factor 3 that is strongly associated with risk of age-related macular degeneration in a large case-control sample.	Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; MIT, Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; Tufts Univ New England Med Ctr, New England Eye Ctr, Ophthal Epidemiol & Genet Serv, Boston, MA 02111 USA; Kings Coll London, Inst Psychiat, Social Genet & Dev Psychiat Ctr, London SE5 8AP, England; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Tufts Medical Center; University of London; King's College London; Harvard University; Harvard Medical School	Seddon, JM (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	mjdaly@chgr.mgh.harvard.edu; jseddon@tufts-nemc.org	maller, julian B/A-9323-2009; Daly, Mark J/B-2453-2017	Daly, Mark J/0000-0002-0949-8752; Maller, Julian/0000-0002-1565-9559	NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020278] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [N01EY002127, R01EY011309] Funding Source: NIH RePORTER; NCRR NIH HHS [U54 RR020278] Funding Source: Medline; NEI NIH HHS [EY11309, R01 EY011309, N01-EY-0-2127] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Abrera-Abeleda MA, 2006, J MED GENET, V43, P582, DOI 10.1136/jmg.2005.038315; BOTTO M, 1990, J EXP MED, V172, P1011, DOI 10.1084/jem.172.4.1011; Brown KM, 2006, NEW ENGL J MED, V354, P2014, DOI 10.1056/NEJMoa052825; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Li M, 2006, NAT GENET, V38, P1049, DOI 10.1038/ng1871; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Seddon JM, 2006, HUM HERED, V61, P157, DOI 10.1159/000094141; WYATT RJ, 1987, RECENT DEV MUCOSAL I; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	14	335	364	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	OCT	2007	39	10					1200	1201		10.1038/ng2131	http://dx.doi.org/10.1038/ng2131			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17767156				2022-12-27	WOS:000249737400014
J	Menzel, S; Garner, C; Gut, I; Matsuda, F; Yamaguchi, M; Heath, S; Foglio, M; Zelenika, D; Boland, A; Rooks, H; Best, S; Spector, TD; Farrall, M; Lathrop, M; Thein, SL				Menzel, Stephan; Garner, Chad; Gut, Ivo; Matsuda, Fumihiko; Yamaguchi, Masao; Heath, Simon; Foglio, Mario; Zelenika, Diana; Boland, Anne; Rooks, Helen; Best, Steve; Spector, Tim D.; Farrall, Martin; Lathrop, Mark; Thein, Swee Lay			A QTL influencing F cell production maps to a gene encoding a zinc-finger protein on chromosome 2p15	NATURE GENETICS			English	Article							FETAL-HEMOGLOBIN; ASSOCIATION; ADULTS	F cells measure the presence of fetal hemoglobin, a heritable quantitative trait in adults that accounts for substantial phenotypic diversity of sickle cell disease and beta thalassemia. We applied a genome-wide association mapping strategy to individuals with contrasting extreme trait values and mapped a new F cell quantitative trait locus to BCL11A, which encodes a zinc-finger protein, on chromosome 2p15. The 2p15 BCL11A quantitative trait locus accounts for 15.1% of the trait variance.	Kings Coll London, Sch Med, Div Gene & Cell Based Therapy, London SE5 9PJ, England; Univ Calif Irvine, Dept Med, Div Epidemiol, Irvine, CA 92697 USA; Ctr Natl Genotypage, Inst Genom, Commissariat Lenergie Atom, F-91006 Evry, France; St Thomas Hosp, Univ London Kings Coll, Sch Med, Div Genet & Mol Med, London SE1 7EH, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Cardiovasc Med, Oxford OX3 7BN, England; Kings Coll Hosp London, Dept Haematol Med, London SE5 9RS, England	University of London; King's College London; University of California System; University of California Irvine; CEA; UDICE-French Research Universities; Universite Paris Saclay; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Oxford; Wellcome Centre for Human Genetics; King's College Hospital NHS Foundation Trust; King's College Hospital	Thein, SL (corresponding author), Kings Coll London, Sch Med, Div Gene & Cell Based Therapy, Kings Denmark Hill Campus, London SE5 9PJ, England.	sl.thein@kcl.ac.uk	Menzel, Stephan/U-6906-2019; Matsuda, Fumihiko/B-9893-2009; Spector, Tim D/F-6533-2012; Gut, Ivo/ABF-3188-2020; Best, Steve/A-7531-2012; Foglio, mary A./B-9149-2012; Heath, Simon C/J-4138-2012	Gut, Ivo/0000-0001-7219-632X; Foglio, mary A./0000-0001-7715-4452; Heath, Simon C/0000-0002-9550-0897; Menzel, Stephan/0000-0002-1590-9108	Medical Research Council [G0000111] Funding Source: Medline; Wellcome Trust Funding Source: Medline; MRC [G0000111] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Bank A, 2006, BLOOD, V107, P435, DOI 10.1182/blood-2005-05-2113; Craig JE, 1996, NAT GENET, V12, P58, DOI 10.1038/ng0196-58; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Garner C, 2000, BLOOD, V95, P342; Garner C, 2000, GENESCREEN, V1, P9, DOI DOI 10.1046/J.1466-9218.2000.00001.X; Hardison R., 2001, DISORDERS HEMOGLOBIN, P95, DOI 10.1017/CBO9780511596582; Liu PT, 2003, NAT IMMUNOL, V4, P525, DOI 10.1038/ni925; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Senawong T, 2005, ARCH BIOCHEM BIOPHYS, V434, P316, DOI 10.1016/j.abb.2004.10.028; Spector TD, 2002, TWIN RES, V5, P440, DOI 10.1375/twin.5.5.440; Tenesa A, 2005, BEHAV GENET, V35, P219, DOI 10.1007/s10519-004-0811-5; Thein SL, 1998, HEMOGLOBIN, V22, P401, DOI 10.3109/03630269809071538; Thein SL, 2007, P NATL ACAD SCI USA, V104, P11346, DOI 10.1073/pnas.0611393104	15	384	408	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2007	39	10					1197	1199		10.1038/ng2108	http://dx.doi.org/10.1038/ng2108			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17767159				2022-12-27	WOS:000249737400013
J	Brems, H; Chmara, M; Sahbatou, M; Denayer, E; Taniguchi, K; Kato, R; Somers, R; Messiaen, L; De Schepper, S; Fryns, JP; Cools, J; Marynen, P; Thomas, G; Yoshimura, A; Legius, E				Brems, Hilde; Chmara, Magdalena; Sahbatou, Mourad; Denayer, Ellen; Taniguchi, Koji; Kato, Reiko; Somers, Riet; Messiaen, Ludwine; De Schepper, Sofie; Fryns, Jean-Pierre; Cools, Jan; Marynen, Peter; Thomas, Gilles; Yoshimura, Akihiko; Legius, Eric			Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype	NATURE GENETICS			English	Article							SPROUTY DOMAIN; SUPPRESSOR; PTPN11; GENE; IDENTIFICATION; PATHWAY; PROTEIN; TYPE-1	We report germline loss- of- function mutations in SPRED1 in a newly identified autosomal dominant human disorder. SPRED1 is a member of the SPROUTY/ SPRED family(1) of proteins that act as negative regulators of RAS- RAF interaction and mitogen-activated protein kinase ( MAPK) signaling(2). The clinical features of the reported disorder resemble those of neurofibromatosis type 1 and consist of multiple cafe - au- lait spots, axillary freckling and macrocephaly. Melanocytes from a cafe - au- lait spot showed, in addition to the germline SPRED1 mutation, an acquired somatic mutation in the wild- type SPRED1 allele, indicating that complete SPRED1 inactivation is needed to generate a cafe - au- lait spot in this syndrome. This disorder is yet another member of the recently characterized group of phenotypically overlapping syndromes caused by mutations in the genes encoding key components of the RAS- MAPK pathway(3,4). To our knowledge, this is the first report of mutations in the SPRY ( SPROUTY)/ SPRED family of genes in human disease.	Catholic Univ Louvain, Dept Human Genet, B-3000 Louvain, Belgium; Med Univ Gdansk, Dept Biol & Genet, Gdansk, Poland; CEPH, Fdn Jean Dausset, F-75010 Paris, France; Kyushu Univ, Med Inst Bioregulat, Div Mol & Cellular Immunol, Fukuoka 8128582, Japan; VIB, Flanders Inst Biotechnol, Dept Mol & Dev Genet, Human Genome Lab, Louvain, Belgium; Univ Alabama Birmingham, Dept Genet, Med Genom Lab, Birmingham, AL USA; Ghent Univ Hosp, Dept Dermatol, Ghent, Belgium; NCI, Dept Canc Epidemiol & Genet, Bethesda, MD 20892 USA	Universite Catholique Louvain; Fahrenheit Universities; Medical University Gdansk; Foundation Jean Dausset-CEPH; Kyushu University; Flanders Institute for Biotechnology (VIB); University of Alabama System; University of Alabama Birmingham; Ghent University; Ghent University Hospital; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Legius, E (corresponding author), Catholic Univ Louvain, Dept Human Genet, B-3000 Louvain, Belgium.	Eric.Legius@uz.kuleuven.be	Yoshimura, Akihiko/K-5515-2013; Brems, Hilde/AAN-4075-2020; Legius, Eric/H-1735-2011	Cools, Jan/0000-0001-6626-5843; Chmara, Magdalena/0000-0003-1430-8367				[Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Aoki Y, 2005, NAT GENET, V37, P1038, DOI 10.1038/ng1641; Bentires-Alj M, 2006, NAT MED, V12, P283, DOI 10.1038/nm0306-283; Bundschu K, 2006, J BIOL CHEM, V281, P36477, DOI 10.1074/jbc.R600023200; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; De Schepper S, 2006, ARCH DERMATOL RES, V297, P439, DOI 10.1007/s00403-006-0644-6; Digilio MC, 2002, AM J HUM GENET, V71, P389, DOI 10.1086/341528; Engelhardt CM, 2004, HISTOCHEM CELL BIOL, V122, P527, DOI 10.1007/s00418-004-0725-6; GILLE H, 1995, EMBO J, V14, P951, DOI 10.1002/j.1460-2075.1995.tb07076.x; Inoue H, 2005, J EXP MED, V201, P73, DOI 10.1084/jem.20040616; King JAJ, 2005, BIOCHEM J, V388, P445, DOI 10.1042/BJ20041284; Legius E, 2002, J MED GENET, V39, P571, DOI 10.1136/jmg.39.8.571; LEGIUS E, 1993, NAT GENET, V3, P122, DOI 10.1038/ng0293-122; Maertens O, 2007, AM J HUM GENET, V81, P243, DOI 10.1086/519562; Messiaen LM, 2000, HUM MUTAT, V15, P541, DOI 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.3.CO;2-E; Miyoshi K, 2004, ONCOGENE, V23, P5567, DOI 10.1038/sj.onc.1207759; NILHORI T, 2006, NAT GENET, V38, P294; Roberts AE, 2007, NAT GENET, V39, P70, DOI 10.1038/ng1926; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Schubbert S, 2006, NAT GENET, V38, P331, DOI 10.1038/ng1748; Shannon K, 2007, NAT GENET, V39, P8, DOI 10.1038/ng0107-8; Taniguchi K, 2007, MOL CELL BIOL, V27, P4541, DOI 10.1128/MCB.01600-06; Tartaglia M, 2001, NAT GENET, V29, P465, DOI 10.1038/ng772; Tartaglia M, 2007, NAT GENET, V39, P75, DOI 10.1038/ng1939; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082	26	286	304	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1120	1126		10.1038/ng2113	http://dx.doi.org/10.1038/ng2113			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17704776				2022-12-27	WOS:000249122400022
J	Srinivas, BP; Woo, J; Leong, WY; Roy, S				Srinivas, Bhylahalli P.; Woo, Jennifer; Leong, Wan Ying; Roy, Sudipto			A conserved molecular pathway mediates myoblast fusion in insects and vertebrates	NATURE GENETICS			English	Article							IMMUNOGLOBULIN SUPERFAMILY; MYOSIN EXPRESSION; SKELETAL-MUSCLE; IN-VIVO; ZEBRAFISH; CELLS; DROSOPHILA; HEDGEHOG; SLOW; GENE	Skeletal muscles arise by fusion of precursor cells, myoblasts, into multinucleated fibers. In vertebrates, mechanisms controlling this essential step in myogenesis remain poorly understood1,2. Here we provide evidence that Kirrel, a homolog of receptor proteins that organize myoblast fusion in Drosophila melanogaster(3,4), is necessary for muscle precursor fusion in zebrafish. Within developing somites, Kirrel expression localized to membranes of fusion-competent myoblasts of the fast-twitch lineage. Unlike wild-type myoblasts that form spatially arrayed syncytial ( multinucleated) fast myofibers, those deficient in Kirrel showed a significant reduction in fusion capacity. Inhibition of Rac, a GTPase and the most downstream intracellular transducer of the fusion signal in D. melanogaster(1,5,6), also compromised fast-muscle precursor fusion in zebrafish. However, unlike in D. melanogaster(6), constitutive Rac activation in zebrafish led to hyperfused giant syncytia, highlighting an entirely new function for this protein in zebrafish for gating the number and polarity of fusion events. These findings uncover a substantial degree of evolutionary conservation in the genetic regulation of myoblast fusion.	Inst Mol & Cell Biol, Singapore 138673, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Roy, S (corresponding author), Inst Mol & Cell Biol, Proteos 61 Biopolis Dr, Singapore 138673, Singapore.	sudipto@imcb.a-star.edu.sg						Baxendale S, 2004, NAT GENET, V36, P88, DOI 10.1038/ng1280; Blagden CS, 1997, GENE DEV, V11, P2163, DOI 10.1101/gad.11.17.2163; Bour BA, 2000, GENE DEV, V14, P1498; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Chen EH, 2004, TRENDS CELL BIOL, V14, P452, DOI 10.1016/j.tcb.2004.07.008; Chen EH, 2003, CELL, V114, P751, DOI 10.1016/S0092-8674(03)00720-7; CROW MT, 1986, DEV BIOL, V113, P238, DOI 10.1016/0012-1606(86)90126-0; DANGOOR M, 1990, J MUSCLE RES CELL M, V11, P216, DOI 10.1007/BF01843575; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Du SJ, 1997, J CELL BIOL, V139, P145, DOI 10.1083/jcb.139.1.145; Du SJ, 2003, COMP BIOCHEM PHYS B, V134, P123, DOI 10.1016/S1096-4959(02)00194-X; Galletta BJ, 2004, MECH DEVELOP, V121, P1455, DOI 10.1016/j.mod.2004.08.001; GARDAHAUT MF, 1992, DEVELOPMENT, V115, P1121; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Horsley V, 2004, CELLS TISSUES ORGANS, V176, P67, DOI 10.1159/000075028; Koprunner M, 2001, GENE DEV, V15, P2877; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Mann CJ, 2006, GENE EXPR PATTERNS, V6, P952, DOI 10.1016/j.modgep.2006.03.010; Pauls S, 2001, DEV GENES EVOL, V211, P603, DOI 10.1007/s00427-001-0196-x; Roy S, 2001, GENE DEV, V15, P1563, DOI 10.1101/gad.195801; Ruiz-Gomez M, 2000, CELL, V102, P189, DOI 10.1016/S0092-8674(00)00024-6; Sellin L, 2002, FASEB J, V16, P115, DOI 10.1096/fj.02-0242fje; Strunkelnberg M, 2001, DEVELOPMENT, V128, P4229; Sun C, 2003, GENOMICS, V82, P130, DOI 10.1016/S0888-7543(03)00110-1; Taylor MV, 2002, CURR BIOL, V12, pR224, DOI 10.1016/S0960-9822(02)00757-1; Ueno H, 2003, NAT IMMUNOL, V4, P457, DOI 10.1038/ni916; Weinberg ES, 1996, DEVELOPMENT, V122, P271	27	107	109	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2007	39	6					781	786		10.1038/ng2055	http://dx.doi.org/10.1038/ng2055			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17529975				2022-12-27	WOS:000246859100023
J	Khor, CC; Chapman, SJ; Vannberg, FO; Dunne, A; Murphy, C; Ling, EY; Frodsham, AJ; Walley, AJ; Kyrieleis, O; Khan, A; Aucan, C; Segal, S; Moore, CE; Knox, K; Campbell, SJ; Lienhardt, C; Scott, A; Aaby, P; Sow, OY; Grignani, RT; Sillah, J; Sirugo, G; Peshu, N; Williams, TN; Maitland, K; Davies, RJO; Kwiatkowski, DP; Day, NP; Yala, D; Crook, DW; Marsh, K; Berkley, JA; O'Neill, LAJ; Hill, AVS				Khor, Chiea C.; Chapman, Stephen J.; Vannberg, Fredrik O.; Dunne, Aisling; Murphy, Caroline; Ling, Edmund Y.; Frodsham, Angela J.; Walley, Andrew J.; Kyrieleis, Otto; Khan, Amir; Aucan, Christophe; Segal, Shelley; Moore, Catrin E.; Knox, Kyle; Campbell, Sarah J.; Lienhardt, Christian; Scott, Anthony; Aaby, Peter; Sow, Oumou Y.; Grignani, Robert T.; Sillah, Jackson; Sirugo, Giorgio; Peshu, Nobert; Williams, Thomas N.; Maitland, Kathryn; Davies, Robert J. O.; Kwiatkowski, Dominic P.; Day, Nicholas P.; Yala, Djamel; Crook, Derrick W.; Marsh, Kevin; Berkley, James A.; O'Neill, Luke A. J.; Hill, Adrian V. S.			A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis	NATURE GENETICS			English	Article							TOLL-LIKE RECEPTORS; TLR4; GENE; LIPOPOLYSACCHARIDE; POLYMORPHISM; INDUCTION; MOLECULE; TIRAP; MICE; CD36	Toll-like receptors (TLRs) and members of their signaling pathway are important in the initiation of the innate immune response to a wide variety of pathogens(1-3). The adaptor protein Mal (also known as TIRAP), encoded by TIRAP (MIM 606252), mediates downstream signaling of TLR2 and TLR4 (refs. 4-6). We report a case-control study of 6,106 individuals from the UK, Vietnam and several African countries with invasive pneumococcal disease, bacteremia, malaria and tuberculosis. We genotyped 33 SNPs, including rs8177374, which encodes a leucine substitution at Ser180 of Mal. We found that heterozygous carriage of this variant associated independently with all four infectious diseases in the different study populations. Combining the study groups, we found substantial support for a protective effect of S180L heterozygosity against these infectious diseases (N = 6,106; overall P = 9.6 x 10(-8)). We found that the Mal S180L variant attenuated TLR2 signal transduction.	Churchill Hosp, Osler Chest Unit, Oxford, England; Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland; John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England; John Radcliffe Hosp, Dept Microbiol, Oxford OX3 9DU, England; Inst Rech Dev, Dakar, Senegal; Kilifi District Hosp, Ctr Geog Med Res, Kenya Med Res Inst, Wellcome Trust Programme, Kilifi, Kenya; Bandim Hlth Project, Bissau, Guinea Bissau; Univ Ignace Deen, Serv Pneumophtisol, Conarky 634, Guinea; MRC Labs, Fajara, Gambia; Cho Quan Hosp, Ctr Trop Dis, Ho Chi Minh City, Vietnam; Inst Pasteur, Serv TB, Algiers, Algeria; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England	University of Oxford; Trinity College Dublin; University of Oxford; University of Oxford; Institut de Recherche pour le Developpement (IRD); Kenya Medical Research Institute; MRC Laboratory Molecular Biology; University of Oxford; Wellcome Centre for Human Genetics	Hill, AVS (corresponding author), Hammersmith Hosp, Imperial Coll London, Sect Genom Med, Du Cane Rd, London W12 0NN, England.	laoneill@tcd.ie; adrian.hill@well.ox.ac.uk	Walley, Andrew J/D-2573-2009; HILL, Adrian V>S>/C-1306-2008; Sirugo, Giorgio/L-1628-2016; Ling, Edmund/B-7923-2010; Sirugo, Giorgio/N-9056-2019; Lienhardt, Christian/AAU-4969-2021; Moore, Catrin/K-1980-2017	Walley, Andrew J/0000-0001-7707-7549; Lienhardt, Christian/0000-0003-0233-893X; Moore, Catrin/0000-0002-8639-9846; Maitland, Kathryn/0000-0002-0007-0645; Pickett, Sarah/0000-0002-1242-2927; Khor, Chiea Chuen/0000-0002-1128-4729; Talbot, Angela/0000-0002-0386-8070; O'Neill, Luke/0000-0002-4333-2748; Aaby, Peter/0000-0001-8331-1389; Khan, Amir/0000-0003-1176-6952; Berkley, James/0000-0002-1236-849X; dunne, aisling/0000-0002-2342-9518; Kwiatkowski, Dominic/0000-0002-5023-0176	MRC [G0200454, MC_U122888468, G19/9] Funding Source: UKRI; Medical Research Council [G0200454, G19/9, MC_U122888468] Funding Source: Medline; Wellcome Trust [081835, 076934, 061089, 077092] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aitman TJ, 2000, NATURE, V405, P1015, DOI 10.1038/35016636; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Annane D, 2005, LANCET, V365, P63, DOI 10.1016/S0140-6736(04)17667-8; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Clatworthy MR, 2004, J EXP MED, V199, P717, DOI 10.1084/jem.20032197; Clayton D, 1999, AM J HUM GENET, V65, P1170, DOI 10.1086/302577; CUNDELL DR, 1995, NATURE, V377, P435, DOI 10.1038/377435a0; Dean M, 2002, ANNU REV GENOM HUM G, V3, P263, DOI 10.1146/annurev.genom.3.022502.103149; Doffinger R, 2001, NAT GENET, V27, P277, DOI 10.1038/85837; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Hoshino K, 1999, J IMMUNOL, V162, P3749; Jurinke Christian, 2002, Adv Biochem Eng Biotechnol, V77, P57; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Thoma-Uszynski S, 2001, SCIENCE, V291, P1544, DOI 10.1126/science.291.5508.1544; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182	28	349	365	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2007	39	4					523	528		10.1038/ng1976	http://dx.doi.org/10.1038/ng1976			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17322885	Green Accepted, Green Submitted			2022-12-27	WOS:000245271200023
J	Lim, HN; van Oudenaarden, A				Lim, Han N.; van Oudenaarden, Alexander			A multistep epigenetic switch enables the stable inheritance of DNA methylation states	NATURE GENETICS			English	Article							OUTER-MEMBRANE PROTEIN; ESCHERICHIA-COLI K-12; DEPENDENT PHASE VARIATION; MU MOM OPERON; ADENINE METHYLATION; COLONY MORPHOLOGY; GENE-EXPRESSION; DAM; OXYR; MECHANISM	In many prokaryotes and eukaryotes, DNA methylation at cis-regulatory sequences determines whether gene expression is on or off. Stable inheritance of these expression states is required in bacterial pathogenesis, cancer and developmental pathways(1,2). Here we delineate the factors that control the stability of these states by using the agn43 gene in Escherichia coli as a model system. Systematic disruption of this system shows that a functional switch requires the presence of several, rarely occupied, intermediate states that separate the 'on' and 'off' states. Cells that leave the on and off state enter different intermediate states, where there is a strong bias that drives cells back to their original state. The intermediate states therefore act as buffers that prevent back and forth switching. This mechanism of generating multiple states is an alternative to feedback regulation(3-5), and its general principle should be applicable to the analysis of other epigenetic switches and the design of synthetic circuits.	MIT, Dept Phys, Cambridge, MA 02139 USA; Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley	Lim, HN (corresponding author), MIT, Dept Phys, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	hanlim@berkeley.edu	van Oudenaarden, Alexander/AAA-1705-2019		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077183] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01-GM077183] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CAMPBELL JL, 1988, GENE, V74, P189, DOI 10.1016/0378-1119(88)90283-1; Correnti J, 2002, MOL MICROBIOL, V44, P521, DOI 10.1046/j.1365-2958.2002.02918.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Geanacopoulos M, 2001, NAT STRUCT BIOL, V8, P432, DOI 10.1038/87595; Gerdes SY, 2003, J BACTERIOL, V185, P5673, DOI 10.1128/JB.185.19.5673-5684.2003; Haagmans W, 2000, MOL MICROBIOL, V35, P877, DOI 10.1046/j.1365-2958.2000.01762.x; Hasman H, 2000, J BACTERIOL, V182, P1089, DOI 10.1128/JB.182.4.1089-1095.2000; Hattman S, 1999, PHARMACOL THERAPEUT, V84, P367, DOI 10.1016/S0163-7258(99)00042-X; Henderson IR, 1999, J BACTERIOL, V181, P2132, DOI 10.1128/JB.181.7.2132-2141.1999; Henderson IR, 1997, ADV EXP MED BIOL, V412, P349; Henderson IR, 1997, FEMS MICROBIOL LETT, V149, P115, DOI 10.1016/S0378-1097(97)00065-7; Hernday AD, 2003, MOL CELL, V12, P947, DOI 10.1016/S1097-2765(03)00383-6; HOPFIELD JJ, 1974, P NATL ACAD SCI USA, V71, P4135, DOI 10.1073/pnas.71.10.4135; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; KLOSE RJ, 2006, TRENDS BIOCH SCI; KULLIK I, 1995, J BACTERIOL, V177, P1275, DOI 10.1128/jb.177.5.1275-1284.1995; Low DA, 2001, INFECT IMMUN, V69, P7197, DOI 10.1128/IAI.69.12.7197-7204.2001; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Oehler S, 2006, NUCLEIC ACIDS RES, V34, P606, DOI 10.1093/nar/gkj453; OWEN P, 1987, J BACTERIOL, V169, P3770, DOI 10.1128/jb.169.8.3770-3777.1987; Owen P, 1996, FEMS IMMUNOL MED MIC, V16, P63; Stancheva I, 1999, EMBO J, V18, P6542, DOI 10.1093/emboj/18.22.6542; Sun WY, 1996, NUCLEIC ACIDS RES, V24, P4042, DOI 10.1093/nar/24.20.4042; Urig S, 2002, J MOL BIOL, V319, P1085, DOI 10.1016/S0022-2836(02)00371-6; Waldron DE, 2002, MOL MICROBIOL, V44, P509, DOI 10.1046/j.1365-2958.2002.02905.x; Wallecha A, 2003, J BACTERIOL, V185, P2203, DOI 10.1128/JB.185.7.2203-2209.2003; Wallecha A, 2002, J BACTERIOL, V184, P3338, DOI 10.1128/JB.184.12.3338-3347.2002; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	30	76	78	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2007	39	2					269	275		10.1038/ng1956	http://dx.doi.org/10.1038/ng1956			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17220888				2022-12-27	WOS:000244063900028
J	Schmahl, J; Raymond, CS; Soriano, P				Schmahl, Jennifer; Raymond, Christopher S.; Soriano, Philippe			PDGF signaling specificity is mediated through multiple immediate early genes	NATURE GENETICS			English	Article							CELL-DEVELOPMENT; RECEPTOR; IDENTIFICATION; EXPRESSION; ALPHA; PATHWAYS; CLONING; ROLES; MOUSE; MICE	Growth factor signaling leads to the induction or repression of immediate early genes, but how these genes act collectively as effectors of downstream processes remains unresolved. We have used gene trap-coupled microarray analysis to identify and mutate multiple platelet-derived growth factor (PDGF) intermediate early genes in mice. Mutations in these genes lead to a high frequency of phenotypes that affect the same cell types and processes as those controlled by the PDGF pathway. We conclude that these genes form a network that controls specific processes downstream of PDGF signaling.	Fred Hutchinson Canc Res Ctr, Program Dev Biol, Seattle, WA 98109 USA; Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center; Fred Hutchinson Cancer Center	Soriano, P (corresponding author), Fred Hutchinson Canc Res Ctr, Program Dev Biol, 1100 Fairview Ave N, Seattle, WA 98109 USA.	psoriano@fhcrc.org	Soriano, Philippe M/E-5797-2015	Soriano, Philippe M/0000-0002-0427-926X; Raymond, Christopher/0000-0003-1128-8524	NCI NIH HHS [CA09657] Funding Source: Medline; NICHD NIH HHS [HD24875, R01 HD024875, R37 HD025326] Funding Source: Medline; NIGMS NIH HHS [GM071158] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD024875] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM071158] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Bertotti A, 2003, TRENDS BIOCHEM SCI, V28, P527, DOI 10.1016/j.tibs.2003.09.001; Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069; Bodnar JS, 2002, NAT GENET, V30, P110, DOI 10.1038/ng811; Chen WSV, 2004, NAT GENET, V36, P304, DOI 10.1038/ng1306; El Mezgueldi M, 2002, J BIOL CHEM, V277, P21514, DOI 10.1074/jbc.M200713200; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Freeman M, 1996, CELL, V87, P651, DOI 10.1016/S0092-8674(00)81385-9; Goutebroze L, 2000, MOL CELL BIOL, V20, P1699, DOI 10.1128/MCB.20.5.1699-1712.2000; GRUNEBERG H, 1960, GENET RES, V1, P69, DOI 10.1017/S0016672300000094; Hellstrom M, 2001, J CELL BIOL, V153, P543, DOI 10.1083/jcb.153.3.543; Hoch RV, 2006, DEVELOPMENT, V133, P663, DOI 10.1242/dev.02242; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; Ishiguro H, 2001, ONCOGENE, V20, P5062, DOI 10.1038/sj.onc.1204603; Klinghoffer RA, 2002, DEV CELL, V2, P103, DOI 10.1016/S1534-5807(01)00103-4; Klinghoffer RA, 2001, MOL CELL, V7, P343, DOI 10.1016/S1097-2765(01)00182-4; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; Lemmon MA, 2002, FEBS LETT, V513, P71, DOI 10.1016/S0014-5793(01)03243-4; Lindahl P, 1998, DEVELOPMENT, V125, P3313; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Pawson T, 1999, CELL, V97, P675, DOI 10.1016/S0092-8674(00)80779-5; ROLLINS BJ, 1989, ADV CANCER RES, V53, P1; Simon MA, 2000, CELL, V103, P13, DOI 10.1016/S0092-8674(00)00100-8; Socolovsky M, 1998, BLOOD, V92, P1491, DOI 10.1182/blood.V92.5.1491.417k40_1491_1496; Soriano P, 1997, DEVELOPMENT, V124, P2691; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; Takemoto M, 2006, EMBO J, V25, P1160, DOI 10.1038/sj.emboj.7601014; Tallquist MD, 2003, DEVELOPMENT, V130, P507, DOI 10.1242/dev.00241; Zhou JH, 1998, BIOCHEM BIOPH RES CO, V242, P502, DOI 10.1006/bbrc.1997.7993	32	144	154	2	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JAN	2007	39	1					52	60		10.1038/ng1922	http://dx.doi.org/10.1038/ng1922			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	17143286				2022-12-27	WOS:000243136500017
J	Richardson, RJ; Dixon, J; Malhotra, S; Hardman, MJ; Knowles, L; Boot-Handford, RP; Shore, P; Whitmarsh, A; Dixon, MJ				Richardson, Rebecca J.; Dixon, Jill; Malhotra, Saimon; Hardman, Matthew J.; Knowles, Lynnette; Boot-Handford, Ray P.; Shore, Paul; Whitmarsh, Alan; Dixon, Michael J.			Irf6 is a key determinant of the keratinocyte proliferation-differentiation switch	NATURE GENETICS			English	Article							POPLITEAL PTERYGIUM SYNDROME; REPEATED-EPILATION; EPIDERMAL MORPHOGENESIS; MICE LACKING; IKK-ALPHA; SKIN; P63; 14-3-3-SIGMA; MUTATION; KINASE	The epidermis is a highly organized structure, the integrity of which is central to the protection of an organism(1). Development and subsequent maintenance of this tissue depends critically on the intricate balance between proliferation and differentiation of a resident stem cell population(1,2); however, the signals controlling the proliferation-differentiation switch in vivo remain elusive(3). Here, we show that mice carrying a homozygous missense mutation in interferon regulatory factor 6 (Irf6), the homolog of the gene mutated in the human congenital disorders Van der Woude syndrome and popliteal pterygium syndrome, have a hyperproliferative epidermis that fails to undergo terminal differentiation, resulting in soft tissue fusions. We further demonstrate that mice that are compound heterozygotes for mutations in Irf6 and the gene encoding the cell cycle regulator protein stratifin (Sfn; also known as 14-3-3 sigma) show similar defects of keratinizing epithelia. Our results indicate that Irf6 is a key determinant of the keratinocyte proliferation-differentiation switch and that Irf6 and Sfn interact genetically in this process.	Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; Univ Manchester, Sch Dent, Manchester M13 9PT, Lancs, England	University of Manchester; University of Manchester	Dixon, MJ (corresponding author), Univ Manchester, Fac Life Sci, Oxford Rd, Manchester M13 9PT, Lancs, England.	mike.dixon@manchester.ac.uk	Hardman, Matthew/ABE-4936-2020; Richardson, Rebecca/L-5198-2019	Richardson, Rebecca/0000-0002-4701-8713; Hardman, Matthew/0000-0002-6423-5074; Shore, Paul/0000-0002-1832-5976; Whitmarsh, Alan/0000-0003-1184-6610; Boot-Handford, Raymond/0000-0002-6167-8419	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P50DE016215] Funding Source: NIH RePORTER; MRC [G0400264] Funding Source: UKRI; Medical Research Council [G0400264] Funding Source: Medline; NIDCR NIH HHS [P50-DE016215] Funding Source: Medline; Wellcome Trust [066173, 064732] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Wellcome Trust(Wellcome Trust)		Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Dixon J, 2006, P NATL ACAD SCI USA, V103, P13403, DOI 10.1073/pnas.0603730103; Dotto GP, 1999, CRIT REV ORAL BIOL M, V10, P442; Escalante CR, 1998, NATURE, V391, P103, DOI 10.1038/34224; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Ghassibe M, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.009274; GUENET JL, 1979, J HERED, V70, P90, DOI 10.1093/oxfordjournals.jhered.a109223; Hardman MJ, 1998, DEVELOPMENT, V125, P1541; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; Herron BJ, 2005, NAT GENET, V37, P1210, DOI 10.1038/ng1652; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; INGRAHAM CR, 2006, ABNORMAL SKIN LIMB C, DOI DOI 10.1038/NG1903; Inman CK, 2005, MOL CELL BIOL, V25, P3182, DOI 10.1128/MCB.25.8.3182-3193.2005; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Lees MM, 1999, J MED GENET, V36, P888; Li QT, 2005, P NATL ACAD SCI USA, V102, P15977, DOI 10.1073/pnas.0508310102; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mooney LM, 2004, J BIOL CHEM, V279, P11843, DOI 10.1074/jbc.M311841200; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Sil AK, 2004, NATURE, V428, P660, DOI 10.1038/nature02421; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; WALLIN J, 1994, DEVELOPMENT, V120, P1109; Watt FM, 2001, CURR OPIN GENET DEV, V11, P410, DOI 10.1016/S0959-437X(00)00211-2; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539	28	232	240	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2006	38	11					1329	1334		10.1038/ng1894	http://dx.doi.org/10.1038/ng1894			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	099KH	17041603				2022-12-27	WOS:000241592700023
J	Unoki, H; Takahashi, A; Kawaguchi, T; Hara, K; Horikoshi, M; Andersen, G; Ng, DPK; Holmkvist, J; Borch-Johnsen, K; Jorgensen, T; Sandbaek, A; Lauritzen, T; Hansen, T; Nurbaya, S; Tsunoda, T; Kubo, M; Babazono, T; Hirose, H; Hayashi, M; Iwamoto, Y; Kashiwagi, A; Kaku, K; Kawamori, R; Tai, ES; Pedersen, O; Kamatani, N; Kadowaki, T; Kikkawa, R; Nakamura, Y; Maeda, S				Unoki, Hiroyuki; Takahashi, Atsushi; Kawaguchi, Takahisa; Hara, Kazuo; Horikoshi, Momoko; Andersen, Gitte; Ng, Daniel P. K.; Holmkvist, Johan; Borch-Johnsen, Knut; Jorgensen, Torben; Sandbaek, Annelli; Lauritzen, Torsten; Hansen, Torben; Nurbaya, Siti; Tsunoda, Tatsuhiko; Kubo, Michiaki; Babazono, Tetsuya; Hirose, Hiroshi; Hayashi, Matsuhiko; Iwamoto, Yasuhiko; Kashiwagi, Atsunori; Kaku, Kohei; Kawamori, Ryuzo; Tai, E. Shyong; Pedersen, Oluf; Kamatani, Naoyuki; Kadowaki, Takashi; Kikkawa, Ryuichi; Nakamura, Yusuke; Maeda, Shiro			SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TARGETED DISRUPTION; RISK LOCI; INTERVENTION; REPLICATION; JERVELL; VARIANT	We conducted a genome-wide association study using 207,097 SNP markers in Japanese individuals with type 2 diabetes and unrelated controls, and identified KCNQ1 (potassium voltage-gated channel, KQT-like subfamily, member 1) to be a strong candidate for conferring susceptibility to type 2 diabetes. We detected consistent association of a SNP in KCNQ1 (rs2283228) with the disease in several independent case-control studies (additive model P = 3.1 x 10(-12); OR = 1.26, 95% CI = 1.18-1.34). Several other SNPs in the same linkage disequilibrium (LD) block were strongly associated with type 2 diabetes (additive model: rs2237895, P = 7.3 x 10(-9); OR = 1.32, 95% CI = 1.20-1.45, rs2237897, P = 6.8 x 10(-13); OR = 1.41, 95% CI = 1.29-1.55). The association of these SNPs with type 2 diabetes was replicated in samples from Singaporean (additive model: rs2237895, P = 8.5 x 10(-3); OR = 1.14, rs2237897, P = 2.4 x 10(-4); OR = 1.22) and Danish populations (additive model: rs2237895, P = 3.7 x 10(-11); OR = 1.24, rs2237897, P = 1.2 x 10(-4); OR = 1.36).	[Unoki, Hiroyuki; Maeda, Shiro] RIKEN, Lab Endocrinol & Metab, Yokohama, Kanagawa 2300045, Japan; [Takahashi, Atsushi; Kamatani, Naoyuki] RIKEN, Lab Stat Anal, Yokohama, Kanagawa 2300045, Japan; [Kawaguchi, Takahisa; Tsunoda, Tatsuhiko] RIKEN, Lab Med Informat, Ctr Gen Med, Yokohama, Kanagawa 2300045, Japan; [Hara, Kazuo; Horikoshi, Momoko; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Metab Dis, Tokyo 1138655, Japan; [Andersen, Gitte; Holmkvist, Johan; Borch-Johnsen, Knut; Pedersen, Oluf] Steno Diabet Ctr, DK-2820 Copenhagen, Denmark; [Ng, Daniel P. K.; Nurbaya, Siti] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Community Occupat & Family Med, Singapore 117597, Singapore; [Borch-Johnsen, Knut; Jorgensen, Torben] Glostrup Univ Hosp, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; [Borch-Johnsen, Knut] Univ Aarhus, Fac Hlth Sci, DK-8000 Aarhus, Denmark; [Sandbaek, Annelli; Lauritzen, Torsten] Univ Aarhus, Dept Gen Practice, DK-8000 Aarhus, Denmark; [Kubo, Michiaki] RIKEN, Ctr Genom Med, Lab Genotyping Dev, Yokohama, Kanagawa 2300045, Japan; [Babazono, Tetsuya; Iwamoto, Yasuhiko] Tokyo Womens Med Univ, Ctr Diabet, Tokyo 1628666, Japan; [Hirose, Hiroshi] Keio Univ, Sch Med, Ctr Hlth, Tokyo 1608582, Japan; [Hayashi, Matsuhiko] Keio Univ, Sch Med, Dept Internal Med, Tokyo 1608582, Japan; [Kashiwagi, Atsunori; Kikkawa, Ryuichi] Shiga Univ Med Sci, Dept Med, Shiga 5202192, Japan; [Kaku, Kohei] Kawasaki Med Sch, Dept Internal Med, Div Endocrinol & Metab, Okayama 7010192, Japan; [Kawamori, Ryuzo] Juntendo Univ, Sch Med, Dept Med Metab & Endocrinol, Tokyo 1138421, Japan; [Tai, E. Shyong] Singapore Gen Hosp, Dept Endocrinol, Singapore 169608, Singapore; [Nakamura, Yusuke] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo 1088639, Japan	RIKEN; RIKEN; RIKEN; University of Tokyo; Steno Diabetes Center; National University of Singapore; University of Copenhagen; Aarhus University; Aarhus University; RIKEN; Tokyo Women's Medical University; Keio University; Keio University; Shiga University of Medical Science; Kawasaki Medical School; Juntendo University; Singapore General Hospital; University of Tokyo	Maeda, S (corresponding author), RIKEN, Lab Endocrinol & Metab, Yokohama, Kanagawa 2300045, Japan.	smaeda@src.riken.jp	Kashiwagi, Atsunori/H-8712-2019; Kubo, Michiaki/N-7947-2015; Horikoshi, Momoko/AAF-9034-2019; Tsunoda, Tatsuhiko/K-2061-2014; Unoki-Kubota, Hiroyuki/H-7268-2019; Pedersen, Oluf/Z-1731-2019; Pedersen, Oluf/AAG-8015-2020; Tai, E Shyong/J-9831-2013; Jørgensen, Torben/Z-1335-2018; Hirose, Hiroshi/F-8556-2014; Hayashi, Matsuhiko/J-4748-2013	Tsunoda, Tatsuhiko/0000-0002-5439-7918; Unoki-Kubota, Hiroyuki/0000-0003-4827-8805; Pedersen, Oluf/0000-0002-3321-3972; Hansen, Torben/0000-0001-8748-3831; Tai, E Shyong/0000-0003-2929-8966; Jorgensen, Torben/0000-0001-9453-2830	Ministry of Education, Culture, Sports, Science and Technology Japan; Lundbeck Foundation Centre of Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LUCAMP); European Union [LSHM-CT-2004-512013]; Danish Medical Research Council; National Medical Research Council [NMRC/1115/2007]	Ministry of Education, Culture, Sports, Science and Technology Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Lundbeck Foundation Centre of Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LUCAMP); European Union(European Commission); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all participating doctors and staff from collaborating institutes for providing DNA samples. We also thank the technical staff of the Laboratory for Endocrinology and Metabolism at the Center for Genomic Medicine for providing technical assistance. This work was partly supported by a grant from the Leading Project of Ministry of Education, Culture, Sports, Science and Technology Japan. The Danish study was supported by Lundbeck Foundation Centre of Applied Medical Genomics in Personalized Disease Prediction, Prevention and Care (LUCAMP), the European Union (EUGENE2, grant no. LSHM-CT-2004-512013) and the Danish Medical Research Council. Funding for Singapore arm of the study was supported by the National Medical Research Council (NMRC/1115/2007). We thank the staff of National Healthcare Group Polyclinics and National University of Singapore for their contributions towards the establishment of the Singapore Diabetes Cohort Study.	Casimiro MC, 2001, P NATL ACAD SCI USA, V98, P2526, DOI 10.1073/pnas.041398998; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Cutter J, 2001, B WORLD HEALTH ORGAN, V79, P908; DEVLIN B, 1995, GENOMICS, V29, P311, DOI 10.1006/geno.1995.9003; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Lauritzen T, 2000, INT J OBESITY, V24, pS6, DOI 10.1038/sj.ijo.0801420; Lee MP, 2000, J CLIN INVEST, V106, P1447, DOI 10.1172/JCI10897; Mori S, 2008, DIABETES, V57, P791, DOI 10.2337/db07-0979; Moss AJ, 2007, CIRCULATION, V115, P2481, DOI 10.1161/CIRCULATIONAHA.106.665406; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; O'Rahilly S, 2005, SCIENCE, V307, P370, DOI 10.1126/science.1104346; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Sparso T, 2008, DIABETOLOGIA, V51, P70, DOI 10.1007/s00125-007-0865-z; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Vallon V, 2005, P NATL ACAD SCI USA, V102, P17864, DOI 10.1073/pnas.0505860102; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	25	537	565	0	39	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2008	40	9					1098	1102		10.1038/ng.208	http://dx.doi.org/10.1038/ng.208			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	18711366				2022-12-27	WOS:000258761200023
J	Uppal, S; Diggle, CP; Carr, IM; Fishwick, CWG; Ahmed, M; Ibrahim, GH; Helliwell, PS; Latos-Bielenska, A; Phillips, SEV; Markham, AF; Bennett, CP; Bonthron, DT				Uppal, Sandeep; Diggle, Christine P.; Carr, Ian M.; Fishwick, Colin W. G.; Ahmed, Mushtaq; Ibrahim, Gamal H.; Helliwell, Philip S.; Latos-Bielenska, Anna; Phillips, Simon E. V.; Markham, Alexander F.; Bennett, Christopher P.; Bonthron, David T.			Mutations in 15-hydroxyprostaglandin dehydrogenase cause primary hypertrophic osteoarthropathy	NATURE GENETICS			English	Article							DUCTUS-ARTERIOSUS; LUNG-CANCER; PACHYDERMOPERIOSTOSIS; DISEASE; PROSTAGLANDINS; SUPPRESSOR	Digital clubbing, recognized by Hippocrates in the fifth century BC, is the outward hallmark of pulmonary hypertrophic osteoarthropathy, a clinical constellation that develops secondary to various acquired diseases, especially intrathoracic neoplasm(1). The pathogenesis of clubbing and hypertrophic osteoarthropathy has hitherto been poorly understood, but a clinically indistinguishable primary (idiopathic) form of hypertrophic osteoarthropathy (PHO) is recognized(2,3). This familial disorder can cause diagnostic confusion, as well as significant disability. By autozygosity methods, we mapped PHO to chromosome 4q33-q34 and identified mutations in HPGD, encoding 15-hydroxyprostaglandin dehydrogenase, the main enzyme of prostaglandin degradation. Homozygous individuals develop PHO secondary to chronically elevated prostaglandin E-2 levels. Heterozygous relatives also show milder biochemical and clinical manifestations. These findings not only suggest therapies for PHO, but also imply that clubbing secondary to other pathologies may be prostaglandin mediated. Testing for HPGD mutations and biochemical testing for HPGD deficiency in patients with unexplained clubbing might help to obviate extensive searches for occult pathology.	[Uppal, Sandeep; Diggle, Christine P.; Carr, Ian M.; Helliwell, Philip S.; Markham, Alexander F.; Bonthron, David T.] Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England; [Uppal, Sandeep] York Hosp, Dept Ear Nose & Throat, York YO31 8HE, N Yorkshire, England; [Fishwick, Colin W. G.] Univ Leeds, Sch Chem, Leeds LS2 9JT, W Yorkshire, England; [Ahmed, Mushtaq; Bennett, Christopher P.; Bonthron, David T.] St James Univ Hosp, Yorkshire Reg Genet Serv, Leeds LS9 7TF, W Yorkshire, England; [Ibrahim, Gamal H.] St Lukes Hosp, Dept Rheumatol, Bradford BD5 0NA, W Yorkshire, England; [Latos-Bielenska, Anna] Univ Med Sci, Dept Med Genet, PL-60352 Poznan, Poland; [Phillips, Simon E. V.] Univ Leeds, Inst Mol & Cellular Biol, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England	Saint James's University Hospital; University of Leeds; University of Leeds; Saint James's University Hospital; University of Leeds	Bonthron, DT (corresponding author), Univ Leeds, St Jamess Univ Hosp, Leeds Inst Mol Med, Beckett St, Leeds LS9 7TF, W Yorkshire, England.	d.t.bonthron@leeds.ac.uk	Ahmed, Mushtaq/GSN-9818-2022; Fishwick, Colin/A-8482-2010	Fishwick, Colin/0000-0003-1283-2181; Bonthron, David/0000-0001-8132-8179	Cancer Research UK Funding Source: Medline; Medical Research Council [G84/6495] Funding Source: Medline; MRC [G84/6495] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Backlund MG, 2005, J BIOL CHEM, V280, P3217, DOI 10.1074/jbc.M411221200; Carr IM, 2006, HUM MUTAT, V27, P1041, DOI 10.1002/humu.20383; Castori M, 2005, CLIN GENET, V68, P477, DOI 10.1111/j.1399-0004.2005.00533.x; CATTRAL MS, 1994, AM J MED, V97, P369, DOI 10.1016/0002-9343(94)90305-0; CHANG DGB, 1981, BIOCHEM BIOPH RES CO, V101, P898, DOI 10.1016/0006-291X(81)91834-9; Choa H, 2006, BIOORGAN MED CHEM, V14, P6486, DOI 10.1016/j.bmc.2006.06.030; Coggins KG, 2002, NAT MED, V8, P91, DOI 10.1038/nm0202-91; COURY C, 1960, BRIT J DIS CHEST, V54, P202, DOI 10.1016/S0007-0971(60)80001-0; CURRARINO G, 1961, AMER J ROENTGENOL RA, V85, P633; CURRIE AE, 1988, BRIT J DIS CHEST, V82, P382, DOI 10.1016/0007-0971(88)90092-7; Dabir T, 2007, CLIN DYSMORPHOL, V16, P197, DOI 10.1097/MCD.0b013e32801470d8; DICKINSON CJ, 1987, LANCET, V2, P1434; Ding YF, 2005, CARCINOGENESIS, V26, P65, DOI 10.1093/carcin/bgh277; FERREIRA SH, 1967, NATURE, V216, P868, DOI 10.1038/216868a0; FORSLUND T, 1987, SCAND J RHEUMATOL, V16, P371, DOI 10.3109/03009748709102510; JOSEPH B, 1985, RADIOLOGY, V154, P343, DOI 10.1148/radiology.154.2.3966121; JUNG A, 1975, H-S Z PHYSIOL CHEM, V356, P787, DOI 10.1515/bchm2.1975.356.s1.787; Latos-Bielenska A, 2007, EUR J PEDIATR, V166, P1237, DOI 10.1007/s00431-006-0407-6; LEMEN RJ, 1978, AM REV RESPIR DIS, V117, P639; MARTINEZLAVIN M, 1987, J RHEUMATOL, V14, P6; MARTINEZLAVIN M, 1993, PEDIATR CARDIOL, V14, P181, DOI 10.1007/BF00795652; Murphey LJ, 2004, ANAL BIOCHEM, V334, P266, DOI 10.1016/j.ab.2004.08.019; Myung SJ, 2006, P NATL ACAD SCI USA, V103, P12098, DOI 10.1073/pnas.0603235103; Pilbeam CC, 2004, EICOSANOIDS, P289; Sinha GP, 1997, BRIT J RHEUMATOL, V36, P1224; Tai HH, 2002, PROSTAG OTH LIPID M, V68-9, P483, DOI 10.1016/S0090-6980(02)00050-3; TOKUMOTO H, 1982, J BIOL CHEM, V257, P13576; Touraine A, 1935, PRESSE MED, V43, P1820; UEDA K, 1980, J PEDIATR-US, V97, P834, DOI 10.1016/S0022-3476(80)80282-4; WEST S, 1897, T CLIN SOC LONDON, V30, P60	30	185	200	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2008	40	6					789	793		10.1038/ng.153	http://dx.doi.org/10.1038/ng.153			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18500342				2022-12-27	WOS:000256212000022
J	Du, ZQ; Park, KW; Yu, HJ; Fan, Q; Li, LM				Du, Zhiqiang; Park, Kyung-Won; Yu, Haijing; Fan, Qing; Li, Liming			Newly identified prion linked to the chromatin-remodeling factor Swi1 in Saccharomyces cerevisiae	NATURE GENETICS			English	Article							DE-NOVO APPEARANCE; PSI+ PRION; YEAST; PROTEIN; EXPRESSION; RICH; AGGREGATION; DOMAINS; COMPLEX; GENES	SWI/SNF, an evolutionarily conserved ATP-dependent chromatin-remodeling complex, has an important role in transcriptional regulation(1). In Saccharomyces cerevisiae, SWI/SNF regulates the expression of similar to 6% of total genes through activation or repression(2). Swi1, a subunit of SWI/SNF, contains an N-terminal region rich in glutamine and asparagine, a notable feature shared by all characterized yeast prions-a group of unique proteins capable of self-perpetuating changes in conformation and function(3). Here we provide evidence that Swi1 can become a prion, [SWI+]. Swi1 aggregates in [SWI+] cells but not in nonprion cells. Cells bearing [SWI+] show a partial loss-of-function phenotype of SWI/SNF. [SWI+] can be eliminated by guanidine hydrochloride treatment, HSP104 deletion or loss of Swi1. Moreover, we show [SWI+] is dominantly and cytoplasmically transmitted. Our findings reveal a novel mechanism of 'protein-only' inheritance that results in modification of chromatin-remodeling and, ultimately, global gene regulation.	[Du, Zhiqiang; Park, Kyung-Won; Yu, Haijing; Fan, Qing; Li, Liming] Northwestern Univ, Dept Biol Chem & Mol Pharmacol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Li, LM (corresponding author), Northwestern Univ, Dept Biol Chem & Mol Pharmacol, Feinberg Sch Med, Searle 5-474,320 E Super St, Chicago, IL 60611 USA.	limingli@northwestern.edu	FAN, QING/G-6356-2012; Du, Zhiqiang/G-2649-2012		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS056086] Funding Source: NIH RePORTER; NINDS NIH HHS [R01NS056086, R01 NS056086, R01 NS056086-01A2] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		CHERNOFF YO, 1993, CURR GENET, V24, P268, DOI 10.1007/BF00351802; CONDE J, 1976, P NATL ACAD SCI USA, V73, P3651, DOI 10.1073/pnas.73.10.3651; COX BS, 1965, HEREDITY, V20, P505, DOI 10.1038/hdy.1965.65; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Derkatch IL, 1997, GENETICS, V147, P507; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Guidi CJ, 2001, MOL CELL BIOL, V21, P3598, DOI 10.1128/MCB.21.10.3598-3603.2001; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; LACROUTE F, 1971, J BACTERIOL, V106, P519, DOI 10.1128/JB.106.2.519-522.1971; LAURENT BC, 1990, MOL CELL BIOL, V10, P5616, DOI 10.1128/MCB.10.11.5616; Li LM, 2000, SCIENCE, V287, P661, DOI 10.1126/science.287.5453.661; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; MASISON DC, 1995, SCIENCE, V270, P93, DOI 10.1126/science.270.5233.93; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; NEIGEBORN L, 1984, GENETICS, V108, P845; NEIGEBORN L, 1987, GENETICS, V115, P247; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Park KW, 2006, GENETICS, V173, P35, DOI 10.1534/genetics.105.054221; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Ross ED, 2005, NAT CELL BIOL, V7, P1039, DOI 10.1038/ncb1105-1039; Saha A, 2006, NAT REV MOL CELL BIO, V7, P437, DOI 10.1038/nrm1945; Smith CL, 2003, NAT STRUCT BIOL, V10, P141, DOI 10.1038/nsb888; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Sudarsanam P, 2000, P NATL ACAD SCI USA, V97, P3364, DOI 10.1073/pnas.050407197; Tuite MF, 2003, NAT REV MOL CELL BIO, V4, P878, DOI 10.1038/nrm1247; TUITE MF, 1981, GENETICS, V98, P691; Uptain SM, 2002, ANNU REV MICROBIOL, V56, P703, DOI 10.1146/annurev.micro.56.013002.100603; WICKNER RB, 1994, SCIENCE, V264, P566, DOI 10.1126/science.7909170	30	234	240	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2008	40	4					460	465		10.1038/ng.112	http://dx.doi.org/10.1038/ng.112			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18362884	Green Accepted			2022-12-27	WOS:000254388100018
J	Eberhart, JK; He, XJ; Swartz, ME; Yan, YL; Song, H; Boling, TC; Kunerth, AK; Walker, MB; Kimmel, CB; Postlethwait, JH				Eberhart, Johann K.; He, Xinjun; Swartz, Mary E.; Yan, Yin-Lin; Song, Hao; Boling, Taylor C.; Kunerth, Allison K.; Walker, Macie B.; Kimmel, Charles B.; Postlethwait, John H.			MicroRNA Mirn140 modulates Pdgf signaling during palatogenesis	NATURE GENETICS			English	Article							CREST CELL-MIGRATION; GROWTH-FACTOR; SONIC HEDGEHOG; ALPHA; EXPRESSION; RECEPTOR; SPECIFICATION; REQUIREMENT; CARTILAGE; ORIGINS	Disruption of signaling pathways such as those mediated by sonic hedgehog (Shh) or platelet-derived growth factor (Pdgf) causes craniofacial abnormalities, including cleft palate. The role that microRNAs play in modulating palatogenesis, however, is completely unknown. We show that, in zebrafish, the microRNA Mirn140 negatively regulates Pdgf signaling during palatal development, and we provide a mechanism for how disruption of Pdgf signaling causes palatal clefting. The pdgf receptor alpha (pdgfra) 3' UTR contained a Mirn140 binding site functioning in the negative regulation of Pdgfra protein levels in vivo. pdgfra mutants and Mirn140-injected embryos shared a range of facial defects, including clefting of the crest-derived cartilages that develop in the roof of the larval mouth. Concomitantly, the oral ectoderm beneath where these cartilages develop lost pitx2 and shha expression. Mirn140 modulated Pdgf-mediated attraction of cranial neural crest cells to the oral ectoderm, where crest-derived signals were necessary for oral ectodermal gene expression. Mirn140 loss of function elevated Pdgfra protein levels, altered palatal shape and caused neural crest cells to accumulate around the optic stalk, a source of the ligand Pdgfaa. These results suggest that the conserved regulatory interactions of mirn140 and pdgfra define an ancient mechanism of palatogenesis, and they provide candidate genes for cleft palate.	[Eberhart, Johann K.; He, Xinjun; Swartz, Mary E.; Yan, Yin-Lin; Song, Hao; Boling, Taylor C.; Kunerth, Allison K.; Kimmel, Charles B.; Postlethwait, John H.] 1254 Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA	University of Oregon	Eberhart, JK (corresponding author), 1254 Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA.	eberhart@uoneuro.uoregon.edu	He, Xinjun/F-9797-2011; Eberhart, Johann/AAO-4241-2020; Swartz, Mary/AAO-4293-2020	Kunerth, Allison/0000-0002-9035-507X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR020833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K99DE018088, R00DE018088] Funding Source: NIH RePORTER; NCRR NIH HHS [R01 RR020833-03, R01 RR020833-04, R01 RR020833, 5R01RR020833] Funding Source: Medline; NICHD NIH HHS [P01 HD22486, P01 HD022486-22, P01 HD022486, P01 HD022486-220001, P01 HD022486-159007, P01 HD022486-169007] Funding Source: Medline; NIDCR NIH HHS [R00 DE018088, K99 DE018088-01, R00 DE018088-03, 5 K99 DE018088, K99 DE018088-02, K99 DE018088] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ason B, 2006, P NATL ACAD SCI USA, V103, P14385, DOI 10.1073/pnas.0603529103; Bachler M, 2001, MECH DEVELOP, V100, P313, DOI 10.1016/S0925-4773(00)00518-9; Betsholtz C, 2001, BIOESSAYS, V23, P494, DOI 10.1002/bies.1069; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; Brugmann SA, 2007, DEVELOPMENT, V134, P3283, DOI 10.1242/dev.005132; DARNELL DK, 2006, DEV DYNAM, V235, P3516; Ding H, 2004, NAT GENET, V36, P1111, DOI 10.1038/ng1415; Eberhart JK, 2006, DEVELOPMENT, V133, P1069, DOI 10.1242/dev.02281; Gammill LS, 2007, DEV NEUROBIOL, V67, P47, DOI 10.1002/dneu.20326; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Hilliard SA, 2005, J ANAT, V207, P655, DOI 10.1111/j.1469-7580.2005.00474.x; HO L, 1994, MECH DEVELOP, V48, P165, DOI 10.1016/0925-4773(94)90057-4; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Hu D, 1999, DEVELOPMENT, V126, P4873; Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711; Lee Chung-Tien, 2006, Birth Defects Research, V78, P129, DOI 10.1002/bdrc.20072; Liu LH, 2002, MECH DEVELOP, V116, P227, DOI 10.1016/S0925-4773(02)00142-9; Liu LH, 2002, DEV GENES EVOL, V212, P298, DOI 10.1007/s00427-002-0234-3; McLennan R, 2007, DEV BIOL, V301, P227, DOI 10.1016/j.ydbio.2006.08.019; Nagel M, 2004, DEVELOPMENT, V131, P2727, DOI 10.1242/dev.01141; Neff MM, 1998, PLANT J, V14, P387, DOI 10.1046/j.1365-313X.1998.00124.x; ORRURTREGER A, 1992, DEVELOPMENT, V115, P1045; OSUMIYAMASHITA N, 1994, DEV BIOL, V164, P409, DOI 10.1006/dbio.1994.1211; Ovcharenko I, 2004, GENOME RES, V14, P472, DOI 10.1101/gr.2129504; Riley BM, 2007, P NATL ACAD SCI USA, V104, P4512, DOI 10.1073/pnas.0607956104; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; SADAGHIANI B, 1987, DEV BIOL, V124, P91, DOI 10.1016/0012-1606(87)90463-5; Schneider RA, 2003, SCIENCE, V299, P565, DOI 10.1126/science.1077827; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Song Lin, 2006, Birth Defects Research, V78, P140, DOI 10.1002/bdrc.20070; Soriano P, 1997, DEVELOPMENT, V124, P2691; Tallquist MD, 2003, DEVELOPMENT, V130, P507, DOI 10.1242/dev.00241; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; Trainor PA, 2003, INT J DEV BIOL, V47, P541; Trainor PA, 2001, CURR OPIN CELL BIOL, V13, P698, DOI 10.1016/S0955-0674(00)00273-8; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; Wada N, 2005, DEVELOPMENT, V132, P3977, DOI 10.1242/dev.01943; Walker MB, 2007, BIOTECH HISTOCHEM, V82, P23, DOI 10.1080/10520290701333558; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Yu HH, 2005, DEV BIOL, V280, P373, DOI 10.1016/j.ydbio.2005.01.029; Zhang H, 2004, J CELL SCI, V117, P93, DOI 10.1242/jcs.00827	43	249	267	4	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2008	40	3					290	298		10.1038/ng.82	http://dx.doi.org/10.1038/ng.82			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18264099	Green Accepted			2022-12-27	WOS:000253548400019
J	Bovee, D; Zhou, Y; Haugen, E; Wu, ZN; Hayden, HS; Gillett, W; Tuzun, E; Cooper, GM; Sampas, N; Phelps, K; Levy, R; Morrison, VA; Sprague, J; Jewett, D; Buckley, D; Subramaniam, S; Chang, J; Smith, DR; Olson, MV; Eichler, EE; Kaul, R				Bovee, Donald; Zhou, Yang; Haugen, Eric; Wu, Zaining; Hayden, Hillary S.; Gillett, Will; Tuzun, Eray; Cooper, Gregory M.; Sampas, Nick; Phelps, Karen; Levy, Ruth; Morrison, V. Anne; Sprague, James; Jewett, Donald; Buckley, Danielle; Subramaniam, Sandhya; Chang, Jean; Smith, Douglas R.; Olson, Maynard V.; Eichler, Evan E.; Kaul, Rajinder			Closing gaps in the human genome with fosmid resources generated from multiple individuals	NATURE GENETICS			English	Article							COPY NUMBER POLYMORPHISM; HUMAN GENETIC-VARIATION; SEGMENTAL DUPLICATIONS; STRUCTURAL VARIATION; SEQUENCE; PREDISPOSES	The human genome sequence has been finished to very high standards; however, more than 340 gaps remained when the finished genome was published by the International Human Genome Sequencing Consortium in 2004. Using fosmid resources generated from multiple individuals, we targeted gaps in the euchromatic part of the human genome. Here we report 2,488,842 bp of previously unknown euchromatic sequence, 363,114 bp of which close 26 of 250 euchromatic gaps, or 10%, including two remaining euchromatic gaps on chromosome 19. Eight (30.7%) of the closed gaps were found to be polymorphic. These sequences allow complete annotation of several human genes as well as the assignment of mRNAs. The gap sequences are 2.3-fold enriched in segmentally duplicated sequences compared to the whole genome. Our analysis confirms that not all gaps within 'finished' genomes are recalcitrant to subcloning and suggests that the paired-end-sequenced fosmid libraries could prove to be a rich resource for completion of the human euchromatic genome.	[Bovee, Donald; Zhou, Yang; Haugen, Eric; Hayden, Hillary S.; Gillett, Will; Phelps, Karen; Levy, Ruth; Jewett, Donald; Buckley, Danielle; Subramaniam, Sandhya; Chang, Jean; Olson, Maynard V.; Kaul, Rajinder] Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA; [Tuzun, Eray; Cooper, Gregory M.; Morrison, V. Anne; Sprague, James; Olson, Maynard V.; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Sampas, Nick] Agilent Technol, Mol Technol Lab, Santa Clara, CA 95051 USA; [Smith, Douglas R.] Agencourt Biosci Corp, Agencourt Sequencing Ctr, Cummings Ctr 500, Beverly, MA 01519 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Agilent Technologies; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Kaul, R (corresponding author), Univ Washington, Dept Med, Div Med Genet, Seattle, WA 98195 USA.	rkkaul@u.washington.edu	Tuzun, Eray/AAD-7282-2021; Tuzun, Eray/B-5949-2018; Cooper, Gregory/D-6914-2011	Tuzun, Eray/0000-0002-5550-7816; Tuzun, Eray/0000-0002-5550-7816; Cooper, Gregory/0000-0001-5509-9923; Haugen, Eric/0000-0001-7444-8981; Kaul, Rajinder/0000-0002-7895-9284	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG002043, P01HG004120] Funding Source: NIH RePORTER; NHGRI NIH HHS [3 U54 HG002043, HG004120] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Eichler EE, 2006, NAT GENET, V38, P9, DOI 10.1038/ng0106-9; Eichler EE, 2004, NAT REV GENET, V5, P345, DOI 10.1038/nrg1322; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; Freeman JL, 2006, GENOME RES, V16, P949, DOI 10.1101/gr.3677206; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Istrail S, 2004, P NATL ACAD SCI USA, V101, P1916, DOI 10.1073/pnas.0307971100; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Kouprina N, 2003, EMBO REP, V4, P257, DOI 10.1038/sj.embor.embor766; Leem SH, 2004, GENOME RES, V14, P239, DOI 10.1101/gr.1929904; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Newman TL, 2006, HUM MOL GENET, V15, P1159, DOI 10.1093/hmg/ddl031; Raymond CK, 2005, GENOMICS, V86, P759, DOI 10.1016/j.ygeno.2005.08.013; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; She XW, 2006, GENOME RES, V16, P576, DOI 10.1101/gr.4949406; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Wong GKS, 1997, P NATL ACAD SCI USA, V94, P5225, DOI 10.1073/pnas.94.10.5225	27	40	43	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2008	40	1					96	101		10.1038/ng.2007.34	http://dx.doi.org/10.1038/ng.2007.34			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18157130				2022-12-27	WOS:000252118600024
J	Jaeger, E; Webb, E; Howarth, K; Carvajal-Carmona, L; Rowan, A; Broderick, P; Walther, A; Spain, S; Pittman, A; Kemp, Z; Sullivan, K; Heinimann, K; Lubbe, S; Domingo, E; Barclay, E; Martin, L; Gorman, M; Chandler, I; Vijayakrishnan, J; Wood, W; Papaemmanuil, E; Penegar, S; Qureshi, M; Farrington, S; Tenesa, A; Cazier, JB; Kerr, D; Gray, R; Peto, J; Dunlop, M; Campbell, H; Thomas, H; Houlston, R; Tomlinson, I				Jaeger, Emma; Webb, Emily; Howarth, Kimberley; Carvajal-Carmona, Luis; Rowan, Andrew; Broderick, Peter; Walther, Axel; Spain, Sarah; Pittman, Alan; Kemp, Zoe; Sullivan, Kate; Heinimann, Karl; Lubbe, Steven; Domingo, Enric; Barclay, Ella; Martin, Lynn; Gorman, Maggie; Chandler, Ian; Vijayakrishnan, Jayaram; Wood, Wendy; Papaemmanuil, Elli; Penegar, Steven; Qureshi, Mobshra; Farrington, Susan; Tenesa, Albert; Cazier, Jean-Baptiste; Kerr, David; Gray, Richard; Peto, Julian; Dunlop, Malcolm; Campbell, Harry; Thomas, Huw; Houlston, Richard; Tomlinson, Ian		CORGI Consortium	Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MIXED POLYPOSIS SYNDROME; PROSTATE-CANCER; SUSCEPTIBILITY; SCAN; 8Q24	We mapped a high-penetrance gene (CRAC1; also known as HMPS) associated with colorectal cancer (CRC) in the Ashkenazi population to a 0.6-Mb region on chromosome 15 containing SCG5 (also known as SGNE1), GREM1 and FMN1. We hypothesized that the CRAC1 locus harbored low-penetrance variants that increased CRC risk in the general population. In a large series of colorectal cancer cases and controls, SNPs near GREM1 and SCG5 were strongly associated with increased CRC risk (for rs4779584, P=4.44x10(-14)).	[Jaeger, Emma; Howarth, Kimberley; Carvajal-Carmona, Luis; Rowan, Andrew; Walther, Axel; Spain, Sarah; Kemp, Zoe; Domingo, Enric; Barclay, Ella; Martin, Lynn; Gorman, Maggie; Tomlinson, Ian] Canc Res UK, Mol & Populat Genet Lab, London WC2A 3PX, England; [Webb, Emily; Broderick, Peter; Pittman, Alan; Lubbe, Steven; Chandler, Ian; Vijayakrishnan, Jayaram; Wood, Wendy; Papaemmanuil, Elli; Penegar, Steven; Qureshi, Mobshra] Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; [Carvajal-Carmona, Luis; Tomlinson, Ian] Univ London, Queen Mary Coll, Barts & London Med Sch, Inst Canc, London EC1M 6BQ, England; [Heinimann, Karl] KBW Ctr Biomed, Dept Clin & Biol Sci, Res Grp Human Genet, CH-4058 Basel, Switzerland; [Martin, Lynn] St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England; [Martin, Lynn] Birmingham Womens Hosp, Dept Med Genet, Birmingham B15 2TG, W Midlands, England; [Farrington, Susan; Dunlop, Malcolm] Univ Edinburgh, Canc Res Ctr, Colon Canc Genet Grp, Edinburgh EH4 2XU, Midlothian, Scotland; [Farrington, Susan; Dunlop, Malcolm] Western Gen Hosp, UK Med Res Council, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Tenesa, Albert; Campbell, Harry] Univ Edinburgh, Edinburgh EH8 9AG, Midlothian, Scotland; [Cazier, Jean-Baptiste] Canc Res UK, London WC2A 3PX, England; [Kerr, David] Univ Oxford, Dept Clin Pharmacol, Radcliffe Infirm, Oxford OX2 6HA, England; [Gray, Richard] Univ Birmingham, Birmingham Clin Trials Unit, Birmingham B15 2TT, W Midlands, England; [Peto, Julian] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Peto, Julian] Univ London London Sch Hyg & Trop Med, Non Communicable Dis Epidemiol Unit, London WC1E 7HT, England; [Peto, Julian] Inst Canc Res, Sutton SM2 5NG, Surrey, England; [Thomas, Huw] St Marks Hosp, Family Canc Clin & Imperial Coll, Harrow HA1 3UJ, Middx, England	Cancer Research UK; University of London; Institute of Cancer Research - UK; University of London; Queen Mary University London; University of Manchester; Birmingham Women's Hospital; University of Edinburgh; University of Edinburgh; University of Edinburgh; Cancer Research UK; Radcliffe Infirmary; University of Oxford; University of Birmingham; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; London School of Hygiene & Tropical Medicine; University of London; Institute of Cancer Research - UK; Imperial College London	Tomlinson, I (corresponding author), Canc Res UK, Mol & Populat Genet Lab, London WC2A 3PX, England.	richard.houlston@icr.ac.uk; ian.tomlinson@cancer.org.uk	Farrington, Susan M/C-7319-2013; Cazier, Jean-Baptiste/GLR-2949-2022; Domingo, Enric/A-9099-2018; Lubbe, Steven/L-8261-2013; Cazier, Jean-Baptiste/F-2369-2010; Dunlop, Malcolm G/F-1973-2011; Carvajal-Carmona, Luis G/B-3882-2010; Campbell, Harry/E-2959-2010; Pittman, Alan/AAP-2534-2020; Evans, D Gareth/AAB-4308-2022; Pittman, Alan M/D-6231-2012; Farrington, Susan M/Q-2710-2019; Spain, Sarah/G-1968-2010; Lucassen, Anneke/D-7764-2017	Cazier, Jean-Baptiste/0000-0001-7581-9051; Domingo, Enric/0000-0003-4390-8767; Lubbe, Steven/0000-0002-7103-6671; Cazier, Jean-Baptiste/0000-0001-7581-9051; Dunlop, Malcolm G/0000-0002-3033-5851; Carvajal-Carmona, Luis G/0000-0001-7129-2918; Campbell, Harry/0000-0002-6169-6262; Pittman, Alan/0000-0002-8112-2987; Evans, D Gareth/0000-0002-8482-5784; Pittman, Alan M/0000-0002-8112-2987; Farrington, Susan M/0000-0001-5955-7389; Houlston, Richard/0000-0002-5268-0242; Spain, Sarah/0000-0002-7591-8364; Gray, Richard/0000-0003-4440-574X; Penegar, Steven/0000-0002-3768-0236; Tenesa, Albert/0000-0003-4884-4475; Lucassen, Anneke/0000-0003-3324-4338; Vijayakrishnan, Jayaram/0000-0002-8284-2249; Wood, Wendy/0000-0001-9062-4455; Broderick, Peter/0000-0002-8348-5829; Green, Andrew/0000-0002-1077-7417; Webb, Emily/0000-0002-4019-7456	MRC [MC_U127527198, G0301096] Funding Source: UKRI; Medical Research Council [G0301096, MC_U127527198] Funding Source: Medline; Chief Scientist Office [CZB/4/449] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office		Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Jaeger EEM, 2003, AM J HUM GENET, V72, P1261, DOI 10.1086/375144; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Sun T, 2007, NAT GENET, V39, P605, DOI 10.1038/ng2030; Tomlinson I, 1999, GASTROENTEROLOGY, V116, P789, DOI 10.1016/S0016-5085(99)70061-2; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Whitelaw SC, 1997, GASTROENTEROLOGY, V112, P327, DOI 10.1053/gast.1997.v112.pm9024286; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	15	250	257	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2008	40	1					26	28		10.1038/ng.2007.41	http://dx.doi.org/10.1038/ng.2007.41			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	247YN	18084292				2022-12-27	WOS:000252118600013
J	Houlden, H; Johnson, J; Gardner-Thorpe, C; Lashley, T; Hernandez, D; Worth, P; Singleton, AB; Hilton, DA; Holton, J; Revesz, T; Davis, MB; Giunti, P; Wood, NW				Houlden, Henry; Johnson, Janel; Gardner-Thorpe, Christopher; Lashley, Tammaryn; Hernandez, Dena; Worth, Paul; Singleton, Andrew B.; Hilton, David A.; Holton, Janice; Revesz, Tamas; Davis, Mary B.; Giunti, Paolo; Wood, Nicholas W.			Mutations in TTBK2, encoding a kinase implicated in tau phosphorylation, segregate with spinocerebellar ataxia type 11	NATURE GENETICS			English	Article							DOMINANT CEREBELLAR ATAXIAS; ALZHEIMERS-DISEASE; CLINICAL-FEATURES; DISORDERS; PROTEIN; FAMILY	The microtubule-associated protein tau ( encoded by MAPT) and several tau kinases have been implicated in neurodegeneration, but only MAPT has a proven role in disease. We identified mutations in the gene encoding tau tubulin kinase 2 ( TTBK2) as the cause of spinocerebellar ataxia type 11. Affected brain tissue showed substantial cerebellar degeneration and tau deposition. These data suggest that TTBK2 is important in the tau cascade and in spinocerebellar degeneration.	UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; NIA, NIH, Neurogenet Lab, Mol Genet Unit, Bethesda, MD 20892 USA; Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England; Norwich Univ Hosp, Dept Neurol, Natl Hlth Serv, Norwich NR4 7UY, Norfolk, England; Derriford Hosp, Dept Histopathol, Plymouth PL6 8DH, Devon, England	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Exeter; NHS Blood & Transplant (NHSBT); Derriford Hospital	Houlden, H (corresponding author), UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, Dept Mol Neurosci, Queen Square, London WC1N 3BG, England.	h.houlden@ion.ucl.ac.uk; n.wood@ion.ucl.ac.uk	Singleton, Andrew B/C-3010-2009; Wood, Nicholas W/C-2505-2009; Johnson, Janel/A-7136-2010; Giunti, Paola/E-5526-2012; Revesz, Tamas/A-8732-2010; Holton, Janice L/F-6831-2011; Houlden, Henry J/C-1532-2008; Lashley, Tammaryn/D-2583-2009	Wood, Nicholas W/0000-0002-9500-3348; Giunti, Paola/0000-0003-3508-4788; Revesz, Tamas/0000-0003-2501-0259; Holton, Janice L/0000-0002-3882-5249; Houlden, Henry J/0000-0002-2866-7777; 	Intramural NIH HHS Funding Source: Medline; Medical Research Council [G108/638] Funding Source: Medline; MRC [G108/638] Funding Source: UKRI; NATIONAL INSTITUTE ON AGING [Z01AG000958, ZIAAG000958] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; HARDING AE, 1982, BRAIN, V105, P1, DOI 10.1093/brain/105.1.1; Kitano-Takahashi M, 2007, ACTA CRYSTALLOGR F, V63, P602, DOI 10.1107/S1744309107028783; Kraemer BC, 2006, HUM MOL GENET, V15, P1483, DOI 10.1093/hmg/ddl067; MANN DMA, 1990, NEUROPATH APPL NEURO, V16, P17, DOI 10.1111/j.1365-2990.1990.tb00928.x; MUKAETOVALADINSKA EB, 1993, AM J PATHOL, V143, P565; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Ranum LPW, 2002, CURR OPIN GENET DEV, V12, P266, DOI 10.1016/S0959-437X(02)00297-6; Riudavets MA, 2006, J NEUROPATH EXP NEUR, V65, P1143, DOI 10.1097/01.jnen.0000248548.20799.a3; Sato S, 2006, J NEUROCHEM, V98, P1573, DOI 10.1111/j.1471-4159.2006.04059.x; Schols L, 2004, LANCET NEUROL, V3, P291, DOI 10.1016/S1474-4422(04)00737-9; TAKAHASHI M, 1995, FEBS LETT, V372, P59, DOI 10.1016/0014-5793(95)00955-9; Worth PF, 1999, AM J HUM GENET, V65, P420, DOI 10.1086/302495	15	122	129	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2007	39	12					1434	1436		10.1038/ng.2007.43	http://dx.doi.org/10.1038/ng.2007.43			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	235XK	18037885				2022-12-27	WOS:000251267400008
J	Kim, S; Plagnol, V; Hu, TT; Toomajian, C; Clark, RM; Ossowski, S; Ecker, JR; Weigel, D; Nordborg, M				Kim, Sung; Plagnol, Vincent; Hu, Tina T.; Toomajian, Christopher; Clark, Richard M.; Ossowski, Stephan; Ecker, Joseph R.; Weigel, Detlef; Nordborg, Magnus			Recombination and linkage disequilibrium in Arabidopsis thaliana	NATURE GENETICS			English	Article							GENE CONVERSION; HUMAN GENOME; HISTORY; DNA; POLYMORPHISM; POPULATIONS; ASSOCIATION; DROSOPHILA; PATTERNS; RATES	Linkage disequilibrium ( LD) is a major aspect of the organization of genetic variation in natural populations. Here we describe the genome- wide pattern of LD in a sample of 19 Arabidopsis thaliana accessions using 341,602 non- singleton SNPs. LD decays within 10 kb on average, considerably faster than previously estimated. Tag SNP selection algorithms and ' hide- the- SNP' simulations suggest that genome- wide association mapping will require only 40% - 50% of the observed SNPs, a reduction similar to estimates in a sample of African Americans. An Affymetrix genotyping array containing 250,000 SNPs has been designed based on these results; we demonstrate that it should have more than adequate coverage for genome- wide association mapping. The extent of LD is highly variable, and we find clear evidence of recombination hotspots, which seem to occur preferentially in intergenic regions. LD also reflects the action of selection, and it is more extensive between nonsynonymous polymorphisms than between synonymous polymorphisms.	Univ So Calif, Los Angeles, CA 90089 USA; Univ Cambridge, Cambridge Inst Med Res, Cambridge CB2 0XY, England; Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; Salk Inst Biol Studies, Salk Inst Genome Anal Lab, La Jolla, CA 92037 USA; Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA	University of Southern California; University of Cambridge; Max Planck Society; Salk Institute; Salk Institute	Nordborg, M (corresponding author), Univ So Calif, Los Angeles, CA 90089 USA.	magnus@usc.edu	Weigel, Detlef/C-1418-2008; Ecker, Joseph R/B-9144-2008; Ossowski, Stephan/E-2139-2011; Weigel, Detlef/GSJ-0799-2022; Plagnol, Vincent/A-5667-2011; Weigel, Detlef/AAR-3312-2021; Toomajian, Christopher/ABA-2615-2021	Weigel, Detlef/0000-0002-2114-7963; Ecker, Joseph R/0000-0001-5799-5895; Ossowski, Stephan/0000-0002-7416-9568; Weigel, Detlef/0000-0002-2114-7963; Toomajian, Christopher/0000-0002-6763-0678; Plagnol, Vincent/0000-0002-5597-9215; Nordborg, Magnus/0000-0001-7178-9748	NHGRI NIH HHS [HG002790] Funding Source: Medline; NIGMS NIH HHS [R01 GM062932, GM62932] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062932] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Andolfatto P, 1998, GENETICS, V148, P1397; Andolfatto P, 2005, NATURE, V437, P1149, DOI 10.1038/nature04107; Arnheim N, 2003, AM J HUM GENET, V73, P5, DOI 10.1086/376419; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Drouaud J, 2006, GENOME RES, V16, P106, DOI 10.1101/gr.4319006; Frisse L, 2001, AM J HUM GENET, V69, P831, DOI 10.1086/323612; Haddrill PR, 2005, GENOME RES, V15, P790, DOI 10.1101/gr.3541005; Hagenblad J, 2002, GENETICS, V161, P289; Haubold B, 2002, GENETICS, V161, P1269; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hudson RR, 2001, GENETICS, V159, P1805; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; HUDSON RR, 1985, GENETICS, V111, P147; Johnson GCL, 2001, NAT GENET, V29, P233, DOI 10.1038/ng1001-233; Li N, 2003, GENETICS, V165, P2213; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Nordborg M, 2002, TRENDS GENET, V18, P83, DOI 10.1016/S0168-9525(02)02557-X; Nordborg M, 2000, GENETICS, V154, P923; Padhukasahasram B, 2006, GENETICS, V174, P1517, DOI 10.1534/genetics.106.060723; Pagnol V, 2006, GENETICS, V172, P2441, DOI 10.1534/genetics.104.040311; Przeworski M, 2001, GENET RES, V77, P143, DOI 10.1017/S0016672301004967; Schmuths H, 2004, ANN BOT-LONDON, V93, P317, DOI 10.1093/aob/mch037; Wall JD, 2003, NAT REV GENET, V4, P587, DOI 10.1038/nrg1123; Zondervan KT, 2004, NAT REV GENET, V5, P89, DOI 10.1038/nrg1270	27	388	397	0	95	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1151	1155		10.1038/ng2115	http://dx.doi.org/10.1038/ng2115			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17676040				2022-12-27	WOS:000249122400027
J	Lowe, CE; Cooper, JD; Brusko, T; Walker, NM; Smyth, DJ; Bailey, R; Bourget, K; Plagnol, V; Field, S; Atkinson, M; Clayton, DG; Wicker, LS; Todd, JA				Lowe, Christopher E.; Cooper, Jason D.; Brusko, Todd; Walker, Neil M.; Smyth, Deborah J.; Bailey, Rebecca; Bourget, Kirsi; Plagnol, Vincent; Field, Sarah; Atkinson, Mark; Clayton, David G.; Wicker, Linda S.; Todd, John A.			Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; LINKAGE DISEQUILIBRIUM; INSULIN GENE; T-CELLS; INTERLEUKIN-2; SEQUENCE; RECEPTOR; LOCUS; HLA; SUSCEPTIBILITY	Genome- wide association studies are now identifying disease- associated chromosome regions. However, even after convincing replication, the localization of the causal variant( s) requires comprehensive resequencing, extensive genotyping and statistical analyses in large sample sets leading to targeted functional studies. Here, we have localized the type 1 diabetes ( T1D) association in the interleukin 2 receptor alpha ( IL2RA) gene region to two independent groups of SNPs, spanning overlapping regions of 14 and 40 kb, encompassing IL2RA intron 1 and the 5' regions of IL2RA and RBM17 ( odds ratio 2.04, 95% confidence interval 1.70 - 2.45; P 1.92 x 10(-28); control frequency 0.635). Furthermore, we have associated IL2RA T1D susceptibility genotypes with lower circulating levels of the biomarker, soluble IL- 2RA ( P 6.28 x 10(-28)), suggesting that an inherited lower immune responsiveness predisposes to T1D.	Univ Cambridge, Addenbrookes Hosp, Juvenile Diabet Res Fdn,Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab,Dept Med Ge, Cambridge CB2 0XY, England; Univ Florida, Coll Med, Gainesville, FL 32610 USA	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; State University System of Florida; University of Florida	Todd, JA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Juvenile Diabet Res Fdn,Cambridge Inst Med Res, Wellcome Trust Diabet & Inflammat Lab,Dept Med Ge, Cambridge CB2 0XY, England.	john.todd@cimr.cam.ac.uk	Plagnol, Vincent/A-5667-2011; Todd, John A/A-3542-2010; Wicker, Linda S/F-7384-2010	Todd, John A/0000-0003-2740-8148; Brusko, Todd/0000-0003-2878-9296; smyth, deborah/0000-0002-6330-2669; Walker, Neil/0000-0001-9796-7688; Plagnol, Vincent/0000-0002-5597-9215	MRC [G0000934] Funding Source: UKRI; Medical Research Council [G0000934] Funding Source: Medline; Wellcome Trust [061859, 068545/Z/02] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; BAIN SC, 1990, AUTOIMMUNITY, V7, P83, DOI 10.3109/08916939008993380; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BELL GI, 1984, DIABETES, V33, P176, DOI 10.2337/diabetes.33.2.176; Bleesing J, 2007, ARTHRITIS RHEUM-US, V56, P965, DOI 10.1002/art.22416; Bonfield JK, 1998, NUCLEIC ACIDS RES, V26, P3404, DOI 10.1093/nar/26.14.3404; Brand OJ, 2007, CLIN ENDOCRINOL, V66, P508, DOI 10.1111/j.1365-2265.2007.02762.x; Burren Oliver S., 2004, Human Genomics, V1, P98; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chapman JM, 2003, HUM HERED, V56, P18, DOI 10.1159/000073729; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cordell HJ, 2002, AM J HUM GENET, V70, P124, DOI 10.1086/338007; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fehniger TA, 2001, BLOOD, V97, P14, DOI 10.1182/blood.V97.1.14; Feltbower RG, 2003, DIABETIC MED, V20, P437, DOI 10.1046/j.1464-5491.2003.00960.x; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; GIORDANO C, 1989, DIABETES, V38, P310, DOI 10.2337/diabetes.38.3.310; Hardenbol P, 2003, NAT BIOTECHNOL, V21, P673, DOI 10.1038/nbt821; Ionescu-Tirgoviste C, 2001, DIABETOLOGIA, V44, pB60, DOI 10.1007/PL00002956; Kim HP, 2006, CYTOKINE GROWTH F R, V17, P349, DOI 10.1016/j.cytogfr.2006.07.003; KLOSE RJ, 1993, TRENDS BIOCHEM SCI, V52, P506; Kuniyasu Y, 2000, INT IMMUNOL, V12, P1145, DOI 10.1093/intimm/12.8.1145; LEONARD WJ, 1984, NATURE, V311, P626, DOI 10.1038/311626a0; LERNMARK A, 1990, AM J HUM GENET, V47, P1028; Makis AC, 2005, J INFECTION, V51, P206, DOI 10.1016/j.jinf.2004.10.013; Naranjo-Gomez M, 2007, EUR J IMMUNOL, V37, P1764, DOI 10.1002/eji.200636980; Patterson CC, 1996, DIABETOLOGIA, V39, P1063, DOI 10.1007/BF00400655; Plagnol V, 2007, PLOS GENET, V3, P759, DOI 10.1371/journal.pgen.0030074; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Qu HQ, 2007, DIABETES, V56, P1174, DOI 10.2337/db06-1555; ROBB RJ, 1987, J IMMUNOL, V139, P855; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Rubinstein MP, 2006, P NATL ACAD SCI USA, V103, P9166, DOI 10.1073/pnas.0600240103; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; She JX, 1999, P NATL ACAD SCI USA, V96, P8116, DOI 10.1073/pnas.96.14.8116; Smink LJ, 2005, NUCLEIC ACIDS RES, V33, pD544; Smyth DJ, 2005, NAT GENET, V37, P110, DOI 10.1038/ng0205-110; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Todd JA, 2006, NAT GENET, V38, P731, DOI 10.1038/ng0706-731; Todd JA, 2007, NAT GENET, V39, P857, DOI 10.1038/ng2068; Tree TIM, 2006, ANN NY ACAD SCI, V1079, P9, DOI 10.1196/annals.1375.002; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; UNDLIEN DE, 1995, AM J HUM GENET, V57, P1511; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Waldmann TA, 2006, NAT REV IMMUNOL, V6, P595, DOI 10.1038/nri1901; Wang WYS, 2005, NAT REV GENET, V6, P109, DOI 10.1038/nrg1522; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958	49	314	323	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	SEP	2007	39	9					1074	1082		10.1038/ng2102	http://dx.doi.org/10.1038/ng2102			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	205OA	17676041				2022-12-27	WOS:000249122400016
J	Kassmann, CM; Lappe-Siefke, C; Baes, M; Brugger, B; Mildner, A; Werner, HB; Natt, O; Michaelis, T; Prinz, M; Frahm, J; Nave, KA				Kassmann, Celia M.; Lappe-Siefke, Corinna; Baes, Myriam; Bruegger, Britta; Mildner, Alexander; Werner, Hauke B.; Natt, Oliver; Michaelis, Thomas; Prinz, Marco; Frahm, Jens; Nave, Klaus-Armin			Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes	NATURE GENETICS			English	Article							X-LINKED ADRENOLEUKODYSTROPHY; MOUSE MODEL; MULTIPLE-SCLEROSIS; PROTEOLIPID PROTEIN; NERVOUS-SYSTEM; MICE; DEGENERATION; MYELIN; CELLS; GENE	Oligodendrocytes myelinate axons for rapid impulse conduction and contribute to normal axonal functions in the central nervous system. In multiple sclerosis, demyelination is caused by autoimmune attacks, but the role of oligodendroglial cells in disease progression and axon degeneration is unclear. Here we show that oligodendrocytes harbor peroxisomes whose function is essential for maintaining white matter tracts throughout adult life. By selectively inactivating the import factor PEX5 in myelinating glia, we generated mutant mice that developed normally, but within several months showed ataxia, tremor and premature death. Absence of functional peroxisomes from oligodendrocytes caused widespread axonal degeneration and progressive subcortical demyelination, but did not interfere with glial survival. Moreover, it caused a strong proinflammatory milieu and, unexpectedly, the infiltration of B and activated CD8(+) T cells into brain lesions. We conclude that peroxisomes provide oligodendrocytes with an essential neuroprotective function against axon degeneration and neuroinflammation, which is relevant for human demyelinating diseases.	Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; Katholieke Univ Leuven, Fac Pharm, Lab Cell Metab, B-3000 Louvain, Belgium; Heidelberg Univ, Zentrum Biochem, D-69120 Heidelberg, Germany; Univ Gottingen, Dept Neuropathol, D-37075 Gottingen, Germany; Biomed NMR Forsch GmbH, Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany	Max Planck Society; KU Leuven; Ruprecht Karls University Heidelberg; University of Gottingen; Max Planck Society	Nave, KA (corresponding author), Max Planck Inst Expt Med, Dept Neurogenet, Hermann Rein Str 3, D-37075 Gottingen, Germany.	nave@em.mpg.de	mildner, alexander/AFK-2161-2022; Mildner, Alexander/ABG-6122-2020; mildner, alexander/GQA-3761-2022; Nave, Klaus-Armin/C-8883-2011; mildner, alexander/AAF-9451-2022	mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; mildner, alexander/0000-0002-2019-8427; Werner, Hauke/0000-0002-7710-5738; Baes, Myriam/0000-0002-2525-2269				Baes M, 2002, GENESIS, V32, P177, DOI 10.1002/gene.10047; Baes M, 1997, NAT GENET, V17, P49, DOI 10.1038/ng0997-49; Barnett FH, 2004, NEUROSURGERY, V55, P468, DOI 10.1227/00006123-200408000-00083; Barth PG, 2001, NEUROLOGY, V57, P1949, DOI 10.1212/WNL.57.11.1949; Baumgartner MR, 1998, ANN NEUROL, V44, P720, DOI 10.1002/ana.410440505; Bielschowsky M, 1904, J PSYCHOL NEUROL, V3, P169; Bjartmar C, 2001, CURR OPIN NEUROL, V14, P271, DOI 10.1097/00019052-200106000-00003; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chang CC, 1999, J CELL SCI, V112, P1579; DODT G, 1995, NAT GENET, V9, P115, DOI 10.1038/ng0295-115; Dubois-Dalcq M, 1999, TRENDS NEUROSCI, V22, P4, DOI 10.1016/S0166-2236(98)01319-8; Edgar JM, 2004, J CELL BIOL, V166, P121, DOI 10.1083/jcb.200312012; Ferreirinha F, 2004, J CLIN INVEST, V113, P231, DOI 10.1172/JCI200420138; ForssPetter S, 1997, J NEUROSCI RES, V50, P829, DOI 10.1002/(SICI)1097-4547(19971201)50:5<829::AID-JNR19>3.0.CO;2-W; Gallyas F, 1979, Neurol Res, V1, P203; Genoud S, 2002, J CELL BIOL, V158, P709, DOI 10.1083/jcb.200202002; Gould SJ, 2002, NAT REV MOL CELL BIO, V3, P382, DOI 10.1038/nrm807; GOVERMAN J, 2005, ALLERGY, V4, P239; Griffiths I, 1998, SCIENCE, V280, P1610, DOI 10.1126/science.280.5369.1610; Gutcher I, 2006, NAT IMMUNOL, V7, P946, DOI 10.1038/ni1377; Hirrlinger J, 2002, J NEUROCHEM, V82, P635, DOI 10.1046/j.1471-4159.2002.00999.x; Hudspeth MP, 2007, J NEUROIMMUNOL, V182, P5, DOI 10.1016/j.jneuroim.2006.10.009; Ip CW, 2006, J NEUROSCI, V26, P8206, DOI 10.1523/JNEUROSCI.1921-06.2006; Jung M, 1996, J NEUROSCI, V16, P7920; Kemp S, 2007, MOL GENET METAB, V90, P268, DOI 10.1016/j.ymgme.2006.10.001; Kobayashi T, 1997, BIOCHEM BIOPH RES CO, V232, P631, DOI 10.1006/bbrc.1997.6340; Koivusalo M, 2001, J LIPID RES, V42, P663; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lazzarini R. A., 2004, MYELIN BIOL DISORDER; Loers G, 2004, MOL CELL NEUROSCI, V27, P175, DOI 10.1016/j.mcn.2004.06.006; Loes DJ, 2003, NEUROLOGY, V61, P369, DOI 10.1212/01.WNL.0000079050.91337.83; Lu JF, 1997, P NATL ACAD SCI USA, V94, P9366, DOI 10.1073/pnas.94.17.9366; McManus C, 1998, J NEUROIMMUNOL, V86, P20, DOI 10.1016/S0165-5728(98)00002-2; MOSER HW, 1991, BIOCHEM CELL BIOL, V69, P463, DOI 10.1139/o91-070; MOSSER J, 1993, NATURE, V361, P726, DOI 10.1038/361726a0; Natt O, 2002, J NEUROSCI METH, V120, P203, DOI 10.1016/S0165-0270(02)00211-X; NORTON WT, 1973, J NEUROCHEM, V21, P749, DOI 10.1111/j.1471-4159.1973.tb07519.x; Pujol A, 2002, HUM MOL GENET, V11, P499, DOI 10.1093/hmg/11.5.499; Raivich G, 1998, J NEUROSCI, V18, P5804; Rodemer C, 2003, HUM MOL GENET, V12, P1881, DOI 10.1093/hmg/ddg191; Saher G, 2005, NAT NEUROSCI, V8, P468, DOI 10.1038/nn1426; Schrader M, 2004, HISTOCHEM CELL BIOL, V122, P383, DOI 10.1007/s00418-004-0673-1; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Simpson JE, 1998, J NEUROIMMUNOL, V84, P238, DOI 10.1016/S0165-5728(97)00208-7; Suter U, 2003, NAT REV NEUROSCI, V4, P714, DOI 10.1038/nrn1196; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Wanders RJA, 2005, CLIN GENET, V67, P107, DOI 10.1111/j.1399-0004.2004.00329.x; Wanders RJA, 2004, MOL GENET METAB, V83, P16, DOI 10.1016/j.ymgme.2004.08.016; Wilken B, 2003, NEUROPEDIATRICS, V34, P237; ZOELLER RA, 1986, P NATL ACAD SCI USA, V83, P5170, DOI 10.1073/pnas.83.14.5170	50	234	238	1	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2007	39	8					969	976		10.1038/ng2070	http://dx.doi.org/10.1038/ng2070			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17643102				2022-12-27	WOS:000248446900013
J	Sobacchi, C; Frattini, A; Guerrini, MM; Abinun, M; Pangrazio, A; Susani, L; Bredius, R; Mancini, G; Cant, A; Bishop, N; Grabowski, P; Del Fattore, A; Messina, C; Errigo, G; Coxon, FP; Scott, DI; Teti, A; Rogers, MJ; Vezzoni, P; Villa, A; Helfrich, MH				Sobacchi, Cristina; Frattini, Annalisa; Guerrini, Matteo M.; Abinun, Mario; Pangrazio, Alessandra; Susani, Lucia; Bredius, Robbert; Mancini, Grazia; Cant, Andrew; Bishop, Nick; Grabowski, Peter; Del Fattore, Andrea; Messina, Chiara; Errigo, Gabriella; Coxon, Fraser P.; Scott, Debbie I.; Teti, Anna; Rogers, Michael J.; Vezzoni, Paolo; Villa, Anna; Helfrich, Miep H.			Osteoclast-poor human osteopetrosis due to mutations in the gene encoding RANKL	NATURE GENETICS			English	Article							AUTOSOMAL RECESSIVE OSTEOPETROSIS; MICE; DEFICIENCY; REGULATOR; DEFECTS; RESCUE; MOUSE	Autosomal recessive osteopetrosis is usually associated with normal or elevated numbers of nonfunctional osteoclasts. Here we report mutations in the gene encoding RANKL ( receptor activator of nuclear factor - KB ligand) in six individuals with autosomal recessive osteopetrosis whose bone biopsy specimens lacked osteoclasts. These individuals did not show any obvious defects in immunological parameters and could not be cured by hematopoietic stem cell transplantation; however, exogenous RANKL induced formation of functional osteoclasts from their monocytes, suggesting that they could, theoretically, benefit from exogenous RANKL administration.	CNR, Inst Biomed Technol, I-20090 Segrate, Italy; Ist Clin Humanitas, I-20089 Rozzano, Italy; Newcastle Gen Hosp, Childrens Bone Marrow Transplant Unit, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Fac Med, Inst Cellular Med, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; Leiden Univ, Med Ctr, Dept Pediat, Leiden, Netherlands; Erasmus Univ, Med Ctr, Dept Clin Genet, NL-3000 CA Rotterdam, Netherlands; Univ Sheffield, Acad Unit Child Hlth, Sheffield S1O 2TH, S Yorkshire, England; Univ Aquila, Dept Expt Med, I-67100 Laquila, Italy; Univ Padua, Pediat Hematol & Oncol Unit, I-35122 Padua, Italy; Univ Aberdeen, Bone & Musculoskeletal Programme, Aberdeen AB25 2ZD, Scotland; Univ Vita & Salute San Raffaele, Telethon Inst GeneTherapy, I-20090 Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); IRCCS Humanitas Research Hospital; Newcastle General Hospital; Newcastle University - UK; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; University of Sheffield; University of L'Aquila; University of Padua; University of Aberdeen; Vita-Salute San Raffaele University	Frattini, A (corresponding author), CNR, Inst Biomed Technol, Via F Cervi 93, I-20090 Segrate, Italy.	annalisa.frattini@itb.cnr.it	Bredius, Robbert/AAF-2592-2019; Grabowski, Peter S/G-2345-2010; Vezzoni, Paolo/K-3197-2018; SOBACCHI, CRISTINA/J-9345-2018; Susani, Lucia/HHM-4185-2022; Frattini, Annalisa/B-7684-2015; Del Fattore, Andrea/AAP-2045-2020; Del Fattore, Andrea/H-4409-2015; Vezzoni, Paolo/R-3416-2019	Grabowski, Peter S/0000-0001-5924-1587; SOBACCHI, CRISTINA/0000-0002-2684-7184; Susani, Lucia/0000-0003-3368-2135; Frattini, Annalisa/0000-0002-1166-3091; Del Fattore, Andrea/0000-0003-3848-412X; Del Fattore, Andrea/0000-0003-3848-412X; Teti, Anna Maria/0000-0002-5887-4419; Villa, Anna/0000-0003-4428-9013; Vezzoni, Paolo/0000-0002-6382-3923; Bredius, Robbert/0000-0001-8151-1539; Rogers, Michael/0000-0002-1818-9249; Wilkinson, Debbie/0000-0003-0237-3807	Telethon [TGT06S01, TGT06A04] Funding Source: Medline; Chief Scientist Office [CZB/4/495] Funding Source: Medline	Telethon(Fondazione Telethon); Chief Scientist Office		Chalhoub N, 2003, NAT MED, V9, P399, DOI 10.1038/nm842; Chen W, 2007, HUM MOL GENET, V16, P410, DOI 10.1093/hmg/ddl474; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Frattini A, 2003, J BONE MINER RES, V18, P1740, DOI 10.1359/jbmr.2003.18.10.1740; Kim N, 2000, P NATL ACAD SCI USA, V97, P10905, DOI 10.1073/pnas.200294797; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kornak U, 2001, CELL, V104, P205, DOI 10.1016/S0092-8674(01)00206-9; Kostenuik PJ, 2005, CURR OPIN PHARMACOL, V5, P618, DOI 10.1016/j.coph.2005.06.005; Lam J, 2001, J CLIN INVEST, V108, P971, DOI 10.1172/JCI13890; Mizuno A, 2002, J BONE MINER METAB, V20, P337, DOI 10.1007/s007740200049; Nataf S, 2005, AM J PATHOL, V166, P275, DOI 10.1016/S0002-9440(10)62251-1; Pangrazio A, 2006, J BONE MINER RES, V21, P1098, DOI 10.1359/JBMR.060403; SLY WS, 1983, P NATL ACAD SCI-BIOL, V80, P2752, DOI 10.1073/pnas.80.9.2752; Sobacchi C, 2001, HUM MOL GENET, V10, P1767, DOI 10.1093/hmg/10.17.1767; Susani L, 2004, HUM MUTAT, V24, P225, DOI 10.1002/humu.20076	15	288	299	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					960	962		10.1038/ng2076	http://dx.doi.org/10.1038/ng2076			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17632511				2022-12-27	WOS:000248446900010
J	Pennington, JM; Rosenberg, SM				Pennington, Jeanine M.; Rosenberg, Susan M.			Spontaneous DNA breakage in single living Escherichia coli cells	NATURE GENETICS			English	Article							STALLED REPLICATION FORKS; RECOMBINATIONAL REPAIR; CHROMOSOME; FIDELITY; MUTANTS; CANCER; DAMAGE; AMPLIFICATION; DYNAMICS; BACTERIA	Spontaneous DNA breakage is predicted to be a frequent, inevitable consequence of DNA replication and is thought to underlie much of the genomic change that fuels cancer and evolution(1-3). Despite its importance, there has been little direct measurement of the amounts, types, sources and fates of spontaneous DNA lesions in living cells. We present a direct, sensitive flow cytometric assay in single living Escherichia coli cells for DNA lesions capable of inducing the SOS DNA damage response, and we report its use in quantification of spontaneous DNA double-strand breaks (DSBs). We report efficient detection of single chromosomal DSBs and rates of spontaneous breakage similar to 20- to 100-fold lower than predicted. In addition, we implicate DNA replication in the origin of spontaneous DSBs with the finding of fewer spontaneous DSBs in a mutant with altered DNA polymerase III. The data imply that spontaneous DSBs induce genomic changes and instability 20-100 times more potently than previously appreciated. Finally, FACS demonstrated two main cell fates after spontaneous DNA damage: viability with or without resumption of proliferation.	Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA; Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Baylor Coll Med, Dept Biochem & Mol Biol, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Rosenberg, SM (corresponding author), Baylor Coll Med, Interdept Program Cell & Mol Biol, 1 Baylor Plaza, Houston, TX 77030 USA.	smr@bcm.tmc.edu		Rosenberg, Susan M./0000-0003-1444-473X	NATIONAL CANCER INSTITUTE [R01CA085777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053158] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA85777, R01 CA085777] Funding Source: Medline; NIGMS NIH HHS [R01-GM53158, R01 GM053158-11A1, R01 GM053158-10, R01 GM053158] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amor-Gueret M, 2006, CANCER LETT, V236, P1, DOI 10.1016/j.canlet.2005.04.023; Bates D, 2005, CELL, V121, P899, DOI 10.1016/j.cell.2005.04.013; Bowater R, 2006, PLOS GENET, V2, P93, DOI 10.1371/journal.pgen.0020008; Campisi J, 2005, SCIENCE, V309, P886, DOI 10.1126/science.1116801; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; Eichler EE, 2003, SCIENCE, V301, P793, DOI 10.1126/science.1086132; FIJALKOWSKA IJ, 1993, GENETICS, V134, P1023; FRAME R, 1971, BIOCHEM J, V121, P93, DOI 10.1042/bj1210093; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Johnson RD, 2000, EMBO J, V19, P3398, DOI 10.1093/emboj/19.13.3398; KADYK LC, 1992, GENETICS, V132, P387; Kuzminov A, 1999, MICROBIOL MOL BIOL R, V63, P751, DOI 10.1128/MMBR.63.4.751-813.1999; LEWIS LK, 1994, J MOL BIOL, V241, P507, DOI 10.1006/jmbi.1994.1528; McCool JD, 2004, MOL MICROBIOL, V53, P1343, DOI 10.1111/j.1365-2958.2004.04225.x; McKenzie GJ, 2001, MOL CELL, V7, P571, DOI 10.1016/S1097-2765(01)00204-0; Michel B, 2004, P NATL ACAD SCI USA, V101, P12783, DOI 10.1073/pnas.0401586101; Nystrom T, 2002, CURR OPIN MICROBIOL, V5, P596, DOI 10.1016/S1369-5274(02)00367-3; Pellicioli A, 2001, MOL CELL, V7, P293, DOI 10.1016/S1097-2765(01)00177-0; Ponder RG, 2005, MOL CELL, V19, P791, DOI 10.1016/j.molcel.2005.07.025; Robu ME, 2001, P NATL ACAD SCI USA, V98, P8211, DOI 10.1073/pnas.131022698; Rothstein R, 2000, GENE DEV, V14, P1; Sat B, 2003, J BACTERIOL, V185, P1803, DOI 10.1128/JB.185.6.1803-1807.2003; Sincock SA, 2001, METHOD CELL BIOL, V64, P511; Slack A, 2006, PLOS GENET, V2, P385, DOI 10.1371/journal.pgen.0020048; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Wang XD, 2006, GENE DEV, V20, P1727, DOI 10.1101/gad.388406; Watve M, 2006, P NATL ACAD SCI USA, V103, P14831, DOI 10.1073/pnas.0606499103; Withers HL, 1998, J BACTERIOL, V180, P1624, DOI 10.1128/JB.180.7.1624-1631.1998	30	148	150	2	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2007	39	6					797	802		10.1038/ng2051	http://dx.doi.org/10.1038/ng2051			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17529976	Green Accepted			2022-12-27	WOS:000246859100026
J	Baala, L; Briault, S; Etchevers, HC; Laumonnier, F; Natiq, A; Amiel, J; Boddaert, N; Picard, C; Sbiti, A; Asermouh, A; Attie-Bitach, T; Encha-Razavi, F; Munnich, A; Sefiani, A; Lyonnet, S				Baala, Lekbir; Briault, Sylvain; Etchevers, Heather C.; Laumonnier, Frederic; Natiq, Abdelhafid; Amiel, Jeanne; Boddaert, Nathalie; Picard, Capucine; Sbiti, Aziza; Asermouh, Abdellah; Attie-Bitach, Tania; Encha-Razavi, Ferechte; Munnich, Arnold; Sefiani, Abdelaziz; Lyonnet, Stanislas			Homozygous silencing of T-box transcription factor EOMES leads to microcephaly with polymicrogyria and corpus callosum agenesis	NATURE GENETICS			English	Article							RADIAL GLIA; EOMESODERMIN; MOUSE; DIFFERENTIATION; EXPRESSION; NEOCORTEX; TBR2	Neural progenitor proliferation and migration influence brain size during neurogenesis. We report an autosomal recessive microcephaly syndrome cosegregating with a homozygous balanced translocation between chromosomes 3p and 10q, and we show that a position effect at the breakpoint on chromosome 3 silences the eomesodermin transcript (EOMES), also known as T-box-brain2 (TBR2). Together with the expression pattern of EOMES in the developing human brain, our data suggest that EOMES is involved in neuronal division and/or migration. Thus, mutations in genes encoding not only mitotic and apoptotic proteins but also transcription factors may be responsible for malformative microcephaly syndromes.	Hop Necker Enfants Malad, INSERM, U781, Dept Genet, Paris, France; Inst Natl Hyg, Dept Med Genet, Rabat, Morocco; INSERM, Fac Med, U619, Tours, France; Hop Necker Enfants Malad, Serv Radiol Pediat, Paris, France; Ctr Etud Deficits Immunitaires, Paris, France; CHU Avicenne, Hop Enfants, Rabat, Morocco; Univ Paris 05, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Mohammed V University in Rabat; Ibn sina University Hospital Center of Rabat; UDICE-French Research Universities; Universite Paris Cite	Lyonnet, S (corresponding author), Hop Necker Enfants Malad, INSERM, U781, Dept Genet, Paris, France.	lyonnet@necker.fr	Laumonnier, Frederic/N-1165-2016; ATTIE-BITACH, Tania/K-1453-2017; Picard, Capucine/H-3914-2017; amiel, jeanne/AGX-1124-2022; boddaert, nathalie/GWV-2865-2022; Lyonnet, Stanislas/H-5483-2017; Etchevers, Heather C./B-5813-2012; amiel, jeanne/H-3501-2017	Laumonnier, Frederic/0000-0003-2567-0708; ATTIE-BITACH, Tania/0000-0002-1155-3626; Picard, Capucine/0000-0001-8788-5056; Lyonnet, Stanislas/0000-0001-5426-9417; Etchevers, Heather C./0000-0003-0201-3799; amiel, jeanne/0000-0001-5973-4728; boddaert, nathalie/0000-0003-0991-7774				Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0; Barkovich AJ, 2005, NEUROLOGY, V65, P1873, DOI 10.1212/01.wnl.0000183747.05269.2d; Bulfone A, 1999, MECH DEVELOP, V84, P133, DOI 10.1016/S0925-4773(99)00053-2; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fernandez BA, 2005, CLIN GENET, V68, P349, DOI 10.1111/j.1399-0004.2005.00498.x; Fink AJ, 2006, J NEUROSCI, V26, P3066, DOI 10.1523/JNEUROSCI.5203-05.2006; Fougerousse F, 2000, HUM MOL GENET, V9, P165, DOI 10.1093/hmg/9.2.165; Hevner RF, 2006, NEUROSCI RES, V55, P223, DOI 10.1016/j.neures.2006.03.004; Kimura N, 1999, DEV BRAIN RES, V115, P183, DOI 10.1016/S0165-3806(99)00064-4; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515	14	140	144	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	APR	2007	39	4					454	456		10.1038/ng1993	http://dx.doi.org/10.1038/ng1993			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17353897				2022-12-27	WOS:000245271200014
J	Cabral, WA; Chang, W; Barnes, AM; Weis, M; Scott, MA; Leikin, S; Makareeva, E; Kuznetsova, NV; Rosenbaum, KN; Tifft, CJ; Bulas, DI; Kozma, C; Smith, PA; Eyre, DR; Marini, JC				Cabral, Wayne A.; Chang, Weizhong; Barnes, Aileen M.; Weis, MaryAnn; Scott, Melissa A.; Leikin, Sergey; Makareeva, Elena; Kuznetsova, Natalia V.; Rosenbaum, Kenneth N.; Tifft, Cynthia J.; Bulas, Dorothy I.; Kozma, Chahira; Smith, Peter A.; Eyre, David R.; Marini, Joan C.			Prolyl 3-hydroxylase 1 deficiency causes a recessive metabolic bone disorder resembling lethal/severe osteogenesis imperfecta	NATURE GENETICS			English	Article							MEMBRANE-ASSOCIATED PROTEOGLYCAN; CARTILAGE-ASSOCIATED PROTEIN; COLLAGEN TRIPLE-HELIX; I COLLAGEN; RESIDUES; MUTATIONS; LEPRECAN; IDENTIFICATION; FIBRILS; DISEASE	A recessive form of severe osteogenesis imperfecta that is not caused by mutations in type I collagen has long been suspected. Mutations in human CRTAP (cartilage-associated protein) causing recessive bone disease have been reported. CRTAP forms a complex with cyclophilin B and prolyl 3-hydroxylase 1, which is encoded by LEPRE1 and hydroxylates one residue in type I collagen, alpha 1(I) Pro986. We present the first five cases of a new recessive bone disorder resulting from null LEPRE1 alleles; its phenotype overlaps with lethal/severe osteogenesis imperfecta but has distinctive features. Furthermore, a mutant allele from West Africa, also found in African Americans, occurs in four of five cases. All proband LEPRE1 mutations led to premature termination codons and minimal mRNA and protein. Proband collagen had minimal 3-hydroxylation of alpha 1(I) Pro986 but excess lysyl hydroxylation and glycosylation along the collagen helix. Proband collagen secretion was moderately delayed, but total collagen secretion was increased. Prolyl 3-hydroxylase 1 is therefore crucial for bone development and collagen helix formation.	NICHHD, Bione & Extracellular Matrix Branach, NIH, Bethesda, MD 20892 USA; Univ Washington, Orthopaed Res Labs, Seattle, WA 98195 USA; NICHHD, Sect Phys Biochem, NIH, Bethesda, MD 20892 USA; Childrens Natl Med Ctr, Washington, DC 20010 USA; Childrens Natl Med Ctr, Dept Diagnost Imaging & Radiol, Washington, DC 20010 USA; Georgetown Univ Hosp, Dept Pediat, Washington, DC 20007 USA; Shriners Hosp Children, Chicago, IL 60707 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Children's National Health System; Children's National Health System; Georgetown University	Marini, JC (corresponding author), NICHHD, Bione & Extracellular Matrix Branach, NIH, Bethesda, MD 20892 USA.	oidoc@helix.nih.gov	Makareeva, Elena/F-5183-2011; Leikin, Sergey/A-5518-2008	Makareeva, Elena/0000-0002-5815-0760; Leikin, Sergey/0000-0001-7095-0739; Barnes, Aileen/0000-0001-8021-4997	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008830] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD008830, P01HD022657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR037318, R01AR036794, R37AR037318] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 HD008830] Funding Source: Medline; NIAMS NIH HHS [R01 AR036794, AR37318, R01 AR037318, R37 AR037318] Funding Source: Medline; NICHD NIH HHS [P01 HD022657, HD22657] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AITCHISON K, 1988, HUM GENET, V78, P233, DOI 10.1007/BF00291667; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Byers P, 2002, CONNECTIVE TISSUE IT, P385, DOI DOI 10.1002/0471221929.CH8; Cabral WA, 2003, J BIOL CHEM, V278, P10006, DOI 10.1074/jbc.M212523200; DAW S, 1988, J MED GENET, V25, P275; FIETZEK PP, 1972, EUR J BIOCHEM, V30, P163, DOI 10.1111/j.1432-1033.1972.tb02083.x; Forlino A, 1997, BIOCHEM MOL MED, V62, P26, DOI 10.1006/bmme.1997.2620; Jarnum S, 2004, BIOCHEM BIOPH RES CO, V317, P342, DOI 10.1016/j.bbrc.2004.03.060; Jenkins CL, 2003, J AM CHEM SOC, V125, P6422, DOI 10.1021/ja034015j; Kaul SC, 2000, ONCOGENE, V19, P3576, DOI 10.1038/sj.onc.1203696; Kefalides N A, 1973, Int Rev Connect Tissue Res, V6, P63; Labuda M, 2002, BONE, V31, P19, DOI 10.1016/S8756-3282(02)00808-6; Marini JC, 2004, NELSON TXB PEDIAT, P2336; Mizuno K, 2004, J BIOL CHEM, V279, P282, DOI 10.1074/jbc.M308181200; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Noensie EN, 2001, NAT BIOTECHNOL, V19, P434, DOI 10.1038/88099; RAGHUNATH M, 1994, J MOL BIOL, V236, P940, DOI 10.1006/jmbi.1994.1199; ROYCE PM, 1985, BIOCHEM J, V230, P475, DOI 10.1042/bj2300475; Schumacher MA, 2006, J BIOL CHEM, V281, P27566, DOI 10.1074/jbc.M602797200; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; Tonachini L, 1999, CYTOGENET CELL GENET, V87, P191, DOI 10.1159/000015463; TORREBLANCO A, 1992, J BIOL CHEM, V267, P2650; TRYGGVASON K, 1979, BIOCHEM J, V183, P303, DOI 10.1042/bj1830303; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; WALLIS GA, 1993, J MED GENET, V30, P492, DOI 10.1136/jmg.30.6.492; Wang CG, 2002, MATRIX BIOL, V21, P559, DOI 10.1016/S0945-053X(02)00071-9; Ward LM, 2002, BONE, V31, P12, DOI 10.1016/S8756-3282(02)00790-1; Wassnehove-McCarthy DJ, 1999, J BIOL CHEM, V274, P25004, DOI 10.1074/jbc.274.35.25004; Wu J, 2006, EXP CELL RES, V312, P3485, DOI 10.1016/j.yexcr.2006.07.013	30	310	331	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2007	39	3					359	365		10.1038/ng1968	http://dx.doi.org/10.1038/ng1968			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17277775	Green Accepted			2022-12-27	WOS:000244480000018
J	Bertram, L; McQueen, MB; Mullin, K; Blacker, D; Tanzi, RE				Bertram, Lars; McQueen, Matthew B.; Mullin, Kristina; Blacker, Deborah; Tanzi, Rudolph E.			Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database	NATURE GENETICS			English	Article							POLYMORPHISM; SUSCEPTIBILITY; POPULATION; RISK; BIAS; AGE	The past decade has witnessed hundreds of reports declaring or refuting genetic association with putative Alzheimer disease susceptibility genes. This wealth of information has become increasingly difficult to follow, much less interpret. We have created a publicly available, continuously updated database that comprehensively catalogs all genetic association studies in the field of Alzheimer disease (http://www.alzgene.org). We performed systematic meta-analyses for each polymorphism with available genotype data in at least three case-control samples. In addition to identifying the epsilon 4 allele of APOE and related effects, we pinpointed over a dozen potential Alzheimer disease susceptibility genes (ACE, CHRNB2, CST3, ESR1, GAPDHS, IDE, MTHFR, NCSTN, PRNP, PSEN1, TF, TFAM and TNF) with statistically significant allelic summary odds ratios (ranging from 1.11 - 1.38 for risk alleles and 0.92 - 0.67 for protective alleles). Our database provides a powerful tool for deciphering the genetics of Alzheimer disease, and it serves as a potential model for tracking the most viable gene candidates in other genetically complex diseases.	Massachusetts Gen Hosp, Dept Neurol, MIND, Dept Neurol,Genet & Aging Res Unit, Charlestown, MA 02129 USA; Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; Massachusetts Gen Hosp, Gerontol Res Unit, Dept Psychiat, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of Colorado System; University of Colorado Boulder; Harvard University; Massachusetts General Hospital	Bertram, L (corresponding author), Massachusetts Gen Hosp, Dept Neurol, MIND, Dept Neurol,Genet & Aging Res Unit, Charlestown, MA 02129 USA.	bertram@helix.mgh.harvard.edu	McQueen, Matthew/X-5845-2019; Tanzi, Rudolph/AAE-9622-2019; Bertram, Lars/K-3889-2015	Tanzi, Rudolph/0000-0002-7032-1454; Bertram, Lars/0000-0002-0108-124X	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD060726] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD060726] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Beffert U, 1999, NEUROSCI LETT, V259, P29, DOI 10.1016/S0304-3940(98)00888-X; Bertram L, 2004, HUM MOL GENET, V13, pR135, DOI 10.1093/hmg/ddh077; Bracken MB, 2005, AM J EPIDEMIOL, V162, P297, DOI 10.1093/aje/kwi200; Colhoun HM, 2003, LANCET, V361, P865, DOI 10.1016/S0140-6736(03)12715-8; DELBO R, 2006, NEUROBIOL AGING, V27; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Hirschhorn JN, 2002, GENET MED, V4, P45, DOI 10.1097/00125817-200203000-00002; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Ioannidis JPA, 2006, NAT GENET, V38, P3, DOI 10.1038/ng0106-3; Ioannidis JPA, 2001, NAT GENET, V29, P306, DOI 10.1038/ng749; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Lehmann DJ, 2005, AM J EPIDEMIOL, V162, P305, DOI 10.1093/aje/kwi202; Lehmann DJ, 2001, NEUROSCIENCE, V108, P541, DOI 10.1016/S0306-4522(01)00464-X; LEVIN M L, 1953, Acta Unio Int Contra Cancrum, V9, P531; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Rainero I, 2004, NEUROBIOL AGING, V25, P1293, DOI 10.1016/j.neurobiolaging.2004.02.011; ROCKHILL, 1998, AM J PUBLIC HLTH, V88, P15; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; Tanzi RE, 1999, J CLIN INVEST, V104, P1175, DOI 10.1172/JCI8593; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Trikalinos TA, 2006, AM J EPIDEMIOL, V163, P300, DOI 10.1093/aje/kwj046; Weedon MN, 2003, AM J HUM GENET, V73, P1208, DOI 10.1086/379285; Wu XD, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-S1-S97; Yang QH, 2003, EPIDEMIOLOGY, V14, P161, DOI 10.1097/00001648-200303000-00009; Yasuda M, 1999, J NEUROL NEUROSUR PS, V66, P722, DOI 10.1136/jnnp.66.6.722; Zurutuza L, 2000, EUR J HUM GENET, V8, P713, DOI 10.1038/sj.ejhg.5200513	30	1319	1370	2	98	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2007	39	1					17	23		10.1038/ng1934	http://dx.doi.org/10.1038/ng1934			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	17192785				2022-12-27	WOS:000243136500012
J	Richards, JB; Yuan, X; Geller, F; Waterworth, D; Bataille, V; Glass, D; Song, K; Waeber, G; Vollenweider, P; Aben, KKH; Kiemeney, LA; Walters, B; Soranzo, N; Thorsteinsdottir, U; Kong, A; Rafnar, T; Deloukas, P; Sulem, P; Stefansson, H; Stefansson, K; Spector, TD; Mooser, V				Richards, J. Brent; Yuan, Xin; Geller, Frank; Waterworth, Dawn; Bataille, Veronique; Glass, Daniel; Song, Kijoung; Waeber, Gerard; Vollenweider, Peter; Aben, Katja K. H.; Kiemeney, Lambertus A.; Walters, Bragi; Soranzo, Nicole; Thorsteinsdottir, Unnur; Kong, Augustine; Rafnar, Thorunn; Deloukas, Panos; Sulem, Patrick; Stefansson, Hreinn; Stefansson, Kari; Spector, Tim D.; Mooser, Vincent			Male-pattern baldness susceptibility locus at 20p11	NATURE GENETICS			English	Article							ANDROGEN RECEPTOR GENE; HAIR FOLLICLE; ALOPECIA; POLYMORPHISM; ASSOCIATION; RISK	We conducted a genome-wide association study for androgenic alopecia in 1,125 men and identified a newly associated locus at chromosome 20p11.22, confirmed in three independent cohorts (n = 1,650; OR = 1.60, P = 1.1 x 10(-14) for rs1160312). The one man in seven who harbors risk alleles at both 20p11.22 and AR (encoding the androgen receptor) has a sevenfold-increased odds of androgenic alopecia (OR = 7.12, P = 3.7 x 10(-15)).	[Richards, J. Brent; Bataille, Veronique; Glass, Daniel; Soranzo, Nicole; Spector, Tim D.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England; [Richards, J. Brent] McGill Univ, Fac Med, Jewish Gen Hosp, Dept Med, Montreal, PQ H3T 1E2, Canada; [Yuan, Xin; Waterworth, Dawn; Song, Kijoung; Mooser, Vincent] GlaxoSmithKline Inc, Div Genet, King Of Prussia, PA 19406 USA; [Geller, Frank; Walters, Bragi; Thorsteinsdottir, Unnur; Kong, Augustine; Rafnar, Thorunn; Sulem, Patrick; Stefansson, Hreinn; Stefansson, Kari] DeCode Genet, IS-101 Reykjavik, Iceland; [Waeber, Gerard; Vollenweider, Peter] CHUV Univ Hosp, Dept Internal Med, CH-1011 Lausanne, Switzerland; [Aben, Katja K. H.] Radboud Univ Nijmegen, Med Ctr, Comprehens Canc Ctr IKO, NL-6501 BG Nijmegen, Netherlands; [Aben, Katja K. H.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; [Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 GA Nijmegen, Netherlands; [Soranzo, Nicole; Deloukas, Panos] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England	University of London; King's College London; McGill University; GlaxoSmithKline; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Wellcome Trust Sanger Institute	Spector, TD (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London SE1 7EH, England.	tim.spector@kcl.ac.uk	Aben, Katja KH/G-9686-2016; Kiemeney, Lambertus A./D-3357-2009; Richards, J Brent/AAF-4225-2019; Walters, G. Bragi/L-4215-2013; Deloukas, Panos/B-2922-2013; Colaus, PsyColaus/K-6607-2013; Stefansson, Kari/AAE-7187-2019	Aben, Katja KH/0000-0002-0214-2147; Kiemeney, Lambertus A./0000-0002-2368-1326; Richards, J Brent/0000-0002-3746-9086; Walters, G. Bragi/0000-0002-5415-6487; Deloukas, Panos/0000-0001-9251-070X; Stefansson, Hreinn/0000-0002-9331-6666; Waeber, Gerard/0000-0003-4193-788X; Kong, Augustine/0000-0001-8193-5438; Soranzo, Nicole/0000-0003-1095-3852; Geller, Frank/0000-0002-9238-3269	GlaxoSmithKline; deCODE Genetics; Wellcome Trust; NIHR Biomedical Research Centre; Chronic Disease Research Foundation; Canadian Institutes of Health Research; EU [018827]	GlaxoSmithKline(GlaxoSmithKline); deCODE Genetics; Wellcome Trust(Wellcome TrustEuropean Commission); NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Chronic Disease Research Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EU(European Commission)	We wish to acknowledge the cooperation and dedication of the study participants and the personnel at the recruitment centers and core facilities. We would like to acknowledge the genotyping contributions of D. Smyth and J. Todd. This study was funded in part by GlaxoSmithKline; deCODE Genetics; the Wellcome Trust; NIHR Biomedical Research Centre (grant to Guys' and St. Thomas' Hospitals and King's College London); the Chronic Disease Research Foundation; the Canadian Institutes of Health Research (J. B. R.) and the Sixth Framework Program of the EU contract number 018827 (Polygene).	CASH TF, 1993, J AM ACAD DERMATOL, V29, P568, DOI 10.1016/0190-9622(93)70223-G; Domashenko A, 2000, NAT BIOTECHNOL, V18, P420, DOI 10.1038/74480; Ellis JA, 2001, J INVEST DERMATOL, V116, P452, DOI 10.1046/j.1523-1747.2001.01261.x; Hayes VM, 2005, CANCER EPIDEM BIOMAR, V14, P993, DOI 10.1158/1055-9965.EPI-04-0778; Hillmer AM, 2005, AM J HUM GENET, V77, P140, DOI 10.1086/431425; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Levy-Nissenbaum E, 2005, EUR J DERMATOL, V15, P339; LI LN, 1995, NAT MED, V1, P705, DOI 10.1038/nm0795-705; Littman AJ, 2005, ANN EPIDEMIOL, V15, P771, DOI 10.1016/j.annepidem.2005.02.013; Lo JC, 2006, J CLIN ENDOCR METAB, V91, P1357, DOI 10.1210/jc.2005-2430; Nyholt DR, 2003, J INVEST DERMATOL, V121, P1561, DOI 10.1111/j.1523-1747.2003.12615.x; Olsen E.A., 1994, DISORDERS HAIR GROWT, P257; Prodi DA, 2008, J INVEST DERMATOL, V128, P2268, DOI 10.1038/jid.2008.60; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1	14	82	84	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2008	40	11					1282	1284		10.1038/ng.255	http://dx.doi.org/10.1038/ng.255			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18849991	Green Accepted, Green Published			2022-12-27	WOS:000260501500017
J	Cooper, GM; Zerr, T; Kidd, JM; Eichler, EE; Nickerson, DA				Cooper, Gregory M.; Zerr, Troy; Kidd, Jeffrey M.; Eichler, Evan E.; Nickerson, Deborah A.			Systematic assessment of copy number variant detection via genome-wide SNP genotyping	NATURE GENETICS			English	Article							HIDDEN-MARKOV MODEL; STRUCTURAL VARIATION; SEGMENTAL DUPLICATIONS; ASSOCIATION; MAP; POLYMORPHISMS; DISORDERS; DISEASES; GENES	SNP genotyping has emerged as a technology to incorporate copy number variants (CNVs) into genetic analyses of human traits. However, the extent to which SNP platforms accurately capture CNVs remains unclear. Using independent, sequence-based CNV maps, we find that commonly used SNP platforms have limited or no probe coverage for a large fraction of CNVs. Despite this, in 9 samples we inferred 368 CNVs using Illumina SNP genotyping data and experimentally validated over two-thirds of these. We also developed a method (SNP-Conditional Mixture Modeling, SCIMM) to robustly genotype deletions using as few as two SNP probes. We find that HapMap SNPs are strongly correlated with 82% of common deletions, but the newest SNP platforms effectively tag about 50%. We conclude that currently available genome-wide SNP assays can capture CNVs accurately, but improvements in array designs, particularly in duplicated sequences, are necessary to facilitate more comprehensive analyses of genomic variation.	[Cooper, Gregory M.; Zerr, Troy; Kidd, Jeffrey M.; Eichler, Evan E.; Nickerson, Deborah A.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Eichler, Evan E.] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Cooper, GM (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.	coopergm@u.washington.edu	Cooper, Gregory/D-6914-2011	Cooper, Gregory/0000-0001-5509-9923; Kidd, Jeffrey/0000-0002-9631-1465	Merck, Jane Coffin Childs Memorial Fund Postdoctoral Fellowship; National Human Genome Research Institute (NHGRI) [T32 HG00035]; National Science Foundation; National Heart, Lung, and Blood Institute Programs [HL066682]; NHGRI [HG004120]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066682] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000035, P01HG004120] Funding Source: NIH RePORTER	Merck, Jane Coffin Childs Memorial Fund Postdoctoral Fellowship(Merck & Company); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Science Foundation(National Science Foundation (NSF)); National Heart, Lung, and Blood Institute Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank D. Peiffer and colleagues at Illumina for sharing Human 1M and HumanHap 550K genotyping data. We apologize to all colleagues whose work we could not cite because of space constraints. G. M. C. is supported by a Merck, Jane Coffin Childs Memorial Fund Postdoctoral Fellowship. T. Z. acknowledges support from the National Human Genome Research Institute (NHGRI) Interdisciplinary Training in Genomic Sciences grant T32 HG00035. J. M. K. is supported by a National Science Foundation graduate fellowship. This work was supported by the National Heart, Lung, and Blood Institute Programs for Genomic Applications grant HL066682 to D. A. N. and NHGRI grant HG004120 to E. E. E. E. E. E. is an investigator of the Howard Hughes Medical Institute.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Day N, 2007, BIOINFORMATICS, V23, P1424, DOI 10.1093/bioinformatics/btm096; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; Estivill X, 2007, PLOS GENET, V3, P1787, DOI 10.1371/journal.pgen.0030190; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Komura D, 2006, GENOME RES, V16, P1575, DOI 10.1101/gr.5629106; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; Newman TL, 2006, HUM MOL GENET, V15, P1159, DOI 10.1093/hmg/ddl031; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Shaffer LG, 2000, ANNU REV GENET, V34, P297, DOI 10.1146/annurev.genet.34.1.297; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; She XW, 2004, NATURE, V431, P927, DOI 10.1038/nature03062; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907	30	162	171	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2008	40	10					1199	1203		10.1038/ng.236	http://dx.doi.org/10.1038/ng.236			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18776910	Green Accepted			2022-12-27	WOS:000259651000019
J	Fagerholm, R; Hofstetter, B; Tommiska, J; Aaltonen, K; Vrtel, R; Syrjakoski, K; Kallioniemi, A; Kilpivaara, O; Mannermaa, A; Kosma, VM; Uusitupa, M; Eskelinen, M; Kataja, V; Aittomakii, K; von Smitten, K; Heikkila, P; Lukas, J; Holli, K; Bartkova, J; Blomqvist, C; Bartek, J; Nevanlinna, H				Fagerholm, Rainer; Hofstetter, Barbara; Tommiska, Johanna; Aaltonen, Kirsimari; Vrtel, Radek; Syrjakoski, Kirsi; Kallioniemi, Anne; Kilpivaara, Outi; Mannermaa, Arto; Kosma, Veli-Matti; Uusitupa, Matti; Eskelinen, Matti; Kataja, Vesa; Aittomakii, Kristiina; von Smitten, Karl; Heikkilae, Paeivi; Lukas, Jiri; Holli, Kaija; Bartkova, Jirina; Blomqvist, Carl; Bartek, Jiri; Nevanlinna, Heli			NAD(P)H : quinone oxidoreductase 1 NQO1(star)2 genotype (P187S) is a strong prognostic and predictive factor in breast cancer	NATURE GENETICS			English	Article							NAD(P)H QUINONE OXIDOREDUCTASE; P53 PROTEASOMAL DEGRADATION; KAPPA-B; POLYMORPHISM; NQO1; ALPHA; SUSCEPTIBILITY; CELLS; ASSOCIATION; APOPTOSIS	NQO1 guards against oxidative stress and carcinogenesis and stabilizes p53. We find that a homozygous common missense variant (NQO1*2, rs1800566(T), NM_000903.2:c.558C>T) that disables NQO1 strongly predicts poor survival among two independent series of women with breast cancer (P = 0.002, N = 1,005; P = 0.005, N = 1,162), an effect particularly evident after anthracycline-based adjuvant chemotherapy with epirubicin (P = 7.52 x 10(-6)) and in p53-aberrant tumors (P = 6.15 x 10(-5)). Survival after metastasis was reduced among NQO1*2 homozygotes, further implicating NQO1 deficiency in cancer progression and treatment resistance. Consistently, response to epirubicin was impaired in NQO1*2-homozygous breast carcinoma cells in vitro, reflecting both p53-linked and p53-independent roles of NQO1. We propose a model of defective anthracycline response in NQO1-deficient breast tumors, along with increased genomic instability promoted by elevated reactive oxygen species (ROS), and suggest that the NQO1 genotype is a prognostic and predictive marker for breast cancer.	[Hofstetter, Barbara; Vrtel, Radek; Lukas, Jiri; Bartkova, Jirina; Bartek, Jiri] Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark; [Hofstetter, Barbara; Vrtel, Radek; Lukas, Jiri; Bartkova, Jirina; Bartek, Jiri] Danish Canc Soc, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark; [Fagerholm, Rainer; Tommiska, Johanna; Aaltonen, Kirsimari; Kilpivaara, Outi; Nevanlinna, Heli] Univ Helsinki, Cent Hosp, Dept Obstet & Ginecol, FI-00029 Helsinki, Finland; [Aaltonen, Kirsimari] Univ Helsinki, Cent Hosp, Dept Oncol, FI-00029 Helsinki, Finland; [Syrjakoski, Kirsi; Kallioniemi, Anne] Univ Tampere, Inst Med Technol, FI-33014 Tampere, Finland; [Syrjakoski, Kirsi; Kallioniemi, Anne] Univ Tampere, Tampere Univ Hosp, Canc Genet Lab, FI-33014 Tampere, Finland; [Mannermaa, Arto; Kosma, Veli-Matti] Univ Kuopio, Inst Clin Med Pathol & Forens Med, FI-70211 Kuopio, Finland; [Mannermaa, Arto; Kosma, Veli-Matti] Kuopio Univ Hosp, Dept Pathol, FI-70211 Kuopio, Finland; [Uusitupa, Matti] Kuopio Univ Hosp, Dept Publ Hlth & Clin Nutr, FI-70211 Kuopio, Finland; [Eskelinen, Matti] Kuopio Univ Hosp, Dept Surg, FI-70211 Kuopio, Finland; [Kataja, Vesa] Kuopio Univ Hosp, Dept Oncol, FI-70211 Kuopio, Finland; [Kataja, Vesa] Vaasa Cent Hosp, Dept Oncol, FI-651000 Vaasa, Finland; [Aittomakii, Kristiina] Univ Helsinki, Cent Hosp, Dept Clin Genet, FI-00029 Helsinki, Finland; [von Smitten, Karl] Univ Helsinki, Cent Hosp, Dept Surg, FI-00029 Helsinki, Finland; [Heikkilae, Paeivi] Univ Helsinki, Cent Hosp, Dept Pathol, FI-00029 Helsinki, Finland; [Holli, Kaija] Tampere Univ Hosp, Palliat Unit, FI-33014 Tampere, Finland; [Holli, Kaija] Tampere Univ Hosp, Sch Med, FI-33014 Tampere, Finland; [Blomqvist, Carl] Univ Uppsala Hosp, Dept Oncol Radiol & Clin Immunol, SE-75185 Uppsala, Sweden; [Vrtel, Radek; Bartek, Jiri] Palacky Univ, Lab Genome Integr, CZ-77515 Olomouc, Czech Republic	Danish Cancer Society; Danish Cancer Society; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Tampere University; Tampere University; Tampere University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Vaasa Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Helsinki University Central Hospital; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Uppsala University; Uppsala University Hospital; Palacky University Olomouc	Bartek, J (corresponding author), Danish Canc Soc, Inst Canc Biol, DK-2100 Copenhagen, Denmark.	jb@cancer.dk; heli.nevanlinna@hus.fi	Uusitupa, Matti Ilmari Julius/AAX-4929-2020; Bartek, Jiri/G-5870-2014	Kallioniemi, Anne/0000-0003-3552-8158; Kataja, Vesa/0000-0003-4846-4843; Blomqvist, Carl/0000-0003-3041-1938; Nevanlinna, Heli/0000-0002-0916-2976; Lukas, Jiri/0000-0001-9087-506X; Tommiska, Johanna/0000-0001-7958-8262				Abe O, 2005, LANCET, V366, P2087; AHERN RP, 1993, BRIT J CANCER, V67, P801, DOI 10.1038/bjc.1993.146; Ahn KS, 2006, J BIOL CHEM, V281, P19798, DOI 10.1074/jbc.M601162200; Anwar A, 2003, J BIOL CHEM, V278, P10368, DOI 10.1074/jbc.M211981200; Arrigo AP, 2005, METHODS, V35, P126, DOI 10.1016/j.ymeth.2004.08.003; Asher G, 2002, P NATL ACAD SCI USA, V99, P3099, DOI 10.1073/pnas.052706799; Asher G, 2001, P NATL ACAD SCI USA, V98, P1188, DOI 10.1073/pnas.021558898; Asher G, 2005, CELL CYCLE, V4, P1015, DOI 10.4161/cc.4.8.1900; Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Berberoglu U, 2004, INT J BIOL MARKER, V19, P130, DOI 10.1177/172460080401900207; Beyer RE, 1996, P NATL ACAD SCI USA, V93, P2528, DOI 10.1073/pnas.93.6.2528; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Estevam FR, 2005, CANCER IMMUNOL IMMUN, V54, P671, DOI 10.1007/s00262-004-0639-0; Fitzgibbons PL, 2000, ARCH PATHOL LAB MED, V124, P966; Fossati R, 1998, J CLIN ONCOL, V16, P3439, DOI 10.1200/JCO.1998.16.10.3439; Fowke JH, 2004, CANCER EPIDEM BIOMAR, V13, P1308; Garte S, 2005, CHEM-BIOL INTERACT, V153, P247, DOI 10.1016/j.cbi.2005.03.030; Goldhirsch A, 2001, J CLIN ONCOL, V19, P3817, DOI 10.1200/JCO.2001.19.18.3817; Goode EL, 2002, CANCER RES, V62, P3052; Iskander K, 2005, CANCER RES, V65, P2054, DOI 10.1158/0008-5472.CAN-04-3157; Janssens S, 2006, CELL DEATH DIFFER, V13, P773, DOI 10.1038/sj.cdd.4401843; Kelsey KT, 1997, BRIT J CANCER, V76, P852, DOI 10.1038/bjc.1997.474; Kovalenko A, 2006, MOL CELL, V22, P433, DOI 10.1016/j.molcel.2006.05.002; Krajinovic M, 2002, INT J CANCER, V97, P230, DOI 10.1002/ijc.1589; Krajinovic M, 2002, CLIN CANCER RES, V8, P802; Larson RA, 1999, BLOOD, V94, P803, DOI 10.1182/blood.V94.2.803.414k44_803_807; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Long DJ, 2000, CANCER RES, V60, P5913; Menzel HJ, 2004, BRIT J CANCER, V90, P1989, DOI 10.1038/sj.bjc.6601779; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Naoe T, 2000, CLIN CANCER RES, V6, P4091; Nioi P, 2004, MUTAT RES-FUND MOL M, V555, P149, DOI 10.1016/j.mrfmmm.2004.05.023; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Perik PJ, 2006, ACTA ONCOL, V45, P175, DOI 10.1080/02841860500482225; Pritchard KI, 2006, NEW ENGL J MED, V354, P2103, DOI 10.1056/NEJMoa054504; Rothman N, 1997, CANCER RES, V57, P2839; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sarmanova J, 2004, EUR J HUM GENET, V12, P848, DOI 10.1038/sj.ejhg.5201249; Siegel D, 1999, PHARMACOGENETICS, V9, P113, DOI 10.1097/00008571-199902000-00015; Siegel D, 2001, MOL PHARMACOL, V59, P263, DOI 10.1124/mol.59.2.263; Siegel D, 1997, MOL PHARMACOL, V52, P300, DOI 10.1124/mol.52.2.300; Siegel D, 2004, MOL PHARMACOL, V65, P1238, DOI 10.1124/mol.65.5.1238; Siemankowski LM, 2000, CANCER RES, V60, P3638; Smith MT, 2002, BLOOD, V100, P4590, DOI 10.1182/blood-2001-12-0264; Tommiska J, 2005, CLIN CANCER RES, V11, P5098, DOI 10.1158/1078-0432.CCR-05-0173; Toyama T, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1682; Wiemels JL, 1999, CANCER RES, V59, P4095; Winski SL, 2001, BIOCHEM PHARMACOL, V61, P1509, DOI 10.1016/S0006-2952(01)00631-1; Wu ZH, 2006, SCIENCE, V311, P1141, DOI 10.1126/science.1121513	49	171	180	2	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2008	40	7					844	853		10.1038/ng.155	http://dx.doi.org/10.1038/ng.155			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	319MA	18511948				2022-12-27	WOS:000257166500019
J	Novembre, J; Stephens, M				Novembre, John; Stephens, Matthew			Interpreting principal component analyses of spatial population genetic variation	NATURE GENETICS			English	Article							SYNTHETIC MAPS; DEMIC EXPANSIONS; ASSOCIATION; STRATIFICATION; EUROPE; ORIGIN	Nearly 30 years ago, Cavalli-Sforza et al. pioneered the use of principal component analysis (PCA) in population genetics and used PCA to produce maps summarizing human genetic variation across continental regions(1). They interpreted gradient and wave patterns in these maps as signatures of specific migration events(1-3). These interpretations have been controversial(4-7), but influential(8), and the use of PCA has become widespread in analysis of population genetics data(9-13). However, the behavior of PCA for genetic data showing continuous spatial variation, such as might exist within human continental groups, has been less well characterized. Here, we find that gradients and waves observed in Cavalli-Sforza et al.'s maps resemble sinusoidal mathematical artifacts that arise generally when PCA is applied to spatial data, implying that the patterns do not necessarily reflect specific migration events. Our findings aid interpretation of PCA results and suggest how PCA can help correct for continuous population structure in association studies.	[Novembre, John; Stephens, Matthew] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Stephens, M (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St,CLSC 5th Floor, Chicago, IL 60637 USA.	stephens@galton.uchicago.edu	Novembre, John/G-1339-2011		NHGRI NIH HHS [R01 HG002585, R01 HG02585-01] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002585] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		AHMED N, 1974, IEEE T COMPUT, VC 23, P90, DOI 10.1109/T-C.1974.223784; Bauchet M, 2007, AM J HUM GENET, V80, P948, DOI 10.1086/513477; Brillinger D. R., 1975, TIME SERIES DATA ANA; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; CAVALLISFORZA LL, 1993, SCIENCE, V259, P639, DOI 10.1126/science.8430313; Currat M, 2005, P ROY SOC B-BIOL SCI, V272, P679, DOI 10.1098/rspb.2004.2999; DIACONIS P, IN PRESS ANN APPL ST; FREIBERGER WF, 1960, INT DICT APPL MATH; Haak W, 2005, SCIENCE, V310, P1016, DOI 10.1126/science.1118725; Handley LJL, 2007, TRENDS GENET, V23, P432, DOI 10.1016/j.tig.2007.07.002; Hanotte O, 2002, SCIENCE, V296, P336, DOI 10.1126/science.1069878; Heidemann G, 2006, IEEE T PATTERN ANAL, V28, P822, DOI 10.1109/TPAMI.2006.107; INWIN DE, 2005, SCIENCE, V307, P414; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; MENOZZI P, 1978, SCIENCE, V201, P786, DOI 10.1126/science.356262; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pinhasi R, 2005, PLOS BIOL, V3, P2220, DOI 10.1371/journal.pbio.0030410; Podani J, 2002, ECOLOGY, V83, P3331; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; RENDINE S, 1986, AM NAT, V128, P681, DOI 10.1086/284597; Rendine S, 1999, HUM BIOL, V71, P15; RICHMAN MB, 1986, J CLIMATOL, V6, P293, DOI 10.1002/joc.3370060305; Semino O, 2004, AM J HUM GENET, V74, P1023, DOI 10.1086/386295; Sokal RR, 1999, HUM BIOL, V71, P1; Wakefield J, 2007, BIOSTATISTICS, V8, P158, DOI 10.1093/biostatistics/kxl008; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210	30	356	358	2	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					646	649		10.1038/ng.139	http://dx.doi.org/10.1038/ng.139			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18425127	Green Accepted			2022-12-27	WOS:000255366700034
J	Twigger, SN; Pruitt, KD; Fernandez-Suarez, XM; Karolchik, D; Worley, KC; Maglott, DR; Brown, G; Weinstock, G; Gibbs, RA; Kent, J; Birney, E; Jacob, HJ				Twigger, Simon N.; Pruitt, Kim D.; Fernandez-Suarez, Xose M.; Karolchik, Donna; Worley, Kim C.; Maglott, Donna R.; Brown, Garth; Weinstock, George; Gibbs, Richards A.; Kent, Jim; Birney, Ewan; Jacob, Howard J.			What everybody should know about the rat genome and its online resources	NATURE GENETICS			English	Editorial Material							DATABASE; GENE; MOUSE; SEQUENCE; BROWSER	It has been four years since the original publication of the draft sequence of the rat genome. Five groups are now working together to assemble, annotate and release an updated version of the rat genome. As the prevailing model for physiology, complex disease and pharmacological studies, there is an acute need for the rat's genomic resources to keep pace with the rat's prominence in the laboratory. In this commentary, we describe the current status of the rat genome sequence and the plans for its impending 'upgrade'. We then cover the key online resources providing access to the rat genome, including the new SNP views at Ensembl, the RefSeq and Genes databases at the US National Center for Biotechnology Information, Genome Browser at the University of California Santa Cruz and the disease portals for cardiovascular disease and obesity at the Rat Genome Database.	[Twigger, Simon N.; Jacob, Howard J.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Pruitt, Kim D.; Karolchik, Donna] Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; [Fernandez-Suarez, Xose M.; Birney, Ewan] European Bioinformat Inst, Cambridge CB10 1SD, England; [Maglott, Donna R.; Kent, Jim] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Worley, Kim C.; Weinstock, George; Gibbs, Richards A.] Baylor Coll Med, Houston, TX 77030 USA	Medical College of Wisconsin; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); European Molecular Biology Laboratory (EMBL); University of California System; University of California Santa Cruz; Baylor College of Medicine	Twigger, SN (corresponding author), Med Coll Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	simont@hmgc.mcw.edu	Weinstock, George M/C-6314-2013; Fernandez, Xose/ABA-7117-2020	Weinstock, George M/0000-0002-2997-4592; Fernandez, Xose/0000-0001-7139-6215; Birney, Ewan/0000-0001-8314-8497; Pruitt, Kim/0000-0001-7950-1374; Twigger, Simon/0000-0001-5659-3632; Worley, Kim/0000-0002-0282-1000	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064541] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; Intramural NIH HHS [Z99 LM999999] Funding Source: Medline; NHGRI NIH HHS [HG-002273, U54 HG003273, U41 HG002273, R01 HG002273, P41 HG002273, HG-003273] Funding Source: Medline; NHLBI NIH HHS [R01 HL064541, HL-64541] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aitman TJ, 2008, NAT GENET, V40, P516, DOI 10.1038/ng.147; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Bodenreider O, 2006, BRIEF BIOINFORM, V7, P256, DOI 10.1093/bib/bbl027; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Cunningham F, 2006, NAT GENET, V38, P853, DOI 10.1038/ng0806-853a; Curwen V, 2004, GENOME RES, V14, P942, DOI 10.1101/gr.1858004; Eyras E, 2004, GENOME RES, V14, P976, DOI 10.1101/gr.1862204; FERNANDEZSUAREZ XM, 2006, SILICO GENOMICS PROT, P109; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kasprzyk A, 2004, GENOME RES, V14, P160, DOI 10.1101/gr.1645104; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Maglott D, 2007, NUCLEIC ACIDS RES, V35, pD26, DOI 10.1093/nar/gkl993; Mueller M, 2006, BIOINFORMATICS, V22, P509, DOI 10.1093/bioinformatics/btk007; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Saar K, 2008, NAT GENET, V40, P560, DOI 10.1038/ng.124; Smith CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r7; Twigger SN, 2007, NUCLEIC ACIDS RES, V35, pD658, DOI 10.1093/nar/gkl988; Walker JR, 2004, GENOME RES, V14, P742, DOI 10.1101/gr.2161804; Worley KC, 2008, PHYSIOL GENOMICS, V32, P273, DOI 10.1152/physiolgenomics.00208.2007; Zimdahl H, 2004, SCIENCE, V303, P807, DOI 10.1126/science.1092427	24	35	37	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2008	40	5					523	527		10.1038/ng0508-523	http://dx.doi.org/10.1038/ng0508-523			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	293WS	18443589	Green Accepted			2022-12-27	WOS:000255366700017
J	Puschendorf, M; Terranova, R; Boutsma, E; Mao, XH; Isono, KI; Brykczynska, U; Kolb, C; Otte, AP; Koseki, H; Orkin, SH; van Lohuizen, M; Peters, AHFM				Puschendorf, Mareike; Terranova, Remi; Boutsma, Erwin; Mao, Xiaohong; Isono, Kyo-ichi; Brykczynska, Urszula; Kolb, Carolin; Otte, Arie P.; Koseki, Haruhiko; Orkin, Stuart H.; van Lohuizen, Maarten; Peters, Antoine H. F. M.			PRC1 and Suv39h specify parental asymmetry at constitutive heterochromatin in early mouse embryos	NATURE GENETICS			English	Article							REPRESSIVE HISTONE METHYLATION; H3 LYSINE-9 METHYLATION; PERICENTRIC HETEROCHROMATIN; X-INACTIVATION; SATELLITE REPEATS; DNA METHYLATION; CLONED EMBRYOS; GROUP PROTEINS; POLYCOMB; CHROMATIN	In eukaryotes, Suv39h H3K9 trimethyltransferases are required for pericentric heterochromatin formation and function. In early mouse preimplantation embryos, however, paternal pericentric heterochromatin lacks Suv39h-mediated H3K9me3 and downstream marks. Here we demonstrate Ezh2-independent targeting of maternally provided polycomb repressive complex 1 (PRC1) components to paternal heterochromatin. In Suv39h2 maternally deficient zygotes, PRC1 also associates with maternal heterochromatin lacking H3K9me3, thereby revealing hierarchy between repressive pathways. In Rnf2 maternally deficient zygotes, the PRC1 complex is disrupted, and levels of pericentric major satellite transcripts are increased at the paternal but not the maternal genome. We conclude that in early embryos, Suv39h-mediated H3K9me3 constitutes the dominant maternal transgenerational signal for pericentric heterochromatin formation. In absence of this signal, PRC1 functions as the default repressive back-up mechanism. Parental epigenetic asymmetry, also observed along cleavage chromosomes, is resolved by the end of the 8-cell stage-concurrent with blastomere polarization-marking the end of the maternal-to-embryonic transition.	[Puschendorf, Mareike; Terranova, Remi; Brykczynska, Urszula; Kolb, Carolin; Peters, Antoine H. F. M.] Friedrich Miescher Inst, CH-4058 Basel, Switzerland; [Boutsma, Erwin; van Lohuizen, Maarten] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands; [Boutsma, Erwin; van Lohuizen, Maarten] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands; [Mao, Xiaohong; Orkin, Stuart H.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Mao, Xiaohong; Orkin, Stuart H.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Harvard Stem Cell Inst, Boston, MA 02115 USA; [Isono, Kyo-ichi; Koseki, Haruhiko] RIKEN Yokohama Inst, RIKEN Res Ctr Allergy & Immunol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Otte, Arie P.] Univ Amsterdam, Swammerdam Inst Life Sci, NL-1098 SM Amsterdam, Netherlands	Friedrich Miescher Institute for Biomedical Research; Netherlands Cancer Institute; Netherlands Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; RIKEN; University of Amsterdam	Peters, AHFM (corresponding author), Friedrich Miescher Inst, Maulbeerst 66, CH-4058 Basel, Switzerland.	antoine.peters@fmi.ch	Peters, Antoine/ABA-6283-2020; Koseki, Haruhiko/I-3825-2014; Albert, Mareike/AAJ-5980-2020	Koseki, Haruhiko/0000-0001-8424-5854; Albert, Mareike/0000-0001-9855-9344; Isono, Kyoichi/0000-0002-4609-8985; Peters, Antoine/0000-0002-0311-1887				Aoki F, 1997, DEV BIOL, V181, P296, DOI 10.1006/dbio.1996.8466; Arney KL, 2002, INT J DEV BIOL, V46, P317; Baxter J, 2004, EMBO J, V23, P4462, DOI 10.1038/sj.emboj.7600414; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Blewitt ME, 2006, PLOS GENET, V2, P399, DOI 10.1371/journal.pgen.0020049; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chong SY, 2007, NAT GENET, V39, P614, DOI 10.1038/ng2031; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Ekwall K, 1996, J CELL SCI, V109, P2637; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Fujimura Y, 2006, DEVELOPMENT, V133, P2371, DOI 10.1242/dev.02405; Govin J, 2007, J CELL BIOL, V176, P283, DOI 10.1083/jcb.200604141; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Johnson M H, 1986, Dev Biol (N Y 1985), V4, P279; Kishigami S, 2006, DEV BIOL, V289, P195, DOI 10.1016/j.ydbio.2005.10.026; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Leeb M, 2007, J CELL BIOL, V178, P219, DOI 10.1083/jcb.200612127; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; Liu HL, 2004, DEVELOPMENT, V131, P2269, DOI 10.1242/dev.01116; Lu J, 2007, J CELL BIOL, V179, P411, DOI 10.1083/jcb.200706176; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Martin C, 2006, DEV BIOL, V292, P317, DOI 10.1016/j.ydbio.2006.01.009; Mayer W, 2000, J CELL BIOL, V148, P629, DOI 10.1083/jcb.148.4.629; Merico V, 2007, CHROMOSOME RES, V15, P341, DOI 10.1007/s10577-007-1130-5; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Peters AHFM, 2005, CURR OPIN CELL BIOL, V17, P230, DOI 10.1016/j.ceb.2005.02.006; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Probst AV, 2007, CHROMOSOMA, V116, P403, DOI 10.1007/s00412-007-0106-8; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rudolph T, 2007, MOL CELL, V26, P103, DOI 10.1016/j.molcel.2007.02.025; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Sun F, 2007, CELL RES, V17, P117, DOI 10.1038/cr.2007.1; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467; van der Heijden GW, 2006, DEV BIOL, V298, P458, DOI 10.1016/j.ydbio.2006.06.051; van der Heijden GW, 2005, MECH DEVELOP, V122, P1008, DOI 10.1016/j.mod.2005.04.009; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; WUSTMANN G, 1989, MOL GEN GENET, V217, P520, DOI 10.1007/BF02464926; Yoshida N, 2007, DEV BIOL, V301, P464, DOI 10.1016/j.ydbio.2006.08.006	49	248	251	1	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2008	40	4					411	420		10.1038/ng.99	http://dx.doi.org/10.1038/ng.99			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18311137				2022-12-27	WOS:000254388100011
J	Kathiresan, S; Melander, O; Guiducci, C; Surti, A; Burtt, NP; Rieder, MJ; Cooper, GM; Roos, C; Voight, BF; Havulinna, AS; Wahlstrand, B; Hedner, T; Corella, D; Tai, ES; Ordovas, JM; Berglund, G; Vartiainen, E; Jousilahti, P; Hedblad, B; Taskinen, MR; Newton-Cheh, C; Salomaa, V; Peltonen, L; Groop, L; Altshuler, DM; Orho-Melander, M				Kathiresan, Sekar; Melander, Olle; Guiducci, Candace; Surti, Aarti; Burtt, Noel P.; Rieder, Mark J.; Cooper, Gregory M.; Roos, Charlotta; Voight, Benjamin F.; Havulinna, Aki S.; Wahlstrand, Bjorn; Hedner, Thomas; Corella, Dolores; Tai, E. Shyong; Ordovas, Jose M.; Berglund, Goran; Vartiainen, Erkki; Jousilahti, Pekka; Hedblad, Bo; Taskinen, Marja-Riitta; Newton-Cheh, Christopher; Salomaa, Veikko; Peltonen, Leena; Groop, Leif; Altshuler, David M.; Orho-Melander, Marju			Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans	NATURE GENETICS			English	Article							CORONARY-HEART-DISEASE; PLASMA-LEVELS; CARDIOVASCULAR RISK; GENERAL-POPULATION; HDL CHOLESTEROL; LIPASE; POLYMORPHISM; CONTRIBUTES; HAPLOTYPES; PROTEIN	Blood concentrations of lipoproteins and lipids are heritable(1) risk factors for cardiovascular disease(2,3). Using genome-wide association data from three studies (n = 8,816 that included 2,758 individuals from the Diabetes Genetics Initiative specific to the current paper as well as 1,874 individuals from the FUSION study of type 2 diabetes and 4,184 individuals from the SardiNIA study of aging-associated variables reported in a companion paper in this issue(4)) and targeted replication association analyses in up to 18,554 independent participants, we show that common SNPs at 18 loci are reproducibly associated with concentrations of low-density lipoprotein (LDL) cholesterol, high-density lipoprotein (HDL) cholesterol, and/or triglycerides. Six of these loci are new (P < 5 x 10(-8) for each new locus). Of the six newly identified chromosomal regions, two were associated with LDL cholesterol (1p13 near CELSR2, PSRC1 and SORT1 and 19p13 near CILP2 and PBX4), one with HDL cholesterol (1q42 in GALNT2) and five with triglycerides (7q11 near TBL2 and MLXIPL, 8q24 near TRIB1, 1q42 in GALNT2, 19p13 near CILP2 and PBX4 and 1p31 near ANGPTL3). At 1p13, the LDL-associated SNP was also strongly correlated with CELSR2, PSRC1, and SORT1 transcript levels in human liver, and a proxy for this SNP was recently shown to affect risk for coronary artery disease(5). Understanding the molecular, cellular and clinical consequences of the newly identified loci may inform therapy and clinical care.	[Kathiresan, Sekar; Newton-Cheh, Christopher] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Kathiresan, Sekar; Guiducci, Candace; Surti, Aarti; Burtt, Noel P.; Voight, Benjamin F.; Newton-Cheh, Christopher; Peltonen, Leena; Altshuler, David M.] MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Kathiresan, Sekar; Guiducci, Candace; Surti, Aarti; Burtt, Noel P.; Voight, Benjamin F.; Newton-Cheh, Christopher; Peltonen, Leena; Altshuler, David M.] Harvard Univ, Cambridge, MA 02142 USA; [Kathiresan, Sekar; Newton-Cheh, Christopher; Altshuler, David M.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Melander, Olle] Lund Univ, Malmo Univ Hosp, Dept Clin Sci Hypertens & Cardiovasc Dis, S-20502 Malmo, Sweden; [Rieder, Mark J.; Cooper, Gregory M.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Roos, Charlotta; Groop, Leif; Orho-Melander, Marju] Lund Univ, Malmo Univ Hosp, Dept Clin Sci Diabet & Endocrinol, S-20502 Malmo, Sweden; [Voight, Benjamin F.; Altshuler, David M.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Voight, Benjamin F.; Altshuler, David M.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Havulinna, Aki S.; Vartiainen, Erkki; Jousilahti, Pekka; Salomaa, Veikko; Peltonen, Leena] Natl Publ Hlth Inst, SF-00300 Helsinki, Finland; [Wahlstrand, Bjorn; Hedner, Thomas] Sahlgrens Univ Hosp, Dept Clin Pharmacol, S-41345 Gothenburg, Sweden; [Corella, Dolores] Univ Valencia, Sch Med, Dept Prevent Med, Valencia 46010, Spain; [Tai, E. Shyong] Singapore Gen Hosp, Dept Endocrinol, Singapore 169608, Singapore; [Ordovas, Jose M.] Tufts Univ, Nutr & Genom Lab, Jean Mayer US Dept Agr, Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Berglund, Goran] Lund Univ, Malmo Univ Hosp, Dept Internal Med, S-20502 Malmo, Sweden; [Hedblad, Bo] Lund Univ, Malmo Univ Hosp, Dept Epidemiol Res, S-20502 Malmo, Sweden; [Taskinen, Marja-Riitta] Univ Helsinki, Dept Med, Helsinki 00029, Finland; [Peltonen, Leena] Univ Helsinki, Dept Med Genet, Helsinki 00029, Finland; [Peltonen, Leena] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Groop, Leif] Helsinki Univ Hosp, Dept Med, Helsinki 00029, Finland; [Altshuler, David M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Harvard Medical School; Lund University; Skane University Hospital; University of Washington; University of Washington Seattle; Lund University; Skane University Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Finland National Institute for Health & Welfare; Sahlgrenska University Hospital; University of Valencia; Singapore General Hospital; Tufts University; United States Department of Agriculture (USDA); Lund University; Skane University Hospital; Lund University; Skane University Hospital; University of Helsinki; University of Helsinki; Wellcome Trust Sanger Institute; University of Helsinki; Helsinki University Central Hospital; Harvard University; Harvard Medical School	Kathiresan, S (corresponding author), Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA.	skathiresan@partners.org; marju.orho-melander@med.lu.se	Altshuler, David M/A-4476-2009; Tai, E Shyong/J-9831-2013; Cooper, Gregory/D-6914-2011; Havulinna, Aki/AAM-4769-2021; Taskinen, Marja-Riitta/AAN-5432-2020; Voight, Benjamin/F-1775-2011; Ordovas, Jose/B-8727-2013	Altshuler, David M/0000-0002-7250-4107; Cooper, Gregory/0000-0001-5509-9923; Taskinen, Marja-Riitta/0000-0002-6229-3588; Tai, E Shyong/0000-0003-2929-8966; Melander, Olle/0000-0002-2581-484X; Voight, Benjamin/0000-0002-6205-9994; Ordovas, Jose/0000-0002-7581-5680	Wellcome Trust [089061] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Benn M, 2005, J CLIN ENDOCR METAB, V90, P5797, DOI 10.1210/jc.2005-0974; BERGLUND G, 1993, J INTERN MED, V233, P45, DOI 10.1111/j.1365-2796.1993.tb00647.x; Boekholdt SM, 2005, CIRCULATION, V111, P278, DOI 10.1161/01.CIR.0000153341.46271.40; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Cutter J, 2001, B WORLD HEALTH ORGAN, V79, P908; DEEKS JJ, 2007, COCHRANE HDB SYSTEMA; Frikke-Schmidt R, 2004, J CLIN INVEST, V114, P1343, DOI 10.1172/JCI200420361; Guerra R, 1997, P NATL ACAD SCI USA, V94, P4532, DOI 10.1073/pnas.94.9.4532; Hansson L, 2000, LANCET, V356, P359, DOI 10.1016/S0140-6736(00)02526-5; Hutter CM, 2006, ATHEROSCLEROSIS, V185, P78, DOI 10.1016/j.atherosclerosis.2005.05.033; KANNEL WB, 1961, ANN INTERN MED, V55, P33, DOI 10.7326/0003-4819-55-1-33; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; Knoblauch H, 2004, HUM MOL GENET, V13, P993, DOI 10.1093/hmg/ddh119; Koishi R, 2002, NAT GENET, V30, P151, DOI 10.1038/ng814; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; MILLER NE, 1975, LANCET, V1, P1033, DOI 10.1016/S0140-6736(75)91977-7; NAMBOODIRI K K, 1985, Genetic Epidemiology, V2, P227, DOI 10.1002/gepi.1370020302; Nielsen MS, 1999, J BIOL CHEM, V274, P8832, DOI 10.1074/jbc.274.13.8832; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rip J, 2006, ARTERIOSCL THROM VAS, V26, P1236, DOI 10.1161/01.ATV.0000219283.10832.43; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; SING CF, 1985, AM J HUM GENET, V37, P268; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Vartiainen E, 2000, INT J EPIDEMIOL, V29, P49, DOI 10.1093/ije/29.1.49; WILLER CJ, 2008, NAT GENET       0103	30	1092	1123	0	78	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	FEB	2008	40	2					189	197		10.1038/ng.75	http://dx.doi.org/10.1038/ng.75			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18193044	Green Accepted			2022-12-27	WOS:000252732900017
J	MacArthur, DG; Seto, JT; Raftery, JM; Quinlan, KG; Huttley, GA; Hook, JW; Lemckert, FA; Kee, AJ; Edwards, MR; Berman, Y; Hardeman, EC; Gunning, PW; Easteal, S; Yang, N; North, KN				MacArthur, Daniel G.; Seto, Jane T.; Raftery, Joanna M.; Quinlan, Kate G.; Huttley, Gavin A.; Hook, Jeff W.; Lemckert, Frances A.; Kee, Anthony J.; Edwards, Michael R.; Berman, Yemima; Hardeman, Edna C.; Gunning, Peter W.; Easteal, Simon; Yang, Nan; North, Kathryn N.			Loss of ACTN3 gene function alters mouse muscle metabolism and shows evidence of positive selection in humans	NATURE GENETICS			English	Article							ALPHA-ACTININ-3; PERFORMANCE; DEFICIENCY; ENDURANCE; GENOTYPE	More than a billion humans worldwide are predicted to be completely deficient in the fast skeletal muscle fiber protein alpha-actinin-3 owing to homozygosity for a premature stop codon polymorphism, R577X, in the ACTN3 gene. The R577X polymorphism is associated with elite athlete status and human muscle performance, suggesting that alpha-actinin-3 deficiency influences the function of fast muscle fibers. Here we show that loss of alpha-actinin-3 expression in a knockout mouse model results in a shift in muscle metabolism toward the more efficient aerobic pathway and an increase in intrinsic endurance performance. In addition, we demonstrate that the genomic region surrounding the 577X null allele shows low levels of genetic variation and recombination in individuals of European and East Asian descent, consistent with strong, recent positive selection. We propose that the 577X allele has been positively selected in some human populations owing to its effect on skeletal muscle metabolism.	Childrens Hosp Westmead, Inst Neuromascular Res, Sydney, NSW 2145, Australia; Univ Sydney, Fac Med, Discipline Paediatric & Child Hlth, Sydney, NSW 2006, Australia; Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 0200, Australia; Childrens Hosp Westmead, Oncol Res Unit, Sydney, NSW 2145, Australia; Childrens Med Res Inst, Muscle Dev Unit, Sydney, NSW 2145, Australia; Univ New S Wales, Sydney, NSW 2052, Australia	University of Sydney; University of Sydney; Australian National University; John Curtin School of Medical Research; University of Sydney; Children's Medical Research Institute - Australia; University of Sydney; University of New South Wales Sydney	North, KN (corresponding author), Childrens Hosp Westmead, Inst Neuromascular Res, Sydney, NSW 2145, Australia.	kathryn@chw.edu.au	Seto, Jane/AAN-4581-2021; Hardeman, Edna C/F-8872-2012; Huttley, Gavin A/G-5169-2015; Gunning, Peter W/E-9058-2010; North, Kathryn N/K-6476-2012; MacArthur, Daniel/E-3275-2010	Huttley, Gavin A/0000-0001-7224-2074; North, Kathryn N/0000-0003-0841-8009; Gunning, Peter/0000-0003-0833-3128; Berman, Yemima/0000-0003-2495-4928; Easteal, Simon/0000-0002-0462-502X; Seto, Jane/0000-0003-2864-6199; MacArthur, Daniel/0000-0002-5771-2290; Quinlan, Kate/0000-0002-5722-8183; Hardeman, Edna/0000-0003-1649-7712				Clarkson PM, 2005, J APPL PHYSIOL, V99, P154, DOI 10.1152/japplphysiol.01139.2004; Cooper ST, 2003, NEUROLOGY, V61, P93, DOI 10.1212/01.WNL.0000069460.53438.38; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Jones KJ, 2003, NEUROMUSCULAR DISORD, V13, P456, DOI 10.1016/S0960-8966(03)00066-X; Knight R, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r171; Koch LG, 2001, PHYSIOL GENOMICS, V5, P45, DOI 10.1152/physiolgenomics.2001.5.1.45; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Mills MA, 2001, HUM MOL GENET, V10, P1335, DOI 10.1093/hmg/10.13.1335; Moran CN, 2007, EUR J HUM GENET, V15, P88, DOI 10.1038/sj.ejhg.5201724; Niemi AK, 2005, EUR J HUM GENET, V13, P965, DOI 10.1038/sj.ejhg.5201438; North KN, 1999, NAT GENET, V21, P353, DOI 10.1038/7675; REICHMANN H, 1983, PFLUG ARCH EUR J PHY, V397, P202, DOI 10.1007/BF00584358; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang ET, 2006, P NATL ACAD SCI USA, V103, P135, DOI 10.1073/pnas.0509691102; Yang N, 2003, AM J HUM GENET, V73, P627, DOI 10.1086/377590	16	224	226	3	37	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2007	39	10					1261	1265		10.1038/ng2122	http://dx.doi.org/10.1038/ng2122			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17828264	Green Published			2022-12-27	WOS:000249737400023
J	Risheg, H; Graham, JM; Clark, RD; Rogers, RC; Opitz, JM; Moeschler, JB; Peiffer, AP; May, M; Joseph, SM; Jones, JR; Stevenson, RE; Schwartz, CE; Friez, MJ				Risheg, Hiba; Graham, John M., Jr.; Clark, Robin D.; Rogers, R. Curtis; Opitz, John M.; Moeschler, John B.; Peiffer, Andreas P.; May, Melanie; Joseph, Sumy M.; Jones, Julie R.; Stevenson, Roger E.; Schwartz, Charles E.; Friez, Michael J.			A recurrent mutation in MED12 leading to R961W causes Opitz-Kaveggia syndrome	NATURE GENETICS			English	Article							MENTAL-RETARDATION; FG-SYNDROME; DODECAMER DUPLICATION; NEURAL CREST; MEDIATOR; GENE; ASSOCIATION; VARIANT; HOPA	Opitz-Kaveggia syndrome (also known as FG syndrome) is an X-linked disorder characterized by mental retardation, relative macrocephaly, hypotonia and constipation. We report here that the original family for whom the condition is named and five other families have a recurrent mutation (2881C > T, leading to R961W) in MED12 (also called TRAP230 or HOPA), a gene located at Xq13 that functions as a thyroid receptor associated protein in the Mediator complex.	Greenwood Genet Ctr, Greenwood, SC 29646 USA; Univ Calif Los Angeles, Cedars Sinai Med Ctr, Med Genet Inst, David Geffen Sch Med, Los Angeles, CA 90048 USA; Loma Linda Univ, Dept Pediat, Childrens Hosp, Loma Linda, CA 92354 USA; Univ Utah, Sch Med, Dept Pediat Med Genet Human Genet Pathol Obstet &, Salt Lake City, UT 84112 USA; Dartmouth Hitchcock Med Ctr, Lebanon, NH 03756 USA	Greenwood Genetic Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Children's Hospital Los Angeles; Loma Linda University; Utah System of Higher Education; University of Utah; Dartmouth College	Friez, MJ (corresponding author), Greenwood Genet Ctr, Greenwood, SC 29646 USA.	friez@ggc.org	Graham, John M./J-1429-2019	joseph, sumy/0000-0001-8586-2109	NICHD NIH HHS [HD 26202] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD026202] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Battaglia A, 2006, AM J MED GENET A, V140A, P2075, DOI 10.1002/ajmg.a.31302; Beyer KS, 2002, AM J MED GENET, V114, P110, DOI 10.1002/ajmg.1613; Briault S, 1997, AM J MED GENET, V73, P87; Friez MJ, 2000, HUM GENET, V106, P36, DOI 10.1007/s004390051006; Hong SK, 2005, P NATL ACAD SCI USA, V102, P18473, DOI 10.1073/pnas.0509457102; Janody F, 2003, DEVELOPMENT, V130, P3691, DOI 10.1242/dev.00607; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Kleefstra T, 2005, CLIN GENET, V67, P451, DOI 10.1111/j.1399-0004.2005.00434.x; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; OPITZ JM, 1974, Z KINDERHEILKD, V117, P1, DOI 10.1007/BF00439020; Philibert RA, 1998, MOL PSYCHIATR, V3, P303, DOI 10.1038/sj.mp.4000442; Rau MJ, 2006, DEV BIOL, V296, P83, DOI 10.1016/j.ydbio.2006.04.437; Schwartz CE, 2005, AM J HUM GENET, V77, P41, DOI 10.1086/431313; Wang X, 2006, P NATL ACAD SCI USA, V103, P17284, DOI 10.1073/pnas.0605414103; Zhou HY, 2006, MOL CELL BIOL, V26, P8667, DOI 10.1128/MCB.00443-06	15	153	157	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2007	39	4					451	453		10.1038/ng1992	http://dx.doi.org/10.1038/ng1992			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	151EE	17334363				2022-12-27	WOS:000245271200013
J	Ercan, S; Giresi, PG; Whittle, CM; Zhang, XM; Green, RD; Lieb, JD				Ercan, Sevinc; Giresi, Paul G.; Whittle, Christina M.; Zhang, Xinmin; Green, Roland D.; Lieb, Jason D.			X chromosome repression by localization of the C-elegans dosage compensation machinery to sites of transcription initiation	NATURE GENETICS			English	Article							CAENORHABDITIS-ELEGANS; SACCHAROMYCES-CEREVISIAE; COMPLEX; GENOME; GENE; SEX; BINDING; ARRAY; TOOL	Among organisms with chromosome-based mechanisms of sex determination, failure to equalize expression of X-linked genes between the sexes is typically lethal. In C. elegans, XX hermaphrodites halve transcription from each X chromosome to match the output of XO males(1). Here, we mapped the binding location of the condensin homolog DPY-27 and the zinc finger protein SDC-3, two components of the C. elegans dosage compensation complex (DCC)(2,3). We observed strong foci of DCC binding on X, surrounded by broader regions of localization. Binding foci, but not adjacent regions of localization, were distinguished by clusters of a 10-bp DNA motif, suggesting a recruitment-and-spreading mechanism for X recognition. The DCC was preferentially bound upstream of genes, suggesting modulation of transcriptional initiation and polymerase-coupled spreading. Stronger DCC binding upstream of genes with high transcriptional activity indicated a mechanism for tuning DCC activity at specific loci. These data aid in understanding how proteins involved in higherorder chromosome dynamics can regulate transcription at individual loci.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Carloina Ctr Genome Sci, Chapel Hill, NC 27599 USA; NimbleGen Syst Inc, Madison, WI 53711 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Roche Holding; Roche NimbleGen	Lieb, JD (corresponding author), Univ N Carolina, Dept Biol, 202 Fordham Hall, Chapel Hill, NC 27599 USA.	jlieb@bio.unc.edu		Lieb, Jason/0000-0001-7601-8061	NHGRI NIH HHS [U01 HG004270-01, U01 HG004270] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004270] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Baugh LR, 2003, DEVELOPMENT, V130, P889, DOI 10.1242/dev.00302; Buck MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r97; Chu DS, 2002, GENE DEV, V16, P796, DOI 10.1101/gad.972702; CHUANG PT, 1994, CELL, V79, P459, DOI 10.1016/0092-8674(94)90255-0; Csankovszki G, 2004, SCIENCE, V303, P1182, DOI 10.1126/science.1092938; Davis TL, 1997, DEVELOPMENT, V124, P1019; Dawes HE, 1999, SCIENCE, V284, P1800, DOI 10.1126/science.284.5421.1800; Glynn EF, 2004, PLOS BIOL, V2, P1325, DOI 10.1371/journal.pbio.0020259; Hagstrom KA, 2002, GENE DEV, V16, P729, DOI 10.1101/gad.968302; Hirano T, 2005, CURR BIOL, V15, pR265, DOI 10.1016/j.cub.2005.03.037; HODGKIN J, 1994, DEVELOPMENT, V120, P3681; HSU DR, 1995, DEVELOPMENT, V121, P3323; Jiang M, 2001, P NATL ACAD SCI USA, V98, P218, DOI 10.1073/pnas.011520898; Lengronne A, 2004, NATURE, V430, P573, DOI 10.1038/nature02742; Lewis JA, 1995, METHOD CELL BIOL, V48, P3; Li WQ, 1999, GENETICS, V152, P237; Lieb JD, 1998, CELL, V92, P265, DOI 10.1016/S0092-8674(00)80920-4; Liu X, 2001, Pac Symp Biocomput, P127; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; McDonel P, 2006, NATURE, V444, P614, DOI 10.1038/nature05338; MEYER BJ, 1986, CELL, V47, P871, DOI 10.1016/0092-8674(86)90802-0; MEYER BJ, 2005, X CHROMOSOME DOSAGE; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Nicoll M, 1997, NATURE, V388, P200, DOI 10.1038/40645; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Wang BD, 2005, MOL CELL BIOL, V25, P7216, DOI 10.1128/MCB.25.16.7216-7225.2005; Workman CT, 2005, NUCLEIC ACIDS RES, V33, pW389, DOI 10.1093/nar/gki439	30	91	94	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAR	2007	39	3					403	408		10.1038/ng1983	http://dx.doi.org/10.1038/ng1983			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17293863	Green Accepted, Green Submitted			2022-12-27	WOS:000244480000025
J	McClean, MN; Mody, A; Broach, JR; Ramanathan, S				McClean, Megan N.; Mody, Areez; Broach, James R.; Ramanathan, Sharad			Cross-talk and decision making in MAP kinase pathways	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; SIGNALING SPECIFICITY; PROTEIN-KINASES; FLUORESCENT PROTEIN; MATING PATHWAY; BUDDING YEAST; CASCADE; HOG; ACTIVATION; STE5	Cells must respond specifically to different environmental stimuli in order to survive. The signal transduction pathways involved in sensing these stimuli often share the same or homologous proteins. Despite potential cross-wiring, cells show specificity of response. We show, through modeling, that the physiological response of such pathways exposed to simultaneous and temporally ordered inputs can demonstrate system-level mechanisms by which pathways achieve specificity. We apply these results to the hyperosmolar and pheromone mitogen-activated protein (MAP) kinase pathways in the yeast Saccharomyces cerevisiae. These two pathways specifically sense osmolar and pheromone signals(1-3), despite sharing a MAPKKK, Ste11, and having homologous MAPKs (Fus3 and Hog1). We show that in a single cell, the pathways are bistable over a range of inputs, and the cell responds to only one stimulus even when exposed to both. Our results imply that these pathways achieve specificity by filtering out spurious cross-talk through mutual inhibition. The variability between cells allows for heterogeneity of the decisions.	Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; Harvard Univ, Div Engn & Appl Sci, Cambridge, MA 02138 USA; Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; Bell Labs, Lucent Technol, Murray Hill, NJ 07974 USA	Harvard University; Harvard University; Princeton University; Alcatel-Lucent; Lucent Technologies; AT&T	Ramanathan, S (corresponding author), Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA.	sharadr@alcatel-lucent.com	McClean, Megan/D-4108-2013; McClean, Megan N./D-9211-2018	McClean, Megan/0000-0002-1141-4802; McClean, Megan N./0000-0002-1141-4802; Broach, James/0000-0003-1197-0312				Banuett F, 1998, MICROBIOL MOL BIOL R, V62, P249, DOI 10.1128/MMBR.62.2.249-274.1998; Bhattacharyya RP, 2006, SCIENCE, V311, P822, DOI 10.1126/science.1120941; Breitkreutz A, 2002, TRENDS CELL BIOL, V12, P254, DOI 10.1016/S0962-8924(02)02284-5; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; CHOI KY, 1994, CELL, V78, P499; Ferrell JE, 1998, SCIENCE, V280, P895, DOI 10.1126/science.280.5365.895; GIMENO CJ, 1992, CELL, V68, P1077, DOI 10.1016/0092-8674(92)90079-R; HAGEN DC, 1991, MOL CELL BIOL, V11, P2952, DOI 10.1128/MCB.11.6.2952; Hall JP, 1996, MOL CELL BIOL, V16, P6715; Harris K, 2001, CURR BIOL, V11, P1815, DOI 10.1016/S0960-9822(01)00567-X; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Murray, 2002, MATH BIOL I INTRO IN; O'Rourke SM, 2004, MOL BIOL CELL, V15, P532, DOI 10.1091/mbc.E03-07-0521; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; Philips J, 1997, J CELL BIOL, V138, P961, DOI 10.1083/jcb.138.5.961; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Posas F, 1996, CELL, V86, P865, DOI 10.1016/S0092-8674(00)80162-2; Posas F, 1998, CURR OPIN MICROBIOL, V1, P175, DOI 10.1016/S1369-5274(98)80008-8; Posas F, 1998, EMBO J, V17, P1385, DOI 10.1093/emboj/17.5.1385; Pryciak PM, 1998, GENE DEV, V12, P2684, DOI 10.1101/gad.12.17.2684; Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Sprague GF, 1998, GENE DEV, V12, P2817, DOI 10.1101/gad.12.18.2817; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576	27	117	119	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2007	39	3					409	414		10.1038/ng1957	http://dx.doi.org/10.1038/ng1957			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17259986				2022-12-27	WOS:000244480000026
J	Buck, MJ; Lieb, JD				Buck, Michael J.; Lieb, Jason D.			A chromatin-mediated mechanism for specification of conditional transcription factor targets	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; GENOME-WIDE; DNA-BINDING; HDA1 DEACETYLASE; OSMOTIC-STRESS; REPRESSION; YEAST; COMPLEX; GENES; IDENTIFICATION	Organisms respond to changes in their environment, and many such responses are initiated at the level of gene transcription. Here, we provide evidence for a previously undiscovered mechanism for directing transcriptional regulators to new binding targets in response to an environmental change. We show that repressor-activator protein 1 (Rap1), a master regulator of yeast metabolism, binds to an expanded target set after glucose depletion despite decreasing protein levels and no evidence of posttranslational modification. Computational analysis predicts that proteins capable of recruiting the chromatin regulator Tup1 act to restrict the binding distribution of Rap1 in the presence of glucose. Deletion of the gene(s) encoding Tup1, recruiters of Tup1 or chromatin regulators recruited by Tup1 cause Rap1 to bind specifically and inappropriately to low-glucose targets. These data, combined with whole-genome measurements of nucleosome occupancy and Tup1 distribution, provide evidence for a mechanism of dynamic target specification that coordinates the genome-wide distribution of intermediate-affinity DNA sequence motifs with chromatin-mediated regulation of accessibility to those sites.	Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; Univ N Carolina, Ctr Genome Sci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Lieb, JD (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	jlieb@bio.unc.edu		Lieb, Jason/0000-0001-7601-8061	NHGRI NIH HHS [HG0029989] Funding Source: Medline; NIGMS NIH HHS [R01 GM072518-01A1, R01 GM072518-02, GM072518, R01 GM072518] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072518] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Buck MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r97; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davie JK, 2003, J BIOL CHEM, V278, P50158, DOI 10.1074/jbc.M309753200; DeVit MJ, 1997, MOL BIOL CELL, V8, P1603, DOI 10.1091/mbc.8.8.1603; Fazzio TG, 2001, MOL CELL BIOL, V21, P6450, DOI 10.1128/MCB.21.19.6450-6460.2001; Green SR, 2004, MOL BIOL CELL, V15, P4191, DOI 10.1091/mbc.E04-05-0412; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Haverty PM, 2004, NUCLEIC ACIDS RES, V32, P179, DOI 10.1093/nar/gkh183; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Park SH, 1999, MOL CELL BIOL, V19, P2044; Proft M, 2005, EUKARYOT CELL, V4, P1343, DOI 10.1128/EC.4.8.1343-1352.2005; Proft M, 1999, MOL CELL BIOL, V19, P537; Proft M, 2002, MOL CELL, V9, P1307, DOI 10.1016/S1097-2765(02)00557-9; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Regnacq M, 2001, MOL MICROBIOL, V40, P1085, DOI 10.1046/j.1365-2958.2001.02450.x; SHORE D, 1994, TRENDS GENET, V10, P408, DOI 10.1016/0168-9525(94)90058-2; Smith RL, 2000, TRENDS BIOCHEM SCI, V25, P325, DOI 10.1016/S0968-0004(00)01592-9; TZAMARIAS D, 1994, NATURE, V369, P758, DOI 10.1038/369758a0; Watson AD, 2000, GENE DEV, V14, P2737, DOI 10.1101/gad.829100; Wu JS, 2001, MOL CELL, V7, P117, DOI 10.1016/S1097-2765(01)00160-5; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5; Zhang Z, 2004, EMBO J, V23, P2246, DOI 10.1038/sj.emboj.7600227; Zhu H, 2000, NAT GENET, V26, P283, DOI 10.1038/81576; ZUBAY G, 1970, P NATL ACAD SCI USA, V66, P104, DOI 10.1073/pnas.66.1.104	30	74	75	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2006	38	12					1446	1451		10.1038/ng1917	http://dx.doi.org/10.1038/ng1917			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110TR	17099712	Green Submitted, Green Accepted			2022-12-27	WOS:000242404200024
J	Pan, Q; Shai, O; Lee, LJ; Frey, J; Blencowe, BJ				Pan, Qun; Shai, Ofer; Lee, Leo J.; Frey, J.; Blencowe, Benjamin J.			Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing	NATURE GENETICS			English	Article							GENOME; MOUSE	We carried out the first analysis of alternative splicing complexity in human tissues using mRNA-Seq data. New splice junctions were detected in similar to 20% of multiexon genes, many of which are tissue specific. By combining mRNA-Seq and EST-cDNA sequence data, we estimate that transcripts from similar to 95% of multiexon genes undergo alternative splicing and that there are similar to 100,000 intermediate- to high-abundance alternative splicing events in major human tissues. From a comparison with quantitative alternative splicing microarray profiling data, we also show that mRNA-Seq data provide reliable measurements for exon inclusion levels.	[Pan, Qun; Shai, Ofer; Lee, Leo J.; Frey, J.; Blencowe, Benjamin J.] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada; [Shai, Ofer; Lee, Leo J.; Frey, J.] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON M5S 3G4, Canada; [Blencowe, Benjamin J.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 3E1, Canada	University of Toronto; University of Toronto; University of Toronto	Blencowe, BJ (corresponding author), Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5S 3E1, Canada.	b.blencowe@utoronto.ca			Canadian Institutes of Health Research; Genome Canada through the Ontario Genomics Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada through the Ontario Genomics Institute(Genome Canada)	We thank S. Luo, I. Khrebtukova and G. Schroth of Illumina Inc. for providing some of the mRNA-Seq datasets used in this analysis. We also thank M. Brudno, Y. Barash, J. Calarco and S. Ahmad for helpful suggestions and comments on the manuscript. B.J.B and B.J.F. acknowledge support from the Canadian Institutes of Health Research and from Genome Canada through the Ontario Genomics Institute.	Bainbridge MN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-246; Ben-Dov C, 2008, J BIOL CHEM, V283, P1229, DOI 10.1074/jbc.R700033200; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Calarco JA, 2007, ADV EXP MED BIOL, V623, P64, DOI 10.1007/978-0-387-77374-2_5; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Sorek R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-273; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; Yeo G, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r74; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16	15	2401	2533	6	248	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1413	1415		10.1038/ng.259	http://dx.doi.org/10.1038/ng.259			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	18978789				2022-12-27	WOS:000261215900017
J	Kiemeney, LA; Thorlacius, S; Sulem, P; Geller, F; Aben, KKH; Stacey, SN; Gudmundsson, J; Jakobsdottir, M; Bergthorsson, JT; Sigurdsson, A; Blondal, T; Witjes, JA; Vermeulen, SH; Hulsbergen-van de Kaa, CA; Swinkels, DW; Ploeg, M; Cornel, EB; Vergunst, H; Thorgeirsson, TE; Gudbjartsson, D; Gudjonsson, SA; Thorleifsson, G; Kristinsson, KT; Mouy, M; Snorradottir, S; Placidi, D; Campagna, M; Arici, C; Koppova, K; Gurzau, E; Rudnai, P; Kellen, E; Polidoro, S; Guarrera, S; Sacerdote, C; Sanchez, M; Saez, B; Valdivia, G; Ryk, C; De Verdier, P; Lindblom, A; Golka, K; Bishop, DT; Knowles, MA; Nikulasson, S; Petursdottir, V; Jonsson, E; Geirsson, G; Kristjansson, B; Mayordomo, JI; Steineck, G; Porru, S; Buntinx, F; Zeegers, MP; Fletcher, T; Kumar, R; Matullo, G; Vineis, P; Kiltie, AE; Gulcher, JR; Thorsteinsdottir, U; Kong, A; Rafnar, T; Stefansson, K				Kiemeney, Lambertus A.; Thorlacius, Steinunn; Sulem, Patrick; Geller, Frank; Aben, Katja K. H.; Stacey, Simon N.; Gudmundsson, Julius; Jakobsdottir, Margret; Bergthorsson, Jon T.; Sigurdsson, Asgeir; Blondal, Thorarinn; Witjes, J. Alfred; Vermeulen, Sita H.; Hulsbergen-van de Kaa, Christina A.; Swinkels, Dorine W.; Ploeg, Martine; Cornel, Erik B.; Vergunst, Henk; Thorgeirsson, Thorgeir E.; Gudbjartsson, Daniel; Gudjonsson, Sigurjon A.; Thorleifsson, Gudmar; Kristinsson, Kari T.; Mouy, Magali; Snorradottir, Steinunn; Placidi, Donatella; Campagna, Marcello; Arici, Cecilia; Koppova, Kvetoslava; Gurzau, Eugene; Rudnai, Peter; Kellen, Eliane; Polidoro, Silvia; Guarrera, Simonetta; Sacerdote, Carlotta; Sanchez, Manuel; Saez, Berta; Valdivia, Gabriel; Ryk, Charlotta; de Verdier, Petra; Lindblom, Annika; Golka, Klaus; Bishop, D. Timothy; Knowles, Margaret A.; Nikulasson, Sigfus; Petursdottir, Vigdis; Jonsson, Eirikur; Geirsson, Gudmundur; Kristjansson, Baldvin; Mayordomo, Jose I.; Steineck, Gunnar; Porru, Stefano; Buntinx, Frank; Zeegers, Maurice P.; Fletcher, Tony; Kumar, Rajiv; Matullo, Giuseppe; Vineis, Paolo; Kiltie, Anne E.; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Rafnar, Thorunn; Stefansson, Kari			Sequence variant on 8q24 confers susceptibility to urinary bladder cancer	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; UROTHELIAL CELL-CARCINOMA; PROSTATE-CANCER; LUNG-CANCER; NICOTINE DEPENDENCE; GENE-EXPRESSION; P63 EXPRESSION; BREAST-CANCER; RISK; DISEASE	We conducted a genome-wide SNP association study on 1,803 urinary bladder cancer (UBC) cases and 34,336 controls from Iceland and The Netherlands and follow up studies in seven additional case-control groups (2,165 cases and 3,800 controls). The strongest association was observed with allele T of rs9642880 on chromosome 8q24, 30 kb upstream of MYC (allele-specific odds ratio (OR) = 1.22; P = 9.34 x 10(-12)). Approximately 20% of individuals of European ancestry are homozygous for rs9642880[T], and their estimated risk of developing UBC is 1.49 times that of noncarriers. No association was observed between UBC and the four 8q24 variants previously associated with prostate, colorectal and breast cancers, nor did rs9642880 associate with any of these three cancers. A weaker signal, but nonetheless of genome-wide significance, was captured by rs710521[A] located near TP63 on chromosome 3q28 (allele-specific OR = 1.19; P = 1.15 x 10(-7)).	[Kiemeney, Lambertus A.; Aben, Katja K. H.; Vermeulen, Sita H.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; [Kiemeney, Lambertus A.; Witjes, J. Alfred; Ploeg, Martine] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6500 HB Nijmegen, Netherlands; [Kiemeney, Lambertus A.; Aben, Katja K. H.] Ctr Comprehens Canc E, NL-6501 BG Nijmegen, Netherlands; [Thorlacius, Steinunn; Sulem, Patrick; Geller, Frank; Stacey, Simon N.; Gudmundsson, Julius; Jakobsdottir, Margret; Bergthorsson, Jon T.; Sigurdsson, Asgeir; Blondal, Thorarinn; Thorgeirsson, Thorgeir E.; Gudbjartsson, Daniel; Gudjonsson, Sigurjon A.; Thorleifsson, Gudmar; Kristinsson, Kari T.; Mouy, Magali; Snorradottir, Steinunn; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Rafnar, Thorunn; Stefansson, Kari] DeCode Genet, IS-101 Reykjavik, Iceland; [Hulsbergen-van de Kaa, Christina A.] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6500 HB Nijmegen, Netherlands; [Swinkels, Dorine W.] Radboud Univ Nijmegen, Med Ctr, Dept Clin Chem, NL-6500 HB Nijmegen, Netherlands; [Cornel, Erik B.] Streekziekenhuis Midden Twente, Dept Urol, NL-7550 AM Hengelo, Netherlands; [Vergunst, Henk] Canisius Wilhelmina Ziekenhuis, Dept Urol, NL-6500 GS Nijmegen, Netherlands; [Placidi, Donatella; Campagna, Marcello; Arici, Cecilia; Porru, Stefano] Univ Brescia, Dept Expt & Appl Med, Sect Occupat Med & Ind Hyg, I-25125 Brescia, Italy; [Koppova, Kvetoslava] State Hlth Inst, SK-97556 Banska Bystrica, Slovakia; [Gurzau, Eugene] Ctr Environm Hlth, Cluj Napoca 400166, Romania; [Rudnai, Peter] Natl Inst Environm Hlth, H-1450 Budapest, Hungary; [Kellen, Eliane; Buntinx, Frank] Catholic Univ Louvain, Dept Gen Practice, B-3000 Louvain, Belgium; [Kellen, Eliane] Catholic Univ Louvain, Ctr Canc Prevent LUCK, B-3000 Louvain, Belgium; [Polidoro, Silvia; Matullo, Giuseppe; Vineis, Paolo] ISI Fdn, Turin, Italy; [Polidoro, Silvia; Guarrera, Simonetta; Matullo, Giuseppe] Univ Turin, Dept Genet Biol & Biochem, I-10126 Turin, Italy; [Sacerdote, Carlotta] Univ Turin, Canc Epidemiol Unit, I-10123 Turin, Italy; Ctr Canc Epidemiol & Prevent CPO Piemonte, I-10123 Turin, Italy; [Sanchez, Manuel] Univ Hosp, Div Urol, Zaragoza 50009, Spain; [Valdivia, Gabriel] Univ Zaragoza, Sch Med, Dept Urol, E-50009 Zaragoza, Spain; [Ryk, Charlotta; de Verdier, Petra; Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Golka, Klaus] Univ Dortmund, Inst Occupat Physiol, Dortmund, Germany; [Bishop, D. Timothy] St James Univ Hosp, Leeds Inst Mol Med, Epidemiol & Biostat Sect, Leeds LS9 7TF, W Yorkshire, England; [Knowles, Margaret A.; Kiltie, Anne E.] St James Univ Hosp, Leeds Inst Mol Med, Sect Expt Oncol, Leeds LS9 7TF, W Yorkshire, England; [Nikulasson, Sigfus; Petursdottir, Vigdis] Landspitali Univ Hosp, Dept Pathol, IS-101 Reykjavik, Iceland; [Jonsson, Eirikur; Geirsson, Gudmundur; Kristjansson, Baldvin] Landspitali Univ Hosp, Dept Urol, IS-101 Reykjavik, Iceland; [Mayordomo, Jose I.] Univ Hosp, Div Med Oncol, Zaragoza 50009, Spain; [Mayordomo, Jose I.] Hlth Sci Inst, Nanotechnol Inst Aragon, Zaragoza 50009, Spain; [Steineck, Gunnar] Karolinska Hosp, Dept Oncol & Pathol, S-17176 Stockholm, Sweden; [Steineck, Gunnar] Sahlgrens Univ Hosp, Dept Oncol, S-41345 Gothenburg, Sweden; [Buntinx, Frank] Maastricht Univ, Dept Gen Practice, NL-6200 MD Maastricht, Netherlands; [Zeegers, Maurice P.] Univ Birmingham, Dept Publ Hlth & Epidemiol, Unit Genet Epidemiol, Birmingham B15 2TT, W Midlands, England; [Zeegers, Maurice P.] Nutr & Toxicol Res Inst, Dept Complex Genet, NL-6200 MD Maastricht, Netherlands; [Fletcher, Tony] London Sch Hyg & Trop Med, London WC1E 7HT, England; [Kumar, Rajiv] German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany; [Vineis, Paolo] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Canisius-Wilhelmina Hospital; University of Brescia; Universite Catholique Louvain; Universite Catholique Louvain; University of Turin; University of Turin; Miguel Servet University Hospital; University of Zaragoza; Karolinska Institutet; Dortmund University of Technology; Saint James's University Hospital; University of Leeds; Saint James's University Hospital; University of Leeds; Landspitali National University Hospital; Landspitali National University Hospital; Miguel Servet University Hospital; Karolinska Institutet; Karolinska University Hospital; Sahlgrenska University Hospital; Maastricht University; University of Birmingham; Maastricht University; University of London; London School of Hygiene & Tropical Medicine; Helmholtz Association; German Cancer Research Center (DKFZ); Imperial College London; University of Iceland	Stefansson, K (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands.	b.kiemeney@ebh.umcn.nl; kstefans@decode.is	Stefansson, Kari/AAE-7187-2019; Steineck, Gunnar/W-1515-2019; Campagna, Marcello/L-1011-2016; Aben, Katja KH/G-9686-2016; Placidi, Donatella/A-6965-2011; Matullo, Giuseppe/K-6383-2016; Guarrera, Simonetta/AAB-8482-2022; de Kaa, Christina A Hulsbergen-van/L-4399-2015; Kiemeney, Lambertus A./D-3357-2009; Mayordomo, Jose/K-3453-2013; Polidoro, Silvia/GYJ-3517-2022; Witjes, Fred/N-9665-2013; Buntinx, Frank/E-4950-2011; Swinkels, Dorine W./H-8098-2014; Vermeulen, Sita H./L-4716-2015; Kumar, Rajiv/H-6431-2019; Arici, Cecilia/AAO-7689-2020; Fletcher, Tony/D-2394-2011	Steineck, Gunnar/0000-0002-0787-3969; Campagna, Marcello/0000-0002-5277-8477; Aben, Katja KH/0000-0002-0214-2147; Placidi, Donatella/0000-0003-1606-5397; Matullo, Giuseppe/0000-0003-0674-7757; Kiemeney, Lambertus A./0000-0002-2368-1326; Swinkels, Dorine W./0000-0002-1040-9446; Vermeulen, Sita H./0000-0003-4913-8601; Kumar, Rajiv/0000-0002-6093-0395; Arici, Cecilia/0000-0003-1493-590X; Saez, Berta/0000-0003-0753-1165; Knowles, Margaret/0000-0002-9363-8657; Gudbjartsson, Daniel/0000-0002-5222-9857; Zeegers, Maurice/0000-0002-2387-083X; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Polidoro, Silvia/0000-0003-2968-0575; Kiltie, Anne/0000-0001-7208-2912; Bishop, Tim/0000-0002-8752-8785; Fletcher, Tony/0000-0003-3385-200X; Geller, Frank/0000-0002-9238-3269; Ryk, Charlotta/0000-0002-7881-7614; Kong, Augustine/0000-0001-8193-5438; Sacerdote, Carlotta/0000-0002-8008-5096; Gurzau, Eugen/0000-0002-8688-6118; Thorgeirsson, Thorgeir/0000-0002-5149-7040; Bergthorsson, Jon Thor/0000-0002-0560-2639	European Commission [LSHC-CT-2005-018827, LSHM-CT-2004-005166]; National Institute of Health [R01-DA017932]; Radboud University Nijmegen Medical Centre; Cancer Research UK; Yorkshire Cancer Research; ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility),; European Union [513943]; compagnia di San Paolo; Italian Association for Cancer Research, Italy; Piedmont Region Progetti di Ricerca Sanitaria Finalizzata; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017932] Funding Source: NIH RePORTER	European Commission(European CommissionEuropean Commission Joint Research Centre); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Radboud University Nijmegen Medical Centre; Cancer Research UK(Cancer Research UK); Yorkshire Cancer Research; ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility),; European Union(European Commission); compagnia di San Paolo(Compagnia di San Paolo); Italian Association for Cancer Research, Italy(Fondazione AIRC per la ricerca sul cancro); Piedmont Region Progetti di Ricerca Sanitaria Finalizzata; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank the individuals that participated in the study and whose contribution made this work possible. We also thank the nurses at Noatun (deCODE's participant recruitment center) and the personnel at the deCODE core facilities. We acknowledge the Icelandic Cancer Registry for assistance in the ascertainment of the Icelandic UBC cases. Collection of samples and data in Iceland and The Netherlands was funded in part by the European Commission (POLYGENE: LSHC-CT-2005-018827 and GENADDICT: LSHM-CT-2004-005166), the National Institute of Health (R01-DA017932) and a research investment grant of the Radboud University Nijmegen Medical Centre. The Leeds Bladder Cancer Study was funded by Cancer Research UK and Yorkshire Cancer Research. Torino Bladder Cancer Case Control Study was supported by a grant to ECNIS (Environmental Cancer Risk, Nutrition and Individual Susceptibility), a network of excellence operating within the European Union 6th Framework Program, Priority 5: "Food Quality and Safety'' (Contract No 513943); by a grant of the compagnia di San Paolo, the Italian Association for Cancer Research, Italy and the Piedmont Region Progetti di Ricerca Sanitaria Finalizzata.	Aben KKH, 2006, EUR J CANCER, V42, P1428, DOI 10.1016/j.ejca.2005.07.039; Aben KKH, 2002, INT J CANCER, V98, P274, DOI 10.1002/ijc.10191; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; DEPINHO RA, 1991, ADV CANCER RES, V57, P1; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Epstein JI, 1998, AM J SURG PATHOL, V22, P1435, DOI 10.1097/00000478-199812000-00001; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Gombert WM, 2003, MOL CELL BIOL, V23, P9338, DOI 10.1128/MCB.23.24.9338-9348.2003; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Hallikas O, 2006, CELL, V124, P47, DOI 10.1016/j.cell.2005.10.042; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Koga F, 2003, CLIN CANCER RES, V9, P5501; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mhawech-Fauceglia P, 2006, CANCER-AM CANCER SOC, V106, P1205, DOI 10.1002/cncr.21743; Murta-Nascimento C, 2007, CANCER EPIDEM BIOMAR, V16, P1595, DOI 10.1158/1055-9965.EPI-06-0743; *NAT CANC I DIV CA, 2007, SURV EP END RES PROG; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Stefansson H, 2005, NAT GENET, V37, P129, DOI 10.1038/ng1508; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Urist MJ, 2002, AM J PATHOL, V161, P1199, DOI 10.1016/S0002-9440(10)64396-9; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	30	323	334	4	31	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2008	40	11					1307	1312		10.1038/ng.229	http://dx.doi.org/10.1038/ng.229			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18794855	Green Accepted			2022-12-27	WOS:000260501500022
J	Stacey, SN; Gudbjartsson, DF; Sulem, P; Bergthorsson, JT; Kumar, R; Thorleifsson, G; Sigurdsson, A; Jakobsdottir, M; Sigurgeirsson, B; Benediktsdottir, KR; Thorisdottir, K; Ragnarsson, R; Scherer, D; Rudnai, P; Gurzau, E; Koppova, K; Hoiom, V; Botella-Estrada, R; Soriano, V; Juberias, P; Grasa, M; Carapeto, FJ; Tabuenca, P; Gilaberte, Y; Gudmundsson, J; Thorlacius, S; Helgason, A; Thorlacius, T; Jonasdottir, A; Blondal, T; Gudjonsson, SA; Jonsson, GF; Saemundsdottir, J; Kristjansson, K; Bjornsdottir, G; Sveinsdottir, SG; Mouy, M; Geller, F; Nagore, E; Mayordomo, JI; Hansson, J; Rafnar, T; Kong, A; Olafsson, JH; Thorsteinsdottir, U; Stefansson, K				Stacey, Simon N.; Gudbjartsson, Daniel F.; Sulem, Patrick; Bergthorsson, Jon T.; Kumar, Rajiv; Thorleifsson, Gudmar; Sigurdsson, Asgeir; Jakobsdottir, Margret; Sigurgeirsson, Bardur; Benediktsdottir, Kristrun R.; Thorisdottir, Kristin; Ragnarsson, Rafn; Scherer, Dominique; Rudnai, Peter; Gurzau, Eugene; Koppova, Kvetoslava; Hoiom, Veronica; Botella-Estrada, Rafael; Soriano, Virtudes; Juberias, Pablo; Grasa, Matilde; Carapeto, Francisco J.; Tabuenca, Pilar; Gilaberte, Yolanda; Gudmundsson, Julius; Thorlacius, Steinunn; Helgason, Agnar; Thorlacius, Theodora; Jonasdottir, Aslaug; Blondal, Thorarinn; Gudjonsson, Sigurjon A.; Jonsson, Gudbjroern F.; Saemundsdottir, Jona; Kristjansson, Kristleifur; Bjornsdottir, Gyda; Sveinsdottir, Steinunn G.; Mouy, Magali; Geller, Frank; Nagore, Eduardo; Mayordomo, Jose I.; Hansson, Johan; Rafnar, Thorunn; Kong, Augustine; Olafsson, Jon H.; Thorsteinsdottir, Unnur; Stefansson, Kari			Common variants on 1p36 and 1q42 are associated with cutaneous basal cell carcinoma but not with melanoma or pigmentation traits	NATURE GENETICS			English	Article							SKIN-CANCER; PEPTIDYLARGININE DEIMINASE; GENETIC-DETERMINANTS; HUMAN HOMOLOG; RISK-FACTORS; CITRULLINATION; EPIDEMIOLOGY; MEMBER; FAMILY	To search for new sequence variants that confer risk of cutaneous basal cell carcinoma (BCC), we conducted a genome-wide SNP association study of 930 Icelanders with BCC and 33,117 controls. After analyzing 304,083 SNPs, we observed signals from loci at 1p36 and 1q42, and replicated these associations in additional sample sets from Iceland and Eastern Europe. Overall, the most significant signals were from rs7538876 on 1p36 (OR = 1.28, P = 4.4 x 10(-12)) and rs801114 on 1q42 (OR = 1.28, P = 5.9 x. 10(-12)). The 1p36 locus contains the candidate genes PADI4, PADI6, RCC2 and ARHGEF10L, and the gene nearest to the 1q42 locus is the ras-homolog RHOU. Neither locus was associated with fair pigmentation traits that are known risk factors for BCC, and no risk was observed for melanoma. Approximately 1.6% of individuals of European ancestry are homozygous for both variants, and their estimated risk of BCC is 2.68 times that of noncarriers.	[Stacey, Simon N.; Gudbjartsson, Daniel F.; Sulem, Patrick; Bergthorsson, Jon T.; Thorleifsson, Gudmar; Sigurdsson, Asgeir; Jakobsdottir, Margret; Gudmundsson, Julius; Thorlacius, Steinunn; Helgason, Agnar; Thorlacius, Theodora; Jonasdottir, Aslaug; Blondal, Thorarinn; Gudjonsson, Sigurjon A.; Jonsson, Gudbjroern F.; Saemundsdottir, Jona; Kristjansson, Kristleifur; Bjornsdottir, Gyda; Mouy, Magali; Geller, Frank; Rafnar, Thorunn; Kong, Augustine; Thorsteinsdottir, Unnur; Stefansson, Kari] Decode Genet, IS-101 Reykjavik, Iceland; [Kumar, Rajiv; Scherer, Dominique] German Canc Res Ctr, Div Mol Genet Epidemiol, D-69120 Heidelberg, Germany; [Sigurgeirsson, Bardur; Benediktsdottir, Kristrun R.; Thorisdottir, Kristin; Ragnarsson, Rafn; Olafsson, Jon H.] Landspitali Univ Hosp, Dept Dermatol, IS-101 Reykjavik, Iceland; [Sigurgeirsson, Bardur; Benediktsdottir, Kristrun R.; Thorisdottir, Kristin; Ragnarsson, Rafn; Olafsson, Jon H.] Landspitali Univ Hosp, Dept Pathol, IS-101 Reykjavik, Iceland; [Rudnai, Peter] Natl Inst Environm Hlth, H-1450 Budapest, Hungary; [Gurzau, Eugene] Ctr Environm Hlth, Cluj Napoca, Romania; [Koppova, Kvetoslava] State Hlth Inst, SK-97556 Banska Bystrica, Slovakia; [Hoiom, Veronica; Hansson, Johan] Karolinska Univ Hosp Solna, Karolinska Inst, Canc Ctr Karolinska, Dept Oncol Pathol, S-17176 Stockholm, Sweden; [Botella-Estrada, Rafael; Soriano, Virtudes; Nagore, Eduardo] Inst Valenciano Oncol, Dept Dermatol, Valencia 46009, Spain; [Juberias, Pablo; Grasa, Matilde; Carapeto, Francisco J.] Univ Hosp, Div Dermatol, Zaragoza 50009, Spain; [Tabuenca, Pilar] Hlth Sci Inst, Zaragoza 50009, Spain; [Gilaberte, Yolanda] San Jorge Gen Hosp, Div Dermatol, Huesca 22004, Spain; [Sveinsdottir, Steinunn G.] Clin Res Ctr, IS-110 Reykjavik, Iceland; [Mayordomo, Jose I.] Univ Hosp, Div Med Oncol, Zaragoza 50009, Spain; [Sigurgeirsson, Bardur; Benediktsdottir, Kristrun R.; Thorisdottir, Kristin; Ragnarsson, Rafn; Olafsson, Jon H.] Landspitali Univ Hosp, Dept Plast Surg, IS-101 Reykjavik, Iceland	Helmholtz Association; German Cancer Research Center (DKFZ); Landspitali National University Hospital; Landspitali National University Hospital; Karolinska Institutet; Karolinska University Hospital; Instituto Valenciano De Oncologia; Miguel Servet University Hospital; Hospital Universidad San Jorge; Miguel Servet University Hospital; Landspitali National University Hospital	Thorsteinsdottir, U (corresponding author), Decode Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	unnur.thorsteinsdottir@decode.is; kari.stefansson@decode.is	Gilaberte, Yolanda/K-6416-2019; Höiom, Veronica/F-4153-2012; Mayordomo, Jose/K-3453-2013; Stefansson, Kari/AAE-7187-2019; Kumar, Rajiv/H-6431-2019; Helgason, Agnar/K-1522-2015; Sigurgeirsson, Bárður/B-6130-2011; Sigurgeirsson, Bardur/AAP-7755-2020; Nagore, Eduardo/Z-2126-2019	Kumar, Rajiv/0000-0002-6093-0395; Nagore, Eduardo/0000-0003-3433-8707; Sigurgeirsson, Bardur/0000-0002-9733-9742; Geller, Frank/0000-0002-9238-3269; Gilaberte, Yolanda/0000-0001-8034-3617; Helgason, Agnar/0000-0002-8545-3767; Gurzau, Eugen/0000-0002-8688-6118; Gudbjartsson, Daniel/0000-0002-5222-9857; Kong, Augustine/0000-0001-8193-5438; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Bjornsdottir, Gyda/0000-0002-8100-0306; Bergthorsson, Jon Thor/0000-0002-0560-2639				Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; Bastiaens MT, 2001, AM J HUM GENET, V68, P884, DOI 10.1086/319500; Chavanas S, 2006, J DERMATOL SCI, V44, P63, DOI 10.1016/j.jdermsci.2006.07.004; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Esposito G, 2007, MOL CELL ENDOCRINOL, V273, P25, DOI 10.1016/j.mce.2007.05.005; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Gyorgy B, 2006, INT J BIOCHEM CELL B, V38, P1662, DOI 10.1016/j.biocel.2006.03.008; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Han JL, 2006, INT J EPIDEMIOL, V35, P1514, DOI 10.1093/ije/dyl197; Han JL, 2006, INT J CANCER, V119, P1976, DOI 10.1002/ijc.22074; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Lear JT, 2005, CLIN EXP DERMATOL, V30, P49, DOI 10.1111/j.1365-2230.2004.01669.x; Markovic SN, 2007, MAYO CLIN PROC, V82, P364; Mollinari C, 2003, DEV CELL, V5, P295, DOI 10.1016/S1534-5807(03)00205-3; O'Driscoll L, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-74; Roewert-Huber J, 2007, BRIT J DERMATOL, V157, P47, DOI 10.1111/j.1365-2133.2007.08273.x; Scherer D, 2008, INT J CANCER, V122, P1787, DOI 10.1002/ijc.23257; Sulem P, 2008, NAT GENET, V40, P835, DOI 10.1038/ng.160; Sulem P, 2007, NAT GENET, V39, P1443, DOI 10.1038/ng.2007.13; Suzuki A, 2007, ANN NY ACAD SCI, V1108, P323, DOI 10.1196/annals.1422.034; Tao WK, 2001, GENE DEV, V15, P1796, DOI 10.1101/gad.894301; Winkler S, 2005, BIOCHEM BIOPH RES CO, V335, P1280, DOI 10.1016/j.bbrc.2005.08.025; Wysocka J, 2006, FRONT BIOSCI-LANDMRK, V11, P344, DOI 10.2741/1802; Xu LY, 2006, INT J DERMATOL, V45, P1275, DOI 10.1111/j.1365-4632.2006.02999.x; Yang SH, 2008, NAT GENET, V40, P1130, DOI 10.1038/ng.192	28	96	104	0	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2008	40	11					1313	1318		10.1038/ng.234	http://dx.doi.org/10.1038/ng.234			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18849993				2022-12-27	WOS:000260501500023
J	Patterson, EE; Minor, KM; Tchernatynskaia, AV; Taylor, SM; Shelton, GD; Ekenstedt, KJ; Mickelson, JR				Patterson, Edward E.; Minor, Katie M.; Tchernatynskaia, Anna V.; Taylor, Susan M.; Shelton, G. Diane; Ekenstedt, Kari J.; Mickelson, James R.			A canine DNM1 mutation is highly associated with the syndrome of exercise-induced collapse	NATURE GENETICS			English	Article							DROSOPHILA-MELANOGASTER; CENTRONUCLEAR MYOPATHY; LINKAGE ANALYSIS; GENOME; GENE; TEMPERATURE; DYNAMIN; DOGS; IDENTIFICATION; POPULATION	Labrador retrievers are the most common dog breed in the world, with over 200,000 new kennel club registrations per year. The syndrome of exercise-induced collapse (EIC) in this breed is manifested by muscle weakness, incoordination and life-threatening collapse after intense exercise. Using a genome-wide microsatellite marker scan for linkage in pedigrees, we mapped the EIC locus to canine chromosome 9. We then used SNP association and haplotype analysis to fine map the locus, and identified a mutation in the dynamin 1 gene (DNM1) that causes an R256L substitution in a highly conserved region of the protein. This first documented mammalian DNM1 mutation is present at a high frequency in the breed and is a compelling candidate causal mutation for EIC, as the dynamin 1 protein has an essential role in neurotransmission and synaptic vesicle endocytosis.	[Patterson, Edward E.; Tchernatynskaia, Anna V.] Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA; [Minor, Katie M.; Mickelson, James R.] Univ Minnesota, Coll Vet Med, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Taylor, Susan M.] Univ Saskatchewan, Western Coll Vet Med, Dept Small Anim Clin Sci, Saskatoon, SK S7N 5B4, Canada; [Shelton, G. Diane] Univ Calif San Diego, Dept Pathol, Comparat Neuromuscular Lab, La Jolla, CA 92093 USA; [Ekenstedt, Kari J.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Saskatchewan; University of California System; University of California San Diego; University of Minnesota System; University of Minnesota Twin Cities	Patterson, EE (corresponding author), Univ Minnesota, Coll Vet Med, Dept Vet Clin Sci, St Paul, MN 55108 USA.	patte037@umn.edu	Fiumefreddo, Andrea/T-2977-2019	Mickelson, James/0000-0001-6951-0234; Minor, Katie/0000-0002-5472-5088				Breen M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-65; Chen XH, 2008, NEUROGENETICS, V9, P41, DOI 10.1007/s10048-007-0112-2; Clark SG, 1997, P NATL ACAD SCI USA, V94, P10438, DOI 10.1073/pnas.94.19.10438; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Echaniz-Laguna A, 2007, NEUROMUSCULAR DISORD, V17, P955, DOI 10.1016/j.nmd.2007.06.467; Ferguson SM, 2007, SCIENCE, V316, P570, DOI 10.1126/science.1140621; Grant D, 1998, GENETICS, V149, P1019; GRIGLIATTI TA, 1973, MOL GEN GENET, V120, P107, DOI 10.1007/BF00267238; Guyon R, 2003, P NATL ACAD SCI USA, V100, P5296, DOI 10.1073/pnas.0831002100; Hungs M, 2001, GENOME RES, V11, P531, DOI 10.1101/gr.GR-1610R; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; LANDER E, 1995, NAT GENET, V11, P241, DOI 10.1038/ng1195-241; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lingaas F, 2003, HUM MOL GENET, V12, P3043, DOI 10.1093/hmg/ddg336; Lohi H, 2005, SCIENCE, V307, P81, DOI 10.1126/science.1102832; Matwichuk CL, 1999, AM J VET RES, V60, P88; Noakes PG, 1999, J COMP NEUROL, V410, P531; Pele M, 2005, HUM MOL GENET, V14, P1417, DOI 10.1093/hmg/ddi151; Pennisi E, 2007, SCIENCE, V317, P1668, DOI 10.1126/science.317.5845.1668; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; TAYLOR SM, 2007, BLACKWELLS 5 MINUTE, P458; TAYLOR SM, J AM ANIM H IN PRESS; van de Sluis B, 2002, HUM MOL GENET, V11, P165, DOI 10.1093/hmg/11.2.165; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Zuchner S, 2005, NAT GENET, V37, P289, DOI 10.1038/ng1514	28	45	46	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2008	40	10					1235	1239		10.1038/ng.224	http://dx.doi.org/10.1038/ng.224			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18806795				2022-12-27	WOS:000259651000025
J	Stacey, SN; Manolescu, A; Sulem, P; Thorlacius, S; Gudjonsson, SA; Jonsson, GF; Jakobsdottir, M; Bergthorsson, JT; Gudmundsson, J; Aben, KK; Strobbe, LJ; Swinkels, DW; van Engelenburg, KCA; Henderson, BE; Kolonel, LN; Le Marchand, L; Millastre, E; Andres, R; Saez, B; Lambea, J; Godino, J; Polo, E; Tres, A; Picelli, S; Rantala, J; Margolin, S; Jonsson, T; Sigurdsson, H; Jonsdottir, T; Hrafnkelsson, J; Johannsson, J; Sveinsson, T; Myrdal, G; Grimsson, HN; Sveinsdottir, SG; Alexiusdottir, K; Saemundsdottir, J; Sigurdsson, A; Kostic, J; Gudmundsson, L; Kristjansson, K; Masson, G; Fackenthal, JD; Adebamowo, C; Ogundiran, T; Olopade, OI; Haiman, CA; Lindblom, A; Mayordomo, JI; Kiemeney, LA; Gulcher, JR; Rafnar, T; Thorsteinsdottir, U; Johannsson, OT; Kong, A; Stefansson, K				Stacey, Simon N.; Manolescu, Andrei; Sulem, Patrick; Thorlacius, Steinunn; Gudjonsson, Sigurjon A.; Jonsson, Gudbjorn F.; Jakobsdottir, Margret; Bergthorsson, Jon T.; Gudmundsson, Julius; Aben, Katja K.; Strobbe, Luc J.; Swinkels, Dorine W.; van Engelenburg, K. C. Anton; Henderson, Brian E.; Kolonel, Laurence N.; Le Marchand, Loic; Millastre, Esther; Andres, Raquel; Saez, Berta; Lambea, Julio; Godino, Javier; Polo, Eduardo; Tres, Alejandro; Picelli, Simone; Rantala, Johanna; Margolin, Sara; Jonsson, Thorvaldur; Sigurdsson, Helgi; Jonsdottir, Thora; Hrafnkelsson, Jon; Johannsson, Jakob; Sveinsson, Thorarinn; Myrdal, Gardar; Grimsson, Hlynur Niels; Sveinsdottir, Steinunn G.; Alexiusdottir, Kristin; Saemundsdottir, Jona; Sigurdsson, Asgeir; Kostic, Jelena; Gudmundsson, Larus; Kristjansson, Kristleifur; Masson, Gisli; Fackenthal, James D.; Adebamowo, Clement; Ogundiran, Temidayo; Olopade, Olufunmilayo I.; Haiman, Christopher A.; Lindblom, Annika; Mayordomo, Jose I.; Kiemeney, Lambertus A.; Gulcher, Jeffrey R.; Rafnar, Thorunn; Thorsteinsdottir, Unnur; Johannsson, Oskar T.; Kong, Augustine; Stefansson, Kari			Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; TUMORS; FGFR2; RISK	We carried out a genome-wide association study of breast cancer predisposition with replication and refinement studies involving 6,145 cases and 33,016 controls and identified two SNPs (rs4415084 and rs10941679) on 5p12 that confer risk, preferentially for estrogen receptor (ER)-positive tumors (OR = 1.27, P = 2.5 x 10(-12) for rs10941679). The nearest gene, MRPS30, was previously implicated in apoptosis, ER-positive tumors and favorable prognosis. A recently reported signal in FGFR2 was also found to associate specifically with ER-positive breast cancer.	[Stacey, Simon N.; Manolescu, Andrei; Sulem, Patrick; Thorlacius, Steinunn; Gudjonsson, Sigurjon A.; Jonsson, Gudbjorn F.; Jakobsdottir, Margret; Bergthorsson, Jon T.; Gudmundsson, Julius; Saemundsdottir, Jona; Sigurdsson, Asgeir; Kostic, Jelena; Gudmundsson, Larus; Kristjansson, Kristleifur; Masson, Gisli; Gulcher, Jeffrey R.; Rafnar, Thorunn; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Aben, Katja K.; Kiemeney, Lambertus A.] Comprehens Canc Ctr IKO, NL-6501 BG Nijmegen, Netherlands; [Aben, Katja K.; Swinkels, Dorine W.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; [Aben, Katja K.; Swinkels, Dorine W.; Kiemeney, Lambertus A.] Radboud Univ Nijmegen, Med Ctr, Dept Clin Chem & Urol, NL-6500 HB Nijmegen, Netherlands; [Strobbe, Luc J.] Canisius Wilhelmina Hosp, Dept Surg, NL-6500 GS Nijmegen, Netherlands; [van Engelenburg, K. C. Anton] Slingeland Hosp, Dept Surg, NL-7009 BL Doetinchem, Netherlands; [Henderson, Brian E.; Haiman, Christopher A.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Kolonel, Laurence N.; Le Marchand, Loic] Univ Hawaii, Canc Res Ctr, Honolulu, HI 96813 USA; [Millastre, Esther; Andres, Raquel; Lambea, Julio; Tres, Alejandro; Mayordomo, Jose I.] Univ Hosp, Div Med Oncol, Zaragoza 50009, Spain; [Saez, Berta; Godino, Javier] Nanotechnol Inst Aragon, Hlth Sci Inst, Zaragoza 50009, Spain; [Polo, Eduardo] Ernest Lluch Hosp, Div Med Oncol, Calatayud 50300, Spain; [Picelli, Simone; Rantala, Johanna; Lindblom, Annika] Karolinska Inst, Dept Mol Med, S-17176 Stockholm, Sweden; [Margolin, Sara] Karolinska Univ Hosp Sodersjukhuset, Dept Oncol, S-11883 Stockholm, Sweden; [Jonsson, Thorvaldur; Sigurdsson, Helgi; Jonsdottir, Thora; Hrafnkelsson, Jon; Johannsson, Jakob; Sveinsson, Thorarinn; Myrdal, Gardar; Grimsson, Hlynur Niels; Johannsson, Oskar T.] Landspitali Univ Hosp, Dept Oncol, IS-101 Reykjavik, Iceland; [Jonsson, Thorvaldur; Sigurdsson, Helgi; Jonsdottir, Thora; Hrafnkelsson, Jon; Johannsson, Jakob; Sveinsson, Thorarinn; Myrdal, Gardar; Grimsson, Hlynur Niels; Johannsson, Oskar T.] Landspitali Univ Hosp, Dept Surg, IS-101 Reykjavik, Iceland; [Jonsson, Thorvaldur; Sigurdsson, Helgi; Jonsdottir, Thora; Hrafnkelsson, Jon; Johannsson, Jakob; Sveinsson, Thorarinn; Myrdal, Gardar; Grimsson, Hlynur Niels; Johannsson, Oskar T.] Landspitali Univ Hosp, Dept Radiat Phys, IS-101 Reykjavik, Iceland; [Sveinsdottir, Steinunn G.; Alexiusdottir, Kristin] Clin Res Ctr, IS-110 Reykjavik, Iceland; [Fackenthal, James D.; Olopade, Olufunmilayo I.] Univ Chicago, Dept Med, Chicago, IL 60615 USA; [Adebamowo, Clement; Ogundiran, Temidayo] Univ Ibadan, Univ Coll Ibadan Hosp, Coll Med, Div Oncol,Dept Surg, Ibadan, Oyo State, Nigeria	Radboud University Nijmegen; Radboud University Nijmegen; Canisius-Wilhelmina Hospital; University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System; Miguel Servet University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; University of Chicago; University of Ibadan	Stacey, SN (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	simon.stacey@decode.is; kari.stefansson@decode.is	Mayordomo, Jose/K-3453-2013; Margolin, Sara/AAX-9034-2020; Adebamowo, Clement/C-8778-2011; Stefansson, Kari/AAE-7187-2019; Godino, Javier/M-3753-2018; Strobbe, Luc JA/N-8760-2018; Swinkels, Dorine W./H-8098-2014; Manolescu, Andrei/G-4565-2014; Kiemeney, Lambertus A./D-3357-2009; Aben, Katja KH/G-9686-2016	Adebamowo, Clement/0000-0002-6571-2880; Godino, Javier/0000-0002-5653-2722; Swinkels, Dorine W./0000-0002-1040-9446; Manolescu, Andrei/0000-0002-0713-4664; Kiemeney, Lambertus A./0000-0002-2368-1326; Aben, Katja KH/0000-0002-0214-2147; Margolin, Sara/0000-0002-5526-5570; Kong, Augustine/0000-0001-8193-5438; Bergthorsson, Jon Thor/0000-0002-0560-2639; Saez, Berta/0000-0003-0753-1165; Gudjonsson, Sigurjon A./0000-0001-9314-7412; Millastre Bocos, Maria Esther/0000-0002-4781-068X	NATIONAL CANCER INSTITUTE [R01CA089085] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA89085-01A] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		CAVDAR KE, 2001, FEBS LETT, V492, P166; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Grigoriadis A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1604; Huijts PEA, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1793; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Koc EC, 2001, J BIOL CHEM, V276, P19363, DOI 10.1074/jbc.M100727200; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; Sun LJ, 1998, GENE, V208, P157, DOI 10.1016/S0378-1119(97)00626-4; Theodorou V, 2004, ONCOGENE, V23, P6047, DOI 10.1038/sj.onc.1207816; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Yu K, 2006, CLIN CANCER RES, V12, P3288, DOI 10.1158/1078-0432.CCR-05-1530	14	375	388	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2008	40	6					703	706		10.1038/ng.131	http://dx.doi.org/10.1038/ng.131			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18438407				2022-12-27	WOS:000256212000008
J	Kozyrev, SV; Abelson, AK; Wojcik, J; Zaghlool, A; Reddy, MVPL; Sanchez, E; Gunnarsson, I; Svenungsson, E; Sturfelt, G; Jonsen, A; Truedsson, L; Pons-Estel, BA; Witte, T; D'Alfonso, S; Barrizzone, N; Danieli, MG; Gutierrez, C; Suarez, A; Junker, P; Laustrup, H; Gonzalez-Escribano, MF; Martin, J; Abderrahim, H; Alarcon-Riquelme, ME				Kozyrev, Sergey V.; Abelson, Anna-Karin; Wojcik, Jerome; Zaghlool, Ammar; Reddy, M. V. Prasad Linga; Sanchez, Elena; Gunnarsson, Iva; Svenungsson, Elisabet; Sturfelt, Gunnar; Jonsen, Andreas; Truedsson, Lennart; Pons-Estel, Bernardo A.; Witte, Torsten; D'Alfonso, Sandra; Barrizzone, Nadia; Danieli, Maria Giovanna; Gutierrez, Carmen; Suarez, Ana; Junker, Peter; Laustrup, Helle; Gonzalez-Escribano, Maria Francisca; Martin, Javier; Abderrahim, Hadi; Alarcon-Riquelme, Marta E.			Corrigendum: Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus (vol 40, pg 211, 2008)	NATURE GENETICS			English	Correction													D'Alfonso, Sandra/K-7295-2014; Martín, María/HDL-9512-2022; Witte, Torsten/B-5783-2016; Martin, Javier/B-8141-2008; Alarcón-Riquelme, Marta E./ABF-8163-2020; Martín, Javier/AAV-5209-2021; Suarez, Ana/F-4492-2015	D'Alfonso, Sandra/0000-0002-3983-9925; Martin, Javier/0000-0002-2202-0622; Alarcón-Riquelme, Marta E./0000-0002-7632-4154; Suarez, Ana/0000-0002-4452-7539; Kozyrev, Sergey/0000-0001-6209-4100; Laustrup, Helle/0000-0002-4421-9907; Danieli, Maria Giovanna/0000-0002-9608-2252; Svenungsson, Elisabet/0000-0003-3396-3244; Abelson, Anna-Karin/0000-0002-4205-3456; Pons-Estel, Bernardo/0000-0003-2518-0266; Rapa, Anna/0000-0002-5523-5224				Kozyrev SV, 2008, NAT GENET, V40, P211, DOI 10.1038/ng.79	1	7	8	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2008	40	4					484	484		10.1038/ng0408-484	http://dx.doi.org/10.1038/ng0408-484			1	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18368128	Bronze			2022-12-27	WOS:000254388100022
J	Griffith, E; Walker, S; Martin, CA; Vagnarelli, P; Stiff, T; Vernay, B; Al Sanna, N; Saggar, A; Hamel, B; Earnshaw, WC; Jeggo, PA; Jackson, AP; O'Driscoll, M				Griffith, Elen; Walker, Sarah; Martin, Carol-Anne; Vagnarelli, Paola; Stiff, Tom; Vernay, Bertrand; Al Sanna, Nouriya; Saggar, Anand; Hamel, Ben; Earnshaw, William C.; Jeggo, Penny A.; Jackson, Andrew P.; O'Driscoll, Mark			Mutations in pericentrin cause Seckel syndrome with defective ATR-dependent DNA damage signaling	NATURE GENETICS			English	Article							MICROTUBULE ORGANIZATION; SPINDLE ORGANIZATION; MITOTIC ENTRY; PROTEIN; CENTROSOME; CONTRIBUTES; PATHWAY; MITOSIS; FLORES; PHASE	Large brain size is one of the defining characteristics of modern humans. Seckel syndrome (MIM 210600), a disorder of markedly reduced brain and body size(1,2), is associated with defective ATR-dependent DNA damage signaling(3). Only a single hypomorphic mutation of ATR has been identified in this genetically heterogeneous condition(4). We now report that mutations in the gene encoding pericentrin (PCNT)-resulting in the loss of pericentrin from the centrosome, where it has key functions anchoring both structural and regulatory proteins-also cause Seckel syndrome(5,6). Furthermore, we find that cells of individuals with Seckel syndrome due to mutations in PCNT (PCNT-Seckel) have defects in ATR-dependent checkpoint signaling, providing the first evidence linking a structural centrosomal protein with DNA damage signaling. These findings also suggest that other known microcephaly genes implicated in either DNA repair responses(7) or centrosomal function(8,9), may act in common developmental pathways determining human brain and body size.	[Griffith, Elen; Martin, Carol-Anne; Vernay, Bertrand; Jackson, Andrew P.] Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Walker, Sarah; Stiff, Tom; Jeggo, Penny A.; O'Driscoll, Mark] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Vagnarelli, Paola; Earnshaw, William C.] Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Al Sanna, Nouriya] Dhahran Hlth Ctr, Pediat Serv Div, Dhahran, Saudi Arabia; [Saggar, Anand] St George Hosp, Sch Med, SW Thames Reg Genet Serv, London SW17 0RE, England; [Hamel, Ben] Radboud Univ Nijmegen Med Ctr, Dept Human Genet 417, NL-6525 GA Nijmegen, Netherlands	University of Edinburgh; University of Sussex; University of Edinburgh; St Georges University London; Radboud University Nijmegen	Jackson, AP (corresponding author), Western Gen Hosp, MRC, Human Genet Unit, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	andrew.jackson@hgu.mrc.ac.uk	Earnshaw, William/AAY-7438-2020; Vagnarelli, Paola/AAI-1996-2020; Jackson, Andrew P/D-3442-2009	Vagnarelli, Paola/0000-0002-0000-2271; Jackson, Andrew P/0000-0002-8739-2646; Earnshaw, William/0000-0002-7191-0621; Martin, Carol-Anne/0000-0001-5914-2757; Mason, Sarah/0000-0002-0065-1503; O'Driscoll, Mark/0000-0003-2765-316X; Vernay, Bertrand/0000-0002-7843-3872	Medical Research Council [U.1275.03.008(80972), MC_U127580972, MC_PC_U127580972] Funding Source: Medline; Wellcome Trust [073915] Funding Source: Medline; Medical Research Council [G0300662B] Funding Source: researchfish; MRC [MC_U127580972] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Alderton GK, 2006, NAT CELL BIOL, V8, P725, DOI 10.1038/ncb1431; Alderton GK, 2004, HUM MOL GENET, V13, P3127, DOI 10.1093/hmg/ddh335; Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Chen D, 2004, J BIOL CHEM, V279, P4829, DOI 10.1074/jbc.M311196200; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Diviani D, 2000, CURR BIOL, V10, P417, DOI 10.1016/S0960-9822(00)00422-X; Dodson H, 2004, EMBO J, V23, P3864, DOI 10.1038/sj.emboj.7600393; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; Flory MR, 2003, GENOMICS, V82, P401, DOI 10.1016/S0888-7543(03)00119-8; Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165; Liu QQ, 2001, J CELL SCI, V114, P797; Loffler H, 2007, CELL CYCLE, V6, P2541; MAJEWSKI F, 1982, AM J MED GENET, V12, P7, DOI 10.1002/ajmg.1320120103; Martin RD, 2006, ANAT REC PART A, V288A, P1123, DOI 10.1002/ar.a.20389; Martinez-Campos M, 2004, J CELL BIOL, V165, P673, DOI 10.1083/jcb.200402130; Miyoshi K, 2006, BIOCHEM BIOPH RES CO, V351, P745, DOI 10.1016/j.bbrc.2006.10.101; Niida H, 2007, MOL CELL BIOL, V27, P2572, DOI 10.1128/MCB.01611-06; O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129; Ponting C, 2005, CURR OPIN GENET DEV, V15, P241, DOI 10.1016/j.gde.2005.04.009; Purohit A, 1999, J CELL BIOL, V147, P481, DOI 10.1083/jcb.147.3.481; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; SECKEL HPG, 1960, BIRD HEADED DRAFTS S; Sengupta S, 2004, J CELL BIOL, V166, P801, DOI 10.1083/jcb.200405128; Shiloh Y, 2001, CURR OPIN GENET DEV, V11, P71, DOI 10.1016/S0959-437X(00)00159-3; Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930; Zhang SS, 2007, J CELL BIOCHEM, V101, P451, DOI 10.1002/jcb.21195; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	30	234	239	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					232	236		10.1038/ng.2007.80	http://dx.doi.org/10.1038/ng.2007.80			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18157127	Green Accepted			2022-12-27	WOS:000252732900023
J	Kagami, M; Sekita, Y; Nishimura, G; Irie, M; Kato, F; Okada, M; Yamamori, S; Kishimoto, H; Nakayama, M; Tanaka, Y; Matsuoka, K; Takahashi, T; Noguchi, M; Tanaka, Y; Masumoto, K; Utsunomiya, T; Kouzan, H; Komatsu, Y; Ohashi, H; Kurosawa, K; Kosaki, K; Ferguson-Smith, AC; Ishino, F; Ogata, T				Kagami, Masayo; Sekita, Yoichi; Nishimura, Gen; Irie, Masahito; Kato, Fumiko; Okada, Michiyo; Yamamori, Shunji; Kishimoto, Hiroshi; Nakayama, Masahiro; Tanaka, Yukichi; Matsuoka, Kentarou; Takahashi, Tsutomu; Noguchi, Mika; Tanaka, Yoko; Masumoto, Kouji; Utsunomiya, Takeshi; Kouzan, Hiroko; Komatsu, Yumiko; Ohashi, Hirofumi; Kurosawa, Kenji; Kosaki, Kenjirou; Ferguson-Smith, Anne C.; Ishino, Fumitoshi; Ogata, Tsutomu			Deletions and epimutations affecting the human 14q32.2 imprinted region in individuals with paternal and maternal upd(14)-like phenotypes	NATURE GENETICS			English	Article							REPRESSIVE HISTONE METHYLATION; UNIPARENTAL DISOMY; GENE-EXPRESSION; DOMAIN; PLACENTA; LOCUS; IDENTIFICATION; MICE	Human chromosome 14q32.2 carries a cluster of imprinted genes including paternally expressed genes (PEGs) such as DLK1 and RTL1 and maternally expressed genes (MEGs) such as MEG3 (also known as GTL2), RTL1as (RTL1 antisense) and MEG8 (refs. 1,2), together with the intergenic differentially methylated region (IG-DMR) and the MEG3-DMR3-5. Consistent with this, paternal and maternal uniparental disomy for chromosome 14 (upd(14) pat and upd(14) mat) cause distinct phenotypes(6,7). We studied eight individuals (cases 1-8) with a upd(14) pat-like phenotype and three individuals (cases 9-11) with a upd(14) mat-like phenotype in the absence of upd(14) and identified various deletions and epimutations affecting the imprinted region. The results, together with recent mouse data(4,8-10), imply that the IG-DMR has an important cis-acting regulatory function on the maternally inherited chromosome and that excessive RTL1 expression and decreased DLK1 and RTL1 expression are relevant to upd(14) pat-like and upd(14) mat-like phenotypes, respectively.	[Sekita, Yoichi; Irie, Masahito; Ishino, Fumitoshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Epigenet, Tokyo 1010062, Japan; [Kagami, Masayo; Kato, Fumiko; Okada, Michiyo; Ogata, Tsutomu] Nat Res Inst Child Hlth & Dev, Dept Endocrinol & Metab, Tokyo 1578535, Japan; [Nishimura, Gen] Tokyo Metropolitan Kiyose Childrens Hosp, Dept Radiol, Tokyo 2048567, Japan; [Yamamori, Shunji] Mitsubishi Chem Medience Corp, Tokyo 1748555, Japan; [Kishimoto, Hiroshi] Saitama Childrens Med Ctr, Div Pathol, Kawagoe, Saitama 3398551, Japan; [Nakayama, Masahiro] Osaka Med Ctr & Res Inst Maternal & Child Hlth, Div Pathol, Osaka 5941101, Japan; [Tanaka, Yukichi] Kanagawa Childrens Med Ctr, Div Pathol, Yokohama, Kanagawa 2328555, Japan; [Matsuoka, Kentarou] Natl Ctr Child Hlth & Dev, Div Pathol, Tokyo 1578535, Japan; [Takahashi, Tsutomu] Akita Univ, Sch Med, Dept Pediat, Akita 0108543, Japan; [Noguchi, Mika] Chiba Kaihin Municipal Hosp, Dept Neonatol, Chiba 2610012, Japan; [Tanaka, Yoko] Tokyo Dent Coll Ichikawa Gen Hosp, Dept Pediat, Ichikawa 2728513, Japan; [Utsunomiya, Takeshi] Kyushu Univ, Sch Med, Dept Pediat Surg, Fukuoka 8128582, Japan; [Kouzan, Hiroko] Takamatsu Red Cross Hosp, Dept Pediat, Takamatsu, Kagawa 7600017, Japan; [Komatsu, Yumiko] Numazu City Hosp, Dept Pediat, Numazu 4100302, Japan; [Ohashi, Hirofumi] Saitama Childrens Med Ctr, Div Med Genet, Kawagoe, Saitama 3398551, Japan; [Kurosawa, Kenji] Kanagawa Childrens Med Ctr, Div Med Genet, Yokohama, Kanagawa 2328555, Japan; [Kosaki, Kenjirou] Keio Univ, Sch Med, Dept Pediat, Tokyo 1608582, Japan; [Ferguson-Smith, Anne C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Utsunomiya, Takeshi] Kagoshima City Hosp, Dept Neonatol, Kagoshima 8928580, Japan	Tokyo Medical & Dental University (TMDU); National Center for Child Health & Development - Japan; Saitama Children's Medical Center; National Center for Child Health & Development - Japan; Akita University; Tokyo Dental College; Kyushu University; Saitama Children's Medical Center; Keio University; University of Cambridge; Kagoshima City Hospital	Ishino, F (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Epigenet, Tokyo 1010062, Japan.	fishino.epgn@mri.tmd.ac.jp; tomogata@nch.go.jp	Ferguson-Smith, Anne C/G-7534-2011; Utsunomiya, Takeshi/AGK-3535-2022; Kurosawa, Kenji/B-6561-2016; Kosaki, Kenjiro/K-5350-2013	Utsunomiya, Takeshi/0000-0003-2332-4377; Kurosawa, Kenji/0000-0002-6817-7748; SEKITA, YOICHI/0000-0002-6230-8719; Kagami, Masayo/0000-0003-3020-455X; Ogata, Tsutomu/0000-0001-7178-9991; Ferguson-Smith, Anne/0000-0002-7608-5894	Medical Research Council [G0400156] Funding Source: Medline; MRC [G0400156] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Cavaille J, 2002, HUM MOL GENET, V11, P1527, DOI 10.1093/hmg/11.13.1527; Charlier C, 2001, GENOME RES, V11, P850, DOI 10.1101/gr.172701; Coan PM, 2005, PLACENTA, V26, pS10, DOI 10.1016/j.placenta.2004.12.009; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Georgiades P, 2000, DEVELOPMENT, V127, P4719; Gicquel C, 2005, NAT GENET, V37, P1003, DOI 10.1038/ng1629; Hernandez A, 2006, J CLIN INVEST, V116, P476, DOI 10.1172/JCI26240; Kagami M, 2005, AM J MED GENET A, V138A, P127, DOI 10.1002/ajmg.a.30941; Kaneko-Ishino T, 2006, CYTOGENET GENOME RES, V113, P24, DOI 10.1159/000090811; Kaneko-Ishino T, 2003, J BIOCHEM, V133, P699, DOI 10.1093/jb/mvg090; Kosaki K, 2000, J Med Genet, V37, pE19, DOI 10.1136/jmg.37.9.e19; Kotzot D, 2004, ANN GENET-PARIS, V47, P251, DOI 10.1016/j.anngen.2004.03.006; Kubota T, 1997, NAT GENET, V16, P16, DOI 10.1038/ng0597-16; Lewis A, 2004, NAT GENET, V36, P1291, DOI 10.1038/ng1468; Lin SP, 2007, DEVELOPMENT, V134, P417, DOI 10.1242/dev.02726; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Murphy SK, 2003, HUM MUTAT, V22, P92, DOI 10.1002/humu.10237; Paulsen M, 2001, GENOME RES, V11, P2085, DOI 10.1101/gr.206901; Rosa AL, 2005, CHROMOSOME RES, V13, P809, DOI 10.1007/s10577-005-1015-4; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sekita Y, 2006, CYTOGENET GENOME RES, V113, P223, DOI 10.1159/000090836; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; Takada S, 2002, HUM MOL GENET, V11, P77, DOI 10.1093/hmg/11.1.77; Takahashi I, 2005, TOHOKU J EXP MED, V207, P333, DOI 10.1620/tjem.207.333; Temple IK, 2007, J MED GENET, V44, P637, DOI 10.1136/jmg.2007.050807; Tsai CE, 2002, CURR BIOL, V12, P1221, DOI 10.1016/S0960-9822(02)00951-X; Umlauf D, 2004, NAT GENET, V36, P1296, DOI 10.1038/ng1467	28	229	236	0	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					237	242		10.1038/ng.2007.56	http://dx.doi.org/10.1038/ng.2007.56			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18176563				2022-12-27	WOS:000252732900024
J	Nath, SK; Han, SZ; Kim-Howard, X; Kelly, JA; Viswanathan, P; Gilkeson, GS; Chen, W; Zhu, C; McEver, RP; Kimberly, RP; Alarcon-Riquelme, ME; Vyse, TJ; Li, QZ; Wakeland, EK; Merrill, JT; James, JA; Kaufman, KM; Guthridge, JM; Harley, JB				Nath, Swapan K.; Han, Shizhong; Kim-Howard, Xana; Kelly, Jennifer A.; Viswanathan, Parvathi; Gilkeson, Gary S.; Chen, Wei; Zhu, Cheng; McEver, Rodger P.; Kimberly, Robert P.; Alarcon-Riquelme, Marta E.; Vyse, Timothy J.; Li, Quan-Zhen; Wakeland, Edward K.; Merrill, Joan T.; James, Judith A.; Kaufman, Kenneth M.; Guthridge, Joel M.; Harley, John B.			A nonsynonymous functional variant in integrin-alpha M (encoded by ITGAM) is associated with systemic lupus erythematosus	NATURE GENETICS			English	Article							SUSCEPTIBILITY LOCI; BETA-PROPELLER	We identified and replicated an association between ITGAM (CD11b) at 16p11.2 and risk of systemic lupus erythematosus (SLE) in 3,818 individuals of European descent. The strongest association was at a nonsynonymous SNP, rs1143679 (P 1.7 x 10(-17), odds ratio 1.78). We further replicated this association in two independent samples of individuals of African descent (P = 0.0002 and 0.003; overall meta-analysis P 6.9 x 10(-22)). The genetic association between ITGAM and SLE implicates the alpha(M)beta(2)-integrin adhesion pathway in disease development.	[Nath, Swapan K.; Han, Shizhong; Kim-Howard, Xana; Viswanathan, Parvathi] Oklahoma Med Res Fdn, Genet Epidemiol Unit, Oklahoma City, OK 73104 USA; [Nath, Swapan K.; Han, Shizhong; Kim-Howard, Xana; Kelly, Jennifer A.; Viswanathan, Parvathi; James, Judith A.; Kaufman, Kenneth M.; Guthridge, Joel M.; Harley, John B.] Oklahoma Med Res Fdn, Arthritis & Immunol Program, Oklahoma City, OK 73104 USA; [Gilkeson, Gary S.] Med Univ S Carolina, Div Rheumatol, Dept Med, Charleston, SC 29403 USA; [Chen, Wei; Zhu, Cheng] Georgia Inst Technol, George W Woodruff Sch Mech Engn, Atlanta, GA 30332 USA; [Zhu, Cheng] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [McEver, Rodger P.] Oklahoma Med Res Fdn, Cardiovasc Biol Program, Oklahoma City, OK 73104 USA; [Kimberly, Robert P.] Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; [Alarcon-Riquelme, Marta E.] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, SE-75105 Uppsala, Sweden; [Vyse, Timothy J.] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Rheumatol Sect, London W12 0NN, England; [Li, Quan-Zhen; Wakeland, Edward K.] Univ Texas SW Med Ctr Dallas, Dept Immunol, Dallas, TX 75235 USA; [Merrill, Joan T.] Oklahoma Med Res Fdn, Dept Clin Pharmacol, Oklahoma City, OK 73104 USA; [James, Judith A.] Oklahoma Med Res Fdn, Dept Med, Oklahoma City, OK 73104 USA; [James, Judith A.; Harley, John B.] Oklahoma Med Res Fdn, Dept Pathol, Oklahoma City, OK 73104 USA; [Kaufman, Kenneth M.; Harley, John B.] US Dept Vet Affairs Med Ctr, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation; Medical University of South Carolina; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; Oklahoma Medical Research Foundation; University of Alabama System; University of Alabama Birmingham; Uppsala University; Imperial College London; University of Texas System; University of Texas Southwestern Medical Center Dallas; Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center	Nath, SK (corresponding author), Oklahoma Med Res Fdn, Genet Epidemiol Unit, 825 NE 13th St, Oklahoma City, OK 73104 USA.	Swapan-Nath@omrf.org	Han, Shizhong/H-5785-2011; Alarcón-Riquelme, Marta E./ABF-8163-2020; Merrill, Joan/HDL-9141-2022; Han, Shizhong/E-4084-2010; Zhu, Cheng/A-5724-2011; Chen, Wei/A-5266-2011	Alarcón-Riquelme, Marta E./0000-0002-7632-4154; Guthridge, Joel/0000-0002-9308-237X; Han, Shizhong/0000-0002-5114-6742; Kimberly, Robert/0000-0002-5330-3086; Kelly, Jennifer/0000-0002-3203-2467	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020143, M01RR014467] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034363, R37HL034363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI024717, R21AI053747, R01AI063622, R01AI044902, R01AI024717, R21AI044902, R01AI031584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [N01AR012253, P01AR049084, R01AR042460, P50AR048940, R03AR048928, P30AR053483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015223] Funding Source: NIH RePORTER; NCRR NIH HHS [RR020143, RR01577, RR14467] Funding Source: Medline; NHLBI NIH HHS [HL 34363] Funding Source: Medline; NIAID NIH HHS [AI044902, AI053747, AI24717, AI063622, AI31584] Funding Source: Medline; NIAMS NIH HHS [AR048940, P30 AR053483, AR048928, AR049084, AR42460, AR12253] Funding Source: Medline; NIDCR NIH HHS [DE15223] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		BUYON JP, 1988, CLIN IMMUNOL IMMUNOP, V46, P141, DOI 10.1016/0090-1229(88)90014-1; Fagerholm SC, 2006, BLOOD, V108, P3379, DOI 10.1182/blood-2006-03-013557; Hepburn AL, 2006, CLIN EXP IMMUNOL, V146, P133, DOI 10.1111/j.1365-2249.2006.03174.x; Lee YH, 2005, HUM GENET, V118, P434, DOI 10.1007/s00439-005-0073-1; Li Y, 2003, J BIOL CHEM, V278, P34395, DOI 10.1074/jbc.M304190200; McCleverty CJ, 2003, BIOCHEM J, V372, P121, DOI 10.1042/BJ20021273; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Seldin MF, 2006, PLOS GENET, V2, P1339, DOI 10.1371/journal.pgen.0020143; Springer TA, 1997, P NATL ACAD SCI USA, V94, P65, DOI 10.1073/pnas.94.1.65; TODD JA, 1989, NATURE, V338, P587, DOI 10.1038/338587a0; WITTE T, 1993, J CLIN INVEST, V92, P1181, DOI 10.1172/JCI116688	12	245	251	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					152	154		10.1038/ng.71	http://dx.doi.org/10.1038/ng.71			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18204448				2022-12-27	WOS:000252732900011
J	Broderick, P; Carvajal-Carmona, L; Pittman, AM; Webb, E; Howarth, K; Rowan, A; Lubbe, S; Spain, S; Sullivan, K; Fielding, S; Jaeger, E; Vijayakrishnan, J; Kemp, Z; Gorman, M; Chandler, I; Papaemmanuil, E; Penegar, S; Wood, W; Sellick, G; Qureshi, M; Teixeira, A; Domingo, E; Barclay, E; Martin, L; Sieber, O; Kerr, D; Gray, R; Peto, J; Cazier, JB; Tomlinson, I; Houlston, RS				Broderick, Peter; Carvajal-Carmona, Luis; Pittman, Alan M.; Webb, Emily; Howarth, Kimberley; Rowan, Andrew; Lubbe, Steven; Spain, Sarah; Sullivan, Kate; Fielding, Sarah; Jaeger, Emma; Vijayakrishnan, Jayaram; Kemp, Zoe; Gorman, Maggie; Chandler, Ian; Papaemmanuil, Elli; Penegar, Steven; Wood, Wendy; Sellick, Gabrielle; Qureshi, Mobshra; Teixeira, Ana; Domingo, Enric; Barclay, Ella; Martin, Lynn; Sieber, Oliver; Kerr, David; Gray, Richard; Peto, Julian; Cazier, Jean-Baptiste; Tomlinson, Ian; Houlston, Richard S.			A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk	NATURE GENETICS			English	Article								To identify risk variants for colorectal cancer (CRC), we conducted a genome-wide association study, genotyping 550,163 tag SNPs in 940 individuals with familial colorectal tumor ( 627 CRC, 313 advanced adenomas) and 965 controls. We evaluated selected SNPs in three replication sample sets ( 7,473 cases, 5,984 controls) and identified three SNPs in SMAD7 ( involved in TGF-beta and Wnt signaling) associated with CRC. Across the four sample sets, the association between rs4939827 and CRC was highly statistically significant ( P-trend 1.0 x 10(-12)).	Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Canc Res UK, London Res Inst, Mol & Populat Genet Lab, London WC2A 3PX, England; Univ London, Queen Mary Coll, Inst Canc, Barts & London Med Sch, London EC1M 6BQ, England; St Marys Hosp, Dept Med Genet, Manchester M13 0JH, Lancs, England; Birmingham Womens Hosp, Dept Med Genet, Birmingham B15 2TG, W Midlands, England; Univ Oxford, Weatherall Inst Mol Med, Canc & Immunogenet Lab, Oxford OX3 9DS, England; Univ Oxford, Radcliffe Infirm, Dept Clin Pharmacol, Oxford OX2 6HA, England; Univ Birmingham, Birmingham Clin Trials Unit, Birmingham B15 2TT, W Midlands, England; Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; Univ London London Sch Hyg & Trop Med, Non Communicable Dis Epidemiol Unit, London WC1E 7HT, England	University of London; Institute of Cancer Research - UK; Cancer Research UK; University of London; Queen Mary University London; University of Manchester; Birmingham Women's Hospital; University of Oxford; Radcliffe Infirmary; University of Oxford; University of Birmingham; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of London; London School of Hygiene & Tropical Medicine	Houlston, RS (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England.	ian.tomlinson@cancer.org.uk; richard.houlston@icr.ac.uk	Carvajal-Carmona, Luis G/B-3882-2010; Lubbe, Steven/L-8261-2013; Sieber, Oliver/M-9473-2015; Pittman, Alan M/D-6231-2012; Domingo, Enric/A-9099-2018; Evans, D Gareth/AAB-4308-2022; Cazier, Jean-Baptiste/GLR-2949-2022; Sieber, Oliver/ABA-9211-2021; Cazier, Jean-Baptiste/F-2369-2010; Pittman, Alan/AAP-2534-2020; Spain, Sarah/G-1968-2010	Carvajal-Carmona, Luis G/0000-0001-7129-2918; Lubbe, Steven/0000-0002-7103-6671; Sieber, Oliver/0000-0001-9480-0786; Pittman, Alan M/0000-0002-8112-2987; Domingo, Enric/0000-0003-4390-8767; Evans, D Gareth/0000-0002-8482-5784; Cazier, Jean-Baptiste/0000-0001-7581-9051; Sieber, Oliver/0000-0001-9480-0786; Cazier, Jean-Baptiste/0000-0001-7581-9051; Pittman, Alan/0000-0002-8112-2987; Webb, Emily/0000-0002-4019-7456; Vijayakrishnan, Jayaram/0000-0002-8284-2249; Gray, Richard/0000-0003-4440-574X; Broderick, Peter/0000-0002-8348-5829; Houlston, Richard/0000-0002-5268-0242; Spain, Sarah/0000-0002-7591-8364; Penegar, Steven/0000-0002-3768-0236	MRC [G0301100] Funding Source: UKRI; Medical Research Council [G0301100] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aaltonen L, 2007, CLIN CANCER RES, V13, P356, DOI 10.1158/1078-0432.CCR-06-1256; Gaasenbeek M, 2006, CANCER RES, V66, P3471, DOI 10.1158/0008-5472.CAN-05-3285; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P954, DOI 10.1038/ng2098; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Han GW, 2006, DEV CELL, V11, P301, DOI 10.1016/j.devcel.2006.06.014; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Minichiello MJ, 2006, AM J HUM GENET, V79, P910, DOI 10.1086/508901; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089	12	416	432	0	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2007	39	11					1315	1317		10.1038/ng.2007.18	http://dx.doi.org/10.1038/ng.2007.18			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17934461				2022-12-27	WOS:000250575900014
J	Lee, W; Tillo, D; Bray, N; Morse, RH; Davis, RW; Hughes, TR; Nislow, C				Lee, William; Tillo, Desiree; Bray, Nicolas; Morse, Randall H.; Davis, Ronald W.; Hughes, Timothy R.; Nislow, Corey			A high- resolution atlas of nucleosome occupancy in yeast	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; IN-VIVO; EUKARYOTIC GENOME; RNA-POLYMERASE; BUDDING YEAST; Z-DNA; CHROMATIN; TRANSCRIPTION; BINDING; PROMOTER	We present the first complete high-resolution map of nucleosome occupancy across the whole Saccharomyces cerevisiae genome, identifying over 70,000 positioned nucleosomes occupying 81% of the genome. On a genome-wide scale, the persistent nucleosome-depleted region identified previously in a subset of genes demarcates the transcription start site. Both nucleosome occupancy signatures and overall occupancy correlate with transcript abundance and transcription rate. In addition, functionally related genes can be clustered on the basis of the nucleosome occupancy patterns observed at their promoters. A quantitative model of nucleosome occupancy indicates that DNA structural features may account for much of the global nucleosome occupancy.	Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; Stanford Genome Technol, Palo Alto, CA 94304 USA; Univ Toronto, Dept Mol & Med Genet, Toronto, ON M5S 1A8, Canada; New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; Banting & Best Dept Med Res, Toronto, ON M5S 1L6, Canada	Stanford University; University of Toronto; State University of New York (SUNY) System; Wadsworth Center; University of Toronto; University of Toronto	Nislow, C (corresponding author), Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA.	corey.nislow@utoronto.ca		Nislow, Corey/0000-0002-4016-8874; Morse, Randall/0000-0003-0000-8718; Lee, William/0000-0001-9582-4413				Albert I, 2007, NATURE, V446, P572, DOI 10.1038/nature05632; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bernstein BE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r62; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Champ PC, 2004, NUCLEIC ACIDS RES, V32, P6501, DOI 10.1093/nar/gkh988; David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; ElHassan MA, 1996, J MOL BIOL, V259, P95, DOI 10.1006/jmbi.1996.0304; FEDOR MJ, 1988, J MOL BIOL, V204, P109, DOI 10.1016/0022-2836(88)90603-1; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hogan GJ, 2006, PLOS GENET, V2, P1433, DOI 10.1371/journal.pgen.0020158; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ioshikhes IP, 2006, NAT GENET, V38, P1210, DOI 10.1038/ng1878; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Johnson SM, 2006, GENOME RES, V16, P1505, DOI 10.1101/gr.5560806; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Kasten MM, 1997, MOL GEN GENET, V256, P376, DOI 10.1007/s004380050581; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677; Lascaris RF, 2000, NUCLEIC ACIDS RES, V28, P1390, DOI 10.1093/nar/28.6.1390; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Liu X, 2006, GENOME RES, V16, P1517, DOI 10.1101/gr.5655606; LOHR D, 1995, J BIOL CHEM, V270, P27671, DOI 10.1074/jbc.270.46.27671; MacIsaac KD, 2006, BIOINFORMATICS, V22, P423, DOI 10.1093/bioinformatics/bti815; MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113; Martinez-Campa C, 2004, MOL CELL, V15, P69, DOI 10.1016/j.molcel.2004.05.022; Moreira JMA, 1998, EMBO J, V17, P6028, DOI 10.1093/emboj/17.20.6028; Morse RH, 2003, BIOCHEM CELL BIOL, V81, P101, DOI 10.1139/o03-039; NOLL M, 1977, J MOL BIOL, V109, P393, DOI 10.1016/S0022-2836(77)80019-3; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Ponomarenko JV, 1999, BIOINFORMATICS, V15, P654, DOI 10.1093/bioinformatics/15.7.654; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; SATCHWELL SC, 1986, J MOL BIOL, V191, P659, DOI 10.1016/0022-2836(86)90452-3; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Sekinger EA, 2005, MOL CELL, V18, P735, DOI 10.1016/j.molcel.2005.05.003; Sivolob A, 2000, J MOL BIOL, V295, P55, DOI 10.1006/jmbi.1999.3302; STRAKA C, 1991, EMBO J, V10, P361, DOI 10.1002/j.1460-2075.1991.tb07957.x; Studitsky VM, 1997, SCIENCE, V278, P1960, DOI 10.1126/science.278.5345.1960; Suter B, 2000, NUCLEIC ACIDS RES, V28, P4083, DOI 10.1093/nar/28.21.4083; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; WANG YH, 1994, SCIENCE, V265, P669, DOI 10.1126/science.8036515; Wong B, 2007, P NATL ACAD SCI USA, V104, P2229, DOI 10.1073/pnas.0611447104; Yarragudi A, 2004, MOL CELL BIOL, V24, P9152, DOI 10.1128/MCB.24.20.9152-9164.2004; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zanton SJ, 2006, GENE DEV, V20, P2250, DOI 10.1101/gad.1437506	49	648	666	0	48	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2007	39	10					1235	1244		10.1038/ng2117	http://dx.doi.org/10.1038/ng2117			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17873876				2022-12-27	WOS:000249737400019
J	Perry, GH; Dominy, NJ; Claw, KG; Lee, AS; Fiegler, H; Redon, R; Werner, J; Villanea, FA; Mountain, JL; Misra, R; Carter, NP; Lee, C; Stone, AC				Perry, George H.; Dominy, Nathaniel J.; Claw, Katrina G.; Lee, Arthur S.; Fiegler, Heike; Redon, Richard; Werner, John; Villanea, Fernando A.; Mountain, Joanna L.; Misra, Rajeev; Carter, Nigel P.; Lee, Charles; Stone, Anne C.			Diet and the evolution of human amylase gene copy number variation	NATURE GENETICS			English	Article							SALIVARY AMYLASE; PLANT; CHIMPANZEE; DIGESTION; LINEAGE; ORIGINS; GENOME; FOODS	Starch consumption is a prominent characteristic of agricultural societies and hunter-gatherers in arid environments. In contrast, rainforest and circum-arctic hunter-gatherers and some pastoralists consume much less starch(1-3). This behavioral variation raises the possibility that different selective pressures have acted on amylase, the enzyme responsible for starch hydrolysis(4). We found that copy number of the salivary amylase gene (AMY1) is correlated positively with salivary amylase protein level and that individuals from populations with high-starch diets have, on average, more AMY1 copies than those with traditionally low-starch diets. Comparisons with other loci in a subset of these populations suggest that the extent of AMY1 copy number differentiation is highly unusual. This example of positive selection on a copy number-variable gene is, to our knowledge, one of the first discovered in the human genome. Higher AMY1 copy numbers and protein levels probably improve the digestion of starchy foods and may buffer against the fitness-reducing effects of intestinal disease.	Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA; Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; Univ Calif Santa Cruz, Dept Anthropol, Santa Cruz, CA 95064 USA; Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Stanford Univ, Dept Anthropol Sci, Stanford, CA 94305 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Arizona State University; Arizona State University-Tempe; Harvard University; Brigham & Women's Hospital; University of California System; University of California Santa Cruz; Arizona State University; Arizona State University-Tempe; Wellcome Trust Sanger Institute; Stanford University; Harvard University; Harvard Medical School	Dominy, NJ (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ 85287 USA.	njdominy@ucsc.edu	Stone, Anne C/B-5719-2009; Martinez, Octavio/B-7375-2009; Redon, Richard/F-3303-2014; Dominy, Nathaniel Jay/A-6151-2013	Redon, Richard/0000-0001-7751-2280; Dominy, Nathaniel Jay/0000-0001-5916-418X; Stone, Anne/0000-0001-8021-8314; Claw, Katrina/0000-0003-2239-5018	NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR014491, C06RR016483, U42RR015087] Funding Source: NIH RePORTER; NCRR NIH HHS [RR016483, RR014491, C06 RR014491-01, C06 RR016483-01, U42 RR015087-01, U42 RR015087, C06 RR014491, RR015087, C06 RR016483] Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Wellcome Trust(Wellcome TrustEuropean Commission)		Cheng Z, 2005, NATURE, V437, P88, DOI 10.1038/nature04000; COURSEY DG, 1973, MAN, V8, P634; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; DRAPER HH, 1977, AM ANTHROPOL, V79, P309, DOI 10.1525/aa.1977.79.2.02a00070; FIEGLER H, 2002, GENOME RES, V16, P156; Fortna A, 2004, PLOS BIOL, V2, P937, DOI 10.1371/journal.pbio.0020207; FRIED M, 1987, DIGEST DIS SCI, V32, P1097, DOI 10.1007/BF01300195; GROOT PC, 1989, GENOMICS, V5, P29, DOI 10.1016/0888-7543(89)90083-9; HART TB, 1986, HUM ECOL, V14, P29, DOI 10.1007/BF00889209; Hawkes K, 1998, P NATL ACAD SCI USA, V95, P1336, DOI 10.1073/pnas.95.3.1336; HOHMAN G, 2006, FEEDING ECOLOGY APES; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Klein RG, 2000, EVOL ANTHROPOL, V9, P17, DOI 10.1002/(SICI)1520-6505(2000)9:1<17::AID-EVAN3>3.0.CO;2-A; Laden G, 2005, J HUM EVOL, V49, P482, DOI 10.1016/j.jhevol.2005.05.007; Lambert JE, 2005, AM J PHYS ANTHROPOL, V126, P183, DOI 10.1002/ajpa.10440; LEBENTHAL E, 1987, DIGEST DIS SCI, V32, P1155, DOI 10.1007/BF01300204; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; MCGEACHIN RL, 1982, COMP BIOCHEM PHYS A, V72, P267, DOI 10.1016/0300-9629(82)90045-7; Perry GH, 2006, P NATL ACAD SCI USA, V103, P8006, DOI 10.1073/pnas.0602318103; READ NW, 1986, BRIT J NUTR, V55, P43, DOI 10.1079/BJN19860008; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; SAMUELSON LC, 1990, MOL CELL BIOL, V10, P2513, DOI 10.1128/MCB.10.6.2513; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; TOKAREV SA, 1956, PEOPLES SIBERIA, P243; VALDEZ IH, 1991, DIGEST DIS, V9, P125, DOI 10.1159/000171298; Vincent A. S., 1984, WORLD ARCHAEOL, V17, P131; Wilson GM, 2006, GENOME RES, V16, P173, DOI 10.1101/gr.4456006; Wrangham RW, 1999, CURR ANTHROPOL, V40, P567, DOI 10.1086/300083; Zohary D, 2000, DOMESTICATION PLANTS, DOI DOI 10.1006/ANBO.2001.1505	30	902	924	57	572	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2007	39	10					1256	1260		10.1038/ng2123	http://dx.doi.org/10.1038/ng2123			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	214KW	17828263	Green Accepted			2022-12-27	WOS:000249737400022
J	Haiman, CA; Le Marchand, L; Yamamato, J; Stram, DO; Sheng, X; Kolonel, LN; Wu, AH; Reich, D; Henderson, BE				Haiman, Christopher A.; Le Marchand, Loic; Yamamato, Jennifer; Stram, Daniel O.; Sheng, Xin; Kolonel, Laurence N.; Wu, Anna H.; Reich, David; Henderson, Brian E.			A common genetic risk factor for colorectal and prostate cancer	NATURE GENETICS			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; WIDE ASSOCIATION; LOCUS; OCT4; 8Q24	Variants on chromosome 8q24 contribute risk for prostate cancer; here, we tested whether they also modulate risk for colorectal cancer. We studied 1,807 affected individuals and 5,511 controls and found that one variant, rs6983267, is also significantly associated with colorectal cancer ( odds ratio = 1.22; P = 4.4 x 10(-6)) and that the apportionment of risk among the variants differs significantly between the two cancers. Comprehensive testing in the region uncovered variants capturing significant additional risk. Our results show that variants at 8q24 have different effects on cancer development that depend on the tissue type.	Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA; Univ Hawaii, Canc Res Ctr Hawaii, Program Epidemiol, Honolulu, HI 96813 USA; Broad Inst Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; MIT, Cambridge, MA 02142 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA	University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Haiman, CA (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90089 USA.	haiman@usc.edu			NATIONAL CANCER INSTITUTE [U01CA063464, R01CA060987, R01CA063464, P01CA017054, R37CA054281, R01CA072520, R01CA054281] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA054281, R37 CA054281, P01 CA17054, CA72520, CA54281, U01 CA063464, R01 CA072520, R01 CA063464, R01 CA060987, R01 CA063464-09S1, CA60987, CA63464, P01 CA017054] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Douglas EJ, 2004, CANCER RES, V64, P4817, DOI 10.1158/0008-5472.CAN-04-0328; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Ried T, 1996, GENE CHROMOSOME CANC, V15, P234, DOI 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Sun JS, 2007, PROSTATE, V67, P692, DOI 10.1002/pros.20543; Suo GL, 2005, BIOCHEM BIOPH RES CO, V337, P1047, DOI 10.1016/j.bbrc.2005.09.157; VISAKORPI T, 1995, CANCER RES, V55, P342; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	13	301	312	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	AUG	2007	39	8					954	956		10.1038/ng2098	http://dx.doi.org/10.1038/ng2098			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17618282	Green Accepted			2022-12-27	WOS:000248446900008
J	Sandhu, MS; Weedon, MN; Fawcett, KA; Wasson, J; Debenham, SL; Daly, A; Lango, H; Frayling, TM; Neumann, RJ; Sherva, R; Blech, I; Pharoah, PD; Palmer, CNA; Kimber, C; Tavendale, R; Morris, AD; McCarthy, MI; Walker, M; Hitman, G; Glaser, B; Permutt, MA; Hattersley, AT; Wareham, NJ; Barroso, I				Sandhu, Manjinder S.; Weedon, Michael N.; Fawcett, Katherine A.; Wasson, Jon; Debenham, Sally L.; Daly, Allan; Lango, Hana; Frayling, Timothy M.; Neumann, Rosalind J.; Sherva, Richard; Blech, Ilana; Pharoah, Paul D.; Palmer, Colin N. A.; Kimber, Charlotte; Tavendale, Roger; Morris, Andrew D.; McCarthy, Mark I.; Walker, Mark; Hitman, Graham; Glaser, Benjamin; Permutt, M. Alan; Hattersley, Andrew T.; Wareham, Nicholas J.; Barroso, Ines			Common variants in WFS1 confer risk of type 2 diabetes	NATURE GENETICS			English	Article							ENDOPLASMIC-RETICULUM STRESS; NUCLEAR FACTOR-4-ALPHA GENE; BETA-CELL LOSS; TRANSMEMBRANE PROTEIN; OPTIC ATROPHY; E23K VARIANT; POLYMORPHISM; ASSOCIATION; MELLITUS	We studied genes involved in pancreatic beta cell function and survival, identifying associations between SNPs in WFS1 and diabetes risk in UK populations that we replicated in an Ashkenazi population and in additional UK studies. In a pooled analysis comprising 9,533 cases and 11,389 controls, SNPs in WFS1 were strongly associated with diabetes risk. Rare mutations in WFS1 cause Wolfram syndrome; using a gene-centric approach, we show that variation in WFS1 also predisposes to common type 2 diabetes.	UK Med Res Council, Epidemiol Unit, Strangeways Res Lab, Cambridge CB1 8RN, England; Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 0SR, England; Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX1 2LU, Devon, England; Wellcome Trust Sanger Inst, Metab Dis Grp, Cambridge CB10 1SA, England; Washington Univ, Sch Med, St Louis, MO 63110 USA; Hadassah Hebrew Univ, Med Ctr, Endocrine & Metab Serv, IL-91120 Jerusalem, Israel; Univ Cambridge, Strangeways Res Lab, Dept Oncol, Canc Res UK, Cambridge CB1 8RN, England; Univ Dundee, Ninewells Hosp & Med Sch, Div Med & Therapeut, Diabet Res Grp, Dundee DD1 9SY, Scotland; Univ Dundee, Ninewells Hosp & Med Sch, Populat Pharmacogenet Grp, Biomed Res Ctr, Dundee DD1 9SY, Scotland; Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Newcastle, Sch Clin Med Sci, Diabet Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ London, Queen Marys Sch Med & Dent, Ctr Diabet & Metab Med, London E1 1BB, England	University of Cambridge; University of Cambridge; University of Exeter; Wellcome Trust Sanger Institute; Washington University (WUSTL); Hebrew University of Jerusalem; Hadassah University Medical Center; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Dundee; University of Dundee; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Newcastle University - UK; University of London; Queen Mary University London	Sandhu, MS (corresponding author), UK Med Res Council, Epidemiol Unit, Strangeways Res Lab, Cambridge CB1 8RN, England.	manj.sandhu@srl.cam.ac.uk; ib1@sanger.ac.uk	Study, GoDARTS/K-9448-2016; Allen, Hana Lango/G-9026-2012; Palmer, Colin NA/C-7053-2008; Morris, Andrew D/C-2837-2009; Glaser, Benjamin/F-8411-2017; Pharoah, Paul/V-6658-2019; McCarthy, Mark/M-3763-2015	Allen, Hana Lango/0000-0002-7803-8688; Palmer, Colin NA/0000-0002-6415-6560; Glaser, Benjamin/0000-0003-4711-5000; Pharoah, Paul/0000-0001-8494-732X; Weedon, Michael/0000-0002-6174-6135; Sherva, Richard/0000-0003-2133-1493; Fawcett, Katherine/0000-0002-6675-2112; Barroso, Ines/0000-0001-5800-4520; McCarthy, Mark/0000-0002-4393-0510; Ricketts, Sally/0000-0002-5644-7958; Hattersley, Andrew/0000-0001-5620-473X	MRC [G0500070] Funding Source: UKRI; Medical Research Council [MC_U106179471, G0500070] Funding Source: Medline; Wellcome Trust [068545/z/02, 077016] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Gloyn AL, 2003, DIABETES, V52, P568, DOI 10.2337/diabetes.52.2.568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Inoue H, 1998, NAT GENET, V20, P143, DOI 10.1038/2441; Ishihara H, 2004, HUM MOL GENET, V13, P1159, DOI 10.1093/hmg/ddh125; KARASIK A, 1989, DIABETES CARE, V12, P135, DOI 10.2337/diacare.12.2.135; Love-Gregory LD, 2004, DIABETES, V53, P1134, DOI 10.2337/diabetes.53.4.1134; Minton JAL, 2002, DIABETES, V51, P1287, DOI 10.2337/diabetes.51.4.1287; Nielsen EMD, 2003, DIABETES, V52, P573, DOI 10.2337/diabetes.52.2.573; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Riggs AC, 2005, DIABETOLOGIA, V48, P2313, DOI 10.1007/s00125-005-1947-4; Silander K, 2004, DIABETES, V53, P1141, DOI 10.2337/diabetes.53.4.1141; Strom TM, 1998, HUM MOL GENET, V7, P2021, DOI 10.1093/hmg/7.13.2021; Yamada T, 2006, HUM MOL GENET, V15, P1600, DOI 10.1093/hmg/ddl081	14	272	281	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	AUG	2007	39	8					951	953		10.1038/ng2067	http://dx.doi.org/10.1038/ng2067			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	195XX	17603484	Green Accepted			2022-12-27	WOS:000248446900007
J	den Hollander, AI; Koenekoop, RK; Mohamed, MD; Arts, HH; Boldt, K; Towns, KV; Sedmak, T; Beer, M; Nagel-Wolfrum, K; McKibbin, M; Dharmaraj, S; Lopez, I; Ivings, L; Williams, GA; Springell, K; Woods, CG; Jafri, H; Rashid, Y; Strom, TM; van der Zwaag, B; Gosens, I; Kersten, FFJ; van Wijk, E; Veltman, JA; Zonneveld, MN; van Beersum, SEC; Maumenee, IH; Wolfrum, U; Cheetham, ME; Ueffing, M; Cremers, FPM; Inglehearn, CF; Roepman, R				den Hollander, Anneke I.; Koenekoop, Robert K.; Mohamed, Moin D.; Arts, Heleen H.; Boldt, Karsten; Towns, Katherine V.; Sedmak, Tina; Beer, Monika; Nagel-Wolfrum, Kerstin; McKibbin, Martin; Dharmaraj, Sharola; Lopez, Irma; Ivings, Lenka; Williams, Grange A.; Springell, Kelly; Woods, C. Geoff; Jafri, Hussain; Rashid, Yasmin; Strom, Tim M.; van der Zwaag, Bert; Gosens, Ilse; Kersten, Ferry F. J.; van Wijk, Erwin; Veltman, Joris A.; Zonneveld, Marijke N.; van Beersum, Sylvia E. C.; Maumenee, Irene H.; Wolfrum, Uwe; Cheetham, Michael E.; Ueffing, Marius; Cremers, Frans P. M.; Inglehearn, Chris F.; Roepman, Ronald			Mutations in LCA5, encoding the ciliary protein lebercilin, cause Leber congenital amaurosis	NATURE GENETICS			English	Article							CASEIN KINASE-II; CENTROSOMAL PROTEIN; JOUBERT-SYNDROME; ASSOCIATION; NUCLEOLIN; INTERACTS; NUCLEOPHOSMIN/B23; PHOSPHORYLATION; LOCALIZATION; CENTRIOLES	Leber congenital amaurosis ( LCA) causes blindness or severe visual impairment at or within a few months of birth. Here we show, using homozygosity mapping, that the LCA5 gene on chromosome 6q14, which encodes the previously unknown ciliary protein lebercilin, is associated with this disease. We detected homozygous nonsense and frameshift mutations in LCA5 in five families affected with LCA. In a sixth family, the LCA5 transcript was completely absent. LCA5 is expressed widely throughout development, although the phenotype in affected individuals is limited to the eye. Lebercilin localizes to the connecting cilia of photoreceptors and to the microtubules, centrioles and primary cilia of cultured mammalian cells. Using tandem affinity purification, we identified 24 proteins that link lebercilin to centrosomal and ciliary functions. Members of this interactome represent candidate genes for LCA and other ciliopathies. Our findings emphasize the emerging role of disrupted ciliary processes in the molecular pathogenesis of LCA.	Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, Nijmegen, Netherlands; McGill Univ, Hlth Sci Ctr, McGill Ocular Genet Ctr, Montreal, PQ H3A 2T5, Canada; St James Univ Hosp, Leeds Inst Mol Med, Sect Ophthalmol & Neurosci, Leeds, W Yorkshire, England; St Thomas Hosp, Dept Ophthalmol, London, England; GSF Natl Res Ctr Environm & Hlth, Inst Human Genet, Munich, Germany; Tech Univ Munich, Inst Human Genet, D-8000 Munich, Germany; Johannes Gutenberg Univ Mainz, Inst Zool, D-6500 Mainz, Germany; St James Univ Hosp, Eye Dept, Leeds, W Yorkshire, England; INRA, FLAVIC, Eye & Nutr Res Grp, Dijon, France; Addenbrookes Hosp, Cambridge Inst Med Tes, Dept Med Genet, Cambridge, England; Gene Tech Lab 146 1, Lahore, Pakistan; King Edward Med Univ, Dept Obstet & Gynaecol, Lahore, Pakistan; Univ Utrecht, Med Ctr, Rudolf Magnus Inst Neurosci, Dept Pharmacol & Anat, NL-3508 TC Utrecht, Netherlands; Johns Hopkins Univ, Wilmer Eye Inst, Baltimore, MD 21218 USA; UCL, Inst Ophthalmol, Div Mol & Cellular Neurosci, London WC1E 6BT, England	Radboud University Nijmegen; McGill University; University of Manitoba; Children's Hospital Research Institute of Manitoba; Saint James's University Hospital; University of Leeds; Guy's & St Thomas' NHS Foundation Trust; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Technical University of Munich; Johannes Gutenberg University of Mainz; Saint James's University Hospital; INRAE; Institut Agro; AgroSup Dijon; Universite de Bourgogne; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Utrecht University; Utrecht University Medical Center; Johns Hopkins University; Johns Hopkins Medicine; University of London; University College London	den Hollander, AI (corresponding author), Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, Nijmegen, Netherlands.	a.denhollander@antrg.umcn.nl	van Wijk, Erwin/J-8913-2014; Veltman, Joris A/F-5128-2010; Cheetham, Michael/B-4672-2011; woods, christopher g/A-1361-2010; Koenekoop, Robert/AAT-6676-2021; Nagel-Wolfrum, Kerstin/AAX-6477-2020; arts, heleen/ACL-6040-2022; Cremers, Frans/A-5625-2014; Boldt, Karsten/B-7538-2014; Kersten, Ferry F.J./ABC-7666-2020; Roepman, Ronald/B-1339-2014; van Beersum, Sylvia E.C./P-8653-2015; Hollander, Anneke den/N-4911-2014; Inglehearn, Chris/GYD-9783-2022	van Wijk, Erwin/0000-0002-5702-3460; Veltman, Joris A/0000-0002-3218-8250; Cremers, Frans/0000-0002-4954-5592; Roepman, Ronald/0000-0002-5178-8163; van Beersum, Sylvia E.C./0000-0002-4552-2908; Cheetham, Michael/0000-0001-6429-654X; Arts, Heleen/0000-0002-9860-3744	Wellcome Trust [073477, 061682, 068579] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Brandstatter JH, 1996, J NEUROSCI, V16, P4749; Burakov A, 2003, J CELL BIOL, V162, P963, DOI 10.1083/jcb.200305082; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Chen CY, 2006, BIOCHEM BIOPH RES CO, V342, P1203, DOI 10.1016/j.bbrc.2006.02.089; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Dharmaraj S, 2000, AM J HUM GENET, V66, P319, DOI 10.1086/302719; Faust M, 2002, CELL MOL LIFE SCI, V59, P2155, DOI 10.1007/s000180200022; Gherman A, 2006, NAT GENET, V38, P961, DOI 10.1038/ng0906-961; Giessl A, 2004, J BIOL CHEM, V279, P51472, DOI 10.1074/jbc.M406770200; Ginisty H, 1999, J CELL SCI, V112, P761; Guarguaglini G, 2005, MOL BIOL CELL, V16, P1095, DOI 10.1091/mbc.E04-10-0939; Hollander BA, 1999, CELL MOTIL CYTOSKEL, V43, P114, DOI 10.1002/(SICI)1097-0169(1999)43:2<114::AID-CM3>3.3.CO;2-D; Hu JH, 2006, MOL BIOL CELL, V17, P2200, DOI 10.1091/mbc.E05-10-0935; Li DX, 1996, J BIOL CHEM, V271, P15662, DOI 10.1074/jbc.271.26.15662; Lim ACB, 2004, J BIOL CHEM, V279, P4433, DOI 10.1074/jbc.M310563200; Ma Z, 2006, MOL CELL BIOL, V26, P9016, DOI 10.1128/MCB.01383-06; Mhawech P, 2005, CELL RES, V15, P228, DOI 10.1038/sj.cr.7290291; Mohamed MD, 2003, BRIT J OPHTHALMOL, V87, P473, DOI 10.1136/bjo.87.4.473; Ostrowski LE, 2002, MOL CELL PROTEOMICS, V1, P451, DOI 10.1074/mcp.M200037-MCP200; Pietromonaco SF, 1996, BLOOD CELL MOL DIS, V22, P225, DOI 10.1006/bcmd.1996.0103; Quintyne NJ, 1999, J CELL BIOL, V147, P321, DOI 10.1083/jcb.147.2.321; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Roepman R, 2005, P NATL ACAD SCI USA, V102, P18520, DOI 10.1073/pnas.0505774102; Sayer JA, 2006, NAT GENET, V38, P674, DOI 10.1038/ng1786; Schermer B, 2005, EMBO J, V24, P4415, DOI 10.1038/sj.emboj.7600885; Shinmura K, 2005, FEBS LETT, V579, P6621, DOI 10.1016/j.febslet.2005.10.057; Shu X, 2005, HUM MOL GENET, V14, P1183, DOI 10.1093/hmg/ddi129; Valente EM, 2006, NAT GENET, V38, P623, DOI 10.1038/ng1805; van Wijk E, 2006, HUM MOL GENET, V15, P751, DOI 10.1093/hmg/ddi490; Zhang H, 2004, J BIOL CHEM, V279, P35726, DOI 10.1074/jbc.M403264200	30	141	146	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39	7					889	895		10.1038/ng2066	http://dx.doi.org/10.1038/ng2066			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17546029				2022-12-27	WOS:000247619800020
J	Stacey, SN; Manolescu, A; Sulem, P; Rafnar, T; Gudmundsson, J; Gudjonsson, SA; Masson, G; Jakobsdottir, M; Thorlacius, S; Helgason, A; Aben, KK; Strobbe, LJ; Albers-Akkers, MT; Swinkels, DW; Henderson, BE; Kolonel, LN; Le Marchand, L; Millastre, E; Andres, R; Godino, J; Garcia-Prats, MD; Polo, E; Tres, A; Mouy, M; Saemundsdottir, J; Backman, VM; Gudmundsson, L; Kristjansson, K; Bergthorsson, JT; Kostic, J; Frigge, ML; Geller, F; Gudbjartsson, D; Sigurdsson, H; Jonsdottir, T; Hrafnkelsson, J; Johannsson, J; Sveinsson, T; Myrdal, G; Grimsson, HN; Jonsson, T; von Holst, S; Werelius, B; Margolin, S; Lindblom, A; Mayordomo, JI; Haiman, CA; Kiemeney, LA; Johannsson, OT; Gulcher, JR; Thorsteinsdottir, U; Kong, A; Stefansson, K				Stacey, Simon N.; Manolescu, Andrei; Sulem, Patrick; Rafnar, Thorunn; Gudmundsson, Julius; Gudjonsson, Sigurjon A.; Masson, Gisli; Jakobsdottir, Margret; Thorlacius, Steinunn; Helgason, Agnar; Aben, Katja K.; Strobbe, Luc J.; Albers-Akkers, Marjo T.; Swinkels, Dorine W.; Henderson, Brian E.; Kolonel, Laurence N.; Le Marchand, Loic; Millastre, Esther; Andres, Raquel; Godino, Javier; Garcia-Prats, Maria Dolores; Polo, Eduardo; Tres, Alejandro; Mouy, Magali; Saemundsdottir, Jona; Backman, Valgerdur M.; Gudmundsson, Larus; Kristjansson, Kristleifur; Bergthorsson, Jon T.; Kostic, Jelena; Frigge, Michael L.; Geller, Frank; Gudbjartsson, Daniel; Sigurdsson, Helgi; Jonsdottir, Thora; Hrafnkelsson, Jon; Johannsson, Jakob; Sveinsson, Thorarinn; Myrdal, Gardar; Grimsson, Hlynur Niels; Jonsson, Thorvaldur; von Holst, Susanna; Werelius, Barbro; Margolin, Sara; Lindblom, Annika; Mayordomo, Jose I.; Haiman, Christopher A.; Kiemeney, Lambertus A.; Johannsson, Oskar Th; Gulcher, Jeffrey R.; Thorsteinsdottir, Unnur; Kong, Augustine; Stefansson, Kari			Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; RISK; FEATURES; GENES; BONE	Familial clustering studies indicate that breast cancer risk has a substantial genetic component(1-3). To identify new breast cancer risk variants, we genotyped approximately 300,000 SNPs in 1,600 Icelandic individuals with breast cancer and 11,563 controls using the Illumina Hap300 platform. We then tested selected SNPs in five replication sample sets. Overall, we studied 4,554 affected individuals and 17,577 controls. Two SNPs consistently associated with breast cancer: similar to 25% of individuals of European descent are homozygous for allele A of rs13387042 on chromosome 2q35 and have an estimated 1.44- fold greater risk than noncarriers, and for allele T of rs3803662 on 16q12, about 7% are homozygous and have a 1.64- fold greater risk. Risk from both alleles was confined to estrogen receptor - positive tumors. At present, no genes have been identified in the linkage disequilibrium block containing rs13387042. rs3803662 is near the 5' end of TNRC9, a high mobility group chromatin - associated protein whose expression is implicated in breast cancer metastasis to bone(4).	deCODE Genet, IS-101 Reykjavik, Iceland; Ctr Comprehens Canc, NL-6501 BG Nijmegen, Netherlands; Radboud Univ Nijmegen Med Ctr, Dept Epidemiol & Biostat, NL-6500 HB Nijmegen, Netherlands; Radboud Univ Nijmegen Med Ctr, Dept Clin Chem, NL-6500 HB Nijmegen, Netherlands; Canisius Wilhelmina Hosp, Dept Surg, NL-6500 GS Nijmegen, Netherlands; INR Thrombosis Serv, NL-6525 ED Nijmegen, Netherlands; Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; Univ Hawaii, Canc Res Ctr, Honolulu, HI 96813 USA; Univ Hosp, Div Med Oncol, Zaragoza 50009, Spain; Nanotechnol Inst Aragon, Hlth Sci Inst, Zaragoza, Spain; San Jorge Gen Hosp, Div Pathol, Huesca 22004, Spain; Ernest Lluch Hosp, Div Med Oncol, Calatayud 50300, Spain; Univ Hosp, Landspitali, Dept Oncol, Reykjavik, Iceland; Univ Hosp, Landspitali, Dept Surg, Reykjavik, Iceland; Univ Hosp, Landspitali, Dept Radiat Phys, Reykjavik, Iceland; Karolinska Inst, Dept Mol Med, S-17176 Stockholm, Sweden; Karolinska Univ Hosp, Sodersjukhuset, S-11883 Stockholm, Sweden	Radboud University Nijmegen; Radboud University Nijmegen; Canisius-Wilhelmina Hospital; University of Southern California; Cancer Research Center of Hawaii; University of Hawaii System; Miguel Servet University Hospital; Hospital Universidad San Jorge; Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Sodersjukhuset Hospital	Stacey, SN (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	simon.stacey@decode.is; kari.stefansson@decode.is	Helgason, Agnar/K-1522-2015; Strobbe, Luc JA/N-8760-2018; Swinkels, Dorine W./H-8098-2014; Godino, Javier/M-3753-2018; Stefansson, Kari/AAE-7187-2019; Margolin, Sara/AAX-9034-2020; Kiemeney, Lambertus A./D-3357-2009; Aben, Katja KH/G-9686-2016; Manolescu, Andrei/G-4565-2014; Mayordomo, Jose/K-3453-2013	Swinkels, Dorine W./0000-0002-1040-9446; Godino, Javier/0000-0002-5653-2722; Kiemeney, Lambertus A./0000-0002-2368-1326; Aben, Katja KH/0000-0002-0214-2147; Manolescu, Andrei/0000-0002-0713-4664; Margolin, Sara/0000-0002-5526-5570; Kong, Augustine/0000-0001-8193-5438; Gudbjartsson, Daniel/0000-0002-5222-9857; Bergthorsson, Jon Thor/0000-0002-0560-2639; Geller, Frank/0000-0002-9238-3269; Millastre Bocos, Maria Esther/0000-0002-4781-068X; Helgason, Agnar/0000-0002-8545-3767; Gudjonsson, Sigurjon A./0000-0001-9314-7412				Amundadottir LT, 2004, PLOS MED, V1, P229, DOI 10.1371/journal.pmed.0010065; Balmain A, 2003, NAT GENET, V33, P238, DOI 10.1038/ng1107; Barrett JC, 2006, NAT GENET, V38, P659, DOI 10.1038/ng1801; CANNONALBRIGHT LA, 1994, CANCER RES, V54, P2378; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Easton D F, 1999, Breast Cancer Res, V1, P14, DOI 10.1186/bcr6; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Honrado E, 2006, CRIT REV ONCOL HEMAT, V59, P27, DOI 10.1016/j.critrevonc.2006.01.006; James JJ, 2003, BRIT J CANCER, V89, P660, DOI 10.1038/sj.bjc.6601198; Johannsson OT, 1997, EUR J CANCER, V33, P362, DOI 10.1016/S0959-8049(96)00469-8; KOENDERS PG, 1991, BREAST CANCER RES TR, V18, P27, DOI 10.1007/BF01975440; Kutyavin IV, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl679; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Pharoah P, 2006, JNCI-J NATL CANCER I, V98, P1382, DOI 10.1093/jnci/djj374; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Rakha EA, 2006, GENE CHROMOSOME CANC, V45, P527, DOI 10.1002/gcc.20318; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Smid M, 2006, J CLIN ONCOL, V24, P2261, DOI 10.1200/JCO.2005.03.8802; Trikalinos TA, 2004, EUR J HUM GENET, V12, P762, DOI 10.1038/sj.ejhg.5201227; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322	24	588	621	1	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39	7					865	869		10.1038/ng2064	http://dx.doi.org/10.1038/ng2064			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	184CX	17529974				2022-12-27	WOS:000247619800016
J	Dong, PDS; Munson, CA; Norton, W; Crosnier, C; Pan, XF; Gong, ZY; Neumann, CJ; Stainier, DYR				Dong, P. Duc Si; Munson, Chantilly A.; Norton, William; Crosnier, Cecile; Pan, Xiufang; Gong, Zhiyuan; Neumann, Carl J.; Stainier, Didier Y. R.			Fgf10 regulates hepatopancreatic ductal system patterning and differentiation	NATURE GENETICS			English	Article							TRANSGENIC ZEBRAFISH; PANCREAS DEVELOPMENT; DIGESTIVE-SYSTEM; ENDOCRINE-CELLS; MORPHOGENESIS; EPITHELIUM; MAINTAINS; EXOCRINE; REQUIRES; GROWTH	During organogenesis, the foregut endoderm gives rise to the many different cell types that comprise the hepatopancreatic system, including hepatic, pancreatic and gallbladder cells, as well as the epithelial cells of the hepatopancreatic ductal system that connects these organs together and with the intestine. However, the mechanisms responsible for demarcating ducts versus organs are poorly understood. Here, we show that Fgf10 signaling from the adjacent mesenchyme is responsible for refining the boundaries between the hepatopancreatic duct and organs. In zebrafish fgf10 mutants, the hepatopancreatic ductal epithelium is severely dysmorphic, and cells of the hepatopancreatic ductal system and adjacent intestine misdifferentiate toward hepatic and pancreatic fates. Furthermore, Fgf10 also functions to prevent the differentiation of the proximal pancreas and liver into hepatic and pancreatic cells, respectively. These data shed light onto how the multipotent cells of the foregut endoderm, and subsequently those of the hepatopancreatic duct, are directed toward different organ fates.	Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; Univ Calif San Francisco, Program Dev Biol, San Francisco, CA 94158 USA; Univ Calif San Francisco, Genet Program, San Francisco, CA 94158 USA; Univ Calif San Francisco, Program Human Genet, San Francisco, CA 94158 USA; Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94158 USA; European Mol Biol Lab, Dev Biol Program, D-60117 Heidelberg, Germany; Canc Res UK, Vertebrate Dev Lab, London WC2A 3PX, England; Natl Univ Singapore, Dept Biol Sci, Singapore 119260, Singapore; Univ Cincinnati, Childrens Hosp, Med Ctr, Dept Pulm Biol, Cincinnati, OH 45229 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; European Molecular Biology Laboratory (EMBL); Cancer Research UK; National University of Singapore; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Stainier, DYR (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, 1550 4th St, San Francisco, CA 94158 USA.	didier_stainier@biochem.ucsf.edu	Gong, Zhiyuan/H-8794-2012; Norton, William/E-9924-2012	Gong, Zhiyuan/0000-0002-9660-5260; Stainier, Didier/0000-0002-0382-0026; Norton, William/0000-0002-3244-0145				Ahlgren U, 1997, NATURE, V385, P257, DOI 10.1038/385257a0; Alexander J, 1998, DEV GENET, V22, P288, DOI 10.1002/(SICI)1520-6408(1998)22:3<288::AID-DVG10>3.3.CO;2-T; Bhushan A, 2001, DEVELOPMENT, V128, P5109; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; Field HA, 2003, DEV BIOL, V253, P279, DOI 10.1016/S0012-1606(02)00017-9; Hart A, 2003, DEV DYNAM, V228, P185, DOI 10.1002/dvdy.10368; Her GM, 2003, DEV DYNAM, V227, P347, DOI 10.1002/dvdy.10324; Jacquemin P, 2006, DEV BIOL, V290, P189, DOI 10.1016/j.ydbio.2005.11.023; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Li JX, 2000, GENE DEV, V14, P464; Lu WQ, 1999, J BIOL CHEM, V274, P12827, DOI 10.1074/jbc.274.18.12827; Naya FJ, 1997, GENE DEV, V11, P2323, DOI 10.1101/gad.11.18.2323; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; Norgaard GA, 2003, DEV BIOL, V264, P323, DOI 10.1016/j.ydbio.2003.08.013; Norton WHJ, 2005, DEVELOPMENT, V132, P4963, DOI 10.1242/dev.02084; Pulkkinen MA, 2003, MECH DEVELOP, V120, P167, DOI 10.1016/S0925-4773(02)00440-9; Sosa-Pineda B, 2000, NAT GENET, V25, P254, DOI 10.1038/76996; Sussel L, 1998, DEVELOPMENT, V125, P2213; Tonou-Fujimori N, 2002, MECH DEVELOP, V119, pS173, DOI 10.1016/S0925-4773(03)00112-6; Wan HY, 2006, EXP CELL RES, V312, P1526, DOI 10.1016/j.yexcr.2006.01.016; Wang JF, 2005, DEV BIOL, V286, P182, DOI 10.1016/j.ydbio.2005.07.021	21	146	152	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2007	39	3					397	402		10.1038/ng1961	http://dx.doi.org/10.1038/ng1961			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	140CK	17259985				2022-12-27	WOS:000244480000024
J	Reid, S; Schindler, D; Hanenberg, H; Barker, K; Hanks, S; Kalb, R; Neveling, K; Kelly, P; Seal, S; Freund, M; Wurm, M; Batish, SD; Lach, FP; Yetgin, S; Neitzel, H; Ariffin, H; Tischkowitz, M; Mathew, CG; D Auerbach, A; Rahman, N				Reid, Sarah; Schindler, Detlev; Hanenberg, Helmut; Barker, Karen; Hanks, Sandra; Kalb, Reinhard; Neveling, Kornelia; Kelly, Patrick; Seal, Sheila; Freund, Marcel; Wurm, Melanie; Batish, Sat Dev; Lach, Francis P.; Yetgin, Sevgi; Neitzel, Heidemarie; Ariffin, Hany; Tischkowitz, Marc; Mathew, Christopher G.; D Auerbach, Arleen; Rahman, Nazneen			Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer	NATURE GENETICS			English	Article							SHARED GENETIC SUSCEPTIBILITY; COMPLEMENTATION GROUPS; BREAST-CANCER; BRCA2; TUMORS	PALB2 was recently identified as a nuclear binding partner of BRCA2. Biallelic BRCA2 mutations cause Fanconi anemia subtype FA- D1 and predispose to childhood malignancies. We identified pathogenic mutations in PALB2 ( also known as FANCN) in seven families affected with Fanconi anemia and cancer in early childhood, demonstrating that biallelic PALB2 mutations cause a new subtype of Fanconi anemia, FA-N, and, similar to biallelic BRCA2 mutations, confer a high risk of childhood cancer.	Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Univ Wurzburg, Dept Human Genet, D-97074 Wurzburg, Germany; Univ Dusseldorf, Dept Pediat Oncol Hematol & Immunol, D-40225 Dusseldorf, Germany; Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; Rockefeller Univ, Lab Human Genet & Hematol, New York, NY 10021 USA; Cornell Univ, Weill Med Coll, Dept Pathol & Lab Med, New York, NY 10021 USA; Hacettepe Univ, Div Pediat Hematol, Ihsan Dooramacy Children Hosp, TR-06100 Ankara, Turkey; Charite Univ Med Berlin, Dept Human Genet, D-13353 Berlin, Germany; Univ Malaya, Med Ctr, Paediat Haematol Oncol Unit, Kuala Lumpur, Malaysia; Sir Mortimer B Davis Jewish Hosp, Canc Prevent Ctr, Montreal, PQ H3T 1E2, Canada; McGill Univ, Program Canc Genet, Dept Oncol, Montreal, PQ H3A 1B1, Canada; McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; Kings Coll London, Sch Med, Guys Hosp, Dept Med & Mol Genet, London SE1 9RT, England	University of London; Institute of Cancer Research - UK; University of Wurzburg; Heinrich Heine University Dusseldorf; Indiana University System; Indiana University-Purdue University Indianapolis; Rockefeller University; Cornell University; Hacettepe University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universiti Malaya; McGill University; McGill University; McGill University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Rahman, N (corresponding author), Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England.	nazneen.rahman@icr.ac.uk	Tischkowitz, Marc/O-4452-2018; ARIFFIN, HANY/B-8590-2010; Mathew, Christopher G/G-3434-2015; Rahman, Nazneen/B-8890-2012; Kalb, Reinhard/AAR-3249-2021; Rahman, Nazneen/D-2802-2013	Tischkowitz, Marc/0000-0002-7880-0628; ARIFFIN, HANY/0000-0002-4607-8837; Mathew, Christopher G/0000-0003-4178-1838; Kalb, Reinhard/0000-0003-3906-6907; Rahman, Nazneen/0000-0003-4376-0440; Auerbach, Arleen/0000-0002-6911-8379; Lach, Francis/0000-0003-3708-7122	NCI NIH HHS [R01CA82678] Funding Source: Medline; NHLBI NIH HHS [R37HL32987] Funding Source: Medline; Wellcome Trust [068545/Z/02] Funding Source: Medline; Breast Cancer Now [2003:592] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA082678] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL032987] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Wellcome Trust(Wellcome TrustEuropean Commission); Breast Cancer Now; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Breast Canc Linkage Consortium, 1999, JNCI-J NATL CANCER I, V91, P1310; Chandra S, 2005, MOL THER, V12, P976, DOI 10.1016/j.ymthe.2005.04.021; DECHADAREVIAN JP, 1985, ARCH PATHOL LAB MED, V109, P367; Godthelp BC, 2006, MUTAT RES-FUND MOL M, V594, P39, DOI 10.1016/j.mrfmmm.2005.07.008; Hirsch B, 2004, BLOOD, V103, P2554, DOI 10.1182/blood-2003-06-1970; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Kutler DI, 2003, BLOOD, V101, P1249, DOI 10.1182/blood-2002-07-2170; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Offit K, 2003, JNCI-J NATL CANCER I, V95, P1548, DOI 10.1093/jnci/djg072; Reid S, 2005, J MED GENET, V42, P147, DOI 10.1136/jmg.2004.022673; Shivji MKK, 2004, DNA REPAIR, V3, P835, DOI 10.1016/j.dnarep.2004.03.008; Taniguchi T, 2006, BLOOD, V107, P4223, DOI 10.1182/blood-2005-10-4240; Wagner JE, 2004, BLOOD, V103, P3226, DOI 10.1182/blood-2003-09-3138; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022	15	449	460	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					162	164		10.1038/ng1947	http://dx.doi.org/10.1038/ng1947			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17200671				2022-12-27	WOS:000244063900012
J	Klein, C; Grudzien, M; Appaswamy, G; Germeshausen, M; Sandrock, I; Schaffer, AA; Rathinam, C; Boztug, K; Schwinzer, B; Rezaei, N; Bohn, G; Melin, M; Carlsson, G; Fadeel, B; Dahl, N; Palmblad, J; Henter, JI; Zeidler, C; Grimbacher, B; Welte, K				Klein, Christoph; Grudzien, Magda; Appaswamy, Giridharan; Germeshausen, Manuela; Sandrock, Inga; Schaffer, Alejandro A.; Rathinam, Chozhavendan; Boztug, Kaan; Schwinzer, Beate; Rezaei, Nima; Bohn, Georg; Melin, Malin; Carlsson, Goran; Fadeel, Bengt; Dahl, Niklas; Palmblad, Jan; Henter, Jan-Inge; Zeidler, Cornelia; Grimbacher, Bodo; Welte, Karl			HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease)	NATURE GENETICS			English	Article							COLONY-STIMULATING-FACTOR; MYELOID PROGENITOR CELLS; PROTEIN HAX-1; MITOCHONDRIA; APOPTOSIS; DEATH; NEUTROPHILS; MUTATIONS; INTERACTS; LEUKEMIA	Autosomal recessive severe congenital neutropenia (SCN)(1) constitutes a primary immunodeficiency syndrome associated with increased apoptosis in myeloid cells(2,3), yet the underlying genetic defect remains unknown. Using a positional cloning approach and candidate gene evaluation, we identified a recurrent homozygous germline mutation in HAX1 in three pedigrees. After further molecular screening of individuals with SCN, we identified 19 additional affected individuals with homozygous HAX1 mutations, including three belonging to the original pedigree described by Kostmann(1). HAX1 encodes the mitochondrial protein HAX1, which has been assigned functions in signal transduction(4) and cytoskeletal control(5,6). Here, we show that HAX1 is critical for maintaining the inner mitochondrial membrane potential and protecting against apoptosis in myeloid cells. Our findings suggest that HAX1 is a major regulator of myeloid homeostasis and underline the significance of genetic control of apoptosis in neutrophil development.	Hannover Med Sch, Dept Pediat Hematol Oncol, D-30625 Hannover, Germany; Freiburg Univ Hosp, Med Ctr, Div Rheumatol & Clin Immunol, D-79106 Freiburg, Germany; NIH, Computat Biol Branch, Natl Ctr Biotechnol Informat, Dept Hlth & Human Serv, Bethesda, MD 20894 USA; Univ Tehran Med Sci, Immunol Asthma & Allergy Res Inst, Tehran, Iran; Univ Childrens Hosp, Dept Genet & Pathol, S-75185 Uppsala, Sweden; Karolinska Univ Hosp, Karolinska Inst, Dept Woman & Child Hlth, Childhood Canc Res Unit, S-17176 Stockholm, Sweden; Karolinska Inst, Inst Environm Med, Div Biochem & Toxicol, S-17177 Stockholm, Sweden; Karolinska Univ, Huddinge Hosp, Karolinska Inst, Dept Med, S-14186 Stockholm, Sweden	Hannover Medical School; University of Freiburg; National Institutes of Health (NIH) - USA; Immunology Asthma & Allergy Research Institute - Iran; Tehran University of Medical Sciences; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Klein, C (corresponding author), Hannover Med Sch, Dept Pediat Hematol Oncol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	klein.christoph@mh-hannover.de	Boztug, Kaan/AAM-4161-2021; Rezaei, Nima/B-4245-2008; Schaffer, Alejandro/N-1222-2019; Schaffer, Alejandro A/F-2902-2012	Boztug, Kaan/0000-0001-8387-9185; Rezaei, Nima/0000-0002-3836-1827; Henter, Jan-Inge/0000-0002-0629-2126	NATIONAL LIBRARY OF MEDICINE [Z01LM000097, ZIALM000097] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Cario G, 2005, BRIT J HAEMATOL, V129, P275, DOI 10.1111/j.1365-2141.2005.05428.x; Carlsson G, 2004, BLOOD, V103, P3355, DOI 10.1182/blood-2003-04-1011; Carlsson G, 2001, ACTA PAEDIATR, V90, P757, DOI 10.1080/080352501750315663; Cilenti L, 2004, J BIOL CHEM, V279, P50295, DOI 10.1074/jbc.M406006200; COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252; Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; DONG F, 1995, NEW ENGL J MED, V333, P487, DOI 10.1056/NEJM199508243330804; Dufva M, 2001, J GEN VIROL, V82, P1581, DOI 10.1099/0022-1317-82-7-1581; ELSNER J, 1993, EXP HEMATOL, V21, P38; Gallagher AR, 2000, P NATL ACAD SCI USA, V97, P4017, DOI 10.1073/pnas.97.8.4017; GILMAN PA, 1970, BLOOD-J HEMATOL, V36, P576, DOI 10.1182/blood.V36.5.576.576; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hamasaki A, 1998, J EXP MED, V188, P1985, DOI 10.1084/jem.188.11.1985; Horwitz M, 1999, NAT GENET, V23, P433, DOI 10.1038/70544; Kawaguchi Y, 2000, J VIROL, V74, P10104, DOI 10.1128/JVI.74.21.10104-10111.2000; Klein C, 2000, J EXP MED, V191, P1699, DOI 10.1084/jem.191.10.1699; KOSTMANN R, 1956, Acta Paediatr Suppl, V45, P1; Kroemer G, 2000, NAT MED, V6, P513, DOI 10.1038/74994; Maianski NA, 2004, CELL DEATH DIFFER, V11, P143, DOI 10.1038/sj.cdd.4401320; Maianski NA, 2002, BLOOD, V99, P672, DOI 10.1182/blood.V99.2.672; Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8; Opferman JT, 2003, NAT IMMUNOL, V4, P410, DOI 10.1038/ni0503-410; Radhika V, 2004, J BIOL CHEM, V279, P49406, DOI 10.1074/jbc.M408836200; Rosenberg PS, 2006, BLOOD, V107, P4628, DOI 10.1182/blood-2005-11-4370; SCHAFFER AA, 1994, HUM HERED, V44, P225, DOI 10.1159/000154222; Sharp TV, 2002, J VIROL, V76, P802, DOI 10.1128/JVI.76.2.802-816.2002; Suzuki Y, 1997, J IMMUNOL, V158, P2736; WETTE K, 2006, SEMIN HEMATOL, V43, P189; Yedavalli VSRK, 2005, J VIROL, V79, P13735, DOI 10.1128/JVI.79.21.13735-13746.2005	30	345	361	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JAN	2007	39	1					86	92		10.1038/ng1940	http://dx.doi.org/10.1038/ng1940			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	121CU	17187068				2022-12-27	WOS:000243136500022
J	Shirangi, TR; Taylor, BJ; McKeown, M				Shirangi, Troy R.; Taylor, Barbara J.; McKeown, Michael			A double-switch system regulates male courtship behavior in male and female Drosophila melanogaster	NATURE GENETICS			English	Article							DETERMINATION GENE FRUITLESS; SEXUAL-DIFFERENTIATION; EXPRESSION; MUSCLE; INTERSEX; INNERVATION; ORIENTATION; REPRESSION; MUTATIONS; NEURONS	Current models describe male-specific fruitless (fruM) as a genetic 'switch' regulating sexual behavior in Drosophila melanogaster, and they postulate that female (F) and male (M) doublesex (dsx) products control body sexual morphology. In contradiction to this simple model, we show that dsx, as well as fruM and non-sex-specific retained (retn), affect both male and female sexual behaviors. In females, both retn and dsxF contribute to female receptivity, and both genes act to repress male-like courtship activity in the presence or absence of fruM. In males, consistent with the opposing functions of dsxM and dsxF, dsxM acts as a positive factor for male courtship. retn also acts counter to fruM in the development of the male-specific muscle of Lawrence. Molecularly, retn seems to regulate sexual behavior via a previously described complex that represses zerknullt. Thus, we show that fru and dsx together act as a 'switch' system regulating behavior in the context of other developmental genes, such as retn.	Brown Univ, Mol Biol Cell Biol & Biochem Dept, Providence, RI 02912 USA; Oregon State Univ, Dept Zool, Corvallis, OR 97331 USA	Brown University; Oregon State University	McKeown, M (corresponding author), Brown Univ, Mol Biol Cell Biol & Biochem Dept, 69 Brown St, Providence, RI 02912 USA.	Michael_McKeown@Brown.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033352] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32GM007601] Funding Source: Medline; NINDS NIH HHS [NS33352] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akimaru H, 1997, NAT GENET, V17, P211, DOI 10.1038/ng1097-211; Anand A, 2001, GENETICS, V158, P1569; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; Billeter JC, 2004, J COMP NEUROL, V475, P270, DOI 10.1002/cne.20177; Billeter JC, 2006, CURR BIOL, V16, P1063, DOI 10.1016/j.cub.2006.04.039; CHASE BA, 1995, GENETICS, V139, P1649; Chen GQ, 1999, GENE DEV, V13, P2218, DOI 10.1101/gad.13.17.2218; Christiansen AE, 2002, TRENDS GENET, V18, P510, DOI 10.1016/S0168-9525(02)02769-5; CURRIE DA, 1995, DEVELOPMENT, V121, P2549; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Ditch LM, 2005, DEVELOPMENT, V132, P155, DOI 10.1242/dev.01568; Finley KD, 1997, P NATL ACAD SCI USA, V94, P913, DOI 10.1073/pnas.94.3.913; GAILEY DA, 1991, DEVELOPMENT, V113, P879; Garrett-Engele CM, 2002, DEVELOPMENT, V129, P4661; Gregory SL, 1996, MOL CELL BIOL, V16, P792; HALL JC, 1994, SCIENCE, V264, P1702, DOI 10.1126/science.8209251; Ito H, 1996, P NATL ACAD SCI USA, V93, P9687, DOI 10.1073/pnas.93.18.9687; LAWRENCE PA, 1986, CELL, V45, P505, DOI 10.1016/0092-8674(86)90282-5; Lee G, 2000, J NEUROBIOL, V43, P404, DOI 10.1002/1097-4695(20000615)43:4<404::AID-NEU8>3.0.CO;2-D; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Stockinger P, 2005, CELL, V121, P795, DOI 10.1016/j.cell.2005.04.026; TAYLOR BJ, 1994, DEV GENET, V15, P275, DOI 10.1002/dvg.1020150309; Usui-Aoki K, 2000, NAT CELL BIOL, V2, P500, DOI 10.1038/35019537; Valentine SA, 1998, MOL CELL BIOL, V18, P6584, DOI 10.1128/MCB.18.11.6584; Villella A, 1996, GENETICS, V143, P331; Villella A, 1997, GENETICS, V147, P1107; Waterbury JA, 1999, GENETICS, V152, P1653; Zhou JM, 1998, P NATL ACAD SCI USA, V95, P13483, DOI 10.1073/pnas.95.23.13483	29	41	43	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2006	38	12					1435	1439		10.1038/ng1908	http://dx.doi.org/10.1038/ng1908			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110TR	17086183				2022-12-27	WOS:000242404200022
J	Aulchenko, YS; Hoppenbrouwers, IA; Ramagopalan, SV; Broer, L; Jafari, N; Hillert, J; Link, J; Lundstrom, W; Greiner, E; Sadovnick, AD; Goossens, D; Van Broeckhoven, C; Del-Favero, J; Ebers, GC; Oostra, BA; van Duijn, CM; Hintzen, RQ				Aulchenko, Yurii S.; Hoppenbrouwers, Ilse A.; Ramagopalan, Sreeram V.; Broer, Linda; Jafari, Naghmeh; Hillert, Jan; Link, Jenny; Lundstrom, Wangko; Greiner, Eva; Sadovnick, A. Dessa; Goossens, Dirk; Van Broeckhoven, Christine; Del-Favero, Jurgen; Ebers, George C.; Oostra, Ben A.; van Duijn, Cornelia M.; Hintzen, Rogier Q.			Genetic variation in the KIF1B locus influences susceptibility to multiple sclerosis	NATURE GENETICS			English	Article							LINKAGE DISEQUILIBRIUM; RISK; DYSFUNCTION; MUTATION	The few loci associated with multiple sclerosis (MS) are all related to immune function. We report a GWA study identifying a new locus replicated in 2,679 cases and 3,125 controls. An rs10492972[C] variant located in the KIF1B gene was associated with MS with an odds ratio of 1.35 (P = 2.5 x 10(-10)). KIF1B is a neuronally expressed gene plausibly implicated in the irreversible axonal loss characterizing MS in the long term.	[Hoppenbrouwers, Ilse A.; Broer, Linda; Jafari, Naghmeh; Hintzen, Rogier Q.] Erasmus MC, MS Ctr ErasMS, Dept Neurol, NL-3000 CA Rotterdam, Netherlands; [Aulchenko, Yurii S.; Broer, Linda; Oostra, Ben A.; van Duijn, Cornelia M.] Erasmus MC, Dept Epidemiol & Biostat & Clin Genet, Genet Epidemiol Unit, NL-3000 CA Rotterdam, Netherlands; [Ramagopalan, Sreeram V.; Ebers, George C.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 9DU, England; [Ramagopalan, Sreeram V.; Ebers, George C.] Univ Oxford, Dept Clin Neurol, Oxford OX3 9DU, England; [Hillert, Jan; Link, Jenny; Lundstrom, Wangko; Greiner, Eva] Karolinska Inst, Dept Neurol, SE-14186 Stockholm, Sweden; [Sadovnick, A. Dessa] Univ British Columbia, Dept Med Genet, Div Neurol, Vancouver, BC V6T 2B5, Canada; [Goossens, Dirk; Van Broeckhoven, Christine; Del-Favero, Jurgen] VIB, Dept Mol Genet, Appl Mol Genom Grp, B-2610 Antwerp, Belgium; [Goossens, Dirk; Van Broeckhoven, Christine; Del-Favero, Jurgen] VIB, Dept Mol Genet, Neurodegenerat Brain Dis Grp, B-2610 Antwerp, Belgium; [Goossens, Dirk; Van Broeckhoven, Christine; Del-Favero, Jurgen] Univ Antwerp, B-2610 Antwerp, Belgium	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Karolinska Institutet; University of British Columbia; Flanders Institute for Biotechnology (VIB); Flanders Institute for Biotechnology (VIB); University of Antwerp	Hintzen, RQ (corresponding author), Erasmus MC, MS Ctr ErasMS, Dept Neurol, NL-3000 CA Rotterdam, Netherlands.	rhintzen@xs4all.nl	Van Broeckhoven, Christine/M-7853-2019; Aulchenko, Yurii/M-8270-2013; Van Broeckhoven, Christine/G-8362-2017; Link, Jenny/J-1629-2012	Van Broeckhoven, Christine/0000-0003-0183-7665; Aulchenko, Yurii/0000-0002-7899-1575; Van Broeckhoven, Christine/0000-0003-0183-7665; Goossens, Dirk/0000-0002-2080-7464; Link, Jenny/0000-0002-6134-9404; Ebers, George/0000-0003-4771-4177; Del Favero, jurgen/0000-0002-7427-7489; Van Duijn, Cornelia/0000-0002-2374-9204; Broer, Linda/0000-0003-0011-123X	MS Research Netherlands; Erasmus University Trust Fund; Netherlands Organisation for Scientific Research; Erasmus MC; Multiple Sclerosis Society of Canada Scientific Research Foundation; Multiple Sclerosis Society of the United Kingdom; Centre for Medical Systems Biology (CMSB); Bibbi and Nils Jensen Foundation; Swedish Research Council; EU [LSHM-CT-2005-018637]	MS Research Netherlands(Netherlands Government); Erasmus University Trust Fund; Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Erasmus MC; Multiple Sclerosis Society of Canada Scientific Research Foundation; Multiple Sclerosis Society of the United Kingdom; Centre for Medical Systems Biology (CMSB); Bibbi and Nils Jensen Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); EU(European Commission)	This study was supported by grants from MS Research Netherlands (R. Q. H. and C. M. v. D.), the Erasmus University Trust Fund, The Netherlands Organisation for Scientific Research (ZON-MW, R.Q.H.), the Erasmus MC and the Multiple Sclerosis Society of Canada Scientific Research Foundation and the Multiple Sclerosis Society of the United Kingdom (S.V.R., G.C.E.). The GRIP study is supported by Centre for Medical Systems Biology (CMSB). The Stockholm part of the study was supported by the Bibbi and Nils Jensen Foundation, by the Swedish Research Council and by the EU project no. LSHM-CT-2005-018637, NeuroproMiSe. We are grateful to all participants and their relatives; general practitioners and neurologists for their contributions; P. Veraart for her help in genealogy; D. Lont and the personnel of the VIB Genetic Service Facility for genotyping; and P. Snijders for his help in data collection.	Aulchenko YS, 2004, EUR J HUM GENET, V12, P527, DOI 10.1038/sj.ejhg.5201188; Boldogh IR, 2007, TRENDS CELL BIOL, V17, P502, DOI 10.1016/j.tcb.2007.07.008; Craner MJ, 2004, P NATL ACAD SCI USA, V101, P8168, DOI 10.1073/pnas.0402765101; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Dutta R, 2007, NEUROLOGY, V68, pS22, DOI 10.1212/01.wnl.0000275229.13012.32; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hoppenbrouwers IA, 2008, GENES IMMUN, V9, P334, DOI 10.1038/gene.2008.22; Hoppenbrouwers IA, 2007, MULT SCLER, V13, P17, DOI 10.1177/1352458506071216; Kijima K, 2005, HUM GENET, V116, P23, DOI 10.1007/s00439-004-1199-2; Lundmark F, 2007, NAT GENET, V39, P1108, DOI 10.1038/ng2106; NANGAKU M, 1994, CELL, V79, P1209, DOI 10.1016/0092-8674(94)90012-4; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; Waxman SG, 2008, ANN NEUROL, V63, P411, DOI 10.1002/ana.21361; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4	15	138	149	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	DEC	2008	40	12					1402	1403		10.1038/ng.251	http://dx.doi.org/10.1038/ng.251			2	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	18997785				2022-12-27	WOS:000261215900013
J	Melzer, S; Lens, F; Gennen, J; Vanneste, S; Rohde, A; Beeckman, T				Melzer, Siegbert; Lens, Frederic; Gennen, Jerome; Vanneste, Steffen; Rohde, Antje; Beeckman, Tom			Flowering-time genes modulate meristem determinacy and growth form in Arabidopsis thaliana	NATURE GENETICS			English	Article							FLORAL INDUCTION; FT; ACTIVATION; TRANSITION; EXPRESSION; MORPHOLOGY; FRUITFULL; EVOLUTION; PATHWAYS; SIGNALS	Plants have evolved annual and perennial life forms as alternative strategies to adapt reproduction and survival to environmental constraints. In isolated situations, such as islands, woody perennials have evolved repeatedly from annual ancestors(1). Although the molecular basis of the rapid evolution of insular woodiness is unknown, the molecular difference between perennials and annuals might be rather small, and a change between these life strategies might not require major genetic innovations(2,3). Developmental regulators can strongly affect evolutionary variation(4) and genes involved in meristem transitions are good candidates for a switch in growth habit. We found that the MADS box proteins SUPPRESSOR OF OVEREXPRESSION OF CONSTANS 1 ( SOC1) and FRUITFULL (FUL) not only control flowering time, but also affect determinacy of all meristems. In addition, downregulation of both proteins established phenotypes common to the lifestyle of perennial plants, suggesting their involvement in the prevention of secondary growth and longevity in annual life forms.	[Melzer, Siegbert; Gennen, Jerome; Vanneste, Steffen; Rohde, Antje; Beeckman, Tom] Univ Ghent VIB, Dept Plant Syst Biol, B-9052 Ghent, Belgium; [Melzer, Siegbert; Gennen, Jerome; Vanneste, Steffen; Rohde, Antje; Beeckman, Tom] Univ Ghent, Dept Mol Genet, B-9052 Ghent, Belgium; [Lens, Frederic] Katholieke Univ Leuven, Inst Bot & Microbiol, Lab Plant Syst, B-3001 Louvain, Belgium; [Lens, Frederic] Nat Herbarium Netherlands, Leiden Univ Branch, NL-2300 RA Leiden, Netherlands	Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; KU Leuven; Leiden University; Leiden University - Excl LUMC	Melzer, S (corresponding author), Univ Ghent VIB, Dept Plant Syst Biol, Technol Pk 927, B-9052 Ghent, Belgium.	siegbert.melzer@psb.ugent.be	Rohde, Antje/AFO-6894-2022; Lens, Frederic/B-8482-2011; Vanneste, Steffen/K-8353-2013; Beeckman, Tom/ABA-1164-2020; Beeckman, Tom/ABI-1703-2020	Lens, Frederic/0000-0002-5001-0149; Vanneste, Steffen/0000-0002-9948-9672; Beeckman, Tom/0000-0001-8656-2060; Rohde, Antje/0000-0002-1574-1843; Melzer, Siegbert/0000-0003-4008-4782	Technology in Flanders; Research Foundation-Flanders (FWO)	Technology in Flanders(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Research Foundation-Flanders (FWO)(FWO)	We appreciate the continuous support of K. Apel, D. Inze and E. Smets. We thank J. Chandler and M. De Cock for critical reading of the manuscript. S. V. is indebted to the Institute for the Promotion of Innovation through Science and Technology in Flanders for a predoctoral fellowship. F. L. and A. R. are postdoctoral fellows of the Research Foundation-Flanders (FWO). Seeds of 35S:FT plants were provided by P. Wigge (John Innes Centre), seeds of the soc1-1 allele were provided by G. Coupland (Max Planck Institute for Plant Breeding Research) and seeds of soc1-2 in Col and Ler backgrounds by I. Lee (University of Seoul).	Battey NH, 2002, CURR OPIN PLANT BIOL, V5, P62, DOI 10.1016/S1369-5266(01)00229-1; Bohle UR, 1996, P NATL ACAD SCI USA, V93, P11740, DOI 10.1073/pnas.93.21.11740; Borner R, 2000, PLANT J, V24, P591, DOI 10.1046/j.1365-313x.2000.00906.x; Carlquist S., 1974, ISLAND BIOL, DOI [10.5962/bhl.title.63768, DOI 10.5962/BHL.TITLE.63768]; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Cronk QCB, 2001, NAT REV GENET, V2, P607, DOI 10.1038/35084556; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; Demura T, 2007, TRENDS PLANT SCI, V12, P64, DOI 10.1016/j.tplants.2006.12.006; Ferrandiz C, 2000, DEVELOPMENT, V127, P725; Groover AT, 2005, TRENDS PLANT SCI, V10, P210, DOI 10.1016/j.tplants.2005.03.001; Hempel FD, 1997, DEVELOPMENT, V124, P3845; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Kim SC, 1996, P NATL ACAD SCI USA, V93, P7743, DOI 10.1073/pnas.93.15.7743; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Lee H, 2000, GENE DEV, V14, P2366, DOI 10.1101/gad.813600; Lifschitz E, 2006, P NATL ACAD SCI USA, V103, P6398, DOI 10.1073/pnas.0601620103; Long J, 2000, DEV BIOL, V218, P341, DOI 10.1006/dbio.1999.9572; Poduska B, 2003, GENETICS, V163, P1457; Samach A, 2000, SCIENCE, V288, P1613, DOI 10.1126/science.288.5471.1613; Schmid M, 2003, DEVELOPMENT, V130, P6001, DOI 10.1242/dev.00842; Schonrock N, 2006, GENE DEV, V20, P1667, DOI 10.1101/gad.377206; Sibout R, 2008, CURR BIOL, V18, P458, DOI 10.1016/j.cub.2008.02.070; Teper-Bamnolker P, 2005, PLANT CELL, V17, P2661, DOI 10.1105/tpc.105.035766; Thomas H, 2000, J EXP BOT, V51, P1781, DOI 10.1093/jexbot/51.352.1781; Tooke F, 2005, J EXP BOT, V56, P2587, DOI 10.1093/jxb/eri254; Wang Q, 2007, CURR BIOL, V17, P1513, DOI 10.1016/j.cub.2007.07.059; Wigge PA, 2005, SCIENCE, V309, P1056, DOI 10.1126/science.1114358; Yoo SK, 2005, PLANT PHYSIOL, V139, P770, DOI 10.1104/pp.105.066928	28	290	320	7	111	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2008	40	12					1489	1492		10.1038/ng.253	http://dx.doi.org/10.1038/ng.253			4	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	376XI	18997783	Green Published, Green Submitted			2022-12-27	WOS:000261215900028
J	Sun, J; Zheng, SL; Wiklund, F; Isaacs, SD; Purcell, LD; Gao, Z; Hsu, FC; Kim, ST; Liu, W; Zhu, Y; Stattin, P; Adami, HO; Wiley, KE; Dimitrov, L; Sun, J; Li, T; Turner, AR; Adams, TS; Adolfsson, J; Johansson, JE; Lowey, J; Trock, BJ; Partin, AW; Walsh, PC; Trent, JM; Duggan, D; Carpten, J; Chang, BL; Gronberg, H; Isaacs, WB; Xu, JF				Sun, Jielin; Zheng, Siqun Lilly; Wiklund, Fredrik; Isaacs, Sarah D.; Purcell, Lina D.; Gao, Zhengrong; Hsu, Fang-Chi; Kim, Seong-Tae; Liu, Wennuan; Zhu, Yi; Stattin, Paer; Adami, Hans-Olov; Wiley, Kathleen E.; Dimitrov, Latchezar; Sun, Jishan; Li, Tao; Turner, Aubrey R.; Adams, Tamara S.; Adolfsson, Jan; Johansson, Jan-Erik; Lowey, James; Trock, Bruce J.; Partin, Alan W.; Walsh, Patrick C.; Trent, Jeffrey M.; Duggan, David; Carpten, John; Chang, Bao-Li; Gronberg, Henrik; Isaacs, William B.; Xu, Jianfeng			Evidence for two independent prostate cancer risk-associated loci in the HNF1B gene at 17q12	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; VARIANTS; 8Q24; AMERICANS	We carried out a fine-mapping study in the HNF1B gene at 17q12 in two study populations and identified a second locus associated with prostate cancer risk, similar to 26 kb centromeric to the first known locus (rs4430796); these loci are separated by a recombination hot spot. We confirmed the association with a SNP in the second locus (rs11649743) in five additional populations, with P = 1.7 x 10(-9) for an allelic test of the seven studies combined. The association at each SNP remained significant after adjustment for the other SNP.	[Wiklund, Fredrik; Adami, Hans-Olov; Gronberg, Henrik] Karolinska Inst, CLINTEC, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Sun, Jielin; Zheng, Siqun Lilly; Purcell, Lina D.; Gao, Zhengrong; Hsu, Fang-Chi; Kim, Seong-Tae; Liu, Wennuan; Zhu, Yi; Dimitrov, Latchezar; Sun, Jishan; Li, Tao; Turner, Aubrey R.; Adams, Tamara S.; Chang, Bao-Li; Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Genom, Winston Salem, NC 27157 USA; [Sun, Jielin; Zheng, Siqun Lilly; Purcell, Lina D.; Gao, Zhengrong; Kim, Seong-Tae; Liu, Wennuan; Zhu, Yi; Dimitrov, Latchezar; Sun, Jishan; Li, Tao; Turner, Aubrey R.; Adams, Tamara S.; Chang, Bao-Li; Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Human Genom, Winston Salem, NC 27157 USA; [Isaacs, Sarah D.; Wiley, Kathleen E.; Trock, Bruce J.; Partin, Alan W.; Walsh, Patrick C.; Isaacs, William B.] Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21287 USA; [Hsu, Fang-Chi] Wake Forest Univ, Bowman Gray Sch Med, Dept Biostat Sci, Winston Salem, NC 27157 USA; [Stattin, Paer] Umea Univ Hosp, Dept Surg & Perioperat Sci, SE-90787 Umea, Sweden; [Adami, Hans-Olov] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Adolfsson, Jan] Karolinska Inst, CLINTEC, Ctr Oncol, SE-17177 Stockholm, Sweden; [Johansson, Jan-Erik] Orebro Univ Hosp, Dept Urol, SE-70182 Orebro, Sweden; [Lowey, James; Trent, Jeffrey M.; Duggan, David; Carpten, John] Translat Genom Res Inst, Phoenix, AZ 85004 USA	Karolinska Institutet; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Johns Hopkins University; Johns Hopkins Medicine; Wake Forest University; Wake Forest Baptist Medical Center; Umea University; Harvard University; Harvard T.H. Chan School of Public Health; Karolinska Institutet; Orebro University; Translational Genomics Research Institute	Gronberg, H (corresponding author), Karolinska Inst, CLINTEC, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden.	henrik.gronberg@ki.se; wisaacs@jhmi.edu	LI, TAO/AAL-5932-2020; Kim, Seong-Tae/E-4474-2017	LI, TAO/0000-0001-7343-9688; Kim, Seong-Tae/0000-0001-7436-1405; Adolfsson, Jan/0000-0003-2992-1869	National Cancer Institute [CA106523, CA95052, CA112517, CA58236, CA86323]; Department of Defense [PC051264]; Swedish Cancer Society (Cancerfonden); Swedish Research Council; NATIONAL CANCER INSTITUTE [R01CA112517, R01CA095052, U01CA086323, P50CA058236, R01CA106523] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank all the study subjects who participated in this study. We also thank the Regional Cancer Registries and the CAPS-steering committee, including E. Varenhorst. We acknowledge the support of W. T. Gerrard, M. Duhon, Jennifer and John Chalsty and D. Koch. We also thank the National Cancer Institute Cancer Genetic Markers of Susceptibility Initiative (CGEMS) for making the data available publicly. We take full responsibility for the study design, data collection, analysis and interpretation of the data, the decision to submit the manuscript for publication, and the writing of the manuscript. The study is supported by National Cancer Institute (CA106523, CA106523 and CA95052 to J.X., CA112517, CA58236 to W.B.I., CA86323 to A.W.P., Department of Defense grant PC051264 to J. X.), as well as support from Swedish Cancer Society (Cancerfonden) and Swedish Research Council to H. G.	Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Fearnhead P, 2006, BIOINFORMATICS, V22, P3061, DOI 10.1093/bioinformatics/btl540; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Sun JL, 2008, PROSTATE, V68, P691, DOI 10.1002/pros.20754; Thomas G, 2008, NAT GENET, V40, P310, DOI 10.1038/ng.91; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zheng SL, 2008, NEW ENGL J MED, V358, P910, DOI 10.1056/NEJMoa075819; Zheng SL, 2007, JNCI-J NATL CANCER I, V99, P1525, DOI 10.1093/jnci/djm169	15	134	142	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	OCT	2008	40	10					1153	1155		10.1038/ng.214	http://dx.doi.org/10.1038/ng.214			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	354PH	18758462	Green Accepted			2022-12-27	WOS:000259651000011
J	Yasuda, K; Miyake, K; Horikawa, Y; Hara, K; Osawa, H; Furuta, H; Hirota, Y; Mori, H; Jonsson, A; Sato, Y; Yamagata, K; Hinokio, Y; Wang, HY; Tanahashi, T; Nakamura, N; Oka, Y; Iwasaki, N; Iwamoto, Y; Yamada, Y; Seino, Y; Maegawa, H; Kashiwagi, A; Takeda, J; Maeda, E; Shin, HD; Cho, YM; Park, KS; Lee, HK; Ng, MCY; Ma, RCW; So, WY; Chan, JCN; Lyssenko, V; Tuomi, T; Nilsson, P; Groop, L; Kamatani, N; Sekine, A; Nakamura, Y; Yamamoto, K; Yoshida, T; Tokunaga, K; Itakura, M; Makino, H; Nanjo, K; Kadowaki, T; Kasuga, M				Yasuda, Kazuki; Miyake, Kazuaki; Horikawa, Yukio; Hara, Kazuo; Osawa, Haruhiko; Furuta, Hiroto; Hirota, Yushi; Mori, Hiroyuki; Jonsson, Anna; Sato, Yoshifumi; Yamagata, Kazuya; Hinokio, Yoshinori; Wang, He-Yao; Tanahashi, Toshihito; Nakamura, Naoto; Oka, Yoshitomo; Iwasaki, Naoko; Iwamoto, Yasuhiko; Yamada, Yuichiro; Seino, Yutaka; Maegawa, Hiroshi; Kashiwagi, Atsunori; Takeda, Jun; Maeda, Eiichi; Shin, Hyoung Doo; Cho, Young Min; Park, Kyong Soo; Lee, Hong Kyu; Ng, Maggie C. Y.; Ma, Ronald C. W.; So, Wing-Yee; Chan, Juliana C. N.; Lyssenko, Valeriya; Tuomi, Tiinamaija; Nilsson, Peter; Groop, Leif; Kamatani, Naoyuki; Sekine, Akihiro; Nakamura, Yusuke; Yamamoto, Ken; Yoshida, Teruhiko; Tokunaga, Katsushi; Itakura, Mitsuo; Makino, Hideichi; Nanjo, Kishio; Kadowaki, Takashi; Kasuga, Masato			Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; POTASSIUM CHANNEL GENE; CARDIAC-ARRHYTHMIAS; RISK LOCI; JAPANESE; KVLQT1; REPLICATION; MUTATIONS; GLUCOSE; JERVELL	We carried out a multistage genome-wide association study of type 2 diabetes mellitus in Japanese individuals, with a total of 1,612 cases and 1,424 controls and 100,000 SNPs. The most significant association was obtained with SNPs in KCNQ1, and dense mapping within the gene revealed that rs2237892 in intron 15 showed the lowest P value (6.7 x 10(-13), odds ratio (OR) = 1.49). The association of KCNQ1 with type 2 diabetes was replicated in populations of Korean, Chinese and European ancestry as well as in two independent Japanese populations, and meta-analysis with a total of 19,930 individuals (9,569 cases and 10,361 controls) yielded a P value of 1.7 x 10(-42) (OR = 1.40; 95% CI = 1.34-1.47) for rs2237892. Among control subjects, the risk allele of this polymorphism was associated with impairment of insulin secretion according to the homeostasis model assessment of beta-cell function or the corrected insulin response. Our data thus implicate KCNQ1 as a diabetes susceptibility gene in groups of different ancestries.	[Miyake, Kazuaki; Hirota, Yushi; Mori, Hiroyuki; Kasuga, Masato] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Kobe, Hyogo 6500017, Japan; [Yasuda, Kazuki; Wang, He-Yao] Int Med Ctr Japan, Res Inst, Dept Metab Disorder, Tokyo 1628655, Japan; [Horikawa, Yukio; Takeda, Jun] Gifu Univ, Sch Med, Dept Endocrinol & Diabet, Div Mol & Struct, Gifu 5011194, Japan; [Hara, Kazuo; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Metab Dis, Tokyo 1138655, Japan; [Osawa, Haruhiko; Makino, Hideichi] Ehime Univ, Grad Sch Med, Dept Mol & Genet Med, Ehime 7910295, Japan; [Furuta, Hiroto; Nanjo, Kishio] Wakayama Med Univ, Dept Med 1, Wakayama 6418509, Japan; [Jonsson, Anna; Lyssenko, Valeriya; Groop, Leif] Lund Univ, Malmo Univ Hosp, Dept Clin Sci Diabet & Endocrinol, S-20502 Malmo, Sweden; [Sato, Yoshifumi; Yamagata, Kazuya] Osaka Univ, Grad Sch Med, Dept Metab Med, Osaka 5650871, Japan; [Hinokio, Yoshinori; Oka, Yoshitomo] Tohoku Univ, Grad Sch Med, Div Mol Metab & Diabet, Sendai, Miyagi 9808574, Japan; [Tanahashi, Toshihito; Itakura, Mitsuo] Univ Tokushima, Inst Genome Res, Div Genet Informat, Tokushima 7708503, Japan; [Nakamura, Naoto] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Endocrinol & Metab, Kyoto 6028566, Japan; [Iwasaki, Naoko; Iwamoto, Yasuhiko] Tokyo Womens Med Univ, Dept Med, Ctr Diabet, Tokyo 1628666, Japan; [Yamada, Yuichiro; Seino, Yutaka] Kyoto Univ, Sch Med, Dept Diabet & Clin Nutr, Kyoto 6068501, Japan; [Maegawa, Hiroshi; Kashiwagi, Atsunori] Shiga Univ Med Sci, Dept Med, Div Endocrinol & Metab, Shiga 5202192, Japan; [Maeda, Eiichi] Kobe Univ, Grad Sch Med, Clin Genome Informat Ctr, Kobe, Hyogo 6500017, Japan; [Shin, Hyoung Doo] SNP Genet Inc, Dept Genet Epidemiol, Seoul 110834, South Korea; [Cho, Young Min; Park, Kyong Soo; Lee, Hong Kyu] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea; [Ng, Maggie C. Y.; Ma, Ronald C. W.; So, Wing-Yee; Chan, Juliana C. N.] Chinese Univ Hong Kong, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Tuomi, Tiinamaija; Groop, Leif] Helsinki Univ Hosp, Dept Med, FIN-00300 Helsinki, Finland; [Tuomi, Tiinamaija] Folkhaelsan Res Ctr, FIN-00014 Helsinki, Finland; [Nilsson, Peter] Lund Univ, Malmo Univ Hosp, Med Res Unit, Dept Clin Sci, S-20502 Malmo, Sweden; [Kamatani, Naoyuki] Tokyo Womens Med Univ, Dept Adv Biomed Engn & Sci, Div Gen Med, Tokyo 1628666, Japan; [Sekine, Akihiro] RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Yokohama, Kanagawa 2300045, Japan; [Yamamoto, Ken] Kyushu Univ, Med Inst Bioregulat, Dept Mol Genet, Fukuoka 8128582, Japan; [Yoshida, Teruhiko] Natl Canc Ctr, Res Inst, Div Genet, Tokyo 1040045, Japan; [Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo 1130033, Japan	Kobe University; National Center for Global Health & Medicine - Japan; Gifu University; University of Tokyo; Ehime University; Wakayama Medical University; Lund University; Skane University Hospital; Osaka University; Tohoku University; Tokushima University; Kyoto Prefectural University of Medicine; Tokyo Women's Medical University; Kyoto University; Shiga University of Medical Science; Kobe University; SNP Genetics; Seoul National University (SNU); Chinese University of Hong Kong; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Lund University; Skane University Hospital; Tokyo Women's Medical University; RIKEN; Kyushu University; National Cancer Center - Japan; University of Tokyo	Kasuga, M (corresponding author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet Metab & Endocrinol, Kobe, Hyogo 6500017, Japan.	kasuga@med.kobe-u.ac.jp	Sato, Yoshifumi/GYQ-7230-2022; Chan, Juliana/B-7918-2016; Ma, Ronald/C-2788-2009; Kashiwagi, Atsunori/H-8712-2019; Park, Kyong Soo/C-2265-2008; Cho, Young Min/J-5669-2012	Chan, Juliana/0000-0003-1325-1194; Ma, Ronald/0000-0002-1227-803X; Park, Kyong Soo/0000-0003-3597-342X; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Tuomi, Tiinamaija/0000-0002-8306-6202; Jonsson, Anna/0000-0003-1252-8673; Tanahashi, Toshihito/0000-0002-9308-210X; Maegawa, Hiroshi/0000-0002-4611-8149; Sato, Yoshifumi/0000-0003-0697-1476	Pharmaceuticals and Medical Devices Agency (PMDA) of Japan; National Institute of Biomedical Innovation (NIBIO) of Japan; Ministry of Health, Labour, and Welfare of Japan; New Energy and Industrial Technology Development Organization (NEDO); Cooperative Link of Unique Science and Technology for Economy Revitalization (CLUSTER, Tokushima, Japan); Hong Kong Research Grants Committee Central Allocation Scheme [1/04C]; Ministry of Health and Welfare of the Republic of Korea [00-PJ3-PG6-GN07-001]; Swedish Research Council; Sigrid Juselius Foundation; Folkhaelsan Research Foundation; European Foundation for the Study of Diabetes; Swedish Diabetes Research Foundation	Pharmaceuticals and Medical Devices Agency (PMDA) of Japan; National Institute of Biomedical Innovation (NIBIO) of Japan(National Institute of Biomedical Innovation); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO)); Cooperative Link of Unique Science and Technology for Economy Revitalization (CLUSTER, Tokushima, Japan); Hong Kong Research Grants Committee Central Allocation Scheme(Hong Kong Research Grants Council); Ministry of Health and Welfare of the Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Swedish Research Council(Swedish Research CouncilEuropean Commission); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Folkhaelsan Research Foundation; European Foundation for the Study of Diabetes; Swedish Diabetes Research Foundation	We thank all the participants in the project; S. Sugano and S. Tsuji for support and helpful discussion throughout the project; H. Sakamoto, K. Yoshimura and N. Nishida for genotyping and quality control of the data; M. Yamaoka-Sageshima, K. Nagase, D. Suzuki and A. Berglund for technical assistance; and staff of Mitsui Knowledge Industry Inc. (Tokyo) for help with bioinformatics. This work was supported by a grant from the Program for Promotion of Fundamental Studies in Health Sciences of the Pharmaceuticals and Medical Devices Agency (PMDA) of Japan; a grant from the National Institute of Biomedical Innovation (NIBIO) of Japan; grants from the Ministry of Health, Labour, and Welfare of Japan; a Grant-in-Aid for Scientific Research on Priority Areas (C), "Medical Genome Science (Millennium Genome Project),'' "Applied Genomics'' and "Comprehensive Genomics'' from the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and a grant from New Energy and Industrial Technology Development Organization (NEDO). The replication 2 study was supported by a grant from Cooperative Link of Unique Science and Technology for Economy Revitalization (CLUSTER, Tokushima, Japan). The Hong Kong diabetes case-control study was supported by the Hong Kong Research Grants Committee Central Allocation Scheme 1/04C. The Korean case-control study was supported by a grant from the Korea Health 21 R&D Project of the Ministry of Health and Welfare of the Republic of Korea (00-PJ3-PG6-GN07-001 to K. S. P.). The replication 5 study and Botnia prospective study were supported by Swedish Research Council (Linne grant), Sigrid Juselius Foundation, Folkhaelsan Research Foundation, European Foundation for the Study of Diabetes and Swedish Diabetes Research Foundation.	Bannai M, 2004, ANAL BIOCHEM, V327, P215, DOI 10.1016/j.ab.2004.01.012; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Chouabe C, 1997, EMBO J, V16, P5472, DOI 10.1093/emboj/16.17.5472; Demolombe S, 2001, AM J PHYSIOL-CELL PH, V280, pC359, DOI 10.1152/ajpcell.2001.280.2.C359; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fukushima M, 2004, DIABETES RES CLIN PR, V66, pS37, DOI 10.1016/j.diabres.2003.11.024; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Haga H, 2002, J HUM GENET, V47, P605, DOI 10.1007/s100380200092; HORIKAWA Y, 2002, J CLIN ENDO IN PRESS; Horikoshi M, 2007, DIABETOLOGIA, V50, P2461, DOI 10.1007/s00125-007-0827-5; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miyake K, 2008, J HUM GENET, V53, P174, DOI 10.1007/s10038-007-0231-5; Mori Y, 2002, DIABETES, V51, P1247, DOI 10.2337/diabetes.51.4.1247; Nawata H, 2004, J HUM GENET, V49, P629, DOI 10.1007/s10038-004-0199-3; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Sato Y, 2004, J HUM GENET, V49, P669, DOI 10.1007/s10038-004-0205-9; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Ullrich S, 2005, PFLUG ARCH EUR J PHY, V451, P428, DOI 10.1007/s00424-005-1479-2; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	30	566	593	0	60	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	SEP	2008	40	9					1092	1097		10.1038/ng.207	http://dx.doi.org/10.1038/ng.207			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	342CC	18711367				2022-12-27	WOS:000258761200022
J	Sahoo, T; del Gaudio, D; German, JR; Shinawi, M; Peters, SU; Person, RE; Garnica, A; Cheung, SW; Beaudet, AL				Sahoo, Trilochan; del Gaudio, Daniela; German, Jennifer R.; Shinawi, Marwan; Peters, Sarika U.; Person, Richard E.; Garnica, Adolfo; Cheung, Sau Wai; Beaudet, Arthur L.			Prader-Willi phenotype caused by paternal deficiency for the HBII-85C/D box small nucleolar RNA cluster	NATURE GENETICS			English	Article							TRANSLOCATION BREAKPOINT; SNRPN; GENE; EXCLUSION; DELETION; HBII-52; REGION; UBE3A	Prader-Willi syndrome (PWS) is caused by deficiency for one or more paternally expressed imprinted transcripts within chromosome 15q11-q13, including SNURF-SNRPN and multiple small nucleolar RNAs (snoRNAs). Balanced chromosomal translocations that preserve expression of SNURF-SNRPN and centromeric genes but separate the snoRNA HBII-85 cluster from its promoter cause PWS. A microdeletion of the HBII-85 snoRNAs in a child with PWS provides, in combination with previous data, effectively conclusive evidence that deficiency of HBII-85 snoRNAs causes the key characteristics of the PWS phenotype, although some atypical features suggest that other genes in the region may make more subtle phenotypic contributions.	[Sahoo, Trilochan; del Gaudio, Daniela; German, Jennifer R.; Shinawi, Marwan; Peters, Sarika U.; Person, Richard E.; Cheung, Sau Wai; Beaudet, Arthur L.] Baylor Coll Med, Houston, TX 77030 USA; [Garnica, Adolfo] St Francis Hosp, Tulsa, OK 74136 USA	Baylor College of Medicine; St. Francis Hospital - Oklahoma	Beaudet, AL (corresponding author), Baylor Coll Med, Houston, TX 77030 USA.	abeaudet@bcm.edu		shinawi, Marwan/0000-0003-1329-4100	NCRR NIH HHS [M01 RR000188, U54 RR019478-05S16956, M01-RR00188, U54 RR019478, RR-019478, M01 RR000188-447797] Funding Source: Medline; NICHD NIH HHS [P30 HD024064, HD-037283, HD-024064, R01 HD037283-10, R01 HD037283] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037283, P30HD024064] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR019478, M01RR000188] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Burger J, 2002, AM J MED GENET, V111, P233, DOI 10.1002/ajmg.10498; Conroy JM, 1997, AM J HUM GENET, V61, P388, DOI 10.1086/514852; de los Santos T, 2000, AM J HUM GENET, V67, P1067, DOI 10.1086/303106; Ding F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001709; Gallagher RC, 2002, AM J HUM GENET, V71, P669, DOI 10.1086/342408; Gunay-Aygun M, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.5.e92; Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265; Kuslich CD, 1999, AM J HUM GENET, V64, P70, DOI 10.1086/302177; Runte M, 2005, HUM GENET, V116, P228, DOI 10.1007/s00439-004-1219-2; Runte M, 2001, HUM MOL GENET, V10, P2687, DOI 10.1093/hmg/10.23.2687; Schule B, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-18; Schulze A, 1996, NAT GENET, V12, P452, DOI 10.1038/ng0496-452; Skryabin BV, 2007, PLOS GENET, V3, P2529, DOI 10.1371/journal.pgen.0030235; Sun YM, 1996, HUM MOL GENET, V5, P517, DOI 10.1093/hmg/5.4.517; Wirth J, 2001, HUM MOL GENET, V10, P201, DOI 10.1093/hmg/10.3.201	15	411	428	0	21	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2008	40	6					719	721		10.1038/ng.158	http://dx.doi.org/10.1038/ng.158			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18500341	Green Accepted			2022-12-27	WOS:000256212000013
J	Markstein, M; Pitsouli, C; Villalta, C; Celniker, SE; Perrimon, N				Markstein, Michele; Pitsouli, Chrysoula; Villalta, Christians; Celniker, Susan E.; Perrimon, Norbert			Exploiting position effects and the gypsy retrovirus insulator to engineer precisely expressed transgenes	NATURE GENETICS			English	Article							DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; WHITE GENE; CHROMOSOMAL POSITION; TRANSPOSABLE ELEMENT; REGULATORY ELEMENTS; PHI-C31 INTEGRASE; RNA INTERFERENCE; TRANSFORMATION; PROTEIN	A major obstacle to creating precisely expressed transgenes lies in the epigenetic effects of the host chromatin that surrounds them. Here we present a strategy to overcome this problem, employing a Gal4-inducible luciferase assay to systematically quantify position effects of host chromatin and the ability of insulators to counteract these effects at phiC31 integration loci randomly distributed throughout the Drosophila genome. We identify loci that can be exploited to deliver precise doses of transgene expression to specific tissues. Moreover, we uncover a previously unrecognized property of the gypsy retrovirus insulator to boost gene expression to levels severalfold greater than at most or possibly all un-insulated loci, in every tissue tested. These findings provide the first opportunity to create a battery of transgenes that can be reliably expressed at high levels in virtually any tissue by integration at a single locus, and conversely, to engineer a controlled phenotypic allelic series by exploiting several loci. The generality of our approach makes it adaptable to other model systems to identify and modify loci for optimal transgene expression.	[Markstein, Michele; Pitsouli, Chrysoula; Villalta, Christians; Perrimon, Norbert] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Markstein, Michele; Pitsouli, Chrysoula; Villalta, Christians; Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Celniker, Susan E.] Lawrence Berkeley Natl Lab, Dept Genome & Computat Biol, Berkeley, CA 94720 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Markstein, M (corresponding author), Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA.	mmarkstein@genetics.med.harvard.edu		Markstein, Michele/0000-0003-2635-8118; Perrimon, Norbert/0000-0001-7542-472X; Pitsouli, Chrysoula/0000-0003-4074-9684	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Allen BG, 2005, NAT METHODS, V2, P975, DOI 10.1038/NMETH814; Anderson KV, 2003, NAT GENET, V33, P285, DOI 10.1038/ng1105; Arnone MI, 2004, METHOD CELL BIOL, V74, P621; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; CHUNG JH, 1993, CELL, V74, P505, DOI 10.1016/0092-8674(93)80052-G; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; FIETZ MJ, 1995, CURR BIOL, V5, P643, DOI 10.1016/S0960-9822(95)00129-1; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gerlitz O, 2002, INT J DEV BIOL, V46, P173; GEYER PK, 1992, GENE DEV, V6, P1865, DOI 10.1101/gad.6.10.1865; Giraldo P, 2003, TRANSGENIC RES, V12, P751, DOI 10.1023/B:TRAG.0000005089.30408.25; GLOOR GB, 1993, GENETICS, V135, P81; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; HOGAN BL, 1995, MANIPULATING MOUSE E; KELLUM R, 1991, CELL, V64, P941, DOI 10.1016/0092-8674(91)90318-S; Kuhn EJ, 2003, EMBO J, V22, P2463, DOI 10.1093/emboj/cdg241; Ledford H, 2007, NATURE, V448, P115, DOI 10.1038/448115a; LEVIS R, 1985, SCIENCE, V229, P558, DOI 10.1126/science.2992080; LEWIS EB, 1950, ADV GENET, V3, P73, DOI 10.1016/S0065-2660(08)60083-8; Liao GC, 2000, P NATL ACAD SCI USA, V97, P3347, DOI 10.1073/pnas.050017397; Markstein M, 2004, DEVELOPMENT, V131, P2387, DOI 10.1242/dev.01124; Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; PIRROTTA V, 1985, EMBO J, V4, P3501, DOI 10.1002/j.1460-2075.1985.tb04109.x; Potts W, 2000, BIOCHEM BIOPH RES CO, V273, P1015, DOI 10.1006/bbrc.2000.3013; Presente A, 2002, GENESIS, V34, P165, DOI 10.1002/gene.10149; QIANQIAN Z, 2007, FLY, V1, P55; Ranganayakulu G, 1996, DEV BIOL, V176, P143, DOI 10.1006/dbio.1996.9987; Reeves N, 2005, DEV CELL, V8, P413, DOI 10.1016/j.devcel.2005.01.020; ROBERTSON HM, 1988, GENETICS, V118, P461; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; ROSEMAN RR, 1993, EMBO J, V12, P435, DOI 10.1002/j.1460-2075.1993.tb05675.x; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; SMALL S, 1992, EMBO J, V11, P4047, DOI 10.1002/j.1460-2075.1992.tb05498.x; SMITH PA, 1995, GENETICS, V139, P215; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; SPRADLING AC, 1983, CELL, V34, P47, DOI 10.1016/0092-8674(83)90135-6; Stathopoulos A, 2005, DEV CELL, V9, P449, DOI 10.1016/j.devcel.2005.09.005; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; Sullivan W., 2000, DROSOPHILA PROTOCOLS; Sun BH, 1999, P NATL ACAD SCI USA, V96, P10438, DOI 10.1073/pnas.96.18.10438; Thummel CS, 1992, DROS INF SERV, V71, P150; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Yu J, 2006, GENESIS, V44, P252, DOI 10.1002/dvg.20213	49	361	364	1	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2008	40	4					476	483		10.1038/ng.101	http://dx.doi.org/10.1038/ng.101			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18311141	Green Accepted, Green Published			2022-12-27	WOS:000254388100021
J	Vitart, V; Rudan, I; Hayward, C; Gray, NK; Floyd, J; Palmer, CN; Knott, SA; Kolcic, I; Polasek, O; Graessler, J; Wilson, JF; Marinaki, A; Riches, PL; Shu, X; Janicijevic, B; Smolej-Narancic, N; Gorgoni, B; Morgan, J; Campbell, S; Biloglav, Z; Barac-Lauc, L; Pericic, M; Klaric, IM; Zgaga, L; Skaric-Juric, T; Wild, SH; Richardson, WA; Hohenstein, P; Kimber, CH; Tenesa, A; Donnelly, LA; Fairbanks, LD; Aringer, M; McKeigue, PM; Ralston, SH; Morris, AD; Rudan, P; Hastie, ND; Campbell, H; Wright, AF				Vitart, Veronique; Rudan, Igor; Hayward, Caroline; Gray, Nicola K.; Floyd, James; Palmer, Colin Na; Knott, Sara A.; Kolcic, Ivana; Polasek, Ozren; Graessler, Juergen; Wilson, James F.; Marinaki, Anthony; Riches, Philip L.; Shu, Xinhua; Janicijevic, Branka; Smolej-Narancic, Nina; Gorgoni, Barbara; Morgan, Joanne; Campbell, Susan; Biloglav, Zrinka; Barac-Lauc, Lovorka; Pericic, Marijana; Klaric, Irena Martinovic; Zgaga, Lina; Skaric-Juric, Tatjana; Wild, Sarah H.; Richardson, William A.; Hohenstein, Peter; Kimber, Charley H.; Tenesa, Albert; Donnelly, Louise A.; Fairbanks, Lynette D.; Aringer, Martin; McKeigue, Paul M.; Ralston, Stuart H.; Morris, Andrew D.; Rudan, Pavao; Hastie, Nicholas D.; Campbell, Harry; Wright, Alan F.			SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout	NATURE GENETICS			English	Article							METABOLIC SYNDROME; URIC-ACID; ASSOCIATION; GLUCOSE; GENOME; HYPERURICEMIA; FRUCTOSE; FAMILY; POPULATION; DISEASE	Uric acid is the end product of purine metabolism in humans and great apes, which have lost hepatic uricase activity, leading to uniquely high serum uric acid concentrations (200 500 mu M) compared with other mammals (3-120 mu M)(1). About 70% of daily urate disposal occurs via the kidneys, and in 5-25% of the human population, impaired renal excretion leads to hyperuricemia(2). About 10% of people with hyperuricemia develop gout, an inflammatory arthritis that results from deposition of monosodium urate crystals in the joint. We have identified genetic variants within a transporter gene, SLC2A9, that explain 1.7-5.3% of the variance in serum uric acid concentrations, following a genome-wide association scan in a Croatian population sample. SLC2A9 variants were also associated with low fractional excretion of uric acid and/or gout in UK, Croatian and German population samples. SLC2A9 is a known fructose transporter(3), and we now show that it has strong uric acid transport activity in Xenopus laevis oocytes.	[Vitart, Veronique; Hayward, Caroline; Gray, Nicola K.; Shu, Xinhua; Morgan, Joanne; Campbell, Susan; Richardson, William A.; Hohenstein, Peter; Hastie, Nicholas D.; Wright, Alan F.] Western Gen Hosp, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Rudan, Igor; Polasek, Ozren; Wilson, James F.; Wild, Sarah H.; McKeigue, Paul M.] Univ Edinburgh, Sch Med, Community Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland; [Rudan, Igor] Univ Split, Fac Med, Croatian Ctr Global Hlth, Split 21000, Croatia; [Floyd, James; Knott, Sara A.] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3JT, Midlothian, Scotland; [Palmer, Colin Na; Kimber, Charley H.; Donnelly, Louise A.] Ninewells Hosp & Med Sch, Biomed Res Ctr, Populat Pharmacogenet Grp, Dundee DD1 9SY, Scotland; [Kolcic, Ivana; Polasek, Ozren; Biloglav, Zrinka; Zgaga, Lina] Univ Zagreb, Fac Med, Andriji Stampar Sch Publ Hlth, Zagreb 10000, Croatia; [Graessler, Juergen; Aringer, Martin] Tech Univ Dresden, Carl Gustav Carus Med Sch, Dept Internal Med, Div Pathol Biochem & Rheumatol, D-01307 Dresden, Germany; [Marinaki, Anthony] Guys & St Thomas Hosp, Univ London Kings Coll, Dept Chem Pathol, Purine Res Lab, London SE1 9RT, England; [Riches, Philip L.; Fairbanks, Lynette D.; Ralston, Stuart H.] Univ Edinburgh, Western Gen Hosp, Rheumat Dis Unit, Sch Mol & Clin Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Tenesa, Albert] Univ Edinburgh, Western Gen Hosp, Colon Canc Genet Grp, Sch Mol & Clin Med, Edinburgh EH4 2XU, Midlothian, Scotland; [Janicijevic, Branka; Smolej-Narancic, Nina; Barac-Lauc, Lovorka; Pericic, Marijana; Klaric, Irena Martinovic; Skaric-Juric, Tatjana; Rudan, Pavao] Inst Anthropol Res, Zagreb 10000, Croatia; [Gray, Nicola K.; Gorgoni, Barbara] Univ Edinburgh, Sch Clin Sci & Community Hlth, Edinburgh EH16 4SB, Midlothian, Scotland; [Morris, Andrew D.] Ninewells Hosp & Med Sch, Div Med Therapeut, Diabet Res Grp, Dundee DD1 9SY, Scotland	University of Edinburgh; University of Edinburgh; University of Split; University of Edinburgh; University of Dundee; University of Zagreb; Technische Universitat Dresden; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Edinburgh; University of Edinburgh; Institute for Anthropological Research Zagreb; University of Edinburgh; University of Dundee	Wright, AF (corresponding author), Western Gen Hosp, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland.	alan.wright@hg.mrc.ac.uk	Aringer, Martin/AAJ-7641-2020; Palmer, Colin NA/C-7053-2008; Study, GoDARTS/K-9448-2016; Morris, Andrew D/C-2837-2009; Knott, Sara A/H-2466-2013; Hayward, Caroline/M-8818-2016; Kolcic, Ivana/E-2713-2017; Campbell, Harry/E-2959-2010; Riches, Philip/C-7308-2013; Polasek, Ozren/B-6002-2011; Skaric-Juric, Tatjana/H-5997-2011; Wilson, James F/A-5704-2009; Rudan, Igor/I-1467-2012; Zgaga, Lina/Q-9415-2018; Hohenstein, Peter/Y-2428-2018	Aringer, Martin/0000-0003-4471-8375; Palmer, Colin NA/0000-0002-6415-6560; Knott, Sara A/0000-0002-4568-2928; Hayward, Caroline/0000-0002-9405-9550; Kolcic, Ivana/0000-0001-7918-6052; Campbell, Harry/0000-0002-6169-6262; Riches, Philip/0000-0003-3029-7098; Polasek, Ozren/0000-0002-5765-1862; Wilson, James F/0000-0001-5751-9178; Rudan, Igor/0000-0001-6993-6884; Zgaga, Lina/0000-0003-4089-9703; Skaric-Juric, Tatjana/0000-0003-3708-6170; Martinovic Klaric, Irena/0000-0002-6545-5589; Vitart, Veronique/0000-0002-4991-3797; Tenesa, Albert/0000-0003-4884-4475; Hohenstein, Peter/0000-0001-8548-4734; gray, nicola/0000-0002-0413-1767	MRC [MC_U127561128, G117/564, MC_U127561111] Funding Source: UKRI; Arthritis Research UK Funding Source: Medline; Medical Research Council [MC_U127561128, MC_U127561111, G117/564] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Chief Scientist Office [CZB/4/710] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Arthritis Research UK(Versus Arthritis); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Chief Scientist Office		Augustin R, 2004, J BIOL CHEM, V279, P16229, DOI 10.1074/jbc.M312226200; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Becker MA, 2006, RHEUM DIS CLIN N AM, V32, P275, DOI 10.1016/j.rdc.2006.02.005; Campbell H, 2007, HUM MOL GENET, V16, P233, DOI 10.1093/hmg/ddl473; Choi HK, 2007, AM J MED, V120, P442, DOI 10.1016/j.amjmed.2006.06.040; EMMERSON BT, 1974, ANN RHEUM DIS, V33, P276, DOI 10.1136/ard.33.3.276; Enomoto Atsushi, 2005, Clin Exp Nephrol, V9, P195, DOI 10.1007/s10157-005-0368-5; Ford ES, 2007, CIRCULATION, V115, P2526, DOI 10.1161/CIRCULATIONAHA.106.657627; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Graessler J, 2006, ARTHRITIS RHEUM, V54, P292, DOI 10.1002/art.21499; Gray NK, 2000, EMBO J, V19, P4723, DOI 10.1093/emboj/19.17.4723; Grundy SM, 2004, CIRCULATION, V109, P433, DOI 10.1161/01.CIR.0000111245.75752.C6; Hagos Y, 2007, J AM SOC NEPHROL, V18, P430, DOI 10.1681/ASN.2006040415; Heinig M, 2006, CLEV CLIN J MED, V73, P1059, DOI 10.3949/ccjm.73.12.1059; Johnson RJ, 2005, SEMIN NEPHROL, V25, P3, DOI 10.1016/j.semnephrol.2004.09.002; Keembiyehetty C, 2006, MOL ENDOCRINOL, V20, P686, DOI 10.1210/me.2005-0010; Kimber CH, 2007, DIABETOLOGIA, V50, P1186, DOI 10.1007/s00125-007-0661-9; Li S, 2007, PLOS GENET, V3, P2156, DOI 10.1371/journal.pgen.0030194; Manolescu AR, 2007, MOL MEMBR BIOL, V24, P455, DOI 10.1080/09687680701298143; Morris AD, 1997, LANCET, V350, P1505, DOI 10.1016/S0140-6736(97)06234-X; Mount DB, 2006, RHEUM DIS CLIN N AM, V32, P313, DOI 10.1016/j.rdc.2006.02.006; Phay JE, 2000, GENOMICS, V66, P217, DOI 10.1006/geno.2000.6195; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Richardson S, 2003, OSTEOARTHR CARTILAGE, V11, P92, DOI 10.1053/joca.2002.0858; Rudan I, 2006, CROAT MED J, V47, P601; Rutledge AC, 2007, NUTR REV, V65, pS13, DOI [10.1111/j.1753-4887.2007.tb00322.x, 10.1301/nr.2007.jun.S13-S23]; Seatter MJ, 1998, BIOCHEMISTRY-US, V37, P1322, DOI 10.1021/bi972322u; Uldry M, 2004, PFLUG ARCH EUR J PHY, V447, P480, DOI 10.1007/s00424-003-1085-0; Wallace C, 2008, AM J HUM GENET, V82, P139, DOI 10.1016/j.ajhg.2007.11.001; WALLACE SL, 1977, ARTHRITIS RHEUM, V20, P895, DOI 10.1002/art.1780200320	30	537	587	5	88	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	APR	2008	40	4					437	442		10.1038/ng.106	http://dx.doi.org/10.1038/ng.106			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	279XG	18327257				2022-12-27	WOS:000254388100014
J	Sebat, J				Sebat, Jonathan			Major changes in our DNA lead to major changes in our thinking	NATURE GENETICS			English	Editorial Material							COPY NUMBER POLYMORPHISM; GENOMIC REARRANGEMENTS; MOLECULAR-GENETICS; ARRAY; MAP; SUSCEPTIBILITY; DUPLICATIONS; DISORDERS; DELETIONS; AUTISM	Variability in the human genome has far exceeded expectations. In the course of the past three years, we have learned that much of our naturally occurring genetic variation consists of large-scale differences in genome structure, including copy-number variants (CNVs) and balanced rearrangements such as inversions. Recent studies have begun to reveal that structural variants are an important contributor to disease risk; however, structural variants as a class may not conform well to expectations of current methods for gene mapping. New approaches are needed to understand the contribution of structural variants to disease.	Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Sebat, J (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	sebat@cshl.edu		Sebat, Jonathan/0000-0002-9087-526X				Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Bassett AS, 1996, SCHIZOPHR RES, V21, P151, DOI 10.1016/0920-9964(96)00018-7; BLUNT T, 1994, ANN HUM GENET, V58, P19, DOI 10.1111/j.1469-1809.1994.tb00722.x; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; HIGGS DR, 1989, BLOOD, V73, P1081; HOOGENDIJK JE, 1992, LANCET, V339, P1081, DOI 10.1016/0140-6736(92)90668-S; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jacobs P A, 1977, Prog Med Genet, V2, P251; Jacquemont ML, 2006, J MED GENET, V43, P843, DOI 10.1136/jmg.2006.043166; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; Lam KWG, 2006, P NATL ACAD SCI USA, V103, P8921, DOI 10.1073/pnas.0602690103; LEDBETTER DH, 1981, NEW ENGL J MED, V304, P325, DOI 10.1056/NEJM198102053040604; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; PICKLES A, 1995, AM J HUM GENET, V57, P717; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rice Catherine, 2007, Morbidity and Mortality Weekly Report, V56, P12; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shaw-Smith C, 2004, J MED GENET, V41, P241, DOI 10.1136/jmg.2003.017731; Shaw-Smith C, 2006, NAT GENET, V38, P1032, DOI 10.1038/ng1858; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; VOLLRATH D, 1988, SCIENCE, V240, P1669, DOI 10.1126/science.2837827; Wang DG, 1998, SCIENCE, V280, P1077, DOI 10.1126/science.280.5366.1077	39	80	86	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39			7			S3	S5		10.1038/ng2095	http://dx.doi.org/10.1038/ng2095			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	274AO	17597778				2022-12-27	WOS:000253974400002
J	Odom, DT; Dowell, RD; Jacobsen, ES; Gordon, W; Danford, TW; MacIsaac, KD; Rolfe, PA; Conboy, CM; Gifford, DK; Fraenkel, E				Odom, Duncan T.; Dowell, Robin D.; Jacobsen, Elizabeth S.; Gordon, William; Danford, Timothy W.; MacIsaac, Kenzie D.; Rolfe, P. Alexander; Conboy, Caitlin M.; Gifford, David K.; Fraenkel, Ernest			Tissue-specific transcriptional regulation has diverged significantly between human and mouse	NATURE GENETICS			English	Article							EMBRYONIC STEM-CELLS; EVOLUTION; GENOME; LIVER	We demonstrate that the binding sites for highly conserved transcription factors vary extensively between human and mouse. We mapped the binding of four tissue-specific transcription factors (FOXA2, HNF1A, HNF4A and HNF6) to 4,000 orthologous gene pairs in hepatocytes purified from human and mouse livers. Despite the conserved function of these factors, from 41% to 89% of their binding events seem to be species specific. When the same protein binds the promoters of orthologous genes, approximately two-thirds of the binding sites do not align.	Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol Engn, Cambridge, MA 02139 USA; MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Fraenkel, E (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	fraenkel-admin@mit.edu	Young, Richard A/F-6495-2012; Pillay, Nischalan/F-9536-2012	Young, Richard A/0000-0001-8855-8647; DOWELL, ROBIN/0000-0001-7665-9985; Fraenkel, Ernest/0000-0001-9249-8181; Conboy, Caitlin/0000-0001-8280-056X; Odom, Duncan/0000-0001-6201-5599	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK076284, K25DK070813, R01DK068655, N01DK092310] Funding Source: NIH RePORTER; Cancer Research UK [15603, A15603] Funding Source: Medline; NIDDK NIH HHS [DK68655, F32 DK076284, K25 DK070813, DK92310, DK70813, DK076284, R01 DK068655] Funding Source: Medline; NLM NIH HHS [N01DK92310] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Cancer Research UK(Cancer Research UK); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Bird CP, 2006, CURR OPIN GENET DEV, V16, P559, DOI 10.1016/j.gde.2006.10.003; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Kim SH, 2004, DIABETES, V53, P1375, DOI 10.2337/diabetes.53.5.1375; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MacIsaac KD, 2006, BIOINFORMATICS, V22, P423, DOI 10.1093/bioinformatics/bti815; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; NATARAJAN AT, 1991, MUTAGENESIS, V6, P399, DOI 10.1093/mutage/6.5.399; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Qi Y, 2006, NAT BIOTECHNOL, V24, P963, DOI 10.1038/nbt1233; Richert L, 2006, DRUG METAB DISPOS, V34, P870, DOI 10.1124/dmd.105.007708; Schwartz S, 2003, GENOME RES, V13, P103, DOI 10.1101/gr.809403; Zaret KS, 2002, NAT REV GENET, V3, P499, DOI 10.1038/nrg837	14	402	415	0	23	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2007	39	6					730	732		10.1038/ng2047	http://dx.doi.org/10.1038/ng2047			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17529977	Green Accepted			2022-12-27	WOS:000246859100016
J	Helgason, A; Palsson, S; Thorleifsson, G; Grant, SFA; Emilsson, V; Gunnarsdottir, S; Adeyemo, A; Chen, YX; Chen, GJ; Reynisdottir, I; Benediktsson, R; Hinney, A; Hansen, T; Andersen, G; Borch-Johnsen, K; Jorgensen, T; Schafer, H; Faruque, M; Doumatey, A; Zhou, J; Wilensky, RL; Reilly, MP; Rader, DJ; Bagger, Y; Christiansen, C; Sigurdsson, G; Hebebrand, J; Pedersen, O; Thorsteinsdottir, U; Gulcher, JR; Kong, A; Rotimi, C; Stefansson, K				Helgason, Agnar; Palsson, Snaebjorn; Thorleifsson, Gudmar; Grant, Struan F. A.; Emilsson, Valur; Gunnarsdottir, Steinunn; Adeyemo, Adebowale; Chen, Yuanxiu; Chen, Guanjie; Reynisdottir, Inga; Benediktsson, Rafn; Hinney, Anke; Hansen, Torben; Andersen, Gitte; Borch-Johnsen, Knut; Jorgensen, Torben; Schaefer, Helmut; Faruque, Mezbah; Doumatey, Ayo; Zhou, Jie; Wilensky, Robert L.; Reilly, Muredach P.; Rader, Daniel J.; Bagger, Yu; Christiansen, Claus; Sigurdsson, Gunnar; Hebebrand, Johannes; Pedersen, Oluf; Thorsteinsdottir, Unnur; Gulcher, Jeffrey R.; Kong, Augustine; Rotimi, Charles; Stefansson, Kari			Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution	NATURE GENETICS			English	Article							HUMAN GENOME; CONFERS RISK; POPULATION; ASSOCIATION; RECOMBINATION; PROGRAM; OBESITY; MAP	We recently described an association between risk of type 2 diabetes and variants in the transcription factor 7- like 2 gene ( TCF7L2; formerly TCF4), with a population attributable risk ( PAR) of 17% - 28% in three populations of European ancestry(1). Here, we refine the definition of the TCF7L2 type 2 diabetes risk variant, HapB(T2D), to the ancestral T allele of a SNP, rs7903146, through replication in West African and Danish type 2 diabetes case-control studies and an expanded Icelandic study. We also identify another variant of the same gene, HapA, that shows evidence of positive selection in East Asian, European and West African populations. Notably, HapA shows a suggestive association with body mass index and altered concentrations of the hunger-satiety hormones ghrelin and leptin in males, indicating that the selective advantage of HapA may have been mediated through effects on energy metabolism.	DeCODE Genet, IS-101 Reykjavik, Iceland; Univ Iceland, IS-101 Reykjavik, Iceland; Howard Univ, Natl Human Gen Ctr, Dept Community & Family Med, Washington, DC 20060 USA; Iceland Heart Assoc, IS-201 Kopavogur, Iceland; Natl Univ Hosp Reykjavik, IS-101 Reykjavik, Iceland; Univ Duisburg Essen, Rhein Klin Essen, Dept Child & Adolescent Psychiat, D-45147 Essen, Germany; Steno Diabet Ctr, DK-2820 Gentofte, Denmark; Univ Aarhus, DK-8000 Aarhus, Denmark; Univ Hosp Glostrup, Res Ctr Prevent & Hlth, DK-2600 Glostrup, Denmark; Univ Marburg, Inst Med Biometry & Epidemiol, D-35037 Marburg, Germany; Univ Penn, Sch Med, Philadelphia, PA 19104 USA; Ctr Clin & Basic Res AS, DK-2750 Ballerup, Denmark	University of Iceland; Howard University; Icelandic Heart Association; Landspitali National University Hospital; University of Duisburg Essen; Steno Diabetes Center; Aarhus University; University of Copenhagen; Philipps University Marburg; University of Pennsylvania; Center Clinical & Basic Research	Helgason, A (corresponding author), DeCODE Genet, IS-101 Reykjavik, Iceland.	agnar@decode.is; kstefans@decode.is	Helgason, Agnar/K-1522-2015; Stefansson, Kari/AAE-7187-2019; Jørgensen, Torben/Z-1335-2018; Palsson, Snaebjorn/J-9113-2012; Pedersen, Oluf/AAG-8015-2020; Pedersen, Oluf/Z-1731-2019; Benediktsson, Rafn/R-2457-2018; Hinney, Anke/D-6953-2011	Pedersen, Oluf/0000-0002-3321-3972; Benediktsson, Rafn/0000-0002-2954-9801; Hinney, Anke/0000-0001-5659-0706; Reilly, Muredach/0000-0002-3035-9386; Palsson, Snaebjorn/0000-0002-4297-3500; Hansen, Torben/0000-0001-8748-3831; Adeyemo, Adebowale/0000-0002-3105-3231; Kong, Augustine/0000-0001-8193-5438; Helgason, Agnar/0000-0002-8545-3767; Jorgensen, Torben/0000-0001-9453-2830; Grant, Struan/0000-0003-2025-5302; Reynisdottir, Inga/0000-0002-9730-7476; Emilsson, Valur/0000-0001-9982-0524	FIC NIH HHS [3T37TW00041-03S2] Funding Source: Medline; NIDDK NIH HHS [DK-54001] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [T37TW000041] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Adeyemo AA, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-38; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Andersen G, 2006, DIABETOLOGIA, V49, P75, DOI 10.1007/s00125-005-0049-7; Arora S, 2006, NEUROPEPTIDES, V40, P375, DOI 10.1016/j.npep.2006.07.001; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Erdmann J, 2005, DIABETES, V54, P1371, DOI 10.2337/diabetes.54.5.1371; EXCOFFIER L, 1992, GENETICS, V131, P491; FALK CT, 1987, ANN HUM GENET, V51, P227, DOI 10.1111/j.1469-1809.1987.tb00875.x; Florez JC, 2006, NEW ENGL J MED, V355, P241, DOI 10.1056/NEJMoa062418; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Groves CJ, 2006, DIABETES, V55, P2640, DOI 10.2337/db06-0355; Hinney A, 2003, J CLIN ENDOCR METAB, V88, P4258, DOI 10.1210/jc.2003-030233; Jonsdottir LS, 2002, J CARDIOVASC RISK, V9, P67, DOI 10.1097/00043798-200204000-00001; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Laval G, 2004, BIOINFORMATICS, V20, P2485, DOI 10.1093/bioinformatics/bth264; MANTEL N, 1959, J NATL CANCER I, V22, P719; McVean G, 2002, GENETICS, V160, P1231; NEEL JV, 1962, AM J HUM GENET, V14, P353; O'Rahilly S, 2005, SCIENCE, V307, P370, DOI 10.1126/science.1104346; Rotimi CN, 2001, ANN EPIDEMIOL, V11, P51, DOI 10.1016/S1047-2797(00)00180-0; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; Slatkin M, 2001, GENETICS, V158, P865; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072	30	389	406	0	28	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					218	225		10.1038/ng1960	http://dx.doi.org/10.1038/ng1960			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17206141				2022-12-27	WOS:000244063900020
J	Tsuji, K; Bandyopadhyay, A; Harfe, BD; Cox, K; Kakar, S; Gerstenfeld, L; Einhorn, T; Tabin, CJ; Rosen, V				Tsuji, Kunikazu; Bandyopadhyay, Amitabha; Harfe, Brian D.; Cox, Karen; Kakar, Sanjeev; Gerstenfeld, Louis; Einhorn, Thomas; Tabin, Clifford J.; Rosen, Vicki			BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing	NATURE GENETICS			English	Article							SKELETAL OVEREXPRESSION; BETA FAMILY; EXPRESSION; MICE; PROTEIN; OSTEOPENIA; CARTILAGE; COLLAGEN; DEFECTS; REVEALS	Adult bones have a notable regenerative capacity. Over 40 years ago, an intrinsic activity capable of initiating this reparative response was found to reside within bone itself, and the term bone morphogenetic protein(1) (BMP) was coined to describe the molecules responsible for it. A family of BMP proteins was subsequently identified(2-4), but no individual BMP has been shown to be the initiator of the endogenous bone repair response. Here we demonstrate that BMP2 is a necessary component of the signaling cascade that governs fracture repair. Mice lacking the ability to produce BMP2 in their limb bones have spontaneous fractures that do not resolve with time. In fact, in bones lacking BMP2, the earliest steps of fracture healing seem to be blocked. Although other osteogenic stimuli are still present in the limb skeleton of BMP2-deficient mice, they cannot compensate for the absence of BMP2. Collectively, our results identify BMP2 as an endogenous mediator necessary for fracture repair.	Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA; Boston Univ, Sch Med, Dept Orthoped, Boston, MA 02118 USA	Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School; State University System of Florida; University of Florida; Boston University	Rosen, V (corresponding author), Harvard Univ, Sch Dent Med, Dept Dev Biol, 188 Longwood Ave, Boston, MA 02115 USA.	vicki_rosen@hsdm.harvard.edu	Bandyopadhyay, Amitabha/B-9735-2008; Tsuji, Kunikazu/HDM-9242-2022	Tsuji, Kunikazu/0000-0002-1013-8359; Einhorn, Thomas/0000-0002-5075-4885; Bandyopadhyay, Amitabha/0000-0002-0429-438X; /0000-0002-0477-1211				BERNARD MP, 1983, BIOCHEMISTRY-US, V22, P5213, DOI 10.1021/bi00291a023; Bertone AL, 2004, J ORTHOP RES, V22, P1261, DOI 10.1016/j.orthres.2004.03.014; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Brent AE, 2003, CELL, V113, P235, DOI 10.1016/S0092-8674(03)00268-X; CELESTE AJ, 1990, P NATL ACAD SCI USA, V87, P9843, DOI 10.1073/pnas.87.24.9843; Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513; COOK SD, 1994, CLIN ORTHOP RELAT R, P302; DESBOIS C, 1994, J BIOL CHEM, V269, P1183; Devlin RD, 2003, ENDOCRINOLOGY, V144, P1972, DOI 10.1210/en.2002-220918; Gazzerro E, 2005, ENDOCRINOLOGY, V146, P655, DOI 10.1210/en.2004-0766; Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001; Katagiri T, 1998, DEV GENET, V22, P340, DOI 10.1002/(SICI)1520-6408(1998)22:4<340::AID-DVG4>3.0.CO;2-6; KOHNO K, 1984, J BIOL CHEM, V259, P3668; Lanske B, 1998, ENDOCRINOLOGY, V139, P5194, DOI 10.1210/en.139.12.5194; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; LYONS KM, 1995, MECH DEVELOP, V50, P71, DOI 10.1016/0925-4773(94)00326-I; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Murnaghan M, 2005, J ORTHOP RES, V23, P625, DOI 10.1016/j.orthres.2004.12.008; Niikura T, 2006, J ORTHOP RES, V24, P1463, DOI 10.1002/jor.20182; OLDBERG A, 1986, P NATL ACAD SCI USA, V83, P8819, DOI 10.1073/pnas.83.23.8819; OZKAYNAK E, 1990, EMBO J, V9, P2085, DOI 10.1002/j.1460-2075.1990.tb07376.x; Razzaque MS, 2005, J PATHOL, V207, P453, DOI 10.1002/path.1870; Rountree RB, 2004, PLOS BIOL, V2, P1815, DOI 10.1371/journal.pbio.0020355; Sipe JB, 2004, BONE, V35, P1316, DOI 10.1016/j.bone.2004.08.020; Solloway MJ, 1998, DEV GENET, V22, P321, DOI 10.1002/(SICI)1520-6408(1998)22:4<321::AID-DVG3>3.3.CO;2-7; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Wu XB, 2003, J CLIN INVEST, V112, P924, DOI 10.1172/JCI200315543; YASKO AW, 1992, J BONE JOINT SURG AM, V74A, P659, DOI 10.2106/00004623-199274050-00005; Zhang HB, 1996, DEVELOPMENT, V122, P2977	30	610	640	1	61	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	DEC	2006	38	12					1424	1429		10.1038/ng1916	http://dx.doi.org/10.1038/ng1916			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	110TR	17099713				2022-12-27	WOS:000242404200020
J	Ahmed, ZM; Masmoudi, S; Kalay, E; Belyantseva, IA; Mosrati, MA; Collin, RWJ; Riazuddin, S; Hmani-Aifa, M; Venselaar, H; Kawar, MN; Tlili, A; van der Zwaag, B; Khan, SY; Ayadi, L; Riazuddin, SA; Morell, RJ; Griffith, AJ; Charfedine, I; Caylan, R; Oostrik, J; Karaguzel, A; Ghorbel, A; Riazuddin, S; Friedman, TB; Ayadi, H; Kremer, H				Ahmed, Zubair M.; Masmoudi, Saber; Kalay, Ersan; Belyantseva, Inna A.; Mosrati, Mohamed Ali; Collin, Rob W. J.; Riazuddin, Saima; Hmani-Aifa, Mounira; Venselaar, Hanka; Kawar, Mayya N.; Tlili, Abdelaziz; van der Zwaag, Bert; Khan, Shahid Y.; Ayadi, Leila; Riazuddin, S. Amer; Morell, Robert J.; Griffith, Andrew J.; Charfedine, Ilhem; Caylan, Refik; Oostrik, Jaap; Karaguzel, Ahmet; Ghorbel, Abdelmonem; Riazuddin, Sheikh; Friedman, Thomas B.; Ayadi, Hammadi; Kremer, Hannie			Mutations of LRTOMT, a fusion gene with alternative reading frames, cause nonsyndromic deafness in humans	NATURE GENETICS			English	Article							CATECHOL-O-METHYLTRANSFERASE; OUTER HAIR-CELLS; HEARING IMPAIRMENT; CORTICAL LATTICE; LOCUS DFNB63; GENOME-WIDE; EAR; TRANSCRIPTION; LOCALIZATION; METHYLATION	Many proteins necessary for sound transduction have been identified through positional cloning of genes that cause deafness(1-3). We report here that mutations of LRTOMT are associated with profound nonsyndromic hearing loss at the DFNB63 locus on human chromosome 11q13.3-q13.4. LRTOMT has two alternative reading frames and encodes two different proteins, LRTOMT1 and LRTOMT2, detected by protein blot analyses. LRTOMT2 is a putative methyltransferase. During evolution, new transcripts can arise through partial or complete coalescence of genes(4). We provide evidence that in the primate lineage LRTOMT evolved from the fusion of two neighboring ancestral genes, which exist as separate genes (Lrrc51 and Tomt) in rodents.	[Kalay, Ersan; Collin, Rob W. J.; Oostrik, Jaap; Kremer, Hannie] Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, NL-6500 HB Nijmegen, Netherlands; [Kalay, Ersan; Collin, Rob W. J.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Ahmed, Zubair M.; Belyantseva, Inna A.; Riazuddin, Saima; Kawar, Mayya N.; Morell, Robert J.; Friedman, Thomas B.] Natl Inst Deafness & Other Commun Disorders, Mol Genet Lab, Rockville, MD 20850 USA; [Masmoudi, Saber; Mosrati, Mohamed Ali; Hmani-Aifa, Mounira; Tlili, Abdelaziz; Ayadi, Leila; Ayadi, Hammadi] Ctr Biotechnol, Unite Cibles Diagnost & Therapie, Sfax 3018, Tunisia; [Kalay, Ersan; Karaguzel, Ahmet] Karadeniz Tech Univ, Fac Med, Dept Med Biol, TR-61080 Trabzon, Turkey; [Venselaar, Hanka] Radboud Univ Nijmegen, Ctr Mol & Biomol Informat, NL-6500 HB Nijmegen, Netherlands; [van der Zwaag, Bert] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, NL-3584 CG Utrecht, Netherlands; [Khan, Shahid Y.; Riazuddin, S. Amer; Riazuddin, Sheikh] Univ Punjab, Natl Ctr Excellence Mol Biol, Lahore 53700, Pakistan; [Griffith, Andrew J.] Natl Inst Deafness & Other Commun Disorders, Otolaryngol Branch, Rockville, MD 20850 USA; [Charfedine, Ilhem; Ghorbel, Abdelmonem] CHU Habib Bourguiba Sfax, Serv ORL, Sfax 3029, Tunisia; [Caylan, Refik] Karadeniz Tech Univ, Fac Med, Dept Otorhinolaryngol, TR-61080 Trabzon, Turkey; [Kremer, Hannie] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Kremer, Hannie] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Centre de Biotechnologie de Borj Cedria; Centre de Biotechnologie de Sfax; Universite de Sfax; Karadeniz Technical University; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; National Center of Excellence in Molecular Biology - Pakistan; University of Punjab; National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); Universite de Sfax; Hopital Habib Bourguiba; Karadeniz Technical University; Radboud University Nijmegen; Radboud University Nijmegen	Kremer, H (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Otorhinolaryngol, NL-6500 HB Nijmegen, Netherlands.	friedman@nidcd.nih.gov; directeur.general@cbs.rnrt.tn; H.Kremer@antrg.umcn.nl	Tlili, Abdelaziz/AAE-8699-2020; Kalay, Ersan/AAL-2906-2021; Oostrik, Jaap/A-1703-2016; Venselaar, Hanka/D-2009-2016; Kremer, Hannie/F-5126-2010; SHEIKH, RIAZUDDIN/L-2406-2015; Morell, Robert James/Q-2042-2019; Collin, Rob/N-3575-2014; Masmoudi, Saber/W-1478-2019; Mosrati, Mohamed Ali/D-9625-2019	Kalay, Ersan/0000-0002-1467-2268; Venselaar, Hanka/0000-0001-9824-6559; Kremer, Hannie/0000-0002-0841-8693; Mosrati, Mohamed Ali/0000-0001-9663-9885; Saber, Masmoudi/0000-0002-1076-5256; Tlili, Abdelaziz/0000-0002-8039-3013; Morell, Robert/0000-0003-1537-7356	NIDCD/NIH [ZO1DC00035-06, ZO1DC000060, ZO1DC000064]; European Commission FP6 Integrated Project EUROHEAR [LSHG-CT-20054-512063:2]; Heinsius Houbolt Foundation; Karadeniz Technical University Research Fund [2002.114.001.3, 2006.114.001.1]; Le Ministere de l'Enseignement Superieur; de la Recherche Scientifique et de la Technologie, Tunisia; Higher Education Commission and the Ministry of Science and Technology in Islamabad, Pakistan; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000039, ZIADC000060] Funding Source: NIH RePORTER	NIDCD/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); European Commission FP6 Integrated Project EUROHEAR(European CommissionEuropean Commission Joint Research Centre); Heinsius Houbolt Foundation; Karadeniz Technical University Research Fund; Le Ministere de l'Enseignement Superieur; de la Recherche Scientifique et de la Technologie, Tunisia; Higher Education Commission and the Ministry of Science and Technology in Islamabad, Pakistan; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank the families for their participation in this study, which was supported by NIDCD/NIH (intramural research fund ZO1DC00035-06 and ZO1DC00035-06 to T.B.F., ZO1DC000060 and ZO1DC000064 to A.J.G.), funds from the European Commission FP6 Integrated Project EUROHEAR (contract number LSHG-CT-20054-512063:2), the Heinsius Houbolt Foundation and the Karadeniz Technical University Research Fund (contract numbers 2002.114.001.3 and 2006.114.001.1). In Tunisia work was also funded by Le Ministere de l'Enseignement Superieur, de la Recherche Scientifique et de la Technologie, Tunisia. In Pakistan the Higher Education Commission and the Ministry of Science and Technology in Islamabad, Pakistan supported this project. We thank B. Ploplis, M. Ansari, A. Lagziel, E. Boger, S. Kitajiri, E. van Wijk, T. Peters and H. Spierenburg for their technical help and G. Vriend, F. Cremers, H. Brunner and C. Cremers for discussion. We also thank J. Bird, D. Drayna, M. Meisler and S. Sullivan for advice and comments in preparing the manuscript. We thank the Southwest National Primate Research Center, San Antonio, Texas for providing brain tissue samples from chimpanzee and baboon, and the Duke Lemur Center, Durham, North Carolina for brain tissue samples from a lemur.	Ahmed ZM, 2003, HUM MOL GENET, V12, P3215, DOI 10.1093/hmg/ddg358; Ahmed ZM, 2001, AM J HUM GENET, V69, P25, DOI 10.1086/321277; Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Bonifacio MJ, 2002, MOL PHARMACOL, V62, P795, DOI 10.1124/mol.62.4.795; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; Chung WY, 2007, PLOS COMPUT BIOL, V3, P855, DOI 10.1371/journal.pcbi.0030091; Collin RWJ, 2008, AM J HUM GENET, V82, P125, DOI 10.1016/j.ajhg.2007.09.008; Dallos P, 2002, NAT REV MOL CELL BIO, V3, P104, DOI 10.1038/nrm730; Friedman TB, 2003, ANNU REV GENOM HUM G, V4, P341, DOI 10.1146/annurev.genom.4.070802.110347; Frolenkov GI, 1998, MOL BIOL CELL, V9, P1961, DOI 10.1091/mbc.9.8.1961; Gogos JA, 1998, P NATL ACAD SCI USA, V95, P9991, DOI 10.1073/pnas.95.17.9991; Grant L, 2007, PFLUG ARCH EUR J PHY, V454, P793, DOI 10.1007/s00424-007-0253-z; Gregory-Evans CY, 2007, HUM MOL GENET, V16, P2482, DOI 10.1093/hmg/ddm204; HOLLEY MC, 1990, J CELL SCI, V96, P283; HOLLEY MC, 1992, J CELL SCI, V102, P569; Kalay E, 2007, J MOL MED, V85, P397, DOI 10.1007/s00109-006-0136-3; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Khan SY, 2007, HUM GENET, V120, P789, DOI 10.1007/s00439-006-0275-1; Lautala P, 2001, MOL PHARMACOL, V59, P393, DOI 10.1124/mol.59.2.393; Liang H, 2006, GENOME RES, V16, P190, DOI 10.1101/gr.4246506; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; NISHIDA Y, 1993, HEARING RES, V65, P274, DOI 10.1016/0378-5955(93)90220-U; Parra MK, 2008, EMBO J, V27, P122, DOI 10.1038/sj.emboj.7601957; Pasek S, 2006, BIOINFORMATICS, V22, P1418, DOI 10.1093/bioinformatics/btl135; QUELLE DE, 1995, CELL, V83, P993; Tekin M, 2007, AM J HUM GENET, V80, P338, DOI 10.1086/510920; Tlili A, 2007, ANN HUM GENET, V71, P271, DOI 10.1111/j.1469-1809.2006.00337.x; Zhu BT, 2002, CURR DRUG METAB, V3, P321, DOI 10.2174/1389200023337586	30	49	62	2	27	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2008	40	11					1335	1340		10.1038/ng.245	http://dx.doi.org/10.1038/ng.245			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	366RQ	18953341	Green Accepted			2022-12-27	WOS:000260501500027
J	Kondo, Y; Shen, L; Cheng, AS; Ahmed, S; Boumber, Y; Charo, C; Yamochi, T; Urano, T; Furukawa, K; Kwabi-Addo, B; Gold, DL; Sekido, Y; Huang, THM; Issa, JPJ				Kondo, Yutaka; Shen, Lanlan; Cheng, Alfred S.; Ahmed, Saira; Boumber, Yanis; Charo, Chantale; Yamochi, Tadanori; Urano, Takeshi; Furukawa, Koichi; Kwabi-Addo, Bernard; Gold, David L.; Sekido, Yoshitaka; Huang, Tim Hui-Ming; Issa, Jean-Pierre J.			Gene silencing in cancer by histone H3 lysine 27 trimethylation independent of promoter DNA methylation	NATURE GENETICS			English	Article							HISTONE LYSINE METHYLATION; CPG ISLAND MICROARRAY; EMBRYONIC STEM-CELLS; GROUP PROTEIN EZH2; CHROMATIN IMMUNOPRECIPITATION; COLORECTAL-CANCER; PROSTATE-CANCER; SUPPRESSOR GENE; H3; HYPERMETHYLATION	Epigenetic silencing in cancer cells is mediated by at least two distinct histone modifications, polycomb-based histone H3 lysine 27 trimethylation (H3K27triM) and H3K9 dimethylation. The relationship between DNA hypermethylation and these histone modifications is not completely understood. Using chromatin immunoprecipitation microarrays (ChIP-chip) in prostate cancer cells compared to normal prostate, we found that up to 5% of promoters (16% CpG islands and 84% non-CpG islands) were enriched with H3K27triM. These genes were silenced specifically in prostate cancer, and those CpG islands affected showed low levels of DNA methylation. Downregulation of the EZH2 histone methyltransferase restored expression of the H3K27triM target genes alone or in synergy with histone deacetylase inhibition, without affecting promoter DNA methylation, and with no effect on the expression of genes silenced by DNA hypermethylation. These data establish EZH2-mediated H3K27triM as a mechanism of tumor-suppressor gene silencing in cancer that is potentially independent of promoter DNA methylation.	[Kondo, Yutaka; Shen, Lanlan; Ahmed, Saira; Boumber, Yanis; Charo, Chantale; Issa, Jean-Pierre J.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Kondo, Yutaka; Sekido, Yoshitaka] Aichi Canc Ctr, Res Inst, Div Mol Oncol, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Cheng, Alfred S.; Huang, Tim Hui-Ming] Ohio State Univ, Human Canc Genet Program, Dept Mol Virol Immunol & Med Genet, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Yamochi, Tadanori] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma Myeloma, Houston, TX 77030 USA; [Urano, Takeshi; Furukawa, Koichi] Nagoya Univ, Grad Sch Med, Dept Biochem 2, Showa Ku, Nagoya, Aichi 4668550, Japan; [Kwabi-Addo, Bernard] Baylor Coll Med & Michael E DeBakey, Dept Pathol, Dept Vet Affairs Med Ctr, Houston, TX 77030 USA; [Gold, David L.] Univ Texas MD Anderson Canc Ctr, Dept Biostat & Appl Math, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Aichi Cancer Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of Texas System; UTMD Anderson Cancer Center; Nagoya University; Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; University of Texas System; UTMD Anderson Cancer Center	Issa, JPJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jpissa@mdanderson.org	Sekido, Yoshitaka/P-9756-2015; Cheng, Alfred SL/C-3327-2014; Boumber, Yanis/AAP-8901-2021; Kwabi-Addo, Bernard/A-6993-2016	Cheng, Alfred SL/0000-0003-2345-6951; Urano, Takeshi/0000-0003-3383-3554; Boumber, Yanis/0000-0001-5003-248X; Issa, Jean-Pierre/0000-0003-2258-5030; Sekido, Yoshitaka/0000-0002-2428-3848; Kwabi-Addo, Bernard/0000-0003-3692-6350	NCI NIH HHS [R33CA89837, R01CA098006, P50CA100632, P50CA058204] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098006, P50CA100632, P50CA058204, R33CA089837] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Asatiani E, 2005, CANCER RES, V65, P1164, DOI 10.1158/0008-5472.CAN-04-2688; Benetti R, 2001, EMBO J, V20, P2702, DOI 10.1093/emboj/20.11.2702; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Campisi Judith, 2003, Methods Mol Biol, V223, P155; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Colella S, 2003, BIOTECHNIQUES, V35, P146, DOI 10.2144/03351md01; CROSS SH, 1994, NAT GENET, V6, P236, DOI 10.1038/ng0394-236; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; DEY A, 1994, MOL CELL BIOL, V14, P8191, DOI 10.1128/MCB.14.12.8191; Estecio MRH, 2007, GENOME RES, V17, P1529, DOI 10.1101/gr.6417007; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Kondo Y, 2004, P NATL ACAD SCI USA, V101, P7398, DOI 10.1073/pnas.0306641101; Kondo Y, 2003, J BIOL CHEM, V278, P27658, DOI 10.1074/jbc.M304072200; Lachner M, 2002, CURR OPIN CELL BIOL, V14, P286, DOI 10.1016/S0955-0674(02)00335-6; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Shao ZH, 1999, CELL, V98, P37, DOI 10.1016/S0092-8674(00)80604-2; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Toyota M, 1999, CANCER RES, V59, P2307; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941	37	483	506	0	52	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2008	40	6					741	750		10.1038/ng.159	http://dx.doi.org/10.1038/ng.159			10	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18488029				2022-12-27	WOS:000256212000016
J	Loos, RJF; Lindgren, CM; Li, SX; Wheeler, E; Zhao, JH; Prokopenko, I; Inouye, M; Freathy, RM; Attwood, AP; Beckmann, JS; Berndt, SI; Bergmann, S; Bennett, AJ; Bingham, SA; Bochud, M; Brown, M; Cauchi, S; Connell, JM; Cooper, C; Smith, GD; Day, I; Dina, C; De, S; Dermitzakis, ET; Doney, ASF; Elliott, KS; Elliott, P; Evans, DM; Farooqi, IS; Froguel, P; Ghori, J; Groves, CJ; Gwilliam, R; Hadley, D; Hall, AS; Hattersley, AT; Hebebrand, J; Heid, IM; Herrera, B; Hinney, A; Hunt, SE; Jarvelin, MR; Johnson, T; Jolley, JDM; Karpe, F; Keniry, A; Khaw, KT; Luben, RN; Mangino, M; Marchini, J; McArdle, WL; McGinnis, R; Meyre, D; Munroe, PB; Morris, AD; Ness, AR; Neville, MJ; Nica, AC; Ong, KK; O'Rahilly, S; Owen, KR; Palmer, CNA; Papadakis, K; Potter, S; Pouta, A; Qi, L; Randall, JC; Rayner, NW; Ring, SM; Sandhu, MS; Scherag, A; Sims, MA; Song, K; Soranzo, N; Speliotes, EK; Syddall, HE; Teichmann, SA; Timpson, NJ; Tobias, JH; Uda, M; Vogel, CIG; Wallace, C; Waterworth, DM; Weedon, MN; Willer, CJ; Wraight, VL; Yuan, X; Zeggini, E; Hirschhorn, JN; Strachan, DP; Ouwehand, WH; Caulfield, MJ; Samani, NJ; Frayling, TM; Vollenweider, P; Waeber, G; Mooser, V; Deloukas, P; McCarthy, MI; Wareham, NJ; Barroso, I				Loos, Ruth J. F.; Lindgren, Cecilia M.; Li, Shengxu; Wheeler, Eleanor; Zhao, Jing Hua; Prokopenko, Inga; Inouye, Michael; Freathy, Rachel M.; Attwood, Antony P.; Beckmann, Jacques S.; Berndt, Sonja I.; Bergmann, Sven; Bennett, Amanda J.; Bingham, Sheila A.; Bochud, Murielle; Brown, Morris; Cauchi, Stephane; Connell, John M.; Cooper, Cyrus; Smith, George Davey; Day, Ian; Dina, Christian; De, Subhajyoti; Dermitzakis, Emmanouil T.; Doney, Alex S. F.; Elliott, Katherine S.; Elliott, Paul; Evans, David M.; Farooqi, I. Sadaf; Froguel, Philippe; Ghori, Jilur; Groves, Christopher J.; Gwilliam, Rhian; Hadley, David; Hall, Alistair S.; Hattersley, Andrew T.; Hebebrand, Johannes; Heid, Iris M.; Herrera, Blanca; Hinney, Anke; Hunt, Sarah E.; Jarvelin, Marjo-Riitta; Johnson, Toby; Jolley, Jennifer D. M.; Karpe, Fredrik; Keniry, Andrew; Khaw, Kay-Tee; Luben, Robert N.; Mangino, Massimo; Marchini, Jonathan; McArdle, Wendy L.; McGinnis, Ralph; Meyre, David; Munroe, Patricia B.; Morris, Andrew D.; Ness, Andrew R.; Neville, Matthew J.; Nica, Alexandra C.; Ong, Ken K.; O'Rahilly, Stephen; Owen, Katharine R.; Palmer, Colin N. A.; Papadakis, Konstantinos; Potter, Simon; Pouta, Anneli; Qi, Lu; Randall, Joshua C.; Rayner, Nigel W.; Ring, Susan M.; Sandhu, Manjinder S.; Scherag, Andre; Sims, Matthew A.; Song, Kijoung; Soranzo, Nicole; Speliotes, Elizabeth K.; Syddall, Holly E.; Teichmann, Sarah A.; Timpson, Nicholas J.; Tobias, Jonathan H.; Uda, Manuela; Vogel, Carla I. Ganz; Wallace, Chris; Waterworth, Dawn M.; Weedon, Michael N.; Willer, Cristen J.; Wraight, Vicki L.; Yuan, Xin; Zeggini, Eleftheria; Hirschhorn, Joel N.; Strachan, David P.; Ouwehand, Willem H.; Caulfield, Mark J.; Samani, Nilesh J.; Frayling, Timothy M.; Vollenweider, Peter; Waeber, Gerard; Mooser, Vincent; Deloukas, Panos; McCarthy, Mark I.; Wareham, Nicholas J.; Barroso, Ines		Prostate Lung Colorectal Ovarian; KORA; Nurses' Health Study; Diabetes Genetics Initiative; SardiNIA Study; Wellcome Trust Case Control Consor; FUSION	Common variants near MC4R are associated with fat mass, weight and risk of obesity	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; MELANOCORTIN-4 RECEPTOR GENE; EARLY-ONSET OBESITY; FRAMESHIFT MUTATION; ADULT OBESITY; FTO GENE; EXPRESSION; DEFICIENCY; CHILDHOOD; DOMINANT	To identify common variants influencing body mass index (BMI), we analyzed genome-wide association data from 16,876 individuals of European descent. After previously reported variants in FTO, the strongest association signal (rs17782313, P = 2.9 x 10(-6)) mapped 188 kb downstream of MC4R (melanocortin-4 receptor), mutations of which are the leading cause of monogenic severe childhood-onset obesity. We confirmed the BMI association in 60,352 adults (per-allele effect = 0.05 Z-score units; P = 2.8 x 10(-15)) and 5,988 children aged 7-11 (0.13 Z-score units; P = 1.5 x 10(-8)). In case-control analyses (n = 10,583), the odds for severe childhood obesity reached 1.30 (P = 8.0 x 10(-11)). Furthermore, we observed overtransmission of the risk allele to obese offspring in 660 families (P (pedigree disequilibrium test average; PDT-avg) 2.4 x 10(-4)). The SNP location and patterns of phenotypic associations are consistent with effects mediated through altered MC4R function. Our findings establish that common variants near MC4R influence fat mass, weight and obesity risk at the population level and reinforce the need for large-scale data integration to identify variants influencing continuous biomedical traits.	[Lindgren, Cecilia M.; Prokopenko, Inga; Bennett, Amanda J.; Elliott, Katherine S.; Evans, David M.; Groves, Christopher J.; Herrera, Blanca; Randall, Joshua C.; Rayner, Nigel W.; Timpson, Nicholas J.; Zeggini, Eleftheria; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Loos, Ruth J. F.; Li, Shengxu; Zhao, Jing Hua; Sandhu, Manjinder S.; Sims, Matthew A.; Wareham, Nicholas J.] Addenbrookes Hosp, MRC, Epidemiol Unit, Cambridge CB2 0QQ, England; [Loos, Ruth J. F.; Li, Shengxu; Zhao, Jing Hua; Farooqi, I. Sadaf; Ong, Ken K.; O'Rahilly, Stephen; Sims, Matthew A.; Wraight, Vicki L.; Wareham, Nicholas J.] Addenbrookes Hosp, Inst Metab Sci, Cambridge CB2 0QQ, England; [Lindgren, Cecilia M.; Prokopenko, Inga; Bennett, Amanda J.; Groves, Christopher J.; Herrera, Blanca; Karpe, Fredrik; Neville, Matthew J.; Owen, Katharine R.; Randall, Joshua C.; Rayner, Nigel W.; McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Wheeler, Eleanor; Inouye, Michael; Attwood, Antony P.; Dermitzakis, Emmanouil T.; Ghori, Jilur; Gwilliam, Rhian; Hunt, Sarah E.; Keniry, Andrew; McGinnis, Ralph; Nica, Alexandra C.; Potter, Simon; Soranzo, Nicole; Deloukas, Panos; Barroso, Ines] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Freathy, Rachel M.; Hattersley, Andrew T.; Weedon, Michael N.; Frayling, Timothy M.] Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX1 2LU, Devon, England; [Freathy, Rachel M.; Hattersley, Andrew T.; Weedon, Michael N.; Frayling, Timothy M.] Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England; [Attwood, Antony P.; Jolley, Jennifer D. M.; Ouwehand, Willem H.] Univ Cambridge, Dept Haematol, Cambridge, England; [Attwood, Antony P.; Jolley, Jennifer D. M.; Ouwehand, Willem H.] Cambridge Ctr, NHS Blood & Transplant, Cambridge, England; [Beckmann, Jacques S.; Bergmann, Sven; Johnson, Toby] Univ Lausanne, Dept Med Genet, CH-1011 Lausanne, Switzerland; [Beckmann, Jacques S.] CHU Vaudois, Serv Med Genet, CH-1011 Lausanne, Switzerland; [Berndt, Sonja I.] NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Bethesda, MD 20892 USA; [Bergmann, Sven; Johnson, Toby] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Bingham, Sheila A.] MRC, Dunn Human Nutr Unit, Cambridge CB2 0XY, England; [Bochud, Murielle; Johnson, Toby] CHU Vaudois, Univ Inst Social & Prevent Med, CH-1011 Lausanne, Switzerland; [Brown, Morris] Univ Cambridge, Clin Pharmacol Unit, Addenbrookes Hosp, Cambridge, England; [Cauchi, Stephane; Dina, Christian; Froguel, Philippe; Meyre, David] Inst Pasteur, CNRS, Inst Biol 8090, F-5900 Lille, France; [Connell, John M.] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland; [Cooper, Cyrus; Day, Ian; Syddall, Holly E.] Univ Southampton, MRC, Epidemiol Resource Ctr, Southampton SO16 6YD, Hants, England; [Smith, George Davey; Evans, David M.; Timpson, Nicholas J.] Univ Bristol, MRC, Ctr Causal Analyses Translat Epidemiol, Bristol BS8 2PR, Avon, England; [De, Subhajyoti; Teichmann, Sarah A.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Doney, Alex S. F.; Morris, Andrew D.] Univ Dundee, Ninewells Hosp & Med Sch, Diabet Res Grp, Div Med & Therapeut, Dundee DD1 9SY, Scotland; [Elliott, Paul; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Elliott, Paul] Univ Oulu, Dept Publ Hlth Sci & Gen Practice, FIN-90014 Oulu, Finland; [Farooqi, I. Sadaf; O'Rahilly, Stephen; Wraight, Vicki L.] Univ Cambridge, Metab Res Labs, Cambridge CB2 0QQ, England; [Froguel, Philippe] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London W12 0NN, England; [Hadley, David; Papadakis, Konstantinos; Strachan, David P.] St Georges Univ London, Div Community Hlth Sci, London SW17 0RE, England; [Hall, Alistair S.] Univ Leeds, LIGHT Res Inst, Fac Med & Hlth, Leeds LS2 9JT, W Yorkshire, England; [Hebebrand, Johannes; Hinney, Anke; Vogel, Carla I. Ganz] Univ Duisburg Essen, Dept Child & Adolescent Psychiat, D-45147 Essen, Germany; [Heid, Iris M.] GSF, Inst Epidemiol, D-85764 Neuherberg, Germany; [Heid, Iris M.] Univ Munich, IBE Chair Epidemiol, D-81377 Munich, Germany; [Jarvelin, Marjo-Riitta; Pouta, Anneli] Natl Publ Hlth Inst, Dept Child & Adolescent Hlth, Oulu 90221, Finland; [Khaw, Kay-Tee; Luben, Robert N.; Sandhu, Manjinder S.] Univ Cambridge, Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England; [Mangino, Massimo; Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Glenfield Hosp, Leicester LE3 9QP, Leics, England; [Marchini, Jonathan] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [McArdle, Wendy L.; Ring, Susan M.] Univ Bristol, Dept Social Med, Bristol BS8 2PR, Avon, England; [Munroe, Patricia B.; Wallace, Chris; Caulfield, Mark J.] Barts & London Queen Marys Sch Med & Dent, Barts & London Genome Ctr, William Harvey Res Inst, London EC1M 6BQ, England; [Ness, Andrew R.] Univ Bristol, Dept Oral & Dent Sci, Bristol Dent Sch, Bristol BS1 2LY, Avon, England; [Palmer, Colin N. A.] Univ Dundee, Ninewells Hosp & Med Sch, Populat Pharmacogenet Grp, Dundee DD1 9SY, Scotland; [Pouta, Anneli] Univ Hosp, Dept Obstet & Gynaecol, Oulu 90221, Finland; [Qi, Lu] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Scherag, Andre] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, D-45122 Essen, Germany; [Song, Kijoung; Waterworth, Dawn M.; Yuan, Xin; Mooser, Vincent] Med Genet Clin Pharmacol & Discovery Med, King Of Prussia, PA 19406 USA; [Speliotes, Elizabeth K.] Massachusetts Gen Hosp, Dept Gastroenterol, Boston, MA 02114 USA; [Speliotes, Elizabeth K.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Speliotes, Elizabeth K.; Hirschhorn, Joel N.] MIT, Broad Inst, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Tobias, Jonathan H.] Univ Bristol, Bristol BS2 8AE, Avon, England; [Uda, Manuela] CNR, Ist Neurogenet & Neurofarmacol, I-09100 Cagliari, Italy; [Willer, Cristen J.] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Willer, Cristen J.] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Hirschhorn, Joel N.] Childrens Hosp, Div Genet, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Hirschhorn, Joel N.] Childrens Hosp, Div Endocrinol, Boston, MA 02115 USA; [Vollenweider, Peter; Waeber, Gerard] CHU Vaudois, Dept Med & Internal Med, CH-1011 Lausanne, Switzerland; Bioinformed Consulting Serv, Gaithersburg, MD 20877 USA; NCI, Pediat Oncol Branch, Ctr Canc Res, NIH,DHHS, Bethesda, MD 20892 USA; GSF, Inst Human Genet, D-85764 Neuherberg, Germany; Tech Univ Munich, Inst Human Genet, D-81671 Munich, Germany; Harvard Univ, Sch Publ Hlth, Program Mol & Genet Epidemiol, Boston, MA 02115 USA; Brigham & Womens Hosp, Dept Med, Channing Lab, Boston, MA 02115 USA; Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; Lund Univ, Malmo Univ Hosp, Dept Clin Sci, Diabet & Endocrinol Res Unit, S-20502 Malmo, Sweden; Univ Helsinki, Dept Med, Helsinki Univ Hosp, Helsinki 00029, Finland; Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; NIA, Gerontol Res Ctr, Baltimore, MD 21244 USA; Natl Publ Hlth Inst, Diabet Unit, Dept Epidemiol & Hlth Promot, SF-00300 Helsinki, Finland; Univ Helsinki, Dept Publ Hlth, FIN-00014 Helsinki, Finland; S Ostrobothnia Cent Hosp, Seinajoki 60220, Finland; NHGRI, Genome Technol Branch, Bethesda, MD 20892 USA; Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA	University of Oxford; Wellcome Centre for Human Genetics; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Oxford; Wellcome Trust Sanger Institute; University of Exeter; University of Exeter; University of Cambridge; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Swiss Institute of Bioinformatics; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); MRC Human Nutrition Research; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; University of Glasgow; University of Southampton; University of Bristol; MRC Laboratory Molecular Biology; University of Dundee; Imperial College London; University of Oulu; University of Cambridge; Imperial College London; St Georges University London; University of Leeds; University of Duisburg Essen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Finland National Institute for Health & Welfare; University of Cambridge; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Oxford; University of Bristol; University of London; Queen Mary University London; University of Bristol; University of Dundee; Harvard University; Harvard T.H. Chan School of Public Health; University of Duisburg Essen; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard Medical School; University of Bristol; Consiglio Nazionale delle Ricerche (CNR); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Lund University; Skane University Hospital; University of Helsinki; Helsinki University Central Hospital; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Finland National Institute for Health & Welfare; University of Helsinki; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of North Carolina; University of North Carolina Chapel Hill	McCarthy, MI (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	mark.mccarthy@drl.ox.ac.uk; nick.wareham@mrc-epid.cam.ac.uk; ib1@sanger.ac.uk	Marchini, Jonathan/ABE-9024-2020; Timpson, Nicholas John/O-7548-2015; Brown, Matthew A/E-5749-2010; Palmer, Colin NA/C-7053-2008; Davey Smith, George/A-7407-2013; Farooqi, Ismaa Sadaf/AAZ-3046-2020; Morris, Andrew D/C-2837-2009; HILL, Adrian V>S>/C-1306-2008; FROGUEL, Philippe/O-6799-2017; Prokopenko, Inga/H-3241-2014; Fox, Laura J/C-6249-2016; Vogel, Carla Ivane/X-3419-2019; Dermitzakis, Emmanouil/B-7687-2013; sanna, serena/H-3009-2019; Meitinger, Thomas/O-1318-2015; Scherag, Andre/B-3805-2014; Colaus, PsyColaus/K-6607-2013; Khaw, Kay-Tee/AAZ-3209-2021; O'Rahilly, Stephen/ABF-6509-2020; Hall, Alistair/K-1953-2019; Doney, Alexander SF/P-7437-2017; Attrill, Lauren/V-1688-2018; Loos, Ruth J F/Q-2862-2016; Study, GoDARTS/K-9448-2016; Meyre, David/D-7315-2011; Dominiczak, Anna F/P-9390-2017; Hadley, David/I-6902-2012; Burton, Paul R/H-7527-2016; Li, Shengxu/D-8915-2012; Abecasis, Goncalo R/B-7840-2010; Genetic Epidemiology, Innsbruck Med.Univ./C-2095-2008; Yuldasheva, Dr. Nadira Yusupovna/GXM-9013-2022; Berndt, Sonja I/J-8423-2016; Bochud, Murielle/A-3981-2010; Hinney, Anke/D-6953-2011; Loos, Ruth/GON-5877-2022; Luben, Robert N/H-5519-2015; Berryman, Katie/J-4236-2014; Evans, David M/H-6325-2013; Beckmann, Jacques S/A-9772-2008; Dina, Christian R/D-3535-2015; Ness, Andy R/M-7612-2013; Prokopenko, Inga/AAU-9895-2020; Uda, Manuela/AAC-2645-2019; eyre, stephen/K-3776-2017; Tobias, Jon/E-2832-2014; Mangino, Massimo/F-5134-2011; Deloukas, Panos/B-2922-2013; McCarthy, Mark/M-3763-2015	Marchini, Jonathan/0000-0003-0610-8322; Timpson, Nicholas John/0000-0002-7141-9189; Brown, Matthew A/0000-0003-0538-8211; Palmer, Colin NA/0000-0002-6415-6560; Davey Smith, George/0000-0002-1407-8314; FROGUEL, Philippe/0000-0003-2972-0784; Prokopenko, Inga/0000-0003-1624-7457; sanna, serena/0000-0002-3768-1749; O'Rahilly, Stephen/0000-0003-2199-4449; Doney, Alexander SF/0000-0002-6210-5620; Loos, Ruth J F/0000-0002-8532-5087; Meyre, David/0000-0003-4850-7444; Dominiczak, Anna F/0000-0003-4913-3608; Yuldasheva, Dr. Nadira Yusupovna/0000-0001-6213-6358; Bochud, Murielle/0000-0002-5727-0218; Hinney, Anke/0000-0001-5659-0706; Luben, Robert N/0000-0002-5088-6343; Evans, David M/0000-0003-0663-4621; Beckmann, Jacques S/0000-0002-9741-1900; Dina, Christian R/0000-0002-7722-7348; Ness, Andy R/0000-0003-3548-9523; Uda, Manuela/0000-0002-4890-6456; eyre, stephen/0000-0002-1251-6974; Tobias, Jon/0000-0002-7475-3932; Mangino, Massimo/0000-0002-2167-7470; Deloukas, Panos/0000-0001-9251-070X; Hattersley, Andrew/0000-0001-5620-473X; McGinnis, Ralph/0000-0003-4540-9857; Vogel, Carla/0000-0003-1715-2556; Cooper, Cyrus/0000-0003-3510-0709; Abecasis, Goncalo/0000-0003-1509-1825; Inouye, Michael/0000-0001-9413-6520; Freathy, Rachel/0000-0003-4152-2238; Lango Allen, Hana/0000-0002-7803-8688; Jacobs, Kevin/0000-0002-4657-6473; Meitinger, Thomas/0000-0002-8838-8403; Caulfield, Mark/0000-0001-9295-3594; Barroso, Ines/0000-0001-5800-4520; s, hema/0000-0002-3440-9475; Hall, Alistair/0000-0003-0306-7887; Wallace, Chris/0000-0001-9755-1703; Bergmann, Sven/0000-0002-6785-9034; Willer, Cristen/0000-0001-5645-4966; Farooqi, Sadaf/0000-0001-7609-3504; Wheeler, Eleanor/0000-0002-8616-6444; Munroe, Patricia/0000-0002-4176-2947; Zeggini, Eleftheria/0000-0003-4238-659X; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; bennett, amanda/0000-0003-2140-8710; Voight, Benjamin/0000-0002-6205-9994; Parkes, Miles/0000-0002-6467-0631; Lindgren, Cecilia/0000-0002-4903-9374; Forbes, Alastair/0000-0001-7416-9843; Gieger, Christian/0000-0001-6986-9554; McCarthy, Mark/0000-0002-4393-0510; Johnson, Toby/0000-0002-5998-3270; Dunger, Professor David/0000-0002-2566-9304; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Hayes, Richard/0000-0002-0918-661X; Karpe, Fredrik/0000-0002-2751-1770; Randall, Joshua/0000-0003-1540-203X; Teichmann, Sarah/0000-0002-6294-6366; Soranzo, Nicole/0000-0003-1095-3852; Lees, Charlie/0000-0002-0732-8215; Hunt, Sarah/0000-0002-8350-1235; Waeber, Gerard/0000-0003-4193-788X; Weedon, Michael/0000-0002-6174-6135; Scherag, Andre/0000-0002-9406-4704	Medical Research Council [MC_qA137934, U1475000001] Funding Source: researchfish; National Institute for Health Research [DHCS/07/07/008] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK079466, P30DK040561, K23DK080145, R01DK072193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000675] Funding Source: NIH RePORTER; MRC [MC_U105630924, MC_U105161047, G0600705, G0000934, G0601261, G9824984, G0600331, MC_U106179472, G9828345, G9521010, G0701863, MC_qA137934, G0400874, MC_U106188470] Funding Source: UKRI; British Heart Foundation Funding Source: Medline; Cancer Research UK Funding Source: Medline; Medical Research Council [G9521010, MC_U105630924, MC_U147585824, G0600331, G0000934(68341), G9824984, G0000934, G0701863, G9521010(63660), MC_QA137934, G0400874, G0601261, U.1475.00.002.00001.01 (85824), G0401527, MC_U106188470, G0600705, MC_U106179472, MC_U105161047, MC_UP_A620_1014, G9828345] Funding Source: Medline; NIDDK NIH HHS [R01 DK072193, F32 DK079466-01, P30 DK040561, P30 DK040561-13, F32 DK079466, K23 DK080145-01, K23 DK080145] Funding Source: Medline; Wellcome Trust [076113, 068545, 077016, 084713, 090532, 079557] Funding Source: Medline; Department of Health [DHCS/07/07/008] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome Trust); Department of Health		Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Day N, 1999, BRIT J CANCER, V80, P95; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dixon AL, 2007, NAT GENET, V39, P1202, DOI 10.1038/ng2109; Farooqi IS, 2000, J CLIN INVEST, V106, P271, DOI 10.1172/JCI9397; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Geller F, 2004, AM J HUM GENET, V74, P572, DOI 10.1086/382490; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Kim JY, 2004, J EXP MED, V199, P113, DOI 10.1084/jem.20030613; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stutzmann F, 2007, HUM MOL GENET, V16, P1837, DOI 10.1093/hmg/ddm132; Sutton AJAK, 2000, METHODS METAANALYSIS; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Vollenweider P, 2006, Rev Med Suisse, V2, P2528; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404; Young EH, 2007, INT J OBESITY, V31, P1437, DOI 10.1038/sj.ijo.0803609; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	30	970	1016	1	142	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2008	40	6					768	775		10.1038/ng.140	http://dx.doi.org/10.1038/ng.140			8	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	305XV	18454148	Green Accepted, Green Published			2022-12-27	WOS:000256212000019
J	Krishnan, KJ; Reeve, AK; Samuels, DC; Chinnery, PF; Blackwood, JK; Taylor, RW; Wanrooij, S; Spelbrink, JN; Lightowlers, RN; Turnbull, DM				Krishnan, Kim J.; Reeve, Amy K.; Samuels, David C.; Chinnery, Patrick F.; Blackwood, John K.; Taylor, Robert W.; Wanrooij, Sjoerd; Spelbrink, Johannes N.; Lightowlers, Robert N.; Turnbull, Doug M.			What causes mitochondrial DNA deletions in human cells?	NATURE GENETICS			English	Article							AICARDI-GOUTIERES-SYNDROME; SUBSTANTIA-NIGRA NEURONS; DOUBLE-STRAND BREAKS; EXTERNAL OPHTHALMOPLEGIA; ESCHERICHIA-COLI; COMMON DELETION; MTDNA DELETIONS; LAGGING-STRAND; MUSCLE-FIBERS; HUMAN-DISEASE	Mitochondrial DNA (mtDNA) deletions are a primary cause of mitochondrial disease and are likely to have a central role in the aging of postmitotic tissues. Understanding the mechanism of the formation and subsequent clonal expansion of these mtDNA deletions is an essential first step in trying to prevent their occurrence. We review the previous literature and recent results from our own laboratories, and conclude that mtDNA deletions are most likely to occur during repair of damaged mtDNA rather than during replication. This conclusion has important implications for prevention of mtDNA disease and, potentially, for our understanding of the aging process.	[Krishnan, Kim J.; Reeve, Amy K.; Chinnery, Patrick F.; Blackwood, John K.; Taylor, Robert W.; Lightowlers, Robert N.; Turnbull, Doug M.] Univ Newcastle Upon Tyne, Mitochondrial Res Grp, Sch Med, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; [Krishnan, Kim J.; Turnbull, Doug M.] Univ Newcastle Upon Tyne, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England; [Samuels, David C.] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Blacksburg, VA 24061 USA; [Wanrooij, Sjoerd; Spelbrink, Johannes N.] Inst Med Technol, Tampere 33014, Finland; [Wanrooij, Sjoerd; Spelbrink, Johannes N.] Tampere Univ Hosp, Tampere 33014, Finland; [Wanrooij, Sjoerd] Karolinska Inst, Dept Metab Dis, SE-14186 Huddinge, Sweden	Newcastle University - UK; Newcastle University - UK; Virginia Polytechnic Institute & State University; Tampere University; Tampere University Hospital; Karolinska Institutet	Krishnan, KJ (corresponding author), Univ Newcastle Upon Tyne, Mitochondrial Res Grp, Sch Med, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England.	d.m.turnbull@ncl.ac.uk	Samuels, David/C-1365-2012; Samuels, David C/A-5393-2008; Spelbrink, Johannes N/L-4661-2015; Wanrooij, Sjoerd/J-1367-2019; Samuels, David/AHC-8381-2022	Samuels, David C/0000-0003-3529-7791; Spelbrink, Johannes N/0000-0002-9756-2602; Samuels, David/0000-0003-3529-7791; Chinnery, Patrick/0000-0002-7065-6617; Wanrooij, Sjoerd/0000-0001-6126-4382; Blackwood, John/0000-0003-1511-7562; Reeve, Amy/0000-0002-4474-2204	MRC [G0700718] Funding Source: UKRI; Medical Research Council [G0700718] Funding Source: Medline; Wellcome Trust [074454] Funding Source: Medline; Medical Research Council [G0601943B] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Arai T, 2006, ACTA NEUROPATHOL, V112, P139, DOI 10.1007/s00401-006-0081-9; Barnerias C, 2006, DEV MED CHILD NEUROL, V48, P227, DOI 10.1017/S001216220600048X; Barritt JA, 1999, MOL HUM REPROD, V5, P927, DOI 10.1093/molehr/5.10.927; Bender A, 2006, NAT GENET, V38, P515, DOI 10.1038/ng1769; Berneburg M, 1999, J BIOL CHEM, V274, P15345, DOI 10.1074/jbc.274.22.15345; Blakely EL, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.011296; Bowmaker M, 2003, J BIOL CHEM, V278, P50961, DOI 10.1074/jbc.M308028200; Bua E, 2006, AM J HUM GENET, V79, P469, DOI 10.1086/507132; Chan CCW, 2005, MOL HUM REPROD, V11, P843, DOI 10.1093/molehr/gah243; CHEN X, 1995, AM J HUM GENET, V57, P239; Chinnery PF, 2004, LANCET, V364, P592, DOI 10.1016/S0140-6736(04)16851-7; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; deGrey ADNJ, 1997, BIOESSAYS, V19, P161, DOI 10.1002/bies.950190211; Elson JL, 2001, AM J HUM GENET, V68, P802, DOI 10.1086/318801; Esposito LA, 1999, P NATL ACAD SCI USA, V96, P4820, DOI 10.1073/pnas.96.9.4820; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Haber JE, 2000, TRENDS GENET, V16, P259, DOI 10.1016/S0168-9525(00)02022-9; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; Hanekamp T, 1999, CURR GENET, V34, P438, DOI 10.1007/s002940050418; HOLT IJ, 1988, NATURE, V331, P717, DOI 10.1038/331717a0; Holt IJ, 2000, CELL, V100, P515, DOI 10.1016/S0092-8674(00)80688-1; Horiguchi M, 2001, CANCER RES, V61, P3913; Hudson G, 2006, HUM MOL GENET, V15, pR244, DOI 10.1093/hmg/ddl233; Kraytsberg Y, 2006, NAT GENET, V38, P518, DOI 10.1038/ng1778; Krishnan KJ, 2004, J INVEST DERMATOL, V123, P1020, DOI 10.1111/j.0022-202X.2004.23457.x; Murphy JEJ, 2005, MUTAT RES-GEN TOX EN, V585, P127, DOI 10.1016/j.mrgentox.2005.04.011; Nguyen LH, 2000, J BIOL CHEM, V275, P25900, DOI 10.1074/jbc.M002672200; Prithivirajsingh S, 2004, FEBS LETT, V571, P227, DOI 10.1016/j.febslet.2004.06.078; Reeve AK, 2008, AM J HUM GENET, V82, P228, DOI 10.1016/j.ajhg.2007.09.018; ROBBERSO.DL, 1972, P NATL ACAD SCI USA, V69, P3810, DOI 10.1073/pnas.69.12.3810; Samuels DC, 2004, TRENDS GENET, V20, P393, DOI 10.1016/j.tig.2004.07.003; SARGENTINI NJ, 1992, MUTAT RES, V265, P83, DOI 10.1016/0027-5107(92)90041-Y; Schaefer AM, 2008, ANN NEUROL, V63, P35, DOI 10.1002/ana.21217; SCIACCO M, 1994, HUM MOL GENET, V3, P13, DOI 10.1093/hmg/3.1.13; SHOFFNER JM, 1989, P NATL ACAD SCI USA, V86, P7952, DOI 10.1073/pnas.86.20.7952; Srivastava S, 2005, HUM MOL GENET, V14, P893, DOI 10.1093/hmg/ddi082; Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435; Taylor RW, 2005, NAT REV GENET, V6, P389, DOI 10.1038/nrg1606; THACKER J, 1992, NUCLEIC ACIDS RES, V20, P6183, DOI 10.1093/nar/20.23.6183; VanGoethem G, 1997, EUR J NEUROL, V4, P476; WALLACE DC, 1988, CELL, V55, P601, DOI 10.1016/0092-8674(88)90218-8; WALLACE DC, 1992, SCIENCE, V256, P628, DOI 10.1126/science.1533953; Wang GJ, 1997, BIOCHEM PHARMACOL, V54, P181, DOI 10.1016/S0006-2952(97)00158-5; Wanrooij S, 2004, NUCLEIC ACIDS RES, V32, P3053, DOI 10.1093/nar/gkh634; Wanrooij S, 2007, NUCLEIC ACIDS RES, V35, P3238, DOI 10.1093/nar/gkm215; Yang MY, 2002, CELL, V111, P495, DOI 10.1016/S0092-8674(02)01075-9; Yasukawa T, 2006, EMBO J, V25, P5358, DOI 10.1038/sj.emboj.7601392; YONEDA M, 1992, P NATL ACAD SCI USA, V89, P11164, DOI 10.1073/pnas.89.23.11164	48	283	295	0	33	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAR	2008	40	3					275	279		10.1038/ng.f.94	http://dx.doi.org/10.1038/ng.f.94			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	267ZT	18305478				2022-12-27	WOS:000253548400015
J	Visel, A; Prabhakar, S; Akiyama, JA; Shoukry, M; Lewis, KD; Holt, A; Plajzer-Frick, I; Afzal, V; Rubin, EM; Pennacchio, LA				Visel, Axel; Prabhakar, Shyam; Akiyama, Jennifer A.; Shoukry, Malak; Lewis, Keith D.; Holt, Amy; Plajzer-Frick, Ingrid; Afzal, Veena; Rubin, Edward M.; Pennacchio, Len A.			Ultraconservation identifies a small subset of extremely constrained developmental enhancers	NATURE GENETICS			English	Article							CONSERVED NONCODING SEQUENCES; REGULATORY ELEMENTS; VERTEBRATE	Extended perfect human-rodent sequence identity of at least 200 base pairs (ultraconservation) is potentially indicative of evolutionary or functional uniqueness. We used a transgenic mouse assay to compare the embryonic enhancer activity of 231 noncoding ultraconserved human genome regions with that of 206 extremely conserved regions lacking ultraconservation. Developmental enhancers were equally prevalent in both populations, suggesting instead that ultraconservation identifies a small, functionally indistinct subset of similarly constrained cis-regulatory elements.	[Visel, Axel; Prabhakar, Shyam; Akiyama, Jennifer A.; Shoukry, Malak; Lewis, Keith D.; Holt, Amy; Plajzer-Frick, Ingrid; Afzal, Veena; Rubin, Edward M.; Pennacchio, Len A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; [Rubin, Edward M.; Pennacchio, Len A.] US Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Pennacchio, LA (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, MS 84-171, Berkeley, CA 94720 USA.	LAPennacchio@lbl.gov	Visel, Axel/A-9398-2009; Pillay, Nischalan/F-9536-2012	Visel, Axel/0000-0002-4130-7784; Pennacchio, Len/0000-0002-8748-3732	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066681] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003988] Funding Source: NIH RePORTER; NHGRI NIH HHS [R01 HG003988-02, R01 HG003988, HG003988] Funding Source: Medline; NHLBI NIH HHS [HL066681, U01 HL066681] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; de la Calle-Mustienes E, 2005, GENOME RES, V15, P1061, DOI 10.1101/gr.4004805; Derti A, 2006, NAT GENET, V38, P1216, DOI 10.1038/ng1888; Drake JA, 2006, NAT GENET, V38, P223, DOI 10.1038/ng1710; Ghanem N, 2007, J NEUROSCI, V27, P5012, DOI 10.1523/JNEUROSCI.4725-06.2007; Hardison RC, 1997, GENOME RES, V7, P959, DOI 10.1101/gr.7.10.959; Katzman S, 2007, SCIENCE, V317, P915, DOI 10.1126/science.1142430; Paparidis Z, 2007, DEV GROWTH DIFFER, V49, P543, DOI 10.1111/j.1440-169x.2007.00954.x; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Poulin F, 2005, GENOMICS, V85, P774, DOI 10.1016/j.ygeno.2005.03.003; Prabhakar S, 2006, GENOME RES, V16, P855, DOI 10.1101/gr.4717506; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262	15	237	244	2	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2008	40	2					158	160		10.1038/ng.2007.55	http://dx.doi.org/10.1038/ng.2007.55			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	256MJ	18176564	Green Submitted, Green Accepted			2022-12-27	WOS:000252732900013
J	Foss, EJ; Radulovic, D; Shaffer, SA; Ruderfer, DM; Bedalov, A; Goodlett, DR; Kruglyak, L				Foss, Eric J.; Radulovic, Dragan; Shaffer, Scott A.; Ruderfer, Douglas M.; Bedalov, Antonio; Goodlett, David R.; Kruglyak, Leonid			Genetic basis of proteome variation in yeast	NATURE GENETICS			English	Article							TANDEM MASS-SPECTROMETRY; SACCHAROMYCES-CEREVISIAE; LIQUID-CHROMATOGRAPHY; LC-MS; EXPRESSION; TRAITS; MOUSE; POPULATION; ALIGNMENT; DELETION	Proper regulation of protein levels is essential for health, and abnormal levels of proteins are hallmarks of many diseases. A number of studies have recently shown that messenger RNA levels vary among individuals of a species and that genetic linkage analysis can be used to identify quantitative trait loci that influence these levels. By contrast, little is known about the genetic basis of variation in protein levels in genetically diverse populations, in large part because techniques for large-scale measurements of protein abundance lag far behind those for measuring transcript abundance. Here we describe a label-free, mass spectrometry based approach to measuring protein levels in total unfractionated cellular proteins, and we apply this approach to elucidate the genetic basis of variation in protein abundance in a cross between two diverse strains of yeast. Loci that influenced protein abundance differed from those that influenced transcript levels, emphasizing the importance of direct analysis of the proteome.	Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; Florida Atlantic Univ, Boca Raton, FL 33431 USA; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Washington, Seattle, WA 98195 USA	Princeton University; Princeton University; State University System of Florida; Florida Atlantic University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Kruglyak, L (corresponding author), Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA.	leonid@genomics.princeton.edu	Shaffer, Scott A/F-8650-2010; Ruderfer, Douglas M/M-5795-2016	Ruderfer, Douglas M/0000-0002-2365-386X	NCI NIH HHS [CA015704] Funding Source: Medline; NCRR NIH HHS [1S10RR17262-01] Funding Source: Medline; NIAID NIH HHS [1U54 AI57141-01] Funding Source: Medline; NIEHS NIH HHS [P30ES07033] Funding Source: Medline; NIGMS NIH HHS [P50GM071508] Funding Source: Medline; NIMH NIH HHS [R37 MH059520] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA015704] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR017262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH059520] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Ashburner M, 2001, GENOME RES, V11, P1425; Bellew M, 2006, BIOINFORMATICS, V22, P1902, DOI 10.1093/bioinformatics/btl276; Brachmann CB, 1998, YEAST, V14, P115; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; DAMERVAL C, 1994, GENETICS, V137, P289; DeSouza L, 2005, J PROTEOME RES, V4, P377, DOI 10.1021/pr049821j; Domon B, 2006, SCIENCE, V312, P212, DOI 10.1126/science.1124619; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fischer B, 2006, BIOINFORMATICS, V22, pE132, DOI 10.1093/bioinformatics/btl219; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hinnebusch AG, 2002, EUKARYOT CELL, V1, P22, DOI 10.1128/EC.01.1.22-32.2002; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Klose J, 2002, NAT GENET, V30, P385, DOI 10.1038/ng861; LANDER ES, 1989, GENETICS, V121, P185; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Mehrabian M, 2005, NAT GENET, V37, P1224, DOI 10.1038/ng1619; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Radulovic D, 2004, MOL CELL PROTEOMICS, V3, P984, DOI 10.1074/mcp.M400061-MCP200; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Ronald J, 2005, PLOS GENET, V1, P213, DOI 10.1371/journal.pgen.0010025; Ruderfer DM, 2006, NAT GENET, V38, P1077, DOI 10.1038/ng1859; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Wang P, 2007, BIOSTATISTICS, V8, P357, DOI 10.1093/biostatistics/kxl015; Wang WX, 2003, ANAL CHEM, V75, P4818, DOI 10.1021/ac026468x; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222	33	173	176	0	19	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	NOV	2007	39	11					1369	1375		10.1038/ng.2007.22	http://dx.doi.org/10.1038/ng.2007.22			7	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17952072				2022-12-27	WOS:000250575900021
J	Newport, M; Sirugo, G; Lyons, E; Vannberg, F; Hill, AVS; Bradbury, LA; Farrar, C; Pointon, JJ; Wordsworth, P; Brown, MA; Franklyn, JA; Heward, JM; Simmonds, MJ; Gough, SC; Seal, S; Stratton, MR; Rahman, N; Ban, M; Goris, A; Sawcer, SJ; Compston, A; Conway, D; Jallow, M; Newport, M; Sirugo, G; Rockett, KA; Kwiatkowski, DP; Bumpstead, SJ; Chaney, A; Downes, K; Ghori, MJ; Gwilliam, R; Hunt, SE; Inouye, M; Keniry, A; King, E; McGinnis, R; Potter, S; Ravindrarajah, R; Whittaker, P; Widden, C; Withers, D; Deloukas, P; Leung, HT; Nutland, S; Stevens, HE; Walker, NM; Todd, JA; Easton, D; Clayton, DG; Burton, PR; Tobin, MD; Barrett, JC; Evans, DM; Morris, AP; Cardon, LR; Cardin, NJ; Davison, D; Ferreira, T; Pereira-Gale, J; Hallgrimsdottir, IB; Howie, BN; Marchini, JL; Spencer, CC; Su, Z; Teo, YY; Vukcevic, D; Donnelly, P; Bentley, D; Brown, MA; Cardon, LR; Caulfield, M; Clayton, DG; Compston, A; Craddock, N; Deloukas, P; Donnelly, P; Farrall, M; Barton, A; Bruce, IN; Donovan, H; Eyre, S; Gilbert, PD; Hilder, SL; Hinks, AM; John, SL; Potter, C; Silman, AJ; Symmons, DPM; Thomson, W; Worthington, J; Gough, SC; Hall, AS; Hattersley, AT; Hill, AVS; Kwiatkowski, DP; Matthew, CG; McCarthy, MI; Ouwehand, WH; Parkes, M; Pembrey, M; Rahman, N; Samani, NJ; Stratton, MR; Todd, JA; Worthington, J; Mitchell, SL; Newby, PR; Brand, OJ; Carr-Smith, J; Pearce, SHS; Gough, SCL; McGinnis, R; Keniry, A; Deloukas, P; Reveille, JD; Zhou, X; Bradbury, LA; Sims, AM; Dowling, A; Taylor, J; Doan, T; Cardon, LR; Davis, JC; Pointon, JJ; Savage, L; Ward, MM; Learch, TL; Weisman, MH; Wordsworth, P; Brown, MA				Newport, Melanie; Sirugo, Giorgio; Lyons, Emily; Vannberg, Fredrik; Hill, Adrian V. S.; Bradbury, Linda A.; Farrar, Claire; Pointon, Jennifer J.; Wordsworth, Paul; Brown, Matthew A.; Franklyn, Jayne A.; Heward, Joanne M.; Simmonds, Matthew J.; Gough, Stephen C. L.; Seal, Sheila; Stratton, Michael R.; Rahman, Nazneen; Ban, Maria; Goris, An; Sawcer, Stephen J.; Compston, Alastair; Conway, David; Jallow, Muminatou; Newport, Melanie; Sirugo, Giorgio; Rockett, Kirk A.; Kwiatkowski, Dominic P.; Bumpstead, Suzannah J.; Chaney, Amy; Downes, Kate; Ghori, Mohammed J. R.; Gwilliam, Rhian; Hunt, Sarah E.; Inouye, Michael; Keniry, Andrew; King, Emma; McGinnis, Ralph; Potter, Simon; Ravindrarajah, Rathi; Whittaker, Pamela; Widden, Claire; Withers, David; Deloukas, Panos; Leung, Hin-Tak; Nutland, Sarah; Stevens, Helen E.; Walker, Neil M.; Todd, John A.; Easton, Doug; Clayton, David G.; Burton, Paul R.; Tobin, Martin D.; Barrett, Jeffrey C.; Evans, David M.; Morris, Andrew P.; Cardon, Lon R.; Cardin, Niall J.; Davison, Dan; Ferreira, Teresa; Pereira-Gale, Joanne; Hallgrimsdottir, Ingeleif B.; Howie, Bryan N.; Marchini, Jonathan L.; Spencer, Chris C. A.; Su, Zhan; Teo, Yik Ying; Vukcevic, Damjan; Donnelly, Peter; Bentley, David; Brown, Matthew A.; Cardon, Lon R.; Caulfield, Mark; Clayton, David G.; Compston, Alastair; Craddock, Nick; Deloukas, Panos; Donnelly, Peter; Farrall, Martin; Barton, Anne; Bruce, Ian N.; Donovan, Hannah; Eyre, Steve; Gilbert, Paul D.; Hilder, Samantha L.; Hinks, Anne M.; John, Sally L.; Potter, Catherine; Silman, Alan J.; Symmons, Deborah P. M.; Thomson, Wendy; Worthington, Jane; Gough, Stephen C. L.; Hall, Alistair S.; Hattersley, Andrew T.; Hill, Adrian V. S.; Kwiatkowski, Dominic P.; Matthew, Christopher G.; McCarthy, Mark I.; Ouwehand, Willem H.; Parkes, Miles; Pembrey, Marcus; Rahman, Nazneen; Samani, Nilesh J.; Stratton, Michael R.; Todd, John A.; Worthington, Jane; Mitchell, Sarah L.; Newby, Paul R.; Brand, Oliver J.; Carr-Smith, Jackie; Pearce, Simon H. S.; Gough, Stephen C. L.; McGinnis, R.; Keniry, A.; Deloukas, P.; Reveille, John D.; Zhou, Xiaodong; Bradbury, Linda A.; Sims, Anne-Marie; Dowling, Alison; Taylor, Jacqueline; Doan, Tracy; Cardon, Lon R.; Davis, John C.; Pointon, Jennifer J.; Savage, Laurie; Ward, Michael M.; Learch, Thomas L.; Weisman, Michael H.; Wordsworth, Paul; Brown, Matthew A.			Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants	NATURE GENETICS			English	Article							GENOME-WIDE ASSOCIATION; CROHN-DISEASE; POPULATION-STRUCTURE; SUSCEPTIBILITY; AMINOPEPTIDASE; RISK; RECEPTOR; LOCUS; GENE; EXPRESSION	We have genotyped 14,436 nonsynonymous SNPs (nsSNPs) and 897 major histocompatibility complex (MHC) tag SNPs from 1,000 independent cases of ankylosing spondylitis ( AS), autoimmune thyroid disease (AITD), multiple sclerosis ( MS) and breast cancer ( BC). Comparing these data against a common control dataset derived from 1,500 randomly selected healthy British individuals, we report initial association and independent replication in a North American sample of two new loci related to ankylosing spondylitis, ARTS1 and IL23R, and confirmation of the previously reported association of AITD with TSHR and FCRL3. These findings, enabled in part by increased statistical power resulting from the expansion of the control reference group to include individuals from the other disease groups, highlight notable new possibilities for autoimmune regulation and suggest that IL23R may be a common susceptibility factor for the major `seronegative' diseases.	Univ Leicester, Dept Hlth Sci, Genet Epidemiol Grp, Leicester LE1 7RH, Leics, England; Univ Cambridge, Cambridge Inst Med Res, Dept Med Genet, Juvenile Diabet Res Fdn Wellcome Trust Diabet & I, Cambridge CB2 0XY, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Cardiff Univ, Sch Med, Dept Psychol Med, Cardiff CF14 4XN, Wales; Wellcome Trust Res Labs, London NW1 2BE, England; Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Med, Oxford OX3 7LJ, England; Univ Cambridge, Dept Haematol, Cambridge CB2 2PT, England; Cambridge Ctr, Natl Hlth Serv Blood & Transplant, Cambridge CB2 2PT, England; Univ Leicester, Dept Cardiovasc Sci, Glenfield Hosp, Leicester LE3 9QP, Leics, England; Univ Oxford, Dept Stat, Oxford OX1 3TG, England; Strangeways Res Lab, Canc Res UK Genet Epidemiol Unit, Cambridge CB1 8RN, England; Natl Hlth Serv Blood & Transplant, Sheffield Ctr, Sheffield S5 7JN, S Yorkshire, England; Natl Hlth Serv Blood & Transplant, Brentwood Ctr, Brentwood CM15 8DP, Essex, England; Scottish Natl Blood Transfus Serv, Edinburgh CB17 7QT, Midlothian, Scotland; Natl Hlth Serv Blood & Transplant, Southampton Ctr, Southampton SO16 5AF, Hants, England; Univ Bristol, Avon Longitudinal Study Parents & Children, Bristol BS8 1TQ, Avon, England; St Georges Univ London, Div Community Hlth Serv, London SW17 0RE, England; UCL, Inst Child Hlth, London WC1N 1EH, England; Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland; Univ Birmingham, Div Neurosci, Dept Psychiat, Birmingham B15 2QZ, W Midlands, England; Cardiff Univ, Sch Med, Dept Med Psychol, Cardiff CF14 4XN, Wales; Kings Coll London, Inst Psychiat, SGDP, London SE5 8AF, England; Royal Victoria Infirm, Sch Neurol Neurobiol & Psychiat, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Univ Leeds, Fac Med & Hlth, LIGHT & LIMM Res Inst, Leeds LS1 3EX, W Yorkshire, England; Univ Cambridge, Addenbrookes Hosp, IBD Res Grp, Cambridge CB2 2QQ, England; Univ Edinburgh, Western Gen Hosp, Sch Mol & Clin Med, Gastrointestinal Unit, Edinburgh EH4 2XU, Midlothian, Scotland; Kings Coll London, Sch Med, Guys Hosp, Dept Med & Mol Genet, London SE1 9RT, England; UCL, Hosp Trust, Inst Digest Dis, London NW1 2BU, England; Guys & St Thomas NHS Fdn Trust, Dept Gastroenterol, London SE1 7EH, England; Newcastle Univ, Royal Victoria Infirm, Dept Gastroenterol & Hepatol, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England; Univ Oxford, Radcliffe Infirm, Gastroenterol Unit, Oxford OX2 6HE, England; Aberdeen Royal Infirm, Aberdeen AB9 2ZB, Scotland; Univ Cambridge, Addenbrookes Hosp, Clin Pharmacol Unit, Cambridge CB2 2QQ, England; Univ Cambridge, Addenbrookes Hosp, Diabet & Inflammat Lab, Cambridge CB2 2QQ, England; Ctr Natl Genotypage, F-91057 Paris, France; Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Glasgow G12 8TA, Lanark, Scotland; Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, Clin Pharmacol & Barts & London Genome Ctr, London EC1M 6BQ, England; Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Manchester, Arc Epidemiol Res Unit, Manchester M13 9PT, Lancs, England; Univ Cambridge, Addenbrookes Hosp, Dept Paediat, Cambridge CB2 2QQ, England; Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX1 2LU, Devon, England; Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5DU, Devon, England; Barts & London Royal London Hosp, Ctr Diabet & Metab Med, London E1 1BB, England; Univ Newcastle, Sch Clin Med Sci, Diabet Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; Univ Bristol, MRC Ctr Causal Anal Translat Epidemiol, Bristol BS2 8PR, Avon, England; MRC Labs, Fajara, Gambia; Univ Queensland, Princess Alexandra Hosp, Diamantina Inst Canc Immunol & Metab Med, Woolloongabba, Qld 4102, Australia; Univ Oxford, Botnar Res Ctr, Oxford OX3 7BN, England; Univ Birmingham, Biomed Res Inst, Div Med Sci, Dept Med, Birmingham B15 2TT, W Midlands, England; Inst Canc Res, Sect Canc Genet, Sutton SM2 5NG, Surrey, England; Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England; Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; Illumina Cambridge, Saffron Walden CB10 1XL, Essex, England; Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Newcastle, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; Univ Texas, Houston Med Sch, Houston, TX 77030 USA; Univ Queensland, Diamantina Inst Canc Immunol & Metab Med, St Lucia, Qld 4072, Australia; Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; Univ Calif San Francisco, Dept Rheumatol, San Francisco, CA 94143 USA; Spondylitis Assoc Amer, Sherman Oaks, CA 91403 USA; Univ Oxford, Botnar Res Ctr, Oxford OX3 7BN, England; NIAMSD, Natl Inst Hlth, Bethesda, MD 20892 USA; Cedars Sinai Med Ctr, Dept Radiol, Los Angeles, CA 90048 USA; Cedars Sinai Med Ctr, Dept Rheumatol Med, Los Angeles, CA 90048 USA	University of Leicester; University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics; Cardiff University; Wellcome Trust Sanger Institute; University of Oxford; University of Cambridge; NHS Blood & Transplant (NHSBT); University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Oxford; Cancer Research UK; University of Cambridge; NHS Blood & Transplant (NHSBT); NHS Blood & Transplant (NHSBT); NHS Blood & Transplant (NHSBT); University of Southampton; University of Bristol; St Georges University London; University of London; University College London; University of Aberdeen; University of Birmingham; Cardiff University; University of London; King's College London; Newcastle University - UK; University of Leeds; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Edinburgh; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; Newcastle University - UK; Radcliffe Infirmary; University of Oxford; University of Aberdeen; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; CEA; University of Glasgow; University of London; Queen Mary University London; University of Oxford; Wellcome Centre for Human Genetics; University of Manchester; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Exeter; University of Exeter; Barts Health NHS Trust; Royal London Hospital; Newcastle University - UK; University of Bristol; MRC Laboratory Molecular Biology; University of Queensland; University of Oxford; University of Birmingham; University of London; Institute of Cancer Research - UK; University of Cambridge; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Illumina; Fred Hutchinson Cancer Center; Newcastle University - UK; University of Texas System; University of Texas Health Science Center Houston; University of Queensland; University of Oxford; Wellcome Centre for Human Genetics; University of California System; University of California San Francisco; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Cedars Sinai Medical Center; Cedars Sinai Medical Center	Newport, M (corresponding author), Univ Leicester, Dept Hlth Sci, Genet Epidemiol Grp, Adrian Bldg,Univ Rd, Leicester LE1 7RH, Leics, England.		Marchini, Jonathan/ABE-9024-2020; Breen, Gerome D/A-5540-2010; Prescott, Natalie J/F-6490-2011; eyre, stephen/K-3776-2017; Burton, Paul R/H-7527-2016; Dowling, Alison/AAW-3631-2021; Hinks, Anne/E-1853-2015; Hall, Alistair/K-1953-2019; Timpson, Nicholas John/O-7548-2015; Dominiczak, Anna F/D-2262-2009; Newhouse, Stephen J/C-9330-2011; Fox, Laura J/C-6249-2016; Barton, Anne/N-2053-2014; Brown, Matthew A/E-5749-2010; Worthington, Jane/M-9770-2014; Todd, John A/A-3542-2010; Yuldasheva, Dr. Nadira Yusupovna/GXM-9013-2022; Goris, An/L-5852-2019; Sirugo, Giorgio/L-1628-2016; Collier, David A/D-1649-2011; Goris, An/F-2943-2010; Sirugo, Giorgio/N-9056-2019; Breen, Gerome/Y-2706-2019; HILL, Adrian V>S>/C-1306-2008; Attrill, Lauren/V-1688-2018; O'Donovan, Michael C/P-7005-2018; Evans, David M/H-6325-2013; Pearce, Simon/AAB-3692-2019; Deloukas, Panos/B-2922-2013; Rahman, Nazneen/B-8890-2012; Dominiczak, Anna F/P-9390-2017; Lewis, Cathryn/A-5225-2010; dobson, richard/C-9269-2011; McCarthy, Mark/M-3763-2015; Rahman, Nazneen/D-2802-2013	Marchini, Jonathan/0000-0003-0610-8322; Breen, Gerome D/0000-0003-2053-1792; Prescott, Natalie J/0000-0002-5901-7371; eyre, stephen/0000-0002-1251-6974; Hinks, Anne/0000-0001-8843-3967; Timpson, Nicholas John/0000-0002-7141-9189; Newhouse, Stephen J/0000-0002-1843-9842; Barton, Anne/0000-0003-3316-2527; Brown, Matthew A/0000-0003-0538-8211; Worthington, Jane/0000-0003-0544-042X; Todd, John A/0000-0003-2740-8148; Yuldasheva, Dr. Nadira Yusupovna/0000-0001-6213-6358; Goris, An/0000-0002-1276-6682; Collier, David A/0000-0003-4087-1559; Goris, An/0000-0002-1276-6682; Breen, Gerome/0000-0003-2053-1792; O'Donovan, Michael C/0000-0001-7073-2379; Evans, David M/0000-0003-0663-4621; Pearce, Simon/0000-0001-8384-8063; Deloukas, Panos/0000-0001-9251-070X; Dominiczak, Anna F/0000-0003-4913-3608; Kirov, George/0000-0002-3427-3950; Donnelly, Peter/0000-0001-9495-3408; Newport, Melanie/0000-0002-8946-7525; Munroe, Patricia/0000-0002-4176-2947; s, hema/0000-0002-3440-9475; Forbes, Alastair/0000-0001-7416-9843; Burke, Beverley/0000-0002-4164-297X; Hattersley, Andrew/0000-0001-5620-473X; Hunt, Sarah/0000-0002-8350-1235; Simmonds, Matt/0000-0003-3154-3510; Tobin, Martin/0000-0002-3596-7874; Cummings, Fraser/0000-0002-9659-3247; Lindgren, Cecilia/0000-0002-4903-9374; Caulfield, Mark/0000-0001-9295-3594; Dunger, Professor David/0000-0002-2566-9304; Weedon, Michael/0000-0002-6174-6135; Potter, Simon/0000-0003-4208-4102; Lewis, Cathryn/0000-0002-8249-8476; Zeggini, Eleftheria/0000-0003-4238-659X; Inouye, Michael/0000-0001-9413-6520; Symmons, Deborah/0000-0002-8625-1200; Thomson, Wendy/0000-0002-9022-5179; dobson, richard/0000-0003-4224-9245; Evans, Gareth/0000-0002-8482-5784; McCarthy, Mark/0000-0002-4393-0510; Jones, Lisa/0000-0002-5122-8334; Lees, Charlie/0000-0002-0732-8215; Wallace, Chris/0000-0001-9755-1703; Parkes, Miles/0000-0002-6467-0631; Grozeva, Detelina/0000-0003-3239-8415; Bishop, Tim/0000-0002-8752-8785; Hall, Alistair/0000-0003-0306-7887; Lango Allen, Hana/0000-0002-7803-8688; King, Emma/0000-0003-3611-9647; Walker, Neil/0000-0001-9796-7688; Kwiatkowski, Dominic/0000-0002-5023-0176; Bruce, Ian/0000-0003-3047-500X; Rahman, Nazneen/0000-0003-4376-0440	MRC [G0501942, G0000934, G19/9, G9810900, G0600329, G90/106, G0600705] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000425, UL1RR024148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048465, R01AR046208] Funding Source: NIH RePORTER; Arthritis Research UK [17552] Funding Source: Medline; Cancer Research UK [A4994] Funding Source: Medline; Medical Research Council [G0600705, G9810900, G0800759, G0600329, G90/106, G0000934, G19/9, G0501942, G0701003] Funding Source: Medline; Multiple Sclerosis Society [730] Funding Source: Medline; NCRR NIH HHS [UL1 RR024148, M01 RR000425] Funding Source: Medline; NIAMS NIH HHS [R01 AR046208, R01 AR048465] Funding Source: Medline; Wellcome Trust [076113, 057097, 081682, 089989, 090532] Funding Source: Medline; Chief Scientist Office [CZB/4/540] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Research UK(Versus Arthritis); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Multiple Sclerosis Society(National Multiple Sclerosis Society); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Wellcome Trust(Wellcome Trust); Chief Scientist Office		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; Brown MA, 1996, ANN RHEUM DIS, V55, P268, DOI 10.1136/ard.55.4.268; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Capon F, 2001, J INVEST DERMATOL, V116, P728, DOI 10.1046/j.1523-1747.2001.01311.x; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chang SC, 2005, P NATL ACAD SCI USA, V102, P17107, DOI 10.1073/pnas.0500721102; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Cui XL, 2003, J BIOL CHEM, V278, P28677, DOI 10.1074/jbc.M300456200; Cui XL, 2002, J CLIN INVEST, V110, P515, DOI 10.1172/JCI200213847; Cui XL, 2003, J IMMUNOL, V171, P6814, DOI 10.4049/jimmunol.171.12.6814; Dai KZ, 2001, GENES IMMUN, V2, P263, DOI 10.1038/sj.gene.6363774; Dechairo BM, 2005, EUR J HUM GENET, V13, P1223, DOI 10.1038/sj.ejhg.5201485; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; DUERR RH, 2006, SCIENCE; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hiratani H, 2005, J CLIN ENDOCR METAB, V90, P2898, DOI 10.1210/jc.2004-2148; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Jiang HR, 2006, J IMMUNOL, V177, P2258, DOI 10.4049/jimmunol.177.4.2258; Jorgenson E, 2006, AM J HUM GENET, V78, P884, DOI 10.1086/503751; Kochi Y, 2005, NAT GENET, V37, P478, DOI 10.1038/ng1540; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Mannon PJ, 2004, NEW ENGL J MED, V351, P2069, DOI 10.1056/NEJMoa033402; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; McGinnis R, 2002, BEHAV GENET, V32, P135, DOI 10.1023/A:1015205924326; MIETTINE.OS, 1974, AM J EPIDEMIOL, V99, P325, DOI 10.1093/oxfordjournals.aje.a121617; Miretti MM, 2005, AM J HUM GENET, V76, P634, DOI 10.1086/429393; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Purcell S, 2007, BIOINFORMATICS, V23, P255, DOI 10.1093/bioinformatics/btl580; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Saveanu L, 2005, NAT IMMUNOL, V6, P689, DOI 10.1038/ni1208; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Simmonds MJ, 2006, J CLIN ENDOCR METAB, V91, P1056, DOI 10.1210/jc.2005-1634; Sims AM, 2007, GENES IMMUN, V8, P115, DOI 10.1038/sj.gene.6364362; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Thomas DC, 2004, JNCI-J NATL CANCER I, V96, P421, DOI 10.1093/jnci/djh094; Tremelling M, 2007, GASTROENTEROLOGY, V132, P1657, DOI 10.1053/j.gastro.2007.02.051; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	49	1081	1110	1	87	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	NOV	2007	39	11					1329	1337		10.1038/ng.2007.17	http://dx.doi.org/10.1038/ng.2007.17			9	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	226GM	17952073	Green Accepted			2022-12-27	WOS:000250575900017
J	McCarroll, SA; Altshuler, DM				McCarroll, Steven A.; Altshuler, David M.			Copy-number variation and association studies of human disease	NATURE GENETICS			English	Article							HUMAN GENOME; LINKAGE DISEQUILIBRIUM; SEGMENTAL DUPLICATIONS; STRUCTURAL VARIANTS; GENETIC ASSOCIATION; LARGE-SCALE; POLYMORPHISM; SUSCEPTIBILITY; NUCLEOTIDE; MAP	The central goal of human genetics is to understand the inherited basis of human variation in phenotypes, elucidating human physiology, evolution and disease. Rare mutations have been found underlying two thousand mendelian diseases; more recently, it has become possible to assess systematically the contribution of common SNPs to complex disease. The known role of copy-number alterations in sporadic genomic disorders, combined with emerging information about inherited copy-number variation, indicate the importance of systematically assessing copy-number variants (CNVs), including common copy-number polymorphisms (CNPs), in disease. Here we discuss evidence that CNVs affect phenotypes, directions for basic knowledge to support clinical study of CNVs, the challenge of genotyping CNPs in clinical cohorts, the use of SNPs as markers for CNPs and statistical challenges in testing CNVs for association with disease. Critical needs are high-resolution maps of common CNPs and techniques that accurately determine the allelic state of affected individuals.	[McCarroll, Steven A.; Altshuler, David M.] Harvard Univ, MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02138 USA; [McCarroll, Steven A.; Altshuler, David M.] Harvard Univ, Cambridge, MA 02138 USA; [McCarroll, Steven A.; Altshuler, David M.] Harvard Univ, Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Altshuler, David M.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Altshuler, David M.] Harvard Univ, Dept Genet & Med, Boston, MA 02115 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	McCarroll, SA (corresponding author), Harvard Univ, MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02138 USA.	smccarro@broad.mit.edu	McCarroll, Steven A/A-8433-2009; Altshuler, David M/A-4476-2009; Pillay, Nischalan/F-9536-2012	Altshuler, David M/0000-0002-7250-4107; McCarroll, Steven/0000-0002-6954-8184				Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607; Clayton DG, 2005, NAT GENET, V37, P1243, DOI 10.1038/ng1653; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Conrad DF, 2006, NAT GENET, V38, P75, DOI 10.1038/ng1697; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; Fanciulli M, 2007, NAT GENET, V39, P721, DOI 10.1038/ng2046; Fiegler H, 2006, GENOME RES, V16, P1566, DOI 10.1101/gr.5630906; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Inoue K, 2002, ANNU REV GENOM HUM G, V3, P199, DOI 10.1146/annurev.genom.3.032802.120023; Khaja R, 2006, NAT GENET, V38, P1413, DOI 10.1038/ng1921; Le Marechal C, 2006, NAT GENET, V38, P1372, DOI 10.1038/ng1904; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Lieberfarb ME, 2003, CANCER RES, V63, P4781; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Lohmueller KE, 2003, NAT GENET, V33, P177, DOI 10.1038/ng1071; Lupski JR, 2007, NAT GENET, V39, pS43, DOI 10.1038/ng2084; McCarroll SA, 2006, NAT GENET, V38, P86, DOI 10.1038/ng1696; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Padiath QS, 2006, NAT GENET, V38, P1114, DOI 10.1038/ng1872; Pe'er I, 2006, NAT GENET, V38, P663, DOI 10.1038/ng1816; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reich DE, 2003, NAT GENET, V33, P457, DOI 10.1038/ng1133; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916; Zhao XJ, 2004, CANCER RES, V64, P3060, DOI 10.1158/0008-5472.CAN-03-3308; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	42	427	477	4	50	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUL	2007	39			7			S37	S42		10.1038/ng2080	http://dx.doi.org/10.1038/ng2080			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	274AO	17597780				2022-12-27	WOS:000253974400007
J	Holst, F; Stahl, PR; Ruiz, C; Hellwinkel, O; Jehan, Z; Wendland, M; Lebeau, A; Terracciano, L; Al-Kuraya, K; Janicke, F; Sauter, G; Simon, R				Holst, Frederik; Stahl, Phillip R.; Ruiz, Christian; Hellwinkel, Olaf; Jehan, Zeenath; Wendland, Marc; Lebeau, Annette; Terracciano, Luigi; Al-Kuraya, Khawla; Jaenicke, Fritz; Sauter, Guido; Simon, Ronald			Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer	NATURE GENETICS			English	Article							URINARY-BLADDER CANCER; IN-SITU HYBRIDIZATION; CLINICAL-TRIALS; TISSUE; OVEREXPRESSION; PROLIFERATION; HETEROGENEITY; EXPRESSION; TAMOXIFEN; THERAPY	Using an Affymetrix 10K SNP array to screen for gene copy number changes in breast cancer, we detected a single-gene amplification of the ESR1 gene, which encodes estrogen receptor alpha, at 6q25. A subsequent tissue microarray analysis of more than 2,000 clinical breast cancer samples showed ESR1 amplification in 20.6% of breast cancers. Ninety-nine percent of tumors with ESR1 amplification showed estrogen receptor protein overexpression, compared with 66.6% cancers without ESR1 amplification ( P < 0.0001). In 175 women who had received adjuvant tamoxifen monotherapy, survival was significantly longer for women with cancer with ESR1 amplification than for women with estrogen receptor - expressing cancers without ESR1 amplification ( P = 0.023). Notably, we also found ESR1 amplification in benign and precancerous breast diseases, suggesting that ESR1 amplification may be a common mechanism in proliferative breast disease and a very early genetic alteration in a large subset of breast cancers.	Univ Med Ctr Hamburg Eppendorf, Dept Pathol, D-20246 Hamburg, Germany; Univ Basel Hosp, Dept Pathol, CH-4031 Basel, Switzerland; Univ Med Ctr Hamburg Eppendorf, Dept Urol, D-20246 Hamburg, Germany; Univ Med Ctr Hamburg Eppendorf, Dept Gynecol, D-20246 Hamburg, Germany; King Faisal Specialist Hosp & Res Ctr, Riyadh 21211, Saudi Arabia	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Basel; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; King Faisal Specialist Hospital & Research Center	Simon, R (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Pathol, D-20246 Hamburg, Germany.	r.simon@uke.uni-hamburg.de	Terracciano, Luigi M./AAB-5335-2022; Holst, Frederik/H-3149-2019	Terracciano, Luigi M./0000-0002-9393-9660; Holst, Frederik/0000-0002-5928-2175; Simon, Ronald/0000-0003-0158-4258				Al-Kuraya K, 2004, CANCER RES, V64, P8534, DOI 10.1158/0008-5472.CAN-04-1945; ANDERSEN J, 1989, CANCER, V64, P1901, DOI 10.1002/1097-0142(19891101)64:9<1901::AID-CNCR2820640924>3.0.CO;2-W; Courjal F, 1996, INT J CANCER, V69, P247; Dybdal N, 2005, BREAST CANCER RES TR, V93, P3, DOI 10.1007/s10549-004-6275-8; FERLAY J, 2000, GLOBOCAN 2000 CANC I; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; IP M, 1979, SCIENCE, V203, P361, DOI 10.1126/science.760195; KATZENELLENBOGEN BS, 1987, CANCER RES, V47, P4355; Khan SA, 1998, J NATL CANCER I, V90, P37, DOI 10.1093/jnci/90.1.37; Koivisto P, 1997, CANCER RES, V57, P314; Nessling M, 2005, CANCER RES, V65, P439; Pauletti G, 1996, ONCOGENE, V13, P63; Pegram MD, 1998, J CLIN ONCOL, V16, P2659, DOI 10.1200/JCO.1998.16.8.2659; Press MF, 2005, CLIN CANCER RES, V11, P6598, DOI 10.1158/1078-0432.CCR-05-0636; Rose C, 1980, Recent Results Cancer Res, V71, P134; Ruiz C, 2006, INT J CANCER, V118, P2190, DOI 10.1002/ijc.21581; SAUTER G, 1993, CANCER RES, V53, P2199; SAUTER G, 1995, CYTOMETRY, V21, P40, DOI 10.1002/cyto.990210109; Shoker BS, 1999, J PATHOL, V188, P237; Simon R, 2002, ONCOGENE, V21, P2476, DOI 10.1038/sj.onc.1205304; Simon R, 2001, J NATL CANCER I, V93, P1141, DOI 10.1093/jnci/93.15.1141; STIERER M, 1993, ANN SURG, V218, P13, DOI 10.1097/00000658-199307000-00004; SUNDERLAND MC, 1991, J CLIN ONCOL, V9, P1283, DOI 10.1200/JCO.1991.9.7.1283; Wagner U, 1997, AM J PATHOL, V151, P753; Wolmark N, 2001, ANN NY ACAD SCI, V949, P99	25	274	284	2	35	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	MAY	2007	39	5					655	660		10.1038/ng2006	http://dx.doi.org/10.1038/ng2006			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17417639				2022-12-27	WOS:000245971300022
J	Hu, ZZ; Killion, PJ; Iyer, VR				Hu, Zhanzhi; Killion, Patrick J.; Iyer, Vishwanath R.			Genetic reconstruction of a functional transcriptional regulatory network	NATURE GENETICS			English	Article							SACCHAROMYCES-CEREVISIAE; BINDING-SITES; EXPRESSION; GENOME; PHENOTYPES; CHROMATIN; PATHWAYS; DATABASE; TARGET	Although global analyses of transcription factor binding provide one view of potential transcriptional regulatory networks(1,2), regulation also occurs at levels distinct from transcription factor binding(3,4). Here, we use a genetic approach to identify targets of transcription factors in yeast and reconstruct a functional regulatory network. First, we profiled transcriptional responses in S. cerevisiae strains with individual deletions of 263 transcription factors. Then we used directed-weighted graph modeling and regulatory epistasis analysis to identify indirect regulatory relationships between these transcription factors, and from this we reconstructed a functional transcriptional regulatory network. The enrichment of promoter motifs and Gene Ontology annotations provide insight into the biological functions of the transcription factors.	Univ Texas, Ctr Syst & Synth Biol, Inst Mol & Cellular Biol, Sect Mol Genet & Microbiol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Iyer, VR (corresponding author), Univ Texas, Ctr Syst & Synth Biol, Inst Mol & Cellular Biol, Sect Mol Genet & Microbiol, 1 Univ Stn A4800, Austin, TX 78712 USA.	vishy@mail.utexas.edu		Hu, Zhanzhi/0000-0003-2171-0071				Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Chiang DY, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r43; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Dilova I, 2004, J BIOL CHEM, V279, P46527, DOI 10.1074/jbc.M409012200; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Hahn JS, 2004, MOL CELL BIOL, V24, P5249, DOI 10.1128/MCB.24.12.5249-5256.2004; Hall DA, 2004, SCIENCE, V306, P482, DOI 10.1126/science.1096773; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Hartemink A J, 2001, Pac Symp Biocomput, P422; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Killion PJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-32; Komeili A, 2000, J CELL BIOL, V151, P863, DOI 10.1083/jcb.151.4.863; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Liu XS, 2002, NAT BIOTECHNOL, V20, P835, DOI 10.1038/nbt717; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Radonjic M, 2005, MOL CELL, V18, P171, DOI 10.1016/j.molcel.2005.03.010; Rosenfeld N, 2003, J MOL BIOL, V329, P645, DOI 10.1016/S0022-2836(03)00506-0; Roth FP, 1998, NAT BIOTECHNOL, V16, P939, DOI 10.1038/nbt1098-939; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Sekinger EA, 2001, CELL, V105, P403, DOI 10.1016/S0092-8674(01)00329-4; Simon I, 2001, CELL, V106, P697, DOI 10.1016/S0092-8674(01)00494-9; Sopko R, 2006, MOL CELL, V21, P319, DOI 10.1016/j.molcel.2005.12.011; Van Driessche N, 2005, NAT GENET, V37, P471, DOI 10.1038/ng1545; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yeang CH, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r62; Zhu J, 1999, BIOINFORMATICS, V15, P607, DOI 10.1093/bioinformatics/15.7.607	29	290	297	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	MAY	2007	39	5					683	687		10.1038/ng2012	http://dx.doi.org/10.1038/ng2012			5	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	160VU	17417638				2022-12-27	WOS:000245971300027
J	Kubo, M; Hata, J; Ninomiya, T; Matsuda, K; Yonemoto, K; Nakano, T; Matsushita, T; Yamazaki, K; Ohnishi, Y; Saito, S; Kitazono, T; Ibayashi, S; Sueishi, K; Iida, M; Nakamura, Y; Kiyohara, Y				Kubo, Michiaki; Hata, Jun; Ninomiya, Toshiharu; Matsuda, Koichi; Yonemoto, Koji; Nakano, Toshiaki; Matsushita, Tomonaga; Yamazaki, Keiko; Ohnishi, Yozo; Saito, Susumu; Kitazono, Takanari; Ibayashi, Setsuro; Sueishi, Katsuo; Iida, Mitsuo; Nakamura, Yusuke; Kiyohara, Yutaka			A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction	NATURE GENETICS			English	Article							PKC-ETA; JAPANESE COMMUNITY; NPKC-ETA; EXPRESSION; ISOFORM; GENE; CELL; CLASSIFICATION; SUSCEPTIBILITY; ASSOCIATION	Cerebral infarction is the most common type of stroke an often causes long-term disability. To investigate the genetic contribution to cerebral infarction, we conducted a case-control study using 52,608 gene-based tag SNPs selected from the JSNP database. Here we report that a nonsynonymous SNP in a member of protein kinase C ( PKC) family, PRKCH, was significantly associated with lacunar infarction in two independent Japanese samples ( P =5.1 X 10(-7), crude odds ratio of 1.40). This SNP is likely to affect PKC activity. Furthermore, a 14- year follow- up cohort study in Hisayama ( Fukuoka, Japan) supported involvement of this SNP in the development of cerebral infarction ( P =0.03, age- and sex-adjusted hazard ratio of 2.83). We also found that PKC eta was expressed mainly in vascular endothelial cells and foamy macrophages in human atherosclerotic lesions, and its expression increased as the lesion type progressed. Our results support a role for PRKCH in the pathogenesis of cerebral infarction.	Kyushu Univ, Dept Environm Med, Fukuoka 8128582, Japan; Kyushu Univ, Dept Med & Clin Sci, Fukuoka 8128582, Japan; Univ Tokyo, Inst Med Sci, Mol Med Lab, Ctr Human Genet, Tokyo 1088639, Japan; Kyushu Univ, Grad Sch Med Sci, Fukuoka 8128582, Japan; RIKEN, Lab Genotyping, SNP Res Ctr, Inst Phys & Chem Res, Yokohama, Kanagawa 2300045, Japan	Kyushu University; Kyushu University; University of Tokyo; Kyushu University; RIKEN	Kubo, M (corresponding author), Kyushu Univ, Dept Environm Med, Fukuoka 8128582, Japan.	mkubo@ims.u-tokyo.ac.jp	Kubo, Michiaki/N-7947-2015; Matsuda, Koichi/D-4597-2011	Matsuda, Koichi/0000-0001-7292-2686				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Aeder SE, 2004, ONCOGENE, V23, P9062, DOI 10.1038/sj.onc.1208093; [Anonymous], 1986, Arch Neurol, V43, P71; Chen CC, 1998, J BIOL CHEM, V273, P19424, DOI 10.1074/jbc.273.31.19424; Fima E, 2001, ONCOGENE, V20, P6794, DOI 10.1038/sj.onc.1204885; Flossmann E, 2004, STROKE, V35, P212, DOI 10.1161/01.STR.0000107187.84390.AA; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; Hirschhorn JN, 2005, NAT REV GENET, V6, P95, DOI 10.1038/nrg1521; IKUTA T, 1994, CELL GROWTH DIFFER, V5, P943; Kiyohara Y, 2003, STROKE, V34, P2343, DOI 10.1161/01.STR.0000091845.14833.43; Kochi Y, 2005, NAT GENET, V37, P478, DOI 10.1038/ng1540; Kubo M, 2003, STROKE, V34, P2349, DOI 10.1161/01.STR.0000090348.52943.A2; Kubo M, 2006, NEUROLOGY, V66, P1539, DOI 10.1212/01.wnl.0000216132.95207.b4; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Masso-Welch PA, 2001, BREAST CANCER RES TR, V68, P211, DOI 10.1023/A:1012265703669; Matsumura M, 2003, BIOCHEM BIOPH RES CO, V303, P350, DOI 10.1016/S0006-291X(03)00345-0; Nakano T, 2005, HUM PATHOL, V36, P330, DOI 10.1016/j.humpath.2005.01.001; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; OSADA S, 1993, CELL GROWTH DIFFER, V4, P167; OSADA S, 1990, J BIOL CHEM, V265, P22434; Ozaki K, 2002, NAT GENET, V32, P650, DOI 10.1038/ng1047; Pham TNQ, 2003, NITRIC OXIDE-BIOL CH, V9, P123, DOI 10.1016/j.niox.2003.09.006; Poole AAW, 2004, TRENDS PHARMACOL SCI, V25, P528, DOI 10.1016/j.tips.2004.08.006; Pritchard JK, 1999, AM J HUM GENET, V65, P220, DOI 10.1086/302449; Spitaler M, 2004, NAT IMMUNOL, V5, P785, DOI 10.1038/ni1097; STARY HC, 1995, CIRCULATION, V92, P1355, DOI 10.1161/01.CIR.92.5.1355; Suzuki A, 2003, NAT GENET, V34, P395, DOI 10.1038/ng1206; Tsunoda T, 2004, HUM MOL GENET, V13, P1623, DOI 10.1093/hmg/ddh177; WHISNANT JP, 1990, STROKE, V21, P707, DOI 10.1161/01.STR.21.5.707; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379	30	165	183	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	FEB	2007	39	2					212	217		10.1038/ng1945	http://dx.doi.org/10.1038/ng1945			6	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	134DU	17206144				2022-12-27	WOS:000244063900019
J	Fanciulli, M; Norsworthy, PJ; Petretto, E; Dong, R; Harper, L; Kamesh, L; Heward, JM; Gough, SCL; de Smith, A; Blakemore, AIF; Owen, CJ; Pearce, SHS; Teixeira, L; Guillevin, L; Graham, DSC; Pusey, CD; Cook, HT; Vyse, TJ; Aitman, TJ				Fanciulli, Manuela; Norsworthy, Penny J.; Petretto, Enrico; Dong, Rong; Harper, Lorraine; Kamesh, Lavanya; Heward, Joanne M.; Gough, Stephen C. L.; de Smith, Adam; Blakemore, Alexandra I. F.; Owen, Catherine J.; Pearce, Simon H. S.; Teixeira, Luis; Guillevin, Loic; Graham, Deborah S. Cunninghame; Pusey, Charles D.; Cook, H. Terence; Vyse, Timothy J.; Aitman, Timothy J.			FCGR3B copy number variation is associated with susceptibility to systemic, but not organ-specific, autoimmunity	NATURE GENETICS			English	Article							HUMAN GENOME; STRUCTURAL VARIATION; RECEPTORS; PATHOGENESIS; POLYMORPHISM; DISEASE; GENE	Naturally occurring variation in gene copy number is increasingly recognized as a heritable source of susceptibility to genetically complex diseases. Here we report strong association between FCGR3B copy number and risk of systemic lupus erythematosus (P = 2.7 x 10(-8)), microscopic polyangiitis (P = 2.9 x 10(-4)) and Wegener's granulomatosis in two independent cohorts from the UK ( P = 3 x 10(-3)) and France ( P = 1.1 x 10(-4)). We did not observe this association in the organ- specific Graves' disease or Addison's disease. Our findings suggest that low FCGR3B copy number, and in particular complete FCGR3B deficiency, has a key role in the development of systemic autoimmunity.	Univ London Imperial Coll Sci Technol & Med, Physiol Genom & Med Grp, UK Med Res Council, Clin Sci Ctr, London W12 0NN, England; Univ Birmingham, Sch Med, Div Med Sci, Birmingham B15 277, W Midlands, England; Univ Birmingham, Sch Med, Div Immun & Infect, Birmingham B15 277, W Midlands, England; Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Sect Genom Med, Div Med, London W12 0NN, England; Inst Pasteur, Inst Biol, CNRS, UMR 8090, F-59800 Lille, France; Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 EBZ, Tyne & Wear, England; Paris Descartes Univ, AP HP, Cochin Hosp, Dept Internal Med,Reference Ctr Vascul & System S, F-75679 Paris 14, France; Univ London Imperial Coll Sci Technol & Med, Sect Mol Genet & Rheumatol, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Sect Renal Med, London W12 0NN, England; Univ London Imperial Coll Sci Technol & Med, Dept Histopathol, London W12 0NN, England	Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Birmingham; University of Birmingham; Imperial College London; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Imperial College London; Imperial College London; Imperial College London	Aitman, TJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Physiol Genom & Med Grp, UK Med Res Council, Clin Sci Ctr, London W12 0NN, England.	t.aitman@csc.mrc.ac.uk	Teixeira, Luis/C-3694-2013; Pearce, Simon/AAB-3692-2019; Blakemore, Alexandra I F/D-2253-2009; FROGUEL, Philippe/O-6799-2017	Pearce, Simon/0000-0001-8384-8063; Blakemore, Alexandra I F/0000-0003-0661-564X; FROGUEL, Philippe/0000-0003-2972-0784; Aitman, Timothy/0000-0002-7875-4502; de Smith, Adam/0000-0003-4880-7543; Teixeira, Luis/0000-0003-1049-9661; Norsworthy, Penny/0000-0002-5572-8491	MRC [G0000934, G84/5959, MC_U120061454, G0400116] Funding Source: UKRI; Medical Research Council [G84/5959, G0000934, MC_U120097112, MC_U120061454, G0400116] Funding Source: Medline; Medical Research Council [MC_U120097112, MC_U120061454] Funding Source: Medline; Wellcome Trust [068545/Z/02, 066780] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Aitman TJ, 2006, NATURE, V439, P851, DOI 10.1038/nature04489; CLARK MR, 1990, J CLIN INVEST, V86, P341, DOI 10.1172/JCI114706; Coxon A, 2001, IMMUNITY, V14, P693, DOI 10.1016/S1074-7613(01)00150-9; DEHAAS M, 1995, BLOOD, V86, P2403, DOI 10.1182/blood.V86.6.2403.bloodjournal8662403; Gonzalez E, 2005, SCIENCE, V307, P1434, DOI 10.1126/science.1101160; Harper L, 2000, J PATHOL, V190, P349, DOI 10.1002/(SICI)1096-9896(200002)190:3<349::AID-PATH524>3.0.CO;2-A; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Lupski JR, 2006, NAT GENET, V38, P974, DOI 10.1038/ng0906-974; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Salmon JE, 2001, ARTHRITIS RHEUM, V44, P739; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Stankiewicz P, 2002, TRENDS GENET, V18, P74, DOI 10.1016/S0168-9525(02)02592-1; Takai T, 2005, J CLIN IMMUNOL, V25, P1, DOI 10.1007/s10875-005-0353-8; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562	15	398	418	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1061-4036			NAT GENET	Nature Genet.	JUN	2007	39	6					721	723		10.1038/ng2046	http://dx.doi.org/10.1038/ng2046			3	Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Genetics & Heredity	173FO	17968342	Green Accepted			2022-12-27	WOS:000246859100013
